data_2kwb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kwb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.51 0.195 . . . . 61.520000000000003 110.852 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 179' ' ' GLU . 26.5 tp -84.59 125.53 32.53 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 122.134 -0.354 . . . . 73.439999999999998 110.559 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.761 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 56.2 mt -100.32 119.47 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.717 0.294 . . . . 73.099999999999994 110.884 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.829 ' HB2' HD13 ' A' ' 176' ' ' ILE . 35.7 p90 -106.59 135.49 48.02 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.3 0.571 . . . . 74.239999999999995 112.048 -178.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.525 ' HB2' HD13 ' A' ' 13' ' ' LEU . 74.6 tttt -134.53 114.34 12.72 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.017 -0.992 . . . . 72.310000000000002 110.842 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 175' ' ' ALA . 6.3 m-20 -79.69 161.42 25.82 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.157 0.504 . . . . 71.049999999999997 111.263 173.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.4 pt -64.82 -21.07 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.013 -0.54 . . . . 73.450000000000003 111.258 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.45 ' HE2' ' HA ' ' A' ' 152' ' ' GLN . 36.9 p90 -109.13 -27.7 9.45 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.388 0.514 . . . . 73.230000000000004 112.388 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.519 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 4.8 m -88.88 15.37 8.55 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.236 0.541 . . . . 73.049999999999997 111.268 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -57.79 -12.66 3.23 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.516 0.562 . . . . 75.310000000000002 112.516 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.43 -61.74 1.7 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.977 0.418 . . . . 73.140000000000001 112.064 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -112.97 25.59 11.26 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.124 0.786 . . . . 70.209999999999994 113.124 -170.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.525 HD13 ' HB2' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -42.41 139.39 1.5 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.809 0.338 . . . . 73.340000000000003 111.532 176.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.3 m -135.62 178.19 7.23 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.66 0.615 . . . . 62.009999999999998 112.66 -168.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.523 ' HB3' HG12 ' A' ' 3' ' ' ILE . 86.6 p -124.28 125.14 43.86 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.299 0.481 . . . . 63.030000000000001 112.299 -174.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -137.62 -172.75 3.31 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.2 0.524 . . . . 73.099999999999994 111.425 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.2 m -138.45 89.73 2.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.201 -0.454 . . . . 75.230000000000004 111.082 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -142.67 132.71 12.24 Favored Pre-proline 0 N--CA 1.473 0.717 0 CA-C-N 116.556 -0.293 . . . . 73.430000000000007 111.515 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.11 145.94 14.07 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.704 2.27 . . . . 73.0 112.837 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.5 164.02 27.51 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.108 0.48 . . . . 74.329999999999998 112.243 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.621 ' HZ2' ' HB3' ' A' ' 21' ' ' LYS . 8.3 mtpm? -121.82 104.26 9.44 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.115 -0.493 . . . . 74.319999999999993 110.881 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.5 tp -74.54 104.1 5.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.216 0.531 . . . . 74.430000000000007 111.643 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.23 134.42 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 121.341 0.591 . . . . 73.530000000000001 111.905 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.2 t70 59.22 14.24 3.48 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.085 -0.961 . . . . 71.409999999999997 112.383 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.0 t70 63.55 18.62 11.2 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.595 0.712 . . . . 73.140000000000001 110.79 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.0 tp -113.57 -50.14 2.86 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.983 -0.553 . . . . 65.150000000000006 112.441 -175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.627 HG11 ' HA ' ' A' ' 172' ' ' VAL . 15.5 m -133.54 150.14 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 113.04 0.756 . . . . 64.120000000000005 113.04 -175.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 170' ' ' MET . 19.3 m-85 -85.7 125.29 33.08 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.644 -0.707 . . . . 74.409999999999997 110.808 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -99.25 127.21 45.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.023 -0.535 . . . . 75.239999999999995 110.628 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.729 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 67.3 t80 -119.65 139.65 51.87 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.03 0.443 . . . . 72.219999999999999 111.34 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -90.0 126.84 35.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.081 -0.508 . . . . 72.219999999999999 111.33 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.72 173.54 14.95 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.989 -0.624 . . . . 74.140000000000001 114.44 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -133.33 153.9 51.18 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.894 0.478 . . . . 75.409999999999997 109.944 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -91.34 107.03 18.92 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.065 -0.397 . . . . 74.239999999999995 110.189 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.22 165.8 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.257 0.551 . . . . 73.549999999999997 112.272 -173.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.1 m -115.9 146.56 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.396 0.517 . . . . 72.010000000000005 112.396 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.548 ' HG2' HD13 ' A' ' 72' ' ' LEU . 5.0 mmp_? . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.25 0.548 . . . . 74.150000000000006 111.172 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 10.4 pt-20 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 114.667 1.358 . . . . 74.530000000000001 114.667 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -126.23 109.95 12.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.052 0.387 . . . . 72.219999999999999 111.293 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.47 -165.73 28.29 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.585 -0.817 . . . . 55.140000000000001 113.506 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.3 pt -111.61 145.56 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 122.425 -0.456 . . . . 74.430000000000007 111.895 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -46.2 -39.8 10.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.211 0.604 . . . . 73.219999999999999 112.044 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.9 mt -53.83 -49.97 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.887 -0.597 . . . . 75.409999999999997 112.503 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.575 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 23.2 m -87.72 -39.3 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.519 0.563 . . . . 74.329999999999998 112.519 -171.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.548 HD13 ' HG2' ' A' ' 37' ' ' ARG . 61.8 mt -64.42 -38.08 89.76 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.189 0.518 . . . . 72.230000000000004 111.679 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -84.48 -15.1 47.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.196 -0.457 . . . . 73.019999999999996 112.088 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -109.08 4.21 22.83 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 122.185 -0.322 . . . . 75.120000000000005 111.349 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 58.06 71.12 0.6 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.367 0.603 . . . . 74.230000000000004 112.161 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.575 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 60.4 mt -127.23 124.16 38.26 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.516 -0.765 . . . . 73.230000000000004 110.533 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.94 148.53 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.833 0.349 . . . . 71.140000000000001 111.34 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -76.59 130.82 38.4 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.583 0.706 . . . . 74.420000000000002 112.604 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' A' ' 84' ' ' ASP . 12.5 tpt -117.22 122.77 44.92 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.061 -0.972 . . . . 63.119999999999997 108.994 171.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -82.84 139.55 33.42 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.212 0.53 . . . . 65.530000000000001 112.193 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 62.3 m -52.45 -40.05 61.81 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.204 0.816 . . . . 75.400000000000006 113.204 -174.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -57.27 -32.78 66.96 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.882 0.327 . . . . 73.120000000000005 111.882 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.48 -36.41 10.34 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.973 0.416 . . . . 72.340000000000003 110.949 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.524 ' HB2' ' HG3' ' A' ' 79' ' ' MET . 14.2 t70 -66.92 -11.42 56.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.251 -0.431 . . . . 71.299999999999997 111.594 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.573 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -36.68 -54.86 0.89 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.697 0.629 . . . . 62.200000000000003 112.697 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.7 t -67.81 -36.19 79.96 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.061 0.393 . . . . 61.229999999999997 112.061 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.2 ttm -67.84 -60.63 2.37 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 111.918 0.34 . . . . 75.400000000000006 111.918 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.573 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 16.0 p90 -62.21 -35.17 78.07 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 120.368 -0.533 . . . . 73.329999999999998 111.245 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 42.0 tptt -61.48 -39.36 90.65 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.185 0.517 . . . . 74.230000000000004 110.615 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.71 74.73 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.053 -0.521 . . . . 74.200000000000003 111.481 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -61.66 -44.76 96.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.529 -0.305 . . . . 73.519999999999996 111.519 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 88' ' ' PHE . 42.2 mm -62.04 -35.9 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 120.787 0.327 . . . . 73.219999999999999 111.301 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.07 -57.3 13.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.149 0.5 . . . . 72.299999999999997 110.831 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -59.58 -45.57 91.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.849 -0.614 . . . . 74.430000000000007 111.095 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.632 ' HE2' HG12 ' A' ' 120' ' ' ILE . 47.8 t80 -55.73 -61.54 2.29 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.399 -0.819 . . . . 73.540000000000006 111.997 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 58.6 ttp -54.59 -43.8 72.46 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.013 0.435 . . . . 72.340000000000003 111.278 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -61.59 -47.83 83.69 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.041 -0.527 . . . . 75.0 111.301 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -70.68 -44.1 67.69 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.448 0.536 . . . . 73.329999999999998 112.448 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.685 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . 35.9 m -65.04 -47.2 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.093 0.405 . . . . 70.140000000000001 112.093 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.436 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 47.3 mm -63.42 -45.61 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.898 0.38 . . . . 74.010000000000005 110.358 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -53.6 -55.4 26.08 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.964 -0.562 . . . . 71.340000000000003 112.069 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.685 ' HD2' ' HA ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -66.54 -27.51 67.81 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 122.219 -0.301 . . . . 72.420000000000002 111.244 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.475 ' HG3' HG13 ' A' ' 113' ' ' VAL . 12.1 tpt -73.84 -50.78 18.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.821 0.343 . . . . 74.230000000000004 111.337 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 9.7 pt-20 -66.35 -25.74 66.95 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.19 -0.319 . . . . 73.209999999999994 111.143 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -56.18 -39.21 72.02 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.159 0.429 . . . . 75.340000000000003 112.159 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -103.74 -37.91 7.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.037 0.754 . . . . 65.329999999999998 113.037 -175.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 108' ' ' ARG . 60.1 t30 -97.34 -35.15 10.8 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.511 0.559 . . . . 74.219999999999999 112.511 -173.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.438 ' HB3' ' O ' ' A' ' 107' ' ' ASN . 26.3 ttp180 71.59 -35.7 0.34 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.07 1.137 . . . . 75.340000000000003 114.07 174.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 113' ' ' VAL . 72.2 m-20 -65.71 114.38 4.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.807 0.669 . . . . 72.409999999999997 112.807 -168.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.74 -24.45 65.72 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.548 -0.751 . . . . 72.409999999999997 112.675 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.16 -32.21 58.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.894 0.378 . . . . 64.25 111.853 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.65 -51.31 7.85 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.548 -0.296 . . . . 73.239999999999995 111.706 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 109' ' ' ASP . 6.4 m -60.63 -31.12 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 111.947 0.351 . . . . 74.519999999999996 111.947 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.97 -38.93 83.34 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.91 0.386 . . . . 75.129999999999995 110.634 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.6 78.43 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.233 -0.44 . . . . 75.400000000000006 111.062 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.465 ' CZ ' ' HG3' ' A' ' 174' ' ' GLU . 22.2 t80 -56.85 -49.25 76.03 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.352 -0.385 . . . . 74.120000000000005 111.096 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -57.59 -32.81 67.55 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.626 -0.261 . . . . 72.209999999999994 111.067 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -66.63 -39.99 88.55 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.541 0.21 . . . . 74.239999999999995 111.286 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -53.65 -58.48 7.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.31 0.576 . . . . 73.430000000000007 111.038 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.632 HG12 ' HE2' ' A' ' 95' ' ' PHE . 10.9 tp -67.84 -32.49 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.743 -0.662 . . . . 74.230000000000004 111.568 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.412 ' NE2' HG22 ' A' ' 125' ' ' VAL . 23.3 tm0? -58.64 -52.41 65.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.729 0.299 . . . . 71.140000000000001 110.709 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.92 -42.9 96.98 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.932 -0.651 . . . . 70.439999999999998 112.528 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -58.83 -55.15 38.84 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 111.62 0.23 . . . . 73.099999999999994 111.62 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.7 m -65.25 -48.35 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.373 0.509 . . . . 72.549999999999997 112.373 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.412 HG22 ' NE2' ' A' ' 121' ' ' GLN . 92.1 t -57.98 -41.14 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.98 -0.45 . . . . 74.150000000000006 111.487 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.5 t -70.44 -47.96 58.24 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.012 0.434 . . . . 64.310000000000002 111.139 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.33 -33.81 74.23 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.311 -0.404 . . . . 74.310000000000002 111.805 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 80.8 mt -85.13 2.24 44.37 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.212 0.449 . . . . 75.219999999999999 112.212 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.62 89.06 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.304 0.574 . . . . 61.240000000000002 110.392 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 134' ' ' LYS . 36.3 ttpt -51.66 -59.66 4.03 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 114.373 1.249 . . . . 75.040000000000006 114.373 -165.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.81 -34.17 72.7 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.217 0.821 . . . . 75.200000000000003 113.217 -168.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -84.0 -53.61 5.44 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.089 0.471 . . . . 75.109999999999999 111.375 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -74.46 -3.96 33.79 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.208 0.528 . . . . 72.310000000000002 111.763 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 130' ' ' LYS . 33.0 ttpt -35.79 -32.32 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.694 1.198 . . . . 74.120000000000005 113.724 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -96.85 35.11 1.59 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.503 0.557 . . . . 73.219999999999999 112.503 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 38.2 mt -89.31 162.33 15.89 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.775 0.321 . . . . 72.430000000000007 110.622 170.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -132.13 133.5 44.35 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.236 0.458 . . . . 74.120000000000005 112.236 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.41 ' HB3' HG12 ' A' ' 153' ' ' VAL . 80.3 m-85 -100.82 107.57 19.16 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.641 0.257 . . . . 74.140000000000001 110.413 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.568 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 38.6 m-85 -101.54 124.74 47.69 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.863 -0.523 . . . . 74.409999999999997 111.616 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 16.9 tt -110.09 151.98 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.965 -0.562 . . . . 71.310000000000002 111.293 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.515 ' HA2' HD21 ' A' ' 76' ' ' LEU . . . -61.62 140.7 47.38 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 114.405 0.522 . . . . 72.420000000000002 114.405 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -44.18 -52.48 7.31 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.146 0.579 . . . . 72.439999999999998 112.096 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -51.58 -49.63 61.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.058 -0.519 . . . . 74.519999999999996 111.446 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.632 ' HB2' ' HA3' ' A' ' 151' ' ' GLY . . . -64.59 -50.09 68.57 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.237 0.458 . . . . 71.010000000000005 112.237 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.73 -41.24 77.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.061 0.458 . . . . 62.109999999999999 111.758 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -82.2 -24.86 34.69 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.932 -0.576 . . . . 73.519999999999996 111.465 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -101.09 -3.64 54.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.166 -0.54 . . . . 54.049999999999997 114.061 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 59.68 24.34 13.2 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.428 0.529 . . . . 74.439999999999998 112.428 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -103.51 -173.36 2.29 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.835 0.68 . . . . 64.099999999999994 112.835 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -88.98 58.1 4.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.242 0.544 . . . . 73.5 112.112 -172.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.632 ' HA3' ' HB2' ' A' ' 144' ' ' ALA . . . -70.94 167.96 50.66 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.897 -0.668 . . . . 72.120000000000005 113.085 173.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.45 ' HA ' ' HE2' ' A' ' 8' ' ' PHE . 45.9 tt0 -70.67 128.12 34.99 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.278 0.473 . . . . 63.310000000000002 112.278 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.41 HG12 ' HB3' ' A' ' 138' ' ' PHE . 40.6 t -94.48 104.26 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.233 0.54 . . . . 73.5 110.266 170.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.742 ' HB3' HD13 ' A' ' 169' ' ' LEU . . . -80.45 136.41 36.33 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.864 -0.607 . . . . 64.150000000000006 111.56 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.54 ' HB ' ' HG3' ' A' ' 170' ' ' MET . 39.2 mm -89.23 109.4 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.846 0.355 . . . . 73.349999999999994 111.254 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.439 HG13 ' CD1' ' A' ' 139' ' ' PHE . 48.1 mm -93.91 108.12 20.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 120.968 0.413 . . . . 65.109999999999999 111.307 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -99.47 149.17 23.48 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.069 -0.968 . . . . 64.310000000000002 112.424 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -95.25 122.77 38.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.411 -0.813 . . . . 74.439999999999998 110.052 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.613 ' NH2' HG22 ' A' ' 168' ' ' THR . 4.8 ttp180 -156.39 131.08 8.93 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.613 -0.68 . . . . 74.219999999999999 112.084 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -103.54 143.91 32.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.198 -0.456 . . . . 64.129999999999995 111.521 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.13 100.89 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.454 -0.339 . . . . 72.230000000000004 110.444 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.4 t70 66.74 6.57 4.62 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 121.233 0.539 . . . . 64.219999999999999 111.514 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 128.78 -21.63 5.29 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.265 -0.493 . . . . 37.359999999999999 113.03 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 66.7 p -82.08 106.73 14.22 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.403 -0.469 . . . . 75.329999999999998 110.874 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -75.21 111.12 10.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.437 0.636 . . . . 73.319999999999993 112.391 -172.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.07 145.4 41.72 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.001 -0.545 . . . . 73.209999999999994 111.616 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -78.67 117.88 4.07 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.479 2.119 . . . . 73.510000000000005 112.213 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.613 HG22 ' NH2' ' A' ' 159' ' ' ARG . 83.5 m -107.4 122.02 45.77 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.904 0.383 . . . . 74.140000000000001 111.67 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.742 HD13 ' HB3' ' A' ' 154' ' ' ALA . 50.0 tp -88.87 139.94 29.95 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.566 -0.288 . . . . 75.019999999999996 110.981 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.54 ' HG3' ' HB ' ' A' ' 155' ' ' ILE . 21.1 ptp -133.87 141.26 47.32 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.714 0.768 . . . . 74.450000000000003 112.089 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -139.54 141.21 37.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.557 -1.201 . . . . 70.349999999999994 109.345 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.627 ' HA ' HG11 ' A' ' 27' ' ' VAL . 21.9 t -85.18 123.68 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.838 -0.538 . . . . 72.120000000000005 111.901 -173.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.423 ' HD3' ' OH ' ' A' ' 28' ' ' TYR . 45.2 tptt -53.17 -47.48 68.77 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.62 0.6 . . . . 64.319999999999993 112.62 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.465 ' HG3' ' CZ ' ' A' ' 116' ' ' PHE . 39.9 mm-40 -67.78 -1.92 6.24 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.433 0.531 . . . . 75.329999999999998 112.433 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -107.68 -44.55 4.23 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.521 -0.309 . . . . 70.530000000000001 110.718 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.829 HD13 ' HB2' ' A' ' 4' ' ' TYR . 9.5 tp -96.27 111.45 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 121.811 0.815 . . . . 64.349999999999994 112.193 -175.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.4 mm -105.06 144.07 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.169 -0.469 . . . . 75.430000000000007 110.749 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.93 146.83 38.3 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.63 0.729 . . . . 63.299999999999997 112.659 -175.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.761 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 8.8 tp10 -114.39 120.42 40.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.182 -0.917 . . . . 73.409999999999997 109.596 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.736 ' HB2' ' HZ1' ' A' ' 180' ' ' LYS . 4.9 ttmp? . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 112.419 0.526 . . . . 75.510000000000005 112.419 -171.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.675 0.274 . . . . 75.109999999999999 111.125 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.6 tp -89.52 131.47 35.53 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.985 0.422 . . . . 72.140000000000001 110.806 174.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 56.7 mt -118.94 120.58 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.385 . . . . 74.340000000000003 110.776 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -115.0 133.93 55.62 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.73 0.776 . . . . 72.200000000000003 111.244 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.401 ' HG2' ' CD1' ' A' ' 13' ' ' LEU . 34.9 mtpt -120.12 120.0 34.94 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.021 -0.991 . . . . 75.409999999999997 111.178 -172.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.93 177.5 3.64 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.764 0.654 . . . . 63.32 112.764 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -70.68 -57.03 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.012 -0.54 . . . . 75.25 111.502 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -102.15 -41.36 6.43 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.529 0.566 . . . . 74.010000000000005 112.529 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.523 HG21 ' HA2' ' A' ' 151' ' ' GLY . 12.1 p -80.48 16.28 1.39 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.542 0.571 . . . . 74.340000000000003 112.542 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -47.02 -34.7 5.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.16 0.584 . . . . 73.5 111.638 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.44 -39.61 80.32 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.529 0.566 . . . . 73.439999999999998 112.529 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -65.96 -33.49 75.94 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.546 0.213 . . . . 72.209999999999994 111.279 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.401 ' CD1' ' HG2' ' A' ' 5' ' ' LYS . 11.9 tp 57.2 112.2 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.441 0.904 . . . . 72.239999999999995 113.441 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.7 m -104.24 124.79 49.78 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.844 -0.535 . . . . 63.229999999999997 111.374 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 83.1 p -140.22 142.17 35.86 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.403 0.52 . . . . 72.310000000000002 112.403 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -171.61 -147.87 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.848 -0.614 . . . . 62.299999999999997 110.657 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 p -150.06 30.01 0.72 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.331 0.493 . . . . 70.329999999999998 112.331 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 97.9 m-85 -89.74 123.41 66.49 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.792 0.33 . . . . 73.120000000000005 111.503 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 12.0 Cg_exo -70.8 144.65 49.06 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.237 2.625 . . . . 71.209999999999994 113.959 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.434 ' C ' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -131.89 166.35 21.82 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.751 -0.658 . . . . 71.319999999999993 111.496 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -130.98 136.77 48.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.86 0.362 . . . . 75.430000000000007 111.166 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.0 tp -87.26 109.34 19.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.061 0.458 . . . . 75.239999999999995 112.065 -176.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -98.57 142.99 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.989 0.424 . . . . 71.420000000000002 111.041 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 t70 63.11 6.87 2.47 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.986 -0.552 . . . . 73.109999999999999 111.432 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.52 28.67 14.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.151 0.5 . . . . 72.519999999999996 111.979 -174.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.2 tp -134.17 -44.01 0.78 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.102 -0.499 . . . . 64.329999999999998 111.861 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 172' ' ' VAL . 12.7 m -125.24 148.95 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 112.524 0.565 . . . . 74.019999999999996 112.524 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -88.17 151.12 22.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.169 -0.469 . . . . 75.400000000000006 112.009 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -107.57 140.88 39.9 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.471 -0.786 . . . . 65.140000000000001 111.591 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.68 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 47.9 t80 -139.99 105.75 5.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.21 -0.663 . . . . 71.530000000000001 109.21 165.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HB3' HG22 ' A' ' 168' ' ' THR . 13.1 ptpt -109.93 121.78 46.04 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.797 0.665 . . . . 74.319999999999993 112.797 -171.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.9 -152.85 8.64 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.91 -0.586 . . . . 72.200000000000003 113.601 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -117.3 174.07 6.34 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.108 0.48 . . . . 75.019999999999996 112.097 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.446 ' CE1' ' HD3' ' A' ' 167' ' ' PRO . 68.7 m80 -97.2 110.58 23.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.071 -0.513 . . . . 75.0 110.073 172.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.4 HG22 HD11 ' A' ' 72' ' ' LEU . 18.4 m -135.63 140.77 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.318 0.58 . . . . 73.5 112.18 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 30.2 m -120.0 117.2 52.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.342 0.591 . . . . 64.129999999999995 111.338 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.672 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 66.4 ttt180 . . . . . 0 CA--C 1.539 0.531 0 CA-C-N 116.099 -0.501 . . . . 75.140000000000001 110.547 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.672 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 27.7 tt0 . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 122.28 1.038 . . . . 74.140000000000001 109.299 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 11.0 ptm180 -104.67 140.38 38.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.597 -1.183 . . . . 73.150000000000006 111.927 -173.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.94 -131.11 3.72 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.548 -0.834 . . . . 37.229999999999997 113.785 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.417 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 32.3 pt -111.09 139.77 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 122.461 -0.435 . . . . 75.420000000000002 111.608 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -48.29 -35.76 12.83 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.078 -0.51 . . . . 65.019999999999996 112.355 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.421 HG21 ' HB2' ' A' ' 169' ' ' LEU . 68.4 mt -52.56 -58.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.201 0.524 . . . . 73.129999999999995 112.221 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.5 m -75.25 -33.59 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.142 -0.481 . . . . 75.109999999999999 111.688 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 64.8 mt -64.98 -34.49 78.57 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.966 0.413 . . . . 75.340000000000003 111.037 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -57.55 -48.66 78.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.247 -0.433 . . . . 71.349999999999994 111.94 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -99.04 -3.45 34.75 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.325 0.491 . . . . 71.409999999999997 112.325 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 59.56 70.86 0.61 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.623 0.725 . . . . 75.120000000000005 111.525 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 60.4 mt -98.3 127.78 44.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.667 -0.697 . . . . 74.430000000000007 110.951 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.94 143.85 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.66 0.266 . . . . 75.540000000000006 110.849 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -84.8 150.91 24.72 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.569 0.7 . . . . 71.549999999999997 112.838 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.2 ttm -145.19 138.33 26.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.459 -0.791 . . . . 75.349999999999994 110.413 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.509 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 18.0 m-80 -109.77 167.55 10.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.08 -0.509 . . . . 74.340000000000003 111.102 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 79.6 m -55.43 -38.92 69.63 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.553 0.945 . . . . 73.400000000000006 113.553 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 80' ' ' ASN . 10.8 p90 -65.5 -23.23 66.84 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.654 -0.654 . . . . 73.310000000000002 111.406 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -94.13 -32.5 13.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.197 0.523 . . . . 74.319999999999993 110.732 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.1 -16.14 38.98 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.606 -0.725 . . . . 75.340000000000003 112.31 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.467 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . . . -43.21 -57.55 2.91 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.693 0.627 . . . . 74.140000000000001 112.693 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 t -69.92 -27.53 64.85 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 55.229999999999997 111.524 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.574 ' HA ' ' HE2' ' A' ' 87' ' ' MET . 23.4 mmt -70.92 -63.36 1.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.535 -0.302 . . . . 65.530000000000001 111.637 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.467 ' HE1' ' HA ' ' A' ' 85' ' ' ALA . 5.0 p90 -60.44 -34.3 73.78 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.351 -0.218 . . . . 75.450000000000003 111.312 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -58.12 -54.39 47.54 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.935 0.398 . . . . 74.319999999999993 111.222 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.96 -35.56 81.58 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.141 0.496 . . . . 61.140000000000001 111.059 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.637 ' HE2' ' HG3' ' A' ' 152' ' ' GLN . 56.5 t80 -56.71 -57.02 14.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.765 -0.652 . . . . 73.109999999999999 111.043 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.2 mm -57.83 -37.33 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.768 0.318 . . . . 75.420000000000002 111.631 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -60.13 -56.66 18.91 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.005 0.372 . . . . 73.439999999999998 112.005 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -72.32 -36.59 68.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.946 0.403 . . . . 75.329999999999998 111.835 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.417 ' O ' HG23 ' A' ' 99' ' ' VAL . 55.2 t80 -60.34 -55.34 34.76 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.075 -0.511 . . . . 74.329999999999998 111.229 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.1 ttt -54.87 -44.38 73.97 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.172 -0.467 . . . . 75.109999999999999 111.317 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -62.89 -46.62 86.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.372 -0.376 . . . . 72.099999999999994 111.612 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -63.44 -51.87 63.88 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.686 0.279 . . . . 75.310000000000002 111.625 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.487 ' O ' ' SD ' ' A' ' 103' ' ' MET . 32.1 m -64.07 -41.8 93.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.542 0.571 . . . . 71.439999999999998 112.542 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.7 mm -66.81 -46.45 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 121.755 -0.591 . . . . 75.329999999999998 110.983 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.99 -34.22 75.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.181 0.515 . . . . 73.120000000000005 110.993 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -68.93 -57.41 5.54 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.786 -0.643 . . . . 73.439999999999998 111.385 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 99' ' ' VAL . 0.2 OUTLIER -66.64 -44.72 81.2 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.007 0.743 . . . . 73.120000000000005 113.007 -175.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -50.46 -48.19 56.65 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.367 0.506 . . . . 74.530000000000001 112.367 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -60.41 -14.64 20.06 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.821 0.674 . . . . 72.349999999999994 112.821 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -115.4 -33.65 5.2 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.358 0.599 . . . . 62.229999999999997 111.564 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.45 ' O ' HG11 ' A' ' 113' ' ' VAL . 32.6 m-80 -122.13 28.52 7.46 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.665 -0.698 . . . . 72.319999999999993 111.886 -173.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.486 HH11 ' HB2' ' A' ' 109' ' ' ASP . 3.3 ppt_? -38.41 -23.81 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.874 1.805 . . . . 71.219999999999999 115.874 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.486 ' HB2' HH11 ' A' ' 108' ' ' ARG . 21.3 t70 -63.38 136.85 57.91 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.792 0.724 . . . . 71.019999999999996 111.269 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 110' ' ' LYS . 13.0 mptt -68.95 4.64 1.43 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.306 0.854 . . . . 75.450000000000003 113.306 -171.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.5 -47.88 6.91 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.996 0.427 . . . . 72.319999999999993 110.848 170.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -70.62 -58.09 4.04 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.989 -0.55 . . . . 73.109999999999999 112.234 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 107' ' ' ASN . 5.3 m -61.77 -32.54 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.793 0.294 . . . . 71.239999999999995 111.793 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -66.96 -43.25 83.6 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.77 0.319 . . . . 74.25 110.98 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.71 -51.42 70.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.028 0.442 . . . . 73.310000000000002 110.919 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.697 ' HE1' ' HG3' ' A' ' 174' ' ' GLU . 65.1 t80 -56.11 -50.1 72.0 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.003 -0.544 . . . . 65.25 111.148 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -51.57 -47.18 63.57 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.096 -0.502 . . . . 74.430000000000007 111.426 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -66.22 -34.64 78.48 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.013 0.375 . . . . 72.209999999999994 112.013 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -60.62 -54.48 44.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.1 0.476 . . . . 71.299999999999997 111.301 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -71.37 -31.71 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.973 0.416 . . . . 72.450000000000003 111.128 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.406 ' O ' HG21 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -61.48 -48.87 79.1 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.914 0.388 . . . . 72.140000000000001 110.927 176.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.02 -37.19 93.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.867 -0.682 . . . . 62.420000000000002 112.431 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.42 ' NE1' ' SD ' ' A' ' 170' ' ' MET . 51.7 t90 -61.77 -56.45 19.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.38 0.272 . . . . 75.109999999999999 111.343 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 m -63.21 -45.78 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.437 0.532 . . . . 73.530000000000001 112.437 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 121' ' ' GLN . 82.8 t -56.6 -46.61 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.852 0.358 . . . . 73.010000000000005 111.759 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.2 p -70.7 -38.19 73.64 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.968 0.413 . . . . 72.109999999999999 111.262 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.425 HD23 HD13 ' A' ' 155' ' ' ILE . 36.5 tp -67.64 -36.3 80.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.255 -0.43 . . . . 73.109999999999999 112.124 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 78.8 mt -80.71 2.29 26.61 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.503 0.557 . . . . 73.239999999999995 112.503 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 133' ' ' PHE . . . -66.89 87.07 0.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.408 0.623 . . . . 72.120000000000005 110.797 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -62.74 -22.75 66.79 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.841 1.052 . . . . 75.530000000000001 113.841 -169.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' NZ ' ' A' ' 134' ' ' LYS . 24.8 t70 -58.79 -47.33 85.1 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.084 -0.385 . . . . 63.219999999999999 111.958 -173.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -102.49 -38.4 7.57 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.136 0.493 . . . . 72.200000000000003 111.122 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 45.3 m-85 -68.5 -5.43 19.45 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.714 0.635 . . . . 72.25 112.714 -176.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 131' ' ' ASP . 23.6 pttm -62.37 -7.1 3.87 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.762 -0.586 . . . . 74.150000000000006 110.914 168.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.66 9.31 16.61 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 116.32 -0.4 . . . . 72.319999999999993 110.689 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.474 ' CD2' ' HA ' ' A' ' 157' ' ' GLU . 90.8 mt -88.65 162.91 16.06 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.905 0.383 . . . . 74.340000000000003 111.49 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.66 137.67 40.3 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.445 -0.343 . . . . 75.140000000000001 111.415 175.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.687 ' HB3' HG11 ' A' ' 153' ' ' VAL . 89.0 m-85 -100.08 120.92 40.59 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.727 0.299 . . . . 75.439999999999998 110.647 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.411 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 52.9 m-85 -122.45 139.97 53.26 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.188 0.518 . . . . 64.310000000000002 112.081 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -137.67 147.68 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.092 -0.504 . . . . 75.409999999999997 110.013 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.51 ' N ' HD12 ' A' ' 140' ' ' ILE . . . -51.14 126.17 26.34 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.433 -0.413 . . . . 65.409999999999997 114.046 -176.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -51.59 -59.67 4.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.844 0.354 . . . . 75.049999999999997 111.777 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -60.88 -32.29 71.73 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.865 0.364 . . . . 73.010000000000005 111.388 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.08 -53.1 50.79 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.541 -0.3 . . . . 74.040000000000006 111.139 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 140' ' ' ILE . . . -64.53 -20.26 66.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.07 0.462 . . . . 74.329999999999998 111.615 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -69.61 -26.03 64.24 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.013 -0.54 . . . . 74.219999999999999 110.811 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -113.63 -58.2 0.4 Allowed Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.13 -0.486 . . . . 64.099999999999994 112.307 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.86 92.08 8.54 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.175 0.512 . . . . 61.310000000000002 110.97 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.68 -2.46 11.82 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.008 -0.542 . . . . 73.230000000000004 112.375 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -124.79 27.56 6.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.763 0.425 . . . . 74.150000000000006 110.987 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.523 ' HA2' HG21 ' A' ' 9' ' ' THR . . . -57.67 155.27 20.02 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.961 -0.563 . . . . 71.109999999999999 114.432 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.637 ' HG3' ' HE2' ' A' ' 91' ' ' TYR . 43.4 tt0 -68.34 128.93 38.37 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.137 0.494 . . . . 62.100000000000001 111.653 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.687 HG11 ' HB3' ' A' ' 138' ' ' PHE . 68.7 t -91.66 144.06 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.239 0.542 . . . . 71.140000000000001 112.393 -177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.753 ' HB1' HD13 ' A' ' 169' ' ' LEU . . . -102.93 137.12 41.56 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.803 -0.635 . . . . 74.400000000000006 110.409 174.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.425 HD13 HD23 ' A' ' 127' ' ' LEU . 59.9 mt -95.27 126.54 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.381 0.512 . . . . 70.340000000000003 112.381 -172.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.1 mm -95.83 110.89 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.494 -0.321 . . . . 74.400000000000006 110.858 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.474 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 55.2 tt0 -96.22 148.78 22.37 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.842 -0.617 . . . . 73.040000000000006 111.934 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -98.23 123.23 42.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.814 -0.63 . . . . 73.299999999999997 110.558 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -121.15 114.49 21.51 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.975 0.417 . . . . 74.040000000000006 111.609 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.85 106.04 4.03 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.905 0.384 . . . . 74.129999999999995 111.116 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.28 107.66 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 120.742 0.306 . . . . 72.219999999999999 110.863 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 58.41 17.92 5.19 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.435 0.531 . . . . 73.109999999999999 112.435 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 114.86 -21.86 13.3 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.151 -0.547 . . . . 70.040000000000006 113.644 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 83.8 m -105.62 129.39 53.88 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.167 0.483 . . . . 74.140000000000001 111.355 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.28 128.27 35.0 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.397 0.617 . . . . 65.230000000000004 112.429 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.76 148.66 39.79 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.05 -0.523 . . . . 71.129999999999995 110.532 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.446 ' HD3' ' CE1' ' A' ' 34' ' ' HIS . 93.7 Cg_endo -87.12 120.9 1.64 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.425 2.083 . . . . 75.230000000000004 112.66 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.591 HG22 ' HB3' ' A' ' 31' ' ' LYS . 39.9 p -117.51 119.0 33.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.215 0.531 . . . . 75.319999999999993 111.446 177.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.753 HD13 ' HB1' ' A' ' 154' ' ' ALA . 60.2 tp -76.78 130.43 37.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.084 -0.507 . . . . 75.0 110.59 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.42 ' SD ' ' NE1' ' A' ' 123' ' ' TRP . 50.8 ttm -116.15 124.34 50.08 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 116.178 -0.464 . . . . 73.420000000000002 111.385 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.9 mt -135.85 124.73 24.08 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.985 -0.552 . . . . 73.510000000000005 111.902 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.473 ' HA ' HG11 ' A' ' 27' ' ' VAL . 41.4 t -71.22 118.7 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 122.205 -0.309 . . . . 74.140000000000001 111.439 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -66.99 -19.91 65.8 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.023 0.44 . . . . 75.349999999999994 111.558 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.697 ' HG3' ' HE1' ' A' ' 116' ' ' PHE . 4.8 mm-40 -81.76 -8.96 59.75 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.989 0.423 . . . . 72.219999999999999 111.134 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.37 -44.29 6.94 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.057 0.456 . . . . 61.109999999999999 110.92 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 27.2 pt -100.28 128.85 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.196 0.522 . . . . 74.019999999999996 111.163 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 177' ' ' ILE . 1.7 mp -93.34 117.99 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 74.019999999999996 110.225 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.45 137.81 32.02 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.793 0.806 . . . . 71.510000000000005 112.48 -177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -144.78 99.82 3.41 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.229 -0.896 . . . . 74.239999999999995 109.69 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 112.719 0.637 . . . . 74.420000000000002 112.719 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.471 ' HE1' ' HB2' ' A' ' 15' ' ' SER . 18.9 ptt? . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.61 0.243 . . . . 73.140000000000001 110.929 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.6 tp -80.23 132.38 35.85 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.954 0.407 . . . . 73.150000000000006 111.437 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.618 ' HB ' HD12 ' A' ' 13' ' ' LEU . 8.6 pt -117.13 121.39 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.239 0.542 . . . . 75.239999999999995 111.658 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -101.59 122.31 43.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.083 -0.508 . . . . 74.140000000000001 111.112 -174.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.438 ' HG3' HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -111.66 118.73 36.47 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 111.988 0.366 . . . . 73.129999999999995 111.988 179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.74 132.62 40.6 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.838 0.351 . . . . 65.439999999999998 111.142 172.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 tt -48.23 -47.11 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 112.821 0.674 . . . . 73.140000000000001 112.821 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.54 ' HD1' ' HG1' ' A' ' 9' ' ' THR . 1.2 p90 -110.24 -2.59 16.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.411 0.893 . . . . 75.349999999999994 113.411 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.54 ' HG1' ' HD1' ' A' ' 8' ' ' PHE . 28.5 m -127.21 16.81 7.19 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.195 0.522 . . . . 74.319999999999993 111.994 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -50.43 -13.84 0.15 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.282 0.845 . . . . 75.120000000000005 113.282 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -53.93 -40.96 67.19 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.887 0.375 . . . . 70.120000000000005 111.415 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -85.95 24.94 1.19 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 120.857 0.361 . . . . 73.549999999999997 111.38 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.618 HD12 ' HB ' ' A' ' 3' ' ' ILE . 25.0 tp -31.28 120.32 0.23 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.396 0.887 . . . . 62.329999999999998 113.396 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -97.85 140.31 32.41 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.181 -0.463 . . . . 72.310000000000002 110.785 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.471 ' HB2' ' HE1' ' A' ' 1' ' ' MET . 88.9 p -128.88 96.52 4.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.835 0.35 . . . . 62.399999999999999 111.272 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -147.18 -168.85 3.16 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.202 0.525 . . . . 75.409999999999997 111.742 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.7 m -127.3 82.97 2.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.172 -0.467 . . . . 61.310000000000002 110.663 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -114.16 121.91 35.55 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.136 0.421 . . . . 75.230000000000004 112.136 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.31 103.01 1.62 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.664 2.243 . . . . 75.349999999999994 112.618 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.57 166.25 11.94 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.308 0.575 . . . . 72.329999999999998 112.315 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 25.6 mtpp -123.99 107.81 11.72 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.136 -0.484 . . . . 75.129999999999995 111.102 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.0 tp -79.43 94.38 5.54 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.939 -0.476 . . . . 73.030000000000001 111.248 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.76 138.88 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.985 0.422 . . . . 73.430000000000007 111.683 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.8 t70 57.7 13.38 1.96 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.84 -0.618 . . . . 53.43 112.007 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 63.18 14.6 7.86 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.571 0.348 . . . . 72.129999999999995 111.751 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.512 ' HA ' ' HZ3' ' A' ' 173' ' ' LYS . 52.1 tp -114.45 -50.87 2.78 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.966 0.358 . . . . 72.140000000000001 111.966 -176.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.9 m -130.01 152.03 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.207 0.527 . . . . 71.120000000000005 112.353 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.441 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 90.4 m-85 -90.95 120.18 31.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.928 -0.578 . . . . 72.340000000000003 110.996 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 8.6 pt-20 -99.58 105.64 17.53 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.273 0.559 . . . . 73.510000000000005 110.398 172.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 41.0 t80 -91.64 137.74 32.13 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.027 -0.42 . . . . 74.209999999999994 111.169 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.495 ' HE3' HG23 ' A' ' 161' ' ' VAL . 12.1 mmmm -81.82 121.94 27.08 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.15 -0.477 . . . . 74.010000000000005 112.047 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.48 ' HA3' HG12 ' A' ' 70' ' ' ILE . . . -121.71 173.18 15.66 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.316 -0.469 . . . . 44.210000000000001 113.196 176.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.01 140.55 50.86 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.384 -0.48 . . . . 75.120000000000005 111.09 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -73.43 119.77 18.11 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.509 -0.314 . . . . 74.340000000000003 110.393 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.7 m -143.77 178.12 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.462 1.125 . . . . 64.140000000000001 113.788 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.4 m -123.25 129.99 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.327 -1.306 . . . . 75.409999999999997 109.931 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.436 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 112.572 0.582 . . . . 72.420000000000002 112.572 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 . . . . . 0 CA--C 1.548 0.902 0 N-CA-C 113.377 0.88 . . . . 65.400000000000006 113.377 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -115.97 129.76 56.53 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.4 -0.813 . . . . 61.409999999999997 111.879 -169.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.449 ' HA3' HD23 ' A' ' 72' ' ' LEU . . . 160.19 164.61 15.55 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 119.131 -1.509 . . . . 64.420000000000002 114.9 167.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 pt -90.13 138.47 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 122.42 -0.459 . . . . 73.420000000000002 110.294 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -48.41 -32.47 7.7 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.775 0.321 . . . . 63.240000000000002 111.822 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.48 HG12 ' HA3' ' A' ' 32' ' ' GLY . 35.6 mm -48.48 -58.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.38 0.609 . . . . 75.150000000000006 112.056 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 16.4 m -81.14 -28.4 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.993 -0.548 . . . . 73.319999999999993 112.136 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.449 HD23 ' HA3' ' A' ' 67' ' ' GLY . 55.2 mt -71.04 -33.61 70.48 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.953 0.406 . . . . 74.400000000000006 111.188 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -58.4 -48.62 80.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.124 -0.489 . . . . 62.450000000000003 112.252 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -109.68 13.74 23.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.851 0.315 . . . . 71.400000000000006 111.851 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 54.76 71.2 0.55 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.135 0.493 . . . . 73.430000000000007 111.916 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 75.3 mt -103.07 125.54 49.85 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 122.2 -0.313 . . . . 73.239999999999995 111.248 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.2 145.33 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.75 0.31 . . . . 72.150000000000006 110.789 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.24 137.3 35.85 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.026 0.75 . . . . 75.420000000000002 113.026 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.534 ' HE3' ' HG2' ' A' ' 87' ' ' MET . 78.1 mtp -125.91 145.5 50.24 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.058 -0.974 . . . . 65.049999999999997 108.887 169.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.484 ' HB2' ' CD1' ' A' ' 82' ' ' TYR . 16.8 m120 -115.93 -162.28 0.83 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.326 0.584 . . . . 65.120000000000005 112.398 -171.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.1 p -100.27 -2.5 33.57 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.148 0.795 . . . . 61.32 113.148 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.484 ' CD1' ' HB2' ' A' ' 80' ' ' ASN . 24.1 p90 -79.15 -61.4 2.02 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.113 0.782 . . . . 72.420000000000002 113.113 -170.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -105.3 -17.51 14.43 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.719 0.771 . . . . 74.430000000000007 111.208 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.86 9.53 1.12 Allowed 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.26 -0.882 . . . . 75.540000000000006 112.165 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -46.76 -56.91 5.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.193 0.597 . . . . 72.450000000000003 112.592 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.0 m -53.35 -36.35 61.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.874 0.369 . . . . 74.329999999999998 111.643 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.534 ' HG2' ' HE3' ' A' ' 79' ' ' MET . 51.4 tpp -73.88 -63.89 1.12 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.282 0.475 . . . . 73.439999999999998 112.282 -176.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -68.47 -29.07 67.62 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.863 -0.523 . . . . 75.519999999999996 112.305 -174.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -72.69 -41.81 64.93 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.917 -0.313 . . . . 72.430000000000007 110.909 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.71 -39.37 91.26 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.01 0.433 . . . . 74.299999999999997 110.325 173.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -57.11 -59.23 5.4 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.996 -0.547 . . . . 72.420000000000002 111.775 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.7 tp -62.4 -39.03 82.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 112.263 0.468 . . . . 73.540000000000006 112.263 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -71.49 -44.63 64.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 111.99 0.366 . . . . 71.109999999999999 111.99 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -63.67 -44.84 92.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.261 0.553 . . . . 74.540000000000006 110.287 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.452 ' O ' HG23 ' A' ' 99' ' ' VAL . 48.9 t80 -56.22 -58.07 9.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.505 -0.77 . . . . 74.420000000000002 111.283 174.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 53.0 tpp -51.56 -54.07 31.41 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.112 -0.495 . . . . 74.329999999999998 111.76 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -57.92 -44.74 87.05 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.962 0.356 . . . . 72.319999999999993 111.962 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -72.09 -45.98 58.56 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.368 0.507 . . . . 65.219999999999999 112.368 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 95' ' ' PHE . 35.8 m -67.83 -38.05 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 122.186 -0.321 . . . . 62.5 111.615 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.9 mm -63.77 -48.64 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.63 0.253 . . . . 73.439999999999998 110.603 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.423 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 17.1 t70 -52.51 -47.39 66.65 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.08 0.466 . . . . 71.150000000000006 111.873 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -71.15 -42.94 68.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.545 -0.298 . . . . 73.409999999999997 111.625 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.527 ' HG3' HG13 ' A' ' 113' ' ' VAL . 12.7 tpt -59.88 -43.18 94.91 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.824 0.305 . . . . 74.340000000000003 111.824 -178.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.537 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -65.96 -28.55 68.99 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.837 0.31 . . . . 73.25 111.837 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.1 mtmm -69.52 -8.0 43.23 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.251 0.463 . . . . 75.420000000000002 112.251 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -99.97 -31.71 11.33 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.301 0.572 . . . . 72.340000000000003 110.332 172.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.661 HD22 ' HB3' ' A' ' 111' ' ' ALA . 28.3 t-20 -123.64 -80.34 0.62 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.583 -0.735 . . . . 62.549999999999997 111.929 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 73.7 ttt180 72.25 -15.74 0.46 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.915 0.709 . . . . 73.120000000000005 112.915 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -80.22 8.89 6.43 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.935 -0.478 . . . . 74.230000000000004 111.771 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.46 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 57.5 mtmt 60.52 20.23 10.02 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.219 0.533 . . . . 75.0 112.137 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.661 ' HB3' HD22 ' A' ' 107' ' ' ASN . . . -85.42 -62.54 1.51 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.105 -0.498 . . . . 73.209999999999994 110.288 172.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -79.52 -46.71 16.87 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.401 -0.363 . . . . 73.299999999999997 111.601 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.527 HG13 ' HG3' ' A' ' 103' ' ' MET . 28.0 m -63.81 -29.61 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 113.176 0.806 . . . . 74.120000000000005 113.176 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.39 -39.07 68.27 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 122.012 -0.43 . . . . 73.549999999999997 110.238 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.64 -47.54 69.28 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.172 -0.467 . . . . 64.109999999999999 111.195 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -53.89 -48.86 69.69 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.152 -0.476 . . . . 75.349999999999994 110.503 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -54.26 -47.69 72.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.696 -0.684 . . . . 75.219999999999999 111.317 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -56.27 -43.33 78.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.235 -0.439 . . . . 73.239999999999995 111.123 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -66.81 -60.49 2.62 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.942 0.349 . . . . 73.200000000000003 111.942 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -60.94 -35.07 62.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 111.905 0.335 . . . . 72.540000000000006 111.905 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 125' ' ' VAL . 58.5 tp60 -67.09 -43.21 83.15 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.687 0.279 . . . . 74.310000000000002 110.627 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.23 -35.47 88.1 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.828 -0.701 . . . . 71.450000000000003 112.271 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.5 t90 -63.89 -51.7 63.32 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.296 0.238 . . . . 72.25 111.222 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' A' ' 121' ' ' GLN . 30.8 m -67.61 -38.03 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 112.306 0.484 . . . . 71.230000000000004 112.306 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 121' ' ' GLN . 52.9 t -57.78 -46.55 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.357 0.599 . . . . 74.150000000000006 110.854 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.6 m -67.83 -48.95 64.78 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.087 -0.506 . . . . 73.340000000000003 111.31 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.22 -41.5 96.97 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.05 0.54 . . . . 61.539999999999999 112.447 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.0 mt -84.82 3.31 38.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.243 0.46 . . . . 65.129999999999995 112.243 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.46 86.41 0.11 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.337 0.589 . . . . 74.5 110.929 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -54.5 -20.4 7.65 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.62 0.971 . . . . 72.239999999999995 113.62 -172.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.81 -47.53 77.71 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.649 0.611 . . . . 64.439999999999998 112.649 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -109.91 -30.69 7.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.446 0.535 . . . . 72.230000000000004 112.446 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -85.66 -7.11 59.01 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.147 0.795 . . . . 63.409999999999997 113.147 -171.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.86 -19.8 66.07 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.726 -0.608 . . . . 73.239999999999995 110.538 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -78.95 10.02 3.78 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.002 -0.545 . . . . 70.5 111.873 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 157' ' ' GLU . 88.0 mt -89.06 161.21 16.67 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.971 0.415 . . . . 74.019999999999996 110.948 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.43 137.48 54.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.64 -0.254 . . . . 74.230000000000004 111.644 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.654 ' HB3' HG12 ' A' ' 153' ' ' VAL . 56.8 m-85 -107.88 106.96 17.48 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 122.273 -0.267 . . . . 75.219999999999999 110.667 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.592 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 39.8 m-85 -102.51 143.67 31.93 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.196 0.522 . . . . 75.400000000000006 112.273 -176.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.7 tt -130.5 150.81 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.835 -0.62 . . . . 71.219999999999999 110.626 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.437 ' HA2' HD21 ' A' ' 76' ' ' LEU . . . -56.21 135.69 49.49 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.352 -0.452 . . . . 61.450000000000003 113.669 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.25 -39.62 66.98 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.091 0.472 . . . . 64.109999999999999 111.393 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -69.07 -55.92 9.3 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.081 -0.509 . . . . 75.450000000000003 111.296 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.07 -25.59 67.05 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.203 0.446 . . . . 63.240000000000002 112.203 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.44 -19.03 61.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.75 0.648 . . . . 74.019999999999996 112.75 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -70.47 -12.02 61.3 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.225 0.536 . . . . 62.420000000000002 111.144 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.41 41.2 2.81 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.369 -0.443 . . . . 62.439999999999998 112.967 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.12 -71.72 0.16 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.012 0.434 . . . . 75.230000000000004 111.769 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -123.8 -77.39 0.59 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.126 0.488 . . . . 73.540000000000006 110.223 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -134.79 -59.98 0.79 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.929 -0.578 . . . . 70.120000000000005 110.401 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.448 ' HA2' HG21 ' A' ' 9' ' ' THR . . . 103.28 139.56 10.4 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.294 -0.479 . . . . 73.140000000000001 112.837 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -73.73 112.2 9.61 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 122.548 -0.383 . . . . 63.5 111.47 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.654 HG12 ' HB3' ' A' ' 138' ' ' PHE . 58.8 t -77.49 88.0 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.648 0.737 . . . . 74.310000000000002 110.079 169.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.914 ' HB1' HD13 ' A' ' 169' ' ' LEU . . . -79.4 117.53 20.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.534 -0.757 . . . . 70.310000000000002 110.471 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.77 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 58.1 mt -88.53 134.73 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.028 0.442 . . . . 73.510000000000005 111.991 -172.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.4 mm -103.22 115.48 45.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 116.443 -0.344 . . . . 74.150000000000006 111.063 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.518 ' HB2' ' HE2' ' A' ' 170' ' ' MET . 38.2 tt0 -108.33 145.4 34.5 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 123.73 0.644 . . . . 74.420000000000002 111.831 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -90.2 117.47 28.98 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.06 0.457 . . . . 73.140000000000001 110.834 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -132.65 128.8 37.83 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.408 0.521 . . . . 72.310000000000002 112.408 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -83.77 116.14 22.56 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.046 -0.525 . . . . 65.010000000000005 110.144 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.495 HG23 ' HE3' ' A' ' 31' ' ' LYS . 98.8 t -114.72 105.98 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.472 -0.331 . . . . 75.319999999999993 110.483 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 59.81 23.79 12.75 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.292 -0.413 . . . . 73.109999999999999 111.615 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.01 -18.91 51.12 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 113.294 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 28.3 m -82.19 132.72 35.24 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.644 -0.327 . . . . 74.409999999999997 111.517 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.23 98.82 11.14 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.548 0.69 . . . . 75.319999999999993 111.646 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.92 147.22 48.15 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.103 -0.498 . . . . 75.140000000000001 112.09 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.39 120.81 2.18 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.697 2.265 . . . . 74.5 113.008 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.8 p -94.17 129.72 40.66 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.207 0.527 . . . . 74.340000000000003 111.187 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.914 HD13 ' HB1' ' A' ' 154' ' ' ALA . 43.7 tp -87.94 123.06 32.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.068 -0.514 . . . . 74.030000000000001 111.31 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.77 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 62.8 mtt -92.75 124.07 36.49 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.797 0.332 . . . . 75.209999999999994 111.355 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 86.5 mt -132.4 143.39 49.79 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.458 -0.792 . . . . 73.530000000000001 109.818 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 175' ' ' ALA . 48.5 t -101.85 122.77 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 122.078 -0.389 . . . . 75.120000000000005 111.755 -173.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.512 ' HZ3' ' HA ' ' A' ' 26' ' ' LEU . 22.9 pttm -68.62 -29.37 67.86 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.182 0.438 . . . . 75.120000000000005 112.182 -173.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -89.09 5.86 42.54 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.265 0.555 . . . . 63.439999999999998 111.36 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.522 ' HB2' ' HB ' ' A' ' 172' ' ' VAL . . . -113.91 -22.96 9.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.899 -0.591 . . . . 73.040000000000006 111.278 172.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 172' ' ' VAL . 34.5 pt -129.77 137.15 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.975 0.417 . . . . 61.149999999999999 111.198 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.6 mm -103.46 110.87 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.844 0.354 . . . . 73.349999999999994 111.489 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -74.15 95.71 2.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.193 -0.458 . . . . 73.230000000000004 109.909 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.595 ' HB3' HG13 ' A' ' 3' ' ' ILE . 29.5 tt0 -95.23 119.04 33.06 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.237 0.541 . . . . 75.329999999999998 111.37 -174.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 121.434 0.635 . . . . 75.420000000000002 112.706 -174.075 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 tpp . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.688 0.28 . . . . 71.010000000000005 111.565 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.19 130.09 40.56 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.763 0.315 . . . . 75.439999999999998 111.139 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.2 mt -102.66 134.11 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.758 -0.201 . . . . 75.319999999999993 111.048 -177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -123.49 141.57 51.87 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.58 0.705 . . . . 74.239999999999995 112.282 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.433 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 21.6 ttmm -111.38 110.55 21.06 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.759 -1.109 . . . . 72.230000000000004 111.013 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.512 ' HB2' ' H ' ' A' ' 9' ' ' THR . 1.4 m-20 -83.14 149.54 26.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.558 -0.292 . . . . 71.209999999999994 110.955 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 175' ' ' ALA . 68.9 mt -61.02 -33.89 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.398 0.618 . . . . 75.239999999999995 110.77 173.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -105.14 -29.26 10.49 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.669 0.618 . . . . 74.030000000000001 112.669 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.512 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 2.0 m -106.48 11.81 30.29 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.058 0.392 . . . . 73.209999999999994 112.058 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.433 ' OD1' ' HG3' ' A' ' 5' ' ' LYS . 17.7 t70 -50.92 -35.93 35.8 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.218 0.451 . . . . 71.030000000000001 112.218 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.32 -19.55 35.93 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 111.954 0.353 . . . . 74.109999999999999 111.954 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -91.32 -30.11 16.76 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 111.72 0.267 . . . . 75.439999999999998 111.72 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.6 tp 40.3 90.8 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.17 0.588 . . . . 74.120000000000005 111.787 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 t -103.15 169.5 8.52 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.12 0.785 . . . . 72.299999999999997 113.12 -164.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 87.9 p -137.97 150.14 46.76 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.656 -0.702 . . . . 61.219999999999999 111.315 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -145.47 175.33 10.41 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.328 -0.396 . . . . 73.109999999999999 110.709 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.6 p -133.92 15.66 3.91 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.651 0.612 . . . . 55.409999999999997 112.651 -178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -109.92 121.93 40.5 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 120.912 0.386 . . . . 73.010000000000005 111.768 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.43 102.3 1.46 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.87 2.38 . . . . 63.149999999999999 113.106 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.1 ptt? -85.89 153.91 21.88 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.354 -0.385 . . . . 65.150000000000006 111.588 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 89.6 mttt -99.04 123.9 43.67 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 111.813 0.301 . . . . 75.230000000000004 111.813 -174.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 tp -78.44 99.15 6.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.966 0.412 . . . . 73.140000000000001 110.949 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -95.71 146.78 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.9 0.381 . . . . 65.450000000000003 111.101 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.44 7.76 3.15 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 116.267 -0.424 . . . . 74.319999999999993 111.851 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 58.19 21.7 8.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.881 0.372 . . . . 74.25 111.764 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.2 tp -129.46 -43.89 1.26 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.018 0.437 . . . . 71.510000000000005 111.718 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.25 153.34 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.15 0.5 . . . . 72.310000000000002 112.288 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.485 ' CE2' ' HB3' ' A' ' 173' ' ' LYS . 95.0 m-85 -91.61 134.47 34.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.238 -0.437 . . . . 72.019999999999996 111.105 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 8.7 pt-20 -104.84 131.78 51.9 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.318 0.58 . . . . 72.329999999999998 110.81 172.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 74.7 t80 -130.91 119.07 21.61 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.197 -0.456 . . . . 74.140000000000001 111.153 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -101.57 130.67 47.93 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.937 0.399 . . . . 74.099999999999994 111.411 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.77 -160.08 10.88 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.354 -0.45 . . . . 71.209999999999994 112.785 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -109.26 165.76 11.37 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.439 -0.448 . . . . 73.239999999999995 111.761 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -98.34 106.43 18.72 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.406 -0.361 . . . . 64.329999999999998 110.614 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.97 159.6 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.141 0.496 . . . . 74.230000000000004 111.574 -176.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 5.6 m -127.8 137.59 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.28 -0.418 . . . . 74.530000000000001 110.176 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.459 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 30.0 ttp180 . . . . . 0 C--O 1.241 0.652 0 CA-C-O 121.573 0.702 . . . . 70.450000000000003 112.179 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 43.7 mt-10 . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 121.386 0.613 . . . . 71.239999999999995 109.881 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.63 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -106.85 148.42 28.56 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.006 -0.543 . . . . 72.219999999999999 111.99 -175.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.29 -113.62 1.4 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.935 -0.65 . . . . 64.549999999999997 113.294 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.605 HG23 ' HB3' ' A' ' 167' ' ' PRO . 31.4 pt -111.68 132.3 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.194 0.521 . . . . 75.120000000000005 112.213 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -51.1 -33.59 26.85 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.015 -0.539 . . . . 73.430000000000007 112.109 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.468 HG22 ' HB2' ' A' ' 169' ' ' LEU . 64.5 mt -47.87 -49.56 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 112.329 0.492 . . . . 75.430000000000007 112.329 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 23.4 m -85.68 -30.32 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.41 -0.359 . . . . 74.109999999999999 111.899 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 66.8 mt -67.82 -49.96 59.37 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.093 0.473 . . . . 75.400000000000006 111.211 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -60.85 -36.21 78.54 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.897 -0.592 . . . . 75.420000000000002 111.755 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -100.51 8.03 43.75 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.236 0.458 . . . . 61.32 112.236 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 54.89 69.67 0.71 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.673 0.619 . . . . 75.530000000000001 112.673 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.555 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 73.5 mt -116.61 125.93 52.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.056 -0.52 . . . . 74.200000000000003 110.505 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 p -82.58 143.08 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.969 0.414 . . . . 73.230000000000004 111.886 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -77.84 129.15 35.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.824 -0.625 . . . . 73.219999999999999 112.506 -175.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.5 mmt -136.13 165.22 26.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.984 -0.553 . . . . 72.239999999999995 111.169 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -144.91 143.24 30.46 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.276 0.56 . . . . 74.239999999999995 111.923 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 21.3 p -40.86 -32.43 0.23 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.753 1.76 . . . . 74.200000000000003 115.753 -167.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -51.15 -46.36 61.98 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.86 0.689 . . . . 75.439999999999998 112.86 -172.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -103.71 -20.48 13.95 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.007 -0.433 . . . . 73.219999999999999 111.551 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.84 -22.32 66.97 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.02 0.378 . . . . 73.409999999999997 112.02 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.47 -42.33 54.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.046 0.45 . . . . 72.299999999999997 111.312 175.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.9 t -62.83 -42.96 99.95 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.251 0.548 . . . . 71.019999999999996 111.233 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.2 ttm -64.31 -43.54 94.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.081 -0.509 . . . . 73.510000000000005 110.878 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.529 ' HA ' ' HB3' ' A' ' 91' ' ' TYR . 62.9 m-85 -66.91 -30.49 70.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.998 0.37 . . . . 74.319999999999993 111.998 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.8 -53.48 57.37 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.002 0.429 . . . . 74.120000000000005 110.488 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.08 -41.24 90.98 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.046 0.45 . . . . 74.0 111.615 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.571 ' HE1' ' HG3' ' A' ' 152' ' ' GLN . 78.7 t80 -56.89 -63.37 1.23 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.04 -0.527 . . . . 74.540000000000006 111.602 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.9 mm -57.87 -31.26 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.463 -0.335 . . . . 74.310000000000002 111.767 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -56.91 -67.29 0.33 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.055 0.455 . . . . 75.319999999999993 111.575 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -63.39 -40.76 98.12 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.175 -0.466 . . . . 72.329999999999998 111.102 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.453 ' HZ ' HG12 ' A' ' 172' ' ' VAL . 86.8 t80 -54.94 -55.62 28.7 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.866 -0.606 . . . . 74.409999999999997 111.304 178.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -55.83 -50.23 71.11 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.883 0.327 . . . . 71.129999999999995 111.883 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -62.63 -37.77 87.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.076 0.398 . . . . 75.25 112.076 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -76.07 -46.73 27.63 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.257 -0.277 . . . . 72.439999999999998 111.746 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.506 HG12 ' HB3' ' A' ' 174' ' ' GLU . 22.0 m -65.77 -42.55 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 112.085 0.402 . . . . 73.209999999999994 112.085 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.1 mm -65.42 -43.53 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 122.228 -0.295 . . . . 65.200000000000003 111.071 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.15 -38.9 74.2 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.139 0.495 . . . . 75.310000000000002 110.847 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -60.76 -56.59 19.4 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.018 -0.537 . . . . 70.019999999999996 111.639 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.529 ' HE3' HD22 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -67.88 -28.46 67.54 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.127 0.489 . . . . 73.430000000000007 111.591 -178.251 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 37.5 tt0 -68.53 -27.2 65.89 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.18 -0.464 . . . . 61.399999999999999 111.568 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -72.64 -36.72 68.06 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.902 0.382 . . . . 74.150000000000006 111.824 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.529 HD22 ' HE3' ' A' ' 103' ' ' MET . 2.3 p-10 -86.58 -29.89 22.27 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 111.942 0.349 . . . . 61.009999999999998 111.942 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 109' ' ' ASP . 20.3 t-20 -125.61 -74.92 0.59 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.357 0.502 . . . . 75.5 112.357 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 24.1 ttt180 67.92 -30.73 0.17 Allowed 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 113.02 0.748 . . . . 74.5 113.02 -174.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 111' ' ' ALA . 23.0 t0 -90.94 80.26 5.79 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.652 -0.655 . . . . 70.109999999999999 111.925 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.466 ' HG3' ' N ' ' A' ' 111' ' ' ALA . 10.0 ptpp? 50.14 -67.1 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.671 1.588 . . . . 74.409999999999997 115.056 169.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 109' ' ' ASP . . . -33.47 -54.51 0.43 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.01 1.115 . . . . 63.25 114.01 -172.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -95.97 -44.88 7.16 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.45 0.537 . . . . 64.409999999999997 112.45 -176.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 m -61.53 -37.24 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 112.564 0.579 . . . . 63.039999999999999 112.564 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.89 -41.55 87.0 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.081 0.467 . . . . 71.129999999999995 110.881 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.02 -48.89 74.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.188 -0.46 . . . . 71.420000000000002 111.054 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -57.85 -48.85 78.58 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.238 -0.437 . . . . 74.549999999999997 111.322 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -51.99 -51.71 55.44 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.771 -0.455 . . . . 75.319999999999993 109.771 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -57.61 -38.02 74.24 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.143 -0.48 . . . . 74.209999999999994 111.298 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -63.52 -62.5 1.63 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.003 0.43 . . . . 72.219999999999999 111.81 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.1 tp -69.22 -32.65 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.394 -0.366 . . . . 75.299999999999997 111.88 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -62.84 -49.39 75.1 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.918 0.39 . . . . 73.519999999999996 110.196 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.29 -38.23 85.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.88 -0.676 . . . . 70.230000000000004 112.556 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 44.3 t90 -60.68 -55.38 33.9 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.306 0.242 . . . . 73.239999999999995 111.457 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.7 m -65.85 -40.83 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.079 0.4 . . . . 75.230000000000004 112.079 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 68.8 t -59.09 -36.11 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.098 0.475 . . . . 73.409999999999997 111.223 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.5 m -76.51 -47.25 23.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.017 0.437 . . . . 74.019999999999996 110.975 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.1 tp -62.2 -36.07 80.79 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.967 -0.561 . . . . 75.099999999999994 112.139 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.6 mt -88.56 3.2 51.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.469 0.544 . . . . 74.349999999999994 112.469 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 133' ' ' PHE . . . -68.26 81.97 0.24 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.404 0.621 . . . . 54.340000000000003 110.911 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -48.07 -45.34 32.35 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.885 1.069 . . . . 72.319999999999993 113.885 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -43.31 -46.62 6.42 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.502 0.556 . . . . 74.109999999999999 112.502 -171.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.501 ' HG3' ' CD1' ' A' ' 133' ' ' PHE . 2.3 ptp180 -109.74 -42.15 4.35 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.185 0.439 . . . . 73.129999999999995 112.185 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.501 ' CD1' ' HG3' ' A' ' 132' ' ' ARG . 52.9 m-85 -71.04 -8.16 51.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.962 0.727 . . . . 73.5 112.962 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -56.01 -22.59 27.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.234 0.54 . . . . 73.25 111.08 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.532 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 58.3 m-20 -76.65 6.05 6.55 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.595 -0.73 . . . . 75.040000000000006 112.215 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.8 mt -89.19 148.98 23.34 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.026 0.441 . . . . 74.140000000000001 111.579 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.05 146.38 30.2 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.173 -0.467 . . . . 65.109999999999999 111.217 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -114.09 125.43 53.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.969 0.414 . . . . 74.019999999999996 110.879 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.521 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 58.1 m-85 -126.2 127.95 46.47 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.018 0.437 . . . . 74.329999999999998 111.555 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.425 HG23 ' HB2' ' A' ' 145' ' ' ALA . 10.3 tt -121.63 152.32 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.341 -0.39 . . . . 71.120000000000005 111.176 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.49 136.87 35.48 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 114.142 0.417 . . . . 62.240000000000002 114.142 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.05 -41.42 68.1 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.34 0.496 . . . . 73.140000000000001 112.34 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.547 ' H ' ' HD2' ' A' ' 143' ' ' ARG . 1.2 mpt_? -80.29 -43.12 21.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.914 0.387 . . . . 71.540000000000006 110.975 -177.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.63 -53.49 57.0 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.244 -0.434 . . . . 75.450000000000003 111.499 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.425 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -59.06 -24.43 62.87 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.492 0.553 . . . . 60.310000000000002 112.492 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.72 -29.19 16.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.91 0.386 . . . . 70.219999999999999 111.663 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -88.38 -49.32 3.73 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.109 -0.567 . . . . 54.5 113.15 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.75 124.13 10.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.747 0.308 . . . . 74.049999999999997 111.22 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -18.41 59.81 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.852 0.358 . . . . 74.129999999999995 111.513 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -78.07 44.45 0.48 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.1 0.476 . . . . 75.439999999999998 111.29 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.87 179.24 35.37 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.171 -0.468 . . . . 75.329999999999998 113.207 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.668 HE22 HG22 ' A' ' 176' ' ' ILE . 46.4 tt0 -98.43 115.85 29.4 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.09 0.471 . . . . 74.329999999999998 111.671 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.2 t -81.05 139.57 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.171 0.51 . . . . 74.099999999999994 111.916 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.796 ' HB1' HD12 ' A' ' 169' ' ' LEU . . . -97.82 133.45 42.32 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.922 -0.581 . . . . 72.430000000000007 110.651 175.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.664 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 45.6 mm -86.77 124.74 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.73 0.3 . . . . 74.010000000000005 111.504 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.425 HG13 ' CD1' ' A' ' 139' ' ' PHE . 46.5 mm -110.57 106.79 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.273 0.559 . . . . 64.549999999999997 112.444 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.507 ' HG2' ' N ' ' A' ' 158' ' ' TYR . 28.4 tt0 -103.1 158.65 16.15 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.277 -0.874 . . . . 75.019999999999996 110.148 172.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.594 ' HB2' ' HB3' ' A' ' 165' ' ' GLU . 0.6 OUTLIER -115.83 115.01 25.52 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.476 0.655 . . . . 73.010000000000005 111.243 168.167 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.443 HH21 HG23 ' A' ' 168' ' ' THR . 3.5 tpp180 -69.04 141.18 54.89 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.408 -0.814 . . . . 75.230000000000004 112.153 -176.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.51 102.97 7.17 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.255 -0.43 . . . . 74.430000000000007 111.388 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 83.5 t -111.01 90.79 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.963 0.411 . . . . 70.030000000000001 110.625 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 58.28 19.69 6.52 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.058 -0.519 . . . . 65.329999999999998 111.833 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 112.3 -23.41 16.03 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 116.265 -0.425 . . . . 71.120000000000005 112.653 -175.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 92.8 m -84.26 118.63 24.3 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.067 0.461 . . . . 64.329999999999998 110.886 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 26.0 mt-10 -85.34 100.32 11.74 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.007 -0.542 . . . . 75.519999999999996 111.236 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 25.2 m -98.4 149.79 36.08 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 111.981 0.363 . . . . 74.209999999999994 111.981 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.605 ' HB3' HG23 ' A' ' 68' ' ' ILE . 18.0 Cg_endo -58.88 136.25 72.34 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.69 2.26 . . . . 75.540000000000006 114.278 -176.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.443 HG23 HH21 ' A' ' 159' ' ' ARG . 83.2 m -143.27 108.83 5.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.762 -0.654 . . . . 74.319999999999993 110.9 176.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.796 HD12 ' HB1' ' A' ' 154' ' ' ALA . 63.5 tp -82.55 145.41 29.76 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.209 -0.45 . . . . 75.019999999999996 111.665 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.664 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 64.7 mtt -126.45 126.47 43.83 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.843 0.354 . . . . 74.420000000000002 111.462 176.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -134.51 129.94 35.9 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.091 -0.504 . . . . 75.209999999999994 111.2 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.453 HG12 ' HZ ' ' A' ' 95' ' ' PHE . 22.3 t -80.32 126.86 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 O-C-N 122.019 -0.426 . . . . 71.0 111.711 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.485 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -72.29 -14.59 61.79 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.332 0.493 . . . . 75.209999999999994 112.332 -179.147 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.506 ' HB3' HG12 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -81.07 -11.69 59.45 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.9 0.381 . . . . 72.219999999999999 111.229 169.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.437 ' HB3' ' HE1' ' A' ' 95' ' ' PHE . . . -96.95 -39.25 9.46 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.981 0.42 . . . . 72.140000000000001 110.804 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.668 HG22 HE22 ' A' ' 152' ' ' GLN . 29.6 pt -119.88 114.07 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.087 0.47 . . . . 63.240000000000002 111.563 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -94.42 130.42 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 109.282 -0.636 . . . . 72.329999999999998 109.282 175.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.43 ' N ' HD12 ' A' ' 177' ' ' ILE . 1.5 pp20? -94.59 153.0 18.07 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.812 0.815 . . . . 73.230000000000004 112.961 -172.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -127.09 99.16 5.58 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.418 -0.81 . . . . 73.409999999999997 109.694 173.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 64.0 tttm . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.263 0.554 . . . . 74.319999999999993 110.637 179.307 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtm . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.796 0.332 . . . . 74.150000000000006 111.233 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 15' ' ' SER . 29.8 tp -109.46 130.72 55.49 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.649 -0.5 . . . . 74.319999999999993 109.649 170.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.751 HG13 ' HB3' ' A' ' 179' ' ' GLU . 17.4 pt -117.19 127.79 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.191 0.519 . . . . 63.210000000000001 111.607 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -121.8 147.61 45.74 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.96 -0.564 . . . . 75.200000000000003 112.104 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.412 ' HE3' ' CG2' ' A' ' 177' ' ' ILE . 20.7 ttpp -124.05 117.24 24.26 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.348 -0.387 . . . . 71.319999999999993 111.525 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.79 173.31 6.39 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.031 -0.531 . . . . 64.420000000000002 111.362 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.76 HD11 ' HB1' ' A' ' 175' ' ' ALA . 57.7 mt -78.28 -49.59 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.055 0.455 . . . . 74.129999999999995 111.619 175.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -93.16 -38.62 11.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.006 -0.543 . . . . 73.329999999999998 112.13 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -97.9 17.95 17.0 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.701 -0.682 . . . . 73.540000000000006 110.945 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -47.68 -39.9 18.57 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.095 1.146 . . . . 71.239999999999995 114.095 -169.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.26 -28.0 62.58 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.124 0.416 . . . . 75.019999999999996 112.124 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 35.0 tt0 -89.05 25.11 1.91 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 120.669 0.271 . . . . 74.450000000000003 111.509 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.433 HD22 ' HB ' ' A' ' 3' ' ' ILE . 7.8 tt -34.67 122.09 0.52 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.324 0.65 . . . . 75.329999999999998 111.698 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t -126.64 179.42 5.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.399 -0.364 . . . . 63.119999999999997 111.493 -171.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 2' ' ' LEU . 83.8 p -124.66 148.04 48.2 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.444 -0.344 . . . . 60.509999999999998 111.419 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -138.78 -172.74 3.38 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.514 0.673 . . . . 75.549999999999997 111.691 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -149.28 29.31 0.79 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.406 -0.815 . . . . 74.549999999999997 111.016 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -90.16 113.05 55.89 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 112.026 0.38 . . . . 72.230000000000004 112.026 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.54 77.46 1.74 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.189 1.926 . . . . 75.420000000000002 112.32 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.3 mtt -84.76 143.27 29.24 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.075 0.465 . . . . 72.450000000000003 111.247 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 27.1 ttpp -99.63 118.58 36.46 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.164 -0.471 . . . . 74.450000000000003 111.012 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.4 tp -76.24 135.56 39.67 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.882 0.373 . . . . 75.239999999999995 111.021 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.23 134.65 65.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.2 0.524 . . . . 74.230000000000004 111.656 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.1 t70 61.9 15.93 7.59 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.464 -0.789 . . . . 72.319999999999993 111.951 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 59.0 19.72 7.5 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.002 0.521 . . . . 64.140000000000001 112.112 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.1 tp -119.74 -49.72 2.32 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.099 0.407 . . . . 75.219999999999999 112.099 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.596 HG11 ' HA ' ' A' ' 172' ' ' VAL . 13.6 m -132.53 149.55 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.581 0.586 . . . . 74.230000000000004 112.581 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -86.52 144.43 27.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.262 -0.426 . . . . 70.209999999999994 111.065 174.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 16.2 pt-20 -122.1 133.42 54.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.038 0.447 . . . . 73.040000000000006 110.489 174.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -137.53 135.48 36.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.833 0.349 . . . . 75.230000000000004 110.838 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -92.2 121.54 33.83 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.591 0.589 . . . . 73.519999999999996 112.591 -173.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.92 165.51 12.93 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.08 -0.509 . . . . 55.210000000000001 112.358 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 12.0 mmmm -121.95 145.01 48.53 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 122.367 -0.49 . . . . 73.230000000000004 111.109 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -73.62 109.64 7.28 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.328 0.585 . . . . 75.219999999999999 112.04 -175.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.426 HG22 HD13 ' A' ' 72' ' ' LEU . 26.8 m -134.63 166.2 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.246 -0.433 . . . . 72.310000000000002 110.474 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.5 m -131.4 150.74 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 122.067 -0.395 . . . . 71.129999999999995 111.249 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.646 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 34.9 mmt180 . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 121.498 0.666 . . . . 73.530000000000001 112.208 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.646 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 48.2 mt-10 . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.568 0.699 . . . . 73.430000000000007 110.08 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -85.79 129.29 34.87 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.149 -0.932 . . . . 74.239999999999995 112.194 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.92 -149.74 11.68 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.01 -0.615 . . . . 63.009999999999998 112.803 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 28.7 pt -111.45 154.11 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 122.601 -0.352 . . . . 63.119999999999997 111.573 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -41.27 -48.94 3.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.257 0.465 . . . . 65.25 112.257 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.406 HG22 HD23 ' A' ' 169' ' ' LEU . 56.1 mt -49.6 -55.49 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 112.584 0.587 . . . . 72.299999999999997 112.584 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.406 ' HA ' HD11 ' A' ' 76' ' ' LEU . 23.0 m -80.53 -34.76 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.333 0.494 . . . . 75.209999999999994 112.333 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.426 HD13 HG22 ' A' ' 35' ' ' VAL . 87.3 mt -71.03 -40.81 71.52 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.979 0.419 . . . . 75.129999999999995 111.527 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -64.42 -35.98 82.68 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.909 0.385 . . . . 75.239999999999995 111.969 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -101.43 4.81 41.69 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.531 0.567 . . . . 71.319999999999993 112.531 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.0 70.33 0.62 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.158 0.504 . . . . 72.420000000000002 112.149 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.406 HD11 ' HA ' ' A' ' 71' ' ' VAL . 76.5 mt -115.04 135.08 54.61 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.287 -0.415 . . . . 74.310000000000002 111.25 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.18 143.25 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.577 0.227 . . . . 72.439999999999998 111.211 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -88.88 134.05 34.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.408 0.623 . . . . 73.230000000000004 112.631 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.43 138.09 50.6 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.845 -0.616 . . . . 75.5 110.618 171.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.557 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.7 OUTLIER -105.07 144.49 31.81 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.98 -0.554 . . . . 74.120000000000005 110.407 175.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 40.9 t -49.32 -16.68 0.2 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.297 1.591 . . . . 74.519999999999996 115.297 -169.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -93.59 -19.37 21.24 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.558 -0.714 . . . . 73.109999999999999 112.701 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -83.06 -46.51 12.73 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.283 0.563 . . . . 75.310000000000002 111.852 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.572 ' HB2' ' HB2' ' A' ' 87' ' ' MET . 9.9 p-10 -108.17 21.77 16.89 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.601 -0.727 . . . . 71.310000000000002 112.163 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.578 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -36.26 -50.13 0.72 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.92 1.081 . . . . 75.109999999999999 113.92 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.9 t -73.06 -30.48 63.74 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.951 0.405 . . . . 63.530000000000001 111.542 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.572 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 80.2 mtp -67.8 -60.38 2.57 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.197 0.443 . . . . 75.200000000000003 112.197 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.578 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 6.1 p90 -63.4 -28.26 69.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.178 -0.609 . . . . 75.219999999999999 110.654 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -58.2 -40.35 81.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.12 0.486 . . . . 74.040000000000006 110.543 172.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.47 80.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.214 -0.448 . . . . 71.439999999999998 111.048 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -54.68 -54.39 42.35 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.156 -0.475 . . . . 74.540000000000006 111.225 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.5 -35.1 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.52 -0.309 . . . . 74.519999999999996 111.74 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.685 ' HZ1' ' HB2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -60.86 -60.43 3.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.776 0.322 . . . . 75.239999999999995 111.488 177.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -64.96 -38.66 91.69 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.064 0.459 . . . . 75.150000000000006 111.298 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.674 ' HZ ' HD11 ' A' ' 120' ' ' ILE . 41.6 t80 -57.18 -53.25 60.2 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.052 -0.522 . . . . 71.349999999999994 111.838 176.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -61.83 -46.92 87.38 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.845 0.355 . . . . 73.329999999999998 111.496 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.44 -36.05 82.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.647 -0.251 . . . . 73.230000000000004 111.554 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.54 -52.82 34.32 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.513 -0.312 . . . . 74.519999999999996 111.782 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.1 m -58.72 -39.31 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 111.893 0.331 . . . . 73.099999999999994 111.893 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 117' ' ' LYS . 17.6 mm -77.95 -36.44 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.147 0.425 . . . . 74.019999999999996 112.147 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -60.97 -39.16 88.52 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.32 0.581 . . . . 75.540000000000006 109.952 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -71.79 -70.3 0.34 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.468 -0.787 . . . . 70.019999999999996 111.438 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 11.9 tpt -63.01 -43.32 99.11 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.835 0.68 . . . . 74.230000000000004 112.835 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.441 ' HA ' HG13 ' A' ' 113' ' ' VAL . 32.1 tt0 -71.95 -10.96 60.52 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.032 -0.417 . . . . 75.230000000000004 111.591 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.764 ' HZ3' ' HB2' ' A' ' 105' ' ' LYS . 4.4 ttmp? -87.16 -45.16 10.93 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.221 -0.299 . . . . 74.230000000000004 111.367 177.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -80.5 -31.35 37.23 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.933 0.345 . . . . 72.340000000000003 111.933 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -96.04 -51.34 4.48 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 122.268 -0.27 . . . . 74.549999999999997 111.625 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 74.06 -35.34 0.3 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.954 1.465 . . . . 74.439999999999998 114.954 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.6 ' O ' HG23 ' A' ' 113' ' ' VAL . 28.3 t70 -63.19 121.33 13.39 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.648 -0.658 . . . . 73.420000000000002 112.28 -172.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.601 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -46.29 -51.16 15.1 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.438 -0.801 . . . . 74.349999999999994 113.129 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.481 ' N ' ' HG2' ' A' ' 110' ' ' LYS . . . -70.26 -33.52 71.71 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.085 0.402 . . . . 72.319999999999993 112.085 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -77.54 -49.68 14.17 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.032 0.444 . . . . 43.119999999999997 110.846 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 109' ' ' ASP . 31.1 m -66.52 -22.59 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 122.058 -0.401 . . . . 72.200000000000003 111.073 175.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.58 -50.09 74.25 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.809 0.338 . . . . 74.109999999999999 110.322 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.46 -43.81 96.52 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.237 -0.438 . . . . 44.5 111.084 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.41 ' HE1' ' HB3' ' A' ' 174' ' ' GLU . 87.4 t80 -57.73 -58.29 9.02 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.256 -0.429 . . . . 75.540000000000006 111.8 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.593 ' HA ' HG22 ' A' ' 120' ' ' ILE . 17.6 ptpt -65.46 -30.96 71.81 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.293 -0.254 . . . . 75.400000000000006 111.436 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -58.81 -45.74 89.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.369 0.604 . . . . 74.549999999999997 110.501 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -67.44 -57.38 6.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.508 -0.769 . . . . 75.519999999999996 111.92 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.674 HD11 ' HZ ' ' A' ' 95' ' ' PHE . 10.5 tp -66.38 -39.56 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 112.257 0.465 . . . . 73.340000000000003 112.257 -173.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -73.64 -43.52 59.29 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 122.07 -0.394 . . . . 65.420000000000002 110.449 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.0 -34.4 61.86 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.955 -0.64 . . . . 72.540000000000006 112.228 174.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -62.85 -57.69 9.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.42 0.288 . . . . 74.420000000000002 111.076 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.471 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 26.1 m -62.18 -48.88 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 112.414 0.524 . . . . 75.129999999999995 112.414 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.03 -29.02 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.788 -0.57 . . . . 75.109999999999999 111.952 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.9 t -84.87 -33.85 22.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.846 0.355 . . . . 45.240000000000002 111.331 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.453 HD21 HD13 ' A' ' 155' ' ' ILE . 40.2 tp -70.37 -32.76 70.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.218 0.532 . . . . 74.450000000000003 111.251 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.6 mt -80.29 2.34 25.01 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.147 -0.478 . . . . 73.299999999999997 111.888 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.06 82.39 0.32 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.564 0.697 . . . . 74.030000000000001 110.434 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.707 ' HZ2' ' HB3' ' A' ' 130' ' ' LYS . 5.5 ttpm? -65.0 -6.41 8.51 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.716 -0.675 . . . . 75.109999999999999 112.72 -170.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.49 -47.23 86.31 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.93 -0.481 . . . . 73.239999999999995 111.212 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -108.94 -35.4 6.36 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.039 0.447 . . . . 75.109999999999999 111.429 172.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -69.69 -6.65 33.07 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.436 0.532 . . . . 72.120000000000005 112.436 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -52.78 -25.76 12.29 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.118 0.414 . . . . 75.409999999999997 112.118 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -83.33 12.09 5.87 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.211 0.449 . . . . 75.329999999999998 112.211 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 81.5 mt -90.28 156.8 18.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.259 0.552 . . . . 72.310000000000002 112.093 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.31 126.29 25.98 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.967 -0.56 . . . . 74.230000000000004 110.261 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.492 ' HB2' ' CG1' ' A' ' 153' ' ' VAL . 14.0 p90 -116.91 126.78 53.48 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.382 0.61 . . . . 73.200000000000003 111.33 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -97.95 148.12 23.78 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.706 -0.679 . . . . 75.25 112.18 -172.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 14.1 tt -136.04 150.33 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.716 -0.674 . . . . 74.25 110.592 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.01 140.26 46.73 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.132 -0.556 . . . . 71.329999999999998 113.392 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -50.81 -52.9 36.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.854 0.359 . . . . 72.200000000000003 111.588 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -54.25 -30.71 51.3 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.169 -0.469 . . . . 74.430000000000007 112.149 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.8 -56.49 4.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.489 -0.323 . . . . 73.049999999999997 111.266 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.36 -24.21 66.32 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.144 0.497 . . . . 63.030000000000001 111.589 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -54.72 -29.23 52.84 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.572 -0.74 . . . . 74.439999999999998 112.558 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.5 -34.27 0.1 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.558 -0.83 . . . . 60.049999999999997 113.764 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 149' ' ' GLU . . . -56.74 -50.95 70.71 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.47 0.544 . . . . 74.109999999999999 112.47 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 148' ' ' ALA . 10.8 pt-20 58.48 -22.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 125.273 1.429 . . . . 73.109999999999999 114.362 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 148' ' ' ALA . 20.0 t-20 -88.84 60.76 5.66 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.025 0.916 . . . . 75.010000000000005 109.703 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -129.8 172.75 19.96 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.89 -1.05 . . . . 61.130000000000003 112.697 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -79.04 144.25 34.84 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.016 0.436 . . . . 65.049999999999997 111.396 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.492 ' CG1' ' HB2' ' A' ' 138' ' ' PHE . 37.6 t -114.03 137.14 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.194 -0.457 . . . . 75.200000000000003 111.506 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.744 ' HB2' HD13 ' A' ' 169' ' ' LEU . . . -104.87 119.76 39.78 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.18 -0.464 . . . . 74.230000000000004 110.777 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.453 HD13 HD21 ' A' ' 127' ' ' LEU . 60.7 mt -91.07 138.6 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.159 0.429 . . . . 65.299999999999997 112.159 -174.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.1 mm -115.46 120.14 63.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.022 0.439 . . . . 75.439999999999998 111.144 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -110.99 157.68 19.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.617 -0.72 . . . . 73.209999999999994 111.104 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -106.89 115.19 29.75 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.187 0.518 . . . . 65.120000000000005 111.771 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -115.76 140.04 49.59 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.177 -0.465 . . . . 75.519999999999996 111.769 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -102.52 109.41 21.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.505 -0.316 . . . . 72.099999999999994 110.385 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 52.7 t -90.39 89.85 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.043 0.449 . . . . 74.150000000000006 111.111 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.6 t70 55.38 27.33 9.87 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.866 -0.606 . . . . 74.319999999999993 112.308 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 119.23 -1.61 14.44 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.941 -0.647 . . . . 75.120000000000005 113.985 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 41.6 m -118.61 121.13 39.44 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 117.397 0.598 . . . . 75.129999999999995 111.245 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.25 121.45 26.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.293 0.568 . . . . 73.150000000000006 111.796 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.83 137.66 31.46 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 116.202 -0.454 . . . . 74.0 111.873 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.97 118.42 3.39 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.232 2.621 . . . . 72.109999999999999 112.845 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.3 p -103.95 146.19 29.05 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.29 0.567 . . . . 71.310000000000002 112.188 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.744 HD13 ' HB2' ' A' ' 154' ' ' ALA . 69.9 tp -95.47 137.88 33.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.922 -0.581 . . . . 73.049999999999997 110.916 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.447 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 25.3 mmt -123.16 124.31 42.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.5 0.32 . . . . 73.239999999999995 111.608 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 98.1 mt -139.3 130.21 26.29 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.82 0.448 . . . . 73.430000000000007 111.038 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.596 ' HA ' HG11 ' A' ' 27' ' ' VAL . 60.5 t -78.49 121.94 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 112.132 0.419 . . . . 72.200000000000003 112.132 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -76.96 -36.8 56.23 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.834 0.349 . . . . 72.409999999999997 111.828 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.41 ' HB3' ' HE1' ' A' ' 116' ' ' PHE . 7.0 mm-40 -73.94 6.33 3.44 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.232 0.456 . . . . 71.239999999999995 112.232 -172.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.76 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -107.38 -42.75 4.73 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.047 0.451 . . . . 74.109999999999999 111.331 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 22.4 pt -96.05 170.21 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.917 -0.583 . . . . 75.319999999999993 111.233 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.412 ' CG2' ' HE3' ' A' ' 5' ' ' LYS . 5.2 tp -128.1 111.62 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.669 0.747 . . . . 73.409999999999997 111.927 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.2 153.21 22.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.137 -0.938 . . . . 75.109999999999999 111.411 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.751 ' HB3' HG13 ' A' ' 3' ' ' ILE . 21.4 tp10 -140.32 136.47 33.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.184 0.516 . . . . 72.420000000000002 111.685 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt . . . . . 0 CA--C 1.536 0.423 0 CA-C-N 116.389 -0.369 . . . . 73.340000000000003 111.897 -179.366 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.929 0.395 . . . . 75.340000000000003 111.791 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.9 tp -134.16 128.41 33.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.522 -0.308 . . . . 73.120000000000005 110.225 174.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.539 HG21 ' HB3' ' A' ' 15' ' ' SER . 35.2 pt -111.32 128.09 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 120.9 0.381 . . . . 74.040000000000006 111.798 -175.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -124.04 141.69 51.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.16 0.505 . . . . 74.329999999999998 112.073 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.505 ' HB2' ' HZ3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -103.65 115.37 30.38 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.389 -0.823 . . . . 75.340000000000003 110.356 177.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.69 ' HA ' HG23 ' A' ' 176' ' ' ILE . 3.9 m-20 -77.14 169.63 17.99 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.274 0.559 . . . . 71.450000000000003 112.389 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.427 HG21 ' CD2' ' A' ' 8' ' ' PHE . 10.4 tt -88.54 -31.02 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.029 0.442 . . . . 64.120000000000005 111.541 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.554 ' HB2' ' HB2' ' A' ' 152' ' ' GLN . 91.1 m-85 -98.82 -38.25 9.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.219 0.533 . . . . 70.510000000000005 111.933 178.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.7 p -106.82 21.5 17.42 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.552 0.575 . . . . 74.120000000000005 112.552 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 18.1 t70 -45.54 -45.81 13.67 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.053 0.76 . . . . 63.049999999999997 113.053 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.43 -26.98 67.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.51 0.672 . . . . 74.219999999999999 111.236 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -109.39 24.63 12.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.451 -0.795 . . . . 75.439999999999998 111.054 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -44.35 150.13 0.33 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.808 0.67 . . . . 75.129999999999995 112.808 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.5 t -120.8 168.56 11.31 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.621 0.971 . . . . 73.030000000000001 113.621 -168.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.539 ' HB3' HG21 ' A' ' 3' ' ' ILE . 61.0 p -133.95 107.06 7.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.924 -1.035 . . . . 65.120000000000005 110.69 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -120.16 -177.53 3.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.843 0.354 . . . . 74.400000000000006 111.578 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.0 m -147.22 83.55 1.56 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.14 0.495 . . . . 72.549999999999997 111.243 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.49 ' HB2' ' HE2' ' A' ' 30' ' ' PHE . 85.7 m-85 -135.55 161.73 61.37 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.161 -0.472 . . . . 72.5 111.042 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.4 158.86 40.44 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.532 2.155 . . . . 73.340000000000003 112.613 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -144.08 131.17 20.58 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.248 0.547 . . . . 71.340000000000003 112.318 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -123.49 97.52 5.43 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.125 -0.488 . . . . 74.120000000000005 110.706 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.3 tp -76.93 116.77 17.89 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.48 0.548 . . . . 65.510000000000005 112.48 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.1 p -104.64 139.2 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.058 0.456 . . . . 74.430000000000007 111.824 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 59.02 9.56 1.29 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.534 0.734 . . . . 72.219999999999999 111.783 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.7 t70 55.42 31.75 17.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.763 0.792 . . . . 75.430000000000007 110.36 -174.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.1 tp -124.23 -49.8 1.8 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.876 -0.602 . . . . 74.319999999999993 111.214 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.44 HG12 HG22 ' A' ' 172' ' ' VAL . 3.2 m -128.68 143.94 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.581 0.585 . . . . 73.439999999999998 112.581 -177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.497 ' CE2' ' HB3' ' A' ' 173' ' ' LYS . 60.8 m-85 -86.61 130.74 34.37 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.117 -0.492 . . . . 75.209999999999994 111.522 177.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.95 118.44 30.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.02 -0.991 . . . . 71.209999999999994 110.002 173.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.49 ' HE2' ' HB2' ' A' ' 18' ' ' PHE . 6.2 m-85 -108.94 119.43 39.53 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.217 0.451 . . . . 74.040000000000006 112.217 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -94.61 89.44 5.78 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.048 0.451 . . . . 74.25 111.358 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.87 -157.76 17.43 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 116.007 -0.542 . . . . 61.009999999999998 112.881 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -143.06 132.8 23.88 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 122.029 -0.689 . . . . 74.129999999999995 111.635 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -72.08 106.89 4.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.582 0.23 . . . . 74.010000000000005 110.447 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -134.41 164.44 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.209 0.528 . . . . 74.209999999999994 112.222 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 66' ' ' ARG . 29.4 m -138.67 131.88 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.103 -0.499 . . . . 74.439999999999998 110.745 175.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 43.5 ttp180 . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 120.877 0.37 . . . . 73.25 111.556 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 1.2 mp0 . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 121.486 0.66 . . . . 75.450000000000003 110.983 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.556 ' HA ' HG12 ' A' ' 36' ' ' VAL . 6.2 ttp180 -83.32 110.69 18.33 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.398 -0.819 . . . . 72.409999999999997 111.709 177.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.25 -153.98 12.45 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.852 -0.689 . . . . 75.540000000000006 112.943 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 167' ' ' PRO . 33.6 pt -112.03 150.52 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.224 -0.574 . . . . 74.040000000000006 111.799 176.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -38.39 -56.87 1.2 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.65 0.78 . . . . 75.040000000000006 112.724 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.4 mt -53.88 -55.16 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.824 0.676 . . . . 71.109999999999999 112.824 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.458 ' HA ' HD11 ' A' ' 76' ' ' LEU . 19.4 m -68.38 -35.2 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.147 0.425 . . . . 71.209999999999994 112.147 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.42 -47.01 68.36 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.066 0.46 . . . . 72.200000000000003 110.852 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -66.64 -44.15 82.75 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.881 -0.6 . . . . 74.239999999999995 111.659 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.454 ' HD2' HD22 ' A' ' 76' ' ' LEU . 78.1 t60 -82.14 -6.04 58.89 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.851 0.358 . . . . 74.549999999999997 111.188 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.714 ' HZ3' ' HB2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 62.34 70.08 0.59 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.611 0.72 . . . . 72.209999999999994 111.865 176.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.648 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 71.7 mt -111.8 137.72 49.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.401 -0.818 . . . . 75.329999999999998 111.418 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.3 p -91.25 143.54 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.081 0.467 . . . . 73.450000000000003 111.563 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -79.44 127.46 32.14 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.078 -0.51 . . . . 75.430000000000007 112.308 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 35.3 mtm -131.11 164.92 24.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.167 0.508 . . . . 75.530000000000001 110.999 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -142.58 158.88 43.21 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.179 -0.464 . . . . 72.230000000000004 111.013 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.8 m -49.71 -27.7 5.12 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.565 0.95 . . . . 73.329999999999998 113.565 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -48.27 -41.15 27.0 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.101 0.477 . . . . 74.230000000000004 111.244 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -105.3 -38.36 6.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.377 0.608 . . . . 71.329999999999998 110.972 174.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -71.9 -13.52 61.68 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.917 0.71 . . . . 63.240000000000002 112.917 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.52 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -43.69 -66.1 0.42 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.858 0.688 . . . . 73.439999999999998 112.858 -177.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.2 t -71.62 -18.28 62.22 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.245 -0.284 . . . . 74.409999999999997 111.487 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.27 -63.54 1.06 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.8 -0.182 . . . . 64.430000000000007 111.168 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 17.7 p90 -59.53 -33.08 70.94 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.854 -0.338 . . . . 74.540000000000006 110.717 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -57.23 -47.41 81.41 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.131 0.491 . . . . 72.209999999999994 110.964 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.14 -38.45 82.17 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.245 -0.434 . . . . 70.030000000000001 111.605 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -65.05 -41.33 95.28 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.669 -0.242 . . . . 73.319999999999993 111.358 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.84 -37.09 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.965 0.412 . . . . 73.329999999999998 110.853 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -58.57 -56.26 24.46 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.161 0.505 . . . . 71.420000000000002 110.855 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -59.78 -45.09 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.895 -0.593 . . . . 74.010000000000005 111.061 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.413 ' CE1' ' HB1' ' A' ' 175' ' ' ALA . 83.0 t80 -56.96 -61.91 2.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.817 -0.629 . . . . 71.120000000000005 111.976 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.45 ' O ' HG21 ' A' ' 100' ' ' ILE . 48.5 mtt -53.62 -50.12 66.38 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 111.899 0.333 . . . . 73.310000000000002 111.899 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.13 -41.98 97.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.773 0.321 . . . . 74.430000000000007 111.638 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -68.57 -48.19 64.86 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.743 0.306 . . . . 74.109999999999999 111.63 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.22 -41.35 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.258 0.466 . . . . 73.340000000000003 112.258 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.45 HG21 ' O ' ' A' ' 96' ' ' MET . 10.5 tp -68.27 -37.73 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 122.113 -0.367 . . . . 74.120000000000005 110.573 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 15.4 t70 -54.82 -60.92 2.7 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.131 0.491 . . . . 74.409999999999997 110.547 175.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -62.36 -34.55 76.91 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.335 -0.393 . . . . 74.439999999999998 111.843 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 10.8 tpt -61.38 -42.34 98.56 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.099 0.476 . . . . 75.510000000000005 110.883 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.7 -8.59 58.85 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 111.883 0.327 . . . . 75.530000000000001 111.883 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 61.7 mmtt -81.58 -27.69 34.18 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.698 -0.626 . . . . 63.219999999999999 111.761 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -102.44 -36.92 8.24 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.694 0.627 . . . . 74.329999999999998 112.694 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -98.57 -51.06 4.05 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.872 -0.517 . . . . 75.430000000000007 111.096 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.63 -36.86 0.27 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.646 0.98 . . . . 75.120000000000005 113.646 167.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -82.79 144.32 30.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.239 0.542 . . . . 75.200000000000003 112.432 -173.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.07 -38.27 79.02 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.627 -0.715 . . . . 75.510000000000005 112.617 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.25 27.26 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.065 0.394 . . . . 65.129999999999995 112.065 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -94.97 -61.05 1.55 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.984 0.421 . . . . 71.329999999999998 111.285 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.7 m -60.91 -27.53 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 113.185 0.809 . . . . 71.140000000000001 113.185 -173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.24 -38.7 88.52 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.04 0.448 . . . . 73.409999999999997 110.567 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.1 -46.22 62.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.199 -0.455 . . . . 70.329999999999998 111.235 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -57.16 -52.22 66.17 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.133 0.492 . . . . 74.25 111.332 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -61.1 -29.74 69.94 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.849 -0.614 . . . . 75.109999999999999 110.515 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -69.38 -46.91 65.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.222 -0.444 . . . . 71.310000000000002 111.635 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -59.61 -51.71 68.64 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.812 0.339 . . . . 65.109999999999999 111.895 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -67.0 -33.64 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 120.769 0.318 . . . . 75.019999999999996 111.507 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.95 -48.61 68.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.911 0.386 . . . . 73.430000000000007 110.399 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.63 -35.75 87.07 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.001 -0.619 . . . . 74.5 112.205 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.406 ' HZ2' ' HE3' ' A' ' 170' ' ' MET . 55.2 t90 -58.3 -57.04 14.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.622 0.369 . . . . 74.299999999999997 111.399 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 m -61.94 -48.2 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.352 0.501 . . . . 74.519999999999996 112.352 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.3 -28.92 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 121.912 -0.492 . . . . 64.5 111.896 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.9 m -82.27 -24.87 34.52 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.05 0.452 . . . . 62.340000000000003 111.031 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.47 -28.13 22.25 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.973 -0.558 . . . . 72.120000000000005 111.828 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.3 mt -79.96 2.43 23.57 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.765 0.654 . . . . 74.310000000000002 112.765 -176.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.47 92.11 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.32 0.581 . . . . 74.010000000000005 111.173 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -54.64 -43.36 72.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.12 0.785 . . . . 75.219999999999999 113.12 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -53.24 -34.87 58.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.351 0.5 . . . . 73.120000000000005 112.351 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.416 ' N ' ' HD2' ' A' ' 132' ' ' ARG . 8.2 mpt_? -102.91 -48.12 4.17 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.26 0.553 . . . . 74.209999999999994 111.206 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.459 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 97.6 m-85 -78.3 -6.6 55.55 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.287 0.847 . . . . 73.430000000000007 113.287 -171.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -12.02 3.53 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.527 -0.733 . . . . 74.219999999999999 111.727 173.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -92.64 18.39 8.8 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.106 0.41 . . . . 55.109999999999999 112.106 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 81.0 mt -88.36 144.71 26.23 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.939 -0.476 . . . . 73.129999999999995 111.65 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.28 122.21 45.76 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.056 -0.52 . . . . 74.310000000000002 110.802 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -97.91 108.6 21.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.855 0.359 . . . . 73.409999999999997 111.189 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.648 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 67.3 m-85 -102.88 130.41 49.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.08 0.467 . . . . 74.209999999999994 111.666 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.441 HD11 ' HA3' ' A' ' 151' ' ' GLY . 14.3 tt -128.31 155.1 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.084 -0.507 . . . . 75.310000000000002 110.9 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.41 143.54 41.44 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.351 -0.452 . . . . 73.040000000000006 113.614 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -50.85 -63.76 1.02 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.196 0.443 . . . . 74.400000000000006 112.196 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 2.6 mmp_? -49.4 -34.12 15.48 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.23 0.456 . . . . 75.150000000000006 112.23 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.673 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . . . -63.88 -56.38 15.78 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.02 0.438 . . . . 63.539999999999999 111.732 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.88 -28.89 69.85 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.801 0.334 . . . . 71.400000000000006 111.634 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.73 -31.52 63.41 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.104 -0.498 . . . . 64.200000000000003 112.148 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.15 -43.93 0.03 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.279 -0.962 . . . . 65.129999999999995 114.301 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.673 ' HB1' ' HA ' ' A' ' 144' ' ' ALA . . . -66.29 86.26 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.196 0.522 . . . . 72.239999999999995 112.129 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.25 4.22 0.75 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.35 0.5 . . . . 75.409999999999997 112.35 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 8' ' ' PHE . 3.2 p-10 -91.93 24.08 3.39 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.158 0.504 . . . . 63.210000000000001 110.381 170.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.587 ' HA3' ' HB3' ' A' ' 144' ' ' ALA . . . -77.56 134.23 14.32 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 114.232 0.453 . . . . 55.32 114.232 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 8' ' ' PHE . 48.1 tt0 -93.98 134.6 36.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 122.558 0.343 . . . . 65.140000000000001 111.005 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 98.7 t -95.01 136.31 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.407 0.521 . . . . 75.510000000000005 112.407 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.76 ' HB3' HD11 ' A' ' 169' ' ' LEU . . . -103.98 136.21 44.05 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.865 -0.607 . . . . 73.040000000000006 110.069 173.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.502 ' HB ' ' HG3' ' A' ' 170' ' ' MET . 62.3 mt -102.53 128.31 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 120.003 -0.679 . . . . 72.340000000000003 112.734 -170.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 46.1 mm -102.5 117.63 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.782 0.325 . . . . 71.219999999999999 111.49 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -106.74 145.49 31.99 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.252 0.549 . . . . 64.040000000000006 112.285 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -77.13 98.14 4.97 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.699 0.761 . . . . 73.340000000000003 110.136 171.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.446 ' HB2' ' OG1' ' A' ' 168' ' ' THR . 0.0 OUTLIER -93.43 97.03 10.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.099 -0.501 . . . . 75.319999999999993 111.11 -174.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 7.4 p-10 -66.99 119.2 11.56 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.162 0.506 . . . . 75.329999999999998 111.217 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.6 t -121.53 105.61 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.084 -0.507 . . . . 73.510000000000005 110.899 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 53.41 34.62 18.53 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.416 0.524 . . . . 71.329999999999998 112.416 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.15 -23.49 27.09 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.284 -0.417 . . . . 72.200000000000003 113.759 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 85.8 m -105.88 113.92 27.76 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.502 -0.411 . . . . 73.140000000000001 111.757 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 49.4 mt-10 -73.48 110.24 7.61 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.754 0.312 . . . . 72.239999999999995 111.156 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.69 140.14 20.82 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 120.747 0.308 . . . . 72.439999999999998 111.145 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.409 ' HB2' HG23 ' A' ' 68' ' ' ILE . 73.4 Cg_endo -74.62 114.35 4.01 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.12 1.88 . . . . 63.130000000000003 112.704 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 159' ' ' ARG . 23.7 p -118.78 150.86 39.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.228 0.537 . . . . 74.310000000000002 111.588 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.76 HD11 ' HB3' ' A' ' 154' ' ' ALA . 38.7 tp -100.4 140.12 35.1 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.044 -0.526 . . . . 74.230000000000004 111.025 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.502 ' HG3' ' HB ' ' A' ' 155' ' ' ILE . 22.2 ptm -123.41 134.63 53.94 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 121.132 0.491 . . . . 61.149999999999999 111.236 177.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 86.3 mt -141.6 148.31 39.03 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.146 -0.934 . . . . 74.530000000000001 111.433 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 27' ' ' VAL . 10.7 t -100.96 122.66 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.254 0.222 . . . . 64.439999999999998 110.745 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -74.13 -5.98 44.92 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.793 -0.567 . . . . 64.519999999999996 112.04 -177.246 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.67 -15.24 60.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.364 0.602 . . . . 75.530000000000001 110.08 170.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 95' ' ' PHE . . . -99.03 -22.88 15.5 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.701 -0.682 . . . . 75.439999999999998 111.67 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.69 HG23 ' HA ' ' A' ' 6' ' ' ASP . 40.3 pt -137.13 130.73 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.281 0.562 . . . . 73.439999999999998 111.972 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.3 mm -104.42 118.99 52.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.316 -0.402 . . . . 74.25 110.305 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.55 146.09 25.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.426 0.631 . . . . 73.140000000000001 112.167 -176.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -131.23 143.89 50.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.985 -0.552 . . . . 75.299999999999997 110.994 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 21.0 pttp . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 121.344 0.592 . . . . 74.140000000000001 112.014 -175.542 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.895 0.379 . . . . 71.5 111.594 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.432 HD13 ' HB3' ' A' ' 178' ' ' GLU . 44.1 tp -95.58 131.44 41.78 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.147 -0.346 . . . . 73.109999999999999 110.851 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.6 mt -121.15 118.97 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 122.245 -0.284 . . . . 72.040000000000006 110.485 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.412 ' O ' HD13 ' A' ' 13' ' ' LEU . 47.1 p90 -116.41 149.27 39.7 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.107 0.78 . . . . 75.040000000000006 113.107 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.651 ' HG3' ' HB2' ' A' ' 10' ' ' ASP . 48.0 tttp -137.07 119.0 15.25 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.544 -1.207 . . . . 75.019999999999996 111.416 -173.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 2.8 m-20 -68.85 173.5 5.25 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.451 0.644 . . . . 75.430000000000007 111.795 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 175' ' ' ALA . 71.6 mt -81.38 -38.78 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.261 0.553 . . . . 72.099999999999994 110.474 168.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -108.69 -44.3 4.07 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.909 -0.587 . . . . 73.549999999999997 112.526 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -91.72 14.41 15.36 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.861 0.363 . . . . 72.099999999999994 111.868 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.651 ' HB2' ' HG3' ' A' ' 5' ' ' LYS . 7.0 p-10 -61.78 -10.47 9.02 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.783 0.66 . . . . 41.439999999999998 112.783 -173.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.77 -27.5 51.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.568 0.699 . . . . 74.109999999999999 110.192 173.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -93.32 24.74 3.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.07 -0.968 . . . . 75.439999999999998 111.868 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 4' ' ' TYR . 62.8 tp -34.15 109.13 0.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.408 0.683 . . . . 74.230000000000004 112.291 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.5 m -113.2 140.77 47.67 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.982 0.734 . . . . 63.340000000000003 112.982 -169.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.6 p -110.83 105.54 14.41 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.755 -0.657 . . . . 73.409999999999997 110.254 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -123.16 179.89 4.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 120.716 0.294 . . . . 75.510000000000005 111.47 -173.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.2 t -109.22 -28.59 8.94 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.892 0.701 . . . . 72.030000000000001 112.892 -176.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -66.27 118.32 51.99 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 112.203 0.446 . . . . 74.540000000000006 112.203 -175.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -91.24 152.83 3.74 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.112 2.542 . . . . 75.120000000000005 113.826 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 20' ' ' MET . 0.6 OUTLIER -114.63 165.77 12.43 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.339 -0.392 . . . . 74.239999999999995 111.113 178.331 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -100.01 120.72 40.26 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.094 -0.379 . . . . 71.420000000000002 110.532 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.1 tp -83.39 120.89 26.45 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.076 0.465 . . . . 70.150000000000006 111.22 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.77 149.07 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.286 -0.415 . . . . 74.439999999999998 111.103 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.6 t70 62.8 9.11 3.42 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 116.436 -0.347 . . . . 73.150000000000006 111.652 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 55.06 23.43 5.21 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.106 0.479 . . . . 64.040000000000006 111.739 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.1 tp -134.16 -43.26 0.79 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.264 -0.425 . . . . 75.129999999999995 111.917 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.3 155.58 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.032 0.444 . . . . 71.310000000000002 112.164 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' A' ' 170' ' ' MET . 90.5 m-85 -92.88 149.28 21.37 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.41 -0.359 . . . . 73.239999999999995 110.752 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -136.42 116.47 13.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.745 0.418 . . . . 74.109999999999999 110.652 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.548 ' CZ ' HD23 ' A' ' 169' ' ' LEU . 16.9 p90 -151.13 134.55 16.2 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.082 1.141 . . . . 73.519999999999996 114.082 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.776 ' HG3' ' HB ' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -98.88 120.8 39.94 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.574 -0.739 . . . . 74.420000000000002 110.798 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.93 -120.25 0.46 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.972 -0.633 . . . . 52.329999999999998 113.158 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -150.64 141.43 22.78 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 122.654 -0.321 . . . . 75.329999999999998 110.442 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -77.66 106.48 9.49 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.653 0.263 . . . . 73.329999999999998 110.957 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.4 m -143.36 171.96 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.455 0.645 . . . . 72.0 112.434 -175.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.96 128.43 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.807 -0.633 . . . . 72.030000000000001 110.686 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.421 HH21 ' CD ' ' A' ' 65' ' ' GLU . 47.4 ttp180 . . . . . 0 CA--C 1.539 0.519 0 CA-C-O 121.283 0.563 . . . . 71.450000000000003 111.411 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' ' 37' ' ' ARG . 48.5 mt-10 . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.788 0.804 . . . . 73.239999999999995 110.146 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -84.11 142.54 30.31 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.916 -1.038 . . . . 74.239999999999995 111.917 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.41 -138.78 6.48 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.063 -0.589 . . . . 73.019999999999996 113.047 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.8 pt -111.16 142.23 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 O-C-N 122.377 -0.484 . . . . 75.150000000000006 111.449 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -44.17 -42.52 6.47 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.593 0.59 . . . . 72.040000000000006 112.593 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.0 mt -47.75 -52.2 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.107 0.48 . . . . 64.549999999999997 112.216 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 26.7 m -83.3 -34.94 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 112.059 -174.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.84 -44.24 96.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.834 0.349 . . . . 73.510000000000005 111.782 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -67.56 -18.41 65.0 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.238 0.458 . . . . 64.430000000000007 112.238 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -111.24 7.15 21.04 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.219 -0.301 . . . . 75.310000000000002 111.393 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp 50.73 52.53 14.72 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.29 0.636 . . . . 70.209999999999994 112.685 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 55.7 mt -91.4 128.16 37.12 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.997 -0.547 . . . . 72.420000000000002 110.644 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.8 p -93.18 147.32 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.584 0.231 . . . . 74.439999999999998 111.26 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.09 140.19 30.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.718 0.77 . . . . 74.239999999999995 112.989 -175.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 65.3 mtm -135.38 166.08 23.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.243 -0.89 . . . . 61.420000000000002 109.609 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.4 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 44.5 t30 -133.16 145.45 50.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.346 0.593 . . . . 72.019999999999996 111.938 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.6 t -42.16 -30.44 0.3 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.928 1.455 . . . . 74.430000000000007 114.928 -170.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.4 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 20.8 p90 -59.96 -32.24 70.63 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.985 -0.447 . . . . 74.420000000000002 111.644 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -101.28 -31.25 11.07 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.763 0.316 . . . . 71.099999999999994 111.132 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -71.78 -12.38 61.27 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.791 0.663 . . . . 71.349999999999994 112.791 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.461 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -31.03 -73.64 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.195 1.184 . . . . 75.299999999999997 114.195 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.2 m -71.03 -23.18 62.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.022 0.378 . . . . 74.230000000000004 112.022 -176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.8 ttm -70.17 -57.3 5.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.62 -0.264 . . . . 72.430000000000007 111.58 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.461 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 11.0 p90 -65.22 -26.14 67.99 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.469 -0.492 . . . . 72.040000000000006 110.816 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.31 -42.24 99.2 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.02 0.438 . . . . 75.420000000000002 110.915 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.22 -36.19 76.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.098 0.475 . . . . 75.030000000000001 111.154 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.17 -55.24 26.81 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.029 -0.532 . . . . 73.409999999999997 111.728 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.1 tp -60.58 -29.5 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.185 0.517 . . . . 74.219999999999999 111.011 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.52 -58.52 8.23 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.819 -0.628 . . . . 75.109999999999999 111.063 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.625 ' HA ' ' HD2' ' A' ' 97' ' ' LYS . 68.1 mttm -64.64 -34.21 77.76 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.178 -0.465 . . . . 75.120000000000005 111.28 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.538 ' HZ ' HG12 ' A' ' 172' ' ' VAL . 66.1 t80 -56.02 -53.44 56.87 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.79 -0.641 . . . . 73.129999999999995 110.889 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -52.45 -46.63 66.54 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.016 0.436 . . . . 74.109999999999999 111.038 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.625 ' HD2' ' HA ' ' A' ' 94' ' ' LYS . 61.9 mttm -52.7 -59.31 4.64 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.813 -0.63 . . . . 73.219999999999999 111.783 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -68.24 -43.12 78.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.036 0.754 . . . . 74.299999999999997 113.036 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.7 m -64.11 -45.03 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.048 0.388 . . . . 74.239999999999995 112.048 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 mm -69.01 -37.19 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 122.064 -0.397 . . . . 73.420000000000002 110.73 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 105' ' ' LYS . 29.5 t70 -59.94 -45.76 91.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.137 0.494 . . . . 74.329999999999998 110.455 174.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -64.41 -50.06 69.09 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.929 -0.578 . . . . 74.409999999999997 111.936 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 49.7 tpp -70.56 -47.35 60.72 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.011 0.434 . . . . 74.349999999999994 112.032 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -73.96 -19.39 60.69 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 122.066 -0.396 . . . . 73.129999999999995 111.43 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 101' ' ' ASP . 86.8 tttt -59.6 -55.03 39.58 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.289 0.566 . . . . 75.219999999999999 111.647 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -102.44 -37.69 7.91 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.594 0.59 . . . . 73.329999999999998 112.594 -174.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -76.63 -53.65 7.74 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.806 0.336 . . . . 74.129999999999995 110.749 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 46.11 11.76 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.865 1.432 . . . . 74.329999999999998 114.865 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 113' ' ' VAL . 12.6 t70 -77.62 109.21 11.4 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.676 -0.64 . . . . 74.200000000000003 110.21 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -54.21 -27.12 32.26 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.146 0.795 . . . . 74.540000000000006 113.146 -174.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.02 -37.0 34.99 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.978 0.418 . . . . 55.109999999999999 111.344 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -74.82 -53.13 9.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.299 -0.41 . . . . 73.349999999999994 111.354 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 109' ' ' ASP . 22.4 m -58.78 -31.31 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 111.991 0.367 . . . . 65.510000000000005 111.991 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.61 -36.92 79.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.814 0.34 . . . . 74.540000000000006 110.469 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.26 -48.89 71.65 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.439 -0.346 . . . . 70.340000000000003 110.855 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -55.94 -52.01 65.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.179 0.514 . . . . 73.239999999999995 111.062 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -56.72 -38.61 72.59 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.843 -0.617 . . . . 75.310000000000002 111.489 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -66.03 -41.34 91.05 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.012 0.434 . . . . 74.010000000000005 111.347 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -66.32 -49.43 67.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.192 -0.458 . . . . 73.510000000000005 111.628 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.9 tp -65.93 -34.35 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.804 0.335 . . . . 73.510000000000005 111.033 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -64.08 -49.0 73.98 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.874 0.368 . . . . 74.409999999999997 110.966 175.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.53 -39.3 92.97 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.047 -0.596 . . . . 71.219999999999999 112.527 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 53.5 t90 -61.38 -56.67 17.69 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.331 0.252 . . . . 74.209999999999994 111.327 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.43 -41.89 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.645 0.609 . . . . 74.310000000000002 112.645 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.5 p -64.03 -33.58 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.89 -0.506 . . . . 73.510000000000005 111.861 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.5 t -80.17 -40.43 27.28 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.089 0.471 . . . . 75.519999999999996 111.139 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.471 HD21 HD13 ' A' ' 155' ' ' ILE . 39.1 tp -67.43 -42.28 83.42 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.279 0.474 . . . . 73.230000000000004 112.279 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.2 mt -72.5 1.4 8.16 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.435 0.531 . . . . 72.450000000000003 112.435 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.1 72.49 0.18 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.523 0.678 . . . . 64.319999999999993 110.623 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -59.49 -22.13 61.13 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.622 -0.717 . . . . 75.430000000000007 112.319 -174.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.18 -31.03 63.05 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.203 0.525 . . . . 60.399999999999999 110.948 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -109.31 -37.31 5.79 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.812 -0.631 . . . . 74.219999999999999 111.545 174.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -93.23 -5.73 49.26 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.656 1.354 . . . . 74.219999999999999 114.656 -169.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -58.7 -13.56 6.26 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.096 0.862 . . . . 73.010000000000005 111.806 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -90.1 24.46 2.47 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.233 -0.44 . . . . 63.119999999999997 112.058 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.0 mt -88.36 153.88 20.83 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.0 0.429 . . . . 74.430000000000007 111.001 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.653 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -105.18 112.41 25.53 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.884 0.374 . . . . 61.340000000000003 111.286 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -98.43 107.18 19.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.906 0.384 . . . . 75.120000000000005 110.946 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.408 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 59.7 m-85 -97.82 143.53 28.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.161 0.505 . . . . 74.420000000000002 112.297 -177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.416 HG21 ' HB2' ' A' ' 145' ' ' ALA . 14.3 tt -134.97 151.47 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.929 -0.578 . . . . 74.25 111.06 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.44 150.68 49.28 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 114.478 0.551 . . . . 54.43 114.478 -176.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -47.3 -58.08 4.51 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.295 0.638 . . . . 74.200000000000003 112.104 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -65.5 -45.55 83.14 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.868 0.366 . . . . 74.219999999999999 111.691 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.54 -38.01 79.91 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.413 0.523 . . . . 64.239999999999995 112.413 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.416 ' HB2' HG21 ' A' ' 140' ' ' ILE . . . -63.31 -54.5 36.14 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.177 0.513 . . . . 70.430000000000007 111.783 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -68.06 -40.53 82.76 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.272 -0.422 . . . . 74.450000000000003 111.146 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.2 -20.77 79.6 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.404 -0.426 . . . . 64.239999999999995 113.681 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 63.08 21.91 13.14 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.845 0.683 . . . . 73.109999999999999 112.845 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -73.45 82.43 1.45 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.655 0.613 . . . . 72.430000000000007 112.655 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.6 m120 74.24 -41.91 0.49 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.834 0.854 . . . . 73.239999999999995 113.033 172.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.09 78.7 1.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.363 -0.446 . . . . 64.439999999999998 114.095 177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -70.6 102.0 2.16 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.224 -0.574 . . . . 74.310000000000002 109.699 172.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 96.6 t -86.65 125.01 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 113.239 0.829 . . . . 72.450000000000003 113.239 -172.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.543 ' HB1' HD13 ' A' ' 169' ' ' LEU . . . -92.86 113.29 25.53 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.703 -0.681 . . . . 75.219999999999999 109.669 169.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.471 HD13 HD21 ' A' ' 127' ' ' LEU . 55.5 mt -92.13 112.98 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.384 0.513 . . . . 74.5 112.384 -170.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.653 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 49.2 mm -90.74 106.17 17.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 120.837 0.351 . . . . 65.319999999999993 110.637 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -106.92 132.02 53.34 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.688 -0.687 . . . . 75.430000000000007 111.279 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -89.43 138.47 31.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.212 -0.449 . . . . 74.299999999999997 111.409 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -137.63 119.65 15.45 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.746 0.307 . . . . 73.219999999999999 111.533 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -85.78 92.33 8.58 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.574 0.702 . . . . 74.230000000000004 111.223 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.45 102.55 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.109 -0.496 . . . . 73.319999999999993 110.42 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 58.64 19.27 6.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.241 0.543 . . . . 65.120000000000005 111.038 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.47 -12.93 33.19 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.043 -0.526 . . . . 60.350000000000001 113.229 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.5 m -84.25 115.58 22.53 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.451 -0.441 . . . . 74.040000000000006 111.074 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.42 117.56 15.32 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.359 0.504 . . . . 71.530000000000001 112.359 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.776 ' HB ' ' HG3' ' A' ' 31' ' ' LYS . 25.7 m -128.82 112.32 18.84 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 121.012 0.434 . . . . 75.540000000000006 111.595 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.55 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 6.9 Cg_exo -75.1 113.63 3.83 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.521 2.147 . . . . 71.549999999999997 112.377 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.493 HG21 ' HB2' ' A' ' 31' ' ' LYS . 44.2 p -109.3 159.05 17.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.59 -0.277 . . . . 74.219999999999999 111.504 -176.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.548 HD23 ' CZ ' ' A' ' 30' ' ' PHE . 23.0 tp -104.73 126.8 52.17 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.9 0.381 . . . . 74.430000000000007 111.038 177.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.596 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 48.6 ttm -105.01 126.12 51.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.281 -0.872 . . . . 64.129999999999995 110.993 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.451 ' HB3' HD11 ' A' ' 176' ' ' ILE . 94.4 mt -137.03 123.07 20.29 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.034 -0.53 . . . . 62.240000000000002 111.36 -178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.538 HG12 ' HZ ' ' A' ' 95' ' ' PHE . 22.6 t -74.85 122.01 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 122.095 -0.378 . . . . 74.219999999999999 111.425 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -11.33 60.72 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.893 0.701 . . . . 73.219999999999999 112.893 -176.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -91.83 -11.18 37.25 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.815 0.341 . . . . 74.129999999999995 111.598 174.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.491 ' HB3' ' HE1' ' A' ' 95' ' ' PHE . . . -96.14 -38.44 10.16 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.381 0.61 . . . . 64.299999999999997 110.232 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.451 HD11 ' HB3' ' A' ' 171' ' ' LEU . 32.4 pt -127.45 118.94 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.371 -0.831 . . . . 73.019999999999996 109.28 168.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.8 tp -94.6 110.86 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.511 0.672 . . . . 65.319999999999993 111.563 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.44 ' HG2' ' HH ' ' A' ' 28' ' ' TYR . 16.7 mm-40 -79.57 115.81 19.41 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.609 -0.723 . . . . 74.340000000000003 110.585 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.422 ' O ' HD12 ' A' ' 2' ' ' LEU . 10.1 tp10 -92.92 116.29 28.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.455 0.645 . . . . 71.030000000000001 109.856 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.399 -0.819 . . . . 74.230000000000004 112.999 -167.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 111.917 0.34 . . . . 73.420000000000002 111.917 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' A' ' 178' ' ' GLU . 38.1 tp -75.22 122.93 24.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.759 0.314 . . . . 71.310000000000002 111.261 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.686 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 50.7 mt -97.59 120.79 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.586 0.232 . . . . 73.510000000000005 111.016 -174.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.43 ' CE1' ' HB2' ' A' ' 14' ' ' SER . 34.9 p90 -107.85 139.27 42.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.704 0.631 . . . . 75.540000000000006 112.704 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.605 ' HB2' HD11 ' A' ' 13' ' ' LEU . 52.0 tttp -130.02 122.16 27.87 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.805 -1.089 . . . . 65.329999999999998 111.071 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.609 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 33.1 t70 -80.54 173.31 12.72 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.484 0.183 . . . . 75.209999999999994 110.552 175.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.5 mt -75.72 -46.23 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.836 -0.54 . . . . 73.019999999999996 111.698 176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -108.49 -41.27 4.88 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.273 0.558 . . . . 74.430000000000007 112.122 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.4 16.55 7.37 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.27 0.628 . . . . 64.209999999999994 111.804 -175.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.609 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 10.7 p-10 -59.86 -4.26 0.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.952 1.093 . . . . 74.5 113.952 -170.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.53 -19.66 64.97 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.877 -0.514 . . . . 53.530000000000001 111.331 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.63 23.35 1.68 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.611 0.244 . . . . 73.340000000000003 111.358 170.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 5' ' ' LYS . 57.2 tp -49.28 104.04 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.516 0.326 . . . . 74.040000000000006 110.53 173.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.43 ' HB2' ' CE1' ' A' ' 4' ' ' TYR . 70.0 m -133.51 147.61 51.63 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.223 0.823 . . . . 75.230000000000004 113.223 -170.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.2 p -82.51 88.84 6.62 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.632 -0.713 . . . . 54.43 110.568 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -90.11 179.35 5.95 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.766 -0.652 . . . . 72.219999999999999 111.855 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.8 p -161.85 25.99 0.12 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.267 0.469 . . . . 72.140000000000001 112.267 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -89.69 149.87 43.02 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-O 120.6 0.238 . . . . 72.450000000000003 111.625 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.97 72.67 1.53 Allowed 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.804 2.336 . . . . 75.420000000000002 113.461 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 55.0 ttp -87.69 115.36 25.08 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.27 -0.423 . . . . 73.530000000000001 110.793 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -102.44 159.05 15.76 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.699 0.285 . . . . 74.319999999999993 111.67 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.9 tp -104.86 142.53 34.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.033 0.444 . . . . 62.039999999999999 111.408 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.483 HG12 HG23 ' A' ' 27' ' ' VAL . 7.2 p -134.13 141.12 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-N 116.144 -0.48 . . . . 73.219999999999999 111.115 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 56.83 23.61 8.27 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.763 0.653 . . . . 74.349999999999994 112.763 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 60.91 3.98 0.73 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.041 0.756 . . . . 55.509999999999998 113.041 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 120' ' ' ILE . 41.0 tp -125.3 -43.56 1.92 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.945 0.72 . . . . 71.310000000000002 112.945 -169.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.483 HG23 HG12 ' A' ' 23' ' ' VAL . 1.2 m -123.82 149.4 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.284 0.476 . . . . 72.540000000000006 112.284 -175.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 58.6 m-85 -85.84 147.6 26.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.888 0.375 . . . . 73.310000000000002 111.337 176.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.429 ' HB2' ' NH2' ' A' ' 159' ' ' ARG . 14.9 pt-20 -121.1 137.98 54.41 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.009 -0.541 . . . . 74.439999999999998 110.941 176.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -150.75 113.16 4.64 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.404 -0.362 . . . . 75.430000000000007 110.119 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -75.07 135.38 41.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.172 0.51 . . . . 74.099999999999994 112.331 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.54 133.37 11.43 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.335 -0.46 . . . . 63.210000000000001 112.184 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -91.92 152.41 20.07 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.332 0.566 . . . . 74.150000000000006 112.173 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -71.11 105.28 3.31 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.568 -0.742 . . . . 65.310000000000002 111.636 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.498 HG22 HD11 ' A' ' 72' ' ' LEU . 19.7 m -143.99 -177.97 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.977 0.418 . . . . 75.299999999999997 111.595 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.6 m -119.12 145.74 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 112.382 0.512 . . . . 64.019999999999996 112.382 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.694 ' HB3' HD23 ' A' ' 72' ' ' LEU . 7.6 tpm_? . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 121.577 0.703 . . . . 74.310000000000002 110.807 175.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 33.6 tt0 . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 113.354 0.872 . . . . 73.230000000000004 113.354 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -111.2 135.54 51.59 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.4 -0.812 . . . . 75.519999999999996 111.862 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.405 ' HA3' HD21 ' A' ' 72' ' ' LEU . . . 169.56 -170.53 42.74 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.044 -1.074 . . . . 53.439999999999998 113.77 169.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.7 pt -103.57 146.65 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.797 -0.237 . . . . 74.400000000000006 110.556 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -38.99 -53.15 1.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.997 0.74 . . . . 73.319999999999993 112.997 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.594 HG22 HD21 ' A' ' 169' ' ' LEU . 60.7 mt -49.04 -62.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 112.673 0.62 . . . . 74.230000000000004 112.673 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 m -66.12 -31.99 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.261 -0.427 . . . . 74.150000000000006 112.031 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.694 HD23 ' HB3' ' A' ' 37' ' ' ARG . 76.0 mt -76.59 -33.02 58.45 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.063 0.459 . . . . 71.319999999999993 111.39 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -73.29 -42.71 62.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.083 -0.508 . . . . 65.420000000000002 111.516 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -94.77 -3.43 49.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 111.782 0.29 . . . . 73.530000000000001 111.782 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 65.24 71.63 0.44 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.296 0.57 . . . . 74.299999999999997 112.195 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 49.9 mt -108.7 128.51 54.92 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.754 -0.657 . . . . 74.329999999999998 110.595 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.4 p -89.57 149.33 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.804 0.335 . . . . 72.549999999999997 111.459 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.41 148.83 35.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.401 0.619 . . . . 71.319999999999993 112.619 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.683 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 85.4 mtp -140.16 153.09 46.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.425 -0.807 . . . . 74.310000000000002 109.956 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.529 ' HB2' ' HE1' ' A' ' 82' ' ' TYR . 13.7 m120 -133.29 139.74 47.06 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.236 0.541 . . . . 73.239999999999995 112.081 -174.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 52.0 t -46.22 -36.72 6.35 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.502 1.297 . . . . 71.409999999999997 114.502 -172.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.529 ' HE1' ' HB2' ' A' ' 80' ' ' ASN . 1.3 p90 -63.57 -27.44 69.25 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.487 0.551 . . . . 74.319999999999993 112.487 -175.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -102.18 -31.77 10.42 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.452 0.538 . . . . 74.439999999999998 112.452 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.46 ' O ' ' HD1' ' A' ' 88' ' ' PHE . 9.8 m-20 -76.57 -5.95 49.85 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.473 0.545 . . . . 74.510000000000005 112.473 -174.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.489 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . . . -34.19 -72.76 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.005 1.113 . . . . 60.049999999999997 114.005 -172.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.7 t -64.59 -31.84 73.24 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.88 0.372 . . . . 65.519999999999996 111.553 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.634 ' HE1' ' HA ' ' A' ' 87' ' ' MET . 25.4 mmt -64.64 -63.89 1.01 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.206 -0.452 . . . . 75.310000000000002 112.175 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.489 ' HE1' ' HA ' ' A' ' 85' ' ' ALA . 1.8 p90 -70.77 -26.69 63.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.133 -0.354 . . . . 71.430000000000007 111.461 -176.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -68.01 -41.35 82.34 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.015 0.436 . . . . 72.430000000000007 110.11 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -40.44 81.61 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.85 0.357 . . . . 74.409999999999997 111.174 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -61.27 -51.0 70.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.368 -0.378 . . . . 74.150000000000006 111.695 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.0 tp -62.69 -32.3 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.821 0.343 . . . . 73.049999999999997 111.285 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -68.55 -55.85 10.28 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.727 0.269 . . . . 70.319999999999993 111.727 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.659 ' HZ2' ' HB3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -57.71 -37.24 73.17 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.071 0.463 . . . . 74.209999999999994 110.677 177.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.635 ' HZ ' HG12 ' A' ' 172' ' ' VAL . 26.0 t80 -61.32 -54.48 43.36 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.034 -0.53 . . . . 74.319999999999993 111.284 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -53.78 -49.6 67.91 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.321 -0.4 . . . . 72.319999999999993 111.267 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.1 -38.45 90.77 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.679 -0.237 . . . . 74.420000000000002 111.438 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -64.23 -52.09 60.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.691 0.282 . . . . 65.329999999999998 111.702 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.3 m -64.01 -42.62 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 111.826 0.306 . . . . 75.109999999999999 111.826 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.6 mm -62.98 -45.45 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.851 0.358 . . . . 75.200000000000003 110.748 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.608 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 18.0 t70 -56.3 -48.09 77.37 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.293 -0.412 . . . . 74.420000000000002 111.634 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -66.67 -29.03 68.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.769 0.319 . . . . 73.519999999999996 111.536 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.0 tpt -75.58 -54.45 6.98 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.055 0.455 . . . . 74.430000000000007 111.367 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -54.05 -34.04 59.01 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.343 0.497 . . . . 74.030000000000001 112.343 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -51.4 -36.85 45.36 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.293 -0.255 . . . . 72.340000000000003 111.353 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -116.66 -5.87 11.62 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.257 0.836 . . . . 71.150000000000006 113.257 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -141.41 35.26 1.67 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.607 0.595 . . . . 75.140000000000001 112.607 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -5.82 1.07 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.749 1.388 . . . . 75.109999999999999 114.749 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 111' ' ' ALA . 4.4 m-20 -74.99 76.04 2.2 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.61 -0.681 . . . . 72.430000000000007 112.413 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt 37.52 -79.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.168 1.387 . . . . 73.209999999999994 114.655 171.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 109' ' ' ASP . . . -51.19 -42.82 61.14 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.059 0.762 . . . . 72.549999999999997 113.059 -170.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.22 -56.32 17.63 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.946 0.403 . . . . 75.209999999999994 111.882 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.8 m -67.9 -32.42 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.591 0.589 . . . . 71.519999999999996 112.591 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.69 -34.58 62.67 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.326 -0.233 . . . . 74.409999999999997 111.189 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.34 -45.41 72.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.198 0.523 . . . . 73.140000000000001 111.009 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -61.18 -46.72 89.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.193 0.52 . . . . 73.010000000000005 110.363 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -59.67 -32.58 70.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.921 -0.581 . . . . 74.219999999999999 111.307 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' A' ' 118' ' ' LYS . 8.9 tppt? -60.17 -45.44 93.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.171 0.51 . . . . 72.0 110.86 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -68.26 -46.88 69.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.07 -0.514 . . . . 75.549999999999997 111.189 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.499 HD12 HD21 ' A' ' 26' ' ' LEU . 29.8 mm -58.97 -43.58 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.768 0.318 . . . . 75.540000000000006 111.365 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -63.04 -45.23 93.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.569 0.223 . . . . 73.239999999999995 110.719 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.08 -42.6 99.85 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.95 -0.643 . . . . 71.150000000000006 112.246 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 40.1 t90 -61.39 -49.94 74.88 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.493 0.317 . . . . 75.420000000000002 111.294 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.95 -42.05 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.388 0.514 . . . . 74.129999999999995 112.388 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.75 -25.28 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.243 0.544 . . . . 73.219999999999999 110.938 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.3 m -86.46 -51.55 6.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 111.117 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.408 HD11 HG23 ' A' ' 155' ' ' ILE . 27.8 tp -59.55 -35.77 74.89 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.184 0.516 . . . . 74.439999999999998 111.864 -177.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.7 mt -85.25 3.71 38.19 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.075 -0.511 . . . . 73.540000000000006 112.073 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 133' ' ' PHE . . . -62.45 97.74 0.1 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.207 0.527 . . . . 70.540000000000006 110.849 176.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 28.7 ttpp -45.33 -64.51 0.7 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.067 1.136 . . . . 72.040000000000006 114.067 -170.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.41 -46.55 85.86 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.238 0.829 . . . . 72.530000000000001 113.238 -168.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -73.47 -50.99 18.75 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.359 0.6 . . . . 74.230000000000004 111.43 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 129' ' ' ALA . 30.1 m-85 -82.43 -5.78 58.88 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.848 -0.614 . . . . 75.200000000000003 112.653 -173.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 26.1 ttpp -50.01 -22.84 1.73 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.102 0.477 . . . . 74.400000000000006 111.683 170.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.58 ' N ' HD21 ' A' ' 135' ' ' ASN . 0.8 OUTLIER -82.66 15.07 2.76 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.313 0.486 . . . . 73.049999999999997 112.313 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.534 HD21 ' HG2' ' A' ' 157' ' ' GLU . 49.5 mt -89.52 161.72 16.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.32 0.581 . . . . 73.329999999999998 112.212 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -123.7 126.33 46.35 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.776 -0.647 . . . . 63.409999999999997 111.138 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.683 ' HB2' ' HB2' ' A' ' 79' ' ' MET . 43.6 m-85 -96.91 133.55 41.4 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.125 -0.324 . . . . 74.430000000000007 110.125 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 58.2 m-85 -128.74 131.02 47.85 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.084 -0.385 . . . . 72.340000000000003 111.561 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.573 HG21 ' HB2' ' A' ' 145' ' ' ALA . 15.4 tt -125.24 148.07 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 120.976 0.417 . . . . 74.409999999999997 111.375 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.85 140.88 45.56 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 114.373 0.509 . . . . 64.349999999999994 114.373 -176.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -42.03 -54.2 3.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.308 0.643 . . . . 72.25 112.115 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -62.5 -35.71 80.23 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.998 0.428 . . . . 72.540000000000006 112.137 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.9 -37.16 48.56 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.146 0.425 . . . . 72.099999999999994 112.146 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.573 ' HB2' HG21 ' A' ' 140' ' ' ILE . . . -62.81 -56.2 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.932 0.396 . . . . 75.329999999999998 111.944 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.09 -21.44 58.94 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.488 -0.324 . . . . 51.409999999999997 111.429 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -72.6 -21.87 79.32 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.954 -0.641 . . . . 75.329999999999998 112.423 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 61.15 42.05 12.78 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.263 0.468 . . . . 73.540000000000006 112.263 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.45 4.35 53.37 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.591 0.589 . . . . 73.510000000000005 112.591 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.4 p30 41.91 35.68 0.56 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.344 0.658 . . . . 74.5 112.447 -175.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.68 -135.43 1.01 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.117 -0.492 . . . . 74.140000000000001 114.269 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -67.24 104.25 1.43 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.764 0.653 . . . . 73.450000000000003 112.764 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.36 118.68 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.215 0.531 . . . . 63.210000000000001 110.834 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.705 ' HB2' HD13 ' A' ' 169' ' ' LEU . . . -79.86 124.2 28.44 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.949 -0.569 . . . . 65.219999999999999 111.209 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 43.3 mm -89.59 120.0 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.673 0.273 . . . . 72.430000000000007 111.5 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.3 mm -99.38 107.51 20.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-O 120.971 0.415 . . . . 72.230000000000004 111.012 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.534 ' HG2' HD21 ' A' ' 136' ' ' LEU . 0.4 OUTLIER -111.49 137.43 49.31 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.467 -0.788 . . . . 70.540000000000006 109.967 -178.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -92.19 123.92 35.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.152 0.501 . . . . 75.430000000000007 112.061 -174.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.429 ' NH2' ' HB2' ' A' ' 29' ' ' GLU . 77.8 mtm180 -130.16 154.3 47.66 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.278 0.561 . . . . 75.450000000000003 112.193 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -83.2 143.92 30.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.777 0.658 . . . . 74.129999999999995 112.777 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.1 t -128.71 87.9 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.749 -0.659 . . . . 74.349999999999994 109.65 167.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 48.37 41.92 17.31 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.835 0.68 . . . . 70.049999999999997 112.835 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.72 -23.26 22.33 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.294 -0.479 . . . . 73.340000000000003 113.21 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 91.7 m -95.52 106.15 18.2 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.486 -0.42 . . . . 74.230000000000004 111.352 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.54 112.64 14.53 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.245 -0.434 . . . . 60.310000000000002 111.091 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 35.7 m -119.37 141.72 31.2 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 112.083 0.401 . . . . 75.400000000000006 112.083 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 166' ' ' VAL . 8.0 Cg_exo -73.64 114.77 4.12 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.752 2.302 . . . . 73.319999999999993 112.117 174.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.8 p -109.37 140.79 42.62 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.927 0.394 . . . . 64.400000000000006 111.789 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' A' ' 154' ' ' ALA . 64.1 tp -77.54 145.16 37.1 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.97 -0.559 . . . . 74.010000000000005 111.962 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.488 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 48.1 ttm -130.18 124.49 32.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.766 -0.652 . . . . 73.319999999999993 110.909 176.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.87 161.23 33.49 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.05 -0.722 . . . . 73.439999999999998 109.05 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.635 HG12 ' HZ ' ' A' ' 95' ' ' PHE . 44.1 t -96.39 131.23 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.501 -0.749 . . . . 73.540000000000006 112.114 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.556 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 14.2 tmtt? -56.34 -55.69 30.34 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.185 -0.461 . . . . 74.049999999999997 111.611 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -75.25 4.6 6.76 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.017 0.377 . . . . 75.019999999999996 112.017 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.26 -21.02 17.5 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.261 0.553 . . . . 75.5 110.473 173.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 68.0 mt -118.73 108.97 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.853 -0.612 . . . . 75.409999999999997 110.587 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -92.16 113.96 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.118 0.485 . . . . 75.329999999999998 110.503 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.491 ' HB2' HD13 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -91.8 152.68 20.02 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.621 0.724 . . . . 75.319999999999993 112.771 -174.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.686 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 9.3 tp10 -114.83 110.87 20.34 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.581 -0.736 . . . . 73.030000000000001 109.336 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 61.9 tttm . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 121.261 0.553 . . . . 73.099999999999994 112.302 -171.062 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.696 0.284 . . . . 75.049999999999997 111.308 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.7 tp -104.19 147.38 27.52 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.153 0.501 . . . . 70.540000000000006 111.203 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.26 141.0 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.545 -0.298 . . . . 74.200000000000003 110.565 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -122.92 158.75 29.71 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 121.904 -0.498 . . . . 73.140000000000001 111.461 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 5.4 ptpp? -139.04 111.04 7.27 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.136 -0.483 . . . . 75.519999999999996 111.754 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 175' ' ' ALA . 7.0 m-20 -75.81 164.32 26.35 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.241 -0.287 . . . . 75.120000000000005 110.791 172.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.1 pt -61.19 -9.76 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 121.03 0.443 . . . . 74.239999999999995 111.493 173.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -107.92 -30.5 8.45 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.301 -0.409 . . . . 70.450000000000003 111.118 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.478 ' HB ' ' H ' ' A' ' 6' ' ' ASP . 11.1 m -92.63 -13.67 29.25 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.087 0.773 . . . . 72.219999999999999 113.087 -171.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.436 ' HA ' ' HB2' ' A' ' 5' ' ' LYS . 4.0 p30 -55.54 -16.93 4.45 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.106 0.78 . . . . 74.150000000000006 113.106 -173.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -69.26 -46.28 67.66 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.055 0.391 . . . . 64.400000000000006 112.055 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -121.07 -1.24 9.84 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.202 0.815 . . . . 53.140000000000001 113.202 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 5' ' ' LYS . 3.7 mm? 64.19 169.44 0.17 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.535 0.939 . . . . 70.120000000000005 113.535 173.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.8 m -148.01 136.85 21.87 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.949 -0.569 . . . . 74.450000000000003 110.678 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.5 p -115.35 119.27 35.72 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.675 0.62 . . . . 74.109999999999999 112.675 -172.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -149.7 -169.6 3.42 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.099 -0.501 . . . . 74.219999999999999 111.222 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 t -155.3 91.94 1.38 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.026 0.441 . . . . 74.0 111.435 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -130.6 118.75 18.02 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 116.433 -0.349 . . . . 74.299999999999997 111.207 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.81 87.68 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.372 2.048 . . . . 73.030000000000001 112.207 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.412 ' HG2' ' HB2' ' A' ' 30' ' ' PHE . 64.7 mtt -93.33 148.04 22.4 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.356 0.598 . . . . 73.340000000000003 112.123 -177.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -102.17 113.06 26.0 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.623 -0.717 . . . . 74.340000000000003 110.303 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.481 HD23 ' HD2' ' A' ' 173' ' ' LYS . 61.4 tp -74.61 87.84 2.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.159 0.504 . . . . 75.540000000000006 110.135 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.79 137.43 21.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.087 -0.506 . . . . 74.239999999999995 111.544 -175.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.8 12.49 5.74 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.736 -0.665 . . . . 74.230000000000004 111.292 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.428 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 66.4 m-20 54.3 22.02 3.47 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.009 -0.542 . . . . 74.540000000000006 111.922 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.2 tp -121.71 -41.04 2.49 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.926 0.393 . . . . 72.230000000000004 111.259 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.475 HG11 ' HA ' ' A' ' 172' ' ' VAL . 4.2 m -137.58 147.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.1 0.476 . . . . 73.439999999999998 111.952 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 170' ' ' MET . 70.0 m-85 -85.96 145.05 27.3 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.207 -0.451 . . . . 74.340000000000003 110.624 176.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 34.5 tt0 -127.63 135.63 50.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.677 0.275 . . . . 74.430000000000007 110.88 176.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.412 ' HB2' ' HG2' ' A' ' 20' ' ' MET . 84.4 t80 -128.96 128.43 43.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.861 0.363 . . . . 75.450000000000003 111.548 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HA ' HG23 ' A' ' 168' ' ' THR . 1.8 tmmm? -92.31 121.55 33.92 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.231 -0.44 . . . . 74.200000000000003 110.837 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.23 -163.35 13.96 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.308 -0.473 . . . . 71.510000000000005 113.089 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -121.12 139.37 53.42 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.316 -0.52 . . . . 75.439999999999998 111.512 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -75.27 106.15 6.65 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.879 -0.6 . . . . 74.109999999999999 110.663 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.67 160.15 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.1 -0.5 . . . . 74.329999999999998 111.054 -177.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.52 HG12 ' HB2' ' A' ' 66' ' ' ARG . 34.1 m -128.77 105.14 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.433 0.635 . . . . 72.219999999999999 110.94 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 97.6 mtt180 . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.187 0.518 . . . . 51.0 111.015 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 45.2 mt-10 . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.755 0.788 . . . . 65.230000000000004 110.652 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.52 ' HB2' HG12 ' A' ' 36' ' ' VAL . 33.4 ptt85 -95.3 134.72 37.76 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.727 -0.67 . . . . 75.109999999999999 112.672 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.72 -133.82 3.03 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.606 -0.724 . . . . 74.409999999999997 112.447 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.461 HD12 HD12 ' A' ' 70' ' ' ILE . 21.4 pt -111.12 131.81 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 122.35 -0.5 . . . . 74.150000000000006 110.957 176.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.6 -23.14 15.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 111.858 0.318 . . . . 63.240000000000002 111.858 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.461 HD12 HD12 ' A' ' 68' ' ' ILE . 55.7 mt -50.71 -56.23 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.236 0.541 . . . . 71.549999999999997 111.591 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.7 m -81.16 -30.61 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.146 -0.479 . . . . 74.010000000000005 111.693 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.8 mt -65.02 -35.72 82.09 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.131 0.491 . . . . 75.209999999999994 110.863 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.36 -40.99 71.95 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.961 -0.563 . . . . 72.430000000000007 111.78 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -100.78 -1.04 35.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.43 -0.35 . . . . 71.120000000000005 111.779 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt 53.88 70.55 0.59 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.285 0.564 . . . . 72.420000000000002 111.583 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 67.3 mt -100.04 135.74 41.01 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.877 -0.601 . . . . 65.349999999999994 111.247 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.27 145.97 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.876 0.37 . . . . 75.409999999999997 111.281 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -83.47 136.35 34.33 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.575 0.583 . . . . 74.239999999999995 112.575 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.2 mmm -115.82 145.59 42.71 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 116.004 -0.543 . . . . 74.510000000000005 110.268 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.413 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 15.6 m-80 -88.86 123.86 33.64 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.634 0.605 . . . . 52.219999999999999 112.634 -169.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 44.2 t -54.12 -32.94 56.48 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.136 0.791 . . . . 74.299999999999997 113.136 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 4.5 p90 -81.71 -30.73 32.41 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.937 0.399 . . . . 73.140000000000001 111.865 -176.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -94.69 -47.32 6.55 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.469 0.544 . . . . 71.310000000000002 112.469 -170.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.634 ' HA ' ' SD ' ' A' ' 87' ' ' MET . 23.5 m-20 -81.2 18.96 0.99 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.546 0.573 . . . . 71.099999999999994 112.546 -174.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.429 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . . . -55.94 -42.59 76.4 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.844 0.354 . . . . 65.140000000000001 111.849 177.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.483 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 53.3 m -60.24 -36.57 78.05 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.326 0.584 . . . . 73.109999999999999 111.091 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.665 ' N ' ' SD ' ' A' ' 87' ' ' MET . 0.6 OUTLIER -66.04 -38.66 88.93 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.014 -0.539 . . . . 73.420000000000002 110.278 176.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HD2' ' HA ' ' A' ' 85' ' ' ALA . 32.0 m-85 -69.05 -43.86 73.8 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.928 -0.578 . . . . 74.120000000000005 112.274 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.545 ' HZ1' ' HB2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -62.56 -36.09 81.55 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.959 0.409 . . . . 73.519999999999996 110.893 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.1 -40.11 62.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.066 0.46 . . . . 53.43 111.198 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -61.83 -44.09 97.55 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.164 -0.471 . . . . 72.510000000000005 110.735 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.33 -34.35 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.121 -0.491 . . . . 73.129999999999995 111.259 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -56.03 -51.5 67.56 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.146 0.498 . . . . 74.219999999999999 110.976 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -69.66 -43.03 73.39 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.139 -0.482 . . . . 74.120000000000005 110.949 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.456 ' CZ ' HG12 ' A' ' 172' ' ' VAL . 68.9 t80 -52.8 -54.08 39.3 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.146 -0.479 . . . . 74.329999999999998 111.559 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 57.0 ttp -54.51 -43.82 72.19 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.076 -0.511 . . . . 73.140000000000001 110.99 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -54.78 -57.53 11.16 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.101 -0.5 . . . . 70.299999999999997 111.497 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -59.55 -55.81 29.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.616 0.599 . . . . 71.129999999999995 112.616 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.6 m -62.82 -43.38 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.718 0.636 . . . . 73.420000000000002 112.718 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.9 mm -74.33 -47.49 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 122.138 -0.351 . . . . 71.25 111.785 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 8.9 t70 -61.07 -38.98 88.14 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.992 0.425 . . . . 64.219999999999999 110.845 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -69.94 -41.47 74.53 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.98 0.419 . . . . 74.340000000000003 110.923 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 49.4 tpp -61.59 -35.15 77.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.322 0.582 . . . . 75.319999999999993 111.002 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 32.2 tt0 -68.05 -15.95 63.82 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.912 -0.585 . . . . 71.019999999999996 111.793 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.642 ' HB3' ' HZ1' ' A' ' 105' ' ' LYS . 1.7 mmmp? -81.09 -31.53 34.29 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.764 -0.585 . . . . 74.5 111.87 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -115.5 -36.45 4.28 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.473 0.916 . . . . 74.439999999999998 113.473 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -91.37 -76.43 0.45 Allowed 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.471 0.545 . . . . 71.439999999999998 112.471 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 104' ' ' GLU . 62.5 mtm-85 67.68 -6.49 0.68 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.863 1.06 . . . . 74.420000000000002 113.863 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 113' ' ' VAL . 38.3 t70 -68.59 106.0 2.44 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.033 -0.417 . . . . 73.299999999999997 110.61 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -48.91 -37.88 21.13 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.8 0.667 . . . . 75.340000000000003 112.8 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.91 -44.06 86.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.822 0.344 . . . . 75.230000000000004 111.543 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.6 -54.43 9.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.484 -0.326 . . . . 65.099999999999994 111.7 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 109' ' ' ASP . 23.0 m -59.26 -33.24 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 112.092 0.404 . . . . 74.239999999999995 112.092 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.96 -36.41 77.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.802 0.334 . . . . 71.200000000000003 110.587 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.73 -48.84 73.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.392 -0.367 . . . . 74.439999999999998 111.171 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -60.15 -50.32 74.13 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.841 0.353 . . . . 72.5 110.947 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -49.49 -49.26 46.39 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.212 0.529 . . . . 74.25 110.488 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.72 -36.3 82.15 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.789 -0.641 . . . . 65.230000000000004 111.566 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -67.01 -47.91 70.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.753 0.311 . . . . 72.510000000000005 110.791 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 31.3 mm -65.51 -38.72 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.485 -0.325 . . . . 71.0 111.112 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -58.13 -47.43 83.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.861 0.362 . . . . 72.519999999999996 110.679 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.3 -33.74 78.56 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.128 -0.558 . . . . 53.119999999999997 112.612 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -60.65 -54.28 47.2 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.574 0.35 . . . . 73.400000000000006 111.438 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.76 -46.79 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.699 0.629 . . . . 73.049999999999997 112.699 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.6 m -60.26 -33.26 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 122.061 -0.4 . . . . 74.340000000000003 111.59 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.7 m -77.08 -44.77 29.39 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.054 0.454 . . . . 64.109999999999999 111.002 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.467 HD23 HD13 ' A' ' 155' ' ' ILE . 48.4 tp -66.59 -32.17 73.34 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.058 -0.519 . . . . 74.040000000000006 112.207 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.7 mt -91.52 1.77 56.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.452 0.538 . . . . 74.019999999999996 112.452 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.6 95.81 0.08 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.346 0.593 . . . . 70.120000000000005 111.014 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.632 ' H ' ' HD2' ' A' ' 130' ' ' LYS . 2.5 mptp? -58.18 -33.11 68.88 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.17 0.804 . . . . 75.439999999999998 113.17 -168.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.51 -47.61 38.76 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.003 0.742 . . . . 64.150000000000006 113.003 -172.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 132' ' ' ARG . 0.4 OUTLIER -111.11 -26.32 9.28 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.633 0.605 . . . . 73.430000000000007 112.633 174.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.408 ' HD2' HD13 ' A' ' 136' ' ' LEU . 88.8 m-85 -83.19 -5.82 59.26 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.406 0.521 . . . . 75.019999999999996 112.406 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.92 -24.77 54.85 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.457 0.646 . . . . 74.230000000000004 110.501 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -78.21 13.41 1.5 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.694 -0.685 . . . . 72.420000000000002 112.232 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.408 HD13 ' HD2' ' A' ' 133' ' ' PHE . 77.8 mt -88.11 161.99 17.0 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.431 0.634 . . . . 74.430000000000007 111.799 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -134.33 122.35 22.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.706 -0.679 . . . . 74.140000000000001 110.362 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -105.36 110.8 23.28 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.955 0.407 . . . . 74.230000000000004 110.82 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 80.3 m-85 -98.98 147.18 25.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.471 0.545 . . . . 74.219999999999999 112.471 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 12.4 tt -147.22 155.77 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.028 -0.533 . . . . 73.209999999999994 110.827 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.64 146.11 34.99 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.184 -0.532 . . . . 72.230000000000004 113.689 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -54.73 -62.85 1.39 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.105 0.409 . . . . 75.329999999999998 112.105 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -61.3 -28.6 69.31 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.898 0.38 . . . . 74.519999999999996 111.259 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . . . -63.62 -53.73 46.92 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.037 0.446 . . . . 74.340000000000003 111.304 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.46 -19.13 62.26 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.128 0.49 . . . . 71.439999999999998 111.643 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.5 -40.65 34.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.166 -0.47 . . . . 71.209999999999994 111.596 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.21 42.02 0.09 OUTLIER Glycine 0 CA--C 1.529 0.953 0 C-N-CA 120.606 -0.807 . . . . 74.310000000000002 113.866 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.586 ' HB2' ' HA ' ' A' ' 144' ' ' ALA . . . -154.43 88.2 1.21 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.078 0.466 . . . . 74.140000000000001 111.235 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.16 -1.75 11.05 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.38 0.882 . . . . 71.109999999999999 113.38 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.36 57.79 3.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.485 0.66 . . . . 74.310000000000002 110.392 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -130.87 149.53 19.14 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.705 -0.679 . . . . 71.150000000000006 113.492 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -83.72 144.33 29.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.904 0.383 . . . . 73.510000000000005 111.477 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.86 115.15 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.329 0.585 . . . . 72.400000000000006 111.479 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.32 109.38 15.77 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.695 -0.684 . . . . 72.329999999999998 110.901 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.467 HD13 HD23 ' A' ' 127' ' ' LEU . 52.5 mt -86.48 124.84 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.573 0.225 . . . . 73.109999999999999 111.272 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' A' ' 169' ' ' LEU . 48.6 mm -118.05 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 111.967 0.358 . . . . 74.340000000000003 111.967 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 7.3 pt-20 -130.58 158.26 40.48 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.106 0.479 . . . . 72.219999999999999 111.273 175.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -78.05 108.8 11.59 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.066 0.46 . . . . 71.230000000000004 111.552 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 159' ' ' ARG . 5.6 tpp180 -104.51 128.81 52.53 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.432 -0.349 . . . . 74.25 111.682 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.71 111.24 14.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.735 0.302 . . . . 75.420000000000002 110.434 173.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.05 88.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.158 0.504 . . . . 63.520000000000003 110.24 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 54.79 33.86 20.59 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.721 -0.672 . . . . 62.0 112.104 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 113.37 -24.74 12.0 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.059 -0.591 . . . . 61.43 113.403 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.459 HG22 HG13 ' A' ' 166' ' ' VAL . 89.8 m -97.31 106.54 18.88 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.438 -0.448 . . . . 74.109999999999999 111.044 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -80.54 108.26 14.03 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.272 -0.422 . . . . 73.129999999999995 111.636 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.459 HG13 HG22 ' A' ' 164' ' ' THR . 25.0 m -128.23 142.56 44.97 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 120.908 0.385 . . . . 73.219999999999999 111.65 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 17.4 Cg_exo -68.56 119.15 6.16 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.801 2.334 . . . . 72.310000000000002 112.921 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.575 HG23 ' HA ' ' A' ' 31' ' ' LYS . 38.2 p -107.52 163.68 12.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.983 0.42 . . . . 74.219999999999999 112.039 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 51.9 tp -102.06 138.52 38.91 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.604 0.594 . . . . 73.25 112.604 -175.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 1.2 mpt? -122.87 136.79 54.99 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.418 0.525 . . . . 74.030000000000001 112.418 176.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.9 mt -136.81 148.42 47.16 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.57 -0.741 . . . . 75.25 110.08 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 176' ' ' ILE . 58.6 t -87.15 127.46 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.744 0.646 . . . . 55.43 112.744 -173.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.481 ' HD2' HD23 ' A' ' 22' ' ' LEU . 57.4 tttm -52.78 -54.79 28.96 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.81 0.671 . . . . 73.409999999999997 112.81 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.08 12.21 0.58 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.818 0.673 . . . . 72.319999999999993 112.818 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -114.35 -51.51 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 71.400000000000006 109.838 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 172' ' ' VAL . 4.1 tt -102.96 108.97 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.611 -0.722 . . . . 75.109999999999999 111.699 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.5 mm -101.35 142.37 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 111.315 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.13 141.91 50.76 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.249 0.547 . . . . 74.530000000000001 112.254 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -135.46 104.11 5.72 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.764 -0.653 . . . . 72.400000000000006 110.124 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 121.366 0.603 . . . . 71.109999999999999 112.4 -176.234 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.714 0.292 . . . . 73.239999999999995 111.091 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 180' ' ' LYS . 21.5 tp -95.38 124.09 39.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.083 -0.34 . . . . 71.140000000000001 110.083 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 179' ' ' GLU . 53.5 mt -105.72 129.22 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.497 0.189 . . . . 74.329999999999998 111.385 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -122.78 144.67 49.03 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.322 0.582 . . . . 62.240000000000002 112.343 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.674 ' HB3' ' HB ' ' A' ' 177' ' ' ILE . 23.7 ttmm -138.55 111.26 7.65 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.804 -0.634 . . . . 64.25 110.903 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.575 ' HA ' HG23 ' A' ' 176' ' ' ILE . 5.6 t70 -83.03 166.16 19.02 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.564 0.346 . . . . 71.230000000000004 111.293 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 pt -81.23 -18.18 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 113.069 0.766 . . . . 74.510000000000005 113.069 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.62 -42.86 7.46 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.069 0.461 . . . . 74.549999999999997 111.555 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.545 HG21 ' HB3' ' A' ' 6' ' ' ASP . 15.2 t -103.85 19.65 19.56 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.998 -0.546 . . . . 64.010000000000005 112.092 -176.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 12.4 p-10 -46.06 -40.47 10.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.748 1.018 . . . . 71.140000000000001 113.748 -172.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -53.07 -34.76 57.99 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.094 0.473 . . . . 64.450000000000003 111.962 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.35 26.5 0.65 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.803 0.668 . . . . 75.319999999999993 112.803 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.67 HD13 ' HB2' ' A' ' 5' ' ' LYS . 69.4 tp -32.11 109.28 0.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.286 0.634 . . . . 72.219999999999999 112.014 174.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -131.15 -175.88 3.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 111.873 0.323 . . . . 74.310000000000002 111.873 -172.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.0 p -150.33 144.28 25.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.17 0.804 . . . . 74.549999999999997 113.17 -174.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -144.88 -157.7 0.82 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.736 -0.666 . . . . 75.430000000000007 109.963 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.3 t -148.45 86.49 1.54 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.932 -0.48 . . . . 65.140000000000001 112.177 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -138.25 101.95 8.26 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.177 -0.465 . . . . 74.209999999999994 111.192 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.82 142.76 98.59 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.191 2.594 . . . . 73.450000000000003 114.324 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.416 ' HE2' ' HD2' ' A' ' 30' ' ' PHE . 24.0 ptp -146.37 161.31 40.64 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.859 -0.61 . . . . 71.010000000000005 111.003 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 18.2 ptpt -99.5 158.75 15.52 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.585 0.231 . . . . 74.219999999999999 111.061 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.7 tp -107.09 110.45 22.56 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.91 0.385 . . . . 74.040000000000006 111.224 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -104.02 145.5 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.032 0.444 . . . . 75.140000000000001 111.568 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 63.93 10.55 5.36 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 116.112 -0.495 . . . . 74.5 112.136 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 60.87 12.11 3.64 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.864 0.466 . . . . 74.209999999999994 111.875 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.5 tp -127.52 -43.16 1.6 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.938 0.399 . . . . 73.109999999999999 111.733 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 172' ' ' VAL . 17.0 m -127.71 148.8 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.254 0.55 . . . . 75.109999999999999 112.352 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -86.97 134.37 33.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.293 -0.412 . . . . 71.439999999999998 111.132 174.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 36.3 tt0 -103.92 108.07 19.23 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.062 0.458 . . . . 72.0 110.257 174.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.577 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 31.6 t80 -90.37 127.61 36.23 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.247 -0.283 . . . . 71.049999999999997 110.335 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.428 ' HD3' ' H ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -74.32 131.12 40.86 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.47 0.652 . . . . 74.230000000000004 112.059 -176.618 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.464 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -140.08 174.34 22.5 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.726 -0.67 . . . . 71.200000000000003 112.494 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.413 ' HG3' HG11 ' A' ' 35' ' ' VAL . 16.4 ptpt -151.92 166.28 31.96 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.793 0.664 . . . . 73.540000000000006 112.793 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -71.51 106.6 4.04 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.082 -0.963 . . . . 75.299999999999997 110.799 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.413 HG11 ' HG3' ' A' ' 33' ' ' LYS . 31.5 m -138.06 154.58 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.21 0.529 . . . . 74.010000000000005 111.788 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.431 HG12 ' HG3' ' A' ' 66' ' ' ARG . 35.1 m -143.05 142.55 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.317 -0.401 . . . . 74.439999999999998 111.12 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.583 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 5.5 ttm180 . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 120.843 0.354 . . . . 61.149999999999999 110.954 174.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 26.3 tt0 . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 121.869 0.842 . . . . 71.109999999999999 110.694 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.431 ' HG3' HG12 ' A' ' 36' ' ' VAL . 11.3 ttm180 -92.5 133.69 35.68 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.15 -0.932 . . . . 74.319999999999993 110.606 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.35 -135.78 4.11 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 119.63 -1.271 . . . . 73.340000000000003 114.422 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 167' ' ' PRO . 12.5 mt -110.27 141.88 24.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.553 -0.324 . . . . 73.230000000000004 111.581 -173.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -47.9 -38.04 15.55 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.871 0.367 . . . . 60.310000000000002 111.321 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 169' ' ' LEU . 63.6 mt -60.75 -54.72 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.097 0.475 . . . . 74.239999999999995 112.185 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -72.48 -38.3 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.797 -0.638 . . . . 75.299999999999997 112.124 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.511 HD23 ' HG2' ' A' ' 65' ' ' GLU . 47.8 mt -68.54 -43.21 77.19 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.148 0.499 . . . . 74.310000000000002 110.529 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -54.92 -42.58 72.39 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.939 -0.573 . . . . 71.319999999999993 112.09 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -98.84 1.54 45.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.741 0.645 . . . . 75.310000000000002 112.741 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.415 ' HD3' ' N ' ' A' ' 75' ' ' LYS . 3.6 mppt? 54.07 69.05 0.76 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.318 0.58 . . . . 73.409999999999997 111.46 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 69.5 mt -106.66 137.41 44.74 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.964 -0.562 . . . . 72.420000000000002 110.725 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.443 HG11 ' HB3' ' A' ' 145' ' ' ALA . 10.0 p -88.27 151.55 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.109 0.48 . . . . 75.519999999999996 111.717 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.0 131.36 44.94 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.206 -0.906 . . . . 72.200000000000003 113.374 -175.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 83.5 mtp -138.6 153.68 48.66 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.931 -0.577 . . . . 73.030000000000001 109.946 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.46 168.16 28.21 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.168 0.803 . . . . 75.519999999999996 113.168 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -36.97 -55.85 0.9 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.71 1.745 . . . . 62.310000000000002 115.71 -169.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.447 ' CE2' ' HG2' ' A' ' 83' ' ' GLU . 43.8 p90 -56.96 -31.57 65.15 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.983 0.734 . . . . 75.439999999999998 112.983 -170.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.447 ' HG2' ' CE2' ' A' ' 82' ' ' TYR . 58.3 mm-40 -92.38 -44.54 8.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.158 0.504 . . . . 73.549999999999997 111.107 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.674 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 3.2 m-20 -67.58 -17.95 64.82 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.739 1.014 . . . . 63.420000000000002 113.739 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -43.87 -60.98 1.59 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.022 0.439 . . . . 74.120000000000005 111.287 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.9 m -72.54 -27.57 62.31 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.349 -0.387 . . . . 73.329999999999998 111.677 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.674 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 58.6 tpp -63.28 -65.92 0.62 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 111.495 0.183 . . . . 74.120000000000005 111.495 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.47 ' HA ' ' HB3' ' A' ' 91' ' ' TYR . 13.6 p90 -64.31 -22.75 67.06 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 122.12 -0.362 . . . . 74.329999999999998 111.38 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -60.65 -55.52 32.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.867 0.365 . . . . 73.319999999999993 110.858 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.7 96.26 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.044 0.45 . . . . 74.420000000000002 111.292 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.47 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 6.8 t80 -57.36 -55.86 29.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.829 -0.623 . . . . 72.409999999999997 111.348 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.7 -32.7 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.779 0.323 . . . . 74.230000000000004 111.542 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -65.82 -54.55 25.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.997 0.427 . . . . 75.129999999999995 111.073 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -63.77 -41.19 98.02 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.153 0.502 . . . . 71.030000000000001 110.532 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 175' ' ' ALA . 17.8 t80 -55.04 -58.35 7.99 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.852 -0.613 . . . . 75.420000000000002 111.647 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.425 ' O ' HG21 ' A' ' 100' ' ' ILE . 46.8 ttp -50.3 -52.01 40.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.019 -0.537 . . . . 63.240000000000002 111.559 -177.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -63.52 -50.49 69.39 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.716 0.293 . . . . 72.310000000000002 111.436 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.31 -50.64 72.28 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.264 0.468 . . . . 73.329999999999998 112.264 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 95' ' ' PHE . 35.1 m -69.44 -40.35 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.58 0.585 . . . . 75.230000000000004 112.58 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.425 HG21 ' O ' ' A' ' 96' ' ' MET . 10.9 tp -74.05 -42.11 52.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 120.791 -0.364 . . . . 73.099999999999994 111.18 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.12 -29.51 69.81 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.097 0.475 . . . . 73.400000000000006 110.282 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -76.09 -65.26 0.94 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.822 -0.626 . . . . 75.420000000000002 111.48 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.0 ttt -64.43 -45.26 88.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.764 0.653 . . . . 75.540000000000006 112.764 -171.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.695 ' HA ' HG13 ' A' ' 113' ' ' VAL . 36.8 tt0 -68.52 -11.79 60.36 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.235 0.54 . . . . 72.319999999999993 111.289 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -82.32 -42.49 18.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.038 -0.528 . . . . 74.319999999999993 111.756 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -89.66 -37.19 14.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.514 0.561 . . . . 74.010000000000005 112.514 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.438 ' O ' ' HD3' ' A' ' 108' ' ' ARG . 26.8 t-20 -76.15 -60.34 2.37 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.228 -0.295 . . . . 54.509999999999998 111.507 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 71.3 -21.69 0.2 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.155 1.169 . . . . 74.310000000000002 114.155 175.138 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.503 ' O ' HG23 ' A' ' 113' ' ' VAL . 40.8 m-20 -78.87 129.69 34.83 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.624 0.726 . . . . 64.230000000000004 112.595 -176.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -64.1 -8.04 10.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.245 -0.888 . . . . 73.129999999999995 112.459 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.03 -41.52 50.64 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 111.878 0.325 . . . . 75.400000000000006 111.878 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -95.34 -62.13 1.35 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.65 0.611 . . . . 70.450000000000003 112.65 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.695 HG13 ' HA ' ' A' ' 104' ' ' GLU . 27.3 m -57.82 -36.73 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.089 0.774 . . . . 71.439999999999998 113.089 -172.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.91 -45.75 87.92 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.83 0.348 . . . . 74.140000000000001 110.498 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.06 97.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.347 -0.388 . . . . 74.329999999999998 111.463 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.402 ' CE1' ' HG3' ' A' ' 174' ' ' GLU . 48.9 t80 -63.24 -57.62 9.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.309 -0.405 . . . . 73.540000000000006 111.373 176.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -52.6 -46.03 66.8 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.418 0.628 . . . . 71.319999999999993 111.053 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.53 -40.24 96.14 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.43 -0.805 . . . . 73.420000000000002 111.963 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -68.78 -50.6 48.98 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.892 0.377 . . . . 74.140000000000001 110.915 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.97 -33.49 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.856 0.36 . . . . 73.310000000000002 111.205 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -65.03 -42.27 94.5 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.096 0.474 . . . . 72.549999999999997 110.534 174.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.27 -39.26 97.48 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.895 -0.669 . . . . 62.409999999999997 112.024 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 49.2 t90 -58.63 -53.92 52.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.531 0.332 . . . . 75.340000000000003 111.224 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.426 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.4 m -64.19 -46.26 93.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 112.657 0.614 . . . . 72.329999999999998 112.657 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.81 -31.53 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.882 -0.511 . . . . 74.030000000000001 111.669 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.8 t -78.19 -42.99 29.78 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.208 0.528 . . . . 64.140000000000001 111.039 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.27 -31.0 71.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.037 -0.529 . . . . 73.430000000000007 112.309 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 71.0 mt -87.2 3.22 47.36 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.031 0.382 . . . . 75.510000000000005 112.031 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.72 103.79 0.15 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.062 0.458 . . . . 61.539999999999999 112.223 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.634 ' HZ2' ' HB3' ' A' ' 130' ' ' LYS . 0.3 OUTLIER -62.06 -24.58 67.17 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.897 0.703 . . . . 73.200000000000003 112.897 -174.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -80.31 -40.07 27.48 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.339 0.496 . . . . 73.310000000000002 112.339 -175.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -100.31 -60.43 1.53 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.218 0.532 . . . . 74.530000000000001 112.242 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.402 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 16.5 m-85 -74.11 -5.99 44.97 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.667 0.988 . . . . 74.409999999999997 113.667 -168.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.709 ' HZ2' ' HB3' ' A' ' 134' ' ' LYS . 6.2 ttpm? -58.11 -18.65 26.57 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.879 -0.513 . . . . 74.430000000000007 111.45 176.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -85.49 15.64 4.38 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.527 0.566 . . . . 65.230000000000004 112.527 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 82.1 mt -89.82 142.34 27.79 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.235 0.54 . . . . 73.109999999999999 111.472 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.26 153.46 22.13 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.289 -0.414 . . . . 75.019999999999996 110.825 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -119.85 138.71 53.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 61.43 110.425 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 50.6 m-85 -134.27 136.5 43.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.12 0.486 . . . . 71.319999999999993 111.455 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.515 HD11 ' HA3' ' A' ' 151' ' ' GLY . 8.0 tt -124.47 149.06 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 115.917 -0.583 . . . . 75.400000000000006 110.889 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.69 129.74 49.32 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.262 -0.494 . . . . 71.430000000000007 113.579 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -46.93 -43.78 19.34 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.648 0.379 . . . . 71.549999999999997 111.886 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -49.52 -34.29 16.87 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.247 0.832 . . . . 73.409999999999997 113.247 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -94.91 -25.19 16.66 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.029 -0.42 . . . . 71.140000000000001 111.857 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.443 ' HB3' HG11 ' A' ' 77' ' ' VAL . . . -49.48 -30.24 7.9 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.267 1.21 . . . . 75.219999999999999 114.267 -173.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.72 -26.82 67.45 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.719 0.637 . . . . 74.340000000000003 112.719 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 169.86 -22.73 0.09 OUTLIER Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.588 -0.815 . . . . 64.150000000000006 113.869 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.37 97.79 0.44 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.981 0.42 . . . . 70.219999999999999 111.806 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -4.9 21.65 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.361 -0.381 . . . . 62.229999999999997 111.94 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -84.81 20.79 1.71 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.745 0.307 . . . . 74.310000000000002 111.68 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.515 ' HA3' HD11 ' A' ' 140' ' ' ILE . . . -92.86 135.64 12.77 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.208 -0.52 . . . . 42.0 112.636 176.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.443 ' NE2' HD22 ' A' ' 171' ' ' LEU . 42.8 tt0 -68.84 119.01 12.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.25 0.463 . . . . 61.119999999999997 112.25 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 37.6 t -80.08 124.91 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.089 0.471 . . . . 75.019999999999996 111.027 172.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.565 ' HB1' HD13 ' A' ' 169' ' ' LEU . . . -102.21 135.46 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.076 -0.511 . . . . 73.109999999999999 110.594 177.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.722 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 61.5 mt -90.28 137.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 112.338 0.496 . . . . 71.209999999999994 112.338 -172.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.1 mm -108.47 117.49 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.391 -0.368 . . . . 75.540000000000006 111.67 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.405 ' HB2' ' HE2' ' A' ' 170' ' ' MET . 35.9 tt0 -110.47 137.11 48.6 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.38 -0.373 . . . . 62.420000000000002 111.389 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -73.26 88.14 1.5 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.51 -0.552 . . . . 75.329999999999998 109.51 169.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.03 121.65 22.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.166 0.508 . . . . 75.540000000000006 110.611 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -69.19 139.78 54.58 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.385 0.612 . . . . 71.409999999999997 112.033 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 163' ' ' GLY . 98.3 t -129.78 150.27 34.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.923 -1.51 . . . . 71.040000000000006 106.923 167.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.27 70.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.403 0.62 . . . . 73.099999999999994 111.058 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 161' ' ' VAL . . . 133.89 -12.47 4.78 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.774 -0.648 . . . . 63.43 113.862 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 m -143.55 148.57 36.16 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.087 -0.655 . . . . 73.420000000000002 111.526 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.94 108.74 18.61 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.421 0.629 . . . . 64.400000000000006 111.004 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.451 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 27.1 m -115.91 130.05 24.7 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.228 -0.442 . . . . 75.420000000000002 111.657 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 166' ' ' VAL . 6.1 Cg_exo -79.66 115.01 3.3 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.633 2.222 . . . . 73.5 113.121 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.9 p -104.53 165.58 10.96 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.169 0.509 . . . . 74.439999999999998 111.824 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.585 ' HB2' HD13 ' A' ' 70' ' ' ILE . 21.1 tp -107.13 139.48 41.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.104 -0.498 . . . . 74.310000000000002 111.936 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.722 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 62.4 mtt -108.97 126.21 52.86 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 122.61 0.364 . . . . 74.409999999999997 111.633 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.443 HD22 ' NE2' ' A' ' 152' ' ' GLN . 82.1 mt -136.81 120.34 17.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.037 -0.529 . . . . 75.310000000000002 110.784 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.472 ' HA ' HG11 ' A' ' 27' ' ' VAL . 46.0 t -74.22 121.18 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.628 -0.67 . . . . 64.450000000000003 111.927 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -70.14 -31.26 68.69 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.606 0.595 . . . . 74.540000000000006 112.606 -174.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.402 ' HG3' ' CE1' ' A' ' 116' ' ' PHE . 28.8 mm-40 -82.18 -1.3 48.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.941 0.4 . . . . 73.120000000000005 111.629 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.513 ' HB3' ' CE1' ' A' ' 95' ' ' PHE . . . -96.53 -54.83 3.11 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.278 0.561 . . . . 75.540000000000006 110.462 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 6' ' ' ASP . 29.3 pt -95.66 144.61 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.783 -0.644 . . . . 74.109999999999999 110.939 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.674 ' HB ' ' HB3' ' A' ' 5' ' ' LYS . 1.7 mp -91.84 110.7 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.348 0.594 . . . . 75.519999999999996 109.804 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -106.03 129.53 54.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.151 -0.932 . . . . 64.319999999999993 110.648 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 46.2 mt-10 -130.82 98.98 4.77 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.16 0.505 . . . . 73.129999999999995 110.818 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.406 ' HA ' HD12 ' A' ' 2' ' ' LEU . 32.8 ttpt . . . . . 0 CA--C 1.535 0.402 0 CA-C-N 116.003 -0.544 . . . . 75.099999999999994 111.924 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.558 0.218 . . . . 71.140000000000001 110.916 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 15' ' ' SER . 32.0 tp -84.55 138.17 32.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.319 -0.623 . . . . 75.450000000000003 109.319 170.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.468 HG23 HD13 ' A' ' 13' ' ' LEU . 53.1 mt -121.03 118.48 56.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.251 -0.277 . . . . 73.109999999999999 110.251 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -118.88 146.89 44.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.272 0.471 . . . . 74.030000000000001 112.272 -172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.642 ' HB3' HD11 ' A' ' 13' ' ' LEU . 20.8 ptmt -151.37 127.33 10.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.758 0.651 . . . . 75.299999999999997 112.758 176.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.775 ' HB3' ' HB ' ' A' ' 9' ' ' THR . 18.3 t70 -79.37 166.13 22.39 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.866 -0.606 . . . . 37.93 110.761 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.9 pt -73.21 -41.29 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 113.133 0.79 . . . . 72.430000000000007 113.133 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -105.66 -14.13 15.36 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.942 -0.473 . . . . 73.439999999999998 111.882 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.775 ' HB ' ' HB3' ' A' ' 6' ' ' ASP . 4.1 m -94.82 18.08 12.45 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.935 0.874 . . . . 73.230000000000004 109.48 172.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -45.8 -45.05 14.53 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.595 1.158 . . . . 73.109999999999999 113.439 -172.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.17 -21.65 66.35 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.153 0.797 . . . . 64.439999999999998 113.153 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.46 ' HB2' HG22 ' A' ' 9' ' ' THR . 37.7 mt-10 -88.8 24.38 2.05 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.144 0.424 . . . . 74.230000000000004 112.144 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.642 HD11 ' HB3' ' A' ' 5' ' ' LYS . 61.0 tp -44.28 118.6 1.56 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.866 0.467 . . . . 75.349999999999994 111.495 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -141.44 165.9 26.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.37 0.508 . . . . 73.140000000000001 112.37 -175.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 2' ' ' LEU . 99.2 p -112.06 147.17 36.59 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.227 -0.442 . . . . 63.420000000000002 111.378 176.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -142.36 -170.37 3.17 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.385 0.612 . . . . 71.439999999999998 112.017 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -153.84 63.11 0.72 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.604 -0.725 . . . . 73.329999999999998 110.44 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -124.23 157.18 65.23 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 116.232 -0.44 . . . . 72.420000000000002 111.73 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.36 148.53 11.56 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.775 2.317 . . . . 74.140000000000001 112.777 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -146.31 145.67 30.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.08 0.467 . . . . 74.049999999999997 112.107 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -116.12 109.76 17.92 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.354 -0.385 . . . . 74.129999999999995 111.593 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.594 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 52.0 tp -79.99 96.7 6.5 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.908 -0.495 . . . . 74.329999999999998 110.963 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 p -87.96 140.17 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-O 120.967 0.413 . . . . 73.310000000000002 111.187 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.17 8.43 1.52 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.009 0.374 . . . . 71.239999999999995 112.009 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.594 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 40.9 m-20 55.17 20.2 3.26 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.214 0.53 . . . . 72.329999999999998 111.599 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.487 ' HA ' ' HZ3' ' A' ' 173' ' ' LYS . 26.0 tp -117.85 -43.21 2.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.217 -0.447 . . . . 74.109999999999999 110.749 -177.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 172' ' ' VAL . 16.5 m -133.52 149.69 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.97 0.414 . . . . 74.319999999999993 111.731 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -89.59 124.92 34.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.548 -0.297 . . . . 74.239999999999995 110.791 174.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 11.8 pt-20 -107.63 143.44 36.09 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.86 0.362 . . . . 74.239999999999995 110.885 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -151.59 119.58 6.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.643 0.259 . . . . 75.409999999999997 111.242 173.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -74.94 124.75 27.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.856 0.36 . . . . 71.349999999999994 111.331 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.88 172.3 42.05 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 114.186 0.435 . . . . 71.299999999999997 114.186 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -105.73 116.34 31.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.563 0.345 . . . . 72.140000000000001 110.61 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.21 107.05 2.64 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.179 0.514 . . . . 74.400000000000006 111.891 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -140.66 156.99 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.016 0.436 . . . . 74.439999999999998 111.618 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.11 125.67 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.073 0.463 . . . . 75.420000000000002 110.965 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.835 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 32.0 ttt-85 . . . . . 0 CA--C 1.539 0.547 0 CA-C-N 116.537 -0.301 . . . . 73.450000000000003 111.515 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.835 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 19.7 mm-40 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 121.278 0.561 . . . . 65.310000000000002 110.323 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -82.59 135.3 35.1 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.673 -0.694 . . . . 70.140000000000001 111.464 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.09 -142.59 8.94 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.778 -0.725 . . . . 62.109999999999999 113.269 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.0 pt -111.04 143.84 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 122.499 -0.412 . . . . 62.210000000000001 112.015 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -41.66 -42.21 2.45 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.633 -0.712 . . . . 71.019999999999996 112.597 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 55.2 mt -51.75 -61.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.246 0.546 . . . . 74.420000000000002 112.271 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.8 m -72.29 -34.38 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.116 -0.493 . . . . 73.219999999999999 112.227 -174.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.0 -44.18 77.19 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.763 0.316 . . . . 74.439999999999998 111.145 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -63.03 -36.67 84.33 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.882 0.372 . . . . 75.420000000000002 111.637 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -94.32 2.14 55.86 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.057 0.391 . . . . 74.549999999999997 112.057 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.732 ' HB2' ' HZ2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 53.11 66.21 1.3 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.937 0.495 . . . . 72.230000000000004 112.08 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.4 mt -104.64 129.64 52.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.446 -0.343 . . . . 74.25 111.19 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 140' ' ' ILE . 11.2 p -78.66 137.02 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.787 0.327 . . . . 73.129999999999995 111.066 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -85.44 135.86 33.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.257 0.551 . . . . 72.299999999999997 112.071 -177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.3 mmm -130.19 159.41 36.94 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.374 -0.83 . . . . 70.349999999999994 109.735 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -132.04 140.87 49.04 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.248 0.833 . . . . 74.319999999999993 113.248 -169.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.408 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 27.5 p -48.73 -42.82 36.48 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.791 1.034 . . . . 75.319999999999993 113.791 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -53.33 -33.09 52.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.354 0.502 . . . . 74.450000000000003 112.354 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -103.44 -47.21 4.35 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.083 0.468 . . . . 70.420000000000002 111.643 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -77.6 4.8 10.45 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.545 0.572 . . . . 71.340000000000003 112.545 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.466 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -48.61 -46.31 39.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.072 0.463 . . . . 74.450000000000003 111.712 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 78.4 p -66.08 -41.95 90.02 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.973 -0.558 . . . . 62.130000000000003 111.533 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.3 ttp -63.03 -51.76 65.49 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.314 -0.403 . . . . 73.519999999999996 111.829 -175.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.515 ' HA ' ' HB2' ' A' ' 91' ' ' TYR . 8.1 p90 -75.87 -17.58 59.75 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 120.199 -0.601 . . . . 72.219999999999999 111.582 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -64.8 -45.66 85.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.255 0.55 . . . . 75.209999999999994 110.122 170.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.19 -42.58 93.44 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.094 -0.503 . . . . 73.010000000000005 110.736 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.515 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 13.9 m-30 -59.06 -49.44 77.89 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.165 0.431 . . . . 73.219999999999999 112.165 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.5 tp -65.55 -31.64 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.612 0.244 . . . . 74.349999999999994 111.439 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -63.8 -51.15 66.09 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.996 0.426 . . . . 75.329999999999998 110.778 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -65.08 -41.76 94.75 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.172 0.51 . . . . 73.340000000000003 110.982 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.601 ' HE1' ' HB3' ' A' ' 175' ' ' ALA . 78.7 t80 -58.64 -56.99 15.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.419 -0.809 . . . . 75.230000000000004 111.102 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 50.9 ttp -50.74 -48.11 59.13 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.01 0.433 . . . . 70.129999999999995 111.463 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.68 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -63.28 -46.57 86.15 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.127 -0.488 . . . . 75.420000000000002 111.48 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -70.66 -42.56 70.63 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.255 0.465 . . . . 65.420000000000002 112.255 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.36 -33.61 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.18 0.437 . . . . 73.439999999999998 112.18 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.415 HG21 ' O ' ' A' ' 97' ' ' LYS . 10.0 tp -67.82 -38.23 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.533 -0.467 . . . . 75.310000000000002 110.309 175.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -65.25 -48.03 74.67 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.315 0.579 . . . . 72.239999999999995 110.552 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -60.0 -29.89 68.78 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.662 -0.699 . . . . 73.230000000000004 111.789 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 54.5 tpp -90.64 -60.52 1.9 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.813 0.339 . . . . 74.019999999999996 111.684 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.12 -32.69 68.37 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.144 0.424 . . . . 72.140000000000001 112.144 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -55.86 -44.07 77.72 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.287 0.477 . . . . 73.329999999999998 112.287 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -95.83 -36.69 11.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.99 0.366 . . . . 72.230000000000004 111.99 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -67.09 -62.94 1.18 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.644 -0.253 . . . . 72.310000000000002 111.591 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 108' ' ' ARG . 49.1 mtm180 62.59 23.74 14.12 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.992 1.108 . . . . 75.200000000000003 113.992 173.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.512 ' O ' HG22 ' A' ' 113' ' ' VAL . 20.3 t70 -120.88 121.24 37.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.691 -0.63 . . . . 74.349999999999994 111.391 175.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 3.3 ptpp? -66.44 -1.25 3.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.887 1.069 . . . . 73.439999999999998 113.887 -175.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.95 -44.35 8.48 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.83 -0.544 . . . . 72.420000000000002 110.862 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -71.08 -51.39 25.46 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.386 -0.37 . . . . 64.200000000000003 111.408 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 109' ' ' ASP . 34.4 m -61.84 -28.45 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.727 0.299 . . . . 74.510000000000005 111.205 177.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 18.9 t70 -61.2 -56.33 21.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.082 0.468 . . . . 64.409999999999997 110.318 174.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 119' ' ' LYS . . . -59.92 -40.9 90.46 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.828 -0.624 . . . . 71.400000000000006 111.245 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -57.02 -61.96 2.09 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.288 0.477 . . . . 75.319999999999993 112.288 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 114' ' ' ASP . 62.7 pttt -55.19 -45.23 75.81 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.885 0.374 . . . . 75.329999999999998 111.274 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -65.91 -28.63 69.07 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.828 0.307 . . . . 75.420000000000002 111.828 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 37.1 tptt -72.75 -56.84 4.67 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.049 0.452 . . . . 74.439999999999998 110.739 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.4 tp -68.18 -39.27 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.896 -0.593 . . . . 75.019999999999996 111.763 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.506 HE21 ' HA ' ' A' ' 121' ' ' GLN . 0.0 OUTLIER -62.83 -51.41 67.16 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.283 -0.261 . . . . 74.140000000000001 111.422 177.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.63 -44.92 68.82 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.913 -0.661 . . . . 74.420000000000002 112.656 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -58.71 -58.39 8.79 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 111.561 0.208 . . . . 75.450000000000003 111.561 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.458 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.7 m -61.76 -44.68 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 112.546 0.573 . . . . 54.329999999999998 112.546 -175.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.1 m -63.34 -26.98 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.88 -0.513 . . . . 73.310000000000002 111.418 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 m -81.25 -36.49 29.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.215 0.531 . . . . 63.210000000000001 110.767 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 51.4 tp -71.61 -31.39 66.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.736 -0.665 . . . . 73.519999999999996 112.102 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 80.7 mt -80.56 2.36 25.83 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.167 0.432 . . . . 74.340000000000003 112.167 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.501 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -58.69 103.47 0.16 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.223 0.535 . . . . 71.109999999999999 112.012 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 37.8 ttpt -65.74 -23.24 66.69 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.29 0.848 . . . . 74.140000000000001 113.29 -171.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -77.87 -31.83 51.59 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.052 0.76 . . . . 62.130000000000003 113.052 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -108.35 -51.78 2.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.259 0.552 . . . . 75.329999999999998 111.517 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.501 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 45.8 m-85 -71.22 -5.6 33.21 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.943 0.72 . . . . 75.439999999999998 112.943 -172.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 21.8 ptmt -51.36 -26.19 7.31 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.067 -0.395 . . . . 72.439999999999998 111.556 172.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -82.18 18.53 1.37 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.67 0.618 . . . . 74.329999999999998 112.67 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 75.3 mt -89.68 137.32 32.43 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.982 -0.449 . . . . 74.25 111.297 176.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.9 123.82 45.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.258 -0.428 . . . . 75.049999999999997 110.603 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.411 ' HB3' HG11 ' A' ' 153' ' ' VAL . 88.8 m-85 -101.73 106.17 17.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.982 0.42 . . . . 72.420000000000002 111.195 -176.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -97.39 136.14 38.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.066 0.46 . . . . 73.239999999999995 111.33 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.454 ' O ' HG13 ' A' ' 77' ' ' VAL . 13.2 tt -140.03 154.72 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.784 0.326 . . . . 74.519999999999996 110.88 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.18 125.89 35.13 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.706 -0.759 . . . . 71.219999999999999 112.145 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -48.5 -47.56 38.76 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.669 0.387 . . . . 71.219999999999999 111.751 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 143' ' ' ARG . 31.3 ttp180 -48.68 -52.4 23.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.087 -0.506 . . . . 74.0 111.408 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.593 ' HB3' ' H ' ' A' ' 151' ' ' GLY . . . -68.62 -28.05 66.56 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.182 0.438 . . . . 71.120000000000005 112.182 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.22 -17.8 64.95 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.748 0.419 . . . . 74.430000000000007 111.681 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -66.62 -7.97 24.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.172 -0.467 . . . . 64.310000000000002 112.004 175.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.0 17.53 76.79 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.106 -0.568 . . . . 75.450000000000003 112.806 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.46 -60.87 1.52 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.948 0.404 . . . . 71.530000000000001 111.073 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -74.74 -35.81 62.63 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.381 -0.372 . . . . 73.349999999999994 111.459 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 21.8 m120 57.69 34.53 24.6 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.943 0.401 . . . . 72.140000000000001 111.241 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.593 ' H ' ' HB3' ' A' ' 144' ' ' ALA . . . -54.09 162.47 3.58 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.61 -0.723 . . . . 53.420000000000002 114.216 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -59.59 144.44 47.57 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.948 0.722 . . . . 74.209999999999994 112.948 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.411 HG11 ' HB3' ' A' ' 138' ' ' PHE . 50.0 t -91.44 127.5 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.99 -0.55 . . . . 75.329999999999998 111.526 175.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.479 ' HB3' HD13 ' A' ' 169' ' ' LEU . . . -85.21 116.11 23.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.783 -0.644 . . . . 73.109999999999999 110.807 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.687 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 62.6 mt -88.8 124.44 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.821 0.343 . . . . 73.400000000000006 111.72 -176.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.8 mm -110.52 120.24 60.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.942 0.401 . . . . 71.420000000000002 111.775 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 26.0 tt0 -107.78 128.81 54.92 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.245 -0.434 . . . . 64.239999999999995 111.947 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -72.62 89.06 1.29 Allowed 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.969 -0.457 . . . . 73.239999999999995 110.486 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -92.2 133.95 35.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.926 0.393 . . . . 74.540000000000006 111.919 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.86 123.9 33.68 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.094 0.473 . . . . 55.299999999999997 111.506 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.6 t -130.1 105.06 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.875 0.369 . . . . 75.200000000000003 111.441 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.2 t70 56.19 30.94 17.41 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.335 0.588 . . . . 73.25 111.916 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.41 -24.55 24.04 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.171 -0.537 . . . . 63.020000000000003 113.664 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.5 p -90.16 148.58 22.88 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.924 0.392 . . . . 73.329999999999998 111.58 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 0.1 OUTLIER -102.97 96.47 6.83 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.462 0.649 . . . . 75.530000000000001 110.74 178.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 166' ' ' VAL . 25.0 m -104.16 106.59 54.16 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 121.348 0.594 . . . . 63.149999999999999 112.066 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 34.2 Cg_exo -62.08 114.35 2.28 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.531 2.154 . . . . 75.409999999999997 112.481 176.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 90.9 m -99.15 133.07 43.95 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.921 0.391 . . . . 75.329999999999998 111.967 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 57.8 tp -77.83 140.1 39.35 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.898 -0.592 . . . . 74.230000000000004 111.702 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.687 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 24.0 mmt -127.96 124.36 37.1 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.693 0.397 . . . . 71.230000000000004 111.597 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.3 mt -141.09 130.63 23.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.651 0.38 . . . . 73.200000000000003 111.431 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.522 ' HA ' HG13 ' A' ' 27' ' ' VAL . 19.6 t -79.97 129.17 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.121 0.415 . . . . 65.030000000000001 112.121 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.489 ' HZ2' ' CD ' ' A' ' 174' ' ' GLU . 2.7 pptp? -77.48 -15.21 59.43 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.599 0.592 . . . . 74.010000000000005 112.599 -175.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.489 ' CD ' ' HZ2' ' A' ' 173' ' ' LYS . 3.8 mp0 -57.33 -27.63 62.39 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.846 0.355 . . . . 70.439999999999998 111.821 171.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.601 ' HB3' ' HE1' ' A' ' 95' ' ' PHE . . . -97.3 -42.72 7.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.144 -0.48 . . . . 70.519999999999996 111.93 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.4 pt -95.9 118.56 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.607 0.718 . . . . 75.409999999999997 112.373 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.417 ' N ' HD13 ' A' ' 177' ' ' ILE . 1.6 mp -94.88 115.63 34.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.798 -0.637 . . . . 75.140000000000001 110.255 175.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -97.96 112.88 24.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.567 -0.742 . . . . 73.439999999999998 111.407 -176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -97.71 123.03 41.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.557 0.343 . . . . 71.129999999999995 110.797 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.6 pttt . . . . . 0 CA--C 1.544 0.748 0 N-CA-C 112.993 0.738 . . . . 74.319999999999993 112.993 -171.943 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 111.747 0.277 . . . . 64.209999999999994 111.747 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.0 tp -126.18 131.01 52.1 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.857 0.361 . . . . 73.25 110.535 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.551 HG12 ' HB3' ' A' ' 15' ' ' SER . 57.5 mt -98.05 134.11 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 112.004 0.372 . . . . 74.519999999999996 112.004 -175.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -123.52 137.27 54.8 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.083 0.468 . . . . 73.450000000000003 111.115 171.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -143.54 141.39 30.69 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.989 -0.55 . . . . 72.530000000000001 111.361 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 176' ' ' ILE . 5.2 m-20 -86.98 167.74 13.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.4 0.619 . . . . 75.230000000000004 111.258 172.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.415 HD12 ' OD1' ' A' ' 98' ' ' ASN . 15.2 pt -63.05 -26.86 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.97 -0.559 . . . . 71.519999999999996 111.458 173.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.479 ' HE1' ' HA ' ' A' ' 152' ' ' GLN . 13.2 p90 -109.95 -35.65 6.09 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.321 0.86 . . . . 75.340000000000003 113.321 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.489 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 2.7 m -83.12 15.61 2.76 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.95 0.722 . . . . 75.099999999999994 112.95 -173.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -58.28 -15.11 8.93 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.849 0.685 . . . . 75.409999999999997 112.849 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -67.81 -56.02 10.77 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 122.156 -0.34 . . . . 74.450000000000003 111.267 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -84.14 25.02 0.87 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.832 0.349 . . . . 61.539999999999999 111.747 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tt -40.12 131.07 2.08 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.535 0.734 . . . . 73.209999999999994 111.589 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 m -126.11 139.9 53.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.143 0.497 . . . . 75.239999999999995 112.279 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.551 ' HB3' HG12 ' A' ' 3' ' ' ILE . 47.8 p -111.55 111.04 21.76 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.869 -0.605 . . . . 72.310000000000002 110.944 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.405 ' HB3' ' HD1' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -151.05 -156.83 0.75 Allowed 'General case' 0 CA--C 1.544 0.741 0 O-C-N 122.355 -0.216 . . . . 54.310000000000002 111.204 -175.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -127.63 24.77 6.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.136 0.421 . . . . 74.340000000000003 112.136 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.405 ' HD1' ' HB3' ' A' ' 16' ' ' ASP . 59.1 m-85 -60.18 134.15 90.56 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.03 0.382 . . . . 71.400000000000006 112.03 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.99 -169.84 0.88 Allowed 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.779 2.319 . . . . 75.030000000000001 113.08 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.6 ptp -145.89 135.43 23.17 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.442 0.534 . . . . 62.549999999999997 112.442 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 75.7 mmtt -124.45 100.41 6.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.614 -0.513 . . . . 75.409999999999997 109.614 170.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.403 HD11 ' O ' ' A' ' 27' ' ' VAL . 33.0 tp -93.03 124.46 37.01 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.174 0.805 . . . . 74.420000000000002 113.174 -170.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.68 142.35 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.896 -0.593 . . . . 64.420000000000002 111.01 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 57.44 13.44 1.82 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.481 0.549 . . . . 75.200000000000003 112.481 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 50.76 26.86 2.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.216 0.532 . . . . 74.209999999999994 111.03 -172.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 119' ' ' LYS . 20.0 tp -121.62 -42.71 2.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.159 -0.473 . . . . 71.409999999999997 111.967 -174.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.662 ' HB ' ' SD ' ' A' ' 170' ' ' MET . 2.6 m -138.19 151.73 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.803 0.668 . . . . 70.219999999999999 112.803 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 76.0 m-85 -104.57 138.52 40.79 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.879 -0.6 . . . . 75.040000000000006 111.117 176.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -104.39 137.73 41.84 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.397 . . . . 74.239999999999995 110.526 167.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.832 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.4 t80 -115.59 134.25 55.24 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.943 0.401 . . . . 75.340000000000003 111.141 177.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -93.1 113.79 26.14 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.199 -0.455 . . . . 72.519999999999996 111.859 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.09 -174.82 18.31 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.275 -0.488 . . . . 61.420000000000002 113.598 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -128.14 144.25 51.1 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 122.482 -0.422 . . . . 75.540000000000006 111.298 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -80.08 114.16 18.79 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.866 -0.42 . . . . 74.519999999999996 109.866 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.1 m -144.23 174.42 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.302 0.573 . . . . 75.319999999999993 111.949 -174.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.5 m -110.85 121.75 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.168 0.509 . . . . 75.030000000000001 110.558 173.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.608 ' HB2' HD13 ' A' ' 72' ' ' LEU . 9.8 mmm180 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 121.095 0.474 . . . . 74.420000000000002 111.111 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.466 ' HA ' ' C ' ' A' ' 37' ' ' ARG . 39.7 tt0 . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 121.397 0.617 . . . . 72.310000000000002 109.354 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -137.02 122.02 18.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.746 -0.661 . . . . 73.239999999999995 111.202 -176.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.53 -148.78 15.5 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.532 -0.842 . . . . 74.219999999999999 113.736 175.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.426 HD12 HD11 ' A' ' 70' ' ' ILE . 36.7 pt -111.07 138.82 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 122.417 -0.46 . . . . 75.150000000000006 111.356 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -48.14 -35.75 12.16 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.379 0.511 . . . . 75.420000000000002 112.379 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.426 HD11 HD12 ' A' ' 68' ' ' ILE . 55.8 mt -49.81 -64.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.401 0.62 . . . . 73.209999999999994 112.021 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 18.5 m -74.38 -31.98 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.964 -0.562 . . . . 71.430000000000007 112.08 -174.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.608 HD13 ' HB2' ' A' ' 37' ' ' ARG . 72.6 mt -68.7 -30.78 69.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.286 -0.415 . . . . 74.239999999999995 111.64 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -90.63 -27.13 19.27 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 111.852 0.316 . . . . 72.120000000000005 111.852 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -97.84 3.65 49.82 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.02 -0.425 . . . . 75.200000000000003 111.782 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 58.29 70.87 0.62 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.406 0.622 . . . . 73.319999999999993 112.581 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.758 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 88.0 mt -122.26 138.92 54.33 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.003 -0.544 . . . . 73.200000000000003 111.256 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 p -93.76 146.67 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 120.856 0.36 . . . . 73.310000000000002 111.842 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.42 127.51 32.29 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.368 0.877 . . . . 64.409999999999997 113.368 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.482 ' HE3' ' SD ' ' A' ' 87' ' ' MET . 87.0 mtp -140.26 110.61 6.65 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.172 -0.467 . . . . 75.239999999999995 110.139 174.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.495 ' HB2' ' HE1' ' A' ' 82' ' ' TYR . 18.4 m120 -95.74 167.11 11.47 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.852 -0.53 . . . . 73.409999999999997 112.134 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 43.1 t -43.5 -56.13 3.82 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.87 1.063 . . . . 72.340000000000003 113.87 -172.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.495 ' HE1' ' HB2' ' A' ' 80' ' ' ASN . 13.4 p90 -50.24 -33.0 18.11 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.457 0.54 . . . . 72.230000000000004 112.457 -177.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.76 -38.24 9.55 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.773 -0.649 . . . . 64.200000000000003 112.087 -174.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 88' ' ' PHE . 25.4 t0 -91.21 -7.63 50.77 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.477 0.547 . . . . 72.129999999999995 112.477 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.585 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -39.71 -61.49 0.82 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.369 0.878 . . . . 74.430000000000007 113.369 -175.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.4 m -61.86 -35.25 77.74 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.262 0.467 . . . . 62.340000000000003 112.262 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.482 ' SD ' ' HE3' ' A' ' 79' ' ' MET . 44.5 ttm -75.74 -54.4 7.01 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.139 0.422 . . . . 72.230000000000004 112.139 -174.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 7.6 p90 -63.47 -27.09 69.04 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.114 -0.634 . . . . 74.510000000000005 111.617 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -64.32 -44.8 90.46 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.867 0.365 . . . . 72.420000000000002 110.645 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.64 -38.0 89.51 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.2 0.524 . . . . 73.329999999999998 110.714 173.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.521 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 27.8 t80 -55.82 -50.99 69.0 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.72 -0.673 . . . . 73.420000000000002 110.978 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 88' ' ' PHE . 32.6 mm -57.68 -42.72 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 116.283 -0.417 . . . . 71.120000000000005 111.593 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.93 -56.38 17.7 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.865 0.32 . . . . 74.519999999999996 111.865 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.527 ' HZ2' ' HA ' ' A' ' 150' ' ' ASN . 39.1 ttpt -59.94 -39.21 84.77 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.897 0.379 . . . . 73.109999999999999 111.147 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.516 ' CZ ' HG12 ' A' ' 172' ' ' VAL . 20.3 t80 -59.49 -59.15 5.91 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.121 -0.49 . . . . 72.329999999999998 111.221 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 55.6 ttp -52.82 -44.43 66.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.161 -0.472 . . . . 73.540000000000006 111.4 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -61.67 -49.56 76.02 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.36 -0.382 . . . . 72.299999999999997 111.321 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.415 ' OD1' HD12 ' A' ' 7' ' ' ILE . 26.0 t-20 -61.33 -56.06 24.73 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.76 0.281 . . . . 64.299999999999997 111.76 -176.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.569 ' HB ' ' HZ ' ' A' ' 116' ' ' PHE . 27.5 m -57.46 -41.72 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.407 0.521 . . . . 74.040000000000006 112.407 -176.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.6 tp -74.74 -35.9 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 122.077 -0.39 . . . . 71.5 111.006 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.73 -13.81 61.03 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.336 0.588 . . . . 70.109999999999999 110.8 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -90.36 -37.79 13.77 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.16 -0.337 . . . . 74.530000000000001 111.343 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 64.0 mtt -93.13 -62.88 1.29 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.523 0.564 . . . . 71.409999999999997 112.523 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.646 ' HA ' HG13 ' A' ' 113' ' ' VAL . 38.9 tt0 -58.29 -26.34 62.9 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.38 0.511 . . . . 72.439999999999998 112.38 -174.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -57.27 -46.21 83.31 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 111.991 0.367 . . . . 75.420000000000002 111.991 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.02 -14.52 14.72 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.566 0.58 . . . . 74.549999999999997 112.566 -175.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.449 ' OD1' HG11 ' A' ' 113' ' ' VAL . 27.6 t-20 -92.72 -68.9 0.77 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.666 0.269 . . . . 73.219999999999999 111.398 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.422 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 36.6 ttm180 63.14 11.96 5.67 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.248 0.833 . . . . 73.219999999999999 113.248 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 113' ' ' VAL . 22.2 t70 -75.53 120.36 20.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.385 -0.822 . . . . 75.409999999999997 110.954 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -57.78 -12.31 2.94 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.468 0.914 . . . . 75.109999999999999 113.468 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.1 -53.25 4.2 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.997 -0.439 . . . . 75.310000000000002 112.043 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -74.12 -60.07 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.238 0.459 . . . . 74.150000000000006 112.238 -170.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 104' ' ' GLU . 27.6 m -60.47 -26.6 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.692 0.282 . . . . 72.319999999999993 111.722 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.79 -53.22 50.38 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.573 -0.285 . . . . 75.120000000000005 110.483 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -56.57 -43.66 80.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.042 0.449 . . . . 61.240000000000002 111.258 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.569 ' HZ ' ' HB ' ' A' ' 99' ' ' VAL . 44.1 t80 -61.07 -59.21 5.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.882 0.372 . . . . 61.109999999999999 111.624 177.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -57.0 -35.14 68.88 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.175 0.512 . . . . 65.549999999999997 111.169 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -68.97 -40.15 79.02 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.786 -0.643 . . . . 74.120000000000005 111.385 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.497 ' HB3' HD21 ' A' ' 26' ' ' LEU . 51.9 mtmt -65.69 -44.18 86.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.512 0.196 . . . . 74.109999999999999 111.103 175.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.423 ' CD1' HD13 ' A' ' 26' ' ' LEU . 37.6 mm -62.01 -45.58 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.917 0.389 . . . . 75.450000000000003 111.055 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.54 -50.99 71.78 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.184 -0.462 . . . . 72.140000000000001 110.776 177.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.73 -36.85 93.88 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.922 -0.656 . . . . 75.319999999999993 112.724 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.2 t90 -60.6 -56.4 21.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.642 0.377 . . . . 74.219999999999999 111.587 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.522 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.8 m -63.36 -42.72 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 112.241 0.46 . . . . 72.140000000000001 112.241 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.6 t -59.81 -37.23 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 122.066 -0.396 . . . . 75.519999999999996 111.43 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.2 t -77.16 -39.62 48.41 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.042 0.449 . . . . 75.010000000000005 110.984 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.0 tp -62.41 -28.38 69.75 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.994 0.517 . . . . 73.299999999999997 112.148 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 29.3 mt -92.58 1.81 57.05 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.916 0.339 . . . . 73.200000000000003 111.916 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.89 108.08 2.43 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.091 0.472 . . . . 65.310000000000002 111.451 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -16.58 49.19 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.076 0.769 . . . . 72.129999999999995 113.076 -172.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -54.91 -49.05 72.24 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.904 0.383 . . . . 61.340000000000003 111.404 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -111.24 -43.34 3.74 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.403 0.62 . . . . 74.400000000000006 111.27 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -74.23 -7.26 52.08 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.327 0.862 . . . . 75.230000000000004 113.327 -167.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -63.7 -32.35 73.81 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.197 0.523 . . . . 70.310000000000002 110.426 170.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -89.7 33.9 0.84 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.003 -0.544 . . . . 75.099999999999994 112.199 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.73 156.95 18.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.504 0.669 . . . . 65.450000000000003 111.93 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.36 112.63 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.461 -0.79 . . . . 74.010000000000005 110.288 172.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.569 ' HB3' HG12 ' A' ' 153' ' ' VAL . 54.5 m-85 -90.9 132.93 35.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.916 0.388 . . . . 75.340000000000003 110.226 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.758 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 61.4 m-85 -121.94 125.39 46.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.863 0.364 . . . . 74.109999999999999 111.331 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 13.8 tt -113.4 154.63 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 116.552 -0.294 . . . . 74.329999999999998 111.348 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.99 142.8 41.42 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.447 -0.342 . . . . 73.109999999999999 113.645 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.414 ' HG3' ' HG3' ' A' ' 143' ' ' ARG . 14.2 pt-20 -53.29 -40.06 64.42 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.643 0.609 . . . . 75.430000000000007 112.643 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.414 ' HG3' ' HG3' ' A' ' 142' ' ' GLU . 85.1 mtm180 -78.17 -38.44 43.51 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.019 0.377 . . . . 72.439999999999998 112.019 -176.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.54 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . . . -74.89 -28.48 60.65 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.085 0.402 . . . . 75.299999999999997 112.085 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -50.16 -38.79 41.24 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.04 1.126 . . . . 74.349999999999994 114.04 -174.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -73.52 6.16 3.26 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.756 1.021 . . . . 74.230000000000004 113.756 -172.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.26 -11.69 1.19 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.981 -1.104 . . . . 64.519999999999996 114.881 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.54 ' HB1' ' HA ' ' A' ' 144' ' ' ALA . . . -77.93 95.11 4.7 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 117.778 0.789 . . . . 74.340000000000003 111.59 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -74.27 19.85 0.12 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.473 0.546 . . . . 72.439999999999998 112.473 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.527 ' HA ' ' HZ2' ' A' ' 94' ' ' LYS . 40.7 t30 -111.49 5.88 19.83 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.943 0.401 . . . . 60.310000000000002 110.827 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.81 171.59 52.59 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.423 -0.418 . . . . 63.340000000000003 113.472 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.479 ' HA ' ' HE1' ' A' ' 8' ' ' PHE . 37.3 tt0 -86.72 116.96 25.17 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.421 -0.458 . . . . 62.5 112.085 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.569 HG12 ' HB3' ' A' ' 138' ' ' PHE . 27.5 t -83.29 107.17 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.152 0.501 . . . . 73.540000000000006 110.589 170.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.466 ' HB1' ' CD1' ' A' ' 169' ' ' LEU . . . -82.09 117.39 22.23 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.065 -0.516 . . . . 64.420000000000002 110.89 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 59.4 mt -89.27 105.12 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.854 0.359 . . . . 75.510000000000005 111.252 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.5 mm -93.77 117.8 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.027 0.381 . . . . 65.510000000000005 112.027 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.86 129.49 56.44 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.393 -0.595 . . . . 73.430000000000007 109.393 174.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -90.51 88.99 7.37 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.047 0.451 . . . . 75.209999999999994 110.456 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -97.17 159.05 15.13 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.329 0.585 . . . . 71.109999999999999 112.171 -170.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.01 134.09 48.7 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.926 -0.579 . . . . 73.019999999999996 111.295 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.1 t -119.2 104.84 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.642 0.258 . . . . 73.230000000000004 110.962 175.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 60.4 9.75 2.14 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.863 0.69 . . . . 74.040000000000006 112.863 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 116.27 2.05 20.06 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.427 -0.416 . . . . 60.219999999999999 113.096 -175.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 94.5 m -107.8 130.24 54.99 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.977 0.418 . . . . 71.120000000000005 111.966 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -74.03 112.48 10.21 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.986 -0.552 . . . . 74.209999999999994 112.191 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.408 ' O ' HG21 ' A' ' 166' ' ' VAL . 27.9 m -129.22 117.4 18.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 121.168 0.508 . . . . 65.400000000000006 111.932 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.96 114.5 3.99 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.838 1.692 . . . . 75.129999999999995 111.693 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 67.3 p -101.07 129.22 46.91 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.164 0.506 . . . . 74.120000000000005 112.047 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.832 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.1 tp -89.81 122.9 33.32 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.84 -0.618 . . . . 75.329999999999998 111.087 176.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.662 ' SD ' ' HB ' ' A' ' 27' ' ' VAL . 39.4 tpp -103.22 125.52 49.93 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.755 0.312 . . . . 73.140000000000001 111.596 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -140.9 152.09 44.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.189 0.596 . . . . 72.510000000000005 109.983 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.624 ' HA ' HG11 ' A' ' 27' ' ' VAL . 41.9 t -89.89 117.34 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.829 0.677 . . . . 72.319999999999993 112.829 -173.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -59.88 -31.81 70.15 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.045 -0.525 . . . . 75.0 111.832 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.419 ' HG3' ' HE1' ' A' ' 116' ' ' PHE . 5.5 mm-40 -85.27 11.55 9.85 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.464 -0.335 . . . . 64.400000000000006 111.803 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -127.09 -41.87 1.76 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.829 0.347 . . . . 40.420000000000002 111.083 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 172' ' ' VAL . 12.8 tt -100.18 132.18 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.093 0.473 . . . . 74.319999999999993 111.062 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.5 tp -130.25 153.53 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.95 0.405 . . . . 74.129999999999995 111.548 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.05 152.06 41.43 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.115 0.483 . . . . 70.510000000000005 111.35 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.511 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 11.2 tp10 -138.98 133.19 31.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.095 0.474 . . . . 75.439999999999998 110.697 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 121.729 0.776 . . . . 73.299999999999997 112.939 -172.929 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.764 0.316 . . . . 75.219999999999999 110.856 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 33.9 tp -100.8 130.92 46.89 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 110.117 -0.327 . . . . 74.140000000000001 110.117 173.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.74 ' HB ' HD21 ' A' ' 13' ' ' LEU . 21.1 pt -114.2 123.02 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.22 0.533 . . . . 75.219999999999999 111.557 -176.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HE1' ' HB2' ' A' ' 16' ' ' ASP . 35.7 p90 -122.8 143.28 49.94 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.231 0.539 . . . . 75.310000000000002 112.154 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.705 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 12.0 ptmt -130.1 150.0 51.56 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.688 -0.687 . . . . 75.030000000000001 111.242 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.513 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 7.0 p-10 -97.81 -178.33 4.06 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.212 0.53 . . . . 62.299999999999997 111.261 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.45 -43.83 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 113.239 0.829 . . . . 72.200000000000003 113.239 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.512 ' HD2' HG21 ' A' ' 9' ' ' THR . 9.2 p90 -108.48 -52.65 2.74 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.647 1.351 . . . . 75.239999999999995 114.647 -168.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.512 HG21 ' HD2' ' A' ' 8' ' ' PHE . 17.7 p -89.48 18.51 5.26 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.67 -0.644 . . . . 75.310000000000002 112.616 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.705 ' HB2' ' HB2' ' A' ' 5' ' ' LYS . 3.8 p-10 -50.87 -20.55 1.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.797 1.406 . . . . 71.540000000000006 114.797 -172.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -66.86 -19.79 65.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.363 0.602 . . . . 72.299999999999997 110.814 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.31 24.94 4.1 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.499 -0.773 . . . . 73.239999999999995 110.861 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.74 HD21 ' HB ' ' A' ' 3' ' ' ILE . 7.8 tt -38.52 138.61 0.48 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.815 0.846 . . . . 75.120000000000005 112.498 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.0 m -118.72 149.61 41.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.997 0.427 . . . . 62.240000000000002 111.934 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.5 p -109.77 129.91 55.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.236 -0.438 . . . . 74.319999999999993 110.557 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.5 ' HB2' ' HE1' ' A' ' 4' ' ' TYR . 2.5 t70 -137.41 179.04 6.64 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.657 0.265 . . . . 74.109999999999999 111.192 -177.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.7 t -132.74 4.97 3.92 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.275 0.472 . . . . 52.539999999999999 112.275 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -78.26 146.08 69.97 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 122.07 -0.394 . . . . 73.049999999999997 111.842 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -85.99 126.38 2.85 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.973 2.449 . . . . 64.400000000000006 113.386 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 87.7 mmm -89.74 124.63 34.8 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.502 -0.317 . . . . 74.310000000000002 111.163 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 56.5 mttm -103.48 112.24 25.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.34 0.256 . . . . 73.519999999999996 111.573 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.48 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 33.9 tp -84.54 106.65 16.27 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.809 -0.557 . . . . 72.0 112.159 -175.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -98.04 139.29 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.084 0.468 . . . . 74.150000000000006 111.131 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 58.32 15.56 3.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.565 0.58 . . . . 75.340000000000003 112.565 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 59.98 11.46 2.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.328 0.492 . . . . 73.129999999999995 112.328 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.1 tp -115.83 -45.54 2.87 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.07 0.396 . . . . 75.319999999999993 112.07 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.517 HG11 ' HA ' ' A' ' 172' ' ' VAL . 3.8 m -129.29 143.7 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.431 0.53 . . . . 73.209999999999994 112.431 -176.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.627 ' O ' ' HA ' ' A' ' 170' ' ' MET . 98.0 m-85 -92.0 142.03 27.98 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.074 -0.512 . . . . 74.450000000000003 110.876 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 16.4 pt-20 -128.87 146.97 50.79 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 110.242 -0.281 . . . . 71.409999999999997 110.242 174.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.495 ' CE2' HD12 ' A' ' 70' ' ' ILE . 43.6 p90 -152.48 145.67 24.65 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.626 0.973 . . . . 65.230000000000004 113.626 172.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -94.91 130.51 41.49 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.366 -0.834 . . . . 73.5 111.525 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.88 -133.96 7.69 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 114.472 0.549 . . . . 75.25 114.472 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -138.45 123.78 19.36 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.636 -0.332 . . . . 72.209999999999994 111.229 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -66.24 107.0 1.82 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.923 0.392 . . . . 74.439999999999998 111.839 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.406 HG22 HD13 ' A' ' 72' ' ' LEU . 35.6 m -138.96 168.17 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.267 -0.424 . . . . 74.200000000000003 111.481 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.91 144.74 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.482 -0.326 . . . . 74.219999999999999 110.933 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 29.6 tpt85 . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 121.832 0.825 . . . . 73.430000000000007 111.979 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 35.1 mt-10 . . . . . 0 CA--C 1.539 0.549 0 CA-C-O 121.653 0.74 . . . . 72.450000000000003 110.069 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.54 ' HD2' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -114.48 149.56 36.16 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.915 -0.584 . . . . 73.129999999999995 111.748 -177.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 141.67 -113.65 0.84 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.205 -0.522 . . . . 65.209999999999994 112.802 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.424 HD11 HD13 ' A' ' 70' ' ' ILE . 17.1 pt -111.51 134.52 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.959 0.409 . . . . 62.32 111.85 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -46.25 -36.31 6.02 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.829 -0.623 . . . . 73.329999999999998 112.222 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.495 HD12 ' CE2' ' A' ' 30' ' ' PHE . 50.9 mt -48.66 -64.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.304 0.573 . . . . 75.319999999999993 112.29 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 33.8 m -66.04 -36.75 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.911 -0.586 . . . . 73.230000000000004 112.188 -175.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.406 HD13 HG22 ' A' ' 35' ' ' VAL . 42.7 mt -67.46 -38.32 84.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.095 0.474 . . . . 71.109999999999999 111.299 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -66.41 -45.2 80.75 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.077 -0.51 . . . . 75.340000000000003 111.247 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -90.43 7.94 36.21 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.38 0.511 . . . . 74.400000000000006 112.38 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.8 mttm 57.4 69.08 0.77 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.496 0.665 . . . . 75.340000000000003 112.759 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 75.0 mt -114.74 120.86 41.52 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.935 -0.575 . . . . 73.349999999999994 110.541 177.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 14.4 p -86.62 144.17 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.911 0.386 . . . . 75.439999999999998 111.615 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.55 126.31 30.76 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.105 -0.498 . . . . 74.329999999999998 112.214 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.2 mmt -132.35 159.46 39.15 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.201 -0.454 . . . . 74.25 111.133 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.452 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 93.5 m-20 -127.39 147.3 50.27 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.139 0.495 . . . . 75.030000000000001 111.175 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.1 p -52.19 -16.43 0.8 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.852 1.427 . . . . 65.109999999999999 114.852 -169.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.452 ' CE1' ' HB2' ' A' ' 80' ' ' ASN . 50.2 p90 -58.94 -41.63 87.82 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.418 0.525 . . . . 73.430000000000007 112.418 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -101.34 -37.92 8.27 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.126 -0.359 . . . . 64.129999999999995 111.824 -178.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.64 6.88 0.98 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.833 0.679 . . . . 64.219999999999999 112.833 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.32 -50.59 38.85 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.359 0.503 . . . . 73.430000000000007 112.359 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.7 m -68.96 -35.27 76.56 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.625 0.25 . . . . 65.540000000000006 111.612 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 95.9 mmm -56.46 -50.85 70.51 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.681 0.277 . . . . 65.409999999999997 110.698 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -68.32 -33.73 74.85 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.84 0.311 . . . . 73.230000000000004 111.84 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -55.6 -54.72 40.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.104 0.478 . . . . 74.209999999999994 110.967 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.48 -38.22 68.25 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.2 -0.455 . . . . 71.120000000000005 111.792 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -59.01 -54.82 42.77 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.633 -0.258 . . . . 75.030000000000001 111.288 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.4 mm -62.4 -35.43 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.696 -0.229 . . . . 73.5 111.272 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.436 ' HE3' ' HD2' ' A' ' 97' ' ' LYS . 57.4 tptt -57.33 -60.56 3.44 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.709 0.29 . . . . 74.439999999999998 111.11 175.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -61.77 -39.5 91.86 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.167 0.508 . . . . 75.430000000000007 111.097 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.588 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 78.3 t80 -57.36 -56.68 18.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.86 -0.609 . . . . 75.420000000000002 111.527 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 51.8 ttm -53.79 -43.7 69.49 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.09 0.472 . . . . 71.409999999999997 111.33 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.436 ' HD2' ' HE3' ' A' ' 93' ' ' LYS . 28.0 mtpp -61.71 -43.85 98.06 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.989 -0.55 . . . . 74.510000000000005 111.79 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -73.42 -44.45 58.28 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.95 0.352 . . . . 71.319999999999993 111.95 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.0 m -66.33 -38.73 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.395 0.517 . . . . 73.349999999999994 112.395 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 34.5 mm -65.51 -47.0 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.856 0.36 . . . . 75.140000000000001 110.756 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.95 -42.89 85.89 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 72.540000000000006 110.512 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -64.83 -35.55 81.48 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.709 -0.678 . . . . 63.439999999999998 111.285 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.566 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 15.0 mmt -68.05 -39.62 82.97 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.651 0.241 . . . . 75.430000000000007 111.651 177.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.65 -35.68 72.93 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.491 0.663 . . . . 74.430000000000007 110.53 171.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -70.09 -46.35 65.04 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.283 -0.871 . . . . 72.510000000000005 112.702 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.566 ' ND2' ' HA ' ' A' ' 103' ' ' MET . 0.1 OUTLIER -97.51 -26.15 14.92 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.122 1.156 . . . . 73.319999999999993 114.122 -174.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.566 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 87.7 m-20 -124.06 -63.21 1.22 Allowed 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.874 -0.516 . . . . 63.240000000000002 112.114 -175.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 107' ' ' ASN . 5.9 ptt180 67.91 -14.71 0.22 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.308 1.043 . . . . 74.519999999999996 113.399 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.568 ' O ' HG23 ' A' ' 113' ' ' VAL . 24.7 t70 -61.64 127.63 32.37 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.2 -0.313 . . . . 72.200000000000003 111.676 -176.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -50.63 -39.64 50.91 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.727 0.64 . . . . 75.209999999999994 112.727 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.94 -35.63 50.17 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.648 0.261 . . . . 72.329999999999998 111.576 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -67.71 -51.36 50.32 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.783 0.325 . . . . 64.019999999999996 111.083 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 109' ' ' ASP . 16.1 m -66.73 -23.07 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 111.813 0.301 . . . . 63.530000000000001 111.813 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.581 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 29.1 t70 -69.96 -61.43 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.039 -0.356 . . . . 74.329999999999998 110.039 171.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.85 -40.16 63.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.865 0.364 . . . . 70.150000000000006 111.608 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -58.83 -59.34 5.59 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.384 -0.371 . . . . 74.319999999999993 111.242 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 8.4 ptpp? -59.39 -31.8 69.58 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.958 -0.297 . . . . 74.019999999999996 111.065 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 33.7 mmtp -62.4 -46.66 87.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.851 0.357 . . . . 74.510000000000005 110.802 175.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -67.37 -56.25 10.46 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.071 -0.513 . . . . 73.239999999999995 111.991 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.0 tp -67.36 -40.6 85.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.587 0.588 . . . . 72.540000000000006 112.587 -175.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.478 ' HB3' ' O ' ' A' ' 117' ' ' LYS . 14.3 tm0? -68.12 -45.74 72.8 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.023 -0.423 . . . . 72.319999999999993 110.737 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.41 -41.61 95.32 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.647 -0.787 . . . . 71.109999999999999 112.05 173.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -59.44 -54.1 50.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.4 0.28 . . . . 71.030000000000001 111.717 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.0 m -64.82 -36.7 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.485 0.55 . . . . 75.540000000000006 112.485 -177.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 121' ' ' GLN . 78.0 t -59.37 -43.51 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.98 -0.45 . . . . 72.230000000000004 111.148 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.7 t -76.05 -37.64 58.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.116 0.484 . . . . 74.099999999999994 111.119 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.5 ' HA ' ' CD2' ' A' ' 133' ' ' PHE . 51.1 tp -61.25 -33.55 73.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.987 0.515 . . . . 75.519999999999996 111.704 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 65.7 mt -88.47 3.01 51.65 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.35 -0.386 . . . . 72.010000000000005 111.918 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.27 102.86 0.1 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.151 0.5 . . . . 71.549999999999997 111.642 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.721 ' HZ2' ' HB3' ' A' ' 130' ' ' LYS . 0.3 OUTLIER -62.33 -11.44 15.35 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.794 1.035 . . . . 72.299999999999997 113.794 -172.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.97 -48.35 6.03 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.642 0.608 . . . . 74.319999999999993 112.642 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.7 tpp85 -92.8 -56.01 3.16 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.185 0.516 . . . . 74.519999999999996 111.667 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.5 ' CD2' ' HA ' ' A' ' 127' ' ' LEU . 8.0 m-85 -71.2 -5.86 35.13 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.117 0.484 . . . . 75.219999999999999 111.975 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 27.6 ttpp -49.81 -21.84 1.25 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.144 -0.48 . . . . 71.120000000000005 112.08 172.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -82.18 9.35 8.84 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.916 0.71 . . . . 74.409999999999997 112.916 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.25 136.12 33.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.06 0.457 . . . . 75.25 111.771 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.14 118.45 37.01 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.154 -0.475 . . . . 72.420000000000002 110.296 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -97.08 108.32 21.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.001 0.429 . . . . 73.140000000000001 111.278 -176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.532 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 45.7 m-85 -98.64 124.49 43.47 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.1 0.476 . . . . 73.430000000000007 111.481 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.52 HG21 ' HB3' ' A' ' 145' ' ' ALA . 10.6 tt -135.56 148.75 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.315 -0.402 . . . . 73.439999999999998 110.929 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.37 121.94 8.07 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.276 -0.487 . . . . 45.539999999999999 112.815 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -32.31 60.81 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.931 0.715 . . . . 73.299999999999997 112.931 -175.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -61.32 -39.34 90.15 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.066 0.395 . . . . 74.25 112.066 173.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -80.52 -40.53 25.86 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.939 0.399 . . . . 62.450000000000003 111.562 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.52 ' HB3' HG21 ' A' ' 140' ' ' ILE . . . -58.56 -20.68 48.69 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.128 -0.487 . . . . 71.420000000000002 112.058 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -62.84 -16.89 60.33 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.072 -0.513 . . . . 75.120000000000005 111.761 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.13 31.37 14.57 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.252 -0.499 . . . . 74.209999999999994 112.485 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.46 -19.89 19.5 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.193 0.442 . . . . 75.109999999999999 112.193 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -161.78 -170.87 2.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.641 -0.254 . . . . 75.319999999999993 111.08 -176.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -65.66 -66.47 0.54 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.781 0.324 . . . . 75.420000000000002 111.784 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.29 146.2 0.21 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.345 -0.455 . . . . 51.340000000000003 113.67 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -102.17 135.99 42.78 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.313 -0.522 . . . . 65.25 111.265 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 56.1 t -94.69 127.86 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.19 0.519 . . . . 74.299999999999997 112.015 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.835 ' HB2' HD11 ' A' ' 169' ' ' LEU . . . -96.05 123.28 39.6 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.688 -0.687 . . . . 64.120000000000005 110.422 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 55.4 mt -93.3 118.98 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.18 0.437 . . . . 75.150000000000006 112.18 -173.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.0 mm -102.94 117.59 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.677 -0.238 . . . . 73.030000000000001 111.222 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -109.76 125.13 52.37 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.16 0.505 . . . . 74.319999999999993 111.59 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -87.52 88.87 7.8 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.039 -0.528 . . . . 73.430000000000007 109.824 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 159' ' ' ARG . 18.9 ptt85 -124.82 172.49 9.3 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.203 0.525 . . . . 74.219999999999999 112.324 -175.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -89.3 135.92 33.31 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.31 0.576 . . . . 75.129999999999995 112.213 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 78.1 t -108.8 95.48 3.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.889 -0.782 . . . . 73.030000000000001 108.889 169.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.4 t70 69.74 -56.96 0.56 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.533 -0.758 . . . . 73.510000000000005 111.564 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.02 6.65 0.14 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 121.1 -0.572 . . . . 73.319999999999993 114.224 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.4 m -120.5 134.76 55.23 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.749 0.774 . . . . 75.209999999999994 111.697 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -83.28 107.93 16.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.582 -0.281 . . . . 62.450000000000003 111.409 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.1 m -128.79 147.32 64.0 Favored Pre-proline 0 N--CA 1.474 0.747 0 CA-C-O 121.078 0.466 . . . . 71.450000000000003 112.016 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -90.94 114.72 0.43 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.928 2.419 . . . . 60.030000000000001 113.366 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 79.2 p -103.52 154.87 18.99 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.631 -0.259 . . . . 55.100000000000001 110.658 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.835 HD11 ' HB2' ' A' ' 154' ' ' ALA . 13.7 tp -100.28 120.89 40.62 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.221 -0.299 . . . . 73.400000000000006 111.312 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.627 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 60.8 mtt -107.54 134.89 49.9 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.678 0.621 . . . . 73.430000000000007 112.678 -175.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.8 mt -143.41 146.4 33.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.278 -0.874 . . . . 70.310000000000002 110.092 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.588 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 44.5 t -77.19 134.67 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 112.277 0.473 . . . . 74.209999999999994 112.277 -176.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.783 ' HB3' ' HZ1' ' A' ' 173' ' ' LYS . 5.9 ttpm? -59.6 -47.67 84.66 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.983 -0.553 . . . . 74.530000000000001 112.089 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -85.16 11.48 9.76 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.918 0.389 . . . . 71.329999999999998 111.964 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.514 ' HB3' ' HE1' ' A' ' 95' ' ' PHE . . . -103.3 -13.07 16.85 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.75 0.31 . . . . 71.25 111.133 173.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.2 pt -136.9 133.58 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.216 0.532 . . . . 75.219999999999999 111.485 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.504 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 50.6 mm -94.58 110.79 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.958 0.409 . . . . 70.519999999999996 110.218 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.7 123.15 31.55 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.319 -0.4 . . . . 72.209999999999994 110.822 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.557 ' HB3' HG13 ' A' ' 3' ' ' ILE . 11.8 tp10 -121.41 139.4 53.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.182 0.515 . . . . 75.140000000000001 110.702 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 112.776 0.658 . . . . 63.119999999999997 112.776 -172.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.565 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 24.0 mmt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.664 0.269 . . . . 71.109999999999999 111.264 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 15' ' ' SER . 57.7 tp -71.98 133.58 45.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.725 0.298 . . . . 72.430000000000007 110.781 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.1 mt -97.19 120.47 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 111.872 0.323 . . . . 72.5 111.872 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.691 ' HH ' ' HB2' ' A' ' 16' ' ' ASP . 7.8 m-85 -106.59 115.05 29.53 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.439 -0.346 . . . . 74.439999999999998 110.638 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.422 ' HG2' HD12 ' A' ' 13' ' ' LEU . 97.7 mttt -112.6 112.22 23.6 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.321 0.388 . . . . 75.319999999999993 111.231 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.61 154.98 38.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.088 0.47 . . . . 73.430000000000007 111.199 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.4 -42.67 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.081 0.467 . . . . 74.299999999999997 110.579 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -109.97 -33.54 6.68 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.461 0.911 . . . . 62.32 113.461 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.651 ' HG1' ' HB3' ' A' ' 152' ' ' GLN . 1.3 m -89.61 15.17 9.95 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 112.729 0.64 . . . . 71.239999999999995 112.729 -175.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -54.64 -17.87 3.86 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.93 0.715 . . . . 72.299999999999997 112.93 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.45 -33.11 72.08 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.357 0.599 . . . . 70.109999999999999 111.13 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -94.08 24.29 4.42 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.997 -0.547 . . . . 53.229999999999997 111.845 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 4' ' ' TYR . 65.5 tp -31.04 117.26 0.17 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.787 0.835 . . . . 72.040000000000006 112.436 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.6 t -110.01 163.6 13.41 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.284 0.564 . . . . 74.439999999999998 112.364 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.565 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 79.3 p -150.17 107.59 3.63 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.598 -0.728 . . . . 74.319999999999993 110.688 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.691 ' HB2' ' HH ' ' A' ' 4' ' ' TYR . 10.6 m-20 -135.71 173.69 11.44 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.25 0.547 . . . . 73.219999999999999 112.328 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 m -133.9 84.7 2.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.875 -0.602 . . . . 70.450000000000003 110.489 173.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.59 152.01 73.84 Favored Pre-proline 0 N--CA 1.474 0.754 0 CA-C-N 116.367 -0.379 . . . . 75.430000000000007 111.381 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -93.0 94.21 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.862 2.374 . . . . 74.540000000000006 112.901 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.529 ' HB3' ' HB3' ' A' ' 28' ' ' TYR . 4.0 mpp? -85.41 144.82 27.78 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.857 0.36 . . . . 72.239999999999995 111.36 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -99.12 108.1 20.64 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.876 0.37 . . . . 72.030000000000001 111.863 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.2 tp -75.75 95.49 3.45 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.046 0.45 . . . . 74.420000000000002 111.084 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -86.75 140.34 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.038 0.446 . . . . 74.439999999999998 111.71 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.5 t70 58.03 16.46 3.79 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.854 -0.612 . . . . 74.019999999999996 111.679 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 57.18 20.4 5.62 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.054 -0.521 . . . . 75.010000000000005 111.762 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.475 HD23 ' HB3' ' A' ' 119' ' ' LYS . 32.2 tp -118.43 -50.17 2.45 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.055 0.455 . . . . 71.109999999999999 111.963 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.465 HG11 HG22 ' A' ' 172' ' ' VAL . 14.3 m -130.8 155.38 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 112.581 0.586 . . . . 75.349999999999994 112.581 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.529 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 77.5 m-85 -92.24 124.86 36.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.086 -0.506 . . . . 75.049999999999997 110.816 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 15.1 pt-20 -101.93 139.32 37.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.997 0.427 . . . . 74.129999999999995 110.217 171.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 168' ' ' THR . 42.5 t80 -141.56 112.35 7.2 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.629 -0.259 . . . . 73.120000000000005 111.11 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -75.48 130.89 39.64 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.33 0.492 . . . . 75.200000000000003 112.33 -179.441 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.428 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -126.09 162.04 20.36 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.385 -0.436 . . . . 42.229999999999997 113.606 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -97.24 126.83 42.7 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.463 -0.434 . . . . 74.430000000000007 111.539 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.408 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 15.9 p80 -74.5 106.57 6.16 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.142 0.496 . . . . 74.349999999999994 110.619 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.7 m -140.81 177.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.381 0.61 . . . . 75.400000000000006 111.862 -176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 66' ' ' ARG . 34.9 m -132.43 146.87 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.971 -0.559 . . . . 74.540000000000006 111.219 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.925 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 56.7 ttt-85 . . . . . 0 C--O 1.245 0.851 0 CA-C-O 121.256 0.551 . . . . 74.209999999999994 110.892 174.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.925 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.7 mp0 . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.238 0.542 . . . . 62.25 110.633 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.404 ' HA ' HG12 ' A' ' 36' ' ' VAL . 60.6 mtp180 -87.57 131.76 34.29 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.741 -0.663 . . . . 74.299999999999997 111.528 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.32 -150.42 22.02 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.67 -0.776 . . . . 63.530000000000001 113.117 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.4 pt -110.45 146.15 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 122.349 -0.501 . . . . 74.519999999999996 111.397 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -40.36 -47.38 2.53 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.211 0.604 . . . . 71.129999999999995 112.18 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.428 HG13 ' HA3' ' A' ' 32' ' ' GLY . 61.9 mt -48.9 -53.84 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.757 -0.656 . . . . 75.409999999999997 112.333 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 m -83.22 -32.0 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 112.087 0.403 . . . . 74.140000000000001 112.087 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.75 -36.03 82.42 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.727 0.298 . . . . 74.329999999999998 111.367 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -81.42 -6.41 58.91 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.925 0.393 . . . . 75.040000000000006 111.324 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -124.48 8.21 8.35 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.952 0.352 . . . . 63.439999999999998 111.952 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.1 pttm 39.47 59.31 1.81 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.791 0.805 . . . . 73.439999999999998 112.699 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 84.9 mt -93.97 141.9 28.0 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.769 -0.65 . . . . 74.430000000000007 111.516 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 p -96.06 140.19 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 120.684 0.278 . . . . 75.040000000000006 111.267 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -89.57 148.25 23.48 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.533 0.682 . . . . 74.409999999999997 112.744 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.469 ' HG3' ' HB2' ' A' ' 138' ' ' PHE . 15.2 ptp -147.65 165.27 30.93 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.214 -0.903 . . . . 75.219999999999999 109.75 174.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.435 ' HA ' ' HD2' ' A' ' 138' ' ' PHE . 3.4 p30 -163.01 157.86 21.43 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.454 0.645 . . . . 73.010000000000005 112.259 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 64.3 m -37.53 -34.02 0.09 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 116.495 2.035 . . . . 73.030000000000001 116.495 -162.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -67.92 -31.98 72.12 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.433 -0.792 . . . . 71.510000000000005 112.348 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.87 -46.97 5.74 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.236 0.541 . . . . 73.549999999999997 111.913 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.444 ' OD1' ' HB2' ' A' ' 79' ' ' MET . 0.4 OUTLIER -95.2 12.89 27.25 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.494 0.924 . . . . 72.129999999999995 113.494 -173.001 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -41.06 -61.39 1.0 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.645 0.609 . . . . 64.129999999999995 112.645 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.5 m -65.45 -32.8 74.61 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.334 -0.394 . . . . 72.310000000000002 111.772 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 67.5 mtm -71.7 -52.62 16.91 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.06 0.392 . . . . 73.310000000000002 112.06 -175.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.478 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 16.5 p90 -71.96 -19.39 61.9 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.69 -0.631 . . . . 71.099999999999994 111.224 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -64.01 -44.21 93.29 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.08 0.467 . . . . 74.040000000000006 110.534 171.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.16 99.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.195 0.521 . . . . 74.299999999999997 110.455 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.452 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 44.0 t80 -54.6 -53.1 59.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.588 -0.733 . . . . 62.140000000000001 111.972 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.9 tp -67.66 -32.27 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 111.83 0.307 . . . . 74.219999999999999 111.83 -177.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.413 ' C ' ' HD3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -63.35 -53.25 55.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.665 0.269 . . . . 73.140000000000001 110.656 176.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -60.2 -49.48 77.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.934 0.397 . . . . 75.209999999999994 110.745 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.489 ' HZ ' HG12 ' A' ' 172' ' ' VAL . 85.1 t80 -51.25 -58.09 7.09 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.082 -0.508 . . . . 61.310000000000002 111.916 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -54.57 -49.52 70.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.428 -0.351 . . . . 65.239999999999995 111.465 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -65.83 -48.51 71.42 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.605 -0.27 . . . . 73.420000000000002 111.7 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.49 -40.3 96.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.715 0.635 . . . . 74.439999999999998 112.715 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.7 m -67.95 -45.84 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 122.21 -0.306 . . . . 74.230000000000004 111.611 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.4 mm -67.55 -45.42 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.889 0.376 . . . . 74.420000000000002 111.131 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.51 -40.98 96.57 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.236 -0.438 . . . . 74.049999999999997 111.546 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -58.71 -47.02 86.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.942 0.401 . . . . 63.340000000000003 110.885 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.525 ' HE1' ' HB3' ' A' ' 112' ' ' ASP . 18.9 ttt -68.67 -45.68 71.08 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.164 0.507 . . . . 74.329999999999998 110.737 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -58.93 -37.38 76.55 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.281 -0.418 . . . . 74.430000000000007 111.729 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -54.37 -50.91 66.39 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.12 -0.491 . . . . 72.430000000000007 112.296 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -102.31 -36.92 8.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.791 0.663 . . . . 73.120000000000005 112.791 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -74.89 -56.02 5.19 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.965 -0.46 . . . . 72.439999999999998 111.659 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 66.65 -0.47 1.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.876 0.47 . . . . 75.450000000000003 112.19 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 113' ' ' VAL . 13.6 t70 -86.24 119.85 26.97 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.132 -0.355 . . . . 73.200000000000003 110.717 -177.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -65.64 -35.01 79.56 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.522 0.564 . . . . 74.040000000000006 112.522 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.93 -38.64 89.19 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.796 0.331 . . . . 73.150000000000006 111.435 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.525 ' HB3' ' HE1' ' A' ' 103' ' ' MET . 9.2 m-20 -72.73 -53.17 12.36 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.729 0.27 . . . . 74.340000000000003 111.729 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 109' ' ' ASP . 30.0 m -65.55 -21.73 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 112.098 0.407 . . . . 75.140000000000001 112.098 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -74.96 -42.35 57.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.965 0.412 . . . . 74.109999999999999 110.683 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.12 73.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.98 0.419 . . . . 62.119999999999997 110.986 176.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.18 -47.52 85.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.169 -0.468 . . . . 75.549999999999997 111.093 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -56.63 -40.87 76.16 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.53 -0.304 . . . . 75.420000000000002 110.915 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.5 tppt? -59.26 -40.33 85.67 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.604 0.24 . . . . 64.349999999999994 111.171 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.475 ' HB3' HD23 ' A' ' 26' ' ' LEU . 29.3 mmtp -61.73 -57.8 10.52 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.683 -0.235 . . . . 74.400000000000006 111.584 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.8 mm -59.95 -45.58 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.021 0.378 . . . . 75.230000000000004 112.021 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.44 ' O ' HG23 ' A' ' 125' ' ' VAL . 24.7 tm0? -61.62 -51.61 67.8 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.707 0.289 . . . . 64.329999999999998 110.942 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.79 -36.98 93.55 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.724 -0.751 . . . . 75.019999999999996 112.378 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -57.16 -53.75 54.58 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.862 0.465 . . . . 75.329999999999998 111.596 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.17 -42.44 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 112.189 0.44 . . . . 73.129999999999995 112.189 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 121' ' ' GLN . 69.9 t -55.92 -43.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.881 0.372 . . . . 74.310000000000002 111.396 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.5 t -72.03 -47.22 53.39 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.195 0.521 . . . . 73.430000000000007 111.569 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.441 HD22 HD12 ' A' ' 155' ' ' ILE . 31.5 tp -65.3 -28.06 69.05 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.126 -0.488 . . . . 74.310000000000002 111.914 -176.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.9 mt -84.54 2.56 40.63 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.133 0.419 . . . . 75.109999999999999 112.133 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.468 ' HB2' ' CD1' ' A' ' 133' ' ' PHE . . . -62.03 78.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.652 0.739 . . . . 53.119999999999997 110.977 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -60.08 -15.26 21.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.546 0.943 . . . . 72.319999999999993 113.546 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.19 -46.79 87.49 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 122.274 -0.266 . . . . 73.349999999999994 111.493 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -109.15 -39.24 5.32 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.836 0.351 . . . . 74.120000000000005 111.789 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.48 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 69.5 m-85 -63.62 -4.5 3.0 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.526 0.565 . . . . 75.209999999999994 112.526 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -44.35 -26.76 0.36 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 120.952 0.406 . . . . 73.420000000000002 111.841 168.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -83.54 20.34 1.4 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 112.79 0.663 . . . . 70.299999999999997 112.79 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 71.2 mt -88.51 132.06 34.66 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.925 -0.484 . . . . 75.319999999999993 111.318 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.28 123.21 48.44 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.134 -0.485 . . . . 73.299999999999997 110.734 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.633 ' HB3' HG12 ' A' ' 153' ' ' VAL . 53.6 m-85 -102.61 125.92 49.51 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.257 -0.277 . . . . 75.450000000000003 110.839 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.545 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 75.6 m-85 -121.61 142.14 50.41 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.05 0.389 . . . . 74.140000000000001 112.05 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 152' ' ' GLN . 34.4 pt -129.62 173.07 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.89 0.376 . . . . 75.140000000000001 111.09 174.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.48 153.88 50.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.274 -0.489 . . . . 72.310000000000002 114.01 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.52 -58.42 7.23 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.062 0.458 . . . . 75.439999999999998 112.045 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.573 ' HA ' ' HB3' ' A' ' 146' ' ' GLU . 30.3 mtm180 -73.09 -19.37 61.17 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.857 0.36 . . . . 74.219999999999999 111.284 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.658 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . . . -61.03 -40.77 94.87 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.271 0.558 . . . . 71.329999999999998 110.467 170.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.1 -19.14 40.73 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.083 0.468 . . . . 65.450000000000003 111.374 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.573 ' HB3' ' HA ' ' A' ' 143' ' ' ARG . 42.6 tt0 -87.27 -24.26 24.41 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.252 0.464 . . . . 72.409999999999997 112.252 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.33 -46.52 0.02 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 120.472 -0.871 . . . . 72.200000000000003 114.336 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 144' ' ' ALA . . . -71.0 86.58 0.72 Allowed 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.307 -0.526 . . . . 74.439999999999998 111.827 -177.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -61.34 -9.8 5.97 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.247 0.832 . . . . 73.230000000000004 113.247 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -93.38 27.21 2.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.809 0.338 . . . . 73.010000000000005 111.421 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 9' ' ' THR . . . -60.44 115.83 8.29 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.469 -0.396 . . . . 62.420000000000002 113.698 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.651 ' HB3' ' HG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -60.25 134.55 57.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.244 0.545 . . . . 74.010000000000005 111.272 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.633 HG12 ' HB3' ' A' ' 138' ' ' PHE . 63.0 t -83.0 109.92 17.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.154 -0.476 . . . . 75.530000000000001 111.707 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.714 ' HB3' HD13 ' A' ' 169' ' ' LEU . . . -81.06 119.03 23.02 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.04 -0.527 . . . . 53.049999999999997 110.197 171.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.441 HD12 HD22 ' A' ' 127' ' ' LEU . 61.5 mt -96.12 117.1 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 112.468 0.544 . . . . 70.420000000000002 112.468 -170.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.2 mm -94.5 113.14 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.723 0.297 . . . . 74.230000000000004 111.219 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 158' ' ' TYR . 42.7 tt0 -105.75 157.33 17.51 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.973 0.416 . . . . 63.32 111.305 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.438 ' N ' ' HG2' ' A' ' 157' ' ' GLU . 23.1 p90 -92.51 105.24 17.45 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.967 0.413 . . . . 74.239999999999995 111.191 176.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.448 ' HD3' ' OG1' ' A' ' 168' ' ' THR . 54.9 mtp85 -127.44 132.33 50.07 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.966 0.412 . . . . 73.140000000000001 111.114 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.839 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 6.4 p-10 -88.25 143.08 27.24 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.768 0.655 . . . . 51.229999999999997 112.768 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.0 t -109.29 98.2 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.641 -0.708 . . . . 75.310000000000002 110.585 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.1 t70 61.59 7.08 1.72 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.543 0.737 . . . . 75.340000000000003 112.918 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.26 -27.72 1.54 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.533 -0.842 . . . . 72.0 114.065 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 84.3 m -104.27 114.49 28.76 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 117.252 0.526 . . . . 73.510000000000005 111.125 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.839 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 9.3 pt-20 -76.37 122.54 24.62 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.611 0.72 . . . . 71.319999999999993 112.098 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -127.14 149.85 70.63 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.471 -0.786 . . . . 72.010000000000005 111.639 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.95 120.72 7.92 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.785 2.323 . . . . 74.099999999999994 112.766 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.448 ' OG1' ' HD3' ' A' ' 159' ' ' ARG . 69.6 p -111.22 133.37 53.61 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.79 0.328 . . . . 65.209999999999994 111.756 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.714 HD13 ' HB3' ' A' ' 154' ' ' ALA . 68.9 tp -77.36 130.99 37.84 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.179 -0.464 . . . . 63.340000000000003 111.258 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 24.3 mmt -113.27 124.46 52.55 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.594 0.358 . . . . 71.239999999999995 111.445 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.99 134.82 38.97 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.076 -0.511 . . . . 73.329999999999998 110.864 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.489 HG12 ' HZ ' ' A' ' 95' ' ' PHE . 25.7 t -93.13 126.35 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 122.099 -0.375 . . . . 75.310000000000002 111.425 -178.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.425 ' HZ3' ' CD ' ' A' ' 174' ' ' GLU . 22.4 pttp -72.42 -14.88 61.8 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.831 0.678 . . . . 75.329999999999998 112.831 -175.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.425 ' CD ' ' HZ3' ' A' ' 173' ' ' LYS . 1.3 mp0 -88.31 -2.4 58.58 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.137 -0.352 . . . . 74.420000000000002 111.716 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.5 -46.39 6.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.309 0.576 . . . . 73.430000000000007 110.428 174.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.7 pt -105.4 132.18 52.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.498 -0.774 . . . . 70.120000000000005 110.504 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.403 ' CG1' ' HB2' ' A' ' 5' ' ' LYS . 46.8 pt -94.85 143.47 11.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.2 0.524 . . . . 74.25 111.314 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -94.25 118.24 31.3 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.612 -0.722 . . . . 71.209999999999994 111.331 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -122.97 113.99 19.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.359 0.6 . . . . 73.319999999999993 110.897 172.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt . . . . . 0 CA--C 1.536 0.435 0 CA-C-N 115.734 -0.666 . . . . 62.420000000000002 112.106 -175.113 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.456 ' HE2' ' HB3' ' A' ' 17' ' ' SER . 83.6 mtp . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 120.935 0.398 . . . . 73.25 111.643 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.64 HD13 ' HB2' ' A' ' 178' ' ' GLU . 42.2 tp -92.34 139.0 31.05 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.521 -0.309 . . . . 75.299999999999997 110.943 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.0 mt -125.91 119.21 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 122.384 -0.197 . . . . 74.400000000000006 110.473 175.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.703 ' HE1' ' HB2' ' A' ' 16' ' ' ASP . 39.6 p90 -121.81 149.8 42.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.47 0.545 . . . . 72.329999999999998 112.47 -173.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.554 ' HB3' HD13 ' A' ' 13' ' ' LEU . 12.4 ptmm? -142.92 127.22 17.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.939 -0.573 . . . . 72.299999999999997 111.303 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.827 ' HB3' HG22 ' A' ' 176' ' ' ILE . 2.7 p30 -97.29 179.29 4.94 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.206 0.527 . . . . 74.409999999999997 111.63 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -47.12 -34.8 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 115.51 -0.768 . . . . 75.430000000000007 112.716 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.574 ' HB2' ' HA2' ' A' ' 151' ' ' GLY . 83.2 m-85 -100.27 -49.61 4.21 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.603 0.594 . . . . 71.209999999999994 112.603 -175.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 p -70.33 14.97 0.1 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.028 0.751 . . . . 71.019999999999996 113.028 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 8' ' ' PHE . 8.4 t70 -47.89 -32.24 6.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.207 0.603 . . . . 64.519999999999996 111.933 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.67 -61.96 1.57 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.641 0.608 . . . . 73.510000000000005 112.641 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -102.43 -33.16 9.64 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.801 0.667 . . . . 74.010000000000005 112.801 -174.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 5' ' ' LYS . 0.8 OUTLIER 40.42 -170.75 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.21 1.189 . . . . 75.25 114.21 -176.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -149.44 165.65 31.46 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.474 0.654 . . . . 74.010000000000005 112.655 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -114.2 170.16 8.49 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.699 -0.682 . . . . 74.420000000000002 111.082 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.703 ' HB2' ' HE1' ' A' ' 4' ' ' TYR . 6.5 t70 -154.28 169.15 24.35 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 120.878 0.371 . . . . 71.310000000000002 111.486 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.456 ' HB3' ' HE2' ' A' ' 1' ' ' MET . 98.2 p -151.7 19.44 0.71 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.027 0.38 . . . . 54.329999999999998 112.027 -176.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -108.65 151.07 41.51 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 121.037 0.446 . . . . 73.510000000000005 112.194 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.4 111.99 3.27 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.601 2.2 . . . . 72.340000000000003 113.595 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.65 ' SD ' ' HB2' ' A' ' 30' ' ' PHE . 18.5 mmt -106.31 166.27 10.65 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.009 -0.541 . . . . 70.439999999999998 110.876 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.632 ' HB3' ' HZ3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -134.22 129.05 35.14 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.187 -0.321 . . . . 74.5 111.221 172.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.457 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 61.4 tp -87.87 101.96 14.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.766 0.317 . . . . 74.109999999999999 111.284 -177.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 p -89.19 139.06 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-O 120.909 0.385 . . . . 73.319999999999993 111.58 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.2 15.99 2.11 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.139 -0.482 . . . . 72.219999999999999 112.264 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.457 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 52.8 m-20 52.77 26.75 4.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.847 0.459 . . . . 52.520000000000003 111.646 -177.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.17 -45.68 2.34 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.103 0.478 . . . . 75.409999999999997 111.156 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.3 m -133.68 146.06 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.295 0.569 . . . . 75.129999999999995 112.51 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 170' ' ' MET . 96.9 m-85 -87.34 144.91 26.55 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.937 -0.574 . . . . 73.329999999999998 110.368 172.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 40.7 mt-10 -118.28 143.57 46.48 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.748 0.308 . . . . 73.329999999999998 110.85 170.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.678 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 85.6 t80 -133.03 118.44 18.81 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.806 0.336 . . . . 75.219999999999999 111.175 175.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.665 ' HB2' ' HZ2' ' A' ' 31' ' ' LYS . 9.8 mtmp? -84.02 109.33 17.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.793 0.33 . . . . 75.540000000000006 111.715 -177.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.509 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -90.76 176.6 41.28 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.14 -0.553 . . . . 72.310000000000002 113.851 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.509 ' HG3' HG11 ' A' ' 35' ' ' VAL . 10.8 ptpp? -118.46 163.2 17.11 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.725 -0.279 . . . . 75.040000000000006 111.123 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -86.53 111.93 21.06 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.522 0.201 . . . . 72.319999999999993 110.904 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.509 HG11 ' HG3' ' A' ' 33' ' ' LYS . 17.3 m -139.65 159.31 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.142 0.496 . . . . 75.129999999999995 111.728 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 33.2 m -138.04 122.11 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.354 -0.385 . . . . 72.519999999999996 111.407 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.805 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 78.8 mtt180 . . . . . 0 C--O 1.24 0.588 0 CA-C-O 121.49 0.662 . . . . 72.120000000000005 111.259 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.805 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 7.1 mp0 . . . . . 0 CA--C 1.535 0.381 0 CA-C-O 121.52 0.676 . . . . 74.450000000000003 110.743 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.503 ' O ' ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -96.62 135.27 38.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.552 -0.749 . . . . 74.040000000000006 111.631 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.58 -125.68 1.5 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.536 -0.84 . . . . 60.409999999999997 113.866 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.7 pt -110.61 131.33 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.404 0.621 . . . . 70.230000000000004 112.487 -174.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -50.11 -35.22 24.74 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.413 -0.812 . . . . 71.420000000000002 112.598 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.509 HG13 ' HA3' ' A' ' 32' ' ' GLY . 66.3 mt -47.28 -50.2 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.18 0.437 . . . . 75.420000000000002 112.18 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 17.3 m -90.61 -32.63 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.11 0.411 . . . . 74.420000000000002 112.11 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.448 HD12 HG22 ' A' ' 35' ' ' VAL . 80.3 mt -65.76 -37.44 86.35 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.031 0.443 . . . . 73.010000000000005 111.415 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -87.49 -1.73 58.13 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 120.715 0.293 . . . . 75.299999999999997 111.611 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -123.65 4.1 8.91 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.838 -0.539 . . . . 73.329999999999998 112.158 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp 56.06 67.32 1.02 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.41 0.624 . . . . 74.310000000000002 112.335 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 68.1 mt -116.79 136.5 52.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.124 -0.489 . . . . 74.439999999999998 111.071 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.28 145.05 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.932 0.396 . . . . 63.229999999999997 111.372 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -80.37 122.19 26.63 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.977 0.732 . . . . 64.519999999999996 112.977 -173.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 94.4 mmm -125.62 155.69 40.36 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.961 -0.563 . . . . 74.239999999999995 109.95 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.41 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 47.6 t-20 -139.41 145.75 39.29 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.841 -0.537 . . . . 74.129999999999995 111.4 -176.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.6 p -46.83 -43.13 18.26 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.95 1.093 . . . . 71.310000000000002 113.95 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.41 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 38.7 p90 -56.3 -31.44 63.67 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.354 0.502 . . . . 71.200000000000003 112.354 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -104.83 -47.25 4.09 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.043 0.449 . . . . 74.109999999999999 110.927 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.36 3.26 16.11 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.453 0.538 . . . . 64.540000000000006 112.453 -172.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.487 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -40.66 -57.68 1.82 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.297 0.851 . . . . 75.109999999999999 113.297 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.5 t -65.01 -33.1 75.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.178 0.436 . . . . 44.420000000000002 112.178 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.66 -61.79 1.79 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.416 -0.356 . . . . 75.319999999999993 111.791 -174.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.684 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 29.7 p90 -65.48 -30.06 70.8 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.08 -0.387 . . . . 75.019999999999996 111.308 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -58.48 -43.34 88.92 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.289 0.566 . . . . 75.209999999999994 110.719 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.23 -34.15 77.37 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.987 -0.551 . . . . 73.209999999999994 111.274 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.684 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 25.4 m-85 -60.92 -44.07 97.7 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.598 0.237 . . . . 75.140000000000001 110.745 173.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.3 mm -55.44 -40.2 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.569 -0.287 . . . . 75.120000000000005 111.133 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -55.6 -63.97 1.0 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.774 0.321 . . . . 75.430000000000007 111.509 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.91 -31.06 72.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.479 -0.328 . . . . 75.200000000000003 111.875 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 175' ' ' ALA . 36.9 t80 -62.53 -58.8 6.27 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.664 0.268 . . . . 72.030000000000001 111.322 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 56.5 ttp -59.47 -41.91 90.82 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.95 0.405 . . . . 72.109999999999999 110.836 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -55.58 -48.12 75.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.059 -0.519 . . . . 74.400000000000006 111.262 177.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -66.61 -54.6 21.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.088 -0.505 . . . . 70.310000000000002 112.003 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.4 m -59.8 -38.39 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.162 0.43 . . . . 73.219999999999999 112.162 -176.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.523 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 46.4 mm -70.51 -46.77 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 122.207 -0.308 . . . . 73.140000000000001 110.971 176.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.8 -24.27 61.63 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.976 0.417 . . . . 75.109999999999999 111.859 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -89.34 -29.82 18.86 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.455 -0.339 . . . . 74.010000000000005 111.763 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 11.9 tpt -81.11 -53.98 5.93 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.732 0.642 . . . . 75.450000000000003 112.732 -172.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -71.05 -10.59 60.02 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.05 0.759 . . . . 71.129999999999995 113.05 -174.24 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.651 ' HA ' ' HE3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -60.72 -48.14 83.13 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.152 0.501 . . . . 75.409999999999997 111.042 172.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -107.55 -36.72 6.38 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.841 0.682 . . . . 73.209999999999994 112.841 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.507 ' O ' HG11 ' A' ' 113' ' ' VAL . 3.0 m-20 -112.24 41.15 2.04 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.966 0.412 . . . . 60.520000000000003 111.893 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -45.05 -30.46 1.07 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.813 0.845 . . . . 65.140000000000001 112.966 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -51.76 140.45 19.16 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.618 0.723 . . . . 73.230000000000004 112.66 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 54.2 mttp -65.87 -19.92 66.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.742 1.016 . . . . 71.420000000000002 113.742 -169.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.04 -20.96 47.63 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.689 -0.632 . . . . 74.109999999999999 111.465 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -94.37 -65.43 0.99 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.884 0.328 . . . . 73.510000000000005 111.884 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.507 HG11 ' O ' ' A' ' 107' ' ' ASN . 5.1 m -59.55 -45.6 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 112.921 0.712 . . . . 74.150000000000006 112.921 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 26.2 t70 -60.81 -43.81 97.71 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.634 0.255 . . . . 74.549999999999997 111.248 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.41 -49.35 74.1 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.858 0.361 . . . . 74.310000000000002 111.277 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -56.43 -54.33 46.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.978 0.418 . . . . 73.329999999999998 111.332 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.41 ' HA ' HG21 ' A' ' 120' ' ' ILE . 62.2 tttm -61.73 -31.13 71.28 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.435 -0.348 . . . . 75.409999999999997 111.237 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -65.76 -43.34 89.2 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.782 0.325 . . . . 74.230000000000004 111.237 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -57.5 -58.13 9.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.048 0.452 . . . . 74.049999999999997 111.166 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.41 HG21 ' HA ' ' A' ' 117' ' ' LYS . 11.1 tp -64.37 -40.42 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.018 -0.537 . . . . 75.129999999999995 112.066 -175.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.593 HE21 ' HA ' ' A' ' 121' ' ' GLN . 0.0 OUTLIER -66.25 -50.73 62.75 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.315 -0.241 . . . . 65.430000000000007 111.412 178.118 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.1 -42.26 61.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.586 -0.816 . . . . 64.230000000000004 112.199 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -62.81 -61.9 2.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.332 0.253 . . . . 75.129999999999995 111.253 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.433 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.5 m -61.26 -44.93 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 112.604 0.594 . . . . 61.140000000000001 112.604 -176.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.74 -34.58 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.972 0.415 . . . . 74.099999999999994 111.525 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.1 m -80.02 -29.11 39.32 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.031 0.443 . . . . 65.140000000000001 111.273 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.9 tp -80.03 -28.82 39.27 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.148 -0.478 . . . . 73.120000000000005 111.684 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 93.6 mt -85.14 2.27 44.3 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.598 0.592 . . . . 75.310000000000002 112.598 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.21 82.06 0.08 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.231 0.539 . . . . 55.109999999999999 110.917 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 65.5 pttt -64.08 -14.99 58.53 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.568 0.951 . . . . 74.409999999999997 113.568 -169.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.33 -42.38 98.58 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.138 0.494 . . . . 73.140000000000001 110.887 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -108.57 -50.78 2.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.992 -0.549 . . . . 74.030000000000001 111.393 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.52 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 55.3 m-85 -66.74 -4.5 9.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.592 0.96 . . . . 72.430000000000007 113.592 -173.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 14.1 ptmm? -50.99 -6.6 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.242 0.83 . . . . 73.450000000000003 113.242 175.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -77.46 13.28 1.27 Allowed 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.759 -0.588 . . . . 65.209999999999994 112.024 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 95.6 mt -89.54 127.92 35.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.014 0.435 . . . . 72.219999999999999 111.607 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -100.52 127.59 46.84 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.401 -0.363 . . . . 62.240000000000002 110.934 177.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -98.99 110.62 23.2 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.838 0.352 . . . . 74.319999999999993 110.976 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.401 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 65.4 m-85 -112.75 139.98 47.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.205 0.526 . . . . 71.109999999999999 111.797 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 150' ' ' ASN . 11.2 tt -133.26 155.16 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.821 -0.627 . . . . 74.400000000000006 110.96 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.34 125.35 13.03 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.567 -0.349 . . . . 62.020000000000003 113.553 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -49.91 -48.8 51.43 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.201 0.445 . . . . 72.219999999999999 112.201 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -79.7 -22.11 43.81 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.97 0.414 . . . . 72.219999999999999 111.865 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.32 93.36 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.957 0.408 . . . . 73.150000000000006 111.296 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.7 -30.93 65.9 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.992 -0.549 . . . . 64.219999999999999 111.919 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.81 -28.49 65.76 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.633 0.254 . . . . 74.010000000000005 111.668 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.83 -20.53 1.62 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.976 -0.631 . . . . 50.32 113.702 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.84 76.85 0.46 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 117.132 0.466 . . . . 74.349999999999994 111.951 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 54.38 103.68 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.72 0.772 . . . . 74.030000000000001 112.229 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.563 ' HB3' ' OH ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -54.48 -27.56 38.62 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.282 -0.872 . . . . 74.430000000000007 112.604 -173.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 8' ' ' PHE . . . 59.5 -166.21 9.39 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 114.821 0.689 . . . . 61.030000000000001 114.821 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -96.44 144.01 26.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.786 0.327 . . . . 74.319999999999993 111.387 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 44.8 t -77.99 138.01 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.912 0.387 . . . . 73.109999999999999 110.748 171.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.61 ' HB1' HD13 ' A' ' 169' ' ' LEU . . . -94.54 133.62 37.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.424 -0.353 . . . . 63.340000000000003 111.505 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.75 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 35.4 mm -91.98 113.54 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.751 0.31 . . . . 75.129999999999995 111.653 -178.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.609 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 49.8 mm -96.45 110.04 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.682 0.277 . . . . 74.310000000000002 111.084 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.61 132.93 50.28 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.402 -0.363 . . . . 73.200000000000003 110.271 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -90.09 89.13 7.55 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.459 0.647 . . . . 74.340000000000003 110.624 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -93.53 111.82 23.57 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.612 -0.722 . . . . 75.239999999999995 111.816 -172.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.598 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 32.4 t70 -69.91 118.76 13.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.041 0.448 . . . . 73.530000000000001 112.048 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 51.9 t -104.37 93.25 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.092 -0.503 . . . . 75.409999999999997 110.681 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 60.13 13.78 4.06 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.015 0.746 . . . . 74.409999999999997 113.015 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 133.42 -17.94 4.45 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.824 -0.703 . . . . 73.120000000000005 113.351 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.3 m -110.12 106.1 15.44 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.548 -0.384 . . . . 62.109999999999999 111.453 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 42.7 mt-10 -73.38 106.32 5.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.75 0.31 . . . . 74.409999999999997 111.181 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.7 m -105.18 143.23 26.33 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 120.888 0.375 . . . . 72.439999999999998 111.356 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.66 123.58 5.39 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.339 2.026 . . . . 73.310000000000002 112.682 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 60.0 p -108.29 125.67 51.95 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.174 0.511 . . . . 74.25 111.129 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.678 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 61.5 tp -78.26 114.69 17.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.023 -0.535 . . . . 72.540000000000006 111.121 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.75 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 42.5 ttm -101.82 124.25 47.14 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.464 0.306 . . . . 73.310000000000002 111.584 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 81.0 mt -138.33 130.71 28.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.794 0.438 . . . . 74.129999999999995 111.353 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.432 HG12 ' HG2' ' A' ' 174' ' ' GLU . 39.3 t -82.41 126.83 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 122.012 -0.43 . . . . 72.120000000000005 111.853 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -71.21 -33.95 70.38 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.985 0.421 . . . . 74.319999999999993 111.845 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.432 ' HG2' HG12 ' A' ' 172' ' ' VAL . 0.8 OUTLIER -72.81 -4.46 31.78 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.896 0.379 . . . . 75.209999999999994 111.343 177.254 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.481 ' HB3' ' CE1' ' A' ' 95' ' ' PHE . . . -101.17 -49.5 4.07 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.15 0.5 . . . . 73.140000000000001 110.609 173.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.827 HG22 ' HB3' ' A' ' 6' ' ' ASP . 36.0 pt -101.21 117.45 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.022 -0.536 . . . . 75.299999999999997 111.049 176.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 tp -93.57 128.08 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 121.903 -0.498 . . . . 75.099999999999994 109.916 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.64 ' HB2' HD13 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -110.43 131.8 54.74 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.863 0.84 . . . . 74.129999999999995 113.115 -171.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -94.68 103.48 15.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.819 -1.082 . . . . 72.239999999999995 109.309 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 41.9 pttt . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 113.368 0.877 . . . . 75.439999999999998 113.368 -169.58 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.437 ' HE1' HD11 ' A' ' 3' ' ' ILE . 25.7 ptt? . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 120.623 0.249 . . . . 73.400000000000006 111.129 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 15' ' ' SER . 29.1 tp -107.14 129.05 54.89 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.903 -0.498 . . . . 73.319999999999993 110.721 177.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.478 HG12 ' HB3' ' A' ' 15' ' ' SER . 60.0 mt -110.38 126.26 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.77 0.319 . . . . 74.230000000000004 111.124 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -123.38 145.74 48.52 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.933 0.397 . . . . 75.099999999999994 111.557 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 3.9 ptpp? -129.36 130.38 45.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.088 0.47 . . . . 73.319999999999993 111.652 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.532 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 4.0 m-20 -73.02 178.09 4.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.905 -0.588 . . . . 75.219999999999999 112.258 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.8 mt -66.56 -41.72 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.122 0.487 . . . . 64.530000000000001 111.24 173.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.449 ' HB3' ' HB3' ' A' ' 150' ' ' ASN . 37.9 m-85 -106.28 -32.64 8.09 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 112.001 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -93.48 15.0 16.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.278 0.561 . . . . 75.5 111.566 -174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.532 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 13.4 p-10 -60.26 -26.03 66.15 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.08 0.77 . . . . 72.340000000000003 113.08 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -68.3 -18.59 64.56 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.858 0.688 . . . . 52.130000000000003 112.858 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -85.66 -33.08 21.66 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.646 0.609 . . . . 75.420000000000002 112.646 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 56.29 98.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.218 0.532 . . . . 75.109999999999999 112.398 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.4 m -95.66 124.63 39.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.157 -0.339 . . . . 63.43 110.73 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.478 ' HB3' HG12 ' A' ' 3' ' ' ILE . 15.3 p -118.69 103.86 10.07 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.074 0.464 . . . . 75.299999999999997 112.1 -174.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -132.41 -172.57 2.93 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.035 0.445 . . . . 51.509999999999998 111.909 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.1 p -138.42 18.07 2.74 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.413 -0.358 . . . . 71.5 111.809 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -69.11 140.29 90.77 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 111.748 0.277 . . . . 74.420000000000002 111.748 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.12 143.25 35.58 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.841 2.361 . . . . 64.439999999999998 113.43 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptp -147.35 137.73 23.3 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.992 0.425 . . . . 73.099999999999994 111.996 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 67.1 mttm -112.28 156.38 22.49 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.553 -0.294 . . . . 72.0 110.564 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.494 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 55.4 tp -121.25 104.5 9.78 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.219 0.451 . . . . 73.540000000000006 112.219 -171.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.69 144.92 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-O 121.038 0.447 . . . . 72.409999999999997 111.737 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 56.67 12.67 1.17 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.168 -0.469 . . . . 64.230000000000004 111.888 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.494 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 62.8 m-20 50.7 29.7 4.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.365 0.602 . . . . 74.329999999999998 111.307 -174.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' A' ' 119' ' ' LYS . 53.9 tp -126.27 -48.68 1.57 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.899 -0.591 . . . . 75.219999999999999 111.41 -177.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.1 m -128.56 144.86 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.232 -0.44 . . . . 74.0 111.735 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 170' ' ' MET . 98.3 m-85 -85.55 141.09 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 65.420000000000002 110.375 176.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 2.8 pm0 -130.97 111.54 12.14 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.389 0.614 . . . . 74.310000000000002 111.058 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -150.46 141.19 22.7 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.977 1.103 . . . . 75.109999999999999 113.977 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -94.5 133.64 37.9 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.341 -0.845 . . . . 73.120000000000005 111.547 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.63 -167.77 42.44 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.852 -0.69 . . . . 72.209999999999994 113.25 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HG3' HG11 ' A' ' 35' ' ' VAL . 57.3 tptt -91.74 128.13 37.45 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 122.478 -0.425 . . . . 75.030000000000001 110.424 177.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -73.62 106.22 5.29 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.06 0.457 . . . . 73.099999999999994 110.996 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.479 HG11 ' HG3' ' A' ' 33' ' ' LYS . 27.2 m -137.28 155.22 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.116 -0.493 . . . . 73.430000000000007 111.007 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 m -122.54 119.15 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.43 0.633 . . . . 74.349999999999994 111.392 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.479 ' HD3' ' OE2' ' A' ' 65' ' ' GLU . 43.0 ttt180 . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 121.059 0.457 . . . . 74.329999999999998 111.785 -173.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.609 ' HG2' HD22 ' A' ' 72' ' ' LEU . 28.5 tt0 . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 121.801 0.81 . . . . 72.219999999999999 110.16 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -87.44 138.3 31.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.225 -0.898 . . . . 74.230000000000004 111.38 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.84 -146.24 9.25 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.447 -0.882 . . . . 75.219999999999999 113.612 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.6 pt -110.61 145.04 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.795 0.331 . . . . 72.319999999999993 111.763 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 14.9 t70 -41.03 -43.88 2.27 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.625 0.77 . . . . 72.150000000000006 112.308 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.9 mt -49.94 -56.29 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.724 0.639 . . . . 73.439999999999998 112.724 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.505 ' HA ' HD11 ' A' ' 76' ' ' LEU . 30.1 m -80.23 -35.05 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.394 0.516 . . . . 74.329999999999998 112.394 -172.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.609 HD22 ' HG2' ' A' ' 65' ' ' GLU . 85.5 mt -67.53 -46.39 72.96 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.715 0.293 . . . . 74.510000000000005 111.657 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -69.25 -21.75 63.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.412 0.523 . . . . 64.530000000000001 112.412 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -103.77 8.28 37.2 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 122.129 -0.357 . . . . 74.150000000000006 111.243 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.9 tptm 46.49 69.74 0.45 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.698 0.761 . . . . 73.340000000000003 112.501 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.505 HD11 ' HA ' ' A' ' 71' ' ' VAL . 82.0 mt -106.38 122.03 45.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.644 -0.707 . . . . 64.140000000000001 110.343 177.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 p -82.65 141.41 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.09 0.472 . . . . 74.319999999999993 111.419 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -79.54 141.41 36.67 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.762 -0.654 . . . . 62.210000000000001 112.41 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.418 ' HG3' ' HB2' ' A' ' 84' ' ' ASP . 41.8 tpp -143.55 149.29 37.21 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.923 -0.58 . . . . 74.109999999999999 109.903 174.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -130.9 163.69 26.92 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.77 0.655 . . . . 72.439999999999998 112.77 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 67.9 m -38.07 -56.46 1.16 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.581 1.326 . . . . 71.140000000000001 114.581 -171.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -60.3 -29.76 69.04 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.424 0.898 . . . . 73.340000000000003 113.424 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -103.59 -21.34 13.76 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.949 -0.469 . . . . 73.230000000000004 111.655 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.418 ' HB2' ' HG3' ' A' ' 79' ' ' MET . 12.5 t70 -77.64 1.15 20.64 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.148 0.425 . . . . 74.549999999999997 112.148 -175.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.453 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . . . -39.8 -59.21 1.21 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.444 0.535 . . . . 42.25 112.444 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.7 t -53.23 -39.45 63.78 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.098 -0.501 . . . . 62.140000000000001 111.986 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.435 ' O ' ' HD1' ' A' ' 91' ' ' TYR . 25.9 mmt -73.22 -73.88 0.19 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.297 0.48 . . . . 71.409999999999997 112.297 -174.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.453 ' CE1' ' HA ' ' A' ' 85' ' ' ALA . 33.4 p90 -55.72 -29.6 59.75 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.406 0.521 . . . . 75.120000000000005 112.406 -173.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.434 ' O ' HG22 ' A' ' 92' ' ' ILE . 32.8 mmtp -68.64 -60.49 2.37 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.928 0.394 . . . . 74.219999999999999 111.795 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.54 -43.21 99.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.159 0.504 . . . . 64.510000000000005 111.972 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.435 ' HD1' ' O ' ' A' ' 87' ' ' MET . 49.5 m-85 -69.74 -37.61 76.52 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.935 0.717 . . . . 73.420000000000002 112.935 -176.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 89' ' ' LYS . 11.0 tp -67.03 -33.37 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.304 0.573 . . . . 74.519999999999996 110.506 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -66.8 -45.81 77.2 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.914 -0.585 . . . . 75.019999999999996 110.975 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -61.7 -39.74 92.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.202 0.525 . . . . 71.230000000000004 110.684 172.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.462 ' HE1' ' HB3' ' A' ' 175' ' ' ALA . 89.2 t80 -60.26 -57.89 10.84 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.651 -0.704 . . . . 75.239999999999995 111.866 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.1 ptm -54.09 -39.43 66.32 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.842 0.354 . . . . 63.520000000000003 111.195 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -64.32 -49.98 69.61 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.66 -0.245 . . . . 71.340000000000003 111.574 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -61.43 -46.25 90.92 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.172 0.434 . . . . 71.329999999999998 112.172 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.3 m -66.81 -43.06 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.221 0.452 . . . . 75.439999999999998 112.221 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.9 mm -69.38 -38.17 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.735 0.302 . . . . 74.099999999999994 110.727 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.24 -54.17 40.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.019 0.437 . . . . 74.299999999999997 110.915 175.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -68.88 -53.04 23.43 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.22 0.452 . . . . 70.450000000000003 112.22 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.649 ' HA ' ' HE1' ' A' ' 103' ' ' MET . 4.7 tpt -65.14 -56.89 10.3 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.254 0.465 . . . . 73.0 112.254 -174.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.8 -43.03 99.88 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.057 0.392 . . . . 73.319999999999993 112.057 -174.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -48.97 -45.17 41.65 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.209 0.818 . . . . 74.140000000000001 113.209 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.56 18.05 20.12 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.061 0.458 . . . . 72.299999999999997 112.095 -176.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.452 ' OD1' HG11 ' A' ' 113' ' ' VAL . 3.1 t-20 -127.61 -65.51 0.92 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.372 -0.377 . . . . 65.209999999999994 110.774 176.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 70.01 -25.4 0.15 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.694 0.998 . . . . 74.129999999999995 113.694 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 113' ' ' VAL . 42.0 m-20 -66.14 112.99 4.19 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.932 0.396 . . . . 75.120000000000005 111.584 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -56.05 -32.18 63.82 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.178 0.436 . . . . 72.400000000000006 112.178 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.01 -33.96 65.38 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.072 0.397 . . . . 74.420000000000002 112.072 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.421 ' HB2' ' OD1' ' A' ' 107' ' ' ASN . 3.3 m-20 -94.05 -55.15 3.31 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.129 0.418 . . . . 75.310000000000002 112.129 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.452 HG11 ' OD1' ' A' ' 107' ' ' ASN . 17.0 m -62.79 -35.26 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.999 0.74 . . . . 73.310000000000002 112.999 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -75.39 -25.7 57.86 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.283 0.563 . . . . 74.040000000000006 110.452 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.05 -44.81 52.93 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.143 -0.48 . . . . 72.049999999999997 110.673 173.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.42 -46.28 90.59 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.21 0.529 . . . . 74.239999999999995 110.164 173.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -50.3 -42.1 51.99 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.667 -0.697 . . . . 73.219999999999999 111.065 171.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -64.33 -42.24 96.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.178 -0.464 . . . . 73.200000000000003 111.691 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.558 ' HB3' HD23 ' A' ' 26' ' ' LEU . 14.6 mptt -58.1 -55.18 38.31 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.8 0.333 . . . . 75.450000000000003 110.985 174.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.508 HD11 HD21 ' A' ' 26' ' ' LEU . 41.8 mm -59.51 -41.86 86.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.447 -0.342 . . . . 73.420000000000002 111.391 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -57.08 -57.08 14.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.512 -0.313 . . . . 74.140000000000001 111.13 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.12 -40.11 82.44 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.077 -0.582 . . . . 72.420000000000002 112.579 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -61.55 -51.6 67.92 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 111.631 0.234 . . . . 75.219999999999999 111.631 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.28 -41.25 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 112.573 0.583 . . . . 73.109999999999999 112.573 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.9 m -64.54 -26.0 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 121.936 -0.478 . . . . 71.430000000000007 111.37 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.6 t -84.89 -46.84 10.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.901 0.381 . . . . 72.530000000000001 110.883 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.5 tp -58.62 -39.21 79.82 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.983 0.513 . . . . 72.129999999999995 112.282 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.5 mt -81.6 2.6 28.57 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.226 0.454 . . . . 63.009999999999998 112.226 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.45 90.46 0.73 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.108 0.48 . . . . 75.400000000000006 111.169 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 23.7 pttm -52.19 -32.34 35.85 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.718 -0.674 . . . . 73.109999999999999 112.597 -177.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -65.59 -28.81 69.41 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.354 0.501 . . . . 73.209999999999994 112.354 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -108.03 -58.88 1.92 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.543 0.687 . . . . 74.299999999999997 111.302 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.543 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 29.7 m-85 -67.9 -3.27 9.26 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.365 0.876 . . . . 73.319999999999993 113.365 -172.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 36.9 ttmt -36.11 -32.48 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.886 0.699 . . . . 75.219999999999999 112.886 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -91.25 33.08 0.99 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.786 0.662 . . . . 74.519999999999996 112.786 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 56.6 mt -88.47 125.99 35.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.215 0.531 . . . . 65.450000000000003 111.529 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -101.25 112.84 25.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.042 -0.526 . . . . 71.420000000000002 110.532 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.625 ' HB3' HG11 ' A' ' 153' ' ' VAL . 93.1 m-85 -89.81 109.4 20.4 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.543 -0.298 . . . . 63.119999999999997 111.257 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.415 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 67.1 m-85 -99.77 124.48 45.08 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.161 0.505 . . . . 74.530000000000001 111.662 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.49 ' HB ' HG23 ' A' ' 153' ' ' VAL . 8.6 tt -121.36 146.82 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.08 -0.509 . . . . 73.299999999999997 111.134 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.7 124.24 35.67 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.335 -0.46 . . . . 50.030000000000001 113.794 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -44.61 -51.1 9.36 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.53 0.567 . . . . 72.230000000000004 112.53 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -50.76 -36.42 36.55 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.902 0.705 . . . . 75.299999999999997 112.902 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -93.38 -34.57 13.41 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.848 0.356 . . . . 64.120000000000005 111.946 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.82 -19.56 51.57 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.524 0.565 . . . . 74.439999999999998 112.524 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -65.21 -18.56 65.41 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.865 0.364 . . . . 70.430000000000007 111.875 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.72 47.97 0.02 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.714 -0.755 . . . . 44.32 113.346 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 150' ' ' ASN . . . -132.77 116.66 16.84 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.954 0.407 . . . . 72.239999999999995 111.614 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -74.5 23.15 0.09 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.258 0.466 . . . . 71.25 112.258 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 8' ' ' PHE . 37.6 m-80 -125.6 18.95 8.04 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.109 0.48 . . . . 72.340000000000003 111.001 177.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.2 91.95 1.63 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.079 -0.581 . . . . 75.450000000000003 112.46 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -58.96 119.46 7.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.285 0.564 . . . . 73.430000000000007 111.617 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.625 HG11 ' HB3' ' A' ' 138' ' ' PHE . 91.9 t -87.68 142.16 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.823 0.675 . . . . 70.230000000000004 112.823 -175.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.873 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -101.78 133.21 46.89 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.641 -0.709 . . . . 74.319999999999993 110.442 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.4 mt -99.94 117.3 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 112.655 0.613 . . . . 71.120000000000005 112.655 -171.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 40.9 mm -100.94 123.33 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 111.76 0.282 . . . . 71.340000000000003 111.76 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -111.9 133.68 53.94 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.696 0.284 . . . . 74.129999999999995 111.046 173.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -84.68 95.57 8.95 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.332 0.586 . . . . 71.340000000000003 110.183 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.81 113.38 24.3 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.637 -0.711 . . . . 71.530000000000001 111.277 -173.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -74.18 118.24 16.91 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.468 -0.333 . . . . 73.329999999999998 110.49 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.52 91.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.781 0.324 . . . . 71.109999999999999 111.814 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 t70 52.72 38.54 26.57 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.641 0.608 . . . . 74.540000000000006 112.641 173.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 103.03 -5.72 50.42 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.145 -0.55 . . . . 70.510000000000005 113.772 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.524 HG23 HG13 ' A' ' 166' ' ' VAL . 61.0 m -110.21 122.19 47.06 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.349 -0.501 . . . . 74.209999999999994 110.925 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 0.4 OUTLIER -92.69 100.38 12.89 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.285 0.564 . . . . 71.219999999999999 111.24 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.524 HG13 HG23 ' A' ' 164' ' ' THR . 19.0 m -108.07 113.27 60.97 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 112.361 0.504 . . . . 62.130000000000003 112.361 -177.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.12 113.8 3.87 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.089 1.859 . . . . 72.109999999999999 111.611 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.6 p -104.64 151.98 23.02 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.482 -0.326 . . . . 73.200000000000003 111.378 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.873 HD11 ' HB1' ' A' ' 154' ' ' ALA . 26.2 tp -102.3 122.95 45.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.54 -0.3 . . . . 74.439999999999998 110.857 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.571 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 63.0 mtt -101.81 124.25 47.13 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.599 0.562 . . . . 73.239999999999995 111.378 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.9 mt -138.2 130.58 29.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.492 -0.777 . . . . 71.340000000000003 110.609 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.407 HG11 ' H ' ' A' ' 174' ' ' GLU . 25.9 t -79.72 123.37 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 122.077 -0.389 . . . . 62.229999999999997 111.177 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.768 ' HZ2' ' HB2' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -68.75 -11.07 59.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.642 0.608 . . . . 74.549999999999997 112.642 -175.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.407 ' H ' HG11 ' A' ' 172' ' ' VAL . 13.9 mm-40 -97.3 -8.3 30.05 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.073 0.463 . . . . 64.519999999999996 111.125 172.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.462 ' HB3' ' HE1' ' A' ' 95' ' ' PHE . . . -97.45 -14.37 21.2 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.291 0.567 . . . . 71.400000000000006 110.669 175.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 63.4 mt -134.77 128.59 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.469 -0.787 . . . . 73.310000000000002 109.806 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 43.5 mm -93.47 128.41 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.773 0.321 . . . . 74.109999999999999 111.392 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -84.94 114.44 22.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.245 -0.434 . . . . 73.200000000000003 110.949 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.44 112.72 23.46 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.706 0.765 . . . . 72.310000000000002 110.89 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.735 ' HB2' ' HZ2' ' A' ' 180' ' ' LYS . 4.9 ttmp? . . . . . 0 CA--C 1.544 0.717 0 CA-C-N 115.657 -0.702 . . . . 74.200000000000003 112.095 -172.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.737 0.303 . . . . 75.129999999999995 111.761 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.41 160.01 14.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.457 0.303 . . . . 71.420000000000002 111.092 -176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 33.9 pt -130.58 138.8 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.976 -0.452 . . . . 73.239999999999995 112.037 177.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 14' ' ' SER . 49.7 p90 -122.55 138.24 54.63 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.231 0.539 . . . . 74.430000000000007 111.532 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.662 ' HZ1' ' HB3' ' A' ' 5' ' ' LYS . 5.2 mtpm? -132.18 112.91 12.68 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.46 -0.791 . . . . 74.430000000000007 111.307 -176.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 176' ' ' ILE . 6.6 m-20 -73.46 155.31 39.39 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.041 -0.412 . . . . 74.219999999999999 111.495 173.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 pt -72.46 -24.93 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.967 0.413 . . . . 71.209999999999994 111.513 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.73 -41.76 4.92 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.537 0.569 . . . . 73.219999999999999 112.537 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.563 ' HG1' ' HB2' ' A' ' 152' ' ' GLN . 2.6 m -88.69 15.13 8.66 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.304 0.573 . . . . 72.420000000000002 111.548 -177.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.434 ' OD1' ' NZ ' ' A' ' 5' ' ' LYS . 34.2 t70 -49.05 -37.81 22.02 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.838 1.051 . . . . 75.349999999999994 113.838 -173.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.1 -37.13 81.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.703 0.631 . . . . 75.430000000000007 112.703 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -104.2 25.79 9.62 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.887 -0.508 . . . . 73.400000000000006 112.014 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.652 HD11 ' HG2' ' A' ' 5' ' ' LYS . 2.2 pt? -44.16 158.76 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.02 -0.536 . . . . 74.329999999999998 111.812 173.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 62.6 m -143.55 152.56 41.59 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.425 0.898 . . . . 74.340000000000003 113.425 -174.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 78.0 p -91.58 125.41 36.31 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.646 -0.707 . . . . 71.150000000000006 109.851 172.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -112.89 175.65 5.35 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.98 0.419 . . . . 73.239999999999995 111.708 -171.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.1 t -144.82 8.5 1.28 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.052 0.39 . . . . 63.340000000000003 112.052 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 78.9 m-85 -96.87 150.14 36.55 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 122.221 -0.299 . . . . 74.049999999999997 111.674 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -91.66 104.67 0.24 Allowed 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.842 2.361 . . . . 74.099999999999994 113.468 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.497 ' N ' ' SD ' ' A' ' 20' ' ' MET . 1.6 mpt? -85.9 162.11 18.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.963 0.411 . . . . 75.430000000000007 111.534 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -129.19 119.89 24.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.411 -0.359 . . . . 75.129999999999995 111.139 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 tp -74.79 114.37 13.15 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.207 0.527 . . . . 73.319999999999993 111.081 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.31 145.63 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.302 -0.408 . . . . 71.329999999999998 111.132 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.9 t70 62.79 8.51 3.1 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 120.987 0.422 . . . . 53.520000000000003 111.413 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 58.02 11.8 1.59 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.266 0.627 . . . . 74.140000000000001 111.598 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.491 HD23 HD13 ' A' ' 120' ' ' ILE . 30.8 tp -117.51 -46.74 2.66 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.042 -0.526 . . . . 73.540000000000006 111.279 -172.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.96 149.22 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.69 0.626 . . . . 53.43 112.69 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.574 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 75.3 m-85 -86.45 123.89 32.17 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.143 -0.48 . . . . 72.319999999999993 111.006 175.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -99.86 138.25 37.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.062 -0.517 . . . . 73.510000000000005 110.642 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.485 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 46.4 t80 -137.79 122.7 18.93 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.19 0.519 . . . . 75.400000000000006 111.562 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -75.37 123.46 25.41 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.57 0.581 . . . . 74.519999999999996 112.57 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.15 142.74 15.72 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.197 -0.456 . . . . 71.519999999999996 112.873 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -91.7 145.32 24.68 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.707 -0.29 . . . . 72.310000000000002 111.185 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -66.72 105.42 1.55 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.302 . . . . 72.319999999999993 110.578 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.508 HG22 HD11 ' A' ' 72' ' ' LEU . 10.8 m -146.82 158.84 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.33 0.585 . . . . 72.120000000000005 111.419 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.26 146.92 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.084 -0.507 . . . . 71.430000000000007 111.171 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.475 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 19.9 mmt85 . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 120.873 0.368 . . . . 73.409999999999997 111.136 172.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.487 ' HB3' HD23 ' A' ' 72' ' ' LEU . 39.8 mt-10 . . . . . 0 CA--C 1.537 0.47 0 CA-C-O 121.357 0.599 . . . . 72.25 110.567 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -88.31 132.64 34.33 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.858 -0.61 . . . . 64.409999999999997 111.231 177.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.5 -133.65 3.53 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.197 -1.001 . . . . 45.200000000000003 113.979 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 70' ' ' ILE . 7.4 pt -111.2 141.48 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.028 0.442 . . . . 75.299999999999997 112.189 -175.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -45.99 -34.44 4.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.868 -0.605 . . . . 75.349999999999994 112.013 177.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 68' ' ' ILE . 50.7 mt -48.26 -62.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.309 0.576 . . . . 73.129999999999995 111.913 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.3 m -77.22 -31.11 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.022 -0.535 . . . . 74.140000000000001 112.211 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.508 HD11 HG22 ' A' ' 35' ' ' VAL . 68.8 mt -74.08 -38.61 63.85 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.835 0.35 . . . . 72.299999999999997 111.802 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -83.91 -26.18 29.57 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.801 0.334 . . . . 73.109999999999999 111.386 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -95.43 -1.12 51.57 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 120.837 0.351 . . . . 75.219999999999999 110.745 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.7 tptm 49.65 70.92 0.44 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.141 0.976 . . . . 75.25 112.955 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.1 mt -107.14 148.91 28.25 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.791 -0.641 . . . . 72.129999999999995 111.041 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 140' ' ' ILE . 14.1 p -91.08 142.34 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 120.971 0.415 . . . . 71.549999999999997 111.873 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -79.16 143.32 35.54 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.964 0.727 . . . . 63.43 112.964 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.405 ' C ' HD21 ' A' ' 80' ' ' ASN . 96.8 mmm -139.46 155.42 47.6 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.28 0.632 . . . . 75.400000000000006 110.939 177.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.405 HD21 ' C ' ' A' ' 79' ' ' MET . 0.9 OUTLIER -131.75 133.1 44.42 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.035 0.445 . . . . 72.25 112.145 -173.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.4 p -38.32 -46.76 1.14 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.924 1.453 . . . . 73.340000000000003 114.924 -173.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -55.68 -34.76 65.34 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.02 0.438 . . . . 75.329999999999998 111.824 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -91.68 -37.69 12.88 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.16 0.505 . . . . 64.109999999999999 111.19 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.26 -6.34 42.3 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.602 0.593 . . . . 74.540000000000006 112.602 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.456 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -39.6 -63.24 0.59 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 112.992 0.738 . . . . 75.120000000000005 112.992 -177.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.5 m -60.35 -35.3 75.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.15 0.5 . . . . 74.540000000000006 111.602 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.8 mtp -69.66 -56.48 7.13 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.064 -0.517 . . . . 72.150000000000006 112.288 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 4.2 p90 -68.63 -25.98 65.11 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.915 -0.49 . . . . 70.530000000000001 112.304 -175.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.424 ' HA ' HG21 ' A' ' 92' ' ' ILE . 18.4 ptmt -73.91 -32.93 63.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 119.883 -0.727 . . . . 74.140000000000001 110.993 176.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.58 74.61 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.465 0.65 . . . . 64.219999999999999 110.157 170.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -53.43 -55.92 21.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.131 -0.94 . . . . 74.340000000000003 111.174 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.424 HG21 ' HA ' ' A' ' 89' ' ' LYS . 10.4 tp -63.27 -34.45 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 111.744 0.276 . . . . 74.530000000000001 111.744 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -63.5 -55.65 22.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.831 0.348 . . . . 73.310000000000002 111.213 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -61.09 -42.17 98.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.731 0.3 . . . . 75.200000000000003 111.361 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.494 ' O ' HG23 ' A' ' 99' ' ' VAL . 41.0 t80 -52.31 -57.48 9.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.157 -0.474 . . . . 75.239999999999995 111.278 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.613 ' HA ' ' HE1' ' A' ' 96' ' ' MET . 3.2 mmt -55.3 -52.95 61.78 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.393 -0.367 . . . . 73.150000000000006 111.851 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -54.14 -50.51 66.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.834 0.349 . . . . 72.549999999999997 111.481 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -64.17 -56.79 12.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.243 -0.435 . . . . 75.439999999999998 111.94 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 95' ' ' PHE . 24.2 m -63.58 -40.09 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.37 0.507 . . . . 75.230000000000004 112.37 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.6 mm -69.92 -44.98 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 122.217 -0.302 . . . . 65.340000000000003 111.375 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.61 -42.34 98.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.98 0.419 . . . . 62.329999999999998 111.035 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -68.38 -49.57 59.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.11 -0.496 . . . . 70.540000000000006 111.641 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.4 ttm -66.48 -49.49 66.44 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.923 0.342 . . . . 75.540000000000006 111.923 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.35 -11.76 11.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.895 0.379 . . . . 73.120000000000005 111.819 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -68.59 -48.0 65.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.861 0.362 . . . . 72.209999999999994 111.059 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.51 -36.01 6.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.134 0.42 . . . . 72.310000000000002 112.134 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -84.74 19.35 2.07 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 120.961 0.41 . . . . 72.109999999999999 111.039 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -28.41 -30.97 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.448 1.647 . . . . 74.209999999999994 115.448 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -50.27 118.22 2.85 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.022 0.439 . . . . 74.150000000000006 111.586 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 96.1 mttt -56.95 -22.49 38.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.163 -0.471 . . . . 71.120000000000005 111.547 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.02 -31.05 44.54 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.039 0.447 . . . . 70.310000000000002 111.82 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -77.21 -62.22 1.73 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.195 0.521 . . . . 70.209999999999994 110.927 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.3 m -63.24 -24.29 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.739 0.644 . . . . 70.25 112.739 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 20.4 t70 -62.33 -47.94 82.02 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.004 0.43 . . . . 73.329999999999998 110.159 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 119' ' ' LYS . . . -59.8 -42.32 93.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.947 -0.569 . . . . 73.0 111.453 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -64.24 -55.17 23.42 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.7 0.285 . . . . 71.319999999999993 111.708 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -55.57 -42.33 74.56 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.366 0.603 . . . . 75.310000000000002 110.997 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . 28.0 ttmt -71.35 -30.08 65.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.627 -0.715 . . . . 73.510000000000005 110.954 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 37.9 tptt -64.25 -41.66 96.86 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.259 0.552 . . . . 74.430000000000007 109.929 173.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.491 HD13 HD23 ' A' ' 26' ' ' LEU . 31.8 mm -65.71 -42.0 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.618 -0.719 . . . . 75.430000000000007 110.835 173.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.423 ' O ' HG21 ' A' ' 125' ' ' VAL . 10.9 mm100 -55.84 -51.87 66.01 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.72 0.267 . . . . 70.030000000000001 111.72 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.21 -42.85 83.46 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.474 -0.869 . . . . 72.519999999999996 112.198 175.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -59.92 -55.54 32.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.94 0.496 . . . . 74.409999999999997 111.547 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.0 m -66.98 -42.13 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 112.529 0.566 . . . . 74.019999999999996 112.529 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 121' ' ' GLN . 69.1 t -57.73 -34.55 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.254 0.549 . . . . 74.540000000000006 111.212 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.5 t -75.94 -42.73 47.78 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.224 -0.444 . . . . 72.040000000000006 111.52 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.423 HD21 HD12 ' A' ' 155' ' ' ILE . 30.5 tp -75.0 -29.07 60.78 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.958 -0.565 . . . . 75.329999999999998 112.248 -173.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.17 2.75 51.44 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.64 0.607 . . . . 75.129999999999995 112.64 -176.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' A' ' 133' ' ' PHE . . . -60.3 94.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.196 0.522 . . . . 65.219999999999999 111.17 177.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.555 ' HD2' ' N ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.58 -16.85 58.41 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.16 0.8 . . . . 75.420000000000002 113.16 -170.365 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.555 ' N ' ' HD2' ' A' ' 130' ' ' LYS . 3.9 m-20 -67.35 -46.01 74.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.002 0.43 . . . . 74.540000000000006 111.557 -175.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.531 HH21 ' HE2' ' A' ' 158' ' ' TYR . 39.8 mtp180 -107.36 -48.53 3.43 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.371 0.605 . . . . 73.109999999999999 111.796 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.509 ' CD1' ' HB1' ' A' ' 129' ' ' ALA . 44.5 m-85 -67.92 -6.33 21.46 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.849 -0.614 . . . . 74.120000000000005 112.608 -172.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 38.4 ttpt -53.09 -26.0 14.84 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.099 0.476 . . . . 74.209999999999994 110.93 171.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -97.19 34.04 1.84 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.579 0.585 . . . . 52.210000000000001 112.579 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 70.6 mt -87.96 151.18 22.98 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.895 0.379 . . . . 74.420000000000002 110.87 175.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -108.79 134.62 51.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.673 -0.239 . . . . 74.239999999999995 111.453 -178.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.542 ' HB3' HG12 ' A' ' 153' ' ' VAL . 66.7 m-85 -109.66 133.46 53.09 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.268 -0.27 . . . . 74.450000000000003 110.629 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -129.41 138.89 51.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.089 0.471 . . . . 73.049999999999997 111.017 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.474 ' O ' HG13 ' A' ' 77' ' ' VAL . 12.7 tt -141.33 158.85 22.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.367 -0.379 . . . . 73.310000000000002 111.139 -175.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.97 137.78 50.16 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.931 -0.652 . . . . 72.140000000000001 112.169 173.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -36.92 85.07 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.624 0.602 . . . . 63.210000000000001 112.624 -175.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.416 ' HD3' ' HA ' ' A' ' 143' ' ' ARG . 24.6 mmt180 -63.45 -49.3 74.23 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.128 -0.357 . . . . 72.010000000000005 111.319 176.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.474 ' HB3' ' HA3' ' A' ' 151' ' ' GLY . . . -55.86 -50.34 70.86 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.022 0.439 . . . . 60.350000000000001 111.501 173.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.408 ' HB2' HG21 ' A' ' 140' ' ' ILE . . . -57.61 -30.93 65.74 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.12 0.415 . . . . 73.450000000000003 112.12 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -102.05 14.74 31.12 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.474 0.546 . . . . 74.129999999999995 112.474 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.7 -44.53 0.02 OUTLIER Glycine 0 CA--C 1.531 1.067 0 C-N-CA 119.996 -1.097 . . . . 70.219999999999999 114.976 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -111.76 108.93 18.53 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.873 0.694 . . . . 64.25 112.873 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -63.55 -24.59 67.87 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.762 0.315 . . . . 74.439999999999998 111.766 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -92.03 19.86 6.37 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.835 0.309 . . . . 71.430000000000007 111.835 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.474 ' HA3' ' HB3' ' A' ' 144' ' ' ALA . . . -68.33 163.11 49.06 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.048 -0.596 . . . . 60.420000000000002 113.133 178.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.563 ' HB2' ' HG1' ' A' ' 9' ' ' THR . 40.6 tt0 -68.11 102.32 1.31 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.417 -0.461 . . . . 70.409999999999997 112.038 -177.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 138' ' ' PHE . 24.6 t -80.92 99.93 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.383 0.611 . . . . 72.519999999999996 110.332 168.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.666 ' HB2' HD13 ' A' ' 169' ' ' LEU . . . -73.8 129.79 38.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.676 -0.693 . . . . 73.439999999999998 110.635 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.423 HD12 HD21 ' A' ' 127' ' ' LEU . 57.6 mt -95.57 125.62 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.991 0.424 . . . . 65.439999999999998 111.429 -175.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.548 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 50.3 mm -100.04 106.7 19.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-O 121.039 0.447 . . . . 75.239999999999995 110.695 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.43 152.62 20.15 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.727 -1.124 . . . . 74.329999999999998 111.239 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.531 ' HE2' HH21 ' A' ' 132' ' ' ARG . 39.7 p90 -100.3 122.22 42.74 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.983 -0.448 . . . . 74.140000000000001 110.62 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.568 ' HE ' ' HB ' ' A' ' 168' ' ' THR . 0.1 OUTLIER -136.93 156.4 48.51 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.873 0.694 . . . . 74.319999999999993 112.873 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.46 127.61 32.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.18 -0.918 . . . . 73.25 112.575 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.5 t -129.36 99.93 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.968 -0.56 . . . . 75.5 110.969 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 57.23 25.11 10.65 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.321 0.489 . . . . 72.120000000000005 112.321 176.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.46 -23.36 26.77 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.314 -0.469 . . . . 52.140000000000001 113.465 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.2 p -101.58 149.3 24.25 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.409 -0.465 . . . . 74.209999999999994 111.666 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.27 121.34 34.54 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.324 0.583 . . . . 71.239999999999995 112.076 -176.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.77 126.93 26.83 Favored Pre-proline 0 C--O 1.24 0.584 0 O-C-N 121.654 -0.654 . . . . 74.239999999999995 111.256 174.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.99 114.53 3.02 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.264 1.976 . . . . 64.109999999999999 111.426 171.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.568 ' HB ' ' HE ' ' A' ' 159' ' ' ARG . 10.2 t -101.48 149.81 23.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.303 -0.408 . . . . 74.109999999999999 111.888 -176.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 154' ' ' ALA . 53.0 tp -78.67 128.46 33.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.225 -0.443 . . . . 70.219999999999999 110.337 174.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 46.8 tpp -117.7 122.53 43.76 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.868 0.366 . . . . 73.519999999999996 111.021 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 98.1 mt -137.78 155.13 49.36 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.808 0.443 . . . . 73.230000000000004 109.875 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.486 HG12 ' CZ ' ' A' ' 95' ' ' PHE . 40.6 t -99.87 134.82 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.744 -0.598 . . . . 73.019999999999996 112.112 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.574 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -60.74 -39.67 89.51 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.155 0.798 . . . . 75.340000000000003 113.155 -172.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.457 ' CD ' ' HZ2' ' A' ' 173' ' ' LYS . 2.2 pm0 -95.15 12.43 28.79 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.854 0.687 . . . . 63.109999999999999 112.854 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.4 -33.67 8.08 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.558 0.694 . . . . 63.409999999999997 109.985 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 6' ' ' ASP . 3.9 tt -128.01 117.59 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.043 -0.98 . . . . 73.439999999999998 110.424 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 5' ' ' LYS . 8.3 tp -94.25 129.41 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.585 0.707 . . . . 74.549999999999997 111.869 -175.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -92.9 123.58 36.26 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.524 -0.762 . . . . 72.409999999999997 110.336 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -124.9 143.37 50.89 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.283 0.563 . . . . 64.510000000000005 111.153 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.577 0.703 . . . . 64.349999999999994 111.816 179.218 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.949 0.404 . . . . 71.510000000000005 111.95 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 178' ' ' GLU . 59.8 tp -134.28 131.9 38.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.659 -0.496 . . . . 63.5 109.659 172.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 54.3 mt -104.1 117.69 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 121.903 -0.498 . . . . 74.209999999999994 110.473 -177.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -111.05 142.73 42.81 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.859 0.838 . . . . 74.519999999999996 112.233 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -137.46 111.15 8.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.686 -1.143 . . . . 74.420000000000002 110.777 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.13 174.39 8.66 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.279 0.561 . . . . 54.109999999999999 111.489 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.6 mt -68.42 -28.16 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.356 0.598 . . . . 74.530000000000001 110.474 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -97.26 -44.0 7.1 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.783 -0.644 . . . . 64.239999999999995 112.161 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.8 p -81.07 15.62 1.81 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.319 0.859 . . . . 74.010000000000005 113.319 -172.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -54.68 -31.02 57.18 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.913 0.387 . . . . 73.540000000000006 111.692 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -71.68 -37.85 70.69 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.205 0.526 . . . . 75.200000000000003 111.129 174.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 10.0 tp10 -96.25 25.06 5.17 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.837 -0.619 . . . . 64.25 111.105 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.49 107.22 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.867 0.867 . . . . 72.310000000000002 112.089 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.9 t -122.16 175.29 6.45 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.704 0.631 . . . . 71.420000000000002 112.704 -166.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.7 p -150.33 130.94 13.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.937 -0.574 . . . . 64.510000000000005 111.535 -176.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -123.97 -162.76 1.09 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 120.825 0.345 . . . . 63.039999999999999 111.23 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.5 m -152.32 29.95 0.55 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.087 0.47 . . . . 63.130000000000003 110.826 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -108.27 146.11 32.91 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 111.036 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.52 159.14 54.76 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.246 1.964 . . . . 61.240000000000002 113.904 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.504 ' HE2' ' HG3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -142.05 128.9 20.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.327 0.584 . . . . 73.540000000000006 110.639 174.458 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.678 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 11.2 mmmm -98.91 97.96 9.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.259 -0.428 . . . . 74.120000000000005 111.925 -173.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 43.2 tp -75.13 91.21 2.57 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.643 -0.661 . . . . 73.109999999999999 111.37 -178.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.3 p -90.5 146.89 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 115.9 -0.591 . . . . 72.299999999999997 111.148 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 56.49 11.61 0.89 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 120.788 0.328 . . . . 72.450000000000003 111.76 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.467 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 7.9 m-20 52.92 30.68 9.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.164 0.507 . . . . 75.549999999999997 111.106 -175.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.451 HD13 HD12 ' A' ' 120' ' ' ILE . 30.0 tp -130.23 -43.5 1.17 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.195 -0.457 . . . . 73.409999999999997 111.723 -176.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.13 159.78 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.353 0.501 . . . . 64.040000000000006 112.353 -175.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 170' ' ' MET . 66.1 m-85 -103.27 129.97 50.39 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.945 -0.57 . . . . 74.5 111.464 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.678 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 15.3 tt0 -96.43 142.15 28.88 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.877 0.871 . . . . 73.140000000000001 110.627 175.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.612 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 63.3 t80 -147.33 130.66 16.59 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.74 0.305 . . . . 74.140000000000001 111.222 173.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -94.56 135.95 35.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.006 0.432 . . . . 75.120000000000005 111.176 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.729 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -123.02 147.68 16.72 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.203 -0.522 . . . . 72.019999999999996 113.192 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -91.22 136.59 32.99 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.607 -0.349 . . . . 74.420000000000002 110.724 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -65.25 106.87 1.43 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.119 0.485 . . . . 74.510000000000005 110.923 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.84 158.2 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.045 0.45 . . . . 73.099999999999994 111.136 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.644 HG12 ' HG3' ' A' ' 66' ' ' ARG . 12.2 m -137.27 137.44 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.772 0.32 . . . . 71.150000000000006 111.182 -178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.883 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 6.5 ttm180 . . . . . 0 C--O 1.238 0.471 0 CA-C-O 120.868 0.366 . . . . 74.109999999999999 111.863 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.883 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 32.5 tt0 . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 121.838 0.828 . . . . 64.409999999999997 109.851 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.644 ' HG3' HG12 ' A' ' 36' ' ' VAL . 40.4 ttp180 -105.51 124.53 49.71 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.297 -0.865 . . . . 73.5 111.652 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.4 ' N ' HD12 ' A' ' 72' ' ' LEU . . . 162.52 -132.28 2.74 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.032 -0.604 . . . . 61.530000000000001 113.064 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.611 HD12 HD12 ' A' ' 70' ' ' ILE . 22.1 pt -111.1 137.66 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 112.271 0.471 . . . . 73.400000000000006 112.271 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -39.54 -44.49 1.44 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.327 0.651 . . . . 74.200000000000003 112.55 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.729 HG13 ' HA3' ' A' ' 32' ' ' GLY . 67.0 mt -40.39 -53.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.773 0.657 . . . . 73.120000000000005 112.773 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.499 ' HA ' HD11 ' A' ' 76' ' ' LEU . 23.1 m -94.68 -33.91 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.406 0.521 . . . . 71.430000000000007 112.406 -173.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 67' ' ' GLY . 62.1 mt -68.38 -49.75 57.9 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.024 0.44 . . . . 75.109999999999999 111.534 -176.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -62.67 -21.16 65.52 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 120.854 0.359 . . . . 74.329999999999998 111.553 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -104.92 -0.28 27.17 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.822 0.305 . . . . 75.25 111.822 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.42 69.98 0.68 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.247 0.546 . . . . 75.140000000000001 112.273 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.499 HD11 ' HA ' ' A' ' 71' ' ' VAL . 91.4 mt -110.85 136.48 49.82 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.095 -0.502 . . . . 62.210000000000001 111.086 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.6 p -88.04 142.15 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.17 0.51 . . . . 75.230000000000004 111.437 -179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER -85.71 137.91 32.49 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.342 0.867 . . . . 74.219999999999999 113.342 -171.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 75.0 mtp -134.49 140.31 46.1 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.667 -0.697 . . . . 65.409999999999997 110.896 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -89.34 157.54 18.14 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.023 0.439 . . . . 75.109999999999999 111.937 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 136' ' ' LEU . 79.8 m -53.85 -45.03 70.8 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.919 0.711 . . . . 74.340000000000003 112.919 -175.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -60.39 -20.29 59.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.606 0.595 . . . . 73.019999999999996 112.606 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -99.42 -28.98 13.01 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.164 0.431 . . . . 72.239999999999995 112.164 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.41 -7.53 55.24 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.626 0.602 . . . . 72.430000000000007 112.626 -173.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.31 -43.21 10.55 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.078 0.77 . . . . 64.430000000000007 113.078 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.3 m -66.97 -39.58 87.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.732 0.301 . . . . 73.219999999999999 111.498 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.5 mmt -62.75 -44.44 96.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.401 -0.363 . . . . 74.140000000000001 110.657 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -51.91 -52.08 52.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.801 0.334 . . . . 63.420000000000002 111.578 173.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -58.84 -43.01 90.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.922 0.391 . . . . 75.040000000000006 111.656 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.34 -50.87 23.57 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.025 0.44 . . . . 65.510000000000005 111.881 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -58.83 -53.75 54.9 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.781 -0.645 . . . . 75.299999999999997 111.86 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.4 mm -64.11 -37.33 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 111.907 0.336 . . . . 72.319999999999993 111.907 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.604 ' HB2' ' HZ2' ' A' ' 93' ' ' LYS . 4.7 ttmp? -57.36 -62.66 1.62 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.204 0.526 . . . . 75.140000000000001 111.028 176.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.67 -44.67 85.91 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.806 -0.634 . . . . 74.310000000000002 111.221 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.495 ' CZ ' HG12 ' A' ' 172' ' ' VAL . 66.1 t80 -61.07 -66.11 0.59 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.936 -0.574 . . . . 72.319999999999993 112.314 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 48.0 ttm -54.95 -45.2 74.86 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.174 0.435 . . . . 74.099999999999994 112.174 -172.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.31 -43.96 93.08 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.696 0.284 . . . . 74.540000000000006 111.643 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -71.19 -43.01 68.27 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.182 0.438 . . . . 65.530000000000001 112.182 -176.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.1 m -72.2 -39.05 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.23 0.456 . . . . 74.430000000000007 112.23 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.99 -45.97 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 122.152 -0.342 . . . . 75.299999999999997 110.26 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.9 -38.76 73.27 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.369 0.604 . . . . 73.510000000000005 110.647 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -60.59 -38.85 85.98 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.729 -0.669 . . . . 74.439999999999998 111.976 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.468 ' HG2' HG12 ' A' ' 113' ' ' VAL . 35.3 ttm -88.39 -48.85 7.33 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.228 0.455 . . . . 74.549999999999997 112.228 -173.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.53 ' HA ' HG13 ' A' ' 113' ' ' VAL . 11.5 pt-20 -62.2 -24.45 67.22 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.174 -0.329 . . . . 74.420000000000002 111.814 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -58.54 -54.61 45.14 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.003 0.371 . . . . 74.209999999999994 112.003 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -100.6 -37.04 8.94 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.837 0.68 . . . . 70.230000000000004 112.837 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -68.39 -50.49 52.64 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.862 -0.524 . . . . 64.510000000000005 110.51 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 45.67 19.87 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.676 1.361 . . . . 74.299999999999997 114.676 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -102.68 124.51 48.36 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.858 -0.526 . . . . 75.230000000000004 110.595 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -52.9 -58.11 8.03 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.626 0.602 . . . . 74.120000000000005 112.626 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.61 -11.9 13.49 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.686 0.625 . . . . 75.340000000000003 112.686 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -91.16 -63.09 1.31 Allowed 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.927 0.394 . . . . 74.040000000000006 111.0 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.53 HG13 ' HA ' ' A' ' 104' ' ' GLU . 17.4 m -66.72 -33.74 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 112.631 0.604 . . . . 73.0 112.631 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.18 -31.3 71.62 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.998 0.428 . . . . 75.209999999999994 110.343 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.51 -46.01 60.86 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.26 -0.427 . . . . 71.439999999999998 111.171 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.437 ' CZ ' ' HG3' ' A' ' 174' ' ' GLU . 85.4 t80 -59.43 -48.0 83.32 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.189 0.519 . . . . 71.25 110.728 175.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -55.18 -39.07 69.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.913 -0.585 . . . . 74.140000000000001 110.774 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -65.42 -36.61 84.46 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.054 -0.521 . . . . 75.209999999999994 110.972 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -64.0 -52.45 59.52 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.216 -0.447 . . . . 74.219999999999999 111.61 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.451 HD12 HD13 ' A' ' 26' ' ' LEU . 42.1 mm -63.41 -42.44 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.853 0.359 . . . . 75.120000000000005 111.38 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -60.95 -48.26 82.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.824 0.345 . . . . 74.010000000000005 110.922 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.51 -38.22 95.44 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.157 -0.544 . . . . 54.219999999999999 112.564 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 50.7 t90 -60.73 -55.1 37.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.647 0.261 . . . . 74.530000000000001 111.215 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.427 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.2 m -66.17 -47.47 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 112.482 0.549 . . . . 71.310000000000002 112.482 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -59.52 -35.93 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 121.995 -0.441 . . . . 72.439999999999998 111.684 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.5 t -78.52 -41.46 32.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.913 0.387 . . . . 74.219999999999999 111.017 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.463 HD22 HD13 ' A' ' 155' ' ' ILE . 52.1 tp -63.82 -38.24 90.36 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.104 -0.498 . . . . 74.040000000000006 112.02 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 84.3 mt -77.17 3.26 13.1 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.477 0.547 . . . . 74.430000000000007 112.477 -177.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.44 ' HB3' ' HD2' ' A' ' 133' ' ' PHE . . . -62.71 78.72 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.442 0.639 . . . . 55.5 111.716 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.597 ' HD3' ' H ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -39.47 -39.15 0.65 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.35 1.241 . . . . 71.439999999999998 114.35 -178.143 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.96 -44.76 67.38 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.271 0.471 . . . . 75.409999999999997 112.271 -169.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.642 ' HD2' ' H ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -108.22 -36.33 6.31 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.267 -0.424 . . . . 73.099999999999994 111.652 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.44 ' HD2' ' HB3' ' A' ' 129' ' ' ALA . 86.7 m-85 -73.94 -5.79 43.39 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.241 0.46 . . . . 74.340000000000003 112.241 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -44.69 -26.52 0.39 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.1 0.476 . . . . 65.230000000000004 112.128 168.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -91.89 23.81 3.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.535 0.569 . . . . 74.420000000000002 112.535 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.461 ' HB2' ' SG ' ' A' ' 81' ' ' CYS . 66.9 mt -89.38 157.64 18.08 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.206 0.527 . . . . 74.140000000000001 111.204 176.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.4 120.83 36.15 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.001 -0.545 . . . . 73.439999999999998 110.653 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -109.36 121.73 45.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.066 0.46 . . . . 75.430000000000007 110.752 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.494 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 56.9 m-85 -110.47 132.01 54.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.402 0.62 . . . . 74.040000000000006 111.895 -177.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 145' ' ' ALA . 6.1 tp -115.14 146.87 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.541 -0.754 . . . . 75.329999999999998 110.985 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.04 153.9 37.65 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.155 0.422 . . . . 73.0 114.155 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -46.94 -70.55 0.09 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.06 0.763 . . . . 62.450000000000003 113.06 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -68.8 -21.74 64.3 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.261 0.553 . . . . 72.310000000000002 111.196 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.694 ' HB3' ' HA2' ' A' ' 151' ' ' GLY . . . -66.52 -49.93 64.89 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.879 -0.6 . . . . 73.209999999999994 111.577 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 140' ' ' ILE . . . -61.82 -17.95 58.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.183 -0.462 . . . . 64.409999999999997 111.865 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -82.22 11.05 5.76 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.16 -0.473 . . . . 72.219999999999999 111.711 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.1 54.61 7.87 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.219 -0.515 . . . . 72.129999999999995 113.181 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' A' ' 150' ' ' ASN . . . -115.09 18.71 16.16 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.71 0.633 . . . . 72.239999999999995 112.71 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 69.17 -26.42 0.15 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.934 0.716 . . . . 75.010000000000005 112.934 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.429 ' H ' ' C ' ' A' ' 148' ' ' ALA . 51.1 t30 -77.42 44.52 0.43 Allowed 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.568 0.699 . . . . 63.340000000000003 110.529 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.694 ' HA2' ' HB3' ' A' ' 144' ' ' ALA . . . -96.63 100.77 2.52 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.058 -0.519 . . . . 50.229999999999997 114.021 -175.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -119.88 126.8 51.83 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.725 0.298 . . . . 74.0 110.575 174.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 81.4 t -86.24 134.39 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.734 0.642 . . . . 72.019999999999996 112.734 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.04 122.27 42.07 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.816 -0.629 . . . . 74.209999999999994 109.719 170.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.463 HD13 HD22 ' A' ' 127' ' ' LEU . 47.5 mt -91.42 140.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.774 -0.37 . . . . 72.519999999999996 111.865 -171.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 168' ' ' THR . 43.3 mm -123.17 109.59 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.227 -0.442 . . . . 72.239999999999995 111.183 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -90.86 149.33 21.98 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.261 0.553 . . . . 74.450000000000003 111.926 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -87.78 109.34 19.66 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.181 -0.463 . . . . 72.409999999999997 109.826 171.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.424 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 2.3 mmp_? -110.45 135.4 51.19 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.003 0.371 . . . . 74.510000000000005 112.003 -174.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -86.56 116.31 24.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.125 0.488 . . . . 54.329999999999998 111.39 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -108.14 90.61 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.294 -0.412 . . . . 70.409999999999997 110.778 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.1 t70 57.38 33.54 23.42 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.815 -0.63 . . . . 63.030000000000001 111.563 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 100.97 8.2 48.55 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.088 -0.577 . . . . 70.099999999999994 113.323 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 m -122.72 106.06 10.61 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 122.473 -0.428 . . . . 65.219999999999999 111.021 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -78.31 104.22 8.75 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.926 0.393 . . . . 73.549999999999997 111.567 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 35.2 m -118.57 144.15 34.78 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.817 0.342 . . . . 73.040000000000006 111.588 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 166' ' ' VAL . 16.6 Cg_exo -70.42 146.3 55.74 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.974 2.449 . . . . 53.229999999999997 113.47 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 90.8 m -136.02 150.74 49.32 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.294 -0.412 . . . . 64.519999999999996 110.82 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.612 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 58.9 tp -95.8 135.54 37.39 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.595 0.591 . . . . 74.310000000000002 112.595 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 36.0 ttp -127.41 130.15 48.81 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.303 0.573 . . . . 75.310000000000002 111.762 174.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 88.1 mt -139.61 141.7 37.11 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.61 -0.723 . . . . 64.319999999999993 110.895 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.495 HG12 ' CZ ' ' A' ' 95' ' ' PHE . 21.2 t -87.11 132.22 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.538 -0.726 . . . . 72.219999999999999 112.309 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.4 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 14.7 ptmm? -57.88 -39.72 78.53 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.586 0.587 . . . . 73.0 112.586 -176.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.437 ' HG3' ' CZ ' ' A' ' 116' ' ' PHE . 23.5 mm-40 -75.54 -0.17 19.43 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 111.971 0.36 . . . . 75.239999999999995 111.971 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.72 -30.61 8.86 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.12 0.486 . . . . 74.400000000000006 110.481 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 172' ' ' VAL . 5.3 tt -127.45 109.19 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.295 -0.866 . . . . 73.519999999999996 111.178 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.4 mm -100.81 118.52 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.407 -0.36 . . . . 75.129999999999995 111.142 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.504 ' HG3' ' HE2' ' A' ' 20' ' ' MET . 0.0 OUTLIER -92.84 121.36 34.13 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.832 0.825 . . . . 74.299999999999997 111.259 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -94.61 111.03 22.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.74 0.781 . . . . 74.239999999999995 110.44 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.197 -0.911 . . . . 74.450000000000003 111.384 -177.737 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 120.543 0.211 . . . . 74.420000000000002 111.012 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.584 HD11 ' HB2' ' A' ' 178' ' ' GLU . 59.1 tp -114.53 128.42 56.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.796 0.331 . . . . 75.439999999999998 110.866 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.487 HG12 ' HB3' ' A' ' 15' ' ' SER . 52.6 mt -105.24 127.38 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.641 -0.254 . . . . 71.450000000000003 110.703 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -118.16 149.0 41.8 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.2 0.524 . . . . 75.109999999999999 111.789 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.431 ' HB2' ' CD1' ' A' ' 13' ' ' LEU . 17.0 ttpp -150.64 120.93 7.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.666 -0.697 . . . . 70.530000000000001 111.29 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.593 ' HB2' HG21 ' A' ' 9' ' ' THR . 1.3 m-20 -71.83 174.05 7.43 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.778 0.323 . . . . 75.319999999999993 110.293 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.8 pt -86.51 -3.97 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.981 0.42 . . . . 63.140000000000001 111.433 172.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.444 ' HE1' ' HD2' ' A' ' 94' ' ' LYS . 73.7 m-85 -108.98 -27.61 9.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.11 0.411 . . . . 74.340000000000003 112.11 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.593 HG21 ' HB2' ' A' ' 6' ' ' ASP . 2.0 t -106.0 20.33 19.12 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.591 0.589 . . . . 72.439999999999998 112.591 -170.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -44.83 -19.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.218 1.192 . . . . 65.140000000000001 114.218 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -86.96 -33.26 19.72 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 122.026 -0.421 . . . . 72.400000000000006 111.733 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.75 25.49 2.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.81 0.444 . . . . 75.0 111.893 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.431 ' CD1' ' HB2' ' A' ' 5' ' ' LYS . 56.6 tp -38.08 124.34 1.18 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.233 0.613 . . . . 74.420000000000002 112.249 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -137.87 174.35 10.67 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.243 0.461 . . . . 55.210000000000001 112.243 -175.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.487 ' HB3' HG12 ' A' ' 3' ' ' ILE . 78.5 p -141.39 135.52 30.49 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.635 0.606 . . . . 72.420000000000002 112.635 -175.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -129.75 -173.95 3.17 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.04 0.448 . . . . 72.120000000000005 111.652 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.5 p -103.89 -3.84 24.27 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.9 0.704 . . . . 73.430000000000007 112.9 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 79.9 m-85 -76.36 131.55 74.68 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 112.004 0.372 . . . . 72.120000000000005 112.004 -175.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 6.7 Cg_exo -74.0 172.69 15.41 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.113 2.542 . . . . 74.420000000000002 113.555 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.483 ' HE1' ' HE1' ' A' ' 28' ' ' TYR . 25.0 ptm -111.64 130.75 55.66 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.044 0.387 . . . . 74.310000000000002 112.044 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -120.73 98.21 5.91 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.876 -0.416 . . . . 73.420000000000002 109.876 172.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 25' ' ' ASP . 52.8 tp -100.04 133.88 43.77 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.201 -0.454 . . . . 71.430000000000007 112.193 -172.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.55 134.7 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.234 0.54 . . . . 73.230000000000004 111.722 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 t70 55.73 15.21 1.51 Allowed 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.195 -0.911 . . . . 53.200000000000003 111.885 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.406 ' HA ' HD23 ' A' ' 22' ' ' LEU . 4.7 m-20 53.36 25.7 4.76 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.937 0.398 . . . . 72.530000000000001 111.867 -175.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 tp -114.26 -49.64 2.84 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.162 -0.472 . . . . 75.530000000000001 111.25 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.589 HG11 ' HA ' ' A' ' 172' ' ' VAL . 16.9 m -137.42 157.77 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.923 0.392 . . . . 74.150000000000006 111.913 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.483 ' HE1' ' HE1' ' A' ' 20' ' ' MET . 62.7 m-85 -92.47 149.28 21.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.433 -0.348 . . . . 74.230000000000004 110.369 175.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 31.8 tt0 -125.78 124.48 41.09 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.202 0.314 . . . . 75.299999999999997 110.597 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.401 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 59.1 t80 -127.45 131.25 50.24 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.006 0.432 . . . . 74.340000000000003 110.818 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.45 ' HG2' HG23 ' A' ' 168' ' ' THR . 36.5 mtmm -119.93 119.09 32.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.73 0.3 . . . . 74.400000000000006 110.971 -178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.13 -157.42 19.4 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.217 0.447 . . . . 71.310000000000002 114.217 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -112.47 159.04 19.15 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.922 0.391 . . . . 75.319999999999993 111.84 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -89.05 107.1 18.85 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.375 -0.375 . . . . 75.219999999999999 110.436 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 m -142.34 159.5 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.495 0.664 . . . . 75.349999999999994 112.361 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 66' ' ' ARG . 17.3 m -139.15 139.94 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.475 -0.784 . . . . 73.310000000000002 110.279 175.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 20.6 ttt180 . . . . . 0 N--CA 1.468 0.425 0 CA-C-O 121.441 0.639 . . . . 73.239999999999995 111.223 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.6 mp0 . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 121.393 0.616 . . . . 75.519999999999996 109.558 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.523 ' HA ' HG12 ' A' ' 36' ' ' VAL . 11.6 ptm180 -98.27 137.47 36.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.499 -0.773 . . . . 73.530000000000001 112.684 -176.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.58 -127.02 4.69 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.914 -0.66 . . . . 54.030000000000001 113.296 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.568 HD11 HD13 ' A' ' 70' ' ' ILE . 23.2 pt -110.55 138.21 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.838 0.352 . . . . 72.340000000000003 111.817 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -46.33 -34.75 4.78 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.021 -0.536 . . . . 72.400000000000006 111.864 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.568 HD13 HD11 ' A' ' 68' ' ' ILE . 57.1 mt -48.36 -58.73 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.315 0.579 . . . . 73.510000000000005 112.311 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.62 -31.26 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.021 -0.536 . . . . 72.120000000000005 112.191 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.2 mt -67.5 -41.36 84.63 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.004 0.43 . . . . 74.310000000000002 111.241 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -54.62 -38.25 66.59 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.846 -0.616 . . . . 74.540000000000006 111.701 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -107.72 19.51 20.03 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.535 -0.302 . . . . 75.439999999999998 111.156 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt 43.89 43.07 5.0 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.897 0.879 . . . . 75.120000000000005 113.273 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.1 mt -70.52 162.16 29.31 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.206 0.527 . . . . 72.239999999999995 112.135 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.13 141.17 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 116.38 -0.373 . . . . 72.129999999999995 110.98 176.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -81.06 119.06 23.06 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.003 0.43 . . . . 72.450000000000003 112.065 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 53.2 ttm -112.19 139.48 47.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.062 -0.517 . . . . 74.239999999999995 109.82 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -122.57 156.77 33.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.391 0.615 . . . . 73.209999999999994 112.117 -175.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 25.1 p -72.17 -3.18 21.89 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.612 0.967 . . . . 75.230000000000004 113.612 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.408 ' CG ' ' N ' ' A' ' 83' ' ' GLU . 11.0 p90 -54.96 -54.83 37.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.914 0.387 . . . . 65.120000000000005 111.707 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.408 ' N ' ' CG ' ' A' ' 82' ' ' TYR . 8.8 tp10 -104.17 -45.08 4.81 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.612 0.72 . . . . 71.150000000000006 110.583 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.16 18.08 0.09 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.456 -0.793 . . . . 72.519999999999996 113.029 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.545 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -54.28 -41.74 69.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.231 0.539 . . . . 62.409999999999997 110.956 173.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -70.13 -24.4 63.18 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.853 -0.612 . . . . 54.200000000000003 111.905 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -62.81 -62.48 1.69 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.65 -0.25 . . . . 73.099999999999994 110.784 -179.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 30.2 p90 -68.38 -23.08 64.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.722 -0.391 . . . . 75.120000000000005 111.312 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -54.39 -60.35 3.47 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.188 0.518 . . . . 74.430000000000007 111.034 171.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.23 -38.43 75.22 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.176 -0.466 . . . . 73.239999999999995 111.414 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.469 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 55.7 t80 -57.13 -52.6 64.66 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.127 -0.488 . . . . 73.5 110.909 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.511 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 41.4 mm -65.81 -31.0 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.03 0.382 . . . . 73.430000000000007 112.03 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -59.43 -60.46 3.82 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.039 0.447 . . . . 73.329999999999998 111.202 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HD2' ' HE1' ' A' ' 8' ' ' PHE . 8.0 tmtm? -62.05 -41.52 98.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.14 0.495 . . . . 74.140000000000001 110.128 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.623 ' HZ ' HG12 ' A' ' 172' ' ' VAL . 21.7 t80 -52.87 -45.87 67.64 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.878 -0.601 . . . . 70.319999999999993 111.676 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 55.2 ttp -58.13 -50.14 74.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.304 0.573 . . . . 74.129999999999995 110.944 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -64.22 -35.53 81.11 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.114 -0.494 . . . . 72.239999999999995 111.786 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.92 -41.91 64.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.563 -0.289 . . . . 74.319999999999993 111.631 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.0 m -65.31 -39.6 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.957 -0.464 . . . . 74.349999999999994 111.144 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.04 -44.79 95.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.821 0.343 . . . . 72.239999999999995 110.398 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.97 -40.11 69.67 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.235 0.54 . . . . 75.209999999999994 111.011 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -66.31 -43.99 84.71 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.996 -0.547 . . . . 74.549999999999997 112.329 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 96.4 mmm -86.71 -53.69 4.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.772 0.656 . . . . 74.340000000000003 112.772 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -49.62 -40.2 38.35 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.739 0.415 . . . . 75.239999999999995 111.748 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -53.8 -43.1 69.06 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.225 0.454 . . . . 75.420000000000002 112.225 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -102.28 -3.01 27.91 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.466 0.543 . . . . 75.409999999999997 112.466 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.479 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 4.4 m-20 -101.03 -61.79 1.33 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.297 0.48 . . . . 75.5 112.297 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 107' ' ' ASN . 2.5 ptp180 72.49 -15.29 0.5 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.096 0.958 . . . . 74.540000000000006 112.543 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 113' ' ' VAL . 0.4 OUTLIER -71.71 84.5 0.9 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.317 0.58 . . . . 75.129999999999995 111.557 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -52.71 -18.82 2.01 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.85 -0.614 . . . . 72.310000000000002 112.54 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.42 -42.75 19.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.1 0.407 . . . . 61.399999999999999 112.1 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.446 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 37.2 t70 -81.21 -46.08 15.36 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 122.212 -0.305 . . . . 74.040000000000006 111.768 -174.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 109' ' ' ASP . 24.3 m -58.42 -27.36 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 122.052 -0.405 . . . . 72.200000000000003 111.177 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -70.78 -35.71 72.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.327 -0.397 . . . . 75.430000000000007 110.665 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.82 -46.7 74.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.341 -0.39 . . . . 70.319999999999993 110.868 176.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 82.5 t80 -62.84 -42.02 99.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.971 0.415 . . . . 73.019999999999996 110.384 174.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 117' ' ' LYS . 4.1 tmmm? -50.96 -46.95 61.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.27 -0.423 . . . . 72.530000000000001 110.064 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -63.46 -34.66 78.25 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.37 -0.377 . . . . 72.209999999999994 111.648 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 116' ' ' PHE . 71.8 mmtt -56.61 -60.73 3.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.991 0.425 . . . . 63.340000000000003 111.196 174.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.17 -32.21 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 116.102 -0.499 . . . . 75.319999999999993 111.607 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.418 ' O ' HG23 ' A' ' 125' ' ' VAL . 19.5 tm0? -64.57 -55.76 18.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.87 0.367 . . . . 71.200000000000003 110.859 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.27 -32.86 78.14 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.871 -0.681 . . . . 60.009999999999998 112.471 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 -62.49 -57.7 10.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.207 0.203 . . . . 73.310000000000002 111.188 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.48 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 30.6 m -63.66 -38.82 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.249 0.463 . . . . 71.430000000000007 112.249 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 121' ' ' GLN . 53.4 t -55.39 -44.01 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.173 0.511 . . . . 54.43 111.159 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.9 m -75.62 -35.97 60.37 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.098 0.475 . . . . 74.310000000000002 111.016 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.473 HD22 HD11 ' A' ' 155' ' ' ILE . 41.3 tp -66.41 -28.91 68.99 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.831 -0.622 . . . . 73.0 111.83 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 74.5 mt -90.04 3.97 51.64 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.289 -0.414 . . . . 64.420000000000002 112.086 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.475 ' HB2' ' CD1' ' A' ' 133' ' ' PHE . . . -59.63 92.72 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.413 0.625 . . . . 75.319999999999993 111.057 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -66.87 -7.86 24.87 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.695 0.998 . . . . 72.430000000000007 113.695 -170.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -71.48 -46.38 60.01 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.812 -0.555 . . . . 73.310000000000002 111.024 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 44.0 mtm-85 -109.36 -50.38 3.0 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.123 0.487 . . . . 74.540000000000006 111.806 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.475 ' CD1' ' HB2' ' A' ' 129' ' ' ALA . 22.4 m-85 -68.07 -7.56 30.47 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.404 0.52 . . . . 72.420000000000002 112.404 -173.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.51 -14.12 38.16 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.072 0.463 . . . . 73.219999999999999 111.324 175.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -93.32 19.36 8.31 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.151 0.426 . . . . 73.409999999999997 112.151 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.7 mt -88.51 147.29 24.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.318 0.58 . . . . 74.530000000000001 111.796 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.4 119.04 38.36 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.055 -0.521 . . . . 74.310000000000002 111.28 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -95.04 106.32 18.31 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.883 0.373 . . . . 75.099999999999994 110.544 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -94.48 132.81 38.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.519 0.676 . . . . 75.540000000000006 112.185 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 tp -124.7 149.08 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.32 -0.855 . . . . 74.329999999999998 110.394 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.64 141.56 27.48 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.289 -0.481 . . . . 75.340000000000003 113.377 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -48.28 -57.13 6.41 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.055 0.542 . . . . 73.209999999999994 111.739 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 143' ' ' ARG . 4.0 tmt_? -77.81 -28.97 50.49 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.189 0.518 . . . . 74.310000000000002 110.999 177.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.42 78.14 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.139 0.422 . . . . 73.109999999999999 112.139 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.33 -40.03 77.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.015 0.436 . . . . 73.409999999999997 111.737 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -71.09 -27.36 63.55 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.005 -0.543 . . . . 74.430000000000007 111.048 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -78.54 -44.14 11.27 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.218 -0.515 . . . . 74.010000000000005 112.963 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 64.83 2.29 1.67 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.286 0.847 . . . . 53.140000000000001 113.286 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -133.05 13.02 4.29 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.92 -0.488 . . . . 75.299999999999997 111.83 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -151.07 85.01 1.33 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.96 0.41 . . . . 73.200000000000003 110.22 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 158.33 133.52 1.56 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.948 -0.644 . . . . 75.230000000000004 113.52 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.38 142.12 29.52 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.695 -0.483 . . . . 73.140000000000001 109.695 174.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 48.4 t -75.9 117.28 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.581 0.705 . . . . 74.150000000000006 111.911 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.82 98.95 8.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.746 -0.661 . . . . 73.209999999999994 110.659 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 57.1 mt -85.99 117.08 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 120.794 0.331 . . . . 73.209999999999994 111.519 -175.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 51.0 mm -99.58 115.9 41.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.434 -0.348 . . . . 74.25 111.5 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 32.1 tt0 -104.02 144.36 31.65 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.868 -0.606 . . . . 75.540000000000006 111.659 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -85.81 88.8 7.61 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.251 0.548 . . . . 74.310000000000002 110.233 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.518 ' NH2' HG22 ' A' ' 161' ' ' VAL . 16.0 ttp180 -100.29 154.89 18.11 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.466 0.651 . . . . 71.349999999999994 111.959 -174.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.98 142.23 28.0 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.743 -0.662 . . . . 72.329999999999998 111.389 176.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.518 HG22 ' NH2' ' A' ' 159' ' ' ARG . 72.1 t -129.22 89.31 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.92 0.39 . . . . 75.129999999999995 110.824 171.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 51.76 25.64 3.05 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.926 -0.579 . . . . 73.150000000000006 112.305 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 129.18 -37.84 2.13 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.368 -0.444 . . . . 41.229999999999997 113.493 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 78.4 p -88.88 119.41 29.36 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.564 -0.374 . . . . 75.030000000000001 111.737 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.66 114.31 15.26 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.095 -0.502 . . . . 60.200000000000003 111.117 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.76 138.22 31.54 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 121.042 0.449 . . . . 75.200000000000003 112.085 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.504 ' HG2' HG23 ' A' ' 68' ' ' ILE . 15.8 Cg_exo -71.36 115.99 4.51 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.884 2.39 . . . . 64.239999999999995 112.62 173.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 31' ' ' LYS . 69.8 p -96.1 138.89 33.07 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.152 0.501 . . . . 74.209999999999994 112.01 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 61.1 tp -89.11 117.3 28.0 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.086 -0.506 . . . . 74.5 111.525 176.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.536 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 61.7 mtt -101.32 124.38 46.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.791 0.329 . . . . 61.43 111.413 176.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.472 ' HB3' HD11 ' A' ' 176' ' ' ILE . 96.0 mt -133.87 122.14 22.75 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.528 -0.306 . . . . 74.030000000000001 110.903 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.623 HG12 ' HZ ' ' A' ' 95' ' ' PHE . 59.0 t -68.35 118.97 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.057 0.456 . . . . 62.539999999999999 111.899 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.47 -24.23 67.11 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.789 0.663 . . . . 73.319999999999993 112.789 -177.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.434 ' HB2' ' HZ ' ' A' ' 116' ' ' PHE . 5.5 tp10 -90.86 -3.08 57.64 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.966 -0.459 . . . . 73.099999999999994 111.06 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.562 ' HB3' ' HE1' ' A' ' 95' ' ' PHE . . . -97.03 -44.09 7.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.056 0.455 . . . . 70.109999999999999 110.219 175.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.472 HD11 ' HB3' ' A' ' 171' ' ' LEU . 29.1 pt -116.79 109.4 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.877 -0.601 . . . . 70.030000000000001 110.611 172.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.5 tp -94.42 138.88 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.969 0.414 . . . . 75.109999999999999 110.808 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.584 ' HB2' HD11 ' A' ' 2' ' ' LEU . 1.8 pp20? -104.99 153.94 20.76 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.396 0.617 . . . . 71.439999999999998 112.394 -174.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.439 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 35.3 tt0 -140.09 99.77 3.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 74.109999999999999 109.406 172.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.562 ' HB3' HD12 ' A' ' 2' ' ' LEU . 19.3 pttm . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 113.313 0.857 . . . . 74.129999999999995 113.313 -170.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 121.041 0.448 . . . . 73.030000000000001 111.615 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 34.5 tp -109.53 135.0 51.23 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.571 -0.529 . . . . 72.349999999999994 109.571 174.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.0 tt -100.5 120.64 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.284 0.564 . . . . 72.120000000000005 111.668 -175.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 47.2 p90 -118.84 143.01 47.21 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.182 0.515 . . . . 72.230000000000004 111.416 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 5' ' ' LYS . 19.7 ptpt -140.29 121.88 15.22 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.646 -0.706 . . . . 75.129999999999995 110.771 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.45 164.53 25.63 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.813 -0.555 . . . . 71.239999999999995 111.119 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.3 mt -55.81 -33.07 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.183 -0.462 . . . . 73.519999999999996 111.371 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 150' ' ' ASN . 9.1 p90 -109.45 -24.38 11.05 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.28 0.844 . . . . 74.430000000000007 113.28 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.475 ' HG1' ' HB3' ' A' ' 152' ' ' GLN . 2.9 m -90.65 14.95 11.94 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.429 0.529 . . . . 64.219999999999999 112.429 -173.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.445 ' O ' HD21 ' A' ' 13' ' ' LEU . 8.5 p-10 -62.37 -10.76 12.3 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.619 0.97 . . . . 72.329999999999998 113.619 -173.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -86.48 -43.46 12.75 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.105 0.478 . . . . 73.109999999999999 111.324 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.718 ' HG3' ' HB2' ' A' ' 144' ' ' ALA . 18.1 mm-40 -96.16 22.9 7.07 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.297 -0.41 . . . . 72.310000000000002 111.537 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 2.0 pt? -57.89 165.04 1.92 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.186 0.517 . . . . 75.010000000000005 111.868 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 75.3 m -141.37 156.86 45.78 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.512 0.56 . . . . 64.200000000000003 112.512 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.6 p -127.24 110.22 12.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.856 -0.611 . . . . 71.310000000000002 111.333 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -161.67 176.36 11.05 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.74 -0.467 . . . . 73.140000000000001 109.74 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.3 m -123.88 79.86 1.76 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.932 -0.48 . . . . 74.230000000000004 111.772 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -98.37 125.73 42.15 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 111.093 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.03 117.64 4.84 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.613 2.209 . . . . 73.140000000000001 112.713 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.404 ' HA ' ' HB3' ' A' ' 30' ' ' PHE . 61.3 mtt -109.84 162.23 14.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.377 0.608 . . . . 71.329999999999998 112.412 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 62.4 mttm -127.44 103.06 7.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.901 -0.59 . . . . 74.450000000000003 110.219 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.404 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 54.0 tp -75.49 101.85 5.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.07 0.462 . . . . 75.129999999999995 111.635 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.34 133.86 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.092 0.472 . . . . 74.230000000000004 111.783 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t0 56.5 19.21 3.99 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.59 -0.732 . . . . 74.099999999999994 112.058 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.404 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 45.3 m-20 59.35 9.86 1.58 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.233 0.613 . . . . 74.049999999999997 112.561 -177.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.2 tp -106.21 -47.1 3.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.908 0.385 . . . . 71.430000000000007 111.881 -173.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.478 HG11 ' HA ' ' A' ' 172' ' ' VAL . 3.2 m -134.71 150.19 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.678 0.622 . . . . 71.400000000000006 112.678 -176.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.547 ' HE2' HG23 ' A' ' 176' ' ' ILE . 64.2 m-85 -86.02 122.14 29.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.886 -0.597 . . . . 75.049999999999997 110.696 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 33.4 tt0 -114.09 108.48 17.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.604 0.362 . . . . 71.540000000000006 110.148 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.405 ' CZ ' HD23 ' A' ' 169' ' ' LEU . 15.1 p90 -143.62 121.0 11.63 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.784 1.031 . . . . 70.439999999999998 113.784 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 168' ' ' THR . 10.3 tmtt? -90.72 121.28 32.48 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.891 -1.049 . . . . 74.319999999999993 110.794 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.72 -120.95 1.12 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.107 -0.568 . . . . 71.230000000000004 113.093 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 69' ' ' ASP . 67.0 mttm -114.09 134.97 54.52 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.319 -0.519 . . . . 73.099999999999994 110.449 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -86.85 107.0 18.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.181 0.515 . . . . 73.140000000000001 109.62 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.402 HG22 HD11 ' A' ' 72' ' ' LEU . 28.8 m -137.81 145.37 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.981 0.419 . . . . 73.109999999999999 111.933 -173.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.56 134.44 65.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.061 0.458 . . . . 74.519999999999996 110.919 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.783 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 26.3 mmm180 . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 120.93 0.395 . . . . 74.140000000000001 111.372 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.783 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 2.5 mp0 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.218 0.532 . . . . 72.200000000000003 111.141 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 66' ' ' ARG . 9.5 ptm180 -93.24 116.9 29.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.898 -0.592 . . . . 73.019999999999996 111.909 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.6 -140.46 5.2 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.547 -0.835 . . . . 72.430000000000007 113.812 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.1 pt -110.94 143.61 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 112.354 0.502 . . . . 74.540000000000006 112.354 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . 27.3 t70 -45.16 -43.46 9.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.913 -0.585 . . . . 74.239999999999995 112.433 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 58.5 mt -49.51 -60.88 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.242 0.46 . . . . 74.140000000000001 112.242 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.5 ' HA ' HD11 ' A' ' 76' ' ' LEU . 21.1 m -73.89 -33.11 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.097 0.406 . . . . 73.140000000000001 112.097 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.402 HD11 HG22 ' A' ' 35' ' ' VAL . 87.5 mt -74.3 -28.22 61.08 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.014 0.376 . . . . 71.219999999999999 112.014 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -83.37 -40.74 19.03 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.661 0.267 . . . . 51.039999999999999 111.424 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -86.68 -9.76 55.27 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.076 0.399 . . . . 74.540000000000006 112.076 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 67.4 71.13 0.36 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.355 0.598 . . . . 73.239999999999995 111.993 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.5 HD11 ' HA ' ' A' ' 71' ' ' VAL . 67.6 mt -106.71 135.97 47.33 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.897 -0.592 . . . . 75.349999999999994 110.513 176.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.17 140.06 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.218 0.532 . . . . 73.219999999999999 112.379 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.23 143.51 57.73 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.396 0.888 . . . . 74.329999999999998 113.396 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.582 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 84.7 mtp -134.92 153.67 51.98 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.008 -0.542 . . . . 74.530000000000001 110.669 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.454 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 25.1 t-20 -148.06 156.47 42.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.63 0.253 . . . . 73.120000000000005 111.06 -177.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 40.9 t -37.32 -48.95 0.94 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.55 1.315 . . . . 72.439999999999998 114.55 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.454 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 12.2 p90 -59.75 -36.73 77.22 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.143 0.423 . . . . 75.340000000000003 112.143 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -81.85 -37.41 27.02 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.867 0.365 . . . . 74.040000000000006 111.395 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 2.7 m-20 -66.76 -22.58 66.04 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.689 0.626 . . . . 62.009999999999998 112.689 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.418 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -42.4 -64.88 0.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.021 0.439 . . . . 65.219999999999999 111.98 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.3 t -64.6 -33.17 75.29 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.887 0.375 . . . . 75.519999999999996 111.625 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.453 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 25.4 mmt -64.15 -65.24 0.7 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.278 -0.419 . . . . 75.109999999999999 112.034 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.418 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 10.5 p90 -61.66 -28.7 69.58 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.715 -0.394 . . . . 74.329999999999998 111.311 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -55.01 -61.64 2.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.724 -0.39 . . . . 75.150000000000006 110.799 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.14 82.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.285 -0.416 . . . . 64.409999999999997 111.841 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -60.47 -59.71 4.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.22 0.452 . . . . 72.420000000000002 112.22 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.3 mm -54.9 -39.77 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.166 0.432 . . . . 75.430000000000007 112.166 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -59.54 -57.29 13.62 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.04 0.385 . . . . 73.450000000000003 112.04 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.88 -51.8 60.0 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.803 0.335 . . . . 75.409999999999997 111.149 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.474 ' CZ ' HG12 ' A' ' 172' ' ' VAL . 29.3 t80 -46.43 -48.94 18.73 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.095 0.558 . . . . 65.040000000000006 112.118 176.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 37.5 ttp -62.09 -34.7 76.8 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.996 0.427 . . . . 74.219999999999999 111.377 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.629 ' HZ3' ' HB2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -65.4 -49.71 68.22 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.466 -0.333 . . . . 73.409999999999997 110.901 174.462 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -59.85 -46.32 89.67 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.31 0.485 . . . . 72.120000000000005 112.31 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.5 -39.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 112.071 0.397 . . . . 74.450000000000003 112.071 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.462 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 15.0 mm -70.27 -49.2 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 122.271 -0.268 . . . . 60.310000000000002 111.355 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.6 -41.17 69.62 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.423 0.63 . . . . 73.010000000000005 110.5 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -55.29 -57.11 13.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.615 -0.721 . . . . 75.129999999999995 110.995 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.497 ' HG3' HG13 ' A' ' 113' ' ' VAL . 12.6 tpt -62.59 -44.76 95.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.476 0.546 . . . . 73.239999999999995 112.476 -173.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 11.2 pt-20 -72.46 -38.69 68.17 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.942 -0.474 . . . . 72.299999999999997 112.161 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.517 ' HB3' ' HZ3' ' A' ' 105' ' ' LYS . 5.7 ttpm? -68.86 -17.97 64.08 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.439 0.533 . . . . 72.219999999999999 112.439 -174.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -113.19 -17.0 12.46 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.001 -0.437 . . . . 61.43 112.008 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -128.63 -73.28 0.59 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.627 0.232 . . . . 74.420000000000002 111.627 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 75.24 -18.73 0.43 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.999 1.111 . . . . 73.519999999999996 113.999 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.486 ' O ' HG23 ' A' ' 113' ' ' VAL . 70.9 m-20 -57.91 121.39 10.42 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.743 -0.598 . . . . 64.120000000000005 111.782 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -44.58 -49.49 10.12 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.982 -0.554 . . . . 75.400000000000006 112.356 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.47 68.43 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.698 0.629 . . . . 61.329999999999998 112.698 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -92.7 -39.61 11.18 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 111.951 0.352 . . . . 74.340000000000003 111.951 -175.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.497 HG13 ' HG3' ' A' ' 103' ' ' MET . 16.3 m -68.89 -37.11 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.857 -0.527 . . . . 75.530000000000001 112.062 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.25 -35.98 74.16 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.963 0.411 . . . . 71.5 110.483 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.97 78.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.125 0.488 . . . . 74.150000000000006 111.007 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.17 -48.83 80.07 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.953 -0.567 . . . . 75.129999999999995 111.118 174.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -55.6 -38.25 69.18 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.922 -0.581 . . . . 75.5 111.062 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.28 -40.61 96.31 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.473 -0.33 . . . . 72.420000000000002 111.509 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -58.8 -57.26 13.81 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.331 -0.395 . . . . 74.019999999999996 111.394 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.0 tp -66.55 -35.33 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.34 -0.391 . . . . 73.129999999999995 111.384 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -62.31 -45.27 93.99 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.995 0.426 . . . . 73.230000000000004 110.609 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.67 -37.52 94.38 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.061 -0.59 . . . . 53.409999999999997 112.414 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 49.5 t90 -62.97 -50.25 71.52 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.866 -0.196 . . . . 74.450000000000003 111.51 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.5 m -68.59 -41.12 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.665 0.617 . . . . 72.400000000000006 112.665 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.95 -29.77 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.778 -0.576 . . . . 72.310000000000002 111.621 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.4 t -77.84 -51.29 10.7 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.054 0.454 . . . . 75.109999999999999 110.77 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.6 tp -57.94 -46.34 85.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.002 -0.545 . . . . 63.340000000000003 112.302 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.62 2.81 21.07 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.434 0.531 . . . . 73.400000000000006 112.434 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.09 80.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.377 0.608 . . . . 74.120000000000005 111.1 176.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -58.42 -14.62 8.12 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.875 0.694 . . . . 73.530000000000001 112.875 -173.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.27 -49.92 75.98 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.784 0.326 . . . . 71.030000000000001 111.369 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -112.41 -36.23 5.33 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.254 0.464 . . . . 75.219999999999999 112.254 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -67.64 -6.86 22.42 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.832 0.678 . . . . 73.299999999999997 112.832 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 14.9 ptmm? -55.31 -17.13 4.17 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.257 0.465 . . . . 75.239999999999995 112.257 176.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -90.41 20.96 4.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.448 0.536 . . . . 74.109999999999999 112.448 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.44 158.4 17.74 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.1 0.476 . . . . 74.310000000000002 111.634 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.81 51.81 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.152 -0.476 . . . . 74.349999999999994 110.62 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.594 ' HB3' HG12 ' A' ' 153' ' ' VAL . 36.1 m-85 -112.18 157.24 21.11 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.218 -0.301 . . . . 71.340000000000003 110.888 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -137.53 147.21 44.98 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.806 0.336 . . . . 64.450000000000003 111.827 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.491 HD11 ' HA3' ' A' ' 151' ' ' GLY . 14.6 tt -138.67 160.01 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 116.421 -0.354 . . . . 75.230000000000004 110.813 177.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.05 156.81 28.37 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.278 -0.487 . . . . 64.319999999999993 113.848 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -59.13 -60.33 4.04 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.959 0.409 . . . . 72.120000000000005 111.006 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.519 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 4.0 mmp_? -73.69 -32.63 64.04 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.957 0.408 . . . . 74.409999999999997 111.104 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.718 ' HB2' ' HG3' ' A' ' 12' ' ' GLU . . . -53.06 -38.67 62.68 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.12 -0.491 . . . . 70.349999999999994 112.08 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.29 -39.42 63.95 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.286 0.476 . . . . 74.209999999999994 112.286 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -96.43 -17.05 20.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.846 0.355 . . . . 73.219999999999999 111.691 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.6 -48.44 13.21 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.216 -0.516 . . . . 71.430000000000007 113.172 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 72.26 -46.04 0.63 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.915 0.709 . . . . 70.329999999999998 112.915 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -78.54 0.37 26.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.079 0.4 . . . . 71.030000000000001 112.079 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 23.0 p-10 -142.45 28.25 1.66 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 111.842 0.312 . . . . 72.420000000000002 111.842 -176.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.491 ' HA3' HD11 ' A' ' 140' ' ' ILE . . . -115.36 142.5 17.64 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 120.898 -0.668 . . . . 71.150000000000006 113.975 -175.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.475 ' HB3' ' HG1' ' A' ' 9' ' ' THR . 3.7 pt20 -120.24 140.64 50.88 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.728 0.299 . . . . 73.329999999999998 110.795 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.594 HG12 ' HB3' ' A' ' 138' ' ' PHE . 39.2 t -86.86 102.78 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 121.363 0.601 . . . . 72.450000000000003 111.211 174.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.534 ' HB2' HD12 ' A' ' 169' ' ' LEU . . . -78.67 112.25 15.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.993 -0.549 . . . . 73.420000000000002 110.337 174.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.693 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 59.8 mt -89.16 119.01 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.15 0.426 . . . . 75.140000000000001 112.15 -172.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.9 mm -104.61 117.3 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.801 0.334 . . . . 72.409999999999997 111.282 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -107.31 126.73 52.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.006 0.432 . . . . 72.439999999999998 111.358 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -84.71 89.07 7.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.205 0.526 . . . . 74.230000000000004 109.646 172.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -90.91 149.01 22.08 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.991 -0.55 . . . . 73.0 111.514 -173.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -98.63 121.75 40.97 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.309 -0.405 . . . . 74.439999999999998 111.755 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 99.0 t -110.67 98.55 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 110.046 -0.353 . . . . 72.349999999999994 110.046 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 57.12 21.3 6.32 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.987 0.423 . . . . 75.219999999999999 111.588 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.98 24.5 27.16 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.257 -0.496 . . . . 71.439999999999998 112.697 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 m -112.19 141.06 46.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.704 0.288 . . . . 65.120000000000005 110.973 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -73.34 109.38 6.82 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.478 0.548 . . . . 74.040000000000006 112.478 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 166' ' ' VAL . 24.3 m -128.58 96.51 29.98 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 121.254 0.55 . . . . 75.409999999999997 111.799 171.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.79 114.11 3.14 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.472 2.115 . . . . 74.109999999999999 112.055 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 5.2 t -107.69 161.06 15.22 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.506 0.558 . . . . 74.329999999999998 112.506 -176.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 154' ' ' ALA . 22.5 tp -111.13 131.75 54.85 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.827 0.346 . . . . 64.430000000000007 111.035 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.693 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 46.9 ttm -110.96 125.67 53.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.108 -0.496 . . . . 74.549999999999997 111.252 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.86 150.39 50.45 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.623 -0.717 . . . . 74.230000000000004 109.996 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.478 ' HA ' HG11 ' A' ' 27' ' ' VAL . 47.7 t -89.74 120.73 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.946 -0.471 . . . . 73.219999999999999 112.27 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -46.9 87.47 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.049 -0.523 . . . . 74.439999999999998 110.632 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -63.37 -20.43 65.52 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.003 -0.544 . . . . 72.019999999999996 112.307 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.448 ' HB1' ' HE1' ' A' ' 95' ' ' PHE . . . -101.78 -19.71 15.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.315 0.487 . . . . 71.299999999999997 112.315 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.547 HG23 ' HE2' ' A' ' 28' ' ' TYR . 9.0 tp -96.01 121.4 46.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.417 0.627 . . . . 63.439999999999998 111.866 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.4 mm -99.05 112.14 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.957 0.408 . . . . 74.230000000000004 110.927 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.15 134.61 34.98 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.847 0.356 . . . . 72.040000000000006 111.466 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -129.99 144.01 51.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.497 0.665 . . . . 72.200000000000003 111.258 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.7 pttp . . . . . 0 CA--C 1.541 0.611 0 CA-C-N 115.499 -0.773 . . . . 72.510000000000005 112.093 -173.279 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.51 0.195 . . . . 61.520000000000003 110.852 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 179' ' ' GLU . 26.5 tp -84.59 125.53 32.53 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 122.134 -0.354 . . . . 73.439999999999998 110.559 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.761 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 56.2 mt -100.32 119.47 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.717 0.294 . . . . 73.099999999999994 110.884 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.829 ' HB2' HD13 ' A' ' 176' ' ' ILE . 35.7 p90 -106.59 135.49 48.02 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.3 0.571 . . . . 74.239999999999995 112.048 -178.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.525 ' HB2' HD13 ' A' ' 13' ' ' LEU . 74.6 tttt -134.53 114.34 12.72 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.017 -0.992 . . . . 72.310000000000002 110.842 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 175' ' ' ALA . 6.3 m-20 -79.69 161.42 25.82 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.157 0.504 . . . . 71.049999999999997 111.263 173.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.4 pt -64.82 -21.07 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.013 -0.54 . . . . 73.450000000000003 111.258 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.45 ' HE2' ' HA ' ' A' ' 152' ' ' GLN . 36.9 p90 -109.13 -27.7 9.45 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.388 0.514 . . . . 73.230000000000004 112.388 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.519 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 4.8 m -88.88 15.37 8.55 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.236 0.541 . . . . 73.049999999999997 111.268 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -57.79 -12.66 3.23 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.516 0.562 . . . . 75.310000000000002 112.516 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.43 -61.74 1.7 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.977 0.418 . . . . 73.140000000000001 112.064 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -112.97 25.59 11.26 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.124 0.786 . . . . 70.209999999999994 113.124 -170.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.525 HD13 ' HB2' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -42.41 139.39 1.5 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.809 0.338 . . . . 73.340000000000003 111.532 176.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.3 m -135.62 178.19 7.23 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.66 0.615 . . . . 62.009999999999998 112.66 -168.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.523 ' HB3' HG12 ' A' ' 3' ' ' ILE . 86.6 p -124.28 125.14 43.86 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.299 0.481 . . . . 63.030000000000001 112.299 -174.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -137.62 -172.75 3.31 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.2 0.524 . . . . 73.099999999999994 111.425 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.2 m -138.45 89.73 2.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.201 -0.454 . . . . 75.230000000000004 111.082 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -142.67 132.71 12.24 Favored Pre-proline 0 N--CA 1.473 0.717 0 CA-C-N 116.556 -0.293 . . . . 73.430000000000007 111.515 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.11 145.94 14.07 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.704 2.27 . . . . 73.0 112.837 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.5 164.02 27.51 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.108 0.48 . . . . 74.329999999999998 112.243 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.621 ' HZ2' ' HB3' ' A' ' 21' ' ' LYS . 8.3 mtpm? -121.82 104.26 9.44 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.115 -0.493 . . . . 74.319999999999993 110.881 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.5 tp -74.54 104.1 5.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.216 0.531 . . . . 74.430000000000007 111.643 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.23 134.42 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 121.341 0.591 . . . . 73.530000000000001 111.905 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.2 t70 59.22 14.24 3.48 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.085 -0.961 . . . . 71.409999999999997 112.383 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.0 t70 63.55 18.62 11.2 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.595 0.712 . . . . 73.140000000000001 110.79 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.0 tp -113.57 -50.14 2.86 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.983 -0.553 . . . . 65.150000000000006 112.441 -175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.627 HG11 ' HA ' ' A' ' 172' ' ' VAL . 15.5 m -133.54 150.14 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 113.04 0.756 . . . . 64.120000000000005 113.04 -175.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 170' ' ' MET . 19.3 m-85 -85.7 125.29 33.08 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.644 -0.707 . . . . 74.409999999999997 110.808 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -99.25 127.21 45.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.023 -0.535 . . . . 75.239999999999995 110.628 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.729 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 67.3 t80 -119.65 139.65 51.87 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.03 0.443 . . . . 72.219999999999999 111.34 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -90.0 126.84 35.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.081 -0.508 . . . . 72.219999999999999 111.33 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.72 173.54 14.95 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.989 -0.624 . . . . 74.140000000000001 114.44 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -133.33 153.9 51.18 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.894 0.478 . . . . 75.409999999999997 109.944 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -91.34 107.03 18.92 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.065 -0.397 . . . . 74.239999999999995 110.189 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.451 HG12 HD21 ' A' ' 44' ' ' LEU . 27.4 m -135.22 165.8 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.257 0.551 . . . . 73.549999999999997 112.272 -173.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.497 HG21 ' H ' ' A' ' 43' ' ' VAL . 32.1 m -115.9 146.56 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.396 0.517 . . . . 72.010000000000005 112.396 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.548 ' HG2' HD13 ' A' ' 72' ' ' LEU . 5.0 mmp_? -127.27 102.82 7.09 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.25 0.548 . . . . 74.150000000000006 111.172 172.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.556 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 38.2 ttmt -137.39 136.57 37.98 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.188 -0.32 . . . . 71.329999999999998 110.718 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -55.63 -24.86 35.9 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.136 0.421 . . . . 75.5 112.136 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.32 35.22 2.63 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.306 -0.473 . . . . 71.239999999999995 113.279 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 25.4 tt0 -163.85 139.59 6.4 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.587 0.588 . . . . 71.439999999999998 112.587 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.471 HD11 HH21 ' A' ' 37' ' ' ARG . 5.4 tp -145.63 82.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.796 0.808 . . . . 75.109999999999999 110.925 171.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.497 ' H ' HG21 ' A' ' 36' ' ' VAL . 38.8 t -127.77 100.79 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.86 -0.609 . . . . 75.209999999999994 111.097 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.451 HD21 HG12 ' A' ' 35' ' ' VAL . 2.6 pp -113.01 2.73 15.85 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.543 0.571 . . . . 74.430000000000007 112.543 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.54 -19.18 63.7 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.131 0.789 . . . . 55.530000000000001 113.131 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.83 88.09 0.01 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.855 0.702 . . . . 64.049999999999997 114.855 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.9 p -94.88 78.4 3.63 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.061 0.458 . . . . 74.239999999999995 110.405 173.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.563 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 33.7 t30 -172.38 -53.64 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.827 0 CA-C-N 115.935 -0.575 . . . . 73.109999999999999 111.396 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 48' ' ' ASN . 91.7 Cg_endo -83.29 114.61 2.18 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.03 1.82 . . . . 74.310000000000002 112.734 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 92.7 p -73.36 -178.59 3.04 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.038 0.446 . . . . 64.150000000000006 111.607 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -133.65 -62.32 0.78 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.998 0.37 . . . . 62.340000000000003 111.998 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 135' ' ' ASN . 1.2 mp0 69.0 -58.3 0.5 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.239 0.616 . . . . 75.030000000000001 111.66 -175.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -123.03 166.21 15.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.075 0.55 . . . . 71.5 110.262 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.5 -110.52 0.03 OUTLIER Glycine 0 CA--C 1.531 1.066 0 N-CA-C 115.309 0.884 . . . . 63.240000000000002 115.309 -169.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -138.45 -164.23 1.6 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.428 0.632 . . . . 74.010000000000005 111.674 -172.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -128.71 -40.72 1.54 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.624 -0.716 . . . . 74.519999999999996 111.547 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -69.31 153.16 44.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.949 0.722 . . . . 75.140000000000001 112.949 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.23 45.32 0.45 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.55 -0.75 . . . . 63.210000000000001 111.559 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 63' ' ' HIS . . . -59.62 -17.08 39.86 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 114.97 0.748 . . . . 65.519999999999996 114.97 -172.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 64' ' ' VAL . 4.6 p 73.24 152.39 0.13 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.784 0.834 . . . . 73.019999999999996 111.273 -174.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -38.5 -61.11 0.73 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.929 1.085 . . . . 74.019999999999996 113.929 -171.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.561 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 10.2 pt-20 -82.84 -13.1 56.8 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.136 0.791 . . . . 72.030000000000001 113.136 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.5 ' HB3' ' O ' ' A' ' 59' ' ' GLY . 38.7 t-80 -115.71 26.7 9.82 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.213 0.53 . . . . 74.0 111.985 -170.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 60' ' ' SER . 43.3 t -82.44 99.26 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 O-C-N 121.393 -0.817 . . . . 74.299999999999997 112.318 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 10.4 pt-20 -27.95 -40.9 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.667 1.358 . . . . 74.530000000000001 114.667 170.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -126.23 109.95 12.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.052 0.387 . . . . 72.219999999999999 111.293 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.47 -165.73 28.29 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.585 -0.817 . . . . 55.140000000000001 113.506 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.3 pt -111.61 145.56 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 122.425 -0.456 . . . . 74.430000000000007 111.895 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -46.2 -39.8 10.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.211 0.604 . . . . 73.219999999999999 112.044 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.9 mt -53.83 -49.97 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.887 -0.597 . . . . 75.409999999999997 112.503 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.575 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 23.2 m -87.72 -39.3 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.519 0.563 . . . . 74.329999999999998 112.519 -171.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.548 HD13 ' HG2' ' A' ' 37' ' ' ARG . 61.8 mt -64.42 -38.08 89.76 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.189 0.518 . . . . 72.230000000000004 111.679 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -84.48 -15.1 47.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.196 -0.457 . . . . 73.019999999999996 112.088 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -109.08 4.21 22.83 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 122.185 -0.322 . . . . 75.120000000000005 111.349 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.561 ' HG2' ' HB3' ' A' ' 62' ' ' GLU . 49.3 mtmt 58.06 71.12 0.6 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.367 0.603 . . . . 74.230000000000004 112.161 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.575 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 60.4 mt -127.23 124.16 38.26 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.516 -0.765 . . . . 73.230000000000004 110.533 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.94 148.53 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.833 0.349 . . . . 71.140000000000001 111.34 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -76.59 130.82 38.4 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.583 0.706 . . . . 74.420000000000002 112.604 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' A' ' 84' ' ' ASP . 12.5 tpt -117.22 122.77 44.92 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.061 -0.972 . . . . 63.119999999999997 108.994 171.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -82.84 139.55 33.42 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.212 0.53 . . . . 65.530000000000001 112.193 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 62.3 m -52.45 -40.05 61.81 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.204 0.816 . . . . 75.400000000000006 113.204 -174.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -57.27 -32.78 66.96 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.882 0.327 . . . . 73.120000000000005 111.882 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.48 -36.41 10.34 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.973 0.416 . . . . 72.340000000000003 110.949 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.524 ' HB2' ' HG3' ' A' ' 79' ' ' MET . 14.2 t70 -66.92 -11.42 56.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.251 -0.431 . . . . 71.299999999999997 111.594 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.573 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -36.68 -54.86 0.89 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.697 0.629 . . . . 62.200000000000003 112.697 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.7 t -67.81 -36.19 79.96 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.061 0.393 . . . . 61.229999999999997 112.061 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.2 ttm -67.84 -60.63 2.37 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 111.918 0.34 . . . . 75.400000000000006 111.918 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.573 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 16.0 p90 -62.21 -35.17 78.07 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 120.368 -0.533 . . . . 73.329999999999998 111.245 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 42.0 tptt -61.48 -39.36 90.65 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.185 0.517 . . . . 74.230000000000004 110.615 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.71 74.73 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.053 -0.521 . . . . 74.200000000000003 111.481 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -61.66 -44.76 96.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.529 -0.305 . . . . 73.519999999999996 111.519 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 88' ' ' PHE . 42.2 mm -62.04 -35.9 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 120.787 0.327 . . . . 73.219999999999999 111.301 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.07 -57.3 13.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.149 0.5 . . . . 72.299999999999997 110.831 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -59.58 -45.57 91.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.849 -0.614 . . . . 74.430000000000007 111.095 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.632 ' HE2' HG12 ' A' ' 120' ' ' ILE . 47.8 t80 -55.73 -61.54 2.29 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.399 -0.819 . . . . 73.540000000000006 111.997 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 58.6 ttp -54.59 -43.8 72.46 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.013 0.435 . . . . 72.340000000000003 111.278 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -61.59 -47.83 83.69 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.041 -0.527 . . . . 75.0 111.301 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -70.68 -44.1 67.69 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.448 0.536 . . . . 73.329999999999998 112.448 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.685 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . 35.9 m -65.04 -47.2 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.093 0.405 . . . . 70.140000000000001 112.093 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.436 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 47.3 mm -63.42 -45.61 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.898 0.38 . . . . 74.010000000000005 110.358 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -53.6 -55.4 26.08 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.964 -0.562 . . . . 71.340000000000003 112.069 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.685 ' HD2' ' HA ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -66.54 -27.51 67.81 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 122.219 -0.301 . . . . 72.420000000000002 111.244 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.475 ' HG3' HG13 ' A' ' 113' ' ' VAL . 12.1 tpt -73.84 -50.78 18.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.821 0.343 . . . . 74.230000000000004 111.337 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 9.7 pt-20 -66.35 -25.74 66.95 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.19 -0.319 . . . . 73.209999999999994 111.143 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -56.18 -39.21 72.02 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.159 0.429 . . . . 75.340000000000003 112.159 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -103.74 -37.91 7.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.037 0.754 . . . . 65.329999999999998 113.037 -175.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 108' ' ' ARG . 60.1 t30 -97.34 -35.15 10.8 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.511 0.559 . . . . 74.219999999999999 112.511 -173.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.438 ' HB3' ' O ' ' A' ' 107' ' ' ASN . 26.3 ttp180 71.59 -35.7 0.34 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.07 1.137 . . . . 75.340000000000003 114.07 174.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 113' ' ' VAL . 72.2 m-20 -65.71 114.38 4.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.807 0.669 . . . . 72.409999999999997 112.807 -168.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.74 -24.45 65.72 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.548 -0.751 . . . . 72.409999999999997 112.675 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.16 -32.21 58.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.894 0.378 . . . . 64.25 111.853 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.65 -51.31 7.85 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.548 -0.296 . . . . 73.239999999999995 111.706 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 109' ' ' ASP . 6.4 m -60.63 -31.12 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 111.947 0.351 . . . . 74.519999999999996 111.947 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.97 -38.93 83.34 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.91 0.386 . . . . 75.129999999999995 110.634 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.6 78.43 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.233 -0.44 . . . . 75.400000000000006 111.062 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.465 ' CZ ' ' HG3' ' A' ' 174' ' ' GLU . 22.2 t80 -56.85 -49.25 76.03 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.352 -0.385 . . . . 74.120000000000005 111.096 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -57.59 -32.81 67.55 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.626 -0.261 . . . . 72.209999999999994 111.067 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -66.63 -39.99 88.55 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.541 0.21 . . . . 74.239999999999995 111.286 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -53.65 -58.48 7.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.31 0.576 . . . . 73.430000000000007 111.038 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.632 HG12 ' HE2' ' A' ' 95' ' ' PHE . 10.9 tp -67.84 -32.49 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.743 -0.662 . . . . 74.230000000000004 111.568 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.412 ' NE2' HG22 ' A' ' 125' ' ' VAL . 23.3 tm0? -58.64 -52.41 65.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.729 0.299 . . . . 71.140000000000001 110.709 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.92 -42.9 96.98 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.932 -0.651 . . . . 70.439999999999998 112.528 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -58.83 -55.15 38.84 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 111.62 0.23 . . . . 73.099999999999994 111.62 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.7 m -65.25 -48.35 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.373 0.509 . . . . 72.549999999999997 112.373 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.412 HG22 ' NE2' ' A' ' 121' ' ' GLN . 92.1 t -57.98 -41.14 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.98 -0.45 . . . . 74.150000000000006 111.487 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.5 t -70.44 -47.96 58.24 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.012 0.434 . . . . 64.310000000000002 111.139 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.33 -33.81 74.23 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.311 -0.404 . . . . 74.310000000000002 111.805 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 80.8 mt -85.13 2.24 44.37 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.212 0.449 . . . . 75.219999999999999 112.212 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.62 89.06 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.304 0.574 . . . . 61.240000000000002 110.392 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 134' ' ' LYS . 36.3 ttpt -51.66 -59.66 4.03 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 114.373 1.249 . . . . 75.040000000000006 114.373 -165.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.81 -34.17 72.7 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.217 0.821 . . . . 75.200000000000003 113.217 -168.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -84.0 -53.61 5.44 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.089 0.471 . . . . 75.109999999999999 111.375 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -74.46 -3.96 33.79 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.208 0.528 . . . . 72.310000000000002 111.763 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 130' ' ' LYS . 33.0 ttpt -35.79 -32.32 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.694 1.198 . . . . 74.120000000000005 113.724 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.555 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 2.7 p-10 -96.85 35.11 1.59 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.503 0.557 . . . . 73.219999999999999 112.503 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 38.2 mt -89.31 162.33 15.89 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.775 0.321 . . . . 72.430000000000007 110.622 170.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -132.13 133.5 44.35 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.236 0.458 . . . . 74.120000000000005 112.236 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.41 ' HB3' HG12 ' A' ' 153' ' ' VAL . 80.3 m-85 -100.82 107.57 19.16 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.641 0.257 . . . . 74.140000000000001 110.413 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.568 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 38.6 m-85 -101.54 124.74 47.69 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.863 -0.523 . . . . 74.409999999999997 111.616 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 16.9 tt -110.09 151.98 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.965 -0.562 . . . . 71.310000000000002 111.293 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.515 ' HA2' HD21 ' A' ' 76' ' ' LEU . . . -61.62 140.7 47.38 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 114.405 0.522 . . . . 72.420000000000002 114.405 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -44.18 -52.48 7.31 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.146 0.579 . . . . 72.439999999999998 112.096 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -51.58 -49.63 61.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.058 -0.519 . . . . 74.519999999999996 111.446 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.632 ' HB2' ' HA3' ' A' ' 151' ' ' GLY . . . -64.59 -50.09 68.57 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.237 0.458 . . . . 71.010000000000005 112.237 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.73 -41.24 77.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.061 0.458 . . . . 62.109999999999999 111.758 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -82.2 -24.86 34.69 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.932 -0.576 . . . . 73.519999999999996 111.465 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -101.09 -3.64 54.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.166 -0.54 . . . . 54.049999999999997 114.061 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 59.68 24.34 13.2 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.428 0.529 . . . . 74.439999999999998 112.428 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -103.51 -173.36 2.29 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.835 0.68 . . . . 64.099999999999994 112.835 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -88.98 58.1 4.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.242 0.544 . . . . 73.5 112.112 -172.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.632 ' HA3' ' HB2' ' A' ' 144' ' ' ALA . . . -70.94 167.96 50.66 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.897 -0.668 . . . . 72.120000000000005 113.085 173.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.45 ' HA ' ' HE2' ' A' ' 8' ' ' PHE . 45.9 tt0 -70.67 128.12 34.99 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.278 0.473 . . . . 63.310000000000002 112.278 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.41 HG12 ' HB3' ' A' ' 138' ' ' PHE . 40.6 t -94.48 104.26 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.233 0.54 . . . . 73.5 110.266 170.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.742 ' HB3' HD13 ' A' ' 169' ' ' LEU . . . -80.45 136.41 36.33 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.864 -0.607 . . . . 64.150000000000006 111.56 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.54 ' HB ' ' HG3' ' A' ' 170' ' ' MET . 39.2 mm -89.23 109.4 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.846 0.355 . . . . 73.349999999999994 111.254 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.439 HG13 ' CD1' ' A' ' 139' ' ' PHE . 48.1 mm -93.91 108.12 20.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 120.968 0.413 . . . . 65.109999999999999 111.307 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -99.47 149.17 23.48 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.069 -0.968 . . . . 64.310000000000002 112.424 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -95.25 122.77 38.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.411 -0.813 . . . . 74.439999999999998 110.052 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.613 ' NH2' HG22 ' A' ' 168' ' ' THR . 4.8 ttp180 -156.39 131.08 8.93 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.613 -0.68 . . . . 74.219999999999999 112.084 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -103.54 143.91 32.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.198 -0.456 . . . . 64.129999999999995 111.521 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.13 100.89 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.454 -0.339 . . . . 72.230000000000004 110.444 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.4 t70 66.74 6.57 4.62 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 121.233 0.539 . . . . 64.219999999999999 111.514 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 128.78 -21.63 5.29 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.265 -0.493 . . . . 37.359999999999999 113.03 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 66.7 p -82.08 106.73 14.22 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.403 -0.469 . . . . 75.329999999999998 110.874 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -75.21 111.12 10.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.437 0.636 . . . . 73.319999999999993 112.391 -172.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.07 145.4 41.72 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.001 -0.545 . . . . 73.209999999999994 111.616 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -78.67 117.88 4.07 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.479 2.119 . . . . 73.510000000000005 112.213 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.613 HG22 ' NH2' ' A' ' 159' ' ' ARG . 83.5 m -107.4 122.02 45.77 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.904 0.383 . . . . 74.140000000000001 111.67 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.742 HD13 ' HB3' ' A' ' 154' ' ' ALA . 50.0 tp -88.87 139.94 29.95 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.566 -0.288 . . . . 75.019999999999996 110.981 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.54 ' HG3' ' HB ' ' A' ' 155' ' ' ILE . 21.1 ptp -133.87 141.26 47.32 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.714 0.768 . . . . 74.450000000000003 112.089 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -139.54 141.21 37.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.557 -1.201 . . . . 70.349999999999994 109.345 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.627 ' HA ' HG11 ' A' ' 27' ' ' VAL . 21.9 t -85.18 123.68 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.838 -0.538 . . . . 72.120000000000005 111.901 -173.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.423 ' HD3' ' OH ' ' A' ' 28' ' ' TYR . 45.2 tptt -53.17 -47.48 68.77 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.62 0.6 . . . . 64.319999999999993 112.62 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.465 ' HG3' ' CZ ' ' A' ' 116' ' ' PHE . 39.9 mm-40 -67.78 -1.92 6.24 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.433 0.531 . . . . 75.329999999999998 112.433 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -107.68 -44.55 4.23 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.521 -0.309 . . . . 70.530000000000001 110.718 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.829 HD13 ' HB2' ' A' ' 4' ' ' TYR . 9.5 tp -96.27 111.45 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 121.811 0.815 . . . . 64.349999999999994 112.193 -175.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.4 mm -105.06 144.07 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.169 -0.469 . . . . 75.430000000000007 110.749 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.93 146.83 38.3 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.63 0.729 . . . . 63.299999999999997 112.659 -175.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.761 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 8.8 tp10 -114.39 120.42 40.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.182 -0.917 . . . . 73.409999999999997 109.596 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.736 ' HB2' ' HZ1' ' A' ' 180' ' ' LYS . 4.9 ttmp? -84.15 109.25 17.58 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.419 0.526 . . . . 75.510000000000005 112.419 -171.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 1' ' ' MET . 41.0 t -132.08 89.14 2.63 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.296 0.569 . . . . 72.409999999999997 111.044 173.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.69 -63.8 1.24 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.986 -0.552 . . . . 75.450000000000003 109.94 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.634 -0.698 . . . . 72.409999999999997 111.191 175.22 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.675 0.274 . . . . 75.109999999999999 111.125 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.6 tp -89.52 131.47 35.53 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.985 0.422 . . . . 72.140000000000001 110.806 174.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 56.7 mt -118.94 120.58 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.385 . . . . 74.340000000000003 110.776 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -115.0 133.93 55.62 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.73 0.776 . . . . 72.200000000000003 111.244 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.401 ' HG2' ' CD1' ' A' ' 13' ' ' LEU . 34.9 mtpt -120.12 120.0 34.94 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.021 -0.991 . . . . 75.409999999999997 111.178 -172.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.93 177.5 3.64 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.764 0.654 . . . . 63.32 112.764 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -70.68 -57.03 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.012 -0.54 . . . . 75.25 111.502 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -102.15 -41.36 6.43 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.529 0.566 . . . . 74.010000000000005 112.529 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.523 HG21 ' HA2' ' A' ' 151' ' ' GLY . 12.1 p -80.48 16.28 1.39 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.542 0.571 . . . . 74.340000000000003 112.542 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -47.02 -34.7 5.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.16 0.584 . . . . 73.5 111.638 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.44 -39.61 80.32 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.529 0.566 . . . . 73.439999999999998 112.529 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -65.96 -33.49 75.94 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.546 0.213 . . . . 72.209999999999994 111.279 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.401 ' CD1' ' HG2' ' A' ' 5' ' ' LYS . 11.9 tp 57.2 112.2 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.441 0.904 . . . . 72.239999999999995 113.441 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.7 m -104.24 124.79 49.78 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.844 -0.535 . . . . 63.229999999999997 111.374 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 83.1 p -140.22 142.17 35.86 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.403 0.52 . . . . 72.310000000000002 112.403 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -171.61 -147.87 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.848 -0.614 . . . . 62.299999999999997 110.657 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 p -150.06 30.01 0.72 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.331 0.493 . . . . 70.329999999999998 112.331 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 97.9 m-85 -89.74 123.41 66.49 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.792 0.33 . . . . 73.120000000000005 111.503 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 12.0 Cg_exo -70.8 144.65 49.06 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.237 2.625 . . . . 71.209999999999994 113.959 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.434 ' C ' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -131.89 166.35 21.82 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.751 -0.658 . . . . 71.319999999999993 111.496 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -130.98 136.77 48.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.86 0.362 . . . . 75.430000000000007 111.166 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.0 tp -87.26 109.34 19.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.061 0.458 . . . . 75.239999999999995 112.065 -176.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -98.57 142.99 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.989 0.424 . . . . 71.420000000000002 111.041 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 t70 63.11 6.87 2.47 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.986 -0.552 . . . . 73.109999999999999 111.432 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.52 28.67 14.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.151 0.5 . . . . 72.519999999999996 111.979 -174.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.2 tp -134.17 -44.01 0.78 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.102 -0.499 . . . . 64.329999999999998 111.861 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 172' ' ' VAL . 12.7 m -125.24 148.95 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 112.524 0.565 . . . . 74.019999999999996 112.524 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -88.17 151.12 22.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.169 -0.469 . . . . 75.400000000000006 112.009 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -107.57 140.88 39.9 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.471 -0.786 . . . . 65.140000000000001 111.591 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.68 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 47.9 t80 -139.99 105.75 5.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.21 -0.663 . . . . 71.530000000000001 109.21 165.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HB3' HG22 ' A' ' 168' ' ' THR . 13.1 ptpt -109.93 121.78 46.04 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.797 0.665 . . . . 74.319999999999993 112.797 -171.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.9 -152.85 8.64 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.91 -0.586 . . . . 72.200000000000003 113.601 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -117.3 174.07 6.34 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.108 0.48 . . . . 75.019999999999996 112.097 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.446 ' CE1' ' HD3' ' A' ' 167' ' ' PRO . 68.7 m80 -97.2 110.58 23.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.071 -0.513 . . . . 75.0 110.073 172.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.667 ' HA ' HD13 ' A' ' 44' ' ' LEU . 18.4 m -135.63 140.77 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.318 0.58 . . . . 73.5 112.18 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 30.2 m -120.0 117.2 52.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.342 0.591 . . . . 64.129999999999995 111.338 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.672 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 66.4 ttt180 -99.8 108.09 20.3 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.099 -0.501 . . . . 75.140000000000001 110.547 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.479 ' HA ' HG12 ' A' ' 64' ' ' VAL . 62.6 tttm -85.13 112.38 20.63 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.054 -0.521 . . . . 75.150000000000006 110.594 -174.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 63.13 -68.29 0.08 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.011 0.525 . . . . 74.549999999999997 111.056 -173.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -152.96 -0.56 0.21 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.452 -0.404 . . . . 54.310000000000002 113.651 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -105.16 137.89 42.23 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.341 0.497 . . . . 74.219999999999999 112.341 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.0 mm -78.31 92.42 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.218 0.532 . . . . 71.540000000000006 110.241 173.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -98.89 -42.84 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.643 0.608 . . . . 64.319999999999993 112.643 -174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.667 HD13 ' HA ' ' A' ' 35' ' ' VAL . 4.3 mm? 58.42 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.921 0.711 . . . . 72.239999999999995 112.921 -176.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.92 109.03 7.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.791 -0.641 . . . . 72.510000000000005 110.116 173.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.04 74.14 0.36 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.229 -0.51 . . . . 53.439999999999998 113.086 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.4 p -99.41 126.33 45.29 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.347 0.594 . . . . 71.25 111.918 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.691 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 19.0 p-10 -80.39 177.56 2.9 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.977 -0.556 . . . . 75.019999999999996 109.518 170.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.691 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 30.4 Cg_endo -64.0 68.37 0.21 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 121.759 1.64 . . . . 75.5 112.463 173.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.3 t -149.69 129.47 13.29 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.825 -0.625 . . . . 71.209999999999994 110.398 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.03 7.64 5.55 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.113 0.483 . . . . 72.400000000000006 111.848 -174.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -98.01 22.02 9.92 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.267 0.556 . . . . 70.319999999999993 110.43 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -100.96 38.74 1.49 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.029 -0.532 . . . . 70.209999999999994 112.281 -173.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.9 81.78 0.03 OUTLIER Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.672 -0.299 . . . . 60.119999999999997 113.41 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.15 -20.91 66.68 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.467 0.543 . . . . 42.210000000000001 112.467 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.75 14.23 23.91 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.218 0.451 . . . . 73.530000000000001 112.218 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -115.09 161.85 17.81 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.768 0.318 . . . . 74.340000000000003 110.958 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -70.37 -12.78 61.81 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.942 0.349 . . . . 74.239999999999995 111.942 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.28 55.65 2.57 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.382 -0.437 . . . . 75.200000000000003 112.407 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.2 t -74.69 13.35 0.64 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 112.359 0.503 . . . . 72.319999999999993 112.359 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.66 -15.6 57.29 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.84 0.681 . . . . 72.540000000000006 112.84 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.05 -32.13 23.04 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.992 -0.443 . . . . 62.100000000000001 111.474 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -88.28 10.93 17.99 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.212 0.449 . . . . 73.450000000000003 112.212 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.634 ' HB ' ' HD2' ' A' ' 66' ' ' ARG . 93.9 t -73.22 131.35 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.043 -0.354 . . . . 63.119999999999997 110.043 171.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.672 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 27.7 tt0 -77.55 68.65 3.68 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.28 1.038 . . . . 74.140000000000001 109.299 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.634 ' HD2' ' HB ' ' A' ' 64' ' ' VAL . 11.0 ptm180 -104.67 140.38 38.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.597 -1.183 . . . . 73.150000000000006 111.927 -173.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.94 -131.11 3.72 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.548 -0.834 . . . . 37.229999999999997 113.785 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.417 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 32.3 pt -111.09 139.77 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 122.461 -0.435 . . . . 75.420000000000002 111.608 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -48.29 -35.76 12.83 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.078 -0.51 . . . . 65.019999999999996 112.355 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.421 HG21 ' HB2' ' A' ' 169' ' ' LEU . 68.4 mt -52.56 -58.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.201 0.524 . . . . 73.129999999999995 112.221 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.5 m -75.25 -33.59 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.142 -0.481 . . . . 75.109999999999999 111.688 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 64.8 mt -64.98 -34.49 78.57 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.966 0.413 . . . . 75.340000000000003 111.037 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -57.55 -48.66 78.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.247 -0.433 . . . . 71.349999999999994 111.94 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -99.04 -3.45 34.75 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.325 0.491 . . . . 71.409999999999997 112.325 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 59.56 70.86 0.61 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.623 0.725 . . . . 75.120000000000005 111.525 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 60.4 mt -98.3 127.78 44.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.667 -0.697 . . . . 74.430000000000007 110.951 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.94 143.85 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.66 0.266 . . . . 75.540000000000006 110.849 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -84.8 150.91 24.72 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.569 0.7 . . . . 71.549999999999997 112.838 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.2 ttm -145.19 138.33 26.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.459 -0.791 . . . . 75.349999999999994 110.413 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.509 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 18.0 m-80 -109.77 167.55 10.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.08 -0.509 . . . . 74.340000000000003 111.102 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 79.6 m -55.43 -38.92 69.63 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.553 0.945 . . . . 73.400000000000006 113.553 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 80' ' ' ASN . 10.8 p90 -65.5 -23.23 66.84 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.654 -0.654 . . . . 73.310000000000002 111.406 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -94.13 -32.5 13.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.197 0.523 . . . . 74.319999999999993 110.732 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.1 -16.14 38.98 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.606 -0.725 . . . . 75.340000000000003 112.31 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.467 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . . . -43.21 -57.55 2.91 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.693 0.627 . . . . 74.140000000000001 112.693 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 t -69.92 -27.53 64.85 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 55.229999999999997 111.524 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.574 ' HA ' ' HE2' ' A' ' 87' ' ' MET . 23.4 mmt -70.92 -63.36 1.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.535 -0.302 . . . . 65.530000000000001 111.637 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.467 ' HE1' ' HA ' ' A' ' 85' ' ' ALA . 5.0 p90 -60.44 -34.3 73.78 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.351 -0.218 . . . . 75.450000000000003 111.312 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -58.12 -54.39 47.54 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.935 0.398 . . . . 74.319999999999993 111.222 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.96 -35.56 81.58 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.141 0.496 . . . . 61.140000000000001 111.059 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.637 ' HE2' ' HG3' ' A' ' 152' ' ' GLN . 56.5 t80 -56.71 -57.02 14.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.765 -0.652 . . . . 73.109999999999999 111.043 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.2 mm -57.83 -37.33 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.768 0.318 . . . . 75.420000000000002 111.631 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -60.13 -56.66 18.91 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.005 0.372 . . . . 73.439999999999998 112.005 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -72.32 -36.59 68.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.946 0.403 . . . . 75.329999999999998 111.835 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.417 ' O ' HG23 ' A' ' 99' ' ' VAL . 55.2 t80 -60.34 -55.34 34.76 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.075 -0.511 . . . . 74.329999999999998 111.229 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.1 ttt -54.87 -44.38 73.97 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.172 -0.467 . . . . 75.109999999999999 111.317 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -62.89 -46.62 86.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.372 -0.376 . . . . 72.099999999999994 111.612 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -63.44 -51.87 63.88 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.686 0.279 . . . . 75.310000000000002 111.625 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.487 ' O ' ' SD ' ' A' ' 103' ' ' MET . 32.1 m -64.07 -41.8 93.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.542 0.571 . . . . 71.439999999999998 112.542 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.7 mm -66.81 -46.45 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 121.755 -0.591 . . . . 75.329999999999998 110.983 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.99 -34.22 75.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.181 0.515 . . . . 73.120000000000005 110.993 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -68.93 -57.41 5.54 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.786 -0.643 . . . . 73.439999999999998 111.385 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 99' ' ' VAL . 0.2 OUTLIER -66.64 -44.72 81.2 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.007 0.743 . . . . 73.120000000000005 113.007 -175.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -50.46 -48.19 56.65 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.367 0.506 . . . . 74.530000000000001 112.367 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -60.41 -14.64 20.06 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.821 0.674 . . . . 72.349999999999994 112.821 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -115.4 -33.65 5.2 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.358 0.599 . . . . 62.229999999999997 111.564 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.45 ' O ' HG11 ' A' ' 113' ' ' VAL . 32.6 m-80 -122.13 28.52 7.46 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.665 -0.698 . . . . 72.319999999999993 111.886 -173.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.486 HH11 ' HB2' ' A' ' 109' ' ' ASP . 3.3 ppt_? -38.41 -23.81 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.874 1.805 . . . . 71.219999999999999 115.874 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.486 ' HB2' HH11 ' A' ' 108' ' ' ARG . 21.3 t70 -63.38 136.85 57.91 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.792 0.724 . . . . 71.019999999999996 111.269 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 110' ' ' LYS . 13.0 mptt -68.95 4.64 1.43 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.306 0.854 . . . . 75.450000000000003 113.306 -171.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.5 -47.88 6.91 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.996 0.427 . . . . 72.319999999999993 110.848 170.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -70.62 -58.09 4.04 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.989 -0.55 . . . . 73.109999999999999 112.234 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 107' ' ' ASN . 5.3 m -61.77 -32.54 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.793 0.294 . . . . 71.239999999999995 111.793 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -66.96 -43.25 83.6 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.77 0.319 . . . . 74.25 110.98 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.71 -51.42 70.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.028 0.442 . . . . 73.310000000000002 110.919 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.697 ' HE1' ' HG3' ' A' ' 174' ' ' GLU . 65.1 t80 -56.11 -50.1 72.0 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.003 -0.544 . . . . 65.25 111.148 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -51.57 -47.18 63.57 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.096 -0.502 . . . . 74.430000000000007 111.426 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -66.22 -34.64 78.48 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.013 0.375 . . . . 72.209999999999994 112.013 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -60.62 -54.48 44.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.1 0.476 . . . . 71.299999999999997 111.301 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -71.37 -31.71 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.973 0.416 . . . . 72.450000000000003 111.128 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.406 ' O ' HG21 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -61.48 -48.87 79.1 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.914 0.388 . . . . 72.140000000000001 110.927 176.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.02 -37.19 93.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.867 -0.682 . . . . 62.420000000000002 112.431 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.42 ' NE1' ' SD ' ' A' ' 170' ' ' MET . 51.7 t90 -61.77 -56.45 19.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.38 0.272 . . . . 75.109999999999999 111.343 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 m -63.21 -45.78 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.437 0.532 . . . . 73.530000000000001 112.437 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 121' ' ' GLN . 82.8 t -56.6 -46.61 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.852 0.358 . . . . 73.010000000000005 111.759 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.2 p -70.7 -38.19 73.64 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.968 0.413 . . . . 72.109999999999999 111.262 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.425 HD23 HD13 ' A' ' 155' ' ' ILE . 36.5 tp -67.64 -36.3 80.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.255 -0.43 . . . . 73.109999999999999 112.124 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 78.8 mt -80.71 2.29 26.61 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.503 0.557 . . . . 73.239999999999995 112.503 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 133' ' ' PHE . . . -66.89 87.07 0.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.408 0.623 . . . . 72.120000000000005 110.797 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -62.74 -22.75 66.79 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.841 1.052 . . . . 75.530000000000001 113.841 -169.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' NZ ' ' A' ' 134' ' ' LYS . 24.8 t70 -58.79 -47.33 85.1 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.084 -0.385 . . . . 63.219999999999999 111.958 -173.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -102.49 -38.4 7.57 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.136 0.493 . . . . 72.200000000000003 111.122 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 45.3 m-85 -68.5 -5.43 19.45 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.714 0.635 . . . . 72.25 112.714 -176.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 131' ' ' ASP . 23.6 pttm -62.37 -7.1 3.87 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.762 -0.586 . . . . 74.150000000000006 110.914 168.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.66 9.31 16.61 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 116.32 -0.4 . . . . 72.319999999999993 110.689 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.474 ' CD2' ' HA ' ' A' ' 157' ' ' GLU . 90.8 mt -88.65 162.91 16.06 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.905 0.383 . . . . 74.340000000000003 111.49 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.66 137.67 40.3 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.445 -0.343 . . . . 75.140000000000001 111.415 175.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.687 ' HB3' HG11 ' A' ' 153' ' ' VAL . 89.0 m-85 -100.08 120.92 40.59 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.727 0.299 . . . . 75.439999999999998 110.647 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.411 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 52.9 m-85 -122.45 139.97 53.26 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.188 0.518 . . . . 64.310000000000002 112.081 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -137.67 147.68 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.092 -0.504 . . . . 75.409999999999997 110.013 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.51 ' N ' HD12 ' A' ' 140' ' ' ILE . . . -51.14 126.17 26.34 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.433 -0.413 . . . . 65.409999999999997 114.046 -176.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -51.59 -59.67 4.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.844 0.354 . . . . 75.049999999999997 111.777 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -60.88 -32.29 71.73 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.865 0.364 . . . . 73.010000000000005 111.388 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.08 -53.1 50.79 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.541 -0.3 . . . . 74.040000000000006 111.139 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 140' ' ' ILE . . . -64.53 -20.26 66.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.07 0.462 . . . . 74.329999999999998 111.615 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -69.61 -26.03 64.24 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.013 -0.54 . . . . 74.219999999999999 110.811 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -113.63 -58.2 0.4 Allowed Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.13 -0.486 . . . . 64.099999999999994 112.307 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.86 92.08 8.54 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.175 0.512 . . . . 61.310000000000002 110.97 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.68 -2.46 11.82 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.008 -0.542 . . . . 73.230000000000004 112.375 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -124.79 27.56 6.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.763 0.425 . . . . 74.150000000000006 110.987 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.523 ' HA2' HG21 ' A' ' 9' ' ' THR . . . -57.67 155.27 20.02 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.961 -0.563 . . . . 71.109999999999999 114.432 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.637 ' HG3' ' HE2' ' A' ' 91' ' ' TYR . 43.4 tt0 -68.34 128.93 38.37 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.137 0.494 . . . . 62.100000000000001 111.653 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.687 HG11 ' HB3' ' A' ' 138' ' ' PHE . 68.7 t -91.66 144.06 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.239 0.542 . . . . 71.140000000000001 112.393 -177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.753 ' HB1' HD13 ' A' ' 169' ' ' LEU . . . -102.93 137.12 41.56 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.803 -0.635 . . . . 74.400000000000006 110.409 174.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.425 HD13 HD23 ' A' ' 127' ' ' LEU . 59.9 mt -95.27 126.54 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.381 0.512 . . . . 70.340000000000003 112.381 -172.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.1 mm -95.83 110.89 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.494 -0.321 . . . . 74.400000000000006 110.858 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.474 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 55.2 tt0 -96.22 148.78 22.37 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.842 -0.617 . . . . 73.040000000000006 111.934 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -98.23 123.23 42.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.814 -0.63 . . . . 73.299999999999997 110.558 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -121.15 114.49 21.51 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.975 0.417 . . . . 74.040000000000006 111.609 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.85 106.04 4.03 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.905 0.384 . . . . 74.129999999999995 111.116 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.28 107.66 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 120.742 0.306 . . . . 72.219999999999999 110.863 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 58.41 17.92 5.19 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.435 0.531 . . . . 73.109999999999999 112.435 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 114.86 -21.86 13.3 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.151 -0.547 . . . . 70.040000000000006 113.644 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 83.8 m -105.62 129.39 53.88 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.167 0.483 . . . . 74.140000000000001 111.355 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.28 128.27 35.0 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.397 0.617 . . . . 65.230000000000004 112.429 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.76 148.66 39.79 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.05 -0.523 . . . . 71.129999999999995 110.532 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.446 ' HD3' ' CE1' ' A' ' 34' ' ' HIS . 93.7 Cg_endo -87.12 120.9 1.64 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.425 2.083 . . . . 75.230000000000004 112.66 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.591 HG22 ' HB3' ' A' ' 31' ' ' LYS . 39.9 p -117.51 119.0 33.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.215 0.531 . . . . 75.319999999999993 111.446 177.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.753 HD13 ' HB1' ' A' ' 154' ' ' ALA . 60.2 tp -76.78 130.43 37.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.084 -0.507 . . . . 75.0 110.59 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.42 ' SD ' ' NE1' ' A' ' 123' ' ' TRP . 50.8 ttm -116.15 124.34 50.08 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 116.178 -0.464 . . . . 73.420000000000002 111.385 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.9 mt -135.85 124.73 24.08 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.985 -0.552 . . . . 73.510000000000005 111.902 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.473 ' HA ' HG11 ' A' ' 27' ' ' VAL . 41.4 t -71.22 118.7 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 122.205 -0.309 . . . . 74.140000000000001 111.439 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -66.99 -19.91 65.8 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.023 0.44 . . . . 75.349999999999994 111.558 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.697 ' HG3' ' HE1' ' A' ' 116' ' ' PHE . 4.8 mm-40 -81.76 -8.96 59.75 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.989 0.423 . . . . 72.219999999999999 111.134 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.37 -44.29 6.94 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.057 0.456 . . . . 61.109999999999999 110.92 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 27.2 pt -100.28 128.85 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.196 0.522 . . . . 74.019999999999996 111.163 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 177' ' ' ILE . 1.7 mp -93.34 117.99 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 74.019999999999996 110.225 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.45 137.81 32.02 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.793 0.806 . . . . 71.510000000000005 112.48 -177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -144.78 99.82 3.41 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.229 -0.896 . . . . 74.239999999999995 109.69 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.452 ' NZ ' ' O ' ' A' ' 182' ' ' LEU . 0.1 OUTLIER -92.76 128.26 38.56 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.719 0.637 . . . . 74.420000000000002 112.719 -172.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 82.5 m -112.94 87.08 2.5 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.238 0.542 . . . . 72.430000000000007 109.831 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.452 ' O ' ' NZ ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER 175.19 -176.22 0.1 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.238 -0.892 . . . . 74.530000000000001 109.9 -178.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.252 1.186 0 N-CA-C 112.237 0.458 . . . . 74.239999999999995 112.237 178.527 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.497 ' O ' ' HB3' ' A' ' 181' ' ' CYS . 18.9 ptt? . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.61 0.243 . . . . 73.140000000000001 110.929 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.6 tp -80.23 132.38 35.85 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.954 0.407 . . . . 73.150000000000006 111.437 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.618 ' HB ' HD12 ' A' ' 13' ' ' LEU . 8.6 pt -117.13 121.39 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.239 0.542 . . . . 75.239999999999995 111.658 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -101.59 122.31 43.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.083 -0.508 . . . . 74.140000000000001 111.112 -174.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.438 ' HG3' HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -111.66 118.73 36.47 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 111.988 0.366 . . . . 73.129999999999995 111.988 179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.74 132.62 40.6 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.838 0.351 . . . . 65.439999999999998 111.142 172.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 tt -48.23 -47.11 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 112.821 0.674 . . . . 73.140000000000001 112.821 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.54 ' HD1' ' HG1' ' A' ' 9' ' ' THR . 1.2 p90 -110.24 -2.59 16.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.411 0.893 . . . . 75.349999999999994 113.411 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.54 ' HG1' ' HD1' ' A' ' 8' ' ' PHE . 28.5 m -127.21 16.81 7.19 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.195 0.522 . . . . 74.319999999999993 111.994 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -50.43 -13.84 0.15 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.282 0.845 . . . . 75.120000000000005 113.282 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -53.93 -40.96 67.19 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.887 0.375 . . . . 70.120000000000005 111.415 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -85.95 24.94 1.19 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 120.857 0.361 . . . . 73.549999999999997 111.38 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.618 HD12 ' HB ' ' A' ' 3' ' ' ILE . 25.0 tp -31.28 120.32 0.23 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.396 0.887 . . . . 62.329999999999998 113.396 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -97.85 140.31 32.41 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.181 -0.463 . . . . 72.310000000000002 110.785 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.471 ' HB2' ' HE1' ' A' ' 1' ' ' MET . 88.9 p -128.88 96.52 4.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.835 0.35 . . . . 62.399999999999999 111.272 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -147.18 -168.85 3.16 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.202 0.525 . . . . 75.409999999999997 111.742 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.7 m -127.3 82.97 2.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.172 -0.467 . . . . 61.310000000000002 110.663 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -114.16 121.91 35.55 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.136 0.421 . . . . 75.230000000000004 112.136 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.31 103.01 1.62 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.664 2.243 . . . . 75.349999999999994 112.618 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.57 166.25 11.94 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.308 0.575 . . . . 72.329999999999998 112.315 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 25.6 mtpp -123.99 107.81 11.72 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.136 -0.484 . . . . 75.129999999999995 111.102 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.0 tp -79.43 94.38 5.54 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.939 -0.476 . . . . 73.030000000000001 111.248 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.76 138.88 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.985 0.422 . . . . 73.430000000000007 111.683 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.8 t70 57.7 13.38 1.96 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.84 -0.618 . . . . 53.43 112.007 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 63.18 14.6 7.86 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.571 0.348 . . . . 72.129999999999995 111.751 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.512 ' HA ' ' HZ3' ' A' ' 173' ' ' LYS . 52.1 tp -114.45 -50.87 2.78 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.966 0.358 . . . . 72.140000000000001 111.966 -176.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.9 m -130.01 152.03 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.207 0.527 . . . . 71.120000000000005 112.353 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.441 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 90.4 m-85 -90.95 120.18 31.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.928 -0.578 . . . . 72.340000000000003 110.996 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 8.6 pt-20 -99.58 105.64 17.53 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.273 0.559 . . . . 73.510000000000005 110.398 172.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 41.0 t80 -91.64 137.74 32.13 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.027 -0.42 . . . . 74.209999999999994 111.169 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.495 ' HE3' HG23 ' A' ' 161' ' ' VAL . 12.1 mmmm -81.82 121.94 27.08 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.15 -0.477 . . . . 74.010000000000005 112.047 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.48 ' HA3' HG12 ' A' ' 70' ' ' ILE . . . -121.71 173.18 15.66 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.316 -0.469 . . . . 44.210000000000001 113.196 176.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.01 140.55 50.86 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.384 -0.48 . . . . 75.120000000000005 111.09 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -73.43 119.77 18.11 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.509 -0.314 . . . . 74.340000000000003 110.393 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.7 m -143.77 178.12 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.462 1.125 . . . . 64.140000000000001 113.788 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.4 m -123.25 129.99 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.327 -1.306 . . . . 75.409999999999997 109.931 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.436 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.7 OUTLIER -128.63 108.3 10.39 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.572 0.582 . . . . 72.420000000000002 112.572 -174.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 pttt -134.71 142.01 46.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.337 -0.616 . . . . 70.319999999999993 109.337 169.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 59.45 12.41 2.71 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.215 0.45 . . . . 54.520000000000003 112.215 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.56 -2.58 87.92 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.478 -0.392 . . . . 62.119999999999997 112.939 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -100.6 -171.71 2.06 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.133 0.492 . . . . 71.230000000000004 112.122 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.563 HG12 ' H ' ' A' ' 44' ' ' LEU . 9.9 tt -146.78 130.18 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 116.081 -0.509 . . . . 75.450000000000003 111.009 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.0 m -103.83 14.67 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 112.324 0.49 . . . . 73.120000000000005 112.324 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.563 ' H ' HG12 ' A' ' 42' ' ' ILE . 2.7 mp -109.71 152.6 25.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.009 0.433 . . . . 64.219999999999999 111.581 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.55 -45.53 7.7 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.033 -0.531 . . . . 65.239999999999995 111.745 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.21 -81.05 0.05 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.902 -0.666 . . . . 74.340000000000003 113.768 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.8 p -103.85 151.45 23.08 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.261 -0.552 . . . . 74.329999999999998 111.888 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 61.72 89.93 0.1 OUTLIER Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 123.226 0.611 . . . . 74.430000000000007 112.573 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.31 141.92 88.45 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.995 2.463 . . . . 75.329999999999998 113.392 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.1 p -90.3 177.15 6.48 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.053 0.454 . . . . 61.420000000000002 112.057 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.75 16.16 2.14 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.246 -0.434 . . . . 74.400000000000006 111.616 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.07 -24.44 67.46 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.134 0.493 . . . . 74.109999999999999 111.892 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -82.83 24.82 0.71 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.11 -0.495 . . . . 73.120000000000005 111.537 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.51 73.26 0.23 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.673 -0.299 . . . . 37.880000000000003 113.823 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.24 -57.82 0.07 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.812 0.339 . . . . 74.209999999999994 111.025 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 59.29 90.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.596 0.712 . . . . 72.0 112.333 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -132.6 112.97 12.5 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.814 -0.63 . . . . 70.400000000000006 110.948 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t70 70.27 -63.96 0.38 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.487 0.715 . . . . 71.510000000000005 112.457 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.24 67.61 1.18 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 114.366 0.506 . . . . 54.149999999999999 114.366 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.9 m -156.14 67.81 0.6 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.312 0.645 . . . . 74.540000000000006 109.846 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -47.29 -63.77 0.96 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.762 1.023 . . . . 71.439999999999998 113.762 -170.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -103.99 1.89 31.66 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.414 0.626 . . . . 74.319999999999993 111.055 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 73.4 m80 56.59 19.8 4.5 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.829 0.677 . . . . 75.5 112.829 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.0 t -63.32 -76.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 122.36 -0.212 . . . . 73.540000000000006 111.107 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 70.41 -32.05 0.23 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.377 0.88 . . . . 65.400000000000006 113.377 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -115.97 129.76 56.53 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.4 -0.813 . . . . 61.409999999999997 111.879 -169.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.449 ' HA3' HD23 ' A' ' 72' ' ' LEU . . . 160.19 164.61 15.55 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 119.131 -1.509 . . . . 64.420000000000002 114.9 167.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 pt -90.13 138.47 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 122.42 -0.459 . . . . 73.420000000000002 110.294 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -48.41 -32.47 7.7 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.775 0.321 . . . . 63.240000000000002 111.822 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.48 HG12 ' HA3' ' A' ' 32' ' ' GLY . 35.6 mm -48.48 -58.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.38 0.609 . . . . 75.150000000000006 112.056 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 16.4 m -81.14 -28.4 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.993 -0.548 . . . . 73.319999999999993 112.136 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.449 HD23 ' HA3' ' A' ' 67' ' ' GLY . 55.2 mt -71.04 -33.61 70.48 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.953 0.406 . . . . 74.400000000000006 111.188 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -58.4 -48.62 80.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.124 -0.489 . . . . 62.450000000000003 112.252 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -109.68 13.74 23.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.851 0.315 . . . . 71.400000000000006 111.851 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 54.76 71.2 0.55 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.135 0.493 . . . . 73.430000000000007 111.916 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 75.3 mt -103.07 125.54 49.85 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 122.2 -0.313 . . . . 73.239999999999995 111.248 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.2 145.33 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.75 0.31 . . . . 72.150000000000006 110.789 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.24 137.3 35.85 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.026 0.75 . . . . 75.420000000000002 113.026 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.534 ' HE3' ' HG2' ' A' ' 87' ' ' MET . 78.1 mtp -125.91 145.5 50.24 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.058 -0.974 . . . . 65.049999999999997 108.887 169.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.484 ' HB2' ' CD1' ' A' ' 82' ' ' TYR . 16.8 m120 -115.93 -162.28 0.83 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.326 0.584 . . . . 65.120000000000005 112.398 -171.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.1 p -100.27 -2.5 33.57 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.148 0.795 . . . . 61.32 113.148 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.484 ' CD1' ' HB2' ' A' ' 80' ' ' ASN . 24.1 p90 -79.15 -61.4 2.02 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.113 0.782 . . . . 72.420000000000002 113.113 -170.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -105.3 -17.51 14.43 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.719 0.771 . . . . 74.430000000000007 111.208 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.86 9.53 1.12 Allowed 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.26 -0.882 . . . . 75.540000000000006 112.165 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -46.76 -56.91 5.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.193 0.597 . . . . 72.450000000000003 112.592 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.0 m -53.35 -36.35 61.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.874 0.369 . . . . 74.329999999999998 111.643 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.534 ' HG2' ' HE3' ' A' ' 79' ' ' MET . 51.4 tpp -73.88 -63.89 1.12 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.282 0.475 . . . . 73.439999999999998 112.282 -176.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -68.47 -29.07 67.62 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.863 -0.523 . . . . 75.519999999999996 112.305 -174.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -72.69 -41.81 64.93 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.917 -0.313 . . . . 72.430000000000007 110.909 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.71 -39.37 91.26 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.01 0.433 . . . . 74.299999999999997 110.325 173.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -57.11 -59.23 5.4 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.996 -0.547 . . . . 72.420000000000002 111.775 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.7 tp -62.4 -39.03 82.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 112.263 0.468 . . . . 73.540000000000006 112.263 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -71.49 -44.63 64.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 111.99 0.366 . . . . 71.109999999999999 111.99 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -63.67 -44.84 92.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.261 0.553 . . . . 74.540000000000006 110.287 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.452 ' O ' HG23 ' A' ' 99' ' ' VAL . 48.9 t80 -56.22 -58.07 9.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.505 -0.77 . . . . 74.420000000000002 111.283 174.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 53.0 tpp -51.56 -54.07 31.41 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.112 -0.495 . . . . 74.329999999999998 111.76 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -57.92 -44.74 87.05 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.962 0.356 . . . . 72.319999999999993 111.962 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -72.09 -45.98 58.56 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.368 0.507 . . . . 65.219999999999999 112.368 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 95' ' ' PHE . 35.8 m -67.83 -38.05 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 122.186 -0.321 . . . . 62.5 111.615 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.9 mm -63.77 -48.64 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.63 0.253 . . . . 73.439999999999998 110.603 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.423 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 17.1 t70 -52.51 -47.39 66.65 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.08 0.466 . . . . 71.150000000000006 111.873 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -71.15 -42.94 68.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.545 -0.298 . . . . 73.409999999999997 111.625 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.527 ' HG3' HG13 ' A' ' 113' ' ' VAL . 12.7 tpt -59.88 -43.18 94.91 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.824 0.305 . . . . 74.340000000000003 111.824 -178.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.537 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -65.96 -28.55 68.99 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.837 0.31 . . . . 73.25 111.837 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.1 mtmm -69.52 -8.0 43.23 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.251 0.463 . . . . 75.420000000000002 112.251 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -99.97 -31.71 11.33 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.301 0.572 . . . . 72.340000000000003 110.332 172.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.661 HD22 ' HB3' ' A' ' 111' ' ' ALA . 28.3 t-20 -123.64 -80.34 0.62 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.583 -0.735 . . . . 62.549999999999997 111.929 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 73.7 ttt180 72.25 -15.74 0.46 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.915 0.709 . . . . 73.120000000000005 112.915 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -80.22 8.89 6.43 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.935 -0.478 . . . . 74.230000000000004 111.771 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.46 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 57.5 mtmt 60.52 20.23 10.02 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.219 0.533 . . . . 75.0 112.137 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.661 ' HB3' HD22 ' A' ' 107' ' ' ASN . . . -85.42 -62.54 1.51 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.105 -0.498 . . . . 73.209999999999994 110.288 172.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -79.52 -46.71 16.87 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.401 -0.363 . . . . 73.299999999999997 111.601 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.527 HG13 ' HG3' ' A' ' 103' ' ' MET . 28.0 m -63.81 -29.61 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 113.176 0.806 . . . . 74.120000000000005 113.176 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.39 -39.07 68.27 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 122.012 -0.43 . . . . 73.549999999999997 110.238 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.64 -47.54 69.28 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.172 -0.467 . . . . 64.109999999999999 111.195 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -53.89 -48.86 69.69 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.152 -0.476 . . . . 75.349999999999994 110.503 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -54.26 -47.69 72.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.696 -0.684 . . . . 75.219999999999999 111.317 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -56.27 -43.33 78.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.235 -0.439 . . . . 73.239999999999995 111.123 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -66.81 -60.49 2.62 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.942 0.349 . . . . 73.200000000000003 111.942 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -60.94 -35.07 62.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 111.905 0.335 . . . . 72.540000000000006 111.905 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 125' ' ' VAL . 58.5 tp60 -67.09 -43.21 83.15 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.687 0.279 . . . . 74.310000000000002 110.627 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.23 -35.47 88.1 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.828 -0.701 . . . . 71.450000000000003 112.271 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.5 t90 -63.89 -51.7 63.32 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.296 0.238 . . . . 72.25 111.222 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' A' ' 121' ' ' GLN . 30.8 m -67.61 -38.03 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 112.306 0.484 . . . . 71.230000000000004 112.306 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 121' ' ' GLN . 52.9 t -57.78 -46.55 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.357 0.599 . . . . 74.150000000000006 110.854 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.6 m -67.83 -48.95 64.78 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.087 -0.506 . . . . 73.340000000000003 111.31 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.22 -41.5 96.97 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.05 0.54 . . . . 61.539999999999999 112.447 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.0 mt -84.82 3.31 38.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.243 0.46 . . . . 65.129999999999995 112.243 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.46 86.41 0.11 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.337 0.589 . . . . 74.5 110.929 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -54.5 -20.4 7.65 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.62 0.971 . . . . 72.239999999999995 113.62 -172.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.81 -47.53 77.71 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.649 0.611 . . . . 64.439999999999998 112.649 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -109.91 -30.69 7.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.446 0.535 . . . . 72.230000000000004 112.446 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -85.66 -7.11 59.01 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.147 0.795 . . . . 63.409999999999997 113.147 -171.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.86 -19.8 66.07 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.726 -0.608 . . . . 73.239999999999995 110.538 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -78.95 10.02 3.78 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.002 -0.545 . . . . 70.5 111.873 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 157' ' ' GLU . 88.0 mt -89.06 161.21 16.67 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.971 0.415 . . . . 74.019999999999996 110.948 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.43 137.48 54.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.64 -0.254 . . . . 74.230000000000004 111.644 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.654 ' HB3' HG12 ' A' ' 153' ' ' VAL . 56.8 m-85 -107.88 106.96 17.48 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 122.273 -0.267 . . . . 75.219999999999999 110.667 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.592 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 39.8 m-85 -102.51 143.67 31.93 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.196 0.522 . . . . 75.400000000000006 112.273 -176.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.7 tt -130.5 150.81 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.835 -0.62 . . . . 71.219999999999999 110.626 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.437 ' HA2' HD21 ' A' ' 76' ' ' LEU . . . -56.21 135.69 49.49 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.352 -0.452 . . . . 61.450000000000003 113.669 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.25 -39.62 66.98 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.091 0.472 . . . . 64.109999999999999 111.393 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -69.07 -55.92 9.3 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.081 -0.509 . . . . 75.450000000000003 111.296 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.07 -25.59 67.05 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.203 0.446 . . . . 63.240000000000002 112.203 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.44 -19.03 61.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.75 0.648 . . . . 74.019999999999996 112.75 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -70.47 -12.02 61.3 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.225 0.536 . . . . 62.420000000000002 111.144 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.41 41.2 2.81 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.369 -0.443 . . . . 62.439999999999998 112.967 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.12 -71.72 0.16 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.012 0.434 . . . . 75.230000000000004 111.769 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -123.8 -77.39 0.59 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.126 0.488 . . . . 73.540000000000006 110.223 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -134.79 -59.98 0.79 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.929 -0.578 . . . . 70.120000000000005 110.401 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.448 ' HA2' HG21 ' A' ' 9' ' ' THR . . . 103.28 139.56 10.4 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.294 -0.479 . . . . 73.140000000000001 112.837 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -73.73 112.2 9.61 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 122.548 -0.383 . . . . 63.5 111.47 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.654 HG12 ' HB3' ' A' ' 138' ' ' PHE . 58.8 t -77.49 88.0 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.648 0.737 . . . . 74.310000000000002 110.079 169.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.914 ' HB1' HD13 ' A' ' 169' ' ' LEU . . . -79.4 117.53 20.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.534 -0.757 . . . . 70.310000000000002 110.471 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.77 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 58.1 mt -88.53 134.73 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.028 0.442 . . . . 73.510000000000005 111.991 -172.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.4 mm -103.22 115.48 45.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 116.443 -0.344 . . . . 74.150000000000006 111.063 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.518 ' HB2' ' HE2' ' A' ' 170' ' ' MET . 38.2 tt0 -108.33 145.4 34.5 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 123.73 0.644 . . . . 74.420000000000002 111.831 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -90.2 117.47 28.98 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.06 0.457 . . . . 73.140000000000001 110.834 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -132.65 128.8 37.83 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.408 0.521 . . . . 72.310000000000002 112.408 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -83.77 116.14 22.56 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.046 -0.525 . . . . 65.010000000000005 110.144 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.495 HG23 ' HE3' ' A' ' 31' ' ' LYS . 98.8 t -114.72 105.98 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.472 -0.331 . . . . 75.319999999999993 110.483 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 59.81 23.79 12.75 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.292 -0.413 . . . . 73.109999999999999 111.615 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.01 -18.91 51.12 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 113.294 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 28.3 m -82.19 132.72 35.24 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.644 -0.327 . . . . 74.409999999999997 111.517 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.23 98.82 11.14 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.548 0.69 . . . . 75.319999999999993 111.646 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.92 147.22 48.15 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.103 -0.498 . . . . 75.140000000000001 112.09 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.39 120.81 2.18 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.697 2.265 . . . . 74.5 113.008 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.8 p -94.17 129.72 40.66 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.207 0.527 . . . . 74.340000000000003 111.187 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.914 HD13 ' HB1' ' A' ' 154' ' ' ALA . 43.7 tp -87.94 123.06 32.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.068 -0.514 . . . . 74.030000000000001 111.31 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.77 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 62.8 mtt -92.75 124.07 36.49 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.797 0.332 . . . . 75.209999999999994 111.355 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 86.5 mt -132.4 143.39 49.79 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.458 -0.792 . . . . 73.530000000000001 109.818 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 175' ' ' ALA . 48.5 t -101.85 122.77 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 122.078 -0.389 . . . . 75.120000000000005 111.755 -173.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.512 ' HZ3' ' HA ' ' A' ' 26' ' ' LEU . 22.9 pttm -68.62 -29.37 67.86 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.182 0.438 . . . . 75.120000000000005 112.182 -173.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -89.09 5.86 42.54 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.265 0.555 . . . . 63.439999999999998 111.36 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.522 ' HB2' ' HB ' ' A' ' 172' ' ' VAL . . . -113.91 -22.96 9.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.899 -0.591 . . . . 73.040000000000006 111.278 172.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 172' ' ' VAL . 34.5 pt -129.77 137.15 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.975 0.417 . . . . 61.149999999999999 111.198 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.6 mm -103.46 110.87 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.844 0.354 . . . . 73.349999999999994 111.489 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -74.15 95.71 2.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.193 -0.458 . . . . 73.230000000000004 109.909 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.595 ' HB3' HG13 ' A' ' 3' ' ' ILE . 29.5 tt0 -95.23 119.04 33.06 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.237 0.541 . . . . 75.329999999999998 111.37 -174.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -78.17 107.9 11.09 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.434 0.635 . . . . 75.420000000000002 112.706 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 1' ' ' MET . 51.3 t -114.94 91.66 3.69 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.811 -0.631 . . . . 62.509999999999998 109.356 171.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 53.0 mt -105.84 32.8 4.11 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.629 0.604 . . . . 75.319999999999993 112.629 -167.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.255 1.393 0 CA-C-O 118.819 -0.61 . . . . 71.010000000000005 110.043 175.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 tpp . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.688 0.28 . . . . 71.010000000000005 111.565 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.19 130.09 40.56 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.763 0.315 . . . . 75.439999999999998 111.139 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.2 mt -102.66 134.11 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.758 -0.201 . . . . 75.319999999999993 111.048 -177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -123.49 141.57 51.87 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.58 0.705 . . . . 74.239999999999995 112.282 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.433 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 21.6 ttmm -111.38 110.55 21.06 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.759 -1.109 . . . . 72.230000000000004 111.013 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.512 ' HB2' ' H ' ' A' ' 9' ' ' THR . 1.4 m-20 -83.14 149.54 26.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.558 -0.292 . . . . 71.209999999999994 110.955 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 175' ' ' ALA . 68.9 mt -61.02 -33.89 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.398 0.618 . . . . 75.239999999999995 110.77 173.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -105.14 -29.26 10.49 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.669 0.618 . . . . 74.030000000000001 112.669 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.512 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 2.0 m -106.48 11.81 30.29 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.058 0.392 . . . . 73.209999999999994 112.058 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.433 ' OD1' ' HG3' ' A' ' 5' ' ' LYS . 17.7 t70 -50.92 -35.93 35.8 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.218 0.451 . . . . 71.030000000000001 112.218 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.32 -19.55 35.93 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 111.954 0.353 . . . . 74.109999999999999 111.954 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -91.32 -30.11 16.76 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 111.72 0.267 . . . . 75.439999999999998 111.72 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.6 tp 40.3 90.8 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.17 0.588 . . . . 74.120000000000005 111.787 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 t -103.15 169.5 8.52 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.12 0.785 . . . . 72.299999999999997 113.12 -164.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 87.9 p -137.97 150.14 46.76 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.656 -0.702 . . . . 61.219999999999999 111.315 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -145.47 175.33 10.41 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.328 -0.396 . . . . 73.109999999999999 110.709 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.6 p -133.92 15.66 3.91 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.651 0.612 . . . . 55.409999999999997 112.651 -178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -109.92 121.93 40.5 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 120.912 0.386 . . . . 73.010000000000005 111.768 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.43 102.3 1.46 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.87 2.38 . . . . 63.149999999999999 113.106 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.1 ptt? -85.89 153.91 21.88 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.354 -0.385 . . . . 65.150000000000006 111.588 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 89.6 mttt -99.04 123.9 43.67 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 111.813 0.301 . . . . 75.230000000000004 111.813 -174.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 tp -78.44 99.15 6.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.966 0.412 . . . . 73.140000000000001 110.949 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -95.71 146.78 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.9 0.381 . . . . 65.450000000000003 111.101 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.44 7.76 3.15 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 116.267 -0.424 . . . . 74.319999999999993 111.851 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 58.19 21.7 8.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.881 0.372 . . . . 74.25 111.764 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.2 tp -129.46 -43.89 1.26 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.018 0.437 . . . . 71.510000000000005 111.718 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.25 153.34 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.15 0.5 . . . . 72.310000000000002 112.288 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.485 ' CE2' ' HB3' ' A' ' 173' ' ' LYS . 95.0 m-85 -91.61 134.47 34.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.238 -0.437 . . . . 72.019999999999996 111.105 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 8.7 pt-20 -104.84 131.78 51.9 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.318 0.58 . . . . 72.329999999999998 110.81 172.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 74.7 t80 -130.91 119.07 21.61 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.197 -0.456 . . . . 74.140000000000001 111.153 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -101.57 130.67 47.93 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.937 0.399 . . . . 74.099999999999994 111.411 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.77 -160.08 10.88 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.354 -0.45 . . . . 71.209999999999994 112.785 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -109.26 165.76 11.37 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.439 -0.448 . . . . 73.239999999999995 111.761 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -98.34 106.43 18.72 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.406 -0.361 . . . . 64.329999999999998 110.614 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.97 159.6 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.141 0.496 . . . . 74.230000000000004 111.574 -176.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 5.6 m -127.8 137.59 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.28 -0.418 . . . . 74.530000000000001 110.176 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.459 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 30.0 ttp180 -125.73 110.79 14.16 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.573 0.702 . . . . 70.450000000000003 112.179 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 98.0 mttt -106.27 160.43 15.36 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.843 -1.071 . . . . 74.439999999999998 109.507 169.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -51.64 -34.35 37.41 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.219 0.452 . . . . 65.5 112.219 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.5 30.07 1.86 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.226 -0.512 . . . . 74.120000000000005 113.243 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 1.2 tm-20 -141.43 146.22 36.27 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 122.581 -0.364 . . . . 73.129999999999995 110.443 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 tp -153.67 92.91 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-O 121.258 0.551 . . . . 74.439999999999998 112.454 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 43' ' ' VAL . 17.8 m -126.75 100.85 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 121.484 0.659 . . . . 72.019999999999996 111.084 172.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -55.99 -45.2 79.09 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.007 0.432 . . . . 74.329999999999998 112.122 -173.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.88 34.08 0.34 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.47 0.544 . . . . 63.299999999999997 112.47 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.3 88.97 0.03 OUTLIER Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.343 -0.456 . . . . 74.109999999999999 112.452 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.7 p -82.27 8.81 10.18 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.124 0.787 . . . . 75.409999999999997 113.124 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.713 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 13.1 m120 -62.06 -55.69 38.54 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 122.188 -0.32 . . . . 62.549999999999997 111.666 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.713 ' HD3' ' HB2' ' A' ' 48' ' ' ASN . 8.3 Cg_endo -88.0 88.15 0.56 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.122 1.881 . . . . 73.099999999999994 112.029 176.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.1 p -165.35 101.25 0.72 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.144 0.497 . . . . 71.299999999999997 112.133 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 63.24 4.08 1.53 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.214 1.19 . . . . 73.109999999999999 114.214 172.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -81.54 -54.31 5.53 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.894 -0.504 . . . . 71.200000000000003 110.446 178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 59.64 19.6 8.22 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.716 -0.675 . . . . 74.510000000000005 112.268 173.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.21 -14.51 64.07 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.485 -0.388 . . . . 72.340000000000003 113.966 -176.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 56' ' ' GLU . . . -83.34 -21.03 33.26 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.389 -0.477 . . . . 74.030000000000001 112.151 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 55' ' ' ALA . 39.7 tt0 72.44 -44.81 0.6 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.303 0.641 . . . . 71.5 112.436 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.42 157.39 8.85 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.444 0.64 . . . . 73.019999999999996 111.921 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.04 77.04 10.0 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.331 0.863 . . . . 74.409999999999997 113.331 -167.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.59 -33.84 2.98 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 115.63 1.012 . . . . 74.010000000000005 115.63 163.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.3 p -61.67 86.83 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.863 0.832 . . . . 75.140000000000001 111.717 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -80.89 -66.27 0.91 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.346 0.499 . . . . 71.310000000000002 112.346 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.472 ' HB3' HG22 ' A' ' 64' ' ' VAL . 35.9 tt0 -129.36 1.94 5.11 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 120.884 0.373 . . . . 64.519999999999996 111.385 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 82.7 t60 64.36 46.31 3.49 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.783 0.801 . . . . 75.510000000000005 110.703 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' A' ' 62' ' ' GLU . 77.2 t -102.68 159.28 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.381 -0.827 . . . . 74.519999999999996 111.269 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 43.7 mt-10 -81.21 60.34 4.29 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.386 0.613 . . . . 71.239999999999995 109.881 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.63 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -106.85 148.42 28.56 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.006 -0.543 . . . . 72.219999999999999 111.99 -175.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.29 -113.62 1.4 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.935 -0.65 . . . . 64.549999999999997 113.294 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.605 HG23 ' HB3' ' A' ' 167' ' ' PRO . 31.4 pt -111.68 132.3 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.194 0.521 . . . . 75.120000000000005 112.213 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -51.1 -33.59 26.85 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.015 -0.539 . . . . 73.430000000000007 112.109 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.468 HG22 ' HB2' ' A' ' 169' ' ' LEU . 64.5 mt -47.87 -49.56 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 112.329 0.492 . . . . 75.430000000000007 112.329 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 23.4 m -85.68 -30.32 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.41 -0.359 . . . . 74.109999999999999 111.899 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 66.8 mt -67.82 -49.96 59.37 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.093 0.473 . . . . 75.400000000000006 111.211 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -60.85 -36.21 78.54 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.897 -0.592 . . . . 75.420000000000002 111.755 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -100.51 8.03 43.75 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.236 0.458 . . . . 61.32 112.236 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 54.89 69.67 0.71 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.673 0.619 . . . . 75.530000000000001 112.673 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.555 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 73.5 mt -116.61 125.93 52.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.056 -0.52 . . . . 74.200000000000003 110.505 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 p -82.58 143.08 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.969 0.414 . . . . 73.230000000000004 111.886 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -77.84 129.15 35.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.824 -0.625 . . . . 73.219999999999999 112.506 -175.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.5 mmt -136.13 165.22 26.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.984 -0.553 . . . . 72.239999999999995 111.169 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -144.91 143.24 30.46 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.276 0.56 . . . . 74.239999999999995 111.923 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 21.3 p -40.86 -32.43 0.23 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.753 1.76 . . . . 74.200000000000003 115.753 -167.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -51.15 -46.36 61.98 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.86 0.689 . . . . 75.439999999999998 112.86 -172.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -103.71 -20.48 13.95 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.007 -0.433 . . . . 73.219999999999999 111.551 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.84 -22.32 66.97 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.02 0.378 . . . . 73.409999999999997 112.02 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.47 -42.33 54.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.046 0.45 . . . . 72.299999999999997 111.312 175.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.9 t -62.83 -42.96 99.95 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.251 0.548 . . . . 71.019999999999996 111.233 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.2 ttm -64.31 -43.54 94.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.081 -0.509 . . . . 73.510000000000005 110.878 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.529 ' HA ' ' HB3' ' A' ' 91' ' ' TYR . 62.9 m-85 -66.91 -30.49 70.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.998 0.37 . . . . 74.319999999999993 111.998 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.8 -53.48 57.37 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.002 0.429 . . . . 74.120000000000005 110.488 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.08 -41.24 90.98 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.046 0.45 . . . . 74.0 111.615 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.571 ' HE1' ' HG3' ' A' ' 152' ' ' GLN . 78.7 t80 -56.89 -63.37 1.23 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.04 -0.527 . . . . 74.540000000000006 111.602 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.9 mm -57.87 -31.26 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.463 -0.335 . . . . 74.310000000000002 111.767 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -56.91 -67.29 0.33 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.055 0.455 . . . . 75.319999999999993 111.575 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -63.39 -40.76 98.12 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.175 -0.466 . . . . 72.329999999999998 111.102 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.453 ' HZ ' HG12 ' A' ' 172' ' ' VAL . 86.8 t80 -54.94 -55.62 28.7 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.866 -0.606 . . . . 74.409999999999997 111.304 178.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -55.83 -50.23 71.11 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.883 0.327 . . . . 71.129999999999995 111.883 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -62.63 -37.77 87.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.076 0.398 . . . . 75.25 112.076 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -76.07 -46.73 27.63 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.257 -0.277 . . . . 72.439999999999998 111.746 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.506 HG12 ' HB3' ' A' ' 174' ' ' GLU . 22.0 m -65.77 -42.55 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 112.085 0.402 . . . . 73.209999999999994 112.085 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.1 mm -65.42 -43.53 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 122.228 -0.295 . . . . 65.200000000000003 111.071 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.15 -38.9 74.2 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.139 0.495 . . . . 75.310000000000002 110.847 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -60.76 -56.59 19.4 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.018 -0.537 . . . . 70.019999999999996 111.639 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.529 ' HE3' HD22 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -67.88 -28.46 67.54 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.127 0.489 . . . . 73.430000000000007 111.591 -178.251 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 37.5 tt0 -68.53 -27.2 65.89 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.18 -0.464 . . . . 61.399999999999999 111.568 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -72.64 -36.72 68.06 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.902 0.382 . . . . 74.150000000000006 111.824 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.529 HD22 ' HE3' ' A' ' 103' ' ' MET . 2.3 p-10 -86.58 -29.89 22.27 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 111.942 0.349 . . . . 61.009999999999998 111.942 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 109' ' ' ASP . 20.3 t-20 -125.61 -74.92 0.59 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.357 0.502 . . . . 75.5 112.357 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 24.1 ttt180 67.92 -30.73 0.17 Allowed 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 113.02 0.748 . . . . 74.5 113.02 -174.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 111' ' ' ALA . 23.0 t0 -90.94 80.26 5.79 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.652 -0.655 . . . . 70.109999999999999 111.925 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.466 ' HG3' ' N ' ' A' ' 111' ' ' ALA . 10.0 ptpp? 50.14 -67.1 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.671 1.588 . . . . 74.409999999999997 115.056 169.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 109' ' ' ASP . . . -33.47 -54.51 0.43 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.01 1.115 . . . . 63.25 114.01 -172.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -95.97 -44.88 7.16 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.45 0.537 . . . . 64.409999999999997 112.45 -176.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 m -61.53 -37.24 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 112.564 0.579 . . . . 63.039999999999999 112.564 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.89 -41.55 87.0 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.081 0.467 . . . . 71.129999999999995 110.881 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.02 -48.89 74.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.188 -0.46 . . . . 71.420000000000002 111.054 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -57.85 -48.85 78.58 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.238 -0.437 . . . . 74.549999999999997 111.322 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -51.99 -51.71 55.44 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.771 -0.455 . . . . 75.319999999999993 109.771 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -57.61 -38.02 74.24 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.143 -0.48 . . . . 74.209999999999994 111.298 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -63.52 -62.5 1.63 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.003 0.43 . . . . 72.219999999999999 111.81 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.1 tp -69.22 -32.65 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.394 -0.366 . . . . 75.299999999999997 111.88 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -62.84 -49.39 75.1 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.918 0.39 . . . . 73.519999999999996 110.196 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.29 -38.23 85.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.88 -0.676 . . . . 70.230000000000004 112.556 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 44.3 t90 -60.68 -55.38 33.9 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.306 0.242 . . . . 73.239999999999995 111.457 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.7 m -65.85 -40.83 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.079 0.4 . . . . 75.230000000000004 112.079 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 68.8 t -59.09 -36.11 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.098 0.475 . . . . 73.409999999999997 111.223 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.5 m -76.51 -47.25 23.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.017 0.437 . . . . 74.019999999999996 110.975 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.1 tp -62.2 -36.07 80.79 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.967 -0.561 . . . . 75.099999999999994 112.139 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.6 mt -88.56 3.2 51.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.469 0.544 . . . . 74.349999999999994 112.469 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 133' ' ' PHE . . . -68.26 81.97 0.24 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.404 0.621 . . . . 54.340000000000003 110.911 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -48.07 -45.34 32.35 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.885 1.069 . . . . 72.319999999999993 113.885 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -43.31 -46.62 6.42 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.502 0.556 . . . . 74.109999999999999 112.502 -171.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.501 ' HG3' ' CD1' ' A' ' 133' ' ' PHE . 2.3 ptp180 -109.74 -42.15 4.35 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.185 0.439 . . . . 73.129999999999995 112.185 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.501 ' CD1' ' HG3' ' A' ' 132' ' ' ARG . 52.9 m-85 -71.04 -8.16 51.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.962 0.727 . . . . 73.5 112.962 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -56.01 -22.59 27.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.234 0.54 . . . . 73.25 111.08 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.532 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 58.3 m-20 -76.65 6.05 6.55 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.595 -0.73 . . . . 75.040000000000006 112.215 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.8 mt -89.19 148.98 23.34 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.026 0.441 . . . . 74.140000000000001 111.579 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.05 146.38 30.2 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.173 -0.467 . . . . 65.109999999999999 111.217 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -114.09 125.43 53.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.969 0.414 . . . . 74.019999999999996 110.879 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.521 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 58.1 m-85 -126.2 127.95 46.47 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.018 0.437 . . . . 74.329999999999998 111.555 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.425 HG23 ' HB2' ' A' ' 145' ' ' ALA . 10.3 tt -121.63 152.32 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.341 -0.39 . . . . 71.120000000000005 111.176 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.49 136.87 35.48 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 114.142 0.417 . . . . 62.240000000000002 114.142 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.05 -41.42 68.1 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.34 0.496 . . . . 73.140000000000001 112.34 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.547 ' H ' ' HD2' ' A' ' 143' ' ' ARG . 1.2 mpt_? -80.29 -43.12 21.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.914 0.387 . . . . 71.540000000000006 110.975 -177.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.63 -53.49 57.0 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.244 -0.434 . . . . 75.450000000000003 111.499 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.425 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -59.06 -24.43 62.87 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.492 0.553 . . . . 60.310000000000002 112.492 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.72 -29.19 16.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.91 0.386 . . . . 70.219999999999999 111.663 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -88.38 -49.32 3.73 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.109 -0.567 . . . . 54.5 113.15 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.75 124.13 10.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.747 0.308 . . . . 74.049999999999997 111.22 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -18.41 59.81 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.852 0.358 . . . . 74.129999999999995 111.513 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -78.07 44.45 0.48 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.1 0.476 . . . . 75.439999999999998 111.29 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.87 179.24 35.37 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.171 -0.468 . . . . 75.329999999999998 113.207 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.668 HE22 HG22 ' A' ' 176' ' ' ILE . 46.4 tt0 -98.43 115.85 29.4 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.09 0.471 . . . . 74.329999999999998 111.671 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.2 t -81.05 139.57 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.171 0.51 . . . . 74.099999999999994 111.916 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.796 ' HB1' HD12 ' A' ' 169' ' ' LEU . . . -97.82 133.45 42.32 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.922 -0.581 . . . . 72.430000000000007 110.651 175.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.664 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 45.6 mm -86.77 124.74 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.73 0.3 . . . . 74.010000000000005 111.504 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.425 HG13 ' CD1' ' A' ' 139' ' ' PHE . 46.5 mm -110.57 106.79 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.273 0.559 . . . . 64.549999999999997 112.444 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.507 ' HG2' ' N ' ' A' ' 158' ' ' TYR . 28.4 tt0 -103.1 158.65 16.15 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.277 -0.874 . . . . 75.019999999999996 110.148 172.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.594 ' HB2' ' HB3' ' A' ' 165' ' ' GLU . 0.6 OUTLIER -115.83 115.01 25.52 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.476 0.655 . . . . 73.010000000000005 111.243 168.167 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.443 HH21 HG23 ' A' ' 168' ' ' THR . 3.5 tpp180 -69.04 141.18 54.89 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.408 -0.814 . . . . 75.230000000000004 112.153 -176.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.51 102.97 7.17 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.255 -0.43 . . . . 74.430000000000007 111.388 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 83.5 t -111.01 90.79 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.963 0.411 . . . . 70.030000000000001 110.625 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 58.28 19.69 6.52 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.058 -0.519 . . . . 65.329999999999998 111.833 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 112.3 -23.41 16.03 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 116.265 -0.425 . . . . 71.120000000000005 112.653 -175.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 92.8 m -84.26 118.63 24.3 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.067 0.461 . . . . 64.329999999999998 110.886 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 26.0 mt-10 -85.34 100.32 11.74 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.007 -0.542 . . . . 75.519999999999996 111.236 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 25.2 m -98.4 149.79 36.08 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 111.981 0.363 . . . . 74.209999999999994 111.981 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.605 ' HB3' HG23 ' A' ' 68' ' ' ILE . 18.0 Cg_endo -58.88 136.25 72.34 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.69 2.26 . . . . 75.540000000000006 114.278 -176.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.443 HG23 HH21 ' A' ' 159' ' ' ARG . 83.2 m -143.27 108.83 5.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.762 -0.654 . . . . 74.319999999999993 110.9 176.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.796 HD12 ' HB1' ' A' ' 154' ' ' ALA . 63.5 tp -82.55 145.41 29.76 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.209 -0.45 . . . . 75.019999999999996 111.665 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.664 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 64.7 mtt -126.45 126.47 43.83 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.843 0.354 . . . . 74.420000000000002 111.462 176.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -134.51 129.94 35.9 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.091 -0.504 . . . . 75.209999999999994 111.2 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.453 HG12 ' HZ ' ' A' ' 95' ' ' PHE . 22.3 t -80.32 126.86 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 O-C-N 122.019 -0.426 . . . . 71.0 111.711 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.485 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -72.29 -14.59 61.79 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.332 0.493 . . . . 75.209999999999994 112.332 -179.147 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.506 ' HB3' HG12 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -81.07 -11.69 59.45 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.9 0.381 . . . . 72.219999999999999 111.229 169.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.437 ' HB3' ' HE1' ' A' ' 95' ' ' PHE . . . -96.95 -39.25 9.46 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.981 0.42 . . . . 72.140000000000001 110.804 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.668 HG22 HE22 ' A' ' 152' ' ' GLN . 29.6 pt -119.88 114.07 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.087 0.47 . . . . 63.240000000000002 111.563 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -94.42 130.42 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 109.282 -0.636 . . . . 72.329999999999998 109.282 175.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.43 ' N ' HD12 ' A' ' 177' ' ' ILE . 1.5 pp20? -94.59 153.0 18.07 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.812 0.815 . . . . 73.230000000000004 112.961 -172.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -127.09 99.16 5.58 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.418 -0.81 . . . . 73.409999999999997 109.694 173.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -79.95 97.06 6.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.263 0.554 . . . . 74.319999999999993 110.637 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 48.6 t -130.22 87.96 2.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.579 0.704 . . . . 73.129999999999995 109.798 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 8.0 mp -108.57 93.2 4.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.608 -0.723 . . . . 71.230000000000004 110.552 -176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--O 1.25 1.094 0 CA-C-N 115.673 -0.694 . . . . 55.409999999999997 111.568 -177.179 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtm . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.796 0.332 . . . . 74.150000000000006 111.233 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 15' ' ' SER . 29.8 tp -109.46 130.72 55.49 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.649 -0.5 . . . . 74.319999999999993 109.649 170.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.751 HG13 ' HB3' ' A' ' 179' ' ' GLU . 17.4 pt -117.19 127.79 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.191 0.519 . . . . 63.210000000000001 111.607 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -121.8 147.61 45.74 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.96 -0.564 . . . . 75.200000000000003 112.104 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.412 ' HE3' ' CG2' ' A' ' 177' ' ' ILE . 20.7 ttpp -124.05 117.24 24.26 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.348 -0.387 . . . . 71.319999999999993 111.525 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.79 173.31 6.39 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.031 -0.531 . . . . 64.420000000000002 111.362 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.76 HD11 ' HB1' ' A' ' 175' ' ' ALA . 57.7 mt -78.28 -49.59 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.055 0.455 . . . . 74.129999999999995 111.619 175.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -93.16 -38.62 11.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.006 -0.543 . . . . 73.329999999999998 112.13 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -97.9 17.95 17.0 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.701 -0.682 . . . . 73.540000000000006 110.945 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -47.68 -39.9 18.57 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.095 1.146 . . . . 71.239999999999995 114.095 -169.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.26 -28.0 62.58 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.124 0.416 . . . . 75.019999999999996 112.124 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 35.0 tt0 -89.05 25.11 1.91 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 120.669 0.271 . . . . 74.450000000000003 111.509 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.433 HD22 ' HB ' ' A' ' 3' ' ' ILE . 7.8 tt -34.67 122.09 0.52 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.324 0.65 . . . . 75.329999999999998 111.698 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t -126.64 179.42 5.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.399 -0.364 . . . . 63.119999999999997 111.493 -171.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 2' ' ' LEU . 83.8 p -124.66 148.04 48.2 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.444 -0.344 . . . . 60.509999999999998 111.419 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -138.78 -172.74 3.38 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.514 0.673 . . . . 75.549999999999997 111.691 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -149.28 29.31 0.79 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.406 -0.815 . . . . 74.549999999999997 111.016 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -90.16 113.05 55.89 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 112.026 0.38 . . . . 72.230000000000004 112.026 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.54 77.46 1.74 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.189 1.926 . . . . 75.420000000000002 112.32 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.3 mtt -84.76 143.27 29.24 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.075 0.465 . . . . 72.450000000000003 111.247 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 27.1 ttpp -99.63 118.58 36.46 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.164 -0.471 . . . . 74.450000000000003 111.012 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.4 tp -76.24 135.56 39.67 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.882 0.373 . . . . 75.239999999999995 111.021 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.23 134.65 65.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.2 0.524 . . . . 74.230000000000004 111.656 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.1 t70 61.9 15.93 7.59 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.464 -0.789 . . . . 72.319999999999993 111.951 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 59.0 19.72 7.5 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.002 0.521 . . . . 64.140000000000001 112.112 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.1 tp -119.74 -49.72 2.32 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.099 0.407 . . . . 75.219999999999999 112.099 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.596 HG11 ' HA ' ' A' ' 172' ' ' VAL . 13.6 m -132.53 149.55 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.581 0.586 . . . . 74.230000000000004 112.581 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -86.52 144.43 27.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.262 -0.426 . . . . 70.209999999999994 111.065 174.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 16.2 pt-20 -122.1 133.42 54.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.038 0.447 . . . . 73.040000000000006 110.489 174.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -137.53 135.48 36.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.833 0.349 . . . . 75.230000000000004 110.838 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -92.2 121.54 33.83 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.591 0.589 . . . . 73.519999999999996 112.591 -173.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.92 165.51 12.93 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.08 -0.509 . . . . 55.210000000000001 112.358 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 12.0 mmmm -121.95 145.01 48.53 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 122.367 -0.49 . . . . 73.230000000000004 111.109 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -73.62 109.64 7.28 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.328 0.585 . . . . 75.219999999999999 112.04 -175.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.426 HG22 HD13 ' A' ' 72' ' ' LEU . 26.8 m -134.63 166.2 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.246 -0.433 . . . . 72.310000000000002 110.474 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.454 HG23 HG11 ' A' ' 43' ' ' VAL . 10.5 m -131.4 150.74 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 122.067 -0.395 . . . . 71.129999999999995 111.249 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.646 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 34.9 mmt180 -117.95 115.49 25.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.498 0.666 . . . . 73.530000000000001 112.208 176.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 99.5 mttt -117.38 141.46 48.3 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.251 -1.018 . . . . 74.439999999999998 108.251 165.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.08 -24.21 16.59 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.125 0.787 . . . . 74.420000000000002 113.125 -173.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -130.2 13.69 5.71 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 120.911 -0.662 . . . . 63.030000000000001 113.715 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 37.4 mt-10 -144.3 134.9 24.8 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 117.329 0.564 . . . . 75.530000000000001 111.745 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tp -116.73 51.72 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 122.028 0.918 . . . . 75.319999999999993 110.426 176.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.454 HG11 HG23 ' A' ' 36' ' ' VAL . 4.7 p -72.48 77.97 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.89 0.852 . . . . 65.439999999999998 112.546 -176.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pp -99.03 -0.5 41.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.073 -0.512 . . . . 70.409999999999997 111.938 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.55 112.98 16.18 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.407 -0.36 . . . . 73.340000000000003 111.883 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.3 -173.86 36.95 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.198 -0.525 . . . . 73.129999999999995 113.314 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 p -106.79 178.44 4.56 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.63 -0.335 . . . . 75.340000000000003 111.242 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -87.5 116.56 66.54 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 122.189 -0.319 . . . . 73.230000000000004 111.175 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.01 123.38 3.56 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.585 2.19 . . . . 72.219999999999999 113.138 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.0 t -87.12 117.53 25.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.973 0.416 . . . . 75.510000000000005 111.091 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.04 48.85 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.134 0.492 . . . . 63.299999999999997 110.254 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -49.15 -56.11 10.23 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.619 -0.719 . . . . 75.319999999999993 112.315 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -103.24 88.01 3.02 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.252 0.548 . . . . 74.409999999999997 111.38 176.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.2 92.88 0.91 Allowed Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.121 -0.49 . . . . 62.5 112.074 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.76 -50.46 4.67 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.862 0.69 . . . . 62.340000000000003 112.862 -174.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.23 -50.81 9.11 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.316 0.858 . . . . 75.319999999999993 113.316 -172.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -62.12 156.52 21.41 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.595 0.591 . . . . 74.129999999999995 112.595 -175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 60' ' ' SER . 13.1 p-10 -128.08 27.02 5.72 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.071 -0.513 . . . . 72.209999999999994 112.205 -175.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.51 82.52 0.01 OUTLIER Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.584 -0.341 . . . . 72.140000000000001 112.561 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 58' ' ' ASP . 19.1 t -68.12 92.02 0.38 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.637 0.977 . . . . 62.009999999999998 113.637 -171.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -123.78 29.17 6.62 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 122.638 1.208 . . . . 74.120000000000005 107.908 166.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -82.03 -38.68 24.64 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.158 -1.383 . . . . 71.019999999999996 113.504 -167.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -80.76 26.11 0.42 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.314 0.486 . . . . 74.409999999999997 112.314 -170.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.19 146.77 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 122.655 0.382 . . . . 71.140000000000001 110.268 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.646 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 48.2 mt-10 -74.7 72.06 1.97 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.568 0.699 . . . . 73.430000000000007 110.08 175.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -85.79 129.29 34.87 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.149 -0.932 . . . . 74.239999999999995 112.194 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.92 -149.74 11.68 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.01 -0.615 . . . . 63.009999999999998 112.803 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 28.7 pt -111.45 154.11 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 122.601 -0.352 . . . . 63.119999999999997 111.573 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -41.27 -48.94 3.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.257 0.465 . . . . 65.25 112.257 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.406 HG22 HD23 ' A' ' 169' ' ' LEU . 56.1 mt -49.6 -55.49 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 112.584 0.587 . . . . 72.299999999999997 112.584 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.406 ' HA ' HD11 ' A' ' 76' ' ' LEU . 23.0 m -80.53 -34.76 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.333 0.494 . . . . 75.209999999999994 112.333 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.426 HD13 HG22 ' A' ' 35' ' ' VAL . 87.3 mt -71.03 -40.81 71.52 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.979 0.419 . . . . 75.129999999999995 111.527 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -64.42 -35.98 82.68 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.909 0.385 . . . . 75.239999999999995 111.969 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -101.43 4.81 41.69 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.531 0.567 . . . . 71.319999999999993 112.531 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.0 70.33 0.62 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.158 0.504 . . . . 72.420000000000002 112.149 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.406 HD11 ' HA ' ' A' ' 71' ' ' VAL . 76.5 mt -115.04 135.08 54.61 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.287 -0.415 . . . . 74.310000000000002 111.25 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.18 143.25 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.577 0.227 . . . . 72.439999999999998 111.211 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -88.88 134.05 34.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.408 0.623 . . . . 73.230000000000004 112.631 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.43 138.09 50.6 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.845 -0.616 . . . . 75.5 110.618 171.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.557 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.7 OUTLIER -105.07 144.49 31.81 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.98 -0.554 . . . . 74.120000000000005 110.407 175.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 40.9 t -49.32 -16.68 0.2 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.297 1.591 . . . . 74.519999999999996 115.297 -169.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -93.59 -19.37 21.24 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.558 -0.714 . . . . 73.109999999999999 112.701 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -83.06 -46.51 12.73 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.283 0.563 . . . . 75.310000000000002 111.852 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.572 ' HB2' ' HB2' ' A' ' 87' ' ' MET . 9.9 p-10 -108.17 21.77 16.89 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.601 -0.727 . . . . 71.310000000000002 112.163 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.578 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -36.26 -50.13 0.72 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.92 1.081 . . . . 75.109999999999999 113.92 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.9 t -73.06 -30.48 63.74 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.951 0.405 . . . . 63.530000000000001 111.542 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.572 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 80.2 mtp -67.8 -60.38 2.57 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.197 0.443 . . . . 75.200000000000003 112.197 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.578 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 6.1 p90 -63.4 -28.26 69.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.178 -0.609 . . . . 75.219999999999999 110.654 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -58.2 -40.35 81.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.12 0.486 . . . . 74.040000000000006 110.543 172.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.47 80.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.214 -0.448 . . . . 71.439999999999998 111.048 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -54.68 -54.39 42.35 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.156 -0.475 . . . . 74.540000000000006 111.225 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.5 -35.1 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.52 -0.309 . . . . 74.519999999999996 111.74 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.685 ' HZ1' ' HB2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -60.86 -60.43 3.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.776 0.322 . . . . 75.239999999999995 111.488 177.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -64.96 -38.66 91.69 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.064 0.459 . . . . 75.150000000000006 111.298 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.674 ' HZ ' HD11 ' A' ' 120' ' ' ILE . 41.6 t80 -57.18 -53.25 60.2 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.052 -0.522 . . . . 71.349999999999994 111.838 176.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -61.83 -46.92 87.38 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.845 0.355 . . . . 73.329999999999998 111.496 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.44 -36.05 82.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.647 -0.251 . . . . 73.230000000000004 111.554 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.54 -52.82 34.32 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.513 -0.312 . . . . 74.519999999999996 111.782 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.1 m -58.72 -39.31 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 111.893 0.331 . . . . 73.099999999999994 111.893 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 117' ' ' LYS . 17.6 mm -77.95 -36.44 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.147 0.425 . . . . 74.019999999999996 112.147 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -60.97 -39.16 88.52 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.32 0.581 . . . . 75.540000000000006 109.952 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -71.79 -70.3 0.34 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.468 -0.787 . . . . 70.019999999999996 111.438 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 11.9 tpt -63.01 -43.32 99.11 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.835 0.68 . . . . 74.230000000000004 112.835 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.441 ' HA ' HG13 ' A' ' 113' ' ' VAL . 32.1 tt0 -71.95 -10.96 60.52 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.032 -0.417 . . . . 75.230000000000004 111.591 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.764 ' HZ3' ' HB2' ' A' ' 105' ' ' LYS . 4.4 ttmp? -87.16 -45.16 10.93 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.221 -0.299 . . . . 74.230000000000004 111.367 177.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -80.5 -31.35 37.23 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.933 0.345 . . . . 72.340000000000003 111.933 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -96.04 -51.34 4.48 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 122.268 -0.27 . . . . 74.549999999999997 111.625 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 74.06 -35.34 0.3 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.954 1.465 . . . . 74.439999999999998 114.954 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.6 ' O ' HG23 ' A' ' 113' ' ' VAL . 28.3 t70 -63.19 121.33 13.39 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.648 -0.658 . . . . 73.420000000000002 112.28 -172.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.601 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -46.29 -51.16 15.1 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.438 -0.801 . . . . 74.349999999999994 113.129 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.481 ' N ' ' HG2' ' A' ' 110' ' ' LYS . . . -70.26 -33.52 71.71 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.085 0.402 . . . . 72.319999999999993 112.085 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -77.54 -49.68 14.17 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.032 0.444 . . . . 43.119999999999997 110.846 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 109' ' ' ASP . 31.1 m -66.52 -22.59 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 122.058 -0.401 . . . . 72.200000000000003 111.073 175.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.58 -50.09 74.25 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.809 0.338 . . . . 74.109999999999999 110.322 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.46 -43.81 96.52 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.237 -0.438 . . . . 44.5 111.084 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.41 ' HE1' ' HB3' ' A' ' 174' ' ' GLU . 87.4 t80 -57.73 -58.29 9.02 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.256 -0.429 . . . . 75.540000000000006 111.8 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.593 ' HA ' HG22 ' A' ' 120' ' ' ILE . 17.6 ptpt -65.46 -30.96 71.81 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.293 -0.254 . . . . 75.400000000000006 111.436 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -58.81 -45.74 89.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.369 0.604 . . . . 74.549999999999997 110.501 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -67.44 -57.38 6.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.508 -0.769 . . . . 75.519999999999996 111.92 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.674 HD11 ' HZ ' ' A' ' 95' ' ' PHE . 10.5 tp -66.38 -39.56 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 112.257 0.465 . . . . 73.340000000000003 112.257 -173.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -73.64 -43.52 59.29 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 122.07 -0.394 . . . . 65.420000000000002 110.449 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.0 -34.4 61.86 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.955 -0.64 . . . . 72.540000000000006 112.228 174.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -62.85 -57.69 9.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.42 0.288 . . . . 74.420000000000002 111.076 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.471 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 26.1 m -62.18 -48.88 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 112.414 0.524 . . . . 75.129999999999995 112.414 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.03 -29.02 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.788 -0.57 . . . . 75.109999999999999 111.952 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.9 t -84.87 -33.85 22.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.846 0.355 . . . . 45.240000000000002 111.331 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.453 HD21 HD13 ' A' ' 155' ' ' ILE . 40.2 tp -70.37 -32.76 70.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.218 0.532 . . . . 74.450000000000003 111.251 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.6 mt -80.29 2.34 25.01 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.147 -0.478 . . . . 73.299999999999997 111.888 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.06 82.39 0.32 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.564 0.697 . . . . 74.030000000000001 110.434 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.707 ' HZ2' ' HB3' ' A' ' 130' ' ' LYS . 5.5 ttpm? -65.0 -6.41 8.51 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.716 -0.675 . . . . 75.109999999999999 112.72 -170.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.49 -47.23 86.31 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.93 -0.481 . . . . 73.239999999999995 111.212 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -108.94 -35.4 6.36 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.039 0.447 . . . . 75.109999999999999 111.429 172.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -69.69 -6.65 33.07 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.436 0.532 . . . . 72.120000000000005 112.436 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -52.78 -25.76 12.29 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.118 0.414 . . . . 75.409999999999997 112.118 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -83.33 12.09 5.87 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.211 0.449 . . . . 75.329999999999998 112.211 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 81.5 mt -90.28 156.8 18.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.259 0.552 . . . . 72.310000000000002 112.093 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.31 126.29 25.98 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.967 -0.56 . . . . 74.230000000000004 110.261 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.492 ' HB2' ' CG1' ' A' ' 153' ' ' VAL . 14.0 p90 -116.91 126.78 53.48 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.382 0.61 . . . . 73.200000000000003 111.33 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -97.95 148.12 23.78 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.706 -0.679 . . . . 75.25 112.18 -172.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 14.1 tt -136.04 150.33 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.716 -0.674 . . . . 74.25 110.592 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.01 140.26 46.73 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.132 -0.556 . . . . 71.329999999999998 113.392 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -50.81 -52.9 36.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.854 0.359 . . . . 72.200000000000003 111.588 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -54.25 -30.71 51.3 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.169 -0.469 . . . . 74.430000000000007 112.149 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.8 -56.49 4.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.489 -0.323 . . . . 73.049999999999997 111.266 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.36 -24.21 66.32 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.144 0.497 . . . . 63.030000000000001 111.589 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -54.72 -29.23 52.84 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.572 -0.74 . . . . 74.439999999999998 112.558 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.5 -34.27 0.1 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.558 -0.83 . . . . 60.049999999999997 113.764 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 149' ' ' GLU . . . -56.74 -50.95 70.71 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.47 0.544 . . . . 74.109999999999999 112.47 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 148' ' ' ALA . 10.8 pt-20 58.48 -22.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 125.273 1.429 . . . . 73.109999999999999 114.362 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 148' ' ' ALA . 20.0 t-20 -88.84 60.76 5.66 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.025 0.916 . . . . 75.010000000000005 109.703 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -129.8 172.75 19.96 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.89 -1.05 . . . . 61.130000000000003 112.697 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -79.04 144.25 34.84 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.016 0.436 . . . . 65.049999999999997 111.396 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.492 ' CG1' ' HB2' ' A' ' 138' ' ' PHE . 37.6 t -114.03 137.14 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.194 -0.457 . . . . 75.200000000000003 111.506 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.744 ' HB2' HD13 ' A' ' 169' ' ' LEU . . . -104.87 119.76 39.78 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.18 -0.464 . . . . 74.230000000000004 110.777 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.453 HD13 HD21 ' A' ' 127' ' ' LEU . 60.7 mt -91.07 138.6 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.159 0.429 . . . . 65.299999999999997 112.159 -174.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.1 mm -115.46 120.14 63.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.022 0.439 . . . . 75.439999999999998 111.144 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -110.99 157.68 19.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.617 -0.72 . . . . 73.209999999999994 111.104 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -106.89 115.19 29.75 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.187 0.518 . . . . 65.120000000000005 111.771 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -115.76 140.04 49.59 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.177 -0.465 . . . . 75.519999999999996 111.769 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -102.52 109.41 21.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.505 -0.316 . . . . 72.099999999999994 110.385 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 52.7 t -90.39 89.85 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.043 0.449 . . . . 74.150000000000006 111.111 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.6 t70 55.38 27.33 9.87 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.866 -0.606 . . . . 74.319999999999993 112.308 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 119.23 -1.61 14.44 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.941 -0.647 . . . . 75.120000000000005 113.985 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 41.6 m -118.61 121.13 39.44 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 117.397 0.598 . . . . 75.129999999999995 111.245 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.25 121.45 26.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.293 0.568 . . . . 73.150000000000006 111.796 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.83 137.66 31.46 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 116.202 -0.454 . . . . 74.0 111.873 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.97 118.42 3.39 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.232 2.621 . . . . 72.109999999999999 112.845 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.3 p -103.95 146.19 29.05 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.29 0.567 . . . . 71.310000000000002 112.188 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.744 HD13 ' HB2' ' A' ' 154' ' ' ALA . 69.9 tp -95.47 137.88 33.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.922 -0.581 . . . . 73.049999999999997 110.916 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.447 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 25.3 mmt -123.16 124.31 42.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.5 0.32 . . . . 73.239999999999995 111.608 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 98.1 mt -139.3 130.21 26.29 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.82 0.448 . . . . 73.430000000000007 111.038 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.596 ' HA ' HG11 ' A' ' 27' ' ' VAL . 60.5 t -78.49 121.94 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 112.132 0.419 . . . . 72.200000000000003 112.132 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -76.96 -36.8 56.23 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.834 0.349 . . . . 72.409999999999997 111.828 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.41 ' HB3' ' HE1' ' A' ' 116' ' ' PHE . 7.0 mm-40 -73.94 6.33 3.44 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.232 0.456 . . . . 71.239999999999995 112.232 -172.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.76 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -107.38 -42.75 4.73 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.047 0.451 . . . . 74.109999999999999 111.331 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 22.4 pt -96.05 170.21 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.917 -0.583 . . . . 75.319999999999993 111.233 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.412 ' CG2' ' HE3' ' A' ' 5' ' ' LYS . 5.2 tp -128.1 111.62 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.669 0.747 . . . . 73.409999999999997 111.927 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.2 153.21 22.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.137 -0.938 . . . . 75.109999999999999 111.411 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.751 ' HB3' HG13 ' A' ' 3' ' ' ILE . 21.4 tp10 -140.32 136.47 33.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.184 0.516 . . . . 72.420000000000002 111.685 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -89.25 121.23 31.33 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.389 -0.369 . . . . 73.340000000000003 111.897 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 43.4 t -132.53 86.43 2.32 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.24 0.543 . . . . 73.420000000000002 109.936 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -175.6 178.04 1.65 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.938 -0.574 . . . . 72.439999999999998 111.62 -174.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 . . . . . 0 C--O 1.255 1.394 0 CA-C-N 115.988 -0.551 . . . . 75.430000000000007 111.358 178.02 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.929 0.395 . . . . 75.340000000000003 111.791 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.9 tp -134.16 128.41 33.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.522 -0.308 . . . . 73.120000000000005 110.225 174.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.539 HG21 ' HB3' ' A' ' 15' ' ' SER . 35.2 pt -111.32 128.09 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 120.9 0.381 . . . . 74.040000000000006 111.798 -175.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -124.04 141.69 51.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.16 0.505 . . . . 74.329999999999998 112.073 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.505 ' HB2' ' HZ3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -103.65 115.37 30.38 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.389 -0.823 . . . . 75.340000000000003 110.356 177.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.69 ' HA ' HG23 ' A' ' 176' ' ' ILE . 3.9 m-20 -77.14 169.63 17.99 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.274 0.559 . . . . 71.450000000000003 112.389 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.427 HG21 ' CD2' ' A' ' 8' ' ' PHE . 10.4 tt -88.54 -31.02 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.029 0.442 . . . . 64.120000000000005 111.541 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.554 ' HB2' ' HB2' ' A' ' 152' ' ' GLN . 91.1 m-85 -98.82 -38.25 9.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.219 0.533 . . . . 70.510000000000005 111.933 178.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.7 p -106.82 21.5 17.42 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.552 0.575 . . . . 74.120000000000005 112.552 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 18.1 t70 -45.54 -45.81 13.67 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.053 0.76 . . . . 63.049999999999997 113.053 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.43 -26.98 67.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.51 0.672 . . . . 74.219999999999999 111.236 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -109.39 24.63 12.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.451 -0.795 . . . . 75.439999999999998 111.054 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -44.35 150.13 0.33 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.808 0.67 . . . . 75.129999999999995 112.808 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.5 t -120.8 168.56 11.31 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.621 0.971 . . . . 73.030000000000001 113.621 -168.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.539 ' HB3' HG21 ' A' ' 3' ' ' ILE . 61.0 p -133.95 107.06 7.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.924 -1.035 . . . . 65.120000000000005 110.69 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -120.16 -177.53 3.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.843 0.354 . . . . 74.400000000000006 111.578 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.0 m -147.22 83.55 1.56 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.14 0.495 . . . . 72.549999999999997 111.243 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.49 ' HB2' ' HE2' ' A' ' 30' ' ' PHE . 85.7 m-85 -135.55 161.73 61.37 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.161 -0.472 . . . . 72.5 111.042 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.4 158.86 40.44 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.532 2.155 . . . . 73.340000000000003 112.613 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -144.08 131.17 20.58 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.248 0.547 . . . . 71.340000000000003 112.318 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -123.49 97.52 5.43 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.125 -0.488 . . . . 74.120000000000005 110.706 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.3 tp -76.93 116.77 17.89 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.48 0.548 . . . . 65.510000000000005 112.48 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.1 p -104.64 139.2 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.058 0.456 . . . . 74.430000000000007 111.824 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 59.02 9.56 1.29 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.534 0.734 . . . . 72.219999999999999 111.783 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.7 t70 55.42 31.75 17.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.763 0.792 . . . . 75.430000000000007 110.36 -174.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.1 tp -124.23 -49.8 1.8 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.876 -0.602 . . . . 74.319999999999993 111.214 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.44 HG12 HG22 ' A' ' 172' ' ' VAL . 3.2 m -128.68 143.94 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.581 0.585 . . . . 73.439999999999998 112.581 -177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.497 ' CE2' ' HB3' ' A' ' 173' ' ' LYS . 60.8 m-85 -86.61 130.74 34.37 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.117 -0.492 . . . . 75.209999999999994 111.522 177.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.95 118.44 30.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.02 -0.991 . . . . 71.209999999999994 110.002 173.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.49 ' HE2' ' HB2' ' A' ' 18' ' ' PHE . 6.2 m-85 -108.94 119.43 39.53 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.217 0.451 . . . . 74.040000000000006 112.217 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -94.61 89.44 5.78 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.048 0.451 . . . . 74.25 111.358 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.87 -157.76 17.43 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 116.007 -0.542 . . . . 61.009999999999998 112.881 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -143.06 132.8 23.88 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 122.029 -0.689 . . . . 74.129999999999995 111.635 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -72.08 106.89 4.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.582 0.23 . . . . 74.010000000000005 110.447 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -134.41 164.44 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.209 0.528 . . . . 74.209999999999994 112.222 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 66' ' ' ARG . 29.4 m -138.67 131.88 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.103 -0.499 . . . . 74.439999999999998 110.745 175.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 43.5 ttp180 -118.16 132.02 56.36 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.877 0.37 . . . . 73.25 111.556 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 40' ' ' GLY . 4.6 tmmm? -94.56 99.51 11.65 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.402 -0.363 . . . . 72.030000000000001 110.107 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 62.7 -72.22 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.13 0.572 . . . . 70.129999999999995 111.961 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 38' ' ' LYS . . . -146.17 27.3 1.71 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.937 -0.465 . . . . 74.200000000000003 111.937 176.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -135.23 136.06 41.45 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 122.556 0.342 . . . . 75.150000000000006 111.782 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 mm -78.8 113.19 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.063 0.459 . . . . 75.409999999999997 111.629 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.2 t -126.13 48.71 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.554 0.693 . . . . 74.140000000000001 110.895 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.507 HD13 ' N ' ' A' ' 45' ' ' ALA . 2.4 pp -83.69 -21.21 32.45 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.397 0.517 . . . . 74.540000000000006 112.397 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.507 ' N ' HD13 ' A' ' 44' ' ' LEU . . . -86.46 102.46 14.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.829 0.347 . . . . 73.519999999999996 111.319 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.19 -49.99 0.35 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.161 -0.542 . . . . 60.140000000000001 112.675 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.1 t -71.14 171.83 10.28 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.953 0.406 . . . . 74.450000000000003 111.372 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -106.15 113.97 62.93 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 120.717 0.294 . . . . 75.299999999999997 111.722 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -81.34 110.68 2.27 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.105 2.536 . . . . 73.439999999999998 112.4 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.8 m -132.01 158.81 40.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.089 0.471 . . . . 73.239999999999995 111.907 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.491 ' HB3' ' HG3' ' A' ' 165' ' ' GLU . . . -106.04 -75.46 0.63 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.743 -0.662 . . . . 64.219999999999999 111.187 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -71.66 -33.06 68.55 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.098 0.475 . . . . 74.549999999999997 111.59 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -77.01 97.88 4.79 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.03 -0.532 . . . . 74.340000000000003 111.737 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -145.28 100.4 0.23 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-N 116.014 -0.539 . . . . 52.039999999999999 112.595 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.11 26.99 5.37 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.506 -0.408 . . . . 73.150000000000006 111.834 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 60.23 69.1 0.72 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.414 0.626 . . . . 71.129999999999995 111.014 -176.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -151.3 175.44 12.21 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.974 -0.557 . . . . 74.439999999999998 111.665 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 59.47 11.52 2.32 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.513 0.561 . . . . 71.319999999999993 112.513 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.75 41.92 2.07 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.328 -0.463 . . . . 70.409999999999997 113.132 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.1 m -70.98 -26.73 63.28 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.37 0.268 . . . . 75.129999999999995 111.707 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.7 t70 71.93 -66.28 0.31 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.428 0.691 . . . . 75.5 111.405 -178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.613 ' HG3' HG22 ' A' ' 64' ' ' VAL . 9.1 pt-20 38.71 37.56 0.2 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.4 0.889 . . . . 70.019999999999996 113.4 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 70.7 1.23 3.62 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.084 0.772 . . . . 74.319999999999993 113.084 174.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.613 HG22 ' HG3' ' A' ' 62' ' ' GLU . 55.2 t -66.76 148.35 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 122.027 -0.421 . . . . 74.340000000000003 111.321 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 1.2 mp0 -73.23 68.94 1.06 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.486 0.66 . . . . 75.450000000000003 110.983 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.556 ' HA ' HG12 ' A' ' 36' ' ' VAL . 6.2 ttp180 -83.32 110.69 18.33 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.398 -0.819 . . . . 72.409999999999997 111.709 177.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.25 -153.98 12.45 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.852 -0.689 . . . . 75.540000000000006 112.943 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 167' ' ' PRO . 33.6 pt -112.03 150.52 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.224 -0.574 . . . . 74.040000000000006 111.799 176.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -38.39 -56.87 1.2 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.65 0.78 . . . . 75.040000000000006 112.724 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.4 mt -53.88 -55.16 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.824 0.676 . . . . 71.109999999999999 112.824 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.458 ' HA ' HD11 ' A' ' 76' ' ' LEU . 19.4 m -68.38 -35.2 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.147 0.425 . . . . 71.209999999999994 112.147 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.42 -47.01 68.36 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.066 0.46 . . . . 72.200000000000003 110.852 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -66.64 -44.15 82.75 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.881 -0.6 . . . . 74.239999999999995 111.659 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.454 ' HD2' HD22 ' A' ' 76' ' ' LEU . 78.1 t60 -82.14 -6.04 58.89 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.851 0.358 . . . . 74.549999999999997 111.188 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.714 ' HZ3' ' HB2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 62.34 70.08 0.59 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.611 0.72 . . . . 72.209999999999994 111.865 176.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.648 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 71.7 mt -111.8 137.72 49.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.401 -0.818 . . . . 75.329999999999998 111.418 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.3 p -91.25 143.54 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.081 0.467 . . . . 73.450000000000003 111.563 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -79.44 127.46 32.14 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.078 -0.51 . . . . 75.430000000000007 112.308 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 35.3 mtm -131.11 164.92 24.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.167 0.508 . . . . 75.530000000000001 110.999 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -142.58 158.88 43.21 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.179 -0.464 . . . . 72.230000000000004 111.013 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.8 m -49.71 -27.7 5.12 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.565 0.95 . . . . 73.329999999999998 113.565 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -48.27 -41.15 27.0 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.101 0.477 . . . . 74.230000000000004 111.244 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -105.3 -38.36 6.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.377 0.608 . . . . 71.329999999999998 110.972 174.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -71.9 -13.52 61.68 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.917 0.71 . . . . 63.240000000000002 112.917 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.52 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -43.69 -66.1 0.42 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.858 0.688 . . . . 73.439999999999998 112.858 -177.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.2 t -71.62 -18.28 62.22 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.245 -0.284 . . . . 74.409999999999997 111.487 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.27 -63.54 1.06 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.8 -0.182 . . . . 64.430000000000007 111.168 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 17.7 p90 -59.53 -33.08 70.94 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.854 -0.338 . . . . 74.540000000000006 110.717 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -57.23 -47.41 81.41 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.131 0.491 . . . . 72.209999999999994 110.964 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.14 -38.45 82.17 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.245 -0.434 . . . . 70.030000000000001 111.605 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -65.05 -41.33 95.28 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.669 -0.242 . . . . 73.319999999999993 111.358 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.84 -37.09 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.965 0.412 . . . . 73.329999999999998 110.853 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -58.57 -56.26 24.46 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.161 0.505 . . . . 71.420000000000002 110.855 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -59.78 -45.09 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.895 -0.593 . . . . 74.010000000000005 111.061 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.413 ' CE1' ' HB1' ' A' ' 175' ' ' ALA . 83.0 t80 -56.96 -61.91 2.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.817 -0.629 . . . . 71.120000000000005 111.976 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.45 ' O ' HG21 ' A' ' 100' ' ' ILE . 48.5 mtt -53.62 -50.12 66.38 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 111.899 0.333 . . . . 73.310000000000002 111.899 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.13 -41.98 97.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.773 0.321 . . . . 74.430000000000007 111.638 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -68.57 -48.19 64.86 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.743 0.306 . . . . 74.109999999999999 111.63 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.22 -41.35 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.258 0.466 . . . . 73.340000000000003 112.258 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.45 HG21 ' O ' ' A' ' 96' ' ' MET . 10.5 tp -68.27 -37.73 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 122.113 -0.367 . . . . 74.120000000000005 110.573 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 15.4 t70 -54.82 -60.92 2.7 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.131 0.491 . . . . 74.409999999999997 110.547 175.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -62.36 -34.55 76.91 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.335 -0.393 . . . . 74.439999999999998 111.843 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 10.8 tpt -61.38 -42.34 98.56 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.099 0.476 . . . . 75.510000000000005 110.883 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.7 -8.59 58.85 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 111.883 0.327 . . . . 75.530000000000001 111.883 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 61.7 mmtt -81.58 -27.69 34.18 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.698 -0.626 . . . . 63.219999999999999 111.761 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -102.44 -36.92 8.24 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.694 0.627 . . . . 74.329999999999998 112.694 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -98.57 -51.06 4.05 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.872 -0.517 . . . . 75.430000000000007 111.096 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.63 -36.86 0.27 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.646 0.98 . . . . 75.120000000000005 113.646 167.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -82.79 144.32 30.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.239 0.542 . . . . 75.200000000000003 112.432 -173.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.07 -38.27 79.02 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.627 -0.715 . . . . 75.510000000000005 112.617 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.25 27.26 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.065 0.394 . . . . 65.129999999999995 112.065 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -94.97 -61.05 1.55 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.984 0.421 . . . . 71.329999999999998 111.285 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.7 m -60.91 -27.53 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 113.185 0.809 . . . . 71.140000000000001 113.185 -173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.24 -38.7 88.52 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.04 0.448 . . . . 73.409999999999997 110.567 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.1 -46.22 62.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.199 -0.455 . . . . 70.329999999999998 111.235 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -57.16 -52.22 66.17 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.133 0.492 . . . . 74.25 111.332 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -61.1 -29.74 69.94 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.849 -0.614 . . . . 75.109999999999999 110.515 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -69.38 -46.91 65.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.222 -0.444 . . . . 71.310000000000002 111.635 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -59.61 -51.71 68.64 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.812 0.339 . . . . 65.109999999999999 111.895 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -67.0 -33.64 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 120.769 0.318 . . . . 75.019999999999996 111.507 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.95 -48.61 68.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.911 0.386 . . . . 73.430000000000007 110.399 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.63 -35.75 87.07 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.001 -0.619 . . . . 74.5 112.205 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.406 ' HZ2' ' HE3' ' A' ' 170' ' ' MET . 55.2 t90 -58.3 -57.04 14.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.622 0.369 . . . . 74.299999999999997 111.399 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 m -61.94 -48.2 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.352 0.501 . . . . 74.519999999999996 112.352 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.3 -28.92 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 121.912 -0.492 . . . . 64.5 111.896 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.9 m -82.27 -24.87 34.52 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.05 0.452 . . . . 62.340000000000003 111.031 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.47 -28.13 22.25 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.973 -0.558 . . . . 72.120000000000005 111.828 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.3 mt -79.96 2.43 23.57 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.765 0.654 . . . . 74.310000000000002 112.765 -176.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.47 92.11 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.32 0.581 . . . . 74.010000000000005 111.173 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -54.64 -43.36 72.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.12 0.785 . . . . 75.219999999999999 113.12 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -53.24 -34.87 58.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.351 0.5 . . . . 73.120000000000005 112.351 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.416 ' N ' ' HD2' ' A' ' 132' ' ' ARG . 8.2 mpt_? -102.91 -48.12 4.17 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.26 0.553 . . . . 74.209999999999994 111.206 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.459 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 97.6 m-85 -78.3 -6.6 55.55 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.287 0.847 . . . . 73.430000000000007 113.287 -171.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -12.02 3.53 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.527 -0.733 . . . . 74.219999999999999 111.727 173.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -92.64 18.39 8.8 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.106 0.41 . . . . 55.109999999999999 112.106 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 81.0 mt -88.36 144.71 26.23 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.939 -0.476 . . . . 73.129999999999995 111.65 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.28 122.21 45.76 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.056 -0.52 . . . . 74.310000000000002 110.802 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -97.91 108.6 21.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.855 0.359 . . . . 73.409999999999997 111.189 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.648 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 67.3 m-85 -102.88 130.41 49.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.08 0.467 . . . . 74.209999999999994 111.666 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.441 HD11 ' HA3' ' A' ' 151' ' ' GLY . 14.3 tt -128.31 155.1 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.084 -0.507 . . . . 75.310000000000002 110.9 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.41 143.54 41.44 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.351 -0.452 . . . . 73.040000000000006 113.614 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -50.85 -63.76 1.02 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.196 0.443 . . . . 74.400000000000006 112.196 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 2.6 mmp_? -49.4 -34.12 15.48 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.23 0.456 . . . . 75.150000000000006 112.23 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.673 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . . . -63.88 -56.38 15.78 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.02 0.438 . . . . 63.539999999999999 111.732 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.88 -28.89 69.85 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.801 0.334 . . . . 71.400000000000006 111.634 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.73 -31.52 63.41 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.104 -0.498 . . . . 64.200000000000003 112.148 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.15 -43.93 0.03 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.279 -0.962 . . . . 65.129999999999995 114.301 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.673 ' HB1' ' HA ' ' A' ' 144' ' ' ALA . . . -66.29 86.26 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.196 0.522 . . . . 72.239999999999995 112.129 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.25 4.22 0.75 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.35 0.5 . . . . 75.409999999999997 112.35 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 8' ' ' PHE . 3.2 p-10 -91.93 24.08 3.39 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.158 0.504 . . . . 63.210000000000001 110.381 170.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.587 ' HA3' ' HB3' ' A' ' 144' ' ' ALA . . . -77.56 134.23 14.32 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 114.232 0.453 . . . . 55.32 114.232 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 8' ' ' PHE . 48.1 tt0 -93.98 134.6 36.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 122.558 0.343 . . . . 65.140000000000001 111.005 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 98.7 t -95.01 136.31 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.407 0.521 . . . . 75.510000000000005 112.407 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.76 ' HB3' HD11 ' A' ' 169' ' ' LEU . . . -103.98 136.21 44.05 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.865 -0.607 . . . . 73.040000000000006 110.069 173.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.502 ' HB ' ' HG3' ' A' ' 170' ' ' MET . 62.3 mt -102.53 128.31 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 120.003 -0.679 . . . . 72.340000000000003 112.734 -170.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 46.1 mm -102.5 117.63 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.782 0.325 . . . . 71.219999999999999 111.49 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -106.74 145.49 31.99 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.252 0.549 . . . . 64.040000000000006 112.285 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -77.13 98.14 4.97 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.699 0.761 . . . . 73.340000000000003 110.136 171.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.446 ' HB2' ' OG1' ' A' ' 168' ' ' THR . 0.0 OUTLIER -93.43 97.03 10.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.099 -0.501 . . . . 75.319999999999993 111.11 -174.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 7.4 p-10 -66.99 119.2 11.56 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.162 0.506 . . . . 75.329999999999998 111.217 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.6 t -121.53 105.61 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.084 -0.507 . . . . 73.510000000000005 110.899 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 53.41 34.62 18.53 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.416 0.524 . . . . 71.329999999999998 112.416 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.15 -23.49 27.09 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.284 -0.417 . . . . 72.200000000000003 113.759 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 85.8 m -105.88 113.92 27.76 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.502 -0.411 . . . . 73.140000000000001 111.757 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 49.4 mt-10 -73.48 110.24 7.61 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.754 0.312 . . . . 72.239999999999995 111.156 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.69 140.14 20.82 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 120.747 0.308 . . . . 72.439999999999998 111.145 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.409 ' HB2' HG23 ' A' ' 68' ' ' ILE . 73.4 Cg_endo -74.62 114.35 4.01 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.12 1.88 . . . . 63.130000000000003 112.704 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 159' ' ' ARG . 23.7 p -118.78 150.86 39.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.228 0.537 . . . . 74.310000000000002 111.588 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.76 HD11 ' HB3' ' A' ' 154' ' ' ALA . 38.7 tp -100.4 140.12 35.1 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.044 -0.526 . . . . 74.230000000000004 111.025 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.502 ' HG3' ' HB ' ' A' ' 155' ' ' ILE . 22.2 ptm -123.41 134.63 53.94 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 121.132 0.491 . . . . 61.149999999999999 111.236 177.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 86.3 mt -141.6 148.31 39.03 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.146 -0.934 . . . . 74.530000000000001 111.433 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 27' ' ' VAL . 10.7 t -100.96 122.66 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.254 0.222 . . . . 64.439999999999998 110.745 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -74.13 -5.98 44.92 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.793 -0.567 . . . . 64.519999999999996 112.04 -177.246 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.67 -15.24 60.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.364 0.602 . . . . 75.530000000000001 110.08 170.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 95' ' ' PHE . . . -99.03 -22.88 15.5 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.701 -0.682 . . . . 75.439999999999998 111.67 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.69 HG23 ' HA ' ' A' ' 6' ' ' ASP . 40.3 pt -137.13 130.73 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.281 0.562 . . . . 73.439999999999998 111.972 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.3 mm -104.42 118.99 52.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.316 -0.402 . . . . 74.25 110.305 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.55 146.09 25.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.426 0.631 . . . . 73.140000000000001 112.167 -176.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -131.23 143.89 50.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.985 -0.552 . . . . 75.299999999999997 110.994 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -89.46 105.85 18.07 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.344 0.592 . . . . 74.140000000000001 112.014 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 74.9 m -116.15 88.38 2.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.062 0.458 . . . . 72.329999999999998 110.971 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.56 HD21 ' HG3' ' A' ' 183' ' ' GLU . 0.0 OUTLIER -161.66 19.54 0.11 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.228 0.537 . . . . 72.409999999999997 111.379 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.56 ' HG3' HD21 ' A' ' 182' ' ' LEU . 38.5 mt-10 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 118.435 -0.793 . . . . 74.329999999999998 111.739 -176.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.895 0.379 . . . . 71.5 111.594 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.432 HD13 ' HB3' ' A' ' 178' ' ' GLU . 44.1 tp -95.58 131.44 41.78 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.147 -0.346 . . . . 73.109999999999999 110.851 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.6 mt -121.15 118.97 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 122.245 -0.284 . . . . 72.040000000000006 110.485 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.412 ' O ' HD13 ' A' ' 13' ' ' LEU . 47.1 p90 -116.41 149.27 39.7 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.107 0.78 . . . . 75.040000000000006 113.107 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.651 ' HG3' ' HB2' ' A' ' 10' ' ' ASP . 48.0 tttp -137.07 119.0 15.25 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.544 -1.207 . . . . 75.019999999999996 111.416 -173.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 2.8 m-20 -68.85 173.5 5.25 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.451 0.644 . . . . 75.430000000000007 111.795 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 175' ' ' ALA . 71.6 mt -81.38 -38.78 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.261 0.553 . . . . 72.099999999999994 110.474 168.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -108.69 -44.3 4.07 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.909 -0.587 . . . . 73.549999999999997 112.526 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -91.72 14.41 15.36 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.861 0.363 . . . . 72.099999999999994 111.868 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.651 ' HB2' ' HG3' ' A' ' 5' ' ' LYS . 7.0 p-10 -61.78 -10.47 9.02 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.783 0.66 . . . . 41.439999999999998 112.783 -173.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.77 -27.5 51.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.568 0.699 . . . . 74.109999999999999 110.192 173.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -93.32 24.74 3.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.07 -0.968 . . . . 75.439999999999998 111.868 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 4' ' ' TYR . 62.8 tp -34.15 109.13 0.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.408 0.683 . . . . 74.230000000000004 112.291 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.5 m -113.2 140.77 47.67 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.982 0.734 . . . . 63.340000000000003 112.982 -169.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.6 p -110.83 105.54 14.41 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.755 -0.657 . . . . 73.409999999999997 110.254 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -123.16 179.89 4.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 120.716 0.294 . . . . 75.510000000000005 111.47 -173.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.2 t -109.22 -28.59 8.94 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.892 0.701 . . . . 72.030000000000001 112.892 -176.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -66.27 118.32 51.99 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 112.203 0.446 . . . . 74.540000000000006 112.203 -175.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -91.24 152.83 3.74 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.112 2.542 . . . . 75.120000000000005 113.826 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 20' ' ' MET . 0.6 OUTLIER -114.63 165.77 12.43 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.339 -0.392 . . . . 74.239999999999995 111.113 178.331 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -100.01 120.72 40.26 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.094 -0.379 . . . . 71.420000000000002 110.532 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.1 tp -83.39 120.89 26.45 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.076 0.465 . . . . 70.150000000000006 111.22 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.77 149.07 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.286 -0.415 . . . . 74.439999999999998 111.103 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.6 t70 62.8 9.11 3.42 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 116.436 -0.347 . . . . 73.150000000000006 111.652 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 55.06 23.43 5.21 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.106 0.479 . . . . 64.040000000000006 111.739 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.1 tp -134.16 -43.26 0.79 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.264 -0.425 . . . . 75.129999999999995 111.917 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.3 155.58 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.032 0.444 . . . . 71.310000000000002 112.164 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' A' ' 170' ' ' MET . 90.5 m-85 -92.88 149.28 21.37 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.41 -0.359 . . . . 73.239999999999995 110.752 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -136.42 116.47 13.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.745 0.418 . . . . 74.109999999999999 110.652 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.548 ' CZ ' HD23 ' A' ' 169' ' ' LEU . 16.9 p90 -151.13 134.55 16.2 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.082 1.141 . . . . 73.519999999999996 114.082 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.776 ' HG3' ' HB ' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -98.88 120.8 39.94 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.574 -0.739 . . . . 74.420000000000002 110.798 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.93 -120.25 0.46 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.972 -0.633 . . . . 52.329999999999998 113.158 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -150.64 141.43 22.78 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 122.654 -0.321 . . . . 75.329999999999998 110.442 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -77.66 106.48 9.49 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.653 0.263 . . . . 73.329999999999998 110.957 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.512 HG12 HD21 ' A' ' 44' ' ' LEU . 31.4 m -143.36 171.96 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.455 0.645 . . . . 72.0 112.434 -175.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.96 128.43 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.807 -0.633 . . . . 72.030000000000001 110.686 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.421 HH21 ' CD ' ' A' ' 65' ' ' GLU . 47.4 ttp180 -104.18 113.52 27.13 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.283 0.563 . . . . 71.450000000000003 111.411 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 59.3 tttp -99.09 157.01 16.65 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.61 -0.723 . . . . 73.109999999999999 110.768 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -11.62 7.74 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.991 0.738 . . . . 75.400000000000006 112.991 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.08 -55.07 0.48 Allowed Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.302 -0.475 . . . . 62.109999999999999 113.083 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.47 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -150.38 -173.69 4.53 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.169 0.509 . . . . 74.140000000000001 112.337 -178.172 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 tt -107.96 109.12 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.3 0.572 . . . . 74.299999999999997 110.97 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.556 HG13 ' H ' ' A' ' 44' ' ' LEU . 3.9 p -79.34 -66.29 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 113.49 0.922 . . . . 74.019999999999996 113.49 -172.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.556 ' H ' HG13 ' A' ' 43' ' ' VAL . 6.1 mp 57.62 98.71 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.307 0.575 . . . . 71.420000000000002 111.724 -173.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.85 -20.59 13.53 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.04 -0.527 . . . . 74.209999999999994 112.111 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.39 118.8 1.99 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.217 -0.516 . . . . 54.329999999999998 112.731 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.9 m -150.38 111.63 4.4 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.477 -0.425 . . . . 65.329999999999998 111.859 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -98.11 148.6 34.72 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.46 -0.336 . . . . 70.230000000000004 110.801 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.11 100.74 0.46 Allowed 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.297 1.998 . . . . 74.0 112.809 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.3 m -91.71 23.7 3.46 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.066 0.395 . . . . 73.540000000000006 112.066 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.23 132.83 3.05 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.059 0.392 . . . . 73.310000000000002 112.059 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.8 -65.27 1.03 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.176 0.512 . . . . 75.209999999999994 110.705 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -80.5 -11.42 59.67 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.043 0.449 . . . . 63.530000000000001 111.333 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.6 4.41 60.36 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.271 -0.422 . . . . 61.539999999999999 112.87 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.96 84.27 1.25 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.485 0.659 . . . . 73.129999999999995 110.874 175.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -89.08 -48.34 7.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.351 -0.841 . . . . 71.420000000000002 111.293 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 55.81 34.18 22.95 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.454 0.538 . . . . 73.109999999999999 112.454 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -91.18 -33.27 15.48 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.018 0.437 . . . . 65.239999999999995 110.92 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.93 66.81 2.44 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 116.225 -0.443 . . . . 64.299999999999997 113.625 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.2 p -109.47 108.1 18.48 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.702 0.287 . . . . 73.230000000000004 110.843 177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -157.61 24.31 0.28 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 111.954 0.353 . . . . 73.0 111.954 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.24 117.49 34.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.754 0.311 . . . . 74.439999999999998 110.897 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -74.43 66.04 1.31 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.232 0.539 . . . . 72.439999999999998 111.258 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.1 t -128.79 136.64 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.929 -0.578 . . . . 75.230000000000004 110.159 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' ' 37' ' ' ARG . 48.5 mt-10 -76.35 72.42 3.09 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.788 0.804 . . . . 73.239999999999995 110.146 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -84.11 142.54 30.31 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.916 -1.038 . . . . 74.239999999999995 111.917 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.41 -138.78 6.48 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.063 -0.589 . . . . 73.019999999999996 113.047 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.8 pt -111.16 142.23 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 O-C-N 122.377 -0.484 . . . . 75.150000000000006 111.449 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -44.17 -42.52 6.47 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.593 0.59 . . . . 72.040000000000006 112.593 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.0 mt -47.75 -52.2 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.107 0.48 . . . . 64.549999999999997 112.216 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 26.7 m -83.3 -34.94 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 112.059 -174.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.84 -44.24 96.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.834 0.349 . . . . 73.510000000000005 111.782 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -67.56 -18.41 65.0 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.238 0.458 . . . . 64.430000000000007 112.238 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -111.24 7.15 21.04 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.219 -0.301 . . . . 75.310000000000002 111.393 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp 50.73 52.53 14.72 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.29 0.636 . . . . 70.209999999999994 112.685 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 55.7 mt -91.4 128.16 37.12 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.997 -0.547 . . . . 72.420000000000002 110.644 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.8 p -93.18 147.32 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.584 0.231 . . . . 74.439999999999998 111.26 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.09 140.19 30.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.718 0.77 . . . . 74.239999999999995 112.989 -175.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 65.3 mtm -135.38 166.08 23.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.243 -0.89 . . . . 61.420000000000002 109.609 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.4 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 44.5 t30 -133.16 145.45 50.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.346 0.593 . . . . 72.019999999999996 111.938 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.6 t -42.16 -30.44 0.3 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.928 1.455 . . . . 74.430000000000007 114.928 -170.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.4 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 20.8 p90 -59.96 -32.24 70.63 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.985 -0.447 . . . . 74.420000000000002 111.644 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -101.28 -31.25 11.07 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.763 0.316 . . . . 71.099999999999994 111.132 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -71.78 -12.38 61.27 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.791 0.663 . . . . 71.349999999999994 112.791 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.461 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -31.03 -73.64 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.195 1.184 . . . . 75.299999999999997 114.195 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.2 m -71.03 -23.18 62.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.022 0.378 . . . . 74.230000000000004 112.022 -176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.8 ttm -70.17 -57.3 5.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.62 -0.264 . . . . 72.430000000000007 111.58 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.461 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 11.0 p90 -65.22 -26.14 67.99 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.469 -0.492 . . . . 72.040000000000006 110.816 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.31 -42.24 99.2 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.02 0.438 . . . . 75.420000000000002 110.915 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.22 -36.19 76.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.098 0.475 . . . . 75.030000000000001 111.154 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.17 -55.24 26.81 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.029 -0.532 . . . . 73.409999999999997 111.728 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.1 tp -60.58 -29.5 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.185 0.517 . . . . 74.219999999999999 111.011 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.52 -58.52 8.23 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.819 -0.628 . . . . 75.109999999999999 111.063 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.625 ' HA ' ' HD2' ' A' ' 97' ' ' LYS . 68.1 mttm -64.64 -34.21 77.76 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.178 -0.465 . . . . 75.120000000000005 111.28 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.538 ' HZ ' HG12 ' A' ' 172' ' ' VAL . 66.1 t80 -56.02 -53.44 56.87 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.79 -0.641 . . . . 73.129999999999995 110.889 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -52.45 -46.63 66.54 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.016 0.436 . . . . 74.109999999999999 111.038 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.625 ' HD2' ' HA ' ' A' ' 94' ' ' LYS . 61.9 mttm -52.7 -59.31 4.64 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.813 -0.63 . . . . 73.219999999999999 111.783 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -68.24 -43.12 78.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.036 0.754 . . . . 74.299999999999997 113.036 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.7 m -64.11 -45.03 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.048 0.388 . . . . 74.239999999999995 112.048 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 mm -69.01 -37.19 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 122.064 -0.397 . . . . 73.420000000000002 110.73 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 105' ' ' LYS . 29.5 t70 -59.94 -45.76 91.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.137 0.494 . . . . 74.329999999999998 110.455 174.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -64.41 -50.06 69.09 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.929 -0.578 . . . . 74.409999999999997 111.936 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 49.7 tpp -70.56 -47.35 60.72 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.011 0.434 . . . . 74.349999999999994 112.032 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -73.96 -19.39 60.69 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 122.066 -0.396 . . . . 73.129999999999995 111.43 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 101' ' ' ASP . 86.8 tttt -59.6 -55.03 39.58 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.289 0.566 . . . . 75.219999999999999 111.647 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -102.44 -37.69 7.91 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.594 0.59 . . . . 73.329999999999998 112.594 -174.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -76.63 -53.65 7.74 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.806 0.336 . . . . 74.129999999999995 110.749 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 46.11 11.76 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.865 1.432 . . . . 74.329999999999998 114.865 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 113' ' ' VAL . 12.6 t70 -77.62 109.21 11.4 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.676 -0.64 . . . . 74.200000000000003 110.21 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -54.21 -27.12 32.26 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.146 0.795 . . . . 74.540000000000006 113.146 -174.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.02 -37.0 34.99 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.978 0.418 . . . . 55.109999999999999 111.344 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -74.82 -53.13 9.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.299 -0.41 . . . . 73.349999999999994 111.354 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 109' ' ' ASP . 22.4 m -58.78 -31.31 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 111.991 0.367 . . . . 65.510000000000005 111.991 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.61 -36.92 79.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.814 0.34 . . . . 74.540000000000006 110.469 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.26 -48.89 71.65 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.439 -0.346 . . . . 70.340000000000003 110.855 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -55.94 -52.01 65.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.179 0.514 . . . . 73.239999999999995 111.062 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -56.72 -38.61 72.59 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.843 -0.617 . . . . 75.310000000000002 111.489 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -66.03 -41.34 91.05 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.012 0.434 . . . . 74.010000000000005 111.347 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -66.32 -49.43 67.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.192 -0.458 . . . . 73.510000000000005 111.628 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.9 tp -65.93 -34.35 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.804 0.335 . . . . 73.510000000000005 111.033 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -64.08 -49.0 73.98 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.874 0.368 . . . . 74.409999999999997 110.966 175.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.53 -39.3 92.97 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.047 -0.596 . . . . 71.219999999999999 112.527 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 53.5 t90 -61.38 -56.67 17.69 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.331 0.252 . . . . 74.209999999999994 111.327 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.43 -41.89 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.645 0.609 . . . . 74.310000000000002 112.645 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.5 p -64.03 -33.58 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.89 -0.506 . . . . 73.510000000000005 111.861 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.5 t -80.17 -40.43 27.28 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.089 0.471 . . . . 75.519999999999996 111.139 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.471 HD21 HD13 ' A' ' 155' ' ' ILE . 39.1 tp -67.43 -42.28 83.42 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.279 0.474 . . . . 73.230000000000004 112.279 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.2 mt -72.5 1.4 8.16 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.435 0.531 . . . . 72.450000000000003 112.435 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.1 72.49 0.18 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.523 0.678 . . . . 64.319999999999993 110.623 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -59.49 -22.13 61.13 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.622 -0.717 . . . . 75.430000000000007 112.319 -174.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.18 -31.03 63.05 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.203 0.525 . . . . 60.399999999999999 110.948 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -109.31 -37.31 5.79 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.812 -0.631 . . . . 74.219999999999999 111.545 174.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -93.23 -5.73 49.26 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.656 1.354 . . . . 74.219999999999999 114.656 -169.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -58.7 -13.56 6.26 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.096 0.862 . . . . 73.010000000000005 111.806 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -90.1 24.46 2.47 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.233 -0.44 . . . . 63.119999999999997 112.058 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.0 mt -88.36 153.88 20.83 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.0 0.429 . . . . 74.430000000000007 111.001 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.653 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -105.18 112.41 25.53 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.884 0.374 . . . . 61.340000000000003 111.286 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -98.43 107.18 19.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.906 0.384 . . . . 75.120000000000005 110.946 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.408 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 59.7 m-85 -97.82 143.53 28.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.161 0.505 . . . . 74.420000000000002 112.297 -177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.416 HG21 ' HB2' ' A' ' 145' ' ' ALA . 14.3 tt -134.97 151.47 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.929 -0.578 . . . . 74.25 111.06 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.44 150.68 49.28 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 114.478 0.551 . . . . 54.43 114.478 -176.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -47.3 -58.08 4.51 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.295 0.638 . . . . 74.200000000000003 112.104 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -65.5 -45.55 83.14 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.868 0.366 . . . . 74.219999999999999 111.691 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.54 -38.01 79.91 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.413 0.523 . . . . 64.239999999999995 112.413 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.416 ' HB2' HG21 ' A' ' 140' ' ' ILE . . . -63.31 -54.5 36.14 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.177 0.513 . . . . 70.430000000000007 111.783 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -68.06 -40.53 82.76 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.272 -0.422 . . . . 74.450000000000003 111.146 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.2 -20.77 79.6 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.404 -0.426 . . . . 64.239999999999995 113.681 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 63.08 21.91 13.14 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.845 0.683 . . . . 73.109999999999999 112.845 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -73.45 82.43 1.45 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.655 0.613 . . . . 72.430000000000007 112.655 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.6 m120 74.24 -41.91 0.49 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.834 0.854 . . . . 73.239999999999995 113.033 172.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.09 78.7 1.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.363 -0.446 . . . . 64.439999999999998 114.095 177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -70.6 102.0 2.16 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.224 -0.574 . . . . 74.310000000000002 109.699 172.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 96.6 t -86.65 125.01 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 113.239 0.829 . . . . 72.450000000000003 113.239 -172.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.543 ' HB1' HD13 ' A' ' 169' ' ' LEU . . . -92.86 113.29 25.53 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.703 -0.681 . . . . 75.219999999999999 109.669 169.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.471 HD13 HD21 ' A' ' 127' ' ' LEU . 55.5 mt -92.13 112.98 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.384 0.513 . . . . 74.5 112.384 -170.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.653 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 49.2 mm -90.74 106.17 17.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 120.837 0.351 . . . . 65.319999999999993 110.637 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -106.92 132.02 53.34 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.688 -0.687 . . . . 75.430000000000007 111.279 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -89.43 138.47 31.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.212 -0.449 . . . . 74.299999999999997 111.409 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -137.63 119.65 15.45 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.746 0.307 . . . . 73.219999999999999 111.533 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -85.78 92.33 8.58 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.574 0.702 . . . . 74.230000000000004 111.223 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.45 102.55 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.109 -0.496 . . . . 73.319999999999993 110.42 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 58.64 19.27 6.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.241 0.543 . . . . 65.120000000000005 111.038 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.47 -12.93 33.19 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.043 -0.526 . . . . 60.350000000000001 113.229 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.5 m -84.25 115.58 22.53 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.451 -0.441 . . . . 74.040000000000006 111.074 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.42 117.56 15.32 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.359 0.504 . . . . 71.530000000000001 112.359 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.776 ' HB ' ' HG3' ' A' ' 31' ' ' LYS . 25.7 m -128.82 112.32 18.84 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 121.012 0.434 . . . . 75.540000000000006 111.595 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.55 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 6.9 Cg_exo -75.1 113.63 3.83 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.521 2.147 . . . . 71.549999999999997 112.377 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.493 HG21 ' HB2' ' A' ' 31' ' ' LYS . 44.2 p -109.3 159.05 17.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.59 -0.277 . . . . 74.219999999999999 111.504 -176.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.548 HD23 ' CZ ' ' A' ' 30' ' ' PHE . 23.0 tp -104.73 126.8 52.17 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.9 0.381 . . . . 74.430000000000007 111.038 177.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.596 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 48.6 ttm -105.01 126.12 51.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.281 -0.872 . . . . 64.129999999999995 110.993 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.451 ' HB3' HD11 ' A' ' 176' ' ' ILE . 94.4 mt -137.03 123.07 20.29 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.034 -0.53 . . . . 62.240000000000002 111.36 -178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.538 HG12 ' HZ ' ' A' ' 95' ' ' PHE . 22.6 t -74.85 122.01 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 122.095 -0.378 . . . . 74.219999999999999 111.425 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -11.33 60.72 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.893 0.701 . . . . 73.219999999999999 112.893 -176.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -91.83 -11.18 37.25 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.815 0.341 . . . . 74.129999999999995 111.598 174.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.491 ' HB3' ' HE1' ' A' ' 95' ' ' PHE . . . -96.14 -38.44 10.16 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.381 0.61 . . . . 64.299999999999997 110.232 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.451 HD11 ' HB3' ' A' ' 171' ' ' LEU . 32.4 pt -127.45 118.94 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.371 -0.831 . . . . 73.019999999999996 109.28 168.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.8 tp -94.6 110.86 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.511 0.672 . . . . 65.319999999999993 111.563 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.44 ' HG2' ' HH ' ' A' ' 28' ' ' TYR . 16.7 mm-40 -79.57 115.81 19.41 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.609 -0.723 . . . . 74.340000000000003 110.585 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.422 ' O ' HD12 ' A' ' 2' ' ' LEU . 10.1 tp10 -92.92 116.29 28.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.455 0.645 . . . . 71.030000000000001 109.856 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -92.13 96.5 10.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.399 -0.819 . . . . 74.230000000000004 112.999 -167.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 73.0 m -124.17 88.33 2.89 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.781 -0.645 . . . . 61.219999999999999 109.454 169.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.475 HD23 ' N ' ' A' ' 182' ' ' LEU . 1.8 mm? -98.91 -40.35 8.13 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.074 0.464 . . . . 75.400000000000006 111.276 -174.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.537 -0.744 . . . . 73.329999999999998 111.255 -178.143 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 111.917 0.34 . . . . 73.420000000000002 111.917 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' A' ' 178' ' ' GLU . 38.1 tp -75.22 122.93 24.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.759 0.314 . . . . 71.310000000000002 111.261 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.686 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 50.7 mt -97.59 120.79 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.586 0.232 . . . . 73.510000000000005 111.016 -174.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.43 ' CE1' ' HB2' ' A' ' 14' ' ' SER . 34.9 p90 -107.85 139.27 42.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.704 0.631 . . . . 75.540000000000006 112.704 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.605 ' HB2' HD11 ' A' ' 13' ' ' LEU . 52.0 tttp -130.02 122.16 27.87 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.805 -1.089 . . . . 65.329999999999998 111.071 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.609 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 33.1 t70 -80.54 173.31 12.72 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.484 0.183 . . . . 75.209999999999994 110.552 175.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.5 mt -75.72 -46.23 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.836 -0.54 . . . . 73.019999999999996 111.698 176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -108.49 -41.27 4.88 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.273 0.558 . . . . 74.430000000000007 112.122 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.4 16.55 7.37 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.27 0.628 . . . . 64.209999999999994 111.804 -175.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.609 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 10.7 p-10 -59.86 -4.26 0.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.952 1.093 . . . . 74.5 113.952 -170.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.53 -19.66 64.97 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.877 -0.514 . . . . 53.530000000000001 111.331 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.63 23.35 1.68 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.611 0.244 . . . . 73.340000000000003 111.358 170.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 5' ' ' LYS . 57.2 tp -49.28 104.04 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.516 0.326 . . . . 74.040000000000006 110.53 173.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.43 ' HB2' ' CE1' ' A' ' 4' ' ' TYR . 70.0 m -133.51 147.61 51.63 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.223 0.823 . . . . 75.230000000000004 113.223 -170.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.2 p -82.51 88.84 6.62 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.632 -0.713 . . . . 54.43 110.568 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -90.11 179.35 5.95 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.766 -0.652 . . . . 72.219999999999999 111.855 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.8 p -161.85 25.99 0.12 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.267 0.469 . . . . 72.140000000000001 112.267 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -89.69 149.87 43.02 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-O 120.6 0.238 . . . . 72.450000000000003 111.625 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.97 72.67 1.53 Allowed 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.804 2.336 . . . . 75.420000000000002 113.461 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 55.0 ttp -87.69 115.36 25.08 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.27 -0.423 . . . . 73.530000000000001 110.793 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -102.44 159.05 15.76 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.699 0.285 . . . . 74.319999999999993 111.67 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.9 tp -104.86 142.53 34.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.033 0.444 . . . . 62.039999999999999 111.408 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.483 HG12 HG23 ' A' ' 27' ' ' VAL . 7.2 p -134.13 141.12 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-N 116.144 -0.48 . . . . 73.219999999999999 111.115 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 56.83 23.61 8.27 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.763 0.653 . . . . 74.349999999999994 112.763 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 60.91 3.98 0.73 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.041 0.756 . . . . 55.509999999999998 113.041 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 120' ' ' ILE . 41.0 tp -125.3 -43.56 1.92 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.945 0.72 . . . . 71.310000000000002 112.945 -169.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.483 HG23 HG12 ' A' ' 23' ' ' VAL . 1.2 m -123.82 149.4 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.284 0.476 . . . . 72.540000000000006 112.284 -175.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 58.6 m-85 -85.84 147.6 26.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.888 0.375 . . . . 73.310000000000002 111.337 176.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.429 ' HB2' ' NH2' ' A' ' 159' ' ' ARG . 14.9 pt-20 -121.1 137.98 54.41 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.009 -0.541 . . . . 74.439999999999998 110.941 176.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -150.75 113.16 4.64 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.404 -0.362 . . . . 75.430000000000007 110.119 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -75.07 135.38 41.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.172 0.51 . . . . 74.099999999999994 112.331 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.54 133.37 11.43 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.335 -0.46 . . . . 63.210000000000001 112.184 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -91.92 152.41 20.07 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.332 0.566 . . . . 74.150000000000006 112.173 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -71.11 105.28 3.31 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.568 -0.742 . . . . 65.310000000000002 111.636 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.498 HG22 HD11 ' A' ' 72' ' ' LEU . 19.7 m -143.99 -177.97 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.977 0.418 . . . . 75.299999999999997 111.595 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 44' ' ' LEU . 23.6 m -119.12 145.74 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 112.382 0.512 . . . . 64.019999999999996 112.382 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.694 ' HB3' HD23 ' A' ' 72' ' ' LEU . 7.6 tpm_? -141.15 108.15 5.44 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.577 0.703 . . . . 74.310000000000002 110.807 175.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 88.5 tttt -104.49 128.76 52.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.631 -0.713 . . . . 73.120000000000005 109.686 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.87 85.29 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.54 0.686 . . . . 74.319999999999993 110.266 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.17 -56.27 0.49 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-N 115.179 -0.919 . . . . 71.430000000000007 112.402 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.503 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 36.2 tt0 -137.72 169.25 18.11 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.409 0.283 . . . . 64.349999999999994 110.53 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.481 HD13 HD21 ' A' ' 44' ' ' LEU . 12.0 tt -144.39 130.35 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 121.948 -0.47 . . . . 73.010000000000005 111.894 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.04 82.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 120.843 0.354 . . . . 74.319999999999993 111.048 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.481 HD21 HD13 ' A' ' 42' ' ' ILE . 4.3 pp -104.59 156.56 17.86 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.166 0.507 . . . . 70.120000000000005 112.161 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.34 12.79 3.02 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.943 -0.571 . . . . 72.5 111.097 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.02 -98.41 0.79 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.284 -0.484 . . . . 72.409999999999997 112.897 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.2 t -97.3 123.84 41.23 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.524 -0.397 . . . . 73.319999999999993 110.952 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -105.33 119.28 53.45 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 120.615 0.245 . . . . 72.310000000000002 111.246 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -73.69 38.16 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.288 2.658 . . . . 75.299999999999997 113.675 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -99.38 -173.86 2.59 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.801 0.334 . . . . 73.140000000000001 111.418 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.89 -2.8 10.52 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.713 1.005 . . . . 61.5 113.713 -174.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -147.96 122.55 9.81 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.548 0.69 . . . . 73.439999999999998 111.379 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -88.44 -43.62 11.33 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.4 -0.818 . . . . 74.099999999999994 111.947 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.21 -114.67 0.07 OUTLIER Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.435 -0.412 . . . . 71.030000000000001 113.217 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 176.2 132.72 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.976 0.417 . . . . 74.099999999999994 111.752 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -130.09 99.44 5.07 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.163 0.506 . . . . 63.350000000000001 110.262 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -110.8 127.6 55.44 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.399 0.618 . . . . 75.439999999999998 112.035 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -102.09 71.33 1.25 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.941 -0.572 . . . . 73.439999999999998 110.075 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 136.12 84.98 0.18 Allowed Glycine 0 CA--C 1.529 0.968 0 CA-C-N 115.769 -0.65 . . . . 70.310000000000002 112.345 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.42 ' O ' HG22 ' A' ' 64' ' ' VAL . 84.9 p -100.4 32.66 2.96 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.916 0.709 . . . . 75.439999999999998 112.916 -171.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.73 -56.04 1.6 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.758 0.651 . . . . 72.430000000000007 112.758 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -55.89 -57.61 11.34 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.16 0.43 . . . . 73.310000000000002 112.16 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -137.15 79.62 1.76 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.965 0.412 . . . . 72.019999999999996 110.359 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 60' ' ' SER . 41.0 t -49.18 -73.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 112.753 0.649 . . . . 75.340000000000003 112.753 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 33.6 tt0 66.16 -10.13 0.26 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.354 0.872 . . . . 73.230000000000004 113.354 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -111.2 135.54 51.59 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.4 -0.812 . . . . 75.519999999999996 111.862 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.405 ' HA3' HD21 ' A' ' 72' ' ' LEU . . . 169.56 -170.53 42.74 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.044 -1.074 . . . . 53.439999999999998 113.77 169.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.7 pt -103.57 146.65 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.797 -0.237 . . . . 74.400000000000006 110.556 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -38.99 -53.15 1.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.997 0.74 . . . . 73.319999999999993 112.997 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.594 HG22 HD21 ' A' ' 169' ' ' LEU . 60.7 mt -49.04 -62.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 112.673 0.62 . . . . 74.230000000000004 112.673 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 m -66.12 -31.99 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.261 -0.427 . . . . 74.150000000000006 112.031 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.694 HD23 ' HB3' ' A' ' 37' ' ' ARG . 76.0 mt -76.59 -33.02 58.45 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.063 0.459 . . . . 71.319999999999993 111.39 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -73.29 -42.71 62.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.083 -0.508 . . . . 65.420000000000002 111.516 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -94.77 -3.43 49.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 111.782 0.29 . . . . 73.530000000000001 111.782 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 65.24 71.63 0.44 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.296 0.57 . . . . 74.299999999999997 112.195 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 49.9 mt -108.7 128.51 54.92 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.754 -0.657 . . . . 74.329999999999998 110.595 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.4 p -89.57 149.33 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.804 0.335 . . . . 72.549999999999997 111.459 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.41 148.83 35.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.401 0.619 . . . . 71.319999999999993 112.619 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.683 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 85.4 mtp -140.16 153.09 46.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.425 -0.807 . . . . 74.310000000000002 109.956 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.529 ' HB2' ' HE1' ' A' ' 82' ' ' TYR . 13.7 m120 -133.29 139.74 47.06 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.236 0.541 . . . . 73.239999999999995 112.081 -174.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 52.0 t -46.22 -36.72 6.35 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.502 1.297 . . . . 71.409999999999997 114.502 -172.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.529 ' HE1' ' HB2' ' A' ' 80' ' ' ASN . 1.3 p90 -63.57 -27.44 69.25 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.487 0.551 . . . . 74.319999999999993 112.487 -175.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -102.18 -31.77 10.42 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.452 0.538 . . . . 74.439999999999998 112.452 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.46 ' O ' ' HD1' ' A' ' 88' ' ' PHE . 9.8 m-20 -76.57 -5.95 49.85 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.473 0.545 . . . . 74.510000000000005 112.473 -174.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.489 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . . . -34.19 -72.76 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.005 1.113 . . . . 60.049999999999997 114.005 -172.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.7 t -64.59 -31.84 73.24 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.88 0.372 . . . . 65.519999999999996 111.553 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.634 ' HE1' ' HA ' ' A' ' 87' ' ' MET . 25.4 mmt -64.64 -63.89 1.01 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.206 -0.452 . . . . 75.310000000000002 112.175 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.489 ' HE1' ' HA ' ' A' ' 85' ' ' ALA . 1.8 p90 -70.77 -26.69 63.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.133 -0.354 . . . . 71.430000000000007 111.461 -176.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -68.01 -41.35 82.34 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.015 0.436 . . . . 72.430000000000007 110.11 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -40.44 81.61 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.85 0.357 . . . . 74.409999999999997 111.174 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -61.27 -51.0 70.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.368 -0.378 . . . . 74.150000000000006 111.695 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.0 tp -62.69 -32.3 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.821 0.343 . . . . 73.049999999999997 111.285 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -68.55 -55.85 10.28 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.727 0.269 . . . . 70.319999999999993 111.727 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.659 ' HZ2' ' HB3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -57.71 -37.24 73.17 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.071 0.463 . . . . 74.209999999999994 110.677 177.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.635 ' HZ ' HG12 ' A' ' 172' ' ' VAL . 26.0 t80 -61.32 -54.48 43.36 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.034 -0.53 . . . . 74.319999999999993 111.284 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -53.78 -49.6 67.91 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.321 -0.4 . . . . 72.319999999999993 111.267 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.1 -38.45 90.77 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.679 -0.237 . . . . 74.420000000000002 111.438 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -64.23 -52.09 60.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.691 0.282 . . . . 65.329999999999998 111.702 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.3 m -64.01 -42.62 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 111.826 0.306 . . . . 75.109999999999999 111.826 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.6 mm -62.98 -45.45 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.851 0.358 . . . . 75.200000000000003 110.748 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.608 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 18.0 t70 -56.3 -48.09 77.37 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.293 -0.412 . . . . 74.420000000000002 111.634 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -66.67 -29.03 68.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.769 0.319 . . . . 73.519999999999996 111.536 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.0 tpt -75.58 -54.45 6.98 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.055 0.455 . . . . 74.430000000000007 111.367 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -54.05 -34.04 59.01 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.343 0.497 . . . . 74.030000000000001 112.343 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -51.4 -36.85 45.36 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.293 -0.255 . . . . 72.340000000000003 111.353 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -116.66 -5.87 11.62 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.257 0.836 . . . . 71.150000000000006 113.257 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -141.41 35.26 1.67 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.607 0.595 . . . . 75.140000000000001 112.607 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -5.82 1.07 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.749 1.388 . . . . 75.109999999999999 114.749 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 111' ' ' ALA . 4.4 m-20 -74.99 76.04 2.2 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.61 -0.681 . . . . 72.430000000000007 112.413 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt 37.52 -79.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.168 1.387 . . . . 73.209999999999994 114.655 171.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 109' ' ' ASP . . . -51.19 -42.82 61.14 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.059 0.762 . . . . 72.549999999999997 113.059 -170.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.22 -56.32 17.63 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.946 0.403 . . . . 75.209999999999994 111.882 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.8 m -67.9 -32.42 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.591 0.589 . . . . 71.519999999999996 112.591 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.69 -34.58 62.67 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.326 -0.233 . . . . 74.409999999999997 111.189 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.34 -45.41 72.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.198 0.523 . . . . 73.140000000000001 111.009 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -61.18 -46.72 89.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.193 0.52 . . . . 73.010000000000005 110.363 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -59.67 -32.58 70.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.921 -0.581 . . . . 74.219999999999999 111.307 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' A' ' 118' ' ' LYS . 8.9 tppt? -60.17 -45.44 93.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.171 0.51 . . . . 72.0 110.86 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -68.26 -46.88 69.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.07 -0.514 . . . . 75.549999999999997 111.189 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.499 HD12 HD21 ' A' ' 26' ' ' LEU . 29.8 mm -58.97 -43.58 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.768 0.318 . . . . 75.540000000000006 111.365 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -63.04 -45.23 93.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.569 0.223 . . . . 73.239999999999995 110.719 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.08 -42.6 99.85 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.95 -0.643 . . . . 71.150000000000006 112.246 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 40.1 t90 -61.39 -49.94 74.88 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.493 0.317 . . . . 75.420000000000002 111.294 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.95 -42.05 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.388 0.514 . . . . 74.129999999999995 112.388 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.75 -25.28 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.243 0.544 . . . . 73.219999999999999 110.938 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.3 m -86.46 -51.55 6.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 111.117 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.408 HD11 HG23 ' A' ' 155' ' ' ILE . 27.8 tp -59.55 -35.77 74.89 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.184 0.516 . . . . 74.439999999999998 111.864 -177.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.7 mt -85.25 3.71 38.19 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.075 -0.511 . . . . 73.540000000000006 112.073 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 133' ' ' PHE . . . -62.45 97.74 0.1 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.207 0.527 . . . . 70.540000000000006 110.849 176.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 28.7 ttpp -45.33 -64.51 0.7 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.067 1.136 . . . . 72.040000000000006 114.067 -170.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.41 -46.55 85.86 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.238 0.829 . . . . 72.530000000000001 113.238 -168.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -73.47 -50.99 18.75 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.359 0.6 . . . . 74.230000000000004 111.43 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 129' ' ' ALA . 30.1 m-85 -82.43 -5.78 58.88 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.848 -0.614 . . . . 75.200000000000003 112.653 -173.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 26.1 ttpp -50.01 -22.84 1.73 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.102 0.477 . . . . 74.400000000000006 111.683 170.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.58 ' N ' HD21 ' A' ' 135' ' ' ASN . 0.8 OUTLIER -82.66 15.07 2.76 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.313 0.486 . . . . 73.049999999999997 112.313 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.534 HD21 ' HG2' ' A' ' 157' ' ' GLU . 49.5 mt -89.52 161.72 16.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.32 0.581 . . . . 73.329999999999998 112.212 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -123.7 126.33 46.35 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.776 -0.647 . . . . 63.409999999999997 111.138 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.683 ' HB2' ' HB2' ' A' ' 79' ' ' MET . 43.6 m-85 -96.91 133.55 41.4 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.125 -0.324 . . . . 74.430000000000007 110.125 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 58.2 m-85 -128.74 131.02 47.85 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.084 -0.385 . . . . 72.340000000000003 111.561 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.573 HG21 ' HB2' ' A' ' 145' ' ' ALA . 15.4 tt -125.24 148.07 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 120.976 0.417 . . . . 74.409999999999997 111.375 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.85 140.88 45.56 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 114.373 0.509 . . . . 64.349999999999994 114.373 -176.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -42.03 -54.2 3.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.308 0.643 . . . . 72.25 112.115 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -62.5 -35.71 80.23 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.998 0.428 . . . . 72.540000000000006 112.137 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.9 -37.16 48.56 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.146 0.425 . . . . 72.099999999999994 112.146 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.573 ' HB2' HG21 ' A' ' 140' ' ' ILE . . . -62.81 -56.2 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.932 0.396 . . . . 75.329999999999998 111.944 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.09 -21.44 58.94 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.488 -0.324 . . . . 51.409999999999997 111.429 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -72.6 -21.87 79.32 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.954 -0.641 . . . . 75.329999999999998 112.423 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 61.15 42.05 12.78 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.263 0.468 . . . . 73.540000000000006 112.263 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.45 4.35 53.37 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.591 0.589 . . . . 73.510000000000005 112.591 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.4 p30 41.91 35.68 0.56 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.344 0.658 . . . . 74.5 112.447 -175.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.68 -135.43 1.01 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.117 -0.492 . . . . 74.140000000000001 114.269 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -67.24 104.25 1.43 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.764 0.653 . . . . 73.450000000000003 112.764 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.36 118.68 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.215 0.531 . . . . 63.210000000000001 110.834 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.705 ' HB2' HD13 ' A' ' 169' ' ' LEU . . . -79.86 124.2 28.44 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.949 -0.569 . . . . 65.219999999999999 111.209 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 43.3 mm -89.59 120.0 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.673 0.273 . . . . 72.430000000000007 111.5 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.3 mm -99.38 107.51 20.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-O 120.971 0.415 . . . . 72.230000000000004 111.012 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.534 ' HG2' HD21 ' A' ' 136' ' ' LEU . 0.4 OUTLIER -111.49 137.43 49.31 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.467 -0.788 . . . . 70.540000000000006 109.967 -178.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -92.19 123.92 35.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.152 0.501 . . . . 75.430000000000007 112.061 -174.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.429 ' NH2' ' HB2' ' A' ' 29' ' ' GLU . 77.8 mtm180 -130.16 154.3 47.66 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.278 0.561 . . . . 75.450000000000003 112.193 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -83.2 143.92 30.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.777 0.658 . . . . 74.129999999999995 112.777 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.1 t -128.71 87.9 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.749 -0.659 . . . . 74.349999999999994 109.65 167.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 48.37 41.92 17.31 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.835 0.68 . . . . 70.049999999999997 112.835 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.72 -23.26 22.33 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.294 -0.479 . . . . 73.340000000000003 113.21 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 91.7 m -95.52 106.15 18.2 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.486 -0.42 . . . . 74.230000000000004 111.352 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.54 112.64 14.53 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.245 -0.434 . . . . 60.310000000000002 111.091 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 35.7 m -119.37 141.72 31.2 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 112.083 0.401 . . . . 75.400000000000006 112.083 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 166' ' ' VAL . 8.0 Cg_exo -73.64 114.77 4.12 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.752 2.302 . . . . 73.319999999999993 112.117 174.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.8 p -109.37 140.79 42.62 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.927 0.394 . . . . 64.400000000000006 111.789 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' A' ' 154' ' ' ALA . 64.1 tp -77.54 145.16 37.1 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.97 -0.559 . . . . 74.010000000000005 111.962 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.488 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 48.1 ttm -130.18 124.49 32.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.766 -0.652 . . . . 73.319999999999993 110.909 176.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.87 161.23 33.49 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.05 -0.722 . . . . 73.439999999999998 109.05 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.635 HG12 ' HZ ' ' A' ' 95' ' ' PHE . 44.1 t -96.39 131.23 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.501 -0.749 . . . . 73.540000000000006 112.114 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.556 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 14.2 tmtt? -56.34 -55.69 30.34 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.185 -0.461 . . . . 74.049999999999997 111.611 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -75.25 4.6 6.76 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.017 0.377 . . . . 75.019999999999996 112.017 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.26 -21.02 17.5 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.261 0.553 . . . . 75.5 110.473 173.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 68.0 mt -118.73 108.97 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.853 -0.612 . . . . 75.409999999999997 110.587 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -92.16 113.96 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.118 0.485 . . . . 75.329999999999998 110.503 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.491 ' HB2' HD13 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -91.8 152.68 20.02 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.621 0.724 . . . . 75.319999999999993 112.771 -174.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.686 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 9.3 tp10 -114.83 110.87 20.34 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.581 -0.736 . . . . 73.030000000000001 109.336 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -81.04 95.1 6.72 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.261 0.553 . . . . 73.099999999999994 112.302 -171.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 52.9 t -134.32 96.93 3.7 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.585 -0.734 . . . . 74.299999999999997 109.834 171.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 64.0 mt -119.36 111.46 18.2 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.229 0.455 . . . . 64.430000000000007 112.229 -172.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.951 -0.547 . . . . 64.519999999999996 111.18 175.139 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.696 0.284 . . . . 75.049999999999997 111.308 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.7 tp -104.19 147.38 27.52 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.153 0.501 . . . . 70.540000000000006 111.203 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.26 141.0 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.545 -0.298 . . . . 74.200000000000003 110.565 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -122.92 158.75 29.71 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 121.904 -0.498 . . . . 73.140000000000001 111.461 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 5.4 ptpp? -139.04 111.04 7.27 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.136 -0.483 . . . . 75.519999999999996 111.754 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 175' ' ' ALA . 7.0 m-20 -75.81 164.32 26.35 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.241 -0.287 . . . . 75.120000000000005 110.791 172.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.1 pt -61.19 -9.76 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 121.03 0.443 . . . . 74.239999999999995 111.493 173.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -107.92 -30.5 8.45 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.301 -0.409 . . . . 70.450000000000003 111.118 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.478 ' HB ' ' H ' ' A' ' 6' ' ' ASP . 11.1 m -92.63 -13.67 29.25 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.087 0.773 . . . . 72.219999999999999 113.087 -171.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.436 ' HA ' ' HB2' ' A' ' 5' ' ' LYS . 4.0 p30 -55.54 -16.93 4.45 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.106 0.78 . . . . 74.150000000000006 113.106 -173.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -69.26 -46.28 67.66 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.055 0.391 . . . . 64.400000000000006 112.055 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -121.07 -1.24 9.84 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.202 0.815 . . . . 53.140000000000001 113.202 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 5' ' ' LYS . 3.7 mm? 64.19 169.44 0.17 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.535 0.939 . . . . 70.120000000000005 113.535 173.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.8 m -148.01 136.85 21.87 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.949 -0.569 . . . . 74.450000000000003 110.678 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.5 p -115.35 119.27 35.72 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.675 0.62 . . . . 74.109999999999999 112.675 -172.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -149.7 -169.6 3.42 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.099 -0.501 . . . . 74.219999999999999 111.222 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 t -155.3 91.94 1.38 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.026 0.441 . . . . 74.0 111.435 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -130.6 118.75 18.02 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 116.433 -0.349 . . . . 74.299999999999997 111.207 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.81 87.68 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.372 2.048 . . . . 73.030000000000001 112.207 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.412 ' HG2' ' HB2' ' A' ' 30' ' ' PHE . 64.7 mtt -93.33 148.04 22.4 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.356 0.598 . . . . 73.340000000000003 112.123 -177.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -102.17 113.06 26.0 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.623 -0.717 . . . . 74.340000000000003 110.303 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.481 HD23 ' HD2' ' A' ' 173' ' ' LYS . 61.4 tp -74.61 87.84 2.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.159 0.504 . . . . 75.540000000000006 110.135 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.79 137.43 21.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.087 -0.506 . . . . 74.239999999999995 111.544 -175.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.8 12.49 5.74 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.736 -0.665 . . . . 74.230000000000004 111.292 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.428 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 66.4 m-20 54.3 22.02 3.47 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.009 -0.542 . . . . 74.540000000000006 111.922 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.2 tp -121.71 -41.04 2.49 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.926 0.393 . . . . 72.230000000000004 111.259 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.475 HG11 ' HA ' ' A' ' 172' ' ' VAL . 4.2 m -137.58 147.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.1 0.476 . . . . 73.439999999999998 111.952 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 170' ' ' MET . 70.0 m-85 -85.96 145.05 27.3 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.207 -0.451 . . . . 74.340000000000003 110.624 176.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 34.5 tt0 -127.63 135.63 50.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.677 0.275 . . . . 74.430000000000007 110.88 176.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.412 ' HB2' ' HG2' ' A' ' 20' ' ' MET . 84.4 t80 -128.96 128.43 43.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.861 0.363 . . . . 75.450000000000003 111.548 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HA ' HG23 ' A' ' 168' ' ' THR . 1.8 tmmm? -92.31 121.55 33.92 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.231 -0.44 . . . . 74.200000000000003 110.837 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.23 -163.35 13.96 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.308 -0.473 . . . . 71.510000000000005 113.089 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -121.12 139.37 53.42 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.316 -0.52 . . . . 75.439999999999998 111.512 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -75.27 106.15 6.65 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.879 -0.6 . . . . 74.109999999999999 110.663 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.67 160.15 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.1 -0.5 . . . . 74.329999999999998 111.054 -177.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.52 HG12 ' HB2' ' A' ' 66' ' ' ARG . 34.1 m -128.77 105.14 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.433 0.635 . . . . 72.219999999999999 110.94 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 97.6 mtt180 -83.27 108.21 16.34 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.187 0.518 . . . . 51.0 111.015 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -100.61 97.55 8.22 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.94 -0.573 . . . . 75.239999999999995 110.448 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 57.02 18.99 4.31 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 121.383 0.611 . . . . 72.540000000000006 111.315 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.11 0.58 28.39 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 121.297 -0.478 . . . . 63.219999999999999 113.784 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -95.64 147.37 23.66 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.134 0.42 . . . . 74.109999999999999 112.134 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.452 ' O ' HG13 ' A' ' 42' ' ' ILE . 10.6 tp -105.51 30.86 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-O 121.67 0.748 . . . . 73.450000000000003 111.45 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.0 t -75.8 85.41 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 O-C-N 121.796 -0.565 . . . . 74.239999999999995 111.377 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pp -97.99 165.42 11.92 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.743 0.646 . . . . 74.230000000000004 112.743 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.06 -4.77 25.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.168 -0.469 . . . . 74.420000000000002 111.397 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.94 -170.19 23.64 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.381 -0.438 . . . . 73.109999999999999 113.199 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.5 p -97.28 101.41 12.95 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.562 -0.375 . . . . 75.519999999999996 111.086 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -113.41 142.6 27.82 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.38 -0.373 . . . . 71.340000000000003 110.574 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -44.53 121.33 3.2 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.966 2.444 . . . . 73.420000000000002 113.815 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.6 t -113.35 108.33 17.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.147 -0.479 . . . . 53.25 111.724 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.0 79.14 1.41 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.327 0.584 . . . . 71.230000000000004 110.624 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -78.52 -42.86 28.28 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.016 -0.538 . . . . 71.340000000000003 112.269 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 68.16 -73.72 0.08 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.978 0.418 . . . . 75.040000000000006 111.425 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -127.42 87.94 0.33 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 116.393 -0.367 . . . . 54.350000000000001 112.412 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.3 105.62 7.08 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 122.666 -0.314 . . . . 74.040000000000006 111.133 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -124.31 81.86 1.97 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.187 -0.46 . . . . 73.219999999999999 111.267 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -112.09 -169.13 1.41 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.881 0.372 . . . . 74.230000000000004 111.61 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 60' ' ' SER . 31.9 t70 -79.75 -3.07 45.91 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.226 0.454 . . . . 74.400000000000006 112.226 -175.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.11 79.46 0.01 OUTLIER Glycine 0 CA--C 1.53 1.026 0 N-CA-C 113.901 0.321 . . . . 74.239999999999995 113.901 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 58' ' ' ASP . 77.4 p -158.61 158.65 34.28 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.824 0.45 . . . . 73.329999999999998 110.939 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 61.22 19.53 10.17 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.435 0.531 . . . . 74.349999999999994 112.435 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.86 -6.31 48.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.594 -0.275 . . . . 74.230000000000004 111.356 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 44.64 38.67 2.86 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.862 0.865 . . . . 74.129999999999995 113.118 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.9 t -101.98 124.19 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.087 -0.506 . . . . 71.439999999999998 110.565 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 45.2 mt-10 -78.29 66.75 3.94 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.755 0.788 . . . . 65.230000000000004 110.652 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.52 ' HB2' HG12 ' A' ' 36' ' ' VAL . 33.4 ptt85 -95.3 134.72 37.76 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.727 -0.67 . . . . 75.109999999999999 112.672 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.72 -133.82 3.03 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.606 -0.724 . . . . 74.409999999999997 112.447 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.461 HD12 HD12 ' A' ' 70' ' ' ILE . 21.4 pt -111.12 131.81 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 122.35 -0.5 . . . . 74.150000000000006 110.957 176.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.6 -23.14 15.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 111.858 0.318 . . . . 63.240000000000002 111.858 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.461 HD12 HD12 ' A' ' 68' ' ' ILE . 55.7 mt -50.71 -56.23 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.236 0.541 . . . . 71.549999999999997 111.591 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.7 m -81.16 -30.61 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.146 -0.479 . . . . 74.010000000000005 111.693 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.8 mt -65.02 -35.72 82.09 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.131 0.491 . . . . 75.209999999999994 110.863 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.36 -40.99 71.95 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.961 -0.563 . . . . 72.430000000000007 111.78 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -100.78 -1.04 35.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.43 -0.35 . . . . 71.120000000000005 111.779 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt 53.88 70.55 0.59 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.285 0.564 . . . . 72.420000000000002 111.583 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 67.3 mt -100.04 135.74 41.01 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.877 -0.601 . . . . 65.349999999999994 111.247 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.27 145.97 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.876 0.37 . . . . 75.409999999999997 111.281 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -83.47 136.35 34.33 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.575 0.583 . . . . 74.239999999999995 112.575 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.2 mmm -115.82 145.59 42.71 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 116.004 -0.543 . . . . 74.510000000000005 110.268 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.413 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 15.6 m-80 -88.86 123.86 33.64 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.634 0.605 . . . . 52.219999999999999 112.634 -169.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 44.2 t -54.12 -32.94 56.48 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.136 0.791 . . . . 74.299999999999997 113.136 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 4.5 p90 -81.71 -30.73 32.41 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.937 0.399 . . . . 73.140000000000001 111.865 -176.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -94.69 -47.32 6.55 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.469 0.544 . . . . 71.310000000000002 112.469 -170.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.634 ' HA ' ' SD ' ' A' ' 87' ' ' MET . 23.5 m-20 -81.2 18.96 0.99 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.546 0.573 . . . . 71.099999999999994 112.546 -174.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.429 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . . . -55.94 -42.59 76.4 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.844 0.354 . . . . 65.140000000000001 111.849 177.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.483 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 53.3 m -60.24 -36.57 78.05 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.326 0.584 . . . . 73.109999999999999 111.091 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.665 ' N ' ' SD ' ' A' ' 87' ' ' MET . 0.6 OUTLIER -66.04 -38.66 88.93 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.014 -0.539 . . . . 73.420000000000002 110.278 176.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HD2' ' HA ' ' A' ' 85' ' ' ALA . 32.0 m-85 -69.05 -43.86 73.8 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.928 -0.578 . . . . 74.120000000000005 112.274 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.545 ' HZ1' ' HB2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -62.56 -36.09 81.55 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.959 0.409 . . . . 73.519999999999996 110.893 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.1 -40.11 62.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.066 0.46 . . . . 53.43 111.198 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -61.83 -44.09 97.55 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.164 -0.471 . . . . 72.510000000000005 110.735 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.33 -34.35 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.121 -0.491 . . . . 73.129999999999995 111.259 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -56.03 -51.5 67.56 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.146 0.498 . . . . 74.219999999999999 110.976 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -69.66 -43.03 73.39 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.139 -0.482 . . . . 74.120000000000005 110.949 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.456 ' CZ ' HG12 ' A' ' 172' ' ' VAL . 68.9 t80 -52.8 -54.08 39.3 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.146 -0.479 . . . . 74.329999999999998 111.559 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 57.0 ttp -54.51 -43.82 72.19 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.076 -0.511 . . . . 73.140000000000001 110.99 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -54.78 -57.53 11.16 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.101 -0.5 . . . . 70.299999999999997 111.497 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -59.55 -55.81 29.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.616 0.599 . . . . 71.129999999999995 112.616 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.6 m -62.82 -43.38 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.718 0.636 . . . . 73.420000000000002 112.718 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.9 mm -74.33 -47.49 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 122.138 -0.351 . . . . 71.25 111.785 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 8.9 t70 -61.07 -38.98 88.14 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.992 0.425 . . . . 64.219999999999999 110.845 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -69.94 -41.47 74.53 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.98 0.419 . . . . 74.340000000000003 110.923 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 49.4 tpp -61.59 -35.15 77.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.322 0.582 . . . . 75.319999999999993 111.002 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 32.2 tt0 -68.05 -15.95 63.82 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.912 -0.585 . . . . 71.019999999999996 111.793 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.642 ' HB3' ' HZ1' ' A' ' 105' ' ' LYS . 1.7 mmmp? -81.09 -31.53 34.29 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.764 -0.585 . . . . 74.5 111.87 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -115.5 -36.45 4.28 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.473 0.916 . . . . 74.439999999999998 113.473 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -91.37 -76.43 0.45 Allowed 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.471 0.545 . . . . 71.439999999999998 112.471 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 104' ' ' GLU . 62.5 mtm-85 67.68 -6.49 0.68 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.863 1.06 . . . . 74.420000000000002 113.863 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 113' ' ' VAL . 38.3 t70 -68.59 106.0 2.44 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.033 -0.417 . . . . 73.299999999999997 110.61 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -48.91 -37.88 21.13 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.8 0.667 . . . . 75.340000000000003 112.8 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.91 -44.06 86.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.822 0.344 . . . . 75.230000000000004 111.543 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.6 -54.43 9.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.484 -0.326 . . . . 65.099999999999994 111.7 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 109' ' ' ASP . 23.0 m -59.26 -33.24 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 112.092 0.404 . . . . 74.239999999999995 112.092 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.96 -36.41 77.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.802 0.334 . . . . 71.200000000000003 110.587 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.73 -48.84 73.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.392 -0.367 . . . . 74.439999999999998 111.171 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -60.15 -50.32 74.13 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.841 0.353 . . . . 72.5 110.947 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -49.49 -49.26 46.39 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.212 0.529 . . . . 74.25 110.488 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.72 -36.3 82.15 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.789 -0.641 . . . . 65.230000000000004 111.566 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -67.01 -47.91 70.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.753 0.311 . . . . 72.510000000000005 110.791 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 31.3 mm -65.51 -38.72 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.485 -0.325 . . . . 71.0 111.112 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -58.13 -47.43 83.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.861 0.362 . . . . 72.519999999999996 110.679 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.3 -33.74 78.56 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.128 -0.558 . . . . 53.119999999999997 112.612 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -60.65 -54.28 47.2 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.574 0.35 . . . . 73.400000000000006 111.438 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.76 -46.79 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.699 0.629 . . . . 73.049999999999997 112.699 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.6 m -60.26 -33.26 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 122.061 -0.4 . . . . 74.340000000000003 111.59 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.7 m -77.08 -44.77 29.39 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.054 0.454 . . . . 64.109999999999999 111.002 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.467 HD23 HD13 ' A' ' 155' ' ' ILE . 48.4 tp -66.59 -32.17 73.34 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.058 -0.519 . . . . 74.040000000000006 112.207 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.7 mt -91.52 1.77 56.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.452 0.538 . . . . 74.019999999999996 112.452 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.6 95.81 0.08 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.346 0.593 . . . . 70.120000000000005 111.014 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.632 ' H ' ' HD2' ' A' ' 130' ' ' LYS . 2.5 mptp? -58.18 -33.11 68.88 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.17 0.804 . . . . 75.439999999999998 113.17 -168.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.51 -47.61 38.76 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.003 0.742 . . . . 64.150000000000006 113.003 -172.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 132' ' ' ARG . 0.4 OUTLIER -111.11 -26.32 9.28 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.633 0.605 . . . . 73.430000000000007 112.633 174.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.408 ' HD2' HD13 ' A' ' 136' ' ' LEU . 88.8 m-85 -83.19 -5.82 59.26 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.406 0.521 . . . . 75.019999999999996 112.406 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.92 -24.77 54.85 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.457 0.646 . . . . 74.230000000000004 110.501 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -78.21 13.41 1.5 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.694 -0.685 . . . . 72.420000000000002 112.232 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.408 HD13 ' HD2' ' A' ' 133' ' ' PHE . 77.8 mt -88.11 161.99 17.0 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.431 0.634 . . . . 74.430000000000007 111.799 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -134.33 122.35 22.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.706 -0.679 . . . . 74.140000000000001 110.362 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -105.36 110.8 23.28 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.955 0.407 . . . . 74.230000000000004 110.82 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 80.3 m-85 -98.98 147.18 25.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.471 0.545 . . . . 74.219999999999999 112.471 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 12.4 tt -147.22 155.77 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.028 -0.533 . . . . 73.209999999999994 110.827 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.64 146.11 34.99 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.184 -0.532 . . . . 72.230000000000004 113.689 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -54.73 -62.85 1.39 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.105 0.409 . . . . 75.329999999999998 112.105 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -61.3 -28.6 69.31 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.898 0.38 . . . . 74.519999999999996 111.259 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . . . -63.62 -53.73 46.92 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.037 0.446 . . . . 74.340000000000003 111.304 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.46 -19.13 62.26 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.128 0.49 . . . . 71.439999999999998 111.643 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.5 -40.65 34.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.166 -0.47 . . . . 71.209999999999994 111.596 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.21 42.02 0.09 OUTLIER Glycine 0 CA--C 1.529 0.953 0 C-N-CA 120.606 -0.807 . . . . 74.310000000000002 113.866 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.586 ' HB2' ' HA ' ' A' ' 144' ' ' ALA . . . -154.43 88.2 1.21 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.078 0.466 . . . . 74.140000000000001 111.235 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.16 -1.75 11.05 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.38 0.882 . . . . 71.109999999999999 113.38 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.36 57.79 3.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.485 0.66 . . . . 74.310000000000002 110.392 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -130.87 149.53 19.14 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.705 -0.679 . . . . 71.150000000000006 113.492 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -83.72 144.33 29.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.904 0.383 . . . . 73.510000000000005 111.477 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.86 115.15 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.329 0.585 . . . . 72.400000000000006 111.479 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.32 109.38 15.77 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.695 -0.684 . . . . 72.329999999999998 110.901 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.467 HD13 HD23 ' A' ' 127' ' ' LEU . 52.5 mt -86.48 124.84 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.573 0.225 . . . . 73.109999999999999 111.272 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' A' ' 169' ' ' LEU . 48.6 mm -118.05 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 111.967 0.358 . . . . 74.340000000000003 111.967 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 7.3 pt-20 -130.58 158.26 40.48 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.106 0.479 . . . . 72.219999999999999 111.273 175.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -78.05 108.8 11.59 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.066 0.46 . . . . 71.230000000000004 111.552 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 159' ' ' ARG . 5.6 tpp180 -104.51 128.81 52.53 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.432 -0.349 . . . . 74.25 111.682 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.71 111.24 14.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.735 0.302 . . . . 75.420000000000002 110.434 173.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.05 88.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.158 0.504 . . . . 63.520000000000003 110.24 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 54.79 33.86 20.59 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.721 -0.672 . . . . 62.0 112.104 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 113.37 -24.74 12.0 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.059 -0.591 . . . . 61.43 113.403 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.459 HG22 HG13 ' A' ' 166' ' ' VAL . 89.8 m -97.31 106.54 18.88 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.438 -0.448 . . . . 74.109999999999999 111.044 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -80.54 108.26 14.03 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.272 -0.422 . . . . 73.129999999999995 111.636 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.459 HG13 HG22 ' A' ' 164' ' ' THR . 25.0 m -128.23 142.56 44.97 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 120.908 0.385 . . . . 73.219999999999999 111.65 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 17.4 Cg_exo -68.56 119.15 6.16 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.801 2.334 . . . . 72.310000000000002 112.921 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.575 HG23 ' HA ' ' A' ' 31' ' ' LYS . 38.2 p -107.52 163.68 12.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.983 0.42 . . . . 74.219999999999999 112.039 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 51.9 tp -102.06 138.52 38.91 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.604 0.594 . . . . 73.25 112.604 -175.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 1.2 mpt? -122.87 136.79 54.99 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.418 0.525 . . . . 74.030000000000001 112.418 176.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.9 mt -136.81 148.42 47.16 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.57 -0.741 . . . . 75.25 110.08 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 176' ' ' ILE . 58.6 t -87.15 127.46 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.744 0.646 . . . . 55.43 112.744 -173.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.481 ' HD2' HD23 ' A' ' 22' ' ' LEU . 57.4 tttm -52.78 -54.79 28.96 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.81 0.671 . . . . 73.409999999999997 112.81 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.08 12.21 0.58 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.818 0.673 . . . . 72.319999999999993 112.818 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -114.35 -51.51 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 71.400000000000006 109.838 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 172' ' ' VAL . 4.1 tt -102.96 108.97 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.611 -0.722 . . . . 75.109999999999999 111.699 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.5 mm -101.35 142.37 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 111.315 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.13 141.91 50.76 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.249 0.547 . . . . 74.530000000000001 112.254 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -135.46 104.11 5.72 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.764 -0.653 . . . . 72.400000000000006 110.124 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -96.02 111.28 23.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.366 0.603 . . . . 71.109999999999999 112.4 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 50.6 t -116.83 87.65 2.74 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.203 0.525 . . . . 70.230000000000004 109.65 170.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 5.9 mp -137.14 -169.7 2.55 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.777 -0.647 . . . . 73.430000000000007 111.008 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 . . . . . 0 C--O 1.254 1.313 0 CA-C-O 118.69 -0.671 . . . . 73.409999999999997 110.876 172.326 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.714 0.292 . . . . 73.239999999999995 111.091 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 180' ' ' LYS . 21.5 tp -95.38 124.09 39.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.083 -0.34 . . . . 71.140000000000001 110.083 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 179' ' ' GLU . 53.5 mt -105.72 129.22 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.497 0.189 . . . . 74.329999999999998 111.385 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -122.78 144.67 49.03 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.322 0.582 . . . . 62.240000000000002 112.343 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.674 ' HB3' ' HB ' ' A' ' 177' ' ' ILE . 23.7 ttmm -138.55 111.26 7.65 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.804 -0.634 . . . . 64.25 110.903 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.575 ' HA ' HG23 ' A' ' 176' ' ' ILE . 5.6 t70 -83.03 166.16 19.02 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.564 0.346 . . . . 71.230000000000004 111.293 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 pt -81.23 -18.18 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 113.069 0.766 . . . . 74.510000000000005 113.069 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.62 -42.86 7.46 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.069 0.461 . . . . 74.549999999999997 111.555 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.545 HG21 ' HB3' ' A' ' 6' ' ' ASP . 15.2 t -103.85 19.65 19.56 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.998 -0.546 . . . . 64.010000000000005 112.092 -176.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 12.4 p-10 -46.06 -40.47 10.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.748 1.018 . . . . 71.140000000000001 113.748 -172.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -53.07 -34.76 57.99 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.094 0.473 . . . . 64.450000000000003 111.962 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.35 26.5 0.65 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.803 0.668 . . . . 75.319999999999993 112.803 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.67 HD13 ' HB2' ' A' ' 5' ' ' LYS . 69.4 tp -32.11 109.28 0.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.286 0.634 . . . . 72.219999999999999 112.014 174.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -131.15 -175.88 3.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 111.873 0.323 . . . . 74.310000000000002 111.873 -172.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.0 p -150.33 144.28 25.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.17 0.804 . . . . 74.549999999999997 113.17 -174.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -144.88 -157.7 0.82 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.736 -0.666 . . . . 75.430000000000007 109.963 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.3 t -148.45 86.49 1.54 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.932 -0.48 . . . . 65.140000000000001 112.177 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -138.25 101.95 8.26 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.177 -0.465 . . . . 74.209999999999994 111.192 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.82 142.76 98.59 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.191 2.594 . . . . 73.450000000000003 114.324 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.416 ' HE2' ' HD2' ' A' ' 30' ' ' PHE . 24.0 ptp -146.37 161.31 40.64 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.859 -0.61 . . . . 71.010000000000005 111.003 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 18.2 ptpt -99.5 158.75 15.52 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.585 0.231 . . . . 74.219999999999999 111.061 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.7 tp -107.09 110.45 22.56 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.91 0.385 . . . . 74.040000000000006 111.224 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -104.02 145.5 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.032 0.444 . . . . 75.140000000000001 111.568 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 63.93 10.55 5.36 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 116.112 -0.495 . . . . 74.5 112.136 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 60.87 12.11 3.64 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.864 0.466 . . . . 74.209999999999994 111.875 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.5 tp -127.52 -43.16 1.6 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.938 0.399 . . . . 73.109999999999999 111.733 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 172' ' ' VAL . 17.0 m -127.71 148.8 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.254 0.55 . . . . 75.109999999999999 112.352 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -86.97 134.37 33.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.293 -0.412 . . . . 71.439999999999998 111.132 174.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 36.3 tt0 -103.92 108.07 19.23 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.062 0.458 . . . . 72.0 110.257 174.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.577 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 31.6 t80 -90.37 127.61 36.23 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.247 -0.283 . . . . 71.049999999999997 110.335 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.428 ' HD3' ' H ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -74.32 131.12 40.86 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.47 0.652 . . . . 74.230000000000004 112.059 -176.618 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.464 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -140.08 174.34 22.5 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.726 -0.67 . . . . 71.200000000000003 112.494 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.413 ' HG3' HG11 ' A' ' 35' ' ' VAL . 16.4 ptpt -151.92 166.28 31.96 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.793 0.664 . . . . 73.540000000000006 112.793 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -71.51 106.6 4.04 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.082 -0.963 . . . . 75.299999999999997 110.799 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.413 HG11 ' HG3' ' A' ' 33' ' ' LYS . 31.5 m -138.06 154.58 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.21 0.529 . . . . 74.010000000000005 111.788 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.431 HG12 ' HG3' ' A' ' 66' ' ' ARG . 35.1 m -143.05 142.55 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.317 -0.401 . . . . 74.439999999999998 111.12 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.583 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 5.5 ttm180 -122.76 110.38 15.4 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.843 0.354 . . . . 61.149999999999999 110.954 174.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.626 ' HB2' ' HZ3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -130.04 98.73 4.84 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.128 0.49 . . . . 73.209999999999994 110.824 173.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 52.64 31.22 9.82 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.811 -0.631 . . . . 70.420000000000002 111.945 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.31 -28.61 13.31 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.367 -0.444 . . . . 74.120000000000005 113.299 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.563 ' HB3' ' HG3' ' A' ' 38' ' ' LYS . 6.7 tp10 -62.9 123.5 18.66 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.173 0.511 . . . . 72.310000000000002 112.137 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.4 mm -101.38 103.19 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 115.973 -0.558 . . . . 74.420000000000002 110.876 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 43' ' ' VAL . 11.4 p -120.33 33.98 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-O 121.96 0.886 . . . . 74.540000000000006 110.79 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.487 HD13 ' N ' ' A' ' 45' ' ' ALA . 3.2 pp -68.99 -19.87 64.15 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.783 -0.644 . . . . 65.049999999999997 112.513 -176.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.487 ' N ' HD13 ' A' ' 44' ' ' LEU . . . -87.56 -13.99 41.41 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.983 0.364 . . . . 42.140000000000001 111.983 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.12 71.09 1.76 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.447 -0.406 . . . . 73.030000000000001 113.032 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.7 p -118.41 173.32 6.89 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.127 0.489 . . . . 73.010000000000005 111.611 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -118.66 98.42 51.18 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 116.407 -0.361 . . . . 74.0 110.657 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.23 99.69 0.82 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.743 2.295 . . . . 74.409999999999997 113.147 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 82.5 p -110.91 -171.47 1.83 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.412 -0.358 . . . . 73.230000000000004 110.236 174.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.35 -13.75 59.87 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.849 0.356 . . . . 72.439999999999998 111.548 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -88.51 87.09 7.16 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.216 0.531 . . . . 72.129999999999995 111.796 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -43.86 42.4 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.981 -0.554 . . . . 75.129999999999995 110.47 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.53 57.03 0.68 Allowed Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.139 -0.482 . . . . 74.140000000000001 112.028 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.23 -11.13 60.54 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.939 0.718 . . . . 72.439999999999998 112.939 -175.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 67.85 34.9 4.09 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.124 0.57 . . . . 73.209999999999994 112.132 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -87.6 122.87 31.85 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.972 -0.455 . . . . 72.209999999999994 111.88 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -111.62 7.12 20.39 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.176 -0.465 . . . . 64.129999999999995 112.198 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.16 86.53 0.05 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.557 -0.292 . . . . 73.349999999999994 113.72 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.4 m -139.65 31.16 2.07 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.989 0.423 . . . . 71.340000000000003 111.35 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -99.39 27.81 4.98 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.105 0.478 . . . . 72.230000000000004 111.829 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 63' ' ' HIS . 13.6 pt-20 -91.92 14.25 16.21 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.954 0.724 . . . . 72.329999999999998 112.954 -173.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.421 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 41.3 m-70 73.66 -38.01 0.39 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.422 0.689 . . . . 74.120000000000005 112.207 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 38' ' ' LYS . 45.1 t -51.67 143.35 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.818 0.447 . . . . 72.329999999999998 110.972 174.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 26.3 tt0 -79.34 66.42 4.79 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.869 0.842 . . . . 71.109999999999999 110.694 -178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.431 ' HG3' HG12 ' A' ' 36' ' ' VAL . 11.3 ttm180 -92.5 133.69 35.68 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.15 -0.932 . . . . 74.319999999999993 110.606 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.35 -135.78 4.11 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 119.63 -1.271 . . . . 73.340000000000003 114.422 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 167' ' ' PRO . 12.5 mt -110.27 141.88 24.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.553 -0.324 . . . . 73.230000000000004 111.581 -173.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -47.9 -38.04 15.55 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.871 0.367 . . . . 60.310000000000002 111.321 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 169' ' ' LEU . 63.6 mt -60.75 -54.72 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.097 0.475 . . . . 74.239999999999995 112.185 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -72.48 -38.3 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.797 -0.638 . . . . 75.299999999999997 112.124 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.511 HD23 ' HG2' ' A' ' 65' ' ' GLU . 47.8 mt -68.54 -43.21 77.19 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.148 0.499 . . . . 74.310000000000002 110.529 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -54.92 -42.58 72.39 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.939 -0.573 . . . . 71.319999999999993 112.09 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -98.84 1.54 45.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.741 0.645 . . . . 75.310000000000002 112.741 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.415 ' HD3' ' N ' ' A' ' 75' ' ' LYS . 3.6 mppt? 54.07 69.05 0.76 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.318 0.58 . . . . 73.409999999999997 111.46 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 69.5 mt -106.66 137.41 44.74 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.964 -0.562 . . . . 72.420000000000002 110.725 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.443 HG11 ' HB3' ' A' ' 145' ' ' ALA . 10.0 p -88.27 151.55 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.109 0.48 . . . . 75.519999999999996 111.717 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.0 131.36 44.94 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.206 -0.906 . . . . 72.200000000000003 113.374 -175.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 83.5 mtp -138.6 153.68 48.66 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.931 -0.577 . . . . 73.030000000000001 109.946 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.46 168.16 28.21 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.168 0.803 . . . . 75.519999999999996 113.168 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -36.97 -55.85 0.9 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.71 1.745 . . . . 62.310000000000002 115.71 -169.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.447 ' CE2' ' HG2' ' A' ' 83' ' ' GLU . 43.8 p90 -56.96 -31.57 65.15 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.983 0.734 . . . . 75.439999999999998 112.983 -170.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.447 ' HG2' ' CE2' ' A' ' 82' ' ' TYR . 58.3 mm-40 -92.38 -44.54 8.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.158 0.504 . . . . 73.549999999999997 111.107 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.674 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 3.2 m-20 -67.58 -17.95 64.82 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.739 1.014 . . . . 63.420000000000002 113.739 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -43.87 -60.98 1.59 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.022 0.439 . . . . 74.120000000000005 111.287 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.9 m -72.54 -27.57 62.31 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.349 -0.387 . . . . 73.329999999999998 111.677 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.674 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 58.6 tpp -63.28 -65.92 0.62 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 111.495 0.183 . . . . 74.120000000000005 111.495 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.47 ' HA ' ' HB3' ' A' ' 91' ' ' TYR . 13.6 p90 -64.31 -22.75 67.06 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 122.12 -0.362 . . . . 74.329999999999998 111.38 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -60.65 -55.52 32.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.867 0.365 . . . . 73.319999999999993 110.858 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.7 96.26 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.044 0.45 . . . . 74.420000000000002 111.292 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.47 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 6.8 t80 -57.36 -55.86 29.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.829 -0.623 . . . . 72.409999999999997 111.348 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.7 -32.7 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.779 0.323 . . . . 74.230000000000004 111.542 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -65.82 -54.55 25.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.997 0.427 . . . . 75.129999999999995 111.073 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -63.77 -41.19 98.02 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.153 0.502 . . . . 71.030000000000001 110.532 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 175' ' ' ALA . 17.8 t80 -55.04 -58.35 7.99 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.852 -0.613 . . . . 75.420000000000002 111.647 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.425 ' O ' HG21 ' A' ' 100' ' ' ILE . 46.8 ttp -50.3 -52.01 40.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.019 -0.537 . . . . 63.240000000000002 111.559 -177.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -63.52 -50.49 69.39 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.716 0.293 . . . . 72.310000000000002 111.436 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.31 -50.64 72.28 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.264 0.468 . . . . 73.329999999999998 112.264 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 95' ' ' PHE . 35.1 m -69.44 -40.35 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.58 0.585 . . . . 75.230000000000004 112.58 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.425 HG21 ' O ' ' A' ' 96' ' ' MET . 10.9 tp -74.05 -42.11 52.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 120.791 -0.364 . . . . 73.099999999999994 111.18 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.12 -29.51 69.81 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.097 0.475 . . . . 73.400000000000006 110.282 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -76.09 -65.26 0.94 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.822 -0.626 . . . . 75.420000000000002 111.48 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.0 ttt -64.43 -45.26 88.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.764 0.653 . . . . 75.540000000000006 112.764 -171.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.695 ' HA ' HG13 ' A' ' 113' ' ' VAL . 36.8 tt0 -68.52 -11.79 60.36 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.235 0.54 . . . . 72.319999999999993 111.289 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -82.32 -42.49 18.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.038 -0.528 . . . . 74.319999999999993 111.756 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -89.66 -37.19 14.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.514 0.561 . . . . 74.010000000000005 112.514 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.438 ' O ' ' HD3' ' A' ' 108' ' ' ARG . 26.8 t-20 -76.15 -60.34 2.37 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.228 -0.295 . . . . 54.509999999999998 111.507 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 71.3 -21.69 0.2 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.155 1.169 . . . . 74.310000000000002 114.155 175.138 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.503 ' O ' HG23 ' A' ' 113' ' ' VAL . 40.8 m-20 -78.87 129.69 34.83 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.624 0.726 . . . . 64.230000000000004 112.595 -176.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -64.1 -8.04 10.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.245 -0.888 . . . . 73.129999999999995 112.459 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.03 -41.52 50.64 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 111.878 0.325 . . . . 75.400000000000006 111.878 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -95.34 -62.13 1.35 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.65 0.611 . . . . 70.450000000000003 112.65 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.695 HG13 ' HA ' ' A' ' 104' ' ' GLU . 27.3 m -57.82 -36.73 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.089 0.774 . . . . 71.439999999999998 113.089 -172.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.91 -45.75 87.92 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.83 0.348 . . . . 74.140000000000001 110.498 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.06 97.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.347 -0.388 . . . . 74.329999999999998 111.463 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.402 ' CE1' ' HG3' ' A' ' 174' ' ' GLU . 48.9 t80 -63.24 -57.62 9.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.309 -0.405 . . . . 73.540000000000006 111.373 176.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -52.6 -46.03 66.8 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.418 0.628 . . . . 71.319999999999993 111.053 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.53 -40.24 96.14 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.43 -0.805 . . . . 73.420000000000002 111.963 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -68.78 -50.6 48.98 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.892 0.377 . . . . 74.140000000000001 110.915 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.97 -33.49 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.856 0.36 . . . . 73.310000000000002 111.205 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -65.03 -42.27 94.5 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.096 0.474 . . . . 72.549999999999997 110.534 174.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.27 -39.26 97.48 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.895 -0.669 . . . . 62.409999999999997 112.024 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 49.2 t90 -58.63 -53.92 52.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.531 0.332 . . . . 75.340000000000003 111.224 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.426 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.4 m -64.19 -46.26 93.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 112.657 0.614 . . . . 72.329999999999998 112.657 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.81 -31.53 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.882 -0.511 . . . . 74.030000000000001 111.669 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.8 t -78.19 -42.99 29.78 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.208 0.528 . . . . 64.140000000000001 111.039 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.27 -31.0 71.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.037 -0.529 . . . . 73.430000000000007 112.309 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 71.0 mt -87.2 3.22 47.36 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.031 0.382 . . . . 75.510000000000005 112.031 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.72 103.79 0.15 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.062 0.458 . . . . 61.539999999999999 112.223 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.634 ' HZ2' ' HB3' ' A' ' 130' ' ' LYS . 0.3 OUTLIER -62.06 -24.58 67.17 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.897 0.703 . . . . 73.200000000000003 112.897 -174.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -80.31 -40.07 27.48 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.339 0.496 . . . . 73.310000000000002 112.339 -175.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -100.31 -60.43 1.53 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.218 0.532 . . . . 74.530000000000001 112.242 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.402 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 16.5 m-85 -74.11 -5.99 44.97 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.667 0.988 . . . . 74.409999999999997 113.667 -168.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.709 ' HZ2' ' HB3' ' A' ' 134' ' ' LYS . 6.2 ttpm? -58.11 -18.65 26.57 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.879 -0.513 . . . . 74.430000000000007 111.45 176.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -85.49 15.64 4.38 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.527 0.566 . . . . 65.230000000000004 112.527 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 82.1 mt -89.82 142.34 27.79 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.235 0.54 . . . . 73.109999999999999 111.472 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.26 153.46 22.13 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.289 -0.414 . . . . 75.019999999999996 110.825 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -119.85 138.71 53.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 61.43 110.425 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 50.6 m-85 -134.27 136.5 43.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.12 0.486 . . . . 71.319999999999993 111.455 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.515 HD11 ' HA3' ' A' ' 151' ' ' GLY . 8.0 tt -124.47 149.06 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 115.917 -0.583 . . . . 75.400000000000006 110.889 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.69 129.74 49.32 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.262 -0.494 . . . . 71.430000000000007 113.579 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -46.93 -43.78 19.34 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.648 0.379 . . . . 71.549999999999997 111.886 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -49.52 -34.29 16.87 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.247 0.832 . . . . 73.409999999999997 113.247 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -94.91 -25.19 16.66 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.029 -0.42 . . . . 71.140000000000001 111.857 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.443 ' HB3' HG11 ' A' ' 77' ' ' VAL . . . -49.48 -30.24 7.9 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.267 1.21 . . . . 75.219999999999999 114.267 -173.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.72 -26.82 67.45 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.719 0.637 . . . . 74.340000000000003 112.719 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 169.86 -22.73 0.09 OUTLIER Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.588 -0.815 . . . . 64.150000000000006 113.869 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.37 97.79 0.44 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.981 0.42 . . . . 70.219999999999999 111.806 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -4.9 21.65 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.361 -0.381 . . . . 62.229999999999997 111.94 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -84.81 20.79 1.71 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.745 0.307 . . . . 74.310000000000002 111.68 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.515 ' HA3' HD11 ' A' ' 140' ' ' ILE . . . -92.86 135.64 12.77 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.208 -0.52 . . . . 42.0 112.636 176.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.443 ' NE2' HD22 ' A' ' 171' ' ' LEU . 42.8 tt0 -68.84 119.01 12.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.25 0.463 . . . . 61.119999999999997 112.25 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 37.6 t -80.08 124.91 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.089 0.471 . . . . 75.019999999999996 111.027 172.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.565 ' HB1' HD13 ' A' ' 169' ' ' LEU . . . -102.21 135.46 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.076 -0.511 . . . . 73.109999999999999 110.594 177.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.722 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 61.5 mt -90.28 137.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 112.338 0.496 . . . . 71.209999999999994 112.338 -172.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.1 mm -108.47 117.49 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.391 -0.368 . . . . 75.540000000000006 111.67 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.405 ' HB2' ' HE2' ' A' ' 170' ' ' MET . 35.9 tt0 -110.47 137.11 48.6 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.38 -0.373 . . . . 62.420000000000002 111.389 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -73.26 88.14 1.5 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.51 -0.552 . . . . 75.329999999999998 109.51 169.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.03 121.65 22.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.166 0.508 . . . . 75.540000000000006 110.611 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -69.19 139.78 54.58 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.385 0.612 . . . . 71.409999999999997 112.033 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 163' ' ' GLY . 98.3 t -129.78 150.27 34.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.923 -1.51 . . . . 71.040000000000006 106.923 167.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.27 70.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.403 0.62 . . . . 73.099999999999994 111.058 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 161' ' ' VAL . . . 133.89 -12.47 4.78 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.774 -0.648 . . . . 63.43 113.862 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 m -143.55 148.57 36.16 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.087 -0.655 . . . . 73.420000000000002 111.526 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.94 108.74 18.61 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.421 0.629 . . . . 64.400000000000006 111.004 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.451 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 27.1 m -115.91 130.05 24.7 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.228 -0.442 . . . . 75.420000000000002 111.657 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 166' ' ' VAL . 6.1 Cg_exo -79.66 115.01 3.3 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.633 2.222 . . . . 73.5 113.121 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.9 p -104.53 165.58 10.96 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.169 0.509 . . . . 74.439999999999998 111.824 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.585 ' HB2' HD13 ' A' ' 70' ' ' ILE . 21.1 tp -107.13 139.48 41.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.104 -0.498 . . . . 74.310000000000002 111.936 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.722 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 62.4 mtt -108.97 126.21 52.86 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 122.61 0.364 . . . . 74.409999999999997 111.633 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.443 HD22 ' NE2' ' A' ' 152' ' ' GLN . 82.1 mt -136.81 120.34 17.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.037 -0.529 . . . . 75.310000000000002 110.784 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.472 ' HA ' HG11 ' A' ' 27' ' ' VAL . 46.0 t -74.22 121.18 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.628 -0.67 . . . . 64.450000000000003 111.927 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -70.14 -31.26 68.69 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.606 0.595 . . . . 74.540000000000006 112.606 -174.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.402 ' HG3' ' CE1' ' A' ' 116' ' ' PHE . 28.8 mm-40 -82.18 -1.3 48.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.941 0.4 . . . . 73.120000000000005 111.629 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.513 ' HB3' ' CE1' ' A' ' 95' ' ' PHE . . . -96.53 -54.83 3.11 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.278 0.561 . . . . 75.540000000000006 110.462 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 6' ' ' ASP . 29.3 pt -95.66 144.61 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.783 -0.644 . . . . 74.109999999999999 110.939 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.674 ' HB ' ' HB3' ' A' ' 5' ' ' LYS . 1.7 mp -91.84 110.7 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.348 0.594 . . . . 75.519999999999996 109.804 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -106.03 129.53 54.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.151 -0.932 . . . . 64.319999999999993 110.648 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 46.2 mt-10 -130.82 98.98 4.77 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.16 0.505 . . . . 73.129999999999995 110.818 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.406 ' HA ' HD12 ' A' ' 2' ' ' LEU . 32.8 ttpt -79.93 112.48 17.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.003 -0.544 . . . . 75.099999999999994 111.924 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 53.3 t -129.42 89.4 2.84 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.616 -0.513 . . . . 70.109999999999999 109.616 169.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.403 HD11 ' O ' ' A' ' 182' ' ' LEU . 3.3 pp -165.83 153.55 10.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.072 -0.513 . . . . 75.340000000000003 111.502 -176.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.811 -0.614 . . . . 65.450000000000003 112.08 -176.912 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.506 ' H1 ' ' HA ' ' A' ' 182' ' ' LEU . 58.1 mtt . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.558 0.218 . . . . 71.140000000000001 110.916 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 15' ' ' SER . 32.0 tp -84.55 138.17 32.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.319 -0.623 . . . . 75.450000000000003 109.319 170.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.468 HG23 HD13 ' A' ' 13' ' ' LEU . 53.1 mt -121.03 118.48 56.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.251 -0.277 . . . . 73.109999999999999 110.251 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -118.88 146.89 44.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.272 0.471 . . . . 74.030000000000001 112.272 -172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.642 ' HB3' HD11 ' A' ' 13' ' ' LEU . 20.8 ptmt -151.37 127.33 10.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.758 0.651 . . . . 75.299999999999997 112.758 176.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.775 ' HB3' ' HB ' ' A' ' 9' ' ' THR . 18.3 t70 -79.37 166.13 22.39 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.866 -0.606 . . . . 37.93 110.761 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.9 pt -73.21 -41.29 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 113.133 0.79 . . . . 72.430000000000007 113.133 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -105.66 -14.13 15.36 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.942 -0.473 . . . . 73.439999999999998 111.882 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.775 ' HB ' ' HB3' ' A' ' 6' ' ' ASP . 4.1 m -94.82 18.08 12.45 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.935 0.874 . . . . 73.230000000000004 109.48 172.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -45.8 -45.05 14.53 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.595 1.158 . . . . 73.109999999999999 113.439 -172.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.17 -21.65 66.35 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.153 0.797 . . . . 64.439999999999998 113.153 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.46 ' HB2' HG22 ' A' ' 9' ' ' THR . 37.7 mt-10 -88.8 24.38 2.05 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.144 0.424 . . . . 74.230000000000004 112.144 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.642 HD11 ' HB3' ' A' ' 5' ' ' LYS . 61.0 tp -44.28 118.6 1.56 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.866 0.467 . . . . 75.349999999999994 111.495 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -141.44 165.9 26.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.37 0.508 . . . . 73.140000000000001 112.37 -175.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 2' ' ' LEU . 99.2 p -112.06 147.17 36.59 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.227 -0.442 . . . . 63.420000000000002 111.378 176.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -142.36 -170.37 3.17 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.385 0.612 . . . . 71.439999999999998 112.017 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -153.84 63.11 0.72 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.604 -0.725 . . . . 73.329999999999998 110.44 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -124.23 157.18 65.23 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 116.232 -0.44 . . . . 72.420000000000002 111.73 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.36 148.53 11.56 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.775 2.317 . . . . 74.140000000000001 112.777 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -146.31 145.67 30.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.08 0.467 . . . . 74.049999999999997 112.107 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -116.12 109.76 17.92 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.354 -0.385 . . . . 74.129999999999995 111.593 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.594 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 52.0 tp -79.99 96.7 6.5 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.908 -0.495 . . . . 74.329999999999998 110.963 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 p -87.96 140.17 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-O 120.967 0.413 . . . . 73.310000000000002 111.187 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.17 8.43 1.52 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.009 0.374 . . . . 71.239999999999995 112.009 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.594 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 40.9 m-20 55.17 20.2 3.26 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.214 0.53 . . . . 72.329999999999998 111.599 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.487 ' HA ' ' HZ3' ' A' ' 173' ' ' LYS . 26.0 tp -117.85 -43.21 2.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.217 -0.447 . . . . 74.109999999999999 110.749 -177.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 172' ' ' VAL . 16.5 m -133.52 149.69 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.97 0.414 . . . . 74.319999999999993 111.731 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -89.59 124.92 34.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.548 -0.297 . . . . 74.239999999999995 110.791 174.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 11.8 pt-20 -107.63 143.44 36.09 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.86 0.362 . . . . 74.239999999999995 110.885 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -151.59 119.58 6.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.643 0.259 . . . . 75.409999999999997 111.242 173.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -74.94 124.75 27.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.856 0.36 . . . . 71.349999999999994 111.331 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.88 172.3 42.05 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 114.186 0.435 . . . . 71.299999999999997 114.186 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -105.73 116.34 31.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.563 0.345 . . . . 72.140000000000001 110.61 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.21 107.05 2.64 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.179 0.514 . . . . 74.400000000000006 111.891 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -140.66 156.99 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.016 0.436 . . . . 74.439999999999998 111.618 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.416 HG21 ' CD2' ' A' ' 44' ' ' LEU . 31.4 m -133.11 125.67 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.073 0.463 . . . . 75.420000000000002 110.965 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.835 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 32.0 ttt-85 -99.67 108.75 21.18 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.537 -0.301 . . . . 73.450000000000003 111.515 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -109.69 103.73 12.62 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.817 0.342 . . . . 73.329999999999998 110.704 174.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 58.76 15.44 3.78 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.001 0.741 . . . . 72.530000000000001 113.001 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.1 -12.71 19.66 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.048 -0.596 . . . . 64.019999999999996 113.956 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -101.59 142.16 33.36 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.49 0.645 . . . . 72.299999999999997 112.246 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.8 tp -115.72 130.86 69.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.592 -0.731 . . . . 71.209999999999994 110.446 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.2 m -105.05 -18.14 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 113.495 0.924 . . . . 73.439999999999998 113.495 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.42 ' N ' HD21 ' A' ' 44' ' ' LEU . 3.0 mm? -74.36 106.05 5.8 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.846 0.355 . . . . 72.310000000000002 111.673 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.13 -16.26 59.23 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.808 0.337 . . . . 73.340000000000003 111.549 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.23 -81.68 0.11 Allowed Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.3 -0.476 . . . . 75.230000000000004 112.843 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.3 t -137.05 105.5 5.78 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.738 0.304 . . . . 71.120000000000005 111.633 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -170.97 100.01 0.41 Allowed Pre-proline 0 CA--C 1.543 0.705 0 CA-C-O 120.905 0.383 . . . . 74.200000000000003 110.687 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -88.85 -156.41 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.251 2.634 . . . . 75.230000000000004 113.76 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.1 p -63.66 -56.15 17.97 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.396 0.517 . . . . 71.209999999999994 112.396 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -114.47 -82.35 0.61 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.972 0.415 . . . . 70.019999999999996 111.912 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.76 -34.93 2.77 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.43 0.53 . . . . 71.519999999999996 112.43 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -151.82 125.11 8.76 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.821 0.343 . . . . 74.200000000000003 110.622 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 178.31 159.83 23.55 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.301 -0.476 . . . . 72.340000000000003 112.558 -175.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.4 -48.39 2.2 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.221 0.534 . . . . 61.229999999999997 111.978 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.54 18.91 6.83 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.238 0.542 . . . . 72.329999999999998 110.41 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.77 82.63 1.62 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.646 -0.706 . . . . 75.209999999999994 112.06 -175.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 177.47 -74.32 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.484 -0.78 . . . . 73.129999999999995 110.165 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.05 95.39 0.1 OUTLIER Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.976 -0.556 . . . . 72.319999999999993 112.29 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.5 m -116.76 88.32 2.87 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.269 -0.548 . . . . 73.019999999999996 111.921 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -144.66 28.07 1.32 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.824 0.821 . . . . 62.439999999999998 109.898 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -91.27 178.55 5.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.41 -0.814 . . . . 64.409999999999997 111.702 -172.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -94.46 15.86 16.74 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.393 -0.822 . . . . 74.540000000000006 110.684 171.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.3 142.78 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.817 -0.629 . . . . 61.100000000000001 110.789 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.835 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 19.7 mm-40 -71.73 70.34 0.7 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.278 0.561 . . . . 65.310000000000002 110.323 175.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -82.59 135.3 35.1 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.673 -0.694 . . . . 70.140000000000001 111.464 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.09 -142.59 8.94 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.778 -0.725 . . . . 62.109999999999999 113.269 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.0 pt -111.04 143.84 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 122.499 -0.412 . . . . 62.210000000000001 112.015 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -41.66 -42.21 2.45 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.633 -0.712 . . . . 71.019999999999996 112.597 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 55.2 mt -51.75 -61.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.246 0.546 . . . . 74.420000000000002 112.271 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.8 m -72.29 -34.38 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.116 -0.493 . . . . 73.219999999999999 112.227 -174.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.0 -44.18 77.19 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.763 0.316 . . . . 74.439999999999998 111.145 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -63.03 -36.67 84.33 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.882 0.372 . . . . 75.420000000000002 111.637 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -94.32 2.14 55.86 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.057 0.391 . . . . 74.549999999999997 112.057 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.732 ' HB2' ' HZ2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 53.11 66.21 1.3 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.937 0.495 . . . . 72.230000000000004 112.08 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.4 mt -104.64 129.64 52.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.446 -0.343 . . . . 74.25 111.19 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 140' ' ' ILE . 11.2 p -78.66 137.02 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.787 0.327 . . . . 73.129999999999995 111.066 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -85.44 135.86 33.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.257 0.551 . . . . 72.299999999999997 112.071 -177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.3 mmm -130.19 159.41 36.94 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.374 -0.83 . . . . 70.349999999999994 109.735 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -132.04 140.87 49.04 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.248 0.833 . . . . 74.319999999999993 113.248 -169.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.408 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 27.5 p -48.73 -42.82 36.48 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.791 1.034 . . . . 75.319999999999993 113.791 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -53.33 -33.09 52.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.354 0.502 . . . . 74.450000000000003 112.354 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -103.44 -47.21 4.35 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.083 0.468 . . . . 70.420000000000002 111.643 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -77.6 4.8 10.45 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.545 0.572 . . . . 71.340000000000003 112.545 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.466 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -48.61 -46.31 39.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.072 0.463 . . . . 74.450000000000003 111.712 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 78.4 p -66.08 -41.95 90.02 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.973 -0.558 . . . . 62.130000000000003 111.533 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.3 ttp -63.03 -51.76 65.49 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.314 -0.403 . . . . 73.519999999999996 111.829 -175.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.515 ' HA ' ' HB2' ' A' ' 91' ' ' TYR . 8.1 p90 -75.87 -17.58 59.75 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 120.199 -0.601 . . . . 72.219999999999999 111.582 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -64.8 -45.66 85.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.255 0.55 . . . . 75.209999999999994 110.122 170.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.19 -42.58 93.44 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.094 -0.503 . . . . 73.010000000000005 110.736 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.515 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 13.9 m-30 -59.06 -49.44 77.89 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.165 0.431 . . . . 73.219999999999999 112.165 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.5 tp -65.55 -31.64 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.612 0.244 . . . . 74.349999999999994 111.439 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -63.8 -51.15 66.09 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.996 0.426 . . . . 75.329999999999998 110.778 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -65.08 -41.76 94.75 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.172 0.51 . . . . 73.340000000000003 110.982 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.601 ' HE1' ' HB3' ' A' ' 175' ' ' ALA . 78.7 t80 -58.64 -56.99 15.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.419 -0.809 . . . . 75.230000000000004 111.102 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 50.9 ttp -50.74 -48.11 59.13 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.01 0.433 . . . . 70.129999999999995 111.463 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.68 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -63.28 -46.57 86.15 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.127 -0.488 . . . . 75.420000000000002 111.48 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -70.66 -42.56 70.63 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.255 0.465 . . . . 65.420000000000002 112.255 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.36 -33.61 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.18 0.437 . . . . 73.439999999999998 112.18 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.415 HG21 ' O ' ' A' ' 97' ' ' LYS . 10.0 tp -67.82 -38.23 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.533 -0.467 . . . . 75.310000000000002 110.309 175.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -65.25 -48.03 74.67 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.315 0.579 . . . . 72.239999999999995 110.552 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -60.0 -29.89 68.78 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.662 -0.699 . . . . 73.230000000000004 111.789 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 54.5 tpp -90.64 -60.52 1.9 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.813 0.339 . . . . 74.019999999999996 111.684 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.12 -32.69 68.37 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.144 0.424 . . . . 72.140000000000001 112.144 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -55.86 -44.07 77.72 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.287 0.477 . . . . 73.329999999999998 112.287 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -95.83 -36.69 11.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.99 0.366 . . . . 72.230000000000004 111.99 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -67.09 -62.94 1.18 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.644 -0.253 . . . . 72.310000000000002 111.591 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 108' ' ' ARG . 49.1 mtm180 62.59 23.74 14.12 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.992 1.108 . . . . 75.200000000000003 113.992 173.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.512 ' O ' HG22 ' A' ' 113' ' ' VAL . 20.3 t70 -120.88 121.24 37.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.691 -0.63 . . . . 74.349999999999994 111.391 175.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 3.3 ptpp? -66.44 -1.25 3.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.887 1.069 . . . . 73.439999999999998 113.887 -175.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.95 -44.35 8.48 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.83 -0.544 . . . . 72.420000000000002 110.862 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -71.08 -51.39 25.46 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.386 -0.37 . . . . 64.200000000000003 111.408 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 109' ' ' ASP . 34.4 m -61.84 -28.45 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.727 0.299 . . . . 74.510000000000005 111.205 177.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 18.9 t70 -61.2 -56.33 21.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.082 0.468 . . . . 64.409999999999997 110.318 174.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 119' ' ' LYS . . . -59.92 -40.9 90.46 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.828 -0.624 . . . . 71.400000000000006 111.245 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -57.02 -61.96 2.09 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.288 0.477 . . . . 75.319999999999993 112.288 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 114' ' ' ASP . 62.7 pttt -55.19 -45.23 75.81 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.885 0.374 . . . . 75.329999999999998 111.274 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -65.91 -28.63 69.07 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.828 0.307 . . . . 75.420000000000002 111.828 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 37.1 tptt -72.75 -56.84 4.67 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.049 0.452 . . . . 74.439999999999998 110.739 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.4 tp -68.18 -39.27 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.896 -0.593 . . . . 75.019999999999996 111.763 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.506 HE21 ' HA ' ' A' ' 121' ' ' GLN . 0.0 OUTLIER -62.83 -51.41 67.16 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.283 -0.261 . . . . 74.140000000000001 111.422 177.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.63 -44.92 68.82 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.913 -0.661 . . . . 74.420000000000002 112.656 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -58.71 -58.39 8.79 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 111.561 0.208 . . . . 75.450000000000003 111.561 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.458 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.7 m -61.76 -44.68 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 112.546 0.573 . . . . 54.329999999999998 112.546 -175.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.1 m -63.34 -26.98 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.88 -0.513 . . . . 73.310000000000002 111.418 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 m -81.25 -36.49 29.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.215 0.531 . . . . 63.210000000000001 110.767 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 51.4 tp -71.61 -31.39 66.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.736 -0.665 . . . . 73.519999999999996 112.102 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 80.7 mt -80.56 2.36 25.83 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.167 0.432 . . . . 74.340000000000003 112.167 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.501 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -58.69 103.47 0.16 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.223 0.535 . . . . 71.109999999999999 112.012 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 37.8 ttpt -65.74 -23.24 66.69 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.29 0.848 . . . . 74.140000000000001 113.29 -171.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -77.87 -31.83 51.59 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.052 0.76 . . . . 62.130000000000003 113.052 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -108.35 -51.78 2.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.259 0.552 . . . . 75.329999999999998 111.517 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.501 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 45.8 m-85 -71.22 -5.6 33.21 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.943 0.72 . . . . 75.439999999999998 112.943 -172.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 21.8 ptmt -51.36 -26.19 7.31 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.067 -0.395 . . . . 72.439999999999998 111.556 172.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -82.18 18.53 1.37 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.67 0.618 . . . . 74.329999999999998 112.67 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 75.3 mt -89.68 137.32 32.43 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.982 -0.449 . . . . 74.25 111.297 176.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.9 123.82 45.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.258 -0.428 . . . . 75.049999999999997 110.603 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.411 ' HB3' HG11 ' A' ' 153' ' ' VAL . 88.8 m-85 -101.73 106.17 17.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.982 0.42 . . . . 72.420000000000002 111.195 -176.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -97.39 136.14 38.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.066 0.46 . . . . 73.239999999999995 111.33 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.454 ' O ' HG13 ' A' ' 77' ' ' VAL . 13.2 tt -140.03 154.72 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.784 0.326 . . . . 74.519999999999996 110.88 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.18 125.89 35.13 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.706 -0.759 . . . . 71.219999999999999 112.145 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -48.5 -47.56 38.76 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.669 0.387 . . . . 71.219999999999999 111.751 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 143' ' ' ARG . 31.3 ttp180 -48.68 -52.4 23.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.087 -0.506 . . . . 74.0 111.408 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.593 ' HB3' ' H ' ' A' ' 151' ' ' GLY . . . -68.62 -28.05 66.56 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.182 0.438 . . . . 71.120000000000005 112.182 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.22 -17.8 64.95 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.748 0.419 . . . . 74.430000000000007 111.681 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -66.62 -7.97 24.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.172 -0.467 . . . . 64.310000000000002 112.004 175.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.0 17.53 76.79 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.106 -0.568 . . . . 75.450000000000003 112.806 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.46 -60.87 1.52 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.948 0.404 . . . . 71.530000000000001 111.073 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -74.74 -35.81 62.63 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.381 -0.372 . . . . 73.349999999999994 111.459 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 21.8 m120 57.69 34.53 24.6 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.943 0.401 . . . . 72.140000000000001 111.241 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.593 ' H ' ' HB3' ' A' ' 144' ' ' ALA . . . -54.09 162.47 3.58 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.61 -0.723 . . . . 53.420000000000002 114.216 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -59.59 144.44 47.57 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.948 0.722 . . . . 74.209999999999994 112.948 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.411 HG11 ' HB3' ' A' ' 138' ' ' PHE . 50.0 t -91.44 127.5 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.99 -0.55 . . . . 75.329999999999998 111.526 175.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.479 ' HB3' HD13 ' A' ' 169' ' ' LEU . . . -85.21 116.11 23.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.783 -0.644 . . . . 73.109999999999999 110.807 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.687 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 62.6 mt -88.8 124.44 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.821 0.343 . . . . 73.400000000000006 111.72 -176.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.8 mm -110.52 120.24 60.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.942 0.401 . . . . 71.420000000000002 111.775 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 26.0 tt0 -107.78 128.81 54.92 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.245 -0.434 . . . . 64.239999999999995 111.947 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -72.62 89.06 1.29 Allowed 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.969 -0.457 . . . . 73.239999999999995 110.486 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -92.2 133.95 35.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.926 0.393 . . . . 74.540000000000006 111.919 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.86 123.9 33.68 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.094 0.473 . . . . 55.299999999999997 111.506 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.6 t -130.1 105.06 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.875 0.369 . . . . 75.200000000000003 111.441 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.2 t70 56.19 30.94 17.41 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.335 0.588 . . . . 73.25 111.916 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.41 -24.55 24.04 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.171 -0.537 . . . . 63.020000000000003 113.664 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.5 p -90.16 148.58 22.88 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.924 0.392 . . . . 73.329999999999998 111.58 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 0.1 OUTLIER -102.97 96.47 6.83 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.462 0.649 . . . . 75.530000000000001 110.74 178.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 166' ' ' VAL . 25.0 m -104.16 106.59 54.16 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 121.348 0.594 . . . . 63.149999999999999 112.066 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 34.2 Cg_exo -62.08 114.35 2.28 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.531 2.154 . . . . 75.409999999999997 112.481 176.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 90.9 m -99.15 133.07 43.95 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.921 0.391 . . . . 75.329999999999998 111.967 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 57.8 tp -77.83 140.1 39.35 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.898 -0.592 . . . . 74.230000000000004 111.702 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.687 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 24.0 mmt -127.96 124.36 37.1 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.693 0.397 . . . . 71.230000000000004 111.597 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.3 mt -141.09 130.63 23.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.651 0.38 . . . . 73.200000000000003 111.431 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.522 ' HA ' HG13 ' A' ' 27' ' ' VAL . 19.6 t -79.97 129.17 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.121 0.415 . . . . 65.030000000000001 112.121 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.489 ' HZ2' ' CD ' ' A' ' 174' ' ' GLU . 2.7 pptp? -77.48 -15.21 59.43 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.599 0.592 . . . . 74.010000000000005 112.599 -175.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.489 ' CD ' ' HZ2' ' A' ' 173' ' ' LYS . 3.8 mp0 -57.33 -27.63 62.39 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.846 0.355 . . . . 70.439999999999998 111.821 171.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.601 ' HB3' ' HE1' ' A' ' 95' ' ' PHE . . . -97.3 -42.72 7.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.144 -0.48 . . . . 70.519999999999996 111.93 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.4 pt -95.9 118.56 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.607 0.718 . . . . 75.409999999999997 112.373 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.417 ' N ' HD13 ' A' ' 177' ' ' ILE . 1.6 mp -94.88 115.63 34.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.798 -0.637 . . . . 75.140000000000001 110.255 175.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -97.96 112.88 24.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.567 -0.742 . . . . 73.439999999999998 111.407 -176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -97.71 123.03 41.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.557 0.343 . . . . 71.129999999999995 110.797 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -103.56 96.94 7.07 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.993 0.738 . . . . 74.319999999999993 112.993 -171.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.406 ' O ' ' N ' ' A' ' 1' ' ' MET . 40.6 t -133.78 88.68 2.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.898 -0.592 . . . . 72.120000000000005 109.983 173.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 182' ' ' LEU . 4.7 mp -104.88 120.62 41.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.85 0.357 . . . . 73.530000000000001 111.596 -172.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 118.656 -0.688 . . . . 74.340000000000003 111.173 179.139 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 111.747 0.277 . . . . 64.209999999999994 111.747 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.0 tp -126.18 131.01 52.1 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.857 0.361 . . . . 73.25 110.535 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.551 HG12 ' HB3' ' A' ' 15' ' ' SER . 57.5 mt -98.05 134.11 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 112.004 0.372 . . . . 74.519999999999996 112.004 -175.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -123.52 137.27 54.8 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.083 0.468 . . . . 73.450000000000003 111.115 171.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -143.54 141.39 30.69 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.989 -0.55 . . . . 72.530000000000001 111.361 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 176' ' ' ILE . 5.2 m-20 -86.98 167.74 13.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.4 0.619 . . . . 75.230000000000004 111.258 172.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.415 HD12 ' OD1' ' A' ' 98' ' ' ASN . 15.2 pt -63.05 -26.86 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.97 -0.559 . . . . 71.519999999999996 111.458 173.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.479 ' HE1' ' HA ' ' A' ' 152' ' ' GLN . 13.2 p90 -109.95 -35.65 6.09 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.321 0.86 . . . . 75.340000000000003 113.321 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.489 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 2.7 m -83.12 15.61 2.76 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.95 0.722 . . . . 75.099999999999994 112.95 -173.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -58.28 -15.11 8.93 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.849 0.685 . . . . 75.409999999999997 112.849 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -67.81 -56.02 10.77 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 122.156 -0.34 . . . . 74.450000000000003 111.267 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -84.14 25.02 0.87 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.832 0.349 . . . . 61.539999999999999 111.747 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tt -40.12 131.07 2.08 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.535 0.734 . . . . 73.209999999999994 111.589 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 m -126.11 139.9 53.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.143 0.497 . . . . 75.239999999999995 112.279 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.551 ' HB3' HG12 ' A' ' 3' ' ' ILE . 47.8 p -111.55 111.04 21.76 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.869 -0.605 . . . . 72.310000000000002 110.944 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.405 ' HB3' ' HD1' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -151.05 -156.83 0.75 Allowed 'General case' 0 CA--C 1.544 0.741 0 O-C-N 122.355 -0.216 . . . . 54.310000000000002 111.204 -175.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -127.63 24.77 6.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.136 0.421 . . . . 74.340000000000003 112.136 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.405 ' HD1' ' HB3' ' A' ' 16' ' ' ASP . 59.1 m-85 -60.18 134.15 90.56 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.03 0.382 . . . . 71.400000000000006 112.03 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.99 -169.84 0.88 Allowed 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.779 2.319 . . . . 75.030000000000001 113.08 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.6 ptp -145.89 135.43 23.17 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.442 0.534 . . . . 62.549999999999997 112.442 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 75.7 mmtt -124.45 100.41 6.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.614 -0.513 . . . . 75.409999999999997 109.614 170.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.403 HD11 ' O ' ' A' ' 27' ' ' VAL . 33.0 tp -93.03 124.46 37.01 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.174 0.805 . . . . 74.420000000000002 113.174 -170.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.68 142.35 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.896 -0.593 . . . . 64.420000000000002 111.01 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 57.44 13.44 1.82 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.481 0.549 . . . . 75.200000000000003 112.481 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 50.76 26.86 2.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.216 0.532 . . . . 74.209999999999994 111.03 -172.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 119' ' ' LYS . 20.0 tp -121.62 -42.71 2.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.159 -0.473 . . . . 71.409999999999997 111.967 -174.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.662 ' HB ' ' SD ' ' A' ' 170' ' ' MET . 2.6 m -138.19 151.73 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.803 0.668 . . . . 70.219999999999999 112.803 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 76.0 m-85 -104.57 138.52 40.79 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.879 -0.6 . . . . 75.040000000000006 111.117 176.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -104.39 137.73 41.84 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.397 . . . . 74.239999999999995 110.526 167.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.832 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.4 t80 -115.59 134.25 55.24 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.943 0.401 . . . . 75.340000000000003 111.141 177.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -93.1 113.79 26.14 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.199 -0.455 . . . . 72.519999999999996 111.859 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.09 -174.82 18.31 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.275 -0.488 . . . . 61.420000000000002 113.598 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -128.14 144.25 51.1 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 122.482 -0.422 . . . . 75.540000000000006 111.298 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -80.08 114.16 18.79 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.866 -0.42 . . . . 74.519999999999996 109.866 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.1 m -144.23 174.42 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.302 0.573 . . . . 75.319999999999993 111.949 -174.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 44' ' ' LEU . 21.5 m -110.85 121.75 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.168 0.509 . . . . 75.030000000000001 110.558 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.608 ' HB2' HD13 ' A' ' 72' ' ' LEU . 9.8 mmm180 -140.61 117.29 10.93 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.095 0.474 . . . . 74.420000000000002 111.111 -174.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -110.72 113.22 25.66 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.965 0.412 . . . . 71.219999999999999 110.945 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 60.63 14.5 5.01 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.534 0.568 . . . . 72.439999999999998 112.534 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.82 -15.98 21.23 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.257 -0.497 . . . . 60.350000000000001 113.688 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -79.72 142.27 35.62 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 117.286 0.543 . . . . 64.019999999999996 111.885 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.598 HD13 HH11 ' A' ' 37' ' ' ARG . 5.1 tp -109.88 122.44 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 116.207 -0.451 . . . . 75.510000000000005 111.906 -177.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 p -162.95 85.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.396 0.617 . . . . 71.430000000000007 112.255 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.511 ' HA ' HG22 ' A' ' 36' ' ' VAL . 8.9 mp -57.14 160.33 3.81 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.156 0.798 . . . . 74.230000000000004 113.156 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 72.07 4.2 4.94 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.026 -0.988 . . . . 70.540000000000006 112.637 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.43 99.13 1.93 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.155 -0.545 . . . . 65.400000000000006 112.975 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.8 m -156.53 -77.62 0.09 Allowed 'General case' 0 N--CA 1.476 0.849 0 O-C-N 122.485 -0.42 . . . . 65.209999999999994 111.631 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 59.52 93.5 0.06 OUTLIER Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 122.848 0.459 . . . . 75.030000000000001 111.813 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.64 155.28 54.56 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.507 2.138 . . . . 70.200000000000003 113.325 -177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.613 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 78.3 p -98.74 114.33 26.81 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.325 -0.398 . . . . 65.540000000000006 110.77 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.48 -75.48 0.11 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.08 0.4 . . . . 74.140000000000001 112.08 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -104.51 21.97 15.79 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.138 0.494 . . . . 73.340000000000003 111.391 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 8.6 tp10 -111.73 113.18 25.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.95 0.405 . . . . 70.530000000000001 110.641 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.19 36.52 91.91 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.14 -0.552 . . . . 44.009999999999998 112.659 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.96 -18.72 58.76 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.213 0.449 . . . . 65.430000000000007 112.213 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.67 29.56 7.9 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.399 -0.364 . . . . 75.430000000000007 111.388 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.59 144.35 51.87 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.256 0.55 . . . . 73.409999999999997 111.95 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -130.74 -0.26 4.32 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.944 -0.571 . . . . 74.510000000000005 111.954 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.75 98.74 0.19 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.896 -0.669 . . . . 73.140000000000001 113.768 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.3 p -156.6 168.62 26.83 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.484 0.314 . . . . 72.530000000000001 110.647 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -99.66 -93.81 0.26 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.923 0.342 . . . . 72.340000000000003 111.923 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 53.07 7.83 0.09 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.833 1.049 . . . . 73.230000000000004 113.833 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -86.3 -16.7 36.7 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.857 -0.527 . . . . 75.239999999999995 110.614 172.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 24.4 t -98.34 163.84 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.997 -1.112 . . . . 73.239999999999995 107.997 164.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 64' ' ' VAL . 39.7 tt0 75.67 -5.1 2.24 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.397 0.617 . . . . 72.310000000000002 109.354 -171.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -137.02 122.02 18.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.746 -0.661 . . . . 73.239999999999995 111.202 -176.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.53 -148.78 15.5 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.532 -0.842 . . . . 74.219999999999999 113.736 175.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.426 HD12 HD11 ' A' ' 70' ' ' ILE . 36.7 pt -111.07 138.82 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 122.417 -0.46 . . . . 75.150000000000006 111.356 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -48.14 -35.75 12.16 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.379 0.511 . . . . 75.420000000000002 112.379 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.426 HD11 HD12 ' A' ' 68' ' ' ILE . 55.8 mt -49.81 -64.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.401 0.62 . . . . 73.209999999999994 112.021 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 18.5 m -74.38 -31.98 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.964 -0.562 . . . . 71.430000000000007 112.08 -174.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.608 HD13 ' HB2' ' A' ' 37' ' ' ARG . 72.6 mt -68.7 -30.78 69.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.286 -0.415 . . . . 74.239999999999995 111.64 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -90.63 -27.13 19.27 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 111.852 0.316 . . . . 72.120000000000005 111.852 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -97.84 3.65 49.82 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.02 -0.425 . . . . 75.200000000000003 111.782 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 58.29 70.87 0.62 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.406 0.622 . . . . 73.319999999999993 112.581 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.758 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 88.0 mt -122.26 138.92 54.33 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.003 -0.544 . . . . 73.200000000000003 111.256 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 p -93.76 146.67 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 120.856 0.36 . . . . 73.310000000000002 111.842 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.42 127.51 32.29 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.368 0.877 . . . . 64.409999999999997 113.368 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.482 ' HE3' ' SD ' ' A' ' 87' ' ' MET . 87.0 mtp -140.26 110.61 6.65 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.172 -0.467 . . . . 75.239999999999995 110.139 174.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.495 ' HB2' ' HE1' ' A' ' 82' ' ' TYR . 18.4 m120 -95.74 167.11 11.47 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.852 -0.53 . . . . 73.409999999999997 112.134 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 43.1 t -43.5 -56.13 3.82 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.87 1.063 . . . . 72.340000000000003 113.87 -172.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.495 ' HE1' ' HB2' ' A' ' 80' ' ' ASN . 13.4 p90 -50.24 -33.0 18.11 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.457 0.54 . . . . 72.230000000000004 112.457 -177.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.76 -38.24 9.55 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.773 -0.649 . . . . 64.200000000000003 112.087 -174.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 88' ' ' PHE . 25.4 t0 -91.21 -7.63 50.77 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.477 0.547 . . . . 72.129999999999995 112.477 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.585 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -39.71 -61.49 0.82 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.369 0.878 . . . . 74.430000000000007 113.369 -175.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.4 m -61.86 -35.25 77.74 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.262 0.467 . . . . 62.340000000000003 112.262 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.482 ' SD ' ' HE3' ' A' ' 79' ' ' MET . 44.5 ttm -75.74 -54.4 7.01 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.139 0.422 . . . . 72.230000000000004 112.139 -174.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 7.6 p90 -63.47 -27.09 69.04 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.114 -0.634 . . . . 74.510000000000005 111.617 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -64.32 -44.8 90.46 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.867 0.365 . . . . 72.420000000000002 110.645 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.64 -38.0 89.51 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.2 0.524 . . . . 73.329999999999998 110.714 173.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.521 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 27.8 t80 -55.82 -50.99 69.0 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.72 -0.673 . . . . 73.420000000000002 110.978 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 88' ' ' PHE . 32.6 mm -57.68 -42.72 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 116.283 -0.417 . . . . 71.120000000000005 111.593 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.93 -56.38 17.7 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.865 0.32 . . . . 74.519999999999996 111.865 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.527 ' HZ2' ' HA ' ' A' ' 150' ' ' ASN . 39.1 ttpt -59.94 -39.21 84.77 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.897 0.379 . . . . 73.109999999999999 111.147 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.516 ' CZ ' HG12 ' A' ' 172' ' ' VAL . 20.3 t80 -59.49 -59.15 5.91 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.121 -0.49 . . . . 72.329999999999998 111.221 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 55.6 ttp -52.82 -44.43 66.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.161 -0.472 . . . . 73.540000000000006 111.4 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -61.67 -49.56 76.02 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.36 -0.382 . . . . 72.299999999999997 111.321 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.415 ' OD1' HD12 ' A' ' 7' ' ' ILE . 26.0 t-20 -61.33 -56.06 24.73 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.76 0.281 . . . . 64.299999999999997 111.76 -176.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.569 ' HB ' ' HZ ' ' A' ' 116' ' ' PHE . 27.5 m -57.46 -41.72 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.407 0.521 . . . . 74.040000000000006 112.407 -176.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.6 tp -74.74 -35.9 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 122.077 -0.39 . . . . 71.5 111.006 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.73 -13.81 61.03 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.336 0.588 . . . . 70.109999999999999 110.8 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -90.36 -37.79 13.77 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.16 -0.337 . . . . 74.530000000000001 111.343 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 64.0 mtt -93.13 -62.88 1.29 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.523 0.564 . . . . 71.409999999999997 112.523 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.646 ' HA ' HG13 ' A' ' 113' ' ' VAL . 38.9 tt0 -58.29 -26.34 62.9 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.38 0.511 . . . . 72.439999999999998 112.38 -174.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -57.27 -46.21 83.31 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 111.991 0.367 . . . . 75.420000000000002 111.991 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.02 -14.52 14.72 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.566 0.58 . . . . 74.549999999999997 112.566 -175.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.449 ' OD1' HG11 ' A' ' 113' ' ' VAL . 27.6 t-20 -92.72 -68.9 0.77 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.666 0.269 . . . . 73.219999999999999 111.398 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.422 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 36.6 ttm180 63.14 11.96 5.67 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.248 0.833 . . . . 73.219999999999999 113.248 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 113' ' ' VAL . 22.2 t70 -75.53 120.36 20.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.385 -0.822 . . . . 75.409999999999997 110.954 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -57.78 -12.31 2.94 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.468 0.914 . . . . 75.109999999999999 113.468 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.1 -53.25 4.2 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.997 -0.439 . . . . 75.310000000000002 112.043 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -74.12 -60.07 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.238 0.459 . . . . 74.150000000000006 112.238 -170.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 104' ' ' GLU . 27.6 m -60.47 -26.6 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.692 0.282 . . . . 72.319999999999993 111.722 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.79 -53.22 50.38 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.573 -0.285 . . . . 75.120000000000005 110.483 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -56.57 -43.66 80.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.042 0.449 . . . . 61.240000000000002 111.258 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.569 ' HZ ' ' HB ' ' A' ' 99' ' ' VAL . 44.1 t80 -61.07 -59.21 5.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.882 0.372 . . . . 61.109999999999999 111.624 177.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -57.0 -35.14 68.88 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.175 0.512 . . . . 65.549999999999997 111.169 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -68.97 -40.15 79.02 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.786 -0.643 . . . . 74.120000000000005 111.385 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.497 ' HB3' HD21 ' A' ' 26' ' ' LEU . 51.9 mtmt -65.69 -44.18 86.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.512 0.196 . . . . 74.109999999999999 111.103 175.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.423 ' CD1' HD13 ' A' ' 26' ' ' LEU . 37.6 mm -62.01 -45.58 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.917 0.389 . . . . 75.450000000000003 111.055 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.54 -50.99 71.78 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.184 -0.462 . . . . 72.140000000000001 110.776 177.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.73 -36.85 93.88 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.922 -0.656 . . . . 75.319999999999993 112.724 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.2 t90 -60.6 -56.4 21.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.642 0.377 . . . . 74.219999999999999 111.587 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.522 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.8 m -63.36 -42.72 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 112.241 0.46 . . . . 72.140000000000001 112.241 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.6 t -59.81 -37.23 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 122.066 -0.396 . . . . 75.519999999999996 111.43 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.2 t -77.16 -39.62 48.41 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.042 0.449 . . . . 75.010000000000005 110.984 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.0 tp -62.41 -28.38 69.75 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.994 0.517 . . . . 73.299999999999997 112.148 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 29.3 mt -92.58 1.81 57.05 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.916 0.339 . . . . 73.200000000000003 111.916 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.89 108.08 2.43 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.091 0.472 . . . . 65.310000000000002 111.451 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -16.58 49.19 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.076 0.769 . . . . 72.129999999999995 113.076 -172.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -54.91 -49.05 72.24 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.904 0.383 . . . . 61.340000000000003 111.404 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -111.24 -43.34 3.74 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.403 0.62 . . . . 74.400000000000006 111.27 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -74.23 -7.26 52.08 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.327 0.862 . . . . 75.230000000000004 113.327 -167.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -63.7 -32.35 73.81 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.197 0.523 . . . . 70.310000000000002 110.426 170.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -89.7 33.9 0.84 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.003 -0.544 . . . . 75.099999999999994 112.199 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.73 156.95 18.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.504 0.669 . . . . 65.450000000000003 111.93 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.36 112.63 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.461 -0.79 . . . . 74.010000000000005 110.288 172.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.569 ' HB3' HG12 ' A' ' 153' ' ' VAL . 54.5 m-85 -90.9 132.93 35.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.916 0.388 . . . . 75.340000000000003 110.226 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.758 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 61.4 m-85 -121.94 125.39 46.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.863 0.364 . . . . 74.109999999999999 111.331 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 13.8 tt -113.4 154.63 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 116.552 -0.294 . . . . 74.329999999999998 111.348 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.99 142.8 41.42 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.447 -0.342 . . . . 73.109999999999999 113.645 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.414 ' HG3' ' HG3' ' A' ' 143' ' ' ARG . 14.2 pt-20 -53.29 -40.06 64.42 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.643 0.609 . . . . 75.430000000000007 112.643 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.414 ' HG3' ' HG3' ' A' ' 142' ' ' GLU . 85.1 mtm180 -78.17 -38.44 43.51 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.019 0.377 . . . . 72.439999999999998 112.019 -176.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.54 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . . . -74.89 -28.48 60.65 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.085 0.402 . . . . 75.299999999999997 112.085 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -50.16 -38.79 41.24 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.04 1.126 . . . . 74.349999999999994 114.04 -174.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -73.52 6.16 3.26 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.756 1.021 . . . . 74.230000000000004 113.756 -172.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.26 -11.69 1.19 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.981 -1.104 . . . . 64.519999999999996 114.881 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.54 ' HB1' ' HA ' ' A' ' 144' ' ' ALA . . . -77.93 95.11 4.7 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 117.778 0.789 . . . . 74.340000000000003 111.59 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -74.27 19.85 0.12 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.473 0.546 . . . . 72.439999999999998 112.473 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.527 ' HA ' ' HZ2' ' A' ' 94' ' ' LYS . 40.7 t30 -111.49 5.88 19.83 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.943 0.401 . . . . 60.310000000000002 110.827 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.81 171.59 52.59 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.423 -0.418 . . . . 63.340000000000003 113.472 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.479 ' HA ' ' HE1' ' A' ' 8' ' ' PHE . 37.3 tt0 -86.72 116.96 25.17 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.421 -0.458 . . . . 62.5 112.085 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.569 HG12 ' HB3' ' A' ' 138' ' ' PHE . 27.5 t -83.29 107.17 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.152 0.501 . . . . 73.540000000000006 110.589 170.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.466 ' HB1' ' CD1' ' A' ' 169' ' ' LEU . . . -82.09 117.39 22.23 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.065 -0.516 . . . . 64.420000000000002 110.89 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 59.4 mt -89.27 105.12 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.854 0.359 . . . . 75.510000000000005 111.252 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.5 mm -93.77 117.8 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.027 0.381 . . . . 65.510000000000005 112.027 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.86 129.49 56.44 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.393 -0.595 . . . . 73.430000000000007 109.393 174.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -90.51 88.99 7.37 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.047 0.451 . . . . 75.209999999999994 110.456 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -97.17 159.05 15.13 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.329 0.585 . . . . 71.109999999999999 112.171 -170.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.01 134.09 48.7 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.926 -0.579 . . . . 73.019999999999996 111.295 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.1 t -119.2 104.84 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.642 0.258 . . . . 73.230000000000004 110.962 175.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 60.4 9.75 2.14 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.863 0.69 . . . . 74.040000000000006 112.863 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 116.27 2.05 20.06 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.427 -0.416 . . . . 60.219999999999999 113.096 -175.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 94.5 m -107.8 130.24 54.99 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.977 0.418 . . . . 71.120000000000005 111.966 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -74.03 112.48 10.21 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.986 -0.552 . . . . 74.209999999999994 112.191 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.408 ' O ' HG21 ' A' ' 166' ' ' VAL . 27.9 m -129.22 117.4 18.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 121.168 0.508 . . . . 65.400000000000006 111.932 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.96 114.5 3.99 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.838 1.692 . . . . 75.129999999999995 111.693 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 67.3 p -101.07 129.22 46.91 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.164 0.506 . . . . 74.120000000000005 112.047 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.832 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.1 tp -89.81 122.9 33.32 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.84 -0.618 . . . . 75.329999999999998 111.087 176.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.662 ' SD ' ' HB ' ' A' ' 27' ' ' VAL . 39.4 tpp -103.22 125.52 49.93 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.755 0.312 . . . . 73.140000000000001 111.596 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -140.9 152.09 44.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.189 0.596 . . . . 72.510000000000005 109.983 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.624 ' HA ' HG11 ' A' ' 27' ' ' VAL . 41.9 t -89.89 117.34 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.829 0.677 . . . . 72.319999999999993 112.829 -173.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -59.88 -31.81 70.15 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.045 -0.525 . . . . 75.0 111.832 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.419 ' HG3' ' HE1' ' A' ' 116' ' ' PHE . 5.5 mm-40 -85.27 11.55 9.85 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.464 -0.335 . . . . 64.400000000000006 111.803 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -127.09 -41.87 1.76 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.829 0.347 . . . . 40.420000000000002 111.083 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 172' ' ' VAL . 12.8 tt -100.18 132.18 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.093 0.473 . . . . 74.319999999999993 111.062 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.5 tp -130.25 153.53 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.95 0.405 . . . . 74.129999999999995 111.548 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.05 152.06 41.43 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.115 0.483 . . . . 70.510000000000005 111.35 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.511 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 11.2 tp10 -138.98 133.19 31.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.095 0.474 . . . . 75.439999999999998 110.697 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -103.57 114.98 29.67 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.729 0.776 . . . . 73.299999999999997 112.939 -172.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 42.7 t -133.5 89.78 2.64 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.945 -0.761 . . . . 72.510000000000005 108.945 169.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 49.5 mt -121.25 94.74 4.43 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.238 0.459 . . . . 75.010000000000005 112.238 -168.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.256 1.421 0 CA-C-O 118.946 -0.55 . . . . 71.040000000000006 111.784 176.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.764 0.316 . . . . 75.219999999999999 110.856 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 33.9 tp -100.8 130.92 46.89 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 110.117 -0.327 . . . . 74.140000000000001 110.117 173.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.74 ' HB ' HD21 ' A' ' 13' ' ' LEU . 21.1 pt -114.2 123.02 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.22 0.533 . . . . 75.219999999999999 111.557 -176.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HE1' ' HB2' ' A' ' 16' ' ' ASP . 35.7 p90 -122.8 143.28 49.94 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.231 0.539 . . . . 75.310000000000002 112.154 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.705 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 12.0 ptmt -130.1 150.0 51.56 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.688 -0.687 . . . . 75.030000000000001 111.242 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.513 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 7.0 p-10 -97.81 -178.33 4.06 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.212 0.53 . . . . 62.299999999999997 111.261 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.45 -43.83 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 113.239 0.829 . . . . 72.200000000000003 113.239 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.512 ' HD2' HG21 ' A' ' 9' ' ' THR . 9.2 p90 -108.48 -52.65 2.74 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.647 1.351 . . . . 75.239999999999995 114.647 -168.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.512 HG21 ' HD2' ' A' ' 8' ' ' PHE . 17.7 p -89.48 18.51 5.26 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.67 -0.644 . . . . 75.310000000000002 112.616 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.705 ' HB2' ' HB2' ' A' ' 5' ' ' LYS . 3.8 p-10 -50.87 -20.55 1.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.797 1.406 . . . . 71.540000000000006 114.797 -172.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -66.86 -19.79 65.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.363 0.602 . . . . 72.299999999999997 110.814 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.31 24.94 4.1 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.499 -0.773 . . . . 73.239999999999995 110.861 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.74 HD21 ' HB ' ' A' ' 3' ' ' ILE . 7.8 tt -38.52 138.61 0.48 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.815 0.846 . . . . 75.120000000000005 112.498 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.0 m -118.72 149.61 41.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.997 0.427 . . . . 62.240000000000002 111.934 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.5 p -109.77 129.91 55.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.236 -0.438 . . . . 74.319999999999993 110.557 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.5 ' HB2' ' HE1' ' A' ' 4' ' ' TYR . 2.5 t70 -137.41 179.04 6.64 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.657 0.265 . . . . 74.109999999999999 111.192 -177.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.7 t -132.74 4.97 3.92 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.275 0.472 . . . . 52.539999999999999 112.275 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -78.26 146.08 69.97 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 122.07 -0.394 . . . . 73.049999999999997 111.842 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -85.99 126.38 2.85 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.973 2.449 . . . . 64.400000000000006 113.386 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 87.7 mmm -89.74 124.63 34.8 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.502 -0.317 . . . . 74.310000000000002 111.163 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 56.5 mttm -103.48 112.24 25.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.34 0.256 . . . . 73.519999999999996 111.573 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.48 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 33.9 tp -84.54 106.65 16.27 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.809 -0.557 . . . . 72.0 112.159 -175.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -98.04 139.29 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.084 0.468 . . . . 74.150000000000006 111.131 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 58.32 15.56 3.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.565 0.58 . . . . 75.340000000000003 112.565 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 59.98 11.46 2.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.328 0.492 . . . . 73.129999999999995 112.328 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.1 tp -115.83 -45.54 2.87 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.07 0.396 . . . . 75.319999999999993 112.07 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.517 HG11 ' HA ' ' A' ' 172' ' ' VAL . 3.8 m -129.29 143.7 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.431 0.53 . . . . 73.209999999999994 112.431 -176.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.627 ' O ' ' HA ' ' A' ' 170' ' ' MET . 98.0 m-85 -92.0 142.03 27.98 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.074 -0.512 . . . . 74.450000000000003 110.876 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 16.4 pt-20 -128.87 146.97 50.79 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 110.242 -0.281 . . . . 71.409999999999997 110.242 174.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.495 ' CE2' HD12 ' A' ' 70' ' ' ILE . 43.6 p90 -152.48 145.67 24.65 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.626 0.973 . . . . 65.230000000000004 113.626 172.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -94.91 130.51 41.49 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.366 -0.834 . . . . 73.5 111.525 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.88 -133.96 7.69 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 114.472 0.549 . . . . 75.25 114.472 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -138.45 123.78 19.36 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.636 -0.332 . . . . 72.209999999999994 111.229 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -66.24 107.0 1.82 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.923 0.392 . . . . 74.439999999999998 111.839 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.406 HG22 HD13 ' A' ' 72' ' ' LEU . 35.6 m -138.96 168.17 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.267 -0.424 . . . . 74.200000000000003 111.481 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.91 144.74 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.482 -0.326 . . . . 74.219999999999999 110.933 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 29.6 tpt85 -137.12 108.08 6.7 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.832 0.825 . . . . 73.430000000000007 111.979 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.858 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 5.6 tppp? -135.96 147.15 47.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.999 -1.0 . . . . 70.310000000000002 108.983 169.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -50.28 -51.47 44.63 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.053 0.454 . . . . 72.219999999999999 111.929 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.8 34.55 5.59 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.34 -0.457 . . . . 73.310000000000002 112.982 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.858 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 9.3 tp10 -162.23 101.88 1.1 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.045 0.45 . . . . 63.439999999999998 111.519 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -149.34 158.32 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 116.306 -0.407 . . . . 71.450000000000003 110.827 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.0 t 69.11 86.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.714 0.769 . . . . 65.329999999999998 110.878 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.4 179.61 7.74 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.056 -0.974 . . . . 74.319999999999993 112.147 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.07 147.82 50.96 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.022 0.439 . . . . 73.230000000000004 111.768 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.23 3.51 85.52 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.354 -0.451 . . . . 73.5 112.965 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.0 t -110.84 132.95 53.76 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.879 0.371 . . . . 62.229999999999997 111.435 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -149.92 87.65 5.01 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.785 0.326 . . . . 72.349999999999994 110.862 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.45 -67.44 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.983 2.456 . . . . 70.510000000000005 113.737 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.8 t -70.07 108.74 4.22 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.495 0.554 . . . . 65.319999999999993 112.495 -172.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.34 105.82 17.38 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.06 -0.518 . . . . 71.319999999999993 110.69 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -168.81 -50.18 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.915 0.388 . . . . 74.230000000000004 111.554 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -84.67 -52.4 6.11 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.64 0.607 . . . . 73.329999999999998 112.64 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.57 98.43 1.85 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.367 -0.444 . . . . 50.399999999999999 113.108 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -168.56 -38.36 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.862 0.319 . . . . 75.409999999999997 111.862 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -28.57 13.32 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.476 0.917 . . . . 70.129999999999995 113.476 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.14 142.11 52.42 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.481 0.658 . . . . 75.530000000000001 112.317 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -114.34 -3.66 13.07 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.843 -0.617 . . . . 62.140000000000001 112.275 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.19 38.16 0.02 OUTLIER Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.406 -0.902 . . . . 73.310000000000002 114.245 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.8 m 69.21 128.11 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.693 0.627 . . . . 73.420000000000002 112.693 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -98.05 -17.29 19.2 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.293 0.479 . . . . 70.109999999999999 112.293 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -94.95 -160.27 0.77 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.505 0.669 . . . . 73.209999999999994 110.452 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -112.1 76.11 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.411 0.625 . . . . 74.030000000000001 109.45 166.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.6 t -92.3 129.99 42.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.806 -0.634 . . . . 74.209999999999994 110.818 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 35.1 mt-10 -80.48 63.97 5.11 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.653 0.74 . . . . 72.450000000000003 110.069 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.54 ' HD2' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -114.48 149.56 36.16 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.915 -0.584 . . . . 73.129999999999995 111.748 -177.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 141.67 -113.65 0.84 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.205 -0.522 . . . . 65.209999999999994 112.802 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.424 HD11 HD13 ' A' ' 70' ' ' ILE . 17.1 pt -111.51 134.52 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.959 0.409 . . . . 62.32 111.85 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -46.25 -36.31 6.02 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.829 -0.623 . . . . 73.329999999999998 112.222 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.495 HD12 ' CE2' ' A' ' 30' ' ' PHE . 50.9 mt -48.66 -64.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.304 0.573 . . . . 75.319999999999993 112.29 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 33.8 m -66.04 -36.75 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.911 -0.586 . . . . 73.230000000000004 112.188 -175.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.406 HD13 HG22 ' A' ' 35' ' ' VAL . 42.7 mt -67.46 -38.32 84.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.095 0.474 . . . . 71.109999999999999 111.299 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -66.41 -45.2 80.75 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.077 -0.51 . . . . 75.340000000000003 111.247 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -90.43 7.94 36.21 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.38 0.511 . . . . 74.400000000000006 112.38 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.8 mttm 57.4 69.08 0.77 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.496 0.665 . . . . 75.340000000000003 112.759 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 75.0 mt -114.74 120.86 41.52 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.935 -0.575 . . . . 73.349999999999994 110.541 177.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 14.4 p -86.62 144.17 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.911 0.386 . . . . 75.439999999999998 111.615 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.55 126.31 30.76 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.105 -0.498 . . . . 74.329999999999998 112.214 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.2 mmt -132.35 159.46 39.15 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.201 -0.454 . . . . 74.25 111.133 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.452 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 93.5 m-20 -127.39 147.3 50.27 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.139 0.495 . . . . 75.030000000000001 111.175 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.1 p -52.19 -16.43 0.8 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.852 1.427 . . . . 65.109999999999999 114.852 -169.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.452 ' CE1' ' HB2' ' A' ' 80' ' ' ASN . 50.2 p90 -58.94 -41.63 87.82 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.418 0.525 . . . . 73.430000000000007 112.418 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -101.34 -37.92 8.27 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.126 -0.359 . . . . 64.129999999999995 111.824 -178.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.64 6.88 0.98 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.833 0.679 . . . . 64.219999999999999 112.833 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.32 -50.59 38.85 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.359 0.503 . . . . 73.430000000000007 112.359 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.7 m -68.96 -35.27 76.56 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.625 0.25 . . . . 65.540000000000006 111.612 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 95.9 mmm -56.46 -50.85 70.51 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.681 0.277 . . . . 65.409999999999997 110.698 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -68.32 -33.73 74.85 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.84 0.311 . . . . 73.230000000000004 111.84 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -55.6 -54.72 40.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.104 0.478 . . . . 74.209999999999994 110.967 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.48 -38.22 68.25 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.2 -0.455 . . . . 71.120000000000005 111.792 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -59.01 -54.82 42.77 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.633 -0.258 . . . . 75.030000000000001 111.288 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.4 mm -62.4 -35.43 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.696 -0.229 . . . . 73.5 111.272 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.436 ' HE3' ' HD2' ' A' ' 97' ' ' LYS . 57.4 tptt -57.33 -60.56 3.44 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.709 0.29 . . . . 74.439999999999998 111.11 175.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -61.77 -39.5 91.86 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.167 0.508 . . . . 75.430000000000007 111.097 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.588 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 78.3 t80 -57.36 -56.68 18.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.86 -0.609 . . . . 75.420000000000002 111.527 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 51.8 ttm -53.79 -43.7 69.49 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.09 0.472 . . . . 71.409999999999997 111.33 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.436 ' HD2' ' HE3' ' A' ' 93' ' ' LYS . 28.0 mtpp -61.71 -43.85 98.06 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.989 -0.55 . . . . 74.510000000000005 111.79 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -73.42 -44.45 58.28 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.95 0.352 . . . . 71.319999999999993 111.95 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.0 m -66.33 -38.73 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.395 0.517 . . . . 73.349999999999994 112.395 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 34.5 mm -65.51 -47.0 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.856 0.36 . . . . 75.140000000000001 110.756 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.95 -42.89 85.89 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 72.540000000000006 110.512 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -64.83 -35.55 81.48 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.709 -0.678 . . . . 63.439999999999998 111.285 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.566 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 15.0 mmt -68.05 -39.62 82.97 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.651 0.241 . . . . 75.430000000000007 111.651 177.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.65 -35.68 72.93 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.491 0.663 . . . . 74.430000000000007 110.53 171.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -70.09 -46.35 65.04 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.283 -0.871 . . . . 72.510000000000005 112.702 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.566 ' ND2' ' HA ' ' A' ' 103' ' ' MET . 0.1 OUTLIER -97.51 -26.15 14.92 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.122 1.156 . . . . 73.319999999999993 114.122 -174.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.566 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 87.7 m-20 -124.06 -63.21 1.22 Allowed 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.874 -0.516 . . . . 63.240000000000002 112.114 -175.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 107' ' ' ASN . 5.9 ptt180 67.91 -14.71 0.22 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.308 1.043 . . . . 74.519999999999996 113.399 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.568 ' O ' HG23 ' A' ' 113' ' ' VAL . 24.7 t70 -61.64 127.63 32.37 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.2 -0.313 . . . . 72.200000000000003 111.676 -176.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -50.63 -39.64 50.91 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.727 0.64 . . . . 75.209999999999994 112.727 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.94 -35.63 50.17 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.648 0.261 . . . . 72.329999999999998 111.576 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -67.71 -51.36 50.32 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.783 0.325 . . . . 64.019999999999996 111.083 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 109' ' ' ASP . 16.1 m -66.73 -23.07 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 111.813 0.301 . . . . 63.530000000000001 111.813 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.581 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 29.1 t70 -69.96 -61.43 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.039 -0.356 . . . . 74.329999999999998 110.039 171.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.85 -40.16 63.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.865 0.364 . . . . 70.150000000000006 111.608 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -58.83 -59.34 5.59 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.384 -0.371 . . . . 74.319999999999993 111.242 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 8.4 ptpp? -59.39 -31.8 69.58 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.958 -0.297 . . . . 74.019999999999996 111.065 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 33.7 mmtp -62.4 -46.66 87.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.851 0.357 . . . . 74.510000000000005 110.802 175.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -67.37 -56.25 10.46 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.071 -0.513 . . . . 73.239999999999995 111.991 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.0 tp -67.36 -40.6 85.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.587 0.588 . . . . 72.540000000000006 112.587 -175.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.478 ' HB3' ' O ' ' A' ' 117' ' ' LYS . 14.3 tm0? -68.12 -45.74 72.8 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.023 -0.423 . . . . 72.319999999999993 110.737 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.41 -41.61 95.32 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.647 -0.787 . . . . 71.109999999999999 112.05 173.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -59.44 -54.1 50.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.4 0.28 . . . . 71.030000000000001 111.717 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.0 m -64.82 -36.7 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.485 0.55 . . . . 75.540000000000006 112.485 -177.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 121' ' ' GLN . 78.0 t -59.37 -43.51 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.98 -0.45 . . . . 72.230000000000004 111.148 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.7 t -76.05 -37.64 58.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.116 0.484 . . . . 74.099999999999994 111.119 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.5 ' HA ' ' CD2' ' A' ' 133' ' ' PHE . 51.1 tp -61.25 -33.55 73.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.987 0.515 . . . . 75.519999999999996 111.704 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 65.7 mt -88.47 3.01 51.65 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.35 -0.386 . . . . 72.010000000000005 111.918 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.27 102.86 0.1 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.151 0.5 . . . . 71.549999999999997 111.642 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.721 ' HZ2' ' HB3' ' A' ' 130' ' ' LYS . 0.3 OUTLIER -62.33 -11.44 15.35 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.794 1.035 . . . . 72.299999999999997 113.794 -172.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.97 -48.35 6.03 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.642 0.608 . . . . 74.319999999999993 112.642 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.7 tpp85 -92.8 -56.01 3.16 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.185 0.516 . . . . 74.519999999999996 111.667 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.5 ' CD2' ' HA ' ' A' ' 127' ' ' LEU . 8.0 m-85 -71.2 -5.86 35.13 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.117 0.484 . . . . 75.219999999999999 111.975 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 27.6 ttpp -49.81 -21.84 1.25 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.144 -0.48 . . . . 71.120000000000005 112.08 172.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -82.18 9.35 8.84 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.916 0.71 . . . . 74.409999999999997 112.916 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.25 136.12 33.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.06 0.457 . . . . 75.25 111.771 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.14 118.45 37.01 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.154 -0.475 . . . . 72.420000000000002 110.296 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -97.08 108.32 21.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.001 0.429 . . . . 73.140000000000001 111.278 -176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.532 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 45.7 m-85 -98.64 124.49 43.47 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.1 0.476 . . . . 73.430000000000007 111.481 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.52 HG21 ' HB3' ' A' ' 145' ' ' ALA . 10.6 tt -135.56 148.75 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.315 -0.402 . . . . 73.439999999999998 110.929 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.37 121.94 8.07 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.276 -0.487 . . . . 45.539999999999999 112.815 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -32.31 60.81 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.931 0.715 . . . . 73.299999999999997 112.931 -175.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -61.32 -39.34 90.15 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.066 0.395 . . . . 74.25 112.066 173.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -80.52 -40.53 25.86 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.939 0.399 . . . . 62.450000000000003 111.562 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.52 ' HB3' HG21 ' A' ' 140' ' ' ILE . . . -58.56 -20.68 48.69 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.128 -0.487 . . . . 71.420000000000002 112.058 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -62.84 -16.89 60.33 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.072 -0.513 . . . . 75.120000000000005 111.761 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.13 31.37 14.57 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.252 -0.499 . . . . 74.209999999999994 112.485 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.46 -19.89 19.5 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.193 0.442 . . . . 75.109999999999999 112.193 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -161.78 -170.87 2.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.641 -0.254 . . . . 75.319999999999993 111.08 -176.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -65.66 -66.47 0.54 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.781 0.324 . . . . 75.420000000000002 111.784 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.29 146.2 0.21 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.345 -0.455 . . . . 51.340000000000003 113.67 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -102.17 135.99 42.78 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.313 -0.522 . . . . 65.25 111.265 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 56.1 t -94.69 127.86 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.19 0.519 . . . . 74.299999999999997 112.015 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.835 ' HB2' HD11 ' A' ' 169' ' ' LEU . . . -96.05 123.28 39.6 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.688 -0.687 . . . . 64.120000000000005 110.422 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 55.4 mt -93.3 118.98 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.18 0.437 . . . . 75.150000000000006 112.18 -173.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.0 mm -102.94 117.59 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.677 -0.238 . . . . 73.030000000000001 111.222 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -109.76 125.13 52.37 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.16 0.505 . . . . 74.319999999999993 111.59 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -87.52 88.87 7.8 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.039 -0.528 . . . . 73.430000000000007 109.824 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 159' ' ' ARG . 18.9 ptt85 -124.82 172.49 9.3 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.203 0.525 . . . . 74.219999999999999 112.324 -175.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -89.3 135.92 33.31 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.31 0.576 . . . . 75.129999999999995 112.213 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 78.1 t -108.8 95.48 3.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.889 -0.782 . . . . 73.030000000000001 108.889 169.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.4 t70 69.74 -56.96 0.56 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.533 -0.758 . . . . 73.510000000000005 111.564 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.02 6.65 0.14 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 121.1 -0.572 . . . . 73.319999999999993 114.224 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.4 m -120.5 134.76 55.23 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.749 0.774 . . . . 75.209999999999994 111.697 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -83.28 107.93 16.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.582 -0.281 . . . . 62.450000000000003 111.409 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.1 m -128.79 147.32 64.0 Favored Pre-proline 0 N--CA 1.474 0.747 0 CA-C-O 121.078 0.466 . . . . 71.450000000000003 112.016 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -90.94 114.72 0.43 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.928 2.419 . . . . 60.030000000000001 113.366 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 79.2 p -103.52 154.87 18.99 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.631 -0.259 . . . . 55.100000000000001 110.658 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.835 HD11 ' HB2' ' A' ' 154' ' ' ALA . 13.7 tp -100.28 120.89 40.62 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.221 -0.299 . . . . 73.400000000000006 111.312 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.627 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 60.8 mtt -107.54 134.89 49.9 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.678 0.621 . . . . 73.430000000000007 112.678 -175.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.8 mt -143.41 146.4 33.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.278 -0.874 . . . . 70.310000000000002 110.092 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.588 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 44.5 t -77.19 134.67 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 112.277 0.473 . . . . 74.209999999999994 112.277 -176.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.783 ' HB3' ' HZ1' ' A' ' 173' ' ' LYS . 5.9 ttpm? -59.6 -47.67 84.66 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.983 -0.553 . . . . 74.530000000000001 112.089 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -85.16 11.48 9.76 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.918 0.389 . . . . 71.329999999999998 111.964 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.514 ' HB3' ' HE1' ' A' ' 95' ' ' PHE . . . -103.3 -13.07 16.85 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.75 0.31 . . . . 71.25 111.133 173.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.2 pt -136.9 133.58 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.216 0.532 . . . . 75.219999999999999 111.485 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.504 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 50.6 mm -94.58 110.79 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.958 0.409 . . . . 70.519999999999996 110.218 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.7 123.15 31.55 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.319 -0.4 . . . . 72.209999999999994 110.822 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.557 ' HB3' HG13 ' A' ' 3' ' ' ILE . 11.8 tp10 -121.41 139.4 53.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.182 0.515 . . . . 75.140000000000001 110.702 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.02 132.43 50.75 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.776 0.658 . . . . 63.119999999999997 112.776 -172.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 53.6 t -127.32 88.08 2.74 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.967 -0.561 . . . . 73.430000000000007 109.993 172.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.25 99.4 6.68 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.985 -0.552 . . . . 73.510000000000005 110.655 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 119.185 -0.436 . . . . 71.5 111.923 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.565 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 24.0 mmt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.664 0.269 . . . . 71.109999999999999 111.264 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 15' ' ' SER . 57.7 tp -71.98 133.58 45.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.725 0.298 . . . . 72.430000000000007 110.781 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.1 mt -97.19 120.47 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 111.872 0.323 . . . . 72.5 111.872 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.691 ' HH ' ' HB2' ' A' ' 16' ' ' ASP . 7.8 m-85 -106.59 115.05 29.53 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.439 -0.346 . . . . 74.439999999999998 110.638 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.422 ' HG2' HD12 ' A' ' 13' ' ' LEU . 97.7 mttt -112.6 112.22 23.6 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.321 0.388 . . . . 75.319999999999993 111.231 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.61 154.98 38.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.088 0.47 . . . . 73.430000000000007 111.199 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.4 -42.67 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.081 0.467 . . . . 74.299999999999997 110.579 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -109.97 -33.54 6.68 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.461 0.911 . . . . 62.32 113.461 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.651 ' HG1' ' HB3' ' A' ' 152' ' ' GLN . 1.3 m -89.61 15.17 9.95 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 112.729 0.64 . . . . 71.239999999999995 112.729 -175.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -54.64 -17.87 3.86 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.93 0.715 . . . . 72.299999999999997 112.93 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.45 -33.11 72.08 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.357 0.599 . . . . 70.109999999999999 111.13 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -94.08 24.29 4.42 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.997 -0.547 . . . . 53.229999999999997 111.845 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 4' ' ' TYR . 65.5 tp -31.04 117.26 0.17 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.787 0.835 . . . . 72.040000000000006 112.436 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.6 t -110.01 163.6 13.41 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.284 0.564 . . . . 74.439999999999998 112.364 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.565 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 79.3 p -150.17 107.59 3.63 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.598 -0.728 . . . . 74.319999999999993 110.688 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.691 ' HB2' ' HH ' ' A' ' 4' ' ' TYR . 10.6 m-20 -135.71 173.69 11.44 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.25 0.547 . . . . 73.219999999999999 112.328 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 m -133.9 84.7 2.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.875 -0.602 . . . . 70.450000000000003 110.489 173.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.59 152.01 73.84 Favored Pre-proline 0 N--CA 1.474 0.754 0 CA-C-N 116.367 -0.379 . . . . 75.430000000000007 111.381 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -93.0 94.21 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.862 2.374 . . . . 74.540000000000006 112.901 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.529 ' HB3' ' HB3' ' A' ' 28' ' ' TYR . 4.0 mpp? -85.41 144.82 27.78 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.857 0.36 . . . . 72.239999999999995 111.36 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -99.12 108.1 20.64 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.876 0.37 . . . . 72.030000000000001 111.863 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.2 tp -75.75 95.49 3.45 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.046 0.45 . . . . 74.420000000000002 111.084 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -86.75 140.34 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.038 0.446 . . . . 74.439999999999998 111.71 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.5 t70 58.03 16.46 3.79 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.854 -0.612 . . . . 74.019999999999996 111.679 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 57.18 20.4 5.62 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.054 -0.521 . . . . 75.010000000000005 111.762 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.475 HD23 ' HB3' ' A' ' 119' ' ' LYS . 32.2 tp -118.43 -50.17 2.45 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.055 0.455 . . . . 71.109999999999999 111.963 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.465 HG11 HG22 ' A' ' 172' ' ' VAL . 14.3 m -130.8 155.38 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 112.581 0.586 . . . . 75.349999999999994 112.581 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.529 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 77.5 m-85 -92.24 124.86 36.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.086 -0.506 . . . . 75.049999999999997 110.816 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 15.1 pt-20 -101.93 139.32 37.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.997 0.427 . . . . 74.129999999999995 110.217 171.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 168' ' ' THR . 42.5 t80 -141.56 112.35 7.2 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.629 -0.259 . . . . 73.120000000000005 111.11 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -75.48 130.89 39.64 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.33 0.492 . . . . 75.200000000000003 112.33 -179.441 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -126.09 162.04 20.36 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.385 -0.436 . . . . 42.229999999999997 113.606 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -97.24 126.83 42.7 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.463 -0.434 . . . . 74.430000000000007 111.539 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.408 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 15.9 p80 -74.5 106.57 6.16 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.142 0.496 . . . . 74.349999999999994 110.619 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 43' ' ' VAL . 29.7 m -140.81 177.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.381 0.61 . . . . 75.400000000000006 111.862 -176.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 66' ' ' ARG . 34.9 m -132.43 146.87 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.971 -0.559 . . . . 74.540000000000006 111.219 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.925 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 56.7 ttt-85 -109.41 121.21 44.68 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.256 0.551 . . . . 74.209999999999994 110.892 174.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -131.14 160.64 34.14 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.691 -1.14 . . . . 75.409999999999997 110.784 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -55.06 -38.23 67.77 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.066 0.395 . . . . 73.239999999999995 112.066 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.41 37.28 2.38 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.091 -0.576 . . . . 63.299999999999997 113.358 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -170.71 132.8 0.94 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.756 -0.261 . . . . 61.140000000000001 110.731 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 tp -149.6 148.74 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 112.293 0.479 . . . . 64.409999999999997 112.293 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.427 HG23 HG13 ' A' ' 35' ' ' VAL . 8.0 p 35.9 80.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.291 1.036 . . . . 72.109999999999999 113.517 176.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.422 ' N ' HD22 ' A' ' 44' ' ' LEU . 1.4 mm? -89.45 100.48 13.26 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.88 -0.512 . . . . 74.400000000000006 110.587 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.53 69.45 2.28 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.184 0.516 . . . . 73.540000000000006 111.633 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.4 163.25 25.03 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.279 -0.486 . . . . 63.229999999999997 113.351 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.5 t -96.07 142.8 27.84 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.923 0.392 . . . . 63.100000000000001 110.645 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -146.55 130.95 8.69 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.556 -0.293 . . . . 72.5 110.364 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.88 -174.64 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.371 2.048 . . . . 63.030000000000001 112.798 176.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.7 p -58.45 117.26 4.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.958 0.409 . . . . 73.140000000000001 111.405 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.55 -10.51 37.38 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.146 0.424 . . . . 72.140000000000001 112.146 -174.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 1.7 tm-20 -69.62 78.19 0.42 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.223 0.535 . . . . 64.129999999999995 110.766 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 177.7 99.68 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.557 -0.747 . . . . 63.340000000000003 110.898 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.03 123.06 0.05 OUTLIER Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.299 -0.477 . . . . 71.549999999999997 113.534 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.47 94.51 3.33 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.414 -0.462 . . . . 72.150000000000006 110.906 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.14 108.15 5.19 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.543 0.687 . . . . 74.140000000000001 111.848 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -125.95 137.64 53.71 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.074 -0.512 . . . . 61.32 111.708 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.19 -41.63 70.04 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.098 -0.501 . . . . 65.430000000000007 110.51 172.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.6 -95.61 0.06 OUTLIER Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.923 -0.581 . . . . 64.209999999999994 113.188 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.3 p 51.16 15.85 0.32 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.873 0.869 . . . . 73.140000000000001 112.741 -176.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -124.19 30.62 6.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.315 0.579 . . . . 72.129999999999995 110.714 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -61.42 -0.83 0.43 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.873 0.694 . . . . 64.230000000000004 112.873 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -68.21 -20.7 64.86 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.984 0.421 . . . . 74.239999999999995 111.056 171.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.0 t -90.2 148.97 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.126 -0.488 . . . . 75.209999999999994 110.104 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.925 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.7 mp0 -79.73 72.85 6.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 119.553 -0.859 . . . . 62.25 110.633 178.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.404 ' HA ' HG12 ' A' ' 36' ' ' VAL . 60.6 mtp180 -87.57 131.76 34.29 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.741 -0.663 . . . . 74.299999999999997 111.528 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.32 -150.42 22.02 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.67 -0.776 . . . . 63.530000000000001 113.117 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.4 pt -110.45 146.15 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 122.349 -0.501 . . . . 74.519999999999996 111.397 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -40.36 -47.38 2.53 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.211 0.604 . . . . 71.129999999999995 112.18 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.428 HG13 ' HA3' ' A' ' 32' ' ' GLY . 61.9 mt -48.9 -53.84 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.757 -0.656 . . . . 75.409999999999997 112.333 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 m -83.22 -32.0 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 112.087 0.403 . . . . 74.140000000000001 112.087 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.75 -36.03 82.42 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.727 0.298 . . . . 74.329999999999998 111.367 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -81.42 -6.41 58.91 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.925 0.393 . . . . 75.040000000000006 111.324 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -124.48 8.21 8.35 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.952 0.352 . . . . 63.439999999999998 111.952 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.1 pttm 39.47 59.31 1.81 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.791 0.805 . . . . 73.439999999999998 112.699 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 84.9 mt -93.97 141.9 28.0 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.769 -0.65 . . . . 74.430000000000007 111.516 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 p -96.06 140.19 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 120.684 0.278 . . . . 75.040000000000006 111.267 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -89.57 148.25 23.48 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.533 0.682 . . . . 74.409999999999997 112.744 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.469 ' HG3' ' HB2' ' A' ' 138' ' ' PHE . 15.2 ptp -147.65 165.27 30.93 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.214 -0.903 . . . . 75.219999999999999 109.75 174.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.435 ' HA ' ' HD2' ' A' ' 138' ' ' PHE . 3.4 p30 -163.01 157.86 21.43 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.454 0.645 . . . . 73.010000000000005 112.259 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 64.3 m -37.53 -34.02 0.09 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 116.495 2.035 . . . . 73.030000000000001 116.495 -162.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -67.92 -31.98 72.12 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.433 -0.792 . . . . 71.510000000000005 112.348 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.87 -46.97 5.74 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.236 0.541 . . . . 73.549999999999997 111.913 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.444 ' OD1' ' HB2' ' A' ' 79' ' ' MET . 0.4 OUTLIER -95.2 12.89 27.25 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.494 0.924 . . . . 72.129999999999995 113.494 -173.001 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -41.06 -61.39 1.0 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.645 0.609 . . . . 64.129999999999995 112.645 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.5 m -65.45 -32.8 74.61 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.334 -0.394 . . . . 72.310000000000002 111.772 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 67.5 mtm -71.7 -52.62 16.91 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.06 0.392 . . . . 73.310000000000002 112.06 -175.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.478 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 16.5 p90 -71.96 -19.39 61.9 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.69 -0.631 . . . . 71.099999999999994 111.224 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -64.01 -44.21 93.29 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.08 0.467 . . . . 74.040000000000006 110.534 171.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.16 99.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.195 0.521 . . . . 74.299999999999997 110.455 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.452 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 44.0 t80 -54.6 -53.1 59.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.588 -0.733 . . . . 62.140000000000001 111.972 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.9 tp -67.66 -32.27 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 111.83 0.307 . . . . 74.219999999999999 111.83 -177.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.413 ' C ' ' HD3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -63.35 -53.25 55.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.665 0.269 . . . . 73.140000000000001 110.656 176.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -60.2 -49.48 77.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.934 0.397 . . . . 75.209999999999994 110.745 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.489 ' HZ ' HG12 ' A' ' 172' ' ' VAL . 85.1 t80 -51.25 -58.09 7.09 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.082 -0.508 . . . . 61.310000000000002 111.916 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -54.57 -49.52 70.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.428 -0.351 . . . . 65.239999999999995 111.465 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -65.83 -48.51 71.42 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.605 -0.27 . . . . 73.420000000000002 111.7 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.49 -40.3 96.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.715 0.635 . . . . 74.439999999999998 112.715 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.7 m -67.95 -45.84 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 122.21 -0.306 . . . . 74.230000000000004 111.611 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.4 mm -67.55 -45.42 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.889 0.376 . . . . 74.420000000000002 111.131 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.51 -40.98 96.57 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.236 -0.438 . . . . 74.049999999999997 111.546 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -58.71 -47.02 86.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.942 0.401 . . . . 63.340000000000003 110.885 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.525 ' HE1' ' HB3' ' A' ' 112' ' ' ASP . 18.9 ttt -68.67 -45.68 71.08 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.164 0.507 . . . . 74.329999999999998 110.737 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -58.93 -37.38 76.55 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.281 -0.418 . . . . 74.430000000000007 111.729 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -54.37 -50.91 66.39 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.12 -0.491 . . . . 72.430000000000007 112.296 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -102.31 -36.92 8.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.791 0.663 . . . . 73.120000000000005 112.791 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -74.89 -56.02 5.19 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.965 -0.46 . . . . 72.439999999999998 111.659 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 66.65 -0.47 1.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.876 0.47 . . . . 75.450000000000003 112.19 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 113' ' ' VAL . 13.6 t70 -86.24 119.85 26.97 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.132 -0.355 . . . . 73.200000000000003 110.717 -177.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -65.64 -35.01 79.56 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.522 0.564 . . . . 74.040000000000006 112.522 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.93 -38.64 89.19 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.796 0.331 . . . . 73.150000000000006 111.435 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.525 ' HB3' ' HE1' ' A' ' 103' ' ' MET . 9.2 m-20 -72.73 -53.17 12.36 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.729 0.27 . . . . 74.340000000000003 111.729 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 109' ' ' ASP . 30.0 m -65.55 -21.73 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 112.098 0.407 . . . . 75.140000000000001 112.098 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -74.96 -42.35 57.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.965 0.412 . . . . 74.109999999999999 110.683 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.12 73.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.98 0.419 . . . . 62.119999999999997 110.986 176.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.18 -47.52 85.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.169 -0.468 . . . . 75.549999999999997 111.093 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -56.63 -40.87 76.16 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.53 -0.304 . . . . 75.420000000000002 110.915 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.5 tppt? -59.26 -40.33 85.67 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.604 0.24 . . . . 64.349999999999994 111.171 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.475 ' HB3' HD23 ' A' ' 26' ' ' LEU . 29.3 mmtp -61.73 -57.8 10.52 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.683 -0.235 . . . . 74.400000000000006 111.584 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.8 mm -59.95 -45.58 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.021 0.378 . . . . 75.230000000000004 112.021 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.44 ' O ' HG23 ' A' ' 125' ' ' VAL . 24.7 tm0? -61.62 -51.61 67.8 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.707 0.289 . . . . 64.329999999999998 110.942 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.79 -36.98 93.55 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.724 -0.751 . . . . 75.019999999999996 112.378 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -57.16 -53.75 54.58 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.862 0.465 . . . . 75.329999999999998 111.596 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.17 -42.44 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 112.189 0.44 . . . . 73.129999999999995 112.189 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 121' ' ' GLN . 69.9 t -55.92 -43.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.881 0.372 . . . . 74.310000000000002 111.396 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.5 t -72.03 -47.22 53.39 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.195 0.521 . . . . 73.430000000000007 111.569 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.441 HD22 HD12 ' A' ' 155' ' ' ILE . 31.5 tp -65.3 -28.06 69.05 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.126 -0.488 . . . . 74.310000000000002 111.914 -176.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.9 mt -84.54 2.56 40.63 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.133 0.419 . . . . 75.109999999999999 112.133 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.468 ' HB2' ' CD1' ' A' ' 133' ' ' PHE . . . -62.03 78.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.652 0.739 . . . . 53.119999999999997 110.977 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -60.08 -15.26 21.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.546 0.943 . . . . 72.319999999999993 113.546 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.19 -46.79 87.49 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 122.274 -0.266 . . . . 73.349999999999994 111.493 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -109.15 -39.24 5.32 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.836 0.351 . . . . 74.120000000000005 111.789 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.48 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 69.5 m-85 -63.62 -4.5 3.0 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.526 0.565 . . . . 75.209999999999994 112.526 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -44.35 -26.76 0.36 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 120.952 0.406 . . . . 73.420000000000002 111.841 168.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -83.54 20.34 1.4 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 112.79 0.663 . . . . 70.299999999999997 112.79 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 71.2 mt -88.51 132.06 34.66 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.925 -0.484 . . . . 75.319999999999993 111.318 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.28 123.21 48.44 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.134 -0.485 . . . . 73.299999999999997 110.734 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.633 ' HB3' HG12 ' A' ' 153' ' ' VAL . 53.6 m-85 -102.61 125.92 49.51 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.257 -0.277 . . . . 75.450000000000003 110.839 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.545 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 75.6 m-85 -121.61 142.14 50.41 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.05 0.389 . . . . 74.140000000000001 112.05 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 152' ' ' GLN . 34.4 pt -129.62 173.07 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.89 0.376 . . . . 75.140000000000001 111.09 174.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.48 153.88 50.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.274 -0.489 . . . . 72.310000000000002 114.01 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.52 -58.42 7.23 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.062 0.458 . . . . 75.439999999999998 112.045 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.573 ' HA ' ' HB3' ' A' ' 146' ' ' GLU . 30.3 mtm180 -73.09 -19.37 61.17 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.857 0.36 . . . . 74.219999999999999 111.284 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.658 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . . . -61.03 -40.77 94.87 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.271 0.558 . . . . 71.329999999999998 110.467 170.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.1 -19.14 40.73 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.083 0.468 . . . . 65.450000000000003 111.374 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.573 ' HB3' ' HA ' ' A' ' 143' ' ' ARG . 42.6 tt0 -87.27 -24.26 24.41 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.252 0.464 . . . . 72.409999999999997 112.252 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.33 -46.52 0.02 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 120.472 -0.871 . . . . 72.200000000000003 114.336 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 144' ' ' ALA . . . -71.0 86.58 0.72 Allowed 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.307 -0.526 . . . . 74.439999999999998 111.827 -177.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -61.34 -9.8 5.97 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.247 0.832 . . . . 73.230000000000004 113.247 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -93.38 27.21 2.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.809 0.338 . . . . 73.010000000000005 111.421 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 9' ' ' THR . . . -60.44 115.83 8.29 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.469 -0.396 . . . . 62.420000000000002 113.698 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.651 ' HB3' ' HG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -60.25 134.55 57.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.244 0.545 . . . . 74.010000000000005 111.272 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.633 HG12 ' HB3' ' A' ' 138' ' ' PHE . 63.0 t -83.0 109.92 17.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.154 -0.476 . . . . 75.530000000000001 111.707 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.714 ' HB3' HD13 ' A' ' 169' ' ' LEU . . . -81.06 119.03 23.02 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.04 -0.527 . . . . 53.049999999999997 110.197 171.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.441 HD12 HD22 ' A' ' 127' ' ' LEU . 61.5 mt -96.12 117.1 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 112.468 0.544 . . . . 70.420000000000002 112.468 -170.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.2 mm -94.5 113.14 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.723 0.297 . . . . 74.230000000000004 111.219 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 158' ' ' TYR . 42.7 tt0 -105.75 157.33 17.51 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.973 0.416 . . . . 63.32 111.305 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.438 ' N ' ' HG2' ' A' ' 157' ' ' GLU . 23.1 p90 -92.51 105.24 17.45 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.967 0.413 . . . . 74.239999999999995 111.191 176.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.448 ' HD3' ' OG1' ' A' ' 168' ' ' THR . 54.9 mtp85 -127.44 132.33 50.07 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.966 0.412 . . . . 73.140000000000001 111.114 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.839 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 6.4 p-10 -88.25 143.08 27.24 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.768 0.655 . . . . 51.229999999999997 112.768 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.0 t -109.29 98.2 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.641 -0.708 . . . . 75.310000000000002 110.585 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.1 t70 61.59 7.08 1.72 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.543 0.737 . . . . 75.340000000000003 112.918 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.26 -27.72 1.54 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.533 -0.842 . . . . 72.0 114.065 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 84.3 m -104.27 114.49 28.76 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 117.252 0.526 . . . . 73.510000000000005 111.125 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.839 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 9.3 pt-20 -76.37 122.54 24.62 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.611 0.72 . . . . 71.319999999999993 112.098 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -127.14 149.85 70.63 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.471 -0.786 . . . . 72.010000000000005 111.639 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.95 120.72 7.92 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.785 2.323 . . . . 74.099999999999994 112.766 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.448 ' OG1' ' HD3' ' A' ' 159' ' ' ARG . 69.6 p -111.22 133.37 53.61 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.79 0.328 . . . . 65.209999999999994 111.756 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.714 HD13 ' HB3' ' A' ' 154' ' ' ALA . 68.9 tp -77.36 130.99 37.84 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.179 -0.464 . . . . 63.340000000000003 111.258 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 24.3 mmt -113.27 124.46 52.55 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.594 0.358 . . . . 71.239999999999995 111.445 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.99 134.82 38.97 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.076 -0.511 . . . . 73.329999999999998 110.864 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.489 HG12 ' HZ ' ' A' ' 95' ' ' PHE . 25.7 t -93.13 126.35 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 122.099 -0.375 . . . . 75.310000000000002 111.425 -178.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.425 ' HZ3' ' CD ' ' A' ' 174' ' ' GLU . 22.4 pttp -72.42 -14.88 61.8 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.831 0.678 . . . . 75.329999999999998 112.831 -175.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.425 ' CD ' ' HZ3' ' A' ' 173' ' ' LYS . 1.3 mp0 -88.31 -2.4 58.58 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.137 -0.352 . . . . 74.420000000000002 111.716 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.5 -46.39 6.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.309 0.576 . . . . 73.430000000000007 110.428 174.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.7 pt -105.4 132.18 52.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.498 -0.774 . . . . 70.120000000000005 110.504 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.403 ' CG1' ' HB2' ' A' ' 5' ' ' LYS . 46.8 pt -94.85 143.47 11.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.2 0.524 . . . . 74.25 111.314 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -94.25 118.24 31.3 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.612 -0.722 . . . . 71.209999999999994 111.331 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -122.97 113.99 19.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.359 0.6 . . . . 73.319999999999993 110.897 172.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -112.55 123.01 49.34 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.734 -0.666 . . . . 62.420000000000002 112.106 -175.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.418 ' C ' HD11 ' A' ' 182' ' ' LEU . 51.8 t -121.93 87.82 2.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.265 0.555 . . . . 64.150000000000006 109.997 169.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.418 HD11 ' C ' ' A' ' 181' ' ' CYS . 5.8 mp -136.04 135.98 39.87 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.706 -0.679 . . . . 73.140000000000001 110.411 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 C--O 1.254 1.326 0 CA-C-O 118.916 -0.564 . . . . 73.150000000000006 111.134 177.013 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.456 ' HE2' ' HB3' ' A' ' 17' ' ' SER . 83.6 mtp . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 120.935 0.398 . . . . 73.25 111.643 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.64 HD13 ' HB2' ' A' ' 178' ' ' GLU . 42.2 tp -92.34 139.0 31.05 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.521 -0.309 . . . . 75.299999999999997 110.943 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.0 mt -125.91 119.21 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 122.384 -0.197 . . . . 74.400000000000006 110.473 175.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.703 ' HE1' ' HB2' ' A' ' 16' ' ' ASP . 39.6 p90 -121.81 149.8 42.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.47 0.545 . . . . 72.329999999999998 112.47 -173.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.554 ' HB3' HD13 ' A' ' 13' ' ' LEU . 12.4 ptmm? -142.92 127.22 17.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.939 -0.573 . . . . 72.299999999999997 111.303 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.827 ' HB3' HG22 ' A' ' 176' ' ' ILE . 2.7 p30 -97.29 179.29 4.94 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.206 0.527 . . . . 74.409999999999997 111.63 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -47.12 -34.8 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 115.51 -0.768 . . . . 75.430000000000007 112.716 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.574 ' HB2' ' HA2' ' A' ' 151' ' ' GLY . 83.2 m-85 -100.27 -49.61 4.21 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.603 0.594 . . . . 71.209999999999994 112.603 -175.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 p -70.33 14.97 0.1 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.028 0.751 . . . . 71.019999999999996 113.028 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 8' ' ' PHE . 8.4 t70 -47.89 -32.24 6.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.207 0.603 . . . . 64.519999999999996 111.933 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.67 -61.96 1.57 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.641 0.608 . . . . 73.510000000000005 112.641 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -102.43 -33.16 9.64 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.801 0.667 . . . . 74.010000000000005 112.801 -174.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 5' ' ' LYS . 0.8 OUTLIER 40.42 -170.75 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.21 1.189 . . . . 75.25 114.21 -176.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -149.44 165.65 31.46 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.474 0.654 . . . . 74.010000000000005 112.655 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -114.2 170.16 8.49 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.699 -0.682 . . . . 74.420000000000002 111.082 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.703 ' HB2' ' HE1' ' A' ' 4' ' ' TYR . 6.5 t70 -154.28 169.15 24.35 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 120.878 0.371 . . . . 71.310000000000002 111.486 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.456 ' HB3' ' HE2' ' A' ' 1' ' ' MET . 98.2 p -151.7 19.44 0.71 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.027 0.38 . . . . 54.329999999999998 112.027 -176.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -108.65 151.07 41.51 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 121.037 0.446 . . . . 73.510000000000005 112.194 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.4 111.99 3.27 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.601 2.2 . . . . 72.340000000000003 113.595 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.65 ' SD ' ' HB2' ' A' ' 30' ' ' PHE . 18.5 mmt -106.31 166.27 10.65 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.009 -0.541 . . . . 70.439999999999998 110.876 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.632 ' HB3' ' HZ3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -134.22 129.05 35.14 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.187 -0.321 . . . . 74.5 111.221 172.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.457 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 61.4 tp -87.87 101.96 14.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.766 0.317 . . . . 74.109999999999999 111.284 -177.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 p -89.19 139.06 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-O 120.909 0.385 . . . . 73.319999999999993 111.58 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.2 15.99 2.11 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.139 -0.482 . . . . 72.219999999999999 112.264 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.457 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 52.8 m-20 52.77 26.75 4.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.847 0.459 . . . . 52.520000000000003 111.646 -177.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.17 -45.68 2.34 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.103 0.478 . . . . 75.409999999999997 111.156 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.3 m -133.68 146.06 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.295 0.569 . . . . 75.129999999999995 112.51 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 170' ' ' MET . 96.9 m-85 -87.34 144.91 26.55 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.937 -0.574 . . . . 73.329999999999998 110.368 172.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 40.7 mt-10 -118.28 143.57 46.48 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.748 0.308 . . . . 73.329999999999998 110.85 170.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.678 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 85.6 t80 -133.03 118.44 18.81 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.806 0.336 . . . . 75.219999999999999 111.175 175.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.665 ' HB2' ' HZ2' ' A' ' 31' ' ' LYS . 9.8 mtmp? -84.02 109.33 17.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.793 0.33 . . . . 75.540000000000006 111.715 -177.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.509 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -90.76 176.6 41.28 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.14 -0.553 . . . . 72.310000000000002 113.851 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.509 ' HG3' HG11 ' A' ' 35' ' ' VAL . 10.8 ptpp? -118.46 163.2 17.11 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.725 -0.279 . . . . 75.040000000000006 111.123 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -86.53 111.93 21.06 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.522 0.201 . . . . 72.319999999999993 110.904 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.509 HG11 ' HG3' ' A' ' 33' ' ' LYS . 17.3 m -139.65 159.31 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.142 0.496 . . . . 75.129999999999995 111.728 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.56 HG23 HD23 ' A' ' 44' ' ' LEU . 33.2 m -138.04 122.11 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.354 -0.385 . . . . 72.519999999999996 111.407 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.805 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 78.8 mtt180 -88.28 107.98 19.09 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.49 0.662 . . . . 72.120000000000005 111.259 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 40' ' ' GLY . 41.7 mtmt -131.68 165.22 24.19 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.566 -1.197 . . . . 75.349999999999994 110.164 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -46.79 84.8 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.304 0.574 . . . . 73.209999999999994 112.051 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 38' ' ' LYS . . . 93.47 11.08 58.66 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.941 -0.572 . . . . 61.310000000000002 114.156 176.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 40.3 mt-10 -132.85 142.93 49.2 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.374 -0.486 . . . . 72.219999999999999 111.351 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.681 HG23 ' H ' ' A' ' 43' ' ' VAL . 2.1 tp -148.5 -76.09 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 112.033 0.383 . . . . 71.030000000000001 112.033 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.681 ' H ' HG23 ' A' ' 42' ' ' ILE . 12.5 m -88.37 94.88 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.627 0.727 . . . . 70.430000000000007 111.154 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.56 HD23 HG23 ' A' ' 36' ' ' VAL . 1.2 mm? -54.59 113.5 1.32 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.561 -0.745 . . . . 73.329999999999998 112.53 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.78 -54.38 2.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.113 -0.494 . . . . 64.519999999999996 110.242 173.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.88 -13.83 42.0 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.003 -0.544 . . . . 65.129999999999995 112.812 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.509 ' HB2' HD12 ' A' ' 44' ' ' LEU . 38.9 m -101.83 175.81 5.42 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.828 0.347 . . . . 72.319999999999993 111.058 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -122.83 149.24 55.85 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.475 -0.33 . . . . 72.010000000000005 110.719 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.86 130.75 41.55 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.399 2.066 . . . . 62.210000000000001 112.644 176.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 63.8 p -64.61 129.13 38.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.865 0.364 . . . . 72.120000000000005 111.816 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.38 -93.59 0.5 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.521 -0.308 . . . . 74.420000000000002 110.827 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 46.39 30.57 1.08 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.417 0.627 . . . . 71.209999999999994 112.111 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.74 90.28 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.501 -0.772 . . . . 71.140000000000001 111.736 -174.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.13 33.79 53.49 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.175 -0.536 . . . . 62.530000000000001 113.028 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.14 58.87 5.28 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 122.5 -0.412 . . . . 72.120000000000005 111.313 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 70.53 -60.87 0.48 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.513 0.725 . . . . 74.200000000000003 111.686 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.82 105.25 0.11 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.022 0.439 . . . . 73.510000000000005 111.64 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -104.2 6.66 35.74 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.209 -0.451 . . . . 72.400000000000006 111.457 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.1 65.23 0.55 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.322 -0.466 . . . . 51.0 113.281 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.1 p -151.23 125.82 9.56 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.545 -0.385 . . . . 75.340000000000003 111.484 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 50.03 33.26 6.63 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.789 0.663 . . . . 71.040000000000006 112.789 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -62.53 -39.03 92.28 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.068 0.461 . . . . 75.519999999999996 112.011 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -95.83 36.38 1.3 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.034 0.445 . . . . 74.040000000000006 111.914 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 37' ' ' ARG . 40.5 t -97.34 139.99 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.021 -0.536 . . . . 75.420000000000002 110.95 175.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.805 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 7.1 mp0 -85.95 64.82 8.8 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.52 0.676 . . . . 74.450000000000003 110.743 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.503 ' O ' ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -96.62 135.27 38.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.552 -0.749 . . . . 74.040000000000006 111.631 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.58 -125.68 1.5 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.536 -0.84 . . . . 60.409999999999997 113.866 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.7 pt -110.61 131.33 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.404 0.621 . . . . 70.230000000000004 112.487 -174.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -50.11 -35.22 24.74 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.413 -0.812 . . . . 71.420000000000002 112.598 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.509 HG13 ' HA3' ' A' ' 32' ' ' GLY . 66.3 mt -47.28 -50.2 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.18 0.437 . . . . 75.420000000000002 112.18 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 17.3 m -90.61 -32.63 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.11 0.411 . . . . 74.420000000000002 112.11 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.448 HD12 HG22 ' A' ' 35' ' ' VAL . 80.3 mt -65.76 -37.44 86.35 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.031 0.443 . . . . 73.010000000000005 111.415 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -87.49 -1.73 58.13 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 120.715 0.293 . . . . 75.299999999999997 111.611 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -123.65 4.1 8.91 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.838 -0.539 . . . . 73.329999999999998 112.158 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp 56.06 67.32 1.02 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.41 0.624 . . . . 74.310000000000002 112.335 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 68.1 mt -116.79 136.5 52.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.124 -0.489 . . . . 74.439999999999998 111.071 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.28 145.05 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.932 0.396 . . . . 63.229999999999997 111.372 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -80.37 122.19 26.63 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.977 0.732 . . . . 64.519999999999996 112.977 -173.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 94.4 mmm -125.62 155.69 40.36 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.961 -0.563 . . . . 74.239999999999995 109.95 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.41 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 47.6 t-20 -139.41 145.75 39.29 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.841 -0.537 . . . . 74.129999999999995 111.4 -176.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.6 p -46.83 -43.13 18.26 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.95 1.093 . . . . 71.310000000000002 113.95 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.41 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 38.7 p90 -56.3 -31.44 63.67 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.354 0.502 . . . . 71.200000000000003 112.354 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -104.83 -47.25 4.09 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.043 0.449 . . . . 74.109999999999999 110.927 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.36 3.26 16.11 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.453 0.538 . . . . 64.540000000000006 112.453 -172.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.487 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -40.66 -57.68 1.82 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.297 0.851 . . . . 75.109999999999999 113.297 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.5 t -65.01 -33.1 75.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.178 0.436 . . . . 44.420000000000002 112.178 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.66 -61.79 1.79 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.416 -0.356 . . . . 75.319999999999993 111.791 -174.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.684 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 29.7 p90 -65.48 -30.06 70.8 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.08 -0.387 . . . . 75.019999999999996 111.308 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -58.48 -43.34 88.92 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.289 0.566 . . . . 75.209999999999994 110.719 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.23 -34.15 77.37 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.987 -0.551 . . . . 73.209999999999994 111.274 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.684 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 25.4 m-85 -60.92 -44.07 97.7 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.598 0.237 . . . . 75.140000000000001 110.745 173.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.3 mm -55.44 -40.2 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.569 -0.287 . . . . 75.120000000000005 111.133 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -55.6 -63.97 1.0 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.774 0.321 . . . . 75.430000000000007 111.509 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.91 -31.06 72.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.479 -0.328 . . . . 75.200000000000003 111.875 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 175' ' ' ALA . 36.9 t80 -62.53 -58.8 6.27 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.664 0.268 . . . . 72.030000000000001 111.322 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 56.5 ttp -59.47 -41.91 90.82 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.95 0.405 . . . . 72.109999999999999 110.836 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -55.58 -48.12 75.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.059 -0.519 . . . . 74.400000000000006 111.262 177.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -66.61 -54.6 21.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.088 -0.505 . . . . 70.310000000000002 112.003 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.4 m -59.8 -38.39 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.162 0.43 . . . . 73.219999999999999 112.162 -176.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.523 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 46.4 mm -70.51 -46.77 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 122.207 -0.308 . . . . 73.140000000000001 110.971 176.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.8 -24.27 61.63 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.976 0.417 . . . . 75.109999999999999 111.859 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -89.34 -29.82 18.86 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.455 -0.339 . . . . 74.010000000000005 111.763 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 11.9 tpt -81.11 -53.98 5.93 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.732 0.642 . . . . 75.450000000000003 112.732 -172.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -71.05 -10.59 60.02 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.05 0.759 . . . . 71.129999999999995 113.05 -174.24 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.651 ' HA ' ' HE3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -60.72 -48.14 83.13 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.152 0.501 . . . . 75.409999999999997 111.042 172.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -107.55 -36.72 6.38 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.841 0.682 . . . . 73.209999999999994 112.841 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.507 ' O ' HG11 ' A' ' 113' ' ' VAL . 3.0 m-20 -112.24 41.15 2.04 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.966 0.412 . . . . 60.520000000000003 111.893 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -45.05 -30.46 1.07 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.813 0.845 . . . . 65.140000000000001 112.966 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -51.76 140.45 19.16 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.618 0.723 . . . . 73.230000000000004 112.66 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 54.2 mttp -65.87 -19.92 66.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.742 1.016 . . . . 71.420000000000002 113.742 -169.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.04 -20.96 47.63 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.689 -0.632 . . . . 74.109999999999999 111.465 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -94.37 -65.43 0.99 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.884 0.328 . . . . 73.510000000000005 111.884 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.507 HG11 ' O ' ' A' ' 107' ' ' ASN . 5.1 m -59.55 -45.6 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 112.921 0.712 . . . . 74.150000000000006 112.921 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 26.2 t70 -60.81 -43.81 97.71 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.634 0.255 . . . . 74.549999999999997 111.248 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.41 -49.35 74.1 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.858 0.361 . . . . 74.310000000000002 111.277 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -56.43 -54.33 46.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.978 0.418 . . . . 73.329999999999998 111.332 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.41 ' HA ' HG21 ' A' ' 120' ' ' ILE . 62.2 tttm -61.73 -31.13 71.28 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.435 -0.348 . . . . 75.409999999999997 111.237 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -65.76 -43.34 89.2 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.782 0.325 . . . . 74.230000000000004 111.237 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -57.5 -58.13 9.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.048 0.452 . . . . 74.049999999999997 111.166 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.41 HG21 ' HA ' ' A' ' 117' ' ' LYS . 11.1 tp -64.37 -40.42 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.018 -0.537 . . . . 75.129999999999995 112.066 -175.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.593 HE21 ' HA ' ' A' ' 121' ' ' GLN . 0.0 OUTLIER -66.25 -50.73 62.75 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.315 -0.241 . . . . 65.430000000000007 111.412 178.118 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.1 -42.26 61.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.586 -0.816 . . . . 64.230000000000004 112.199 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -62.81 -61.9 2.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.332 0.253 . . . . 75.129999999999995 111.253 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.433 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.5 m -61.26 -44.93 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 112.604 0.594 . . . . 61.140000000000001 112.604 -176.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.74 -34.58 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.972 0.415 . . . . 74.099999999999994 111.525 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.1 m -80.02 -29.11 39.32 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.031 0.443 . . . . 65.140000000000001 111.273 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.9 tp -80.03 -28.82 39.27 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.148 -0.478 . . . . 73.120000000000005 111.684 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 93.6 mt -85.14 2.27 44.3 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.598 0.592 . . . . 75.310000000000002 112.598 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.21 82.06 0.08 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.231 0.539 . . . . 55.109999999999999 110.917 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 65.5 pttt -64.08 -14.99 58.53 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.568 0.951 . . . . 74.409999999999997 113.568 -169.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.33 -42.38 98.58 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.138 0.494 . . . . 73.140000000000001 110.887 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -108.57 -50.78 2.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.992 -0.549 . . . . 74.030000000000001 111.393 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.52 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 55.3 m-85 -66.74 -4.5 9.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.592 0.96 . . . . 72.430000000000007 113.592 -173.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 14.1 ptmm? -50.99 -6.6 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.242 0.83 . . . . 73.450000000000003 113.242 175.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -77.46 13.28 1.27 Allowed 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.759 -0.588 . . . . 65.209999999999994 112.024 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 95.6 mt -89.54 127.92 35.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.014 0.435 . . . . 72.219999999999999 111.607 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -100.52 127.59 46.84 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.401 -0.363 . . . . 62.240000000000002 110.934 177.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -98.99 110.62 23.2 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.838 0.352 . . . . 74.319999999999993 110.976 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.401 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 65.4 m-85 -112.75 139.98 47.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.205 0.526 . . . . 71.109999999999999 111.797 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 150' ' ' ASN . 11.2 tt -133.26 155.16 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.821 -0.627 . . . . 74.400000000000006 110.96 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.34 125.35 13.03 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.567 -0.349 . . . . 62.020000000000003 113.553 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -49.91 -48.8 51.43 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.201 0.445 . . . . 72.219999999999999 112.201 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -79.7 -22.11 43.81 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.97 0.414 . . . . 72.219999999999999 111.865 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.32 93.36 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.957 0.408 . . . . 73.150000000000006 111.296 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.7 -30.93 65.9 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.992 -0.549 . . . . 64.219999999999999 111.919 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.81 -28.49 65.76 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.633 0.254 . . . . 74.010000000000005 111.668 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.83 -20.53 1.62 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.976 -0.631 . . . . 50.32 113.702 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.84 76.85 0.46 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 117.132 0.466 . . . . 74.349999999999994 111.951 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 54.38 103.68 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.72 0.772 . . . . 74.030000000000001 112.229 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.563 ' HB3' ' OH ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -54.48 -27.56 38.62 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.282 -0.872 . . . . 74.430000000000007 112.604 -173.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 8' ' ' PHE . . . 59.5 -166.21 9.39 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 114.821 0.689 . . . . 61.030000000000001 114.821 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -96.44 144.01 26.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.786 0.327 . . . . 74.319999999999993 111.387 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 44.8 t -77.99 138.01 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.912 0.387 . . . . 73.109999999999999 110.748 171.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.61 ' HB1' HD13 ' A' ' 169' ' ' LEU . . . -94.54 133.62 37.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.424 -0.353 . . . . 63.340000000000003 111.505 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.75 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 35.4 mm -91.98 113.54 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.751 0.31 . . . . 75.129999999999995 111.653 -178.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.609 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 49.8 mm -96.45 110.04 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.682 0.277 . . . . 74.310000000000002 111.084 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.61 132.93 50.28 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.402 -0.363 . . . . 73.200000000000003 110.271 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -90.09 89.13 7.55 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.459 0.647 . . . . 74.340000000000003 110.624 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -93.53 111.82 23.57 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.612 -0.722 . . . . 75.239999999999995 111.816 -172.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.598 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 32.4 t70 -69.91 118.76 13.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.041 0.448 . . . . 73.530000000000001 112.048 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 51.9 t -104.37 93.25 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.092 -0.503 . . . . 75.409999999999997 110.681 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 60.13 13.78 4.06 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.015 0.746 . . . . 74.409999999999997 113.015 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 133.42 -17.94 4.45 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.824 -0.703 . . . . 73.120000000000005 113.351 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.3 m -110.12 106.1 15.44 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.548 -0.384 . . . . 62.109999999999999 111.453 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 42.7 mt-10 -73.38 106.32 5.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.75 0.31 . . . . 74.409999999999997 111.181 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.7 m -105.18 143.23 26.33 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 120.888 0.375 . . . . 72.439999999999998 111.356 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.66 123.58 5.39 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.339 2.026 . . . . 73.310000000000002 112.682 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 60.0 p -108.29 125.67 51.95 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.174 0.511 . . . . 74.25 111.129 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.678 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 61.5 tp -78.26 114.69 17.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.023 -0.535 . . . . 72.540000000000006 111.121 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.75 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 42.5 ttm -101.82 124.25 47.14 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.464 0.306 . . . . 73.310000000000002 111.584 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 81.0 mt -138.33 130.71 28.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.794 0.438 . . . . 74.129999999999995 111.353 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.432 HG12 ' HG2' ' A' ' 174' ' ' GLU . 39.3 t -82.41 126.83 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 122.012 -0.43 . . . . 72.120000000000005 111.853 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -71.21 -33.95 70.38 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.985 0.421 . . . . 74.319999999999993 111.845 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.432 ' HG2' HG12 ' A' ' 172' ' ' VAL . 0.8 OUTLIER -72.81 -4.46 31.78 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.896 0.379 . . . . 75.209999999999994 111.343 177.254 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.481 ' HB3' ' CE1' ' A' ' 95' ' ' PHE . . . -101.17 -49.5 4.07 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.15 0.5 . . . . 73.140000000000001 110.609 173.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.827 HG22 ' HB3' ' A' ' 6' ' ' ASP . 36.0 pt -101.21 117.45 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.022 -0.536 . . . . 75.299999999999997 111.049 176.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 tp -93.57 128.08 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 121.903 -0.498 . . . . 75.099999999999994 109.916 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.64 ' HB2' HD13 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -110.43 131.8 54.74 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.863 0.84 . . . . 74.129999999999995 113.115 -171.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -94.68 103.48 15.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.819 -1.082 . . . . 72.239999999999995 109.309 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -94.0 96.76 9.89 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.368 0.877 . . . . 75.439999999999998 113.368 -169.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 86.4 m -115.83 89.83 3.2 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.446 -0.797 . . . . 74.510000000000005 109.162 169.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.4 mt -120.91 -84.45 0.66 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.768 0.655 . . . . 75.519999999999996 112.768 -170.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 118.488 -0.768 . . . . 73.409999999999997 111.999 -171.888 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.447 ' O ' ' HB3' ' A' ' 181' ' ' CYS . 25.7 ptt? . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 120.623 0.249 . . . . 73.400000000000006 111.129 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 15' ' ' SER . 29.1 tp -107.14 129.05 54.89 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.903 -0.498 . . . . 73.319999999999993 110.721 177.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.478 HG12 ' HB3' ' A' ' 15' ' ' SER . 60.0 mt -110.38 126.26 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.77 0.319 . . . . 74.230000000000004 111.124 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -123.38 145.74 48.52 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.933 0.397 . . . . 75.099999999999994 111.557 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 3.9 ptpp? -129.36 130.38 45.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.088 0.47 . . . . 73.319999999999993 111.652 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.532 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 4.0 m-20 -73.02 178.09 4.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.905 -0.588 . . . . 75.219999999999999 112.258 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.8 mt -66.56 -41.72 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.122 0.487 . . . . 64.530000000000001 111.24 173.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.449 ' HB3' ' HB3' ' A' ' 150' ' ' ASN . 37.9 m-85 -106.28 -32.64 8.09 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 112.001 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -93.48 15.0 16.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.278 0.561 . . . . 75.5 111.566 -174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.532 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 13.4 p-10 -60.26 -26.03 66.15 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.08 0.77 . . . . 72.340000000000003 113.08 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -68.3 -18.59 64.56 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.858 0.688 . . . . 52.130000000000003 112.858 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -85.66 -33.08 21.66 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.646 0.609 . . . . 75.420000000000002 112.646 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 56.29 98.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.218 0.532 . . . . 75.109999999999999 112.398 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.4 m -95.66 124.63 39.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.157 -0.339 . . . . 63.43 110.73 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.478 ' HB3' HG12 ' A' ' 3' ' ' ILE . 15.3 p -118.69 103.86 10.07 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.074 0.464 . . . . 75.299999999999997 112.1 -174.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -132.41 -172.57 2.93 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.035 0.445 . . . . 51.509999999999998 111.909 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.1 p -138.42 18.07 2.74 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.413 -0.358 . . . . 71.5 111.809 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -69.11 140.29 90.77 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 111.748 0.277 . . . . 74.420000000000002 111.748 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.12 143.25 35.58 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.841 2.361 . . . . 64.439999999999998 113.43 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptp -147.35 137.73 23.3 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.992 0.425 . . . . 73.099999999999994 111.996 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 67.1 mttm -112.28 156.38 22.49 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.553 -0.294 . . . . 72.0 110.564 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.494 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 55.4 tp -121.25 104.5 9.78 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.219 0.451 . . . . 73.540000000000006 112.219 -171.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.69 144.92 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-O 121.038 0.447 . . . . 72.409999999999997 111.737 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 56.67 12.67 1.17 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.168 -0.469 . . . . 64.230000000000004 111.888 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.494 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 62.8 m-20 50.7 29.7 4.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.365 0.602 . . . . 74.329999999999998 111.307 -174.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' A' ' 119' ' ' LYS . 53.9 tp -126.27 -48.68 1.57 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.899 -0.591 . . . . 75.219999999999999 111.41 -177.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.1 m -128.56 144.86 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.232 -0.44 . . . . 74.0 111.735 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 170' ' ' MET . 98.3 m-85 -85.55 141.09 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 65.420000000000002 110.375 176.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 2.8 pm0 -130.97 111.54 12.14 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.389 0.614 . . . . 74.310000000000002 111.058 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -150.46 141.19 22.7 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.977 1.103 . . . . 75.109999999999999 113.977 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -94.5 133.64 37.9 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.341 -0.845 . . . . 73.120000000000005 111.547 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.63 -167.77 42.44 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.852 -0.69 . . . . 72.209999999999994 113.25 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HG3' HG11 ' A' ' 35' ' ' VAL . 57.3 tptt -91.74 128.13 37.45 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 122.478 -0.425 . . . . 75.030000000000001 110.424 177.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -73.62 106.22 5.29 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.06 0.457 . . . . 73.099999999999994 110.996 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.565 ' HB ' HD12 ' A' ' 42' ' ' ILE . 27.2 m -137.28 155.22 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.116 -0.493 . . . . 73.430000000000007 111.007 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.64 HG23 ' HA ' ' A' ' 44' ' ' LEU . 31.4 m -122.54 119.15 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.43 0.633 . . . . 74.349999999999994 111.392 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.479 ' HD3' ' OE2' ' A' ' 65' ' ' GLU . 43.0 ttt180 -102.09 132.96 47.65 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.059 0.457 . . . . 74.329999999999998 111.785 -173.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.478 ' HG2' ' N ' ' A' ' 39' ' ' GLU . 13.5 ttmt -120.48 160.38 23.26 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.313 -0.403 . . . . 73.349999999999994 110.995 -178.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.478 ' N ' ' HG2' ' A' ' 38' ' ' LYS . 12.4 tp10 -64.25 83.02 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.629 0.728 . . . . 73.230000000000004 110.386 174.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.46 -63.48 0.38 Allowed Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.218 -0.901 . . . . 64.0 112.372 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.55 178.97 8.17 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.296 0.569 . . . . 75.200000000000003 112.128 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.565 HD12 ' HB ' ' A' ' 35' ' ' VAL . 8.0 tp -84.91 93.46 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-O 121.883 0.849 . . . . 73.329999999999998 110.654 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 43' ' ' VAL . 11.6 p -82.98 36.49 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 N-CA-C 112.622 0.601 . . . . 74.109999999999999 112.622 -171.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.64 ' HA ' HG23 ' A' ' 36' ' ' VAL . 2.1 pp -58.63 141.97 50.84 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.627 -0.671 . . . . 75.439999999999998 112.086 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.28 175.77 11.13 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.352 -0.385 . . . . 73.430000000000007 111.851 -175.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.97 139.31 14.49 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.367 -0.444 . . . . 63.149999999999999 113.4 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 64.6 m -156.05 141.13 17.36 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.591 -0.358 . . . . 71.329999999999998 111.191 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -70.22 137.43 86.76 Favored Pre-proline 0 N--CA 1.469 0.52 0 O-C-N 122.341 -0.225 . . . . 71.349999999999994 111.169 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.45 92.64 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.167 1.911 . . . . 64.450000000000003 111.727 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.0 m -62.17 90.08 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.169 0.509 . . . . 65.150000000000006 111.948 -176.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.23 -58.59 2.48 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.897 -0.592 . . . . 72.409999999999997 110.821 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -71.66 -33.59 68.99 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.196 0.522 . . . . 75.030000000000001 110.856 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.788 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 18.3 mp0 -81.51 54.7 2.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.071 -0.513 . . . . 75.349999999999994 111.757 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.53 -32.18 80.31 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.031 -0.604 . . . . 74.409999999999997 113.843 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -106.13 29.53 6.67 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.466 -0.432 . . . . 72.129999999999995 112.077 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.788 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 21.1 tp10 -79.45 60.78 3.3 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.13 0.49 . . . . 73.439999999999998 112.057 -175.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 56.98 13.18 1.42 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.747 1.018 . . . . 74.209999999999994 113.747 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -82.97 74.05 9.95 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.455 0.645 . . . . 74.239999999999995 109.591 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.14 19.96 36.53 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.43 -0.804 . . . . 53.409999999999997 113.55 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.6 m 58.92 15.66 4.06 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 112.816 0.673 . . . . 71.230000000000004 112.816 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.46 -30.72 71.12 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.144 0.497 . . . . 65.319999999999993 110.928 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.722 ' HG3' HG23 ' A' ' 64' ' ' VAL . 10.7 tp10 -82.89 88.28 6.81 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.882 -0.784 . . . . 73.329999999999998 108.882 175.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -75.64 64.9 1.75 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.515 0.674 . . . . 74.129999999999995 112.54 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.722 HG23 ' HG3' ' A' ' 62' ' ' GLU . 26.7 t -91.66 149.89 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 CA-C-N 115.556 -0.747 . . . . 73.5 110.352 174.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.609 ' HG2' HD22 ' A' ' 72' ' ' LEU . 28.5 tt0 -75.25 69.65 2.11 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.801 0.81 . . . . 72.219999999999999 110.16 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -87.44 138.3 31.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.225 -0.898 . . . . 74.230000000000004 111.38 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.84 -146.24 9.25 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.447 -0.882 . . . . 75.219999999999999 113.612 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.6 pt -110.61 145.04 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.795 0.331 . . . . 72.319999999999993 111.763 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 14.9 t70 -41.03 -43.88 2.27 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.625 0.77 . . . . 72.150000000000006 112.308 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.9 mt -49.94 -56.29 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.724 0.639 . . . . 73.439999999999998 112.724 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.505 ' HA ' HD11 ' A' ' 76' ' ' LEU . 30.1 m -80.23 -35.05 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.394 0.516 . . . . 74.329999999999998 112.394 -172.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.609 HD22 ' HG2' ' A' ' 65' ' ' GLU . 85.5 mt -67.53 -46.39 72.96 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.715 0.293 . . . . 74.510000000000005 111.657 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -69.25 -21.75 63.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.412 0.523 . . . . 64.530000000000001 112.412 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -103.77 8.28 37.2 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 122.129 -0.357 . . . . 74.150000000000006 111.243 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.9 tptm 46.49 69.74 0.45 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.698 0.761 . . . . 73.340000000000003 112.501 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.505 HD11 ' HA ' ' A' ' 71' ' ' VAL . 82.0 mt -106.38 122.03 45.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.644 -0.707 . . . . 64.140000000000001 110.343 177.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 p -82.65 141.41 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.09 0.472 . . . . 74.319999999999993 111.419 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -79.54 141.41 36.67 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.762 -0.654 . . . . 62.210000000000001 112.41 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.418 ' HG3' ' HB2' ' A' ' 84' ' ' ASP . 41.8 tpp -143.55 149.29 37.21 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.923 -0.58 . . . . 74.109999999999999 109.903 174.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -130.9 163.69 26.92 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.77 0.655 . . . . 72.439999999999998 112.77 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 67.9 m -38.07 -56.46 1.16 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.581 1.326 . . . . 71.140000000000001 114.581 -171.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -60.3 -29.76 69.04 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.424 0.898 . . . . 73.340000000000003 113.424 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -103.59 -21.34 13.76 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.949 -0.469 . . . . 73.230000000000004 111.655 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.418 ' HB2' ' HG3' ' A' ' 79' ' ' MET . 12.5 t70 -77.64 1.15 20.64 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.148 0.425 . . . . 74.549999999999997 112.148 -175.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.453 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . . . -39.8 -59.21 1.21 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.444 0.535 . . . . 42.25 112.444 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.7 t -53.23 -39.45 63.78 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.098 -0.501 . . . . 62.140000000000001 111.986 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.435 ' O ' ' HD1' ' A' ' 91' ' ' TYR . 25.9 mmt -73.22 -73.88 0.19 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.297 0.48 . . . . 71.409999999999997 112.297 -174.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.453 ' CE1' ' HA ' ' A' ' 85' ' ' ALA . 33.4 p90 -55.72 -29.6 59.75 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.406 0.521 . . . . 75.120000000000005 112.406 -173.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.434 ' O ' HG22 ' A' ' 92' ' ' ILE . 32.8 mmtp -68.64 -60.49 2.37 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.928 0.394 . . . . 74.219999999999999 111.795 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.54 -43.21 99.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.159 0.504 . . . . 64.510000000000005 111.972 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.435 ' HD1' ' O ' ' A' ' 87' ' ' MET . 49.5 m-85 -69.74 -37.61 76.52 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.935 0.717 . . . . 73.420000000000002 112.935 -176.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 89' ' ' LYS . 11.0 tp -67.03 -33.37 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.304 0.573 . . . . 74.519999999999996 110.506 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -66.8 -45.81 77.2 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.914 -0.585 . . . . 75.019999999999996 110.975 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -61.7 -39.74 92.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.202 0.525 . . . . 71.230000000000004 110.684 172.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.462 ' HE1' ' HB3' ' A' ' 175' ' ' ALA . 89.2 t80 -60.26 -57.89 10.84 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.651 -0.704 . . . . 75.239999999999995 111.866 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.1 ptm -54.09 -39.43 66.32 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.842 0.354 . . . . 63.520000000000003 111.195 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -64.32 -49.98 69.61 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.66 -0.245 . . . . 71.340000000000003 111.574 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -61.43 -46.25 90.92 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.172 0.434 . . . . 71.329999999999998 112.172 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.3 m -66.81 -43.06 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.221 0.452 . . . . 75.439999999999998 112.221 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.9 mm -69.38 -38.17 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.735 0.302 . . . . 74.099999999999994 110.727 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.24 -54.17 40.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.019 0.437 . . . . 74.299999999999997 110.915 175.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -68.88 -53.04 23.43 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.22 0.452 . . . . 70.450000000000003 112.22 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.649 ' HA ' ' HE1' ' A' ' 103' ' ' MET . 4.7 tpt -65.14 -56.89 10.3 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.254 0.465 . . . . 73.0 112.254 -174.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.8 -43.03 99.88 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.057 0.392 . . . . 73.319999999999993 112.057 -174.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -48.97 -45.17 41.65 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.209 0.818 . . . . 74.140000000000001 113.209 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.56 18.05 20.12 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.061 0.458 . . . . 72.299999999999997 112.095 -176.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.452 ' OD1' HG11 ' A' ' 113' ' ' VAL . 3.1 t-20 -127.61 -65.51 0.92 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.372 -0.377 . . . . 65.209999999999994 110.774 176.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 70.01 -25.4 0.15 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.694 0.998 . . . . 74.129999999999995 113.694 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 113' ' ' VAL . 42.0 m-20 -66.14 112.99 4.19 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.932 0.396 . . . . 75.120000000000005 111.584 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -56.05 -32.18 63.82 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.178 0.436 . . . . 72.400000000000006 112.178 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.01 -33.96 65.38 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.072 0.397 . . . . 74.420000000000002 112.072 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.421 ' HB2' ' OD1' ' A' ' 107' ' ' ASN . 3.3 m-20 -94.05 -55.15 3.31 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.129 0.418 . . . . 75.310000000000002 112.129 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.452 HG11 ' OD1' ' A' ' 107' ' ' ASN . 17.0 m -62.79 -35.26 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.999 0.74 . . . . 73.310000000000002 112.999 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -75.39 -25.7 57.86 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.283 0.563 . . . . 74.040000000000006 110.452 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.05 -44.81 52.93 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.143 -0.48 . . . . 72.049999999999997 110.673 173.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.42 -46.28 90.59 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.21 0.529 . . . . 74.239999999999995 110.164 173.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -50.3 -42.1 51.99 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.667 -0.697 . . . . 73.219999999999999 111.065 171.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -64.33 -42.24 96.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.178 -0.464 . . . . 73.200000000000003 111.691 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.558 ' HB3' HD23 ' A' ' 26' ' ' LEU . 14.6 mptt -58.1 -55.18 38.31 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.8 0.333 . . . . 75.450000000000003 110.985 174.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.508 HD11 HD21 ' A' ' 26' ' ' LEU . 41.8 mm -59.51 -41.86 86.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.447 -0.342 . . . . 73.420000000000002 111.391 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -57.08 -57.08 14.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.512 -0.313 . . . . 74.140000000000001 111.13 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.12 -40.11 82.44 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.077 -0.582 . . . . 72.420000000000002 112.579 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -61.55 -51.6 67.92 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 111.631 0.234 . . . . 75.219999999999999 111.631 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.28 -41.25 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 112.573 0.583 . . . . 73.109999999999999 112.573 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.9 m -64.54 -26.0 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 121.936 -0.478 . . . . 71.430000000000007 111.37 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.6 t -84.89 -46.84 10.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.901 0.381 . . . . 72.530000000000001 110.883 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.5 tp -58.62 -39.21 79.82 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.983 0.513 . . . . 72.129999999999995 112.282 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.5 mt -81.6 2.6 28.57 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.226 0.454 . . . . 63.009999999999998 112.226 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.45 90.46 0.73 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.108 0.48 . . . . 75.400000000000006 111.169 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 23.7 pttm -52.19 -32.34 35.85 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.718 -0.674 . . . . 73.109999999999999 112.597 -177.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -65.59 -28.81 69.41 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.354 0.501 . . . . 73.209999999999994 112.354 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -108.03 -58.88 1.92 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.543 0.687 . . . . 74.299999999999997 111.302 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.543 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 29.7 m-85 -67.9 -3.27 9.26 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.365 0.876 . . . . 73.319999999999993 113.365 -172.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 36.9 ttmt -36.11 -32.48 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.886 0.699 . . . . 75.219999999999999 112.886 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -91.25 33.08 0.99 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.786 0.662 . . . . 74.519999999999996 112.786 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 56.6 mt -88.47 125.99 35.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.215 0.531 . . . . 65.450000000000003 111.529 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -101.25 112.84 25.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.042 -0.526 . . . . 71.420000000000002 110.532 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.625 ' HB3' HG11 ' A' ' 153' ' ' VAL . 93.1 m-85 -89.81 109.4 20.4 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.543 -0.298 . . . . 63.119999999999997 111.257 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.415 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 67.1 m-85 -99.77 124.48 45.08 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.161 0.505 . . . . 74.530000000000001 111.662 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.49 ' HB ' HG23 ' A' ' 153' ' ' VAL . 8.6 tt -121.36 146.82 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.08 -0.509 . . . . 73.299999999999997 111.134 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.7 124.24 35.67 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.335 -0.46 . . . . 50.030000000000001 113.794 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -44.61 -51.1 9.36 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.53 0.567 . . . . 72.230000000000004 112.53 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -50.76 -36.42 36.55 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.902 0.705 . . . . 75.299999999999997 112.902 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -93.38 -34.57 13.41 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.848 0.356 . . . . 64.120000000000005 111.946 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.82 -19.56 51.57 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.524 0.565 . . . . 74.439999999999998 112.524 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -65.21 -18.56 65.41 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.865 0.364 . . . . 70.430000000000007 111.875 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.72 47.97 0.02 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.714 -0.755 . . . . 44.32 113.346 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 150' ' ' ASN . . . -132.77 116.66 16.84 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.954 0.407 . . . . 72.239999999999995 111.614 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -74.5 23.15 0.09 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.258 0.466 . . . . 71.25 112.258 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 8' ' ' PHE . 37.6 m-80 -125.6 18.95 8.04 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.109 0.48 . . . . 72.340000000000003 111.001 177.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.2 91.95 1.63 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.079 -0.581 . . . . 75.450000000000003 112.46 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -58.96 119.46 7.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.285 0.564 . . . . 73.430000000000007 111.617 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.625 HG11 ' HB3' ' A' ' 138' ' ' PHE . 91.9 t -87.68 142.16 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.823 0.675 . . . . 70.230000000000004 112.823 -175.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.873 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -101.78 133.21 46.89 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.641 -0.709 . . . . 74.319999999999993 110.442 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.4 mt -99.94 117.3 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 112.655 0.613 . . . . 71.120000000000005 112.655 -171.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 40.9 mm -100.94 123.33 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 111.76 0.282 . . . . 71.340000000000003 111.76 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -111.9 133.68 53.94 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.696 0.284 . . . . 74.129999999999995 111.046 173.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -84.68 95.57 8.95 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.332 0.586 . . . . 71.340000000000003 110.183 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.81 113.38 24.3 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.637 -0.711 . . . . 71.530000000000001 111.277 -173.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -74.18 118.24 16.91 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.468 -0.333 . . . . 73.329999999999998 110.49 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.52 91.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.781 0.324 . . . . 71.109999999999999 111.814 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 t70 52.72 38.54 26.57 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.641 0.608 . . . . 74.540000000000006 112.641 173.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 103.03 -5.72 50.42 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.145 -0.55 . . . . 70.510000000000005 113.772 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.524 HG23 HG13 ' A' ' 166' ' ' VAL . 61.0 m -110.21 122.19 47.06 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.349 -0.501 . . . . 74.209999999999994 110.925 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 0.4 OUTLIER -92.69 100.38 12.89 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.285 0.564 . . . . 71.219999999999999 111.24 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.524 HG13 HG23 ' A' ' 164' ' ' THR . 19.0 m -108.07 113.27 60.97 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 112.361 0.504 . . . . 62.130000000000003 112.361 -177.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.12 113.8 3.87 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.089 1.859 . . . . 72.109999999999999 111.611 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.6 p -104.64 151.98 23.02 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.482 -0.326 . . . . 73.200000000000003 111.378 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.873 HD11 ' HB1' ' A' ' 154' ' ' ALA . 26.2 tp -102.3 122.95 45.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.54 -0.3 . . . . 74.439999999999998 110.857 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.571 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 63.0 mtt -101.81 124.25 47.13 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.599 0.562 . . . . 73.239999999999995 111.378 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.9 mt -138.2 130.58 29.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.492 -0.777 . . . . 71.340000000000003 110.609 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.407 HG11 ' H ' ' A' ' 174' ' ' GLU . 25.9 t -79.72 123.37 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 122.077 -0.389 . . . . 62.229999999999997 111.177 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.768 ' HZ2' ' HB2' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -68.75 -11.07 59.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.642 0.608 . . . . 74.549999999999997 112.642 -175.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.407 ' H ' HG11 ' A' ' 172' ' ' VAL . 13.9 mm-40 -97.3 -8.3 30.05 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.073 0.463 . . . . 64.519999999999996 111.125 172.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.462 ' HB3' ' HE1' ' A' ' 95' ' ' PHE . . . -97.45 -14.37 21.2 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.291 0.567 . . . . 71.400000000000006 110.669 175.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 63.4 mt -134.77 128.59 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.469 -0.787 . . . . 73.310000000000002 109.806 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 43.5 mm -93.47 128.41 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.773 0.321 . . . . 74.109999999999999 111.392 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -84.94 114.44 22.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.245 -0.434 . . . . 73.200000000000003 110.949 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.44 112.72 23.46 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.706 0.765 . . . . 72.310000000000002 110.89 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.735 ' HB2' ' HZ2' ' A' ' 180' ' ' LYS . 4.9 ttmp? -85.49 112.13 20.63 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.657 -0.702 . . . . 74.200000000000003 112.095 -172.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 1' ' ' MET . 41.3 t -116.91 87.69 2.75 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.464 0.65 . . . . 72.540000000000006 112.222 178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.88 -165.03 0.95 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.51 -0.768 . . . . 71.310000000000002 110.256 175.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.854 -0.594 . . . . 72.129999999999995 111.833 -179.05 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.737 0.303 . . . . 75.129999999999995 111.761 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.41 160.01 14.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.457 0.303 . . . . 71.420000000000002 111.092 -176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 33.9 pt -130.58 138.8 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.976 -0.452 . . . . 73.239999999999995 112.037 177.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 14' ' ' SER . 49.7 p90 -122.55 138.24 54.63 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.231 0.539 . . . . 74.430000000000007 111.532 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.662 ' HZ1' ' HB3' ' A' ' 5' ' ' LYS . 5.2 mtpm? -132.18 112.91 12.68 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.46 -0.791 . . . . 74.430000000000007 111.307 -176.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 176' ' ' ILE . 6.6 m-20 -73.46 155.31 39.39 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.041 -0.412 . . . . 74.219999999999999 111.495 173.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 pt -72.46 -24.93 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.967 0.413 . . . . 71.209999999999994 111.513 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.73 -41.76 4.92 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.537 0.569 . . . . 73.219999999999999 112.537 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.563 ' HG1' ' HB2' ' A' ' 152' ' ' GLN . 2.6 m -88.69 15.13 8.66 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.304 0.573 . . . . 72.420000000000002 111.548 -177.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.434 ' OD1' ' NZ ' ' A' ' 5' ' ' LYS . 34.2 t70 -49.05 -37.81 22.02 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.838 1.051 . . . . 75.349999999999994 113.838 -173.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.1 -37.13 81.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.703 0.631 . . . . 75.430000000000007 112.703 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -104.2 25.79 9.62 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.887 -0.508 . . . . 73.400000000000006 112.014 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.652 HD11 ' HG2' ' A' ' 5' ' ' LYS . 2.2 pt? -44.16 158.76 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.02 -0.536 . . . . 74.329999999999998 111.812 173.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 62.6 m -143.55 152.56 41.59 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.425 0.898 . . . . 74.340000000000003 113.425 -174.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 78.0 p -91.58 125.41 36.31 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.646 -0.707 . . . . 71.150000000000006 109.851 172.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -112.89 175.65 5.35 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.98 0.419 . . . . 73.239999999999995 111.708 -171.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.1 t -144.82 8.5 1.28 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.052 0.39 . . . . 63.340000000000003 112.052 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 78.9 m-85 -96.87 150.14 36.55 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 122.221 -0.299 . . . . 74.049999999999997 111.674 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -91.66 104.67 0.24 Allowed 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.842 2.361 . . . . 74.099999999999994 113.468 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.497 ' N ' ' SD ' ' A' ' 20' ' ' MET . 1.6 mpt? -85.9 162.11 18.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.963 0.411 . . . . 75.430000000000007 111.534 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -129.19 119.89 24.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.411 -0.359 . . . . 75.129999999999995 111.139 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 tp -74.79 114.37 13.15 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.207 0.527 . . . . 73.319999999999993 111.081 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.31 145.63 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.302 -0.408 . . . . 71.329999999999998 111.132 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.9 t70 62.79 8.51 3.1 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 120.987 0.422 . . . . 53.520000000000003 111.413 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 58.02 11.8 1.59 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.266 0.627 . . . . 74.140000000000001 111.598 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.491 HD23 HD13 ' A' ' 120' ' ' ILE . 30.8 tp -117.51 -46.74 2.66 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.042 -0.526 . . . . 73.540000000000006 111.279 -172.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.96 149.22 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.69 0.626 . . . . 53.43 112.69 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.574 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 75.3 m-85 -86.45 123.89 32.17 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.143 -0.48 . . . . 72.319999999999993 111.006 175.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -99.86 138.25 37.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.062 -0.517 . . . . 73.510000000000005 110.642 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.485 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 46.4 t80 -137.79 122.7 18.93 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.19 0.519 . . . . 75.400000000000006 111.562 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -75.37 123.46 25.41 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.57 0.581 . . . . 74.519999999999996 112.57 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.15 142.74 15.72 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.197 -0.456 . . . . 71.519999999999996 112.873 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -91.7 145.32 24.68 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.707 -0.29 . . . . 72.310000000000002 111.185 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -66.72 105.42 1.55 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.302 . . . . 72.319999999999993 110.578 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.508 HG22 HD11 ' A' ' 72' ' ' LEU . 10.8 m -146.82 158.84 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.33 0.585 . . . . 72.120000000000005 111.419 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.426 HG11 HD23 ' A' ' 44' ' ' LEU . 29.4 m -138.26 146.92 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.084 -0.507 . . . . 71.430000000000007 111.171 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.475 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 19.9 mmt85 -123.96 106.32 10.32 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.873 0.368 . . . . 73.409999999999997 111.136 172.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HB2' HG12 ' A' ' 64' ' ' VAL . 56.3 tptt -137.36 95.92 3.17 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.701 -0.227 . . . . 74.420000000000002 111.054 170.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 50.56 -75.84 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.46 0.704 . . . . 74.0 112.541 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 38' ' ' LYS . . . -114.6 -18.68 6.44 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 116.632 -0.258 . . . . 73.040000000000006 113.492 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 8.0 tp10 -72.3 117.55 14.09 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.457 -0.437 . . . . 75.540000000000006 110.837 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.747 HG13 HG23 ' A' ' 43' ' ' VAL . 5.9 tp -160.1 136.56 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 120.932 0.396 . . . . 72.310000000000002 112.034 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.747 HG23 HG13 ' A' ' 42' ' ' ILE . 88.4 t 65.7 105.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.401 0.68 . . . . 74.040000000000006 112.448 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.426 HD23 HG11 ' A' ' 36' ' ' VAL . 1.1 mm? -89.76 141.24 28.8 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.244 -0.435 . . . . 74.219999999999999 110.428 175.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.46 -36.04 15.65 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.387 0.514 . . . . 60.130000000000003 112.387 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -111.56 87.69 0.47 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.318 -0.467 . . . . 74.430000000000007 113.207 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.1 m -86.86 98.4 11.19 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.357 -0.496 . . . . 72.230000000000004 111.483 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -98.15 150.35 36.65 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.19 -0.459 . . . . 62.439999999999998 111.142 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -67.19 137.66 44.59 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.55 2.167 . . . . 71.349999999999994 113.844 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.7 m -62.95 124.14 20.32 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.245 -0.434 . . . . 75.439999999999998 111.264 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.46 -49.66 2.99 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.38 0.511 . . . . 75.150000000000006 112.38 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 59.9 36.85 21.81 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.257 0.551 . . . . 73.25 111.181 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -82.87 -63.65 1.32 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.901 -0.59 . . . . 75.540000000000006 110.878 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.46 -104.69 0.24 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.021 -0.609 . . . . 60.210000000000001 112.43 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.89 -86.09 0.17 Allowed 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.323 -0.516 . . . . 72.329999999999998 110.387 174.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 52.98 13.09 0.33 Allowed 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.529 0.937 . . . . 72.349999999999994 113.529 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -126.98 177.34 6.69 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 122.045 -0.41 . . . . 62.049999999999997 111.316 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.4 t0 65.94 65.88 0.51 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.897 0.856 . . . . 63.009999999999998 110.763 -172.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.0 75.01 0.29 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-N 114.908 -1.042 . . . . 54.109999999999999 111.252 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.0 p -75.53 35.76 0.12 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 112.986 0.736 . . . . 54.219999999999999 112.986 -173.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 68.95 -36.55 0.34 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.836 1.421 . . . . 72.430000000000007 114.836 174.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 60.9 35.43 19.22 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.651 0.66 . . . . 64.420000000000002 110.994 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.3 m80 68.03 20.27 9.12 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.851 -0.613 . . . . 75.329999999999998 112.452 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.635 HG12 ' HB2' ' A' ' 38' ' ' LYS . 90.9 t -81.86 132.79 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 122.292 -0.255 . . . . 73.409999999999997 110.603 172.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.487 ' HB3' HD23 ' A' ' 72' ' ' LEU . 39.8 mt-10 -75.25 68.94 2.04 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.357 0.599 . . . . 72.25 110.567 175.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -88.31 132.64 34.33 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.858 -0.61 . . . . 64.409999999999997 111.231 177.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.5 -133.65 3.53 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.197 -1.001 . . . . 45.200000000000003 113.979 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 70' ' ' ILE . 7.4 pt -111.2 141.48 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.028 0.442 . . . . 75.299999999999997 112.189 -175.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -45.99 -34.44 4.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.868 -0.605 . . . . 75.349999999999994 112.013 177.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 68' ' ' ILE . 50.7 mt -48.26 -62.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.309 0.576 . . . . 73.129999999999995 111.913 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.3 m -77.22 -31.11 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.022 -0.535 . . . . 74.140000000000001 112.211 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.508 HD11 HG22 ' A' ' 35' ' ' VAL . 68.8 mt -74.08 -38.61 63.85 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.835 0.35 . . . . 72.299999999999997 111.802 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -83.91 -26.18 29.57 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.801 0.334 . . . . 73.109999999999999 111.386 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -95.43 -1.12 51.57 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 120.837 0.351 . . . . 75.219999999999999 110.745 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.7 tptm 49.65 70.92 0.44 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.141 0.976 . . . . 75.25 112.955 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.1 mt -107.14 148.91 28.25 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.791 -0.641 . . . . 72.129999999999995 111.041 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 140' ' ' ILE . 14.1 p -91.08 142.34 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 120.971 0.415 . . . . 71.549999999999997 111.873 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -79.16 143.32 35.54 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.964 0.727 . . . . 63.43 112.964 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.405 ' C ' HD21 ' A' ' 80' ' ' ASN . 96.8 mmm -139.46 155.42 47.6 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.28 0.632 . . . . 75.400000000000006 110.939 177.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.405 HD21 ' C ' ' A' ' 79' ' ' MET . 0.9 OUTLIER -131.75 133.1 44.42 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.035 0.445 . . . . 72.25 112.145 -173.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.4 p -38.32 -46.76 1.14 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.924 1.453 . . . . 73.340000000000003 114.924 -173.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -55.68 -34.76 65.34 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.02 0.438 . . . . 75.329999999999998 111.824 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -91.68 -37.69 12.88 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.16 0.505 . . . . 64.109999999999999 111.19 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.26 -6.34 42.3 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.602 0.593 . . . . 74.540000000000006 112.602 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.456 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -39.6 -63.24 0.59 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 112.992 0.738 . . . . 75.120000000000005 112.992 -177.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.5 m -60.35 -35.3 75.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.15 0.5 . . . . 74.540000000000006 111.602 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.8 mtp -69.66 -56.48 7.13 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.064 -0.517 . . . . 72.150000000000006 112.288 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 4.2 p90 -68.63 -25.98 65.11 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.915 -0.49 . . . . 70.530000000000001 112.304 -175.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.424 ' HA ' HG21 ' A' ' 92' ' ' ILE . 18.4 ptmt -73.91 -32.93 63.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 119.883 -0.727 . . . . 74.140000000000001 110.993 176.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.58 74.61 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.465 0.65 . . . . 64.219999999999999 110.157 170.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -53.43 -55.92 21.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.131 -0.94 . . . . 74.340000000000003 111.174 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.424 HG21 ' HA ' ' A' ' 89' ' ' LYS . 10.4 tp -63.27 -34.45 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 111.744 0.276 . . . . 74.530000000000001 111.744 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -63.5 -55.65 22.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.831 0.348 . . . . 73.310000000000002 111.213 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -61.09 -42.17 98.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.731 0.3 . . . . 75.200000000000003 111.361 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.494 ' O ' HG23 ' A' ' 99' ' ' VAL . 41.0 t80 -52.31 -57.48 9.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.157 -0.474 . . . . 75.239999999999995 111.278 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.613 ' HA ' ' HE1' ' A' ' 96' ' ' MET . 3.2 mmt -55.3 -52.95 61.78 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.393 -0.367 . . . . 73.150000000000006 111.851 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -54.14 -50.51 66.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.834 0.349 . . . . 72.549999999999997 111.481 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -64.17 -56.79 12.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.243 -0.435 . . . . 75.439999999999998 111.94 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 95' ' ' PHE . 24.2 m -63.58 -40.09 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.37 0.507 . . . . 75.230000000000004 112.37 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.6 mm -69.92 -44.98 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 122.217 -0.302 . . . . 65.340000000000003 111.375 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.61 -42.34 98.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.98 0.419 . . . . 62.329999999999998 111.035 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -68.38 -49.57 59.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.11 -0.496 . . . . 70.540000000000006 111.641 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.4 ttm -66.48 -49.49 66.44 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.923 0.342 . . . . 75.540000000000006 111.923 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.35 -11.76 11.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.895 0.379 . . . . 73.120000000000005 111.819 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -68.59 -48.0 65.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.861 0.362 . . . . 72.209999999999994 111.059 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.51 -36.01 6.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.134 0.42 . . . . 72.310000000000002 112.134 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -84.74 19.35 2.07 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 120.961 0.41 . . . . 72.109999999999999 111.039 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -28.41 -30.97 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.448 1.647 . . . . 74.209999999999994 115.448 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -50.27 118.22 2.85 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.022 0.439 . . . . 74.150000000000006 111.586 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 96.1 mttt -56.95 -22.49 38.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.163 -0.471 . . . . 71.120000000000005 111.547 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.02 -31.05 44.54 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.039 0.447 . . . . 70.310000000000002 111.82 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -77.21 -62.22 1.73 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.195 0.521 . . . . 70.209999999999994 110.927 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.3 m -63.24 -24.29 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.739 0.644 . . . . 70.25 112.739 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 20.4 t70 -62.33 -47.94 82.02 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.004 0.43 . . . . 73.329999999999998 110.159 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 119' ' ' LYS . . . -59.8 -42.32 93.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.947 -0.569 . . . . 73.0 111.453 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -64.24 -55.17 23.42 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.7 0.285 . . . . 71.319999999999993 111.708 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -55.57 -42.33 74.56 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.366 0.603 . . . . 75.310000000000002 110.997 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . 28.0 ttmt -71.35 -30.08 65.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.627 -0.715 . . . . 73.510000000000005 110.954 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 37.9 tptt -64.25 -41.66 96.86 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.259 0.552 . . . . 74.430000000000007 109.929 173.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.491 HD13 HD23 ' A' ' 26' ' ' LEU . 31.8 mm -65.71 -42.0 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.618 -0.719 . . . . 75.430000000000007 110.835 173.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.423 ' O ' HG21 ' A' ' 125' ' ' VAL . 10.9 mm100 -55.84 -51.87 66.01 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.72 0.267 . . . . 70.030000000000001 111.72 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.21 -42.85 83.46 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.474 -0.869 . . . . 72.519999999999996 112.198 175.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -59.92 -55.54 32.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.94 0.496 . . . . 74.409999999999997 111.547 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.0 m -66.98 -42.13 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 112.529 0.566 . . . . 74.019999999999996 112.529 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 121' ' ' GLN . 69.1 t -57.73 -34.55 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.254 0.549 . . . . 74.540000000000006 111.212 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.5 t -75.94 -42.73 47.78 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.224 -0.444 . . . . 72.040000000000006 111.52 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.423 HD21 HD12 ' A' ' 155' ' ' ILE . 30.5 tp -75.0 -29.07 60.78 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.958 -0.565 . . . . 75.329999999999998 112.248 -173.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.17 2.75 51.44 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.64 0.607 . . . . 75.129999999999995 112.64 -176.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' A' ' 133' ' ' PHE . . . -60.3 94.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.196 0.522 . . . . 65.219999999999999 111.17 177.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.555 ' HD2' ' N ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.58 -16.85 58.41 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.16 0.8 . . . . 75.420000000000002 113.16 -170.365 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.555 ' N ' ' HD2' ' A' ' 130' ' ' LYS . 3.9 m-20 -67.35 -46.01 74.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.002 0.43 . . . . 74.540000000000006 111.557 -175.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.531 HH21 ' HE2' ' A' ' 158' ' ' TYR . 39.8 mtp180 -107.36 -48.53 3.43 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.371 0.605 . . . . 73.109999999999999 111.796 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.509 ' CD1' ' HB1' ' A' ' 129' ' ' ALA . 44.5 m-85 -67.92 -6.33 21.46 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.849 -0.614 . . . . 74.120000000000005 112.608 -172.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 38.4 ttpt -53.09 -26.0 14.84 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.099 0.476 . . . . 74.209999999999994 110.93 171.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -97.19 34.04 1.84 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.579 0.585 . . . . 52.210000000000001 112.579 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 70.6 mt -87.96 151.18 22.98 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.895 0.379 . . . . 74.420000000000002 110.87 175.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -108.79 134.62 51.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.673 -0.239 . . . . 74.239999999999995 111.453 -178.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.542 ' HB3' HG12 ' A' ' 153' ' ' VAL . 66.7 m-85 -109.66 133.46 53.09 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.268 -0.27 . . . . 74.450000000000003 110.629 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -129.41 138.89 51.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.089 0.471 . . . . 73.049999999999997 111.017 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.474 ' O ' HG13 ' A' ' 77' ' ' VAL . 12.7 tt -141.33 158.85 22.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.367 -0.379 . . . . 73.310000000000002 111.139 -175.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.97 137.78 50.16 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.931 -0.652 . . . . 72.140000000000001 112.169 173.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -36.92 85.07 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.624 0.602 . . . . 63.210000000000001 112.624 -175.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.416 ' HD3' ' HA ' ' A' ' 143' ' ' ARG . 24.6 mmt180 -63.45 -49.3 74.23 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.128 -0.357 . . . . 72.010000000000005 111.319 176.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.474 ' HB3' ' HA3' ' A' ' 151' ' ' GLY . . . -55.86 -50.34 70.86 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.022 0.439 . . . . 60.350000000000001 111.501 173.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.408 ' HB2' HG21 ' A' ' 140' ' ' ILE . . . -57.61 -30.93 65.74 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.12 0.415 . . . . 73.450000000000003 112.12 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -102.05 14.74 31.12 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.474 0.546 . . . . 74.129999999999995 112.474 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.7 -44.53 0.02 OUTLIER Glycine 0 CA--C 1.531 1.067 0 C-N-CA 119.996 -1.097 . . . . 70.219999999999999 114.976 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -111.76 108.93 18.53 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.873 0.694 . . . . 64.25 112.873 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -63.55 -24.59 67.87 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.762 0.315 . . . . 74.439999999999998 111.766 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -92.03 19.86 6.37 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.835 0.309 . . . . 71.430000000000007 111.835 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.474 ' HA3' ' HB3' ' A' ' 144' ' ' ALA . . . -68.33 163.11 49.06 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.048 -0.596 . . . . 60.420000000000002 113.133 178.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.563 ' HB2' ' HG1' ' A' ' 9' ' ' THR . 40.6 tt0 -68.11 102.32 1.31 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.417 -0.461 . . . . 70.409999999999997 112.038 -177.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 138' ' ' PHE . 24.6 t -80.92 99.93 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.383 0.611 . . . . 72.519999999999996 110.332 168.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.666 ' HB2' HD13 ' A' ' 169' ' ' LEU . . . -73.8 129.79 38.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.676 -0.693 . . . . 73.439999999999998 110.635 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.423 HD12 HD21 ' A' ' 127' ' ' LEU . 57.6 mt -95.57 125.62 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.991 0.424 . . . . 65.439999999999998 111.429 -175.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.548 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 50.3 mm -100.04 106.7 19.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-O 121.039 0.447 . . . . 75.239999999999995 110.695 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.43 152.62 20.15 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.727 -1.124 . . . . 74.329999999999998 111.239 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.531 ' HE2' HH21 ' A' ' 132' ' ' ARG . 39.7 p90 -100.3 122.22 42.74 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.983 -0.448 . . . . 74.140000000000001 110.62 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.568 ' HE ' ' HB ' ' A' ' 168' ' ' THR . 0.1 OUTLIER -136.93 156.4 48.51 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.873 0.694 . . . . 74.319999999999993 112.873 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.46 127.61 32.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.18 -0.918 . . . . 73.25 112.575 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.5 t -129.36 99.93 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.968 -0.56 . . . . 75.5 110.969 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 57.23 25.11 10.65 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.321 0.489 . . . . 72.120000000000005 112.321 176.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.46 -23.36 26.77 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.314 -0.469 . . . . 52.140000000000001 113.465 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.2 p -101.58 149.3 24.25 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.409 -0.465 . . . . 74.209999999999994 111.666 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.27 121.34 34.54 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.324 0.583 . . . . 71.239999999999995 112.076 -176.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.77 126.93 26.83 Favored Pre-proline 0 C--O 1.24 0.584 0 O-C-N 121.654 -0.654 . . . . 74.239999999999995 111.256 174.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.99 114.53 3.02 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.264 1.976 . . . . 64.109999999999999 111.426 171.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.568 ' HB ' ' HE ' ' A' ' 159' ' ' ARG . 10.2 t -101.48 149.81 23.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.303 -0.408 . . . . 74.109999999999999 111.888 -176.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 154' ' ' ALA . 53.0 tp -78.67 128.46 33.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.225 -0.443 . . . . 70.219999999999999 110.337 174.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 46.8 tpp -117.7 122.53 43.76 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.868 0.366 . . . . 73.519999999999996 111.021 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 98.1 mt -137.78 155.13 49.36 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.808 0.443 . . . . 73.230000000000004 109.875 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.486 HG12 ' CZ ' ' A' ' 95' ' ' PHE . 40.6 t -99.87 134.82 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.744 -0.598 . . . . 73.019999999999996 112.112 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.574 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -60.74 -39.67 89.51 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.155 0.798 . . . . 75.340000000000003 113.155 -172.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.457 ' CD ' ' HZ2' ' A' ' 173' ' ' LYS . 2.2 pm0 -95.15 12.43 28.79 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.854 0.687 . . . . 63.109999999999999 112.854 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.4 -33.67 8.08 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.558 0.694 . . . . 63.409999999999997 109.985 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 6' ' ' ASP . 3.9 tt -128.01 117.59 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.043 -0.98 . . . . 73.439999999999998 110.424 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 5' ' ' LYS . 8.3 tp -94.25 129.41 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.585 0.707 . . . . 74.549999999999997 111.869 -175.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -92.9 123.58 36.26 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.524 -0.762 . . . . 72.409999999999997 110.336 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -124.9 143.37 50.89 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.283 0.563 . . . . 64.510000000000005 111.153 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -119.54 95.88 4.97 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.577 0.703 . . . . 64.349999999999994 111.816 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 40.0 t -117.72 91.04 3.47 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.9 -0.778 . . . . 75.329999999999998 108.9 170.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 182' ' ' LEU . 1.6 pt? -153.7 171.83 18.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.23 0.538 . . . . 73.239999999999995 112.106 -171.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.909 -0.567 . . . . 62.130000000000003 110.8 176.427 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.949 0.404 . . . . 71.510000000000005 111.95 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 178' ' ' GLU . 59.8 tp -134.28 131.9 38.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.659 -0.496 . . . . 63.5 109.659 172.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 54.3 mt -104.1 117.69 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 121.903 -0.498 . . . . 74.209999999999994 110.473 -177.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -111.05 142.73 42.81 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.859 0.838 . . . . 74.519999999999996 112.233 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -137.46 111.15 8.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.686 -1.143 . . . . 74.420000000000002 110.777 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.13 174.39 8.66 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.279 0.561 . . . . 54.109999999999999 111.489 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.6 mt -68.42 -28.16 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.356 0.598 . . . . 74.530000000000001 110.474 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -97.26 -44.0 7.1 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.783 -0.644 . . . . 64.239999999999995 112.161 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.8 p -81.07 15.62 1.81 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.319 0.859 . . . . 74.010000000000005 113.319 -172.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -54.68 -31.02 57.18 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.913 0.387 . . . . 73.540000000000006 111.692 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -71.68 -37.85 70.69 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.205 0.526 . . . . 75.200000000000003 111.129 174.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 10.0 tp10 -96.25 25.06 5.17 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.837 -0.619 . . . . 64.25 111.105 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.49 107.22 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.867 0.867 . . . . 72.310000000000002 112.089 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.9 t -122.16 175.29 6.45 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.704 0.631 . . . . 71.420000000000002 112.704 -166.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.7 p -150.33 130.94 13.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.937 -0.574 . . . . 64.510000000000005 111.535 -176.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -123.97 -162.76 1.09 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 120.825 0.345 . . . . 63.039999999999999 111.23 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.5 m -152.32 29.95 0.55 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.087 0.47 . . . . 63.130000000000003 110.826 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -108.27 146.11 32.91 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 111.036 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.52 159.14 54.76 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.246 1.964 . . . . 61.240000000000002 113.904 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.504 ' HE2' ' HG3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -142.05 128.9 20.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.327 0.584 . . . . 73.540000000000006 110.639 174.458 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.678 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 11.2 mmmm -98.91 97.96 9.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.259 -0.428 . . . . 74.120000000000005 111.925 -173.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 43.2 tp -75.13 91.21 2.57 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.643 -0.661 . . . . 73.109999999999999 111.37 -178.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.3 p -90.5 146.89 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 115.9 -0.591 . . . . 72.299999999999997 111.148 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 56.49 11.61 0.89 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 120.788 0.328 . . . . 72.450000000000003 111.76 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.467 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 7.9 m-20 52.92 30.68 9.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.164 0.507 . . . . 75.549999999999997 111.106 -175.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.451 HD13 HD12 ' A' ' 120' ' ' ILE . 30.0 tp -130.23 -43.5 1.17 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.195 -0.457 . . . . 73.409999999999997 111.723 -176.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.13 159.78 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.353 0.501 . . . . 64.040000000000006 112.353 -175.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 170' ' ' MET . 66.1 m-85 -103.27 129.97 50.39 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.945 -0.57 . . . . 74.5 111.464 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.678 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 15.3 tt0 -96.43 142.15 28.88 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.877 0.871 . . . . 73.140000000000001 110.627 175.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.612 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 63.3 t80 -147.33 130.66 16.59 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.74 0.305 . . . . 74.140000000000001 111.222 173.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -94.56 135.95 35.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.006 0.432 . . . . 75.120000000000005 111.176 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.729 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -123.02 147.68 16.72 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.203 -0.522 . . . . 72.019999999999996 113.192 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -91.22 136.59 32.99 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.607 -0.349 . . . . 74.420000000000002 110.724 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -65.25 106.87 1.43 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.119 0.485 . . . . 74.510000000000005 110.923 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.84 158.2 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.045 0.45 . . . . 73.099999999999994 111.136 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.644 HG12 ' HG3' ' A' ' 66' ' ' ARG . 12.2 m -137.27 137.44 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.772 0.32 . . . . 71.150000000000006 111.182 -178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.883 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 6.5 ttm180 -115.1 111.2 20.69 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.868 0.366 . . . . 74.109999999999999 111.863 176.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 40' ' ' GLY . 57.9 tptt -107.25 126.44 52.42 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.408 -0.96 . . . . 73.150000000000006 108.408 167.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -59.73 82.03 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.716 0.769 . . . . 71.049999999999997 111.453 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 38' ' ' LYS . . . 147.73 -28.25 1.46 Allowed Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.229 -0.896 . . . . 64.129999999999995 113.322 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -152.34 173.52 14.95 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.018 0.747 . . . . 63.240000000000002 113.018 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.9 mm -132.48 125.47 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 115.563 -0.744 . . . . 75.340000000000003 111.297 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 43' ' ' VAL . 13.1 p -135.54 47.88 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-O 122.242 1.02 . . . . 75.219999999999999 111.385 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.26 -11.09 56.59 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.694 -0.684 . . . . 71.540000000000006 112.796 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.94 4.01 43.37 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.159 0.504 . . . . 74.409999999999997 111.53 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.11 145.47 32.2 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.217 -0.516 . . . . 65.230000000000004 112.905 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 76.9 p -89.08 121.9 31.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 74.439999999999998 111.207 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -73.8 146.26 85.24 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.657 -0.247 . . . . 74.120000000000005 111.24 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.17 132.23 33.34 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.387 2.058 . . . . 75.299999999999997 112.833 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 m -67.2 132.28 47.46 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.475 -0.329 . . . . 75.420000000000002 111.444 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.41 154.87 43.02 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.415 0.626 . . . . 74.019999999999996 111.302 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.94 -22.22 39.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.558 -0.746 . . . . 74.439999999999998 111.655 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -143.21 -148.88 0.25 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.189 -0.46 . . . . 73.310000000000002 111.008 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.88 -140.93 0.1 OUTLIER Glycine 0 CA--C 1.532 1.114 0 N-CA-C 114.708 0.643 . . . . 40.119999999999997 114.708 -174.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.11 123.03 6.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.098 0.475 . . . . 75.430000000000007 111.193 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.0 -26.26 0.49 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.743 -0.662 . . . . 73.510000000000005 111.705 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -94.53 -174.75 3.41 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.751 0.31 . . . . 75.420000000000002 111.336 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 t70 72.18 -66.54 0.3 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.458 0.703 . . . . 65.439999999999998 112.338 172.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.64 21.61 31.94 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.311 -0.471 . . . . 54.549999999999997 113.969 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.6 p -117.33 -0.76 11.92 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.351 0.5 . . . . 72.329999999999998 112.351 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -74.55 -72.53 0.28 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.793 0.33 . . . . 73.329999999999998 111.0 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -95.45 156.9 16.13 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.065 0.459 . . . . 72.340000000000003 109.783 172.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -74.36 74.24 1.87 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.354 0.597 . . . . 74.040000000000006 111.398 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.4 t -93.8 117.02 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.941 -0.572 . . . . 75.409999999999997 110.011 175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.883 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 32.5 tt0 -78.94 67.48 4.66 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.838 0.828 . . . . 64.409999999999997 109.851 -177.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.644 ' HG3' HG12 ' A' ' 36' ' ' VAL . 40.4 ttp180 -105.51 124.53 49.71 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.297 -0.865 . . . . 73.5 111.652 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.4 ' N ' HD12 ' A' ' 72' ' ' LEU . . . 162.52 -132.28 2.74 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.032 -0.604 . . . . 61.530000000000001 113.064 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.611 HD12 HD12 ' A' ' 70' ' ' ILE . 22.1 pt -111.1 137.66 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 112.271 0.471 . . . . 73.400000000000006 112.271 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -39.54 -44.49 1.44 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.327 0.651 . . . . 74.200000000000003 112.55 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.729 HG13 ' HA3' ' A' ' 32' ' ' GLY . 67.0 mt -40.39 -53.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.773 0.657 . . . . 73.120000000000005 112.773 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.499 ' HA ' HD11 ' A' ' 76' ' ' LEU . 23.1 m -94.68 -33.91 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.406 0.521 . . . . 71.430000000000007 112.406 -173.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 67' ' ' GLY . 62.1 mt -68.38 -49.75 57.9 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.024 0.44 . . . . 75.109999999999999 111.534 -176.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -62.67 -21.16 65.52 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 120.854 0.359 . . . . 74.329999999999998 111.553 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -104.92 -0.28 27.17 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.822 0.305 . . . . 75.25 111.822 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.42 69.98 0.68 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.247 0.546 . . . . 75.140000000000001 112.273 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.499 HD11 ' HA ' ' A' ' 71' ' ' VAL . 91.4 mt -110.85 136.48 49.82 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.095 -0.502 . . . . 62.210000000000001 111.086 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.6 p -88.04 142.15 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.17 0.51 . . . . 75.230000000000004 111.437 -179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER -85.71 137.91 32.49 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.342 0.867 . . . . 74.219999999999999 113.342 -171.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 75.0 mtp -134.49 140.31 46.1 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.667 -0.697 . . . . 65.409999999999997 110.896 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -89.34 157.54 18.14 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.023 0.439 . . . . 75.109999999999999 111.937 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 136' ' ' LEU . 79.8 m -53.85 -45.03 70.8 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.919 0.711 . . . . 74.340000000000003 112.919 -175.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -60.39 -20.29 59.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.606 0.595 . . . . 73.019999999999996 112.606 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -99.42 -28.98 13.01 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.164 0.431 . . . . 72.239999999999995 112.164 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.41 -7.53 55.24 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.626 0.602 . . . . 72.430000000000007 112.626 -173.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.31 -43.21 10.55 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.078 0.77 . . . . 64.430000000000007 113.078 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.3 m -66.97 -39.58 87.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.732 0.301 . . . . 73.219999999999999 111.498 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.5 mmt -62.75 -44.44 96.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.401 -0.363 . . . . 74.140000000000001 110.657 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -51.91 -52.08 52.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.801 0.334 . . . . 63.420000000000002 111.578 173.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -58.84 -43.01 90.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.922 0.391 . . . . 75.040000000000006 111.656 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.34 -50.87 23.57 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.025 0.44 . . . . 65.510000000000005 111.881 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -58.83 -53.75 54.9 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.781 -0.645 . . . . 75.299999999999997 111.86 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.4 mm -64.11 -37.33 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 111.907 0.336 . . . . 72.319999999999993 111.907 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.604 ' HB2' ' HZ2' ' A' ' 93' ' ' LYS . 4.7 ttmp? -57.36 -62.66 1.62 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.204 0.526 . . . . 75.140000000000001 111.028 176.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.67 -44.67 85.91 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.806 -0.634 . . . . 74.310000000000002 111.221 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.495 ' CZ ' HG12 ' A' ' 172' ' ' VAL . 66.1 t80 -61.07 -66.11 0.59 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.936 -0.574 . . . . 72.319999999999993 112.314 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 48.0 ttm -54.95 -45.2 74.86 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.174 0.435 . . . . 74.099999999999994 112.174 -172.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.31 -43.96 93.08 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.696 0.284 . . . . 74.540000000000006 111.643 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -71.19 -43.01 68.27 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.182 0.438 . . . . 65.530000000000001 112.182 -176.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.1 m -72.2 -39.05 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.23 0.456 . . . . 74.430000000000007 112.23 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.99 -45.97 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 122.152 -0.342 . . . . 75.299999999999997 110.26 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.9 -38.76 73.27 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.369 0.604 . . . . 73.510000000000005 110.647 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -60.59 -38.85 85.98 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.729 -0.669 . . . . 74.439999999999998 111.976 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.468 ' HG2' HG12 ' A' ' 113' ' ' VAL . 35.3 ttm -88.39 -48.85 7.33 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.228 0.455 . . . . 74.549999999999997 112.228 -173.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.53 ' HA ' HG13 ' A' ' 113' ' ' VAL . 11.5 pt-20 -62.2 -24.45 67.22 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.174 -0.329 . . . . 74.420000000000002 111.814 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -58.54 -54.61 45.14 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.003 0.371 . . . . 74.209999999999994 112.003 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -100.6 -37.04 8.94 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.837 0.68 . . . . 70.230000000000004 112.837 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -68.39 -50.49 52.64 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.862 -0.524 . . . . 64.510000000000005 110.51 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 45.67 19.87 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.676 1.361 . . . . 74.299999999999997 114.676 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -102.68 124.51 48.36 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.858 -0.526 . . . . 75.230000000000004 110.595 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -52.9 -58.11 8.03 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.626 0.602 . . . . 74.120000000000005 112.626 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.61 -11.9 13.49 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.686 0.625 . . . . 75.340000000000003 112.686 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -91.16 -63.09 1.31 Allowed 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.927 0.394 . . . . 74.040000000000006 111.0 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.53 HG13 ' HA ' ' A' ' 104' ' ' GLU . 17.4 m -66.72 -33.74 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 112.631 0.604 . . . . 73.0 112.631 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.18 -31.3 71.62 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.998 0.428 . . . . 75.209999999999994 110.343 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.51 -46.01 60.86 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.26 -0.427 . . . . 71.439999999999998 111.171 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.437 ' CZ ' ' HG3' ' A' ' 174' ' ' GLU . 85.4 t80 -59.43 -48.0 83.32 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.189 0.519 . . . . 71.25 110.728 175.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -55.18 -39.07 69.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.913 -0.585 . . . . 74.140000000000001 110.774 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -65.42 -36.61 84.46 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.054 -0.521 . . . . 75.209999999999994 110.972 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -64.0 -52.45 59.52 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.216 -0.447 . . . . 74.219999999999999 111.61 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.451 HD12 HD13 ' A' ' 26' ' ' LEU . 42.1 mm -63.41 -42.44 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.853 0.359 . . . . 75.120000000000005 111.38 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -60.95 -48.26 82.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.824 0.345 . . . . 74.010000000000005 110.922 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.51 -38.22 95.44 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.157 -0.544 . . . . 54.219999999999999 112.564 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 50.7 t90 -60.73 -55.1 37.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.647 0.261 . . . . 74.530000000000001 111.215 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.427 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.2 m -66.17 -47.47 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 112.482 0.549 . . . . 71.310000000000002 112.482 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -59.52 -35.93 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 121.995 -0.441 . . . . 72.439999999999998 111.684 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.5 t -78.52 -41.46 32.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.913 0.387 . . . . 74.219999999999999 111.017 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.463 HD22 HD13 ' A' ' 155' ' ' ILE . 52.1 tp -63.82 -38.24 90.36 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.104 -0.498 . . . . 74.040000000000006 112.02 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 84.3 mt -77.17 3.26 13.1 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.477 0.547 . . . . 74.430000000000007 112.477 -177.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.44 ' HB3' ' HD2' ' A' ' 133' ' ' PHE . . . -62.71 78.72 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.442 0.639 . . . . 55.5 111.716 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.597 ' HD3' ' H ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -39.47 -39.15 0.65 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.35 1.241 . . . . 71.439999999999998 114.35 -178.143 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.96 -44.76 67.38 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.271 0.471 . . . . 75.409999999999997 112.271 -169.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.642 ' HD2' ' H ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -108.22 -36.33 6.31 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.267 -0.424 . . . . 73.099999999999994 111.652 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.44 ' HD2' ' HB3' ' A' ' 129' ' ' ALA . 86.7 m-85 -73.94 -5.79 43.39 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.241 0.46 . . . . 74.340000000000003 112.241 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -44.69 -26.52 0.39 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.1 0.476 . . . . 65.230000000000004 112.128 168.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -91.89 23.81 3.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.535 0.569 . . . . 74.420000000000002 112.535 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.461 ' HB2' ' SG ' ' A' ' 81' ' ' CYS . 66.9 mt -89.38 157.64 18.08 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.206 0.527 . . . . 74.140000000000001 111.204 176.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.4 120.83 36.15 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.001 -0.545 . . . . 73.439999999999998 110.653 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -109.36 121.73 45.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.066 0.46 . . . . 75.430000000000007 110.752 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.494 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 56.9 m-85 -110.47 132.01 54.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.402 0.62 . . . . 74.040000000000006 111.895 -177.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 145' ' ' ALA . 6.1 tp -115.14 146.87 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.541 -0.754 . . . . 75.329999999999998 110.985 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.04 153.9 37.65 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.155 0.422 . . . . 73.0 114.155 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -46.94 -70.55 0.09 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.06 0.763 . . . . 62.450000000000003 113.06 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -68.8 -21.74 64.3 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.261 0.553 . . . . 72.310000000000002 111.196 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.694 ' HB3' ' HA2' ' A' ' 151' ' ' GLY . . . -66.52 -49.93 64.89 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.879 -0.6 . . . . 73.209999999999994 111.577 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 140' ' ' ILE . . . -61.82 -17.95 58.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.183 -0.462 . . . . 64.409999999999997 111.865 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -82.22 11.05 5.76 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.16 -0.473 . . . . 72.219999999999999 111.711 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.1 54.61 7.87 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.219 -0.515 . . . . 72.129999999999995 113.181 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' A' ' 150' ' ' ASN . . . -115.09 18.71 16.16 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.71 0.633 . . . . 72.239999999999995 112.71 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 69.17 -26.42 0.15 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.934 0.716 . . . . 75.010000000000005 112.934 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.429 ' H ' ' C ' ' A' ' 148' ' ' ALA . 51.1 t30 -77.42 44.52 0.43 Allowed 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.568 0.699 . . . . 63.340000000000003 110.529 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.694 ' HA2' ' HB3' ' A' ' 144' ' ' ALA . . . -96.63 100.77 2.52 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.058 -0.519 . . . . 50.229999999999997 114.021 -175.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -119.88 126.8 51.83 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.725 0.298 . . . . 74.0 110.575 174.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 81.4 t -86.24 134.39 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.734 0.642 . . . . 72.019999999999996 112.734 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.04 122.27 42.07 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.816 -0.629 . . . . 74.209999999999994 109.719 170.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.463 HD13 HD22 ' A' ' 127' ' ' LEU . 47.5 mt -91.42 140.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.774 -0.37 . . . . 72.519999999999996 111.865 -171.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 168' ' ' THR . 43.3 mm -123.17 109.59 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.227 -0.442 . . . . 72.239999999999995 111.183 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -90.86 149.33 21.98 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.261 0.553 . . . . 74.450000000000003 111.926 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -87.78 109.34 19.66 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.181 -0.463 . . . . 72.409999999999997 109.826 171.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.424 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 2.3 mmp_? -110.45 135.4 51.19 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.003 0.371 . . . . 74.510000000000005 112.003 -174.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -86.56 116.31 24.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.125 0.488 . . . . 54.329999999999998 111.39 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -108.14 90.61 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.294 -0.412 . . . . 70.409999999999997 110.778 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.1 t70 57.38 33.54 23.42 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.815 -0.63 . . . . 63.030000000000001 111.563 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 100.97 8.2 48.55 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.088 -0.577 . . . . 70.099999999999994 113.323 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 m -122.72 106.06 10.61 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 122.473 -0.428 . . . . 65.219999999999999 111.021 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -78.31 104.22 8.75 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.926 0.393 . . . . 73.549999999999997 111.567 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 35.2 m -118.57 144.15 34.78 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.817 0.342 . . . . 73.040000000000006 111.588 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 166' ' ' VAL . 16.6 Cg_exo -70.42 146.3 55.74 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.974 2.449 . . . . 53.229999999999997 113.47 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 90.8 m -136.02 150.74 49.32 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.294 -0.412 . . . . 64.519999999999996 110.82 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.612 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 58.9 tp -95.8 135.54 37.39 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.595 0.591 . . . . 74.310000000000002 112.595 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 36.0 ttp -127.41 130.15 48.81 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.303 0.573 . . . . 75.310000000000002 111.762 174.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 88.1 mt -139.61 141.7 37.11 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.61 -0.723 . . . . 64.319999999999993 110.895 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.495 HG12 ' CZ ' ' A' ' 95' ' ' PHE . 21.2 t -87.11 132.22 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.538 -0.726 . . . . 72.219999999999999 112.309 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.4 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 14.7 ptmm? -57.88 -39.72 78.53 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.586 0.587 . . . . 73.0 112.586 -176.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.437 ' HG3' ' CZ ' ' A' ' 116' ' ' PHE . 23.5 mm-40 -75.54 -0.17 19.43 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 111.971 0.36 . . . . 75.239999999999995 111.971 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.72 -30.61 8.86 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.12 0.486 . . . . 74.400000000000006 110.481 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 172' ' ' VAL . 5.3 tt -127.45 109.19 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.295 -0.866 . . . . 73.519999999999996 111.178 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.4 mm -100.81 118.52 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.407 -0.36 . . . . 75.129999999999995 111.142 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.504 ' HG3' ' HE2' ' A' ' 20' ' ' MET . 0.0 OUTLIER -92.84 121.36 34.13 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.832 0.825 . . . . 74.299999999999997 111.259 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -94.61 111.03 22.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.74 0.781 . . . . 74.239999999999995 110.44 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -82.16 95.88 7.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.197 -0.911 . . . . 74.450000000000003 111.384 -177.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 42.5 t -102.51 88.05 3.16 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.159 0.504 . . . . 73.540000000000006 110.048 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.15 140.41 52.28 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.044 -0.526 . . . . 73.530000000000001 110.964 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 C--O 1.254 1.322 0 CA-C-O 118.684 -0.674 . . . . 75.129999999999995 111.664 178.897 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 120.543 0.211 . . . . 74.420000000000002 111.012 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.584 HD11 ' HB2' ' A' ' 178' ' ' GLU . 59.1 tp -114.53 128.42 56.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.796 0.331 . . . . 75.439999999999998 110.866 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.487 HG12 ' HB3' ' A' ' 15' ' ' SER . 52.6 mt -105.24 127.38 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.641 -0.254 . . . . 71.450000000000003 110.703 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -118.16 149.0 41.8 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.2 0.524 . . . . 75.109999999999999 111.789 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.431 ' HB2' ' CD1' ' A' ' 13' ' ' LEU . 17.0 ttpp -150.64 120.93 7.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.666 -0.697 . . . . 70.530000000000001 111.29 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.593 ' HB2' HG21 ' A' ' 9' ' ' THR . 1.3 m-20 -71.83 174.05 7.43 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.778 0.323 . . . . 75.319999999999993 110.293 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.8 pt -86.51 -3.97 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.981 0.42 . . . . 63.140000000000001 111.433 172.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.444 ' HE1' ' HD2' ' A' ' 94' ' ' LYS . 73.7 m-85 -108.98 -27.61 9.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.11 0.411 . . . . 74.340000000000003 112.11 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.593 HG21 ' HB2' ' A' ' 6' ' ' ASP . 2.0 t -106.0 20.33 19.12 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.591 0.589 . . . . 72.439999999999998 112.591 -170.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -44.83 -19.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.218 1.192 . . . . 65.140000000000001 114.218 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -86.96 -33.26 19.72 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 122.026 -0.421 . . . . 72.400000000000006 111.733 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.75 25.49 2.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.81 0.444 . . . . 75.0 111.893 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.431 ' CD1' ' HB2' ' A' ' 5' ' ' LYS . 56.6 tp -38.08 124.34 1.18 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.233 0.613 . . . . 74.420000000000002 112.249 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -137.87 174.35 10.67 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.243 0.461 . . . . 55.210000000000001 112.243 -175.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.487 ' HB3' HG12 ' A' ' 3' ' ' ILE . 78.5 p -141.39 135.52 30.49 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.635 0.606 . . . . 72.420000000000002 112.635 -175.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -129.75 -173.95 3.17 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.04 0.448 . . . . 72.120000000000005 111.652 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.5 p -103.89 -3.84 24.27 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.9 0.704 . . . . 73.430000000000007 112.9 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 79.9 m-85 -76.36 131.55 74.68 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 112.004 0.372 . . . . 72.120000000000005 112.004 -175.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 6.7 Cg_exo -74.0 172.69 15.41 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.113 2.542 . . . . 74.420000000000002 113.555 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.483 ' HE1' ' HE1' ' A' ' 28' ' ' TYR . 25.0 ptm -111.64 130.75 55.66 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.044 0.387 . . . . 74.310000000000002 112.044 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -120.73 98.21 5.91 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.876 -0.416 . . . . 73.420000000000002 109.876 172.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 25' ' ' ASP . 52.8 tp -100.04 133.88 43.77 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.201 -0.454 . . . . 71.430000000000007 112.193 -172.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.55 134.7 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.234 0.54 . . . . 73.230000000000004 111.722 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 t70 55.73 15.21 1.51 Allowed 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.195 -0.911 . . . . 53.200000000000003 111.885 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.406 ' HA ' HD23 ' A' ' 22' ' ' LEU . 4.7 m-20 53.36 25.7 4.76 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.937 0.398 . . . . 72.530000000000001 111.867 -175.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 tp -114.26 -49.64 2.84 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.162 -0.472 . . . . 75.530000000000001 111.25 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.589 HG11 ' HA ' ' A' ' 172' ' ' VAL . 16.9 m -137.42 157.77 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.923 0.392 . . . . 74.150000000000006 111.913 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.483 ' HE1' ' HE1' ' A' ' 20' ' ' MET . 62.7 m-85 -92.47 149.28 21.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.433 -0.348 . . . . 74.230000000000004 110.369 175.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 31.8 tt0 -125.78 124.48 41.09 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.202 0.314 . . . . 75.299999999999997 110.597 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.401 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 59.1 t80 -127.45 131.25 50.24 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.006 0.432 . . . . 74.340000000000003 110.818 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.45 ' HG2' HG23 ' A' ' 168' ' ' THR . 36.5 mtmm -119.93 119.09 32.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.73 0.3 . . . . 74.400000000000006 110.971 -178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.13 -157.42 19.4 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.217 0.447 . . . . 71.310000000000002 114.217 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -112.47 159.04 19.15 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.922 0.391 . . . . 75.319999999999993 111.84 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -89.05 107.1 18.85 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.375 -0.375 . . . . 75.219999999999999 110.436 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 m -142.34 159.5 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.495 0.664 . . . . 75.349999999999994 112.361 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 66' ' ' ARG . 17.3 m -139.15 139.94 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.475 -0.784 . . . . 73.310000000000002 110.279 175.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 20.6 ttt180 -121.45 117.57 27.21 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.441 0.639 . . . . 73.239999999999995 111.223 173.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 85.9 tttt -131.86 152.53 50.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.803 -0.635 . . . . 71.430000000000007 110.617 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -42.92 -46.89 5.54 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.188 0.518 . . . . 65.439999999999998 111.774 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.57 49.4 0.88 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 113.28 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.622 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 10.5 tp10 -177.24 138.81 0.25 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.445 0.298 . . . . 75.420000000000002 110.777 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.639 HG13 HG22 ' A' ' 43' ' ' VAL . 6.8 tp -163.85 131.17 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 121.066 0.46 . . . . 64.430000000000007 112.175 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.639 HG22 HG13 ' A' ' 42' ' ' ILE . 75.7 t 59.97 110.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.672 -0.694 . . . . 73.230000000000004 112.08 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -82.93 173.92 11.37 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.136 0.493 . . . . 71.510000000000005 111.533 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.42 -63.73 0.3 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.107 -0.497 . . . . 75.340000000000003 110.857 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.33 -167.21 13.63 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.444 -0.408 . . . . 44.539999999999999 113.121 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.4 p -125.38 -169.9 2.08 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 122.579 -0.365 . . . . 70.239999999999995 111.307 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -93.43 154.59 41.29 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 120.699 0.285 . . . . 74.420000000000002 111.583 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.82 165.33 32.53 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.38 2.053 . . . . 75.030000000000001 112.743 176.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.8 t 61.57 30.2 18.59 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.38 0.61 . . . . 63.340000000000003 111.706 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.06 19.37 0.23 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.678 0.621 . . . . 73.420000000000002 112.678 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.02 -51.02 27.8 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 122.114 -0.366 . . . . 70.409999999999997 110.966 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -69.71 -36.88 76.29 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.987 0.423 . . . . 72.239999999999995 110.961 174.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.4 -36.68 2.21 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 116.167 -0.47 . . . . 41.450000000000003 114.028 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.79 86.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.974 0.731 . . . . 54.039999999999999 112.974 -175.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 42.6 tt0 -131.74 15.56 4.83 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.978 0.894 . . . . 71.010000000000005 109.218 171.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -83.0 103.85 12.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.273 -0.876 . . . . 72.510000000000005 113.127 -172.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -95.75 -5.28 42.36 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.067 0.46 . . . . 72.310000000000002 110.719 170.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.43 81.14 1.53 Allowed Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.143 -0.48 . . . . 54.149999999999999 112.879 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.5 m -78.58 73.64 5.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.981 0.42 . . . . 74.519999999999996 111.092 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -99.12 -74.87 0.58 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 110.061 -0.348 . . . . 65.409999999999997 110.061 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.571 ' HB2' HG21 ' A' ' 64' ' ' VAL . 43.8 mt-10 50.07 21.89 0.82 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.363 0.875 . . . . 73.340000000000003 113.363 176.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.5 m80 59.28 19.46 7.6 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.098 0.407 . . . . 73.040000000000006 112.098 -175.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.571 HG21 ' HB2' ' A' ' 62' ' ' GLU . 99.6 t -66.16 141.28 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 122.714 0.405 . . . . 74.319999999999993 111.841 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.6 mp0 -69.74 69.94 0.31 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.393 0.616 . . . . 75.519999999999996 109.558 169.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.523 ' HA ' HG12 ' A' ' 36' ' ' VAL . 11.6 ptm180 -98.27 137.47 36.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.499 -0.773 . . . . 73.530000000000001 112.684 -176.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.58 -127.02 4.69 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.914 -0.66 . . . . 54.030000000000001 113.296 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.568 HD11 HD13 ' A' ' 70' ' ' ILE . 23.2 pt -110.55 138.21 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.838 0.352 . . . . 72.340000000000003 111.817 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -46.33 -34.75 4.78 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.021 -0.536 . . . . 72.400000000000006 111.864 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.568 HD13 HD11 ' A' ' 68' ' ' ILE . 57.1 mt -48.36 -58.73 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.315 0.579 . . . . 73.510000000000005 112.311 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.62 -31.26 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.021 -0.536 . . . . 72.120000000000005 112.191 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.2 mt -67.5 -41.36 84.63 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.004 0.43 . . . . 74.310000000000002 111.241 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -54.62 -38.25 66.59 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.846 -0.616 . . . . 74.540000000000006 111.701 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -107.72 19.51 20.03 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.535 -0.302 . . . . 75.439999999999998 111.156 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt 43.89 43.07 5.0 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.897 0.879 . . . . 75.120000000000005 113.273 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.1 mt -70.52 162.16 29.31 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.206 0.527 . . . . 72.239999999999995 112.135 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.13 141.17 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 116.38 -0.373 . . . . 72.129999999999995 110.98 176.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -81.06 119.06 23.06 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.003 0.43 . . . . 72.450000000000003 112.065 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 53.2 ttm -112.19 139.48 47.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.062 -0.517 . . . . 74.239999999999995 109.82 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -122.57 156.77 33.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.391 0.615 . . . . 73.209999999999994 112.117 -175.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 25.1 p -72.17 -3.18 21.89 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.612 0.967 . . . . 75.230000000000004 113.612 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.408 ' CG ' ' N ' ' A' ' 83' ' ' GLU . 11.0 p90 -54.96 -54.83 37.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.914 0.387 . . . . 65.120000000000005 111.707 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.408 ' N ' ' CG ' ' A' ' 82' ' ' TYR . 8.8 tp10 -104.17 -45.08 4.81 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.612 0.72 . . . . 71.150000000000006 110.583 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.16 18.08 0.09 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.456 -0.793 . . . . 72.519999999999996 113.029 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.545 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -54.28 -41.74 69.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.231 0.539 . . . . 62.409999999999997 110.956 173.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -70.13 -24.4 63.18 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.853 -0.612 . . . . 54.200000000000003 111.905 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -62.81 -62.48 1.69 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.65 -0.25 . . . . 73.099999999999994 110.784 -179.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 30.2 p90 -68.38 -23.08 64.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.722 -0.391 . . . . 75.120000000000005 111.312 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -54.39 -60.35 3.47 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.188 0.518 . . . . 74.430000000000007 111.034 171.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.23 -38.43 75.22 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.176 -0.466 . . . . 73.239999999999995 111.414 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.469 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 55.7 t80 -57.13 -52.6 64.66 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.127 -0.488 . . . . 73.5 110.909 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.511 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 41.4 mm -65.81 -31.0 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.03 0.382 . . . . 73.430000000000007 112.03 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -59.43 -60.46 3.82 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.039 0.447 . . . . 73.329999999999998 111.202 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HD2' ' HE1' ' A' ' 8' ' ' PHE . 8.0 tmtm? -62.05 -41.52 98.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.14 0.495 . . . . 74.140000000000001 110.128 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.623 ' HZ ' HG12 ' A' ' 172' ' ' VAL . 21.7 t80 -52.87 -45.87 67.64 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.878 -0.601 . . . . 70.319999999999993 111.676 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 55.2 ttp -58.13 -50.14 74.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.304 0.573 . . . . 74.129999999999995 110.944 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -64.22 -35.53 81.11 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.114 -0.494 . . . . 72.239999999999995 111.786 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.92 -41.91 64.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.563 -0.289 . . . . 74.319999999999993 111.631 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.0 m -65.31 -39.6 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.957 -0.464 . . . . 74.349999999999994 111.144 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.04 -44.79 95.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.821 0.343 . . . . 72.239999999999995 110.398 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.97 -40.11 69.67 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.235 0.54 . . . . 75.209999999999994 111.011 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -66.31 -43.99 84.71 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.996 -0.547 . . . . 74.549999999999997 112.329 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 96.4 mmm -86.71 -53.69 4.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.772 0.656 . . . . 74.340000000000003 112.772 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -49.62 -40.2 38.35 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.739 0.415 . . . . 75.239999999999995 111.748 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -53.8 -43.1 69.06 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.225 0.454 . . . . 75.420000000000002 112.225 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -102.28 -3.01 27.91 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.466 0.543 . . . . 75.409999999999997 112.466 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.479 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 4.4 m-20 -101.03 -61.79 1.33 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.297 0.48 . . . . 75.5 112.297 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 107' ' ' ASN . 2.5 ptp180 72.49 -15.29 0.5 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.096 0.958 . . . . 74.540000000000006 112.543 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 113' ' ' VAL . 0.4 OUTLIER -71.71 84.5 0.9 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.317 0.58 . . . . 75.129999999999995 111.557 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -52.71 -18.82 2.01 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.85 -0.614 . . . . 72.310000000000002 112.54 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.42 -42.75 19.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.1 0.407 . . . . 61.399999999999999 112.1 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.446 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 37.2 t70 -81.21 -46.08 15.36 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 122.212 -0.305 . . . . 74.040000000000006 111.768 -174.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 109' ' ' ASP . 24.3 m -58.42 -27.36 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 122.052 -0.405 . . . . 72.200000000000003 111.177 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -70.78 -35.71 72.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.327 -0.397 . . . . 75.430000000000007 110.665 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.82 -46.7 74.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.341 -0.39 . . . . 70.319999999999993 110.868 176.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 82.5 t80 -62.84 -42.02 99.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.971 0.415 . . . . 73.019999999999996 110.384 174.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 117' ' ' LYS . 4.1 tmmm? -50.96 -46.95 61.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.27 -0.423 . . . . 72.530000000000001 110.064 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -63.46 -34.66 78.25 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.37 -0.377 . . . . 72.209999999999994 111.648 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 116' ' ' PHE . 71.8 mmtt -56.61 -60.73 3.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.991 0.425 . . . . 63.340000000000003 111.196 174.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.17 -32.21 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 116.102 -0.499 . . . . 75.319999999999993 111.607 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.418 ' O ' HG23 ' A' ' 125' ' ' VAL . 19.5 tm0? -64.57 -55.76 18.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.87 0.367 . . . . 71.200000000000003 110.859 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.27 -32.86 78.14 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.871 -0.681 . . . . 60.009999999999998 112.471 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 -62.49 -57.7 10.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.207 0.203 . . . . 73.310000000000002 111.188 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.48 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 30.6 m -63.66 -38.82 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.249 0.463 . . . . 71.430000000000007 112.249 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 121' ' ' GLN . 53.4 t -55.39 -44.01 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.173 0.511 . . . . 54.43 111.159 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.9 m -75.62 -35.97 60.37 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.098 0.475 . . . . 74.310000000000002 111.016 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.473 HD22 HD11 ' A' ' 155' ' ' ILE . 41.3 tp -66.41 -28.91 68.99 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.831 -0.622 . . . . 73.0 111.83 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 74.5 mt -90.04 3.97 51.64 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.289 -0.414 . . . . 64.420000000000002 112.086 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.475 ' HB2' ' CD1' ' A' ' 133' ' ' PHE . . . -59.63 92.72 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.413 0.625 . . . . 75.319999999999993 111.057 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -66.87 -7.86 24.87 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.695 0.998 . . . . 72.430000000000007 113.695 -170.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -71.48 -46.38 60.01 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.812 -0.555 . . . . 73.310000000000002 111.024 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 44.0 mtm-85 -109.36 -50.38 3.0 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.123 0.487 . . . . 74.540000000000006 111.806 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.475 ' CD1' ' HB2' ' A' ' 129' ' ' ALA . 22.4 m-85 -68.07 -7.56 30.47 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.404 0.52 . . . . 72.420000000000002 112.404 -173.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.51 -14.12 38.16 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.072 0.463 . . . . 73.219999999999999 111.324 175.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -93.32 19.36 8.31 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.151 0.426 . . . . 73.409999999999997 112.151 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.7 mt -88.51 147.29 24.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.318 0.58 . . . . 74.530000000000001 111.796 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.4 119.04 38.36 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.055 -0.521 . . . . 74.310000000000002 111.28 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -95.04 106.32 18.31 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.883 0.373 . . . . 75.099999999999994 110.544 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -94.48 132.81 38.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.519 0.676 . . . . 75.540000000000006 112.185 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 tp -124.7 149.08 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.32 -0.855 . . . . 74.329999999999998 110.394 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.64 141.56 27.48 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.289 -0.481 . . . . 75.340000000000003 113.377 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -48.28 -57.13 6.41 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.055 0.542 . . . . 73.209999999999994 111.739 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 143' ' ' ARG . 4.0 tmt_? -77.81 -28.97 50.49 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.189 0.518 . . . . 74.310000000000002 110.999 177.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.42 78.14 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.139 0.422 . . . . 73.109999999999999 112.139 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.33 -40.03 77.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.015 0.436 . . . . 73.409999999999997 111.737 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -71.09 -27.36 63.55 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.005 -0.543 . . . . 74.430000000000007 111.048 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -78.54 -44.14 11.27 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.218 -0.515 . . . . 74.010000000000005 112.963 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 64.83 2.29 1.67 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.286 0.847 . . . . 53.140000000000001 113.286 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -133.05 13.02 4.29 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.92 -0.488 . . . . 75.299999999999997 111.83 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -151.07 85.01 1.33 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.96 0.41 . . . . 73.200000000000003 110.22 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 158.33 133.52 1.56 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.948 -0.644 . . . . 75.230000000000004 113.52 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.38 142.12 29.52 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.695 -0.483 . . . . 73.140000000000001 109.695 174.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 48.4 t -75.9 117.28 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.581 0.705 . . . . 74.150000000000006 111.911 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.82 98.95 8.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.746 -0.661 . . . . 73.209999999999994 110.659 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 57.1 mt -85.99 117.08 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 120.794 0.331 . . . . 73.209999999999994 111.519 -175.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 51.0 mm -99.58 115.9 41.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.434 -0.348 . . . . 74.25 111.5 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 32.1 tt0 -104.02 144.36 31.65 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.868 -0.606 . . . . 75.540000000000006 111.659 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -85.81 88.8 7.61 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.251 0.548 . . . . 74.310000000000002 110.233 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.518 ' NH2' HG22 ' A' ' 161' ' ' VAL . 16.0 ttp180 -100.29 154.89 18.11 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.466 0.651 . . . . 71.349999999999994 111.959 -174.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.98 142.23 28.0 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.743 -0.662 . . . . 72.329999999999998 111.389 176.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.518 HG22 ' NH2' ' A' ' 159' ' ' ARG . 72.1 t -129.22 89.31 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.92 0.39 . . . . 75.129999999999995 110.824 171.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 51.76 25.64 3.05 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.926 -0.579 . . . . 73.150000000000006 112.305 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 129.18 -37.84 2.13 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.368 -0.444 . . . . 41.229999999999997 113.493 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 78.4 p -88.88 119.41 29.36 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.564 -0.374 . . . . 75.030000000000001 111.737 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.66 114.31 15.26 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.095 -0.502 . . . . 60.200000000000003 111.117 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.76 138.22 31.54 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 121.042 0.449 . . . . 75.200000000000003 112.085 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.504 ' HG2' HG23 ' A' ' 68' ' ' ILE . 15.8 Cg_exo -71.36 115.99 4.51 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.884 2.39 . . . . 64.239999999999995 112.62 173.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 31' ' ' LYS . 69.8 p -96.1 138.89 33.07 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.152 0.501 . . . . 74.209999999999994 112.01 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 61.1 tp -89.11 117.3 28.0 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.086 -0.506 . . . . 74.5 111.525 176.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.536 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 61.7 mtt -101.32 124.38 46.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.791 0.329 . . . . 61.43 111.413 176.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.472 ' HB3' HD11 ' A' ' 176' ' ' ILE . 96.0 mt -133.87 122.14 22.75 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.528 -0.306 . . . . 74.030000000000001 110.903 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.623 HG12 ' HZ ' ' A' ' 95' ' ' PHE . 59.0 t -68.35 118.97 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.057 0.456 . . . . 62.539999999999999 111.899 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.47 -24.23 67.11 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.789 0.663 . . . . 73.319999999999993 112.789 -177.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.434 ' HB2' ' HZ ' ' A' ' 116' ' ' PHE . 5.5 tp10 -90.86 -3.08 57.64 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.966 -0.459 . . . . 73.099999999999994 111.06 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.562 ' HB3' ' HE1' ' A' ' 95' ' ' PHE . . . -97.03 -44.09 7.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.056 0.455 . . . . 70.109999999999999 110.219 175.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.472 HD11 ' HB3' ' A' ' 171' ' ' LEU . 29.1 pt -116.79 109.4 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.877 -0.601 . . . . 70.030000000000001 110.611 172.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.5 tp -94.42 138.88 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.969 0.414 . . . . 75.109999999999999 110.808 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.584 ' HB2' HD11 ' A' ' 2' ' ' LEU . 1.8 pp20? -104.99 153.94 20.76 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.396 0.617 . . . . 71.439999999999998 112.394 -174.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.439 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 35.3 tt0 -140.09 99.77 3.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 74.109999999999999 109.406 172.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.562 ' HB3' HD12 ' A' ' 2' ' ' LEU . 19.3 pttm -102.27 132.52 48.17 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.313 0.857 . . . . 74.129999999999995 113.313 -170.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 48.6 t -125.21 88.9 2.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.358 -0.837 . . . . 74.430000000000007 109.63 168.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' A' ' 180' ' ' LYS . 3.1 mm? -121.08 104.27 9.65 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.934 -0.576 . . . . 74.230000000000004 110.418 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 119.166 -0.445 . . . . 72.299999999999997 111.281 -177.593 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 121.041 0.448 . . . . 73.030000000000001 111.615 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 34.5 tp -109.53 135.0 51.23 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.571 -0.529 . . . . 72.349999999999994 109.571 174.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.0 tt -100.5 120.64 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.284 0.564 . . . . 72.120000000000005 111.668 -175.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 47.2 p90 -118.84 143.01 47.21 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.182 0.515 . . . . 72.230000000000004 111.416 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 5' ' ' LYS . 19.7 ptpt -140.29 121.88 15.22 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.646 -0.706 . . . . 75.129999999999995 110.771 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.45 164.53 25.63 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.813 -0.555 . . . . 71.239999999999995 111.119 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.3 mt -55.81 -33.07 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.183 -0.462 . . . . 73.519999999999996 111.371 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 150' ' ' ASN . 9.1 p90 -109.45 -24.38 11.05 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.28 0.844 . . . . 74.430000000000007 113.28 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.475 ' HG1' ' HB3' ' A' ' 152' ' ' GLN . 2.9 m -90.65 14.95 11.94 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.429 0.529 . . . . 64.219999999999999 112.429 -173.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.445 ' O ' HD21 ' A' ' 13' ' ' LEU . 8.5 p-10 -62.37 -10.76 12.3 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.619 0.97 . . . . 72.329999999999998 113.619 -173.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -86.48 -43.46 12.75 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.105 0.478 . . . . 73.109999999999999 111.324 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.718 ' HG3' ' HB2' ' A' ' 144' ' ' ALA . 18.1 mm-40 -96.16 22.9 7.07 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.297 -0.41 . . . . 72.310000000000002 111.537 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 2.0 pt? -57.89 165.04 1.92 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.186 0.517 . . . . 75.010000000000005 111.868 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 75.3 m -141.37 156.86 45.78 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.512 0.56 . . . . 64.200000000000003 112.512 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.6 p -127.24 110.22 12.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.856 -0.611 . . . . 71.310000000000002 111.333 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -161.67 176.36 11.05 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.74 -0.467 . . . . 73.140000000000001 109.74 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.3 m -123.88 79.86 1.76 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.932 -0.48 . . . . 74.230000000000004 111.772 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -98.37 125.73 42.15 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 111.093 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.03 117.64 4.84 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.613 2.209 . . . . 73.140000000000001 112.713 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.404 ' HA ' ' HB3' ' A' ' 30' ' ' PHE . 61.3 mtt -109.84 162.23 14.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.377 0.608 . . . . 71.329999999999998 112.412 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 62.4 mttm -127.44 103.06 7.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.901 -0.59 . . . . 74.450000000000003 110.219 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.404 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 54.0 tp -75.49 101.85 5.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.07 0.462 . . . . 75.129999999999995 111.635 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.34 133.86 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.092 0.472 . . . . 74.230000000000004 111.783 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t0 56.5 19.21 3.99 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.59 -0.732 . . . . 74.099999999999994 112.058 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.404 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 45.3 m-20 59.35 9.86 1.58 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.233 0.613 . . . . 74.049999999999997 112.561 -177.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.2 tp -106.21 -47.1 3.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.908 0.385 . . . . 71.430000000000007 111.881 -173.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.478 HG11 ' HA ' ' A' ' 172' ' ' VAL . 3.2 m -134.71 150.19 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.678 0.622 . . . . 71.400000000000006 112.678 -176.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.547 ' HE2' HG23 ' A' ' 176' ' ' ILE . 64.2 m-85 -86.02 122.14 29.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.886 -0.597 . . . . 75.049999999999997 110.696 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 33.4 tt0 -114.09 108.48 17.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.604 0.362 . . . . 71.540000000000006 110.148 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.405 ' CZ ' HD23 ' A' ' 169' ' ' LEU . 15.1 p90 -143.62 121.0 11.63 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.784 1.031 . . . . 70.439999999999998 113.784 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 168' ' ' THR . 10.3 tmtt? -90.72 121.28 32.48 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.891 -1.049 . . . . 74.319999999999993 110.794 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.72 -120.95 1.12 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.107 -0.568 . . . . 71.230000000000004 113.093 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 69' ' ' ASP . 67.0 mttm -114.09 134.97 54.52 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.319 -0.519 . . . . 73.099999999999994 110.449 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -86.85 107.0 18.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.181 0.515 . . . . 73.140000000000001 109.62 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.487 ' HB ' HD11 ' A' ' 42' ' ' ILE . 28.8 m -137.81 145.37 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.981 0.419 . . . . 73.109999999999999 111.933 -173.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 43' ' ' VAL . 2.5 m -127.56 134.44 65.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.061 0.458 . . . . 74.519999999999996 110.919 176.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.783 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 26.3 mmm180 -105.7 110.54 22.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.93 0.395 . . . . 74.140000000000001 111.372 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -105.51 154.08 20.86 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.036 -0.529 . . . . 74.310000000000002 110.472 173.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -60.87 84.73 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.48 0.657 . . . . 72.120000000000005 110.957 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.24 -39.28 1.06 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.26 -0.882 . . . . 73.540000000000006 113.463 178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -171.23 158.92 5.62 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 117.281 0.541 . . . . 71.299999999999997 111.964 -174.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.487 HD11 ' HB ' ' A' ' 35' ' ' VAL . 12.5 tt -90.51 116.66 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-O 121.174 0.512 . . . . 71.409999999999997 111.683 177.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 36' ' ' VAL . 34.2 t -108.39 74.72 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.781 0.801 . . . . 71.319999999999993 111.359 -178.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 35' ' ' VAL . 1.8 pp -85.86 18.01 3.16 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.34 0.867 . . . . 75.049999999999997 113.34 -174.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.85 136.56 47.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.042 0.449 . . . . 71.439999999999998 111.514 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.57 -132.09 3.27 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.508 -0.377 . . . . 54.340000000000003 112.913 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.4 t -169.51 168.24 9.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.347 0.259 . . . . 75.400000000000006 111.096 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -118.92 91.79 43.71 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-O 120.679 0.276 . . . . 74.329999999999998 111.033 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -97.01 147.41 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.196 2.597 . . . . 70.129999999999995 113.982 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.1 p -77.11 95.76 4.31 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.992 0.425 . . . . 73.319999999999993 110.563 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.21 34.68 3.29 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.967 0.413 . . . . 70.450000000000003 112.094 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -76.34 78.25 3.1 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.149 0.5 . . . . 64.510000000000005 111.444 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -177.86 -64.71 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.923 -0.581 . . . . 55.229999999999997 111.181 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.62 92.68 0.14 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.152 -0.547 . . . . 73.140000000000001 113.077 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.67 27.16 0.23 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.29 0.567 . . . . 64.030000000000001 111.248 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.86 -24.9 16.82 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.764 -0.653 . . . . 75.310000000000002 112.35 -174.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.59 -145.22 0.07 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 120.443 0.163 . . . . 65.420000000000002 111.373 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 66.82 16.66 10.42 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.157 0.429 . . . . 74.219999999999999 112.157 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.59 74.01 1.13 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.187 -0.53 . . . . 75.219999999999999 113.293 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.1 m -105.7 4.51 30.14 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.65 -0.323 . . . . 74.120000000000005 111.638 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.49 -66.55 0.52 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 111.808 0.299 . . . . 72.400000000000006 111.808 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 59.99 -77.13 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.045 0.538 . . . . 73.519999999999996 112.419 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -81.4 54.64 2.37 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.666 0.746 . . . . 74.430000000000007 111.609 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.4 t -140.25 122.31 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.586 -0.734 . . . . 62.399999999999999 109.783 175.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.783 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 2.5 mp0 -76.31 66.89 2.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.218 0.532 . . . . 72.200000000000003 111.141 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 66' ' ' ARG . 9.5 ptm180 -93.24 116.9 29.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.898 -0.592 . . . . 73.019999999999996 111.909 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.6 -140.46 5.2 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.547 -0.835 . . . . 72.430000000000007 113.812 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.1 pt -110.94 143.61 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 112.354 0.502 . . . . 74.540000000000006 112.354 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . 27.3 t70 -45.16 -43.46 9.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.913 -0.585 . . . . 74.239999999999995 112.433 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 58.5 mt -49.51 -60.88 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.242 0.46 . . . . 74.140000000000001 112.242 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.5 ' HA ' HD11 ' A' ' 76' ' ' LEU . 21.1 m -73.89 -33.11 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.097 0.406 . . . . 73.140000000000001 112.097 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.402 HD11 HG22 ' A' ' 35' ' ' VAL . 87.5 mt -74.3 -28.22 61.08 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.014 0.376 . . . . 71.219999999999999 112.014 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -83.37 -40.74 19.03 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.661 0.267 . . . . 51.039999999999999 111.424 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -86.68 -9.76 55.27 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.076 0.399 . . . . 74.540000000000006 112.076 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 67.4 71.13 0.36 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.355 0.598 . . . . 73.239999999999995 111.993 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.5 HD11 ' HA ' ' A' ' 71' ' ' VAL . 67.6 mt -106.71 135.97 47.33 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.897 -0.592 . . . . 75.349999999999994 110.513 176.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.17 140.06 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.218 0.532 . . . . 73.219999999999999 112.379 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.23 143.51 57.73 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.396 0.888 . . . . 74.329999999999998 113.396 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.582 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 84.7 mtp -134.92 153.67 51.98 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.008 -0.542 . . . . 74.530000000000001 110.669 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.454 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 25.1 t-20 -148.06 156.47 42.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.63 0.253 . . . . 73.120000000000005 111.06 -177.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 40.9 t -37.32 -48.95 0.94 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.55 1.315 . . . . 72.439999999999998 114.55 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.454 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 12.2 p90 -59.75 -36.73 77.22 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.143 0.423 . . . . 75.340000000000003 112.143 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -81.85 -37.41 27.02 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.867 0.365 . . . . 74.040000000000006 111.395 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 2.7 m-20 -66.76 -22.58 66.04 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.689 0.626 . . . . 62.009999999999998 112.689 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.418 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -42.4 -64.88 0.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.021 0.439 . . . . 65.219999999999999 111.98 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.3 t -64.6 -33.17 75.29 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.887 0.375 . . . . 75.519999999999996 111.625 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.453 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 25.4 mmt -64.15 -65.24 0.7 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.278 -0.419 . . . . 75.109999999999999 112.034 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.418 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 10.5 p90 -61.66 -28.7 69.58 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.715 -0.394 . . . . 74.329999999999998 111.311 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -55.01 -61.64 2.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.724 -0.39 . . . . 75.150000000000006 110.799 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.14 82.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.285 -0.416 . . . . 64.409999999999997 111.841 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -60.47 -59.71 4.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.22 0.452 . . . . 72.420000000000002 112.22 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.3 mm -54.9 -39.77 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.166 0.432 . . . . 75.430000000000007 112.166 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -59.54 -57.29 13.62 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.04 0.385 . . . . 73.450000000000003 112.04 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.88 -51.8 60.0 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.803 0.335 . . . . 75.409999999999997 111.149 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.474 ' CZ ' HG12 ' A' ' 172' ' ' VAL . 29.3 t80 -46.43 -48.94 18.73 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.095 0.558 . . . . 65.040000000000006 112.118 176.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 37.5 ttp -62.09 -34.7 76.8 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.996 0.427 . . . . 74.219999999999999 111.377 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.629 ' HZ3' ' HB2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -65.4 -49.71 68.22 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.466 -0.333 . . . . 73.409999999999997 110.901 174.462 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -59.85 -46.32 89.67 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.31 0.485 . . . . 72.120000000000005 112.31 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.5 -39.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 112.071 0.397 . . . . 74.450000000000003 112.071 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.462 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 15.0 mm -70.27 -49.2 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 122.271 -0.268 . . . . 60.310000000000002 111.355 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.6 -41.17 69.62 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.423 0.63 . . . . 73.010000000000005 110.5 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -55.29 -57.11 13.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.615 -0.721 . . . . 75.129999999999995 110.995 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.497 ' HG3' HG13 ' A' ' 113' ' ' VAL . 12.6 tpt -62.59 -44.76 95.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.476 0.546 . . . . 73.239999999999995 112.476 -173.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 11.2 pt-20 -72.46 -38.69 68.17 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.942 -0.474 . . . . 72.299999999999997 112.161 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.517 ' HB3' ' HZ3' ' A' ' 105' ' ' LYS . 5.7 ttpm? -68.86 -17.97 64.08 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.439 0.533 . . . . 72.219999999999999 112.439 -174.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -113.19 -17.0 12.46 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.001 -0.437 . . . . 61.43 112.008 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -128.63 -73.28 0.59 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.627 0.232 . . . . 74.420000000000002 111.627 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 75.24 -18.73 0.43 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.999 1.111 . . . . 73.519999999999996 113.999 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.486 ' O ' HG23 ' A' ' 113' ' ' VAL . 70.9 m-20 -57.91 121.39 10.42 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.743 -0.598 . . . . 64.120000000000005 111.782 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -44.58 -49.49 10.12 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.982 -0.554 . . . . 75.400000000000006 112.356 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.47 68.43 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.698 0.629 . . . . 61.329999999999998 112.698 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -92.7 -39.61 11.18 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 111.951 0.352 . . . . 74.340000000000003 111.951 -175.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.497 HG13 ' HG3' ' A' ' 103' ' ' MET . 16.3 m -68.89 -37.11 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.857 -0.527 . . . . 75.530000000000001 112.062 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.25 -35.98 74.16 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.963 0.411 . . . . 71.5 110.483 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.97 78.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.125 0.488 . . . . 74.150000000000006 111.007 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.17 -48.83 80.07 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.953 -0.567 . . . . 75.129999999999995 111.118 174.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -55.6 -38.25 69.18 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.922 -0.581 . . . . 75.5 111.062 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.28 -40.61 96.31 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.473 -0.33 . . . . 72.420000000000002 111.509 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -58.8 -57.26 13.81 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.331 -0.395 . . . . 74.019999999999996 111.394 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.0 tp -66.55 -35.33 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.34 -0.391 . . . . 73.129999999999995 111.384 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -62.31 -45.27 93.99 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.995 0.426 . . . . 73.230000000000004 110.609 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.67 -37.52 94.38 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.061 -0.59 . . . . 53.409999999999997 112.414 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 49.5 t90 -62.97 -50.25 71.52 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.866 -0.196 . . . . 74.450000000000003 111.51 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.5 m -68.59 -41.12 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.665 0.617 . . . . 72.400000000000006 112.665 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.95 -29.77 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.778 -0.576 . . . . 72.310000000000002 111.621 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.4 t -77.84 -51.29 10.7 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.054 0.454 . . . . 75.109999999999999 110.77 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.6 tp -57.94 -46.34 85.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.002 -0.545 . . . . 63.340000000000003 112.302 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.62 2.81 21.07 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.434 0.531 . . . . 73.400000000000006 112.434 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.09 80.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.377 0.608 . . . . 74.120000000000005 111.1 176.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -58.42 -14.62 8.12 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.875 0.694 . . . . 73.530000000000001 112.875 -173.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.27 -49.92 75.98 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.784 0.326 . . . . 71.030000000000001 111.369 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -112.41 -36.23 5.33 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.254 0.464 . . . . 75.219999999999999 112.254 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -67.64 -6.86 22.42 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.832 0.678 . . . . 73.299999999999997 112.832 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 14.9 ptmm? -55.31 -17.13 4.17 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.257 0.465 . . . . 75.239999999999995 112.257 176.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -90.41 20.96 4.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.448 0.536 . . . . 74.109999999999999 112.448 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.44 158.4 17.74 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.1 0.476 . . . . 74.310000000000002 111.634 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.81 51.81 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.152 -0.476 . . . . 74.349999999999994 110.62 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.594 ' HB3' HG12 ' A' ' 153' ' ' VAL . 36.1 m-85 -112.18 157.24 21.11 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.218 -0.301 . . . . 71.340000000000003 110.888 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -137.53 147.21 44.98 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.806 0.336 . . . . 64.450000000000003 111.827 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.491 HD11 ' HA3' ' A' ' 151' ' ' GLY . 14.6 tt -138.67 160.01 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 116.421 -0.354 . . . . 75.230000000000004 110.813 177.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.05 156.81 28.37 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.278 -0.487 . . . . 64.319999999999993 113.848 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -59.13 -60.33 4.04 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.959 0.409 . . . . 72.120000000000005 111.006 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.519 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 4.0 mmp_? -73.69 -32.63 64.04 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.957 0.408 . . . . 74.409999999999997 111.104 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.718 ' HB2' ' HG3' ' A' ' 12' ' ' GLU . . . -53.06 -38.67 62.68 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.12 -0.491 . . . . 70.349999999999994 112.08 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.29 -39.42 63.95 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.286 0.476 . . . . 74.209999999999994 112.286 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -96.43 -17.05 20.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.846 0.355 . . . . 73.219999999999999 111.691 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.6 -48.44 13.21 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.216 -0.516 . . . . 71.430000000000007 113.172 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 72.26 -46.04 0.63 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.915 0.709 . . . . 70.329999999999998 112.915 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -78.54 0.37 26.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.079 0.4 . . . . 71.030000000000001 112.079 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 23.0 p-10 -142.45 28.25 1.66 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 111.842 0.312 . . . . 72.420000000000002 111.842 -176.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.491 ' HA3' HD11 ' A' ' 140' ' ' ILE . . . -115.36 142.5 17.64 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 120.898 -0.668 . . . . 71.150000000000006 113.975 -175.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.475 ' HB3' ' HG1' ' A' ' 9' ' ' THR . 3.7 pt20 -120.24 140.64 50.88 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.728 0.299 . . . . 73.329999999999998 110.795 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.594 HG12 ' HB3' ' A' ' 138' ' ' PHE . 39.2 t -86.86 102.78 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 121.363 0.601 . . . . 72.450000000000003 111.211 174.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.534 ' HB2' HD12 ' A' ' 169' ' ' LEU . . . -78.67 112.25 15.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.993 -0.549 . . . . 73.420000000000002 110.337 174.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.693 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 59.8 mt -89.16 119.01 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.15 0.426 . . . . 75.140000000000001 112.15 -172.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.9 mm -104.61 117.3 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.801 0.334 . . . . 72.409999999999997 111.282 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -107.31 126.73 52.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.006 0.432 . . . . 72.439999999999998 111.358 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -84.71 89.07 7.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.205 0.526 . . . . 74.230000000000004 109.646 172.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -90.91 149.01 22.08 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.991 -0.55 . . . . 73.0 111.514 -173.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -98.63 121.75 40.97 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.309 -0.405 . . . . 74.439999999999998 111.755 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 99.0 t -110.67 98.55 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 110.046 -0.353 . . . . 72.349999999999994 110.046 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 57.12 21.3 6.32 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.987 0.423 . . . . 75.219999999999999 111.588 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.98 24.5 27.16 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.257 -0.496 . . . . 71.439999999999998 112.697 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 m -112.19 141.06 46.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.704 0.288 . . . . 65.120000000000005 110.973 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -73.34 109.38 6.82 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.478 0.548 . . . . 74.040000000000006 112.478 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 166' ' ' VAL . 24.3 m -128.58 96.51 29.98 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 121.254 0.55 . . . . 75.409999999999997 111.799 171.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.79 114.11 3.14 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.472 2.115 . . . . 74.109999999999999 112.055 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 5.2 t -107.69 161.06 15.22 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.506 0.558 . . . . 74.329999999999998 112.506 -176.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 154' ' ' ALA . 22.5 tp -111.13 131.75 54.85 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.827 0.346 . . . . 64.430000000000007 111.035 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.693 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 46.9 ttm -110.96 125.67 53.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.108 -0.496 . . . . 74.549999999999997 111.252 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.86 150.39 50.45 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.623 -0.717 . . . . 74.230000000000004 109.996 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.478 ' HA ' HG11 ' A' ' 27' ' ' VAL . 47.7 t -89.74 120.73 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.946 -0.471 . . . . 73.219999999999999 112.27 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -46.9 87.47 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.049 -0.523 . . . . 74.439999999999998 110.632 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -63.37 -20.43 65.52 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.003 -0.544 . . . . 72.019999999999996 112.307 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.448 ' HB1' ' HE1' ' A' ' 95' ' ' PHE . . . -101.78 -19.71 15.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.315 0.487 . . . . 71.299999999999997 112.315 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.547 HG23 ' HE2' ' A' ' 28' ' ' TYR . 9.0 tp -96.01 121.4 46.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.417 0.627 . . . . 63.439999999999998 111.866 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.4 mm -99.05 112.14 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.957 0.408 . . . . 74.230000000000004 110.927 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.15 134.61 34.98 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.847 0.356 . . . . 72.040000000000006 111.466 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -129.99 144.01 51.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.497 0.665 . . . . 72.200000000000003 111.258 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -131.31 103.74 6.63 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.499 -0.773 . . . . 72.510000000000005 112.093 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 43.0 t -133.26 89.84 2.66 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.06 0.457 . . . . 74.340000000000003 110.736 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.448 HD11 ' N ' ' A' ' 182' ' ' LEU . 5.2 mp -112.92 96.18 5.81 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.111 0.481 . . . . 74.230000000000004 111.388 -174.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 . . . . . 0 C--O 1.253 1.283 0 CA-C-O 118.952 -0.547 . . . . 72.209999999999994 111.403 -176.492 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.563 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.51 0.195 . . . . 61.52 110.852 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 179' ' ' GLU . 26.5 tp -84.59 125.53 32.53 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 122.134 -0.354 . . . . 73.44 110.559 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.775 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 56.2 mt -100.32 119.47 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.717 0.294 . . . . 63.42 110.884 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.865 ' HB2' HD11 ' A' ' 176' ' ' ILE . 35.7 p90 -106.59 135.49 48.02 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.3 0.571 . . . . 74.24 112.048 -178.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.531 ' HB2' HD13 ' A' ' 13' ' ' LEU . 74.6 tttt -134.53 114.34 12.72 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.017 -0.992 . . . . 64.32 110.842 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.623 ' HB2' ' H ' ' A' ' 9' ' ' THR . 6.3 m-20 -79.69 161.42 25.82 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.157 0.504 . . . . 64.33 111.263 173.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.4 pt -64.82 -21.07 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.013 -0.54 . . . . 71.41 111.258 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.454 ' HE2' ' HA ' ' A' ' 152' ' ' GLN . 36.9 p90 -109.13 -27.7 9.45 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.388 0.514 . . . . 64.31 112.388 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.623 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 4.8 m -88.88 15.37 8.55 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.236 0.541 . . . . 65.53 111.268 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -57.79 -12.66 3.23 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.516 0.562 . . . . 75.31 112.516 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.43 -61.74 1.7 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.977 0.418 . . . . 73.14 112.064 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -112.97 25.59 11.26 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.124 0.786 . . . . 70.21 113.124 -170.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -42.41 139.39 1.5 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.809 0.338 . . . . 63.1 111.532 176.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.3 m -135.62 178.19 7.23 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.66 0.615 . . . . 62.01 112.66 -168.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.559 ' HB3' HG12 ' A' ' 3' ' ' ILE . 86.6 p -124.28 125.14 43.86 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.299 0.481 . . . . 63.03 112.299 -174.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -137.62 -172.75 3.31 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.2 0.524 . . . . 73.1 111.425 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.2 m -138.45 89.73 2.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.201 -0.454 . . . . 75.23 111.082 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -142.67 132.71 12.24 Favored Pre-proline 0 N--CA 1.473 0.717 0 CA-C-N 116.556 -0.293 . . . . 73.43 111.515 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.11 145.94 14.07 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.704 2.27 . . . . 65.14 112.837 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.5 164.02 27.51 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.108 0.48 . . . . 74.33 112.243 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -121.82 104.26 9.44 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.115 -0.493 . . . . 74.32 110.881 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.5 tp -74.54 104.1 5.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.216 0.531 . . . . 73.33 111.643 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.23 134.42 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 121.341 0.591 . . . . 73.53 111.905 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.2 t70 59.22 14.24 3.48 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.085 -0.961 . . . . 71.41 112.383 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.0 t70 63.55 18.62 11.2 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.595 0.712 . . . . 73.14 110.79 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.433 ' HG ' HG13 ' A' ' 27' ' ' VAL . 59.0 tp -113.57 -50.14 2.86 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.983 -0.553 . . . . 65.15 112.441 -175.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 172' ' ' VAL . 15.5 m -133.54 150.14 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 113.04 0.756 . . . . 62.33 113.04 -175.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 170' ' ' MET . 19.3 m-85 -85.7 125.29 33.08 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.644 -0.707 . . . . 74.41 110.808 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -99.25 127.21 45.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.023 -0.535 . . . . 75.24 110.628 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.754 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 67.3 t80 -119.65 139.65 51.87 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.03 0.443 . . . . 72.22 111.34 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -90.0 126.84 35.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.081 -0.508 . . . . 72.22 111.33 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.72 173.54 14.95 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.989 -0.624 . . . . 74.14 114.44 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -133.33 153.9 51.18 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.894 0.478 . . . . 75.41 109.944 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -91.34 107.03 18.92 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.065 -0.397 . . . . 65.13 110.189 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.411 HG23 HD12 ' A' ' 72' ' ' LEU . 27.4 m -135.22 165.8 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.257 0.551 . . . . 73.55 112.272 -173.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.1 m -115.9 146.56 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.396 0.517 . . . . 71.02 112.396 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.579 ' HG2' HD13 ' A' ' 72' ' ' LEU . 5.0 mmp_? . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.25 0.548 . . . . 74.15 111.172 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 10.4 pt-20 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 114.667 1.358 . . . . 71.14 114.667 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -126.23 109.95 12.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.052 0.387 . . . . 72.22 111.293 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.47 -165.73 28.29 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.585 -0.817 . . . . 55.14 113.506 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.3 pt -111.61 145.56 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 122.425 -0.456 . . . . 74.14 111.895 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -46.2 -39.8 10.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.211 0.604 . . . . 73.22 112.044 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.9 mt -53.83 -49.97 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.887 -0.597 . . . . 75.41 112.503 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 23.2 m -87.72 -39.3 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.519 0.563 . . . . 51.1 112.519 -171.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.579 HD13 ' HG2' ' A' ' 37' ' ' ARG . 61.8 mt -64.42 -38.08 89.76 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.189 0.518 . . . . 63.01 111.679 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -84.48 -15.1 47.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.196 -0.457 . . . . 73.02 112.088 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -109.08 4.21 22.83 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 122.185 -0.322 . . . . 74.3 111.349 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 58.06 71.12 0.6 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.367 0.603 . . . . 61.51 112.161 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 60.4 mt -127.23 124.16 38.26 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.516 -0.765 . . . . 62.13 110.533 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.94 148.53 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.833 0.349 . . . . 63.35 111.34 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -76.59 130.82 38.4 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.583 0.706 . . . . 74.42 112.604 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.536 ' HG3' ' HB2' ' A' ' 84' ' ' ASP . 12.5 tpt -117.22 122.77 44.92 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.061 -0.972 . . . . 54.53 108.994 171.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -82.84 139.55 33.42 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.212 0.53 . . . . 65.53 112.193 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 62.3 m -52.45 -40.05 61.81 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.204 0.816 . . . . 75.4 113.204 -174.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -57.27 -32.78 66.96 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.882 0.327 . . . . 63.35 111.882 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.48 -36.41 10.34 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.973 0.416 . . . . 71.32 110.949 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.536 ' HB2' ' HG3' ' A' ' 79' ' ' MET . 14.2 t70 -66.92 -11.42 56.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.251 -0.431 . . . . 42.42 111.594 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.597 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -36.68 -54.86 0.89 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.697 0.629 . . . . 62.2 112.697 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.7 t -67.81 -36.19 79.96 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.061 0.393 . . . . 53.42 112.061 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.2 ttm -67.84 -60.63 2.37 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 111.918 0.34 . . . . 75.4 111.918 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 16.0 p90 -62.21 -35.17 78.07 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 120.368 -0.533 . . . . 73.33 111.245 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 42.0 tptt -61.48 -39.36 90.65 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.185 0.517 . . . . 71.21 110.615 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.71 74.73 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.053 -0.521 . . . . 74.2 111.481 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -61.66 -44.76 96.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.529 -0.305 . . . . 73.52 111.519 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 88' ' ' PHE . 42.2 mm -62.04 -35.9 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 120.787 0.327 . . . . 73.22 111.301 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.07 -57.3 13.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.149 0.5 . . . . 72.3 110.831 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -59.58 -45.57 91.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.849 -0.614 . . . . 74.43 111.095 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.627 ' HE2' HG12 ' A' ' 120' ' ' ILE . 47.8 t80 -55.73 -61.54 2.29 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.399 -0.819 . . . . 73.21 111.997 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 58.6 ttp -54.59 -43.8 72.46 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.013 0.435 . . . . 72.34 111.278 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -61.59 -47.83 83.69 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.041 -0.527 . . . . 73.51 111.301 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -70.68 -44.1 67.69 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.448 0.536 . . . . 73.33 112.448 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.687 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . 35.9 m -65.04 -47.2 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.093 0.405 . . . . 70.14 112.093 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.443 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 47.3 mm -63.42 -45.61 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.898 0.38 . . . . 73.12 110.358 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -53.6 -55.4 26.08 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.964 -0.562 . . . . 62.52 112.069 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.687 ' HD2' ' HA ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -66.54 -27.51 67.81 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 122.219 -0.301 . . . . 72.42 111.244 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.496 ' HG3' HG12 ' A' ' 113' ' ' VAL . 12.1 tpt -73.84 -50.78 18.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.821 0.343 . . . . 52.25 111.337 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 9.7 pt-20 -66.35 -25.74 66.95 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.19 -0.319 . . . . 73.21 111.143 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -56.18 -39.21 72.02 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.159 0.429 . . . . 74.43 112.159 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -103.74 -37.91 7.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.037 0.754 . . . . 65.33 113.037 -175.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 108' ' ' ARG . 60.1 t30 -97.34 -35.15 10.8 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.511 0.559 . . . . 74.22 112.511 -173.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.442 ' HB3' ' O ' ' A' ' 107' ' ' ASN . 26.3 ttp180 71.59 -35.7 0.34 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.07 1.137 . . . . 74.12 114.07 174.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.55 ' O ' HG22 ' A' ' 113' ' ' VAL . 72.2 m-20 -65.71 114.38 4.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.807 0.669 . . . . 72.21 112.807 -168.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.74 -24.45 65.72 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.548 -0.751 . . . . 72.41 112.675 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.16 -32.21 58.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.894 0.378 . . . . 42.45 111.853 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.65 -51.31 7.85 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.548 -0.296 . . . . 73.24 111.706 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 109' ' ' ASP . 6.4 m -60.63 -31.12 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 111.947 0.351 . . . . 70.33 111.947 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.97 -38.93 83.34 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.91 0.386 . . . . 71.52 110.634 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.6 78.43 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.233 -0.44 . . . . 75.33 111.062 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.473 ' CZ ' ' HG3' ' A' ' 174' ' ' GLU . 22.2 t80 -56.85 -49.25 76.03 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.352 -0.385 . . . . 74.12 111.096 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -57.59 -32.81 67.55 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.626 -0.261 . . . . 72.21 111.067 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -66.63 -39.99 88.55 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.541 0.21 . . . . 73.31 111.286 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -53.65 -58.48 7.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.31 0.576 . . . . 73.43 111.038 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.627 HG12 ' HE2' ' A' ' 95' ' ' PHE . 10.9 tp -67.84 -32.49 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.743 -0.662 . . . . 60.34 111.568 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.41 ' NE2' HG21 ' A' ' 125' ' ' VAL . 23.3 tm0? -58.64 -52.41 65.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.729 0.299 . . . . 71.14 110.709 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.92 -42.9 96.98 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.932 -0.651 . . . . 70.44 112.528 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -58.83 -55.15 38.84 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 111.62 0.23 . . . . 73.1 111.62 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.466 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.7 m -65.25 -48.35 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.373 0.509 . . . . 62.31 112.373 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.41 HG21 ' NE2' ' A' ' 121' ' ' GLN . 92.1 t -57.98 -41.14 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.98 -0.45 . . . . 74.15 111.487 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.5 t -70.44 -47.96 58.24 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.012 0.434 . . . . 64.31 111.139 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.33 -33.81 74.23 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.311 -0.404 . . . . 72.13 111.805 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 80.8 mt -85.13 2.24 44.37 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.212 0.449 . . . . 75.22 112.212 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.62 89.06 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.304 0.574 . . . . 61.24 110.392 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 134' ' ' LYS . 36.3 ttpt -51.66 -59.66 4.03 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 114.373 1.249 . . . . 75.04 114.373 -165.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.81 -34.17 72.7 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.217 0.821 . . . . 75.2 113.217 -168.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -84.0 -53.61 5.44 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.089 0.471 . . . . 71.01 111.375 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.409 ' HD2' HD11 ' A' ' 136' ' ' LEU . 50.7 m-85 -74.46 -3.96 33.79 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.208 0.528 . . . . 62.23 111.763 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 130' ' ' LYS . 33.0 ttpt -35.79 -32.32 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.694 1.198 . . . . 74.12 113.724 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -96.85 35.11 1.59 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.503 0.557 . . . . 73.22 112.503 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.409 HD11 ' HD2' ' A' ' 133' ' ' PHE . 38.2 mt -89.31 162.33 15.89 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.775 0.321 . . . . 61.34 110.622 170.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -132.13 133.5 44.35 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.236 0.458 . . . . 74.12 112.236 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.419 ' HB3' HG13 ' A' ' 153' ' ' VAL . 80.3 m-85 -100.82 107.57 19.16 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.641 0.257 . . . . 74.14 110.413 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 38.6 m-85 -101.54 124.74 47.69 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.863 -0.523 . . . . 74.41 111.616 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 16.9 tt -110.09 151.98 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.965 -0.562 . . . . 71.31 111.293 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.527 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -61.62 140.7 47.38 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 114.405 0.522 . . . . 50.0 114.405 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -44.18 -52.48 7.31 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.146 0.579 . . . . 72.44 112.096 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -51.58 -49.63 61.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.058 -0.519 . . . . 74.52 111.446 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.653 ' HB2' ' HA3' ' A' ' 151' ' ' GLY . . . -64.59 -50.09 68.57 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.237 0.458 . . . . 65.22 112.237 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.73 -41.24 77.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.061 0.458 . . . . 53.51 111.758 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -82.2 -24.86 34.69 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.932 -0.576 . . . . 65.2 111.465 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -101.09 -3.64 54.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.166 -0.54 . . . . 54.05 114.061 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 59.68 24.34 13.2 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.428 0.529 . . . . 74.44 112.428 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -103.51 -173.36 2.29 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.835 0.68 . . . . 64.1 112.835 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -88.98 58.1 4.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.242 0.544 . . . . 53.52 112.112 -172.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.653 ' HA3' ' HB2' ' A' ' 144' ' ' ALA . . . -70.94 167.96 50.66 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.897 -0.668 . . . . 72.12 113.085 173.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.454 ' HA ' ' HE2' ' A' ' 8' ' ' PHE . 6.5 tt0 -70.67 128.12 34.99 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.278 0.473 . . . . 63.31 112.278 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 138' ' ' PHE . 40.6 t -94.48 104.26 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.233 0.54 . . . . 73.5 110.266 170.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.737 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -80.45 136.41 36.33 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.864 -0.607 . . . . 64.15 111.56 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.569 ' HB ' ' HG3' ' A' ' 170' ' ' MET . 39.2 mm -89.23 109.4 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.846 0.355 . . . . 73.35 111.254 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.461 HG13 ' CD1' ' A' ' 139' ' ' PHE . 48.1 mm -93.91 108.12 20.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 120.968 0.413 . . . . 55.43 111.307 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -99.47 149.17 23.48 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.069 -0.968 . . . . 64.31 112.424 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -95.25 122.77 38.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.411 -0.813 . . . . 74.21 110.052 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.632 ' NH2' HG21 ' A' ' 168' ' ' THR . 4.8 ttp180 -156.39 131.08 8.93 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.613 -0.68 . . . . 74.01 112.084 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -103.54 143.91 32.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.198 -0.456 . . . . 64.13 111.521 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.13 100.89 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.454 -0.339 . . . . 72.23 110.444 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.4 t70 66.74 6.57 4.62 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 121.233 0.539 . . . . 64.22 111.514 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 128.78 -21.63 5.29 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.265 -0.493 . . . . 33.21 113.03 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 66.7 p -82.08 106.73 14.22 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.403 -0.469 . . . . 73.3 110.874 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -75.21 111.12 10.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.437 0.636 . . . . 73.32 112.391 -172.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.07 145.4 41.72 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.001 -0.545 . . . . 73.21 111.616 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -78.67 117.88 4.07 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.479 2.119 . . . . 73.51 112.213 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.632 HG21 ' NH2' ' A' ' 159' ' ' ARG . 83.5 m -107.4 122.02 45.77 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.904 0.383 . . . . 74.14 111.67 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.754 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 50.0 tp -88.87 139.94 29.95 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.566 -0.288 . . . . 75.02 110.981 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.569 ' HG3' ' HB ' ' A' ' 155' ' ' ILE . 21.1 ptp -133.87 141.26 47.32 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.714 0.768 . . . . 74.42 112.089 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -139.54 141.21 37.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.557 -1.201 . . . . 70.35 109.345 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.627 ' HA ' HG12 ' A' ' 27' ' ' VAL . 21.9 t -85.18 123.68 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.838 -0.538 . . . . 72.12 111.901 -173.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.437 ' HD3' ' OH ' ' A' ' 28' ' ' TYR . 45.2 tptt -53.17 -47.48 68.77 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.62 0.6 . . . . 55.34 112.62 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.473 ' HG3' ' CZ ' ' A' ' 116' ' ' PHE . 39.9 mm-40 -67.78 -1.92 6.24 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.433 0.531 . . . . 75.33 112.433 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -107.68 -44.55 4.23 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.521 -0.309 . . . . 64.5 110.718 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.865 HD11 ' HB2' ' A' ' 4' ' ' TYR . 9.5 tp -96.27 111.45 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 121.811 0.815 . . . . 41.5 112.193 -175.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.4 mm -105.06 144.07 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.169 -0.469 . . . . 53.34 110.749 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.93 146.83 38.3 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.63 0.729 . . . . 52.3 112.659 -175.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.775 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 8.8 tp10 -114.39 120.42 40.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.182 -0.917 . . . . 73.41 109.596 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.434 ' HB2' ' NZ ' ' A' ' 180' ' ' LYS . 4.9 ttmp? . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 112.419 0.526 . . . . 62.54 112.419 -171.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.675 0.274 . . . . 75.11 111.125 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.6 tp -89.52 131.47 35.53 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.985 0.422 . . . . 71.22 110.806 174.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 56.7 mt -118.94 120.58 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.385 . . . . 73.15 110.776 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -115.0 133.93 55.62 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.73 0.776 . . . . 72.2 111.244 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.409 ' HG2' ' CD1' ' A' ' 13' ' ' LEU . 34.9 mtpt -120.12 120.0 34.94 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.021 -0.991 . . . . 75.41 111.178 -172.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.93 177.5 3.64 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.764 0.654 . . . . 63.32 112.764 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -70.68 -57.03 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.012 -0.54 . . . . 52.31 111.502 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -102.15 -41.36 6.43 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.529 0.566 . . . . 74.01 112.529 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.54 HG21 ' HA2' ' A' ' 151' ' ' GLY . 12.1 p -80.48 16.28 1.39 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.542 0.571 . . . . 74.34 112.542 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -47.02 -34.7 5.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.16 0.584 . . . . 71.43 111.638 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.44 -39.61 80.32 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.529 0.566 . . . . 64.23 112.529 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -65.96 -33.49 75.94 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.546 0.213 . . . . 72.21 111.279 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.409 ' CD1' ' HG2' ' A' ' 5' ' ' LYS . 11.9 tp 57.2 112.2 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.441 0.904 . . . . 72.24 113.441 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.7 m -104.24 124.79 49.78 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.844 -0.535 . . . . 63.23 111.374 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 83.1 p -140.22 142.17 35.86 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.403 0.52 . . . . 70.21 112.403 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -171.61 -147.87 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.848 -0.614 . . . . 52.3 110.657 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 p -150.06 30.01 0.72 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.331 0.493 . . . . 70.33 112.331 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 97.9 m-85 -89.74 123.41 66.49 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.792 0.33 . . . . 73.12 111.503 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 12.0 Cg_exo -70.8 144.65 49.06 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.237 2.625 . . . . 53.33 113.959 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.434 ' SD ' ' C ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -131.89 166.35 21.82 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.751 -0.658 . . . . 52.13 111.496 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -130.98 136.77 48.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.86 0.362 . . . . 73.44 111.166 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 55.0 tp -87.26 109.34 19.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.061 0.458 . . . . 75.24 112.065 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -98.57 142.99 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.989 0.424 . . . . 71.42 111.041 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 t70 63.11 6.87 2.47 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.986 -0.552 . . . . 73.11 111.432 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.403 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 28.7 m-20 56.52 28.67 14.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.151 0.5 . . . . 65.24 111.979 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.2 tp -134.17 -44.01 0.78 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.102 -0.499 . . . . 64.25 111.861 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' A' ' 172' ' ' VAL . 12.7 m -125.24 148.95 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 112.524 0.565 . . . . 74.02 112.524 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -88.17 151.12 22.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.169 -0.469 . . . . 75.4 112.009 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -107.57 140.88 39.9 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.471 -0.786 . . . . 64.12 111.591 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.715 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 47.9 t80 -139.99 105.75 5.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.21 -0.663 . . . . 71.53 109.21 165.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.614 ' HB3' HG22 ' A' ' 168' ' ' THR . 13.1 ptpt -109.93 121.78 46.04 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.797 0.665 . . . . 74.32 112.797 -171.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.9 -152.85 8.64 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.91 -0.586 . . . . 61.22 113.601 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -117.3 174.07 6.34 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.108 0.48 . . . . 64.51 112.097 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.442 ' CE1' ' HD3' ' A' ' 167' ' ' PRO . 68.7 m80 -97.2 110.58 23.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.071 -0.513 . . . . 75.0 110.073 172.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.417 HG23 HD12 ' A' ' 72' ' ' LEU . 18.4 m -135.63 140.77 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.318 0.58 . . . . 64.43 112.18 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 30.2 m -120.0 117.2 52.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.342 0.591 . . . . 62.52 111.338 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.682 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 66.4 ttt180 . . . . . 0 CA--C 1.539 0.531 0 CA-C-N 116.099 -0.501 . . . . 71.03 110.547 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.682 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 27.7 tt0 . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 122.28 1.038 . . . . 61.15 109.299 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 11.0 ptm180 -104.67 140.38 38.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.597 -1.183 . . . . 72.31 111.927 -173.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.94 -131.11 3.72 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.548 -0.834 . . . . 32.4 113.785 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.429 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 32.3 pt -111.09 139.77 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 122.461 -0.435 . . . . 71.41 111.608 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -48.29 -35.76 12.83 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.078 -0.51 . . . . 61.1 112.355 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' A' ' 169' ' ' LEU . 68.4 mt -52.56 -58.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.201 0.524 . . . . 64.13 112.221 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.5 m -75.25 -33.59 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.142 -0.481 . . . . 75.11 111.688 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 64.8 mt -64.98 -34.49 78.57 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.966 0.413 . . . . 73.24 111.037 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -57.55 -48.66 78.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.247 -0.433 . . . . 65.11 111.94 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -99.04 -3.45 34.75 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.325 0.491 . . . . 64.42 112.325 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 59.56 70.86 0.61 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.623 0.725 . . . . 62.51 111.525 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 60.4 mt -98.3 127.78 44.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.667 -0.697 . . . . 74.43 110.951 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.94 143.85 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.66 0.266 . . . . 70.55 110.849 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -84.8 150.91 24.72 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.569 0.7 . . . . 55.5 112.838 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.2 ttm -145.19 138.33 26.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.459 -0.791 . . . . 75.35 110.413 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.526 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 18.0 m-80 -109.77 167.55 10.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.08 -0.509 . . . . 74.34 111.102 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 79.6 m -55.43 -38.92 69.63 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.553 0.945 . . . . 73.4 113.553 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.526 ' CE1' ' HB2' ' A' ' 80' ' ' ASN . 10.8 p90 -65.5 -23.23 66.84 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.654 -0.654 . . . . 73.31 111.406 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -94.13 -32.5 13.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.197 0.523 . . . . 74.32 110.732 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.1 -16.14 38.98 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.606 -0.725 . . . . 60.41 112.31 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.481 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . . . -43.21 -57.55 2.91 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.693 0.627 . . . . 65.44 112.693 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 t -69.92 -27.53 64.85 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 55.23 111.524 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.4 mmt -70.92 -63.36 1.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.535 -0.302 . . . . 65.53 111.637 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.481 ' CE1' ' HA ' ' A' ' 85' ' ' ALA . 5.0 p90 -60.44 -34.3 73.78 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.351 -0.218 . . . . 75.45 111.312 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -58.12 -54.39 47.54 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.935 0.398 . . . . 62.15 111.222 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.96 -35.56 81.58 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.141 0.496 . . . . 61.14 111.059 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.631 ' HE2' ' HG3' ' A' ' 152' ' ' GLN . 56.5 t80 -56.71 -57.02 14.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.765 -0.652 . . . . 73.11 111.043 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 88' ' ' PHE . 48.2 mm -57.83 -37.33 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.768 0.318 . . . . 72.11 111.631 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -60.13 -56.66 18.91 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.005 0.372 . . . . 73.34 112.005 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -72.32 -36.59 68.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.946 0.403 . . . . 75.33 111.835 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.42 ' O ' HG22 ' A' ' 99' ' ' VAL . 55.2 t80 -60.34 -55.34 34.76 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.075 -0.511 . . . . 65.45 111.229 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.1 ttt -54.87 -44.38 73.97 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.172 -0.467 . . . . 65.54 111.317 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -62.89 -46.62 86.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.372 -0.376 . . . . 53.53 111.612 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -63.44 -51.87 63.88 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.686 0.279 . . . . 75.31 111.625 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.487 ' O ' ' SD ' ' A' ' 103' ' ' MET . 32.1 m -64.07 -41.8 93.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.542 0.571 . . . . 71.44 112.542 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.7 mm -66.81 -46.45 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 121.755 -0.591 . . . . 75.33 110.983 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.99 -34.22 75.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.181 0.515 . . . . 73.12 110.993 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -68.93 -57.41 5.54 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.786 -0.643 . . . . 73.44 111.385 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 99' ' ' VAL . 0.2 OUTLIER -66.64 -44.72 81.2 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.007 0.743 . . . . 42.52 113.007 -175.023 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -50.46 -48.19 56.65 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.367 0.506 . . . . 74.53 112.367 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -60.41 -14.64 20.06 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.821 0.674 . . . . 72.35 112.821 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -115.4 -33.65 5.2 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.358 0.599 . . . . 53.03 111.564 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.465 ' O ' HG13 ' A' ' 113' ' ' VAL . 32.6 m-80 -122.13 28.52 7.46 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.665 -0.698 . . . . 72.32 111.886 -173.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.502 HH11 ' HB2' ' A' ' 109' ' ' ASP . 3.3 ppt_? -38.41 -23.81 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.874 1.805 . . . . 71.22 115.874 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.502 ' HB2' HH11 ' A' ' 108' ' ' ARG . 21.3 t70 -63.38 136.85 57.91 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.792 0.724 . . . . 71.02 111.269 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 110' ' ' LYS . 13.0 mptt -68.95 4.64 1.43 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.306 0.854 . . . . 75.45 113.306 -171.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.5 -47.88 6.91 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.996 0.427 . . . . 55.32 110.848 170.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -70.62 -58.09 4.04 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.989 -0.55 . . . . 72.55 112.234 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 107' ' ' ASN . 5.3 m -61.77 -32.54 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.793 0.294 . . . . 51.01 111.793 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -66.96 -43.25 83.6 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.77 0.319 . . . . 74.25 110.98 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -58.71 -51.42 70.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.028 0.442 . . . . 54.32 110.919 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.695 ' HE1' ' HG3' ' A' ' 174' ' ' GLU . 65.1 t80 -56.11 -50.1 72.0 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.003 -0.544 . . . . 65.25 111.148 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -51.57 -47.18 63.57 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.096 -0.502 . . . . 71.3 111.426 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -66.22 -34.64 78.48 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.013 0.375 . . . . 72.21 112.013 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 31.2 mmmt -60.62 -54.48 44.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.1 0.476 . . . . 70.45 111.301 177.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -71.37 -31.71 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.973 0.416 . . . . 72.02 111.128 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -61.48 -48.87 79.1 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.914 0.388 . . . . 72.14 110.927 176.59 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.02 -37.19 93.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.867 -0.682 . . . . 62.42 112.431 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.42 ' NE1' ' SD ' ' A' ' 170' ' ' MET . 51.7 t90 -61.77 -56.45 19.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.38 0.272 . . . . 73.44 111.343 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.468 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 m -63.21 -45.78 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.437 0.532 . . . . 73.53 112.437 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 121' ' ' GLN . 82.8 t -56.6 -46.61 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.852 0.358 . . . . 73.01 111.759 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.2 p -70.7 -38.19 73.64 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.968 0.413 . . . . 72.11 111.262 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.448 HD21 HD13 ' A' ' 155' ' ' ILE . 36.5 tp -67.64 -36.3 80.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.255 -0.43 . . . . 72.41 112.124 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 78.8 mt -80.71 2.29 26.61 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.503 0.557 . . . . 61.04 112.503 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 133' ' ' PHE . . . -66.89 87.07 0.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.408 0.623 . . . . 65.34 110.797 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -62.74 -22.75 66.79 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.841 1.052 . . . . 73.32 113.841 -169.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' O ' ' NZ ' ' A' ' 134' ' ' LYS . 24.8 t70 -58.79 -47.33 85.1 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.084 -0.385 . . . . 63.22 111.958 -173.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -102.49 -38.4 7.57 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.136 0.493 . . . . 71.31 111.122 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.408 ' HD2' HD11 ' A' ' 136' ' ' LEU . 45.3 m-85 -68.5 -5.43 19.45 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.714 0.635 . . . . 63.33 112.714 -176.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.427 ' NZ ' ' O ' ' A' ' 131' ' ' ASP . 23.6 pttm -62.37 -7.1 3.87 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.762 -0.586 . . . . 64.34 110.914 168.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.66 9.31 16.61 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 116.32 -0.4 . . . . 72.32 110.689 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.48 ' CD2' ' HA ' ' A' ' 157' ' ' GLU . 90.8 mt -88.65 162.91 16.06 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.905 0.383 . . . . 74.31 111.49 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.66 137.67 40.3 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.445 -0.343 . . . . 52.53 111.415 175.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.698 ' HB3' HG11 ' A' ' 153' ' ' VAL . 89.0 m-85 -100.08 120.92 40.59 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.727 0.299 . . . . 70.53 110.647 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 52.9 m-85 -122.45 139.97 53.26 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.188 0.518 . . . . 64.31 112.081 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.521 HD13 ' N ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -137.67 147.68 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.092 -0.504 . . . . 75.41 110.013 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.521 ' N ' HD13 ' A' ' 140' ' ' ILE . . . -51.14 126.17 26.34 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.433 -0.413 . . . . 65.41 114.046 -176.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -51.59 -59.67 4.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.844 0.354 . . . . 75.05 111.777 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -60.88 -32.29 71.73 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.865 0.364 . . . . 64.43 111.388 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.08 -53.1 50.79 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.541 -0.3 . . . . 74.04 111.139 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.477 ' HB2' HD12 ' A' ' 140' ' ' ILE . . . -64.53 -20.26 66.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.07 0.462 . . . . 74.33 111.615 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -69.61 -26.03 64.24 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.013 -0.54 . . . . 71.2 110.811 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -113.63 -58.2 0.4 Allowed Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.13 -0.486 . . . . 61.4 112.307 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.86 92.08 8.54 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.175 0.512 . . . . 61.31 110.97 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.68 -2.46 11.82 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.008 -0.542 . . . . 73.23 112.375 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -124.79 27.56 6.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.763 0.425 . . . . 74.15 110.987 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.54 ' HA2' HG21 ' A' ' 9' ' ' THR . . . -57.67 155.27 20.02 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.961 -0.563 . . . . 71.11 114.432 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.631 ' HG3' ' HE2' ' A' ' 91' ' ' TYR . 43.4 tt0 -68.34 128.93 38.37 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.137 0.494 . . . . 55.41 111.653 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.698 HG11 ' HB3' ' A' ' 138' ' ' PHE . 68.7 t -91.66 144.06 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.239 0.542 . . . . 71.14 112.393 -177.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.806 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -102.93 137.12 41.56 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.803 -0.635 . . . . 54.33 110.409 174.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.448 HD13 HD21 ' A' ' 127' ' ' LEU . 59.9 mt -95.27 126.54 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.381 0.512 . . . . 70.34 112.381 -172.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.1 mm -95.83 110.89 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.494 -0.321 . . . . 74.24 110.858 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.48 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 55.2 tt0 -96.22 148.78 22.37 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.842 -0.617 . . . . 73.04 111.934 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -98.23 123.23 42.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.814 -0.63 . . . . 73.3 110.558 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -121.15 114.49 21.51 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.975 0.417 . . . . 72.0 111.609 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.85 106.04 4.03 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.905 0.384 . . . . 72.33 111.116 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.28 107.66 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 120.742 0.306 . . . . 72.22 110.863 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 58.41 17.92 5.19 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.435 0.531 . . . . 73.11 112.435 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 114.86 -21.86 13.3 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.151 -0.547 . . . . 70.04 113.644 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 83.8 m -105.62 129.39 53.88 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.167 0.483 . . . . 62.5 111.355 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 0.1 OUTLIER -73.28 128.27 35.0 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.397 0.617 . . . . 53.14 112.429 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.76 148.66 39.79 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.05 -0.523 . . . . 71.13 110.532 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.442 ' HD3' ' CE1' ' A' ' 34' ' ' HIS . 93.7 Cg_endo -87.12 120.9 1.64 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.425 2.083 . . . . 71.35 112.66 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.614 HG22 ' HB3' ' A' ' 31' ' ' LYS . 39.9 p -117.51 119.0 33.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.215 0.531 . . . . 52.45 111.446 177.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.806 HD11 ' HB1' ' A' ' 154' ' ' ALA . 60.2 tp -76.78 130.43 37.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.084 -0.507 . . . . 64.12 110.59 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.42 ' SD ' ' NE1' ' A' ' 123' ' ' TRP . 50.8 ttm -116.15 124.34 50.08 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 116.178 -0.464 . . . . 63.02 111.385 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.9 mt -135.85 124.73 24.08 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.985 -0.552 . . . . 73.51 111.902 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.499 ' HA ' HG12 ' A' ' 27' ' ' VAL . 41.4 t -71.22 118.7 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 122.205 -0.309 . . . . 74.14 111.439 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -66.99 -19.91 65.8 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.023 0.44 . . . . 60.42 111.558 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.695 ' HG3' ' HE1' ' A' ' 116' ' ' PHE . 4.8 mm-40 -81.76 -8.96 59.75 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.989 0.423 . . . . 70.21 111.134 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.37 -44.29 6.94 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.057 0.456 . . . . 61.11 110.92 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 27.2 pt -100.28 128.85 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.196 0.522 . . . . 74.02 111.163 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 177' ' ' ILE . 1.7 mp -93.34 117.99 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 73.34 110.225 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.45 137.81 32.02 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.793 0.806 . . . . 71.51 112.48 -177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -144.78 99.82 3.41 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.229 -0.896 . . . . 65.41 109.69 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 112.719 0.637 . . . . 72.13 112.719 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptt? . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.61 0.243 . . . . 73.14 110.929 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.6 tp -80.23 132.38 35.85 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.954 0.407 . . . . 70.12 111.437 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.628 ' HB ' HD11 ' A' ' 13' ' ' LEU . 8.6 pt -117.13 121.39 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.239 0.542 . . . . 61.24 111.658 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -101.59 122.31 43.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.083 -0.508 . . . . 71.22 111.112 -174.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.451 ' HG3' HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -111.66 118.73 36.47 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 111.988 0.366 . . . . 64.45 111.988 179.325 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.74 132.62 40.6 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.838 0.351 . . . . 51.31 111.142 172.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 tt -48.23 -47.11 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 112.821 0.674 . . . . 73.14 112.821 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -110.24 -2.59 16.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.411 0.893 . . . . 75.35 113.411 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 9' ' ' THR . 28.5 m -127.21 16.81 7.19 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.195 0.522 . . . . 53.11 111.994 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -50.43 -13.84 0.15 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.282 0.845 . . . . 75.12 113.282 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -53.93 -40.96 67.19 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.887 0.375 . . . . 63.44 111.415 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -85.95 24.94 1.19 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 120.857 0.361 . . . . 73.55 111.38 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.628 HD11 ' HB ' ' A' ' 3' ' ' ILE . 25.0 tp -31.28 120.32 0.23 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.396 0.887 . . . . 62.33 113.396 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -97.85 140.31 32.41 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.181 -0.463 . . . . 63.43 110.785 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.9 p -128.88 96.52 4.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.835 0.35 . . . . 62.4 111.272 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -147.18 -168.85 3.16 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.202 0.525 . . . . 75.41 111.742 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.7 m -127.3 82.97 2.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.172 -0.467 . . . . 42.32 110.663 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -114.16 121.91 35.55 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.136 0.421 . . . . 75.23 112.136 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.31 103.01 1.62 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.664 2.243 . . . . 71.05 112.618 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.57 166.25 11.94 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.308 0.575 . . . . 72.33 112.315 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 25.6 mtpp -123.99 107.81 11.72 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.136 -0.484 . . . . 73.04 111.102 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.406 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 44.0 tp -79.43 94.38 5.54 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.939 -0.476 . . . . 73.03 111.248 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.76 138.88 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.985 0.422 . . . . 72.54 111.683 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.8 t70 57.7 13.38 1.96 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.84 -0.618 . . . . 53.43 112.007 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.406 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 7.9 m-20 63.18 14.6 7.86 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.571 0.348 . . . . 72.13 111.751 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.512 ' HA ' ' HZ2' ' A' ' 173' ' ' LYS . 52.1 tp -114.45 -50.87 2.78 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.966 0.358 . . . . 72.14 111.966 -176.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 172' ' ' VAL . 4.9 m -130.01 152.03 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.207 0.527 . . . . 71.12 112.353 -175.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.441 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 90.4 m-85 -90.95 120.18 31.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.928 -0.578 . . . . 72.34 110.996 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 8.6 pt-20 -99.58 105.64 17.53 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.273 0.559 . . . . 73.51 110.398 172.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.474 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 41.0 t80 -91.64 137.74 32.13 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.027 -0.42 . . . . 73.2 111.169 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.507 ' HE3' HG21 ' A' ' 161' ' ' VAL . 12.1 mmmm -81.82 121.94 27.08 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.15 -0.477 . . . . 73.41 112.047 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.502 ' HA3' HG12 ' A' ' 70' ' ' ILE . . . -121.71 173.18 15.66 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.316 -0.469 . . . . 43.14 113.196 176.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.01 140.55 50.86 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.384 -0.48 . . . . 75.12 111.09 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -73.43 119.77 18.11 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.509 -0.314 . . . . 70.45 110.393 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.7 m -143.77 178.12 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.462 1.125 . . . . 63.31 113.788 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.4 m -123.25 129.99 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.327 -1.306 . . . . 75.41 109.931 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.441 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 112.572 0.582 . . . . 72.42 112.572 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 . . . . . 0 CA--C 1.548 0.902 0 N-CA-C 113.377 0.88 . . . . 61.04 113.377 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -115.97 129.76 56.53 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.4 -0.813 . . . . 61.41 111.879 -169.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' A' ' 72' ' ' LEU . . . 160.19 164.61 15.55 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 119.131 -1.509 . . . . 64.42 114.9 167.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 pt -90.13 138.47 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 122.42 -0.459 . . . . 71.51 110.294 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -48.41 -32.47 7.7 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.775 0.321 . . . . 61.24 111.822 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.502 HG12 ' HA3' ' A' ' 32' ' ' GLY . 35.6 mm -48.48 -58.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.38 0.609 . . . . 72.32 112.056 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 16.4 m -81.14 -28.4 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.993 -0.548 . . . . 73.32 112.136 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' A' ' 67' ' ' GLY . 55.2 mt -71.04 -33.61 70.48 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.953 0.406 . . . . 74.4 111.188 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -58.4 -48.62 80.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.124 -0.489 . . . . 62.45 112.252 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -109.68 13.74 23.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.851 0.315 . . . . 71.4 111.851 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 54.76 71.2 0.55 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.135 0.493 . . . . 73.43 111.916 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 75.3 mt -103.07 125.54 49.85 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 122.2 -0.313 . . . . 73.24 111.248 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.2 145.33 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.75 0.31 . . . . 72.15 110.789 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.24 137.3 35.85 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.026 0.75 . . . . 75.42 113.026 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 78.1 mtp -125.91 145.5 50.24 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.058 -0.974 . . . . 65.05 108.887 169.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.501 ' HB2' ' CD1' ' A' ' 82' ' ' TYR . 16.8 m120 -115.93 -162.28 0.83 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.326 0.584 . . . . 61.23 112.398 -171.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.1 p -100.27 -2.5 33.57 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.148 0.795 . . . . 51.53 113.148 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CD1' ' HB2' ' A' ' 80' ' ' ASN . 24.1 p90 -79.15 -61.4 2.02 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.113 0.782 . . . . 72.42 113.113 -170.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -105.3 -17.51 14.43 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.719 0.771 . . . . 74.43 111.208 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.86 9.53 1.12 Allowed 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.26 -0.882 . . . . 75.54 112.165 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -46.76 -56.91 5.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.193 0.597 . . . . 72.45 112.592 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.0 m -53.35 -36.35 61.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.874 0.369 . . . . 74.33 111.643 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 51.4 tpp -73.88 -63.89 1.12 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.282 0.475 . . . . 73.44 112.282 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -68.47 -29.07 67.62 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.863 -0.523 . . . . 75.52 112.305 -174.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -72.69 -41.81 64.93 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.917 -0.313 . . . . 72.43 110.909 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.71 -39.37 91.26 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.01 0.433 . . . . 74.3 110.325 173.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -57.11 -59.23 5.4 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.996 -0.547 . . . . 72.42 111.775 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.7 tp -62.4 -39.03 82.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 112.263 0.468 . . . . 71.41 112.263 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -71.49 -44.63 64.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 111.99 0.366 . . . . 71.11 111.99 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -63.67 -44.84 92.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.261 0.553 . . . . 74.54 110.287 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.475 ' O ' HG22 ' A' ' 99' ' ' VAL . 48.9 t80 -56.22 -58.07 9.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.505 -0.77 . . . . 74.42 111.283 174.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 53.0 tpp -51.56 -54.07 31.41 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.112 -0.495 . . . . 74.33 111.76 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -57.92 -44.74 87.05 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.962 0.356 . . . . 64.44 111.962 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -72.09 -45.98 58.56 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.368 0.507 . . . . 40.54 112.368 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 95' ' ' PHE . 35.8 m -67.83 -38.05 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 122.186 -0.321 . . . . 42.43 111.615 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.9 mm -63.77 -48.64 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.63 0.253 . . . . 73.44 110.603 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 17.1 t70 -52.51 -47.39 66.65 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.08 0.466 . . . . 71.15 111.873 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -71.15 -42.94 68.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.545 -0.298 . . . . 73.41 111.625 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.549 ' HG3' HG12 ' A' ' 113' ' ' VAL . 12.7 tpt -59.88 -43.18 94.91 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.824 0.305 . . . . 74.34 111.824 -178.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -65.96 -28.55 68.99 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.837 0.31 . . . . 72.24 111.837 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.1 mtmm -69.52 -8.0 43.23 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.251 0.463 . . . . 73.3 112.251 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -99.97 -31.71 11.33 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.301 0.572 . . . . 70.4 110.332 172.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.732 HD21 ' HB3' ' A' ' 111' ' ' ALA . 28.3 t-20 -123.64 -80.34 0.62 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.583 -0.735 . . . . 62.55 111.929 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 73.7 ttt180 72.25 -15.74 0.46 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.915 0.709 . . . . 64.44 112.915 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -80.22 8.89 6.43 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.935 -0.478 . . . . 74.23 111.771 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 57.5 mtmt 60.52 20.23 10.02 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.219 0.533 . . . . 75.0 112.137 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.732 ' HB3' HD21 ' A' ' 107' ' ' ASN . . . -85.42 -62.54 1.51 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.105 -0.498 . . . . 72.34 110.288 172.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -79.52 -46.71 16.87 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.401 -0.363 . . . . 73.3 111.601 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.549 HG12 ' HG3' ' A' ' 103' ' ' MET . 28.0 m -63.81 -29.61 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 113.176 0.806 . . . . 74.12 113.176 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.39 -39.07 68.27 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 122.012 -0.43 . . . . 73.55 110.238 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.64 -47.54 69.28 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.172 -0.467 . . . . 43.13 111.195 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -53.89 -48.86 69.69 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.152 -0.476 . . . . 75.35 110.503 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -54.26 -47.69 72.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.696 -0.684 . . . . 75.22 111.317 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -56.27 -43.33 78.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.235 -0.439 . . . . 73.24 111.123 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -66.81 -60.49 2.62 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.942 0.349 . . . . 65.34 111.942 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -60.94 -35.07 62.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 111.905 0.335 . . . . 72.54 111.905 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.47 ' O ' HG23 ' A' ' 125' ' ' VAL . 58.5 tp60 -67.09 -43.21 83.15 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.687 0.279 . . . . 74.31 110.627 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.23 -35.47 88.1 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.828 -0.701 . . . . 71.45 112.271 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.5 t90 -63.89 -51.7 63.32 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.296 0.238 . . . . 72.25 111.222 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.433 HG22 ' HA ' ' A' ' 121' ' ' GLN . 30.8 m -67.61 -38.03 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 112.306 0.484 . . . . 64.34 112.306 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 121' ' ' GLN . 52.9 t -57.78 -46.55 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.357 0.599 . . . . 74.15 110.854 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.6 m -67.83 -48.95 64.78 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.087 -0.506 . . . . 73.11 111.31 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.22 -41.5 96.97 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.05 0.54 . . . . 61.14 112.447 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.0 mt -84.82 3.31 38.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.243 0.46 . . . . 65.13 112.243 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.46 86.41 0.11 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.337 0.589 . . . . 74.5 110.929 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -54.5 -20.4 7.65 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.62 0.971 . . . . 65.35 113.62 -172.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.81 -47.53 77.71 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.649 0.611 . . . . 64.44 112.649 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -109.91 -30.69 7.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.446 0.535 . . . . 72.23 112.446 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -85.66 -7.11 59.01 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.147 0.795 . . . . 63.41 113.147 -171.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.86 -19.8 66.07 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.726 -0.608 . . . . 73.24 110.538 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -78.95 10.02 3.78 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.002 -0.545 . . . . 70.5 111.873 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.448 HD22 ' HA ' ' A' ' 157' ' ' GLU . 88.0 mt -89.06 161.21 16.67 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.971 0.415 . . . . 74.02 110.948 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.43 137.48 54.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.64 -0.254 . . . . 74.23 111.644 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.665 ' HB3' HG13 ' A' ' 153' ' ' VAL . 56.8 m-85 -107.88 106.96 17.48 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 122.273 -0.267 . . . . 65.54 110.667 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.617 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 39.8 m-85 -102.51 143.67 31.93 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.196 0.522 . . . . 75.4 112.273 -176.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.7 tt -130.5 150.81 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.835 -0.62 . . . . 65.12 110.626 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.44 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -56.21 135.69 49.49 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.352 -0.452 . . . . 61.45 113.669 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.25 -39.62 66.98 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.091 0.472 . . . . 64.11 111.393 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -69.07 -55.92 9.3 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.081 -0.509 . . . . 74.43 111.296 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.07 -25.59 67.05 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.203 0.446 . . . . 43.31 112.203 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.44 -19.03 61.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.75 0.648 . . . . 74.02 112.75 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -70.47 -12.02 61.3 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.225 0.536 . . . . 60.25 111.144 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.41 41.2 2.81 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.369 -0.443 . . . . 62.44 112.967 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.12 -71.72 0.16 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.012 0.434 . . . . 75.23 111.769 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -123.8 -77.39 0.59 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.126 0.488 . . . . 71.51 110.223 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -134.79 -59.98 0.79 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.929 -0.578 . . . . 60.21 110.401 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.445 ' HA2' HG21 ' A' ' 9' ' ' THR . . . 103.28 139.56 10.4 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.294 -0.479 . . . . 73.14 112.837 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -73.73 112.2 9.61 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 122.548 -0.383 . . . . 35.02 111.47 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 138' ' ' PHE . 58.8 t -77.49 88.0 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.648 0.737 . . . . 74.31 110.079 169.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.963 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -79.4 117.53 20.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.534 -0.757 . . . . 70.31 110.471 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.777 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 58.1 mt -88.53 134.73 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.028 0.442 . . . . 52.22 111.991 -172.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.4 mm -103.22 115.48 45.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 116.443 -0.344 . . . . 74.15 111.063 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.448 ' HA ' HD22 ' A' ' 136' ' ' LEU . 38.2 tt0 -108.33 145.4 34.5 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 123.73 0.644 . . . . 74.42 111.831 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -90.2 117.47 28.98 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.06 0.457 . . . . 73.05 110.834 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -132.65 128.8 37.83 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.408 0.521 . . . . 72.31 112.408 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -83.77 116.14 22.56 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.046 -0.525 . . . . 65.01 110.144 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.507 HG21 ' HE3' ' A' ' 31' ' ' LYS . 98.8 t -114.72 105.98 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.472 -0.331 . . . . 62.02 110.483 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 59.81 23.79 12.75 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.292 -0.413 . . . . 73.11 111.615 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.01 -18.91 51.12 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.148 -0.478 . . . . 74.42 113.294 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 28.3 m -82.19 132.72 35.24 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.644 -0.327 . . . . 74.41 111.517 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.23 98.82 11.14 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.548 0.69 . . . . 75.32 111.646 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.92 147.22 48.15 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.103 -0.498 . . . . 75.14 112.09 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.39 120.81 2.18 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.697 2.265 . . . . 64.25 113.008 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.8 p -94.17 129.72 40.66 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.207 0.527 . . . . 74.34 111.187 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.963 HD11 ' HB1' ' A' ' 154' ' ' ALA . 43.7 tp -87.94 123.06 32.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.068 -0.514 . . . . 74.03 111.31 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.777 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 62.8 mtt -92.75 124.07 36.49 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.797 0.332 . . . . 75.21 111.355 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 86.5 mt -132.4 143.39 49.79 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.458 -0.792 . . . . 73.53 109.818 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 175' ' ' ALA . 48.5 t -101.85 122.77 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 122.078 -0.389 . . . . 64.42 111.755 -173.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.512 ' HZ2' ' HA ' ' A' ' 26' ' ' LEU . 22.9 pttm -68.62 -29.37 67.86 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.182 0.438 . . . . 75.12 112.182 -173.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -89.09 5.86 42.54 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.265 0.555 . . . . 63.44 111.36 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.6 ' HB3' ' HB ' ' A' ' 172' ' ' VAL . . . -113.91 -22.96 9.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.899 -0.591 . . . . 72.23 111.278 172.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 172' ' ' VAL . 34.5 pt -129.77 137.15 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.975 0.417 . . . . 42.02 111.198 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.6 mm -103.46 110.87 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.844 0.354 . . . . 73.35 111.489 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -74.15 95.71 2.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.193 -0.458 . . . . 73.23 109.909 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.608 ' HB3' HG13 ' A' ' 3' ' ' ILE . 29.5 tt0 -95.23 119.04 33.06 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.237 0.541 . . . . 75.33 111.37 -174.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 121.434 0.635 . . . . 75.42 112.706 -174.075 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 tpp . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.688 0.28 . . . . 71.01 111.565 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.19 130.09 40.56 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.763 0.315 . . . . 75.44 111.139 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.2 mt -102.66 134.11 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.758 -0.201 . . . . 75.32 111.048 -177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -123.49 141.57 51.87 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.58 0.705 . . . . 74.24 112.282 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.441 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 21.6 ttmm -111.38 110.55 21.06 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.759 -1.109 . . . . 64.34 111.013 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.623 ' HB2' ' H ' ' A' ' 9' ' ' THR . 1.4 m-20 -83.14 149.54 26.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.558 -0.292 . . . . 71.21 110.955 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 175' ' ' ALA . 68.9 mt -61.02 -33.89 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.398 0.618 . . . . 75.24 110.77 173.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -105.14 -29.26 10.49 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.669 0.618 . . . . 72.13 112.669 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.623 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 2.0 m -106.48 11.81 30.29 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.058 0.392 . . . . 71.13 112.058 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.441 ' OD1' ' HG3' ' A' ' 5' ' ' LYS . 17.7 t70 -50.92 -35.93 35.8 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.218 0.451 . . . . 71.03 112.218 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.32 -19.55 35.93 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 111.954 0.353 . . . . 55.33 111.954 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -91.32 -30.11 16.76 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 111.72 0.267 . . . . 75.44 111.72 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.6 tp 40.3 90.8 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.17 0.588 . . . . 61.0 111.787 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 t -103.15 169.5 8.52 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.12 0.785 . . . . 43.22 113.12 -164.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 87.9 p -137.97 150.14 46.76 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.656 -0.702 . . . . 61.22 111.315 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -145.47 175.33 10.41 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.328 -0.396 . . . . 73.11 110.709 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.6 p -133.92 15.66 3.91 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.651 0.612 . . . . 55.41 112.651 -178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 97.6 m-85 -109.92 121.93 40.5 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 120.912 0.386 . . . . 73.01 111.768 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 8.0 Cg_exo -73.43 102.3 1.46 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.87 2.38 . . . . 54.2 113.106 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.1 ptt? -85.89 153.91 21.88 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.354 -0.385 . . . . 63.1 111.588 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 89.6 mttt -99.04 123.9 43.67 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 111.813 0.301 . . . . 75.23 111.813 -174.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 tp -78.44 99.15 6.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.966 0.412 . . . . 42.44 110.949 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -95.71 146.78 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.9 0.381 . . . . 65.45 111.101 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.44 7.76 3.15 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 116.267 -0.424 . . . . 74.32 111.851 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 58.19 21.7 8.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.881 0.372 . . . . 74.25 111.764 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.412 ' O ' ' HG3' ' A' ' 173' ' ' LYS . 40.2 tp -129.46 -43.89 1.26 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.018 0.437 . . . . 70.32 111.718 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 172' ' ' VAL . 13.0 m -134.25 153.34 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.15 0.5 . . . . 72.31 112.288 -175.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.495 ' CE2' ' HB3' ' A' ' 173' ' ' LYS . 95.0 m-85 -91.61 134.47 34.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.238 -0.437 . . . . 72.02 111.105 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 8.7 pt-20 -104.84 131.78 51.9 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.318 0.58 . . . . 71.51 110.81 172.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.571 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 74.7 t80 -130.91 119.07 21.61 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.197 -0.456 . . . . 74.14 111.153 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -101.57 130.67 47.93 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.937 0.399 . . . . 54.04 111.411 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.77 -160.08 10.88 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.354 -0.45 . . . . 71.21 112.785 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -109.26 165.76 11.37 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.439 -0.448 . . . . 63.22 111.761 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -98.34 106.43 18.72 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.406 -0.361 . . . . 64.33 110.614 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.97 159.6 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.141 0.496 . . . . 65.33 111.574 -176.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 5.6 m -127.8 137.59 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.28 -0.418 . . . . 74.53 110.176 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 30.0 ttp180 . . . . . 0 C--O 1.241 0.652 0 CA-C-O 121.573 0.702 . . . . 61.1 112.179 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 43.7 mt-10 . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 121.386 0.613 . . . . 71.24 109.881 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -106.85 148.42 28.56 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.006 -0.543 . . . . 71.14 111.99 -175.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.29 -113.62 1.4 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.935 -0.65 . . . . 64.3 113.294 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.572 HG21 ' HB3' ' A' ' 167' ' ' PRO . 31.4 pt -111.68 132.3 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.194 0.521 . . . . 63.41 112.213 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -51.1 -33.59 26.85 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.015 -0.539 . . . . 72.45 112.109 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.492 HG21 ' HB2' ' A' ' 169' ' ' LEU . 64.5 mt -47.87 -49.56 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 112.329 0.492 . . . . 75.43 112.329 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 23.4 m -85.68 -30.32 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.41 -0.359 . . . . 74.11 111.899 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 66.8 mt -67.82 -49.96 59.37 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.093 0.473 . . . . 75.4 111.211 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -60.85 -36.21 78.54 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.897 -0.592 . . . . 75.42 111.755 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -100.51 8.03 43.75 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.236 0.458 . . . . 61.32 112.236 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 54.89 69.67 0.71 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.673 0.619 . . . . 75.53 112.673 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 73.5 mt -116.61 125.93 52.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.056 -0.52 . . . . 63.52 110.505 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 p -82.58 143.08 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.969 0.414 . . . . 72.55 111.886 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -77.84 129.15 35.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.824 -0.625 . . . . 62.43 112.506 -175.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.5 mmt -136.13 165.22 26.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.984 -0.553 . . . . 72.24 111.169 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -144.91 143.24 30.46 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.276 0.56 . . . . 74.24 111.923 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 21.3 p -40.86 -32.43 0.23 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.753 1.76 . . . . 60.21 115.753 -167.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -51.15 -46.36 61.98 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.86 0.689 . . . . 75.44 112.86 -172.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -103.71 -20.48 13.95 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.007 -0.433 . . . . 62.24 111.551 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.84 -22.32 66.97 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.02 0.378 . . . . 44.33 112.02 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.47 -42.33 54.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.046 0.45 . . . . 72.3 111.312 175.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.9 t -62.83 -42.96 99.95 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.251 0.548 . . . . 65.33 111.233 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.2 ttm -64.31 -43.54 94.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.081 -0.509 . . . . 73.51 110.878 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 91' ' ' TYR . 62.9 m-85 -66.91 -30.49 70.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.998 0.37 . . . . 63.22 111.998 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.8 -53.48 57.37 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.002 0.429 . . . . 71.41 110.488 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.08 -41.24 90.98 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.046 0.45 . . . . 71.15 111.615 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.575 ' HE1' ' HG3' ' A' ' 152' ' ' GLN . 78.7 t80 -56.89 -63.37 1.23 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.04 -0.527 . . . . 74.54 111.602 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.9 mm -57.87 -31.26 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.463 -0.335 . . . . 63.25 111.767 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -56.91 -67.29 0.33 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.055 0.455 . . . . 75.32 111.575 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -63.39 -40.76 98.12 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.175 -0.466 . . . . 63.32 111.102 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.477 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 86.8 t80 -54.94 -55.62 28.7 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.866 -0.606 . . . . 43.12 111.304 178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -55.83 -50.23 71.11 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.883 0.327 . . . . 71.13 111.883 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -62.63 -37.77 87.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.076 0.398 . . . . 75.25 112.076 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -76.07 -46.73 27.63 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.257 -0.277 . . . . 71.44 111.746 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.484 HG12 ' HB3' ' A' ' 174' ' ' GLU . 22.0 m -65.77 -42.55 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 112.085 0.402 . . . . 73.21 112.085 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.1 mm -65.42 -43.53 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 122.228 -0.295 . . . . 54.33 111.071 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.15 -38.9 74.2 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.139 0.495 . . . . 75.31 110.847 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -60.76 -56.59 19.4 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.018 -0.537 . . . . 70.02 111.639 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.637 ' HE2' ' HA ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -67.88 -28.46 67.54 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.127 0.489 . . . . 73.43 111.591 -178.251 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 37.5 tt0 -68.53 -27.2 65.89 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.18 -0.464 . . . . 61.4 111.568 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -72.64 -36.72 68.06 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.902 0.382 . . . . 63.31 111.824 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -86.58 -29.89 22.27 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 111.942 0.349 . . . . 61.01 111.942 -176.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -125.61 -74.92 0.59 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.357 0.502 . . . . 75.5 112.357 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 24.1 ttt180 67.92 -30.73 0.17 Allowed 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 113.02 0.748 . . . . 63.2 113.02 -174.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 111' ' ' ALA . 23.0 t0 -90.94 80.26 5.79 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.652 -0.655 . . . . 70.11 111.925 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.475 ' HG3' ' N ' ' A' ' 111' ' ' ALA . 10.0 ptpp? 50.14 -67.1 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.671 1.588 . . . . 74.2 115.056 169.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 109' ' ' ASP . . . -33.47 -54.51 0.43 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.01 1.115 . . . . 45.23 114.01 -172.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -95.97 -44.88 7.16 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.45 0.537 . . . . 61.32 112.45 -176.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 m -61.53 -37.24 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 112.564 0.579 . . . . 41.53 112.564 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.89 -41.55 87.0 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.081 0.467 . . . . 51.43 110.881 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -64.02 -48.89 74.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.188 -0.46 . . . . 71.42 111.054 176.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -57.85 -48.85 78.58 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.238 -0.437 . . . . 72.04 111.322 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -51.99 -51.71 55.44 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.771 -0.455 . . . . 75.32 109.771 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -57.61 -38.02 74.24 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.143 -0.48 . . . . 74.21 111.298 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 29.7 mmmt -63.52 -62.5 1.63 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.003 0.43 . . . . 72.22 111.81 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.1 tp -69.22 -32.65 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.394 -0.366 . . . . 75.3 111.88 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.411 ' O ' HG23 ' A' ' 125' ' ' VAL . 58.1 tp60 -62.84 -49.39 75.1 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.918 0.39 . . . . 73.52 110.196 175.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.29 -38.23 85.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.88 -0.676 . . . . 51.11 112.556 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 44.3 t90 -60.68 -55.38 33.9 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.306 0.242 . . . . 72.45 111.457 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.7 m -65.85 -40.83 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.079 0.4 . . . . 75.23 112.079 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 121' ' ' GLN . 68.8 t -59.09 -36.11 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.098 0.475 . . . . 62.13 111.223 177.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.5 m -76.51 -47.25 23.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.017 0.437 . . . . 72.43 110.975 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.1 tp -62.2 -36.07 80.79 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.967 -0.561 . . . . 72.4 112.139 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.6 mt -88.56 3.2 51.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.469 0.544 . . . . 74.35 112.469 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.426 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -68.26 81.97 0.24 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.404 0.621 . . . . 43.21 110.911 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -48.07 -45.34 32.35 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.885 1.069 . . . . 63.54 113.885 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -43.31 -46.62 6.42 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.502 0.556 . . . . 64.51 112.502 -171.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.512 ' HG3' ' CD1' ' A' ' 133' ' ' PHE . 2.3 ptp180 -109.74 -42.15 4.35 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.185 0.439 . . . . 70.3 112.185 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.512 ' CD1' ' HG3' ' A' ' 132' ' ' ARG . 52.9 m-85 -71.04 -8.16 51.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.962 0.727 . . . . 73.42 112.962 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -56.01 -22.59 27.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.234 0.54 . . . . 64.23 111.08 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.551 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 58.3 m-20 -76.65 6.05 6.55 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.595 -0.73 . . . . 75.04 112.215 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.8 mt -89.19 148.98 23.34 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.026 0.441 . . . . 73.13 111.579 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.05 146.38 30.2 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.173 -0.467 . . . . 65.11 111.217 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -114.09 125.43 53.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.969 0.414 . . . . 74.02 110.879 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.547 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 58.1 m-85 -126.2 127.95 46.47 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.018 0.437 . . . . 74.33 111.555 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 145' ' ' ALA . 10.3 tt -121.63 152.32 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.341 -0.39 . . . . 71.12 111.176 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.49 136.87 35.48 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 114.142 0.417 . . . . 62.24 114.142 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.05 -41.42 68.1 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.34 0.496 . . . . 54.44 112.34 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.612 ' H ' ' HD2' ' A' ' 143' ' ' ARG . 1.2 mpt_? -80.29 -43.12 21.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.914 0.387 . . . . 71.23 110.975 -177.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.63 -53.49 57.0 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.244 -0.434 . . . . 72.35 111.499 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -59.06 -24.43 62.87 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.492 0.553 . . . . 60.31 112.492 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.72 -29.19 16.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.91 0.386 . . . . 70.22 111.663 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -88.38 -49.32 3.73 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.109 -0.567 . . . . 54.02 113.15 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.75 124.13 10.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.747 0.308 . . . . 61.51 111.22 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -18.41 59.81 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.852 0.358 . . . . 34.35 111.513 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -78.07 44.45 0.48 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.1 0.476 . . . . 53.31 111.29 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.87 179.24 35.37 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.171 -0.468 . . . . 34.5 113.207 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.575 ' HG3' ' HE1' ' A' ' 91' ' ' TYR . 6.9 tt0 -98.43 115.85 29.4 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.09 0.471 . . . . 74.33 111.671 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.2 t -81.05 139.57 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.171 0.51 . . . . 74.1 111.916 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.801 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -97.82 133.45 42.32 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.922 -0.581 . . . . 65.54 110.651 175.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 45.6 mm -86.77 124.74 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.73 0.3 . . . . 53.43 111.504 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.443 HG13 ' CD1' ' A' ' 139' ' ' PHE . 46.5 mm -110.57 106.79 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.273 0.559 . . . . 53.2 112.444 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.519 ' HG2' ' N ' ' A' ' 158' ' ' TYR . 28.4 tt0 -103.1 158.65 16.15 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.277 -0.874 . . . . 75.02 110.148 172.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.605 ' HB2' ' HB3' ' A' ' 165' ' ' GLU . 0.6 OUTLIER -115.83 115.01 25.52 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.476 0.655 . . . . 55.25 111.243 168.167 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.482 HH21 HG21 ' A' ' 168' ' ' THR . 3.5 tpp180 -69.04 141.18 54.89 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.408 -0.814 . . . . 73.2 112.153 -176.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.51 102.97 7.17 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.255 -0.43 . . . . 71.41 111.388 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 83.5 t -111.01 90.79 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.963 0.411 . . . . 70.03 110.625 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 58.28 19.69 6.52 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.058 -0.519 . . . . 65.33 111.833 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 112.3 -23.41 16.03 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 116.265 -0.425 . . . . 71.12 112.653 -175.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 92.8 m -84.26 118.63 24.3 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.067 0.461 . . . . 64.33 110.886 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 26.0 mt-10 -85.34 100.32 11.74 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.007 -0.542 . . . . 75.52 111.236 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 25.2 m -98.4 149.79 36.08 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 111.981 0.363 . . . . 74.21 111.981 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.572 ' HB3' HG21 ' A' ' 68' ' ' ILE . 18.0 Cg_endo -58.88 136.25 72.34 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.69 2.26 . . . . 53.54 114.278 -176.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.482 HG21 HH21 ' A' ' 159' ' ' ARG . 83.2 m -143.27 108.83 5.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.762 -0.654 . . . . 71.51 110.9 176.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.801 HD11 ' HB1' ' A' ' 154' ' ' ALA . 63.5 tp -82.55 145.41 29.76 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.209 -0.45 . . . . 75.02 111.665 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.683 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 64.7 mtt -126.45 126.47 43.83 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.843 0.354 . . . . 71.3 111.462 176.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -134.51 129.94 35.9 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.091 -0.504 . . . . 75.21 111.2 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 174' ' ' GLU . 22.3 t -80.32 126.86 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 O-C-N 122.019 -0.426 . . . . 65.43 111.711 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.495 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -72.29 -14.59 61.79 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.332 0.493 . . . . 75.21 112.332 -179.147 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.541 ' H ' HG12 ' A' ' 172' ' ' VAL . 0.4 OUTLIER -81.07 -11.69 59.45 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.9 0.381 . . . . 72.22 111.229 169.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.442 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -96.95 -39.25 9.46 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.981 0.42 . . . . 62.24 110.804 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 176' ' ' ILE . 29.6 pt -119.88 114.07 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.087 0.47 . . . . 63.24 111.563 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.438 HD13 ' N ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -94.42 130.42 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 109.282 -0.636 . . . . 63.31 109.282 175.611 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.438 ' N ' HD13 ' A' ' 177' ' ' ILE . 1.5 pp20? -94.59 153.0 18.07 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.812 0.815 . . . . 71.13 112.961 -172.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -127.09 99.16 5.58 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.418 -0.81 . . . . 73.41 109.694 173.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 64.0 tttm . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.263 0.554 . . . . 64.31 110.637 179.307 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtm . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.796 0.332 . . . . 71.03 111.233 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 15' ' ' SER . 29.8 tp -109.46 130.72 55.49 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.649 -0.5 . . . . 44.11 109.649 170.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.766 HG13 ' HB3' ' A' ' 179' ' ' GLU . 17.4 pt -117.19 127.79 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.191 0.519 . . . . 63.21 111.607 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -121.8 147.61 45.74 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.96 -0.564 . . . . 71.32 112.104 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.426 ' HE3' ' CG2' ' A' ' 177' ' ' ILE . 20.7 ttpp -124.05 117.24 24.26 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.348 -0.387 . . . . 71.04 111.525 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.79 173.31 6.39 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.031 -0.531 . . . . 64.42 111.362 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.805 HD11 ' HB1' ' A' ' 175' ' ' ALA . 57.7 mt -78.28 -49.59 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.055 0.455 . . . . 70.43 111.619 175.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -93.16 -38.62 11.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.006 -0.543 . . . . 73.33 112.13 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -97.9 17.95 17.0 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.701 -0.682 . . . . 73.54 110.945 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -47.68 -39.9 18.57 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.095 1.146 . . . . 71.24 114.095 -169.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.26 -28.0 62.58 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.124 0.416 . . . . 75.02 112.124 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 35.0 tt0 -89.05 25.11 1.91 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 120.669 0.271 . . . . 74.45 111.509 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.458 HD21 ' HB ' ' A' ' 3' ' ' ILE . 7.8 tt -34.67 122.09 0.52 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.324 0.65 . . . . 75.33 111.698 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t -126.64 179.42 5.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.399 -0.364 . . . . 63.12 111.493 -171.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.478 ' HB3' HG22 ' A' ' 3' ' ' ILE . 83.8 p -124.66 148.04 48.2 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.444 -0.344 . . . . 60.51 111.419 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -138.78 -172.74 3.38 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.514 0.673 . . . . 73.33 111.691 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -149.28 29.31 0.79 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.406 -0.815 . . . . 71.31 111.016 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -90.16 113.05 55.89 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 112.026 0.38 . . . . 64.54 112.026 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.54 77.46 1.74 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.189 1.926 . . . . 71.24 112.32 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.3 mtt -84.76 143.27 29.24 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.075 0.465 . . . . 72.45 111.247 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 27.1 ttpp -99.63 118.58 36.46 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.012 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.4 tp -76.24 135.56 39.67 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.882 0.373 . . . . 64.5 111.021 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.23 134.65 65.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.2 0.524 . . . . 53.32 111.656 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.1 t70 61.9 15.93 7.59 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.464 -0.789 . . . . 72.32 111.951 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 59.0 19.72 7.5 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.002 0.521 . . . . 63.11 112.112 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.1 tp -119.74 -49.72 2.32 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.099 0.407 . . . . 62.52 112.099 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.624 HG12 ' HA ' ' A' ' 172' ' ' VAL . 13.6 m -132.53 149.55 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.581 0.586 . . . . 74.23 112.581 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -86.52 144.43 27.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.262 -0.426 . . . . 70.01 111.065 174.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 16.2 pt-20 -122.1 133.42 54.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.038 0.447 . . . . 73.04 110.489 174.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -137.53 135.48 36.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.833 0.349 . . . . 75.23 110.838 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -92.2 121.54 33.83 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.591 0.589 . . . . 71.14 112.591 -173.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.92 165.51 12.93 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.08 -0.509 . . . . 54.54 112.358 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -121.95 145.01 48.53 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 122.367 -0.49 . . . . 73.23 111.109 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -73.62 109.64 7.28 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.328 0.585 . . . . 75.22 112.04 -175.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.47 HG23 HD12 ' A' ' 72' ' ' LEU . 26.8 m -134.63 166.2 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.246 -0.433 . . . . 72.31 110.474 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.5 m -131.4 150.74 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 122.067 -0.395 . . . . 65.22 111.249 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.672 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 34.9 mmt180 . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 121.498 0.666 . . . . 54.44 112.208 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.672 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 48.2 mt-10 . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.568 0.699 . . . . 73.43 110.08 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -85.79 129.29 34.87 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.149 -0.932 . . . . 74.24 112.194 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.92 -149.74 11.68 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.01 -0.615 . . . . 63.01 112.803 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 pt -111.45 154.11 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 122.601 -0.352 . . . . 53.23 111.573 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -41.27 -48.94 3.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.257 0.465 . . . . 65.25 112.257 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.428 HG21 HD22 ' A' ' 169' ' ' LEU . 56.1 mt -49.6 -55.49 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 112.584 0.587 . . . . 72.3 112.584 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.407 ' HA ' HD12 ' A' ' 76' ' ' LEU . 23.0 m -80.53 -34.76 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.333 0.494 . . . . 75.21 112.333 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.47 HD12 HG23 ' A' ' 35' ' ' VAL . 87.3 mt -71.03 -40.81 71.52 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.979 0.419 . . . . 73.23 111.527 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -64.42 -35.98 82.68 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.909 0.385 . . . . 75.24 111.969 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -101.43 4.81 41.69 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.531 0.567 . . . . 70.25 112.531 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.0 70.33 0.62 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.158 0.504 . . . . 72.42 112.149 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 71' ' ' VAL . 76.5 mt -115.04 135.08 54.61 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.287 -0.415 . . . . 74.31 111.25 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.18 143.25 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.577 0.227 . . . . 72.44 111.211 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 7.9 pt-20 -88.88 134.05 34.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.408 0.623 . . . . 73.23 112.631 -176.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.43 138.09 50.6 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.845 -0.616 . . . . 75.5 110.618 171.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -105.07 144.49 31.81 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.98 -0.554 . . . . 74.12 110.407 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 40.9 t -49.32 -16.68 0.2 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.297 1.591 . . . . 65.31 115.297 -169.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -93.59 -19.37 21.24 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.558 -0.714 . . . . 62.5 112.701 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -83.06 -46.51 12.73 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.283 0.563 . . . . 70.52 111.852 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 87' ' ' MET . 9.9 p-10 -108.17 21.77 16.89 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.601 -0.727 . . . . 71.31 112.163 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.603 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -36.26 -50.13 0.72 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.92 1.081 . . . . 75.11 113.92 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.9 t -73.06 -30.48 63.74 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.951 0.405 . . . . 63.53 111.542 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.581 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 80.2 mtp -67.8 -60.38 2.57 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.197 0.443 . . . . 75.2 112.197 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.603 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 6.1 p90 -63.4 -28.26 69.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.178 -0.609 . . . . 75.22 110.654 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -58.2 -40.35 81.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.12 0.486 . . . . 70.41 110.543 172.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.47 80.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.214 -0.448 . . . . 71.44 111.048 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -54.68 -54.39 42.35 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.156 -0.475 . . . . 74.54 111.225 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.5 -35.1 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.52 -0.309 . . . . 74.52 111.74 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.439 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -60.86 -60.43 3.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.776 0.322 . . . . 75.24 111.488 177.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -64.96 -38.66 91.69 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.064 0.459 . . . . 51.05 111.298 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.688 ' HZ ' HD11 ' A' ' 120' ' ' ILE . 41.6 t80 -57.18 -53.25 60.2 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.052 -0.522 . . . . 64.45 111.838 176.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -61.83 -46.92 87.38 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.845 0.355 . . . . 73.33 111.496 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.44 -36.05 82.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.647 -0.251 . . . . 65.12 111.554 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.54 -52.82 34.32 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.513 -0.312 . . . . 73.32 111.782 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.1 m -58.72 -39.31 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 111.893 0.331 . . . . 63.33 111.893 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.511 HD11 ' HB3' ' A' ' 117' ' ' LYS . 17.6 mm -77.95 -36.44 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.147 0.425 . . . . 74.02 112.147 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -60.97 -39.16 88.52 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.32 0.581 . . . . 75.54 109.952 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -71.79 -70.3 0.34 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.468 -0.787 . . . . 60.03 111.438 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 11.9 tpt -63.01 -43.32 99.11 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.835 0.68 . . . . 74.23 112.835 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.455 ' HA ' HG11 ' A' ' 113' ' ' VAL . 32.1 tt0 -71.95 -10.96 60.52 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.032 -0.417 . . . . 75.23 111.591 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -87.16 -45.16 10.93 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.221 -0.299 . . . . 61.42 111.367 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -80.5 -31.35 37.23 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.933 0.345 . . . . 63.11 111.933 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -96.04 -51.34 4.48 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 122.268 -0.27 . . . . 74.55 111.625 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 74.06 -35.34 0.3 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.954 1.465 . . . . 71.02 114.954 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.612 ' O ' HG22 ' A' ' 113' ' ' VAL . 28.3 t70 -63.19 121.33 13.39 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.648 -0.658 . . . . 73.42 112.28 -172.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.681 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -46.29 -51.16 15.1 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.438 -0.801 . . . . 64.35 113.129 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.473 ' N ' ' HG2' ' A' ' 110' ' ' LYS . . . -70.26 -33.52 71.71 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.085 0.402 . . . . 72.32 112.085 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -77.54 -49.68 14.17 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.032 0.444 . . . . 43.12 110.846 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 109' ' ' ASP . 31.1 m -66.52 -22.59 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 122.058 -0.401 . . . . 64.41 111.073 175.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.58 -50.09 74.25 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.809 0.338 . . . . 53.33 110.322 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.46 -43.81 96.52 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.237 -0.438 . . . . 41.25 111.084 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.413 ' HE1' ' HB3' ' A' ' 174' ' ' GLU . 87.4 t80 -57.73 -58.29 9.02 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.256 -0.429 . . . . 73.41 111.8 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.616 ' HA ' HG22 ' A' ' 120' ' ' ILE . 17.6 ptpt -65.46 -30.96 71.81 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.293 -0.254 . . . . 75.4 111.436 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -58.81 -45.74 89.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.369 0.604 . . . . 74.55 110.501 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -67.44 -57.38 6.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.508 -0.769 . . . . 75.52 111.92 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.688 HD11 ' HZ ' ' A' ' 95' ' ' PHE . 10.5 tp -66.38 -39.56 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 112.257 0.465 . . . . 73.34 112.257 -173.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -73.64 -43.52 59.29 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 122.07 -0.394 . . . . 62.31 110.449 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.0 -34.4 61.86 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.955 -0.64 . . . . 72.21 112.228 174.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -62.85 -57.69 9.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.42 0.288 . . . . 71.21 111.076 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 26.1 m -62.18 -48.88 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 112.414 0.524 . . . . 75.13 112.414 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.03 -29.02 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.788 -0.57 . . . . 74.34 111.952 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.9 t -84.87 -33.85 22.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.846 0.355 . . . . 44.31 111.331 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.473 HD21 HD13 ' A' ' 155' ' ' ILE . 40.2 tp -70.37 -32.76 70.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.218 0.532 . . . . 74.45 111.251 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.6 mt -80.29 2.34 25.01 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.147 -0.478 . . . . 71.34 111.888 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.06 82.39 0.32 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.564 0.697 . . . . 61.04 110.434 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.465 ' NZ ' ' HB3' ' A' ' 130' ' ' LYS . 5.5 ttpm? -65.0 -6.41 8.51 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.716 -0.675 . . . . 74.33 112.72 -170.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.49 -47.23 86.31 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.93 -0.481 . . . . 73.24 111.212 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -108.94 -35.4 6.36 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.039 0.447 . . . . 70.03 111.429 172.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -69.69 -6.65 33.07 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.436 0.532 . . . . 72.12 112.436 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -52.78 -25.76 12.29 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.118 0.414 . . . . 75.41 112.118 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.41 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . 66.9 m-20 -83.33 12.09 5.87 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.211 0.449 . . . . 75.33 112.211 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 81.5 mt -90.28 156.8 18.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.259 0.552 . . . . 72.31 112.093 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.31 126.29 25.98 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.967 -0.56 . . . . 74.23 110.261 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.5 ' HB2' ' CG1' ' A' ' 153' ' ' VAL . 14.0 p90 -116.91 126.78 53.48 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.382 0.61 . . . . 70.4 111.33 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 78' ' ' GLU . 24.5 m-85 -97.95 148.12 23.78 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.706 -0.679 . . . . 71.52 112.18 -172.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 14.1 tt -136.04 150.33 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.716 -0.674 . . . . 74.25 110.592 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.01 140.26 46.73 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.132 -0.556 . . . . 64.13 113.392 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -50.81 -52.9 36.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.854 0.359 . . . . 64.54 111.588 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -54.25 -30.71 51.3 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.169 -0.469 . . . . 74.43 112.149 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.8 -56.49 4.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.489 -0.323 . . . . 73.05 111.266 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.36 -24.21 66.32 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.144 0.497 . . . . 61.22 111.589 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -54.72 -29.23 52.84 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.572 -0.74 . . . . 74.44 112.558 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.5 -34.27 0.1 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.558 -0.83 . . . . 42.11 113.764 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 149' ' ' GLU . . . -56.74 -50.95 70.71 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.47 0.544 . . . . 71.11 112.47 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 148' ' ' ALA . 10.8 pt-20 58.48 -22.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 125.273 1.429 . . . . 71.25 114.362 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 148' ' ' ALA . 20.0 t-20 -88.84 60.76 5.66 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.025 0.916 . . . . 75.01 109.703 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -129.8 172.75 19.96 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.89 -1.05 . . . . 61.13 112.697 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -79.04 144.25 34.84 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.016 0.436 . . . . 64.14 111.396 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.5 ' CG1' ' HB2' ' A' ' 138' ' ' PHE . 37.6 t -114.03 137.14 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.194 -0.457 . . . . 75.2 111.506 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.76 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -104.87 119.76 39.78 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.18 -0.464 . . . . 61.02 110.777 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.473 HD13 HD21 ' A' ' 127' ' ' LEU . 60.7 mt -91.07 138.6 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.159 0.429 . . . . 44.02 112.159 -174.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.1 mm -115.46 120.14 63.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.022 0.439 . . . . 75.11 111.144 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -110.99 157.68 19.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.617 -0.72 . . . . 73.21 111.104 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 135' ' ' ASN . 9.8 p90 -106.89 115.19 29.75 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.187 0.518 . . . . 65.12 111.771 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -115.76 140.04 49.59 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.177 -0.465 . . . . 74.42 111.769 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -102.52 109.41 21.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.505 -0.316 . . . . 72.1 110.385 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 52.7 t -90.39 89.85 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.043 0.449 . . . . 74.15 111.111 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.6 t70 55.38 27.33 9.87 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.866 -0.606 . . . . 74.32 112.308 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 119.23 -1.61 14.44 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.941 -0.647 . . . . 74.43 113.985 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 41.6 m -118.61 121.13 39.44 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 117.397 0.598 . . . . 62.52 111.245 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.25 121.45 26.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.293 0.568 . . . . 73.15 111.796 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.447 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 29.0 m -128.83 137.66 31.46 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 116.202 -0.454 . . . . 74.0 111.873 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 166' ' ' VAL . 5.9 Cg_exo -80.97 118.42 3.39 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.232 2.621 . . . . 72.11 112.845 176.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.3 p -103.95 146.19 29.05 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.29 0.567 . . . . 71.31 112.188 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.76 HD11 ' HB1' ' A' ' 154' ' ' ALA . 69.9 tp -95.47 137.88 33.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.922 -0.581 . . . . 73.05 110.916 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.47 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 25.3 mmt -123.16 124.31 42.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.5 0.32 . . . . 73.24 111.608 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 98.1 mt -139.3 130.21 26.29 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.82 0.448 . . . . 71.5 111.038 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.624 ' HA ' HG12 ' A' ' 27' ' ' VAL . 60.5 t -78.49 121.94 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 112.132 0.419 . . . . 72.2 112.132 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -76.96 -36.8 56.23 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.834 0.349 . . . . 41.13 111.828 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.413 ' HB3' ' HE1' ' A' ' 116' ' ' PHE . 7.0 mm-40 -73.94 6.33 3.44 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.232 0.456 . . . . 61.21 112.232 -172.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.805 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -107.38 -42.75 4.73 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.047 0.451 . . . . 53.32 111.331 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 22.4 pt -96.05 170.21 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.917 -0.583 . . . . 64.32 111.233 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.426 ' CG2' ' HE3' ' A' ' 5' ' ' LYS . 5.2 tp -128.1 111.62 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.669 0.747 . . . . 73.41 111.927 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.2 153.21 22.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.137 -0.938 . . . . 75.11 111.411 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.766 ' HB3' HG13 ' A' ' 3' ' ' ILE . 21.4 tp10 -140.32 136.47 33.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.184 0.516 . . . . 72.42 111.685 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt . . . . . 0 CA--C 1.536 0.423 0 CA-C-N 116.389 -0.369 . . . . 63.11 111.897 -179.366 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.929 0.395 . . . . 60.14 111.791 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.9 tp -134.16 128.41 33.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.522 -0.308 . . . . 72.32 110.225 174.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.574 HG22 ' HB3' ' A' ' 15' ' ' SER . 35.2 pt -111.32 128.09 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 120.9 0.381 . . . . 72.15 111.798 -175.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -124.04 141.69 51.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.16 0.505 . . . . 71.23 112.073 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.65 115.37 30.38 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.389 -0.823 . . . . 75.22 110.356 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.679 ' HA ' HG22 ' A' ' 176' ' ' ILE . 3.9 m-20 -77.14 169.63 17.99 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.274 0.559 . . . . 71.45 112.389 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.434 HG23 ' CD2' ' A' ' 8' ' ' PHE . 10.4 tt -88.54 -31.02 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.029 0.442 . . . . 62.14 111.541 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.566 ' HB2' ' HB2' ' A' ' 152' ' ' GLN . 91.1 m-85 -98.82 -38.25 9.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.219 0.533 . . . . 70.12 111.933 178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.7 p -106.82 21.5 17.42 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.552 0.575 . . . . 73.4 112.552 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 18.1 t70 -45.54 -45.81 13.67 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.053 0.76 . . . . 63.05 113.053 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.43 -26.98 67.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.51 0.672 . . . . 74.22 111.236 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -109.39 24.63 12.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.451 -0.795 . . . . 75.44 111.054 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.411 ' N ' HD23 ' A' ' 13' ' ' LEU . 2.3 pt? -44.35 150.13 0.33 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.808 0.67 . . . . 55.21 112.808 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.5 t -120.8 168.56 11.31 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.621 0.971 . . . . 73.03 113.621 -168.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.574 ' HB3' HG22 ' A' ' 3' ' ' ILE . 61.0 p -133.95 107.06 7.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.924 -1.035 . . . . 54.3 110.69 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.49 ' OD2' ' HD2' ' A' ' 74' ' ' HIS . 2.6 m-20 -120.16 -177.53 3.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.843 0.354 . . . . 70.3 111.578 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.0 m -147.22 83.55 1.56 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.14 0.495 . . . . 54.35 111.243 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.507 ' HB2' ' HE2' ' A' ' 30' ' ' PHE . 85.7 m-85 -135.55 161.73 61.37 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.161 -0.472 . . . . 72.5 111.042 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.4 158.86 40.44 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.532 2.155 . . . . 71.11 112.613 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -144.08 131.17 20.58 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.248 0.547 . . . . 61.34 112.318 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -123.49 97.52 5.43 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.125 -0.488 . . . . 63.42 110.706 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.3 tp -76.93 116.77 17.89 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.48 0.548 . . . . 65.51 112.48 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.1 p -104.64 139.2 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.058 0.456 . . . . 74.43 111.824 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 59.02 9.56 1.29 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.534 0.734 . . . . 72.22 111.783 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.413 ' O ' ' HE3' ' A' ' 173' ' ' LYS . 32.7 t70 55.42 31.75 17.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.763 0.792 . . . . 71.42 110.36 -174.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.1 tp -124.23 -49.8 1.8 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.876 -0.602 . . . . 74.32 111.214 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.493 HG12 HG22 ' A' ' 172' ' ' VAL . 3.2 m -128.68 143.94 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.581 0.585 . . . . 73.44 112.581 -177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE2' ' HB3' ' A' ' 173' ' ' LYS . 60.8 m-85 -86.61 130.74 34.37 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.117 -0.492 . . . . 75.21 111.522 177.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.95 118.44 30.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.02 -0.991 . . . . 71.21 110.002 173.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.507 ' HE2' ' HB2' ' A' ' 18' ' ' PHE . 6.2 m-85 -108.94 119.43 39.53 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.217 0.451 . . . . 74.04 112.217 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -94.61 89.44 5.78 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.048 0.451 . . . . 74.25 111.358 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.87 -157.76 17.43 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 116.007 -0.542 . . . . 40.34 112.881 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -143.06 132.8 23.88 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 122.029 -0.689 . . . . 74.13 111.635 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -72.08 106.89 4.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.582 0.23 . . . . 74.01 110.447 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -134.41 164.44 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.209 0.528 . . . . 74.21 112.222 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 66' ' ' ARG . 29.4 m -138.67 131.88 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.103 -0.499 . . . . 74.44 110.745 175.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 43.5 ttp180 . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 120.877 0.37 . . . . 73.25 111.556 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 1.2 mp0 . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 121.486 0.66 . . . . 75.45 110.983 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.565 ' HA ' HG12 ' A' ' 36' ' ' VAL . 6.2 ttp180 -83.32 110.69 18.33 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.398 -0.819 . . . . 72.41 111.709 177.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.25 -153.98 12.45 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.852 -0.689 . . . . 71.21 112.943 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' A' ' 167' ' ' PRO . 33.6 pt -112.03 150.52 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.224 -0.574 . . . . 74.04 111.799 176.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -38.39 -56.87 1.2 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.65 0.78 . . . . 72.52 112.724 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.4 mt -53.88 -55.16 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.824 0.676 . . . . 71.11 112.824 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.455 ' HA ' HD12 ' A' ' 76' ' ' LEU . 19.4 m -68.38 -35.2 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.147 0.425 . . . . 71.21 112.147 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.42 -47.01 68.36 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.066 0.46 . . . . 72.2 110.852 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -66.64 -44.15 82.75 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.881 -0.6 . . . . 70.43 111.659 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.49 ' HD2' ' OD2' ' A' ' 16' ' ' ASP . 49.2 t-80 -82.14 -6.04 58.89 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.851 0.358 . . . . 74.55 111.188 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.438 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 62.34 70.08 0.59 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.611 0.72 . . . . 55.12 111.865 176.471 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.665 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 71.7 mt -111.8 137.72 49.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.401 -0.818 . . . . 71.42 111.418 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.3 p -91.25 143.54 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.081 0.467 . . . . 73.45 111.563 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -79.44 127.46 32.14 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.078 -0.51 . . . . 75.43 112.308 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 35.3 mtm -131.11 164.92 24.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.167 0.508 . . . . 73.43 110.999 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -142.58 158.88 43.21 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.179 -0.464 . . . . 70.24 111.013 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.8 m -49.71 -27.7 5.12 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.565 0.95 . . . . 62.42 113.565 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -48.27 -41.15 27.0 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.101 0.477 . . . . 74.23 111.244 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -105.3 -38.36 6.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.377 0.608 . . . . 71.33 110.972 174.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -71.9 -13.52 61.68 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.917 0.71 . . . . 50.54 112.917 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.55 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -43.69 -66.1 0.42 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.858 0.688 . . . . 73.44 112.858 -177.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.2 t -71.62 -18.28 62.22 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.245 -0.284 . . . . 74.41 111.487 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.27 -63.54 1.06 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.8 -0.182 . . . . 61.12 111.168 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.55 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 17.7 p90 -59.53 -33.08 70.94 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.854 -0.338 . . . . 74.54 110.717 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -57.23 -47.41 81.41 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.131 0.491 . . . . 72.21 110.964 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.14 -38.45 82.17 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.245 -0.434 . . . . 65.54 111.605 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -65.05 -41.33 95.28 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.669 -0.242 . . . . 73.32 111.358 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 88' ' ' PHE . 35.9 mm -62.84 -37.09 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.965 0.412 . . . . 73.33 110.853 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -58.57 -56.26 24.46 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.161 0.505 . . . . 62.23 110.855 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -59.78 -45.09 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.895 -0.593 . . . . 74.01 111.061 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 175' ' ' ALA . 83.0 t80 -56.96 -61.91 2.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.817 -0.629 . . . . 71.12 111.976 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.47 ' O ' HG22 ' A' ' 100' ' ' ILE . 48.5 mtt -53.62 -50.12 66.38 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 111.899 0.333 . . . . 73.31 111.899 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.13 -41.98 97.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.773 0.321 . . . . 74.43 111.638 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -68.57 -48.19 64.86 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.743 0.306 . . . . 74.11 111.63 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.22 -41.35 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.258 0.466 . . . . 54.04 112.258 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 96' ' ' MET . 10.5 tp -68.27 -37.73 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 122.113 -0.367 . . . . 73.31 110.573 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.618 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 15.4 t70 -54.82 -60.92 2.7 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.131 0.491 . . . . 74.1 110.547 175.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -62.36 -34.55 76.91 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.335 -0.393 . . . . 73.13 111.843 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 10.8 tpt -61.38 -42.34 98.56 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.099 0.476 . . . . 54.13 110.883 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.7 -8.59 58.85 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 111.883 0.327 . . . . 75.53 111.883 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 61.7 mmtt -81.58 -27.69 34.18 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.698 -0.626 . . . . 63.22 111.761 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -102.44 -36.92 8.24 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.694 0.627 . . . . 74.33 112.694 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -98.57 -51.06 4.05 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.872 -0.517 . . . . 75.43 111.096 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.63 -36.86 0.27 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.646 0.98 . . . . 75.12 113.646 167.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -82.79 144.32 30.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.239 0.542 . . . . 75.2 112.432 -173.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.07 -38.27 79.02 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.627 -0.715 . . . . 70.53 112.617 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.25 27.26 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.065 0.394 . . . . 51.41 112.065 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -94.97 -61.05 1.55 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.984 0.421 . . . . 71.33 111.285 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.7 m -60.91 -27.53 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 113.185 0.809 . . . . 61.02 113.185 -173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.24 -38.7 88.52 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.04 0.448 . . . . 73.41 110.567 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.1 -46.22 62.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.199 -0.455 . . . . 70.33 111.235 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -57.16 -52.22 66.17 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.133 0.492 . . . . 74.25 111.332 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -61.1 -29.74 69.94 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.849 -0.614 . . . . 75.11 110.515 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -69.38 -46.91 65.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.222 -0.444 . . . . 71.31 111.635 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -59.61 -51.71 68.64 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.812 0.339 . . . . 64.13 111.895 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -67.0 -33.64 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 120.769 0.318 . . . . 75.02 111.507 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -66.95 -48.61 68.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.911 0.386 . . . . 71.41 110.399 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.63 -35.75 87.07 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.001 -0.619 . . . . 74.5 112.205 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 55.2 t90 -58.3 -57.04 14.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.622 0.369 . . . . 74.3 111.399 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.518 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 m -61.94 -48.2 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.352 0.501 . . . . 74.52 112.352 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.3 -28.92 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 121.912 -0.492 . . . . 64.5 111.896 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.9 m -82.27 -24.87 34.52 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.05 0.452 . . . . 53.25 111.031 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.47 -28.13 22.25 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.973 -0.558 . . . . 71.11 111.828 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.3 mt -79.96 2.43 23.57 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.765 0.654 . . . . 72.21 112.765 -176.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.47 92.11 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.32 0.581 . . . . 74.01 111.173 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -54.64 -43.36 72.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.12 0.785 . . . . 75.22 113.12 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -53.24 -34.87 58.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.351 0.5 . . . . 64.0 112.351 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 132' ' ' ARG . 8.2 mpt_? -102.91 -48.12 4.17 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.26 0.553 . . . . 74.21 111.206 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.468 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 97.6 m-85 -78.3 -6.6 55.55 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.287 0.847 . . . . 73.43 113.287 -171.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -12.02 3.53 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.527 -0.733 . . . . 74.22 111.727 173.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -92.64 18.39 8.8 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.106 0.41 . . . . 55.11 112.106 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 81.0 mt -88.36 144.71 26.23 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.939 -0.476 . . . . 54.12 111.65 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.28 122.21 45.76 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.056 -0.52 . . . . 74.31 110.802 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -97.91 108.6 21.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.855 0.359 . . . . 73.01 111.189 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.665 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 67.3 m-85 -102.88 130.41 49.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.08 0.467 . . . . 74.21 111.666 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.451 HD11 ' HA3' ' A' ' 151' ' ' GLY . 14.3 tt -128.31 155.1 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.084 -0.507 . . . . 75.31 110.9 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.41 143.54 41.44 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.351 -0.452 . . . . 62.33 113.614 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -50.85 -63.76 1.02 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.196 0.443 . . . . 74.4 112.196 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 2.6 mmp_? -49.4 -34.12 15.48 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.23 0.456 . . . . 73.34 112.23 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.654 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -63.88 -56.38 15.78 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.02 0.438 . . . . 43.23 111.732 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.88 -28.89 69.85 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.801 0.334 . . . . 71.4 111.634 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.73 -31.52 63.41 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.104 -0.498 . . . . 64.2 112.148 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.15 -43.93 0.03 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.279 -0.962 . . . . 65.13 114.301 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.654 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -66.29 86.26 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.196 0.522 . . . . 72.24 112.129 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.25 4.22 0.75 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.35 0.5 . . . . 75.41 112.35 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.534 ' O ' ' HB3' ' A' ' 8' ' ' PHE . 3.2 p-10 -91.93 24.08 3.39 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.158 0.504 . . . . 61.04 110.381 170.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.592 ' HA3' ' HB1' ' A' ' 144' ' ' ALA . . . -77.56 134.23 14.32 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 114.232 0.453 . . . . 52.24 114.232 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 8' ' ' PHE . 48.1 tt0 -93.98 134.6 36.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 122.558 0.343 . . . . 65.14 111.005 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 98.7 t -95.01 136.31 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.407 0.521 . . . . 61.43 112.407 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.801 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -103.98 136.21 44.05 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.865 -0.607 . . . . 73.04 110.069 173.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.529 ' HB ' ' HG3' ' A' ' 170' ' ' MET . 62.3 mt -102.53 128.31 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 120.003 -0.679 . . . . 53.34 112.734 -170.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 46.1 mm -102.5 117.63 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.782 0.325 . . . . 54.22 111.49 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -106.74 145.49 31.99 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.252 0.549 . . . . 54.2 112.285 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -77.13 98.14 4.97 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.699 0.761 . . . . 73.34 110.136 171.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.454 ' HB2' ' OG1' ' A' ' 168' ' ' THR . 0.0 OUTLIER -93.43 97.03 10.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.099 -0.501 . . . . 75.32 111.11 -174.244 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 7.4 p-10 -66.99 119.2 11.56 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.162 0.506 . . . . 75.33 111.217 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.6 t -121.53 105.61 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.084 -0.507 . . . . 72.44 110.899 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 53.41 34.62 18.53 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.416 0.524 . . . . 71.33 112.416 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.15 -23.49 27.09 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.284 -0.417 . . . . 53.3 113.759 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 85.8 m -105.88 113.92 27.76 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.502 -0.411 . . . . 54.51 111.757 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 49.4 mt-10 -73.48 110.24 7.61 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.754 0.312 . . . . 55.13 111.156 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.69 140.14 20.82 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 120.747 0.308 . . . . 61.53 111.145 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.435 ' HB2' HG21 ' A' ' 68' ' ' ILE . 73.4 Cg_endo -74.62 114.35 4.01 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.12 1.88 . . . . 63.13 112.704 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 159' ' ' ARG . 23.7 p -118.78 150.86 39.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.228 0.537 . . . . 61.1 111.588 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.801 HD11 ' HB1' ' A' ' 154' ' ' ALA . 38.7 tp -100.4 140.12 35.1 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.044 -0.526 . . . . 62.33 111.025 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.529 ' HG3' ' HB ' ' A' ' 155' ' ' ILE . 22.2 ptm -123.41 134.63 53.94 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 121.132 0.491 . . . . 61.15 111.236 177.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 86.3 mt -141.6 148.31 39.03 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.146 -0.934 . . . . 74.53 111.433 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.493 HG22 HG12 ' A' ' 27' ' ' VAL . 10.7 t -100.96 122.66 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.254 0.222 . . . . 64.44 110.745 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.51 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -74.13 -5.98 44.92 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.793 -0.567 . . . . 62.43 112.04 -177.246 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.484 ' H ' HG12 ' A' ' 172' ' ' VAL . 9.0 mm-40 -74.67 -15.24 60.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.364 0.602 . . . . 75.53 110.08 170.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . . . -99.03 -22.88 15.5 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.701 -0.682 . . . . 75.44 111.67 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 6' ' ' ASP . 40.3 pt -137.13 130.73 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.281 0.562 . . . . 65.41 111.972 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.3 mm -104.42 118.99 52.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.316 -0.402 . . . . 74.25 110.305 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.55 146.09 25.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.426 0.631 . . . . 72.02 112.167 -176.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -131.23 143.89 50.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.985 -0.552 . . . . 75.3 110.994 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 21.0 pttp . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 121.344 0.592 . . . . 74.14 112.014 -175.542 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.895 0.379 . . . . 71.5 111.594 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' A' ' 178' ' ' GLU . 44.1 tp -95.58 131.44 41.78 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.147 -0.346 . . . . 72.54 110.851 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.6 mt -121.15 118.97 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 122.245 -0.284 . . . . 63.45 110.485 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.418 ' O ' HD12 ' A' ' 13' ' ' LEU . 47.1 p90 -116.41 149.27 39.7 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.107 0.78 . . . . 75.04 113.107 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.685 ' HG3' ' HB2' ' A' ' 10' ' ' ASP . 48.0 tttp -137.07 119.0 15.25 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.544 -1.207 . . . . 62.2 111.416 -173.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 2.8 m-20 -68.85 173.5 5.25 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.451 0.644 . . . . 73.14 111.795 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 175' ' ' ALA . 71.6 mt -81.38 -38.78 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.261 0.553 . . . . 72.1 110.474 168.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -108.69 -44.3 4.07 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.909 -0.587 . . . . 73.55 112.526 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -91.72 14.41 15.36 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.861 0.363 . . . . 61.23 111.868 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.685 ' HB2' ' HG3' ' A' ' 5' ' ' LYS . 7.0 p-10 -61.78 -10.47 9.02 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.783 0.66 . . . . 41.44 112.783 -173.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.77 -27.5 51.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.568 0.699 . . . . 63.42 110.192 173.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -93.32 24.74 3.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.07 -0.968 . . . . 75.32 111.868 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 4' ' ' TYR . 62.8 tp -34.15 109.13 0.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.408 0.683 . . . . 74.23 112.291 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.5 m -113.2 140.77 47.67 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.982 0.734 . . . . 63.34 112.982 -169.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.6 p -110.83 105.54 14.41 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.755 -0.657 . . . . 73.41 110.254 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -123.16 179.89 4.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 120.716 0.294 . . . . 72.22 111.47 -173.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.2 t -109.22 -28.59 8.94 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.892 0.701 . . . . 72.03 112.892 -176.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -66.27 118.32 51.99 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 112.203 0.446 . . . . 74.54 112.203 -175.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -91.24 152.83 3.74 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.112 2.542 . . . . 65.42 113.826 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 20' ' ' MET . 0.6 OUTLIER -114.63 165.77 12.43 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.339 -0.392 . . . . 74.24 111.113 178.331 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -100.01 120.72 40.26 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.094 -0.379 . . . . 42.03 110.532 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.1 tp -83.39 120.89 26.45 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.076 0.465 . . . . 64.45 111.22 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.77 149.07 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.286 -0.415 . . . . 72.21 111.103 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.6 t70 62.8 9.11 3.42 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 116.436 -0.347 . . . . 73.15 111.652 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 55.06 23.43 5.21 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.106 0.479 . . . . 64.04 111.739 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.1 tp -134.16 -43.26 0.79 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.264 -0.425 . . . . 74.3 111.917 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.3 155.58 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.032 0.444 . . . . 71.31 112.164 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 170' ' ' MET . 90.5 m-85 -92.88 149.28 21.37 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.41 -0.359 . . . . 63.12 110.752 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -136.42 116.47 13.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.745 0.418 . . . . 74.11 110.652 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.562 ' CZ ' HD23 ' A' ' 169' ' ' LEU . 16.9 p90 -151.13 134.55 16.2 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.082 1.141 . . . . 72.21 114.082 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.796 ' HG3' ' HB ' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -98.88 120.8 39.94 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.574 -0.739 . . . . 74.31 110.798 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.93 -120.25 0.46 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.972 -0.633 . . . . 52.33 113.158 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -150.64 141.43 22.78 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 122.654 -0.321 . . . . 75.33 110.442 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -77.66 106.48 9.49 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.653 0.263 . . . . 73.33 110.957 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.4 m -143.36 171.96 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.455 0.645 . . . . 72.0 112.434 -175.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.96 128.43 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.807 -0.633 . . . . 71.33 110.686 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 65' ' ' GLU . 47.4 ttp180 . . . . . 0 CA--C 1.539 0.519 0 CA-C-O 121.283 0.563 . . . . 60.1 111.411 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 37' ' ' ARG . 48.5 mt-10 . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.788 0.804 . . . . 63.25 110.146 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -84.11 142.54 30.31 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.916 -1.038 . . . . 70.41 111.917 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.41 -138.78 6.48 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.063 -0.589 . . . . 73.02 113.047 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.8 pt -111.16 142.23 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 O-C-N 122.377 -0.484 . . . . 73.32 111.449 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -44.17 -42.52 6.47 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.593 0.59 . . . . 72.04 112.593 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.0 mt -47.75 -52.2 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.107 0.48 . . . . 63.43 112.216 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 26.7 m -83.3 -34.94 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.19 -0.459 . . . . 64.43 112.059 -174.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.84 -44.24 96.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.834 0.349 . . . . 73.51 111.782 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -67.56 -18.41 65.0 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.238 0.458 . . . . 64.43 112.238 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -111.24 7.15 21.04 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.219 -0.301 . . . . 75.31 111.393 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp 50.73 52.53 14.72 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.29 0.636 . . . . 70.21 112.685 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 55.7 mt -91.4 128.16 37.12 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.997 -0.547 . . . . 54.54 110.644 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.8 p -93.18 147.32 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.584 0.231 . . . . 50.15 111.26 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.09 140.19 30.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.718 0.77 . . . . 73.11 112.989 -175.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 65.3 mtm -135.38 166.08 23.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.243 -0.89 . . . . 61.42 109.609 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.405 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 44.5 t30 -133.16 145.45 50.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.346 0.593 . . . . 72.02 111.938 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.421 ' HA ' ' HB2' ' A' ' 84' ' ' ASP . 41.6 t -42.16 -30.44 0.3 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.928 1.455 . . . . 74.43 114.928 -170.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 20.8 p90 -59.96 -32.24 70.63 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.985 -0.447 . . . . 74.42 111.644 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -101.28 -31.25 11.07 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.763 0.316 . . . . 63.14 111.132 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.421 ' HB2' ' HA ' ' A' ' 81' ' ' CYS . 2.0 m-20 -71.78 -12.38 61.27 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.791 0.663 . . . . 71.35 112.791 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.501 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -31.03 -73.64 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.195 1.184 . . . . 64.43 114.195 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.2 m -71.03 -23.18 62.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.022 0.378 . . . . 54.21 112.022 -176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.8 ttm -70.17 -57.3 5.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.62 -0.264 . . . . 62.13 111.58 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.501 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 11.0 p90 -65.22 -26.14 67.99 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.469 -0.492 . . . . 71.22 110.816 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.31 -42.24 99.2 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.02 0.438 . . . . 55.33 110.915 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.22 -36.19 76.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.098 0.475 . . . . 71.21 111.154 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.17 -55.24 26.81 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.029 -0.532 . . . . 73.41 111.728 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.1 tp -60.58 -29.5 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.185 0.517 . . . . 74.22 111.011 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.52 -58.52 8.23 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.819 -0.628 . . . . 75.11 111.063 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.635 ' HA ' ' HD2' ' A' ' 97' ' ' LYS . 68.1 mttm -64.64 -34.21 77.76 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.178 -0.465 . . . . 75.12 111.28 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.554 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 66.1 t80 -56.02 -53.44 56.87 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.79 -0.641 . . . . 73.13 110.889 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -52.45 -46.63 66.54 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.016 0.436 . . . . 70.44 111.038 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.635 ' HD2' ' HA ' ' A' ' 94' ' ' LYS . 61.9 mttm -52.7 -59.31 4.64 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.813 -0.63 . . . . 65.43 111.783 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -68.24 -43.12 78.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.036 0.754 . . . . 74.21 113.036 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.426 HG12 ' HB3' ' A' ' 174' ' ' GLU . 30.7 m -64.11 -45.03 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.048 0.388 . . . . 74.24 112.048 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 mm -69.01 -37.19 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 122.064 -0.397 . . . . 73.12 110.73 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 105' ' ' LYS . 29.5 t70 -59.94 -45.76 91.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.137 0.494 . . . . 74.33 110.455 174.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -64.41 -50.06 69.09 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.929 -0.578 . . . . 74.41 111.936 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 49.7 tpp -70.56 -47.35 60.72 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.011 0.434 . . . . 74.35 112.032 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -73.96 -19.39 60.69 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 122.066 -0.396 . . . . 73.13 111.43 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 101' ' ' ASP . 86.8 tttt -59.6 -55.03 39.58 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.289 0.566 . . . . 75.22 111.647 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -102.44 -37.69 7.91 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.594 0.59 . . . . 62.01 112.594 -174.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -76.63 -53.65 7.74 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.806 0.336 . . . . 74.13 110.749 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 46.11 11.76 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.865 1.432 . . . . 74.33 114.865 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.464 ' O ' HG22 ' A' ' 113' ' ' VAL . 12.6 t70 -77.62 109.21 11.4 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.676 -0.64 . . . . 64.42 110.21 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -54.21 -27.12 32.26 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.146 0.795 . . . . 73.31 113.146 -174.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.02 -37.0 34.99 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.978 0.418 . . . . 44.41 111.344 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -74.82 -53.13 9.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.299 -0.41 . . . . 73.35 111.354 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 109' ' ' ASP . 22.4 m -58.78 -31.31 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 111.991 0.367 . . . . 53.15 111.991 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.61 -36.92 79.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.814 0.34 . . . . 74.54 110.469 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.26 -48.89 71.65 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.439 -0.346 . . . . 64.43 110.855 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -55.94 -52.01 65.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.179 0.514 . . . . 73.24 111.062 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -56.72 -38.61 72.59 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.843 -0.617 . . . . 71.03 111.489 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -66.03 -41.34 91.05 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.012 0.434 . . . . 73.34 111.347 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -66.32 -49.43 67.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.192 -0.458 . . . . 73.51 111.628 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.9 tp -65.93 -34.35 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.804 0.335 . . . . 73.51 111.033 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -64.08 -49.0 73.98 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.874 0.368 . . . . 62.12 110.966 175.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.53 -39.3 92.97 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.047 -0.596 . . . . 71.22 112.527 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 53.5 t90 -61.38 -56.67 17.69 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.331 0.252 . . . . 74.21 111.327 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.43 -41.89 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.645 0.609 . . . . 71.4 112.645 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.5 p -64.03 -33.58 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.89 -0.506 . . . . 70.1 111.861 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.5 t -80.17 -40.43 27.28 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.089 0.471 . . . . 75.52 111.139 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 155' ' ' ILE . 39.1 tp -67.43 -42.28 83.42 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.279 0.474 . . . . 71.12 112.279 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.2 mt -72.5 1.4 8.16 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.435 0.531 . . . . 72.45 112.435 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.1 72.49 0.18 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.523 0.678 . . . . 62.12 110.623 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -59.49 -22.13 61.13 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.622 -0.717 . . . . 65.14 112.319 -174.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.18 -31.03 63.05 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.203 0.525 . . . . 60.4 110.948 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -109.31 -37.31 5.79 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.812 -0.631 . . . . 73.54 111.545 174.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -93.23 -5.73 49.26 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.656 1.354 . . . . 64.21 114.656 -169.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -58.7 -13.56 6.26 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.096 0.862 . . . . 54.2 111.806 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -90.1 24.46 2.47 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.233 -0.44 . . . . 60.11 112.058 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.0 mt -88.36 153.88 20.83 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.0 0.429 . . . . 74.43 111.001 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.668 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -105.18 112.41 25.53 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.884 0.374 . . . . 61.34 111.286 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -98.43 107.18 19.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.906 0.384 . . . . 75.12 110.946 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 59.7 m-85 -97.82 143.53 28.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.161 0.505 . . . . 63.51 112.297 -177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 145' ' ' ALA . 14.3 tt -134.97 151.47 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.929 -0.578 . . . . 73.35 111.06 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.402 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -63.44 150.68 49.28 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 114.478 0.551 . . . . 54.43 114.478 -176.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -47.3 -58.08 4.51 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.295 0.638 . . . . 74.2 112.104 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -65.5 -45.55 83.14 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.868 0.366 . . . . 65.43 111.691 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.54 -38.01 79.91 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.413 0.523 . . . . 64.24 112.413 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.441 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -63.31 -54.5 36.14 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.177 0.513 . . . . 70.43 111.783 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -68.06 -40.53 82.76 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.272 -0.422 . . . . 74.45 111.146 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.2 -20.77 79.6 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.404 -0.426 . . . . 53.14 113.681 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 63.08 21.91 13.14 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.845 0.683 . . . . 73.11 112.845 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -73.45 82.43 1.45 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.655 0.613 . . . . 72.43 112.655 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.6 m120 74.24 -41.91 0.49 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.834 0.854 . . . . 73.24 113.033 172.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.09 78.7 1.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.363 -0.446 . . . . 64.44 114.095 177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -70.6 102.0 2.16 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.224 -0.574 . . . . 63.33 109.699 172.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 96.6 t -86.65 125.01 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 113.239 0.829 . . . . 64.53 113.239 -172.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.579 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -92.86 113.29 25.53 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.703 -0.681 . . . . 73.43 109.669 169.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.494 HD13 HD21 ' A' ' 127' ' ' LEU . 55.5 mt -92.13 112.98 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.384 0.513 . . . . 74.04 112.384 -170.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.668 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 49.2 mm -90.74 106.17 17.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 120.837 0.351 . . . . 61.52 110.637 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -106.92 132.02 53.34 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.688 -0.687 . . . . 75.43 111.279 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -89.43 138.47 31.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.212 -0.449 . . . . 72.25 111.409 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -137.63 119.65 15.45 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.746 0.307 . . . . 70.23 111.533 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -85.78 92.33 8.58 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.574 0.702 . . . . 74.23 111.223 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.45 102.55 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.109 -0.496 . . . . 63.44 110.42 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 58.64 19.27 6.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.241 0.543 . . . . 65.12 111.038 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.47 -12.93 33.19 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.043 -0.526 . . . . 60.35 113.229 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.5 m -84.25 115.58 22.53 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.451 -0.441 . . . . 74.04 111.074 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.42 117.56 15.32 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.359 0.504 . . . . 71.53 112.359 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.796 ' HB ' ' HG3' ' A' ' 31' ' ' LYS . 25.7 m -128.82 112.32 18.84 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 121.012 0.434 . . . . 75.54 111.595 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.559 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 6.9 Cg_exo -75.1 113.63 3.83 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.521 2.147 . . . . 71.55 112.377 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.493 HG22 ' HB2' ' A' ' 31' ' ' LYS . 44.2 p -109.3 159.05 17.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.59 -0.277 . . . . 40.02 111.504 -176.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.579 HD11 ' HB1' ' A' ' 154' ' ' ALA . 23.0 tp -104.73 126.8 52.17 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.9 0.381 . . . . 71.24 111.038 177.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.611 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 48.6 ttm -105.01 126.12 51.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.281 -0.872 . . . . 63.23 110.993 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.479 ' HB3' HD11 ' A' ' 176' ' ' ILE . 94.4 mt -137.03 123.07 20.29 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.034 -0.53 . . . . 62.24 111.36 -178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.554 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 22.6 t -74.85 122.01 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 122.095 -0.378 . . . . 74.22 111.425 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.411 ' HD3' ' HG2' ' A' ' 174' ' ' GLU . 0.0 OUTLIER -69.33 -11.33 60.72 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.893 0.701 . . . . 73.22 112.893 -176.295 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.514 ' H ' HG12 ' A' ' 172' ' ' VAL . 24.1 mm-40 -91.83 -11.18 37.25 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.815 0.341 . . . . 74.13 111.598 174.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.488 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -96.14 -38.44 10.16 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.381 0.61 . . . . 64.3 110.232 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' A' ' 171' ' ' LEU . 32.4 pt -127.45 118.94 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.371 -0.831 . . . . 73.02 109.28 168.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.8 tp -94.6 110.86 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.511 0.672 . . . . 61.13 111.563 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.454 ' HB3' HD11 ' A' ' 2' ' ' LEU . 16.7 mm-40 -79.57 115.81 19.41 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.609 -0.723 . . . . 74.34 110.585 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.43 ' O ' HD12 ' A' ' 2' ' ' LEU . 10.1 tp10 -92.92 116.29 28.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.455 0.645 . . . . 65.32 109.856 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.399 -0.819 . . . . 62.12 112.999 -167.942 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 111.917 0.34 . . . . 73.42 111.917 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 178' ' ' GLU . 38.1 tp -75.22 122.93 24.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.759 0.314 . . . . 61.04 111.261 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.716 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 50.7 mt -97.59 120.79 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.586 0.232 . . . . 73.51 111.016 -174.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 14' ' ' SER . 34.9 p90 -107.85 139.27 42.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.704 0.631 . . . . 75.54 112.704 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.621 ' HG3' ' HB2' ' A' ' 10' ' ' ASP . 52.0 tttp -130.02 122.16 27.87 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.805 -1.089 . . . . 43.32 111.071 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.622 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 33.1 t70 -80.54 173.31 12.72 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.484 0.183 . . . . 75.21 110.552 175.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.5 mt -75.72 -46.23 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.836 -0.54 . . . . 54.01 111.698 176.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -108.49 -41.27 4.88 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.273 0.558 . . . . 74.43 112.122 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.4 16.55 7.37 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.27 0.628 . . . . 64.21 111.804 -175.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.622 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 10.7 p-10 -59.86 -4.26 0.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.952 1.093 . . . . 54.01 113.952 -170.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.53 -19.66 64.97 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.877 -0.514 . . . . 53.53 111.331 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.63 23.35 1.68 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.611 0.244 . . . . 63.32 111.358 170.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.616 HD13 ' HB2' ' A' ' 5' ' ' LYS . 57.2 tp -49.28 104.04 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.516 0.326 . . . . 74.04 110.53 173.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.442 ' HB2' ' CE1' ' A' ' 4' ' ' TYR . 70.0 m -133.51 147.61 51.63 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.223 0.823 . . . . 75.23 113.223 -170.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.2 p -82.51 88.84 6.62 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.632 -0.713 . . . . 53.54 110.568 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -90.11 179.35 5.95 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.766 -0.652 . . . . 70.42 111.855 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.8 p -161.85 25.99 0.12 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.267 0.469 . . . . 72.14 112.267 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -89.69 149.87 43.02 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-O 120.6 0.238 . . . . 72.45 111.625 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.97 72.67 1.53 Allowed 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.804 2.336 . . . . 71.42 113.461 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 55.0 ttp -87.69 115.36 25.08 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.27 -0.423 . . . . 73.53 110.793 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -102.44 159.05 15.76 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.699 0.285 . . . . 63.24 111.67 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 27' ' ' VAL . 47.9 tp -104.86 142.53 34.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.033 0.444 . . . . 60.15 111.408 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.508 HG13 HG23 ' A' ' 27' ' ' VAL . 7.2 p -134.13 141.12 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-N 116.144 -0.48 . . . . 72.43 111.115 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 56.83 23.61 8.27 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.763 0.653 . . . . 74.35 112.763 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 60.91 3.98 0.73 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.041 0.756 . . . . 51.42 113.041 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.521 HD21 HD13 ' A' ' 120' ' ' ILE . 41.0 tp -125.3 -43.56 1.92 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.945 0.72 . . . . 65.21 112.945 -169.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.508 HG23 HG13 ' A' ' 23' ' ' VAL . 1.2 m -123.82 149.4 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.284 0.476 . . . . 43.11 112.284 -175.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.557 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 58.6 m-85 -85.84 147.6 26.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.888 0.375 . . . . 63.23 111.337 176.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.449 ' HB2' HH22 ' A' ' 159' ' ' ARG . 14.9 pt-20 -121.1 137.98 54.41 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.009 -0.541 . . . . 74.44 110.941 176.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -150.75 113.16 4.64 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.404 -0.362 . . . . 75.43 110.119 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -75.07 135.38 41.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.172 0.51 . . . . 62.31 112.331 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.54 133.37 11.43 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.335 -0.46 . . . . 63.21 112.184 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -91.92 152.41 20.07 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.332 0.566 . . . . 74.15 112.173 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -71.11 105.28 3.31 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.568 -0.742 . . . . 65.31 111.636 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.522 HG23 HD12 ' A' ' 72' ' ' LEU . 19.7 m -143.99 -177.97 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.977 0.418 . . . . 75.3 111.595 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.6 m -119.12 145.74 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 112.382 0.512 . . . . 64.02 112.382 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.709 ' HB3' HD22 ' A' ' 72' ' ' LEU . 7.6 tpm_? . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 121.577 0.703 . . . . 74.31 110.807 175.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 33.6 tt0 . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 113.354 0.872 . . . . 73.23 113.354 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -111.2 135.54 51.59 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.4 -0.812 . . . . 75.52 111.862 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' A' ' 72' ' ' LEU . . . 169.56 -170.53 42.74 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.044 -1.074 . . . . 41.14 113.77 169.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.7 pt -103.57 146.65 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.797 -0.237 . . . . 62.32 110.556 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -38.99 -53.15 1.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.997 0.74 . . . . 73.32 112.997 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.609 HG21 HD22 ' A' ' 169' ' ' LEU . 60.7 mt -49.04 -62.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 112.673 0.62 . . . . 62.44 112.673 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 m -66.12 -31.99 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.261 -0.427 . . . . 74.15 112.031 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.709 HD22 ' HB3' ' A' ' 37' ' ' ARG . 76.0 mt -76.59 -33.02 58.45 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.063 0.459 . . . . 64.41 111.39 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -73.29 -42.71 62.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.083 -0.508 . . . . 65.42 111.516 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -94.77 -3.43 49.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 111.782 0.29 . . . . 73.53 111.782 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 65.24 71.63 0.44 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.296 0.57 . . . . 74.3 112.195 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 49.9 mt -108.7 128.51 54.92 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.754 -0.657 . . . . 74.33 110.595 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.4 p -89.57 149.33 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.804 0.335 . . . . 70.21 111.459 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.41 148.83 35.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.401 0.619 . . . . 71.32 112.619 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.72 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 85.4 mtp -140.16 153.09 46.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.425 -0.807 . . . . 74.31 109.956 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.537 ' HB2' ' HE1' ' A' ' 82' ' ' TYR . 84.7 m-20 -133.29 139.74 47.06 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.236 0.541 . . . . 73.24 112.081 -174.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 52.0 t -46.22 -36.72 6.35 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.502 1.297 . . . . 70.11 114.502 -172.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.537 ' HE1' ' HB2' ' A' ' 80' ' ' ASN . 1.3 p90 -63.57 -27.44 69.25 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.487 0.551 . . . . 74.32 112.487 -175.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -102.18 -31.77 10.42 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.452 0.538 . . . . 74.44 112.452 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.464 ' O ' ' HD1' ' A' ' 88' ' ' PHE . 9.8 m-20 -76.57 -5.95 49.85 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.473 0.545 . . . . 74.51 112.473 -174.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.517 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . . . -34.19 -72.76 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.005 1.113 . . . . 52.3 114.005 -172.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.7 t -64.59 -31.84 73.24 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.88 0.372 . . . . 65.52 111.553 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.4 mmt -64.64 -63.89 1.01 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.206 -0.452 . . . . 72.42 112.175 -175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.517 ' HE1' ' HA ' ' A' ' 85' ' ' ALA . 1.8 p90 -70.77 -26.69 63.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.133 -0.354 . . . . 65.31 111.461 -176.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -68.01 -41.35 82.34 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.015 0.436 . . . . 72.43 110.11 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -40.44 81.61 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.85 0.357 . . . . 74.41 111.174 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -61.27 -51.0 70.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.368 -0.378 . . . . 74.15 111.695 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.0 tp -62.69 -32.3 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.821 0.343 . . . . 63.42 111.285 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -68.55 -55.85 10.28 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.727 0.269 . . . . 63.21 111.727 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.71 -37.24 73.17 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.071 0.463 . . . . 74.21 110.677 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.648 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 26.0 t80 -61.32 -54.48 43.36 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.034 -0.53 . . . . 74.0 111.284 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -53.78 -49.6 67.91 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.321 -0.4 . . . . 63.23 111.267 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.1 -38.45 90.77 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.679 -0.237 . . . . 73.42 111.438 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -64.23 -52.09 60.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.691 0.282 . . . . 63.12 111.702 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.3 m -64.01 -42.62 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 111.826 0.306 . . . . 55.05 111.826 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.6 mm -62.98 -45.45 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.851 0.358 . . . . 75.2 110.748 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.622 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 18.0 t70 -56.3 -48.09 77.37 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.293 -0.412 . . . . 74.42 111.634 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -66.67 -29.03 68.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.769 0.319 . . . . 72.21 111.536 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.0 tpt -75.58 -54.45 6.98 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.055 0.455 . . . . 71.05 111.367 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -54.05 -34.04 59.01 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.343 0.497 . . . . 71.15 112.343 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -51.4 -36.85 45.36 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.293 -0.255 . . . . 71.52 111.353 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -116.66 -5.87 11.62 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.257 0.836 . . . . 71.15 113.257 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -141.41 35.26 1.67 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.607 0.595 . . . . 75.14 112.607 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -5.82 1.07 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.749 1.388 . . . . 74.41 114.749 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 111' ' ' ALA . 4.4 m-20 -74.99 76.04 2.2 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.61 -0.681 . . . . 72.43 112.413 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt 37.52 -79.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.168 1.387 . . . . 73.21 114.655 171.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 109' ' ' ASP . . . -51.19 -42.82 61.14 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.059 0.762 . . . . 63.24 113.059 -170.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.22 -56.32 17.63 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.946 0.403 . . . . 75.21 111.882 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.8 m -67.9 -32.42 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.591 0.589 . . . . 70.44 112.591 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.69 -34.58 62.67 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.326 -0.233 . . . . 74.41 111.189 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.34 -45.41 72.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.198 0.523 . . . . 61.21 111.009 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -61.18 -46.72 89.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.193 0.52 . . . . 73.01 110.363 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -59.67 -32.58 70.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.921 -0.581 . . . . 54.32 111.307 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HE2' ' HB2' ' A' ' 118' ' ' LYS . 8.9 tppt? -60.17 -45.44 93.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.171 0.51 . . . . 62.45 110.86 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -68.26 -46.88 69.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.07 -0.514 . . . . 75.55 111.189 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.521 HD13 HD21 ' A' ' 26' ' ' LEU . 29.8 mm -58.97 -43.58 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.768 0.318 . . . . 62.21 111.365 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -63.04 -45.23 93.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.569 0.223 . . . . 73.24 110.719 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.08 -42.6 99.85 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.95 -0.643 . . . . 71.15 112.246 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 40.1 t90 -61.39 -49.94 74.88 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.493 0.317 . . . . 74.31 111.294 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.95 -42.05 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.388 0.514 . . . . 73.2 112.388 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.75 -25.28 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.243 0.544 . . . . 73.22 110.938 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.3 m -86.46 -51.55 6.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.191 -0.459 . . . . 73.34 111.117 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.431 HD11 HG21 ' A' ' 155' ' ' ILE . 27.8 tp -59.55 -35.77 74.89 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.184 0.516 . . . . 74.44 111.864 -177.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.7 mt -85.25 3.71 38.19 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.075 -0.511 . . . . 71.13 112.073 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.498 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -62.45 97.74 0.1 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.207 0.527 . . . . 44.3 110.849 176.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 28.7 ttpp -45.33 -64.51 0.7 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.067 1.136 . . . . 62.04 114.067 -170.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.41 -46.55 85.86 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.238 0.829 . . . . 72.53 113.238 -168.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -73.47 -50.99 18.75 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.359 0.6 . . . . 74.23 111.43 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 30.1 m-85 -82.43 -5.78 58.88 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.848 -0.614 . . . . 70.32 112.653 -173.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 26.1 ttpp -50.01 -22.84 1.73 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.102 0.477 . . . . 72.34 111.683 170.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -82.66 15.07 2.76 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.313 0.486 . . . . 73.05 112.313 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.534 HD21 ' HG2' ' A' ' 157' ' ' GLU . 49.5 mt -89.52 161.72 16.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.32 0.581 . . . . 73.33 112.212 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -123.7 126.33 46.35 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.776 -0.647 . . . . 53.51 111.138 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' A' ' 79' ' ' MET . 43.6 m-85 -96.91 133.55 41.4 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.125 -0.324 . . . . 74.43 110.125 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.443 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 58.2 m-85 -128.74 131.02 47.85 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.084 -0.385 . . . . 72.34 111.561 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.576 HG23 ' HB2' ' A' ' 145' ' ' ALA . 15.4 tt -125.24 148.07 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 120.976 0.417 . . . . 70.33 111.375 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.423 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -57.85 140.88 45.56 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 114.373 0.509 . . . . 64.35 114.373 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -42.03 -54.2 3.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.308 0.643 . . . . 72.25 112.115 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -62.5 -35.71 80.23 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.998 0.428 . . . . 72.54 112.137 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.9 -37.16 48.56 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.146 0.425 . . . . 72.1 112.146 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.576 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -62.81 -56.2 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.932 0.396 . . . . 75.33 111.944 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.09 -21.44 58.94 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.488 -0.324 . . . . 51.12 111.429 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -72.6 -21.87 79.32 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.954 -0.641 . . . . 63.54 112.423 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 61.15 42.05 12.78 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.263 0.468 . . . . 73.54 112.263 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.45 4.35 53.37 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.591 0.589 . . . . 73.51 112.591 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.4 p30 41.91 35.68 0.56 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.344 0.658 . . . . 74.5 112.447 -175.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.68 -135.43 1.01 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.117 -0.492 . . . . 74.14 114.269 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -67.24 104.25 1.43 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.764 0.653 . . . . 73.21 112.764 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.36 118.68 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.215 0.531 . . . . 63.21 110.834 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.687 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -79.86 124.2 28.44 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.949 -0.569 . . . . 65.22 111.209 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 43.3 mm -89.59 120.0 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.673 0.273 . . . . 72.43 111.5 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.3 mm -99.38 107.51 20.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-O 120.971 0.415 . . . . 64.33 111.012 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.534 ' HG2' HD21 ' A' ' 136' ' ' LEU . 0.4 OUTLIER -111.49 137.43 49.31 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.467 -0.788 . . . . 64.45 109.967 -178.613 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -92.19 123.92 35.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.152 0.501 . . . . 75.43 112.061 -174.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.449 HH22 ' HB2' ' A' ' 29' ' ' GLU . 77.8 mtm180 -130.16 154.3 47.66 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.278 0.561 . . . . 74.2 112.193 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -83.2 143.92 30.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.777 0.658 . . . . 74.13 112.777 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.1 t -128.71 87.9 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.749 -0.659 . . . . 74.35 109.65 167.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 48.37 41.92 17.31 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.835 0.68 . . . . 70.05 112.835 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.72 -23.26 22.33 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.294 -0.479 . . . . 73.34 113.21 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 91.7 m -95.52 106.15 18.2 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.486 -0.42 . . . . 74.23 111.352 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.54 112.64 14.53 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.245 -0.434 . . . . 45.34 111.091 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 35.7 m -119.37 141.72 31.2 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 112.083 0.401 . . . . 75.4 112.083 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 166' ' ' VAL . 8.0 Cg_exo -73.64 114.77 4.12 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.752 2.302 . . . . 44.4 112.117 174.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.8 p -109.37 140.79 42.62 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.927 0.394 . . . . 64.4 111.789 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.687 HD11 ' HB1' ' A' ' 154' ' ' ALA . 64.1 tp -77.54 145.16 37.1 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.97 -0.559 . . . . 74.01 111.962 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.492 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 48.1 ttm -130.18 124.49 32.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.766 -0.652 . . . . 73.21 110.909 176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.87 161.23 33.49 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.05 -0.722 . . . . 73.44 109.05 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.648 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 44.1 t -96.39 131.23 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.501 -0.749 . . . . 73.54 112.114 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.557 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 14.2 tmtt? -56.34 -55.69 30.34 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.185 -0.461 . . . . 74.05 111.611 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -75.25 4.6 6.76 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.017 0.377 . . . . 72.03 112.017 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.26 -21.02 17.5 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.261 0.553 . . . . 75.5 110.473 173.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 68.0 mt -118.73 108.97 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.853 -0.612 . . . . 75.41 110.587 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -92.16 113.96 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.118 0.485 . . . . 72.23 110.503 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.488 ' HB2' HD11 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -91.8 152.68 20.02 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.621 0.724 . . . . 75.32 112.771 -174.759 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.716 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 9.3 tp10 -114.83 110.87 20.34 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.581 -0.736 . . . . 73.03 109.336 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 61.9 tttm . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 121.261 0.553 . . . . 73.1 112.302 -171.062 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.696 0.284 . . . . 75.05 111.308 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.7 tp -104.19 147.38 27.52 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.153 0.501 . . . . 70.54 111.203 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.26 141.0 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.545 -0.298 . . . . 72.4 110.565 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -122.92 158.75 29.71 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 121.904 -0.498 . . . . 73.14 111.461 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HB3' HD13 ' A' ' 13' ' ' LEU . 5.4 ptpp? -139.04 111.04 7.27 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.136 -0.483 . . . . 72.43 111.754 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 175' ' ' ALA . 7.0 m-20 -75.81 164.32 26.35 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.241 -0.287 . . . . 75.12 110.791 172.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.1 pt -61.19 -9.76 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 121.03 0.443 . . . . 74.24 111.493 173.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -107.92 -30.5 8.45 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.301 -0.409 . . . . 64.24 111.118 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.547 ' HB ' ' H ' ' A' ' 6' ' ' ASP . 11.1 m -92.63 -13.67 29.25 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.087 0.773 . . . . 71.1 113.087 -171.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.438 ' HA ' ' HB2' ' A' ' 5' ' ' LYS . 4.0 p30 -55.54 -16.93 4.45 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.106 0.78 . . . . 74.15 113.106 -173.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -69.26 -46.28 67.66 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.055 0.391 . . . . 64.4 112.055 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -121.07 -1.24 9.84 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.202 0.815 . . . . 53.14 113.202 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 5' ' ' LYS . 3.7 mm? 64.19 169.44 0.17 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.535 0.939 . . . . 64.43 113.535 173.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.8 m -148.01 136.85 21.87 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.949 -0.569 . . . . 72.34 110.678 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.5 p -115.35 119.27 35.72 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.675 0.62 . . . . 74.11 112.675 -172.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -149.7 -169.6 3.42 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.099 -0.501 . . . . 74.22 111.222 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 t -155.3 91.94 1.38 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.026 0.441 . . . . 74.0 111.435 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -130.6 118.75 18.02 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 116.433 -0.349 . . . . 73.3 111.207 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.81 87.68 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.372 2.048 . . . . 73.03 112.207 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.418 ' HG2' ' HB2' ' A' ' 30' ' ' PHE . 64.7 mtt -93.33 148.04 22.4 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.356 0.598 . . . . 63.11 112.123 -177.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -102.17 113.06 26.0 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.623 -0.717 . . . . 65.13 110.303 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.519 HD21 ' HD2' ' A' ' 173' ' ' LYS . 61.4 tp -74.61 87.84 2.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.159 0.504 . . . . 60.13 110.135 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.79 137.43 21.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.087 -0.506 . . . . 72.32 111.544 -175.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.8 12.49 5.74 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.736 -0.665 . . . . 74.23 111.292 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.437 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 66.4 m-20 54.3 22.02 3.47 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.009 -0.542 . . . . 74.54 111.922 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.2 tp -121.71 -41.04 2.49 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.926 0.393 . . . . 71.52 111.259 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 172' ' ' VAL . 4.2 m -137.58 147.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.1 0.476 . . . . 54.24 111.952 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.565 ' O ' ' HA ' ' A' ' 170' ' ' MET . 70.0 m-85 -85.96 145.05 27.3 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.207 -0.451 . . . . 74.34 110.624 176.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 34.5 tt0 -127.63 135.63 50.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.677 0.275 . . . . 74.43 110.88 176.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.418 ' HB2' ' HG2' ' A' ' 20' ' ' MET . 84.4 t80 -128.96 128.43 43.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.861 0.363 . . . . 73.32 111.548 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HA ' HG22 ' A' ' 168' ' ' THR . 1.8 tmmm? -92.31 121.55 33.92 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.231 -0.44 . . . . 73.01 110.837 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.23 -163.35 13.96 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.308 -0.473 . . . . 32.03 113.089 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -121.12 139.37 53.42 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.316 -0.52 . . . . 75.44 111.512 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -75.27 106.15 6.65 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.879 -0.6 . . . . 74.11 110.663 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.67 160.15 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.1 -0.5 . . . . 63.3 111.054 -177.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.549 HG12 ' HB2' ' A' ' 66' ' ' ARG . 34.1 m -128.77 105.14 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.433 0.635 . . . . 72.21 110.94 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.603 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 97.6 mtt180 . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.187 0.518 . . . . 44.51 111.015 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 45.2 mt-10 . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.755 0.788 . . . . 60.45 110.652 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.549 ' HB2' HG12 ' A' ' 36' ' ' VAL . 33.4 ptt85 -95.3 134.72 37.76 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.727 -0.67 . . . . 74.31 112.672 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.72 -133.82 3.03 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.606 -0.724 . . . . 74.41 112.447 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.481 HD12 HD12 ' A' ' 70' ' ' ILE . 21.4 pt -111.12 131.81 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 122.35 -0.5 . . . . 74.15 110.957 176.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.6 -23.14 15.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 111.858 0.318 . . . . 43.14 111.858 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.481 HD12 HD12 ' A' ' 68' ' ' ILE . 55.7 mt -50.71 -56.23 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.236 0.541 . . . . 65.11 111.591 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.7 m -81.16 -30.61 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.146 -0.479 . . . . 74.0 111.693 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.8 mt -65.02 -35.72 82.09 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.131 0.491 . . . . 75.21 110.863 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.36 -40.99 71.95 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.961 -0.563 . . . . 63.25 111.78 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -100.78 -1.04 35.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.43 -0.35 . . . . 63.43 111.779 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt 53.88 70.55 0.59 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.285 0.564 . . . . 72.1 111.583 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 67.3 mt -100.04 135.74 41.01 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.877 -0.601 . . . . 65.13 111.247 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.27 145.97 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.876 0.37 . . . . 75.41 111.281 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -83.47 136.35 34.33 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.575 0.583 . . . . 74.24 112.575 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.2 mmm -115.82 145.59 42.71 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 116.004 -0.543 . . . . 41.43 110.268 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.429 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 15.6 m-80 -88.86 123.86 33.64 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.634 0.605 . . . . 52.22 112.634 -169.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 44.2 t -54.12 -32.94 56.48 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.136 0.791 . . . . 54.23 113.136 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 4.5 p90 -81.71 -30.73 32.41 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.937 0.399 . . . . 60.24 111.865 -176.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -94.69 -47.32 6.55 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.469 0.544 . . . . 71.31 112.469 -170.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.66 ' HA ' ' SD ' ' A' ' 87' ' ' MET . 23.5 m-20 -81.2 18.96 0.99 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.546 0.573 . . . . 71.1 112.546 -174.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . . . -55.94 -42.59 76.4 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.844 0.354 . . . . 53.31 111.849 177.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.507 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 53.3 m -60.24 -36.57 78.05 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.326 0.584 . . . . 71.41 111.091 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.663 ' N ' ' SD ' ' A' ' 87' ' ' MET . 0.6 OUTLIER -66.04 -38.66 88.93 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.014 -0.539 . . . . 65.0 110.278 176.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.44 ' HD2' ' HA ' ' A' ' 85' ' ' ALA . 32.0 m-85 -69.05 -43.86 73.8 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.928 -0.578 . . . . 74.12 112.274 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 86' ' ' SER . 0.1 OUTLIER -62.56 -36.09 81.55 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.959 0.409 . . . . 73.52 110.893 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.1 -40.11 62.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.066 0.46 . . . . 45.34 111.198 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -61.83 -44.09 97.55 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.164 -0.471 . . . . 72.51 110.735 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.33 -34.35 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.121 -0.491 . . . . 73.13 111.259 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -56.03 -51.5 67.56 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.146 0.498 . . . . 74.22 110.976 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -69.66 -43.03 73.39 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.139 -0.482 . . . . 72.42 110.949 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.466 ' CZ ' HG11 ' A' ' 172' ' ' VAL . 68.9 t80 -52.8 -54.08 39.3 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.146 -0.479 . . . . 64.14 111.559 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 57.0 ttp -54.51 -43.82 72.19 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.076 -0.511 . . . . 62.53 110.99 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -54.78 -57.53 11.16 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.101 -0.5 . . . . 64.31 111.497 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -59.55 -55.81 29.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.616 0.599 . . . . 63.04 112.616 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 95' ' ' PHE . 32.6 m -62.82 -43.38 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.718 0.636 . . . . 73.25 112.718 -174.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.9 mm -74.33 -47.49 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 122.138 -0.351 . . . . 65.23 111.785 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 8.9 t70 -61.07 -38.98 88.14 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.992 0.425 . . . . 64.22 110.845 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -69.94 -41.47 74.53 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.98 0.419 . . . . 74.34 110.923 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 49.4 tpp -61.59 -35.15 77.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.322 0.582 . . . . 75.32 111.002 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 32.2 tt0 -68.05 -15.95 63.82 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.912 -0.585 . . . . 71.02 111.793 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 1.7 mmmp? -81.09 -31.53 34.29 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.764 -0.585 . . . . 73.15 111.87 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -115.5 -36.45 4.28 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.473 0.916 . . . . 74.44 113.473 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -91.37 -76.43 0.45 Allowed 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.471 0.545 . . . . 71.44 112.471 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 104' ' ' GLU . 62.5 mtm-85 67.68 -6.49 0.68 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.863 1.06 . . . . 71.34 113.863 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 113' ' ' VAL . 38.3 t70 -68.59 106.0 2.44 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.033 -0.417 . . . . 73.3 110.61 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -48.91 -37.88 21.13 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.8 0.667 . . . . 75.34 112.8 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.91 -44.06 86.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.822 0.344 . . . . 71.41 111.543 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.6 -54.43 9.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.484 -0.326 . . . . 64.11 111.7 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 109' ' ' ASP . 23.0 m -59.26 -33.24 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 112.092 0.404 . . . . 52.01 112.092 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.96 -36.41 77.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.802 0.334 . . . . 71.2 110.587 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.73 -48.84 73.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.392 -0.367 . . . . 74.44 111.171 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -60.15 -50.32 74.13 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.841 0.353 . . . . 72.5 110.947 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -49.49 -49.26 46.39 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.212 0.529 . . . . 74.25 110.488 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.72 -36.3 82.15 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.789 -0.641 . . . . 51.41 111.566 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -67.01 -47.91 70.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.753 0.311 . . . . 54.44 110.791 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 31.3 mm -65.51 -38.72 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.485 -0.325 . . . . 64.34 111.112 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -58.13 -47.43 83.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.861 0.362 . . . . 72.52 110.679 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.3 -33.74 78.56 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.128 -0.558 . . . . 53.12 112.612 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -60.65 -54.28 47.2 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.574 0.35 . . . . 73.4 111.438 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.76 -46.79 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.699 0.629 . . . . 73.05 112.699 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.6 m -60.26 -33.26 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 122.061 -0.4 . . . . 74.34 111.59 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.7 m -77.08 -44.77 29.39 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.054 0.454 . . . . 64.11 111.002 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.482 HD21 HD13 ' A' ' 155' ' ' ILE . 48.4 tp -66.59 -32.17 73.34 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.058 -0.519 . . . . 74.04 112.207 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.7 mt -91.52 1.77 56.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.452 0.538 . . . . 71.3 112.452 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.6 95.81 0.08 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.346 0.593 . . . . 70.12 111.014 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.708 ' H ' ' HD2' ' A' ' 130' ' ' LYS . 2.5 mptp? -58.18 -33.11 68.88 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.17 0.804 . . . . 62.13 113.17 -168.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.51 -47.61 38.76 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.003 0.742 . . . . 64.15 113.003 -172.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 132' ' ' ARG . 0.4 OUTLIER -111.11 -26.32 9.28 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.633 0.605 . . . . 70.22 112.633 174.632 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.421 ' HD2' HD11 ' A' ' 136' ' ' LEU . 88.8 m-85 -83.19 -5.82 59.26 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.406 0.521 . . . . 75.02 112.406 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.92 -24.77 54.85 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.457 0.646 . . . . 72.31 110.501 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -78.21 13.41 1.5 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.694 -0.685 . . . . 72.42 112.232 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.421 HD11 ' HD2' ' A' ' 133' ' ' PHE . 77.8 mt -88.11 161.99 17.0 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.431 0.634 . . . . 74.43 111.799 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -134.33 122.35 22.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.706 -0.679 . . . . 73.32 110.362 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.42 ' HB3' HG13 ' A' ' 153' ' ' VAL . 82.9 m-85 -105.36 110.8 23.28 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.955 0.407 . . . . 74.23 110.82 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 80.3 m-85 -98.98 147.18 25.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.471 0.545 . . . . 73.25 112.471 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 12.4 tt -147.22 155.77 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.028 -0.533 . . . . 73.21 110.827 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.64 146.11 34.99 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.184 -0.532 . . . . 72.23 113.689 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -54.73 -62.85 1.39 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.105 0.409 . . . . 74.31 112.105 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -61.3 -28.6 69.31 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.898 0.38 . . . . 74.44 111.259 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.597 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -63.62 -53.73 46.92 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.037 0.446 . . . . 74.01 111.304 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.46 -19.13 62.26 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.128 0.49 . . . . 71.44 111.643 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.5 -40.65 34.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.166 -0.47 . . . . 70.32 111.596 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.21 42.02 0.09 OUTLIER Glycine 0 CA--C 1.529 0.953 0 C-N-CA 120.606 -0.807 . . . . 63.22 113.866 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.597 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -154.43 88.2 1.21 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.078 0.466 . . . . 55.25 111.235 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.16 -1.75 11.05 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.38 0.882 . . . . 62.51 113.38 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.36 57.79 3.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.485 0.66 . . . . 74.31 110.392 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -130.87 149.53 19.14 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.705 -0.679 . . . . 71.15 113.492 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -83.72 144.33 29.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.904 0.383 . . . . 73.51 111.477 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 138' ' ' PHE . 22.1 t -88.86 115.15 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.329 0.585 . . . . 72.4 111.479 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.32 109.38 15.77 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.695 -0.684 . . . . 72.33 110.901 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 52.5 mt -86.48 124.84 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.573 0.225 . . . . 64.24 111.272 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 169' ' ' LEU . 48.6 mm -118.05 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 111.967 0.358 . . . . 74.21 111.967 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.498 ' HG2' ' HE1' ' A' ' 170' ' ' MET . 7.3 pt-20 -130.58 158.26 40.48 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.106 0.479 . . . . 72.22 111.273 175.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -78.05 108.8 11.59 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.066 0.46 . . . . 71.23 111.552 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 159' ' ' ARG . 5.6 tpp180 -104.51 128.81 52.53 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.432 -0.349 . . . . 74.25 111.682 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.71 111.24 14.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.735 0.302 . . . . 75.42 110.434 173.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.05 88.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.158 0.504 . . . . 32.54 110.24 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 54.79 33.86 20.59 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.721 -0.672 . . . . 62.0 112.104 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 113.37 -24.74 12.0 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.059 -0.591 . . . . 61.43 113.403 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.479 HG22 HG13 ' A' ' 166' ' ' VAL . 89.8 m -97.31 106.54 18.88 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.438 -0.448 . . . . 74.11 111.044 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -80.54 108.26 14.03 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.272 -0.422 . . . . 71.23 111.636 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 164' ' ' THR . 25.0 m -128.23 142.56 44.97 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 120.908 0.385 . . . . 50.25 111.65 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 17.4 Cg_exo -68.56 119.15 6.16 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.801 2.334 . . . . 72.31 112.921 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 31' ' ' LYS . 38.2 p -107.52 163.68 12.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.983 0.42 . . . . 71.41 112.039 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 51.9 tp -102.06 138.52 38.91 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.604 0.594 . . . . 73.25 112.604 -175.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.565 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 1.2 mpt? -122.87 136.79 54.99 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.418 0.525 . . . . 74.03 112.418 176.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.9 mt -136.81 148.42 47.16 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.57 -0.741 . . . . 73.35 110.08 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.524 ' O ' HG22 ' A' ' 176' ' ' ILE . 58.6 t -87.15 127.46 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.744 0.646 . . . . 55.43 112.744 -173.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.519 ' HD2' HD21 ' A' ' 22' ' ' LEU . 57.4 tttm -52.78 -54.79 28.96 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.81 0.671 . . . . 71.41 112.81 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.08 12.21 0.58 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.818 0.673 . . . . 72.32 112.818 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -114.35 -51.51 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 61.54 109.838 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 172' ' ' VAL . 4.1 tt -102.96 108.97 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.611 -0.722 . . . . 63.23 111.699 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.5 mm -101.35 142.37 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.315 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.13 141.91 50.76 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.249 0.547 . . . . 74.53 112.254 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -135.46 104.11 5.72 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.764 -0.653 . . . . 72.4 110.124 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 121.366 0.603 . . . . 71.11 112.4 -176.234 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.714 0.292 . . . . 73.24 111.091 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 180' ' ' LYS . 21.5 tp -95.38 124.09 39.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.083 -0.34 . . . . 71.14 110.083 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 179' ' ' GLU . 53.5 mt -105.72 129.22 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.497 0.189 . . . . 72.04 111.385 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -122.78 144.67 49.03 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.322 0.582 . . . . 62.24 112.343 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.695 ' HB3' ' HB ' ' A' ' 177' ' ' ILE . 23.7 ttmm -138.55 111.26 7.65 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.804 -0.634 . . . . 64.25 110.903 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.571 ' HA ' HG22 ' A' ' 176' ' ' ILE . 5.6 t70 -83.03 166.16 19.02 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.564 0.346 . . . . 71.23 111.293 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 pt -81.23 -18.18 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 113.069 0.766 . . . . 74.51 113.069 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.62 -42.86 7.46 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.069 0.461 . . . . 74.24 111.555 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.558 HG22 ' HB3' ' A' ' 6' ' ' ASP . 15.2 t -103.85 19.65 19.56 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.998 -0.546 . . . . 64.01 112.092 -176.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 12.4 p-10 -46.06 -40.47 10.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.748 1.018 . . . . 71.14 113.748 -172.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -53.07 -34.76 57.99 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.094 0.473 . . . . 64.45 111.962 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.35 26.5 0.65 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.803 0.668 . . . . 75.32 112.803 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.668 HD13 ' HB2' ' A' ' 5' ' ' LYS . 69.4 tp -32.11 109.28 0.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.286 0.634 . . . . 72.22 112.014 174.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -131.15 -175.88 3.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 111.873 0.323 . . . . 73.24 111.873 -172.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.0 p -150.33 144.28 25.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.17 0.804 . . . . 74.55 113.17 -174.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -144.88 -157.7 0.82 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.736 -0.666 . . . . 75.43 109.963 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.3 t -148.45 86.49 1.54 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.932 -0.48 . . . . 64.11 112.177 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -138.25 101.95 8.26 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.177 -0.465 . . . . 74.21 111.192 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.82 142.76 98.59 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.191 2.594 . . . . 64.02 114.324 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.0 ptp -146.37 161.31 40.64 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.859 -0.61 . . . . 63.12 111.003 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 18.2 ptpt -99.5 158.75 15.52 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.585 0.231 . . . . 74.22 111.061 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.7 tp -107.09 110.45 22.56 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.91 0.385 . . . . 62.25 111.224 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -104.02 145.5 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.032 0.444 . . . . 44.14 111.568 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 63.93 10.55 5.36 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 116.112 -0.495 . . . . 55.12 112.136 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 60.87 12.11 3.64 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.864 0.466 . . . . 74.21 111.875 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.5 tp -127.52 -43.16 1.6 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.938 0.399 . . . . 73.11 111.733 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 172' ' ' VAL . 17.0 m -127.71 148.8 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.254 0.55 . . . . 75.11 112.352 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -86.97 134.37 33.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.293 -0.412 . . . . 62.33 111.132 174.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 36.3 tt0 -103.92 108.07 19.23 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.062 0.458 . . . . 72.0 110.257 174.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.615 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 31.6 t80 -90.37 127.61 36.23 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.247 -0.283 . . . . 71.05 110.335 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.503 ' HD3' ' H ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -74.32 131.12 40.86 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.47 0.652 . . . . 74.23 112.059 -176.618 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.483 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -140.08 174.34 22.5 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.726 -0.67 . . . . 71.2 112.494 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HG3' HG13 ' A' ' 35' ' ' VAL . 16.4 ptpt -151.92 166.28 31.96 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.793 0.664 . . . . 72.41 112.793 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -71.51 106.6 4.04 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.082 -0.963 . . . . 75.3 110.799 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.452 HG23 HD12 ' A' ' 72' ' ' LEU . 31.5 m -138.06 154.58 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.21 0.529 . . . . 63.21 111.788 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.459 HG12 ' HG3' ' A' ' 66' ' ' ARG . 35.1 m -143.05 142.55 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.317 -0.401 . . . . 74.44 111.12 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 5.5 ttm180 . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 120.843 0.354 . . . . 61.15 110.954 174.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 26.3 tt0 . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 121.869 0.842 . . . . 70.33 110.694 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HG3' HG12 ' A' ' 36' ' ' VAL . 11.3 ttm180 -92.5 133.69 35.68 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.15 -0.932 . . . . 74.32 110.606 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.35 -135.78 4.11 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 119.63 -1.271 . . . . 22.11 114.422 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' A' ' 167' ' ' PRO . 12.5 mt -110.27 141.88 24.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.553 -0.324 . . . . 63.52 111.581 -173.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -47.9 -38.04 15.55 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.871 0.367 . . . . 60.31 111.321 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.596 HD13 ' HB2' ' A' ' 169' ' ' LEU . 63.6 mt -60.75 -54.72 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.097 0.475 . . . . 74.24 112.185 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -72.48 -38.3 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.797 -0.638 . . . . 74.45 112.124 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.576 HD22 ' HG2' ' A' ' 65' ' ' GLU . 47.8 mt -68.54 -43.21 77.19 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.148 0.499 . . . . 73.34 110.529 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -54.92 -42.58 72.39 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.939 -0.573 . . . . 63.14 112.09 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -98.84 1.54 45.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.741 0.645 . . . . 75.31 112.741 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.406 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 3.6 mppt? 54.07 69.05 0.76 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.318 0.58 . . . . 62.14 111.46 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 69.5 mt -106.66 137.41 44.74 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.964 -0.562 . . . . 70.41 110.725 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -88.27 151.55 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.109 0.48 . . . . 75.52 111.717 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.0 131.36 44.94 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.206 -0.906 . . . . 72.2 113.374 -175.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.41 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 83.5 mtp -138.6 153.68 48.66 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.931 -0.577 . . . . 73.03 109.946 170.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.46 168.16 28.21 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.168 0.803 . . . . 75.52 113.168 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -36.97 -55.85 0.9 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.71 1.745 . . . . 62.31 115.71 -169.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.462 ' CE2' ' HG2' ' A' ' 83' ' ' GLU . 43.8 p90 -56.96 -31.57 65.15 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.983 0.734 . . . . 75.44 112.983 -170.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.462 ' HG2' ' CE2' ' A' ' 82' ' ' TYR . 58.3 mm-40 -92.38 -44.54 8.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.158 0.504 . . . . 73.55 111.107 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 3.2 m-20 -67.58 -17.95 64.82 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.739 1.014 . . . . 63.42 113.739 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -43.87 -60.98 1.59 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.022 0.439 . . . . 74.12 111.287 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.9 m -72.54 -27.57 62.31 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.349 -0.387 . . . . 73.33 111.677 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.71 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 58.6 tpp -63.28 -65.92 0.62 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 111.495 0.183 . . . . 74.12 111.495 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.477 ' HA ' ' HB3' ' A' ' 91' ' ' TYR . 13.6 p90 -64.31 -22.75 67.06 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 122.12 -0.362 . . . . 74.33 111.38 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -60.65 -55.52 32.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.867 0.365 . . . . 73.32 110.858 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.7 96.26 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.044 0.45 . . . . 74.42 111.292 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.477 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 6.8 t80 -57.36 -55.86 29.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.829 -0.623 . . . . 72.41 111.348 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.7 -32.7 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.779 0.323 . . . . 74.23 111.542 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -65.82 -54.55 25.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.997 0.427 . . . . 75.13 111.073 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -63.77 -41.19 98.02 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.153 0.502 . . . . 70.41 110.532 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CE1' ' HB2' ' A' ' 175' ' ' ALA . 17.8 t80 -55.04 -58.35 7.99 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.852 -0.613 . . . . 74.43 111.647 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.452 ' O ' HG22 ' A' ' 100' ' ' ILE . 46.8 ttp -50.3 -52.01 40.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.019 -0.537 . . . . 61.44 111.559 -177.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -63.52 -50.49 69.39 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.716 0.293 . . . . 72.31 111.436 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -57.31 -50.64 72.28 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.264 0.468 . . . . 73.01 112.264 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 95' ' ' PHE . 35.1 m -69.44 -40.35 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.58 0.585 . . . . 75.23 112.58 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 96' ' ' MET . 10.9 tp -74.05 -42.11 52.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 120.791 -0.364 . . . . 71.35 111.18 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.12 -29.51 69.81 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.097 0.475 . . . . 62.43 110.282 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -76.09 -65.26 0.94 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.822 -0.626 . . . . 64.3 111.48 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.0 ttt -64.43 -45.26 88.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.764 0.653 . . . . 75.54 112.764 -171.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.743 ' HA ' HG11 ' A' ' 113' ' ' VAL . 36.8 tt0 -68.52 -11.79 60.36 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.235 0.54 . . . . 72.32 111.289 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -82.32 -42.49 18.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.038 -0.528 . . . . 73.41 111.756 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -89.66 -37.19 14.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.514 0.561 . . . . 72.33 112.514 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.455 ' O ' ' HD3' ' A' ' 108' ' ' ARG . 26.8 t-20 -76.15 -60.34 2.37 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.228 -0.295 . . . . 54.12 111.507 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 71.3 -21.69 0.2 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.155 1.169 . . . . 64.14 114.155 175.138 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.511 ' O ' HG22 ' A' ' 113' ' ' VAL . 40.8 m-20 -78.87 129.69 34.83 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.624 0.726 . . . . 64.23 112.595 -176.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -64.1 -8.04 10.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.245 -0.888 . . . . 71.55 112.459 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.03 -41.52 50.64 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 111.878 0.325 . . . . 75.4 111.878 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -95.34 -62.13 1.35 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.65 0.611 . . . . 70.22 112.65 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.743 HG11 ' HA ' ' A' ' 104' ' ' GLU . 27.3 m -57.82 -36.73 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.089 0.774 . . . . 71.41 113.089 -172.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.91 -45.75 87.92 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.83 0.348 . . . . 74.14 110.498 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.06 97.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.347 -0.388 . . . . 74.33 111.463 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.405 ' CE1' ' HG3' ' A' ' 174' ' ' GLU . 48.9 t80 -63.24 -57.62 9.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.309 -0.405 . . . . 73.2 111.373 176.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -52.6 -46.03 66.8 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.418 0.628 . . . . 70.14 111.053 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.53 -40.24 96.14 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.43 -0.805 . . . . 73.42 111.963 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -68.78 -50.6 48.98 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.892 0.377 . . . . 74.14 110.915 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.97 -33.49 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.856 0.36 . . . . 73.31 111.205 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -65.03 -42.27 94.5 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.096 0.474 . . . . 72.55 110.534 174.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.27 -39.26 97.48 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.895 -0.669 . . . . 62.41 112.024 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 49.2 t90 -58.63 -53.92 52.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.531 0.332 . . . . 50.52 111.224 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.4 m -64.19 -46.26 93.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 112.657 0.614 . . . . 72.33 112.657 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.81 -31.53 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.882 -0.511 . . . . 72.13 111.669 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.8 t -78.19 -42.99 29.78 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.208 0.528 . . . . 64.14 111.039 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.27 -31.0 71.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.037 -0.529 . . . . 73.33 112.309 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 71.0 mt -87.2 3.22 47.36 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.031 0.382 . . . . 75.51 112.031 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.72 103.79 0.15 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.062 0.458 . . . . 61.54 112.223 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -62.06 -24.58 67.17 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.897 0.703 . . . . 73.2 112.897 -174.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -80.31 -40.07 27.48 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.339 0.496 . . . . 73.31 112.339 -175.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -100.31 -60.43 1.53 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.218 0.532 . . . . 74.53 112.242 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.412 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 16.5 m-85 -74.11 -5.99 44.97 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.667 0.988 . . . . 74.41 113.667 -168.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 6.2 ttpm? -58.11 -18.65 26.57 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.879 -0.513 . . . . 73.22 111.45 176.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -85.49 15.64 4.38 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.527 0.566 . . . . 65.23 112.527 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 82.1 mt -89.82 142.34 27.79 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.235 0.54 . . . . 53.34 111.472 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.26 153.46 22.13 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.289 -0.414 . . . . 60.03 110.825 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -119.85 138.71 53.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 55.31 110.425 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 50.6 m-85 -134.27 136.5 43.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.12 0.486 . . . . 71.32 111.455 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.51 HD11 ' HA3' ' A' ' 151' ' ' GLY . 8.0 tt -124.47 149.06 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 115.917 -0.583 . . . . 75.4 110.889 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.69 129.74 49.32 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.262 -0.494 . . . . 63.14 113.579 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -46.93 -43.78 19.34 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.648 0.379 . . . . 71.55 111.886 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -49.52 -34.29 16.87 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.247 0.832 . . . . 73.41 113.247 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -94.91 -25.19 16.66 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.029 -0.42 . . . . 71.14 111.857 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.48 -30.24 7.9 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.267 1.21 . . . . 62.33 114.267 -173.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.72 -26.82 67.45 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.719 0.637 . . . . 74.34 112.719 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 169.86 -22.73 0.09 OUTLIER Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.588 -0.815 . . . . 64.15 113.869 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.37 97.79 0.44 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.981 0.42 . . . . 54.31 111.806 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -4.9 21.65 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.361 -0.381 . . . . 62.23 111.94 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -84.81 20.79 1.71 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.745 0.307 . . . . 65.24 111.68 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.51 ' HA3' HD11 ' A' ' 140' ' ' ILE . . . -92.86 135.64 12.77 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.208 -0.52 . . . . 33.02 112.636 176.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.451 ' NE2' HD22 ' A' ' 171' ' ' LEU . 42.8 tt0 -68.84 119.01 12.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.25 0.463 . . . . 52.11 112.25 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 37.6 t -80.08 124.91 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.089 0.471 . . . . 75.02 111.027 172.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -102.21 135.46 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.076 -0.511 . . . . 51.54 110.594 177.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.741 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 61.5 mt -90.28 137.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 112.338 0.496 . . . . 53.03 112.338 -172.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.1 mm -108.47 117.49 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.391 -0.368 . . . . 75.54 111.67 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 35.9 tt0 -110.47 137.11 48.6 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.38 -0.373 . . . . 62.42 111.389 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -73.26 88.14 1.5 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.51 -0.552 . . . . 75.33 109.51 169.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.03 121.65 22.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.166 0.508 . . . . 75.54 110.611 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -69.19 139.78 54.58 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.385 0.612 . . . . 64.32 112.033 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 163' ' ' GLY . 98.3 t -129.78 150.27 34.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.923 -1.51 . . . . 65.33 106.923 167.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.27 70.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.403 0.62 . . . . 73.1 111.058 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 161' ' ' VAL . . . 133.89 -12.47 4.78 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.774 -0.648 . . . . 63.43 113.862 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 m -143.55 148.57 36.16 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.087 -0.655 . . . . 73.22 111.526 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 165' ' ' GLU . 0.2 OUTLIER -110.94 108.74 18.61 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.421 0.629 . . . . 64.4 111.004 177.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.443 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 27.1 m -115.91 130.05 24.7 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.228 -0.442 . . . . 75.42 111.657 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.49 ' HB2' HD13 ' A' ' 68' ' ' ILE . 6.1 Cg_exo -79.66 115.01 3.3 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.633 2.222 . . . . 73.5 113.121 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.9 p -104.53 165.58 10.96 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.169 0.509 . . . . 74.42 111.824 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.67 HD11 ' HB1' ' A' ' 154' ' ' ALA . 21.1 tp -107.13 139.48 41.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.104 -0.498 . . . . 74.31 111.936 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.741 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 62.4 mtt -108.97 126.21 52.86 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 122.61 0.364 . . . . 74.41 111.633 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.451 HD22 ' NE2' ' A' ' 152' ' ' GLN . 82.1 mt -136.81 120.34 17.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.037 -0.529 . . . . 71.41 110.784 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 27' ' ' VAL . 46.0 t -74.22 121.18 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.628 -0.67 . . . . 64.45 111.927 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -70.14 -31.26 68.69 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.606 0.595 . . . . 73.53 112.606 -174.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.405 ' HG3' ' CE1' ' A' ' 116' ' ' PHE . 28.8 mm-40 -82.18 -1.3 48.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.941 0.4 . . . . 65.24 111.629 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.533 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . . . -96.53 -54.83 3.11 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.278 0.561 . . . . 75.54 110.462 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.571 HG22 ' HA ' ' A' ' 6' ' ' ASP . 29.3 pt -95.66 144.61 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.783 -0.644 . . . . 74.11 110.939 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.695 ' HB ' ' HB3' ' A' ' 5' ' ' LYS . 1.7 mp -91.84 110.7 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.348 0.594 . . . . 75.22 109.804 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -106.03 129.53 54.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.151 -0.932 . . . . 60.14 110.648 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 46.2 mt-10 -130.82 98.98 4.77 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.16 0.505 . . . . 73.13 110.818 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.415 ' HA ' HD12 ' A' ' 2' ' ' LEU . 32.8 ttpt . . . . . 0 CA--C 1.535 0.402 0 CA-C-N 116.003 -0.544 . . . . 75.1 111.924 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.558 0.218 . . . . 71.14 110.916 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 15' ' ' SER . 32.0 tp -84.55 138.17 32.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.319 -0.623 . . . . 75.45 109.319 170.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.491 HG22 HD11 ' A' ' 13' ' ' LEU . 53.1 mt -121.03 118.48 56.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.251 -0.277 . . . . 71.02 110.251 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -118.88 146.89 44.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.272 0.471 . . . . 71.1 112.272 -172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.637 ' HB3' HD13 ' A' ' 13' ' ' LEU . 20.8 ptmt -151.37 127.33 10.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.758 0.651 . . . . 75.3 112.758 176.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.791 ' HB3' ' HB ' ' A' ' 9' ' ' THR . 18.3 t70 -79.37 166.13 22.39 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.866 -0.606 . . . . 30.34 110.761 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.404 HG13 ' CD2' ' A' ' 8' ' ' PHE . 19.9 pt -73.21 -41.29 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 113.133 0.79 . . . . 62.13 113.133 -177.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.404 ' CD2' HG13 ' A' ' 7' ' ' ILE . 24.0 p90 -105.66 -14.13 15.36 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.942 -0.473 . . . . 73.44 111.882 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 6' ' ' ASP . 4.1 m -94.82 18.08 12.45 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.935 0.874 . . . . 45.54 109.48 172.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -45.8 -45.05 14.53 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.595 1.158 . . . . 73.11 113.439 -172.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.17 -21.65 66.35 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.153 0.797 . . . . 64.44 113.153 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' ' 9' ' ' THR . 37.7 mt-10 -88.8 24.38 2.05 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.144 0.424 . . . . 71.52 112.144 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.637 HD13 ' HB3' ' A' ' 5' ' ' LYS . 61.0 tp -44.28 118.6 1.56 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.866 0.467 . . . . 75.35 111.495 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -141.44 165.9 26.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.37 0.508 . . . . 73.14 112.37 -175.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 2' ' ' LEU . 99.2 p -112.06 147.17 36.59 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.227 -0.442 . . . . 63.42 111.378 176.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -142.36 -170.37 3.17 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.385 0.612 . . . . 71.44 112.017 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -153.84 63.11 0.72 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.604 -0.725 . . . . 73.33 110.44 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -124.23 157.18 65.23 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 116.232 -0.44 . . . . 71.44 111.73 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.36 148.53 11.56 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.775 2.317 . . . . 62.11 112.777 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -146.31 145.67 30.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.08 0.467 . . . . 72.51 112.107 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -116.12 109.76 17.92 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.354 -0.385 . . . . 74.13 111.593 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.597 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 52.0 tp -79.99 96.7 6.5 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.908 -0.495 . . . . 74.14 110.963 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 p -87.96 140.17 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-O 120.967 0.413 . . . . 73.31 111.187 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.17 8.43 1.52 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.009 0.374 . . . . 71.24 112.009 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.597 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 40.9 m-20 55.17 20.2 3.26 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.214 0.53 . . . . 72.33 111.599 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.0 tp -117.85 -43.21 2.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.217 -0.447 . . . . 71.05 110.749 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 172' ' ' VAL . 16.5 m -133.52 149.69 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.97 0.414 . . . . 74.32 111.731 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -89.59 124.92 34.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.548 -0.297 . . . . 74.24 110.791 174.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 11.8 pt-20 -107.63 143.44 36.09 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.86 0.362 . . . . 71.31 110.885 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.403 ' HD2' HD11 ' A' ' 70' ' ' ILE . 34.3 t80 -151.59 119.58 6.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.643 0.259 . . . . 62.55 111.242 173.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.4 ' HG3' ' OG1' ' A' ' 168' ' ' THR . 2.9 mptp? -74.94 124.75 27.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.856 0.36 . . . . 62.32 111.331 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.88 172.3 42.05 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 114.186 0.435 . . . . 71.3 114.186 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -105.73 116.34 31.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.563 0.345 . . . . 71.24 110.61 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.21 107.05 2.64 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.179 0.514 . . . . 74.4 111.891 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -140.66 156.99 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.016 0.436 . . . . 65.13 111.618 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.11 125.67 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.073 0.463 . . . . 70.01 110.965 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.855 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 32.0 ttt-85 . . . . . 0 CA--C 1.539 0.547 0 CA-C-N 116.537 -0.301 . . . . 63.21 111.515 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.855 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 19.7 mm-40 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 121.278 0.561 . . . . 60.52 110.323 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -82.59 135.3 35.1 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.673 -0.694 . . . . 70.14 111.464 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.09 -142.59 8.94 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.778 -0.725 . . . . 62.11 113.269 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.419 HG21 ' HB2' ' A' ' 167' ' ' PRO . 24.0 pt -111.04 143.84 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 122.499 -0.412 . . . . 62.02 112.015 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -41.66 -42.21 2.45 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.633 -0.712 . . . . 71.02 112.597 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.403 HD11 ' HD2' ' A' ' 30' ' ' PHE . 55.2 mt -51.75 -61.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.246 0.546 . . . . 72.42 112.271 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.8 m -72.29 -34.38 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.116 -0.493 . . . . 73.22 112.227 -174.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.0 -44.18 77.19 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.763 0.316 . . . . 64.32 111.145 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -63.03 -36.67 84.33 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.882 0.372 . . . . 73.24 111.637 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -94.32 2.14 55.86 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.057 0.391 . . . . 74.55 112.057 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 53.11 66.21 1.3 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.937 0.495 . . . . 72.12 112.08 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.4 mt -104.64 129.64 52.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.446 -0.343 . . . . 73.31 111.19 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 140' ' ' ILE . 11.2 p -78.66 137.02 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.787 0.327 . . . . 73.13 111.066 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -85.44 135.86 33.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.257 0.551 . . . . 72.3 112.071 -177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.3 mmm -130.19 159.41 36.94 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.374 -0.83 . . . . 64.23 109.735 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -132.04 140.87 49.04 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.248 0.833 . . . . 74.32 113.248 -169.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.415 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 27.5 p -48.73 -42.82 36.48 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.791 1.034 . . . . 74.25 113.791 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -53.33 -33.09 52.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.354 0.502 . . . . 74.45 112.354 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -103.44 -47.21 4.35 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.083 0.468 . . . . 70.42 111.643 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -77.6 4.8 10.45 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.545 0.572 . . . . 71.34 112.545 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.48 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -48.61 -46.31 39.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.072 0.463 . . . . 61.53 111.712 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 78.4 p -66.08 -41.95 90.02 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.973 -0.558 . . . . 23.31 111.533 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.3 ttp -63.03 -51.76 65.49 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.314 -0.403 . . . . 72.51 111.829 -175.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 91' ' ' TYR . 8.1 p90 -75.87 -17.58 59.75 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 120.199 -0.601 . . . . 72.11 111.582 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -64.8 -45.66 85.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.255 0.55 . . . . 72.43 110.122 170.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.19 -42.58 93.44 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.094 -0.503 . . . . 73.01 110.736 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.506 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 13.9 m-30 -59.06 -49.44 77.89 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.165 0.431 . . . . 73.22 112.165 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.5 tp -65.55 -31.64 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.612 0.244 . . . . 74.35 111.439 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -63.8 -51.15 66.09 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.996 0.426 . . . . 75.33 110.778 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -65.08 -41.76 94.75 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.172 0.51 . . . . 41.22 110.982 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.589 ' HE1' ' HB2' ' A' ' 175' ' ' ALA . 78.7 t80 -58.64 -56.99 15.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.419 -0.809 . . . . 63.51 111.102 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 50.9 ttp -50.74 -48.11 59.13 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.01 0.433 . . . . 43.01 111.463 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.678 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -63.28 -46.57 86.15 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.127 -0.488 . . . . 74.24 111.48 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -70.66 -42.56 70.63 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.255 0.465 . . . . 65.42 112.255 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.36 -33.61 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.18 0.437 . . . . 73.44 112.18 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 97' ' ' LYS . 10.0 tp -67.82 -38.23 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.533 -0.467 . . . . 75.31 110.309 175.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -65.25 -48.03 74.67 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.315 0.579 . . . . 71.43 110.552 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -60.0 -29.89 68.78 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.662 -0.699 . . . . 72.23 111.789 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 54.5 tpp -90.64 -60.52 1.9 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.813 0.339 . . . . 74.02 111.684 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.12 -32.69 68.37 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.144 0.424 . . . . 72.14 112.144 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -55.86 -44.07 77.72 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.287 0.477 . . . . 72.32 112.287 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -95.83 -36.69 11.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.99 0.366 . . . . 72.23 111.99 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -67.09 -62.94 1.18 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.644 -0.253 . . . . 71.24 111.591 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 108' ' ' ARG . 49.1 mtm180 62.59 23.74 14.12 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.992 1.108 . . . . 74.24 113.992 173.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.539 ' O ' HG22 ' A' ' 113' ' ' VAL . 20.3 t70 -120.88 121.24 37.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.691 -0.63 . . . . 74.35 111.391 175.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 3.3 ptpp? -66.44 -1.25 3.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.887 1.069 . . . . 73.44 113.887 -175.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.95 -44.35 8.48 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.83 -0.544 . . . . 72.42 110.862 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -71.08 -51.39 25.46 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.386 -0.37 . . . . 64.2 111.408 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 109' ' ' ASP . 34.4 m -61.84 -28.45 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.727 0.299 . . . . 74.51 111.205 177.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.56 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 18.9 t70 -61.2 -56.33 21.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.082 0.468 . . . . 51.53 110.318 174.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 119' ' ' LYS . . . -59.92 -40.9 90.46 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.828 -0.624 . . . . 71.01 111.245 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -57.02 -61.96 2.09 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.288 0.477 . . . . 75.3 112.288 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 114' ' ' ASP . 62.7 pttt -55.19 -45.23 75.81 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.885 0.374 . . . . 75.33 111.274 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -65.91 -28.63 69.07 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.828 0.307 . . . . 61.24 111.828 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 37.1 tptt -72.75 -56.84 4.67 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.049 0.452 . . . . 74.44 110.739 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.4 tp -68.18 -39.27 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.896 -0.593 . . . . 75.02 111.763 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -62.83 -51.41 67.16 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.283 -0.261 . . . . 65.22 111.422 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.63 -44.92 68.82 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.913 -0.661 . . . . 74.42 112.656 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -58.71 -58.39 8.79 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 111.561 0.208 . . . . 71.41 111.561 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.469 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.7 m -61.76 -44.68 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 112.546 0.573 . . . . 54.33 112.546 -175.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.1 m -63.34 -26.98 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.88 -0.513 . . . . 73.31 111.418 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 m -81.25 -36.49 29.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.215 0.531 . . . . 63.21 110.767 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 51.4 tp -71.61 -31.39 66.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.736 -0.665 . . . . 73.52 112.102 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 80.7 mt -80.56 2.36 25.83 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.167 0.432 . . . . 65.2 112.167 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.509 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -58.69 103.47 0.16 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.223 0.535 . . . . 71.11 112.012 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 37.8 ttpt -65.74 -23.24 66.69 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.29 0.848 . . . . 73.22 113.29 -171.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -77.87 -31.83 51.59 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.052 0.76 . . . . 62.13 113.052 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -108.35 -51.78 2.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.259 0.552 . . . . 75.33 111.517 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.509 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 45.8 m-85 -71.22 -5.6 33.21 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.943 0.72 . . . . 70.12 112.943 -172.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 21.8 ptmt -51.36 -26.19 7.31 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.067 -0.395 . . . . 62.12 111.556 172.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -82.18 18.53 1.37 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.67 0.618 . . . . 74.33 112.67 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.4 HD11 ' HD2' ' A' ' 133' ' ' PHE . 75.3 mt -89.68 137.32 32.43 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.982 -0.449 . . . . 74.25 111.297 176.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.9 123.82 45.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.258 -0.428 . . . . 35.11 110.603 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.415 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 88.8 m-85 -101.73 106.17 17.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.982 0.42 . . . . 72.42 111.195 -176.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -97.39 136.14 38.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.066 0.46 . . . . 72.3 111.33 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.455 ' O ' HG12 ' A' ' 77' ' ' VAL . 13.2 tt -140.03 154.72 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.784 0.326 . . . . 74.04 110.88 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.18 125.89 35.13 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.706 -0.759 . . . . 71.22 112.145 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -48.5 -47.56 38.76 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.669 0.387 . . . . 71.22 111.751 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.456 HH11 ' HD3' ' A' ' 143' ' ' ARG . 31.3 ttp180 -48.68 -52.4 23.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.087 -0.506 . . . . 73.43 111.408 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.665 ' HB1' ' H ' ' A' ' 151' ' ' GLY . . . -68.62 -28.05 66.56 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.182 0.438 . . . . 71.12 112.182 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.22 -17.8 64.95 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.748 0.419 . . . . 74.43 111.681 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -66.62 -7.97 24.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.172 -0.467 . . . . 64.31 112.004 175.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.0 17.53 76.79 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.106 -0.568 . . . . 62.4 112.806 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.46 -60.87 1.52 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.948 0.404 . . . . 70.15 111.073 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -74.74 -35.81 62.63 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.381 -0.372 . . . . 73.35 111.459 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 21.8 m120 57.69 34.53 24.6 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.943 0.401 . . . . 72.14 111.241 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.665 ' H ' ' HB1' ' A' ' 144' ' ' ALA . . . -54.09 162.47 3.58 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.61 -0.723 . . . . 53.42 114.216 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -59.59 144.44 47.57 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.948 0.722 . . . . 73.11 112.948 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 50.0 t -91.44 127.5 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.99 -0.55 . . . . 75.33 111.526 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -85.21 116.11 23.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.783 -0.644 . . . . 54.51 110.807 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.704 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 62.6 mt -88.8 124.44 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.821 0.343 . . . . 73.4 111.72 -176.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.8 mm -110.52 120.24 60.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.942 0.401 . . . . 62.2 111.775 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 26.0 tt0 -107.78 128.81 54.92 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.245 -0.434 . . . . 64.24 111.947 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -72.62 89.06 1.29 Allowed 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.969 -0.457 . . . . 73.24 110.486 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -92.2 133.95 35.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.926 0.393 . . . . 70.3 111.919 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.86 123.9 33.68 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.094 0.473 . . . . 55.3 111.506 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.6 t -130.1 105.06 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.875 0.369 . . . . 75.2 111.441 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.2 t70 56.19 30.94 17.41 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.335 0.588 . . . . 62.11 111.916 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.41 -24.55 24.04 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.171 -0.537 . . . . 63.02 113.664 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.5 p -90.16 148.58 22.88 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.924 0.392 . . . . 52.35 111.58 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 165' ' ' GLU . 0.1 OUTLIER -102.97 96.47 6.83 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.462 0.649 . . . . 75.53 110.74 178.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 166' ' ' VAL . 25.0 m -104.16 106.59 54.16 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 121.348 0.594 . . . . 63.15 112.066 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 34.2 Cg_exo -62.08 114.35 2.28 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.531 2.154 . . . . 75.41 112.481 176.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.4 ' OG1' ' HG3' ' A' ' 31' ' ' LYS . 90.9 m -99.15 133.07 43.95 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.921 0.391 . . . . 75.33 111.967 -176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 57.8 tp -77.83 140.1 39.35 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.898 -0.592 . . . . 70.32 111.702 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.704 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 24.0 mmt -127.96 124.36 37.1 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.693 0.397 . . . . 71.23 111.597 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.3 mt -141.09 130.63 23.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.651 0.38 . . . . 73.2 111.431 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.54 ' HA ' HG12 ' A' ' 27' ' ' VAL . 19.6 t -79.97 129.17 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.121 0.415 . . . . 63.11 112.121 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -77.48 -15.21 59.43 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.599 0.592 . . . . 71.15 112.599 -175.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.438 ' H ' HG12 ' A' ' 172' ' ' VAL . 3.8 mp0 -57.33 -27.63 62.39 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.846 0.355 . . . . 70.44 111.821 171.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.589 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -97.3 -42.72 7.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.144 -0.48 . . . . 70.52 111.93 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.4 pt -95.9 118.56 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.607 0.718 . . . . 75.41 112.373 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 177' ' ' ILE . 1.6 mp -94.88 115.63 34.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.798 -0.637 . . . . 73.33 110.255 175.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -97.96 112.88 24.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.567 -0.742 . . . . 63.31 111.407 -176.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 2' ' ' LEU . 54.7 mm-40 -97.71 123.03 41.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.557 0.343 . . . . 71.13 110.797 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.6 pttt . . . . . 0 CA--C 1.544 0.748 0 N-CA-C 112.993 0.738 . . . . 74.32 112.993 -171.943 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 111.747 0.277 . . . . 64.21 111.747 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.0 tp -126.18 131.01 52.1 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.857 0.361 . . . . 64.12 110.535 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.584 HG12 ' HB3' ' A' ' 15' ' ' SER . 57.5 mt -98.05 134.11 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 112.004 0.372 . . . . 74.52 112.004 -175.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -123.52 137.27 54.8 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.083 0.468 . . . . 73.45 111.115 171.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -143.54 141.39 30.69 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.989 -0.55 . . . . 71.3 111.361 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.585 ' HB2' ' H ' ' A' ' 9' ' ' THR . 5.2 m-20 -86.98 167.74 13.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.4 0.619 . . . . 75.23 111.258 172.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.446 HD12 ' OD1' ' A' ' 98' ' ' ASN . 15.2 pt -63.05 -26.86 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.97 -0.559 . . . . 64.14 111.458 173.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.475 ' HE1' ' HA ' ' A' ' 152' ' ' GLN . 13.2 p90 -109.95 -35.65 6.09 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.321 0.86 . . . . 75.34 113.321 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.585 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 2.7 m -83.12 15.61 2.76 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.95 0.722 . . . . 75.1 112.95 -173.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -58.28 -15.11 8.93 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.849 0.685 . . . . 74.23 112.849 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -67.81 -56.02 10.77 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 122.156 -0.34 . . . . 74.45 111.267 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -84.14 25.02 0.87 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.832 0.349 . . . . 55.45 111.747 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tt -40.12 131.07 2.08 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.535 0.734 . . . . 62.45 111.589 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 m -126.11 139.9 53.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.143 0.497 . . . . 62.51 112.279 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.584 ' HB3' HG12 ' A' ' 3' ' ' ILE . 47.8 p -111.55 111.04 21.76 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.869 -0.605 . . . . 72.31 110.944 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.414 ' HB3' ' HD1' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -151.05 -156.83 0.75 Allowed 'General case' 0 CA--C 1.544 0.741 0 O-C-N 122.355 -0.216 . . . . 54.31 111.204 -175.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -127.63 24.77 6.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.136 0.421 . . . . 51.44 112.136 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.414 ' HD1' ' HB3' ' A' ' 16' ' ' ASP . 59.1 m-85 -60.18 134.15 90.56 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.03 0.382 . . . . 54.22 112.03 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.99 -169.84 0.88 Allowed 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.779 2.319 . . . . 75.03 113.08 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.6 ptp -145.89 135.43 23.17 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.442 0.534 . . . . 62.55 112.442 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -124.45 100.41 6.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.614 -0.513 . . . . 75.41 109.614 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 27' ' ' VAL . 33.0 tp -93.03 124.46 37.01 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.174 0.805 . . . . 71.21 113.174 -170.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.68 142.35 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.896 -0.593 . . . . 61.02 111.01 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 57.44 13.44 1.82 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.481 0.549 . . . . 75.2 112.481 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 50.76 26.86 2.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.216 0.532 . . . . 74.21 111.03 -172.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.519 HD22 ' HB3' ' A' ' 119' ' ' LYS . 20.0 tp -121.62 -42.71 2.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.159 -0.473 . . . . 70.44 111.967 -174.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.66 HG12 ' HA ' ' A' ' 172' ' ' VAL . 2.6 m -138.19 151.73 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.803 0.668 . . . . 70.22 112.803 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -104.57 138.52 40.79 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.879 -0.6 . . . . 74.54 111.117 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -104.39 137.73 41.84 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.397 . . . . 72.14 110.526 167.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.845 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.4 t80 -115.59 134.25 55.24 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.943 0.401 . . . . 75.34 111.141 177.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -93.1 113.79 26.14 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.199 -0.455 . . . . 72.52 111.859 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.09 -174.82 18.31 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.275 -0.488 . . . . 61.42 113.598 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -128.14 144.25 51.1 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 122.482 -0.422 . . . . 73.54 111.298 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -80.08 114.16 18.79 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.866 -0.42 . . . . 73.2 109.866 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.1 m -144.23 174.42 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.302 0.573 . . . . 73.24 111.949 -174.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.5 m -110.85 121.75 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.168 0.509 . . . . 72.52 110.558 173.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.619 ' HB2' HD13 ' A' ' 72' ' ' LEU . 9.8 mmm180 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 121.095 0.474 . . . . 72.32 111.111 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.462 ' HA ' ' C ' ' A' ' 37' ' ' ARG . 39.7 tt0 . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 121.397 0.617 . . . . 72.23 109.354 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -137.02 122.02 18.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.746 -0.661 . . . . 72.05 111.202 -176.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.53 -148.78 15.5 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.532 -0.842 . . . . 74.22 113.736 175.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.442 HD12 HD12 ' A' ' 70' ' ' ILE . 36.7 pt -111.07 138.82 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 122.417 -0.46 . . . . 64.32 111.356 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -48.14 -35.75 12.16 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.379 0.511 . . . . 75.42 112.379 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.442 HD12 HD12 ' A' ' 68' ' ' ILE . 55.8 mt -49.81 -64.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.401 0.62 . . . . 70.1 112.021 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 18.5 m -74.38 -31.98 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.964 -0.562 . . . . 71.43 112.08 -174.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.619 HD13 ' HB2' ' A' ' 37' ' ' ARG . 72.6 mt -68.7 -30.78 69.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.286 -0.415 . . . . 55.11 111.64 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -90.63 -27.13 19.27 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 111.852 0.316 . . . . 72.12 111.852 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -97.84 3.65 49.82 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.02 -0.425 . . . . 75.2 111.782 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 58.29 70.87 0.62 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.406 0.622 . . . . 73.32 112.581 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 88.0 mt -122.26 138.92 54.33 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.003 -0.544 . . . . 65.33 111.256 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 p -93.76 146.67 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 120.856 0.36 . . . . 72.34 111.842 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.42 127.51 32.29 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.368 0.877 . . . . 54.51 113.368 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.0 mtp -140.26 110.61 6.65 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.172 -0.467 . . . . 75.24 110.139 174.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.499 ' HB2' ' HE1' ' A' ' 82' ' ' TYR . 18.4 m120 -95.74 167.11 11.47 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.852 -0.53 . . . . 54.42 112.134 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 43.1 t -43.5 -56.13 3.82 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.87 1.063 . . . . 72.34 113.87 -172.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.499 ' HE1' ' HB2' ' A' ' 80' ' ' ASN . 13.4 p90 -50.24 -33.0 18.11 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.457 0.54 . . . . 72.23 112.457 -177.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.76 -38.24 9.55 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.773 -0.649 . . . . 64.2 112.087 -174.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 88' ' ' PHE . 25.4 t0 -91.21 -7.63 50.77 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.477 0.547 . . . . 72.13 112.477 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.614 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -39.71 -61.49 0.82 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.369 0.878 . . . . 74.43 113.369 -175.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.4 m -61.86 -35.25 77.74 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.262 0.467 . . . . 62.34 112.262 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.5 ttm -75.74 -54.4 7.01 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.139 0.422 . . . . 72.23 112.139 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.614 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 7.6 p90 -63.47 -27.09 69.04 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.114 -0.634 . . . . 74.51 111.617 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -64.32 -44.8 90.46 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.867 0.365 . . . . 72.42 110.645 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.64 -38.0 89.51 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.2 0.524 . . . . 33.32 110.714 173.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 27.8 t80 -55.82 -50.99 69.0 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.72 -0.673 . . . . 73.42 110.978 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 88' ' ' PHE . 32.6 mm -57.68 -42.72 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 116.283 -0.417 . . . . 61.54 111.593 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.93 -56.38 17.7 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.865 0.32 . . . . 62.33 111.865 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -59.94 -39.21 84.77 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.897 0.379 . . . . 65.5 111.147 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CZ ' HG11 ' A' ' 172' ' ' VAL . 20.3 t80 -59.49 -59.15 5.91 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.121 -0.49 . . . . 72.33 111.221 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 55.6 ttp -52.82 -44.43 66.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.161 -0.472 . . . . 71.34 111.4 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -61.67 -49.56 76.02 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.36 -0.382 . . . . 72.15 111.321 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.446 ' OD1' HD12 ' A' ' 7' ' ' ILE . 26.0 t-20 -61.33 -56.06 24.73 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.76 0.281 . . . . 63.1 111.76 -176.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.577 ' HB ' ' HZ ' ' A' ' 116' ' ' PHE . 27.5 m -57.46 -41.72 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.407 0.521 . . . . 73.53 112.407 -176.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.6 tp -74.74 -35.9 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 122.077 -0.39 . . . . 71.1 111.006 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.73 -13.81 61.03 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.336 0.588 . . . . 70.11 110.8 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -90.36 -37.79 13.77 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.16 -0.337 . . . . 74.53 111.343 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 64.0 mtt -93.13 -62.88 1.29 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.523 0.564 . . . . 71.41 112.523 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.658 ' HA ' HG11 ' A' ' 113' ' ' VAL . 38.9 tt0 -58.29 -26.34 62.9 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.38 0.511 . . . . 72.44 112.38 -174.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -57.27 -46.21 83.31 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 111.991 0.367 . . . . 71.42 111.991 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -108.02 -14.52 14.72 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.566 0.58 . . . . 74.55 112.566 -175.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.46 ' OD1' HG13 ' A' ' 113' ' ' VAL . 27.6 t-20 -92.72 -68.9 0.77 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.666 0.269 . . . . 70.55 111.398 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 36.6 ttm180 63.14 11.96 5.67 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.248 0.833 . . . . 73.22 113.248 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.621 ' O ' HG22 ' A' ' 113' ' ' VAL . 22.2 t70 -75.53 120.36 20.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.385 -0.822 . . . . 75.41 110.954 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -57.78 -12.31 2.94 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.468 0.914 . . . . 72.12 113.468 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.1 -53.25 4.2 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.997 -0.439 . . . . 75.31 112.043 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -74.12 -60.07 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.238 0.459 . . . . 74.15 112.238 -170.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.658 HG11 ' HA ' ' A' ' 104' ' ' GLU . 27.6 m -60.47 -26.6 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.692 0.282 . . . . 72.32 111.722 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.79 -53.22 50.38 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.573 -0.285 . . . . 75.12 110.483 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -56.57 -43.66 80.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.042 0.449 . . . . 61.24 111.258 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.577 ' HZ ' ' HB ' ' A' ' 99' ' ' VAL . 44.1 t80 -61.07 -59.21 5.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.882 0.372 . . . . 61.11 111.624 177.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -57.0 -35.14 68.88 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.175 0.512 . . . . 55.31 111.169 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -68.97 -40.15 79.02 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.786 -0.643 . . . . 53.34 111.385 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.519 ' HB3' HD22 ' A' ' 26' ' ' LEU . 51.9 mtmt -65.69 -44.18 86.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.512 0.196 . . . . 74.11 111.103 175.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.432 ' CD1' HD11 ' A' ' 26' ' ' LEU . 37.6 mm -62.01 -45.58 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.917 0.389 . . . . 75.45 111.055 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.42 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.6 OUTLIER -58.54 -50.99 71.78 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.184 -0.462 . . . . 62.15 110.776 177.687 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.73 -36.85 93.88 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.922 -0.656 . . . . 75.32 112.724 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.2 t90 -60.6 -56.4 21.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.642 0.377 . . . . 74.22 111.587 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.536 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.8 m -63.36 -42.72 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 112.241 0.46 . . . . 72.14 112.241 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 121' ' ' GLN . 71.6 t -59.81 -37.23 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 122.066 -0.396 . . . . 75.52 111.43 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.2 t -77.16 -39.62 48.41 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.042 0.449 . . . . 74.43 110.984 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.0 tp -62.41 -28.38 69.75 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.994 0.517 . . . . 73.3 112.148 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 29.3 mt -92.58 1.81 57.05 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.916 0.339 . . . . 64.12 111.916 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.89 108.08 2.43 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.091 0.472 . . . . 65.31 111.451 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -16.58 49.19 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.076 0.769 . . . . 55.41 113.076 -172.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -54.91 -49.05 72.24 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.904 0.383 . . . . 54.25 111.404 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -111.24 -43.34 3.74 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.403 0.62 . . . . 74.1 111.27 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -74.23 -7.26 52.08 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.327 0.862 . . . . 70.52 113.327 -167.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -63.7 -32.35 73.81 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.197 0.523 . . . . 70.31 110.426 170.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -89.7 33.9 0.84 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.003 -0.544 . . . . 75.1 112.199 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.73 156.95 18.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.504 0.669 . . . . 53.02 111.93 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.36 112.63 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.461 -0.79 . . . . 74.01 110.288 172.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.585 ' HB3' HG13 ' A' ' 153' ' ' VAL . 54.5 m-85 -90.9 132.93 35.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.916 0.388 . . . . 70.02 110.226 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.788 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 61.4 m-85 -121.94 125.39 46.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.863 0.364 . . . . 73.14 111.331 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 13.8 tt -113.4 154.63 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 116.552 -0.294 . . . . 73.44 111.348 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.99 142.8 41.42 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.447 -0.342 . . . . 73.11 113.645 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.437 ' HG3' ' HG3' ' A' ' 143' ' ' ARG . 14.2 pt-20 -53.29 -40.06 64.42 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.643 0.609 . . . . 73.24 112.643 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.437 ' HG3' ' HG3' ' A' ' 142' ' ' GLU . 85.1 mtm180 -78.17 -38.44 43.51 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.019 0.377 . . . . 72.32 112.019 -176.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.606 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -74.89 -28.48 60.65 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.085 0.402 . . . . 75.3 112.085 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -50.16 -38.79 41.24 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.04 1.126 . . . . 74.35 114.04 -174.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -73.52 6.16 3.26 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.756 1.021 . . . . 74.23 113.756 -172.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.26 -11.69 1.19 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.981 -1.104 . . . . 64.52 114.881 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -77.93 95.11 4.7 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 117.778 0.789 . . . . 70.14 111.59 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -74.27 19.85 0.12 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.473 0.546 . . . . 72.44 112.473 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -111.49 5.88 19.83 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.943 0.401 . . . . 53.24 110.827 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.81 171.59 52.59 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.423 -0.418 . . . . 63.34 113.472 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.475 ' HA ' ' HE1' ' A' ' 8' ' ' PHE . 37.3 tt0 -86.72 116.96 25.17 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.421 -0.458 . . . . 62.5 112.085 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.585 HG13 ' HB3' ' A' ' 138' ' ' PHE . 27.5 t -83.29 107.17 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.152 0.501 . . . . 71.23 110.589 170.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.484 ' HB1' ' CD1' ' A' ' 169' ' ' LEU . . . -82.09 117.39 22.23 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.065 -0.516 . . . . 64.42 110.89 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 59.4 mt -89.27 105.12 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.854 0.359 . . . . 73.43 111.252 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.5 mm -93.77 117.8 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.027 0.381 . . . . 62.33 112.027 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.86 129.49 56.44 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.393 -0.595 . . . . 73.43 109.393 174.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -90.51 88.99 7.37 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.047 0.451 . . . . 73.23 110.456 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -97.17 159.05 15.13 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.329 0.585 . . . . 71.11 112.171 -170.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.01 134.09 48.7 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.926 -0.579 . . . . 73.02 111.295 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.1 t -119.2 104.84 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.642 0.258 . . . . 73.23 110.962 175.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 60.4 9.75 2.14 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.863 0.69 . . . . 74.04 112.863 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 116.27 2.05 20.06 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.427 -0.416 . . . . 60.22 113.096 -175.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 94.5 m -107.8 130.24 54.99 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.977 0.418 . . . . 52.3 111.966 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -74.03 112.48 10.21 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.986 -0.552 . . . . 74.21 112.191 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 166' ' ' VAL . 27.9 m -129.22 117.4 18.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 121.168 0.508 . . . . 61.31 111.932 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.96 114.5 3.99 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.838 1.692 . . . . 75.13 111.693 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 67.3 p -101.07 129.22 46.91 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.164 0.506 . . . . 74.12 112.047 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.845 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.1 tp -89.81 122.9 33.32 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.84 -0.618 . . . . 74.33 111.087 176.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.658 ' SD ' ' HB ' ' A' ' 27' ' ' VAL . 39.4 tpp -103.22 125.52 49.93 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.755 0.312 . . . . 64.05 111.596 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -140.9 152.09 44.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.189 0.596 . . . . 63.55 109.983 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.66 ' HA ' HG12 ' A' ' 27' ' ' VAL . 41.9 t -89.89 117.34 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.829 0.677 . . . . 72.32 112.829 -173.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -59.88 -31.81 70.15 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.045 -0.525 . . . . 75.0 111.832 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.413 ' HG3' ' HE1' ' A' ' 116' ' ' PHE . 5.5 mm-40 -85.27 11.55 9.85 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.464 -0.335 . . . . 64.4 111.803 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -127.09 -41.87 1.76 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.829 0.347 . . . . 40.42 111.083 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 172' ' ' VAL . 12.8 tt -100.18 132.18 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.093 0.473 . . . . 64.41 111.062 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.5 tp -130.25 153.53 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.95 0.405 . . . . 71.32 111.548 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.05 152.06 41.43 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.115 0.483 . . . . 70.51 111.35 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.506 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 11.2 tp10 -138.98 133.19 31.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.095 0.474 . . . . 61.53 110.697 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 121.729 0.776 . . . . 63.34 112.939 -172.929 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.764 0.316 . . . . 74.34 110.856 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 33.9 tp -100.8 130.92 46.89 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 110.117 -0.327 . . . . 74.14 110.117 173.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.747 ' HB ' HD21 ' A' ' 13' ' ' LEU . 21.1 pt -114.2 123.02 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.22 0.533 . . . . 75.14 111.557 -176.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.525 ' HE1' ' HB2' ' A' ' 16' ' ' ASP . 35.7 p90 -122.8 143.28 49.94 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.231 0.539 . . . . 75.31 112.154 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.731 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 12.0 ptmt -130.1 150.0 51.56 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.688 -0.687 . . . . 75.03 111.242 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 7.0 p-10 -97.81 -178.33 4.06 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.212 0.53 . . . . 62.3 111.261 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.45 -43.83 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 113.239 0.829 . . . . 72.2 113.239 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.519 ' HD2' HG23 ' A' ' 9' ' ' THR . 9.2 p90 -108.48 -52.65 2.74 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.647 1.351 . . . . 71.32 114.647 -168.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.519 HG23 ' HD2' ' A' ' 8' ' ' PHE . 17.7 p -89.48 18.51 5.26 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.67 -0.644 . . . . 73.14 112.616 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.731 ' HB2' ' HB2' ' A' ' 5' ' ' LYS . 3.8 p-10 -50.87 -20.55 1.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.797 1.406 . . . . 71.54 114.797 -172.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -66.86 -19.79 65.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.363 0.602 . . . . 54.44 110.814 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.31 24.94 4.1 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.499 -0.773 . . . . 70.44 110.861 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.747 HD21 ' HB ' ' A' ' 3' ' ' ILE . 7.8 tt -38.52 138.61 0.48 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.815 0.846 . . . . 71.42 112.498 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.0 m -118.72 149.61 41.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.997 0.427 . . . . 62.24 111.934 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.5 p -109.77 129.91 55.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.236 -0.438 . . . . 74.32 110.557 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.525 ' HB2' ' HE1' ' A' ' 4' ' ' TYR . 2.5 t70 -137.41 179.04 6.64 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.657 0.265 . . . . 74.11 111.192 -177.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.7 t -132.74 4.97 3.92 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.275 0.472 . . . . 52.54 112.275 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -78.26 146.08 69.97 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 122.07 -0.394 . . . . 73.05 111.842 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -85.99 126.38 2.85 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.973 2.449 . . . . 64.4 113.386 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 87.7 mmm -89.74 124.63 34.8 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.502 -0.317 . . . . 74.31 111.163 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 56.5 mttm -103.48 112.24 25.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.34 0.256 . . . . 73.52 111.573 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 33.9 tp -84.54 106.65 16.27 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.809 -0.557 . . . . 63.33 112.159 -175.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -98.04 139.29 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.084 0.468 . . . . 74.15 111.131 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 58.32 15.56 3.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.565 0.58 . . . . 75.34 112.565 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 59.98 11.46 2.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.328 0.492 . . . . 61.4 112.328 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.1 tp -115.83 -45.54 2.87 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.07 0.396 . . . . 75.32 112.07 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 172' ' ' VAL . 3.8 m -129.29 143.7 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.431 0.53 . . . . 72.3 112.431 -176.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' A' ' 170' ' ' MET . 98.0 m-85 -92.0 142.03 27.98 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.074 -0.512 . . . . 74.45 110.876 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 16.4 pt-20 -128.87 146.97 50.79 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 110.242 -0.281 . . . . 71.41 110.242 174.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.52 ' CE2' HD13 ' A' ' 70' ' ' ILE . 43.6 p90 -152.48 145.67 24.65 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.626 0.973 . . . . 65.23 113.626 172.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -94.91 130.51 41.49 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.366 -0.834 . . . . 73.11 111.525 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.88 -133.96 7.69 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 114.472 0.549 . . . . 75.25 114.472 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -138.45 123.78 19.36 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.636 -0.332 . . . . 62.32 111.229 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -66.24 107.0 1.82 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.923 0.392 . . . . 74.1 111.839 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.418 HG23 HD12 ' A' ' 72' ' ' LEU . 35.6 m -138.96 168.17 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.267 -0.424 . . . . 61.55 111.481 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.91 144.74 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.482 -0.326 . . . . 72.22 110.933 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 29.6 tpt85 . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 121.832 0.825 . . . . 73.01 111.979 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 35.1 mt-10 . . . . . 0 CA--C 1.539 0.549 0 CA-C-O 121.653 0.74 . . . . 72.45 110.069 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.543 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -114.48 149.56 36.16 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.915 -0.584 . . . . 64.15 111.748 -177.656 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 141.67 -113.65 0.84 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.205 -0.522 . . . . 63.22 112.802 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.454 HD12 HD12 ' A' ' 70' ' ' ILE . 17.1 pt -111.51 134.52 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.959 0.409 . . . . 43.2 111.85 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -46.25 -36.31 6.02 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.829 -0.623 . . . . 72.21 112.222 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.52 HD13 ' CE2' ' A' ' 30' ' ' PHE . 50.9 mt -48.66 -64.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.304 0.573 . . . . 75.32 112.29 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 33.8 m -66.04 -36.75 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.911 -0.586 . . . . 72.34 112.188 -175.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.418 HD12 HG23 ' A' ' 35' ' ' VAL . 42.7 mt -67.46 -38.32 84.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.095 0.474 . . . . 64.34 111.299 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -66.41 -45.2 80.75 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.077 -0.51 . . . . 74.34 111.247 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -90.43 7.94 36.21 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.38 0.511 . . . . 73.54 112.38 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.8 mttm 57.4 69.08 0.77 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.496 0.665 . . . . 75.34 112.759 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 75.0 mt -114.74 120.86 41.52 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.935 -0.575 . . . . 71.24 110.541 177.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 14.4 p -86.62 144.17 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.911 0.386 . . . . 75.44 111.615 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.55 126.31 30.76 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.105 -0.498 . . . . 71.23 112.214 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.2 mmt -132.35 159.46 39.15 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.201 -0.454 . . . . 71.21 111.133 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.465 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 93.5 m-20 -127.39 147.3 50.27 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.139 0.495 . . . . 65.31 111.175 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 26.1 p -52.19 -16.43 0.8 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.852 1.427 . . . . 52.31 114.852 -169.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 80' ' ' ASN . 50.2 p90 -58.94 -41.63 87.82 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.418 0.525 . . . . 73.43 112.418 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -101.34 -37.92 8.27 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.126 -0.359 . . . . 64.13 111.824 -178.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.64 6.88 0.98 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.833 0.679 . . . . 64.22 112.833 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.32 -50.59 38.85 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.359 0.503 . . . . 73.43 112.359 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.7 m -68.96 -35.27 76.56 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.625 0.25 . . . . 54.11 111.612 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 95.9 mmm -56.46 -50.85 70.51 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.681 0.277 . . . . 62.44 110.698 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -68.32 -33.73 74.85 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.84 0.311 . . . . 72.53 111.84 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -55.6 -54.72 40.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.104 0.478 . . . . 64.51 110.967 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.48 -38.22 68.25 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.2 -0.455 . . . . 71.12 111.792 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -59.01 -54.82 42.77 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.633 -0.258 . . . . 75.03 111.288 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.4 mm -62.4 -35.43 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.696 -0.229 . . . . 73.1 111.272 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.453 ' HE3' ' HD2' ' A' ' 97' ' ' LYS . 57.4 tptt -57.33 -60.56 3.44 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.709 0.29 . . . . 73.43 111.11 175.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -61.77 -39.5 91.86 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.167 0.508 . . . . 72.35 111.097 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.599 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 78.3 t80 -57.36 -56.68 18.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.86 -0.609 . . . . 74.42 111.527 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 51.8 ttm -53.79 -43.7 69.49 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.09 0.472 . . . . 62.32 111.33 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD2' ' HE3' ' A' ' 93' ' ' LYS . 28.0 mtpp -61.71 -43.85 98.06 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.989 -0.55 . . . . 71.32 111.79 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -73.42 -44.45 58.28 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.95 0.352 . . . . 64.14 111.95 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.0 m -66.33 -38.73 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.395 0.517 . . . . 73.35 112.395 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 34.5 mm -65.51 -47.0 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.856 0.36 . . . . 54.25 110.756 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.95 -42.89 85.89 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 72.54 110.512 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -64.83 -35.55 81.48 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.709 -0.678 . . . . 63.44 111.285 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.423 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . 15.0 mmt -68.05 -39.62 82.97 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.651 0.241 . . . . 75.43 111.651 177.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.65 -35.68 72.93 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.491 0.663 . . . . 74.43 110.53 171.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -70.09 -46.35 65.04 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.283 -0.871 . . . . 64.01 112.702 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.423 ' OD1' ' HA ' ' A' ' 103' ' ' MET . 17.7 p-10 -97.51 -26.15 14.92 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.122 1.156 . . . . 73.32 114.122 -174.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.575 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 87.7 m-20 -124.06 -63.21 1.22 Allowed 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.874 -0.516 . . . . 63.24 112.114 -175.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' A' ' 107' ' ' ASN . 5.9 ptt180 67.91 -14.71 0.22 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.308 1.043 . . . . 74.2 113.399 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 113' ' ' VAL . 24.7 t70 -61.64 127.63 32.37 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.2 -0.313 . . . . 71.23 111.676 -176.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -50.63 -39.64 50.91 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.727 0.64 . . . . 75.21 112.727 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.94 -35.63 50.17 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.648 0.261 . . . . 63.42 111.576 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -67.71 -51.36 50.32 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.783 0.325 . . . . 64.02 111.083 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 109' ' ' ASP . 16.1 m -66.73 -23.07 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 111.813 0.301 . . . . 63.53 111.813 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 29.1 t70 -69.96 -61.43 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.039 -0.356 . . . . 74.33 110.039 171.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.85 -40.16 63.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.865 0.364 . . . . 70.15 111.608 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -58.83 -59.34 5.59 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.384 -0.371 . . . . 73.31 111.242 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 8.4 ptpp? -59.39 -31.8 69.58 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.958 -0.297 . . . . 74.02 111.065 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 33.7 mmtp -62.4 -46.66 87.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.851 0.357 . . . . 74.51 110.802 175.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -67.37 -56.25 10.46 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.071 -0.513 . . . . 60.44 111.991 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.0 tp -67.36 -40.6 85.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.587 0.588 . . . . 61.12 112.587 -175.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 125' ' ' VAL . 14.3 tm0? -68.12 -45.74 72.8 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.023 -0.423 . . . . 71.2 110.737 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.41 -41.61 95.32 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.647 -0.787 . . . . 71.11 112.05 173.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -59.44 -54.1 50.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.4 0.28 . . . . 62.21 111.717 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.0 m -64.82 -36.7 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.485 0.55 . . . . 75.54 112.485 -177.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 121' ' ' GLN . 78.0 t -59.37 -43.51 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.98 -0.45 . . . . 64.4 111.148 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.7 t -76.05 -37.64 58.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.116 0.484 . . . . 74.1 111.119 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.516 ' HA ' ' CD2' ' A' ' 133' ' ' PHE . 51.1 tp -61.25 -33.55 73.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.987 0.515 . . . . 75.52 111.704 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 65.7 mt -88.47 3.01 51.65 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.35 -0.386 . . . . 50.44 111.918 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.27 102.86 0.1 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.151 0.5 . . . . 71.55 111.642 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -62.33 -11.44 15.35 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.794 1.035 . . . . 72.3 113.794 -172.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.97 -48.35 6.03 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.642 0.608 . . . . 74.32 112.642 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.7 tpp85 -92.8 -56.01 3.16 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.185 0.516 . . . . 74.31 111.667 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' A' ' 127' ' ' LEU . 8.0 m-85 -71.2 -5.86 35.13 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.117 0.484 . . . . 74.34 111.975 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 27.6 ttpp -49.81 -21.84 1.25 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.144 -0.48 . . . . 51.51 112.08 172.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -82.18 9.35 8.84 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.916 0.71 . . . . 74.41 112.916 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.25 136.12 33.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.06 0.457 . . . . 75.25 111.771 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.14 118.45 37.01 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.154 -0.475 . . . . 62.42 110.296 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.403 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 66.4 m-85 -97.08 108.32 21.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.001 0.429 . . . . 73.14 111.278 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 45.7 m-85 -98.64 124.49 43.47 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.1 0.476 . . . . 73.33 111.481 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.544 HG23 ' HB2' ' A' ' 145' ' ' ALA . 10.6 tt -135.56 148.75 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.315 -0.402 . . . . 73.44 110.929 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.37 121.94 8.07 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.276 -0.487 . . . . 45.54 112.815 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -32.31 60.81 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.931 0.715 . . . . 73.3 112.931 -175.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -61.32 -39.34 90.15 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.066 0.395 . . . . 74.25 112.066 173.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -80.52 -40.53 25.86 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.939 0.399 . . . . 62.45 111.562 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.544 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -58.56 -20.68 48.69 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.128 -0.487 . . . . 34.21 112.058 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -62.84 -16.89 60.33 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.072 -0.513 . . . . 75.12 111.761 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.13 31.37 14.57 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.252 -0.499 . . . . 41.32 112.485 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.46 -19.89 19.5 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.193 0.442 . . . . 65.34 112.193 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -161.78 -170.87 2.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.641 -0.254 . . . . 75.32 111.08 -176.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -65.66 -66.47 0.54 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.781 0.324 . . . . 65.4 111.784 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.29 146.2 0.21 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.345 -0.455 . . . . 51.34 113.67 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -102.17 135.99 42.78 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.313 -0.522 . . . . 62.33 111.265 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 56.1 t -94.69 127.86 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.19 0.519 . . . . 71.4 112.015 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.901 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -96.05 123.28 39.6 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.688 -0.687 . . . . 64.12 110.422 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 55.4 mt -93.3 118.98 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.18 0.437 . . . . 71.1 112.18 -173.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.0 mm -102.94 117.59 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.677 -0.238 . . . . 63.32 111.222 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -109.76 125.13 52.37 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.16 0.505 . . . . 74.32 111.59 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -87.52 88.87 7.8 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.039 -0.528 . . . . 65.54 109.824 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 159' ' ' ARG . 18.9 ptt85 -124.82 172.49 9.3 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.203 0.525 . . . . 71.32 112.324 -175.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -89.3 135.92 33.31 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.31 0.576 . . . . 63.44 112.213 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 78.1 t -108.8 95.48 3.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.889 -0.782 . . . . 73.03 108.889 169.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.4 t70 69.74 -56.96 0.56 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.533 -0.758 . . . . 73.51 111.564 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.02 6.65 0.14 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 121.1 -0.572 . . . . 60.12 114.224 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.4 m -120.5 134.76 55.23 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.749 0.774 . . . . 64.11 111.697 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -83.28 107.93 16.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.582 -0.281 . . . . 62.45 111.409 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.1 m -128.79 147.32 64.0 Favored Pre-proline 0 N--CA 1.474 0.747 0 CA-C-O 121.078 0.466 . . . . 71.45 112.016 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -90.94 114.72 0.43 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.928 2.419 . . . . 60.03 113.366 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 79.2 p -103.52 154.87 18.99 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.631 -0.259 . . . . 55.1 110.658 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.901 HD11 ' HB1' ' A' ' 154' ' ' ALA . 13.7 tp -100.28 120.89 40.62 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.221 -0.299 . . . . 73.4 111.312 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.643 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 60.8 mtt -107.54 134.89 49.9 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.678 0.621 . . . . 64.45 112.678 -175.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.8 mt -143.41 146.4 33.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.278 -0.874 . . . . 70.31 110.092 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.599 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 44.5 t -77.19 134.67 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 112.277 0.473 . . . . 73.53 112.277 -176.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.698 ' HB3' ' HZ3' ' A' ' 173' ' ' LYS . 5.9 ttpm? -59.6 -47.67 84.66 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.983 -0.553 . . . . 73.31 112.089 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -85.16 11.48 9.76 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.918 0.389 . . . . 71.33 111.964 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.537 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -103.3 -13.07 16.85 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.75 0.31 . . . . 71.25 111.133 173.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.2 pt -136.9 133.58 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.216 0.532 . . . . 45.31 111.485 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.53 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 50.6 mm -94.58 110.79 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.958 0.409 . . . . 70.52 110.218 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.7 123.15 31.55 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.319 -0.4 . . . . 72.21 110.822 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.56 ' HB3' HG13 ' A' ' 3' ' ' ILE . 11.8 tp10 -121.41 139.4 53.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.182 0.515 . . . . 72.24 110.702 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 112.776 0.658 . . . . 43.14 112.776 -172.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.582 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 24.0 mmt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.664 0.269 . . . . 62.11 111.264 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 15' ' ' SER . 57.7 tp -71.98 133.58 45.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.725 0.298 . . . . 72.43 110.781 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.1 mt -97.19 120.47 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 111.872 0.323 . . . . 70.03 111.872 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.464 ' O ' HD12 ' A' ' 13' ' ' LEU . 7.8 m-85 -106.59 115.05 29.53 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.439 -0.346 . . . . 73.42 110.638 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HG2' HD13 ' A' ' 13' ' ' LEU . 97.7 mttt -112.6 112.22 23.6 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.321 0.388 . . . . 62.14 111.231 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.61 154.98 38.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.088 0.47 . . . . 44.41 111.199 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.4 -42.67 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.081 0.467 . . . . 73.05 110.579 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -109.97 -33.54 6.68 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.461 0.911 . . . . 62.32 113.461 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.466 HG23 ' HA2' ' A' ' 151' ' ' GLY . 1.3 m -89.61 15.17 9.95 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 112.729 0.64 . . . . 52.22 112.729 -175.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -54.64 -17.87 3.86 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.93 0.715 . . . . 72.3 112.93 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.45 -33.11 72.08 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.357 0.599 . . . . 70.11 111.13 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -94.08 24.29 4.42 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.997 -0.547 . . . . 53.23 111.845 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 4' ' ' TYR . 65.5 tp -31.04 117.26 0.17 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.787 0.835 . . . . 72.04 112.436 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.6 t -110.01 163.6 13.41 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.284 0.564 . . . . 74.04 112.364 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.582 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 79.3 p -150.17 107.59 3.63 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.598 -0.728 . . . . 73.43 110.688 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -135.71 173.69 11.44 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.25 0.547 . . . . 72.42 112.328 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 m -133.9 84.7 2.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.875 -0.602 . . . . 70.45 110.489 173.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.59 152.01 73.84 Favored Pre-proline 0 N--CA 1.474 0.754 0 CA-C-N 116.367 -0.379 . . . . 75.43 111.381 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -93.0 94.21 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.862 2.374 . . . . 74.54 112.901 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.537 ' HB3' ' HB3' ' A' ' 28' ' ' TYR . 4.0 mpp? -85.41 144.82 27.78 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.857 0.36 . . . . 64.23 111.36 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -99.12 108.1 20.64 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.876 0.37 . . . . 72.03 111.863 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.2 tp -75.75 95.49 3.45 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.046 0.45 . . . . 61.43 111.084 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -86.75 140.34 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.038 0.446 . . . . 74.44 111.71 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.5 t70 58.03 16.46 3.79 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.854 -0.612 . . . . 74.02 111.679 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 57.18 20.4 5.62 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.054 -0.521 . . . . 64.03 111.762 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' A' ' 119' ' ' LYS . 32.2 tp -118.43 -50.17 2.45 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.055 0.455 . . . . 52.2 111.963 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.506 HG12 HG22 ' A' ' 172' ' ' VAL . 14.3 m -130.8 155.38 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 112.581 0.586 . . . . 75.35 112.581 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.537 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 77.5 m-85 -92.24 124.86 36.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.086 -0.506 . . . . 75.05 110.816 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 15.1 pt-20 -101.93 139.32 37.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.997 0.427 . . . . 74.13 110.217 171.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 168' ' ' THR . 42.5 t80 -141.56 112.35 7.2 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.629 -0.259 . . . . 73.04 111.11 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.432 ' HG3' ' H ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -75.48 130.89 39.64 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.33 0.492 . . . . 75.2 112.33 -179.441 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -126.09 162.04 20.36 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.385 -0.436 . . . . 23.41 113.606 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -97.24 126.83 42.7 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.463 -0.434 . . . . 64.31 111.539 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.408 ' ND1' ' O ' ' A' ' 34' ' ' HIS . 15.9 p80 -74.5 106.57 6.16 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.142 0.496 . . . . 74.35 110.619 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.7 m -140.81 177.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.381 0.61 . . . . 64.43 111.862 -176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 66' ' ' ARG . 34.9 m -132.43 146.87 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.971 -0.559 . . . . 74.54 111.219 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.941 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 56.7 ttt-85 . . . . . 0 C--O 1.245 0.851 0 CA-C-O 121.256 0.551 . . . . 74.21 110.892 174.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.941 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.7 mp0 . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.238 0.542 . . . . 61.54 110.633 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.404 ' HA ' HG12 ' A' ' 36' ' ' VAL . 60.6 mtp180 -87.57 131.76 34.29 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.741 -0.663 . . . . 73.2 111.528 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.32 -150.42 22.02 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.67 -0.776 . . . . 63.53 113.117 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.4 pt -110.45 146.15 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 122.349 -0.501 . . . . 65.21 111.397 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -40.36 -47.38 2.53 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.211 0.604 . . . . 71.13 112.18 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.441 HG13 ' HA3' ' A' ' 32' ' ' GLY . 61.9 mt -48.9 -53.84 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.757 -0.656 . . . . 70.13 112.333 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 m -83.22 -32.0 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 112.087 0.403 . . . . 74.14 112.087 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.75 -36.03 82.42 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.727 0.298 . . . . 73.12 111.367 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -81.42 -6.41 58.91 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.925 0.393 . . . . 75.04 111.324 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -124.48 8.21 8.35 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.952 0.352 . . . . 63.44 111.952 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.1 pttm 39.47 59.31 1.81 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.791 0.805 . . . . 60.02 112.699 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 84.9 mt -93.97 141.9 28.0 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.769 -0.65 . . . . 73.41 111.516 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 p -96.06 140.19 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 120.684 0.278 . . . . 75.04 111.267 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -89.57 148.25 23.48 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.533 0.682 . . . . 74.41 112.744 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.51 ' HG3' ' HB2' ' A' ' 138' ' ' PHE . 15.2 ptp -147.65 165.27 30.93 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.214 -0.903 . . . . 75.22 109.75 174.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.435 ' HA ' ' HD2' ' A' ' 138' ' ' PHE . 3.4 p30 -163.01 157.86 21.43 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.454 0.645 . . . . 73.01 112.259 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.402 ' HA ' ' HE2' ' A' ' 88' ' ' PHE . 64.3 m -37.53 -34.02 0.09 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 116.495 2.035 . . . . 72.5 116.495 -162.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -67.92 -31.98 72.12 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.433 -0.792 . . . . 71.13 112.348 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.87 -46.97 5.74 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.236 0.541 . . . . 73.55 111.913 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' A' ' 79' ' ' MET . 0.4 OUTLIER -95.2 12.89 27.25 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.494 0.924 . . . . 72.13 113.494 -173.001 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -41.06 -61.39 1.0 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.645 0.609 . . . . 64.13 112.645 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.5 m -65.45 -32.8 74.61 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.334 -0.394 . . . . 72.31 111.772 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 67.5 mtm -71.7 -52.62 16.91 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.06 0.392 . . . . 73.31 112.06 -175.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.503 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 16.5 p90 -71.96 -19.39 61.9 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.69 -0.631 . . . . 65.1 111.224 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -64.01 -44.21 93.29 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.08 0.467 . . . . 74.04 110.534 171.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.16 99.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.195 0.521 . . . . 73.05 110.455 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.468 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 44.0 t80 -54.6 -53.1 59.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.588 -0.733 . . . . 62.14 111.972 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.9 tp -67.66 -32.27 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 111.83 0.307 . . . . 72.15 111.83 -177.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' C ' ' HD3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -63.35 -53.25 55.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.665 0.269 . . . . 70.2 110.656 176.553 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -60.2 -49.48 77.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.934 0.397 . . . . 71.45 110.745 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.492 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 85.1 t80 -51.25 -58.09 7.09 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.082 -0.508 . . . . 61.31 111.916 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -54.57 -49.52 70.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.428 -0.351 . . . . 61.45 111.465 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -65.83 -48.51 71.42 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.605 -0.27 . . . . 73.42 111.7 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.49 -40.3 96.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.715 0.635 . . . . 62.23 112.715 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.7 m -67.95 -45.84 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 122.21 -0.306 . . . . 42.05 111.611 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.4 mm -67.55 -45.42 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.889 0.376 . . . . 73.31 111.131 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.51 -40.98 96.57 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.236 -0.438 . . . . 74.05 111.546 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -58.71 -47.02 86.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.942 0.401 . . . . 63.34 110.885 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.9 ttt -68.67 -45.68 71.08 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.164 0.507 . . . . 52.34 110.737 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -58.93 -37.38 76.55 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.281 -0.418 . . . . 74.43 111.729 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -54.37 -50.91 66.39 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.12 -0.491 . . . . 72.43 112.296 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -102.31 -36.92 8.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.791 0.663 . . . . 64.02 112.791 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -74.89 -56.02 5.19 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.965 -0.46 . . . . 45.44 111.659 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 66.65 -0.47 1.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.876 0.47 . . . . 63.42 112.19 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.547 ' O ' HG22 ' A' ' 113' ' ' VAL . 13.6 t70 -86.24 119.85 26.97 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.132 -0.355 . . . . 73.2 110.717 -177.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -65.64 -35.01 79.56 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.522 0.564 . . . . 74.04 112.522 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.93 -38.64 89.19 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.796 0.331 . . . . 71.14 111.435 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -72.73 -53.17 12.36 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.729 0.27 . . . . 74.34 111.729 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 109' ' ' ASP . 30.0 m -65.55 -21.73 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 112.098 0.407 . . . . 75.14 112.098 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -74.96 -42.35 57.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.965 0.412 . . . . 74.11 110.683 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.12 73.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.98 0.419 . . . . 41.22 110.986 176.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.18 -47.52 85.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.169 -0.468 . . . . 72.44 111.093 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -56.63 -40.87 76.16 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.53 -0.304 . . . . 75.42 110.915 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.5 tppt? -59.26 -40.33 85.67 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.604 0.24 . . . . 62.33 111.171 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.466 ' HB3' HD22 ' A' ' 26' ' ' LEU . 29.3 mmtp -61.73 -57.8 10.52 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.683 -0.235 . . . . 74.4 111.584 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.8 mm -59.95 -45.58 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.021 0.378 . . . . 73.24 112.021 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.447 ' O ' HG23 ' A' ' 125' ' ' VAL . 24.7 tm0? -61.62 -51.61 67.8 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.707 0.289 . . . . 60.42 110.942 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.79 -36.98 93.55 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.724 -0.751 . . . . 65.02 112.378 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -57.16 -53.75 54.58 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.862 0.465 . . . . 72.25 111.596 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.17 -42.44 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 112.189 0.44 . . . . 63.21 112.189 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 121' ' ' GLN . 69.9 t -55.92 -43.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.881 0.372 . . . . 74.31 111.396 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.5 t -72.03 -47.22 53.39 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.195 0.521 . . . . 73.43 111.569 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.497 HD21 HD13 ' A' ' 155' ' ' ILE . 31.5 tp -65.3 -28.06 69.05 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.126 -0.488 . . . . 70.41 111.914 -176.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.9 mt -84.54 2.56 40.63 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.133 0.419 . . . . 75.11 112.133 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.466 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -62.03 78.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.652 0.739 . . . . 53.12 110.977 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -60.08 -15.26 21.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.546 0.943 . . . . 61.31 113.546 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.19 -46.79 87.49 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 122.274 -0.266 . . . . 73.35 111.493 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -109.15 -39.24 5.32 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.836 0.351 . . . . 64.2 111.789 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.492 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 69.5 m-85 -63.62 -4.5 3.0 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.526 0.565 . . . . 65.05 112.526 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -44.35 -26.76 0.36 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 120.952 0.406 . . . . 73.15 111.841 168.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -83.54 20.34 1.4 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 112.79 0.663 . . . . 54.34 112.79 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 71.2 mt -88.51 132.06 34.66 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.925 -0.484 . . . . 75.32 111.318 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.28 123.21 48.44 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.134 -0.485 . . . . 73.3 110.734 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.653 ' HB3' HG13 ' A' ' 153' ' ' VAL . 53.6 m-85 -102.61 125.92 49.51 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.257 -0.277 . . . . 72.12 110.839 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.568 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 75.6 m-85 -121.61 142.14 50.41 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.05 0.389 . . . . 73.31 112.05 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 152' ' ' GLN . 34.4 pt -129.62 173.07 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.89 0.376 . . . . 75.14 111.09 174.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.48 153.88 50.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.274 -0.489 . . . . 72.31 114.01 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.52 -58.42 7.23 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.062 0.458 . . . . 75.44 112.045 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.609 ' HA ' ' HB3' ' A' ' 146' ' ' GLU . 30.3 mtm180 -73.09 -19.37 61.17 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.857 0.36 . . . . 64.33 111.284 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.67 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -61.03 -40.77 94.87 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.271 0.558 . . . . 71.33 110.467 170.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.1 -19.14 40.73 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.083 0.468 . . . . 60.32 111.374 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.609 ' HB3' ' HA ' ' A' ' 143' ' ' ARG . 42.6 tt0 -87.27 -24.26 24.41 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.252 0.464 . . . . 72.41 112.252 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.33 -46.52 0.02 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 120.472 -0.871 . . . . 72.2 114.336 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.67 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -71.0 86.58 0.72 Allowed 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.307 -0.526 . . . . 74.44 111.827 -177.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -61.34 -9.8 5.97 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.247 0.832 . . . . 73.23 113.247 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -93.38 27.21 2.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.809 0.338 . . . . 54.21 111.421 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.466 ' HA2' HG23 ' A' ' 9' ' ' THR . . . -60.44 115.83 8.29 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.469 -0.396 . . . . 62.42 113.698 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.414 ' O ' HG22 ' A' ' 140' ' ' ILE . 5.0 pp0? -60.25 134.55 57.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.244 0.545 . . . . 74.01 111.272 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.653 HG13 ' HB3' ' A' ' 138' ' ' PHE . 63.0 t -83.0 109.92 17.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.154 -0.476 . . . . 75.53 111.707 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.719 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -81.06 119.03 23.02 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.04 -0.527 . . . . 53.05 110.197 171.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.497 HD13 HD21 ' A' ' 127' ' ' LEU . 61.5 mt -96.12 117.1 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 112.468 0.544 . . . . 62.31 112.468 -170.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 169' ' ' LEU . 48.2 mm -94.5 113.14 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.723 0.297 . . . . 60.21 111.219 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 158' ' ' TYR . 42.7 tt0 -105.75 157.33 17.51 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.973 0.416 . . . . 63.32 111.305 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.445 ' N ' ' HG2' ' A' ' 157' ' ' GLU . 23.1 p90 -92.51 105.24 17.45 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.967 0.413 . . . . 74.24 111.191 176.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.454 ' HD3' ' OG1' ' A' ' 168' ' ' THR . 54.9 mtp85 -127.44 132.33 50.07 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.966 0.412 . . . . 62.41 111.114 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.83 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 6.4 p-10 -88.25 143.08 27.24 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.768 0.655 . . . . 51.23 112.768 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.0 t -109.29 98.2 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.641 -0.708 . . . . 75.31 110.585 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.1 t70 61.59 7.08 1.72 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.543 0.737 . . . . 62.12 112.918 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.26 -27.72 1.54 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.533 -0.842 . . . . 55.11 114.065 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 84.3 m -104.27 114.49 28.76 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 117.252 0.526 . . . . 70.33 111.125 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.83 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 9.3 pt-20 -76.37 122.54 24.62 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.611 0.72 . . . . 51.54 112.098 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -127.14 149.85 70.63 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.471 -0.786 . . . . 53.34 111.639 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.95 120.72 7.92 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.785 2.323 . . . . 74.1 112.766 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.454 ' OG1' ' HD3' ' A' ' 159' ' ' ARG . 69.6 p -111.22 133.37 53.61 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.79 0.328 . . . . 65.21 111.756 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.719 HD11 ' HB1' ' A' ' 154' ' ' ALA . 68.9 tp -77.36 130.99 37.84 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.179 -0.464 . . . . 63.13 111.258 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.403 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 24.3 mmt -113.27 124.46 52.55 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.594 0.358 . . . . 71.24 111.445 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.99 134.82 38.97 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.076 -0.511 . . . . 73.33 110.864 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.506 HG22 HG12 ' A' ' 27' ' ' VAL . 25.7 t -93.13 126.35 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 122.099 -0.375 . . . . 75.31 111.425 -178.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -72.42 -14.88 61.8 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.831 0.678 . . . . 75.33 112.831 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.468 ' H ' HG12 ' A' ' 172' ' ' VAL . 1.3 mp0 -88.31 -2.4 58.58 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.137 -0.352 . . . . 74.42 111.716 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.5 -46.39 6.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.309 0.576 . . . . 73.43 110.428 174.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.7 pt -105.4 132.18 52.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.498 -0.774 . . . . 65.14 110.504 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.415 ' CG1' ' HB2' ' A' ' 5' ' ' LYS . 46.8 pt -94.85 143.47 11.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.2 0.524 . . . . 61.34 111.314 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -94.25 118.24 31.3 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.612 -0.722 . . . . 71.21 111.331 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -122.97 113.99 19.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.359 0.6 . . . . 73.32 110.897 172.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt . . . . . 0 CA--C 1.536 0.435 0 CA-C-N 115.734 -0.666 . . . . 54.41 112.106 -175.113 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 120.935 0.398 . . . . 73.25 111.643 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 178' ' ' GLU . 42.2 tp -92.34 139.0 31.05 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.521 -0.309 . . . . 75.3 110.943 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.0 mt -125.91 119.21 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 122.384 -0.197 . . . . 74.34 110.473 175.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.716 ' HE1' ' HB2' ' A' ' 16' ' ' ASP . 39.6 p90 -121.81 149.8 42.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.47 0.545 . . . . 72.33 112.47 -173.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.567 ' HB3' HD13 ' A' ' 13' ' ' LEU . 12.4 ptmm? -142.92 127.22 17.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.939 -0.573 . . . . 72.23 111.303 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.85 ' HB3' HG22 ' A' ' 176' ' ' ILE . 2.7 p30 -97.29 179.29 4.94 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.206 0.527 . . . . 74.41 111.63 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -47.12 -34.8 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 115.51 -0.768 . . . . 52.04 112.716 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.582 ' HB2' ' HA2' ' A' ' 151' ' ' GLY . 83.2 m-85 -100.27 -49.61 4.21 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.603 0.594 . . . . 71.21 112.603 -175.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 p -70.33 14.97 0.1 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.028 0.751 . . . . 52.51 113.028 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -47.89 -32.24 6.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.207 0.603 . . . . 53.24 111.933 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.67 -61.96 1.57 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.641 0.608 . . . . 73.51 112.641 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.417 ' C ' HD23 ' A' ' 13' ' ' LEU . 43.1 mt-10 -102.43 -33.16 9.64 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.801 0.667 . . . . 65.21 112.801 -174.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.567 HD13 ' HB3' ' A' ' 5' ' ' LYS . 0.8 OUTLIER 40.42 -170.75 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.21 1.189 . . . . 75.25 114.21 -176.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -149.44 165.65 31.46 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.474 0.654 . . . . 62.5 112.655 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -114.2 170.16 8.49 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.699 -0.682 . . . . 74.42 111.082 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.716 ' HB2' ' HE1' ' A' ' 4' ' ' TYR . 6.5 t70 -154.28 169.15 24.35 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 120.878 0.371 . . . . 71.31 111.486 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.2 p -151.7 19.44 0.71 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.027 0.38 . . . . 54.33 112.027 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -108.65 151.07 41.51 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 121.037 0.446 . . . . 52.21 112.194 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.4 111.99 3.27 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.601 2.2 . . . . 62.42 113.595 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.648 ' SD ' ' HB2' ' A' ' 30' ' ' PHE . 18.5 mmt -106.31 166.27 10.65 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.009 -0.541 . . . . 53.34 110.876 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.523 ' NZ ' ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -134.22 129.05 35.14 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.187 -0.321 . . . . 74.5 111.221 172.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 61.4 tp -87.87 101.96 14.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.766 0.317 . . . . 74.11 111.284 -177.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 p -89.19 139.06 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-O 120.909 0.385 . . . . 73.32 111.58 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.2 15.99 2.11 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.139 -0.482 . . . . 72.22 112.264 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.462 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 52.8 m-20 52.77 26.75 4.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.847 0.459 . . . . 45.13 111.646 -177.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.17 -45.68 2.34 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.103 0.478 . . . . 75.41 111.156 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.404 HG12 HG22 ' A' ' 172' ' ' VAL . 30.3 m -133.68 146.06 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.295 0.569 . . . . 75.13 112.51 -177.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 170' ' ' MET . 96.9 m-85 -87.34 144.91 26.55 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.937 -0.574 . . . . 73.33 110.368 172.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 40.7 mt-10 -118.28 143.57 46.48 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.748 0.308 . . . . 73.33 110.85 170.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.705 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 85.6 t80 -133.03 118.44 18.81 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.806 0.336 . . . . 75.22 111.175 175.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.416 ' NZ ' ' HB2' ' A' ' 31' ' ' LYS . 9.8 mtmp? -84.02 109.33 17.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.793 0.33 . . . . 75.54 111.715 -177.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.531 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -90.76 176.6 41.28 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.14 -0.553 . . . . 72.31 113.851 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.514 ' HG3' HG13 ' A' ' 35' ' ' VAL . 10.8 ptpp? -118.46 163.2 17.11 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.725 -0.279 . . . . 63.4 111.123 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -86.53 111.93 21.06 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.522 0.201 . . . . 53.35 110.904 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.514 HG13 ' HG3' ' A' ' 33' ' ' LYS . 17.3 m -139.65 159.31 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.142 0.496 . . . . 54.15 111.728 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 33.2 m -138.04 122.11 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.354 -0.385 . . . . 70.32 111.407 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.838 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 78.8 mtt180 . . . . . 0 C--O 1.24 0.588 0 CA-C-O 121.49 0.662 . . . . 65.23 111.259 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.838 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 7.1 mp0 . . . . . 0 CA--C 1.535 0.381 0 CA-C-O 121.52 0.676 . . . . 72.13 110.743 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.505 ' O ' ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -96.62 135.27 38.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.552 -0.749 . . . . 73.5 111.631 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.58 -125.68 1.5 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.536 -0.84 . . . . 54.44 113.866 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.7 pt -110.61 131.33 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.404 0.621 . . . . 64.14 112.487 -174.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -50.11 -35.22 24.74 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.413 -0.812 . . . . 52.34 112.598 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.531 HG13 ' HA3' ' A' ' 32' ' ' GLY . 66.3 mt -47.28 -50.2 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.18 0.437 . . . . 74.01 112.18 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 17.3 m -90.61 -32.63 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.11 0.411 . . . . 74.42 112.11 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.47 HD12 HG23 ' A' ' 35' ' ' VAL . 80.3 mt -65.76 -37.44 86.35 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.031 0.443 . . . . 73.01 111.415 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -87.49 -1.73 58.13 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 120.715 0.293 . . . . 74.22 111.611 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -123.65 4.1 8.91 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.838 -0.539 . . . . 73.33 112.158 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp 56.06 67.32 1.02 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.41 0.624 . . . . 65.4 112.335 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 68.1 mt -116.79 136.5 52.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.124 -0.489 . . . . 62.23 111.071 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.28 145.05 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.932 0.396 . . . . 55.45 111.372 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -80.37 122.19 26.63 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.977 0.732 . . . . 64.52 112.977 -173.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 94.4 mmm -125.62 155.69 40.36 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.961 -0.563 . . . . 60.44 109.95 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.414 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 47.6 t-20 -139.41 145.75 39.29 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.841 -0.537 . . . . 74.13 111.4 -176.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.6 p -46.83 -43.13 18.26 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.95 1.093 . . . . 71.31 113.95 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.414 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 38.7 p90 -56.3 -31.44 63.67 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.354 0.502 . . . . 53.42 112.354 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -104.83 -47.25 4.09 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.043 0.449 . . . . 74.11 110.927 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.36 3.26 16.11 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.453 0.538 . . . . 64.54 112.453 -172.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.521 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -40.66 -57.68 1.82 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.297 0.851 . . . . 54.02 113.297 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.5 t -65.01 -33.1 75.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.178 0.436 . . . . 44.42 112.178 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.66 -61.79 1.79 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.416 -0.356 . . . . 75.32 111.791 -174.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.694 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 29.7 p90 -65.48 -30.06 70.8 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.08 -0.387 . . . . 75.02 111.308 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -58.48 -43.34 88.92 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.289 0.566 . . . . 75.21 110.719 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.23 -34.15 77.37 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.987 -0.551 . . . . 73.21 111.274 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.694 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 25.4 m-85 -60.92 -44.07 97.7 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.598 0.237 . . . . 71.2 110.745 173.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.3 mm -55.44 -40.2 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.569 -0.287 . . . . 75.12 111.133 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -55.6 -63.97 1.0 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.774 0.321 . . . . 72.43 111.509 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.91 -31.06 72.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.479 -0.328 . . . . 63.41 111.875 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.508 ' CE1' ' HB2' ' A' ' 175' ' ' ALA . 36.9 t80 -62.53 -58.8 6.27 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.664 0.268 . . . . 72.03 111.322 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 56.5 ttp -59.47 -41.91 90.82 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.95 0.405 . . . . 62.11 110.836 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -55.58 -48.12 75.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.059 -0.519 . . . . 74.4 111.262 177.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -66.61 -54.6 21.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.088 -0.505 . . . . 70.31 112.003 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.4 m -59.8 -38.39 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.162 0.43 . . . . 61.34 112.162 -176.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.53 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 46.4 mm -70.51 -46.77 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 122.207 -0.308 . . . . 72.41 110.971 176.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.8 -24.27 61.63 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.976 0.417 . . . . 63.11 111.859 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -89.34 -29.82 18.86 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.455 -0.339 . . . . 72.1 111.763 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 11.9 tpt -81.11 -53.98 5.93 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.732 0.642 . . . . 71.23 112.732 -172.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -71.05 -10.59 60.02 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.05 0.759 . . . . 71.13 113.05 -174.24 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.66 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -60.72 -48.14 83.13 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.152 0.501 . . . . 64.43 111.042 172.723 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -107.55 -36.72 6.38 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.841 0.682 . . . . 73.21 112.841 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.524 ' O ' HG13 ' A' ' 113' ' ' VAL . 3.0 m-20 -112.24 41.15 2.04 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.966 0.412 . . . . 55.12 111.893 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -45.05 -30.46 1.07 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.813 0.845 . . . . 64.03 112.966 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -51.76 140.45 19.16 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.618 0.723 . . . . 73.23 112.66 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 54.2 mttp -65.87 -19.92 66.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.742 1.016 . . . . 64.34 113.742 -169.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.04 -20.96 47.63 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.689 -0.632 . . . . 74.11 111.465 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -94.37 -65.43 0.99 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.884 0.328 . . . . 73.51 111.884 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 107' ' ' ASN . 5.1 m -59.55 -45.6 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 112.921 0.712 . . . . 52.14 112.921 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.516 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 26.2 t70 -60.81 -43.81 97.71 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.634 0.255 . . . . 74.55 111.248 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.41 -49.35 74.1 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.858 0.361 . . . . 74.31 111.277 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -56.43 -54.33 46.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.978 0.418 . . . . 71.1 111.332 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.407 ' HA ' HG22 ' A' ' 120' ' ' ILE . 62.2 tttm -61.73 -31.13 71.28 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.435 -0.348 . . . . 42.52 111.237 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -65.76 -43.34 89.2 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.782 0.325 . . . . 54.42 111.237 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -57.5 -58.13 9.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.048 0.452 . . . . 74.05 111.166 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.407 HG22 ' HA ' ' A' ' 117' ' ' LYS . 11.1 tp -64.37 -40.42 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.018 -0.537 . . . . 75.13 112.066 -175.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.62 ' HA ' HE21 ' A' ' 121' ' ' GLN . 0.0 OUTLIER -66.25 -50.73 62.75 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.315 -0.241 . . . . 65.43 111.412 178.118 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.1 -42.26 61.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.586 -0.816 . . . . 64.23 112.199 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -62.81 -61.9 2.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.332 0.253 . . . . 75.13 111.253 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.5 m -61.26 -44.93 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 112.604 0.594 . . . . 61.14 112.604 -176.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.74 -34.58 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.972 0.415 . . . . 74.1 111.525 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.1 m -80.02 -29.11 39.32 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.031 0.443 . . . . 65.14 111.273 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.9 tp -80.03 -28.82 39.27 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.148 -0.478 . . . . 72.34 111.684 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 93.6 mt -85.14 2.27 44.3 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.598 0.592 . . . . 74.14 112.598 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.21 82.06 0.08 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.231 0.539 . . . . 55.0 110.917 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 65.5 pttt -64.08 -14.99 58.53 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.568 0.951 . . . . 73.4 113.568 -169.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.33 -42.38 98.58 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.138 0.494 . . . . 73.14 110.887 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -108.57 -50.78 2.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.992 -0.549 . . . . 72.33 111.393 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.531 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 55.3 m-85 -66.74 -4.5 9.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.592 0.96 . . . . 72.43 113.592 -173.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 14.1 ptmm? -50.99 -6.6 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.242 0.83 . . . . 72.21 113.242 175.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -77.46 13.28 1.27 Allowed 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.759 -0.588 . . . . 65.21 112.024 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 95.6 mt -89.54 127.92 35.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.014 0.435 . . . . 64.54 111.607 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -100.52 127.59 46.84 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.401 -0.363 . . . . 55.15 110.934 177.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -98.99 110.62 23.2 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.838 0.352 . . . . 73.24 110.976 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.429 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 65.4 m-85 -112.75 139.98 47.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.205 0.526 . . . . 71.11 111.797 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.42 HD11 ' O ' ' A' ' 150' ' ' ASN . 11.2 tt -133.26 155.16 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.821 -0.627 . . . . 74.4 110.96 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.34 125.35 13.03 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.567 -0.349 . . . . 62.02 113.553 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -49.91 -48.8 51.43 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.201 0.445 . . . . 64.44 112.201 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -79.7 -22.11 43.81 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.97 0.414 . . . . 71.14 111.865 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.32 93.36 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.957 0.408 . . . . 73.15 111.296 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.7 -30.93 65.9 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.992 -0.549 . . . . 64.22 111.919 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.81 -28.49 65.76 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.633 0.254 . . . . 74.01 111.668 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.83 -20.53 1.62 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.976 -0.631 . . . . 33.33 113.702 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.84 76.85 0.46 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 117.132 0.466 . . . . 62.05 111.951 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 54.38 103.68 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.72 0.772 . . . . 74.03 112.229 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.577 ' HB3' ' OH ' ' A' ' 91' ' ' TYR . 5.9 m-20 -54.48 -27.56 38.62 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.282 -0.872 . . . . 74.43 112.604 -173.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 8' ' ' PHE . . . 59.5 -166.21 9.39 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 114.821 0.689 . . . . 55.24 114.821 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -96.44 144.01 26.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.786 0.327 . . . . 60.13 111.387 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 44.8 t -77.99 138.01 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.912 0.387 . . . . 70.13 110.748 171.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.611 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -94.54 133.62 37.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.424 -0.353 . . . . 63.34 111.505 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.761 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 35.4 mm -91.98 113.54 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.751 0.31 . . . . 73.1 111.653 -178.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 49.8 mm -96.45 110.04 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.682 0.277 . . . . 63.43 111.084 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.61 132.93 50.28 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.402 -0.363 . . . . 73.2 110.271 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -90.09 89.13 7.55 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.459 0.647 . . . . 74.34 110.624 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -93.53 111.82 23.57 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.612 -0.722 . . . . 75.24 111.816 -172.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.621 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 32.4 t70 -69.91 118.76 13.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.041 0.448 . . . . 54.24 112.048 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 51.9 t -104.37 93.25 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.092 -0.503 . . . . 75.41 110.681 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 60.13 13.78 4.06 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.015 0.746 . . . . 74.41 113.015 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 133.42 -17.94 4.45 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.824 -0.703 . . . . 72.44 113.351 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.3 m -110.12 106.1 15.44 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.548 -0.384 . . . . 62.11 111.453 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 42.7 mt-10 -73.38 106.32 5.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.75 0.31 . . . . 74.41 111.181 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.7 m -105.18 143.23 26.33 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 120.888 0.375 . . . . 71.04 111.356 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.66 123.58 5.39 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.339 2.026 . . . . 72.54 112.682 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 60.0 p -108.29 125.67 51.95 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.174 0.511 . . . . 74.25 111.129 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.705 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 61.5 tp -78.26 114.69 17.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.023 -0.535 . . . . 72.54 111.121 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.761 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 42.5 ttm -101.82 124.25 47.14 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.464 0.306 . . . . 63.31 111.584 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 81.0 mt -138.33 130.71 28.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.794 0.438 . . . . 62.22 111.353 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.441 ' O ' HG12 ' A' ' 176' ' ' ILE . 39.3 t -82.41 126.83 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 122.012 -0.43 . . . . 72.12 111.853 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -71.21 -33.95 70.38 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.985 0.421 . . . . 72.2 111.845 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.438 ' HG2' HG12 ' A' ' 172' ' ' VAL . 0.8 OUTLIER -72.81 -4.46 31.78 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.896 0.379 . . . . 72.32 111.343 177.254 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.508 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . . . -101.17 -49.5 4.07 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.15 0.5 . . . . 51.01 110.609 173.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.85 HG22 ' HB3' ' A' ' 6' ' ' ASP . 36.0 pt -101.21 117.45 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.022 -0.536 . . . . 75.13 111.049 176.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 tp -93.57 128.08 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 121.903 -0.498 . . . . 64.11 109.916 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.666 ' HB2' HD11 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -110.43 131.8 54.74 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.863 0.84 . . . . 74.13 113.115 -171.64 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -94.68 103.48 15.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.819 -1.082 . . . . 63.32 109.309 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 41.9 pttt . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 113.368 0.877 . . . . 71.1 113.368 -169.58 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 120.623 0.249 . . . . 73.4 111.129 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 15' ' ' SER . 29.1 tp -107.14 129.05 54.89 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.903 -0.498 . . . . 64.31 110.721 177.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.512 HG12 ' HB3' ' A' ' 15' ' ' SER . 60.0 mt -110.38 126.26 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.77 0.319 . . . . 71.4 111.124 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -123.38 145.74 48.52 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.933 0.397 . . . . 75.1 111.557 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 3.9 ptpp? -129.36 130.38 45.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.088 0.47 . . . . 71.31 111.652 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 4.0 m-20 -73.02 178.09 4.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.905 -0.588 . . . . 75.22 112.258 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.8 mt -66.56 -41.72 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.122 0.487 . . . . 45.05 111.24 173.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 150' ' ' ASN . 37.9 m-85 -106.28 -32.64 8.09 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.153 -0.476 . . . . 74.4 112.001 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.419 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 2.9 m -93.48 15.0 16.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.278 0.561 . . . . 75.5 111.566 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 13.4 p-10 -60.26 -26.03 66.15 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.08 0.77 . . . . 72.34 113.08 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -68.3 -18.59 64.56 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.858 0.688 . . . . 52.13 112.858 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -85.66 -33.08 21.66 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.646 0.609 . . . . 75.42 112.646 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 56.29 98.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.218 0.532 . . . . 73.21 112.398 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.4 m -95.66 124.63 39.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.157 -0.339 . . . . 55.13 110.73 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.512 ' HB3' HG12 ' A' ' 3' ' ' ILE . 15.3 p -118.69 103.86 10.07 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.074 0.464 . . . . 53.45 112.1 -174.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -132.41 -172.57 2.93 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.035 0.445 . . . . 51.51 111.909 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.1 p -138.42 18.07 2.74 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.413 -0.358 . . . . 71.5 111.809 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -69.11 140.29 90.77 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 111.748 0.277 . . . . 74.42 111.748 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.12 143.25 35.58 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.841 2.361 . . . . 53.4 113.43 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptp -147.35 137.73 23.3 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.992 0.425 . . . . 64.14 111.996 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 67.1 mttm -112.28 156.38 22.49 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.553 -0.294 . . . . 72.0 110.564 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 55.4 tp -121.25 104.5 9.78 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.219 0.451 . . . . 73.54 112.219 -171.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.69 144.92 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-O 121.038 0.447 . . . . 72.41 111.737 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 56.67 12.67 1.17 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.168 -0.469 . . . . 64.23 111.888 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.488 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 62.8 m-20 50.7 29.7 4.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.365 0.602 . . . . 72.14 111.307 -174.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.577 HD22 ' HB3' ' A' ' 119' ' ' LYS . 53.9 tp -126.27 -48.68 1.57 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.899 -0.591 . . . . 75.22 111.41 -177.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 172' ' ' VAL . 10.1 m -128.56 144.86 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.232 -0.44 . . . . 73.13 111.735 -177.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 170' ' ' MET . 98.3 m-85 -85.55 141.09 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 65.42 110.375 176.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 2.8 pm0 -130.97 111.54 12.14 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.389 0.614 . . . . 73.13 111.058 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CZ ' HD23 ' A' ' 169' ' ' LEU . 32.4 p90 -150.46 141.19 22.7 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.977 1.103 . . . . 75.11 113.977 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -94.5 133.64 37.9 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.341 -0.845 . . . . 73.12 111.547 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.63 -167.77 42.44 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.852 -0.69 . . . . 72.21 113.25 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.504 ' HG3' HG13 ' A' ' 35' ' ' VAL . 57.3 tptt -91.74 128.13 37.45 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 122.478 -0.425 . . . . 74.11 110.424 177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -73.62 106.22 5.29 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.06 0.457 . . . . 73.1 110.996 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.504 HG13 ' HG3' ' A' ' 33' ' ' LYS . 27.2 m -137.28 155.22 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.116 -0.493 . . . . 73.43 111.007 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 m -122.54 119.15 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.43 0.633 . . . . 72.13 111.392 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.492 ' HD3' ' OE2' ' A' ' 65' ' ' GLU . 43.0 ttt180 . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 121.059 0.457 . . . . 73.04 111.785 -173.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.633 ' HG2' HD22 ' A' ' 72' ' ' LEU . 28.5 tt0 . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 121.801 0.81 . . . . 72.15 110.16 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -87.44 138.3 31.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.225 -0.898 . . . . 74.23 111.38 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.84 -146.24 9.25 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.447 -0.882 . . . . 62.21 113.612 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.6 pt -110.61 145.04 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.795 0.331 . . . . 72.32 111.763 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 14.9 t70 -41.03 -43.88 2.27 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.625 0.77 . . . . 72.15 112.308 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.9 mt -49.94 -56.29 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.724 0.639 . . . . 73.44 112.724 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.487 ' HA ' HD12 ' A' ' 76' ' ' LEU . 30.1 m -80.23 -35.05 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.394 0.516 . . . . 74.33 112.394 -172.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.633 HD22 ' HG2' ' A' ' 65' ' ' GLU . 85.5 mt -67.53 -46.39 72.96 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.715 0.293 . . . . 72.03 111.657 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -69.25 -21.75 63.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.412 0.523 . . . . 64.53 112.412 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -103.77 8.28 37.2 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 122.129 -0.357 . . . . 74.15 111.243 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.9 tptm 46.49 69.74 0.45 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.698 0.761 . . . . 64.24 112.501 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 71' ' ' VAL . 82.0 mt -106.38 122.03 45.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.644 -0.707 . . . . 64.14 110.343 177.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 p -82.65 141.41 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.09 0.472 . . . . 74.32 111.419 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -79.54 141.41 36.67 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.762 -0.654 . . . . 62.21 112.41 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.424 ' HG3' ' HB2' ' A' ' 84' ' ' ASP . 41.8 tpp -143.55 149.29 37.21 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.923 -0.58 . . . . 63.24 109.903 174.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -130.9 163.69 26.92 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.77 0.655 . . . . 71.21 112.77 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 67.9 m -38.07 -56.46 1.16 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.581 1.326 . . . . 71.14 114.581 -171.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -60.3 -29.76 69.04 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.424 0.898 . . . . 73.34 113.424 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -103.59 -21.34 13.76 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.949 -0.469 . . . . 73.23 111.655 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.424 ' HB2' ' HG3' ' A' ' 79' ' ' MET . 12.5 t70 -77.64 1.15 20.64 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.148 0.425 . . . . 71.23 112.148 -175.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.472 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . . . -39.8 -59.21 1.21 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.444 0.535 . . . . 42.25 112.444 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.7 t -53.23 -39.45 63.78 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.098 -0.501 . . . . 62.14 111.986 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.435 ' O ' ' HD1' ' A' ' 91' ' ' TYR . 25.9 mmt -73.22 -73.88 0.19 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.297 0.48 . . . . 71.41 112.297 -174.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 85' ' ' ALA . 33.4 p90 -55.72 -29.6 59.75 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.406 0.521 . . . . 75.12 112.406 -173.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.427 ' O ' HG22 ' A' ' 92' ' ' ILE . 32.8 mmtp -68.64 -60.49 2.37 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.928 0.394 . . . . 74.22 111.795 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.54 -43.21 99.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.159 0.504 . . . . 54.02 111.972 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.435 ' HD1' ' O ' ' A' ' 87' ' ' MET . 49.5 m-85 -69.74 -37.61 76.52 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.935 0.717 . . . . 73.42 112.935 -176.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 89' ' ' LYS . 11.0 tp -67.03 -33.37 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.304 0.573 . . . . 74.52 110.506 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -66.8 -45.81 77.2 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.914 -0.585 . . . . 71.23 110.975 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -61.7 -39.74 92.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.202 0.525 . . . . 65.54 110.684 172.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.469 ' HE1' ' HB2' ' A' ' 175' ' ' ALA . 89.2 t80 -60.26 -57.89 10.84 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.651 -0.704 . . . . 75.24 111.866 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.1 ptm -54.09 -39.43 66.32 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.842 0.354 . . . . 63.52 111.195 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -64.32 -49.98 69.61 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.66 -0.245 . . . . 71.34 111.574 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -61.43 -46.25 90.92 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.172 0.434 . . . . 64.21 112.172 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.3 m -66.81 -43.06 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.221 0.452 . . . . 75.44 112.221 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.9 mm -69.38 -38.17 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.735 0.302 . . . . 74.1 110.727 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.24 -54.17 40.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.019 0.437 . . . . 65.23 110.915 175.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -68.88 -53.04 23.43 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.22 0.452 . . . . 70.45 112.22 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.7 tpt -65.14 -56.89 10.3 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.254 0.465 . . . . 72.11 112.254 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.8 -43.03 99.88 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.057 0.392 . . . . 72.13 112.057 -174.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -48.97 -45.17 41.65 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.209 0.818 . . . . 74.12 113.209 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.56 18.05 20.12 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.061 0.458 . . . . 72.3 112.095 -176.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.465 ' OD1' HG13 ' A' ' 113' ' ' VAL . 3.1 t-20 -127.61 -65.51 0.92 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.372 -0.377 . . . . 64.2 110.774 176.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 70.01 -25.4 0.15 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.694 0.998 . . . . 74.13 113.694 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' HG22 ' A' ' 113' ' ' VAL . 42.0 m-20 -66.14 112.99 4.19 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.932 0.396 . . . . 75.12 111.584 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -56.05 -32.18 63.82 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.178 0.436 . . . . 71.23 112.178 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.01 -33.96 65.38 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.072 0.397 . . . . 63.24 112.072 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.445 ' HB2' ' OD1' ' A' ' 107' ' ' ASN . 3.3 m-20 -94.05 -55.15 3.31 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.129 0.418 . . . . 75.31 112.129 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.465 HG13 ' OD1' ' A' ' 107' ' ' ASN . 17.0 m -62.79 -35.26 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.999 0.74 . . . . 72.22 112.999 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -75.39 -25.7 57.86 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.283 0.563 . . . . 74.04 110.452 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.05 -44.81 52.93 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.143 -0.48 . . . . 53.04 110.673 173.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.42 -46.28 90.59 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.21 0.529 . . . . 74.24 110.164 173.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -50.3 -42.1 51.99 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.667 -0.697 . . . . 73.22 111.065 171.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -64.33 -42.24 96.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.178 -0.464 . . . . 64.05 111.691 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.577 ' HB3' HD22 ' A' ' 26' ' ' LEU . 14.6 mptt -58.1 -55.18 38.31 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.8 0.333 . . . . 75.45 110.985 174.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.524 HD13 HD21 ' A' ' 26' ' ' LEU . 41.8 mm -59.51 -41.86 86.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.447 -0.342 . . . . 71.25 111.391 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -57.08 -57.08 14.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.512 -0.313 . . . . 74.14 111.13 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.12 -40.11 82.44 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.077 -0.582 . . . . 60.33 112.579 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -61.55 -51.6 67.92 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 111.631 0.234 . . . . 71.0 111.631 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.28 -41.25 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 112.573 0.583 . . . . 73.11 112.573 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.9 m -64.54 -26.0 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 121.936 -0.478 . . . . 71.43 111.37 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.6 t -84.89 -46.84 10.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.901 0.381 . . . . 72.53 110.883 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.5 tp -58.62 -39.21 79.82 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.983 0.513 . . . . 61.05 112.282 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.5 mt -81.6 2.6 28.57 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.226 0.454 . . . . 63.01 112.226 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.45 90.46 0.73 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.108 0.48 . . . . 75.21 111.169 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 23.7 pttm -52.19 -32.34 35.85 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.718 -0.674 . . . . 65.01 112.597 -177.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -65.59 -28.81 69.41 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.354 0.501 . . . . 73.21 112.354 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -108.03 -58.88 1.92 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.543 0.687 . . . . 74.3 111.302 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.552 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 29.7 m-85 -67.9 -3.27 9.26 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.365 0.876 . . . . 73.32 113.365 -172.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 36.9 ttmt -36.11 -32.48 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.886 0.699 . . . . 73.43 112.886 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -91.25 33.08 0.99 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.786 0.662 . . . . 74.52 112.786 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 56.6 mt -88.47 125.99 35.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.215 0.531 . . . . 65.45 111.529 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -101.25 112.84 25.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.042 -0.526 . . . . 62.42 110.532 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.632 ' HB3' HG11 ' A' ' 153' ' ' VAL . 93.1 m-85 -89.81 109.4 20.4 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.543 -0.298 . . . . 63.11 111.257 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.438 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 67.1 m-85 -99.77 124.48 45.08 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.161 0.505 . . . . 71.15 111.662 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.513 ' HB ' HG22 ' A' ' 153' ' ' VAL . 8.6 tt -121.36 146.82 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.08 -0.509 . . . . 73.3 111.134 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.42 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -59.7 124.24 35.67 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.335 -0.46 . . . . 31.21 113.794 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -44.61 -51.1 9.36 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.53 0.567 . . . . 72.23 112.53 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -50.76 -36.42 36.55 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.902 0.705 . . . . 75.3 112.902 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -93.38 -34.57 13.41 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.848 0.356 . . . . 43.21 111.946 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.82 -19.56 51.57 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.524 0.565 . . . . 74.44 112.524 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -65.21 -18.56 65.41 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.865 0.364 . . . . 70.43 111.875 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.72 47.97 0.02 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.714 -0.755 . . . . 44.32 113.346 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.77 116.66 16.84 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.954 0.407 . . . . 72.24 111.614 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -74.5 23.15 0.09 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.258 0.466 . . . . 65.13 112.258 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 8' ' ' PHE . 37.6 m-80 -125.6 18.95 8.04 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.109 0.48 . . . . 65.22 111.001 177.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.2 91.95 1.63 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.079 -0.581 . . . . 75.45 112.46 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -58.96 119.46 7.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.285 0.564 . . . . 73.43 111.617 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 138' ' ' PHE . 91.9 t -87.68 142.16 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.823 0.675 . . . . 70.23 112.823 -175.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.897 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -101.78 133.21 46.89 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.641 -0.709 . . . . 74.32 110.442 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.4 mt -99.94 117.3 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 112.655 0.613 . . . . 71.12 112.655 -171.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 40.9 mm -100.94 123.33 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 111.76 0.282 . . . . 63.34 111.76 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -111.9 133.68 53.94 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.696 0.284 . . . . 74.13 111.046 173.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -84.68 95.57 8.95 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.332 0.586 . . . . 71.34 110.183 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.81 113.38 24.3 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.637 -0.711 . . . . 71.53 111.277 -173.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -74.18 118.24 16.91 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.468 -0.333 . . . . 73.33 110.49 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.52 91.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.781 0.324 . . . . 71.11 111.814 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 t70 52.72 38.54 26.57 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.641 0.608 . . . . 74.54 112.641 173.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 103.03 -5.72 50.42 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.145 -0.55 . . . . 41.33 113.772 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.519 HG22 HG13 ' A' ' 166' ' ' VAL . 61.0 m -110.21 122.19 47.06 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.349 -0.501 . . . . 71.11 110.925 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 165' ' ' GLU . 0.4 OUTLIER -92.69 100.38 12.89 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.285 0.564 . . . . 71.01 111.24 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.519 HG13 HG22 ' A' ' 164' ' ' THR . 19.0 m -108.07 113.27 60.97 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 112.361 0.504 . . . . 62.13 112.361 -177.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.12 113.8 3.87 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.089 1.859 . . . . 62.42 111.611 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.6 p -104.64 151.98 23.02 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.482 -0.326 . . . . 70.23 111.378 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.897 HD11 ' HB1' ' A' ' 154' ' ' ALA . 26.2 tp -102.3 122.95 45.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.54 -0.3 . . . . 74.44 110.857 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.581 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 63.0 mtt -101.81 124.25 47.13 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.599 0.562 . . . . 73.24 111.378 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.9 mt -138.2 130.58 29.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.492 -0.777 . . . . 54.3 110.609 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 174' ' ' GLU . 25.9 t -79.72 123.37 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 122.077 -0.389 . . . . 52.02 111.177 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.498 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -68.75 -11.07 59.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.642 0.608 . . . . 74.55 112.642 -175.695 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.492 ' H ' HG12 ' A' ' 172' ' ' VAL . 13.9 mm-40 -97.3 -8.3 30.05 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.073 0.463 . . . . 64.52 111.125 172.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.469 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -97.45 -14.37 21.2 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.291 0.567 . . . . 71.4 110.669 175.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 63.4 mt -134.77 128.59 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.469 -0.787 . . . . 61.2 109.806 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 43.5 mm -93.47 128.41 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.773 0.321 . . . . 74.11 111.392 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -84.94 114.44 22.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.245 -0.434 . . . . 73.2 110.949 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.44 112.72 23.46 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.706 0.765 . . . . 72.31 110.89 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.456 ' HB2' ' NZ ' ' A' ' 180' ' ' LYS . 4.9 ttmp? . . . . . 0 CA--C 1.544 0.717 0 CA-C-N 115.657 -0.702 . . . . 64.41 112.095 -172.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.737 0.303 . . . . 73.41 111.761 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.41 160.01 14.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.457 0.303 . . . . 71.42 111.092 -176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 33.9 pt -130.58 138.8 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.976 -0.452 . . . . 73.24 112.037 177.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 14' ' ' SER . 49.7 p90 -122.55 138.24 54.63 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.231 0.539 . . . . 74.43 111.532 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.629 ' HG2' HD12 ' A' ' 13' ' ' LEU . 5.2 mtpm? -132.18 112.91 12.68 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.46 -0.791 . . . . 43.2 111.307 -176.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 176' ' ' ILE . 6.6 m-20 -73.46 155.31 39.39 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.041 -0.412 . . . . 74.22 111.495 173.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 pt -72.46 -24.93 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.967 0.413 . . . . 71.21 111.513 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.73 -41.76 4.92 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.537 0.569 . . . . 73.22 112.537 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m -88.69 15.13 8.66 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.304 0.573 . . . . 71.34 111.548 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.446 ' O ' HD22 ' A' ' 13' ' ' LEU . 34.2 t70 -49.05 -37.81 22.02 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.838 1.051 . . . . 75.35 113.838 -173.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.1 -37.13 81.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.703 0.631 . . . . 75.43 112.703 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -104.2 25.79 9.62 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.887 -0.508 . . . . 65.4 112.014 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.629 HD12 ' HG2' ' A' ' 5' ' ' LYS . 2.2 pt? -44.16 158.76 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.02 -0.536 . . . . 74.33 111.812 173.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 62.6 m -143.55 152.56 41.59 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.425 0.898 . . . . 74.34 113.425 -174.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 78.0 p -91.58 125.41 36.31 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.646 -0.707 . . . . 71.15 109.851 172.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -112.89 175.65 5.35 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.98 0.419 . . . . 73.24 111.708 -171.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.1 t -144.82 8.5 1.28 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.052 0.39 . . . . 51.34 112.052 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.433 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 78.9 m-85 -96.87 150.14 36.55 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 122.221 -0.299 . . . . 74.05 111.674 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -91.66 104.67 0.24 Allowed 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.842 2.361 . . . . 71.42 113.468 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.497 ' N ' ' SD ' ' A' ' 20' ' ' MET . 1.6 mpt? -85.9 162.11 18.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.963 0.411 . . . . 51.52 111.534 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -129.19 119.89 24.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.411 -0.359 . . . . 74.23 111.139 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 tp -74.79 114.37 13.15 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.207 0.527 . . . . 73.32 111.081 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.31 145.63 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.302 -0.408 . . . . 61.32 111.132 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.9 t70 62.79 8.51 3.1 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 120.987 0.422 . . . . 53.52 111.413 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 58.02 11.8 1.59 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.266 0.627 . . . . 74.14 111.598 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 120' ' ' ILE . 30.8 tp -117.51 -46.74 2.66 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.042 -0.526 . . . . 72.13 111.279 -172.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.96 149.22 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.69 0.626 . . . . 53.43 112.69 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.573 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 75.3 m-85 -86.45 123.89 32.17 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.143 -0.48 . . . . 71.2 111.006 175.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -99.86 138.25 37.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.062 -0.517 . . . . 73.41 110.642 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.523 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 46.4 t80 -137.79 122.7 18.93 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.19 0.519 . . . . 75.4 111.562 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -75.37 123.46 25.41 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.57 0.581 . . . . 74.52 112.57 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.15 142.74 15.72 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.197 -0.456 . . . . 71.52 112.873 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -91.7 145.32 24.68 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.707 -0.29 . . . . 72.31 111.185 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -66.72 105.42 1.55 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.302 . . . . 72.32 110.578 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.589 HG23 HD12 ' A' ' 72' ' ' LEU . 10.8 m -146.82 158.84 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.33 0.585 . . . . 71.51 111.419 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.26 146.92 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.084 -0.507 . . . . 63.32 111.171 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.51 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 19.9 mmt85 . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 120.873 0.368 . . . . 73.41 111.136 172.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 39.8 mt-10 . . . . . 0 CA--C 1.537 0.47 0 CA-C-O 121.357 0.599 . . . . 62.01 110.567 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -88.31 132.64 34.33 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.858 -0.61 . . . . 64.41 111.231 177.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.5 -133.65 3.53 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.197 -1.001 . . . . 45.2 113.979 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 70' ' ' ILE . 7.4 pt -111.2 141.48 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.028 0.442 . . . . 73.53 112.189 -175.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -45.99 -34.44 4.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.868 -0.605 . . . . 75.35 112.013 177.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 68' ' ' ILE . 50.7 mt -48.26 -62.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.309 0.576 . . . . 71.54 111.913 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.3 m -77.22 -31.11 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.022 -0.535 . . . . 74.14 112.211 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.589 HD12 HG23 ' A' ' 35' ' ' VAL . 68.8 mt -74.08 -38.61 63.85 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.835 0.35 . . . . 61.01 111.802 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -83.91 -26.18 29.57 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.801 0.334 . . . . 64.2 111.386 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -95.43 -1.12 51.57 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 120.837 0.351 . . . . 73.21 110.745 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.7 tptm 49.65 70.92 0.44 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.141 0.976 . . . . 75.25 112.955 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.1 mt -107.14 148.91 28.25 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.791 -0.641 . . . . 63.41 111.041 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 140' ' ' ILE . 14.1 p -91.08 142.34 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 120.971 0.415 . . . . 64.02 111.873 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -79.16 143.32 35.54 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.964 0.727 . . . . 63.43 112.964 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.404 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 96.8 mmm -139.46 155.42 47.6 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.28 0.632 . . . . 75.4 110.939 177.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -131.75 133.1 44.42 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.035 0.445 . . . . 72.25 112.145 -173.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.4 p -38.32 -46.76 1.14 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.924 1.453 . . . . 73.34 114.924 -173.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -55.68 -34.76 65.34 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.02 0.438 . . . . 62.04 111.824 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -91.68 -37.69 12.88 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.16 0.505 . . . . 64.11 111.19 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.404 ' OD1' ' HB3' ' A' ' 79' ' ' MET . 3.8 m-20 -72.26 -6.34 42.3 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.602 0.593 . . . . 74.54 112.602 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.473 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -39.6 -63.24 0.59 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 112.992 0.738 . . . . 42.33 112.992 -177.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.5 m -60.35 -35.3 75.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.15 0.5 . . . . 74.54 111.602 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.8 mtp -69.66 -56.48 7.13 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.064 -0.517 . . . . 71.4 112.288 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.473 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 4.2 p90 -68.63 -25.98 65.11 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.915 -0.49 . . . . 70.53 112.304 -175.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.42 ' HA ' HG22 ' A' ' 92' ' ' ILE . 18.4 ptmt -73.91 -32.93 63.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 119.883 -0.727 . . . . 70.32 110.993 176.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.58 74.61 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.465 0.65 . . . . 52.14 110.157 170.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -53.43 -55.92 21.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.131 -0.94 . . . . 74.33 111.174 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.42 HG22 ' HA ' ' A' ' 89' ' ' LYS . 10.4 tp -63.27 -34.45 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 111.744 0.276 . . . . 74.53 111.744 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -63.5 -55.65 22.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.831 0.348 . . . . 73.12 111.213 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -61.09 -42.17 98.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.731 0.3 . . . . 75.2 111.361 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.511 ' O ' HG22 ' A' ' 99' ' ' VAL . 41.0 t80 -52.31 -57.48 9.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.157 -0.474 . . . . 72.55 111.278 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.426 ' HA ' ' CE ' ' A' ' 96' ' ' MET . 3.2 mmt -55.3 -52.95 61.78 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.393 -0.367 . . . . 73.15 111.851 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -54.14 -50.51 66.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.834 0.349 . . . . 65.22 111.481 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -64.17 -56.79 12.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.243 -0.435 . . . . 75.44 111.94 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 95' ' ' PHE . 24.2 m -63.58 -40.09 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.37 0.507 . . . . 75.14 112.37 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.6 mm -69.92 -44.98 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 122.217 -0.302 . . . . 63.31 111.375 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.61 -42.34 98.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.98 0.419 . . . . 62.33 111.035 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -68.38 -49.57 59.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.11 -0.496 . . . . 70.42 111.641 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.4 ttm -66.48 -49.49 66.44 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.923 0.342 . . . . 75.54 111.923 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.35 -11.76 11.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.895 0.379 . . . . 72.1 111.819 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -68.59 -48.0 65.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.861 0.362 . . . . 62.1 111.059 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.51 -36.01 6.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.134 0.42 . . . . 72.01 112.134 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -84.74 19.35 2.07 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 120.961 0.41 . . . . 53.14 111.039 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -28.41 -30.97 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.448 1.647 . . . . 74.21 115.448 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -50.27 118.22 2.85 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.022 0.439 . . . . 62.45 111.586 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 96.1 mttt -56.95 -22.49 38.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.163 -0.471 . . . . 63.44 111.547 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.02 -31.05 44.54 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.039 0.447 . . . . 70.31 111.82 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -77.21 -62.22 1.73 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.195 0.521 . . . . 70.21 110.927 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.3 m -63.24 -24.29 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.739 0.644 . . . . 64.14 112.739 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 20.4 t70 -62.33 -47.94 82.02 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.004 0.43 . . . . 73.33 110.159 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 119' ' ' LYS . . . -59.8 -42.32 93.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.947 -0.569 . . . . 73.0 111.453 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -64.24 -55.17 23.42 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.7 0.285 . . . . 71.32 111.708 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -55.57 -42.33 74.56 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.366 0.603 . . . . 75.31 110.997 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 118' ' ' LYS . 28.0 ttmt -71.35 -30.08 65.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.627 -0.715 . . . . 73.51 110.954 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 37.9 tptt -64.25 -41.66 96.86 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.259 0.552 . . . . 71.34 109.929 173.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.516 HD13 HD21 ' A' ' 26' ' ' LEU . 31.8 mm -65.71 -42.0 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.618 -0.719 . . . . 70.51 110.835 173.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 125' ' ' VAL . 68.2 mm-40 -55.84 -51.87 66.01 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.72 0.267 . . . . 70.03 111.72 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.21 -42.85 83.46 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.474 -0.869 . . . . 72.52 112.198 175.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -59.92 -55.54 32.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.94 0.496 . . . . 74.41 111.547 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.0 m -66.98 -42.13 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 112.529 0.566 . . . . 74.02 112.529 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 121' ' ' GLN . 69.1 t -57.73 -34.55 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.254 0.549 . . . . 73.05 111.212 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.5 t -75.94 -42.73 47.78 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.224 -0.444 . . . . 70.25 111.52 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.449 HD21 HD13 ' A' ' 155' ' ' ILE . 30.5 tp -75.0 -29.07 60.78 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.958 -0.565 . . . . 75.33 112.248 -173.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.17 2.75 51.44 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.64 0.607 . . . . 73.22 112.64 -176.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.514 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -60.3 94.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.196 0.522 . . . . 53.23 111.17 177.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.58 -16.85 58.41 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.16 0.8 . . . . 75.42 113.16 -170.365 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.56 ' N ' ' HD2' ' A' ' 130' ' ' LYS . 3.9 m-20 -67.35 -46.01 74.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.002 0.43 . . . . 72.34 111.557 -175.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.556 HH21 ' HE2' ' A' ' 158' ' ' TYR . 39.8 mtp180 -107.36 -48.53 3.43 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.371 0.605 . . . . 70.55 111.796 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.514 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 44.5 m-85 -67.92 -6.33 21.46 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.849 -0.614 . . . . 74.12 112.608 -172.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 38.4 ttpt -53.09 -26.0 14.84 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.099 0.476 . . . . 74.21 110.93 171.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -97.19 34.04 1.84 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.579 0.585 . . . . 44.32 112.579 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.412 HD11 ' HD2' ' A' ' 133' ' ' PHE . 70.6 mt -87.96 151.18 22.98 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.895 0.379 . . . . 73.01 110.87 175.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -108.79 134.62 51.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.673 -0.239 . . . . 64.41 111.453 -178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.576 ' HB3' HG13 ' A' ' 153' ' ' VAL . 66.7 m-85 -109.66 133.46 53.09 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.268 -0.27 . . . . 74.33 110.629 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -129.41 138.89 51.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.089 0.471 . . . . 73.05 111.017 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.48 ' O ' HG12 ' A' ' 77' ' ' VAL . 12.7 tt -141.33 158.85 22.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.367 -0.379 . . . . 73.31 111.139 -175.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.97 137.78 50.16 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.931 -0.652 . . . . 34.22 112.169 173.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -36.92 85.07 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.624 0.602 . . . . 63.21 112.624 -175.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 143' ' ' ARG . 24.6 mmt180 -63.45 -49.3 74.23 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.128 -0.357 . . . . 72.01 111.319 176.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.504 ' HB1' ' HA3' ' A' ' 151' ' ' GLY . . . -55.86 -50.34 70.86 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.022 0.439 . . . . 60.35 111.501 173.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.61 -30.93 65.74 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.12 0.415 . . . . 62.21 112.12 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -102.05 14.74 31.12 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.474 0.546 . . . . 74.13 112.474 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.7 -44.53 0.02 OUTLIER Glycine 0 CA--C 1.531 1.067 0 C-N-CA 119.996 -1.097 . . . . 35.33 114.976 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -111.76 108.93 18.53 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.873 0.694 . . . . 64.25 112.873 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -63.55 -24.59 67.87 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.762 0.315 . . . . 74.44 111.766 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -92.03 19.86 6.37 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.835 0.309 . . . . 71.43 111.835 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.504 ' HA3' ' HB1' ' A' ' 144' ' ' ALA . . . -68.33 163.11 49.06 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.048 -0.596 . . . . 51.33 113.133 178.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -68.11 102.32 1.31 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.417 -0.461 . . . . 70.41 112.038 -177.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 138' ' ' PHE . 24.6 t -80.92 99.93 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.383 0.611 . . . . 72.52 110.332 168.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.678 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -73.8 129.79 38.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.676 -0.693 . . . . 71.33 110.635 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.449 HD13 HD21 ' A' ' 127' ' ' LEU . 57.6 mt -95.57 125.62 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.991 0.424 . . . . 64.54 111.429 -175.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 50.3 mm -100.04 106.7 19.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-O 121.039 0.447 . . . . 73.03 110.695 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.43 152.62 20.15 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.727 -1.124 . . . . 74.33 111.239 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.556 ' HE2' HH21 ' A' ' 132' ' ' ARG . 39.7 p90 -100.3 122.22 42.74 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.983 -0.448 . . . . 74.14 110.62 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.566 ' HE ' ' HB ' ' A' ' 168' ' ' THR . 0.1 OUTLIER -136.93 156.4 48.51 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.873 0.694 . . . . 74.32 112.873 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.46 127.61 32.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.18 -0.918 . . . . 73.25 112.575 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.5 t -129.36 99.93 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.968 -0.56 . . . . 72.11 110.969 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 57.23 25.11 10.65 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.321 0.489 . . . . 72.12 112.321 176.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.46 -23.36 26.77 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.314 -0.469 . . . . 52.14 113.465 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.2 p -101.58 149.3 24.25 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.409 -0.465 . . . . 74.21 111.666 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.27 121.34 34.54 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.324 0.583 . . . . 71.24 112.076 -176.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.77 126.93 26.83 Favored Pre-proline 0 C--O 1.24 0.584 0 O-C-N 121.654 -0.654 . . . . 65.2 111.256 174.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.99 114.53 3.02 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.264 1.976 . . . . 64.11 111.426 171.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.566 ' HB ' ' HE ' ' A' ' 159' ' ' ARG . 10.2 t -101.48 149.81 23.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.303 -0.408 . . . . 50.11 111.888 -176.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.678 HD11 ' HB1' ' A' ' 154' ' ' ALA . 53.0 tp -78.67 128.46 33.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.225 -0.443 . . . . 70.11 110.337 174.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 46.8 tpp -117.7 122.53 43.76 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.868 0.366 . . . . 73.52 111.021 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 98.1 mt -137.78 155.13 49.36 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.808 0.443 . . . . 73.23 109.875 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.505 HG11 ' CE1' ' A' ' 95' ' ' PHE . 40.6 t -99.87 134.82 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.744 -0.598 . . . . 73.02 112.112 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.573 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -60.74 -39.67 89.51 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.155 0.798 . . . . 61.45 113.155 -172.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -95.15 12.43 28.79 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.854 0.687 . . . . 51.52 112.854 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.4 -33.67 8.08 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.558 0.694 . . . . 42.24 109.985 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 6' ' ' ASP . 3.9 tt -128.01 117.59 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.043 -0.98 . . . . 73.44 110.424 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 5' ' ' LYS . 8.3 tp -94.25 129.41 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.585 0.707 . . . . 74.55 111.869 -175.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -92.9 123.58 36.26 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.524 -0.762 . . . . 72.41 110.336 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -124.9 143.37 50.89 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.283 0.563 . . . . 64.51 111.153 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.577 0.703 . . . . 64.35 111.816 179.218 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.949 0.404 . . . . 71.51 111.95 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 178' ' ' GLU . 59.8 tp -134.28 131.9 38.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.659 -0.496 . . . . 63.5 109.659 172.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 54.3 mt -104.1 117.69 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 121.903 -0.498 . . . . 72.04 110.473 -177.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -111.05 142.73 42.81 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.859 0.838 . . . . 74.52 112.233 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -137.46 111.15 8.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.686 -1.143 . . . . 62.05 110.777 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.469 ' HB2' ' H ' ' A' ' 9' ' ' THR . 2.4 m-20 -87.13 174.39 8.66 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.279 0.561 . . . . 54.11 111.489 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.6 mt -68.42 -28.16 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.356 0.598 . . . . 73.24 110.474 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -97.26 -44.0 7.1 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.783 -0.644 . . . . 61.43 112.161 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.469 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 37.8 p -81.07 15.62 1.81 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.319 0.859 . . . . 74.01 113.319 -172.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -54.68 -31.02 57.18 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.913 0.387 . . . . 72.21 111.692 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -71.68 -37.85 70.69 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.205 0.526 . . . . 75.2 111.129 174.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 10.0 tp10 -96.25 25.06 5.17 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.837 -0.619 . . . . 64.25 111.105 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.49 107.22 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.867 0.867 . . . . 62.4 112.089 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.9 t -122.16 175.29 6.45 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.704 0.631 . . . . 71.42 112.704 -166.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.7 p -150.33 130.94 13.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.937 -0.574 . . . . 64.33 111.535 -176.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -123.97 -162.76 1.09 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 120.825 0.345 . . . . 63.04 111.23 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.5 m -152.32 29.95 0.55 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.087 0.47 . . . . 51.12 110.826 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -108.27 146.11 32.91 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.167 -0.47 . . . . 74.43 111.036 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.52 159.14 54.76 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.246 1.964 . . . . 60.23 113.904 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.429 ' N ' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -142.05 128.9 20.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.327 0.584 . . . . 63.21 110.639 174.458 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.695 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 11.2 mmmm -98.91 97.96 9.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.259 -0.428 . . . . 74.0 111.925 -173.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 43.2 tp -75.13 91.21 2.57 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.643 -0.661 . . . . 54.12 111.37 -178.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.3 p -90.5 146.89 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 115.9 -0.591 . . . . 72.3 111.148 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 56.49 11.61 0.89 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 120.788 0.328 . . . . 72.45 111.76 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.477 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 7.9 m-20 52.92 30.68 9.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.164 0.507 . . . . 75.55 111.106 -175.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.462 HD11 HD11 ' A' ' 120' ' ' ILE . 30.0 tp -130.23 -43.5 1.17 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.723 -176.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.13 159.78 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.353 0.501 . . . . 44.35 112.353 -175.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 170' ' ' MET . 66.1 m-85 -103.27 129.97 50.39 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.945 -0.57 . . . . 74.5 111.464 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.695 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 15.3 tt0 -96.43 142.15 28.88 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.877 0.871 . . . . 72.52 110.627 175.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.639 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 63.3 t80 -147.33 130.66 16.59 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.74 0.305 . . . . 74.14 111.222 173.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -94.56 135.95 35.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.006 0.432 . . . . 75.12 111.176 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.749 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -123.02 147.68 16.72 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.203 -0.522 . . . . 72.02 113.192 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -91.22 136.59 32.99 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.607 -0.349 . . . . 62.25 110.724 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -65.25 106.87 1.43 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.119 0.485 . . . . 74.51 110.923 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.423 HG23 HD12 ' A' ' 72' ' ' LEU . 34.4 m -131.84 158.2 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.045 0.45 . . . . 73.1 111.136 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.686 HG12 ' HG3' ' A' ' 66' ' ' ARG . 12.2 m -137.27 137.44 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.772 0.32 . . . . 63.11 111.182 -178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.918 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 6.5 ttm180 . . . . . 0 C--O 1.238 0.471 0 CA-C-O 120.868 0.366 . . . . 53.01 111.863 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.918 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 32.5 tt0 . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 121.838 0.828 . . . . 64.41 109.851 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.686 ' HG3' HG12 ' A' ' 36' ' ' VAL . 40.4 ttp180 -105.51 124.53 49.71 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.297 -0.865 . . . . 73.5 111.652 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.52 -132.28 2.74 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.032 -0.604 . . . . 61.53 113.064 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.624 HD12 HD12 ' A' ' 70' ' ' ILE . 22.1 pt -111.1 137.66 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 112.271 0.471 . . . . 64.25 112.271 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -39.54 -44.49 1.44 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.327 0.651 . . . . 74.2 112.55 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.749 HG13 ' HA3' ' A' ' 32' ' ' GLY . 67.0 mt -40.39 -53.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.773 0.657 . . . . 51.51 112.773 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.479 ' HA ' HD12 ' A' ' 76' ' ' LEU . 23.1 m -94.68 -33.91 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.406 0.521 . . . . 64.03 112.406 -173.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.423 HD12 HG23 ' A' ' 35' ' ' VAL . 62.1 mt -68.38 -49.75 57.9 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.024 0.44 . . . . 62.43 111.534 -176.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -62.67 -21.16 65.52 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 120.854 0.359 . . . . 74.33 111.553 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -104.92 -0.28 27.17 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.822 0.305 . . . . 72.43 111.822 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.42 69.98 0.68 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.247 0.546 . . . . 73.34 112.273 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 91.4 mt -110.85 136.48 49.82 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.095 -0.502 . . . . 62.21 111.086 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.405 HG13 HG23 ' A' ' 140' ' ' ILE . 5.6 p -88.04 142.15 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.17 0.51 . . . . 64.41 111.437 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER -85.71 137.91 32.49 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.342 0.867 . . . . 74.22 113.342 -171.709 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 75.0 mtp -134.49 140.31 46.1 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.667 -0.697 . . . . 65.14 110.896 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -89.34 157.54 18.14 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.023 0.439 . . . . 75.11 111.937 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 136' ' ' LEU . 79.8 m -53.85 -45.03 70.8 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.919 0.711 . . . . 74.34 112.919 -175.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -60.39 -20.29 59.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.606 0.595 . . . . 53.53 112.606 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -99.42 -28.98 13.01 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.164 0.431 . . . . 51.13 112.164 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.41 -7.53 55.24 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.626 0.602 . . . . 72.43 112.626 -173.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.31 -43.21 10.55 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.078 0.77 . . . . 61.14 113.078 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.3 m -66.97 -39.58 87.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.732 0.301 . . . . 73.22 111.498 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.5 mmt -62.75 -44.44 96.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.401 -0.363 . . . . 70.51 110.657 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -51.91 -52.08 52.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.801 0.334 . . . . 62.32 111.578 173.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -58.84 -43.01 90.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.922 0.391 . . . . 72.13 111.656 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.34 -50.87 23.57 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.025 0.44 . . . . 65.51 111.881 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -58.83 -53.75 54.9 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.781 -0.645 . . . . 75.3 111.86 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.4 mm -64.11 -37.33 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 111.907 0.336 . . . . 72.32 111.907 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -57.36 -62.66 1.62 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.204 0.526 . . . . 75.14 111.028 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.67 -44.67 85.91 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.806 -0.634 . . . . 74.31 111.221 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.536 ' CZ ' HG11 ' A' ' 172' ' ' VAL . 66.1 t80 -61.07 -66.11 0.59 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.936 -0.574 . . . . 72.32 112.314 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 48.0 ttm -54.95 -45.2 74.86 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.174 0.435 . . . . 54.14 112.174 -172.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.31 -43.96 93.08 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.696 0.284 . . . . 74.03 111.643 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -71.19 -43.01 68.27 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.182 0.438 . . . . 65.53 112.182 -176.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.1 m -72.2 -39.05 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.23 0.456 . . . . 54.41 112.23 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.99 -45.97 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 122.152 -0.342 . . . . 75.3 110.26 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.9 -38.76 73.27 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.369 0.604 . . . . 73.51 110.647 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -60.59 -38.85 85.98 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.729 -0.669 . . . . 70.22 111.976 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.48 ' HG2' HG12 ' A' ' 113' ' ' VAL . 35.3 ttm -88.39 -48.85 7.33 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.228 0.455 . . . . 74.55 112.228 -173.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.548 ' HA ' HG11 ' A' ' 113' ' ' VAL . 11.5 pt-20 -62.2 -24.45 67.22 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.174 -0.329 . . . . 70.23 111.814 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -58.54 -54.61 45.14 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.003 0.371 . . . . 74.21 112.003 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -100.6 -37.04 8.94 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.837 0.68 . . . . 62.41 112.837 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -68.39 -50.49 52.64 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.862 -0.524 . . . . 60.44 110.51 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 45.67 19.87 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.676 1.361 . . . . 62.43 114.676 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -102.68 124.51 48.36 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.858 -0.526 . . . . 72.55 110.595 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -52.9 -58.11 8.03 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.626 0.602 . . . . 74.12 112.626 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.61 -11.9 13.49 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.686 0.625 . . . . 71.24 112.686 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -91.16 -63.09 1.31 Allowed 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.927 0.394 . . . . 74.04 111.0 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 104' ' ' GLU . 17.4 m -66.72 -33.74 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 112.631 0.604 . . . . 71.15 112.631 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.18 -31.3 71.62 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.998 0.428 . . . . 75.21 110.343 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.51 -46.01 60.86 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.26 -0.427 . . . . 60.1 111.171 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.455 ' CZ ' ' HG3' ' A' ' 174' ' ' GLU . 85.4 t80 -59.43 -48.0 83.32 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.189 0.519 . . . . 71.25 110.728 175.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -55.18 -39.07 69.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.913 -0.585 . . . . 73.14 110.774 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -65.42 -36.61 84.46 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.054 -0.521 . . . . 75.21 110.972 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -64.0 -52.45 59.52 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.216 -0.447 . . . . 65.13 111.61 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.462 HD11 HD11 ' A' ' 26' ' ' LEU . 42.1 mm -63.41 -42.44 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.853 0.359 . . . . 75.12 111.38 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -60.95 -48.26 82.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.824 0.345 . . . . 74.01 110.922 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.51 -38.22 95.44 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.157 -0.544 . . . . 54.22 112.564 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 50.7 t90 -60.73 -55.1 37.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.647 0.261 . . . . 74.42 111.215 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.2 m -66.17 -47.47 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 112.482 0.549 . . . . 71.31 112.482 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -59.52 -35.93 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 121.995 -0.441 . . . . 62.2 111.684 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.5 t -78.52 -41.46 32.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.913 0.387 . . . . 74.22 111.017 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 155' ' ' ILE . 52.1 tp -63.82 -38.24 90.36 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.104 -0.498 . . . . 74.04 112.02 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 84.3 mt -77.17 3.26 13.1 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.477 0.547 . . . . 65.15 112.477 -177.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.432 ' HB3' ' HD2' ' A' ' 133' ' ' PHE . . . -62.71 78.72 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.442 0.639 . . . . 55.5 111.716 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.665 ' H ' ' HD3' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -39.47 -39.15 0.65 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.35 1.241 . . . . 65.31 114.35 -178.143 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.96 -44.76 67.38 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.271 0.471 . . . . 75.41 112.271 -169.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.691 ' HD2' ' H ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -108.22 -36.33 6.31 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.267 -0.424 . . . . 71.31 111.652 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.432 ' HD2' ' HB3' ' A' ' 129' ' ' ALA . 86.7 m-85 -73.94 -5.79 43.39 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.241 0.46 . . . . 74.34 112.241 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -44.69 -26.52 0.39 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.1 0.476 . . . . 65.23 112.128 168.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -91.89 23.81 3.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.535 0.569 . . . . 71.32 112.535 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.463 ' HB2' ' SG ' ' A' ' 81' ' ' CYS . 66.9 mt -89.38 157.64 18.08 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.206 0.527 . . . . 73.21 111.204 176.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.4 120.83 36.15 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.001 -0.545 . . . . 73.44 110.653 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.402 ' HE2' ' HG ' ' A' ' 81' ' ' CYS . 59.3 m-85 -109.36 121.73 45.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.066 0.46 . . . . 75.43 110.752 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.52 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 56.9 m-85 -110.47 132.01 54.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.402 0.62 . . . . 74.04 111.895 -177.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 145' ' ' ALA . 6.1 tp -115.14 146.87 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.541 -0.754 . . . . 75.33 110.985 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.04 153.9 37.65 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.155 0.422 . . . . 52.22 114.155 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -46.94 -70.55 0.09 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.06 0.763 . . . . 62.45 113.06 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -68.8 -21.74 64.3 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.261 0.553 . . . . 60.2 111.196 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.693 ' HB1' ' HA2' ' A' ' 151' ' ' GLY . . . -66.52 -49.93 64.89 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.879 -0.6 . . . . 73.14 111.577 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.45 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -61.82 -17.95 58.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.183 -0.462 . . . . 40.34 111.865 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -82.22 11.05 5.76 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.16 -0.473 . . . . 72.22 111.711 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.1 54.61 7.87 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.219 -0.515 . . . . 64.23 113.181 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 150' ' ' ASN . . . -115.09 18.71 16.16 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.71 0.633 . . . . 61.45 112.71 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 69.17 -26.42 0.15 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.934 0.716 . . . . 75.01 112.934 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 148' ' ' ALA . 51.1 t30 -77.42 44.52 0.43 Allowed 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.568 0.699 . . . . 63.34 110.529 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.693 ' HA2' ' HB1' ' A' ' 144' ' ' ALA . . . -96.63 100.77 2.52 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.058 -0.519 . . . . 50.23 114.021 -175.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -119.88 126.8 51.83 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.725 0.298 . . . . 74.0 110.575 174.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 81.4 t -86.24 134.39 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.734 0.642 . . . . 72.02 112.734 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.04 122.27 42.07 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.816 -0.629 . . . . 74.21 109.719 170.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.494 HD13 HD21 ' A' ' 127' ' ' LEU . 47.5 mt -91.42 140.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.774 -0.37 . . . . 72.52 111.865 -171.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 168' ' ' THR . 43.3 mm -123.17 109.59 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.227 -0.442 . . . . 72.24 111.183 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 4.0 mp0 -90.86 149.33 21.98 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.261 0.553 . . . . 63.51 111.926 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -87.78 109.34 19.66 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.181 -0.463 . . . . 72.41 109.826 171.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 2.3 mmp_? -110.45 135.4 51.19 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.003 0.371 . . . . 74.51 112.003 -174.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -86.56 116.31 24.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.125 0.488 . . . . 54.33 111.39 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -108.14 90.61 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.294 -0.412 . . . . 62.35 110.778 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.1 t70 57.38 33.54 23.42 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.815 -0.63 . . . . 63.03 111.563 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 100.97 8.2 48.55 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.088 -0.577 . . . . 70.1 113.323 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 m -122.72 106.06 10.61 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 122.473 -0.428 . . . . 65.22 111.021 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -78.31 104.22 8.75 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.926 0.393 . . . . 73.55 111.567 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 35.2 m -118.57 144.15 34.78 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.817 0.342 . . . . 73.04 111.588 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 16.6 Cg_exo -70.42 146.3 55.74 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.974 2.449 . . . . 45.11 113.47 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 90.8 m -136.02 150.74 49.32 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.294 -0.412 . . . . 64.52 110.82 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 58.9 tp -95.8 135.54 37.39 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.595 0.591 . . . . 72.41 112.595 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 36.0 ttp -127.41 130.15 48.81 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.303 0.573 . . . . 75.31 111.762 174.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 88.1 mt -139.61 141.7 37.11 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.61 -0.723 . . . . 64.32 110.895 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.536 HG11 ' CZ ' ' A' ' 95' ' ' PHE . 21.2 t -87.11 132.22 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.538 -0.726 . . . . 71.33 112.309 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -57.88 -39.72 78.53 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.586 0.587 . . . . 61.44 112.586 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 116' ' ' PHE . 23.5 mm-40 -75.54 -0.17 19.43 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 111.971 0.36 . . . . 43.4 111.971 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.72 -30.61 8.86 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.12 0.486 . . . . 74.4 110.481 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 172' ' ' VAL . 5.3 tt -127.45 109.19 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.295 -0.866 . . . . 65.23 111.178 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.4 mm -100.81 118.52 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.407 -0.36 . . . . 75.13 111.142 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.429 ' HB2' HD21 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -92.84 121.36 34.13 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.832 0.825 . . . . 74.3 111.259 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -94.61 111.03 22.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.74 0.781 . . . . 74.24 110.44 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.197 -0.911 . . . . 74.45 111.384 -177.737 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 120.543 0.211 . . . . 74.42 111.012 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 178' ' ' GLU . 59.1 tp -114.53 128.42 56.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.796 0.331 . . . . 75.44 110.866 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.523 HG12 ' HB3' ' A' ' 15' ' ' SER . 52.6 mt -105.24 127.38 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.641 -0.254 . . . . 70.11 110.703 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -118.16 149.0 41.8 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.2 0.524 . . . . 75.11 111.789 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 13' ' ' LEU . 17.0 ttpp -150.64 120.93 7.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.666 -0.697 . . . . 65.12 111.29 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.638 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.3 m-20 -71.83 174.05 7.43 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.778 0.323 . . . . 75.32 110.293 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.8 pt -86.51 -3.97 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.981 0.42 . . . . 63.14 111.433 172.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.444 ' HE1' ' HD2' ' A' ' 94' ' ' LYS . 73.7 m-85 -108.98 -27.61 9.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.11 0.411 . . . . 74.34 112.11 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.638 HG22 ' HB2' ' A' ' 6' ' ' ASP . 2.0 t -106.0 20.33 19.12 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.591 0.589 . . . . 72.44 112.591 -170.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -44.83 -19.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.218 1.192 . . . . 51.34 114.218 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -86.96 -33.26 19.72 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 122.026 -0.421 . . . . 63.12 111.733 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.75 25.49 2.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.81 0.444 . . . . 75.0 111.893 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 5' ' ' LYS . 56.6 tp -38.08 124.34 1.18 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.233 0.613 . . . . 74.42 112.249 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -137.87 174.35 10.67 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.243 0.461 . . . . 55.21 112.243 -175.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.523 ' HB3' HG12 ' A' ' 3' ' ' ILE . 78.5 p -141.39 135.52 30.49 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.635 0.606 . . . . 72.42 112.635 -175.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -129.75 -173.95 3.17 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.04 0.448 . . . . 72.12 111.652 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.5 p -103.89 -3.84 24.27 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.9 0.704 . . . . 73.43 112.9 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 79.9 m-85 -76.36 131.55 74.68 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 112.004 0.372 . . . . 72.12 112.004 -175.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 6.7 Cg_exo -74.0 172.69 15.41 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.113 2.542 . . . . 74.42 113.555 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.0 ptm -111.64 130.75 55.66 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.044 0.387 . . . . 74.31 112.044 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -120.73 98.21 5.91 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.876 -0.416 . . . . 72.15 109.876 172.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.424 HD21 ' HA ' ' A' ' 25' ' ' ASP . 52.8 tp -100.04 133.88 43.77 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.201 -0.454 . . . . 64.52 112.193 -172.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.55 134.7 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.234 0.54 . . . . 73.23 111.722 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 t70 55.73 15.21 1.51 Allowed 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.195 -0.911 . . . . 53.2 111.885 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.424 ' HA ' HD21 ' A' ' 22' ' ' LEU . 4.7 m-20 53.36 25.7 4.76 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.937 0.398 . . . . 72.53 111.867 -175.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 tp -114.26 -49.64 2.84 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.162 -0.472 . . . . 75.53 111.25 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 172' ' ' VAL . 16.9 m -137.42 157.77 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.923 0.392 . . . . 74.15 111.913 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -92.47 149.28 21.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.433 -0.348 . . . . 74.23 110.369 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 31.8 tt0 -125.78 124.48 41.09 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.202 0.314 . . . . 75.3 110.597 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 59.1 t80 -127.45 131.25 50.24 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.006 0.432 . . . . 74.32 110.818 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HG2' HG22 ' A' ' 168' ' ' THR . 36.5 mtmm -119.93 119.09 32.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.73 0.3 . . . . 72.42 110.971 -178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.13 -157.42 19.4 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.217 0.447 . . . . 71.31 114.217 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -112.47 159.04 19.15 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.922 0.391 . . . . 75.32 111.84 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -89.05 107.1 18.85 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.375 -0.375 . . . . 73.13 110.436 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 m -142.34 159.5 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.495 0.664 . . . . 70.14 112.361 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 66' ' ' ARG . 17.3 m -139.15 139.94 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.475 -0.784 . . . . 73.31 110.279 175.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.496 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 20.6 ttt180 . . . . . 0 N--CA 1.468 0.425 0 CA-C-O 121.441 0.639 . . . . 73.21 111.223 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.6 mp0 . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 121.393 0.616 . . . . 63.31 109.558 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 36' ' ' VAL . 11.6 ptm180 -98.27 137.47 36.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.499 -0.773 . . . . 73.53 112.684 -176.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.58 -127.02 4.69 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.914 -0.66 . . . . 52.22 113.296 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 70' ' ' ILE . 23.2 pt -110.55 138.21 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.838 0.352 . . . . 64.54 111.817 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -46.33 -34.75 4.78 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.021 -0.536 . . . . 71.34 111.864 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 68' ' ' ILE . 57.1 mt -48.36 -58.73 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.315 0.579 . . . . 73.42 112.311 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.62 -31.26 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.021 -0.536 . . . . 64.04 112.191 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.2 mt -67.5 -41.36 84.63 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.004 0.43 . . . . 74.31 111.241 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -54.62 -38.25 66.59 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.846 -0.616 . . . . 63.3 111.701 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -107.72 19.51 20.03 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.535 -0.302 . . . . 75.44 111.156 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt 43.89 43.07 5.0 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.897 0.879 . . . . 75.12 113.273 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.1 mt -70.52 162.16 29.31 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.206 0.527 . . . . 64.14 112.135 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.13 141.17 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 116.38 -0.373 . . . . 72.13 110.98 176.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -81.06 119.06 23.06 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.003 0.43 . . . . 72.45 112.065 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 53.2 ttm -112.19 139.48 47.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.062 -0.517 . . . . 74.24 109.82 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.4 ' HB2' ' HD1' ' A' ' 82' ' ' TYR . 15.9 m120 -122.57 156.77 33.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.391 0.615 . . . . 73.21 112.117 -175.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 25.1 p -72.17 -3.18 21.89 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.612 0.967 . . . . 72.4 113.612 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.408 ' CG ' ' N ' ' A' ' 83' ' ' GLU . 11.0 p90 -54.96 -54.83 37.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.914 0.387 . . . . 54.02 111.707 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.408 ' N ' ' CG ' ' A' ' 82' ' ' TYR . 8.8 tp10 -104.17 -45.08 4.81 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.612 0.72 . . . . 71.15 110.583 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.16 18.08 0.09 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.456 -0.793 . . . . 72.52 113.029 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -54.28 -41.74 69.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.231 0.539 . . . . 53.21 110.956 173.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -70.13 -24.4 63.18 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.853 -0.612 . . . . 33.52 111.905 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -62.81 -62.48 1.69 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.65 -0.25 . . . . 63.24 110.784 -179.626 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.557 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 30.2 p90 -68.38 -23.08 64.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.722 -0.391 . . . . 75.12 111.312 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -54.39 -60.35 3.47 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.188 0.518 . . . . 74.43 111.034 171.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.23 -38.43 75.22 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.176 -0.466 . . . . 73.24 111.414 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.486 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 55.7 t80 -57.13 -52.6 64.66 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.127 -0.488 . . . . 73.5 110.909 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.532 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 41.4 mm -65.81 -31.0 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.03 0.382 . . . . 62.13 112.03 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -59.43 -60.46 3.82 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.039 0.447 . . . . 73.33 111.202 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HD2' ' HE1' ' A' ' 8' ' ' PHE . 8.0 tmtm? -62.05 -41.52 98.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.14 0.495 . . . . 74.12 110.128 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.623 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 21.7 t80 -52.87 -45.87 67.64 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.878 -0.601 . . . . 70.32 111.676 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 55.2 ttp -58.13 -50.14 74.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.304 0.573 . . . . 60.2 110.944 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -64.22 -35.53 81.11 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.114 -0.494 . . . . 70.31 111.786 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.92 -41.91 64.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.563 -0.289 . . . . 74.32 111.631 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.0 m -65.31 -39.6 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.957 -0.464 . . . . 74.35 111.144 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.04 -44.79 95.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.821 0.343 . . . . 63.04 110.398 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.97 -40.11 69.67 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.235 0.54 . . . . 75.21 111.011 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -66.31 -43.99 84.71 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.996 -0.547 . . . . 63.12 112.329 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 96.4 mmm -86.71 -53.69 4.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.772 0.656 . . . . 63.13 112.772 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -49.62 -40.2 38.35 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.739 0.415 . . . . 73.34 111.748 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -53.8 -43.1 69.06 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.225 0.454 . . . . 74.05 112.225 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -102.28 -3.01 27.91 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.466 0.543 . . . . 75.41 112.466 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 4.4 m-20 -101.03 -61.79 1.33 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.297 0.48 . . . . 73.21 112.297 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 107' ' ' ASN . 2.5 ptp180 72.49 -15.29 0.5 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.096 0.958 . . . . 71.45 112.543 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.481 ' O ' HG22 ' A' ' 113' ' ' VAL . 0.4 OUTLIER -71.71 84.5 0.9 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.317 0.58 . . . . 75.13 111.557 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -52.71 -18.82 2.01 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.85 -0.614 . . . . 72.31 112.54 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.42 -42.75 19.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.1 0.407 . . . . 45.55 112.1 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.458 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 37.2 t70 -81.21 -46.08 15.36 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 122.212 -0.305 . . . . 63.23 111.768 -174.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 109' ' ' ASP . 24.3 m -58.42 -27.36 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 122.052 -0.405 . . . . 65.3 111.177 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -70.78 -35.71 72.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.327 -0.397 . . . . 75.43 110.665 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.82 -46.7 74.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.341 -0.39 . . . . 55.0 110.868 176.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 82.5 t80 -62.84 -42.02 99.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.971 0.415 . . . . 73.02 110.384 174.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 117' ' ' LYS . 4.1 tmmm? -50.96 -46.95 61.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.27 -0.423 . . . . 61.44 110.064 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -63.46 -34.66 78.25 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.37 -0.377 . . . . 70.23 111.648 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 116' ' ' PHE . 71.8 mmtt -56.61 -60.73 3.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.991 0.425 . . . . 63.34 111.196 174.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.17 -32.21 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 116.102 -0.499 . . . . 62.51 111.607 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 125' ' ' VAL . 19.5 tm0? -64.57 -55.76 18.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.87 0.367 . . . . 71.2 110.859 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.27 -32.86 78.14 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.871 -0.681 . . . . 53.41 112.471 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 -62.49 -57.7 10.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.207 0.203 . . . . 73.31 111.188 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 30.6 m -63.66 -38.82 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.249 0.463 . . . . 61.33 112.249 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 121' ' ' GLN . 53.4 t -55.39 -44.01 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.173 0.511 . . . . 45.03 111.159 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.9 m -75.62 -35.97 60.37 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.098 0.475 . . . . 74.31 111.016 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 155' ' ' ILE . 41.3 tp -66.41 -28.91 68.99 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.831 -0.622 . . . . 54.53 111.83 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 74.5 mt -90.04 3.97 51.64 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.289 -0.414 . . . . 64.42 112.086 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.476 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -59.63 92.72 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.413 0.625 . . . . 62.34 111.057 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -66.87 -7.86 24.87 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.695 0.998 . . . . 72.43 113.695 -170.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -71.48 -46.38 60.01 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.812 -0.555 . . . . 73.31 111.024 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 44.0 mtm-85 -109.36 -50.38 3.0 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.123 0.487 . . . . 74.32 111.806 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.476 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 22.4 m-85 -68.07 -7.56 30.47 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.404 0.52 . . . . 64.23 112.404 -173.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.51 -14.12 38.16 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.072 0.463 . . . . 72.14 111.324 175.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -93.32 19.36 8.31 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.151 0.426 . . . . 73.41 112.151 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.412 HD11 ' HD2' ' A' ' 133' ' ' PHE . 76.7 mt -88.51 147.29 24.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.318 0.58 . . . . 73.13 111.796 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.4 119.04 38.36 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.055 -0.521 . . . . 71.1 111.28 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -95.04 106.32 18.31 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.883 0.373 . . . . 75.1 110.544 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -94.48 132.81 38.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.519 0.676 . . . . 73.42 112.185 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 tp -124.7 149.08 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.32 -0.855 . . . . 74.33 110.394 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.64 141.56 27.48 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.289 -0.481 . . . . 75.34 113.377 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -48.28 -57.13 6.41 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.055 0.542 . . . . 73.21 111.739 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.424 ' O ' ' HD3' ' A' ' 143' ' ' ARG . 4.0 tmt_? -77.81 -28.97 50.49 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.189 0.518 . . . . 71.42 110.999 177.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.42 78.14 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.139 0.422 . . . . 62.13 112.139 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.33 -40.03 77.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.015 0.436 . . . . 73.41 111.737 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -71.09 -27.36 63.55 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.005 -0.543 . . . . 74.43 111.048 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -78.54 -44.14 11.27 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.218 -0.515 . . . . 74.01 112.963 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 64.83 2.29 1.67 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.286 0.847 . . . . 53.14 113.286 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -133.05 13.02 4.29 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.92 -0.488 . . . . 75.3 111.83 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -151.07 85.01 1.33 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.96 0.41 . . . . 45.53 110.22 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 158.33 133.52 1.56 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.948 -0.644 . . . . 75.23 113.52 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.38 142.12 29.52 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.695 -0.483 . . . . 73.14 109.695 174.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 48.4 t -75.9 117.28 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.581 0.705 . . . . 71.53 111.911 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.82 98.95 8.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.746 -0.661 . . . . 54.53 110.659 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 57.1 mt -85.99 117.08 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 120.794 0.331 . . . . 63.42 111.519 -175.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 51.0 mm -99.58 115.9 41.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.434 -0.348 . . . . 74.12 111.5 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 32.1 tt0 -104.02 144.36 31.65 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.868 -0.606 . . . . 75.54 111.659 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -85.81 88.8 7.61 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.251 0.548 . . . . 74.31 110.233 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.526 ' NH2' HG22 ' A' ' 161' ' ' VAL . 16.0 ttp180 -100.29 154.89 18.11 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.466 0.651 . . . . 71.35 111.959 -174.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.98 142.23 28.0 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.743 -0.662 . . . . 72.33 111.389 176.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.526 HG22 ' NH2' ' A' ' 159' ' ' ARG . 72.1 t -129.22 89.31 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.92 0.39 . . . . 74.31 110.824 171.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 51.76 25.64 3.05 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.926 -0.579 . . . . 71.25 112.305 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 129.18 -37.84 2.13 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.368 -0.444 . . . . 41.23 113.493 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 78.4 p -88.88 119.41 29.36 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.564 -0.374 . . . . 75.03 111.737 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.66 114.31 15.26 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.095 -0.502 . . . . 53.12 111.117 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 161' ' ' VAL . 17.4 m -125.76 138.22 31.54 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 121.042 0.449 . . . . 64.45 112.085 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.495 ' HG2' HG21 ' A' ' 68' ' ' ILE . 15.8 Cg_exo -71.36 115.99 4.51 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.884 2.39 . . . . 54.11 112.62 173.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.472 HG22 ' HG2' ' A' ' 31' ' ' LYS . 69.8 p -96.1 138.89 33.07 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.152 0.501 . . . . 65.45 112.01 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 61.1 tp -89.11 117.3 28.0 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.086 -0.506 . . . . 62.45 111.525 176.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.555 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 61.7 mtt -101.32 124.38 46.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.791 0.329 . . . . 61.43 111.413 176.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.476 ' HB3' HD11 ' A' ' 176' ' ' ILE . 96.0 mt -133.87 122.14 22.75 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.528 -0.306 . . . . 74.03 110.903 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.623 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 59.0 t -68.35 118.97 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.057 0.456 . . . . 51.32 111.899 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.47 -24.23 67.11 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.789 0.663 . . . . 73.32 112.789 -177.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.451 ' HB2' ' HZ ' ' A' ' 116' ' ' PHE . 5.5 tp10 -90.86 -3.08 57.64 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.966 -0.459 . . . . 73.1 111.06 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.583 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -97.03 -44.09 7.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.056 0.455 . . . . 70.11 110.219 175.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 171' ' ' LEU . 29.1 pt -116.79 109.4 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.877 -0.601 . . . . 70.03 110.611 172.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.5 tp -94.42 138.88 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.969 0.414 . . . . 75.11 110.808 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.633 ' HB2' HD11 ' A' ' 2' ' ' LEU . 1.8 pp20? -104.99 153.94 20.76 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.396 0.617 . . . . 71.44 112.394 -174.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 35.3 tt0 -140.09 99.77 3.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 74.11 109.406 172.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.564 ' HB3' HD13 ' A' ' 2' ' ' LEU . 19.3 pttm . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 113.313 0.857 . . . . 74.13 113.313 -170.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 121.041 0.448 . . . . 73.03 111.615 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 34.5 tp -109.53 135.0 51.23 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.571 -0.529 . . . . 72.35 109.571 174.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.0 tt -100.5 120.64 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.284 0.564 . . . . 72.12 111.668 -175.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 47.2 p90 -118.84 143.01 47.21 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.182 0.515 . . . . 72.23 111.416 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 5' ' ' LYS . 19.7 ptpt -140.29 121.88 15.22 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.646 -0.706 . . . . 75.13 110.771 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 9' ' ' THR . 3.6 m-20 -71.45 164.53 25.63 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.813 -0.555 . . . . 71.24 111.119 175.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.3 mt -55.81 -33.07 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.183 -0.462 . . . . 73.12 111.371 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 150' ' ' ASN . 9.1 p90 -109.45 -24.38 11.05 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.28 0.844 . . . . 72.15 113.28 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 152' ' ' GLN . 2.9 m -90.65 14.95 11.94 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.429 0.529 . . . . 63.41 112.429 -173.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.461 ' O ' HD22 ' A' ' 13' ' ' LEU . 8.5 p-10 -62.37 -10.76 12.3 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.619 0.97 . . . . 72.33 113.619 -173.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -86.48 -43.46 12.75 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.105 0.478 . . . . 43.41 111.324 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.75 ' HG3' ' HB2' ' A' ' 144' ' ' ALA . 18.1 mm-40 -96.16 22.9 7.07 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.297 -0.41 . . . . 62.12 111.537 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 2.0 pt? -57.89 165.04 1.92 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.186 0.517 . . . . 61.11 111.868 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 75.3 m -141.37 156.86 45.78 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.512 0.56 . . . . 64.2 112.512 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.6 p -127.24 110.22 12.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.856 -0.611 . . . . 71.31 111.333 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -161.67 176.36 11.05 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.74 -0.467 . . . . 73.14 109.74 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.3 m -123.88 79.86 1.76 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.932 -0.48 . . . . 74.23 111.772 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -98.37 125.73 42.15 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.155 -0.475 . . . . 54.1 111.093 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.03 117.64 4.84 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.613 2.209 . . . . 43.4 112.713 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.434 ' HA ' ' HB3' ' A' ' 30' ' ' PHE . 61.3 mtt -109.84 162.23 14.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.377 0.608 . . . . 54.33 112.412 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 62.4 mttm -127.44 103.06 7.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.901 -0.59 . . . . 64.22 110.219 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 54.0 tp -75.49 101.85 5.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.07 0.462 . . . . 75.13 111.635 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.34 133.86 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.092 0.472 . . . . 74.23 111.783 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t0 56.5 19.21 3.99 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.59 -0.732 . . . . 74.1 112.058 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.419 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 45.3 m-20 59.35 9.86 1.58 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.233 0.613 . . . . 55.41 112.561 -177.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.2 tp -106.21 -47.1 3.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.908 0.385 . . . . 71.33 111.881 -173.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 172' ' ' VAL . 3.2 m -134.71 150.19 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.678 0.622 . . . . 65.1 112.678 -176.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.557 ' HE2' HG21 ' A' ' 176' ' ' ILE . 64.2 m-85 -86.02 122.14 29.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.886 -0.597 . . . . 75.05 110.696 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 33.4 tt0 -114.09 108.48 17.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.604 0.362 . . . . 52.14 110.148 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.434 ' HB3' ' HA ' ' A' ' 20' ' ' MET . 15.1 p90 -143.62 121.0 11.63 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.784 1.031 . . . . 70.31 113.784 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 168' ' ' THR . 10.3 tmtt? -90.72 121.28 32.48 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.891 -1.049 . . . . 74.32 110.794 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.72 -120.95 1.12 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.107 -0.568 . . . . 71.23 113.093 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 69' ' ' ASP . 67.0 mttm -114.09 134.97 54.52 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.319 -0.519 . . . . 73.1 110.449 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -86.85 107.0 18.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.181 0.515 . . . . 73.14 109.62 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.411 HG23 HD12 ' A' ' 72' ' ' LEU . 28.8 m -137.81 145.37 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.981 0.419 . . . . 73.11 111.933 -173.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.56 134.44 65.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.061 0.458 . . . . 71.23 110.919 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.797 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 26.3 mmm180 . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 120.93 0.395 . . . . 74.14 111.372 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.797 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 2.5 mp0 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.218 0.532 . . . . 72.2 111.141 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.45 HH11 ' HD2' ' A' ' 66' ' ' ARG . 9.5 ptm180 -93.24 116.9 29.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.898 -0.592 . . . . 71.23 111.909 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.6 -140.46 5.2 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.547 -0.835 . . . . 72.43 113.812 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.1 pt -110.94 143.61 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 112.354 0.502 . . . . 72.21 112.354 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . 27.3 t70 -45.16 -43.46 9.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.913 -0.585 . . . . 74.24 112.433 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 58.5 mt -49.51 -60.88 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.242 0.46 . . . . 74.14 112.242 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.494 ' HA ' HD12 ' A' ' 76' ' ' LEU . 21.1 m -73.89 -33.11 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.097 0.406 . . . . 52.32 112.097 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.411 HD12 HG23 ' A' ' 35' ' ' VAL . 87.5 mt -74.3 -28.22 61.08 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.014 0.376 . . . . 71.22 112.014 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -83.37 -40.74 19.03 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.661 0.267 . . . . 51.04 111.424 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -86.68 -9.76 55.27 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.076 0.399 . . . . 74.54 112.076 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 67.4 71.13 0.36 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.355 0.598 . . . . 62.11 111.993 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 71' ' ' VAL . 67.6 mt -106.71 135.97 47.33 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.897 -0.592 . . . . 52.13 110.513 176.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.17 140.06 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.218 0.532 . . . . 73.22 112.379 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.23 143.51 57.73 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.396 0.888 . . . . 74.33 113.396 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.616 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 84.7 mtp -134.92 153.67 51.98 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.008 -0.542 . . . . 71.41 110.669 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.457 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 25.1 t-20 -148.06 156.47 42.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.63 0.253 . . . . 65.0 111.06 -177.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 40.9 t -37.32 -48.95 0.94 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.55 1.315 . . . . 72.44 114.55 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 12.2 p90 -59.75 -36.73 77.22 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.143 0.423 . . . . 75.34 112.143 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -81.85 -37.41 27.02 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.867 0.365 . . . . 63.32 111.395 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 2.7 m-20 -66.76 -22.58 66.04 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.689 0.626 . . . . 52.32 112.689 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.434 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -42.4 -64.88 0.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.021 0.439 . . . . 65.22 111.98 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.3 t -64.6 -33.17 75.29 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.887 0.375 . . . . 75.52 111.625 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.467 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 25.4 mmt -64.15 -65.24 0.7 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.278 -0.419 . . . . 75.11 112.034 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.434 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 10.5 p90 -61.66 -28.7 69.58 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.715 -0.394 . . . . 74.32 111.311 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -55.01 -61.64 2.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.724 -0.39 . . . . 75.15 110.799 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.14 82.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.285 -0.416 . . . . 61.13 111.841 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -60.47 -59.71 4.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.22 0.452 . . . . 65.22 112.22 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.3 mm -54.9 -39.77 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.166 0.432 . . . . 74.44 112.166 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -59.54 -57.29 13.62 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.04 0.385 . . . . 73.45 112.04 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.88 -51.8 60.0 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.803 0.335 . . . . 75.41 111.149 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CZ ' HG11 ' A' ' 172' ' ' VAL . 29.3 t80 -46.43 -48.94 18.73 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.095 0.558 . . . . 65.04 112.118 176.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 37.5 ttp -62.09 -34.7 76.8 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.996 0.427 . . . . 74.22 111.377 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.4 -49.71 68.22 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.466 -0.333 . . . . 71.42 110.901 174.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -59.85 -46.32 89.67 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.31 0.485 . . . . 72.05 112.31 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.5 -39.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 112.071 0.397 . . . . 71.12 112.071 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.464 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 15.0 mm -70.27 -49.2 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 122.271 -0.268 . . . . 60.31 111.355 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.6 -41.17 69.62 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.423 0.63 . . . . 73.01 110.5 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -55.29 -57.11 13.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.615 -0.721 . . . . 75.13 110.995 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.567 ' HG3' HG12 ' A' ' 113' ' ' VAL . 12.6 tpt -62.59 -44.76 95.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.476 0.546 . . . . 64.21 112.476 -173.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 11.2 pt-20 -72.46 -38.69 68.17 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.942 -0.474 . . . . 72.3 112.161 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -68.86 -17.97 64.08 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.439 0.533 . . . . 71.42 112.439 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -113.19 -17.0 12.46 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.001 -0.437 . . . . 61.25 112.008 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -128.63 -73.28 0.59 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.627 0.232 . . . . 74.42 111.627 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 28.5 ttt85 75.24 -18.73 0.43 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.999 1.111 . . . . 73.52 113.999 176.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.496 ' O ' HG22 ' A' ' 113' ' ' VAL . 70.9 m-20 -57.91 121.39 10.42 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.743 -0.598 . . . . 64.12 111.782 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -44.58 -49.49 10.12 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.982 -0.554 . . . . 75.4 112.356 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.47 68.43 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.698 0.629 . . . . 61.33 112.698 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -92.7 -39.61 11.18 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 111.951 0.352 . . . . 74.34 111.951 -175.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.567 HG12 ' HG3' ' A' ' 103' ' ' MET . 16.3 m -68.89 -37.11 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.857 -0.527 . . . . 75.53 112.062 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.25 -35.98 74.16 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.963 0.411 . . . . 71.5 110.483 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.97 78.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.125 0.488 . . . . 51.43 111.007 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.17 -48.83 80.07 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.953 -0.567 . . . . 75.13 111.118 174.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -55.6 -38.25 69.18 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.922 -0.581 . . . . 75.5 111.062 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.28 -40.61 96.31 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.473 -0.33 . . . . 72.42 111.509 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -58.8 -57.26 13.81 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.331 -0.395 . . . . 72.42 111.394 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.0 tp -66.55 -35.33 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.34 -0.391 . . . . 61.32 111.384 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -62.31 -45.27 93.99 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.995 0.426 . . . . 73.23 110.609 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.67 -37.52 94.38 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.061 -0.59 . . . . 53.41 112.414 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 49.5 t90 -62.97 -50.25 71.52 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.866 -0.196 . . . . 74.45 111.51 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.5 m -68.59 -41.12 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.665 0.617 . . . . 72.4 112.665 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.95 -29.77 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.778 -0.576 . . . . 70.34 111.621 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.4 t -77.84 -51.29 10.7 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.054 0.454 . . . . 75.11 110.77 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.6 tp -57.94 -46.34 85.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.002 -0.545 . . . . 63.34 112.302 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.62 2.81 21.07 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.434 0.531 . . . . 62.33 112.434 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.09 80.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.377 0.608 . . . . 74.12 111.1 176.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -58.42 -14.62 8.12 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.875 0.694 . . . . 73.53 112.875 -173.642 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.27 -49.92 75.98 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.784 0.326 . . . . 61.51 111.369 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -112.41 -36.23 5.33 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.254 0.464 . . . . 63.1 112.254 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -67.64 -6.86 22.42 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.832 0.678 . . . . 73.3 112.832 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 14.9 ptmm? -55.31 -17.13 4.17 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.257 0.465 . . . . 73.44 112.257 176.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -90.41 20.96 4.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.448 0.536 . . . . 51.52 112.448 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.44 158.4 17.74 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.1 0.476 . . . . 74.31 111.634 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.81 51.81 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.152 -0.476 . . . . 74.35 110.62 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.616 ' HB2' ' HB2' ' A' ' 79' ' ' MET . 36.1 m-85 -112.18 157.24 21.11 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.218 -0.301 . . . . 71.34 110.888 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -137.53 147.21 44.98 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.806 0.336 . . . . 62.33 111.827 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.513 HD11 ' HA3' ' A' ' 151' ' ' GLY . 14.6 tt -138.67 160.01 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 116.421 -0.354 . . . . 65.21 110.813 177.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.05 156.81 28.37 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.278 -0.487 . . . . 64.32 113.848 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -59.13 -60.33 4.04 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.959 0.409 . . . . 72.12 111.006 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.521 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 4.0 mmp_? -73.69 -32.63 64.04 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.957 0.408 . . . . 62.01 111.104 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.75 ' HB2' ' HG3' ' A' ' 12' ' ' GLU . . . -53.06 -38.67 62.68 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.12 -0.491 . . . . 70.35 112.08 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.29 -39.42 63.95 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.286 0.476 . . . . 74.21 112.286 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -96.43 -17.05 20.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.846 0.355 . . . . 54.24 111.691 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.6 -48.44 13.21 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.216 -0.516 . . . . 71.43 113.172 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 72.26 -46.04 0.63 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.915 0.709 . . . . 62.52 112.915 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -78.54 0.37 26.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.079 0.4 . . . . 70.52 112.079 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 23.0 p-10 -142.45 28.25 1.66 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 111.842 0.312 . . . . 52.43 111.842 -176.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.513 ' HA3' HD11 ' A' ' 140' ' ' ILE . . . -115.36 142.5 17.64 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 120.898 -0.668 . . . . 71.15 113.975 -175.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.43 ' HB3' ' OG1' ' A' ' 9' ' ' THR . 29.1 pt20 -120.24 140.64 50.88 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.728 0.299 . . . . 73.12 110.795 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.612 HG13 ' HB3' ' A' ' 138' ' ' PHE . 39.2 t -86.86 102.78 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 121.363 0.601 . . . . 52.25 111.211 174.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.579 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -78.67 112.25 15.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.993 -0.549 . . . . 73.42 110.337 174.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.705 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 59.8 mt -89.16 119.01 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.15 0.426 . . . . 74.22 112.15 -172.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.9 mm -104.61 117.3 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.801 0.334 . . . . 72.41 111.282 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -107.31 126.73 52.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.006 0.432 . . . . 71.34 111.358 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -84.71 89.07 7.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.205 0.526 . . . . 74.23 109.646 172.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -90.91 149.01 22.08 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.991 -0.55 . . . . 72.11 111.514 -173.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -98.63 121.75 40.97 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.309 -0.405 . . . . 74.44 111.755 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.411 HG23 HG21 ' A' ' 166' ' ' VAL . 99.0 t -110.67 98.55 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 110.046 -0.353 . . . . 72.13 110.046 170.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 57.12 21.3 6.32 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.987 0.423 . . . . 75.22 111.588 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.98 24.5 27.16 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.257 -0.496 . . . . 71.44 112.697 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 m -112.19 141.06 46.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.704 0.288 . . . . 65.12 110.973 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -73.34 109.38 6.82 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.478 0.548 . . . . 74.04 112.478 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 166' ' ' VAL . 24.3 m -128.58 96.51 29.98 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 121.254 0.55 . . . . 73.34 111.799 171.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.79 114.11 3.14 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.472 2.115 . . . . 74.11 112.055 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 5.2 t -107.69 161.06 15.22 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.506 0.558 . . . . 74.33 112.506 -176.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.579 HD11 ' HB1' ' A' ' 154' ' ' ALA . 22.5 tp -111.13 131.75 54.85 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.827 0.346 . . . . 64.43 111.035 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.705 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 46.9 ttm -110.96 125.67 53.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.108 -0.496 . . . . 72.54 111.252 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.86 150.39 50.45 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.623 -0.717 . . . . 74.23 109.996 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 27' ' ' VAL . 47.7 t -89.74 120.73 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.946 -0.471 . . . . 73.22 112.27 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.412 ' HA ' HG22 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -59.49 -46.9 87.47 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.049 -0.523 . . . . 74.3 110.632 179.297 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -63.37 -20.43 65.52 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.003 -0.544 . . . . 61.02 112.307 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.432 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -101.78 -19.71 15.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.315 0.487 . . . . 71.3 112.315 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.557 HG21 ' HE2' ' A' ' 28' ' ' TYR . 9.0 tp -96.01 121.4 46.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.417 0.627 . . . . 63.44 111.866 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.4 mm -99.05 112.14 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.957 0.408 . . . . 74.23 110.927 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.15 134.61 34.98 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.847 0.356 . . . . 62.23 111.466 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -129.99 144.01 51.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.497 0.665 . . . . 71.2 111.258 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.7 pttp . . . . . 0 CA--C 1.541 0.611 0 CA-C-N 115.499 -0.773 . . . . 72.51 112.093 -173.279 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.563 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.51 0.195 . . . . 61.52 110.852 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 179' ' ' GLU . 26.5 tp -84.59 125.53 32.53 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 122.134 -0.354 . . . . 73.44 110.559 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.775 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 56.2 mt -100.32 119.47 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.717 0.294 . . . . 63.42 110.884 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.865 ' HB2' HD11 ' A' ' 176' ' ' ILE . 35.7 p90 -106.59 135.49 48.02 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.3 0.571 . . . . 74.24 112.048 -178.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.531 ' HB2' HD13 ' A' ' 13' ' ' LEU . 74.6 tttt -134.53 114.34 12.72 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.017 -0.992 . . . . 64.32 110.842 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.623 ' HB2' ' H ' ' A' ' 9' ' ' THR . 6.3 m-20 -79.69 161.42 25.82 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.157 0.504 . . . . 64.33 111.263 173.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.4 pt -64.82 -21.07 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.013 -0.54 . . . . 71.41 111.258 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.454 ' HE2' ' HA ' ' A' ' 152' ' ' GLN . 36.9 p90 -109.13 -27.7 9.45 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.388 0.514 . . . . 64.31 112.388 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.623 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 4.8 m -88.88 15.37 8.55 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.236 0.541 . . . . 65.53 111.268 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -57.79 -12.66 3.23 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.516 0.562 . . . . 75.31 112.516 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.43 -61.74 1.7 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.977 0.418 . . . . 73.14 112.064 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -112.97 25.59 11.26 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.124 0.786 . . . . 70.21 113.124 -170.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -42.41 139.39 1.5 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.809 0.338 . . . . 63.1 111.532 176.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.3 m -135.62 178.19 7.23 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.66 0.615 . . . . 62.01 112.66 -168.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.559 ' HB3' HG12 ' A' ' 3' ' ' ILE . 86.6 p -124.28 125.14 43.86 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.299 0.481 . . . . 63.03 112.299 -174.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -137.62 -172.75 3.31 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.2 0.524 . . . . 73.1 111.425 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.2 m -138.45 89.73 2.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.201 -0.454 . . . . 75.23 111.082 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -142.67 132.71 12.24 Favored Pre-proline 0 N--CA 1.473 0.717 0 CA-C-N 116.556 -0.293 . . . . 73.43 111.515 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.11 145.94 14.07 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.704 2.27 . . . . 65.14 112.837 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.5 164.02 27.51 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.108 0.48 . . . . 74.33 112.243 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -121.82 104.26 9.44 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.115 -0.493 . . . . 74.32 110.881 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.5 tp -74.54 104.1 5.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.216 0.531 . . . . 73.33 111.643 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.23 134.42 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 121.341 0.591 . . . . 73.53 111.905 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.2 t70 59.22 14.24 3.48 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.085 -0.961 . . . . 71.41 112.383 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.0 t70 63.55 18.62 11.2 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.595 0.712 . . . . 73.14 110.79 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.433 ' HG ' HG13 ' A' ' 27' ' ' VAL . 59.0 tp -113.57 -50.14 2.86 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.983 -0.553 . . . . 65.15 112.441 -175.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 172' ' ' VAL . 15.5 m -133.54 150.14 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 113.04 0.756 . . . . 62.33 113.04 -175.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 170' ' ' MET . 19.3 m-85 -85.7 125.29 33.08 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.644 -0.707 . . . . 74.41 110.808 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -99.25 127.21 45.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.023 -0.535 . . . . 75.24 110.628 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.754 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 67.3 t80 -119.65 139.65 51.87 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.03 0.443 . . . . 72.22 111.34 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -90.0 126.84 35.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.081 -0.508 . . . . 72.22 111.33 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.72 173.54 14.95 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.989 -0.624 . . . . 74.14 114.44 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -133.33 153.9 51.18 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.894 0.478 . . . . 75.41 109.944 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -91.34 107.03 18.92 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.065 -0.397 . . . . 65.13 110.189 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.512 HG12 HD22 ' A' ' 44' ' ' LEU . 27.4 m -135.22 165.8 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.257 0.551 . . . . 73.55 112.272 -173.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.557 HG21 ' H ' ' A' ' 43' ' ' VAL . 32.1 m -115.9 146.56 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.396 0.517 . . . . 71.02 112.396 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.579 ' HG2' HD13 ' A' ' 72' ' ' LEU . 5.0 mmp_? -127.27 102.82 7.09 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.25 0.548 . . . . 74.15 111.172 172.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 38.2 ttmt -137.39 136.57 37.98 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.188 -0.32 . . . . 55.52 110.718 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -55.63 -24.86 35.9 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.136 0.421 . . . . 61.32 112.136 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.478 ' H ' ' HG2' ' A' ' 38' ' ' LYS . . . -129.32 35.22 2.63 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.306 -0.473 . . . . 71.02 113.279 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 25.4 tt0 -163.85 139.59 6.4 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.587 0.588 . . . . 71.44 112.587 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.487 HD13 HH21 ' A' ' 37' ' ' ARG . 5.4 tp -145.63 82.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.796 0.808 . . . . 71.22 110.925 171.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.557 ' H ' HG21 ' A' ' 36' ' ' VAL . 38.8 t -127.77 100.79 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.86 -0.609 . . . . 75.21 111.097 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.512 HD22 HG12 ' A' ' 35' ' ' VAL . 2.6 pp -113.01 2.73 15.85 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.543 0.571 . . . . 74.12 112.543 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.54 -19.18 63.7 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.131 0.789 . . . . 55.53 113.131 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.83 88.09 0.01 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.855 0.702 . . . . 64.05 114.855 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.9 p -94.88 78.4 3.63 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.061 0.458 . . . . 74.24 110.405 173.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.576 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 33.7 t30 -172.38 -53.64 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.827 0 CA-C-N 115.935 -0.575 . . . . 35.33 111.396 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 48' ' ' ASN . 91.7 Cg_endo -83.29 114.61 2.18 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.03 1.82 . . . . 70.11 112.734 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 92.7 p -73.36 -178.59 3.04 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.038 0.446 . . . . 64.15 111.607 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -133.65 -62.32 0.78 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.998 0.37 . . . . 61.02 111.998 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.571 ' HB3' ' HB2' ' A' ' 135' ' ' ASN . 1.2 mp0 69.0 -58.3 0.5 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.239 0.616 . . . . 75.03 111.66 -175.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -123.03 166.21 15.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.075 0.55 . . . . 44.15 110.262 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.5 -110.52 0.03 OUTLIER Glycine 0 CA--C 1.531 1.066 0 N-CA-C 115.309 0.884 . . . . 63.24 115.309 -169.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -138.45 -164.23 1.6 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.428 0.632 . . . . 50.23 111.674 -172.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -128.71 -40.72 1.54 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.624 -0.716 . . . . 74.52 111.547 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -69.31 153.16 44.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.949 0.722 . . . . 75.14 112.949 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.23 45.32 0.45 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.55 -0.75 . . . . 63.21 111.559 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 63' ' ' HIS . . . -59.62 -17.08 39.86 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 114.97 0.748 . . . . 65.52 114.97 -172.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.466 ' O ' HG23 ' A' ' 64' ' ' VAL . 4.6 p 73.24 152.39 0.13 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.784 0.834 . . . . 73.02 111.273 -174.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -38.5 -61.11 0.73 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.929 1.085 . . . . 74.02 113.929 -171.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.575 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 10.2 pt-20 -82.84 -13.1 56.8 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.136 0.791 . . . . 54.54 113.136 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.495 ' HB3' ' O ' ' A' ' 59' ' ' GLY . 38.7 t-80 -115.71 26.7 9.82 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.213 0.53 . . . . 74.0 111.985 -170.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 60' ' ' SER . 43.3 t -82.44 99.26 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 O-C-N 121.393 -0.817 . . . . 74.3 112.318 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 10.4 pt-20 -27.95 -40.9 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.667 1.358 . . . . 71.14 114.667 170.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -126.23 109.95 12.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.052 0.387 . . . . 72.22 111.293 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.47 -165.73 28.29 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.585 -0.817 . . . . 55.14 113.506 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.3 pt -111.61 145.56 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 122.425 -0.456 . . . . 74.14 111.895 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -46.2 -39.8 10.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.211 0.604 . . . . 73.22 112.044 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.9 mt -53.83 -49.97 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.887 -0.597 . . . . 75.41 112.503 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 23.2 m -87.72 -39.3 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.519 0.563 . . . . 51.1 112.519 -171.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.579 HD13 ' HG2' ' A' ' 37' ' ' ARG . 61.8 mt -64.42 -38.08 89.76 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.189 0.518 . . . . 63.01 111.679 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -84.48 -15.1 47.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.196 -0.457 . . . . 73.02 112.088 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -109.08 4.21 22.83 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 122.185 -0.322 . . . . 74.3 111.349 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.575 ' HG2' ' HB3' ' A' ' 62' ' ' GLU . 49.3 mtmt 58.06 71.12 0.6 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.367 0.603 . . . . 61.51 112.161 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 60.4 mt -127.23 124.16 38.26 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.516 -0.765 . . . . 62.13 110.533 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.94 148.53 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.833 0.349 . . . . 63.35 111.34 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -76.59 130.82 38.4 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.583 0.706 . . . . 74.42 112.604 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.536 ' HG3' ' HB2' ' A' ' 84' ' ' ASP . 12.5 tpt -117.22 122.77 44.92 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.061 -0.972 . . . . 54.53 108.994 171.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -82.84 139.55 33.42 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.212 0.53 . . . . 65.53 112.193 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 62.3 m -52.45 -40.05 61.81 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.204 0.816 . . . . 75.4 113.204 -174.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -57.27 -32.78 66.96 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.882 0.327 . . . . 63.35 111.882 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.48 -36.41 10.34 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.973 0.416 . . . . 71.32 110.949 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.536 ' HB2' ' HG3' ' A' ' 79' ' ' MET . 14.2 t70 -66.92 -11.42 56.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.251 -0.431 . . . . 42.42 111.594 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.597 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -36.68 -54.86 0.89 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.697 0.629 . . . . 62.2 112.697 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.7 t -67.81 -36.19 79.96 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.061 0.393 . . . . 53.42 112.061 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.2 ttm -67.84 -60.63 2.37 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 111.918 0.34 . . . . 75.4 111.918 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 16.0 p90 -62.21 -35.17 78.07 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 120.368 -0.533 . . . . 73.33 111.245 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 42.0 tptt -61.48 -39.36 90.65 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.185 0.517 . . . . 71.21 110.615 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.71 74.73 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.053 -0.521 . . . . 74.2 111.481 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -61.66 -44.76 96.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.529 -0.305 . . . . 73.52 111.519 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 88' ' ' PHE . 42.2 mm -62.04 -35.9 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 120.787 0.327 . . . . 73.22 111.301 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.07 -57.3 13.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.149 0.5 . . . . 72.3 110.831 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -59.58 -45.57 91.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.849 -0.614 . . . . 74.43 111.095 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.627 ' HE2' HG12 ' A' ' 120' ' ' ILE . 47.8 t80 -55.73 -61.54 2.29 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.399 -0.819 . . . . 73.21 111.997 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 58.6 ttp -54.59 -43.8 72.46 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.013 0.435 . . . . 72.34 111.278 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -61.59 -47.83 83.69 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.041 -0.527 . . . . 73.51 111.301 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -70.68 -44.1 67.69 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.448 0.536 . . . . 73.33 112.448 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.687 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . 35.9 m -65.04 -47.2 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.093 0.405 . . . . 70.14 112.093 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.443 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 47.3 mm -63.42 -45.61 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.898 0.38 . . . . 73.12 110.358 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -53.6 -55.4 26.08 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.964 -0.562 . . . . 62.52 112.069 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.687 ' HD2' ' HA ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -66.54 -27.51 67.81 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 122.219 -0.301 . . . . 72.42 111.244 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.496 ' HG3' HG12 ' A' ' 113' ' ' VAL . 12.1 tpt -73.84 -50.78 18.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.821 0.343 . . . . 52.25 111.337 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 9.7 pt-20 -66.35 -25.74 66.95 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.19 -0.319 . . . . 73.21 111.143 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -56.18 -39.21 72.02 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.159 0.429 . . . . 74.43 112.159 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -103.74 -37.91 7.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.037 0.754 . . . . 65.33 113.037 -175.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 108' ' ' ARG . 60.1 t30 -97.34 -35.15 10.8 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.511 0.559 . . . . 74.22 112.511 -173.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.442 ' HB3' ' O ' ' A' ' 107' ' ' ASN . 26.3 ttp180 71.59 -35.7 0.34 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.07 1.137 . . . . 74.12 114.07 174.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.55 ' O ' HG22 ' A' ' 113' ' ' VAL . 72.2 m-20 -65.71 114.38 4.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.807 0.669 . . . . 72.21 112.807 -168.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.74 -24.45 65.72 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.548 -0.751 . . . . 72.41 112.675 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.16 -32.21 58.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.894 0.378 . . . . 42.45 111.853 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.65 -51.31 7.85 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.548 -0.296 . . . . 73.24 111.706 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 109' ' ' ASP . 6.4 m -60.63 -31.12 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 111.947 0.351 . . . . 70.33 111.947 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.97 -38.93 83.34 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.91 0.386 . . . . 71.52 110.634 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.6 78.43 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.233 -0.44 . . . . 75.33 111.062 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.473 ' CZ ' ' HG3' ' A' ' 174' ' ' GLU . 22.2 t80 -56.85 -49.25 76.03 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.352 -0.385 . . . . 74.12 111.096 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -57.59 -32.81 67.55 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.626 -0.261 . . . . 72.21 111.067 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -66.63 -39.99 88.55 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.541 0.21 . . . . 73.31 111.286 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -53.65 -58.48 7.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.31 0.576 . . . . 73.43 111.038 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.627 HG12 ' HE2' ' A' ' 95' ' ' PHE . 10.9 tp -67.84 -32.49 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.743 -0.662 . . . . 60.34 111.568 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.41 ' NE2' HG21 ' A' ' 125' ' ' VAL . 23.3 tm0? -58.64 -52.41 65.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.729 0.299 . . . . 71.14 110.709 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.92 -42.9 96.98 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.932 -0.651 . . . . 70.44 112.528 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -58.83 -55.15 38.84 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 111.62 0.23 . . . . 73.1 111.62 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.466 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.7 m -65.25 -48.35 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.373 0.509 . . . . 62.31 112.373 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.41 HG21 ' NE2' ' A' ' 121' ' ' GLN . 92.1 t -57.98 -41.14 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.98 -0.45 . . . . 74.15 111.487 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.5 t -70.44 -47.96 58.24 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.012 0.434 . . . . 64.31 111.139 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.33 -33.81 74.23 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.311 -0.404 . . . . 72.13 111.805 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 80.8 mt -85.13 2.24 44.37 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.212 0.449 . . . . 75.22 112.212 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.62 89.06 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.304 0.574 . . . . 61.24 110.392 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 134' ' ' LYS . 36.3 ttpt -51.66 -59.66 4.03 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 114.373 1.249 . . . . 75.04 114.373 -165.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.81 -34.17 72.7 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.217 0.821 . . . . 75.2 113.217 -168.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -84.0 -53.61 5.44 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.089 0.471 . . . . 71.01 111.375 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.409 ' HD2' HD11 ' A' ' 136' ' ' LEU . 50.7 m-85 -74.46 -3.96 33.79 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.208 0.528 . . . . 62.23 111.763 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 130' ' ' LYS . 33.0 ttpt -35.79 -32.32 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.694 1.198 . . . . 74.12 113.724 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 2.7 p-10 -96.85 35.11 1.59 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.503 0.557 . . . . 73.22 112.503 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.409 HD11 ' HD2' ' A' ' 133' ' ' PHE . 38.2 mt -89.31 162.33 15.89 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.775 0.321 . . . . 61.34 110.622 170.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -132.13 133.5 44.35 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.236 0.458 . . . . 74.12 112.236 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.419 ' HB3' HG13 ' A' ' 153' ' ' VAL . 80.3 m-85 -100.82 107.57 19.16 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.641 0.257 . . . . 74.14 110.413 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 38.6 m-85 -101.54 124.74 47.69 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.863 -0.523 . . . . 74.41 111.616 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 16.9 tt -110.09 151.98 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.965 -0.562 . . . . 71.31 111.293 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.527 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -61.62 140.7 47.38 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 114.405 0.522 . . . . 50.0 114.405 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -44.18 -52.48 7.31 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.146 0.579 . . . . 72.44 112.096 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -51.58 -49.63 61.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.058 -0.519 . . . . 74.52 111.446 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.653 ' HB2' ' HA3' ' A' ' 151' ' ' GLY . . . -64.59 -50.09 68.57 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.237 0.458 . . . . 65.22 112.237 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.73 -41.24 77.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.061 0.458 . . . . 53.51 111.758 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -82.2 -24.86 34.69 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.932 -0.576 . . . . 65.2 111.465 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -101.09 -3.64 54.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.166 -0.54 . . . . 54.05 114.061 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 59.68 24.34 13.2 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.428 0.529 . . . . 74.44 112.428 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -103.51 -173.36 2.29 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.835 0.68 . . . . 64.1 112.835 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -88.98 58.1 4.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.242 0.544 . . . . 53.52 112.112 -172.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.653 ' HA3' ' HB2' ' A' ' 144' ' ' ALA . . . -70.94 167.96 50.66 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.897 -0.668 . . . . 72.12 113.085 173.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.454 ' HA ' ' HE2' ' A' ' 8' ' ' PHE . 6.5 tt0 -70.67 128.12 34.99 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.278 0.473 . . . . 63.31 112.278 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 138' ' ' PHE . 40.6 t -94.48 104.26 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.233 0.54 . . . . 73.5 110.266 170.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.737 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -80.45 136.41 36.33 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.864 -0.607 . . . . 64.15 111.56 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.569 ' HB ' ' HG3' ' A' ' 170' ' ' MET . 39.2 mm -89.23 109.4 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.846 0.355 . . . . 73.35 111.254 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.461 HG13 ' CD1' ' A' ' 139' ' ' PHE . 48.1 mm -93.91 108.12 20.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 120.968 0.413 . . . . 55.43 111.307 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -99.47 149.17 23.48 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.069 -0.968 . . . . 64.31 112.424 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -95.25 122.77 38.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.411 -0.813 . . . . 74.21 110.052 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.632 ' NH2' HG21 ' A' ' 168' ' ' THR . 4.8 ttp180 -156.39 131.08 8.93 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.613 -0.68 . . . . 74.01 112.084 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -103.54 143.91 32.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.198 -0.456 . . . . 64.13 111.521 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.13 100.89 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.454 -0.339 . . . . 72.23 110.444 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.4 t70 66.74 6.57 4.62 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 121.233 0.539 . . . . 64.22 111.514 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 128.78 -21.63 5.29 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.265 -0.493 . . . . 33.21 113.03 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 66.7 p -82.08 106.73 14.22 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.403 -0.469 . . . . 73.3 110.874 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -75.21 111.12 10.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.437 0.636 . . . . 73.32 112.391 -172.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.07 145.4 41.72 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.001 -0.545 . . . . 73.21 111.616 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -78.67 117.88 4.07 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.479 2.119 . . . . 73.51 112.213 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.632 HG21 ' NH2' ' A' ' 159' ' ' ARG . 83.5 m -107.4 122.02 45.77 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.904 0.383 . . . . 74.14 111.67 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.754 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 50.0 tp -88.87 139.94 29.95 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.566 -0.288 . . . . 75.02 110.981 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.569 ' HG3' ' HB ' ' A' ' 155' ' ' ILE . 21.1 ptp -133.87 141.26 47.32 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.714 0.768 . . . . 74.42 112.089 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -139.54 141.21 37.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.557 -1.201 . . . . 70.35 109.345 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.627 ' HA ' HG12 ' A' ' 27' ' ' VAL . 21.9 t -85.18 123.68 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.838 -0.538 . . . . 72.12 111.901 -173.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.437 ' HD3' ' OH ' ' A' ' 28' ' ' TYR . 45.2 tptt -53.17 -47.48 68.77 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.62 0.6 . . . . 55.34 112.62 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.473 ' HG3' ' CZ ' ' A' ' 116' ' ' PHE . 39.9 mm-40 -67.78 -1.92 6.24 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.433 0.531 . . . . 75.33 112.433 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -107.68 -44.55 4.23 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.521 -0.309 . . . . 64.5 110.718 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.865 HD11 ' HB2' ' A' ' 4' ' ' TYR . 9.5 tp -96.27 111.45 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 121.811 0.815 . . . . 41.5 112.193 -175.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.4 mm -105.06 144.07 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.169 -0.469 . . . . 53.34 110.749 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.93 146.83 38.3 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.63 0.729 . . . . 52.3 112.659 -175.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.775 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 8.8 tp10 -114.39 120.42 40.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.182 -0.917 . . . . 73.41 109.596 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.434 ' HB2' ' NZ ' ' A' ' 180' ' ' LYS . 4.9 ttmp? -84.15 109.25 17.58 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.419 0.526 . . . . 62.54 112.419 -171.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 1' ' ' MET . 41.0 t -132.08 89.14 2.63 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.296 0.569 . . . . 62.12 111.044 173.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.69 -63.8 1.24 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.986 -0.552 . . . . 75.45 109.94 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.634 -0.698 . . . . 72.41 111.191 175.22 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.675 0.274 . . . . 75.11 111.125 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.6 tp -89.52 131.47 35.53 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.985 0.422 . . . . 71.22 110.806 174.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 56.7 mt -118.94 120.58 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.385 . . . . 73.15 110.776 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -115.0 133.93 55.62 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.73 0.776 . . . . 72.2 111.244 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.409 ' HG2' ' CD1' ' A' ' 13' ' ' LEU . 34.9 mtpt -120.12 120.0 34.94 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.021 -0.991 . . . . 75.41 111.178 -172.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.93 177.5 3.64 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.764 0.654 . . . . 63.32 112.764 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -70.68 -57.03 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.012 -0.54 . . . . 52.31 111.502 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -102.15 -41.36 6.43 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.529 0.566 . . . . 74.01 112.529 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.54 HG21 ' HA2' ' A' ' 151' ' ' GLY . 12.1 p -80.48 16.28 1.39 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.542 0.571 . . . . 74.34 112.542 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -47.02 -34.7 5.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.16 0.584 . . . . 71.43 111.638 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.44 -39.61 80.32 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.529 0.566 . . . . 64.23 112.529 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -65.96 -33.49 75.94 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.546 0.213 . . . . 72.21 111.279 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.409 ' CD1' ' HG2' ' A' ' 5' ' ' LYS . 11.9 tp 57.2 112.2 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.441 0.904 . . . . 72.24 113.441 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.7 m -104.24 124.79 49.78 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.844 -0.535 . . . . 63.23 111.374 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 83.1 p -140.22 142.17 35.86 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.403 0.52 . . . . 70.21 112.403 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -171.61 -147.87 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.848 -0.614 . . . . 52.3 110.657 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 p -150.06 30.01 0.72 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.331 0.493 . . . . 70.33 112.331 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 97.9 m-85 -89.74 123.41 66.49 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.792 0.33 . . . . 73.12 111.503 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 12.0 Cg_exo -70.8 144.65 49.06 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.237 2.625 . . . . 53.33 113.959 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.434 ' SD ' ' C ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -131.89 166.35 21.82 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.751 -0.658 . . . . 52.13 111.496 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -130.98 136.77 48.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.86 0.362 . . . . 73.44 111.166 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 55.0 tp -87.26 109.34 19.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.061 0.458 . . . . 75.24 112.065 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -98.57 142.99 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.989 0.424 . . . . 71.42 111.041 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 t70 63.11 6.87 2.47 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.986 -0.552 . . . . 73.11 111.432 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.403 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 28.7 m-20 56.52 28.67 14.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.151 0.5 . . . . 65.24 111.979 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.2 tp -134.17 -44.01 0.78 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.102 -0.499 . . . . 64.25 111.861 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' A' ' 172' ' ' VAL . 12.7 m -125.24 148.95 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 112.524 0.565 . . . . 74.02 112.524 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -88.17 151.12 22.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.169 -0.469 . . . . 75.4 112.009 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -107.57 140.88 39.9 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.471 -0.786 . . . . 64.12 111.591 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.715 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 47.9 t80 -139.99 105.75 5.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.21 -0.663 . . . . 71.53 109.21 165.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.614 ' HB3' HG22 ' A' ' 168' ' ' THR . 13.1 ptpt -109.93 121.78 46.04 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.797 0.665 . . . . 74.32 112.797 -171.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.9 -152.85 8.64 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.91 -0.586 . . . . 61.22 113.601 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -117.3 174.07 6.34 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.108 0.48 . . . . 64.51 112.097 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.442 ' CE1' ' HD3' ' A' ' 167' ' ' PRO . 68.7 m80 -97.2 110.58 23.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.071 -0.513 . . . . 75.0 110.073 172.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.68 ' HA ' HD11 ' A' ' 44' ' ' LEU . 18.4 m -135.63 140.77 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.318 0.58 . . . . 64.43 112.18 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 30.2 m -120.0 117.2 52.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.342 0.591 . . . . 62.52 111.338 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.682 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 66.4 ttt180 -99.8 108.09 20.3 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.099 -0.501 . . . . 71.03 110.547 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.472 ' HA ' HG13 ' A' ' 64' ' ' VAL . 62.6 tttm -85.13 112.38 20.63 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.054 -0.521 . . . . 65.54 110.594 -174.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 63.13 -68.29 0.08 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.011 0.525 . . . . 64.33 111.056 -173.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -152.96 -0.56 0.21 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.452 -0.404 . . . . 54.31 113.651 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -105.16 137.89 42.23 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.341 0.497 . . . . 74.22 112.341 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.0 mm -78.31 92.42 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.218 0.532 . . . . 71.54 110.241 173.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -98.89 -42.84 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.643 0.608 . . . . 64.32 112.643 -174.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.68 HD11 ' HA ' ' A' ' 35' ' ' VAL . 4.3 mm? 58.42 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.921 0.711 . . . . 72.24 112.921 -176.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.92 109.03 7.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.791 -0.641 . . . . 72.51 110.116 173.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.04 74.14 0.36 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.229 -0.51 . . . . 53.44 113.086 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.4 p -99.41 126.33 45.29 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.347 0.594 . . . . 71.25 111.918 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.698 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 19.0 p-10 -80.39 177.56 2.9 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.977 -0.556 . . . . 75.02 109.518 170.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.698 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 30.4 Cg_endo -64.0 68.37 0.21 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 121.759 1.64 . . . . 74.34 112.463 173.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.3 t -149.69 129.47 13.29 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.825 -0.625 . . . . 71.21 110.398 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.03 7.64 5.55 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.113 0.483 . . . . 72.4 111.848 -174.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -98.01 22.02 9.92 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.267 0.556 . . . . 70.32 110.43 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -100.96 38.74 1.49 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.029 -0.532 . . . . 70.21 112.281 -173.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.9 81.78 0.03 OUTLIER Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.672 -0.299 . . . . 60.12 113.41 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.15 -20.91 66.68 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.467 0.543 . . . . 35.33 112.467 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.75 14.23 23.91 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.218 0.451 . . . . 73.53 112.218 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -115.09 161.85 17.81 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.768 0.318 . . . . 73.15 110.958 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -70.37 -12.78 61.81 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.942 0.349 . . . . 74.24 111.942 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.28 55.65 2.57 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.382 -0.437 . . . . 75.2 112.407 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.2 t -74.69 13.35 0.64 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 112.359 0.503 . . . . 70.24 112.359 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.66 -15.6 57.29 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.84 0.681 . . . . 72.54 112.84 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.05 -32.13 23.04 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.992 -0.443 . . . . 62.1 111.474 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -88.28 10.93 17.99 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.212 0.449 . . . . 73.45 112.212 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.652 ' HB ' ' HD2' ' A' ' 66' ' ' ARG . 93.9 t -73.22 131.35 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.043 -0.354 . . . . 61.54 110.043 171.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.682 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 27.7 tt0 -77.55 68.65 3.68 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.28 1.038 . . . . 61.15 109.299 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.652 ' HD2' ' HB ' ' A' ' 64' ' ' VAL . 11.0 ptm180 -104.67 140.38 38.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.597 -1.183 . . . . 72.31 111.927 -173.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.94 -131.11 3.72 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.548 -0.834 . . . . 32.4 113.785 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.429 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 32.3 pt -111.09 139.77 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 122.461 -0.435 . . . . 71.41 111.608 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -48.29 -35.76 12.83 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.078 -0.51 . . . . 61.1 112.355 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' A' ' 169' ' ' LEU . 68.4 mt -52.56 -58.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.201 0.524 . . . . 64.13 112.221 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.5 m -75.25 -33.59 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.142 -0.481 . . . . 75.11 111.688 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 64.8 mt -64.98 -34.49 78.57 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.966 0.413 . . . . 73.24 111.037 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -57.55 -48.66 78.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.247 -0.433 . . . . 65.11 111.94 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -99.04 -3.45 34.75 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.325 0.491 . . . . 64.42 112.325 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 59.56 70.86 0.61 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.623 0.725 . . . . 62.51 111.525 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 60.4 mt -98.3 127.78 44.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.667 -0.697 . . . . 74.43 110.951 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.94 143.85 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.66 0.266 . . . . 70.55 110.849 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -84.8 150.91 24.72 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.569 0.7 . . . . 55.5 112.838 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.2 ttm -145.19 138.33 26.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.459 -0.791 . . . . 75.35 110.413 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.526 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 18.0 m-80 -109.77 167.55 10.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.08 -0.509 . . . . 74.34 111.102 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 79.6 m -55.43 -38.92 69.63 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.553 0.945 . . . . 73.4 113.553 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.526 ' CE1' ' HB2' ' A' ' 80' ' ' ASN . 10.8 p90 -65.5 -23.23 66.84 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.654 -0.654 . . . . 73.31 111.406 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -94.13 -32.5 13.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.197 0.523 . . . . 74.32 110.732 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.1 -16.14 38.98 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.606 -0.725 . . . . 60.41 112.31 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.481 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . . . -43.21 -57.55 2.91 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.693 0.627 . . . . 65.44 112.693 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 t -69.92 -27.53 64.85 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 55.23 111.524 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.4 mmt -70.92 -63.36 1.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.535 -0.302 . . . . 65.53 111.637 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.481 ' CE1' ' HA ' ' A' ' 85' ' ' ALA . 5.0 p90 -60.44 -34.3 73.78 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.351 -0.218 . . . . 75.45 111.312 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -58.12 -54.39 47.54 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.935 0.398 . . . . 62.15 111.222 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.96 -35.56 81.58 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.141 0.496 . . . . 61.14 111.059 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.631 ' HE2' ' HG3' ' A' ' 152' ' ' GLN . 56.5 t80 -56.71 -57.02 14.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.765 -0.652 . . . . 73.11 111.043 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 88' ' ' PHE . 48.2 mm -57.83 -37.33 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.768 0.318 . . . . 72.11 111.631 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -60.13 -56.66 18.91 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.005 0.372 . . . . 73.34 112.005 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -72.32 -36.59 68.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.946 0.403 . . . . 75.33 111.835 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.42 ' O ' HG22 ' A' ' 99' ' ' VAL . 55.2 t80 -60.34 -55.34 34.76 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.075 -0.511 . . . . 65.45 111.229 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.1 ttt -54.87 -44.38 73.97 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.172 -0.467 . . . . 65.54 111.317 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -62.89 -46.62 86.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.372 -0.376 . . . . 53.53 111.612 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -63.44 -51.87 63.88 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.686 0.279 . . . . 75.31 111.625 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.487 ' O ' ' SD ' ' A' ' 103' ' ' MET . 32.1 m -64.07 -41.8 93.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.542 0.571 . . . . 71.44 112.542 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.7 mm -66.81 -46.45 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 121.755 -0.591 . . . . 75.33 110.983 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.99 -34.22 75.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.181 0.515 . . . . 73.12 110.993 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -68.93 -57.41 5.54 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.786 -0.643 . . . . 73.44 111.385 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 99' ' ' VAL . 0.2 OUTLIER -66.64 -44.72 81.2 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.007 0.743 . . . . 42.52 113.007 -175.023 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -50.46 -48.19 56.65 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.367 0.506 . . . . 74.53 112.367 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -60.41 -14.64 20.06 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.821 0.674 . . . . 72.35 112.821 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -115.4 -33.65 5.2 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.358 0.599 . . . . 53.03 111.564 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.465 ' O ' HG13 ' A' ' 113' ' ' VAL . 32.6 m-80 -122.13 28.52 7.46 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.665 -0.698 . . . . 72.32 111.886 -173.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.502 HH11 ' HB2' ' A' ' 109' ' ' ASP . 3.3 ppt_? -38.41 -23.81 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.874 1.805 . . . . 71.22 115.874 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.502 ' HB2' HH11 ' A' ' 108' ' ' ARG . 21.3 t70 -63.38 136.85 57.91 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.792 0.724 . . . . 71.02 111.269 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 110' ' ' LYS . 13.0 mptt -68.95 4.64 1.43 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.306 0.854 . . . . 75.45 113.306 -171.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.5 -47.88 6.91 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.996 0.427 . . . . 55.32 110.848 170.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -70.62 -58.09 4.04 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.989 -0.55 . . . . 72.55 112.234 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 107' ' ' ASN . 5.3 m -61.77 -32.54 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.793 0.294 . . . . 51.01 111.793 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -66.96 -43.25 83.6 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.77 0.319 . . . . 74.25 110.98 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -58.71 -51.42 70.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.028 0.442 . . . . 54.32 110.919 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.695 ' HE1' ' HG3' ' A' ' 174' ' ' GLU . 65.1 t80 -56.11 -50.1 72.0 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.003 -0.544 . . . . 65.25 111.148 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -51.57 -47.18 63.57 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.096 -0.502 . . . . 71.3 111.426 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -66.22 -34.64 78.48 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.013 0.375 . . . . 72.21 112.013 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 31.2 mmmt -60.62 -54.48 44.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.1 0.476 . . . . 70.45 111.301 177.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -71.37 -31.71 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.973 0.416 . . . . 72.02 111.128 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -61.48 -48.87 79.1 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.914 0.388 . . . . 72.14 110.927 176.59 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.02 -37.19 93.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.867 -0.682 . . . . 62.42 112.431 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.42 ' NE1' ' SD ' ' A' ' 170' ' ' MET . 51.7 t90 -61.77 -56.45 19.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.38 0.272 . . . . 73.44 111.343 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.468 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 m -63.21 -45.78 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.437 0.532 . . . . 73.53 112.437 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 121' ' ' GLN . 82.8 t -56.6 -46.61 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.852 0.358 . . . . 73.01 111.759 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.2 p -70.7 -38.19 73.64 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.968 0.413 . . . . 72.11 111.262 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.448 HD21 HD13 ' A' ' 155' ' ' ILE . 36.5 tp -67.64 -36.3 80.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.255 -0.43 . . . . 72.41 112.124 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 78.8 mt -80.71 2.29 26.61 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.503 0.557 . . . . 61.04 112.503 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 133' ' ' PHE . . . -66.89 87.07 0.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.408 0.623 . . . . 65.34 110.797 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -62.74 -22.75 66.79 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.841 1.052 . . . . 73.32 113.841 -169.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' O ' ' NZ ' ' A' ' 134' ' ' LYS . 24.8 t70 -58.79 -47.33 85.1 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.084 -0.385 . . . . 63.22 111.958 -173.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -102.49 -38.4 7.57 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.136 0.493 . . . . 71.31 111.122 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.408 ' HD2' HD11 ' A' ' 136' ' ' LEU . 45.3 m-85 -68.5 -5.43 19.45 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.714 0.635 . . . . 63.33 112.714 -176.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.427 ' NZ ' ' O ' ' A' ' 131' ' ' ASP . 23.6 pttm -62.37 -7.1 3.87 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.762 -0.586 . . . . 64.34 110.914 168.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.66 9.31 16.61 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 116.32 -0.4 . . . . 72.32 110.689 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.48 ' CD2' ' HA ' ' A' ' 157' ' ' GLU . 90.8 mt -88.65 162.91 16.06 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.905 0.383 . . . . 74.31 111.49 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.66 137.67 40.3 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.445 -0.343 . . . . 52.53 111.415 175.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.698 ' HB3' HG11 ' A' ' 153' ' ' VAL . 89.0 m-85 -100.08 120.92 40.59 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.727 0.299 . . . . 70.53 110.647 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 52.9 m-85 -122.45 139.97 53.26 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.188 0.518 . . . . 64.31 112.081 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.521 HD13 ' N ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -137.67 147.68 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.092 -0.504 . . . . 75.41 110.013 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.521 ' N ' HD13 ' A' ' 140' ' ' ILE . . . -51.14 126.17 26.34 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.433 -0.413 . . . . 65.41 114.046 -176.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -51.59 -59.67 4.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.844 0.354 . . . . 75.05 111.777 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -60.88 -32.29 71.73 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.865 0.364 . . . . 64.43 111.388 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.08 -53.1 50.79 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.541 -0.3 . . . . 74.04 111.139 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.477 ' HB2' HD12 ' A' ' 140' ' ' ILE . . . -64.53 -20.26 66.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.07 0.462 . . . . 74.33 111.615 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -69.61 -26.03 64.24 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.013 -0.54 . . . . 71.2 110.811 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -113.63 -58.2 0.4 Allowed Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.13 -0.486 . . . . 61.4 112.307 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.86 92.08 8.54 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.175 0.512 . . . . 61.31 110.97 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.68 -2.46 11.82 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.008 -0.542 . . . . 73.23 112.375 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -124.79 27.56 6.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.763 0.425 . . . . 74.15 110.987 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.54 ' HA2' HG21 ' A' ' 9' ' ' THR . . . -57.67 155.27 20.02 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.961 -0.563 . . . . 71.11 114.432 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.631 ' HG3' ' HE2' ' A' ' 91' ' ' TYR . 43.4 tt0 -68.34 128.93 38.37 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.137 0.494 . . . . 55.41 111.653 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.698 HG11 ' HB3' ' A' ' 138' ' ' PHE . 68.7 t -91.66 144.06 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.239 0.542 . . . . 71.14 112.393 -177.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.806 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -102.93 137.12 41.56 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.803 -0.635 . . . . 54.33 110.409 174.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.448 HD13 HD21 ' A' ' 127' ' ' LEU . 59.9 mt -95.27 126.54 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.381 0.512 . . . . 70.34 112.381 -172.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.1 mm -95.83 110.89 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.494 -0.321 . . . . 74.24 110.858 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.48 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 55.2 tt0 -96.22 148.78 22.37 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.842 -0.617 . . . . 73.04 111.934 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -98.23 123.23 42.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.814 -0.63 . . . . 73.3 110.558 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -121.15 114.49 21.51 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.975 0.417 . . . . 72.0 111.609 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.85 106.04 4.03 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.905 0.384 . . . . 72.33 111.116 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.28 107.66 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 120.742 0.306 . . . . 72.22 110.863 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 58.41 17.92 5.19 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.435 0.531 . . . . 73.11 112.435 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 114.86 -21.86 13.3 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.151 -0.547 . . . . 70.04 113.644 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 83.8 m -105.62 129.39 53.88 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.167 0.483 . . . . 62.5 111.355 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 0.1 OUTLIER -73.28 128.27 35.0 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.397 0.617 . . . . 53.14 112.429 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.76 148.66 39.79 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.05 -0.523 . . . . 71.13 110.532 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.442 ' HD3' ' CE1' ' A' ' 34' ' ' HIS . 93.7 Cg_endo -87.12 120.9 1.64 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.425 2.083 . . . . 71.35 112.66 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.614 HG22 ' HB3' ' A' ' 31' ' ' LYS . 39.9 p -117.51 119.0 33.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.215 0.531 . . . . 52.45 111.446 177.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.806 HD11 ' HB1' ' A' ' 154' ' ' ALA . 60.2 tp -76.78 130.43 37.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.084 -0.507 . . . . 64.12 110.59 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.42 ' SD ' ' NE1' ' A' ' 123' ' ' TRP . 50.8 ttm -116.15 124.34 50.08 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 116.178 -0.464 . . . . 63.02 111.385 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.9 mt -135.85 124.73 24.08 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.985 -0.552 . . . . 73.51 111.902 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.499 ' HA ' HG12 ' A' ' 27' ' ' VAL . 41.4 t -71.22 118.7 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 122.205 -0.309 . . . . 74.14 111.439 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -66.99 -19.91 65.8 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.023 0.44 . . . . 60.42 111.558 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.695 ' HG3' ' HE1' ' A' ' 116' ' ' PHE . 4.8 mm-40 -81.76 -8.96 59.75 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.989 0.423 . . . . 70.21 111.134 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.37 -44.29 6.94 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.057 0.456 . . . . 61.11 110.92 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 27.2 pt -100.28 128.85 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.196 0.522 . . . . 74.02 111.163 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 177' ' ' ILE . 1.7 mp -93.34 117.99 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 73.34 110.225 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.45 137.81 32.02 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.793 0.806 . . . . 71.51 112.48 -177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -144.78 99.82 3.41 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.229 -0.896 . . . . 65.41 109.69 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.76 128.26 38.56 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.719 0.637 . . . . 72.13 112.719 -172.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 82.5 m -112.94 87.08 2.5 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.238 0.542 . . . . 61.54 109.831 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 175.19 -176.22 0.1 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.238 -0.892 . . . . 74.53 109.9 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.252 1.186 0 N-CA-C 112.237 0.458 . . . . 73.45 112.237 178.527 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.506 ' O ' ' HB3' ' A' ' 181' ' ' CYS . 18.9 ptt? . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.61 0.243 . . . . 73.14 110.929 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.6 tp -80.23 132.38 35.85 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.954 0.407 . . . . 70.12 111.437 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.628 ' HB ' HD11 ' A' ' 13' ' ' LEU . 8.6 pt -117.13 121.39 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.239 0.542 . . . . 61.24 111.658 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -101.59 122.31 43.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.083 -0.508 . . . . 71.22 111.112 -174.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.451 ' HG3' HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -111.66 118.73 36.47 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 111.988 0.366 . . . . 64.45 111.988 179.325 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.74 132.62 40.6 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.838 0.351 . . . . 51.31 111.142 172.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 tt -48.23 -47.11 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 112.821 0.674 . . . . 73.14 112.821 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -110.24 -2.59 16.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.411 0.893 . . . . 75.35 113.411 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 9' ' ' THR . 28.5 m -127.21 16.81 7.19 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.195 0.522 . . . . 53.11 111.994 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -50.43 -13.84 0.15 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.282 0.845 . . . . 75.12 113.282 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -53.93 -40.96 67.19 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.887 0.375 . . . . 63.44 111.415 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -85.95 24.94 1.19 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 120.857 0.361 . . . . 73.55 111.38 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.628 HD11 ' HB ' ' A' ' 3' ' ' ILE . 25.0 tp -31.28 120.32 0.23 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.396 0.887 . . . . 62.33 113.396 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -97.85 140.31 32.41 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.181 -0.463 . . . . 63.43 110.785 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.9 p -128.88 96.52 4.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.835 0.35 . . . . 62.4 111.272 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -147.18 -168.85 3.16 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.202 0.525 . . . . 75.41 111.742 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.7 m -127.3 82.97 2.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.172 -0.467 . . . . 42.32 110.663 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -114.16 121.91 35.55 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.136 0.421 . . . . 75.23 112.136 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.31 103.01 1.62 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.664 2.243 . . . . 71.05 112.618 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.57 166.25 11.94 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.308 0.575 . . . . 72.33 112.315 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 25.6 mtpp -123.99 107.81 11.72 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.136 -0.484 . . . . 73.04 111.102 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.406 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 44.0 tp -79.43 94.38 5.54 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.939 -0.476 . . . . 73.03 111.248 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.76 138.88 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.985 0.422 . . . . 72.54 111.683 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.8 t70 57.7 13.38 1.96 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.84 -0.618 . . . . 53.43 112.007 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.406 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 7.9 m-20 63.18 14.6 7.86 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.571 0.348 . . . . 72.13 111.751 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.512 ' HA ' ' HZ2' ' A' ' 173' ' ' LYS . 52.1 tp -114.45 -50.87 2.78 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.966 0.358 . . . . 72.14 111.966 -176.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 172' ' ' VAL . 4.9 m -130.01 152.03 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.207 0.527 . . . . 71.12 112.353 -175.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.441 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 90.4 m-85 -90.95 120.18 31.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.928 -0.578 . . . . 72.34 110.996 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 8.6 pt-20 -99.58 105.64 17.53 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.273 0.559 . . . . 73.51 110.398 172.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.474 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 41.0 t80 -91.64 137.74 32.13 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.027 -0.42 . . . . 73.2 111.169 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.507 ' HE3' HG21 ' A' ' 161' ' ' VAL . 12.1 mmmm -81.82 121.94 27.08 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.15 -0.477 . . . . 73.41 112.047 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.502 ' HA3' HG12 ' A' ' 70' ' ' ILE . . . -121.71 173.18 15.66 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.316 -0.469 . . . . 43.14 113.196 176.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.01 140.55 50.86 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.384 -0.48 . . . . 75.12 111.09 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -73.43 119.77 18.11 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.509 -0.314 . . . . 70.45 110.393 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.7 m -143.77 178.12 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.462 1.125 . . . . 63.31 113.788 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.4 m -123.25 129.99 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.327 -1.306 . . . . 75.41 109.931 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.441 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.7 OUTLIER -128.63 108.3 10.39 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.572 0.582 . . . . 72.42 112.572 -174.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 pttt -134.71 142.01 46.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.337 -0.616 . . . . 70.32 109.337 169.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 59.45 12.41 2.71 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.215 0.45 . . . . 33.33 112.215 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.56 -2.58 87.92 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.478 -0.392 . . . . 32.05 112.939 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -100.6 -171.71 2.06 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.133 0.492 . . . . 71.1 112.122 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.642 HG12 ' H ' ' A' ' 44' ' ' LEU . 9.9 tt -146.78 130.18 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 116.081 -0.509 . . . . 75.45 111.009 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.0 m -103.83 14.67 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 112.324 0.49 . . . . 73.12 112.324 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.642 ' H ' HG12 ' A' ' 42' ' ' ILE . 2.7 mp -109.71 152.6 25.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.009 0.433 . . . . 64.22 111.581 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.55 -45.53 7.7 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.033 -0.531 . . . . 65.24 111.745 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.21 -81.05 0.05 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.902 -0.666 . . . . 73.15 113.768 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.8 p -103.85 151.45 23.08 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.261 -0.552 . . . . 74.33 111.888 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 61.72 89.93 0.1 OUTLIER Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 123.226 0.611 . . . . 74.43 112.573 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.31 141.92 88.45 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.995 2.463 . . . . 75.33 113.392 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.1 p -90.3 177.15 6.48 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.053 0.454 . . . . 61.42 112.057 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.75 16.16 2.14 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.246 -0.434 . . . . 72.45 111.616 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.07 -24.44 67.46 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.134 0.493 . . . . 74.11 111.892 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -82.83 24.82 0.71 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.11 -0.495 . . . . 73.12 111.537 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.51 73.26 0.23 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.673 -0.299 . . . . 32.21 113.823 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.24 -57.82 0.07 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.812 0.339 . . . . 74.21 111.025 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 59.29 90.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.596 0.712 . . . . 72.0 112.333 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -132.6 112.97 12.5 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.814 -0.63 . . . . 70.4 110.948 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t70 70.27 -63.96 0.38 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.487 0.715 . . . . 71.51 112.457 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.24 67.61 1.18 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 114.366 0.506 . . . . 54.15 114.366 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.9 m -156.14 67.81 0.6 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.312 0.645 . . . . 74.54 109.846 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -47.29 -63.77 0.96 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.762 1.023 . . . . 71.44 113.762 -170.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -103.99 1.89 31.66 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.414 0.626 . . . . 74.2 111.055 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 56.59 19.8 4.5 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.829 0.677 . . . . 75.5 112.829 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.0 t -63.32 -76.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 122.36 -0.212 . . . . 73.11 111.107 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 70.41 -32.05 0.23 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.377 0.88 . . . . 61.04 113.377 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -115.97 129.76 56.53 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.4 -0.813 . . . . 61.41 111.879 -169.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' A' ' 72' ' ' LEU . . . 160.19 164.61 15.55 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 119.131 -1.509 . . . . 64.42 114.9 167.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 pt -90.13 138.47 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 122.42 -0.459 . . . . 71.51 110.294 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -48.41 -32.47 7.7 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.775 0.321 . . . . 61.24 111.822 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.502 HG12 ' HA3' ' A' ' 32' ' ' GLY . 35.6 mm -48.48 -58.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.38 0.609 . . . . 72.32 112.056 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 16.4 m -81.14 -28.4 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.993 -0.548 . . . . 73.32 112.136 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' A' ' 67' ' ' GLY . 55.2 mt -71.04 -33.61 70.48 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.953 0.406 . . . . 74.4 111.188 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -58.4 -48.62 80.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.124 -0.489 . . . . 62.45 112.252 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -109.68 13.74 23.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.851 0.315 . . . . 71.4 111.851 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 54.76 71.2 0.55 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.135 0.493 . . . . 73.43 111.916 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 75.3 mt -103.07 125.54 49.85 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 122.2 -0.313 . . . . 73.24 111.248 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.2 145.33 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.75 0.31 . . . . 72.15 110.789 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.24 137.3 35.85 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.026 0.75 . . . . 75.42 113.026 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 78.1 mtp -125.91 145.5 50.24 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.058 -0.974 . . . . 65.05 108.887 169.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.501 ' HB2' ' CD1' ' A' ' 82' ' ' TYR . 16.8 m120 -115.93 -162.28 0.83 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.326 0.584 . . . . 61.23 112.398 -171.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.1 p -100.27 -2.5 33.57 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.148 0.795 . . . . 51.53 113.148 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CD1' ' HB2' ' A' ' 80' ' ' ASN . 24.1 p90 -79.15 -61.4 2.02 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.113 0.782 . . . . 72.42 113.113 -170.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -105.3 -17.51 14.43 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.719 0.771 . . . . 74.43 111.208 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.86 9.53 1.12 Allowed 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.26 -0.882 . . . . 75.54 112.165 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -46.76 -56.91 5.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.193 0.597 . . . . 72.45 112.592 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.0 m -53.35 -36.35 61.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.874 0.369 . . . . 74.33 111.643 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 51.4 tpp -73.88 -63.89 1.12 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.282 0.475 . . . . 73.44 112.282 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -68.47 -29.07 67.62 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.863 -0.523 . . . . 75.52 112.305 -174.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -72.69 -41.81 64.93 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.917 -0.313 . . . . 72.43 110.909 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.71 -39.37 91.26 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.01 0.433 . . . . 74.3 110.325 173.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -57.11 -59.23 5.4 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.996 -0.547 . . . . 72.42 111.775 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.7 tp -62.4 -39.03 82.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 112.263 0.468 . . . . 71.41 112.263 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -71.49 -44.63 64.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 111.99 0.366 . . . . 71.11 111.99 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -63.67 -44.84 92.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.261 0.553 . . . . 74.54 110.287 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.475 ' O ' HG22 ' A' ' 99' ' ' VAL . 48.9 t80 -56.22 -58.07 9.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.505 -0.77 . . . . 74.42 111.283 174.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 53.0 tpp -51.56 -54.07 31.41 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.112 -0.495 . . . . 74.33 111.76 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -57.92 -44.74 87.05 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.962 0.356 . . . . 64.44 111.962 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -72.09 -45.98 58.56 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.368 0.507 . . . . 40.54 112.368 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 95' ' ' PHE . 35.8 m -67.83 -38.05 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 122.186 -0.321 . . . . 42.43 111.615 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.9 mm -63.77 -48.64 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.63 0.253 . . . . 73.44 110.603 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 17.1 t70 -52.51 -47.39 66.65 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.08 0.466 . . . . 71.15 111.873 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -71.15 -42.94 68.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.545 -0.298 . . . . 73.41 111.625 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.549 ' HG3' HG12 ' A' ' 113' ' ' VAL . 12.7 tpt -59.88 -43.18 94.91 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.824 0.305 . . . . 74.34 111.824 -178.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -65.96 -28.55 68.99 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.837 0.31 . . . . 72.24 111.837 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.1 mtmm -69.52 -8.0 43.23 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.251 0.463 . . . . 73.3 112.251 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -99.97 -31.71 11.33 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.301 0.572 . . . . 70.4 110.332 172.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.732 HD21 ' HB3' ' A' ' 111' ' ' ALA . 28.3 t-20 -123.64 -80.34 0.62 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.583 -0.735 . . . . 62.55 111.929 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 73.7 ttt180 72.25 -15.74 0.46 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.915 0.709 . . . . 64.44 112.915 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -80.22 8.89 6.43 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.935 -0.478 . . . . 74.23 111.771 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 57.5 mtmt 60.52 20.23 10.02 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.219 0.533 . . . . 75.0 112.137 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.732 ' HB3' HD21 ' A' ' 107' ' ' ASN . . . -85.42 -62.54 1.51 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.105 -0.498 . . . . 72.34 110.288 172.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -79.52 -46.71 16.87 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.401 -0.363 . . . . 73.3 111.601 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.549 HG12 ' HG3' ' A' ' 103' ' ' MET . 28.0 m -63.81 -29.61 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 113.176 0.806 . . . . 74.12 113.176 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.39 -39.07 68.27 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 122.012 -0.43 . . . . 73.55 110.238 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.64 -47.54 69.28 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.172 -0.467 . . . . 43.13 111.195 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -53.89 -48.86 69.69 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.152 -0.476 . . . . 75.35 110.503 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -54.26 -47.69 72.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.696 -0.684 . . . . 75.22 111.317 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -56.27 -43.33 78.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.235 -0.439 . . . . 73.24 111.123 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -66.81 -60.49 2.62 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.942 0.349 . . . . 65.34 111.942 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -60.94 -35.07 62.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 111.905 0.335 . . . . 72.54 111.905 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.47 ' O ' HG23 ' A' ' 125' ' ' VAL . 58.5 tp60 -67.09 -43.21 83.15 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.687 0.279 . . . . 74.31 110.627 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.23 -35.47 88.1 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.828 -0.701 . . . . 71.45 112.271 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.5 t90 -63.89 -51.7 63.32 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.296 0.238 . . . . 72.25 111.222 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.433 HG22 ' HA ' ' A' ' 121' ' ' GLN . 30.8 m -67.61 -38.03 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 112.306 0.484 . . . . 64.34 112.306 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 121' ' ' GLN . 52.9 t -57.78 -46.55 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.357 0.599 . . . . 74.15 110.854 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.6 m -67.83 -48.95 64.78 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.087 -0.506 . . . . 73.11 111.31 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.22 -41.5 96.97 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.05 0.54 . . . . 61.14 112.447 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.0 mt -84.82 3.31 38.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.243 0.46 . . . . 65.13 112.243 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.46 86.41 0.11 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.337 0.589 . . . . 74.5 110.929 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -54.5 -20.4 7.65 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.62 0.971 . . . . 65.35 113.62 -172.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.81 -47.53 77.71 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.649 0.611 . . . . 64.44 112.649 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -109.91 -30.69 7.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.446 0.535 . . . . 72.23 112.446 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -85.66 -7.11 59.01 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.147 0.795 . . . . 63.41 113.147 -171.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.86 -19.8 66.07 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.726 -0.608 . . . . 73.24 110.538 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -78.95 10.02 3.78 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.002 -0.545 . . . . 70.5 111.873 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.448 HD22 ' HA ' ' A' ' 157' ' ' GLU . 88.0 mt -89.06 161.21 16.67 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.971 0.415 . . . . 74.02 110.948 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.43 137.48 54.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.64 -0.254 . . . . 74.23 111.644 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.665 ' HB3' HG13 ' A' ' 153' ' ' VAL . 56.8 m-85 -107.88 106.96 17.48 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 122.273 -0.267 . . . . 65.54 110.667 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.617 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 39.8 m-85 -102.51 143.67 31.93 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.196 0.522 . . . . 75.4 112.273 -176.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.7 tt -130.5 150.81 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.835 -0.62 . . . . 65.12 110.626 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.44 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -56.21 135.69 49.49 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.352 -0.452 . . . . 61.45 113.669 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.25 -39.62 66.98 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.091 0.472 . . . . 64.11 111.393 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -69.07 -55.92 9.3 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.081 -0.509 . . . . 74.43 111.296 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.07 -25.59 67.05 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.203 0.446 . . . . 43.31 112.203 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.44 -19.03 61.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.75 0.648 . . . . 74.02 112.75 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -70.47 -12.02 61.3 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.225 0.536 . . . . 60.25 111.144 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.41 41.2 2.81 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.369 -0.443 . . . . 62.44 112.967 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.12 -71.72 0.16 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.012 0.434 . . . . 75.23 111.769 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -123.8 -77.39 0.59 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.126 0.488 . . . . 71.51 110.223 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -134.79 -59.98 0.79 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.929 -0.578 . . . . 60.21 110.401 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.445 ' HA2' HG21 ' A' ' 9' ' ' THR . . . 103.28 139.56 10.4 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.294 -0.479 . . . . 73.14 112.837 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -73.73 112.2 9.61 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 122.548 -0.383 . . . . 35.02 111.47 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 138' ' ' PHE . 58.8 t -77.49 88.0 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.648 0.737 . . . . 74.31 110.079 169.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.963 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -79.4 117.53 20.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.534 -0.757 . . . . 70.31 110.471 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.777 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 58.1 mt -88.53 134.73 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.028 0.442 . . . . 52.22 111.991 -172.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.4 mm -103.22 115.48 45.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 116.443 -0.344 . . . . 74.15 111.063 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.448 ' HA ' HD22 ' A' ' 136' ' ' LEU . 38.2 tt0 -108.33 145.4 34.5 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 123.73 0.644 . . . . 74.42 111.831 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -90.2 117.47 28.98 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.06 0.457 . . . . 73.05 110.834 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -132.65 128.8 37.83 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.408 0.521 . . . . 72.31 112.408 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -83.77 116.14 22.56 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.046 -0.525 . . . . 65.01 110.144 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.507 HG21 ' HE3' ' A' ' 31' ' ' LYS . 98.8 t -114.72 105.98 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.472 -0.331 . . . . 62.02 110.483 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 59.81 23.79 12.75 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.292 -0.413 . . . . 73.11 111.615 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.01 -18.91 51.12 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.148 -0.478 . . . . 74.42 113.294 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 28.3 m -82.19 132.72 35.24 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.644 -0.327 . . . . 74.41 111.517 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.23 98.82 11.14 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.548 0.69 . . . . 75.32 111.646 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.92 147.22 48.15 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.103 -0.498 . . . . 75.14 112.09 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.39 120.81 2.18 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.697 2.265 . . . . 64.25 113.008 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.8 p -94.17 129.72 40.66 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.207 0.527 . . . . 74.34 111.187 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.963 HD11 ' HB1' ' A' ' 154' ' ' ALA . 43.7 tp -87.94 123.06 32.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.068 -0.514 . . . . 74.03 111.31 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.777 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 62.8 mtt -92.75 124.07 36.49 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.797 0.332 . . . . 75.21 111.355 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 86.5 mt -132.4 143.39 49.79 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.458 -0.792 . . . . 73.53 109.818 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 175' ' ' ALA . 48.5 t -101.85 122.77 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 122.078 -0.389 . . . . 64.42 111.755 -173.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.512 ' HZ2' ' HA ' ' A' ' 26' ' ' LEU . 22.9 pttm -68.62 -29.37 67.86 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.182 0.438 . . . . 75.12 112.182 -173.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -89.09 5.86 42.54 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.265 0.555 . . . . 63.44 111.36 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.6 ' HB3' ' HB ' ' A' ' 172' ' ' VAL . . . -113.91 -22.96 9.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.899 -0.591 . . . . 72.23 111.278 172.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 172' ' ' VAL . 34.5 pt -129.77 137.15 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.975 0.417 . . . . 42.02 111.198 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.6 mm -103.46 110.87 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.844 0.354 . . . . 73.35 111.489 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -74.15 95.71 2.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.193 -0.458 . . . . 73.23 109.909 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.608 ' HB3' HG13 ' A' ' 3' ' ' ILE . 29.5 tt0 -95.23 119.04 33.06 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.237 0.541 . . . . 75.33 111.37 -174.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -78.17 107.9 11.09 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.434 0.635 . . . . 75.42 112.706 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.506 ' HB3' ' O ' ' A' ' 1' ' ' MET . 51.3 t -114.94 91.66 3.69 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.811 -0.631 . . . . 55.3 109.356 171.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 53.0 mt -105.84 32.8 4.11 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.629 0.604 . . . . 54.13 112.629 -167.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.255 1.393 0 CA-C-O 118.819 -0.61 . . . . 71.01 110.043 175.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 tpp . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.688 0.28 . . . . 71.01 111.565 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.19 130.09 40.56 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.763 0.315 . . . . 75.44 111.139 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.2 mt -102.66 134.11 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.758 -0.201 . . . . 75.32 111.048 -177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -123.49 141.57 51.87 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.58 0.705 . . . . 74.24 112.282 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.441 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 21.6 ttmm -111.38 110.55 21.06 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.759 -1.109 . . . . 64.34 111.013 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.623 ' HB2' ' H ' ' A' ' 9' ' ' THR . 1.4 m-20 -83.14 149.54 26.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.558 -0.292 . . . . 71.21 110.955 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 175' ' ' ALA . 68.9 mt -61.02 -33.89 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.398 0.618 . . . . 75.24 110.77 173.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -105.14 -29.26 10.49 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.669 0.618 . . . . 72.13 112.669 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.623 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 2.0 m -106.48 11.81 30.29 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.058 0.392 . . . . 71.13 112.058 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.441 ' OD1' ' HG3' ' A' ' 5' ' ' LYS . 17.7 t70 -50.92 -35.93 35.8 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.218 0.451 . . . . 71.03 112.218 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.32 -19.55 35.93 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 111.954 0.353 . . . . 55.33 111.954 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -91.32 -30.11 16.76 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 111.72 0.267 . . . . 75.44 111.72 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.6 tp 40.3 90.8 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.17 0.588 . . . . 61.0 111.787 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 t -103.15 169.5 8.52 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.12 0.785 . . . . 43.22 113.12 -164.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 87.9 p -137.97 150.14 46.76 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.656 -0.702 . . . . 61.22 111.315 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -145.47 175.33 10.41 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.328 -0.396 . . . . 73.11 110.709 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.6 p -133.92 15.66 3.91 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.651 0.612 . . . . 55.41 112.651 -178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 97.6 m-85 -109.92 121.93 40.5 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 120.912 0.386 . . . . 73.01 111.768 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 8.0 Cg_exo -73.43 102.3 1.46 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.87 2.38 . . . . 54.2 113.106 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.1 ptt? -85.89 153.91 21.88 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.354 -0.385 . . . . 63.1 111.588 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 89.6 mttt -99.04 123.9 43.67 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 111.813 0.301 . . . . 75.23 111.813 -174.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 tp -78.44 99.15 6.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.966 0.412 . . . . 42.44 110.949 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -95.71 146.78 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.9 0.381 . . . . 65.45 111.101 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.44 7.76 3.15 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 116.267 -0.424 . . . . 74.32 111.851 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 58.19 21.7 8.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.881 0.372 . . . . 74.25 111.764 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.412 ' O ' ' HG3' ' A' ' 173' ' ' LYS . 40.2 tp -129.46 -43.89 1.26 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.018 0.437 . . . . 70.32 111.718 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 172' ' ' VAL . 13.0 m -134.25 153.34 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.15 0.5 . . . . 72.31 112.288 -175.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.495 ' CE2' ' HB3' ' A' ' 173' ' ' LYS . 95.0 m-85 -91.61 134.47 34.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.238 -0.437 . . . . 72.02 111.105 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 8.7 pt-20 -104.84 131.78 51.9 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.318 0.58 . . . . 71.51 110.81 172.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.571 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 74.7 t80 -130.91 119.07 21.61 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.197 -0.456 . . . . 74.14 111.153 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -101.57 130.67 47.93 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.937 0.399 . . . . 54.04 111.411 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.77 -160.08 10.88 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.354 -0.45 . . . . 71.21 112.785 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -109.26 165.76 11.37 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.439 -0.448 . . . . 63.22 111.761 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -98.34 106.43 18.72 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.406 -0.361 . . . . 64.33 110.614 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.97 159.6 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.141 0.496 . . . . 65.33 111.574 -176.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 5.6 m -127.8 137.59 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.28 -0.418 . . . . 74.53 110.176 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 30.0 ttp180 -125.73 110.79 14.16 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.573 0.702 . . . . 61.1 112.179 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 98.0 mttt -106.27 160.43 15.36 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.843 -1.071 . . . . 74.44 109.507 169.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 39' ' ' GLU . 2.2 mp0 -51.64 -34.35 37.41 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.219 0.452 . . . . 65.5 112.219 -174.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.5 30.07 1.86 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.226 -0.512 . . . . 34.0 113.243 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 1.2 tm-20 -141.43 146.22 36.27 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 122.581 -0.364 . . . . 73.13 110.443 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 tp -153.67 92.91 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-O 121.258 0.551 . . . . 74.44 112.454 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 43' ' ' VAL . 17.8 m -126.75 100.85 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 121.484 0.659 . . . . 61.21 111.084 172.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 44' ' ' LEU . 6.4 mp -55.99 -45.2 79.09 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.007 0.432 . . . . 71.14 112.122 -173.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.88 34.08 0.34 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.47 0.544 . . . . 63.3 112.47 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.3 88.97 0.03 OUTLIER Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.343 -0.456 . . . . 74.11 112.452 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.7 p -82.27 8.81 10.18 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.124 0.787 . . . . 74.01 113.124 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.705 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 75.7 m-20 -62.06 -55.69 38.54 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 122.188 -0.32 . . . . 62.55 111.666 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.705 ' HD3' ' HB2' ' A' ' 48' ' ' ASN . 8.3 Cg_endo -88.0 88.15 0.56 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.122 1.881 . . . . 73.1 112.029 176.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.1 p -165.35 101.25 0.72 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.144 0.497 . . . . 53.12 112.133 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 63.24 4.08 1.53 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.214 1.19 . . . . 73.11 114.214 172.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -81.54 -54.31 5.53 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.894 -0.504 . . . . 71.2 110.446 178.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 59.64 19.6 8.22 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.716 -0.675 . . . . 74.51 112.268 173.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.21 -14.51 64.07 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.485 -0.388 . . . . 72.34 113.966 -176.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 56' ' ' GLU . . . -83.34 -21.03 33.26 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.389 -0.477 . . . . 74.03 112.151 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 55' ' ' ALA . 39.7 tt0 72.44 -44.81 0.6 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.303 0.641 . . . . 71.5 112.436 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.42 157.39 8.85 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.444 0.64 . . . . 73.02 111.921 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.04 77.04 10.0 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.331 0.863 . . . . 74.41 113.331 -167.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.59 -33.84 2.98 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 115.63 1.012 . . . . 74.01 115.63 163.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.3 p -61.67 86.83 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.863 0.832 . . . . 75.14 111.717 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -80.89 -66.27 0.91 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.346 0.499 . . . . 63.55 112.346 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.473 ' HB3' HG23 ' A' ' 64' ' ' VAL . 35.9 tt0 -129.36 1.94 5.11 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 120.884 0.373 . . . . 60.44 111.385 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 82.7 t60 64.36 46.31 3.49 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.783 0.801 . . . . 75.51 110.703 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.473 HG23 ' HB3' ' A' ' 62' ' ' GLU . 77.2 t -102.68 159.28 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.381 -0.827 . . . . 74.52 111.269 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 43.7 mt-10 -81.21 60.34 4.29 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.386 0.613 . . . . 71.24 109.881 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -106.85 148.42 28.56 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.006 -0.543 . . . . 71.14 111.99 -175.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.29 -113.62 1.4 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.935 -0.65 . . . . 64.3 113.294 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.572 HG21 ' HB3' ' A' ' 167' ' ' PRO . 31.4 pt -111.68 132.3 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.194 0.521 . . . . 63.41 112.213 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -51.1 -33.59 26.85 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.015 -0.539 . . . . 72.45 112.109 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.492 HG21 ' HB2' ' A' ' 169' ' ' LEU . 64.5 mt -47.87 -49.56 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 112.329 0.492 . . . . 75.43 112.329 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 23.4 m -85.68 -30.32 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.41 -0.359 . . . . 74.11 111.899 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 66.8 mt -67.82 -49.96 59.37 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.093 0.473 . . . . 75.4 111.211 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -60.85 -36.21 78.54 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.897 -0.592 . . . . 75.42 111.755 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -100.51 8.03 43.75 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.236 0.458 . . . . 61.32 112.236 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 54.89 69.67 0.71 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.673 0.619 . . . . 75.53 112.673 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 73.5 mt -116.61 125.93 52.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.056 -0.52 . . . . 63.52 110.505 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 p -82.58 143.08 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.969 0.414 . . . . 72.55 111.886 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -77.84 129.15 35.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.824 -0.625 . . . . 62.43 112.506 -175.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.5 mmt -136.13 165.22 26.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.984 -0.553 . . . . 72.24 111.169 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -144.91 143.24 30.46 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.276 0.56 . . . . 74.24 111.923 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 21.3 p -40.86 -32.43 0.23 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.753 1.76 . . . . 60.21 115.753 -167.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -51.15 -46.36 61.98 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.86 0.689 . . . . 75.44 112.86 -172.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -103.71 -20.48 13.95 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.007 -0.433 . . . . 62.24 111.551 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.84 -22.32 66.97 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.02 0.378 . . . . 44.33 112.02 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.47 -42.33 54.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.046 0.45 . . . . 72.3 111.312 175.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.9 t -62.83 -42.96 99.95 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.251 0.548 . . . . 65.33 111.233 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.2 ttm -64.31 -43.54 94.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.081 -0.509 . . . . 73.51 110.878 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 91' ' ' TYR . 62.9 m-85 -66.91 -30.49 70.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.998 0.37 . . . . 63.22 111.998 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.8 -53.48 57.37 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.002 0.429 . . . . 71.41 110.488 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.08 -41.24 90.98 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.046 0.45 . . . . 71.15 111.615 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.575 ' HE1' ' HG3' ' A' ' 152' ' ' GLN . 78.7 t80 -56.89 -63.37 1.23 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.04 -0.527 . . . . 74.54 111.602 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.9 mm -57.87 -31.26 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.463 -0.335 . . . . 63.25 111.767 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -56.91 -67.29 0.33 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.055 0.455 . . . . 75.32 111.575 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -63.39 -40.76 98.12 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.175 -0.466 . . . . 63.32 111.102 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.477 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 86.8 t80 -54.94 -55.62 28.7 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.866 -0.606 . . . . 43.12 111.304 178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -55.83 -50.23 71.11 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.883 0.327 . . . . 71.13 111.883 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -62.63 -37.77 87.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.076 0.398 . . . . 75.25 112.076 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -76.07 -46.73 27.63 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.257 -0.277 . . . . 71.44 111.746 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.484 HG12 ' HB3' ' A' ' 174' ' ' GLU . 22.0 m -65.77 -42.55 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 112.085 0.402 . . . . 73.21 112.085 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.1 mm -65.42 -43.53 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 122.228 -0.295 . . . . 54.33 111.071 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.15 -38.9 74.2 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.139 0.495 . . . . 75.31 110.847 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -60.76 -56.59 19.4 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.018 -0.537 . . . . 70.02 111.639 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.637 ' HE2' ' HA ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -67.88 -28.46 67.54 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.127 0.489 . . . . 73.43 111.591 -178.251 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 37.5 tt0 -68.53 -27.2 65.89 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.18 -0.464 . . . . 61.4 111.568 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -72.64 -36.72 68.06 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.902 0.382 . . . . 63.31 111.824 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -86.58 -29.89 22.27 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 111.942 0.349 . . . . 61.01 111.942 -176.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -125.61 -74.92 0.59 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.357 0.502 . . . . 75.5 112.357 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 24.1 ttt180 67.92 -30.73 0.17 Allowed 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 113.02 0.748 . . . . 63.2 113.02 -174.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 111' ' ' ALA . 23.0 t0 -90.94 80.26 5.79 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.652 -0.655 . . . . 70.11 111.925 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.475 ' HG3' ' N ' ' A' ' 111' ' ' ALA . 10.0 ptpp? 50.14 -67.1 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.671 1.588 . . . . 74.2 115.056 169.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 109' ' ' ASP . . . -33.47 -54.51 0.43 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.01 1.115 . . . . 45.23 114.01 -172.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -95.97 -44.88 7.16 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.45 0.537 . . . . 61.32 112.45 -176.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 m -61.53 -37.24 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 112.564 0.579 . . . . 41.53 112.564 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.89 -41.55 87.0 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.081 0.467 . . . . 51.43 110.881 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -64.02 -48.89 74.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.188 -0.46 . . . . 71.42 111.054 176.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -57.85 -48.85 78.58 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.238 -0.437 . . . . 72.04 111.322 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -51.99 -51.71 55.44 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.771 -0.455 . . . . 75.32 109.771 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -57.61 -38.02 74.24 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.143 -0.48 . . . . 74.21 111.298 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 29.7 mmmt -63.52 -62.5 1.63 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.003 0.43 . . . . 72.22 111.81 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.1 tp -69.22 -32.65 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.394 -0.366 . . . . 75.3 111.88 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.411 ' O ' HG23 ' A' ' 125' ' ' VAL . 58.1 tp60 -62.84 -49.39 75.1 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.918 0.39 . . . . 73.52 110.196 175.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.29 -38.23 85.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.88 -0.676 . . . . 51.11 112.556 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 44.3 t90 -60.68 -55.38 33.9 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.306 0.242 . . . . 72.45 111.457 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.7 m -65.85 -40.83 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.079 0.4 . . . . 75.23 112.079 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 121' ' ' GLN . 68.8 t -59.09 -36.11 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.098 0.475 . . . . 62.13 111.223 177.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.5 m -76.51 -47.25 23.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.017 0.437 . . . . 72.43 110.975 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.1 tp -62.2 -36.07 80.79 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.967 -0.561 . . . . 72.4 112.139 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.6 mt -88.56 3.2 51.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.469 0.544 . . . . 74.35 112.469 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.426 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -68.26 81.97 0.24 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.404 0.621 . . . . 43.21 110.911 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -48.07 -45.34 32.35 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.885 1.069 . . . . 63.54 113.885 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -43.31 -46.62 6.42 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.502 0.556 . . . . 64.51 112.502 -171.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.512 ' HG3' ' CD1' ' A' ' 133' ' ' PHE . 2.3 ptp180 -109.74 -42.15 4.35 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.185 0.439 . . . . 70.3 112.185 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.512 ' CD1' ' HG3' ' A' ' 132' ' ' ARG . 52.9 m-85 -71.04 -8.16 51.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.962 0.727 . . . . 73.42 112.962 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -56.01 -22.59 27.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.234 0.54 . . . . 64.23 111.08 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.551 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 58.3 m-20 -76.65 6.05 6.55 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.595 -0.73 . . . . 75.04 112.215 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.8 mt -89.19 148.98 23.34 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.026 0.441 . . . . 73.13 111.579 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.05 146.38 30.2 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.173 -0.467 . . . . 65.11 111.217 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -114.09 125.43 53.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.969 0.414 . . . . 74.02 110.879 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.547 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 58.1 m-85 -126.2 127.95 46.47 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.018 0.437 . . . . 74.33 111.555 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 145' ' ' ALA . 10.3 tt -121.63 152.32 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.341 -0.39 . . . . 71.12 111.176 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.49 136.87 35.48 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 114.142 0.417 . . . . 62.24 114.142 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.05 -41.42 68.1 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.34 0.496 . . . . 54.44 112.34 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.612 ' H ' ' HD2' ' A' ' 143' ' ' ARG . 1.2 mpt_? -80.29 -43.12 21.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.914 0.387 . . . . 71.23 110.975 -177.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.63 -53.49 57.0 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.244 -0.434 . . . . 72.35 111.499 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -59.06 -24.43 62.87 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.492 0.553 . . . . 60.31 112.492 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.72 -29.19 16.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.91 0.386 . . . . 70.22 111.663 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -88.38 -49.32 3.73 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.109 -0.567 . . . . 54.02 113.15 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.75 124.13 10.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.747 0.308 . . . . 61.51 111.22 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -18.41 59.81 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.852 0.358 . . . . 34.35 111.513 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -78.07 44.45 0.48 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.1 0.476 . . . . 53.31 111.29 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.87 179.24 35.37 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.171 -0.468 . . . . 34.5 113.207 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.575 ' HG3' ' HE1' ' A' ' 91' ' ' TYR . 6.9 tt0 -98.43 115.85 29.4 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.09 0.471 . . . . 74.33 111.671 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.2 t -81.05 139.57 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.171 0.51 . . . . 74.1 111.916 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.801 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -97.82 133.45 42.32 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.922 -0.581 . . . . 65.54 110.651 175.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 45.6 mm -86.77 124.74 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.73 0.3 . . . . 53.43 111.504 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.443 HG13 ' CD1' ' A' ' 139' ' ' PHE . 46.5 mm -110.57 106.79 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.273 0.559 . . . . 53.2 112.444 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.519 ' HG2' ' N ' ' A' ' 158' ' ' TYR . 28.4 tt0 -103.1 158.65 16.15 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.277 -0.874 . . . . 75.02 110.148 172.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.605 ' HB2' ' HB3' ' A' ' 165' ' ' GLU . 0.6 OUTLIER -115.83 115.01 25.52 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.476 0.655 . . . . 55.25 111.243 168.167 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.482 HH21 HG21 ' A' ' 168' ' ' THR . 3.5 tpp180 -69.04 141.18 54.89 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.408 -0.814 . . . . 73.2 112.153 -176.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.51 102.97 7.17 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.255 -0.43 . . . . 71.41 111.388 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 83.5 t -111.01 90.79 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.963 0.411 . . . . 70.03 110.625 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 58.28 19.69 6.52 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.058 -0.519 . . . . 65.33 111.833 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 112.3 -23.41 16.03 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 116.265 -0.425 . . . . 71.12 112.653 -175.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 92.8 m -84.26 118.63 24.3 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.067 0.461 . . . . 64.33 110.886 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 26.0 mt-10 -85.34 100.32 11.74 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.007 -0.542 . . . . 75.52 111.236 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 25.2 m -98.4 149.79 36.08 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 111.981 0.363 . . . . 74.21 111.981 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.572 ' HB3' HG21 ' A' ' 68' ' ' ILE . 18.0 Cg_endo -58.88 136.25 72.34 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.69 2.26 . . . . 53.54 114.278 -176.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.482 HG21 HH21 ' A' ' 159' ' ' ARG . 83.2 m -143.27 108.83 5.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.762 -0.654 . . . . 71.51 110.9 176.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.801 HD11 ' HB1' ' A' ' 154' ' ' ALA . 63.5 tp -82.55 145.41 29.76 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.209 -0.45 . . . . 75.02 111.665 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.683 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 64.7 mtt -126.45 126.47 43.83 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.843 0.354 . . . . 71.3 111.462 176.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -134.51 129.94 35.9 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.091 -0.504 . . . . 75.21 111.2 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 174' ' ' GLU . 22.3 t -80.32 126.86 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 O-C-N 122.019 -0.426 . . . . 65.43 111.711 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.495 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -72.29 -14.59 61.79 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.332 0.493 . . . . 75.21 112.332 -179.147 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.541 ' H ' HG12 ' A' ' 172' ' ' VAL . 0.4 OUTLIER -81.07 -11.69 59.45 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.9 0.381 . . . . 72.22 111.229 169.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.442 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -96.95 -39.25 9.46 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.981 0.42 . . . . 62.24 110.804 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 176' ' ' ILE . 29.6 pt -119.88 114.07 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.087 0.47 . . . . 63.24 111.563 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.438 HD13 ' N ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -94.42 130.42 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 109.282 -0.636 . . . . 63.31 109.282 175.611 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.438 ' N ' HD13 ' A' ' 177' ' ' ILE . 1.5 pp20? -94.59 153.0 18.07 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.812 0.815 . . . . 71.13 112.961 -172.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -127.09 99.16 5.58 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.418 -0.81 . . . . 73.41 109.694 173.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -79.95 97.06 6.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.263 0.554 . . . . 64.31 110.637 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 48.6 t -130.22 87.96 2.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.579 0.704 . . . . 73.13 109.798 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 8.0 mp -108.57 93.2 4.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.608 -0.723 . . . . 62.11 110.552 -176.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--O 1.25 1.094 0 CA-C-N 115.673 -0.694 . . . . 55.41 111.568 -177.179 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtm . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.796 0.332 . . . . 71.03 111.233 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 15' ' ' SER . 29.8 tp -109.46 130.72 55.49 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.649 -0.5 . . . . 44.11 109.649 170.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.766 HG13 ' HB3' ' A' ' 179' ' ' GLU . 17.4 pt -117.19 127.79 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.191 0.519 . . . . 63.21 111.607 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -121.8 147.61 45.74 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.96 -0.564 . . . . 71.32 112.104 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.426 ' HE3' ' CG2' ' A' ' 177' ' ' ILE . 20.7 ttpp -124.05 117.24 24.26 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.348 -0.387 . . . . 71.04 111.525 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.79 173.31 6.39 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.031 -0.531 . . . . 64.42 111.362 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.805 HD11 ' HB1' ' A' ' 175' ' ' ALA . 57.7 mt -78.28 -49.59 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.055 0.455 . . . . 70.43 111.619 175.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -93.16 -38.62 11.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.006 -0.543 . . . . 73.33 112.13 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -97.9 17.95 17.0 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.701 -0.682 . . . . 73.54 110.945 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -47.68 -39.9 18.57 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.095 1.146 . . . . 71.24 114.095 -169.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.26 -28.0 62.58 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.124 0.416 . . . . 75.02 112.124 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 35.0 tt0 -89.05 25.11 1.91 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 120.669 0.271 . . . . 74.45 111.509 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.458 HD21 ' HB ' ' A' ' 3' ' ' ILE . 7.8 tt -34.67 122.09 0.52 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.324 0.65 . . . . 75.33 111.698 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t -126.64 179.42 5.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.399 -0.364 . . . . 63.12 111.493 -171.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.478 ' HB3' HG22 ' A' ' 3' ' ' ILE . 83.8 p -124.66 148.04 48.2 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.444 -0.344 . . . . 60.51 111.419 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -138.78 -172.74 3.38 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.514 0.673 . . . . 73.33 111.691 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -149.28 29.31 0.79 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.406 -0.815 . . . . 71.31 111.016 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -90.16 113.05 55.89 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 112.026 0.38 . . . . 64.54 112.026 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.54 77.46 1.74 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.189 1.926 . . . . 71.24 112.32 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.3 mtt -84.76 143.27 29.24 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.075 0.465 . . . . 72.45 111.247 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 27.1 ttpp -99.63 118.58 36.46 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.012 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.4 tp -76.24 135.56 39.67 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.882 0.373 . . . . 64.5 111.021 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.23 134.65 65.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.2 0.524 . . . . 53.32 111.656 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.1 t70 61.9 15.93 7.59 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.464 -0.789 . . . . 72.32 111.951 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 59.0 19.72 7.5 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.002 0.521 . . . . 63.11 112.112 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.1 tp -119.74 -49.72 2.32 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.099 0.407 . . . . 62.52 112.099 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.624 HG12 ' HA ' ' A' ' 172' ' ' VAL . 13.6 m -132.53 149.55 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.581 0.586 . . . . 74.23 112.581 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -86.52 144.43 27.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.262 -0.426 . . . . 70.01 111.065 174.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 16.2 pt-20 -122.1 133.42 54.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.038 0.447 . . . . 73.04 110.489 174.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -137.53 135.48 36.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.833 0.349 . . . . 75.23 110.838 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -92.2 121.54 33.83 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.591 0.589 . . . . 71.14 112.591 -173.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.92 165.51 12.93 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.08 -0.509 . . . . 54.54 112.358 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -121.95 145.01 48.53 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 122.367 -0.49 . . . . 73.23 111.109 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -73.62 109.64 7.28 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.328 0.585 . . . . 75.22 112.04 -175.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.47 HG23 HD12 ' A' ' 72' ' ' LEU . 26.8 m -134.63 166.2 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.246 -0.433 . . . . 72.31 110.474 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.471 HG21 HG13 ' A' ' 43' ' ' VAL . 10.5 m -131.4 150.74 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 122.067 -0.395 . . . . 65.22 111.249 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.672 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 34.9 mmt180 -117.95 115.49 25.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.498 0.666 . . . . 54.44 112.208 176.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.569 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 99.5 mttt -117.38 141.46 48.3 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.251 -1.018 . . . . 72.21 108.251 165.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.08 -24.21 16.59 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.125 0.787 . . . . 74.42 113.125 -173.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -130.2 13.69 5.71 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 120.911 -0.662 . . . . 63.03 113.715 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 37.4 mt-10 -144.3 134.9 24.8 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 117.329 0.564 . . . . 65.12 111.745 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tp -116.73 51.72 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 122.028 0.918 . . . . 75.32 110.426 176.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.471 HG13 HG21 ' A' ' 36' ' ' VAL . 4.7 p -72.48 77.97 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.89 0.852 . . . . 64.02 112.546 -176.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pp -99.03 -0.5 41.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.073 -0.512 . . . . 70.41 111.938 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.55 112.98 16.18 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.407 -0.36 . . . . 73.34 111.883 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.3 -173.86 36.95 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.198 -0.525 . . . . 73.13 113.314 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 p -106.79 178.44 4.56 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.63 -0.335 . . . . 75.34 111.242 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -87.5 116.56 66.54 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 122.189 -0.319 . . . . 70.11 111.175 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.01 123.38 3.56 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.585 2.19 . . . . 55.11 113.138 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.0 t -87.12 117.53 25.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.973 0.416 . . . . 75.51 111.091 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.04 48.85 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.134 0.492 . . . . 63.3 110.254 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -49.15 -56.11 10.23 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.619 -0.719 . . . . 61.53 112.315 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -103.24 88.01 3.02 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.252 0.548 . . . . 74.41 111.38 176.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.2 92.88 0.91 Allowed Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.121 -0.49 . . . . 60.44 112.074 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.76 -50.46 4.67 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.862 0.69 . . . . 62.34 112.862 -174.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.23 -50.81 9.11 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.316 0.858 . . . . 75.32 113.316 -172.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -62.12 156.52 21.41 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.595 0.591 . . . . 74.13 112.595 -175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 60' ' ' SER . 13.1 p-10 -128.08 27.02 5.72 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.071 -0.513 . . . . 72.21 112.205 -175.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.51 82.52 0.01 OUTLIER Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.584 -0.341 . . . . 72.14 112.561 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 58' ' ' ASP . 19.1 t -68.12 92.02 0.38 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.637 0.977 . . . . 43.25 113.637 -171.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -123.78 29.17 6.62 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 122.638 1.208 . . . . 74.12 107.908 166.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -82.03 -38.68 24.64 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.158 -1.383 . . . . 71.02 113.504 -167.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -80.76 26.11 0.42 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.314 0.486 . . . . 72.12 112.314 -170.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.19 146.77 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 122.655 0.382 . . . . 71.14 110.268 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.672 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 48.2 mt-10 -74.7 72.06 1.97 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.568 0.699 . . . . 73.43 110.08 175.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -85.79 129.29 34.87 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.149 -0.932 . . . . 74.24 112.194 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.92 -149.74 11.68 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.01 -0.615 . . . . 63.01 112.803 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 pt -111.45 154.11 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 122.601 -0.352 . . . . 53.23 111.573 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -41.27 -48.94 3.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.257 0.465 . . . . 65.25 112.257 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.428 HG21 HD22 ' A' ' 169' ' ' LEU . 56.1 mt -49.6 -55.49 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 112.584 0.587 . . . . 72.3 112.584 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.407 ' HA ' HD12 ' A' ' 76' ' ' LEU . 23.0 m -80.53 -34.76 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.333 0.494 . . . . 75.21 112.333 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.47 HD12 HG23 ' A' ' 35' ' ' VAL . 87.3 mt -71.03 -40.81 71.52 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.979 0.419 . . . . 73.23 111.527 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -64.42 -35.98 82.68 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.909 0.385 . . . . 75.24 111.969 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -101.43 4.81 41.69 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.531 0.567 . . . . 70.25 112.531 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.0 70.33 0.62 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.158 0.504 . . . . 72.42 112.149 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 71' ' ' VAL . 76.5 mt -115.04 135.08 54.61 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.287 -0.415 . . . . 74.31 111.25 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.18 143.25 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.577 0.227 . . . . 72.44 111.211 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 7.9 pt-20 -88.88 134.05 34.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.408 0.623 . . . . 73.23 112.631 -176.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.43 138.09 50.6 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.845 -0.616 . . . . 75.5 110.618 171.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -105.07 144.49 31.81 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.98 -0.554 . . . . 74.12 110.407 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 40.9 t -49.32 -16.68 0.2 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.297 1.591 . . . . 65.31 115.297 -169.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -93.59 -19.37 21.24 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.558 -0.714 . . . . 62.5 112.701 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -83.06 -46.51 12.73 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.283 0.563 . . . . 70.52 111.852 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 87' ' ' MET . 9.9 p-10 -108.17 21.77 16.89 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.601 -0.727 . . . . 71.31 112.163 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.603 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -36.26 -50.13 0.72 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.92 1.081 . . . . 75.11 113.92 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.9 t -73.06 -30.48 63.74 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.951 0.405 . . . . 63.53 111.542 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.581 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 80.2 mtp -67.8 -60.38 2.57 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.197 0.443 . . . . 75.2 112.197 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.603 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 6.1 p90 -63.4 -28.26 69.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.178 -0.609 . . . . 75.22 110.654 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -58.2 -40.35 81.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.12 0.486 . . . . 70.41 110.543 172.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.47 80.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.214 -0.448 . . . . 71.44 111.048 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -54.68 -54.39 42.35 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.156 -0.475 . . . . 74.54 111.225 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.5 -35.1 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.52 -0.309 . . . . 74.52 111.74 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.439 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -60.86 -60.43 3.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.776 0.322 . . . . 75.24 111.488 177.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -64.96 -38.66 91.69 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.064 0.459 . . . . 51.05 111.298 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.688 ' HZ ' HD11 ' A' ' 120' ' ' ILE . 41.6 t80 -57.18 -53.25 60.2 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.052 -0.522 . . . . 64.45 111.838 176.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -61.83 -46.92 87.38 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.845 0.355 . . . . 73.33 111.496 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.44 -36.05 82.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.647 -0.251 . . . . 65.12 111.554 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.54 -52.82 34.32 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.513 -0.312 . . . . 73.32 111.782 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.1 m -58.72 -39.31 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 111.893 0.331 . . . . 63.33 111.893 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.511 HD11 ' HB3' ' A' ' 117' ' ' LYS . 17.6 mm -77.95 -36.44 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.147 0.425 . . . . 74.02 112.147 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -60.97 -39.16 88.52 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.32 0.581 . . . . 75.54 109.952 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -71.79 -70.3 0.34 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.468 -0.787 . . . . 60.03 111.438 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 11.9 tpt -63.01 -43.32 99.11 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.835 0.68 . . . . 74.23 112.835 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.455 ' HA ' HG11 ' A' ' 113' ' ' VAL . 32.1 tt0 -71.95 -10.96 60.52 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.032 -0.417 . . . . 75.23 111.591 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -87.16 -45.16 10.93 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.221 -0.299 . . . . 61.42 111.367 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -80.5 -31.35 37.23 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.933 0.345 . . . . 63.11 111.933 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -96.04 -51.34 4.48 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 122.268 -0.27 . . . . 74.55 111.625 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 74.06 -35.34 0.3 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.954 1.465 . . . . 71.02 114.954 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.612 ' O ' HG22 ' A' ' 113' ' ' VAL . 28.3 t70 -63.19 121.33 13.39 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.648 -0.658 . . . . 73.42 112.28 -172.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.681 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -46.29 -51.16 15.1 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.438 -0.801 . . . . 64.35 113.129 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.473 ' N ' ' HG2' ' A' ' 110' ' ' LYS . . . -70.26 -33.52 71.71 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.085 0.402 . . . . 72.32 112.085 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -77.54 -49.68 14.17 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.032 0.444 . . . . 43.12 110.846 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 109' ' ' ASP . 31.1 m -66.52 -22.59 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 122.058 -0.401 . . . . 64.41 111.073 175.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.58 -50.09 74.25 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.809 0.338 . . . . 53.33 110.322 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.46 -43.81 96.52 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.237 -0.438 . . . . 41.25 111.084 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.413 ' HE1' ' HB3' ' A' ' 174' ' ' GLU . 87.4 t80 -57.73 -58.29 9.02 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.256 -0.429 . . . . 73.41 111.8 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.616 ' HA ' HG22 ' A' ' 120' ' ' ILE . 17.6 ptpt -65.46 -30.96 71.81 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.293 -0.254 . . . . 75.4 111.436 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -58.81 -45.74 89.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.369 0.604 . . . . 74.55 110.501 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -67.44 -57.38 6.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.508 -0.769 . . . . 75.52 111.92 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.688 HD11 ' HZ ' ' A' ' 95' ' ' PHE . 10.5 tp -66.38 -39.56 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 112.257 0.465 . . . . 73.34 112.257 -173.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -73.64 -43.52 59.29 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 122.07 -0.394 . . . . 62.31 110.449 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.0 -34.4 61.86 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.955 -0.64 . . . . 72.21 112.228 174.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -62.85 -57.69 9.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.42 0.288 . . . . 71.21 111.076 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 26.1 m -62.18 -48.88 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 112.414 0.524 . . . . 75.13 112.414 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.03 -29.02 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.788 -0.57 . . . . 74.34 111.952 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.9 t -84.87 -33.85 22.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.846 0.355 . . . . 44.31 111.331 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.473 HD21 HD13 ' A' ' 155' ' ' ILE . 40.2 tp -70.37 -32.76 70.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.218 0.532 . . . . 74.45 111.251 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.6 mt -80.29 2.34 25.01 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.147 -0.478 . . . . 71.34 111.888 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.06 82.39 0.32 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.564 0.697 . . . . 61.04 110.434 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.465 ' NZ ' ' HB3' ' A' ' 130' ' ' LYS . 5.5 ttpm? -65.0 -6.41 8.51 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.716 -0.675 . . . . 74.33 112.72 -170.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.49 -47.23 86.31 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.93 -0.481 . . . . 73.24 111.212 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -108.94 -35.4 6.36 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.039 0.447 . . . . 70.03 111.429 172.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -69.69 -6.65 33.07 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.436 0.532 . . . . 72.12 112.436 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -52.78 -25.76 12.29 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.118 0.414 . . . . 75.41 112.118 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.41 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . 66.9 m-20 -83.33 12.09 5.87 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.211 0.449 . . . . 75.33 112.211 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 81.5 mt -90.28 156.8 18.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.259 0.552 . . . . 72.31 112.093 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.31 126.29 25.98 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.967 -0.56 . . . . 74.23 110.261 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.5 ' HB2' ' CG1' ' A' ' 153' ' ' VAL . 14.0 p90 -116.91 126.78 53.48 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.382 0.61 . . . . 70.4 111.33 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 78' ' ' GLU . 24.5 m-85 -97.95 148.12 23.78 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.706 -0.679 . . . . 71.52 112.18 -172.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 14.1 tt -136.04 150.33 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.716 -0.674 . . . . 74.25 110.592 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.01 140.26 46.73 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.132 -0.556 . . . . 64.13 113.392 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -50.81 -52.9 36.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.854 0.359 . . . . 64.54 111.588 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -54.25 -30.71 51.3 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.169 -0.469 . . . . 74.43 112.149 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.8 -56.49 4.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.489 -0.323 . . . . 73.05 111.266 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.36 -24.21 66.32 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.144 0.497 . . . . 61.22 111.589 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -54.72 -29.23 52.84 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.572 -0.74 . . . . 74.44 112.558 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.5 -34.27 0.1 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.558 -0.83 . . . . 42.11 113.764 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 149' ' ' GLU . . . -56.74 -50.95 70.71 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.47 0.544 . . . . 71.11 112.47 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 148' ' ' ALA . 10.8 pt-20 58.48 -22.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 125.273 1.429 . . . . 71.25 114.362 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 148' ' ' ALA . 20.0 t-20 -88.84 60.76 5.66 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.025 0.916 . . . . 75.01 109.703 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -129.8 172.75 19.96 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.89 -1.05 . . . . 61.13 112.697 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -79.04 144.25 34.84 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.016 0.436 . . . . 64.14 111.396 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.5 ' CG1' ' HB2' ' A' ' 138' ' ' PHE . 37.6 t -114.03 137.14 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.194 -0.457 . . . . 75.2 111.506 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.76 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -104.87 119.76 39.78 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.18 -0.464 . . . . 61.02 110.777 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.473 HD13 HD21 ' A' ' 127' ' ' LEU . 60.7 mt -91.07 138.6 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.159 0.429 . . . . 44.02 112.159 -174.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.1 mm -115.46 120.14 63.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.022 0.439 . . . . 75.11 111.144 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -110.99 157.68 19.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.617 -0.72 . . . . 73.21 111.104 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 135' ' ' ASN . 9.8 p90 -106.89 115.19 29.75 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.187 0.518 . . . . 65.12 111.771 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -115.76 140.04 49.59 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.177 -0.465 . . . . 74.42 111.769 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -102.52 109.41 21.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.505 -0.316 . . . . 72.1 110.385 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 52.7 t -90.39 89.85 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.043 0.449 . . . . 74.15 111.111 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.6 t70 55.38 27.33 9.87 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.866 -0.606 . . . . 74.32 112.308 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 119.23 -1.61 14.44 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.941 -0.647 . . . . 74.43 113.985 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 41.6 m -118.61 121.13 39.44 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 117.397 0.598 . . . . 62.52 111.245 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.25 121.45 26.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.293 0.568 . . . . 73.15 111.796 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.447 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 29.0 m -128.83 137.66 31.46 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 116.202 -0.454 . . . . 74.0 111.873 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 166' ' ' VAL . 5.9 Cg_exo -80.97 118.42 3.39 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.232 2.621 . . . . 72.11 112.845 176.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.3 p -103.95 146.19 29.05 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.29 0.567 . . . . 71.31 112.188 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.76 HD11 ' HB1' ' A' ' 154' ' ' ALA . 69.9 tp -95.47 137.88 33.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.922 -0.581 . . . . 73.05 110.916 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.47 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 25.3 mmt -123.16 124.31 42.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.5 0.32 . . . . 73.24 111.608 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 98.1 mt -139.3 130.21 26.29 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.82 0.448 . . . . 71.5 111.038 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.624 ' HA ' HG12 ' A' ' 27' ' ' VAL . 60.5 t -78.49 121.94 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 112.132 0.419 . . . . 72.2 112.132 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -76.96 -36.8 56.23 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.834 0.349 . . . . 41.13 111.828 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.413 ' HB3' ' HE1' ' A' ' 116' ' ' PHE . 7.0 mm-40 -73.94 6.33 3.44 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.232 0.456 . . . . 61.21 112.232 -172.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.805 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -107.38 -42.75 4.73 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.047 0.451 . . . . 53.32 111.331 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 22.4 pt -96.05 170.21 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.917 -0.583 . . . . 64.32 111.233 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.426 ' CG2' ' HE3' ' A' ' 5' ' ' LYS . 5.2 tp -128.1 111.62 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.669 0.747 . . . . 73.41 111.927 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.2 153.21 22.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.137 -0.938 . . . . 75.11 111.411 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.766 ' HB3' HG13 ' A' ' 3' ' ' ILE . 21.4 tp10 -140.32 136.47 33.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.184 0.516 . . . . 72.42 111.685 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -89.25 121.23 31.33 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.389 -0.369 . . . . 63.11 111.897 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 43.4 t -132.53 86.43 2.32 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.24 0.543 . . . . 73.42 109.936 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -175.6 178.04 1.65 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.938 -0.574 . . . . 64.33 111.62 -174.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 . . . . . 0 C--O 1.255 1.394 0 CA-C-N 115.988 -0.551 . . . . 75.43 111.358 178.02 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.929 0.395 . . . . 60.14 111.791 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.9 tp -134.16 128.41 33.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.522 -0.308 . . . . 72.32 110.225 174.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.574 HG22 ' HB3' ' A' ' 15' ' ' SER . 35.2 pt -111.32 128.09 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 120.9 0.381 . . . . 72.15 111.798 -175.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -124.04 141.69 51.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.16 0.505 . . . . 71.23 112.073 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.65 115.37 30.38 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.389 -0.823 . . . . 75.22 110.356 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.679 ' HA ' HG22 ' A' ' 176' ' ' ILE . 3.9 m-20 -77.14 169.63 17.99 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.274 0.559 . . . . 71.45 112.389 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.434 HG23 ' CD2' ' A' ' 8' ' ' PHE . 10.4 tt -88.54 -31.02 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.029 0.442 . . . . 62.14 111.541 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.566 ' HB2' ' HB2' ' A' ' 152' ' ' GLN . 91.1 m-85 -98.82 -38.25 9.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.219 0.533 . . . . 70.12 111.933 178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.7 p -106.82 21.5 17.42 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.552 0.575 . . . . 73.4 112.552 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 18.1 t70 -45.54 -45.81 13.67 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.053 0.76 . . . . 63.05 113.053 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.43 -26.98 67.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.51 0.672 . . . . 74.22 111.236 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -109.39 24.63 12.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.451 -0.795 . . . . 75.44 111.054 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.411 ' N ' HD23 ' A' ' 13' ' ' LEU . 2.3 pt? -44.35 150.13 0.33 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.808 0.67 . . . . 55.21 112.808 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.5 t -120.8 168.56 11.31 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.621 0.971 . . . . 73.03 113.621 -168.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.574 ' HB3' HG22 ' A' ' 3' ' ' ILE . 61.0 p -133.95 107.06 7.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.924 -1.035 . . . . 54.3 110.69 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.49 ' OD2' ' HD2' ' A' ' 74' ' ' HIS . 2.6 m-20 -120.16 -177.53 3.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.843 0.354 . . . . 70.3 111.578 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.0 m -147.22 83.55 1.56 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.14 0.495 . . . . 54.35 111.243 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.507 ' HB2' ' HE2' ' A' ' 30' ' ' PHE . 85.7 m-85 -135.55 161.73 61.37 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.161 -0.472 . . . . 72.5 111.042 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.4 158.86 40.44 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.532 2.155 . . . . 71.11 112.613 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -144.08 131.17 20.58 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.248 0.547 . . . . 61.34 112.318 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -123.49 97.52 5.43 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.125 -0.488 . . . . 63.42 110.706 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.3 tp -76.93 116.77 17.89 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.48 0.548 . . . . 65.51 112.48 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.1 p -104.64 139.2 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.058 0.456 . . . . 74.43 111.824 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 59.02 9.56 1.29 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.534 0.734 . . . . 72.22 111.783 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.413 ' O ' ' HE3' ' A' ' 173' ' ' LYS . 32.7 t70 55.42 31.75 17.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.763 0.792 . . . . 71.42 110.36 -174.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.1 tp -124.23 -49.8 1.8 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.876 -0.602 . . . . 74.32 111.214 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.493 HG12 HG22 ' A' ' 172' ' ' VAL . 3.2 m -128.68 143.94 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.581 0.585 . . . . 73.44 112.581 -177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE2' ' HB3' ' A' ' 173' ' ' LYS . 60.8 m-85 -86.61 130.74 34.37 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.117 -0.492 . . . . 75.21 111.522 177.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.95 118.44 30.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.02 -0.991 . . . . 71.21 110.002 173.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.507 ' HE2' ' HB2' ' A' ' 18' ' ' PHE . 6.2 m-85 -108.94 119.43 39.53 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.217 0.451 . . . . 74.04 112.217 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -94.61 89.44 5.78 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.048 0.451 . . . . 74.25 111.358 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.87 -157.76 17.43 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 116.007 -0.542 . . . . 40.34 112.881 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -143.06 132.8 23.88 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 122.029 -0.689 . . . . 74.13 111.635 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -72.08 106.89 4.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.582 0.23 . . . . 74.01 110.447 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -134.41 164.44 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.209 0.528 . . . . 74.21 112.222 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 66' ' ' ARG . 29.4 m -138.67 131.88 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.103 -0.499 . . . . 74.44 110.745 175.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 43.5 ttp180 -118.16 132.02 56.36 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.877 0.37 . . . . 73.25 111.556 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 40' ' ' GLY . 4.6 tmmm? -94.56 99.51 11.65 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.402 -0.363 . . . . 64.41 110.107 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 62.7 -72.22 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.13 0.572 . . . . 70.1 111.961 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 38' ' ' LYS . . . -146.17 27.3 1.71 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.937 -0.465 . . . . 74.2 111.937 176.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -135.23 136.06 41.45 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 122.556 0.342 . . . . 75.15 111.782 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 mm -78.8 113.19 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.063 0.459 . . . . 71.12 111.629 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.2 t -126.13 48.71 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.554 0.693 . . . . 74.14 110.895 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 45' ' ' ALA . 2.4 pp -83.69 -21.21 32.45 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.397 0.517 . . . . 74.54 112.397 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.524 ' N ' HD12 ' A' ' 44' ' ' LEU . . . -86.46 102.46 14.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.829 0.347 . . . . 73.52 111.319 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.19 -49.99 0.35 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.161 -0.542 . . . . 60.14 112.675 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.1 t -71.14 171.83 10.28 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.953 0.406 . . . . 74.45 111.372 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -106.15 113.97 62.93 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 120.717 0.294 . . . . 75.3 111.722 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -81.34 110.68 2.27 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.105 2.536 . . . . 73.44 112.4 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.8 m -132.01 158.81 40.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.089 0.471 . . . . 73.14 111.907 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.485 ' HB2' ' H ' ' A' ' 165' ' ' GLU . . . -106.04 -75.46 0.63 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.743 -0.662 . . . . 52.25 111.187 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -71.66 -33.06 68.55 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.098 0.475 . . . . 71.13 111.59 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -77.01 97.88 4.79 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.03 -0.532 . . . . 74.34 111.737 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -145.28 100.4 0.23 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-N 116.014 -0.539 . . . . 52.04 112.595 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.11 26.99 5.37 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.506 -0.408 . . . . 72.43 111.834 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 60.23 69.1 0.72 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.414 0.626 . . . . 71.13 111.014 -176.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -151.3 175.44 12.21 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.974 -0.557 . . . . 60.02 111.665 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 59.47 11.52 2.32 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.513 0.561 . . . . 71.32 112.513 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.75 41.92 2.07 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.328 -0.463 . . . . 70.41 113.132 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.1 m -70.98 -26.73 63.28 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.37 0.268 . . . . 74.34 111.707 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.7 t70 71.93 -66.28 0.31 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.428 0.691 . . . . 75.5 111.405 -178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.655 ' HG3' HG23 ' A' ' 64' ' ' VAL . 9.1 pt-20 38.71 37.56 0.2 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.4 0.889 . . . . 70.02 113.4 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 70.7 1.23 3.62 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.084 0.772 . . . . 74.32 113.084 174.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.655 HG23 ' HG3' ' A' ' 62' ' ' GLU . 55.2 t -66.76 148.35 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 122.027 -0.421 . . . . 63.12 111.321 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 1.2 mp0 -73.23 68.94 1.06 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.486 0.66 . . . . 75.45 110.983 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.565 ' HA ' HG12 ' A' ' 36' ' ' VAL . 6.2 ttp180 -83.32 110.69 18.33 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.398 -0.819 . . . . 72.41 111.709 177.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.25 -153.98 12.45 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.852 -0.689 . . . . 71.21 112.943 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' A' ' 167' ' ' PRO . 33.6 pt -112.03 150.52 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.224 -0.574 . . . . 74.04 111.799 176.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -38.39 -56.87 1.2 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.65 0.78 . . . . 72.52 112.724 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.4 mt -53.88 -55.16 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.824 0.676 . . . . 71.11 112.824 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.455 ' HA ' HD12 ' A' ' 76' ' ' LEU . 19.4 m -68.38 -35.2 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.147 0.425 . . . . 71.21 112.147 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.42 -47.01 68.36 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.066 0.46 . . . . 72.2 110.852 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -66.64 -44.15 82.75 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.881 -0.6 . . . . 70.43 111.659 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.49 ' HD2' ' OD2' ' A' ' 16' ' ' ASP . 49.2 t-80 -82.14 -6.04 58.89 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.851 0.358 . . . . 74.55 111.188 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.438 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 62.34 70.08 0.59 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.611 0.72 . . . . 55.12 111.865 176.471 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.665 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 71.7 mt -111.8 137.72 49.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.401 -0.818 . . . . 71.42 111.418 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.3 p -91.25 143.54 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.081 0.467 . . . . 73.45 111.563 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -79.44 127.46 32.14 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.078 -0.51 . . . . 75.43 112.308 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 35.3 mtm -131.11 164.92 24.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.167 0.508 . . . . 73.43 110.999 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -142.58 158.88 43.21 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.179 -0.464 . . . . 70.24 111.013 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.8 m -49.71 -27.7 5.12 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.565 0.95 . . . . 62.42 113.565 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -48.27 -41.15 27.0 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.101 0.477 . . . . 74.23 111.244 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -105.3 -38.36 6.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.377 0.608 . . . . 71.33 110.972 174.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -71.9 -13.52 61.68 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.917 0.71 . . . . 50.54 112.917 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.55 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -43.69 -66.1 0.42 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.858 0.688 . . . . 73.44 112.858 -177.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.2 t -71.62 -18.28 62.22 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.245 -0.284 . . . . 74.41 111.487 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.27 -63.54 1.06 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.8 -0.182 . . . . 61.12 111.168 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.55 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 17.7 p90 -59.53 -33.08 70.94 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.854 -0.338 . . . . 74.54 110.717 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -57.23 -47.41 81.41 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.131 0.491 . . . . 72.21 110.964 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.14 -38.45 82.17 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.245 -0.434 . . . . 65.54 111.605 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -65.05 -41.33 95.28 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.669 -0.242 . . . . 73.32 111.358 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 88' ' ' PHE . 35.9 mm -62.84 -37.09 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.965 0.412 . . . . 73.33 110.853 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -58.57 -56.26 24.46 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.161 0.505 . . . . 62.23 110.855 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -59.78 -45.09 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.895 -0.593 . . . . 74.01 111.061 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 175' ' ' ALA . 83.0 t80 -56.96 -61.91 2.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.817 -0.629 . . . . 71.12 111.976 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.47 ' O ' HG22 ' A' ' 100' ' ' ILE . 48.5 mtt -53.62 -50.12 66.38 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 111.899 0.333 . . . . 73.31 111.899 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.13 -41.98 97.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.773 0.321 . . . . 74.43 111.638 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -68.57 -48.19 64.86 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.743 0.306 . . . . 74.11 111.63 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.22 -41.35 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.258 0.466 . . . . 54.04 112.258 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 96' ' ' MET . 10.5 tp -68.27 -37.73 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 122.113 -0.367 . . . . 73.31 110.573 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.618 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 15.4 t70 -54.82 -60.92 2.7 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.131 0.491 . . . . 74.1 110.547 175.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -62.36 -34.55 76.91 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.335 -0.393 . . . . 73.13 111.843 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 10.8 tpt -61.38 -42.34 98.56 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.099 0.476 . . . . 54.13 110.883 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.7 -8.59 58.85 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 111.883 0.327 . . . . 75.53 111.883 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 61.7 mmtt -81.58 -27.69 34.18 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.698 -0.626 . . . . 63.22 111.761 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -102.44 -36.92 8.24 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.694 0.627 . . . . 74.33 112.694 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -98.57 -51.06 4.05 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.872 -0.517 . . . . 75.43 111.096 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.63 -36.86 0.27 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.646 0.98 . . . . 75.12 113.646 167.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -82.79 144.32 30.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.239 0.542 . . . . 75.2 112.432 -173.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.07 -38.27 79.02 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.627 -0.715 . . . . 70.53 112.617 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.25 27.26 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.065 0.394 . . . . 51.41 112.065 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -94.97 -61.05 1.55 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.984 0.421 . . . . 71.33 111.285 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.7 m -60.91 -27.53 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 113.185 0.809 . . . . 61.02 113.185 -173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.24 -38.7 88.52 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.04 0.448 . . . . 73.41 110.567 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.1 -46.22 62.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.199 -0.455 . . . . 70.33 111.235 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -57.16 -52.22 66.17 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.133 0.492 . . . . 74.25 111.332 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -61.1 -29.74 69.94 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.849 -0.614 . . . . 75.11 110.515 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -69.38 -46.91 65.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.222 -0.444 . . . . 71.31 111.635 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -59.61 -51.71 68.64 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.812 0.339 . . . . 64.13 111.895 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -67.0 -33.64 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 120.769 0.318 . . . . 75.02 111.507 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -66.95 -48.61 68.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.911 0.386 . . . . 71.41 110.399 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.63 -35.75 87.07 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.001 -0.619 . . . . 74.5 112.205 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 55.2 t90 -58.3 -57.04 14.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.622 0.369 . . . . 74.3 111.399 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.518 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 m -61.94 -48.2 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.352 0.501 . . . . 74.52 112.352 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.3 -28.92 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 121.912 -0.492 . . . . 64.5 111.896 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.9 m -82.27 -24.87 34.52 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.05 0.452 . . . . 53.25 111.031 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.47 -28.13 22.25 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.973 -0.558 . . . . 71.11 111.828 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.3 mt -79.96 2.43 23.57 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.765 0.654 . . . . 72.21 112.765 -176.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.47 92.11 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.32 0.581 . . . . 74.01 111.173 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -54.64 -43.36 72.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.12 0.785 . . . . 75.22 113.12 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -53.24 -34.87 58.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.351 0.5 . . . . 64.0 112.351 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 132' ' ' ARG . 8.2 mpt_? -102.91 -48.12 4.17 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.26 0.553 . . . . 74.21 111.206 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.468 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 97.6 m-85 -78.3 -6.6 55.55 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.287 0.847 . . . . 73.43 113.287 -171.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -12.02 3.53 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.527 -0.733 . . . . 74.22 111.727 173.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -92.64 18.39 8.8 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.106 0.41 . . . . 55.11 112.106 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 81.0 mt -88.36 144.71 26.23 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.939 -0.476 . . . . 54.12 111.65 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.28 122.21 45.76 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.056 -0.52 . . . . 74.31 110.802 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -97.91 108.6 21.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.855 0.359 . . . . 73.01 111.189 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.665 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 67.3 m-85 -102.88 130.41 49.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.08 0.467 . . . . 74.21 111.666 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.451 HD11 ' HA3' ' A' ' 151' ' ' GLY . 14.3 tt -128.31 155.1 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.084 -0.507 . . . . 75.31 110.9 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.41 143.54 41.44 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.351 -0.452 . . . . 62.33 113.614 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -50.85 -63.76 1.02 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.196 0.443 . . . . 74.4 112.196 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 2.6 mmp_? -49.4 -34.12 15.48 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.23 0.456 . . . . 73.34 112.23 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.654 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -63.88 -56.38 15.78 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.02 0.438 . . . . 43.23 111.732 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.88 -28.89 69.85 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.801 0.334 . . . . 71.4 111.634 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.73 -31.52 63.41 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.104 -0.498 . . . . 64.2 112.148 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.15 -43.93 0.03 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.279 -0.962 . . . . 65.13 114.301 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.654 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -66.29 86.26 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.196 0.522 . . . . 72.24 112.129 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.25 4.22 0.75 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.35 0.5 . . . . 75.41 112.35 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.534 ' O ' ' HB3' ' A' ' 8' ' ' PHE . 3.2 p-10 -91.93 24.08 3.39 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.158 0.504 . . . . 61.04 110.381 170.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.592 ' HA3' ' HB1' ' A' ' 144' ' ' ALA . . . -77.56 134.23 14.32 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 114.232 0.453 . . . . 52.24 114.232 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 8' ' ' PHE . 48.1 tt0 -93.98 134.6 36.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 122.558 0.343 . . . . 65.14 111.005 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 98.7 t -95.01 136.31 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.407 0.521 . . . . 61.43 112.407 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.801 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -103.98 136.21 44.05 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.865 -0.607 . . . . 73.04 110.069 173.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.529 ' HB ' ' HG3' ' A' ' 170' ' ' MET . 62.3 mt -102.53 128.31 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 120.003 -0.679 . . . . 53.34 112.734 -170.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 46.1 mm -102.5 117.63 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.782 0.325 . . . . 54.22 111.49 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -106.74 145.49 31.99 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.252 0.549 . . . . 54.2 112.285 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -77.13 98.14 4.97 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.699 0.761 . . . . 73.34 110.136 171.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.454 ' HB2' ' OG1' ' A' ' 168' ' ' THR . 0.0 OUTLIER -93.43 97.03 10.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.099 -0.501 . . . . 75.32 111.11 -174.244 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 7.4 p-10 -66.99 119.2 11.56 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.162 0.506 . . . . 75.33 111.217 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.6 t -121.53 105.61 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.084 -0.507 . . . . 72.44 110.899 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 53.41 34.62 18.53 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.416 0.524 . . . . 71.33 112.416 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.15 -23.49 27.09 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.284 -0.417 . . . . 53.3 113.759 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 85.8 m -105.88 113.92 27.76 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.502 -0.411 . . . . 54.51 111.757 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 49.4 mt-10 -73.48 110.24 7.61 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.754 0.312 . . . . 55.13 111.156 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.69 140.14 20.82 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 120.747 0.308 . . . . 61.53 111.145 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.435 ' HB2' HG21 ' A' ' 68' ' ' ILE . 73.4 Cg_endo -74.62 114.35 4.01 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.12 1.88 . . . . 63.13 112.704 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 159' ' ' ARG . 23.7 p -118.78 150.86 39.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.228 0.537 . . . . 61.1 111.588 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.801 HD11 ' HB1' ' A' ' 154' ' ' ALA . 38.7 tp -100.4 140.12 35.1 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.044 -0.526 . . . . 62.33 111.025 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.529 ' HG3' ' HB ' ' A' ' 155' ' ' ILE . 22.2 ptm -123.41 134.63 53.94 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 121.132 0.491 . . . . 61.15 111.236 177.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 86.3 mt -141.6 148.31 39.03 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.146 -0.934 . . . . 74.53 111.433 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.493 HG22 HG12 ' A' ' 27' ' ' VAL . 10.7 t -100.96 122.66 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.254 0.222 . . . . 64.44 110.745 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.51 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -74.13 -5.98 44.92 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.793 -0.567 . . . . 62.43 112.04 -177.246 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.484 ' H ' HG12 ' A' ' 172' ' ' VAL . 9.0 mm-40 -74.67 -15.24 60.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.364 0.602 . . . . 75.53 110.08 170.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . . . -99.03 -22.88 15.5 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.701 -0.682 . . . . 75.44 111.67 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 6' ' ' ASP . 40.3 pt -137.13 130.73 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.281 0.562 . . . . 65.41 111.972 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.3 mm -104.42 118.99 52.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.316 -0.402 . . . . 74.25 110.305 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.55 146.09 25.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.426 0.631 . . . . 72.02 112.167 -176.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -131.23 143.89 50.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.985 -0.552 . . . . 75.3 110.994 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -89.46 105.85 18.07 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.344 0.592 . . . . 74.14 112.014 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 74.9 m -116.15 88.38 2.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.062 0.458 . . . . 72.33 110.971 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.562 HD22 ' HG3' ' A' ' 183' ' ' GLU . 0.0 OUTLIER -161.66 19.54 0.11 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.228 0.537 . . . . 71.34 111.379 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.562 ' HG3' HD22 ' A' ' 182' ' ' LEU . 38.5 mt-10 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 118.435 -0.793 . . . . 72.01 111.739 -176.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.895 0.379 . . . . 71.5 111.594 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' A' ' 178' ' ' GLU . 44.1 tp -95.58 131.44 41.78 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.147 -0.346 . . . . 72.54 110.851 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.6 mt -121.15 118.97 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 122.245 -0.284 . . . . 63.45 110.485 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.418 ' O ' HD12 ' A' ' 13' ' ' LEU . 47.1 p90 -116.41 149.27 39.7 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.107 0.78 . . . . 75.04 113.107 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.685 ' HG3' ' HB2' ' A' ' 10' ' ' ASP . 48.0 tttp -137.07 119.0 15.25 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.544 -1.207 . . . . 62.2 111.416 -173.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 2.8 m-20 -68.85 173.5 5.25 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.451 0.644 . . . . 73.14 111.795 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 175' ' ' ALA . 71.6 mt -81.38 -38.78 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.261 0.553 . . . . 72.1 110.474 168.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -108.69 -44.3 4.07 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.909 -0.587 . . . . 73.55 112.526 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -91.72 14.41 15.36 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.861 0.363 . . . . 61.23 111.868 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.685 ' HB2' ' HG3' ' A' ' 5' ' ' LYS . 7.0 p-10 -61.78 -10.47 9.02 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.783 0.66 . . . . 41.44 112.783 -173.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.77 -27.5 51.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.568 0.699 . . . . 63.42 110.192 173.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -93.32 24.74 3.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.07 -0.968 . . . . 75.32 111.868 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 4' ' ' TYR . 62.8 tp -34.15 109.13 0.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.408 0.683 . . . . 74.23 112.291 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.5 m -113.2 140.77 47.67 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.982 0.734 . . . . 63.34 112.982 -169.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.6 p -110.83 105.54 14.41 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.755 -0.657 . . . . 73.41 110.254 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -123.16 179.89 4.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 120.716 0.294 . . . . 72.22 111.47 -173.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.2 t -109.22 -28.59 8.94 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.892 0.701 . . . . 72.03 112.892 -176.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -66.27 118.32 51.99 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 112.203 0.446 . . . . 74.54 112.203 -175.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -91.24 152.83 3.74 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.112 2.542 . . . . 65.42 113.826 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 20' ' ' MET . 0.6 OUTLIER -114.63 165.77 12.43 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.339 -0.392 . . . . 74.24 111.113 178.331 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -100.01 120.72 40.26 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.094 -0.379 . . . . 42.03 110.532 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.1 tp -83.39 120.89 26.45 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.076 0.465 . . . . 64.45 111.22 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.77 149.07 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.286 -0.415 . . . . 72.21 111.103 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.6 t70 62.8 9.11 3.42 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 116.436 -0.347 . . . . 73.15 111.652 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 55.06 23.43 5.21 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.106 0.479 . . . . 64.04 111.739 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.1 tp -134.16 -43.26 0.79 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.264 -0.425 . . . . 74.3 111.917 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.3 155.58 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.032 0.444 . . . . 71.31 112.164 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 170' ' ' MET . 90.5 m-85 -92.88 149.28 21.37 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.41 -0.359 . . . . 63.12 110.752 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -136.42 116.47 13.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.745 0.418 . . . . 74.11 110.652 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.562 ' CZ ' HD23 ' A' ' 169' ' ' LEU . 16.9 p90 -151.13 134.55 16.2 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.082 1.141 . . . . 72.21 114.082 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.796 ' HG3' ' HB ' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -98.88 120.8 39.94 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.574 -0.739 . . . . 74.31 110.798 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.93 -120.25 0.46 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.972 -0.633 . . . . 52.33 113.158 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -150.64 141.43 22.78 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 122.654 -0.321 . . . . 75.33 110.442 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -77.66 106.48 9.49 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.653 0.263 . . . . 73.33 110.957 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.545 HG12 HD21 ' A' ' 44' ' ' LEU . 31.4 m -143.36 171.96 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.455 0.645 . . . . 72.0 112.434 -175.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.96 128.43 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.807 -0.633 . . . . 71.33 110.686 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 65' ' ' GLU . 47.4 ttp180 -104.18 113.52 27.13 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.283 0.563 . . . . 60.1 111.411 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 59.3 tttp -99.09 157.01 16.65 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.61 -0.723 . . . . 71.34 110.768 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -11.62 7.74 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.991 0.738 . . . . 74.13 112.991 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.08 -55.07 0.48 Allowed Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.302 -0.475 . . . . 62.11 113.083 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -150.38 -173.69 4.53 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.169 0.509 . . . . 72.21 112.337 -178.172 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.405 HG12 HD13 ' A' ' 44' ' ' LEU . 11.2 tt -107.96 109.12 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.3 0.572 . . . . 60.42 110.97 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.579 HG13 ' H ' ' A' ' 44' ' ' LEU . 3.9 p -79.34 -66.29 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 113.49 0.922 . . . . 64.42 113.49 -172.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.579 ' H ' HG13 ' A' ' 43' ' ' VAL . 6.1 mp 57.62 98.71 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.307 0.575 . . . . 71.42 111.724 -173.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.85 -20.59 13.53 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.04 -0.527 . . . . 72.53 112.111 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.39 118.8 1.99 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.217 -0.516 . . . . 54.33 112.731 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.9 m -150.38 111.63 4.4 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.477 -0.425 . . . . 61.25 111.859 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -98.11 148.6 34.72 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.46 -0.336 . . . . 63.33 110.801 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.11 100.74 0.46 Allowed 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.297 1.998 . . . . 71.33 112.809 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.3 m -91.71 23.7 3.46 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.066 0.395 . . . . 42.12 112.066 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.23 132.83 3.05 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.059 0.392 . . . . 73.31 112.059 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.8 -65.27 1.03 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.176 0.512 . . . . 75.21 110.705 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -80.5 -11.42 59.67 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.043 0.449 . . . . 55.05 111.333 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.6 4.41 60.36 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.271 -0.422 . . . . 61.54 112.87 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.96 84.27 1.25 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.485 0.659 . . . . 73.13 110.874 175.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -89.08 -48.34 7.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.351 -0.841 . . . . 61.23 111.293 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 55.81 34.18 22.95 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.454 0.538 . . . . 71.21 112.454 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -91.18 -33.27 15.48 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.018 0.437 . . . . 65.24 110.92 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.93 66.81 2.44 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 116.225 -0.443 . . . . 64.3 113.625 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.2 p -109.47 108.1 18.48 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.702 0.287 . . . . 73.23 110.843 177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -157.61 24.31 0.28 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 111.954 0.353 . . . . 73.0 111.954 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.24 117.49 34.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.754 0.311 . . . . 74.44 110.897 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -74.43 66.04 1.31 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.232 0.539 . . . . 72.44 111.258 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.1 t -128.79 136.64 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.929 -0.578 . . . . 74.34 110.159 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 37' ' ' ARG . 48.5 mt-10 -76.35 72.42 3.09 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.788 0.804 . . . . 63.25 110.146 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -84.11 142.54 30.31 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.916 -1.038 . . . . 70.41 111.917 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.41 -138.78 6.48 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.063 -0.589 . . . . 73.02 113.047 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.8 pt -111.16 142.23 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 O-C-N 122.377 -0.484 . . . . 73.32 111.449 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -44.17 -42.52 6.47 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.593 0.59 . . . . 72.04 112.593 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.0 mt -47.75 -52.2 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.107 0.48 . . . . 63.43 112.216 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 26.7 m -83.3 -34.94 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.19 -0.459 . . . . 64.43 112.059 -174.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.84 -44.24 96.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.834 0.349 . . . . 73.51 111.782 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -67.56 -18.41 65.0 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.238 0.458 . . . . 64.43 112.238 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -111.24 7.15 21.04 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.219 -0.301 . . . . 75.31 111.393 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp 50.73 52.53 14.72 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.29 0.636 . . . . 70.21 112.685 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 55.7 mt -91.4 128.16 37.12 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.997 -0.547 . . . . 54.54 110.644 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.8 p -93.18 147.32 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.584 0.231 . . . . 50.15 111.26 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.09 140.19 30.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.718 0.77 . . . . 73.11 112.989 -175.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 65.3 mtm -135.38 166.08 23.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.243 -0.89 . . . . 61.42 109.609 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.405 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 44.5 t30 -133.16 145.45 50.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.346 0.593 . . . . 72.02 111.938 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.421 ' HA ' ' HB2' ' A' ' 84' ' ' ASP . 41.6 t -42.16 -30.44 0.3 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.928 1.455 . . . . 74.43 114.928 -170.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 20.8 p90 -59.96 -32.24 70.63 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.985 -0.447 . . . . 74.42 111.644 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -101.28 -31.25 11.07 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.763 0.316 . . . . 63.14 111.132 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.421 ' HB2' ' HA ' ' A' ' 81' ' ' CYS . 2.0 m-20 -71.78 -12.38 61.27 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.791 0.663 . . . . 71.35 112.791 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.501 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -31.03 -73.64 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.195 1.184 . . . . 64.43 114.195 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.2 m -71.03 -23.18 62.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.022 0.378 . . . . 54.21 112.022 -176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.8 ttm -70.17 -57.3 5.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.62 -0.264 . . . . 62.13 111.58 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.501 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 11.0 p90 -65.22 -26.14 67.99 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.469 -0.492 . . . . 71.22 110.816 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.31 -42.24 99.2 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.02 0.438 . . . . 55.33 110.915 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.22 -36.19 76.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.098 0.475 . . . . 71.21 111.154 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.17 -55.24 26.81 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.029 -0.532 . . . . 73.41 111.728 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.1 tp -60.58 -29.5 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.185 0.517 . . . . 74.22 111.011 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.52 -58.52 8.23 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.819 -0.628 . . . . 75.11 111.063 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.635 ' HA ' ' HD2' ' A' ' 97' ' ' LYS . 68.1 mttm -64.64 -34.21 77.76 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.178 -0.465 . . . . 75.12 111.28 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.554 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 66.1 t80 -56.02 -53.44 56.87 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.79 -0.641 . . . . 73.13 110.889 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -52.45 -46.63 66.54 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.016 0.436 . . . . 70.44 111.038 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.635 ' HD2' ' HA ' ' A' ' 94' ' ' LYS . 61.9 mttm -52.7 -59.31 4.64 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.813 -0.63 . . . . 65.43 111.783 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -68.24 -43.12 78.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.036 0.754 . . . . 74.21 113.036 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.426 HG12 ' HB3' ' A' ' 174' ' ' GLU . 30.7 m -64.11 -45.03 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.048 0.388 . . . . 74.24 112.048 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 mm -69.01 -37.19 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 122.064 -0.397 . . . . 73.12 110.73 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 105' ' ' LYS . 29.5 t70 -59.94 -45.76 91.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.137 0.494 . . . . 74.33 110.455 174.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -64.41 -50.06 69.09 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.929 -0.578 . . . . 74.41 111.936 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 49.7 tpp -70.56 -47.35 60.72 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.011 0.434 . . . . 74.35 112.032 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -73.96 -19.39 60.69 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 122.066 -0.396 . . . . 73.13 111.43 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 101' ' ' ASP . 86.8 tttt -59.6 -55.03 39.58 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.289 0.566 . . . . 75.22 111.647 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -102.44 -37.69 7.91 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.594 0.59 . . . . 62.01 112.594 -174.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -76.63 -53.65 7.74 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.806 0.336 . . . . 74.13 110.749 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 46.11 11.76 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.865 1.432 . . . . 74.33 114.865 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.464 ' O ' HG22 ' A' ' 113' ' ' VAL . 12.6 t70 -77.62 109.21 11.4 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.676 -0.64 . . . . 64.42 110.21 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -54.21 -27.12 32.26 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.146 0.795 . . . . 73.31 113.146 -174.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.02 -37.0 34.99 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.978 0.418 . . . . 44.41 111.344 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -74.82 -53.13 9.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.299 -0.41 . . . . 73.35 111.354 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 109' ' ' ASP . 22.4 m -58.78 -31.31 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 111.991 0.367 . . . . 53.15 111.991 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.61 -36.92 79.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.814 0.34 . . . . 74.54 110.469 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.26 -48.89 71.65 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.439 -0.346 . . . . 64.43 110.855 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -55.94 -52.01 65.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.179 0.514 . . . . 73.24 111.062 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -56.72 -38.61 72.59 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.843 -0.617 . . . . 71.03 111.489 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -66.03 -41.34 91.05 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.012 0.434 . . . . 73.34 111.347 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -66.32 -49.43 67.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.192 -0.458 . . . . 73.51 111.628 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.9 tp -65.93 -34.35 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.804 0.335 . . . . 73.51 111.033 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -64.08 -49.0 73.98 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.874 0.368 . . . . 62.12 110.966 175.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.53 -39.3 92.97 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.047 -0.596 . . . . 71.22 112.527 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 53.5 t90 -61.38 -56.67 17.69 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.331 0.252 . . . . 74.21 111.327 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.43 -41.89 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.645 0.609 . . . . 71.4 112.645 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.5 p -64.03 -33.58 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.89 -0.506 . . . . 70.1 111.861 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.5 t -80.17 -40.43 27.28 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.089 0.471 . . . . 75.52 111.139 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 155' ' ' ILE . 39.1 tp -67.43 -42.28 83.42 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.279 0.474 . . . . 71.12 112.279 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.2 mt -72.5 1.4 8.16 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.435 0.531 . . . . 72.45 112.435 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.1 72.49 0.18 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.523 0.678 . . . . 62.12 110.623 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -59.49 -22.13 61.13 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.622 -0.717 . . . . 65.14 112.319 -174.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.18 -31.03 63.05 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.203 0.525 . . . . 60.4 110.948 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -109.31 -37.31 5.79 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.812 -0.631 . . . . 73.54 111.545 174.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -93.23 -5.73 49.26 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.656 1.354 . . . . 64.21 114.656 -169.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -58.7 -13.56 6.26 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.096 0.862 . . . . 54.2 111.806 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -90.1 24.46 2.47 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.233 -0.44 . . . . 60.11 112.058 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.0 mt -88.36 153.88 20.83 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.0 0.429 . . . . 74.43 111.001 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.668 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -105.18 112.41 25.53 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.884 0.374 . . . . 61.34 111.286 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -98.43 107.18 19.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.906 0.384 . . . . 75.12 110.946 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 59.7 m-85 -97.82 143.53 28.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.161 0.505 . . . . 63.51 112.297 -177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 145' ' ' ALA . 14.3 tt -134.97 151.47 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.929 -0.578 . . . . 73.35 111.06 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.402 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -63.44 150.68 49.28 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 114.478 0.551 . . . . 54.43 114.478 -176.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -47.3 -58.08 4.51 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.295 0.638 . . . . 74.2 112.104 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -65.5 -45.55 83.14 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.868 0.366 . . . . 65.43 111.691 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.54 -38.01 79.91 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.413 0.523 . . . . 64.24 112.413 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.441 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -63.31 -54.5 36.14 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.177 0.513 . . . . 70.43 111.783 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -68.06 -40.53 82.76 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.272 -0.422 . . . . 74.45 111.146 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.2 -20.77 79.6 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.404 -0.426 . . . . 53.14 113.681 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 63.08 21.91 13.14 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.845 0.683 . . . . 73.11 112.845 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -73.45 82.43 1.45 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.655 0.613 . . . . 72.43 112.655 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.6 m120 74.24 -41.91 0.49 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.834 0.854 . . . . 73.24 113.033 172.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.09 78.7 1.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.363 -0.446 . . . . 64.44 114.095 177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -70.6 102.0 2.16 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.224 -0.574 . . . . 63.33 109.699 172.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 96.6 t -86.65 125.01 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 113.239 0.829 . . . . 64.53 113.239 -172.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.579 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -92.86 113.29 25.53 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.703 -0.681 . . . . 73.43 109.669 169.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.494 HD13 HD21 ' A' ' 127' ' ' LEU . 55.5 mt -92.13 112.98 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.384 0.513 . . . . 74.04 112.384 -170.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.668 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 49.2 mm -90.74 106.17 17.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 120.837 0.351 . . . . 61.52 110.637 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -106.92 132.02 53.34 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.688 -0.687 . . . . 75.43 111.279 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -89.43 138.47 31.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.212 -0.449 . . . . 72.25 111.409 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -137.63 119.65 15.45 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.746 0.307 . . . . 70.23 111.533 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -85.78 92.33 8.58 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.574 0.702 . . . . 74.23 111.223 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.45 102.55 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.109 -0.496 . . . . 63.44 110.42 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 58.64 19.27 6.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.241 0.543 . . . . 65.12 111.038 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.47 -12.93 33.19 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.043 -0.526 . . . . 60.35 113.229 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.5 m -84.25 115.58 22.53 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.451 -0.441 . . . . 74.04 111.074 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.42 117.56 15.32 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.359 0.504 . . . . 71.53 112.359 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.796 ' HB ' ' HG3' ' A' ' 31' ' ' LYS . 25.7 m -128.82 112.32 18.84 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 121.012 0.434 . . . . 75.54 111.595 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.559 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 6.9 Cg_exo -75.1 113.63 3.83 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.521 2.147 . . . . 71.55 112.377 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.493 HG22 ' HB2' ' A' ' 31' ' ' LYS . 44.2 p -109.3 159.05 17.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.59 -0.277 . . . . 40.02 111.504 -176.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.579 HD11 ' HB1' ' A' ' 154' ' ' ALA . 23.0 tp -104.73 126.8 52.17 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.9 0.381 . . . . 71.24 111.038 177.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.611 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 48.6 ttm -105.01 126.12 51.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.281 -0.872 . . . . 63.23 110.993 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.479 ' HB3' HD11 ' A' ' 176' ' ' ILE . 94.4 mt -137.03 123.07 20.29 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.034 -0.53 . . . . 62.24 111.36 -178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.554 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 22.6 t -74.85 122.01 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 122.095 -0.378 . . . . 74.22 111.425 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.411 ' HD3' ' HG2' ' A' ' 174' ' ' GLU . 0.0 OUTLIER -69.33 -11.33 60.72 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.893 0.701 . . . . 73.22 112.893 -176.295 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.514 ' H ' HG12 ' A' ' 172' ' ' VAL . 24.1 mm-40 -91.83 -11.18 37.25 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.815 0.341 . . . . 74.13 111.598 174.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.488 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -96.14 -38.44 10.16 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.381 0.61 . . . . 64.3 110.232 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' A' ' 171' ' ' LEU . 32.4 pt -127.45 118.94 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.371 -0.831 . . . . 73.02 109.28 168.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.8 tp -94.6 110.86 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.511 0.672 . . . . 61.13 111.563 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.454 ' HB3' HD11 ' A' ' 2' ' ' LEU . 16.7 mm-40 -79.57 115.81 19.41 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.609 -0.723 . . . . 74.34 110.585 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.43 ' O ' HD12 ' A' ' 2' ' ' LEU . 10.1 tp10 -92.92 116.29 28.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.455 0.645 . . . . 65.32 109.856 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -92.13 96.5 10.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.399 -0.819 . . . . 62.12 112.999 -167.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 73.0 m -124.17 88.33 2.89 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.781 -0.645 . . . . 61.22 109.454 169.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 182' ' ' LEU . 1.8 mm? -98.91 -40.35 8.13 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.074 0.464 . . . . 75.4 111.276 -174.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.537 -0.744 . . . . 43.0 111.255 -178.143 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 111.917 0.34 . . . . 73.42 111.917 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 178' ' ' GLU . 38.1 tp -75.22 122.93 24.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.759 0.314 . . . . 61.04 111.261 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.716 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 50.7 mt -97.59 120.79 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.586 0.232 . . . . 73.51 111.016 -174.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 14' ' ' SER . 34.9 p90 -107.85 139.27 42.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.704 0.631 . . . . 75.54 112.704 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.621 ' HG3' ' HB2' ' A' ' 10' ' ' ASP . 52.0 tttp -130.02 122.16 27.87 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.805 -1.089 . . . . 43.32 111.071 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.622 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 33.1 t70 -80.54 173.31 12.72 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.484 0.183 . . . . 75.21 110.552 175.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.5 mt -75.72 -46.23 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.836 -0.54 . . . . 54.01 111.698 176.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -108.49 -41.27 4.88 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.273 0.558 . . . . 74.43 112.122 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.4 16.55 7.37 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.27 0.628 . . . . 64.21 111.804 -175.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.622 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 10.7 p-10 -59.86 -4.26 0.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.952 1.093 . . . . 54.01 113.952 -170.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.53 -19.66 64.97 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.877 -0.514 . . . . 53.53 111.331 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.63 23.35 1.68 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.611 0.244 . . . . 63.32 111.358 170.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.616 HD13 ' HB2' ' A' ' 5' ' ' LYS . 57.2 tp -49.28 104.04 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.516 0.326 . . . . 74.04 110.53 173.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.442 ' HB2' ' CE1' ' A' ' 4' ' ' TYR . 70.0 m -133.51 147.61 51.63 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.223 0.823 . . . . 75.23 113.223 -170.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.2 p -82.51 88.84 6.62 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.632 -0.713 . . . . 53.54 110.568 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -90.11 179.35 5.95 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.766 -0.652 . . . . 70.42 111.855 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.8 p -161.85 25.99 0.12 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.267 0.469 . . . . 72.14 112.267 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -89.69 149.87 43.02 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-O 120.6 0.238 . . . . 72.45 111.625 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.97 72.67 1.53 Allowed 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.804 2.336 . . . . 71.42 113.461 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 55.0 ttp -87.69 115.36 25.08 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.27 -0.423 . . . . 73.53 110.793 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -102.44 159.05 15.76 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.699 0.285 . . . . 63.24 111.67 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 27' ' ' VAL . 47.9 tp -104.86 142.53 34.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.033 0.444 . . . . 60.15 111.408 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.508 HG13 HG23 ' A' ' 27' ' ' VAL . 7.2 p -134.13 141.12 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-N 116.144 -0.48 . . . . 72.43 111.115 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 56.83 23.61 8.27 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.763 0.653 . . . . 74.35 112.763 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 60.91 3.98 0.73 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.041 0.756 . . . . 51.42 113.041 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.521 HD21 HD13 ' A' ' 120' ' ' ILE . 41.0 tp -125.3 -43.56 1.92 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.945 0.72 . . . . 65.21 112.945 -169.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.508 HG23 HG13 ' A' ' 23' ' ' VAL . 1.2 m -123.82 149.4 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.284 0.476 . . . . 43.11 112.284 -175.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.557 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 58.6 m-85 -85.84 147.6 26.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.888 0.375 . . . . 63.23 111.337 176.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.449 ' HB2' HH22 ' A' ' 159' ' ' ARG . 14.9 pt-20 -121.1 137.98 54.41 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.009 -0.541 . . . . 74.44 110.941 176.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -150.75 113.16 4.64 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.404 -0.362 . . . . 75.43 110.119 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -75.07 135.38 41.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.172 0.51 . . . . 62.31 112.331 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.54 133.37 11.43 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.335 -0.46 . . . . 63.21 112.184 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -91.92 152.41 20.07 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.332 0.566 . . . . 74.15 112.173 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -71.11 105.28 3.31 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.568 -0.742 . . . . 65.31 111.636 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.522 HG23 HD12 ' A' ' 72' ' ' LEU . 19.7 m -143.99 -177.97 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.977 0.418 . . . . 75.3 111.595 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 44' ' ' LEU . 23.6 m -119.12 145.74 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 112.382 0.512 . . . . 64.02 112.382 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.709 ' HB3' HD22 ' A' ' 72' ' ' LEU . 7.6 tpm_? -141.15 108.15 5.44 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.577 0.703 . . . . 74.31 110.807 175.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 88.5 tttt -104.49 128.76 52.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.631 -0.713 . . . . 54.3 109.686 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.87 85.29 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.54 0.686 . . . . 74.32 110.266 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.17 -56.27 0.49 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-N 115.179 -0.919 . . . . 71.43 112.402 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 36.2 tt0 -137.72 169.25 18.11 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.409 0.283 . . . . 64.35 110.53 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.557 HD11 HD23 ' A' ' 44' ' ' LEU . 12.0 tt -144.39 130.35 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 121.948 -0.47 . . . . 73.01 111.894 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.04 82.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 120.843 0.354 . . . . 71.25 111.048 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.557 HD23 HD11 ' A' ' 42' ' ' ILE . 4.3 pp -104.59 156.56 17.86 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.166 0.507 . . . . 70.12 112.161 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.34 12.79 3.02 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.943 -0.571 . . . . 72.5 111.097 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.02 -98.41 0.79 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.284 -0.484 . . . . 72.41 112.897 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.2 t -97.3 123.84 41.23 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.524 -0.397 . . . . 35.41 110.952 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 2.6 t-20 -105.33 119.28 53.45 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 120.615 0.245 . . . . 72.31 111.246 -177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 10.3 Cg_exo -73.69 38.16 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.288 2.658 . . . . 73.15 113.675 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -99.38 -173.86 2.59 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.801 0.334 . . . . 72.21 111.418 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.89 -2.8 10.52 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.713 1.005 . . . . 52.12 113.713 -174.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -147.96 122.55 9.81 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.548 0.69 . . . . 73.44 111.379 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -88.44 -43.62 11.33 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.4 -0.818 . . . . 72.21 111.947 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.21 -114.67 0.07 OUTLIER Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.435 -0.412 . . . . 54.33 113.217 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 176.2 132.72 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.976 0.417 . . . . 51.35 111.752 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -130.09 99.44 5.07 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.163 0.506 . . . . 63.35 110.262 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.436 ' CG ' ' HE ' ' A' ' 66' ' ' ARG . 14.7 p-10 -110.8 127.6 55.44 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.399 0.618 . . . . 75.44 112.035 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -102.09 71.33 1.25 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.941 -0.572 . . . . 73.44 110.075 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 136.12 84.98 0.18 Allowed Glycine 0 CA--C 1.529 0.968 0 CA-C-N 115.769 -0.65 . . . . 70.31 112.345 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.42 ' O ' HG22 ' A' ' 64' ' ' VAL . 84.9 p -100.4 32.66 2.96 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.916 0.709 . . . . 73.23 112.916 -171.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.73 -56.04 1.6 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.758 0.651 . . . . 70.52 112.758 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -55.89 -57.61 11.34 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.16 0.43 . . . . 73.31 112.16 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -137.15 79.62 1.76 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.965 0.412 . . . . 62.12 110.359 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 66' ' ' ARG . 41.0 t -49.18 -73.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 112.753 0.649 . . . . 75.34 112.753 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 33.6 tt0 66.16 -10.13 0.26 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.354 0.872 . . . . 73.23 113.354 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.439 ' H ' HG12 ' A' ' 64' ' ' VAL . 32.8 ttp85 -111.2 135.54 51.59 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.4 -0.812 . . . . 75.52 111.862 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' A' ' 72' ' ' LEU . . . 169.56 -170.53 42.74 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.044 -1.074 . . . . 41.14 113.77 169.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.7 pt -103.57 146.65 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.797 -0.237 . . . . 62.32 110.556 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -38.99 -53.15 1.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.997 0.74 . . . . 73.32 112.997 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.609 HG21 HD22 ' A' ' 169' ' ' LEU . 60.7 mt -49.04 -62.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 112.673 0.62 . . . . 62.44 112.673 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 m -66.12 -31.99 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.261 -0.427 . . . . 74.15 112.031 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.709 HD22 ' HB3' ' A' ' 37' ' ' ARG . 76.0 mt -76.59 -33.02 58.45 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.063 0.459 . . . . 64.41 111.39 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -73.29 -42.71 62.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.083 -0.508 . . . . 65.42 111.516 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -94.77 -3.43 49.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 111.782 0.29 . . . . 73.53 111.782 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 65.24 71.63 0.44 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.296 0.57 . . . . 74.3 112.195 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 49.9 mt -108.7 128.51 54.92 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.754 -0.657 . . . . 74.33 110.595 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.4 p -89.57 149.33 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.804 0.335 . . . . 70.21 111.459 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.41 148.83 35.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.401 0.619 . . . . 71.32 112.619 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.72 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 85.4 mtp -140.16 153.09 46.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.425 -0.807 . . . . 74.31 109.956 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.537 ' HB2' ' HE1' ' A' ' 82' ' ' TYR . 84.7 m-20 -133.29 139.74 47.06 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.236 0.541 . . . . 73.24 112.081 -174.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 52.0 t -46.22 -36.72 6.35 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.502 1.297 . . . . 70.11 114.502 -172.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.537 ' HE1' ' HB2' ' A' ' 80' ' ' ASN . 1.3 p90 -63.57 -27.44 69.25 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.487 0.551 . . . . 74.32 112.487 -175.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -102.18 -31.77 10.42 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.452 0.538 . . . . 74.44 112.452 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.464 ' O ' ' HD1' ' A' ' 88' ' ' PHE . 9.8 m-20 -76.57 -5.95 49.85 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.473 0.545 . . . . 74.51 112.473 -174.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.517 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . . . -34.19 -72.76 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.005 1.113 . . . . 52.3 114.005 -172.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.7 t -64.59 -31.84 73.24 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.88 0.372 . . . . 65.52 111.553 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.4 mmt -64.64 -63.89 1.01 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.206 -0.452 . . . . 72.42 112.175 -175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.517 ' HE1' ' HA ' ' A' ' 85' ' ' ALA . 1.8 p90 -70.77 -26.69 63.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.133 -0.354 . . . . 65.31 111.461 -176.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -68.01 -41.35 82.34 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.015 0.436 . . . . 72.43 110.11 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -40.44 81.61 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.85 0.357 . . . . 74.41 111.174 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -61.27 -51.0 70.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.368 -0.378 . . . . 74.15 111.695 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.0 tp -62.69 -32.3 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.821 0.343 . . . . 63.42 111.285 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -68.55 -55.85 10.28 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.727 0.269 . . . . 63.21 111.727 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.71 -37.24 73.17 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.071 0.463 . . . . 74.21 110.677 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.648 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 26.0 t80 -61.32 -54.48 43.36 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.034 -0.53 . . . . 74.0 111.284 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -53.78 -49.6 67.91 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.321 -0.4 . . . . 63.23 111.267 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.1 -38.45 90.77 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.679 -0.237 . . . . 73.42 111.438 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -64.23 -52.09 60.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.691 0.282 . . . . 63.12 111.702 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.3 m -64.01 -42.62 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 111.826 0.306 . . . . 55.05 111.826 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.6 mm -62.98 -45.45 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.851 0.358 . . . . 75.2 110.748 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.622 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 18.0 t70 -56.3 -48.09 77.37 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.293 -0.412 . . . . 74.42 111.634 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -66.67 -29.03 68.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.769 0.319 . . . . 72.21 111.536 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.0 tpt -75.58 -54.45 6.98 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.055 0.455 . . . . 71.05 111.367 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -54.05 -34.04 59.01 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.343 0.497 . . . . 71.15 112.343 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -51.4 -36.85 45.36 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.293 -0.255 . . . . 71.52 111.353 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -116.66 -5.87 11.62 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.257 0.836 . . . . 71.15 113.257 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -141.41 35.26 1.67 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.607 0.595 . . . . 75.14 112.607 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -5.82 1.07 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.749 1.388 . . . . 74.41 114.749 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 111' ' ' ALA . 4.4 m-20 -74.99 76.04 2.2 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.61 -0.681 . . . . 72.43 112.413 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt 37.52 -79.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.168 1.387 . . . . 73.21 114.655 171.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 109' ' ' ASP . . . -51.19 -42.82 61.14 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.059 0.762 . . . . 63.24 113.059 -170.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.22 -56.32 17.63 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.946 0.403 . . . . 75.21 111.882 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.8 m -67.9 -32.42 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.591 0.589 . . . . 70.44 112.591 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.69 -34.58 62.67 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.326 -0.233 . . . . 74.41 111.189 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.34 -45.41 72.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.198 0.523 . . . . 61.21 111.009 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -61.18 -46.72 89.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.193 0.52 . . . . 73.01 110.363 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -59.67 -32.58 70.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.921 -0.581 . . . . 54.32 111.307 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HE2' ' HB2' ' A' ' 118' ' ' LYS . 8.9 tppt? -60.17 -45.44 93.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.171 0.51 . . . . 62.45 110.86 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -68.26 -46.88 69.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.07 -0.514 . . . . 75.55 111.189 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.521 HD13 HD21 ' A' ' 26' ' ' LEU . 29.8 mm -58.97 -43.58 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.768 0.318 . . . . 62.21 111.365 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -63.04 -45.23 93.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.569 0.223 . . . . 73.24 110.719 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.08 -42.6 99.85 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.95 -0.643 . . . . 71.15 112.246 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 40.1 t90 -61.39 -49.94 74.88 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.493 0.317 . . . . 74.31 111.294 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.95 -42.05 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.388 0.514 . . . . 73.2 112.388 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.75 -25.28 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.243 0.544 . . . . 73.22 110.938 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.3 m -86.46 -51.55 6.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.191 -0.459 . . . . 73.34 111.117 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.431 HD11 HG21 ' A' ' 155' ' ' ILE . 27.8 tp -59.55 -35.77 74.89 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.184 0.516 . . . . 74.44 111.864 -177.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.7 mt -85.25 3.71 38.19 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.075 -0.511 . . . . 71.13 112.073 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.498 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -62.45 97.74 0.1 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.207 0.527 . . . . 44.3 110.849 176.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 28.7 ttpp -45.33 -64.51 0.7 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.067 1.136 . . . . 62.04 114.067 -170.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.41 -46.55 85.86 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.238 0.829 . . . . 72.53 113.238 -168.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -73.47 -50.99 18.75 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.359 0.6 . . . . 74.23 111.43 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 30.1 m-85 -82.43 -5.78 58.88 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.848 -0.614 . . . . 70.32 112.653 -173.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 26.1 ttpp -50.01 -22.84 1.73 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.102 0.477 . . . . 72.34 111.683 170.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -82.66 15.07 2.76 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.313 0.486 . . . . 73.05 112.313 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.534 HD21 ' HG2' ' A' ' 157' ' ' GLU . 49.5 mt -89.52 161.72 16.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.32 0.581 . . . . 73.33 112.212 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -123.7 126.33 46.35 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.776 -0.647 . . . . 53.51 111.138 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' A' ' 79' ' ' MET . 43.6 m-85 -96.91 133.55 41.4 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.125 -0.324 . . . . 74.43 110.125 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.443 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 58.2 m-85 -128.74 131.02 47.85 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.084 -0.385 . . . . 72.34 111.561 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.576 HG23 ' HB2' ' A' ' 145' ' ' ALA . 15.4 tt -125.24 148.07 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 120.976 0.417 . . . . 70.33 111.375 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.423 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -57.85 140.88 45.56 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 114.373 0.509 . . . . 64.35 114.373 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -42.03 -54.2 3.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.308 0.643 . . . . 72.25 112.115 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -62.5 -35.71 80.23 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.998 0.428 . . . . 72.54 112.137 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.9 -37.16 48.56 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.146 0.425 . . . . 72.1 112.146 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.576 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -62.81 -56.2 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.932 0.396 . . . . 75.33 111.944 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.09 -21.44 58.94 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.488 -0.324 . . . . 51.12 111.429 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -72.6 -21.87 79.32 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.954 -0.641 . . . . 63.54 112.423 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 61.15 42.05 12.78 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.263 0.468 . . . . 73.54 112.263 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.45 4.35 53.37 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.591 0.589 . . . . 73.51 112.591 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.4 p30 41.91 35.68 0.56 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.344 0.658 . . . . 74.5 112.447 -175.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.68 -135.43 1.01 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.117 -0.492 . . . . 74.14 114.269 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -67.24 104.25 1.43 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.764 0.653 . . . . 73.21 112.764 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.36 118.68 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.215 0.531 . . . . 63.21 110.834 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.687 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -79.86 124.2 28.44 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.949 -0.569 . . . . 65.22 111.209 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 43.3 mm -89.59 120.0 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.673 0.273 . . . . 72.43 111.5 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.3 mm -99.38 107.51 20.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-O 120.971 0.415 . . . . 64.33 111.012 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.534 ' HG2' HD21 ' A' ' 136' ' ' LEU . 0.4 OUTLIER -111.49 137.43 49.31 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.467 -0.788 . . . . 64.45 109.967 -178.613 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -92.19 123.92 35.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.152 0.501 . . . . 75.43 112.061 -174.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.449 HH22 ' HB2' ' A' ' 29' ' ' GLU . 77.8 mtm180 -130.16 154.3 47.66 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.278 0.561 . . . . 74.2 112.193 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -83.2 143.92 30.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.777 0.658 . . . . 74.13 112.777 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.1 t -128.71 87.9 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.749 -0.659 . . . . 74.35 109.65 167.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 48.37 41.92 17.31 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.835 0.68 . . . . 70.05 112.835 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.72 -23.26 22.33 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.294 -0.479 . . . . 73.34 113.21 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 91.7 m -95.52 106.15 18.2 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.486 -0.42 . . . . 74.23 111.352 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.54 112.64 14.53 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.245 -0.434 . . . . 45.34 111.091 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 35.7 m -119.37 141.72 31.2 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 112.083 0.401 . . . . 75.4 112.083 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 166' ' ' VAL . 8.0 Cg_exo -73.64 114.77 4.12 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.752 2.302 . . . . 44.4 112.117 174.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.8 p -109.37 140.79 42.62 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.927 0.394 . . . . 64.4 111.789 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.687 HD11 ' HB1' ' A' ' 154' ' ' ALA . 64.1 tp -77.54 145.16 37.1 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.97 -0.559 . . . . 74.01 111.962 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.492 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 48.1 ttm -130.18 124.49 32.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.766 -0.652 . . . . 73.21 110.909 176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.87 161.23 33.49 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.05 -0.722 . . . . 73.44 109.05 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.648 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 44.1 t -96.39 131.23 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.501 -0.749 . . . . 73.54 112.114 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.557 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 14.2 tmtt? -56.34 -55.69 30.34 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.185 -0.461 . . . . 74.05 111.611 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -75.25 4.6 6.76 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.017 0.377 . . . . 72.03 112.017 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.26 -21.02 17.5 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.261 0.553 . . . . 75.5 110.473 173.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 68.0 mt -118.73 108.97 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.853 -0.612 . . . . 75.41 110.587 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -92.16 113.96 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.118 0.485 . . . . 72.23 110.503 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.488 ' HB2' HD11 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -91.8 152.68 20.02 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.621 0.724 . . . . 75.32 112.771 -174.759 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.716 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 9.3 tp10 -114.83 110.87 20.34 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.581 -0.736 . . . . 73.03 109.336 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -81.04 95.1 6.72 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.261 0.553 . . . . 73.1 112.302 -171.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 52.9 t -134.32 96.93 3.7 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.585 -0.734 . . . . 73.11 109.834 171.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 64.0 mt -119.36 111.46 18.2 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.229 0.455 . . . . 54.11 112.229 -172.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.951 -0.547 . . . . 54.41 111.18 175.139 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.696 0.284 . . . . 75.05 111.308 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.7 tp -104.19 147.38 27.52 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.153 0.501 . . . . 70.54 111.203 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.26 141.0 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.545 -0.298 . . . . 72.4 110.565 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -122.92 158.75 29.71 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 121.904 -0.498 . . . . 73.14 111.461 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HB3' HD13 ' A' ' 13' ' ' LEU . 5.4 ptpp? -139.04 111.04 7.27 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.136 -0.483 . . . . 72.43 111.754 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 175' ' ' ALA . 7.0 m-20 -75.81 164.32 26.35 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.241 -0.287 . . . . 75.12 110.791 172.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.1 pt -61.19 -9.76 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 121.03 0.443 . . . . 74.24 111.493 173.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -107.92 -30.5 8.45 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.301 -0.409 . . . . 64.24 111.118 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.547 ' HB ' ' H ' ' A' ' 6' ' ' ASP . 11.1 m -92.63 -13.67 29.25 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.087 0.773 . . . . 71.1 113.087 -171.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.438 ' HA ' ' HB2' ' A' ' 5' ' ' LYS . 4.0 p30 -55.54 -16.93 4.45 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.106 0.78 . . . . 74.15 113.106 -173.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -69.26 -46.28 67.66 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.055 0.391 . . . . 64.4 112.055 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -121.07 -1.24 9.84 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.202 0.815 . . . . 53.14 113.202 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 5' ' ' LYS . 3.7 mm? 64.19 169.44 0.17 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.535 0.939 . . . . 64.43 113.535 173.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.8 m -148.01 136.85 21.87 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.949 -0.569 . . . . 72.34 110.678 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.5 p -115.35 119.27 35.72 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.675 0.62 . . . . 74.11 112.675 -172.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -149.7 -169.6 3.42 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.099 -0.501 . . . . 74.22 111.222 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 t -155.3 91.94 1.38 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.026 0.441 . . . . 74.0 111.435 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -130.6 118.75 18.02 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 116.433 -0.349 . . . . 73.3 111.207 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.81 87.68 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.372 2.048 . . . . 73.03 112.207 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.418 ' HG2' ' HB2' ' A' ' 30' ' ' PHE . 64.7 mtt -93.33 148.04 22.4 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.356 0.598 . . . . 63.11 112.123 -177.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -102.17 113.06 26.0 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.623 -0.717 . . . . 65.13 110.303 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.519 HD21 ' HD2' ' A' ' 173' ' ' LYS . 61.4 tp -74.61 87.84 2.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.159 0.504 . . . . 60.13 110.135 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.79 137.43 21.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.087 -0.506 . . . . 72.32 111.544 -175.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.8 12.49 5.74 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.736 -0.665 . . . . 74.23 111.292 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.437 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 66.4 m-20 54.3 22.02 3.47 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.009 -0.542 . . . . 74.54 111.922 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.2 tp -121.71 -41.04 2.49 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.926 0.393 . . . . 71.52 111.259 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 172' ' ' VAL . 4.2 m -137.58 147.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.1 0.476 . . . . 54.24 111.952 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.565 ' O ' ' HA ' ' A' ' 170' ' ' MET . 70.0 m-85 -85.96 145.05 27.3 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.207 -0.451 . . . . 74.34 110.624 176.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 34.5 tt0 -127.63 135.63 50.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.677 0.275 . . . . 74.43 110.88 176.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.418 ' HB2' ' HG2' ' A' ' 20' ' ' MET . 84.4 t80 -128.96 128.43 43.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.861 0.363 . . . . 73.32 111.548 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HA ' HG22 ' A' ' 168' ' ' THR . 1.8 tmmm? -92.31 121.55 33.92 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.231 -0.44 . . . . 73.01 110.837 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.23 -163.35 13.96 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.308 -0.473 . . . . 32.03 113.089 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -121.12 139.37 53.42 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.316 -0.52 . . . . 75.44 111.512 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -75.27 106.15 6.65 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.879 -0.6 . . . . 74.11 110.663 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.67 160.15 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.1 -0.5 . . . . 63.3 111.054 -177.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.549 HG12 ' HB2' ' A' ' 66' ' ' ARG . 34.1 m -128.77 105.14 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.433 0.635 . . . . 72.21 110.94 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.603 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 97.6 mtt180 -83.27 108.21 16.34 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.187 0.518 . . . . 44.51 111.015 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -100.61 97.55 8.22 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.94 -0.573 . . . . 72.12 110.448 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 57.02 18.99 4.31 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 121.383 0.611 . . . . 72.54 111.315 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.11 0.58 28.39 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 121.297 -0.478 . . . . 63.22 113.784 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -95.64 147.37 23.66 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.134 0.42 . . . . 74.11 112.134 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 42' ' ' ILE . 10.6 tp -105.51 30.86 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-O 121.67 0.748 . . . . 73.45 111.45 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.0 t -75.8 85.41 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 O-C-N 121.796 -0.565 . . . . 70.24 111.377 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pp -97.99 165.42 11.92 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.743 0.646 . . . . 71.34 112.743 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.06 -4.77 25.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.168 -0.469 . . . . 41.24 111.397 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.94 -170.19 23.64 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.381 -0.438 . . . . 73.11 113.199 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.5 p -97.28 101.41 12.95 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.562 -0.375 . . . . 52.31 111.086 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -113.41 142.6 27.82 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.38 -0.373 . . . . 71.34 110.574 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -44.53 121.33 3.2 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.966 2.444 . . . . 54.51 113.815 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.6 t -113.35 108.33 17.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.147 -0.479 . . . . 21.43 111.724 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.0 79.14 1.41 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.327 0.584 . . . . 71.23 110.624 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -78.52 -42.86 28.28 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.016 -0.538 . . . . 71.34 112.269 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 68.16 -73.72 0.08 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.978 0.418 . . . . 75.04 111.425 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -127.42 87.94 0.33 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 116.393 -0.367 . . . . 54.35 112.412 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.3 105.62 7.08 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 122.666 -0.314 . . . . 71.15 111.133 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -124.31 81.86 1.97 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.187 -0.46 . . . . 73.22 111.267 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -112.09 -169.13 1.41 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.881 0.372 . . . . 74.23 111.61 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 60' ' ' SER . 31.9 t70 -79.75 -3.07 45.91 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.226 0.454 . . . . 74.4 112.226 -175.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.11 79.46 0.01 OUTLIER Glycine 0 CA--C 1.53 1.026 0 N-CA-C 113.901 0.321 . . . . 62.21 113.901 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 58' ' ' ASP . 77.4 p -158.61 158.65 34.28 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.824 0.45 . . . . 73.33 110.939 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 61.22 19.53 10.17 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.435 0.531 . . . . 74.35 112.435 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.86 -6.31 48.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.594 -0.275 . . . . 74.23 111.356 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 44.64 38.67 2.86 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.862 0.865 . . . . 74.13 113.118 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.9 t -101.98 124.19 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.087 -0.506 . . . . 71.32 110.565 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 45.2 mt-10 -78.29 66.75 3.94 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.755 0.788 . . . . 60.45 110.652 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.549 ' HB2' HG12 ' A' ' 36' ' ' VAL . 33.4 ptt85 -95.3 134.72 37.76 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.727 -0.67 . . . . 74.31 112.672 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.72 -133.82 3.03 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.606 -0.724 . . . . 74.41 112.447 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.481 HD12 HD12 ' A' ' 70' ' ' ILE . 21.4 pt -111.12 131.81 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 122.35 -0.5 . . . . 74.15 110.957 176.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.6 -23.14 15.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 111.858 0.318 . . . . 43.14 111.858 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.481 HD12 HD12 ' A' ' 68' ' ' ILE . 55.7 mt -50.71 -56.23 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.236 0.541 . . . . 65.11 111.591 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.7 m -81.16 -30.61 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.146 -0.479 . . . . 74.0 111.693 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.8 mt -65.02 -35.72 82.09 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.131 0.491 . . . . 75.21 110.863 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.36 -40.99 71.95 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.961 -0.563 . . . . 63.25 111.78 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -100.78 -1.04 35.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.43 -0.35 . . . . 63.43 111.779 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt 53.88 70.55 0.59 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.285 0.564 . . . . 72.1 111.583 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 67.3 mt -100.04 135.74 41.01 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.877 -0.601 . . . . 65.13 111.247 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.27 145.97 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.876 0.37 . . . . 75.41 111.281 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -83.47 136.35 34.33 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.575 0.583 . . . . 74.24 112.575 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.2 mmm -115.82 145.59 42.71 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 116.004 -0.543 . . . . 41.43 110.268 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.429 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 15.6 m-80 -88.86 123.86 33.64 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.634 0.605 . . . . 52.22 112.634 -169.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 44.2 t -54.12 -32.94 56.48 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.136 0.791 . . . . 54.23 113.136 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 4.5 p90 -81.71 -30.73 32.41 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.937 0.399 . . . . 60.24 111.865 -176.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -94.69 -47.32 6.55 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.469 0.544 . . . . 71.31 112.469 -170.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.66 ' HA ' ' SD ' ' A' ' 87' ' ' MET . 23.5 m-20 -81.2 18.96 0.99 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.546 0.573 . . . . 71.1 112.546 -174.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . . . -55.94 -42.59 76.4 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.844 0.354 . . . . 53.31 111.849 177.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.507 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 53.3 m -60.24 -36.57 78.05 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.326 0.584 . . . . 71.41 111.091 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.663 ' N ' ' SD ' ' A' ' 87' ' ' MET . 0.6 OUTLIER -66.04 -38.66 88.93 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.014 -0.539 . . . . 65.0 110.278 176.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.44 ' HD2' ' HA ' ' A' ' 85' ' ' ALA . 32.0 m-85 -69.05 -43.86 73.8 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.928 -0.578 . . . . 74.12 112.274 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 86' ' ' SER . 0.1 OUTLIER -62.56 -36.09 81.55 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.959 0.409 . . . . 73.52 110.893 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.1 -40.11 62.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.066 0.46 . . . . 45.34 111.198 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -61.83 -44.09 97.55 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.164 -0.471 . . . . 72.51 110.735 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.33 -34.35 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.121 -0.491 . . . . 73.13 111.259 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -56.03 -51.5 67.56 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.146 0.498 . . . . 74.22 110.976 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -69.66 -43.03 73.39 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.139 -0.482 . . . . 72.42 110.949 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.466 ' CZ ' HG11 ' A' ' 172' ' ' VAL . 68.9 t80 -52.8 -54.08 39.3 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.146 -0.479 . . . . 64.14 111.559 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 57.0 ttp -54.51 -43.82 72.19 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.076 -0.511 . . . . 62.53 110.99 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -54.78 -57.53 11.16 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.101 -0.5 . . . . 64.31 111.497 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -59.55 -55.81 29.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.616 0.599 . . . . 63.04 112.616 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 95' ' ' PHE . 32.6 m -62.82 -43.38 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.718 0.636 . . . . 73.25 112.718 -174.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.9 mm -74.33 -47.49 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 122.138 -0.351 . . . . 65.23 111.785 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 8.9 t70 -61.07 -38.98 88.14 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.992 0.425 . . . . 64.22 110.845 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -69.94 -41.47 74.53 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.98 0.419 . . . . 74.34 110.923 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 49.4 tpp -61.59 -35.15 77.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.322 0.582 . . . . 75.32 111.002 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 32.2 tt0 -68.05 -15.95 63.82 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.912 -0.585 . . . . 71.02 111.793 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 1.7 mmmp? -81.09 -31.53 34.29 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.764 -0.585 . . . . 73.15 111.87 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -115.5 -36.45 4.28 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.473 0.916 . . . . 74.44 113.473 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -91.37 -76.43 0.45 Allowed 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.471 0.545 . . . . 71.44 112.471 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 104' ' ' GLU . 62.5 mtm-85 67.68 -6.49 0.68 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.863 1.06 . . . . 71.34 113.863 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 113' ' ' VAL . 38.3 t70 -68.59 106.0 2.44 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.033 -0.417 . . . . 73.3 110.61 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -48.91 -37.88 21.13 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.8 0.667 . . . . 75.34 112.8 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.91 -44.06 86.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.822 0.344 . . . . 71.41 111.543 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.6 -54.43 9.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.484 -0.326 . . . . 64.11 111.7 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 109' ' ' ASP . 23.0 m -59.26 -33.24 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 112.092 0.404 . . . . 52.01 112.092 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.96 -36.41 77.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.802 0.334 . . . . 71.2 110.587 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.73 -48.84 73.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.392 -0.367 . . . . 74.44 111.171 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -60.15 -50.32 74.13 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.841 0.353 . . . . 72.5 110.947 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -49.49 -49.26 46.39 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.212 0.529 . . . . 74.25 110.488 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.72 -36.3 82.15 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.789 -0.641 . . . . 51.41 111.566 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -67.01 -47.91 70.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.753 0.311 . . . . 54.44 110.791 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 31.3 mm -65.51 -38.72 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.485 -0.325 . . . . 64.34 111.112 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -58.13 -47.43 83.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.861 0.362 . . . . 72.52 110.679 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.3 -33.74 78.56 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.128 -0.558 . . . . 53.12 112.612 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -60.65 -54.28 47.2 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.574 0.35 . . . . 73.4 111.438 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.76 -46.79 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.699 0.629 . . . . 73.05 112.699 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.6 m -60.26 -33.26 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 122.061 -0.4 . . . . 74.34 111.59 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.7 m -77.08 -44.77 29.39 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.054 0.454 . . . . 64.11 111.002 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.482 HD21 HD13 ' A' ' 155' ' ' ILE . 48.4 tp -66.59 -32.17 73.34 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.058 -0.519 . . . . 74.04 112.207 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.7 mt -91.52 1.77 56.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.452 0.538 . . . . 71.3 112.452 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.6 95.81 0.08 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.346 0.593 . . . . 70.12 111.014 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.708 ' H ' ' HD2' ' A' ' 130' ' ' LYS . 2.5 mptp? -58.18 -33.11 68.88 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.17 0.804 . . . . 62.13 113.17 -168.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.51 -47.61 38.76 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.003 0.742 . . . . 64.15 113.003 -172.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 132' ' ' ARG . 0.4 OUTLIER -111.11 -26.32 9.28 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.633 0.605 . . . . 70.22 112.633 174.632 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.421 ' HD2' HD11 ' A' ' 136' ' ' LEU . 88.8 m-85 -83.19 -5.82 59.26 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.406 0.521 . . . . 75.02 112.406 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.92 -24.77 54.85 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.457 0.646 . . . . 72.31 110.501 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -78.21 13.41 1.5 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.694 -0.685 . . . . 72.42 112.232 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.421 HD11 ' HD2' ' A' ' 133' ' ' PHE . 77.8 mt -88.11 161.99 17.0 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.431 0.634 . . . . 74.43 111.799 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -134.33 122.35 22.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.706 -0.679 . . . . 73.32 110.362 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.42 ' HB3' HG13 ' A' ' 153' ' ' VAL . 82.9 m-85 -105.36 110.8 23.28 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.955 0.407 . . . . 74.23 110.82 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 80.3 m-85 -98.98 147.18 25.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.471 0.545 . . . . 73.25 112.471 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 12.4 tt -147.22 155.77 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.028 -0.533 . . . . 73.21 110.827 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.64 146.11 34.99 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.184 -0.532 . . . . 72.23 113.689 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -54.73 -62.85 1.39 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.105 0.409 . . . . 74.31 112.105 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -61.3 -28.6 69.31 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.898 0.38 . . . . 74.44 111.259 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.597 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -63.62 -53.73 46.92 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.037 0.446 . . . . 74.01 111.304 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.46 -19.13 62.26 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.128 0.49 . . . . 71.44 111.643 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.5 -40.65 34.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.166 -0.47 . . . . 70.32 111.596 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.21 42.02 0.09 OUTLIER Glycine 0 CA--C 1.529 0.953 0 C-N-CA 120.606 -0.807 . . . . 63.22 113.866 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.597 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -154.43 88.2 1.21 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.078 0.466 . . . . 55.25 111.235 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.16 -1.75 11.05 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.38 0.882 . . . . 62.51 113.38 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.36 57.79 3.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.485 0.66 . . . . 74.31 110.392 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -130.87 149.53 19.14 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.705 -0.679 . . . . 71.15 113.492 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -83.72 144.33 29.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.904 0.383 . . . . 73.51 111.477 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 138' ' ' PHE . 22.1 t -88.86 115.15 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.329 0.585 . . . . 72.4 111.479 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.32 109.38 15.77 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.695 -0.684 . . . . 72.33 110.901 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 52.5 mt -86.48 124.84 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.573 0.225 . . . . 64.24 111.272 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 169' ' ' LEU . 48.6 mm -118.05 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 111.967 0.358 . . . . 74.21 111.967 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.498 ' HG2' ' HE1' ' A' ' 170' ' ' MET . 7.3 pt-20 -130.58 158.26 40.48 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.106 0.479 . . . . 72.22 111.273 175.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -78.05 108.8 11.59 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.066 0.46 . . . . 71.23 111.552 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 159' ' ' ARG . 5.6 tpp180 -104.51 128.81 52.53 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.432 -0.349 . . . . 74.25 111.682 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.71 111.24 14.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.735 0.302 . . . . 75.42 110.434 173.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.05 88.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.158 0.504 . . . . 32.54 110.24 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 54.79 33.86 20.59 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.721 -0.672 . . . . 62.0 112.104 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 113.37 -24.74 12.0 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.059 -0.591 . . . . 61.43 113.403 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.479 HG22 HG13 ' A' ' 166' ' ' VAL . 89.8 m -97.31 106.54 18.88 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.438 -0.448 . . . . 74.11 111.044 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -80.54 108.26 14.03 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.272 -0.422 . . . . 71.23 111.636 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 164' ' ' THR . 25.0 m -128.23 142.56 44.97 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 120.908 0.385 . . . . 50.25 111.65 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 17.4 Cg_exo -68.56 119.15 6.16 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.801 2.334 . . . . 72.31 112.921 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 31' ' ' LYS . 38.2 p -107.52 163.68 12.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.983 0.42 . . . . 71.41 112.039 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 51.9 tp -102.06 138.52 38.91 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.604 0.594 . . . . 73.25 112.604 -175.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.565 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 1.2 mpt? -122.87 136.79 54.99 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.418 0.525 . . . . 74.03 112.418 176.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.9 mt -136.81 148.42 47.16 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.57 -0.741 . . . . 73.35 110.08 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.524 ' O ' HG22 ' A' ' 176' ' ' ILE . 58.6 t -87.15 127.46 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.744 0.646 . . . . 55.43 112.744 -173.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.519 ' HD2' HD21 ' A' ' 22' ' ' LEU . 57.4 tttm -52.78 -54.79 28.96 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.81 0.671 . . . . 71.41 112.81 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.08 12.21 0.58 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.818 0.673 . . . . 72.32 112.818 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -114.35 -51.51 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 61.54 109.838 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 172' ' ' VAL . 4.1 tt -102.96 108.97 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.611 -0.722 . . . . 63.23 111.699 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.5 mm -101.35 142.37 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.315 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.13 141.91 50.76 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.249 0.547 . . . . 74.53 112.254 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -135.46 104.11 5.72 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.764 -0.653 . . . . 72.4 110.124 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -96.02 111.28 23.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.366 0.603 . . . . 71.11 112.4 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 50.6 t -116.83 87.65 2.74 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.203 0.525 . . . . 70.23 109.65 170.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 5.9 mp -137.14 -169.7 2.55 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.777 -0.647 . . . . 63.21 111.008 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 . . . . . 0 C--O 1.254 1.313 0 CA-C-O 118.69 -0.671 . . . . 73.41 110.876 172.326 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.714 0.292 . . . . 73.24 111.091 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 180' ' ' LYS . 21.5 tp -95.38 124.09 39.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.083 -0.34 . . . . 71.14 110.083 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 179' ' ' GLU . 53.5 mt -105.72 129.22 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.497 0.189 . . . . 72.04 111.385 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -122.78 144.67 49.03 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.322 0.582 . . . . 62.24 112.343 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.695 ' HB3' ' HB ' ' A' ' 177' ' ' ILE . 23.7 ttmm -138.55 111.26 7.65 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.804 -0.634 . . . . 64.25 110.903 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' HA ' HG22 ' A' ' 176' ' ' ILE . 5.6 t70 -83.03 166.16 19.02 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.564 0.346 . . . . 71.23 111.293 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 pt -81.23 -18.18 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 113.069 0.766 . . . . 74.51 113.069 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.62 -42.86 7.46 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.069 0.461 . . . . 74.24 111.555 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.558 HG22 ' HB3' ' A' ' 6' ' ' ASP . 15.2 t -103.85 19.65 19.56 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.998 -0.546 . . . . 64.01 112.092 -176.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 12.4 p-10 -46.06 -40.47 10.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.748 1.018 . . . . 71.14 113.748 -172.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -53.07 -34.76 57.99 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.094 0.473 . . . . 64.45 111.962 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.35 26.5 0.65 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.803 0.668 . . . . 75.32 112.803 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.668 HD13 ' HB2' ' A' ' 5' ' ' LYS . 69.4 tp -32.11 109.28 0.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.286 0.634 . . . . 72.22 112.014 174.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -131.15 -175.88 3.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 111.873 0.323 . . . . 73.24 111.873 -172.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.0 p -150.33 144.28 25.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.17 0.804 . . . . 74.55 113.17 -174.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -144.88 -157.7 0.82 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.736 -0.666 . . . . 75.43 109.963 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.3 t -148.45 86.49 1.54 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.932 -0.48 . . . . 64.11 112.177 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -138.25 101.95 8.26 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.177 -0.465 . . . . 74.21 111.192 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.82 142.76 98.59 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.191 2.594 . . . . 64.02 114.324 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.0 ptp -146.37 161.31 40.64 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.859 -0.61 . . . . 63.12 111.003 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 18.2 ptpt -99.5 158.75 15.52 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.585 0.231 . . . . 74.22 111.061 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.7 tp -107.09 110.45 22.56 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.91 0.385 . . . . 62.25 111.224 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -104.02 145.5 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.032 0.444 . . . . 44.14 111.568 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 63.93 10.55 5.36 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 116.112 -0.495 . . . . 55.12 112.136 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 60.87 12.11 3.64 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.864 0.466 . . . . 74.21 111.875 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.5 tp -127.52 -43.16 1.6 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.938 0.399 . . . . 73.11 111.733 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 172' ' ' VAL . 17.0 m -127.71 148.8 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.254 0.55 . . . . 75.11 112.352 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -86.97 134.37 33.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.293 -0.412 . . . . 62.33 111.132 174.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 36.3 tt0 -103.92 108.07 19.23 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.062 0.458 . . . . 72.0 110.257 174.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.615 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 31.6 t80 -90.37 127.61 36.23 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.247 -0.283 . . . . 71.05 110.335 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.503 ' HD3' ' H ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -74.32 131.12 40.86 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.47 0.652 . . . . 74.23 112.059 -176.618 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.483 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -140.08 174.34 22.5 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.726 -0.67 . . . . 71.2 112.494 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HG3' HG13 ' A' ' 35' ' ' VAL . 16.4 ptpt -151.92 166.28 31.96 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.793 0.664 . . . . 72.41 112.793 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -71.51 106.6 4.04 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.082 -0.963 . . . . 75.3 110.799 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.452 HG23 HD12 ' A' ' 72' ' ' LEU . 31.5 m -138.06 154.58 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.21 0.529 . . . . 63.21 111.788 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.459 HG12 ' HG3' ' A' ' 66' ' ' ARG . 35.1 m -143.05 142.55 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.317 -0.401 . . . . 74.44 111.12 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 5.5 ttm180 -122.76 110.38 15.4 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.843 0.354 . . . . 61.15 110.954 174.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.576 ' HG3' ' HB3' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -130.04 98.73 4.84 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.128 0.49 . . . . 73.11 110.824 173.268 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 52.64 31.22 9.82 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.811 -0.631 . . . . 70.42 111.945 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.31 -28.61 13.31 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.367 -0.444 . . . . 74.12 113.299 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.576 ' HB3' ' HG3' ' A' ' 38' ' ' LYS . 6.7 tp10 -62.9 123.5 18.66 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.173 0.511 . . . . 53.43 112.137 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.4 mm -101.38 103.19 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 115.973 -0.558 . . . . 74.42 110.876 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 43' ' ' VAL . 11.4 p -120.33 33.98 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-O 121.96 0.886 . . . . 72.42 110.79 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 45' ' ' ALA . 3.2 pp -68.99 -19.87 64.15 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.783 -0.644 . . . . 65.05 112.513 -176.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.496 ' N ' HD12 ' A' ' 44' ' ' LEU . . . -87.56 -13.99 41.41 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.983 0.364 . . . . 34.12 111.983 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.12 71.09 1.76 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.447 -0.406 . . . . 73.03 113.032 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.7 p -118.41 173.32 6.89 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.127 0.489 . . . . 43.11 111.611 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -118.66 98.42 51.18 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 116.407 -0.361 . . . . 71.4 110.657 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.23 99.69 0.82 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.743 2.295 . . . . 74.41 113.147 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 82.5 p -110.91 -171.47 1.83 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.412 -0.358 . . . . 50.42 110.236 174.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.35 -13.75 59.87 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.849 0.356 . . . . 71.2 111.548 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -88.51 87.09 7.16 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.216 0.531 . . . . 72.13 111.796 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -43.86 42.4 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.981 -0.554 . . . . 73.13 110.47 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.53 57.03 0.68 Allowed Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.139 -0.482 . . . . 50.21 112.028 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.23 -11.13 60.54 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.939 0.718 . . . . 61.45 112.939 -175.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 67.85 34.9 4.09 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.124 0.57 . . . . 73.21 112.132 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -87.6 122.87 31.85 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.972 -0.455 . . . . 72.21 111.88 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -111.62 7.12 20.39 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.176 -0.465 . . . . 61.34 112.198 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.16 86.53 0.05 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.557 -0.292 . . . . 73.35 113.72 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.4 m -139.65 31.16 2.07 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.989 0.423 . . . . 71.34 111.35 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -99.39 27.81 4.98 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.105 0.478 . . . . 72.23 111.829 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 63' ' ' HIS . 13.6 pt-20 -91.92 14.25 16.21 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.954 0.724 . . . . 72.33 112.954 -173.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 41.3 m-70 73.66 -38.01 0.39 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.422 0.689 . . . . 71.21 112.207 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 38' ' ' LYS . 45.1 t -51.67 143.35 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.818 0.447 . . . . 72.01 110.972 174.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 26.3 tt0 -79.34 66.42 4.79 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.869 0.842 . . . . 70.33 110.694 -178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HG3' HG12 ' A' ' 36' ' ' VAL . 11.3 ttm180 -92.5 133.69 35.68 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.15 -0.932 . . . . 74.32 110.606 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.35 -135.78 4.11 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 119.63 -1.271 . . . . 22.11 114.422 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' A' ' 167' ' ' PRO . 12.5 mt -110.27 141.88 24.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.553 -0.324 . . . . 63.52 111.581 -173.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -47.9 -38.04 15.55 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.871 0.367 . . . . 60.31 111.321 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.596 HD13 ' HB2' ' A' ' 169' ' ' LEU . 63.6 mt -60.75 -54.72 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.097 0.475 . . . . 74.24 112.185 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -72.48 -38.3 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.797 -0.638 . . . . 74.45 112.124 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.576 HD22 ' HG2' ' A' ' 65' ' ' GLU . 47.8 mt -68.54 -43.21 77.19 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.148 0.499 . . . . 73.34 110.529 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -54.92 -42.58 72.39 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.939 -0.573 . . . . 63.14 112.09 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -98.84 1.54 45.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.741 0.645 . . . . 75.31 112.741 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.406 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 3.6 mppt? 54.07 69.05 0.76 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.318 0.58 . . . . 62.14 111.46 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 69.5 mt -106.66 137.41 44.74 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.964 -0.562 . . . . 70.41 110.725 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -88.27 151.55 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.109 0.48 . . . . 75.52 111.717 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.0 131.36 44.94 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.206 -0.906 . . . . 72.2 113.374 -175.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.41 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 83.5 mtp -138.6 153.68 48.66 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.931 -0.577 . . . . 73.03 109.946 170.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.46 168.16 28.21 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.168 0.803 . . . . 75.52 113.168 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -36.97 -55.85 0.9 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.71 1.745 . . . . 62.31 115.71 -169.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.462 ' CE2' ' HG2' ' A' ' 83' ' ' GLU . 43.8 p90 -56.96 -31.57 65.15 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.983 0.734 . . . . 75.44 112.983 -170.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.462 ' HG2' ' CE2' ' A' ' 82' ' ' TYR . 58.3 mm-40 -92.38 -44.54 8.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.158 0.504 . . . . 73.55 111.107 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 3.2 m-20 -67.58 -17.95 64.82 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.739 1.014 . . . . 63.42 113.739 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -43.87 -60.98 1.59 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.022 0.439 . . . . 74.12 111.287 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.9 m -72.54 -27.57 62.31 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.349 -0.387 . . . . 73.33 111.677 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.71 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 58.6 tpp -63.28 -65.92 0.62 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 111.495 0.183 . . . . 74.12 111.495 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.477 ' HA ' ' HB3' ' A' ' 91' ' ' TYR . 13.6 p90 -64.31 -22.75 67.06 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 122.12 -0.362 . . . . 74.33 111.38 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -60.65 -55.52 32.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.867 0.365 . . . . 73.32 110.858 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.7 96.26 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.044 0.45 . . . . 74.42 111.292 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.477 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 6.8 t80 -57.36 -55.86 29.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.829 -0.623 . . . . 72.41 111.348 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.7 -32.7 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.779 0.323 . . . . 74.23 111.542 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -65.82 -54.55 25.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.997 0.427 . . . . 75.13 111.073 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -63.77 -41.19 98.02 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.153 0.502 . . . . 70.41 110.532 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CE1' ' HB2' ' A' ' 175' ' ' ALA . 17.8 t80 -55.04 -58.35 7.99 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.852 -0.613 . . . . 74.43 111.647 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.452 ' O ' HG22 ' A' ' 100' ' ' ILE . 46.8 ttp -50.3 -52.01 40.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.019 -0.537 . . . . 61.44 111.559 -177.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -63.52 -50.49 69.39 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.716 0.293 . . . . 72.31 111.436 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -57.31 -50.64 72.28 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.264 0.468 . . . . 73.01 112.264 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 95' ' ' PHE . 35.1 m -69.44 -40.35 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.58 0.585 . . . . 75.23 112.58 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 96' ' ' MET . 10.9 tp -74.05 -42.11 52.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 120.791 -0.364 . . . . 71.35 111.18 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.12 -29.51 69.81 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.097 0.475 . . . . 62.43 110.282 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -76.09 -65.26 0.94 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.822 -0.626 . . . . 64.3 111.48 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.0 ttt -64.43 -45.26 88.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.764 0.653 . . . . 75.54 112.764 -171.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.743 ' HA ' HG11 ' A' ' 113' ' ' VAL . 36.8 tt0 -68.52 -11.79 60.36 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.235 0.54 . . . . 72.32 111.289 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -82.32 -42.49 18.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.038 -0.528 . . . . 73.41 111.756 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -89.66 -37.19 14.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.514 0.561 . . . . 72.33 112.514 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.455 ' O ' ' HD3' ' A' ' 108' ' ' ARG . 26.8 t-20 -76.15 -60.34 2.37 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.228 -0.295 . . . . 54.12 111.507 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 71.3 -21.69 0.2 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.155 1.169 . . . . 64.14 114.155 175.138 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.511 ' O ' HG22 ' A' ' 113' ' ' VAL . 40.8 m-20 -78.87 129.69 34.83 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.624 0.726 . . . . 64.23 112.595 -176.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -64.1 -8.04 10.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.245 -0.888 . . . . 71.55 112.459 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.03 -41.52 50.64 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 111.878 0.325 . . . . 75.4 111.878 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -95.34 -62.13 1.35 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.65 0.611 . . . . 70.22 112.65 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.743 HG11 ' HA ' ' A' ' 104' ' ' GLU . 27.3 m -57.82 -36.73 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.089 0.774 . . . . 71.41 113.089 -172.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.91 -45.75 87.92 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.83 0.348 . . . . 74.14 110.498 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.06 97.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.347 -0.388 . . . . 74.33 111.463 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.405 ' CE1' ' HG3' ' A' ' 174' ' ' GLU . 48.9 t80 -63.24 -57.62 9.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.309 -0.405 . . . . 73.2 111.373 176.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -52.6 -46.03 66.8 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.418 0.628 . . . . 70.14 111.053 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.53 -40.24 96.14 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.43 -0.805 . . . . 73.42 111.963 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -68.78 -50.6 48.98 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.892 0.377 . . . . 74.14 110.915 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.97 -33.49 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.856 0.36 . . . . 73.31 111.205 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -65.03 -42.27 94.5 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.096 0.474 . . . . 72.55 110.534 174.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.27 -39.26 97.48 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.895 -0.669 . . . . 62.41 112.024 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 49.2 t90 -58.63 -53.92 52.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.531 0.332 . . . . 50.52 111.224 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.4 m -64.19 -46.26 93.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 112.657 0.614 . . . . 72.33 112.657 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.81 -31.53 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.882 -0.511 . . . . 72.13 111.669 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.8 t -78.19 -42.99 29.78 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.208 0.528 . . . . 64.14 111.039 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.27 -31.0 71.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.037 -0.529 . . . . 73.33 112.309 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 71.0 mt -87.2 3.22 47.36 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.031 0.382 . . . . 75.51 112.031 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.72 103.79 0.15 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.062 0.458 . . . . 61.54 112.223 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -62.06 -24.58 67.17 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.897 0.703 . . . . 73.2 112.897 -174.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -80.31 -40.07 27.48 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.339 0.496 . . . . 73.31 112.339 -175.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -100.31 -60.43 1.53 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.218 0.532 . . . . 74.53 112.242 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.412 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 16.5 m-85 -74.11 -5.99 44.97 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.667 0.988 . . . . 74.41 113.667 -168.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 6.2 ttpm? -58.11 -18.65 26.57 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.879 -0.513 . . . . 73.22 111.45 176.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -85.49 15.64 4.38 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.527 0.566 . . . . 65.23 112.527 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 82.1 mt -89.82 142.34 27.79 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.235 0.54 . . . . 53.34 111.472 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.26 153.46 22.13 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.289 -0.414 . . . . 60.03 110.825 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -119.85 138.71 53.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 55.31 110.425 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 50.6 m-85 -134.27 136.5 43.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.12 0.486 . . . . 71.32 111.455 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.51 HD11 ' HA3' ' A' ' 151' ' ' GLY . 8.0 tt -124.47 149.06 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 115.917 -0.583 . . . . 75.4 110.889 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.69 129.74 49.32 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.262 -0.494 . . . . 63.14 113.579 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -46.93 -43.78 19.34 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.648 0.379 . . . . 71.55 111.886 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -49.52 -34.29 16.87 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.247 0.832 . . . . 73.41 113.247 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -94.91 -25.19 16.66 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.029 -0.42 . . . . 71.14 111.857 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.48 -30.24 7.9 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.267 1.21 . . . . 62.33 114.267 -173.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.72 -26.82 67.45 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.719 0.637 . . . . 74.34 112.719 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 169.86 -22.73 0.09 OUTLIER Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.588 -0.815 . . . . 64.15 113.869 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.37 97.79 0.44 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.981 0.42 . . . . 54.31 111.806 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -4.9 21.65 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.361 -0.381 . . . . 62.23 111.94 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -84.81 20.79 1.71 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.745 0.307 . . . . 65.24 111.68 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.51 ' HA3' HD11 ' A' ' 140' ' ' ILE . . . -92.86 135.64 12.77 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.208 -0.52 . . . . 33.02 112.636 176.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.451 ' NE2' HD22 ' A' ' 171' ' ' LEU . 42.8 tt0 -68.84 119.01 12.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.25 0.463 . . . . 52.11 112.25 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 37.6 t -80.08 124.91 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.089 0.471 . . . . 75.02 111.027 172.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -102.21 135.46 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.076 -0.511 . . . . 51.54 110.594 177.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.741 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 61.5 mt -90.28 137.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 112.338 0.496 . . . . 53.03 112.338 -172.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.1 mm -108.47 117.49 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.391 -0.368 . . . . 75.54 111.67 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 35.9 tt0 -110.47 137.11 48.6 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.38 -0.373 . . . . 62.42 111.389 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -73.26 88.14 1.5 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.51 -0.552 . . . . 75.33 109.51 169.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.03 121.65 22.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.166 0.508 . . . . 75.54 110.611 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -69.19 139.78 54.58 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.385 0.612 . . . . 64.32 112.033 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 163' ' ' GLY . 98.3 t -129.78 150.27 34.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.923 -1.51 . . . . 65.33 106.923 167.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.27 70.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.403 0.62 . . . . 73.1 111.058 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 161' ' ' VAL . . . 133.89 -12.47 4.78 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.774 -0.648 . . . . 63.43 113.862 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 m -143.55 148.57 36.16 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.087 -0.655 . . . . 73.22 111.526 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 165' ' ' GLU . 0.2 OUTLIER -110.94 108.74 18.61 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.421 0.629 . . . . 64.4 111.004 177.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.443 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 27.1 m -115.91 130.05 24.7 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.228 -0.442 . . . . 75.42 111.657 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.49 ' HB2' HD13 ' A' ' 68' ' ' ILE . 6.1 Cg_exo -79.66 115.01 3.3 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.633 2.222 . . . . 73.5 113.121 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.9 p -104.53 165.58 10.96 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.169 0.509 . . . . 74.42 111.824 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.67 HD11 ' HB1' ' A' ' 154' ' ' ALA . 21.1 tp -107.13 139.48 41.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.104 -0.498 . . . . 74.31 111.936 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.741 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 62.4 mtt -108.97 126.21 52.86 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 122.61 0.364 . . . . 74.41 111.633 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.451 HD22 ' NE2' ' A' ' 152' ' ' GLN . 82.1 mt -136.81 120.34 17.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.037 -0.529 . . . . 71.41 110.784 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 27' ' ' VAL . 46.0 t -74.22 121.18 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.628 -0.67 . . . . 64.45 111.927 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -70.14 -31.26 68.69 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.606 0.595 . . . . 73.53 112.606 -174.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.405 ' HG3' ' CE1' ' A' ' 116' ' ' PHE . 28.8 mm-40 -82.18 -1.3 48.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.941 0.4 . . . . 65.24 111.629 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.533 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . . . -96.53 -54.83 3.11 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.278 0.561 . . . . 75.54 110.462 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.571 HG22 ' HA ' ' A' ' 6' ' ' ASP . 29.3 pt -95.66 144.61 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.783 -0.644 . . . . 74.11 110.939 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.695 ' HB ' ' HB3' ' A' ' 5' ' ' LYS . 1.7 mp -91.84 110.7 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.348 0.594 . . . . 75.22 109.804 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -106.03 129.53 54.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.151 -0.932 . . . . 60.14 110.648 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 46.2 mt-10 -130.82 98.98 4.77 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.16 0.505 . . . . 73.13 110.818 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.415 ' HA ' HD12 ' A' ' 2' ' ' LEU . 32.8 ttpt -79.93 112.48 17.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.003 -0.544 . . . . 75.1 111.924 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 53.3 t -129.42 89.4 2.84 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.616 -0.513 . . . . 70.11 109.616 169.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.413 ' O ' HD12 ' A' ' 182' ' ' LEU . 3.3 pp -165.83 153.55 10.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.072 -0.513 . . . . 75.34 111.502 -176.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.811 -0.614 . . . . 63.4 112.08 -176.912 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.558 0.218 . . . . 71.14 110.916 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 15' ' ' SER . 32.0 tp -84.55 138.17 32.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.319 -0.623 . . . . 75.45 109.319 170.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.491 HG22 HD11 ' A' ' 13' ' ' LEU . 53.1 mt -121.03 118.48 56.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.251 -0.277 . . . . 71.02 110.251 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -118.88 146.89 44.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.272 0.471 . . . . 71.1 112.272 -172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.637 ' HB3' HD13 ' A' ' 13' ' ' LEU . 20.8 ptmt -151.37 127.33 10.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.758 0.651 . . . . 75.3 112.758 176.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.791 ' HB3' ' HB ' ' A' ' 9' ' ' THR . 18.3 t70 -79.37 166.13 22.39 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.866 -0.606 . . . . 30.34 110.761 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.404 HG13 ' CD2' ' A' ' 8' ' ' PHE . 19.9 pt -73.21 -41.29 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 113.133 0.79 . . . . 62.13 113.133 -177.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.404 ' CD2' HG13 ' A' ' 7' ' ' ILE . 24.0 p90 -105.66 -14.13 15.36 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.942 -0.473 . . . . 73.44 111.882 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 6' ' ' ASP . 4.1 m -94.82 18.08 12.45 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.935 0.874 . . . . 45.54 109.48 172.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -45.8 -45.05 14.53 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.595 1.158 . . . . 73.11 113.439 -172.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.17 -21.65 66.35 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.153 0.797 . . . . 64.44 113.153 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' ' 9' ' ' THR . 37.7 mt-10 -88.8 24.38 2.05 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.144 0.424 . . . . 71.52 112.144 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.637 HD13 ' HB3' ' A' ' 5' ' ' LYS . 61.0 tp -44.28 118.6 1.56 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.866 0.467 . . . . 75.35 111.495 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -141.44 165.9 26.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.37 0.508 . . . . 73.14 112.37 -175.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 2' ' ' LEU . 99.2 p -112.06 147.17 36.59 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.227 -0.442 . . . . 63.42 111.378 176.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -142.36 -170.37 3.17 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.385 0.612 . . . . 71.44 112.017 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -153.84 63.11 0.72 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.604 -0.725 . . . . 73.33 110.44 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -124.23 157.18 65.23 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 116.232 -0.44 . . . . 71.44 111.73 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.36 148.53 11.56 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.775 2.317 . . . . 62.11 112.777 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -146.31 145.67 30.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.08 0.467 . . . . 72.51 112.107 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -116.12 109.76 17.92 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.354 -0.385 . . . . 74.13 111.593 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.597 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 52.0 tp -79.99 96.7 6.5 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.908 -0.495 . . . . 74.14 110.963 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 p -87.96 140.17 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-O 120.967 0.413 . . . . 73.31 111.187 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.17 8.43 1.52 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.009 0.374 . . . . 71.24 112.009 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.597 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 40.9 m-20 55.17 20.2 3.26 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.214 0.53 . . . . 72.33 111.599 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.0 tp -117.85 -43.21 2.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.217 -0.447 . . . . 71.05 110.749 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 172' ' ' VAL . 16.5 m -133.52 149.69 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.97 0.414 . . . . 74.32 111.731 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -89.59 124.92 34.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.548 -0.297 . . . . 74.24 110.791 174.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 11.8 pt-20 -107.63 143.44 36.09 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.86 0.362 . . . . 71.31 110.885 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.403 ' HD2' HD11 ' A' ' 70' ' ' ILE . 34.3 t80 -151.59 119.58 6.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.643 0.259 . . . . 62.55 111.242 173.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.4 ' HG3' ' OG1' ' A' ' 168' ' ' THR . 2.9 mptp? -74.94 124.75 27.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.856 0.36 . . . . 62.32 111.331 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.88 172.3 42.05 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 114.186 0.435 . . . . 71.3 114.186 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -105.73 116.34 31.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.563 0.345 . . . . 71.24 110.61 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.21 107.05 2.64 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.179 0.514 . . . . 74.4 111.891 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -140.66 156.99 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.016 0.436 . . . . 65.13 111.618 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.426 HG22 ' CD2' ' A' ' 44' ' ' LEU . 31.4 m -133.11 125.67 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.073 0.463 . . . . 70.01 110.965 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.855 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 32.0 ttt-85 -99.67 108.75 21.18 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.537 -0.301 . . . . 63.21 111.515 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -109.69 103.73 12.62 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.817 0.342 . . . . 73.33 110.704 174.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 58.76 15.44 3.78 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.001 0.741 . . . . 72.53 113.001 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.1 -12.71 19.66 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.048 -0.596 . . . . 64.02 113.956 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -101.59 142.16 33.36 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.49 0.645 . . . . 61.2 112.246 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.8 tp -115.72 130.86 69.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.592 -0.731 . . . . 71.21 110.446 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.2 m -105.05 -18.14 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 113.495 0.924 . . . . 64.12 113.495 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.426 ' CD2' HG22 ' A' ' 36' ' ' VAL . 3.0 mm? -74.36 106.05 5.8 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.846 0.355 . . . . 72.31 111.673 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.13 -16.26 59.23 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.808 0.337 . . . . 64.22 111.549 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.23 -81.68 0.11 Allowed Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.3 -0.476 . . . . 73.51 112.843 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.3 t -137.05 105.5 5.78 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.738 0.304 . . . . 71.12 111.633 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -170.97 100.01 0.41 Allowed Pre-proline 0 CA--C 1.543 0.705 0 CA-C-O 120.905 0.383 . . . . 74.2 110.687 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -88.85 -156.41 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.251 2.634 . . . . 51.45 113.76 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.1 p -63.66 -56.15 17.97 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.396 0.517 . . . . 71.21 112.396 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -114.47 -82.35 0.61 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.972 0.415 . . . . 63.35 111.912 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.76 -34.93 2.77 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.43 0.53 . . . . 71.52 112.43 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -151.82 125.11 8.76 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.821 0.343 . . . . 74.2 110.622 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 178.31 159.83 23.55 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.301 -0.476 . . . . 72.34 112.558 -175.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.4 -48.39 2.2 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.221 0.534 . . . . 60.12 111.978 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.54 18.91 6.83 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.238 0.542 . . . . 65.01 110.41 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.77 82.63 1.62 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.646 -0.706 . . . . 75.21 112.06 -175.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 177.47 -74.32 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.484 -0.78 . . . . 62.43 110.165 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.05 95.39 0.1 OUTLIER Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.976 -0.556 . . . . 72.32 112.29 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.5 m -116.76 88.32 2.87 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.269 -0.548 . . . . 71.45 111.921 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -144.66 28.07 1.32 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.824 0.821 . . . . 44.44 109.898 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -91.27 178.55 5.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.41 -0.814 . . . . 64.41 111.702 -172.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -94.46 15.86 16.74 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.393 -0.822 . . . . 74.54 110.684 171.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.3 142.78 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.817 -0.629 . . . . 51.03 110.789 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.855 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 19.7 mm-40 -71.73 70.34 0.7 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.278 0.561 . . . . 60.52 110.323 175.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -82.59 135.3 35.1 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.673 -0.694 . . . . 70.14 111.464 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.09 -142.59 8.94 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.778 -0.725 . . . . 62.11 113.269 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.419 HG21 ' HB2' ' A' ' 167' ' ' PRO . 24.0 pt -111.04 143.84 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 122.499 -0.412 . . . . 62.02 112.015 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -41.66 -42.21 2.45 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.633 -0.712 . . . . 71.02 112.597 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.403 HD11 ' HD2' ' A' ' 30' ' ' PHE . 55.2 mt -51.75 -61.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.246 0.546 . . . . 72.42 112.271 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.8 m -72.29 -34.38 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.116 -0.493 . . . . 73.22 112.227 -174.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.0 -44.18 77.19 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.763 0.316 . . . . 64.32 111.145 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -63.03 -36.67 84.33 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.882 0.372 . . . . 73.24 111.637 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -94.32 2.14 55.86 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.057 0.391 . . . . 74.55 112.057 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 53.11 66.21 1.3 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.937 0.495 . . . . 72.12 112.08 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.4 mt -104.64 129.64 52.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.446 -0.343 . . . . 73.31 111.19 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 140' ' ' ILE . 11.2 p -78.66 137.02 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.787 0.327 . . . . 73.13 111.066 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -85.44 135.86 33.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.257 0.551 . . . . 72.3 112.071 -177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.3 mmm -130.19 159.41 36.94 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.374 -0.83 . . . . 64.23 109.735 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -132.04 140.87 49.04 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.248 0.833 . . . . 74.32 113.248 -169.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.415 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 27.5 p -48.73 -42.82 36.48 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.791 1.034 . . . . 74.25 113.791 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -53.33 -33.09 52.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.354 0.502 . . . . 74.45 112.354 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -103.44 -47.21 4.35 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.083 0.468 . . . . 70.42 111.643 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -77.6 4.8 10.45 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.545 0.572 . . . . 71.34 112.545 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.48 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -48.61 -46.31 39.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.072 0.463 . . . . 61.53 111.712 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 78.4 p -66.08 -41.95 90.02 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.973 -0.558 . . . . 23.31 111.533 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.3 ttp -63.03 -51.76 65.49 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.314 -0.403 . . . . 72.51 111.829 -175.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 91' ' ' TYR . 8.1 p90 -75.87 -17.58 59.75 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 120.199 -0.601 . . . . 72.11 111.582 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -64.8 -45.66 85.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.255 0.55 . . . . 72.43 110.122 170.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.19 -42.58 93.44 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.094 -0.503 . . . . 73.01 110.736 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.506 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 13.9 m-30 -59.06 -49.44 77.89 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.165 0.431 . . . . 73.22 112.165 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.5 tp -65.55 -31.64 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.612 0.244 . . . . 74.35 111.439 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -63.8 -51.15 66.09 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.996 0.426 . . . . 75.33 110.778 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -65.08 -41.76 94.75 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.172 0.51 . . . . 41.22 110.982 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.589 ' HE1' ' HB2' ' A' ' 175' ' ' ALA . 78.7 t80 -58.64 -56.99 15.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.419 -0.809 . . . . 63.51 111.102 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 50.9 ttp -50.74 -48.11 59.13 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.01 0.433 . . . . 43.01 111.463 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.678 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -63.28 -46.57 86.15 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.127 -0.488 . . . . 74.24 111.48 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -70.66 -42.56 70.63 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.255 0.465 . . . . 65.42 112.255 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.36 -33.61 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.18 0.437 . . . . 73.44 112.18 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 97' ' ' LYS . 10.0 tp -67.82 -38.23 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.533 -0.467 . . . . 75.31 110.309 175.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -65.25 -48.03 74.67 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.315 0.579 . . . . 71.43 110.552 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -60.0 -29.89 68.78 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.662 -0.699 . . . . 72.23 111.789 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 54.5 tpp -90.64 -60.52 1.9 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.813 0.339 . . . . 74.02 111.684 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.12 -32.69 68.37 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.144 0.424 . . . . 72.14 112.144 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -55.86 -44.07 77.72 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.287 0.477 . . . . 72.32 112.287 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -95.83 -36.69 11.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.99 0.366 . . . . 72.23 111.99 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -67.09 -62.94 1.18 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.644 -0.253 . . . . 71.24 111.591 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 108' ' ' ARG . 49.1 mtm180 62.59 23.74 14.12 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.992 1.108 . . . . 74.24 113.992 173.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.539 ' O ' HG22 ' A' ' 113' ' ' VAL . 20.3 t70 -120.88 121.24 37.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.691 -0.63 . . . . 74.35 111.391 175.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 3.3 ptpp? -66.44 -1.25 3.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.887 1.069 . . . . 73.44 113.887 -175.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.95 -44.35 8.48 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.83 -0.544 . . . . 72.42 110.862 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -71.08 -51.39 25.46 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.386 -0.37 . . . . 64.2 111.408 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 109' ' ' ASP . 34.4 m -61.84 -28.45 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.727 0.299 . . . . 74.51 111.205 177.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.56 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 18.9 t70 -61.2 -56.33 21.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.082 0.468 . . . . 51.53 110.318 174.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 119' ' ' LYS . . . -59.92 -40.9 90.46 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.828 -0.624 . . . . 71.01 111.245 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -57.02 -61.96 2.09 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.288 0.477 . . . . 75.3 112.288 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 114' ' ' ASP . 62.7 pttt -55.19 -45.23 75.81 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.885 0.374 . . . . 75.33 111.274 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -65.91 -28.63 69.07 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.828 0.307 . . . . 61.24 111.828 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 37.1 tptt -72.75 -56.84 4.67 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.049 0.452 . . . . 74.44 110.739 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.4 tp -68.18 -39.27 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.896 -0.593 . . . . 75.02 111.763 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -62.83 -51.41 67.16 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.283 -0.261 . . . . 65.22 111.422 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.63 -44.92 68.82 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.913 -0.661 . . . . 74.42 112.656 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -58.71 -58.39 8.79 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 111.561 0.208 . . . . 71.41 111.561 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.469 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.7 m -61.76 -44.68 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 112.546 0.573 . . . . 54.33 112.546 -175.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.1 m -63.34 -26.98 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.88 -0.513 . . . . 73.31 111.418 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 m -81.25 -36.49 29.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.215 0.531 . . . . 63.21 110.767 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 51.4 tp -71.61 -31.39 66.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.736 -0.665 . . . . 73.52 112.102 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 80.7 mt -80.56 2.36 25.83 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.167 0.432 . . . . 65.2 112.167 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.509 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -58.69 103.47 0.16 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.223 0.535 . . . . 71.11 112.012 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 37.8 ttpt -65.74 -23.24 66.69 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.29 0.848 . . . . 73.22 113.29 -171.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -77.87 -31.83 51.59 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.052 0.76 . . . . 62.13 113.052 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -108.35 -51.78 2.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.259 0.552 . . . . 75.33 111.517 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.509 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 45.8 m-85 -71.22 -5.6 33.21 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.943 0.72 . . . . 70.12 112.943 -172.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 21.8 ptmt -51.36 -26.19 7.31 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.067 -0.395 . . . . 62.12 111.556 172.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -82.18 18.53 1.37 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.67 0.618 . . . . 74.33 112.67 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.4 HD11 ' HD2' ' A' ' 133' ' ' PHE . 75.3 mt -89.68 137.32 32.43 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.982 -0.449 . . . . 74.25 111.297 176.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.9 123.82 45.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.258 -0.428 . . . . 35.11 110.603 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.415 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 88.8 m-85 -101.73 106.17 17.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.982 0.42 . . . . 72.42 111.195 -176.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -97.39 136.14 38.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.066 0.46 . . . . 72.3 111.33 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.455 ' O ' HG12 ' A' ' 77' ' ' VAL . 13.2 tt -140.03 154.72 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.784 0.326 . . . . 74.04 110.88 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.18 125.89 35.13 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.706 -0.759 . . . . 71.22 112.145 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -48.5 -47.56 38.76 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.669 0.387 . . . . 71.22 111.751 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.456 HH11 ' HD3' ' A' ' 143' ' ' ARG . 31.3 ttp180 -48.68 -52.4 23.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.087 -0.506 . . . . 73.43 111.408 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.665 ' HB1' ' H ' ' A' ' 151' ' ' GLY . . . -68.62 -28.05 66.56 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.182 0.438 . . . . 71.12 112.182 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.22 -17.8 64.95 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.748 0.419 . . . . 74.43 111.681 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -66.62 -7.97 24.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.172 -0.467 . . . . 64.31 112.004 175.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.0 17.53 76.79 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.106 -0.568 . . . . 62.4 112.806 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.46 -60.87 1.52 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.948 0.404 . . . . 70.15 111.073 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -74.74 -35.81 62.63 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.381 -0.372 . . . . 73.35 111.459 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 21.8 m120 57.69 34.53 24.6 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.943 0.401 . . . . 72.14 111.241 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.665 ' H ' ' HB1' ' A' ' 144' ' ' ALA . . . -54.09 162.47 3.58 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.61 -0.723 . . . . 53.42 114.216 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -59.59 144.44 47.57 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.948 0.722 . . . . 73.11 112.948 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 50.0 t -91.44 127.5 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.99 -0.55 . . . . 75.33 111.526 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -85.21 116.11 23.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.783 -0.644 . . . . 54.51 110.807 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.704 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 62.6 mt -88.8 124.44 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.821 0.343 . . . . 73.4 111.72 -176.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.8 mm -110.52 120.24 60.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.942 0.401 . . . . 62.2 111.775 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 26.0 tt0 -107.78 128.81 54.92 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.245 -0.434 . . . . 64.24 111.947 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -72.62 89.06 1.29 Allowed 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.969 -0.457 . . . . 73.24 110.486 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -92.2 133.95 35.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.926 0.393 . . . . 70.3 111.919 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.86 123.9 33.68 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.094 0.473 . . . . 55.3 111.506 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.6 t -130.1 105.06 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.875 0.369 . . . . 75.2 111.441 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.2 t70 56.19 30.94 17.41 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.335 0.588 . . . . 62.11 111.916 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.41 -24.55 24.04 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.171 -0.537 . . . . 63.02 113.664 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.5 p -90.16 148.58 22.88 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.924 0.392 . . . . 52.35 111.58 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 165' ' ' GLU . 0.1 OUTLIER -102.97 96.47 6.83 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.462 0.649 . . . . 75.53 110.74 178.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 166' ' ' VAL . 25.0 m -104.16 106.59 54.16 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 121.348 0.594 . . . . 63.15 112.066 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 34.2 Cg_exo -62.08 114.35 2.28 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.531 2.154 . . . . 75.41 112.481 176.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.4 ' OG1' ' HG3' ' A' ' 31' ' ' LYS . 90.9 m -99.15 133.07 43.95 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.921 0.391 . . . . 75.33 111.967 -176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 57.8 tp -77.83 140.1 39.35 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.898 -0.592 . . . . 70.32 111.702 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.704 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 24.0 mmt -127.96 124.36 37.1 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.693 0.397 . . . . 71.23 111.597 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.3 mt -141.09 130.63 23.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.651 0.38 . . . . 73.2 111.431 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.54 ' HA ' HG12 ' A' ' 27' ' ' VAL . 19.6 t -79.97 129.17 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.121 0.415 . . . . 63.11 112.121 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -77.48 -15.21 59.43 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.599 0.592 . . . . 71.15 112.599 -175.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.438 ' H ' HG12 ' A' ' 172' ' ' VAL . 3.8 mp0 -57.33 -27.63 62.39 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.846 0.355 . . . . 70.44 111.821 171.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.589 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -97.3 -42.72 7.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.144 -0.48 . . . . 70.52 111.93 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.4 pt -95.9 118.56 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.607 0.718 . . . . 75.41 112.373 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 177' ' ' ILE . 1.6 mp -94.88 115.63 34.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.798 -0.637 . . . . 73.33 110.255 175.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -97.96 112.88 24.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.567 -0.742 . . . . 63.31 111.407 -176.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 2' ' ' LEU . 54.7 mm-40 -97.71 123.03 41.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.557 0.343 . . . . 71.13 110.797 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -103.56 96.94 7.07 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.993 0.738 . . . . 74.32 112.993 -171.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 40.6 t -133.78 88.68 2.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.898 -0.592 . . . . 72.12 109.983 173.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 182' ' ' LEU . 4.7 mp -104.88 120.62 41.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.85 0.357 . . . . 73.53 111.596 -172.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 118.656 -0.688 . . . . 74.3 111.173 179.139 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 111.747 0.277 . . . . 64.21 111.747 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.0 tp -126.18 131.01 52.1 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.857 0.361 . . . . 64.12 110.535 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.584 HG12 ' HB3' ' A' ' 15' ' ' SER . 57.5 mt -98.05 134.11 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 112.004 0.372 . . . . 74.52 112.004 -175.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -123.52 137.27 54.8 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.083 0.468 . . . . 73.45 111.115 171.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -143.54 141.39 30.69 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.989 -0.55 . . . . 71.3 111.361 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.585 ' HB2' ' H ' ' A' ' 9' ' ' THR . 5.2 m-20 -86.98 167.74 13.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.4 0.619 . . . . 75.23 111.258 172.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.446 HD12 ' OD1' ' A' ' 98' ' ' ASN . 15.2 pt -63.05 -26.86 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.97 -0.559 . . . . 64.14 111.458 173.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.475 ' HE1' ' HA ' ' A' ' 152' ' ' GLN . 13.2 p90 -109.95 -35.65 6.09 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.321 0.86 . . . . 75.34 113.321 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.585 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 2.7 m -83.12 15.61 2.76 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.95 0.722 . . . . 75.1 112.95 -173.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -58.28 -15.11 8.93 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.849 0.685 . . . . 74.23 112.849 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -67.81 -56.02 10.77 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 122.156 -0.34 . . . . 74.45 111.267 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -84.14 25.02 0.87 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.832 0.349 . . . . 55.45 111.747 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tt -40.12 131.07 2.08 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.535 0.734 . . . . 62.45 111.589 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 m -126.11 139.9 53.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.143 0.497 . . . . 62.51 112.279 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.584 ' HB3' HG12 ' A' ' 3' ' ' ILE . 47.8 p -111.55 111.04 21.76 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.869 -0.605 . . . . 72.31 110.944 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.414 ' HB3' ' HD1' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -151.05 -156.83 0.75 Allowed 'General case' 0 CA--C 1.544 0.741 0 O-C-N 122.355 -0.216 . . . . 54.31 111.204 -175.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -127.63 24.77 6.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.136 0.421 . . . . 51.44 112.136 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.414 ' HD1' ' HB3' ' A' ' 16' ' ' ASP . 59.1 m-85 -60.18 134.15 90.56 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.03 0.382 . . . . 54.22 112.03 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.99 -169.84 0.88 Allowed 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.779 2.319 . . . . 75.03 113.08 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.6 ptp -145.89 135.43 23.17 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.442 0.534 . . . . 62.55 112.442 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -124.45 100.41 6.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.614 -0.513 . . . . 75.41 109.614 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 27' ' ' VAL . 33.0 tp -93.03 124.46 37.01 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.174 0.805 . . . . 71.21 113.174 -170.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.68 142.35 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.896 -0.593 . . . . 61.02 111.01 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 57.44 13.44 1.82 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.481 0.549 . . . . 75.2 112.481 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 50.76 26.86 2.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.216 0.532 . . . . 74.21 111.03 -172.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.519 HD22 ' HB3' ' A' ' 119' ' ' LYS . 20.0 tp -121.62 -42.71 2.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.159 -0.473 . . . . 70.44 111.967 -174.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.66 HG12 ' HA ' ' A' ' 172' ' ' VAL . 2.6 m -138.19 151.73 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.803 0.668 . . . . 70.22 112.803 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -104.57 138.52 40.79 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.879 -0.6 . . . . 74.54 111.117 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -104.39 137.73 41.84 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.397 . . . . 72.14 110.526 167.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.845 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.4 t80 -115.59 134.25 55.24 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.943 0.401 . . . . 75.34 111.141 177.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -93.1 113.79 26.14 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.199 -0.455 . . . . 72.52 111.859 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.09 -174.82 18.31 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.275 -0.488 . . . . 61.42 113.598 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -128.14 144.25 51.1 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 122.482 -0.422 . . . . 73.54 111.298 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -80.08 114.16 18.79 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.866 -0.42 . . . . 73.2 109.866 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.1 m -144.23 174.42 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.302 0.573 . . . . 73.24 111.949 -174.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 44' ' ' LEU . 21.5 m -110.85 121.75 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.168 0.509 . . . . 72.52 110.558 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.62 HH11 HD13 ' A' ' 42' ' ' ILE . 9.8 mmm180 -140.61 117.29 10.93 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.095 0.474 . . . . 72.32 111.111 -174.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -110.72 113.22 25.66 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.965 0.412 . . . . 63.23 110.945 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 60.63 14.5 5.01 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.534 0.568 . . . . 72.44 112.534 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.82 -15.98 21.23 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.257 -0.497 . . . . 60.35 113.688 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -79.72 142.27 35.62 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 117.286 0.543 . . . . 64.02 111.885 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.62 HD13 HH11 ' A' ' 37' ' ' ARG . 5.1 tp -109.88 122.44 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 116.207 -0.451 . . . . 62.02 111.906 -177.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 p -162.95 85.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.396 0.617 . . . . 71.43 112.255 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' HA ' HG22 ' A' ' 36' ' ' VAL . 8.9 mp -57.14 160.33 3.81 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.156 0.798 . . . . 74.23 113.156 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 72.07 4.2 4.94 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.026 -0.988 . . . . 70.54 112.637 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.43 99.13 1.93 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.155 -0.545 . . . . 65.4 112.975 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.8 m -156.53 -77.62 0.09 Allowed 'General case' 0 N--CA 1.476 0.849 0 O-C-N 122.485 -0.42 . . . . 65.21 111.631 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 59.52 93.5 0.06 OUTLIER Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 122.848 0.459 . . . . 72.43 111.813 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.64 155.28 54.56 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.507 2.138 . . . . 54.33 113.325 -177.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 78.3 p -98.74 114.33 26.81 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.325 -0.398 . . . . 65.54 110.77 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.48 -75.48 0.11 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.08 0.4 . . . . 74.14 112.08 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -104.51 21.97 15.79 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.138 0.494 . . . . 73.34 111.391 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 8.6 tp10 -111.73 113.18 25.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.95 0.405 . . . . 64.25 110.641 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.19 36.52 91.91 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.14 -0.552 . . . . 44.01 112.659 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.96 -18.72 58.76 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.213 0.449 . . . . 65.43 112.213 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.67 29.56 7.9 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.399 -0.364 . . . . 75.43 111.388 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.59 144.35 51.87 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.256 0.55 . . . . 73.41 111.95 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -130.74 -0.26 4.32 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.944 -0.571 . . . . 74.51 111.954 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.75 98.74 0.19 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.896 -0.669 . . . . 72.24 113.768 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.3 p -156.6 168.62 26.83 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.484 0.314 . . . . 72.53 110.647 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -99.66 -93.81 0.26 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.923 0.342 . . . . 71.33 111.923 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 53.07 7.83 0.09 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.833 1.049 . . . . 73.23 113.833 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -86.3 -16.7 36.7 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.857 -0.527 . . . . 75.24 110.614 172.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 24.4 t -98.34 163.84 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.997 -1.112 . . . . 72.14 107.997 164.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 64' ' ' VAL . 39.7 tt0 75.67 -5.1 2.24 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.397 0.617 . . . . 72.23 109.354 -171.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -137.02 122.02 18.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.746 -0.661 . . . . 72.05 111.202 -176.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.53 -148.78 15.5 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.532 -0.842 . . . . 74.22 113.736 175.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.442 HD12 HD12 ' A' ' 70' ' ' ILE . 36.7 pt -111.07 138.82 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 122.417 -0.46 . . . . 64.32 111.356 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -48.14 -35.75 12.16 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.379 0.511 . . . . 75.42 112.379 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.442 HD12 HD12 ' A' ' 68' ' ' ILE . 55.8 mt -49.81 -64.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.401 0.62 . . . . 70.1 112.021 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 18.5 m -74.38 -31.98 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.964 -0.562 . . . . 71.43 112.08 -174.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.619 HD13 ' HB2' ' A' ' 37' ' ' ARG . 72.6 mt -68.7 -30.78 69.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.286 -0.415 . . . . 55.11 111.64 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -90.63 -27.13 19.27 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 111.852 0.316 . . . . 72.12 111.852 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -97.84 3.65 49.82 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.02 -0.425 . . . . 75.2 111.782 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 58.29 70.87 0.62 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.406 0.622 . . . . 73.32 112.581 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 88.0 mt -122.26 138.92 54.33 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.003 -0.544 . . . . 65.33 111.256 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 p -93.76 146.67 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 120.856 0.36 . . . . 72.34 111.842 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.42 127.51 32.29 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.368 0.877 . . . . 54.51 113.368 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.0 mtp -140.26 110.61 6.65 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.172 -0.467 . . . . 75.24 110.139 174.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.499 ' HB2' ' HE1' ' A' ' 82' ' ' TYR . 18.4 m120 -95.74 167.11 11.47 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.852 -0.53 . . . . 54.42 112.134 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 43.1 t -43.5 -56.13 3.82 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.87 1.063 . . . . 72.34 113.87 -172.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.499 ' HE1' ' HB2' ' A' ' 80' ' ' ASN . 13.4 p90 -50.24 -33.0 18.11 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.457 0.54 . . . . 72.23 112.457 -177.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.76 -38.24 9.55 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.773 -0.649 . . . . 64.2 112.087 -174.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 88' ' ' PHE . 25.4 t0 -91.21 -7.63 50.77 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.477 0.547 . . . . 72.13 112.477 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.614 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -39.71 -61.49 0.82 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.369 0.878 . . . . 74.43 113.369 -175.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.4 m -61.86 -35.25 77.74 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.262 0.467 . . . . 62.34 112.262 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.5 ttm -75.74 -54.4 7.01 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.139 0.422 . . . . 72.23 112.139 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.614 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 7.6 p90 -63.47 -27.09 69.04 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.114 -0.634 . . . . 74.51 111.617 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -64.32 -44.8 90.46 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.867 0.365 . . . . 72.42 110.645 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.64 -38.0 89.51 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.2 0.524 . . . . 33.32 110.714 173.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 27.8 t80 -55.82 -50.99 69.0 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.72 -0.673 . . . . 73.42 110.978 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 88' ' ' PHE . 32.6 mm -57.68 -42.72 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 116.283 -0.417 . . . . 61.54 111.593 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.93 -56.38 17.7 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.865 0.32 . . . . 62.33 111.865 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -59.94 -39.21 84.77 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.897 0.379 . . . . 65.5 111.147 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CZ ' HG11 ' A' ' 172' ' ' VAL . 20.3 t80 -59.49 -59.15 5.91 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.121 -0.49 . . . . 72.33 111.221 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 55.6 ttp -52.82 -44.43 66.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.161 -0.472 . . . . 71.34 111.4 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -61.67 -49.56 76.02 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.36 -0.382 . . . . 72.15 111.321 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.446 ' OD1' HD12 ' A' ' 7' ' ' ILE . 26.0 t-20 -61.33 -56.06 24.73 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.76 0.281 . . . . 63.1 111.76 -176.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.577 ' HB ' ' HZ ' ' A' ' 116' ' ' PHE . 27.5 m -57.46 -41.72 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.407 0.521 . . . . 73.53 112.407 -176.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.6 tp -74.74 -35.9 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 122.077 -0.39 . . . . 71.1 111.006 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.73 -13.81 61.03 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.336 0.588 . . . . 70.11 110.8 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -90.36 -37.79 13.77 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.16 -0.337 . . . . 74.53 111.343 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 64.0 mtt -93.13 -62.88 1.29 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.523 0.564 . . . . 71.41 112.523 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.658 ' HA ' HG11 ' A' ' 113' ' ' VAL . 38.9 tt0 -58.29 -26.34 62.9 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.38 0.511 . . . . 72.44 112.38 -174.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -57.27 -46.21 83.31 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 111.991 0.367 . . . . 71.42 111.991 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -108.02 -14.52 14.72 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.566 0.58 . . . . 74.55 112.566 -175.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.46 ' OD1' HG13 ' A' ' 113' ' ' VAL . 27.6 t-20 -92.72 -68.9 0.77 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.666 0.269 . . . . 70.55 111.398 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 36.6 ttm180 63.14 11.96 5.67 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.248 0.833 . . . . 73.22 113.248 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.621 ' O ' HG22 ' A' ' 113' ' ' VAL . 22.2 t70 -75.53 120.36 20.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.385 -0.822 . . . . 75.41 110.954 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -57.78 -12.31 2.94 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.468 0.914 . . . . 72.12 113.468 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.1 -53.25 4.2 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.997 -0.439 . . . . 75.31 112.043 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -74.12 -60.07 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.238 0.459 . . . . 74.15 112.238 -170.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.658 HG11 ' HA ' ' A' ' 104' ' ' GLU . 27.6 m -60.47 -26.6 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.692 0.282 . . . . 72.32 111.722 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.79 -53.22 50.38 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.573 -0.285 . . . . 75.12 110.483 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -56.57 -43.66 80.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.042 0.449 . . . . 61.24 111.258 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.577 ' HZ ' ' HB ' ' A' ' 99' ' ' VAL . 44.1 t80 -61.07 -59.21 5.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.882 0.372 . . . . 61.11 111.624 177.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -57.0 -35.14 68.88 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.175 0.512 . . . . 55.31 111.169 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -68.97 -40.15 79.02 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.786 -0.643 . . . . 53.34 111.385 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.519 ' HB3' HD22 ' A' ' 26' ' ' LEU . 51.9 mtmt -65.69 -44.18 86.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.512 0.196 . . . . 74.11 111.103 175.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.432 ' CD1' HD11 ' A' ' 26' ' ' LEU . 37.6 mm -62.01 -45.58 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.917 0.389 . . . . 75.45 111.055 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.42 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.6 OUTLIER -58.54 -50.99 71.78 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.184 -0.462 . . . . 62.15 110.776 177.687 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.73 -36.85 93.88 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.922 -0.656 . . . . 75.32 112.724 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.2 t90 -60.6 -56.4 21.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.642 0.377 . . . . 74.22 111.587 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.536 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.8 m -63.36 -42.72 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 112.241 0.46 . . . . 72.14 112.241 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 121' ' ' GLN . 71.6 t -59.81 -37.23 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 122.066 -0.396 . . . . 75.52 111.43 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.2 t -77.16 -39.62 48.41 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.042 0.449 . . . . 74.43 110.984 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.0 tp -62.41 -28.38 69.75 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.994 0.517 . . . . 73.3 112.148 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 29.3 mt -92.58 1.81 57.05 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.916 0.339 . . . . 64.12 111.916 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.89 108.08 2.43 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.091 0.472 . . . . 65.31 111.451 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -16.58 49.19 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.076 0.769 . . . . 55.41 113.076 -172.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -54.91 -49.05 72.24 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.904 0.383 . . . . 54.25 111.404 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -111.24 -43.34 3.74 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.403 0.62 . . . . 74.1 111.27 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -74.23 -7.26 52.08 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.327 0.862 . . . . 70.52 113.327 -167.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -63.7 -32.35 73.81 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.197 0.523 . . . . 70.31 110.426 170.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -89.7 33.9 0.84 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.003 -0.544 . . . . 75.1 112.199 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.73 156.95 18.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.504 0.669 . . . . 53.02 111.93 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.36 112.63 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.461 -0.79 . . . . 74.01 110.288 172.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.585 ' HB3' HG13 ' A' ' 153' ' ' VAL . 54.5 m-85 -90.9 132.93 35.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.916 0.388 . . . . 70.02 110.226 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.788 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 61.4 m-85 -121.94 125.39 46.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.863 0.364 . . . . 73.14 111.331 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 13.8 tt -113.4 154.63 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 116.552 -0.294 . . . . 73.44 111.348 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.99 142.8 41.42 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.447 -0.342 . . . . 73.11 113.645 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.437 ' HG3' ' HG3' ' A' ' 143' ' ' ARG . 14.2 pt-20 -53.29 -40.06 64.42 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.643 0.609 . . . . 73.24 112.643 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.437 ' HG3' ' HG3' ' A' ' 142' ' ' GLU . 85.1 mtm180 -78.17 -38.44 43.51 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.019 0.377 . . . . 72.32 112.019 -176.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.606 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -74.89 -28.48 60.65 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.085 0.402 . . . . 75.3 112.085 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -50.16 -38.79 41.24 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.04 1.126 . . . . 74.35 114.04 -174.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -73.52 6.16 3.26 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.756 1.021 . . . . 74.23 113.756 -172.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.26 -11.69 1.19 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.981 -1.104 . . . . 64.52 114.881 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -77.93 95.11 4.7 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 117.778 0.789 . . . . 70.14 111.59 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -74.27 19.85 0.12 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.473 0.546 . . . . 72.44 112.473 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -111.49 5.88 19.83 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.943 0.401 . . . . 53.24 110.827 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.81 171.59 52.59 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.423 -0.418 . . . . 63.34 113.472 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.475 ' HA ' ' HE1' ' A' ' 8' ' ' PHE . 37.3 tt0 -86.72 116.96 25.17 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.421 -0.458 . . . . 62.5 112.085 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.585 HG13 ' HB3' ' A' ' 138' ' ' PHE . 27.5 t -83.29 107.17 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.152 0.501 . . . . 71.23 110.589 170.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.484 ' HB1' ' CD1' ' A' ' 169' ' ' LEU . . . -82.09 117.39 22.23 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.065 -0.516 . . . . 64.42 110.89 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 59.4 mt -89.27 105.12 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.854 0.359 . . . . 73.43 111.252 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.5 mm -93.77 117.8 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.027 0.381 . . . . 62.33 112.027 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.86 129.49 56.44 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.393 -0.595 . . . . 73.43 109.393 174.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -90.51 88.99 7.37 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.047 0.451 . . . . 73.23 110.456 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -97.17 159.05 15.13 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.329 0.585 . . . . 71.11 112.171 -170.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.01 134.09 48.7 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.926 -0.579 . . . . 73.02 111.295 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.1 t -119.2 104.84 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.642 0.258 . . . . 73.23 110.962 175.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 60.4 9.75 2.14 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.863 0.69 . . . . 74.04 112.863 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 116.27 2.05 20.06 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.427 -0.416 . . . . 60.22 113.096 -175.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 94.5 m -107.8 130.24 54.99 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.977 0.418 . . . . 52.3 111.966 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -74.03 112.48 10.21 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.986 -0.552 . . . . 74.21 112.191 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 166' ' ' VAL . 27.9 m -129.22 117.4 18.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 121.168 0.508 . . . . 61.31 111.932 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.96 114.5 3.99 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.838 1.692 . . . . 75.13 111.693 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 67.3 p -101.07 129.22 46.91 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.164 0.506 . . . . 74.12 112.047 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.845 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.1 tp -89.81 122.9 33.32 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.84 -0.618 . . . . 74.33 111.087 176.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.658 ' SD ' ' HB ' ' A' ' 27' ' ' VAL . 39.4 tpp -103.22 125.52 49.93 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.755 0.312 . . . . 64.05 111.596 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -140.9 152.09 44.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.189 0.596 . . . . 63.55 109.983 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.66 ' HA ' HG12 ' A' ' 27' ' ' VAL . 41.9 t -89.89 117.34 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.829 0.677 . . . . 72.32 112.829 -173.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -59.88 -31.81 70.15 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.045 -0.525 . . . . 75.0 111.832 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.413 ' HG3' ' HE1' ' A' ' 116' ' ' PHE . 5.5 mm-40 -85.27 11.55 9.85 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.464 -0.335 . . . . 64.4 111.803 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -127.09 -41.87 1.76 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.829 0.347 . . . . 40.42 111.083 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 172' ' ' VAL . 12.8 tt -100.18 132.18 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.093 0.473 . . . . 64.41 111.062 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.5 tp -130.25 153.53 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.95 0.405 . . . . 71.32 111.548 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.05 152.06 41.43 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.115 0.483 . . . . 70.51 111.35 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.506 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 11.2 tp10 -138.98 133.19 31.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.095 0.474 . . . . 61.53 110.697 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -103.57 114.98 29.67 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.729 0.776 . . . . 63.34 112.939 -172.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 42.7 t -133.5 89.78 2.64 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.945 -0.761 . . . . 72.51 108.945 169.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 49.5 mt -121.25 94.74 4.43 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.238 0.459 . . . . 75.01 112.238 -168.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.256 1.421 0 CA-C-O 118.946 -0.55 . . . . 71.04 111.784 176.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.764 0.316 . . . . 74.34 110.856 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 33.9 tp -100.8 130.92 46.89 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 110.117 -0.327 . . . . 74.14 110.117 173.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.747 ' HB ' HD21 ' A' ' 13' ' ' LEU . 21.1 pt -114.2 123.02 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.22 0.533 . . . . 75.14 111.557 -176.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.525 ' HE1' ' HB2' ' A' ' 16' ' ' ASP . 35.7 p90 -122.8 143.28 49.94 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.231 0.539 . . . . 75.31 112.154 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.731 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 12.0 ptmt -130.1 150.0 51.56 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.688 -0.687 . . . . 75.03 111.242 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 7.0 p-10 -97.81 -178.33 4.06 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.212 0.53 . . . . 62.3 111.261 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.45 -43.83 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 113.239 0.829 . . . . 72.2 113.239 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.519 ' HD2' HG23 ' A' ' 9' ' ' THR . 9.2 p90 -108.48 -52.65 2.74 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.647 1.351 . . . . 71.32 114.647 -168.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.519 HG23 ' HD2' ' A' ' 8' ' ' PHE . 17.7 p -89.48 18.51 5.26 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.67 -0.644 . . . . 73.14 112.616 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.731 ' HB2' ' HB2' ' A' ' 5' ' ' LYS . 3.8 p-10 -50.87 -20.55 1.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.797 1.406 . . . . 71.54 114.797 -172.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -66.86 -19.79 65.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.363 0.602 . . . . 54.44 110.814 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.31 24.94 4.1 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.499 -0.773 . . . . 70.44 110.861 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.747 HD21 ' HB ' ' A' ' 3' ' ' ILE . 7.8 tt -38.52 138.61 0.48 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.815 0.846 . . . . 71.42 112.498 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.0 m -118.72 149.61 41.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.997 0.427 . . . . 62.24 111.934 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.5 p -109.77 129.91 55.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.236 -0.438 . . . . 74.32 110.557 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.525 ' HB2' ' HE1' ' A' ' 4' ' ' TYR . 2.5 t70 -137.41 179.04 6.64 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.657 0.265 . . . . 74.11 111.192 -177.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.7 t -132.74 4.97 3.92 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.275 0.472 . . . . 52.54 112.275 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -78.26 146.08 69.97 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 122.07 -0.394 . . . . 73.05 111.842 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -85.99 126.38 2.85 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.973 2.449 . . . . 64.4 113.386 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 87.7 mmm -89.74 124.63 34.8 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.502 -0.317 . . . . 74.31 111.163 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 56.5 mttm -103.48 112.24 25.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.34 0.256 . . . . 73.52 111.573 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 33.9 tp -84.54 106.65 16.27 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.809 -0.557 . . . . 63.33 112.159 -175.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -98.04 139.29 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.084 0.468 . . . . 74.15 111.131 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 58.32 15.56 3.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.565 0.58 . . . . 75.34 112.565 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 59.98 11.46 2.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.328 0.492 . . . . 61.4 112.328 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.1 tp -115.83 -45.54 2.87 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.07 0.396 . . . . 75.32 112.07 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 172' ' ' VAL . 3.8 m -129.29 143.7 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.431 0.53 . . . . 72.3 112.431 -176.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' A' ' 170' ' ' MET . 98.0 m-85 -92.0 142.03 27.98 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.074 -0.512 . . . . 74.45 110.876 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 16.4 pt-20 -128.87 146.97 50.79 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 110.242 -0.281 . . . . 71.41 110.242 174.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.52 ' CE2' HD13 ' A' ' 70' ' ' ILE . 43.6 p90 -152.48 145.67 24.65 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.626 0.973 . . . . 65.23 113.626 172.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -94.91 130.51 41.49 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.366 -0.834 . . . . 73.11 111.525 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.88 -133.96 7.69 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 114.472 0.549 . . . . 75.25 114.472 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -138.45 123.78 19.36 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.636 -0.332 . . . . 62.32 111.229 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -66.24 107.0 1.82 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.923 0.392 . . . . 74.1 111.839 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.418 HG23 HD12 ' A' ' 72' ' ' LEU . 35.6 m -138.96 168.17 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.267 -0.424 . . . . 61.55 111.481 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.414 HG13 HD23 ' A' ' 44' ' ' LEU . 35.6 m -132.91 144.74 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.482 -0.326 . . . . 72.22 110.933 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 29.6 tpt85 -137.12 108.08 6.7 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.832 0.825 . . . . 73.01 111.979 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.887 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 5.6 tppp? -135.96 147.15 47.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.999 -1.0 . . . . 62.24 108.983 169.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -50.28 -51.47 44.63 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.053 0.454 . . . . 72.22 111.929 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.8 34.55 5.59 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.34 -0.457 . . . . 73.31 112.982 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.887 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 9.3 tp10 -162.23 101.88 1.1 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.045 0.45 . . . . 51.22 111.519 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -149.34 158.32 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 116.306 -0.407 . . . . 71.42 110.827 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.0 t 69.11 86.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.714 0.769 . . . . 53.14 110.878 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.414 HD23 HG13 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -82.4 179.61 7.74 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.056 -0.974 . . . . 70.24 112.147 -178.569 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.07 147.82 50.96 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.022 0.439 . . . . 73.23 111.768 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.23 3.51 85.52 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.354 -0.451 . . . . 73.31 112.965 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.0 t -110.84 132.95 53.76 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.879 0.371 . . . . 62.23 111.435 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -149.92 87.65 5.01 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.785 0.326 . . . . 72.21 110.862 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.45 -67.44 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.983 2.456 . . . . 63.02 113.737 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.8 t -70.07 108.74 4.22 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.495 0.554 . . . . 65.32 112.495 -172.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.34 105.82 17.38 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.06 -0.518 . . . . 53.32 110.69 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -168.81 -50.18 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.915 0.388 . . . . 74.23 111.554 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -84.67 -52.4 6.11 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.64 0.607 . . . . 73.33 112.64 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.57 98.43 1.85 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.367 -0.444 . . . . 50.4 113.108 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -168.56 -38.36 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.862 0.319 . . . . 62.34 111.862 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -28.57 13.32 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.476 0.917 . . . . 62.45 113.476 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.14 142.11 52.42 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.481 0.658 . . . . 74.33 112.317 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -114.34 -3.66 13.07 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.843 -0.617 . . . . 62.14 112.275 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.19 38.16 0.02 OUTLIER Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.406 -0.902 . . . . 65.43 114.245 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.8 m 69.21 128.11 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.693 0.627 . . . . 34.14 112.693 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -98.05 -17.29 19.2 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.293 0.479 . . . . 70.11 112.293 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -94.95 -160.27 0.77 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.505 0.669 . . . . 73.21 110.452 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -112.1 76.11 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.411 0.625 . . . . 74.03 109.45 166.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.6 t -92.3 129.99 42.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.806 -0.634 . . . . 61.43 110.818 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 35.1 mt-10 -80.48 63.97 5.11 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.653 0.74 . . . . 72.45 110.069 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.543 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -114.48 149.56 36.16 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.915 -0.584 . . . . 64.15 111.748 -177.656 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 141.67 -113.65 0.84 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.205 -0.522 . . . . 63.22 112.802 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.454 HD12 HD12 ' A' ' 70' ' ' ILE . 17.1 pt -111.51 134.52 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.959 0.409 . . . . 43.2 111.85 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -46.25 -36.31 6.02 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.829 -0.623 . . . . 72.21 112.222 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.52 HD13 ' CE2' ' A' ' 30' ' ' PHE . 50.9 mt -48.66 -64.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.304 0.573 . . . . 75.32 112.29 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 33.8 m -66.04 -36.75 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.911 -0.586 . . . . 72.34 112.188 -175.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.418 HD12 HG23 ' A' ' 35' ' ' VAL . 42.7 mt -67.46 -38.32 84.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.095 0.474 . . . . 64.34 111.299 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -66.41 -45.2 80.75 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.077 -0.51 . . . . 74.34 111.247 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -90.43 7.94 36.21 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.38 0.511 . . . . 73.54 112.38 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.8 mttm 57.4 69.08 0.77 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.496 0.665 . . . . 75.34 112.759 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 75.0 mt -114.74 120.86 41.52 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.935 -0.575 . . . . 71.24 110.541 177.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 14.4 p -86.62 144.17 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.911 0.386 . . . . 75.44 111.615 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.55 126.31 30.76 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.105 -0.498 . . . . 71.23 112.214 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.2 mmt -132.35 159.46 39.15 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.201 -0.454 . . . . 71.21 111.133 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.465 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 93.5 m-20 -127.39 147.3 50.27 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.139 0.495 . . . . 65.31 111.175 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 26.1 p -52.19 -16.43 0.8 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.852 1.427 . . . . 52.31 114.852 -169.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 80' ' ' ASN . 50.2 p90 -58.94 -41.63 87.82 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.418 0.525 . . . . 73.43 112.418 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -101.34 -37.92 8.27 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.126 -0.359 . . . . 64.13 111.824 -178.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.64 6.88 0.98 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.833 0.679 . . . . 64.22 112.833 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.32 -50.59 38.85 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.359 0.503 . . . . 73.43 112.359 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.7 m -68.96 -35.27 76.56 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.625 0.25 . . . . 54.11 111.612 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 95.9 mmm -56.46 -50.85 70.51 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.681 0.277 . . . . 62.44 110.698 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -68.32 -33.73 74.85 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.84 0.311 . . . . 72.53 111.84 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -55.6 -54.72 40.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.104 0.478 . . . . 64.51 110.967 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.48 -38.22 68.25 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.2 -0.455 . . . . 71.12 111.792 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -59.01 -54.82 42.77 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.633 -0.258 . . . . 75.03 111.288 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.4 mm -62.4 -35.43 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.696 -0.229 . . . . 73.1 111.272 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.453 ' HE3' ' HD2' ' A' ' 97' ' ' LYS . 57.4 tptt -57.33 -60.56 3.44 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.709 0.29 . . . . 73.43 111.11 175.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -61.77 -39.5 91.86 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.167 0.508 . . . . 72.35 111.097 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.599 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 78.3 t80 -57.36 -56.68 18.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.86 -0.609 . . . . 74.42 111.527 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 51.8 ttm -53.79 -43.7 69.49 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.09 0.472 . . . . 62.32 111.33 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD2' ' HE3' ' A' ' 93' ' ' LYS . 28.0 mtpp -61.71 -43.85 98.06 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.989 -0.55 . . . . 71.32 111.79 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -73.42 -44.45 58.28 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.95 0.352 . . . . 64.14 111.95 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.0 m -66.33 -38.73 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.395 0.517 . . . . 73.35 112.395 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 34.5 mm -65.51 -47.0 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.856 0.36 . . . . 54.25 110.756 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.95 -42.89 85.89 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 72.54 110.512 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -64.83 -35.55 81.48 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.709 -0.678 . . . . 63.44 111.285 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.423 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . 15.0 mmt -68.05 -39.62 82.97 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.651 0.241 . . . . 75.43 111.651 177.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.65 -35.68 72.93 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.491 0.663 . . . . 74.43 110.53 171.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -70.09 -46.35 65.04 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.283 -0.871 . . . . 64.01 112.702 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.423 ' OD1' ' HA ' ' A' ' 103' ' ' MET . 17.7 p-10 -97.51 -26.15 14.92 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.122 1.156 . . . . 73.32 114.122 -174.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.575 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 87.7 m-20 -124.06 -63.21 1.22 Allowed 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.874 -0.516 . . . . 63.24 112.114 -175.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' A' ' 107' ' ' ASN . 5.9 ptt180 67.91 -14.71 0.22 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.308 1.043 . . . . 74.2 113.399 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 113' ' ' VAL . 24.7 t70 -61.64 127.63 32.37 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.2 -0.313 . . . . 71.23 111.676 -176.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -50.63 -39.64 50.91 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.727 0.64 . . . . 75.21 112.727 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.94 -35.63 50.17 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.648 0.261 . . . . 63.42 111.576 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -67.71 -51.36 50.32 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.783 0.325 . . . . 64.02 111.083 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 109' ' ' ASP . 16.1 m -66.73 -23.07 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 111.813 0.301 . . . . 63.53 111.813 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 29.1 t70 -69.96 -61.43 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.039 -0.356 . . . . 74.33 110.039 171.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.85 -40.16 63.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.865 0.364 . . . . 70.15 111.608 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -58.83 -59.34 5.59 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.384 -0.371 . . . . 73.31 111.242 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 8.4 ptpp? -59.39 -31.8 69.58 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.958 -0.297 . . . . 74.02 111.065 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 33.7 mmtp -62.4 -46.66 87.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.851 0.357 . . . . 74.51 110.802 175.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -67.37 -56.25 10.46 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.071 -0.513 . . . . 60.44 111.991 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.0 tp -67.36 -40.6 85.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.587 0.588 . . . . 61.12 112.587 -175.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 125' ' ' VAL . 14.3 tm0? -68.12 -45.74 72.8 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.023 -0.423 . . . . 71.2 110.737 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.41 -41.61 95.32 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.647 -0.787 . . . . 71.11 112.05 173.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -59.44 -54.1 50.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.4 0.28 . . . . 62.21 111.717 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.0 m -64.82 -36.7 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.485 0.55 . . . . 75.54 112.485 -177.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 121' ' ' GLN . 78.0 t -59.37 -43.51 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.98 -0.45 . . . . 64.4 111.148 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.7 t -76.05 -37.64 58.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.116 0.484 . . . . 74.1 111.119 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.516 ' HA ' ' CD2' ' A' ' 133' ' ' PHE . 51.1 tp -61.25 -33.55 73.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.987 0.515 . . . . 75.52 111.704 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 65.7 mt -88.47 3.01 51.65 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.35 -0.386 . . . . 50.44 111.918 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.27 102.86 0.1 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.151 0.5 . . . . 71.55 111.642 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -62.33 -11.44 15.35 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.794 1.035 . . . . 72.3 113.794 -172.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.97 -48.35 6.03 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.642 0.608 . . . . 74.32 112.642 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.7 tpp85 -92.8 -56.01 3.16 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.185 0.516 . . . . 74.31 111.667 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' A' ' 127' ' ' LEU . 8.0 m-85 -71.2 -5.86 35.13 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.117 0.484 . . . . 74.34 111.975 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 27.6 ttpp -49.81 -21.84 1.25 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.144 -0.48 . . . . 51.51 112.08 172.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -82.18 9.35 8.84 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.916 0.71 . . . . 74.41 112.916 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.25 136.12 33.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.06 0.457 . . . . 75.25 111.771 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.14 118.45 37.01 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.154 -0.475 . . . . 62.42 110.296 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.403 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 66.4 m-85 -97.08 108.32 21.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.001 0.429 . . . . 73.14 111.278 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 45.7 m-85 -98.64 124.49 43.47 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.1 0.476 . . . . 73.33 111.481 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.544 HG23 ' HB2' ' A' ' 145' ' ' ALA . 10.6 tt -135.56 148.75 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.315 -0.402 . . . . 73.44 110.929 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.37 121.94 8.07 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.276 -0.487 . . . . 45.54 112.815 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -32.31 60.81 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.931 0.715 . . . . 73.3 112.931 -175.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -61.32 -39.34 90.15 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.066 0.395 . . . . 74.25 112.066 173.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -80.52 -40.53 25.86 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.939 0.399 . . . . 62.45 111.562 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.544 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -58.56 -20.68 48.69 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.128 -0.487 . . . . 34.21 112.058 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -62.84 -16.89 60.33 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.072 -0.513 . . . . 75.12 111.761 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.13 31.37 14.57 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.252 -0.499 . . . . 41.32 112.485 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.46 -19.89 19.5 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.193 0.442 . . . . 65.34 112.193 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -161.78 -170.87 2.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.641 -0.254 . . . . 75.32 111.08 -176.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -65.66 -66.47 0.54 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.781 0.324 . . . . 65.4 111.784 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.29 146.2 0.21 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.345 -0.455 . . . . 51.34 113.67 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -102.17 135.99 42.78 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.313 -0.522 . . . . 62.33 111.265 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 56.1 t -94.69 127.86 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.19 0.519 . . . . 71.4 112.015 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.901 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -96.05 123.28 39.6 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.688 -0.687 . . . . 64.12 110.422 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 55.4 mt -93.3 118.98 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.18 0.437 . . . . 71.1 112.18 -173.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.0 mm -102.94 117.59 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.677 -0.238 . . . . 63.32 111.222 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -109.76 125.13 52.37 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.16 0.505 . . . . 74.32 111.59 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -87.52 88.87 7.8 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.039 -0.528 . . . . 65.54 109.824 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 159' ' ' ARG . 18.9 ptt85 -124.82 172.49 9.3 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.203 0.525 . . . . 71.32 112.324 -175.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -89.3 135.92 33.31 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.31 0.576 . . . . 63.44 112.213 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 78.1 t -108.8 95.48 3.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.889 -0.782 . . . . 73.03 108.889 169.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.4 t70 69.74 -56.96 0.56 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.533 -0.758 . . . . 73.51 111.564 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.02 6.65 0.14 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 121.1 -0.572 . . . . 60.12 114.224 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.4 m -120.5 134.76 55.23 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.749 0.774 . . . . 64.11 111.697 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -83.28 107.93 16.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.582 -0.281 . . . . 62.45 111.409 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.1 m -128.79 147.32 64.0 Favored Pre-proline 0 N--CA 1.474 0.747 0 CA-C-O 121.078 0.466 . . . . 71.45 112.016 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -90.94 114.72 0.43 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.928 2.419 . . . . 60.03 113.366 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 79.2 p -103.52 154.87 18.99 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.631 -0.259 . . . . 55.1 110.658 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.901 HD11 ' HB1' ' A' ' 154' ' ' ALA . 13.7 tp -100.28 120.89 40.62 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.221 -0.299 . . . . 73.4 111.312 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.643 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 60.8 mtt -107.54 134.89 49.9 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.678 0.621 . . . . 64.45 112.678 -175.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.8 mt -143.41 146.4 33.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.278 -0.874 . . . . 70.31 110.092 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.599 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 44.5 t -77.19 134.67 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 112.277 0.473 . . . . 73.53 112.277 -176.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.698 ' HB3' ' HZ3' ' A' ' 173' ' ' LYS . 5.9 ttpm? -59.6 -47.67 84.66 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.983 -0.553 . . . . 73.31 112.089 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -85.16 11.48 9.76 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.918 0.389 . . . . 71.33 111.964 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.537 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -103.3 -13.07 16.85 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.75 0.31 . . . . 71.25 111.133 173.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.2 pt -136.9 133.58 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.216 0.532 . . . . 45.31 111.485 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.53 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 50.6 mm -94.58 110.79 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.958 0.409 . . . . 70.52 110.218 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.7 123.15 31.55 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.319 -0.4 . . . . 72.21 110.822 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.56 ' HB3' HG13 ' A' ' 3' ' ' ILE . 11.8 tp10 -121.41 139.4 53.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.182 0.515 . . . . 72.24 110.702 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.02 132.43 50.75 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.776 0.658 . . . . 43.14 112.776 -172.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 53.6 t -127.32 88.08 2.74 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.967 -0.561 . . . . 73.43 109.993 172.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.25 99.4 6.68 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.985 -0.552 . . . . 73.51 110.655 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 119.185 -0.436 . . . . 71.5 111.923 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.582 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 24.0 mmt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.664 0.269 . . . . 62.11 111.264 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 15' ' ' SER . 57.7 tp -71.98 133.58 45.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.725 0.298 . . . . 72.43 110.781 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.1 mt -97.19 120.47 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 111.872 0.323 . . . . 70.03 111.872 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.464 ' O ' HD12 ' A' ' 13' ' ' LEU . 7.8 m-85 -106.59 115.05 29.53 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.439 -0.346 . . . . 73.42 110.638 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HG2' HD13 ' A' ' 13' ' ' LEU . 97.7 mttt -112.6 112.22 23.6 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.321 0.388 . . . . 62.14 111.231 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.61 154.98 38.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.088 0.47 . . . . 44.41 111.199 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.4 -42.67 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.081 0.467 . . . . 73.05 110.579 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -109.97 -33.54 6.68 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.461 0.911 . . . . 62.32 113.461 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.466 HG23 ' HA2' ' A' ' 151' ' ' GLY . 1.3 m -89.61 15.17 9.95 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 112.729 0.64 . . . . 52.22 112.729 -175.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -54.64 -17.87 3.86 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.93 0.715 . . . . 72.3 112.93 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.45 -33.11 72.08 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.357 0.599 . . . . 70.11 111.13 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -94.08 24.29 4.42 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.997 -0.547 . . . . 53.23 111.845 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 4' ' ' TYR . 65.5 tp -31.04 117.26 0.17 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.787 0.835 . . . . 72.04 112.436 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.6 t -110.01 163.6 13.41 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.284 0.564 . . . . 74.04 112.364 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.582 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 79.3 p -150.17 107.59 3.63 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.598 -0.728 . . . . 73.43 110.688 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -135.71 173.69 11.44 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.25 0.547 . . . . 72.42 112.328 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 m -133.9 84.7 2.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.875 -0.602 . . . . 70.45 110.489 173.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.59 152.01 73.84 Favored Pre-proline 0 N--CA 1.474 0.754 0 CA-C-N 116.367 -0.379 . . . . 75.43 111.381 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -93.0 94.21 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.862 2.374 . . . . 74.54 112.901 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.537 ' HB3' ' HB3' ' A' ' 28' ' ' TYR . 4.0 mpp? -85.41 144.82 27.78 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.857 0.36 . . . . 64.23 111.36 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -99.12 108.1 20.64 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.876 0.37 . . . . 72.03 111.863 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.2 tp -75.75 95.49 3.45 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.046 0.45 . . . . 61.43 111.084 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -86.75 140.34 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.038 0.446 . . . . 74.44 111.71 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.5 t70 58.03 16.46 3.79 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.854 -0.612 . . . . 74.02 111.679 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 57.18 20.4 5.62 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.054 -0.521 . . . . 64.03 111.762 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' A' ' 119' ' ' LYS . 32.2 tp -118.43 -50.17 2.45 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.055 0.455 . . . . 52.2 111.963 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.506 HG12 HG22 ' A' ' 172' ' ' VAL . 14.3 m -130.8 155.38 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 112.581 0.586 . . . . 75.35 112.581 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.537 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 77.5 m-85 -92.24 124.86 36.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.086 -0.506 . . . . 75.05 110.816 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 15.1 pt-20 -101.93 139.32 37.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.997 0.427 . . . . 74.13 110.217 171.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 168' ' ' THR . 42.5 t80 -141.56 112.35 7.2 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.629 -0.259 . . . . 73.04 111.11 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.432 ' HG3' ' H ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -75.48 130.89 39.64 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.33 0.492 . . . . 75.2 112.33 -179.441 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -126.09 162.04 20.36 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.385 -0.436 . . . . 23.41 113.606 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -97.24 126.83 42.7 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.463 -0.434 . . . . 64.31 111.539 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.408 ' ND1' ' O ' ' A' ' 34' ' ' HIS . 15.9 p80 -74.5 106.57 6.16 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.142 0.496 . . . . 74.35 110.619 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.428 HG11 HG23 ' A' ' 43' ' ' VAL . 29.7 m -140.81 177.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.381 0.61 . . . . 64.43 111.862 -176.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 66' ' ' ARG . 34.9 m -132.43 146.87 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.971 -0.559 . . . . 74.54 111.219 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.941 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 56.7 ttt-85 -109.41 121.21 44.68 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.256 0.551 . . . . 74.21 110.892 174.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -131.14 160.64 34.14 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.691 -1.14 . . . . 72.15 110.784 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -55.06 -38.23 67.77 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.066 0.395 . . . . 73.24 112.066 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.41 37.28 2.38 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.091 -0.576 . . . . 63.3 113.358 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -170.71 132.8 0.94 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.756 -0.261 . . . . 61.14 110.731 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 tp -149.6 148.74 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 112.293 0.479 . . . . 60.42 112.293 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.428 HG23 HG11 ' A' ' 35' ' ' VAL . 8.0 p 35.9 80.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.291 1.036 . . . . 55.15 113.517 176.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 44' ' ' LEU . 1.4 mm? -89.45 100.48 13.26 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.88 -0.512 . . . . 71.43 110.587 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.53 69.45 2.28 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.184 0.516 . . . . 64.11 111.633 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.4 163.25 25.03 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.279 -0.486 . . . . 63.23 113.351 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.5 t -96.07 142.8 27.84 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.923 0.392 . . . . 63.1 110.645 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -146.55 130.95 8.69 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.556 -0.293 . . . . 72.5 110.364 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.88 -174.64 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.371 2.048 . . . . 44.23 112.798 176.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.7 p -58.45 117.26 4.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.958 0.409 . . . . 65.34 111.405 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.55 -10.51 37.38 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.146 0.424 . . . . 51.11 112.146 -174.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.437 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 1.7 tm-20 -69.62 78.19 0.42 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.223 0.535 . . . . 64.13 110.766 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 177.7 99.68 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.557 -0.747 . . . . 63.34 110.898 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.03 123.06 0.05 OUTLIER Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.299 -0.477 . . . . 63.43 113.534 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.47 94.51 3.33 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.414 -0.462 . . . . 71.31 110.906 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.14 108.15 5.19 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.543 0.687 . . . . 74.14 111.848 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -125.95 137.64 53.71 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.074 -0.512 . . . . 51.54 111.708 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.19 -41.63 70.04 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.098 -0.501 . . . . 62.32 110.51 172.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.6 -95.61 0.06 OUTLIER Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.923 -0.581 . . . . 61.34 113.188 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.3 p 51.16 15.85 0.32 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.873 0.869 . . . . 72.41 112.741 -176.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -124.19 30.62 6.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.315 0.579 . . . . 62.41 110.714 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -61.42 -0.83 0.43 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.873 0.694 . . . . 64.23 112.873 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -68.21 -20.7 64.86 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.984 0.421 . . . . 74.24 111.056 171.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.0 t -90.2 148.97 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.126 -0.488 . . . . 75.21 110.104 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.941 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.7 mp0 -79.73 72.85 6.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 119.553 -0.859 . . . . 61.54 110.633 178.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.404 ' HA ' HG12 ' A' ' 36' ' ' VAL . 60.6 mtp180 -87.57 131.76 34.29 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.741 -0.663 . . . . 73.2 111.528 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.32 -150.42 22.02 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.67 -0.776 . . . . 63.53 113.117 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.4 pt -110.45 146.15 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 122.349 -0.501 . . . . 65.21 111.397 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -40.36 -47.38 2.53 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.211 0.604 . . . . 71.13 112.18 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.441 HG13 ' HA3' ' A' ' 32' ' ' GLY . 61.9 mt -48.9 -53.84 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.757 -0.656 . . . . 70.13 112.333 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 m -83.22 -32.0 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 112.087 0.403 . . . . 74.14 112.087 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.75 -36.03 82.42 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.727 0.298 . . . . 73.12 111.367 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -81.42 -6.41 58.91 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.925 0.393 . . . . 75.04 111.324 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -124.48 8.21 8.35 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.952 0.352 . . . . 63.44 111.952 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.1 pttm 39.47 59.31 1.81 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.791 0.805 . . . . 60.02 112.699 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 84.9 mt -93.97 141.9 28.0 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.769 -0.65 . . . . 73.41 111.516 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 p -96.06 140.19 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 120.684 0.278 . . . . 75.04 111.267 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -89.57 148.25 23.48 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.533 0.682 . . . . 74.41 112.744 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.51 ' HG3' ' HB2' ' A' ' 138' ' ' PHE . 15.2 ptp -147.65 165.27 30.93 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.214 -0.903 . . . . 75.22 109.75 174.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.435 ' HA ' ' HD2' ' A' ' 138' ' ' PHE . 3.4 p30 -163.01 157.86 21.43 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.454 0.645 . . . . 73.01 112.259 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.402 ' HA ' ' HE2' ' A' ' 88' ' ' PHE . 64.3 m -37.53 -34.02 0.09 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 116.495 2.035 . . . . 72.5 116.495 -162.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -67.92 -31.98 72.12 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.433 -0.792 . . . . 71.13 112.348 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.87 -46.97 5.74 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.236 0.541 . . . . 73.55 111.913 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' A' ' 79' ' ' MET . 0.4 OUTLIER -95.2 12.89 27.25 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.494 0.924 . . . . 72.13 113.494 -173.001 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -41.06 -61.39 1.0 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.645 0.609 . . . . 64.13 112.645 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.5 m -65.45 -32.8 74.61 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.334 -0.394 . . . . 72.31 111.772 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 67.5 mtm -71.7 -52.62 16.91 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.06 0.392 . . . . 73.31 112.06 -175.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.503 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 16.5 p90 -71.96 -19.39 61.9 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.69 -0.631 . . . . 65.1 111.224 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -64.01 -44.21 93.29 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.08 0.467 . . . . 74.04 110.534 171.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.16 99.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.195 0.521 . . . . 73.05 110.455 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.468 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 44.0 t80 -54.6 -53.1 59.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.588 -0.733 . . . . 62.14 111.972 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.9 tp -67.66 -32.27 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 111.83 0.307 . . . . 72.15 111.83 -177.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' C ' ' HD3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -63.35 -53.25 55.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.665 0.269 . . . . 70.2 110.656 176.553 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -60.2 -49.48 77.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.934 0.397 . . . . 71.45 110.745 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.492 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 85.1 t80 -51.25 -58.09 7.09 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.082 -0.508 . . . . 61.31 111.916 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -54.57 -49.52 70.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.428 -0.351 . . . . 61.45 111.465 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -65.83 -48.51 71.42 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.605 -0.27 . . . . 73.42 111.7 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.49 -40.3 96.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.715 0.635 . . . . 62.23 112.715 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.7 m -67.95 -45.84 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 122.21 -0.306 . . . . 42.05 111.611 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.4 mm -67.55 -45.42 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.889 0.376 . . . . 73.31 111.131 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.51 -40.98 96.57 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.236 -0.438 . . . . 74.05 111.546 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -58.71 -47.02 86.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.942 0.401 . . . . 63.34 110.885 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.9 ttt -68.67 -45.68 71.08 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.164 0.507 . . . . 52.34 110.737 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -58.93 -37.38 76.55 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.281 -0.418 . . . . 74.43 111.729 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -54.37 -50.91 66.39 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.12 -0.491 . . . . 72.43 112.296 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -102.31 -36.92 8.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.791 0.663 . . . . 64.02 112.791 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -74.89 -56.02 5.19 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.965 -0.46 . . . . 45.44 111.659 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 66.65 -0.47 1.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.876 0.47 . . . . 63.42 112.19 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.547 ' O ' HG22 ' A' ' 113' ' ' VAL . 13.6 t70 -86.24 119.85 26.97 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.132 -0.355 . . . . 73.2 110.717 -177.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -65.64 -35.01 79.56 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.522 0.564 . . . . 74.04 112.522 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.93 -38.64 89.19 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.796 0.331 . . . . 71.14 111.435 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -72.73 -53.17 12.36 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.729 0.27 . . . . 74.34 111.729 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 109' ' ' ASP . 30.0 m -65.55 -21.73 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 112.098 0.407 . . . . 75.14 112.098 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -74.96 -42.35 57.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.965 0.412 . . . . 74.11 110.683 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.12 73.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.98 0.419 . . . . 41.22 110.986 176.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.18 -47.52 85.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.169 -0.468 . . . . 72.44 111.093 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -56.63 -40.87 76.16 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.53 -0.304 . . . . 75.42 110.915 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.5 tppt? -59.26 -40.33 85.67 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.604 0.24 . . . . 62.33 111.171 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.466 ' HB3' HD22 ' A' ' 26' ' ' LEU . 29.3 mmtp -61.73 -57.8 10.52 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.683 -0.235 . . . . 74.4 111.584 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.8 mm -59.95 -45.58 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.021 0.378 . . . . 73.24 112.021 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.447 ' O ' HG23 ' A' ' 125' ' ' VAL . 24.7 tm0? -61.62 -51.61 67.8 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.707 0.289 . . . . 60.42 110.942 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.79 -36.98 93.55 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.724 -0.751 . . . . 65.02 112.378 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -57.16 -53.75 54.58 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.862 0.465 . . . . 72.25 111.596 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.17 -42.44 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 112.189 0.44 . . . . 63.21 112.189 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 121' ' ' GLN . 69.9 t -55.92 -43.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.881 0.372 . . . . 74.31 111.396 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.5 t -72.03 -47.22 53.39 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.195 0.521 . . . . 73.43 111.569 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.497 HD21 HD13 ' A' ' 155' ' ' ILE . 31.5 tp -65.3 -28.06 69.05 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.126 -0.488 . . . . 70.41 111.914 -176.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.9 mt -84.54 2.56 40.63 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.133 0.419 . . . . 75.11 112.133 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.466 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -62.03 78.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.652 0.739 . . . . 53.12 110.977 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -60.08 -15.26 21.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.546 0.943 . . . . 61.31 113.546 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.19 -46.79 87.49 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 122.274 -0.266 . . . . 73.35 111.493 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -109.15 -39.24 5.32 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.836 0.351 . . . . 64.2 111.789 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.492 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 69.5 m-85 -63.62 -4.5 3.0 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.526 0.565 . . . . 65.05 112.526 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -44.35 -26.76 0.36 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 120.952 0.406 . . . . 73.15 111.841 168.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -83.54 20.34 1.4 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 112.79 0.663 . . . . 54.34 112.79 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 71.2 mt -88.51 132.06 34.66 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.925 -0.484 . . . . 75.32 111.318 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.28 123.21 48.44 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.134 -0.485 . . . . 73.3 110.734 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.653 ' HB3' HG13 ' A' ' 153' ' ' VAL . 53.6 m-85 -102.61 125.92 49.51 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.257 -0.277 . . . . 72.12 110.839 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.568 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 75.6 m-85 -121.61 142.14 50.41 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.05 0.389 . . . . 73.31 112.05 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 152' ' ' GLN . 34.4 pt -129.62 173.07 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.89 0.376 . . . . 75.14 111.09 174.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.48 153.88 50.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.274 -0.489 . . . . 72.31 114.01 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.52 -58.42 7.23 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.062 0.458 . . . . 75.44 112.045 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.609 ' HA ' ' HB3' ' A' ' 146' ' ' GLU . 30.3 mtm180 -73.09 -19.37 61.17 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.857 0.36 . . . . 64.33 111.284 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.67 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -61.03 -40.77 94.87 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.271 0.558 . . . . 71.33 110.467 170.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.1 -19.14 40.73 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.083 0.468 . . . . 60.32 111.374 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.609 ' HB3' ' HA ' ' A' ' 143' ' ' ARG . 42.6 tt0 -87.27 -24.26 24.41 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.252 0.464 . . . . 72.41 112.252 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.33 -46.52 0.02 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 120.472 -0.871 . . . . 72.2 114.336 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.67 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -71.0 86.58 0.72 Allowed 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.307 -0.526 . . . . 74.44 111.827 -177.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -61.34 -9.8 5.97 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.247 0.832 . . . . 73.23 113.247 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -93.38 27.21 2.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.809 0.338 . . . . 54.21 111.421 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.466 ' HA2' HG23 ' A' ' 9' ' ' THR . . . -60.44 115.83 8.29 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.469 -0.396 . . . . 62.42 113.698 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.414 ' O ' HG22 ' A' ' 140' ' ' ILE . 5.0 pp0? -60.25 134.55 57.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.244 0.545 . . . . 74.01 111.272 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.653 HG13 ' HB3' ' A' ' 138' ' ' PHE . 63.0 t -83.0 109.92 17.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.154 -0.476 . . . . 75.53 111.707 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.719 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -81.06 119.03 23.02 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.04 -0.527 . . . . 53.05 110.197 171.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.497 HD13 HD21 ' A' ' 127' ' ' LEU . 61.5 mt -96.12 117.1 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 112.468 0.544 . . . . 62.31 112.468 -170.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 169' ' ' LEU . 48.2 mm -94.5 113.14 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.723 0.297 . . . . 60.21 111.219 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 158' ' ' TYR . 42.7 tt0 -105.75 157.33 17.51 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.973 0.416 . . . . 63.32 111.305 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.445 ' N ' ' HG2' ' A' ' 157' ' ' GLU . 23.1 p90 -92.51 105.24 17.45 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.967 0.413 . . . . 74.24 111.191 176.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.454 ' HD3' ' OG1' ' A' ' 168' ' ' THR . 54.9 mtp85 -127.44 132.33 50.07 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.966 0.412 . . . . 62.41 111.114 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.83 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 6.4 p-10 -88.25 143.08 27.24 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.768 0.655 . . . . 51.23 112.768 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.0 t -109.29 98.2 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.641 -0.708 . . . . 75.31 110.585 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.1 t70 61.59 7.08 1.72 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.543 0.737 . . . . 62.12 112.918 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.26 -27.72 1.54 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.533 -0.842 . . . . 55.11 114.065 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 84.3 m -104.27 114.49 28.76 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 117.252 0.526 . . . . 70.33 111.125 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.83 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 9.3 pt-20 -76.37 122.54 24.62 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.611 0.72 . . . . 51.54 112.098 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -127.14 149.85 70.63 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.471 -0.786 . . . . 53.34 111.639 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.95 120.72 7.92 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.785 2.323 . . . . 74.1 112.766 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.454 ' OG1' ' HD3' ' A' ' 159' ' ' ARG . 69.6 p -111.22 133.37 53.61 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.79 0.328 . . . . 65.21 111.756 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.719 HD11 ' HB1' ' A' ' 154' ' ' ALA . 68.9 tp -77.36 130.99 37.84 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.179 -0.464 . . . . 63.13 111.258 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.403 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 24.3 mmt -113.27 124.46 52.55 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.594 0.358 . . . . 71.24 111.445 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.99 134.82 38.97 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.076 -0.511 . . . . 73.33 110.864 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.506 HG22 HG12 ' A' ' 27' ' ' VAL . 25.7 t -93.13 126.35 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 122.099 -0.375 . . . . 75.31 111.425 -178.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -72.42 -14.88 61.8 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.831 0.678 . . . . 75.33 112.831 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.468 ' H ' HG12 ' A' ' 172' ' ' VAL . 1.3 mp0 -88.31 -2.4 58.58 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.137 -0.352 . . . . 74.42 111.716 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.5 -46.39 6.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.309 0.576 . . . . 73.43 110.428 174.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.7 pt -105.4 132.18 52.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.498 -0.774 . . . . 65.14 110.504 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.415 ' CG1' ' HB2' ' A' ' 5' ' ' LYS . 46.8 pt -94.85 143.47 11.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.2 0.524 . . . . 61.34 111.314 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -94.25 118.24 31.3 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.612 -0.722 . . . . 71.21 111.331 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -122.97 113.99 19.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.359 0.6 . . . . 73.32 110.897 172.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -112.55 123.01 49.34 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.734 -0.666 . . . . 54.41 112.106 -175.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.427 ' C ' HD12 ' A' ' 182' ' ' LEU . 51.8 t -121.93 87.82 2.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.265 0.555 . . . . 64.15 109.997 169.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.427 HD12 ' C ' ' A' ' 181' ' ' CYS . 5.8 mp -136.04 135.98 39.87 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.706 -0.679 . . . . 72.2 110.411 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 C--O 1.254 1.326 0 CA-C-O 118.916 -0.564 . . . . 63.14 111.134 177.013 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 120.935 0.398 . . . . 73.25 111.643 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 178' ' ' GLU . 42.2 tp -92.34 139.0 31.05 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.521 -0.309 . . . . 75.3 110.943 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.0 mt -125.91 119.21 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 122.384 -0.197 . . . . 74.34 110.473 175.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.716 ' HE1' ' HB2' ' A' ' 16' ' ' ASP . 39.6 p90 -121.81 149.8 42.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.47 0.545 . . . . 72.33 112.47 -173.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.567 ' HB3' HD13 ' A' ' 13' ' ' LEU . 12.4 ptmm? -142.92 127.22 17.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.939 -0.573 . . . . 72.23 111.303 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.85 ' HB3' HG22 ' A' ' 176' ' ' ILE . 2.7 p30 -97.29 179.29 4.94 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.206 0.527 . . . . 74.41 111.63 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -47.12 -34.8 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 115.51 -0.768 . . . . 52.04 112.716 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.582 ' HB2' ' HA2' ' A' ' 151' ' ' GLY . 83.2 m-85 -100.27 -49.61 4.21 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.603 0.594 . . . . 71.21 112.603 -175.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 p -70.33 14.97 0.1 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.028 0.751 . . . . 52.51 113.028 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -47.89 -32.24 6.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.207 0.603 . . . . 53.24 111.933 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.67 -61.96 1.57 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.641 0.608 . . . . 73.51 112.641 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.417 ' C ' HD23 ' A' ' 13' ' ' LEU . 43.1 mt-10 -102.43 -33.16 9.64 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.801 0.667 . . . . 65.21 112.801 -174.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.567 HD13 ' HB3' ' A' ' 5' ' ' LYS . 0.8 OUTLIER 40.42 -170.75 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.21 1.189 . . . . 75.25 114.21 -176.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -149.44 165.65 31.46 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.474 0.654 . . . . 62.5 112.655 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -114.2 170.16 8.49 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.699 -0.682 . . . . 74.42 111.082 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.716 ' HB2' ' HE1' ' A' ' 4' ' ' TYR . 6.5 t70 -154.28 169.15 24.35 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 120.878 0.371 . . . . 71.31 111.486 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.2 p -151.7 19.44 0.71 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.027 0.38 . . . . 54.33 112.027 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -108.65 151.07 41.51 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 121.037 0.446 . . . . 52.21 112.194 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.4 111.99 3.27 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.601 2.2 . . . . 62.42 113.595 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.648 ' SD ' ' HB2' ' A' ' 30' ' ' PHE . 18.5 mmt -106.31 166.27 10.65 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.009 -0.541 . . . . 53.34 110.876 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.523 ' NZ ' ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -134.22 129.05 35.14 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.187 -0.321 . . . . 74.5 111.221 172.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 61.4 tp -87.87 101.96 14.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.766 0.317 . . . . 74.11 111.284 -177.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 p -89.19 139.06 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-O 120.909 0.385 . . . . 73.32 111.58 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.2 15.99 2.11 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.139 -0.482 . . . . 72.22 112.264 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.462 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 52.8 m-20 52.77 26.75 4.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.847 0.459 . . . . 45.13 111.646 -177.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.17 -45.68 2.34 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.103 0.478 . . . . 75.41 111.156 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.404 HG12 HG22 ' A' ' 172' ' ' VAL . 30.3 m -133.68 146.06 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.295 0.569 . . . . 75.13 112.51 -177.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 170' ' ' MET . 96.9 m-85 -87.34 144.91 26.55 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.937 -0.574 . . . . 73.33 110.368 172.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 40.7 mt-10 -118.28 143.57 46.48 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.748 0.308 . . . . 73.33 110.85 170.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.705 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 85.6 t80 -133.03 118.44 18.81 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.806 0.336 . . . . 75.22 111.175 175.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.416 ' NZ ' ' HB2' ' A' ' 31' ' ' LYS . 9.8 mtmp? -84.02 109.33 17.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.793 0.33 . . . . 75.54 111.715 -177.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.531 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -90.76 176.6 41.28 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.14 -0.553 . . . . 72.31 113.851 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.514 ' HG3' HG13 ' A' ' 35' ' ' VAL . 10.8 ptpp? -118.46 163.2 17.11 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.725 -0.279 . . . . 63.4 111.123 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -86.53 111.93 21.06 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.522 0.201 . . . . 53.35 110.904 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.514 HG13 ' HG3' ' A' ' 33' ' ' LYS . 17.3 m -139.65 159.31 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.142 0.496 . . . . 54.15 111.728 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.757 HG22 HD21 ' A' ' 44' ' ' LEU . 33.2 m -138.04 122.11 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.354 -0.385 . . . . 70.32 111.407 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.838 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 78.8 mtt180 -88.28 107.98 19.09 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.49 0.662 . . . . 65.23 111.259 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 41.7 mtmt -131.68 165.22 24.19 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.566 -1.197 . . . . 75.35 110.164 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -46.79 84.8 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.304 0.574 . . . . 65.55 112.051 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 38' ' ' LYS . . . 93.47 11.08 58.66 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.941 -0.572 . . . . 61.31 114.156 176.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 40.3 mt-10 -132.85 142.93 49.2 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.374 -0.486 . . . . 70.43 111.351 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.7 HG23 ' H ' ' A' ' 43' ' ' VAL . 2.1 tp -148.5 -76.09 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 112.033 0.383 . . . . 61.21 112.033 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.7 ' H ' HG23 ' A' ' 42' ' ' ILE . 12.5 m -88.37 94.88 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.627 0.727 . . . . 70.43 111.154 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.757 HD21 HG22 ' A' ' 36' ' ' VAL . 1.2 mm? -54.59 113.5 1.32 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.561 -0.745 . . . . 73.33 112.53 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.78 -54.38 2.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.113 -0.494 . . . . 53.02 110.242 173.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.88 -13.83 42.0 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.003 -0.544 . . . . 65.13 112.812 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.541 ' HB2' HD12 ' A' ' 44' ' ' LEU . 38.9 m -101.83 175.81 5.42 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.828 0.347 . . . . 72.32 111.058 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -122.83 149.24 55.85 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.475 -0.33 . . . . 62.31 110.719 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.86 130.75 41.55 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.399 2.066 . . . . 62.21 112.644 176.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 63.8 p -64.61 129.13 38.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.865 0.364 . . . . 72.12 111.816 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.38 -93.59 0.5 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.521 -0.308 . . . . 74.42 110.827 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 46.39 30.57 1.08 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.417 0.627 . . . . 71.21 112.111 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.74 90.28 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.501 -0.772 . . . . 71.14 111.736 -174.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.13 33.79 53.49 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.175 -0.536 . . . . 53.22 113.028 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.14 58.87 5.28 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 122.5 -0.412 . . . . 72.12 111.313 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 70.53 -60.87 0.48 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.513 0.725 . . . . 74.2 111.686 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.82 105.25 0.11 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.022 0.439 . . . . 73.51 111.64 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -104.2 6.66 35.74 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.209 -0.451 . . . . 72.4 111.457 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.1 65.23 0.55 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.322 -0.466 . . . . 51.0 113.281 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.1 p -151.23 125.82 9.56 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.545 -0.385 . . . . 54.55 111.484 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 50.03 33.26 6.63 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.789 0.663 . . . . 71.04 112.789 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -62.53 -39.03 92.28 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.068 0.461 . . . . 75.52 112.011 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -95.83 36.38 1.3 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.034 0.445 . . . . 74.04 111.914 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 37' ' ' ARG . 40.5 t -97.34 139.99 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.021 -0.536 . . . . 75.42 110.95 175.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.838 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 7.1 mp0 -85.95 64.82 8.8 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.52 0.676 . . . . 72.13 110.743 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.505 ' O ' ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -96.62 135.27 38.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.552 -0.749 . . . . 73.5 111.631 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.58 -125.68 1.5 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.536 -0.84 . . . . 54.44 113.866 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.7 pt -110.61 131.33 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.404 0.621 . . . . 64.14 112.487 -174.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -50.11 -35.22 24.74 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.413 -0.812 . . . . 52.34 112.598 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.531 HG13 ' HA3' ' A' ' 32' ' ' GLY . 66.3 mt -47.28 -50.2 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.18 0.437 . . . . 74.01 112.18 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 17.3 m -90.61 -32.63 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.11 0.411 . . . . 74.42 112.11 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.47 HD12 HG23 ' A' ' 35' ' ' VAL . 80.3 mt -65.76 -37.44 86.35 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.031 0.443 . . . . 73.01 111.415 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -87.49 -1.73 58.13 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 120.715 0.293 . . . . 74.22 111.611 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -123.65 4.1 8.91 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.838 -0.539 . . . . 73.33 112.158 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp 56.06 67.32 1.02 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.41 0.624 . . . . 65.4 112.335 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 68.1 mt -116.79 136.5 52.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.124 -0.489 . . . . 62.23 111.071 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.28 145.05 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.932 0.396 . . . . 55.45 111.372 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -80.37 122.19 26.63 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.977 0.732 . . . . 64.52 112.977 -173.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 94.4 mmm -125.62 155.69 40.36 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.961 -0.563 . . . . 60.44 109.95 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.414 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 47.6 t-20 -139.41 145.75 39.29 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.841 -0.537 . . . . 74.13 111.4 -176.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.6 p -46.83 -43.13 18.26 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.95 1.093 . . . . 71.31 113.95 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.414 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 38.7 p90 -56.3 -31.44 63.67 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.354 0.502 . . . . 53.42 112.354 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -104.83 -47.25 4.09 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.043 0.449 . . . . 74.11 110.927 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.36 3.26 16.11 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.453 0.538 . . . . 64.54 112.453 -172.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.521 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -40.66 -57.68 1.82 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.297 0.851 . . . . 54.02 113.297 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.5 t -65.01 -33.1 75.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.178 0.436 . . . . 44.42 112.178 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.66 -61.79 1.79 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.416 -0.356 . . . . 75.32 111.791 -174.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.694 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 29.7 p90 -65.48 -30.06 70.8 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.08 -0.387 . . . . 75.02 111.308 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -58.48 -43.34 88.92 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.289 0.566 . . . . 75.21 110.719 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.23 -34.15 77.37 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.987 -0.551 . . . . 73.21 111.274 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.694 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 25.4 m-85 -60.92 -44.07 97.7 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.598 0.237 . . . . 71.2 110.745 173.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.3 mm -55.44 -40.2 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.569 -0.287 . . . . 75.12 111.133 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -55.6 -63.97 1.0 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.774 0.321 . . . . 72.43 111.509 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.91 -31.06 72.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.479 -0.328 . . . . 63.41 111.875 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.508 ' CE1' ' HB2' ' A' ' 175' ' ' ALA . 36.9 t80 -62.53 -58.8 6.27 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.664 0.268 . . . . 72.03 111.322 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 56.5 ttp -59.47 -41.91 90.82 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.95 0.405 . . . . 62.11 110.836 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -55.58 -48.12 75.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.059 -0.519 . . . . 74.4 111.262 177.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -66.61 -54.6 21.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.088 -0.505 . . . . 70.31 112.003 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.4 m -59.8 -38.39 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.162 0.43 . . . . 61.34 112.162 -176.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.53 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 46.4 mm -70.51 -46.77 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 122.207 -0.308 . . . . 72.41 110.971 176.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.8 -24.27 61.63 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.976 0.417 . . . . 63.11 111.859 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -89.34 -29.82 18.86 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.455 -0.339 . . . . 72.1 111.763 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 11.9 tpt -81.11 -53.98 5.93 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.732 0.642 . . . . 71.23 112.732 -172.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -71.05 -10.59 60.02 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.05 0.759 . . . . 71.13 113.05 -174.24 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.66 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -60.72 -48.14 83.13 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.152 0.501 . . . . 64.43 111.042 172.723 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -107.55 -36.72 6.38 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.841 0.682 . . . . 73.21 112.841 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.524 ' O ' HG13 ' A' ' 113' ' ' VAL . 3.0 m-20 -112.24 41.15 2.04 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.966 0.412 . . . . 55.12 111.893 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -45.05 -30.46 1.07 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.813 0.845 . . . . 64.03 112.966 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -51.76 140.45 19.16 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.618 0.723 . . . . 73.23 112.66 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 54.2 mttp -65.87 -19.92 66.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.742 1.016 . . . . 64.34 113.742 -169.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.04 -20.96 47.63 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.689 -0.632 . . . . 74.11 111.465 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -94.37 -65.43 0.99 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.884 0.328 . . . . 73.51 111.884 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 107' ' ' ASN . 5.1 m -59.55 -45.6 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 112.921 0.712 . . . . 52.14 112.921 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.516 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 26.2 t70 -60.81 -43.81 97.71 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.634 0.255 . . . . 74.55 111.248 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.41 -49.35 74.1 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.858 0.361 . . . . 74.31 111.277 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -56.43 -54.33 46.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.978 0.418 . . . . 71.1 111.332 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.407 ' HA ' HG22 ' A' ' 120' ' ' ILE . 62.2 tttm -61.73 -31.13 71.28 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.435 -0.348 . . . . 42.52 111.237 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -65.76 -43.34 89.2 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.782 0.325 . . . . 54.42 111.237 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -57.5 -58.13 9.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.048 0.452 . . . . 74.05 111.166 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.407 HG22 ' HA ' ' A' ' 117' ' ' LYS . 11.1 tp -64.37 -40.42 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.018 -0.537 . . . . 75.13 112.066 -175.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.62 ' HA ' HE21 ' A' ' 121' ' ' GLN . 0.0 OUTLIER -66.25 -50.73 62.75 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.315 -0.241 . . . . 65.43 111.412 178.118 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.1 -42.26 61.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.586 -0.816 . . . . 64.23 112.199 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -62.81 -61.9 2.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.332 0.253 . . . . 75.13 111.253 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.5 m -61.26 -44.93 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 112.604 0.594 . . . . 61.14 112.604 -176.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.74 -34.58 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.972 0.415 . . . . 74.1 111.525 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.1 m -80.02 -29.11 39.32 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.031 0.443 . . . . 65.14 111.273 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.9 tp -80.03 -28.82 39.27 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.148 -0.478 . . . . 72.34 111.684 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 93.6 mt -85.14 2.27 44.3 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.598 0.592 . . . . 74.14 112.598 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.21 82.06 0.08 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.231 0.539 . . . . 55.0 110.917 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 65.5 pttt -64.08 -14.99 58.53 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.568 0.951 . . . . 73.4 113.568 -169.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.33 -42.38 98.58 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.138 0.494 . . . . 73.14 110.887 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -108.57 -50.78 2.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.992 -0.549 . . . . 72.33 111.393 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.531 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 55.3 m-85 -66.74 -4.5 9.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.592 0.96 . . . . 72.43 113.592 -173.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 14.1 ptmm? -50.99 -6.6 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.242 0.83 . . . . 72.21 113.242 175.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -77.46 13.28 1.27 Allowed 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.759 -0.588 . . . . 65.21 112.024 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 95.6 mt -89.54 127.92 35.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.014 0.435 . . . . 64.54 111.607 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -100.52 127.59 46.84 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.401 -0.363 . . . . 55.15 110.934 177.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -98.99 110.62 23.2 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.838 0.352 . . . . 73.24 110.976 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.429 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 65.4 m-85 -112.75 139.98 47.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.205 0.526 . . . . 71.11 111.797 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.42 HD11 ' O ' ' A' ' 150' ' ' ASN . 11.2 tt -133.26 155.16 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.821 -0.627 . . . . 74.4 110.96 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.34 125.35 13.03 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.567 -0.349 . . . . 62.02 113.553 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -49.91 -48.8 51.43 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.201 0.445 . . . . 64.44 112.201 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -79.7 -22.11 43.81 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.97 0.414 . . . . 71.14 111.865 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.32 93.36 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.957 0.408 . . . . 73.15 111.296 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.7 -30.93 65.9 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.992 -0.549 . . . . 64.22 111.919 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.81 -28.49 65.76 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.633 0.254 . . . . 74.01 111.668 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.83 -20.53 1.62 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.976 -0.631 . . . . 33.33 113.702 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.84 76.85 0.46 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 117.132 0.466 . . . . 62.05 111.951 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 54.38 103.68 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.72 0.772 . . . . 74.03 112.229 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.577 ' HB3' ' OH ' ' A' ' 91' ' ' TYR . 5.9 m-20 -54.48 -27.56 38.62 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.282 -0.872 . . . . 74.43 112.604 -173.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 8' ' ' PHE . . . 59.5 -166.21 9.39 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 114.821 0.689 . . . . 55.24 114.821 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -96.44 144.01 26.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.786 0.327 . . . . 60.13 111.387 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 44.8 t -77.99 138.01 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.912 0.387 . . . . 70.13 110.748 171.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.611 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -94.54 133.62 37.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.424 -0.353 . . . . 63.34 111.505 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.761 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 35.4 mm -91.98 113.54 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.751 0.31 . . . . 73.1 111.653 -178.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 49.8 mm -96.45 110.04 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.682 0.277 . . . . 63.43 111.084 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.61 132.93 50.28 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.402 -0.363 . . . . 73.2 110.271 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -90.09 89.13 7.55 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.459 0.647 . . . . 74.34 110.624 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -93.53 111.82 23.57 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.612 -0.722 . . . . 75.24 111.816 -172.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.621 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 32.4 t70 -69.91 118.76 13.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.041 0.448 . . . . 54.24 112.048 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 51.9 t -104.37 93.25 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.092 -0.503 . . . . 75.41 110.681 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 60.13 13.78 4.06 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.015 0.746 . . . . 74.41 113.015 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 133.42 -17.94 4.45 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.824 -0.703 . . . . 72.44 113.351 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.3 m -110.12 106.1 15.44 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.548 -0.384 . . . . 62.11 111.453 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 42.7 mt-10 -73.38 106.32 5.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.75 0.31 . . . . 74.41 111.181 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.7 m -105.18 143.23 26.33 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 120.888 0.375 . . . . 71.04 111.356 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.66 123.58 5.39 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.339 2.026 . . . . 72.54 112.682 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 60.0 p -108.29 125.67 51.95 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.174 0.511 . . . . 74.25 111.129 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.705 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 61.5 tp -78.26 114.69 17.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.023 -0.535 . . . . 72.54 111.121 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.761 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 42.5 ttm -101.82 124.25 47.14 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.464 0.306 . . . . 63.31 111.584 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 81.0 mt -138.33 130.71 28.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.794 0.438 . . . . 62.22 111.353 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.441 ' O ' HG12 ' A' ' 176' ' ' ILE . 39.3 t -82.41 126.83 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 122.012 -0.43 . . . . 72.12 111.853 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -71.21 -33.95 70.38 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.985 0.421 . . . . 72.2 111.845 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.438 ' HG2' HG12 ' A' ' 172' ' ' VAL . 0.8 OUTLIER -72.81 -4.46 31.78 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.896 0.379 . . . . 72.32 111.343 177.254 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.508 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . . . -101.17 -49.5 4.07 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.15 0.5 . . . . 51.01 110.609 173.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.85 HG22 ' HB3' ' A' ' 6' ' ' ASP . 36.0 pt -101.21 117.45 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.022 -0.536 . . . . 75.13 111.049 176.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 tp -93.57 128.08 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 121.903 -0.498 . . . . 64.11 109.916 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.666 ' HB2' HD11 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -110.43 131.8 54.74 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.863 0.84 . . . . 74.13 113.115 -171.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -94.68 103.48 15.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.819 -1.082 . . . . 63.32 109.309 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -94.0 96.76 9.89 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.368 0.877 . . . . 71.1 113.368 -169.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 86.4 m -115.83 89.83 3.2 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.446 -0.797 . . . . 74.43 109.162 169.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.4 mt -120.91 -84.45 0.66 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.768 0.655 . . . . 52.01 112.768 -170.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 118.488 -0.768 . . . . 73.41 111.999 -171.888 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 181' ' ' CYS . 25.7 ptt? . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 120.623 0.249 . . . . 73.4 111.129 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 15' ' ' SER . 29.1 tp -107.14 129.05 54.89 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.903 -0.498 . . . . 64.31 110.721 177.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.512 HG12 ' HB3' ' A' ' 15' ' ' SER . 60.0 mt -110.38 126.26 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.77 0.319 . . . . 71.4 111.124 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -123.38 145.74 48.52 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.933 0.397 . . . . 75.1 111.557 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 3.9 ptpp? -129.36 130.38 45.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.088 0.47 . . . . 71.31 111.652 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 4.0 m-20 -73.02 178.09 4.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.905 -0.588 . . . . 75.22 112.258 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.8 mt -66.56 -41.72 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.122 0.487 . . . . 45.05 111.24 173.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 150' ' ' ASN . 37.9 m-85 -106.28 -32.64 8.09 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.153 -0.476 . . . . 74.4 112.001 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.419 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 2.9 m -93.48 15.0 16.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.278 0.561 . . . . 75.5 111.566 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 13.4 p-10 -60.26 -26.03 66.15 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.08 0.77 . . . . 72.34 113.08 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -68.3 -18.59 64.56 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.858 0.688 . . . . 52.13 112.858 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -85.66 -33.08 21.66 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.646 0.609 . . . . 75.42 112.646 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 56.29 98.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.218 0.532 . . . . 73.21 112.398 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.4 m -95.66 124.63 39.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.157 -0.339 . . . . 55.13 110.73 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.512 ' HB3' HG12 ' A' ' 3' ' ' ILE . 15.3 p -118.69 103.86 10.07 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.074 0.464 . . . . 53.45 112.1 -174.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -132.41 -172.57 2.93 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.035 0.445 . . . . 51.51 111.909 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.1 p -138.42 18.07 2.74 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.413 -0.358 . . . . 71.5 111.809 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -69.11 140.29 90.77 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 111.748 0.277 . . . . 74.42 111.748 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.12 143.25 35.58 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.841 2.361 . . . . 53.4 113.43 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptp -147.35 137.73 23.3 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.992 0.425 . . . . 64.14 111.996 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 67.1 mttm -112.28 156.38 22.49 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.553 -0.294 . . . . 72.0 110.564 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 55.4 tp -121.25 104.5 9.78 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.219 0.451 . . . . 73.54 112.219 -171.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.69 144.92 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-O 121.038 0.447 . . . . 72.41 111.737 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 56.67 12.67 1.17 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.168 -0.469 . . . . 64.23 111.888 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.488 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 62.8 m-20 50.7 29.7 4.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.365 0.602 . . . . 72.14 111.307 -174.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.577 HD22 ' HB3' ' A' ' 119' ' ' LYS . 53.9 tp -126.27 -48.68 1.57 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.899 -0.591 . . . . 75.22 111.41 -177.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 172' ' ' VAL . 10.1 m -128.56 144.86 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.232 -0.44 . . . . 73.13 111.735 -177.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 170' ' ' MET . 98.3 m-85 -85.55 141.09 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 65.42 110.375 176.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 2.8 pm0 -130.97 111.54 12.14 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.389 0.614 . . . . 73.13 111.058 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CZ ' HD23 ' A' ' 169' ' ' LEU . 32.4 p90 -150.46 141.19 22.7 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.977 1.103 . . . . 75.11 113.977 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -94.5 133.64 37.9 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.341 -0.845 . . . . 73.12 111.547 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.63 -167.77 42.44 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.852 -0.69 . . . . 72.21 113.25 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.504 ' HG3' HG13 ' A' ' 35' ' ' VAL . 57.3 tptt -91.74 128.13 37.45 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 122.478 -0.425 . . . . 74.11 110.424 177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -73.62 106.22 5.29 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.06 0.457 . . . . 73.1 110.996 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.582 ' HB ' HD11 ' A' ' 42' ' ' ILE . 27.2 m -137.28 155.22 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.116 -0.493 . . . . 73.43 111.007 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.64 HG22 ' HA ' ' A' ' 44' ' ' LEU . 31.4 m -122.54 119.15 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.43 0.633 . . . . 72.13 111.392 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.492 ' HD3' ' OE2' ' A' ' 65' ' ' GLU . 43.0 ttt180 -102.09 132.96 47.65 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.059 0.457 . . . . 73.04 111.785 -173.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.474 ' HG2' ' N ' ' A' ' 39' ' ' GLU . 13.5 ttmt -120.48 160.38 23.26 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.313 -0.403 . . . . 73.35 110.995 -178.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.474 ' N ' ' HG2' ' A' ' 38' ' ' LYS . 12.4 tp10 -64.25 83.02 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.629 0.728 . . . . 73.23 110.386 174.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.46 -63.48 0.38 Allowed Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.218 -0.901 . . . . 62.51 112.372 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.55 178.97 8.17 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.296 0.569 . . . . 75.2 112.128 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.582 HD11 ' HB ' ' A' ' 35' ' ' VAL . 8.0 tp -84.91 93.46 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-O 121.883 0.849 . . . . 50.33 110.654 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 43' ' ' VAL . 11.6 p -82.98 36.49 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 N-CA-C 112.622 0.601 . . . . 70.15 112.622 -171.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.64 ' HA ' HG22 ' A' ' 36' ' ' VAL . 2.1 pp -58.63 141.97 50.84 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.627 -0.671 . . . . 72.32 112.086 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.28 175.77 11.13 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.352 -0.385 . . . . 72.52 111.851 -175.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.97 139.31 14.49 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.367 -0.444 . . . . 24.41 113.4 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 64.6 m -156.05 141.13 17.36 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.591 -0.358 . . . . 71.33 111.191 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -70.22 137.43 86.76 Favored Pre-proline 0 N--CA 1.469 0.52 0 O-C-N 122.341 -0.225 . . . . 71.35 111.169 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.45 92.64 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.167 1.911 . . . . 63.42 111.727 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.0 m -62.17 90.08 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.169 0.509 . . . . 65.15 111.948 -176.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.23 -58.59 2.48 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.897 -0.592 . . . . 72.41 110.821 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -71.66 -33.59 68.99 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.196 0.522 . . . . 75.03 110.856 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.802 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 18.3 mp0 -81.51 54.7 2.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.071 -0.513 . . . . 75.35 111.757 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.53 -32.18 80.31 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.031 -0.604 . . . . 74.41 113.843 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -106.13 29.53 6.67 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.466 -0.432 . . . . 72.13 112.077 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.802 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 21.1 tp10 -79.45 60.78 3.3 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.13 0.49 . . . . 73.44 112.057 -175.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 56.98 13.18 1.42 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.747 1.018 . . . . 74.21 113.747 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -82.97 74.05 9.95 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.455 0.645 . . . . 74.24 109.591 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.14 19.96 36.53 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.43 -0.804 . . . . 33.45 113.55 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.6 m 58.92 15.66 4.06 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 112.816 0.673 . . . . 71.23 112.816 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.46 -30.72 71.12 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.144 0.497 . . . . 65.32 110.928 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.75 ' HG3' HG23 ' A' ' 64' ' ' VAL . 10.7 tp10 -82.89 88.28 6.81 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.882 -0.784 . . . . 73.33 108.882 175.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -75.64 64.9 1.75 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.515 0.674 . . . . 74.13 112.54 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.75 HG23 ' HG3' ' A' ' 62' ' ' GLU . 26.7 t -91.66 149.89 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 CA-C-N 115.556 -0.747 . . . . 72.35 110.352 174.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.633 ' HG2' HD22 ' A' ' 72' ' ' LEU . 28.5 tt0 -75.25 69.65 2.11 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.801 0.81 . . . . 72.15 110.16 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -87.44 138.3 31.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.225 -0.898 . . . . 74.23 111.38 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.84 -146.24 9.25 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.447 -0.882 . . . . 62.21 113.612 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.6 pt -110.61 145.04 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.795 0.331 . . . . 72.32 111.763 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 14.9 t70 -41.03 -43.88 2.27 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.625 0.77 . . . . 72.15 112.308 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.9 mt -49.94 -56.29 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.724 0.639 . . . . 73.44 112.724 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.487 ' HA ' HD12 ' A' ' 76' ' ' LEU . 30.1 m -80.23 -35.05 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.394 0.516 . . . . 74.33 112.394 -172.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.633 HD22 ' HG2' ' A' ' 65' ' ' GLU . 85.5 mt -67.53 -46.39 72.96 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.715 0.293 . . . . 72.03 111.657 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -69.25 -21.75 63.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.412 0.523 . . . . 64.53 112.412 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -103.77 8.28 37.2 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 122.129 -0.357 . . . . 74.15 111.243 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.9 tptm 46.49 69.74 0.45 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.698 0.761 . . . . 64.24 112.501 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 71' ' ' VAL . 82.0 mt -106.38 122.03 45.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.644 -0.707 . . . . 64.14 110.343 177.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 p -82.65 141.41 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.09 0.472 . . . . 74.32 111.419 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -79.54 141.41 36.67 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.762 -0.654 . . . . 62.21 112.41 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.424 ' HG3' ' HB2' ' A' ' 84' ' ' ASP . 41.8 tpp -143.55 149.29 37.21 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.923 -0.58 . . . . 63.24 109.903 174.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -130.9 163.69 26.92 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.77 0.655 . . . . 71.21 112.77 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 67.9 m -38.07 -56.46 1.16 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.581 1.326 . . . . 71.14 114.581 -171.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -60.3 -29.76 69.04 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.424 0.898 . . . . 73.34 113.424 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -103.59 -21.34 13.76 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.949 -0.469 . . . . 73.23 111.655 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.424 ' HB2' ' HG3' ' A' ' 79' ' ' MET . 12.5 t70 -77.64 1.15 20.64 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.148 0.425 . . . . 71.23 112.148 -175.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.472 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . . . -39.8 -59.21 1.21 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.444 0.535 . . . . 42.25 112.444 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.7 t -53.23 -39.45 63.78 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.098 -0.501 . . . . 62.14 111.986 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.435 ' O ' ' HD1' ' A' ' 91' ' ' TYR . 25.9 mmt -73.22 -73.88 0.19 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.297 0.48 . . . . 71.41 112.297 -174.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 85' ' ' ALA . 33.4 p90 -55.72 -29.6 59.75 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.406 0.521 . . . . 75.12 112.406 -173.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.427 ' O ' HG22 ' A' ' 92' ' ' ILE . 32.8 mmtp -68.64 -60.49 2.37 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.928 0.394 . . . . 74.22 111.795 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.54 -43.21 99.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.159 0.504 . . . . 54.02 111.972 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.435 ' HD1' ' O ' ' A' ' 87' ' ' MET . 49.5 m-85 -69.74 -37.61 76.52 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.935 0.717 . . . . 73.42 112.935 -176.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 89' ' ' LYS . 11.0 tp -67.03 -33.37 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.304 0.573 . . . . 74.52 110.506 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -66.8 -45.81 77.2 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.914 -0.585 . . . . 71.23 110.975 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -61.7 -39.74 92.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.202 0.525 . . . . 65.54 110.684 172.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.469 ' HE1' ' HB2' ' A' ' 175' ' ' ALA . 89.2 t80 -60.26 -57.89 10.84 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.651 -0.704 . . . . 75.24 111.866 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.1 ptm -54.09 -39.43 66.32 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.842 0.354 . . . . 63.52 111.195 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -64.32 -49.98 69.61 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.66 -0.245 . . . . 71.34 111.574 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -61.43 -46.25 90.92 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.172 0.434 . . . . 64.21 112.172 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.3 m -66.81 -43.06 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.221 0.452 . . . . 75.44 112.221 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.9 mm -69.38 -38.17 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.735 0.302 . . . . 74.1 110.727 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.24 -54.17 40.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.019 0.437 . . . . 65.23 110.915 175.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -68.88 -53.04 23.43 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.22 0.452 . . . . 70.45 112.22 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.7 tpt -65.14 -56.89 10.3 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.254 0.465 . . . . 72.11 112.254 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.8 -43.03 99.88 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.057 0.392 . . . . 72.13 112.057 -174.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -48.97 -45.17 41.65 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.209 0.818 . . . . 74.12 113.209 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.56 18.05 20.12 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.061 0.458 . . . . 72.3 112.095 -176.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.465 ' OD1' HG13 ' A' ' 113' ' ' VAL . 3.1 t-20 -127.61 -65.51 0.92 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.372 -0.377 . . . . 64.2 110.774 176.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 70.01 -25.4 0.15 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.694 0.998 . . . . 74.13 113.694 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' HG22 ' A' ' 113' ' ' VAL . 42.0 m-20 -66.14 112.99 4.19 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.932 0.396 . . . . 75.12 111.584 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -56.05 -32.18 63.82 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.178 0.436 . . . . 71.23 112.178 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.01 -33.96 65.38 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.072 0.397 . . . . 63.24 112.072 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.445 ' HB2' ' OD1' ' A' ' 107' ' ' ASN . 3.3 m-20 -94.05 -55.15 3.31 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.129 0.418 . . . . 75.31 112.129 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.465 HG13 ' OD1' ' A' ' 107' ' ' ASN . 17.0 m -62.79 -35.26 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.999 0.74 . . . . 72.22 112.999 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -75.39 -25.7 57.86 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.283 0.563 . . . . 74.04 110.452 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.05 -44.81 52.93 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.143 -0.48 . . . . 53.04 110.673 173.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.42 -46.28 90.59 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.21 0.529 . . . . 74.24 110.164 173.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -50.3 -42.1 51.99 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.667 -0.697 . . . . 73.22 111.065 171.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -64.33 -42.24 96.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.178 -0.464 . . . . 64.05 111.691 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.577 ' HB3' HD22 ' A' ' 26' ' ' LEU . 14.6 mptt -58.1 -55.18 38.31 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.8 0.333 . . . . 75.45 110.985 174.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.524 HD13 HD21 ' A' ' 26' ' ' LEU . 41.8 mm -59.51 -41.86 86.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.447 -0.342 . . . . 71.25 111.391 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -57.08 -57.08 14.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.512 -0.313 . . . . 74.14 111.13 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.12 -40.11 82.44 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.077 -0.582 . . . . 60.33 112.579 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -61.55 -51.6 67.92 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 111.631 0.234 . . . . 71.0 111.631 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.28 -41.25 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 112.573 0.583 . . . . 73.11 112.573 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.9 m -64.54 -26.0 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 121.936 -0.478 . . . . 71.43 111.37 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.6 t -84.89 -46.84 10.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.901 0.381 . . . . 72.53 110.883 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.5 tp -58.62 -39.21 79.82 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.983 0.513 . . . . 61.05 112.282 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.5 mt -81.6 2.6 28.57 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.226 0.454 . . . . 63.01 112.226 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.45 90.46 0.73 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.108 0.48 . . . . 75.21 111.169 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 23.7 pttm -52.19 -32.34 35.85 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.718 -0.674 . . . . 65.01 112.597 -177.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -65.59 -28.81 69.41 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.354 0.501 . . . . 73.21 112.354 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -108.03 -58.88 1.92 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.543 0.687 . . . . 74.3 111.302 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.552 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 29.7 m-85 -67.9 -3.27 9.26 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.365 0.876 . . . . 73.32 113.365 -172.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 36.9 ttmt -36.11 -32.48 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.886 0.699 . . . . 73.43 112.886 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -91.25 33.08 0.99 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.786 0.662 . . . . 74.52 112.786 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 56.6 mt -88.47 125.99 35.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.215 0.531 . . . . 65.45 111.529 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -101.25 112.84 25.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.042 -0.526 . . . . 62.42 110.532 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.632 ' HB3' HG11 ' A' ' 153' ' ' VAL . 93.1 m-85 -89.81 109.4 20.4 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.543 -0.298 . . . . 63.11 111.257 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.438 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 67.1 m-85 -99.77 124.48 45.08 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.161 0.505 . . . . 71.15 111.662 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.513 ' HB ' HG22 ' A' ' 153' ' ' VAL . 8.6 tt -121.36 146.82 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.08 -0.509 . . . . 73.3 111.134 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.42 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -59.7 124.24 35.67 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.335 -0.46 . . . . 31.21 113.794 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -44.61 -51.1 9.36 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.53 0.567 . . . . 72.23 112.53 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -50.76 -36.42 36.55 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.902 0.705 . . . . 75.3 112.902 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -93.38 -34.57 13.41 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.848 0.356 . . . . 43.21 111.946 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.82 -19.56 51.57 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.524 0.565 . . . . 74.44 112.524 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -65.21 -18.56 65.41 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.865 0.364 . . . . 70.43 111.875 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.72 47.97 0.02 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.714 -0.755 . . . . 44.32 113.346 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.77 116.66 16.84 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.954 0.407 . . . . 72.24 111.614 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -74.5 23.15 0.09 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.258 0.466 . . . . 65.13 112.258 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 8' ' ' PHE . 37.6 m-80 -125.6 18.95 8.04 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.109 0.48 . . . . 65.22 111.001 177.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.2 91.95 1.63 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.079 -0.581 . . . . 75.45 112.46 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -58.96 119.46 7.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.285 0.564 . . . . 73.43 111.617 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 138' ' ' PHE . 91.9 t -87.68 142.16 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.823 0.675 . . . . 70.23 112.823 -175.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.897 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -101.78 133.21 46.89 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.641 -0.709 . . . . 74.32 110.442 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.4 mt -99.94 117.3 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 112.655 0.613 . . . . 71.12 112.655 -171.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 40.9 mm -100.94 123.33 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 111.76 0.282 . . . . 63.34 111.76 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -111.9 133.68 53.94 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.696 0.284 . . . . 74.13 111.046 173.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -84.68 95.57 8.95 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.332 0.586 . . . . 71.34 110.183 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.81 113.38 24.3 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.637 -0.711 . . . . 71.53 111.277 -173.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -74.18 118.24 16.91 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.468 -0.333 . . . . 73.33 110.49 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.52 91.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.781 0.324 . . . . 71.11 111.814 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 t70 52.72 38.54 26.57 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.641 0.608 . . . . 74.54 112.641 173.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 103.03 -5.72 50.42 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.145 -0.55 . . . . 41.33 113.772 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.519 HG22 HG13 ' A' ' 166' ' ' VAL . 61.0 m -110.21 122.19 47.06 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.349 -0.501 . . . . 71.11 110.925 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 165' ' ' GLU . 0.4 OUTLIER -92.69 100.38 12.89 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.285 0.564 . . . . 71.01 111.24 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.519 HG13 HG22 ' A' ' 164' ' ' THR . 19.0 m -108.07 113.27 60.97 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 112.361 0.504 . . . . 62.13 112.361 -177.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.12 113.8 3.87 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.089 1.859 . . . . 62.42 111.611 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.6 p -104.64 151.98 23.02 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.482 -0.326 . . . . 70.23 111.378 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.897 HD11 ' HB1' ' A' ' 154' ' ' ALA . 26.2 tp -102.3 122.95 45.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.54 -0.3 . . . . 74.44 110.857 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.581 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 63.0 mtt -101.81 124.25 47.13 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.599 0.562 . . . . 73.24 111.378 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.9 mt -138.2 130.58 29.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.492 -0.777 . . . . 54.3 110.609 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 174' ' ' GLU . 25.9 t -79.72 123.37 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 122.077 -0.389 . . . . 52.02 111.177 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.498 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -68.75 -11.07 59.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.642 0.608 . . . . 74.55 112.642 -175.695 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.492 ' H ' HG12 ' A' ' 172' ' ' VAL . 13.9 mm-40 -97.3 -8.3 30.05 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.073 0.463 . . . . 64.52 111.125 172.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.469 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -97.45 -14.37 21.2 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.291 0.567 . . . . 71.4 110.669 175.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 63.4 mt -134.77 128.59 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.469 -0.787 . . . . 61.2 109.806 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 43.5 mm -93.47 128.41 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.773 0.321 . . . . 74.11 111.392 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -84.94 114.44 22.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.245 -0.434 . . . . 73.2 110.949 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.44 112.72 23.46 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.706 0.765 . . . . 72.31 110.89 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.456 ' HB2' ' NZ ' ' A' ' 180' ' ' LYS . 4.9 ttmp? -85.49 112.13 20.63 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.657 -0.702 . . . . 64.41 112.095 -172.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 1' ' ' MET . 41.3 t -116.91 87.69 2.75 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.464 0.65 . . . . 60.21 112.222 178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.88 -165.03 0.95 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.51 -0.768 . . . . 63.54 110.256 175.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 183' ' ' GLU . 12.8 mp0 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.854 -0.594 . . . . 72.13 111.833 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.737 0.303 . . . . 73.41 111.761 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.41 160.01 14.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.457 0.303 . . . . 71.42 111.092 -176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 33.9 pt -130.58 138.8 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.976 -0.452 . . . . 73.24 112.037 177.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 14' ' ' SER . 49.7 p90 -122.55 138.24 54.63 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.231 0.539 . . . . 74.43 111.532 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.629 ' HG2' HD12 ' A' ' 13' ' ' LEU . 5.2 mtpm? -132.18 112.91 12.68 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.46 -0.791 . . . . 43.2 111.307 -176.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 176' ' ' ILE . 6.6 m-20 -73.46 155.31 39.39 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.041 -0.412 . . . . 74.22 111.495 173.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 pt -72.46 -24.93 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.967 0.413 . . . . 71.21 111.513 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.73 -41.76 4.92 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.537 0.569 . . . . 73.22 112.537 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m -88.69 15.13 8.66 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.304 0.573 . . . . 71.34 111.548 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.446 ' O ' HD22 ' A' ' 13' ' ' LEU . 34.2 t70 -49.05 -37.81 22.02 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.838 1.051 . . . . 75.35 113.838 -173.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.1 -37.13 81.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.703 0.631 . . . . 75.43 112.703 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -104.2 25.79 9.62 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.887 -0.508 . . . . 65.4 112.014 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.629 HD12 ' HG2' ' A' ' 5' ' ' LYS . 2.2 pt? -44.16 158.76 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.02 -0.536 . . . . 74.33 111.812 173.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 62.6 m -143.55 152.56 41.59 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.425 0.898 . . . . 74.34 113.425 -174.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 78.0 p -91.58 125.41 36.31 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.646 -0.707 . . . . 71.15 109.851 172.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -112.89 175.65 5.35 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.98 0.419 . . . . 73.24 111.708 -171.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.1 t -144.82 8.5 1.28 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.052 0.39 . . . . 51.34 112.052 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.433 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 78.9 m-85 -96.87 150.14 36.55 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 122.221 -0.299 . . . . 74.05 111.674 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -91.66 104.67 0.24 Allowed 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.842 2.361 . . . . 71.42 113.468 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.497 ' N ' ' SD ' ' A' ' 20' ' ' MET . 1.6 mpt? -85.9 162.11 18.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.963 0.411 . . . . 51.52 111.534 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -129.19 119.89 24.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.411 -0.359 . . . . 74.23 111.139 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 tp -74.79 114.37 13.15 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.207 0.527 . . . . 73.32 111.081 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.31 145.63 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.302 -0.408 . . . . 61.32 111.132 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.9 t70 62.79 8.51 3.1 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 120.987 0.422 . . . . 53.52 111.413 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 58.02 11.8 1.59 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.266 0.627 . . . . 74.14 111.598 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 120' ' ' ILE . 30.8 tp -117.51 -46.74 2.66 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.042 -0.526 . . . . 72.13 111.279 -172.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.96 149.22 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.69 0.626 . . . . 53.43 112.69 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.573 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 75.3 m-85 -86.45 123.89 32.17 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.143 -0.48 . . . . 71.2 111.006 175.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -99.86 138.25 37.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.062 -0.517 . . . . 73.41 110.642 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.523 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 46.4 t80 -137.79 122.7 18.93 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.19 0.519 . . . . 75.4 111.562 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -75.37 123.46 25.41 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.57 0.581 . . . . 74.52 112.57 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.15 142.74 15.72 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.197 -0.456 . . . . 71.52 112.873 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -91.7 145.32 24.68 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.707 -0.29 . . . . 72.31 111.185 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -66.72 105.42 1.55 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.302 . . . . 72.32 110.578 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.589 HG23 HD12 ' A' ' 72' ' ' LEU . 10.8 m -146.82 158.84 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.33 0.585 . . . . 71.51 111.419 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.485 HG22 HD21 ' A' ' 44' ' ' LEU . 29.4 m -138.26 146.92 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.084 -0.507 . . . . 63.32 111.171 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.51 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 19.9 mmt85 -123.96 106.32 10.32 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.873 0.368 . . . . 73.41 111.136 172.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.665 ' HB2' HG13 ' A' ' 64' ' ' VAL . 56.3 tptt -137.36 95.92 3.17 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.701 -0.227 . . . . 74.42 111.054 170.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 50.56 -75.84 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.46 0.704 . . . . 72.41 112.541 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 38' ' ' LYS . . . -114.6 -18.68 6.44 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 116.632 -0.258 . . . . 71.41 113.492 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 8.0 tp10 -72.3 117.55 14.09 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.457 -0.437 . . . . 75.54 110.837 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.758 HG13 HG23 ' A' ' 43' ' ' VAL . 5.9 tp -160.1 136.56 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 120.932 0.396 . . . . 72.31 112.034 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.758 HG23 HG13 ' A' ' 42' ' ' ILE . 88.4 t 65.7 105.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.401 0.68 . . . . 51.31 112.448 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.485 HD21 HG22 ' A' ' 36' ' ' VAL . 1.1 mm? -89.76 141.24 28.8 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.244 -0.435 . . . . 70.4 110.428 175.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.46 -36.04 15.65 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.387 0.514 . . . . 60.13 112.387 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -111.56 87.69 0.47 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.318 -0.467 . . . . 72.23 113.207 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.1 m -86.86 98.4 11.19 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.357 -0.496 . . . . 72.23 111.483 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -98.15 150.35 36.65 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.19 -0.459 . . . . 62.44 111.142 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -67.19 137.66 44.59 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.55 2.167 . . . . 71.35 113.844 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.7 m -62.95 124.14 20.32 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.264 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.46 -49.66 2.99 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.38 0.511 . . . . 64.44 112.38 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 59.9 36.85 21.81 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.257 0.551 . . . . 64.12 111.181 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -82.87 -63.65 1.32 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.901 -0.59 . . . . 75.54 110.878 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.46 -104.69 0.24 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.021 -0.609 . . . . 44.44 112.43 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.89 -86.09 0.17 Allowed 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.323 -0.516 . . . . 72.33 110.387 174.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 52.98 13.09 0.33 Allowed 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.529 0.937 . . . . 44.12 113.529 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -126.98 177.34 6.69 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 122.045 -0.41 . . . . 62.05 111.316 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.4 t0 65.94 65.88 0.51 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.897 0.856 . . . . 63.01 110.763 -172.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.0 75.01 0.29 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-N 114.908 -1.042 . . . . 52.14 111.252 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.0 p -75.53 35.76 0.12 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 112.986 0.736 . . . . 54.22 112.986 -173.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 68.95 -36.55 0.34 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.836 1.421 . . . . 72.43 114.836 174.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 60.9 35.43 19.22 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.651 0.66 . . . . 60.13 110.994 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.3 m80 68.03 20.27 9.12 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.851 -0.613 . . . . 61.44 112.452 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.665 HG13 ' HB2' ' A' ' 38' ' ' LYS . 90.9 t -81.86 132.79 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 122.292 -0.255 . . . . 73.41 110.603 172.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 39.8 mt-10 -75.25 68.94 2.04 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.357 0.599 . . . . 62.01 110.567 175.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -88.31 132.64 34.33 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.858 -0.61 . . . . 64.41 111.231 177.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.5 -133.65 3.53 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.197 -1.001 . . . . 45.2 113.979 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 70' ' ' ILE . 7.4 pt -111.2 141.48 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.028 0.442 . . . . 73.53 112.189 -175.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -45.99 -34.44 4.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.868 -0.605 . . . . 75.35 112.013 177.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 68' ' ' ILE . 50.7 mt -48.26 -62.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.309 0.576 . . . . 71.54 111.913 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.3 m -77.22 -31.11 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.022 -0.535 . . . . 74.14 112.211 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.589 HD12 HG23 ' A' ' 35' ' ' VAL . 68.8 mt -74.08 -38.61 63.85 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.835 0.35 . . . . 61.01 111.802 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -83.91 -26.18 29.57 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.801 0.334 . . . . 64.2 111.386 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -95.43 -1.12 51.57 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 120.837 0.351 . . . . 73.21 110.745 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.7 tptm 49.65 70.92 0.44 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.141 0.976 . . . . 75.25 112.955 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.1 mt -107.14 148.91 28.25 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.791 -0.641 . . . . 63.41 111.041 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 140' ' ' ILE . 14.1 p -91.08 142.34 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 120.971 0.415 . . . . 64.02 111.873 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -79.16 143.32 35.54 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.964 0.727 . . . . 63.43 112.964 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.404 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 96.8 mmm -139.46 155.42 47.6 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.28 0.632 . . . . 75.4 110.939 177.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -131.75 133.1 44.42 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.035 0.445 . . . . 72.25 112.145 -173.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.4 p -38.32 -46.76 1.14 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.924 1.453 . . . . 73.34 114.924 -173.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -55.68 -34.76 65.34 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.02 0.438 . . . . 62.04 111.824 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -91.68 -37.69 12.88 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.16 0.505 . . . . 64.11 111.19 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.404 ' OD1' ' HB3' ' A' ' 79' ' ' MET . 3.8 m-20 -72.26 -6.34 42.3 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.602 0.593 . . . . 74.54 112.602 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.473 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -39.6 -63.24 0.59 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 112.992 0.738 . . . . 42.33 112.992 -177.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.5 m -60.35 -35.3 75.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.15 0.5 . . . . 74.54 111.602 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.8 mtp -69.66 -56.48 7.13 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.064 -0.517 . . . . 71.4 112.288 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.473 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 4.2 p90 -68.63 -25.98 65.11 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.915 -0.49 . . . . 70.53 112.304 -175.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.42 ' HA ' HG22 ' A' ' 92' ' ' ILE . 18.4 ptmt -73.91 -32.93 63.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 119.883 -0.727 . . . . 70.32 110.993 176.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.58 74.61 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.465 0.65 . . . . 52.14 110.157 170.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -53.43 -55.92 21.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.131 -0.94 . . . . 74.33 111.174 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.42 HG22 ' HA ' ' A' ' 89' ' ' LYS . 10.4 tp -63.27 -34.45 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 111.744 0.276 . . . . 74.53 111.744 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -63.5 -55.65 22.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.831 0.348 . . . . 73.12 111.213 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -61.09 -42.17 98.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.731 0.3 . . . . 75.2 111.361 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.511 ' O ' HG22 ' A' ' 99' ' ' VAL . 41.0 t80 -52.31 -57.48 9.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.157 -0.474 . . . . 72.55 111.278 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.426 ' HA ' ' CE ' ' A' ' 96' ' ' MET . 3.2 mmt -55.3 -52.95 61.78 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.393 -0.367 . . . . 73.15 111.851 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -54.14 -50.51 66.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.834 0.349 . . . . 65.22 111.481 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -64.17 -56.79 12.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.243 -0.435 . . . . 75.44 111.94 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 95' ' ' PHE . 24.2 m -63.58 -40.09 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.37 0.507 . . . . 75.14 112.37 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.6 mm -69.92 -44.98 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 122.217 -0.302 . . . . 63.31 111.375 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.61 -42.34 98.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.98 0.419 . . . . 62.33 111.035 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -68.38 -49.57 59.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.11 -0.496 . . . . 70.42 111.641 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.4 ttm -66.48 -49.49 66.44 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.923 0.342 . . . . 75.54 111.923 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.35 -11.76 11.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.895 0.379 . . . . 72.1 111.819 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -68.59 -48.0 65.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.861 0.362 . . . . 62.1 111.059 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.51 -36.01 6.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.134 0.42 . . . . 72.01 112.134 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -84.74 19.35 2.07 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 120.961 0.41 . . . . 53.14 111.039 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -28.41 -30.97 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.448 1.647 . . . . 74.21 115.448 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -50.27 118.22 2.85 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.022 0.439 . . . . 62.45 111.586 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 96.1 mttt -56.95 -22.49 38.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.163 -0.471 . . . . 63.44 111.547 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.02 -31.05 44.54 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.039 0.447 . . . . 70.31 111.82 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -77.21 -62.22 1.73 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.195 0.521 . . . . 70.21 110.927 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.3 m -63.24 -24.29 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.739 0.644 . . . . 64.14 112.739 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 20.4 t70 -62.33 -47.94 82.02 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.004 0.43 . . . . 73.33 110.159 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 119' ' ' LYS . . . -59.8 -42.32 93.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.947 -0.569 . . . . 73.0 111.453 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -64.24 -55.17 23.42 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.7 0.285 . . . . 71.32 111.708 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -55.57 -42.33 74.56 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.366 0.603 . . . . 75.31 110.997 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 118' ' ' LYS . 28.0 ttmt -71.35 -30.08 65.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.627 -0.715 . . . . 73.51 110.954 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 37.9 tptt -64.25 -41.66 96.86 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.259 0.552 . . . . 71.34 109.929 173.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.516 HD13 HD21 ' A' ' 26' ' ' LEU . 31.8 mm -65.71 -42.0 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.618 -0.719 . . . . 70.51 110.835 173.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 125' ' ' VAL . 68.2 mm-40 -55.84 -51.87 66.01 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.72 0.267 . . . . 70.03 111.72 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.21 -42.85 83.46 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.474 -0.869 . . . . 72.52 112.198 175.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -59.92 -55.54 32.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.94 0.496 . . . . 74.41 111.547 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.0 m -66.98 -42.13 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 112.529 0.566 . . . . 74.02 112.529 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 121' ' ' GLN . 69.1 t -57.73 -34.55 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.254 0.549 . . . . 73.05 111.212 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.5 t -75.94 -42.73 47.78 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.224 -0.444 . . . . 70.25 111.52 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.449 HD21 HD13 ' A' ' 155' ' ' ILE . 30.5 tp -75.0 -29.07 60.78 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.958 -0.565 . . . . 75.33 112.248 -173.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.17 2.75 51.44 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.64 0.607 . . . . 73.22 112.64 -176.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.514 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -60.3 94.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.196 0.522 . . . . 53.23 111.17 177.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.58 -16.85 58.41 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.16 0.8 . . . . 75.42 113.16 -170.365 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.56 ' N ' ' HD2' ' A' ' 130' ' ' LYS . 3.9 m-20 -67.35 -46.01 74.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.002 0.43 . . . . 72.34 111.557 -175.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.556 HH21 ' HE2' ' A' ' 158' ' ' TYR . 39.8 mtp180 -107.36 -48.53 3.43 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.371 0.605 . . . . 70.55 111.796 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.514 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 44.5 m-85 -67.92 -6.33 21.46 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.849 -0.614 . . . . 74.12 112.608 -172.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 38.4 ttpt -53.09 -26.0 14.84 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.099 0.476 . . . . 74.21 110.93 171.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -97.19 34.04 1.84 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.579 0.585 . . . . 44.32 112.579 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.412 HD11 ' HD2' ' A' ' 133' ' ' PHE . 70.6 mt -87.96 151.18 22.98 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.895 0.379 . . . . 73.01 110.87 175.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -108.79 134.62 51.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.673 -0.239 . . . . 64.41 111.453 -178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.576 ' HB3' HG13 ' A' ' 153' ' ' VAL . 66.7 m-85 -109.66 133.46 53.09 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.268 -0.27 . . . . 74.33 110.629 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -129.41 138.89 51.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.089 0.471 . . . . 73.05 111.017 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.48 ' O ' HG12 ' A' ' 77' ' ' VAL . 12.7 tt -141.33 158.85 22.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.367 -0.379 . . . . 73.31 111.139 -175.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.97 137.78 50.16 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.931 -0.652 . . . . 34.22 112.169 173.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -36.92 85.07 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.624 0.602 . . . . 63.21 112.624 -175.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 143' ' ' ARG . 24.6 mmt180 -63.45 -49.3 74.23 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.128 -0.357 . . . . 72.01 111.319 176.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.504 ' HB1' ' HA3' ' A' ' 151' ' ' GLY . . . -55.86 -50.34 70.86 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.022 0.439 . . . . 60.35 111.501 173.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.61 -30.93 65.74 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.12 0.415 . . . . 62.21 112.12 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -102.05 14.74 31.12 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.474 0.546 . . . . 74.13 112.474 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.7 -44.53 0.02 OUTLIER Glycine 0 CA--C 1.531 1.067 0 C-N-CA 119.996 -1.097 . . . . 35.33 114.976 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -111.76 108.93 18.53 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.873 0.694 . . . . 64.25 112.873 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -63.55 -24.59 67.87 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.762 0.315 . . . . 74.44 111.766 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -92.03 19.86 6.37 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.835 0.309 . . . . 71.43 111.835 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.504 ' HA3' ' HB1' ' A' ' 144' ' ' ALA . . . -68.33 163.11 49.06 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.048 -0.596 . . . . 51.33 113.133 178.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -68.11 102.32 1.31 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.417 -0.461 . . . . 70.41 112.038 -177.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 138' ' ' PHE . 24.6 t -80.92 99.93 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.383 0.611 . . . . 72.52 110.332 168.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.678 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -73.8 129.79 38.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.676 -0.693 . . . . 71.33 110.635 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.449 HD13 HD21 ' A' ' 127' ' ' LEU . 57.6 mt -95.57 125.62 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.991 0.424 . . . . 64.54 111.429 -175.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 50.3 mm -100.04 106.7 19.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-O 121.039 0.447 . . . . 73.03 110.695 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.43 152.62 20.15 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.727 -1.124 . . . . 74.33 111.239 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.556 ' HE2' HH21 ' A' ' 132' ' ' ARG . 39.7 p90 -100.3 122.22 42.74 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.983 -0.448 . . . . 74.14 110.62 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.566 ' HE ' ' HB ' ' A' ' 168' ' ' THR . 0.1 OUTLIER -136.93 156.4 48.51 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.873 0.694 . . . . 74.32 112.873 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.46 127.61 32.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.18 -0.918 . . . . 73.25 112.575 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.5 t -129.36 99.93 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.968 -0.56 . . . . 72.11 110.969 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 57.23 25.11 10.65 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.321 0.489 . . . . 72.12 112.321 176.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.46 -23.36 26.77 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.314 -0.469 . . . . 52.14 113.465 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.2 p -101.58 149.3 24.25 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.409 -0.465 . . . . 74.21 111.666 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.27 121.34 34.54 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.324 0.583 . . . . 71.24 112.076 -176.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.77 126.93 26.83 Favored Pre-proline 0 C--O 1.24 0.584 0 O-C-N 121.654 -0.654 . . . . 65.2 111.256 174.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.99 114.53 3.02 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.264 1.976 . . . . 64.11 111.426 171.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.566 ' HB ' ' HE ' ' A' ' 159' ' ' ARG . 10.2 t -101.48 149.81 23.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.303 -0.408 . . . . 50.11 111.888 -176.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.678 HD11 ' HB1' ' A' ' 154' ' ' ALA . 53.0 tp -78.67 128.46 33.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.225 -0.443 . . . . 70.11 110.337 174.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 46.8 tpp -117.7 122.53 43.76 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.868 0.366 . . . . 73.52 111.021 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 98.1 mt -137.78 155.13 49.36 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.808 0.443 . . . . 73.23 109.875 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.505 HG11 ' CE1' ' A' ' 95' ' ' PHE . 40.6 t -99.87 134.82 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.744 -0.598 . . . . 73.02 112.112 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.573 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -60.74 -39.67 89.51 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.155 0.798 . . . . 61.45 113.155 -172.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -95.15 12.43 28.79 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.854 0.687 . . . . 51.52 112.854 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.4 -33.67 8.08 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.558 0.694 . . . . 42.24 109.985 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 6' ' ' ASP . 3.9 tt -128.01 117.59 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.043 -0.98 . . . . 73.44 110.424 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 5' ' ' LYS . 8.3 tp -94.25 129.41 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.585 0.707 . . . . 74.55 111.869 -175.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -92.9 123.58 36.26 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.524 -0.762 . . . . 72.41 110.336 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -124.9 143.37 50.89 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.283 0.563 . . . . 64.51 111.153 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -119.54 95.88 4.97 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.577 0.703 . . . . 64.35 111.816 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 40.0 t -117.72 91.04 3.47 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.9 -0.778 . . . . 75.33 108.9 170.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.447 ' N ' HD23 ' A' ' 182' ' ' LEU . 1.6 pt? -153.7 171.83 18.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.23 0.538 . . . . 72.42 112.106 -171.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.909 -0.567 . . . . 62.13 110.8 176.427 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.949 0.404 . . . . 71.51 111.95 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 178' ' ' GLU . 59.8 tp -134.28 131.9 38.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.659 -0.496 . . . . 63.5 109.659 172.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 54.3 mt -104.1 117.69 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 121.903 -0.498 . . . . 72.04 110.473 -177.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -111.05 142.73 42.81 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.859 0.838 . . . . 74.52 112.233 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -137.46 111.15 8.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.686 -1.143 . . . . 62.05 110.777 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.469 ' HB2' ' H ' ' A' ' 9' ' ' THR . 2.4 m-20 -87.13 174.39 8.66 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.279 0.561 . . . . 54.11 111.489 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.6 mt -68.42 -28.16 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.356 0.598 . . . . 73.24 110.474 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -97.26 -44.0 7.1 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.783 -0.644 . . . . 61.43 112.161 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.469 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 37.8 p -81.07 15.62 1.81 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.319 0.859 . . . . 74.01 113.319 -172.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -54.68 -31.02 57.18 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.913 0.387 . . . . 72.21 111.692 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -71.68 -37.85 70.69 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.205 0.526 . . . . 75.2 111.129 174.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 10.0 tp10 -96.25 25.06 5.17 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.837 -0.619 . . . . 64.25 111.105 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.49 107.22 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.867 0.867 . . . . 62.4 112.089 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.9 t -122.16 175.29 6.45 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.704 0.631 . . . . 71.42 112.704 -166.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.7 p -150.33 130.94 13.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.937 -0.574 . . . . 64.33 111.535 -176.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -123.97 -162.76 1.09 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 120.825 0.345 . . . . 63.04 111.23 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.5 m -152.32 29.95 0.55 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.087 0.47 . . . . 51.12 110.826 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -108.27 146.11 32.91 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.167 -0.47 . . . . 74.43 111.036 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.52 159.14 54.76 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.246 1.964 . . . . 60.23 113.904 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.429 ' N ' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -142.05 128.9 20.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.327 0.584 . . . . 63.21 110.639 174.458 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.695 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 11.2 mmmm -98.91 97.96 9.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.259 -0.428 . . . . 74.0 111.925 -173.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 43.2 tp -75.13 91.21 2.57 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.643 -0.661 . . . . 54.12 111.37 -178.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.3 p -90.5 146.89 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 115.9 -0.591 . . . . 72.3 111.148 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 56.49 11.61 0.89 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 120.788 0.328 . . . . 72.45 111.76 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.477 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 7.9 m-20 52.92 30.68 9.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.164 0.507 . . . . 75.55 111.106 -175.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.462 HD11 HD11 ' A' ' 120' ' ' ILE . 30.0 tp -130.23 -43.5 1.17 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.723 -176.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.13 159.78 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.353 0.501 . . . . 44.35 112.353 -175.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 170' ' ' MET . 66.1 m-85 -103.27 129.97 50.39 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.945 -0.57 . . . . 74.5 111.464 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.695 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 15.3 tt0 -96.43 142.15 28.88 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.877 0.871 . . . . 72.52 110.627 175.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.639 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 63.3 t80 -147.33 130.66 16.59 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.74 0.305 . . . . 74.14 111.222 173.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -94.56 135.95 35.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.006 0.432 . . . . 75.12 111.176 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.749 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -123.02 147.68 16.72 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.203 -0.522 . . . . 72.02 113.192 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -91.22 136.59 32.99 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.607 -0.349 . . . . 62.25 110.724 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -65.25 106.87 1.43 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.119 0.485 . . . . 74.51 110.923 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.423 HG23 HD12 ' A' ' 72' ' ' LEU . 34.4 m -131.84 158.2 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.045 0.45 . . . . 73.1 111.136 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.686 HG12 ' HG3' ' A' ' 66' ' ' ARG . 12.2 m -137.27 137.44 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.772 0.32 . . . . 63.11 111.182 -178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.918 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 6.5 ttm180 -115.1 111.2 20.69 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.868 0.366 . . . . 53.01 111.863 176.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 40' ' ' GLY . 57.9 tptt -107.25 126.44 52.42 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.408 -0.96 . . . . 70.14 108.408 167.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -59.73 82.03 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.716 0.769 . . . . 71.05 111.453 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 38' ' ' LYS . . . 147.73 -28.25 1.46 Allowed Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.229 -0.896 . . . . 64.13 113.322 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -152.34 173.52 14.95 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.018 0.747 . . . . 41.24 113.018 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.9 mm -132.48 125.47 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 115.563 -0.744 . . . . 61.21 111.297 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 43' ' ' VAL . 13.1 p -135.54 47.88 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-O 122.242 1.02 . . . . 45.12 111.385 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.26 -11.09 56.59 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.694 -0.684 . . . . 71.24 112.796 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.94 4.01 43.37 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.159 0.504 . . . . 74.41 111.53 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.11 145.47 32.2 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.217 -0.516 . . . . 53.52 112.905 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 76.9 p -89.08 121.9 31.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 74.44 111.207 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -73.8 146.26 85.24 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.657 -0.247 . . . . 74.12 111.24 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.17 132.23 33.34 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.387 2.058 . . . . 72.25 112.833 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 m -67.2 132.28 47.46 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.475 -0.329 . . . . 62.0 111.444 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.41 154.87 43.02 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.415 0.626 . . . . 74.02 111.302 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.94 -22.22 39.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.558 -0.746 . . . . 74.44 111.655 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.418 ' HA ' ' OD1' ' A' ' 135' ' ' ASN . 10.8 pt-20 -143.21 -148.88 0.25 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.189 -0.46 . . . . 73.31 111.008 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.88 -140.93 0.1 OUTLIER Glycine 0 CA--C 1.532 1.114 0 N-CA-C 114.708 0.643 . . . . 40.12 114.708 -174.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.11 123.03 6.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.098 0.475 . . . . 75.43 111.193 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.0 -26.26 0.49 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.743 -0.662 . . . . 73.51 111.705 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -94.53 -174.75 3.41 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.751 0.31 . . . . 75.42 111.336 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 t70 72.18 -66.54 0.3 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.458 0.703 . . . . 64.21 112.338 172.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.64 21.61 31.94 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.311 -0.471 . . . . 33.32 113.969 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.6 p -117.33 -0.76 11.92 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.351 0.5 . . . . 72.33 112.351 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -74.55 -72.53 0.28 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.793 0.33 . . . . 73.33 111.0 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -95.45 156.9 16.13 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.065 0.459 . . . . 72.34 109.783 172.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -74.36 74.24 1.87 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.354 0.597 . . . . 74.04 111.398 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.4 t -93.8 117.02 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.941 -0.572 . . . . 55.31 110.011 175.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.918 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 32.5 tt0 -78.94 67.48 4.66 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.838 0.828 . . . . 64.41 109.851 -177.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.686 ' HG3' HG12 ' A' ' 36' ' ' VAL . 40.4 ttp180 -105.51 124.53 49.71 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.297 -0.865 . . . . 73.5 111.652 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.52 -132.28 2.74 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.032 -0.604 . . . . 61.53 113.064 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.624 HD12 HD12 ' A' ' 70' ' ' ILE . 22.1 pt -111.1 137.66 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 112.271 0.471 . . . . 64.25 112.271 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -39.54 -44.49 1.44 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.327 0.651 . . . . 74.2 112.55 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.749 HG13 ' HA3' ' A' ' 32' ' ' GLY . 67.0 mt -40.39 -53.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.773 0.657 . . . . 51.51 112.773 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.479 ' HA ' HD12 ' A' ' 76' ' ' LEU . 23.1 m -94.68 -33.91 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.406 0.521 . . . . 64.03 112.406 -173.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.423 HD12 HG23 ' A' ' 35' ' ' VAL . 62.1 mt -68.38 -49.75 57.9 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.024 0.44 . . . . 62.43 111.534 -176.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -62.67 -21.16 65.52 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 120.854 0.359 . . . . 74.33 111.553 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -104.92 -0.28 27.17 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.822 0.305 . . . . 72.43 111.822 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.42 69.98 0.68 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.247 0.546 . . . . 73.34 112.273 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 91.4 mt -110.85 136.48 49.82 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.095 -0.502 . . . . 62.21 111.086 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.405 HG13 HG23 ' A' ' 140' ' ' ILE . 5.6 p -88.04 142.15 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.17 0.51 . . . . 64.41 111.437 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER -85.71 137.91 32.49 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.342 0.867 . . . . 74.22 113.342 -171.709 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 75.0 mtp -134.49 140.31 46.1 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.667 -0.697 . . . . 65.14 110.896 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -89.34 157.54 18.14 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.023 0.439 . . . . 75.11 111.937 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 136' ' ' LEU . 79.8 m -53.85 -45.03 70.8 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.919 0.711 . . . . 74.34 112.919 -175.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -60.39 -20.29 59.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.606 0.595 . . . . 53.53 112.606 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -99.42 -28.98 13.01 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.164 0.431 . . . . 51.13 112.164 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.41 -7.53 55.24 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.626 0.602 . . . . 72.43 112.626 -173.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.31 -43.21 10.55 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.078 0.77 . . . . 61.14 113.078 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.3 m -66.97 -39.58 87.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.732 0.301 . . . . 73.22 111.498 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.5 mmt -62.75 -44.44 96.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.401 -0.363 . . . . 70.51 110.657 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -51.91 -52.08 52.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.801 0.334 . . . . 62.32 111.578 173.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -58.84 -43.01 90.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.922 0.391 . . . . 72.13 111.656 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.34 -50.87 23.57 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.025 0.44 . . . . 65.51 111.881 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -58.83 -53.75 54.9 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.781 -0.645 . . . . 75.3 111.86 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.4 mm -64.11 -37.33 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 111.907 0.336 . . . . 72.32 111.907 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -57.36 -62.66 1.62 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.204 0.526 . . . . 75.14 111.028 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.67 -44.67 85.91 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.806 -0.634 . . . . 74.31 111.221 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.536 ' CZ ' HG11 ' A' ' 172' ' ' VAL . 66.1 t80 -61.07 -66.11 0.59 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.936 -0.574 . . . . 72.32 112.314 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 48.0 ttm -54.95 -45.2 74.86 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.174 0.435 . . . . 54.14 112.174 -172.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.31 -43.96 93.08 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.696 0.284 . . . . 74.03 111.643 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -71.19 -43.01 68.27 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.182 0.438 . . . . 65.53 112.182 -176.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.1 m -72.2 -39.05 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.23 0.456 . . . . 54.41 112.23 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.99 -45.97 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 122.152 -0.342 . . . . 75.3 110.26 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.9 -38.76 73.27 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.369 0.604 . . . . 73.51 110.647 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -60.59 -38.85 85.98 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.729 -0.669 . . . . 70.22 111.976 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.48 ' HG2' HG12 ' A' ' 113' ' ' VAL . 35.3 ttm -88.39 -48.85 7.33 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.228 0.455 . . . . 74.55 112.228 -173.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.548 ' HA ' HG11 ' A' ' 113' ' ' VAL . 11.5 pt-20 -62.2 -24.45 67.22 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.174 -0.329 . . . . 70.23 111.814 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -58.54 -54.61 45.14 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.003 0.371 . . . . 74.21 112.003 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -100.6 -37.04 8.94 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.837 0.68 . . . . 62.41 112.837 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -68.39 -50.49 52.64 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.862 -0.524 . . . . 60.44 110.51 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 45.67 19.87 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.676 1.361 . . . . 62.43 114.676 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -102.68 124.51 48.36 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.858 -0.526 . . . . 72.55 110.595 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -52.9 -58.11 8.03 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.626 0.602 . . . . 74.12 112.626 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.61 -11.9 13.49 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.686 0.625 . . . . 71.24 112.686 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -91.16 -63.09 1.31 Allowed 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.927 0.394 . . . . 74.04 111.0 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 104' ' ' GLU . 17.4 m -66.72 -33.74 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 112.631 0.604 . . . . 71.15 112.631 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.18 -31.3 71.62 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.998 0.428 . . . . 75.21 110.343 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.51 -46.01 60.86 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.26 -0.427 . . . . 60.1 111.171 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.455 ' CZ ' ' HG3' ' A' ' 174' ' ' GLU . 85.4 t80 -59.43 -48.0 83.32 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.189 0.519 . . . . 71.25 110.728 175.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -55.18 -39.07 69.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.913 -0.585 . . . . 73.14 110.774 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -65.42 -36.61 84.46 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.054 -0.521 . . . . 75.21 110.972 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -64.0 -52.45 59.52 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.216 -0.447 . . . . 65.13 111.61 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.462 HD11 HD11 ' A' ' 26' ' ' LEU . 42.1 mm -63.41 -42.44 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.853 0.359 . . . . 75.12 111.38 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -60.95 -48.26 82.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.824 0.345 . . . . 74.01 110.922 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.51 -38.22 95.44 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.157 -0.544 . . . . 54.22 112.564 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 50.7 t90 -60.73 -55.1 37.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.647 0.261 . . . . 74.42 111.215 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.2 m -66.17 -47.47 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 112.482 0.549 . . . . 71.31 112.482 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -59.52 -35.93 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 121.995 -0.441 . . . . 62.2 111.684 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.5 t -78.52 -41.46 32.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.913 0.387 . . . . 74.22 111.017 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 155' ' ' ILE . 52.1 tp -63.82 -38.24 90.36 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.104 -0.498 . . . . 74.04 112.02 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 84.3 mt -77.17 3.26 13.1 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.477 0.547 . . . . 65.15 112.477 -177.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.432 ' HB3' ' HD2' ' A' ' 133' ' ' PHE . . . -62.71 78.72 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.442 0.639 . . . . 55.5 111.716 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.665 ' H ' ' HD3' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -39.47 -39.15 0.65 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.35 1.241 . . . . 65.31 114.35 -178.143 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.96 -44.76 67.38 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.271 0.471 . . . . 75.41 112.271 -169.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.691 ' HD2' ' H ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -108.22 -36.33 6.31 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.267 -0.424 . . . . 71.31 111.652 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.432 ' HD2' ' HB3' ' A' ' 129' ' ' ALA . 86.7 m-85 -73.94 -5.79 43.39 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.241 0.46 . . . . 74.34 112.241 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -44.69 -26.52 0.39 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.1 0.476 . . . . 65.23 112.128 168.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 53' ' ' GLU . 27.3 m-80 -91.89 23.81 3.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.535 0.569 . . . . 71.32 112.535 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.463 ' HB2' ' SG ' ' A' ' 81' ' ' CYS . 66.9 mt -89.38 157.64 18.08 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.206 0.527 . . . . 73.21 111.204 176.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.4 120.83 36.15 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.001 -0.545 . . . . 73.44 110.653 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.402 ' HE2' ' HG ' ' A' ' 81' ' ' CYS . 59.3 m-85 -109.36 121.73 45.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.066 0.46 . . . . 75.43 110.752 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.52 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 56.9 m-85 -110.47 132.01 54.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.402 0.62 . . . . 74.04 111.895 -177.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 145' ' ' ALA . 6.1 tp -115.14 146.87 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.541 -0.754 . . . . 75.33 110.985 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.04 153.9 37.65 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.155 0.422 . . . . 52.22 114.155 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -46.94 -70.55 0.09 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.06 0.763 . . . . 62.45 113.06 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -68.8 -21.74 64.3 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.261 0.553 . . . . 60.2 111.196 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.693 ' HB1' ' HA2' ' A' ' 151' ' ' GLY . . . -66.52 -49.93 64.89 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.879 -0.6 . . . . 73.14 111.577 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.45 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -61.82 -17.95 58.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.183 -0.462 . . . . 40.34 111.865 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -82.22 11.05 5.76 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.16 -0.473 . . . . 72.22 111.711 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.1 54.61 7.87 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.219 -0.515 . . . . 64.23 113.181 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 150' ' ' ASN . . . -115.09 18.71 16.16 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.71 0.633 . . . . 61.45 112.71 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 69.17 -26.42 0.15 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.934 0.716 . . . . 75.01 112.934 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 148' ' ' ALA . 51.1 t30 -77.42 44.52 0.43 Allowed 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.568 0.699 . . . . 63.34 110.529 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.693 ' HA2' ' HB1' ' A' ' 144' ' ' ALA . . . -96.63 100.77 2.52 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.058 -0.519 . . . . 50.23 114.021 -175.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -119.88 126.8 51.83 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.725 0.298 . . . . 74.0 110.575 174.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 81.4 t -86.24 134.39 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.734 0.642 . . . . 72.02 112.734 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.04 122.27 42.07 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.816 -0.629 . . . . 74.21 109.719 170.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.494 HD13 HD21 ' A' ' 127' ' ' LEU . 47.5 mt -91.42 140.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.774 -0.37 . . . . 72.52 111.865 -171.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 168' ' ' THR . 43.3 mm -123.17 109.59 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.227 -0.442 . . . . 72.24 111.183 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 4.0 mp0 -90.86 149.33 21.98 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.261 0.553 . . . . 63.51 111.926 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -87.78 109.34 19.66 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.181 -0.463 . . . . 72.41 109.826 171.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 2.3 mmp_? -110.45 135.4 51.19 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.003 0.371 . . . . 74.51 112.003 -174.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -86.56 116.31 24.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.125 0.488 . . . . 54.33 111.39 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -108.14 90.61 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.294 -0.412 . . . . 62.35 110.778 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.1 t70 57.38 33.54 23.42 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.815 -0.63 . . . . 63.03 111.563 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 100.97 8.2 48.55 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.088 -0.577 . . . . 70.1 113.323 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 m -122.72 106.06 10.61 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 122.473 -0.428 . . . . 65.22 111.021 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -78.31 104.22 8.75 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.926 0.393 . . . . 73.55 111.567 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 35.2 m -118.57 144.15 34.78 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.817 0.342 . . . . 73.04 111.588 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 16.6 Cg_exo -70.42 146.3 55.74 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.974 2.449 . . . . 45.11 113.47 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 90.8 m -136.02 150.74 49.32 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.294 -0.412 . . . . 64.52 110.82 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 58.9 tp -95.8 135.54 37.39 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.595 0.591 . . . . 72.41 112.595 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 36.0 ttp -127.41 130.15 48.81 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.303 0.573 . . . . 75.31 111.762 174.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 88.1 mt -139.61 141.7 37.11 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.61 -0.723 . . . . 64.32 110.895 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.536 HG11 ' CZ ' ' A' ' 95' ' ' PHE . 21.2 t -87.11 132.22 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.538 -0.726 . . . . 71.33 112.309 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -57.88 -39.72 78.53 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.586 0.587 . . . . 61.44 112.586 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 116' ' ' PHE . 23.5 mm-40 -75.54 -0.17 19.43 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 111.971 0.36 . . . . 43.4 111.971 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.72 -30.61 8.86 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.12 0.486 . . . . 74.4 110.481 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 172' ' ' VAL . 5.3 tt -127.45 109.19 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.295 -0.866 . . . . 65.23 111.178 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.4 mm -100.81 118.52 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.407 -0.36 . . . . 75.13 111.142 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.429 ' HB2' HD21 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -92.84 121.36 34.13 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.832 0.825 . . . . 74.3 111.259 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -94.61 111.03 22.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.74 0.781 . . . . 74.24 110.44 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -82.16 95.88 7.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.197 -0.911 . . . . 74.45 111.384 -177.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 42.5 t -102.51 88.05 3.16 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.159 0.504 . . . . 73.54 110.048 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.15 140.41 52.28 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.044 -0.526 . . . . 73.53 110.964 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 C--O 1.254 1.322 0 CA-C-O 118.684 -0.674 . . . . 75.13 111.664 178.897 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 120.543 0.211 . . . . 74.42 111.012 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 178' ' ' GLU . 59.1 tp -114.53 128.42 56.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.796 0.331 . . . . 75.44 110.866 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.523 HG12 ' HB3' ' A' ' 15' ' ' SER . 52.6 mt -105.24 127.38 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.641 -0.254 . . . . 70.11 110.703 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -118.16 149.0 41.8 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.2 0.524 . . . . 75.11 111.789 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 13' ' ' LEU . 17.0 ttpp -150.64 120.93 7.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.666 -0.697 . . . . 65.12 111.29 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.638 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.3 m-20 -71.83 174.05 7.43 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.778 0.323 . . . . 75.32 110.293 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.8 pt -86.51 -3.97 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.981 0.42 . . . . 63.14 111.433 172.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.444 ' HE1' ' HD2' ' A' ' 94' ' ' LYS . 73.7 m-85 -108.98 -27.61 9.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.11 0.411 . . . . 74.34 112.11 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.638 HG22 ' HB2' ' A' ' 6' ' ' ASP . 2.0 t -106.0 20.33 19.12 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.591 0.589 . . . . 72.44 112.591 -170.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -44.83 -19.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.218 1.192 . . . . 51.34 114.218 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -86.96 -33.26 19.72 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 122.026 -0.421 . . . . 63.12 111.733 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.75 25.49 2.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.81 0.444 . . . . 75.0 111.893 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 5' ' ' LYS . 56.6 tp -38.08 124.34 1.18 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.233 0.613 . . . . 74.42 112.249 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -137.87 174.35 10.67 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.243 0.461 . . . . 55.21 112.243 -175.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.523 ' HB3' HG12 ' A' ' 3' ' ' ILE . 78.5 p -141.39 135.52 30.49 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.635 0.606 . . . . 72.42 112.635 -175.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -129.75 -173.95 3.17 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.04 0.448 . . . . 72.12 111.652 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.5 p -103.89 -3.84 24.27 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.9 0.704 . . . . 73.43 112.9 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 79.9 m-85 -76.36 131.55 74.68 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 112.004 0.372 . . . . 72.12 112.004 -175.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 6.7 Cg_exo -74.0 172.69 15.41 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.113 2.542 . . . . 74.42 113.555 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.0 ptm -111.64 130.75 55.66 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.044 0.387 . . . . 74.31 112.044 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -120.73 98.21 5.91 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.876 -0.416 . . . . 72.15 109.876 172.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.424 HD21 ' HA ' ' A' ' 25' ' ' ASP . 52.8 tp -100.04 133.88 43.77 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.201 -0.454 . . . . 64.52 112.193 -172.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.55 134.7 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.234 0.54 . . . . 73.23 111.722 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 t70 55.73 15.21 1.51 Allowed 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.195 -0.911 . . . . 53.2 111.885 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.424 ' HA ' HD21 ' A' ' 22' ' ' LEU . 4.7 m-20 53.36 25.7 4.76 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.937 0.398 . . . . 72.53 111.867 -175.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 tp -114.26 -49.64 2.84 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.162 -0.472 . . . . 75.53 111.25 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 172' ' ' VAL . 16.9 m -137.42 157.77 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.923 0.392 . . . . 74.15 111.913 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -92.47 149.28 21.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.433 -0.348 . . . . 74.23 110.369 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 31.8 tt0 -125.78 124.48 41.09 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.202 0.314 . . . . 75.3 110.597 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 59.1 t80 -127.45 131.25 50.24 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.006 0.432 . . . . 74.32 110.818 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HG2' HG22 ' A' ' 168' ' ' THR . 36.5 mtmm -119.93 119.09 32.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.73 0.3 . . . . 72.42 110.971 -178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.13 -157.42 19.4 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.217 0.447 . . . . 71.31 114.217 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -112.47 159.04 19.15 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.922 0.391 . . . . 75.32 111.84 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -89.05 107.1 18.85 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.375 -0.375 . . . . 73.13 110.436 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 m -142.34 159.5 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.495 0.664 . . . . 70.14 112.361 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 66' ' ' ARG . 17.3 m -139.15 139.94 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.475 -0.784 . . . . 73.31 110.279 175.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.496 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 20.6 ttt180 -121.45 117.57 27.21 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.441 0.639 . . . . 73.21 111.223 173.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 85.9 tttt -131.86 152.53 50.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.803 -0.635 . . . . 71.43 110.617 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -42.92 -46.89 5.54 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.188 0.518 . . . . 65.44 111.774 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' H ' ' HG2' ' A' ' 38' ' ' LYS . . . -120.57 49.4 0.88 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-N 116.183 -0.462 . . . . 73.02 113.28 178.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.635 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 10.5 tp10 -177.24 138.81 0.25 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.445 0.298 . . . . 75.42 110.777 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.647 HG13 HG23 ' A' ' 43' ' ' VAL . 6.8 tp -163.85 131.17 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 121.066 0.46 . . . . 64.22 112.175 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.647 HG23 HG13 ' A' ' 42' ' ' ILE . 75.7 t 59.97 110.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.672 -0.694 . . . . 42.4 112.08 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.501 HD21 HG22 ' A' ' 36' ' ' VAL . 1.1 mm? -82.93 173.92 11.37 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.136 0.493 . . . . 71.51 111.533 -178.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.42 -63.73 0.3 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.107 -0.497 . . . . 42.54 110.857 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.33 -167.21 13.63 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.444 -0.408 . . . . 44.54 113.121 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.4 p -125.38 -169.9 2.08 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 122.579 -0.365 . . . . 55.3 111.307 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -93.43 154.59 41.29 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 120.699 0.285 . . . . 74.42 111.583 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.82 165.33 32.53 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.38 2.053 . . . . 54.42 112.743 176.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.8 t 61.57 30.2 18.59 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.38 0.61 . . . . 62.3 111.706 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.06 19.37 0.23 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.678 0.621 . . . . 70.24 112.678 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.02 -51.02 27.8 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 122.114 -0.366 . . . . 45.12 110.966 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -69.71 -36.88 76.29 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.987 0.423 . . . . 72.24 110.961 174.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.4 -36.68 2.21 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 116.167 -0.47 . . . . 23.13 114.028 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.79 86.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.974 0.731 . . . . 53.01 112.974 -175.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 42.6 tt0 -131.74 15.56 4.83 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.978 0.894 . . . . 51.33 109.218 171.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -83.0 103.85 12.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.273 -0.876 . . . . 72.51 113.127 -172.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -95.75 -5.28 42.36 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.067 0.46 . . . . 72.31 110.719 170.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.43 81.14 1.53 Allowed Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.143 -0.48 . . . . 50.44 112.879 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.5 m -78.58 73.64 5.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.981 0.42 . . . . 53.33 111.092 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -99.12 -74.87 0.58 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 110.061 -0.348 . . . . 65.41 110.061 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.604 ' HB2' HG23 ' A' ' 64' ' ' VAL . 43.8 mt-10 50.07 21.89 0.82 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.363 0.875 . . . . 73.34 113.363 176.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.5 m80 59.28 19.46 7.6 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.098 0.407 . . . . 71.12 112.098 -175.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.604 HG23 ' HB2' ' A' ' 62' ' ' GLU . 99.6 t -66.16 141.28 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 122.714 0.405 . . . . 64.23 111.841 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.6 mp0 -69.74 69.94 0.31 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.393 0.616 . . . . 63.31 109.558 169.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 36' ' ' VAL . 11.6 ptm180 -98.27 137.47 36.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.499 -0.773 . . . . 73.53 112.684 -176.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.58 -127.02 4.69 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.914 -0.66 . . . . 52.22 113.296 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 70' ' ' ILE . 23.2 pt -110.55 138.21 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.838 0.352 . . . . 64.54 111.817 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -46.33 -34.75 4.78 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.021 -0.536 . . . . 71.34 111.864 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 68' ' ' ILE . 57.1 mt -48.36 -58.73 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.315 0.579 . . . . 73.42 112.311 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.62 -31.26 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.021 -0.536 . . . . 64.04 112.191 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.2 mt -67.5 -41.36 84.63 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.004 0.43 . . . . 74.31 111.241 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -54.62 -38.25 66.59 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.846 -0.616 . . . . 63.3 111.701 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -107.72 19.51 20.03 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.535 -0.302 . . . . 75.44 111.156 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt 43.89 43.07 5.0 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.897 0.879 . . . . 75.12 113.273 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.1 mt -70.52 162.16 29.31 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.206 0.527 . . . . 64.14 112.135 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.13 141.17 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 116.38 -0.373 . . . . 72.13 110.98 176.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -81.06 119.06 23.06 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.003 0.43 . . . . 72.45 112.065 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 53.2 ttm -112.19 139.48 47.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.062 -0.517 . . . . 74.24 109.82 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.4 ' HB2' ' HD1' ' A' ' 82' ' ' TYR . 15.9 m120 -122.57 156.77 33.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.391 0.615 . . . . 73.21 112.117 -175.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 25.1 p -72.17 -3.18 21.89 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.612 0.967 . . . . 72.4 113.612 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.408 ' CG ' ' N ' ' A' ' 83' ' ' GLU . 11.0 p90 -54.96 -54.83 37.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.914 0.387 . . . . 54.02 111.707 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.408 ' N ' ' CG ' ' A' ' 82' ' ' TYR . 8.8 tp10 -104.17 -45.08 4.81 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.612 0.72 . . . . 71.15 110.583 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.16 18.08 0.09 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.456 -0.793 . . . . 72.52 113.029 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -54.28 -41.74 69.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.231 0.539 . . . . 53.21 110.956 173.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -70.13 -24.4 63.18 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.853 -0.612 . . . . 33.52 111.905 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -62.81 -62.48 1.69 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.65 -0.25 . . . . 63.24 110.784 -179.626 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.557 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 30.2 p90 -68.38 -23.08 64.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.722 -0.391 . . . . 75.12 111.312 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -54.39 -60.35 3.47 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.188 0.518 . . . . 74.43 111.034 171.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.23 -38.43 75.22 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.176 -0.466 . . . . 73.24 111.414 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.486 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 55.7 t80 -57.13 -52.6 64.66 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.127 -0.488 . . . . 73.5 110.909 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.532 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 41.4 mm -65.81 -31.0 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.03 0.382 . . . . 62.13 112.03 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -59.43 -60.46 3.82 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.039 0.447 . . . . 73.33 111.202 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HD2' ' HE1' ' A' ' 8' ' ' PHE . 8.0 tmtm? -62.05 -41.52 98.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.14 0.495 . . . . 74.12 110.128 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.623 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 21.7 t80 -52.87 -45.87 67.64 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.878 -0.601 . . . . 70.32 111.676 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 55.2 ttp -58.13 -50.14 74.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.304 0.573 . . . . 60.2 110.944 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -64.22 -35.53 81.11 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.114 -0.494 . . . . 70.31 111.786 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.92 -41.91 64.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.563 -0.289 . . . . 74.32 111.631 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.0 m -65.31 -39.6 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.957 -0.464 . . . . 74.35 111.144 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.04 -44.79 95.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.821 0.343 . . . . 63.04 110.398 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.97 -40.11 69.67 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.235 0.54 . . . . 75.21 111.011 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -66.31 -43.99 84.71 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.996 -0.547 . . . . 63.12 112.329 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 96.4 mmm -86.71 -53.69 4.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.772 0.656 . . . . 63.13 112.772 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -49.62 -40.2 38.35 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.739 0.415 . . . . 73.34 111.748 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -53.8 -43.1 69.06 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.225 0.454 . . . . 74.05 112.225 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -102.28 -3.01 27.91 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.466 0.543 . . . . 75.41 112.466 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 4.4 m-20 -101.03 -61.79 1.33 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.297 0.48 . . . . 73.21 112.297 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 107' ' ' ASN . 2.5 ptp180 72.49 -15.29 0.5 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.096 0.958 . . . . 71.45 112.543 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.481 ' O ' HG22 ' A' ' 113' ' ' VAL . 0.4 OUTLIER -71.71 84.5 0.9 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.317 0.58 . . . . 75.13 111.557 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -52.71 -18.82 2.01 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.85 -0.614 . . . . 72.31 112.54 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.42 -42.75 19.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.1 0.407 . . . . 45.55 112.1 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.458 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 37.2 t70 -81.21 -46.08 15.36 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 122.212 -0.305 . . . . 63.23 111.768 -174.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 109' ' ' ASP . 24.3 m -58.42 -27.36 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 122.052 -0.405 . . . . 65.3 111.177 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -70.78 -35.71 72.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.327 -0.397 . . . . 75.43 110.665 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.82 -46.7 74.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.341 -0.39 . . . . 55.0 110.868 176.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 82.5 t80 -62.84 -42.02 99.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.971 0.415 . . . . 73.02 110.384 174.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 117' ' ' LYS . 4.1 tmmm? -50.96 -46.95 61.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.27 -0.423 . . . . 61.44 110.064 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -63.46 -34.66 78.25 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.37 -0.377 . . . . 70.23 111.648 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 116' ' ' PHE . 71.8 mmtt -56.61 -60.73 3.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.991 0.425 . . . . 63.34 111.196 174.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.17 -32.21 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 116.102 -0.499 . . . . 62.51 111.607 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 125' ' ' VAL . 19.5 tm0? -64.57 -55.76 18.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.87 0.367 . . . . 71.2 110.859 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.27 -32.86 78.14 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.871 -0.681 . . . . 53.41 112.471 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 -62.49 -57.7 10.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.207 0.203 . . . . 73.31 111.188 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 30.6 m -63.66 -38.82 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.249 0.463 . . . . 61.33 112.249 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 121' ' ' GLN . 53.4 t -55.39 -44.01 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.173 0.511 . . . . 45.03 111.159 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.9 m -75.62 -35.97 60.37 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.098 0.475 . . . . 74.31 111.016 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 155' ' ' ILE . 41.3 tp -66.41 -28.91 68.99 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.831 -0.622 . . . . 54.53 111.83 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 74.5 mt -90.04 3.97 51.64 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.289 -0.414 . . . . 64.42 112.086 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.476 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -59.63 92.72 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.413 0.625 . . . . 62.34 111.057 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -66.87 -7.86 24.87 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.695 0.998 . . . . 72.43 113.695 -170.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -71.48 -46.38 60.01 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.812 -0.555 . . . . 73.31 111.024 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 44.0 mtm-85 -109.36 -50.38 3.0 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.123 0.487 . . . . 74.32 111.806 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.476 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 22.4 m-85 -68.07 -7.56 30.47 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.404 0.52 . . . . 64.23 112.404 -173.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.51 -14.12 38.16 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.072 0.463 . . . . 72.14 111.324 175.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -93.32 19.36 8.31 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.151 0.426 . . . . 73.41 112.151 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.412 HD11 ' HD2' ' A' ' 133' ' ' PHE . 76.7 mt -88.51 147.29 24.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.318 0.58 . . . . 73.13 111.796 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.4 119.04 38.36 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.055 -0.521 . . . . 71.1 111.28 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -95.04 106.32 18.31 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.883 0.373 . . . . 75.1 110.544 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -94.48 132.81 38.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.519 0.676 . . . . 73.42 112.185 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 tp -124.7 149.08 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.32 -0.855 . . . . 74.33 110.394 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.64 141.56 27.48 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.289 -0.481 . . . . 75.34 113.377 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -48.28 -57.13 6.41 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.055 0.542 . . . . 73.21 111.739 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.424 ' O ' ' HD3' ' A' ' 143' ' ' ARG . 4.0 tmt_? -77.81 -28.97 50.49 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.189 0.518 . . . . 71.42 110.999 177.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.42 78.14 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.139 0.422 . . . . 62.13 112.139 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.33 -40.03 77.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.015 0.436 . . . . 73.41 111.737 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -71.09 -27.36 63.55 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.005 -0.543 . . . . 74.43 111.048 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -78.54 -44.14 11.27 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.218 -0.515 . . . . 74.01 112.963 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 64.83 2.29 1.67 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.286 0.847 . . . . 53.14 113.286 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -133.05 13.02 4.29 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.92 -0.488 . . . . 75.3 111.83 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -151.07 85.01 1.33 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.96 0.41 . . . . 45.53 110.22 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 158.33 133.52 1.56 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.948 -0.644 . . . . 75.23 113.52 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.38 142.12 29.52 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.695 -0.483 . . . . 73.14 109.695 174.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 48.4 t -75.9 117.28 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.581 0.705 . . . . 71.53 111.911 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.82 98.95 8.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.746 -0.661 . . . . 54.53 110.659 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 57.1 mt -85.99 117.08 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 120.794 0.331 . . . . 63.42 111.519 -175.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 51.0 mm -99.58 115.9 41.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.434 -0.348 . . . . 74.12 111.5 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 32.1 tt0 -104.02 144.36 31.65 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.868 -0.606 . . . . 75.54 111.659 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -85.81 88.8 7.61 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.251 0.548 . . . . 74.31 110.233 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.526 ' NH2' HG22 ' A' ' 161' ' ' VAL . 16.0 ttp180 -100.29 154.89 18.11 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.466 0.651 . . . . 71.35 111.959 -174.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.98 142.23 28.0 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.743 -0.662 . . . . 72.33 111.389 176.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.526 HG22 ' NH2' ' A' ' 159' ' ' ARG . 72.1 t -129.22 89.31 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.92 0.39 . . . . 74.31 110.824 171.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 51.76 25.64 3.05 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.926 -0.579 . . . . 71.25 112.305 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 129.18 -37.84 2.13 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.368 -0.444 . . . . 41.23 113.493 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 78.4 p -88.88 119.41 29.36 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.564 -0.374 . . . . 75.03 111.737 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.66 114.31 15.26 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.095 -0.502 . . . . 53.12 111.117 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 161' ' ' VAL . 17.4 m -125.76 138.22 31.54 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 121.042 0.449 . . . . 64.45 112.085 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.495 ' HG2' HG21 ' A' ' 68' ' ' ILE . 15.8 Cg_exo -71.36 115.99 4.51 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.884 2.39 . . . . 54.11 112.62 173.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.472 HG22 ' HG2' ' A' ' 31' ' ' LYS . 69.8 p -96.1 138.89 33.07 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.152 0.501 . . . . 65.45 112.01 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 61.1 tp -89.11 117.3 28.0 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.086 -0.506 . . . . 62.45 111.525 176.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.555 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 61.7 mtt -101.32 124.38 46.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.791 0.329 . . . . 61.43 111.413 176.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.476 ' HB3' HD11 ' A' ' 176' ' ' ILE . 96.0 mt -133.87 122.14 22.75 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.528 -0.306 . . . . 74.03 110.903 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.623 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 59.0 t -68.35 118.97 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.057 0.456 . . . . 51.32 111.899 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.47 -24.23 67.11 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.789 0.663 . . . . 73.32 112.789 -177.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.451 ' HB2' ' HZ ' ' A' ' 116' ' ' PHE . 5.5 tp10 -90.86 -3.08 57.64 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.966 -0.459 . . . . 73.1 111.06 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.583 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -97.03 -44.09 7.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.056 0.455 . . . . 70.11 110.219 175.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 171' ' ' LEU . 29.1 pt -116.79 109.4 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.877 -0.601 . . . . 70.03 110.611 172.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.5 tp -94.42 138.88 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.969 0.414 . . . . 75.11 110.808 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.633 ' HB2' HD11 ' A' ' 2' ' ' LEU . 1.8 pp20? -104.99 153.94 20.76 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.396 0.617 . . . . 71.44 112.394 -174.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 35.3 tt0 -140.09 99.77 3.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 74.11 109.406 172.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.564 ' HB3' HD13 ' A' ' 2' ' ' LEU . 19.3 pttm -102.27 132.52 48.17 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.313 0.857 . . . . 74.13 113.313 -170.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 48.6 t -125.21 88.9 2.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.358 -0.837 . . . . 74.43 109.63 168.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 180' ' ' LYS . 3.1 mm? -121.08 104.27 9.65 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.934 -0.576 . . . . 74.22 110.418 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 119.166 -0.445 . . . . 71.15 111.281 -177.593 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 121.041 0.448 . . . . 73.03 111.615 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 34.5 tp -109.53 135.0 51.23 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.571 -0.529 . . . . 72.35 109.571 174.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.0 tt -100.5 120.64 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.284 0.564 . . . . 72.12 111.668 -175.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 47.2 p90 -118.84 143.01 47.21 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.182 0.515 . . . . 72.23 111.416 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 5' ' ' LYS . 19.7 ptpt -140.29 121.88 15.22 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.646 -0.706 . . . . 75.13 110.771 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 9' ' ' THR . 3.6 m-20 -71.45 164.53 25.63 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.813 -0.555 . . . . 71.24 111.119 175.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.3 mt -55.81 -33.07 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.183 -0.462 . . . . 73.12 111.371 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 150' ' ' ASN . 9.1 p90 -109.45 -24.38 11.05 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.28 0.844 . . . . 72.15 113.28 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 152' ' ' GLN . 2.9 m -90.65 14.95 11.94 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.429 0.529 . . . . 63.41 112.429 -173.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.461 ' O ' HD22 ' A' ' 13' ' ' LEU . 8.5 p-10 -62.37 -10.76 12.3 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.619 0.97 . . . . 72.33 113.619 -173.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -86.48 -43.46 12.75 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.105 0.478 . . . . 43.41 111.324 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.75 ' HG3' ' HB2' ' A' ' 144' ' ' ALA . 18.1 mm-40 -96.16 22.9 7.07 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.297 -0.41 . . . . 62.12 111.537 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 2.0 pt? -57.89 165.04 1.92 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.186 0.517 . . . . 61.11 111.868 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 75.3 m -141.37 156.86 45.78 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.512 0.56 . . . . 64.2 112.512 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.6 p -127.24 110.22 12.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.856 -0.611 . . . . 71.31 111.333 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -161.67 176.36 11.05 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.74 -0.467 . . . . 73.14 109.74 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.3 m -123.88 79.86 1.76 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.932 -0.48 . . . . 74.23 111.772 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -98.37 125.73 42.15 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.155 -0.475 . . . . 54.1 111.093 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.03 117.64 4.84 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.613 2.209 . . . . 43.4 112.713 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.434 ' HA ' ' HB3' ' A' ' 30' ' ' PHE . 61.3 mtt -109.84 162.23 14.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.377 0.608 . . . . 54.33 112.412 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 62.4 mttm -127.44 103.06 7.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.901 -0.59 . . . . 64.22 110.219 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 54.0 tp -75.49 101.85 5.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.07 0.462 . . . . 75.13 111.635 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.34 133.86 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.092 0.472 . . . . 74.23 111.783 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t0 56.5 19.21 3.99 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.59 -0.732 . . . . 74.1 112.058 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.419 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 45.3 m-20 59.35 9.86 1.58 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.233 0.613 . . . . 55.41 112.561 -177.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.2 tp -106.21 -47.1 3.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.908 0.385 . . . . 71.33 111.881 -173.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 172' ' ' VAL . 3.2 m -134.71 150.19 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.678 0.622 . . . . 65.1 112.678 -176.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.557 ' HE2' HG21 ' A' ' 176' ' ' ILE . 64.2 m-85 -86.02 122.14 29.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.886 -0.597 . . . . 75.05 110.696 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 33.4 tt0 -114.09 108.48 17.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.604 0.362 . . . . 52.14 110.148 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.434 ' HB3' ' HA ' ' A' ' 20' ' ' MET . 15.1 p90 -143.62 121.0 11.63 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.784 1.031 . . . . 70.31 113.784 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 168' ' ' THR . 10.3 tmtt? -90.72 121.28 32.48 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.891 -1.049 . . . . 74.32 110.794 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.72 -120.95 1.12 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.107 -0.568 . . . . 71.23 113.093 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 69' ' ' ASP . 67.0 mttm -114.09 134.97 54.52 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.319 -0.519 . . . . 73.1 110.449 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -86.85 107.0 18.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.181 0.515 . . . . 73.14 109.62 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.484 ' HB ' HD11 ' A' ' 42' ' ' ILE . 28.8 m -137.81 145.37 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.981 0.419 . . . . 73.11 111.933 -173.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 43' ' ' VAL . 2.5 m -127.56 134.44 65.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.061 0.458 . . . . 71.23 110.919 176.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.797 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 26.3 mmm180 -105.7 110.54 22.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.93 0.395 . . . . 74.14 111.372 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -105.51 154.08 20.86 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.036 -0.529 . . . . 74.31 110.472 173.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -60.87 84.73 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.48 0.657 . . . . 51.34 110.957 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.24 -39.28 1.06 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.26 -0.882 . . . . 73.54 113.463 178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -171.23 158.92 5.62 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 117.281 0.541 . . . . 71.3 111.964 -174.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.484 HD11 ' HB ' ' A' ' 35' ' ' VAL . 12.5 tt -90.51 116.66 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-O 121.174 0.512 . . . . 71.41 111.683 177.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 36' ' ' VAL . 34.2 t -108.39 74.72 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.781 0.801 . . . . 53.31 111.359 -178.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 35' ' ' VAL . 1.8 pp -85.86 18.01 3.16 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.34 0.867 . . . . 75.05 113.34 -174.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.85 136.56 47.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.042 0.449 . . . . 71.44 111.514 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.57 -132.09 3.27 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.508 -0.377 . . . . 45.13 112.913 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.4 t -169.51 168.24 9.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.347 0.259 . . . . 73.22 111.096 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -118.92 91.79 43.71 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-O 120.679 0.276 . . . . 74.33 111.033 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -97.01 147.41 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.196 2.597 . . . . 55.42 113.982 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.1 p -77.11 95.76 4.31 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.992 0.425 . . . . 73.32 110.563 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.21 34.68 3.29 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.967 0.413 . . . . 70.45 112.094 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -76.34 78.25 3.1 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.149 0.5 . . . . 64.51 111.444 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -177.86 -64.71 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.923 -0.581 . . . . 55.23 111.181 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.62 92.68 0.14 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.152 -0.547 . . . . 60.41 113.077 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.67 27.16 0.23 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.29 0.567 . . . . 64.03 111.248 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -94.86 -24.9 16.82 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.764 -0.653 . . . . 75.31 112.35 -174.636 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.59 -145.22 0.07 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 120.443 0.163 . . . . 65.42 111.373 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 66.82 16.66 10.42 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.157 0.429 . . . . 74.22 112.157 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.59 74.01 1.13 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.187 -0.53 . . . . 75.22 113.293 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.1 m -105.7 4.51 30.14 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.65 -0.323 . . . . 74.12 111.638 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.49 -66.55 0.52 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 111.808 0.299 . . . . 72.11 111.808 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 59.99 -77.13 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.045 0.538 . . . . 73.52 112.419 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -81.4 54.64 2.37 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.666 0.746 . . . . 62.1 111.609 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.4 t -140.25 122.31 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.586 -0.734 . . . . 43.11 109.783 175.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.797 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 2.5 mp0 -76.31 66.89 2.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.218 0.532 . . . . 72.2 111.141 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.45 HH11 ' HD2' ' A' ' 66' ' ' ARG . 9.5 ptm180 -93.24 116.9 29.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.898 -0.592 . . . . 71.23 111.909 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.6 -140.46 5.2 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.547 -0.835 . . . . 72.43 113.812 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.1 pt -110.94 143.61 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 112.354 0.502 . . . . 72.21 112.354 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . 27.3 t70 -45.16 -43.46 9.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.913 -0.585 . . . . 74.24 112.433 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 58.5 mt -49.51 -60.88 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.242 0.46 . . . . 74.14 112.242 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.494 ' HA ' HD12 ' A' ' 76' ' ' LEU . 21.1 m -73.89 -33.11 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.097 0.406 . . . . 52.32 112.097 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.411 HD12 HG23 ' A' ' 35' ' ' VAL . 87.5 mt -74.3 -28.22 61.08 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.014 0.376 . . . . 71.22 112.014 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -83.37 -40.74 19.03 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.661 0.267 . . . . 51.04 111.424 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -86.68 -9.76 55.27 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.076 0.399 . . . . 74.54 112.076 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 67.4 71.13 0.36 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.355 0.598 . . . . 62.11 111.993 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 71' ' ' VAL . 67.6 mt -106.71 135.97 47.33 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.897 -0.592 . . . . 52.13 110.513 176.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.17 140.06 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.218 0.532 . . . . 73.22 112.379 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.23 143.51 57.73 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.396 0.888 . . . . 74.33 113.396 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.616 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 84.7 mtp -134.92 153.67 51.98 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.008 -0.542 . . . . 71.41 110.669 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.457 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 25.1 t-20 -148.06 156.47 42.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.63 0.253 . . . . 65.0 111.06 -177.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 40.9 t -37.32 -48.95 0.94 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.55 1.315 . . . . 72.44 114.55 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 12.2 p90 -59.75 -36.73 77.22 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.143 0.423 . . . . 75.34 112.143 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -81.85 -37.41 27.02 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.867 0.365 . . . . 63.32 111.395 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 2.7 m-20 -66.76 -22.58 66.04 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.689 0.626 . . . . 52.32 112.689 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.434 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -42.4 -64.88 0.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.021 0.439 . . . . 65.22 111.98 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.3 t -64.6 -33.17 75.29 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.887 0.375 . . . . 75.52 111.625 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.467 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 25.4 mmt -64.15 -65.24 0.7 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.278 -0.419 . . . . 75.11 112.034 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.434 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 10.5 p90 -61.66 -28.7 69.58 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.715 -0.394 . . . . 74.32 111.311 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -55.01 -61.64 2.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.724 -0.39 . . . . 75.15 110.799 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.14 82.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.285 -0.416 . . . . 61.13 111.841 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -60.47 -59.71 4.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.22 0.452 . . . . 65.22 112.22 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.3 mm -54.9 -39.77 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.166 0.432 . . . . 74.44 112.166 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -59.54 -57.29 13.62 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.04 0.385 . . . . 73.45 112.04 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.88 -51.8 60.0 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.803 0.335 . . . . 75.41 111.149 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CZ ' HG11 ' A' ' 172' ' ' VAL . 29.3 t80 -46.43 -48.94 18.73 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.095 0.558 . . . . 65.04 112.118 176.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 37.5 ttp -62.09 -34.7 76.8 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.996 0.427 . . . . 74.22 111.377 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.4 -49.71 68.22 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.466 -0.333 . . . . 71.42 110.901 174.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -59.85 -46.32 89.67 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.31 0.485 . . . . 72.05 112.31 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.5 -39.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 112.071 0.397 . . . . 71.12 112.071 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.464 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 15.0 mm -70.27 -49.2 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 122.271 -0.268 . . . . 60.31 111.355 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.6 -41.17 69.62 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.423 0.63 . . . . 73.01 110.5 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -55.29 -57.11 13.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.615 -0.721 . . . . 75.13 110.995 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.567 ' HG3' HG12 ' A' ' 113' ' ' VAL . 12.6 tpt -62.59 -44.76 95.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.476 0.546 . . . . 64.21 112.476 -173.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 11.2 pt-20 -72.46 -38.69 68.17 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.942 -0.474 . . . . 72.3 112.161 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -68.86 -17.97 64.08 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.439 0.533 . . . . 71.42 112.439 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -113.19 -17.0 12.46 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.001 -0.437 . . . . 61.25 112.008 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -128.63 -73.28 0.59 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.627 0.232 . . . . 74.42 111.627 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 28.5 ttt85 75.24 -18.73 0.43 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.999 1.111 . . . . 73.52 113.999 176.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.496 ' O ' HG22 ' A' ' 113' ' ' VAL . 70.9 m-20 -57.91 121.39 10.42 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.743 -0.598 . . . . 64.12 111.782 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -44.58 -49.49 10.12 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.982 -0.554 . . . . 75.4 112.356 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.47 68.43 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.698 0.629 . . . . 61.33 112.698 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -92.7 -39.61 11.18 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 111.951 0.352 . . . . 74.34 111.951 -175.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.567 HG12 ' HG3' ' A' ' 103' ' ' MET . 16.3 m -68.89 -37.11 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.857 -0.527 . . . . 75.53 112.062 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.25 -35.98 74.16 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.963 0.411 . . . . 71.5 110.483 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.97 78.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.125 0.488 . . . . 51.43 111.007 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.17 -48.83 80.07 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.953 -0.567 . . . . 75.13 111.118 174.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -55.6 -38.25 69.18 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.922 -0.581 . . . . 75.5 111.062 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.28 -40.61 96.31 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.473 -0.33 . . . . 72.42 111.509 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -58.8 -57.26 13.81 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.331 -0.395 . . . . 72.42 111.394 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.0 tp -66.55 -35.33 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.34 -0.391 . . . . 61.32 111.384 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -62.31 -45.27 93.99 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.995 0.426 . . . . 73.23 110.609 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.67 -37.52 94.38 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.061 -0.59 . . . . 53.41 112.414 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 49.5 t90 -62.97 -50.25 71.52 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.866 -0.196 . . . . 74.45 111.51 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.5 m -68.59 -41.12 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.665 0.617 . . . . 72.4 112.665 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.95 -29.77 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.778 -0.576 . . . . 70.34 111.621 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.4 t -77.84 -51.29 10.7 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.054 0.454 . . . . 75.11 110.77 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.6 tp -57.94 -46.34 85.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.002 -0.545 . . . . 63.34 112.302 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.62 2.81 21.07 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.434 0.531 . . . . 62.33 112.434 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.09 80.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.377 0.608 . . . . 74.12 111.1 176.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -58.42 -14.62 8.12 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.875 0.694 . . . . 73.53 112.875 -173.642 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.27 -49.92 75.98 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.784 0.326 . . . . 61.51 111.369 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -112.41 -36.23 5.33 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.254 0.464 . . . . 63.1 112.254 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -67.64 -6.86 22.42 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.832 0.678 . . . . 73.3 112.832 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 14.9 ptmm? -55.31 -17.13 4.17 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.257 0.465 . . . . 73.44 112.257 176.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -90.41 20.96 4.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.448 0.536 . . . . 51.52 112.448 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.44 158.4 17.74 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.1 0.476 . . . . 74.31 111.634 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.81 51.81 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.152 -0.476 . . . . 74.35 110.62 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.616 ' HB2' ' HB2' ' A' ' 79' ' ' MET . 36.1 m-85 -112.18 157.24 21.11 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.218 -0.301 . . . . 71.34 110.888 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -137.53 147.21 44.98 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.806 0.336 . . . . 62.33 111.827 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.513 HD11 ' HA3' ' A' ' 151' ' ' GLY . 14.6 tt -138.67 160.01 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 116.421 -0.354 . . . . 65.21 110.813 177.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.05 156.81 28.37 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.278 -0.487 . . . . 64.32 113.848 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -59.13 -60.33 4.04 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.959 0.409 . . . . 72.12 111.006 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.521 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 4.0 mmp_? -73.69 -32.63 64.04 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.957 0.408 . . . . 62.01 111.104 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.75 ' HB2' ' HG3' ' A' ' 12' ' ' GLU . . . -53.06 -38.67 62.68 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.12 -0.491 . . . . 70.35 112.08 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.29 -39.42 63.95 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.286 0.476 . . . . 74.21 112.286 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -96.43 -17.05 20.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.846 0.355 . . . . 54.24 111.691 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.6 -48.44 13.21 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.216 -0.516 . . . . 71.43 113.172 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 72.26 -46.04 0.63 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.915 0.709 . . . . 62.52 112.915 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -78.54 0.37 26.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.079 0.4 . . . . 70.52 112.079 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 23.0 p-10 -142.45 28.25 1.66 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 111.842 0.312 . . . . 52.43 111.842 -176.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.513 ' HA3' HD11 ' A' ' 140' ' ' ILE . . . -115.36 142.5 17.64 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 120.898 -0.668 . . . . 71.15 113.975 -175.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.43 ' HB3' ' OG1' ' A' ' 9' ' ' THR . 29.1 pt20 -120.24 140.64 50.88 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.728 0.299 . . . . 73.12 110.795 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.612 HG13 ' HB3' ' A' ' 138' ' ' PHE . 39.2 t -86.86 102.78 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 121.363 0.601 . . . . 52.25 111.211 174.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.579 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -78.67 112.25 15.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.993 -0.549 . . . . 73.42 110.337 174.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.705 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 59.8 mt -89.16 119.01 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.15 0.426 . . . . 74.22 112.15 -172.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.9 mm -104.61 117.3 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.801 0.334 . . . . 72.41 111.282 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -107.31 126.73 52.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.006 0.432 . . . . 71.34 111.358 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -84.71 89.07 7.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.205 0.526 . . . . 74.23 109.646 172.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -90.91 149.01 22.08 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.991 -0.55 . . . . 72.11 111.514 -173.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -98.63 121.75 40.97 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.309 -0.405 . . . . 74.44 111.755 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.411 HG23 HG21 ' A' ' 166' ' ' VAL . 99.0 t -110.67 98.55 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 110.046 -0.353 . . . . 72.13 110.046 170.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 57.12 21.3 6.32 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.987 0.423 . . . . 75.22 111.588 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.98 24.5 27.16 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.257 -0.496 . . . . 71.44 112.697 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 m -112.19 141.06 46.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.704 0.288 . . . . 65.12 110.973 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -73.34 109.38 6.82 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.478 0.548 . . . . 74.04 112.478 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 166' ' ' VAL . 24.3 m -128.58 96.51 29.98 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 121.254 0.55 . . . . 73.34 111.799 171.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.79 114.11 3.14 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.472 2.115 . . . . 74.11 112.055 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 5.2 t -107.69 161.06 15.22 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.506 0.558 . . . . 74.33 112.506 -176.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.579 HD11 ' HB1' ' A' ' 154' ' ' ALA . 22.5 tp -111.13 131.75 54.85 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.827 0.346 . . . . 64.43 111.035 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.705 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 46.9 ttm -110.96 125.67 53.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.108 -0.496 . . . . 72.54 111.252 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.86 150.39 50.45 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.623 -0.717 . . . . 74.23 109.996 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 27' ' ' VAL . 47.7 t -89.74 120.73 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.946 -0.471 . . . . 73.22 112.27 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.412 ' HA ' HG22 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -59.49 -46.9 87.47 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.049 -0.523 . . . . 74.3 110.632 179.297 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -63.37 -20.43 65.52 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.003 -0.544 . . . . 61.02 112.307 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.432 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -101.78 -19.71 15.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.315 0.487 . . . . 71.3 112.315 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.557 HG21 ' HE2' ' A' ' 28' ' ' TYR . 9.0 tp -96.01 121.4 46.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.417 0.627 . . . . 63.44 111.866 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.4 mm -99.05 112.14 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.957 0.408 . . . . 74.23 110.927 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.15 134.61 34.98 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.847 0.356 . . . . 62.23 111.466 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -129.99 144.01 51.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.497 0.665 . . . . 71.2 111.258 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -131.31 103.74 6.63 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.499 -0.773 . . . . 72.51 112.093 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 43.0 t -133.26 89.84 2.66 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.06 0.457 . . . . 74.14 110.736 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 182' ' ' LEU . 5.2 mp -112.92 96.18 5.81 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.111 0.481 . . . . 52.53 111.388 -174.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 . . . . . 0 C--O 1.253 1.283 0 CA-C-O 118.952 -0.547 . . . . 62.43 111.403 -176.492 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.563 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.51 0.195 . . . . 61.52 110.852 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 179' ' ' GLU . 26.5 tp -84.59 125.53 32.53 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 122.134 -0.354 . . . . 73.44 110.559 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.775 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 56.2 mt -100.32 119.47 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.717 0.294 . . . . 63.42 110.884 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.865 ' HB2' HD11 ' A' ' 176' ' ' ILE . 35.7 p90 -106.59 135.49 48.02 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.3 0.571 . . . . 74.24 112.048 -178.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.531 ' HB2' HD13 ' A' ' 13' ' ' LEU . 74.6 tttt -134.53 114.34 12.72 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.017 -0.992 . . . . 64.32 110.842 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.623 ' HB2' ' H ' ' A' ' 9' ' ' THR . 6.3 m-20 -79.69 161.42 25.82 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.157 0.504 . . . . 64.33 111.263 173.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.4 pt -64.82 -21.07 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.013 -0.54 . . . . 71.41 111.258 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.454 ' HE2' ' HA ' ' A' ' 152' ' ' GLN . 36.9 p90 -109.13 -27.7 9.45 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.388 0.514 . . . . 64.31 112.388 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.623 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 4.8 m -88.88 15.37 8.55 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.236 0.541 . . . . 65.53 111.268 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -57.79 -12.66 3.23 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.516 0.562 . . . . 75.31 112.516 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.43 -61.74 1.7 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.977 0.418 . . . . 73.14 112.064 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -112.97 25.59 11.26 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.124 0.786 . . . . 70.21 113.124 -170.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -42.41 139.39 1.5 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.809 0.338 . . . . 63.1 111.532 176.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.3 m -135.62 178.19 7.23 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.66 0.615 . . . . 62.01 112.66 -168.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.559 ' HB3' HG12 ' A' ' 3' ' ' ILE . 86.6 p -124.28 125.14 43.86 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.299 0.481 . . . . 63.03 112.299 -174.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -137.62 -172.75 3.31 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.2 0.524 . . . . 73.1 111.425 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.2 m -138.45 89.73 2.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.201 -0.454 . . . . 75.23 111.082 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -142.67 132.71 12.24 Favored Pre-proline 0 N--CA 1.473 0.717 0 CA-C-N 116.556 -0.293 . . . . 73.43 111.515 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.11 145.94 14.07 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.704 2.27 . . . . 65.14 112.837 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.5 164.02 27.51 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.108 0.48 . . . . 74.33 112.243 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -121.82 104.26 9.44 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.115 -0.493 . . . . 74.32 110.881 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.5 tp -74.54 104.1 5.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.216 0.531 . . . . 73.33 111.643 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.23 134.42 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 121.341 0.591 . . . . 73.53 111.905 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.2 t70 59.22 14.24 3.48 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.085 -0.961 . . . . 71.41 112.383 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.0 t70 63.55 18.62 11.2 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.595 0.712 . . . . 73.14 110.79 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.433 ' HG ' HG13 ' A' ' 27' ' ' VAL . 59.0 tp -113.57 -50.14 2.86 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.983 -0.553 . . . . 65.15 112.441 -175.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 172' ' ' VAL . 15.5 m -133.54 150.14 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 113.04 0.756 . . . . 62.33 113.04 -175.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 170' ' ' MET . 19.3 m-85 -85.7 125.29 33.08 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.644 -0.707 . . . . 74.41 110.808 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -99.25 127.21 45.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.023 -0.535 . . . . 75.24 110.628 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.754 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 67.3 t80 -119.65 139.65 51.87 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.03 0.443 . . . . 72.22 111.34 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -90.0 126.84 35.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.081 -0.508 . . . . 72.22 111.33 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.72 173.54 14.95 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.989 -0.624 . . . . 74.14 114.44 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -133.33 153.9 51.18 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.894 0.478 . . . . 75.41 109.944 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -91.34 107.03 18.92 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.065 -0.397 . . . . 65.13 110.189 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.411 HG23 HD12 ' A' ' 72' ' ' LEU . 27.4 m -135.22 165.8 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.257 0.551 . . . . 73.55 112.272 -173.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.1 m -115.9 146.56 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.396 0.517 . . . . 71.02 112.396 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.579 ' HG2' HD13 ' A' ' 72' ' ' LEU . 5.0 mmp_? . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.25 0.548 . . . . 74.15 111.172 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 10.4 pt-20 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 114.667 1.358 . . . . 71.14 114.667 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -126.23 109.95 12.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.052 0.387 . . . . 72.22 111.293 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.47 -165.73 28.29 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.585 -0.817 . . . . 55.14 113.506 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.3 pt -111.61 145.56 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 122.425 -0.456 . . . . 74.14 111.895 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -46.2 -39.8 10.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.211 0.604 . . . . 73.22 112.044 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.9 mt -53.83 -49.97 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.887 -0.597 . . . . 75.41 112.503 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 23.2 m -87.72 -39.3 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.519 0.563 . . . . 51.1 112.519 -171.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.579 HD13 ' HG2' ' A' ' 37' ' ' ARG . 61.8 mt -64.42 -38.08 89.76 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.189 0.518 . . . . 63.01 111.679 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -84.48 -15.1 47.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.196 -0.457 . . . . 73.02 112.088 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -109.08 4.21 22.83 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 122.185 -0.322 . . . . 74.3 111.349 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 58.06 71.12 0.6 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.367 0.603 . . . . 61.51 112.161 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 60.4 mt -127.23 124.16 38.26 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.516 -0.765 . . . . 62.13 110.533 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.94 148.53 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.833 0.349 . . . . 63.35 111.34 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -76.59 130.82 38.4 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.583 0.706 . . . . 74.42 112.604 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.536 ' HG3' ' HB2' ' A' ' 84' ' ' ASP . 12.5 tpt -117.22 122.77 44.92 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.061 -0.972 . . . . 54.53 108.994 171.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -82.84 139.55 33.42 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.212 0.53 . . . . 65.53 112.193 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 62.3 m -52.45 -40.05 61.81 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.204 0.816 . . . . 75.4 113.204 -174.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -57.27 -32.78 66.96 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.882 0.327 . . . . 63.35 111.882 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.48 -36.41 10.34 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.973 0.416 . . . . 71.32 110.949 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.536 ' HB2' ' HG3' ' A' ' 79' ' ' MET . 14.2 t70 -66.92 -11.42 56.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.251 -0.431 . . . . 42.42 111.594 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.597 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -36.68 -54.86 0.89 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.697 0.629 . . . . 62.2 112.697 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.7 t -67.81 -36.19 79.96 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.061 0.393 . . . . 53.42 112.061 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.2 ttm -67.84 -60.63 2.37 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 111.918 0.34 . . . . 75.4 111.918 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 16.0 p90 -62.21 -35.17 78.07 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 120.368 -0.533 . . . . 73.33 111.245 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 42.0 tptt -61.48 -39.36 90.65 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.185 0.517 . . . . 71.21 110.615 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.71 74.73 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.053 -0.521 . . . . 74.2 111.481 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -61.66 -44.76 96.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.529 -0.305 . . . . 73.52 111.519 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 88' ' ' PHE . 42.2 mm -62.04 -35.9 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 120.787 0.327 . . . . 73.22 111.301 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.07 -57.3 13.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.149 0.5 . . . . 72.3 110.831 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -59.58 -45.57 91.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.849 -0.614 . . . . 74.43 111.095 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.627 ' HE2' HG12 ' A' ' 120' ' ' ILE . 47.8 t80 -55.73 -61.54 2.29 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.399 -0.819 . . . . 73.21 111.997 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 58.6 ttp -54.59 -43.8 72.46 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.013 0.435 . . . . 72.34 111.278 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -61.59 -47.83 83.69 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.041 -0.527 . . . . 73.51 111.301 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -70.68 -44.1 67.69 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.448 0.536 . . . . 73.33 112.448 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.687 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . 35.9 m -65.04 -47.2 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.093 0.405 . . . . 70.14 112.093 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.443 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 47.3 mm -63.42 -45.61 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.898 0.38 . . . . 73.12 110.358 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -53.6 -55.4 26.08 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.964 -0.562 . . . . 62.52 112.069 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.687 ' HD2' ' HA ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -66.54 -27.51 67.81 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 122.219 -0.301 . . . . 72.42 111.244 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.496 ' HG3' HG12 ' A' ' 113' ' ' VAL . 12.1 tpt -73.84 -50.78 18.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.821 0.343 . . . . 52.25 111.337 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 9.7 pt-20 -66.35 -25.74 66.95 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.19 -0.319 . . . . 73.21 111.143 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -56.18 -39.21 72.02 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.159 0.429 . . . . 74.43 112.159 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -103.74 -37.91 7.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.037 0.754 . . . . 65.33 113.037 -175.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 108' ' ' ARG . 60.1 t30 -97.34 -35.15 10.8 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.511 0.559 . . . . 74.22 112.511 -173.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.442 ' HB3' ' O ' ' A' ' 107' ' ' ASN . 26.3 ttp180 71.59 -35.7 0.34 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.07 1.137 . . . . 74.12 114.07 174.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.55 ' O ' HG22 ' A' ' 113' ' ' VAL . 72.2 m-20 -65.71 114.38 4.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.807 0.669 . . . . 72.21 112.807 -168.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.74 -24.45 65.72 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.548 -0.751 . . . . 72.41 112.675 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.16 -32.21 58.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.894 0.378 . . . . 42.45 111.853 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.65 -51.31 7.85 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.548 -0.296 . . . . 73.24 111.706 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 109' ' ' ASP . 6.4 m -60.63 -31.12 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 111.947 0.351 . . . . 70.33 111.947 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.97 -38.93 83.34 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.91 0.386 . . . . 71.52 110.634 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.6 78.43 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.233 -0.44 . . . . 75.33 111.062 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.473 ' CZ ' ' HG3' ' A' ' 174' ' ' GLU . 22.2 t80 -56.85 -49.25 76.03 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.352 -0.385 . . . . 74.12 111.096 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -57.59 -32.81 67.55 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.626 -0.261 . . . . 72.21 111.067 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -66.63 -39.99 88.55 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.541 0.21 . . . . 73.31 111.286 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -53.65 -58.48 7.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.31 0.576 . . . . 73.43 111.038 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.627 HG12 ' HE2' ' A' ' 95' ' ' PHE . 10.9 tp -67.84 -32.49 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.743 -0.662 . . . . 60.34 111.568 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.41 ' NE2' HG21 ' A' ' 125' ' ' VAL . 23.3 tm0? -58.64 -52.41 65.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.729 0.299 . . . . 71.14 110.709 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.92 -42.9 96.98 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.932 -0.651 . . . . 70.44 112.528 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -58.83 -55.15 38.84 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 111.62 0.23 . . . . 73.1 111.62 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.466 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.7 m -65.25 -48.35 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.373 0.509 . . . . 62.31 112.373 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.41 HG21 ' NE2' ' A' ' 121' ' ' GLN . 92.1 t -57.98 -41.14 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.98 -0.45 . . . . 74.15 111.487 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.5 t -70.44 -47.96 58.24 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.012 0.434 . . . . 64.31 111.139 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.33 -33.81 74.23 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.311 -0.404 . . . . 72.13 111.805 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 80.8 mt -85.13 2.24 44.37 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.212 0.449 . . . . 75.22 112.212 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.62 89.06 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.304 0.574 . . . . 61.24 110.392 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 134' ' ' LYS . 36.3 ttpt -51.66 -59.66 4.03 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 114.373 1.249 . . . . 75.04 114.373 -165.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.81 -34.17 72.7 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.217 0.821 . . . . 75.2 113.217 -168.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -84.0 -53.61 5.44 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.089 0.471 . . . . 71.01 111.375 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.409 ' HD2' HD11 ' A' ' 136' ' ' LEU . 50.7 m-85 -74.46 -3.96 33.79 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.208 0.528 . . . . 62.23 111.763 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 130' ' ' LYS . 33.0 ttpt -35.79 -32.32 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.694 1.198 . . . . 74.12 113.724 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -96.85 35.11 1.59 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.503 0.557 . . . . 73.22 112.503 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.409 HD11 ' HD2' ' A' ' 133' ' ' PHE . 38.2 mt -89.31 162.33 15.89 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.775 0.321 . . . . 61.34 110.622 170.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -132.13 133.5 44.35 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.236 0.458 . . . . 74.12 112.236 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.419 ' HB3' HG13 ' A' ' 153' ' ' VAL . 80.3 m-85 -100.82 107.57 19.16 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.641 0.257 . . . . 74.14 110.413 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 38.6 m-85 -101.54 124.74 47.69 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.863 -0.523 . . . . 74.41 111.616 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 16.9 tt -110.09 151.98 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.965 -0.562 . . . . 71.31 111.293 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.527 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -61.62 140.7 47.38 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 114.405 0.522 . . . . 50.0 114.405 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -44.18 -52.48 7.31 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.146 0.579 . . . . 72.44 112.096 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -51.58 -49.63 61.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.058 -0.519 . . . . 74.52 111.446 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.653 ' HB2' ' HA3' ' A' ' 151' ' ' GLY . . . -64.59 -50.09 68.57 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.237 0.458 . . . . 65.22 112.237 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.73 -41.24 77.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.061 0.458 . . . . 53.51 111.758 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -82.2 -24.86 34.69 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.932 -0.576 . . . . 65.2 111.465 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -101.09 -3.64 54.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.166 -0.54 . . . . 54.05 114.061 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 59.68 24.34 13.2 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.428 0.529 . . . . 74.44 112.428 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -103.51 -173.36 2.29 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.835 0.68 . . . . 64.1 112.835 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -88.98 58.1 4.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.242 0.544 . . . . 53.52 112.112 -172.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.653 ' HA3' ' HB2' ' A' ' 144' ' ' ALA . . . -70.94 167.96 50.66 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.897 -0.668 . . . . 72.12 113.085 173.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.454 ' HA ' ' HE2' ' A' ' 8' ' ' PHE . 45.9 tt0 -70.67 128.12 34.99 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.278 0.473 . . . . 63.31 112.278 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 138' ' ' PHE . 40.6 t -94.48 104.26 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.233 0.54 . . . . 73.5 110.266 170.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.737 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -80.45 136.41 36.33 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.864 -0.607 . . . . 64.15 111.56 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.569 ' HB ' ' HG3' ' A' ' 170' ' ' MET . 39.2 mm -89.23 109.4 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.846 0.355 . . . . 73.35 111.254 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.461 HG13 ' CD1' ' A' ' 139' ' ' PHE . 48.1 mm -93.91 108.12 20.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 120.968 0.413 . . . . 55.43 111.307 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -99.47 149.17 23.48 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.069 -0.968 . . . . 64.31 112.424 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -95.25 122.77 38.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.411 -0.813 . . . . 74.21 110.052 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.632 ' NH2' HG21 ' A' ' 168' ' ' THR . 4.8 ttp180 -156.39 131.08 8.93 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.613 -0.68 . . . . 74.01 112.084 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -103.54 143.91 32.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.198 -0.456 . . . . 64.13 111.521 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.13 100.89 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.454 -0.339 . . . . 72.23 110.444 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.4 t70 66.74 6.57 4.62 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 121.233 0.539 . . . . 64.22 111.514 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 128.78 -21.63 5.29 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.265 -0.493 . . . . 33.21 113.03 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 66.7 p -82.08 106.73 14.22 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.403 -0.469 . . . . 73.3 110.874 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -75.21 111.12 10.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.437 0.636 . . . . 73.32 112.391 -172.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.07 145.4 41.72 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.001 -0.545 . . . . 73.21 111.616 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -78.67 117.88 4.07 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.479 2.119 . . . . 73.51 112.213 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.632 HG21 ' NH2' ' A' ' 159' ' ' ARG . 83.5 m -107.4 122.02 45.77 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.904 0.383 . . . . 74.14 111.67 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.754 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 50.0 tp -88.87 139.94 29.95 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.566 -0.288 . . . . 75.02 110.981 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.569 ' HG3' ' HB ' ' A' ' 155' ' ' ILE . 21.1 ptp -133.87 141.26 47.32 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.714 0.768 . . . . 74.42 112.089 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -139.54 141.21 37.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.557 -1.201 . . . . 70.35 109.345 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.627 ' HA ' HG12 ' A' ' 27' ' ' VAL . 21.9 t -85.18 123.68 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.838 -0.538 . . . . 72.12 111.901 -173.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.437 ' HD3' ' OH ' ' A' ' 28' ' ' TYR . 45.2 tptt -53.17 -47.48 68.77 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.62 0.6 . . . . 55.34 112.62 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.473 ' HG3' ' CZ ' ' A' ' 116' ' ' PHE . 39.9 mm-40 -67.78 -1.92 6.24 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.433 0.531 . . . . 75.33 112.433 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -107.68 -44.55 4.23 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.521 -0.309 . . . . 64.5 110.718 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.865 HD11 ' HB2' ' A' ' 4' ' ' TYR . 9.5 tp -96.27 111.45 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 121.811 0.815 . . . . 41.5 112.193 -175.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.4 mm -105.06 144.07 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.169 -0.469 . . . . 53.34 110.749 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.93 146.83 38.3 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.63 0.729 . . . . 52.3 112.659 -175.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.775 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 8.8 tp10 -114.39 120.42 40.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.182 -0.917 . . . . 73.41 109.596 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.434 ' HB2' ' NZ ' ' A' ' 180' ' ' LYS . 4.9 ttmp? . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 112.419 0.526 . . . . 62.54 112.419 -171.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.675 0.274 . . . . 75.11 111.125 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.6 tp -89.52 131.47 35.53 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.985 0.422 . . . . 71.22 110.806 174.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 56.7 mt -118.94 120.58 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.385 . . . . 73.15 110.776 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -115.0 133.93 55.62 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.73 0.776 . . . . 72.2 111.244 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.409 ' HG2' ' CD1' ' A' ' 13' ' ' LEU . 34.9 mtpt -120.12 120.0 34.94 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.021 -0.991 . . . . 75.41 111.178 -172.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.93 177.5 3.64 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.764 0.654 . . . . 63.32 112.764 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -70.68 -57.03 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.012 -0.54 . . . . 52.31 111.502 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -102.15 -41.36 6.43 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.529 0.566 . . . . 74.01 112.529 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.54 HG21 ' HA2' ' A' ' 151' ' ' GLY . 12.1 p -80.48 16.28 1.39 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.542 0.571 . . . . 74.34 112.542 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -47.02 -34.7 5.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.16 0.584 . . . . 71.43 111.638 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.44 -39.61 80.32 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.529 0.566 . . . . 64.23 112.529 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -65.96 -33.49 75.94 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.546 0.213 . . . . 72.21 111.279 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.409 ' CD1' ' HG2' ' A' ' 5' ' ' LYS . 11.9 tp 57.2 112.2 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.441 0.904 . . . . 72.24 113.441 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.7 m -104.24 124.79 49.78 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.844 -0.535 . . . . 63.23 111.374 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 83.1 p -140.22 142.17 35.86 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.403 0.52 . . . . 70.21 112.403 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -171.61 -147.87 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.848 -0.614 . . . . 52.3 110.657 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 p -150.06 30.01 0.72 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.331 0.493 . . . . 70.33 112.331 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 97.9 m-85 -89.74 123.41 66.49 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.792 0.33 . . . . 73.12 111.503 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 12.0 Cg_exo -70.8 144.65 49.06 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.237 2.625 . . . . 53.33 113.959 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.434 ' SD ' ' C ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -131.89 166.35 21.82 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.751 -0.658 . . . . 52.13 111.496 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -130.98 136.77 48.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.86 0.362 . . . . 73.44 111.166 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 55.0 tp -87.26 109.34 19.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.061 0.458 . . . . 75.24 112.065 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -98.57 142.99 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.989 0.424 . . . . 71.42 111.041 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 t70 63.11 6.87 2.47 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.986 -0.552 . . . . 73.11 111.432 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.403 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 28.7 m-20 56.52 28.67 14.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.151 0.5 . . . . 65.24 111.979 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.2 tp -134.17 -44.01 0.78 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.102 -0.499 . . . . 64.25 111.861 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' A' ' 172' ' ' VAL . 12.7 m -125.24 148.95 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 112.524 0.565 . . . . 74.02 112.524 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -88.17 151.12 22.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.169 -0.469 . . . . 75.4 112.009 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -107.57 140.88 39.9 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.471 -0.786 . . . . 64.12 111.591 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.715 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 47.9 t80 -139.99 105.75 5.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.21 -0.663 . . . . 71.53 109.21 165.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.614 ' HB3' HG22 ' A' ' 168' ' ' THR . 13.1 ptpt -109.93 121.78 46.04 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.797 0.665 . . . . 74.32 112.797 -171.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.9 -152.85 8.64 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.91 -0.586 . . . . 61.22 113.601 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -117.3 174.07 6.34 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.108 0.48 . . . . 64.51 112.097 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.442 ' CE1' ' HD3' ' A' ' 167' ' ' PRO . 68.7 m80 -97.2 110.58 23.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.071 -0.513 . . . . 75.0 110.073 172.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.417 HG23 HD12 ' A' ' 72' ' ' LEU . 18.4 m -135.63 140.77 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.318 0.58 . . . . 64.43 112.18 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 30.2 m -120.0 117.2 52.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.342 0.591 . . . . 62.52 111.338 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.682 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 66.4 ttt180 . . . . . 0 CA--C 1.539 0.531 0 CA-C-N 116.099 -0.501 . . . . 71.03 110.547 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.682 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 27.7 tt0 . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 122.28 1.038 . . . . 61.15 109.299 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 11.0 ptm180 -104.67 140.38 38.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.597 -1.183 . . . . 72.31 111.927 -173.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.94 -131.11 3.72 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.548 -0.834 . . . . 32.4 113.785 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.429 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 32.3 pt -111.09 139.77 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 122.461 -0.435 . . . . 71.41 111.608 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -48.29 -35.76 12.83 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.078 -0.51 . . . . 61.1 112.355 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' A' ' 169' ' ' LEU . 68.4 mt -52.56 -58.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.201 0.524 . . . . 64.13 112.221 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.5 m -75.25 -33.59 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.142 -0.481 . . . . 75.11 111.688 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 64.8 mt -64.98 -34.49 78.57 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.966 0.413 . . . . 73.24 111.037 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -57.55 -48.66 78.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.247 -0.433 . . . . 65.11 111.94 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -99.04 -3.45 34.75 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.325 0.491 . . . . 64.42 112.325 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 59.56 70.86 0.61 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.623 0.725 . . . . 62.51 111.525 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 60.4 mt -98.3 127.78 44.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.667 -0.697 . . . . 74.43 110.951 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.94 143.85 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.66 0.266 . . . . 70.55 110.849 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -84.8 150.91 24.72 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.569 0.7 . . . . 55.5 112.838 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.2 ttm -145.19 138.33 26.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.459 -0.791 . . . . 75.35 110.413 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.526 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 18.0 m-80 -109.77 167.55 10.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.08 -0.509 . . . . 74.34 111.102 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 79.6 m -55.43 -38.92 69.63 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.553 0.945 . . . . 73.4 113.553 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.526 ' CE1' ' HB2' ' A' ' 80' ' ' ASN . 10.8 p90 -65.5 -23.23 66.84 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.654 -0.654 . . . . 73.31 111.406 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -94.13 -32.5 13.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.197 0.523 . . . . 74.32 110.732 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.1 -16.14 38.98 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.606 -0.725 . . . . 60.41 112.31 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.481 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . . . -43.21 -57.55 2.91 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.693 0.627 . . . . 65.44 112.693 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 t -69.92 -27.53 64.85 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 55.23 111.524 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.4 mmt -70.92 -63.36 1.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.535 -0.302 . . . . 65.53 111.637 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.481 ' CE1' ' HA ' ' A' ' 85' ' ' ALA . 5.0 p90 -60.44 -34.3 73.78 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.351 -0.218 . . . . 75.45 111.312 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -58.12 -54.39 47.54 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.935 0.398 . . . . 62.15 111.222 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.96 -35.56 81.58 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.141 0.496 . . . . 61.14 111.059 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.631 ' HE2' ' HG3' ' A' ' 152' ' ' GLN . 56.5 t80 -56.71 -57.02 14.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.765 -0.652 . . . . 73.11 111.043 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 88' ' ' PHE . 48.2 mm -57.83 -37.33 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.768 0.318 . . . . 72.11 111.631 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -60.13 -56.66 18.91 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.005 0.372 . . . . 73.34 112.005 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -72.32 -36.59 68.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.946 0.403 . . . . 75.33 111.835 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.42 ' O ' HG22 ' A' ' 99' ' ' VAL . 55.2 t80 -60.34 -55.34 34.76 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.075 -0.511 . . . . 65.45 111.229 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.1 ttt -54.87 -44.38 73.97 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.172 -0.467 . . . . 65.54 111.317 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -62.89 -46.62 86.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.372 -0.376 . . . . 53.53 111.612 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -63.44 -51.87 63.88 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.686 0.279 . . . . 75.31 111.625 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.487 ' O ' ' SD ' ' A' ' 103' ' ' MET . 32.1 m -64.07 -41.8 93.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.542 0.571 . . . . 71.44 112.542 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.7 mm -66.81 -46.45 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 121.755 -0.591 . . . . 75.33 110.983 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.99 -34.22 75.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.181 0.515 . . . . 73.12 110.993 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -68.93 -57.41 5.54 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.786 -0.643 . . . . 73.44 111.385 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 99' ' ' VAL . 0.2 OUTLIER -66.64 -44.72 81.2 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.007 0.743 . . . . 42.52 113.007 -175.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -50.46 -48.19 56.65 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.367 0.506 . . . . 74.53 112.367 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -60.41 -14.64 20.06 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.821 0.674 . . . . 72.35 112.821 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -115.4 -33.65 5.2 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.358 0.599 . . . . 53.03 111.564 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.465 ' O ' HG13 ' A' ' 113' ' ' VAL . 32.6 m-80 -122.13 28.52 7.46 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.665 -0.698 . . . . 72.32 111.886 -173.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.502 HH11 ' HB2' ' A' ' 109' ' ' ASP . 3.3 ppt_? -38.41 -23.81 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.874 1.805 . . . . 71.22 115.874 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.502 ' HB2' HH11 ' A' ' 108' ' ' ARG . 21.3 t70 -63.38 136.85 57.91 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.792 0.724 . . . . 71.02 111.269 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 110' ' ' LYS . 13.0 mptt -68.95 4.64 1.43 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.306 0.854 . . . . 75.45 113.306 -171.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.5 -47.88 6.91 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.996 0.427 . . . . 55.32 110.848 170.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -70.62 -58.09 4.04 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.989 -0.55 . . . . 72.55 112.234 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 107' ' ' ASN . 5.3 m -61.77 -32.54 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.793 0.294 . . . . 51.01 111.793 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -66.96 -43.25 83.6 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.77 0.319 . . . . 74.25 110.98 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -58.71 -51.42 70.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.028 0.442 . . . . 54.32 110.919 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.695 ' HE1' ' HG3' ' A' ' 174' ' ' GLU . 65.1 t80 -56.11 -50.1 72.0 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.003 -0.544 . . . . 65.25 111.148 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -51.57 -47.18 63.57 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.096 -0.502 . . . . 71.3 111.426 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -66.22 -34.64 78.48 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.013 0.375 . . . . 72.21 112.013 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 31.2 mmmt -60.62 -54.48 44.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.1 0.476 . . . . 70.45 111.301 177.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -71.37 -31.71 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.973 0.416 . . . . 72.02 111.128 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -61.48 -48.87 79.1 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.914 0.388 . . . . 72.14 110.927 176.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.02 -37.19 93.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.867 -0.682 . . . . 62.42 112.431 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.42 ' NE1' ' SD ' ' A' ' 170' ' ' MET . 51.7 t90 -61.77 -56.45 19.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.38 0.272 . . . . 73.44 111.343 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.468 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 m -63.21 -45.78 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.437 0.532 . . . . 73.53 112.437 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 121' ' ' GLN . 82.8 t -56.6 -46.61 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.852 0.358 . . . . 73.01 111.759 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.2 p -70.7 -38.19 73.64 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.968 0.413 . . . . 72.11 111.262 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.448 HD21 HD13 ' A' ' 155' ' ' ILE . 36.5 tp -67.64 -36.3 80.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.255 -0.43 . . . . 72.41 112.124 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 78.8 mt -80.71 2.29 26.61 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.503 0.557 . . . . 61.04 112.503 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 133' ' ' PHE . . . -66.89 87.07 0.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.408 0.623 . . . . 65.34 110.797 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -62.74 -22.75 66.79 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.841 1.052 . . . . 73.32 113.841 -169.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' O ' ' NZ ' ' A' ' 134' ' ' LYS . 24.8 t70 -58.79 -47.33 85.1 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.084 -0.385 . . . . 63.22 111.958 -173.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -102.49 -38.4 7.57 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.136 0.493 . . . . 71.31 111.122 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.408 ' HD2' HD11 ' A' ' 136' ' ' LEU . 45.3 m-85 -68.5 -5.43 19.45 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.714 0.635 . . . . 63.33 112.714 -176.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.427 ' NZ ' ' O ' ' A' ' 131' ' ' ASP . 23.6 pttm -62.37 -7.1 3.87 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.762 -0.586 . . . . 64.34 110.914 168.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.66 9.31 16.61 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 116.32 -0.4 . . . . 72.32 110.689 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.48 ' CD2' ' HA ' ' A' ' 157' ' ' GLU . 90.8 mt -88.65 162.91 16.06 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.905 0.383 . . . . 74.31 111.49 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.66 137.67 40.3 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.445 -0.343 . . . . 52.53 111.415 175.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.698 ' HB3' HG11 ' A' ' 153' ' ' VAL . 89.0 m-85 -100.08 120.92 40.59 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.727 0.299 . . . . 70.53 110.647 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 52.9 m-85 -122.45 139.97 53.26 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.188 0.518 . . . . 64.31 112.081 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.521 HD13 ' N ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -137.67 147.68 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.092 -0.504 . . . . 75.41 110.013 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.521 ' N ' HD13 ' A' ' 140' ' ' ILE . . . -51.14 126.17 26.34 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.433 -0.413 . . . . 65.41 114.046 -176.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -51.59 -59.67 4.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.844 0.354 . . . . 75.05 111.777 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -60.88 -32.29 71.73 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.865 0.364 . . . . 64.43 111.388 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.08 -53.1 50.79 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.541 -0.3 . . . . 74.04 111.139 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.477 ' HB2' HD12 ' A' ' 140' ' ' ILE . . . -64.53 -20.26 66.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.07 0.462 . . . . 74.33 111.615 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -69.61 -26.03 64.24 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.013 -0.54 . . . . 71.2 110.811 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -113.63 -58.2 0.4 Allowed Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.13 -0.486 . . . . 61.4 112.307 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.86 92.08 8.54 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.175 0.512 . . . . 61.31 110.97 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.68 -2.46 11.82 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.008 -0.542 . . . . 73.23 112.375 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -124.79 27.56 6.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.763 0.425 . . . . 74.15 110.987 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.54 ' HA2' HG21 ' A' ' 9' ' ' THR . . . -57.67 155.27 20.02 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.961 -0.563 . . . . 71.11 114.432 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.631 ' HG3' ' HE2' ' A' ' 91' ' ' TYR . 43.4 tt0 -68.34 128.93 38.37 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.137 0.494 . . . . 55.41 111.653 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.698 HG11 ' HB3' ' A' ' 138' ' ' PHE . 68.7 t -91.66 144.06 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.239 0.542 . . . . 71.14 112.393 -177.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.806 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -102.93 137.12 41.56 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.803 -0.635 . . . . 54.33 110.409 174.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.448 HD13 HD21 ' A' ' 127' ' ' LEU . 59.9 mt -95.27 126.54 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.381 0.512 . . . . 70.34 112.381 -172.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.1 mm -95.83 110.89 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.494 -0.321 . . . . 74.24 110.858 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.48 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 55.2 tt0 -96.22 148.78 22.37 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.842 -0.617 . . . . 73.04 111.934 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -98.23 123.23 42.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.814 -0.63 . . . . 73.3 110.558 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -121.15 114.49 21.51 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.975 0.417 . . . . 72.0 111.609 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.85 106.04 4.03 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.905 0.384 . . . . 72.33 111.116 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.28 107.66 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 120.742 0.306 . . . . 72.22 110.863 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 58.41 17.92 5.19 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.435 0.531 . . . . 73.11 112.435 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 114.86 -21.86 13.3 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.151 -0.547 . . . . 70.04 113.644 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 83.8 m -105.62 129.39 53.88 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.167 0.483 . . . . 62.5 111.355 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 0.1 OUTLIER -73.28 128.27 35.0 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.397 0.617 . . . . 53.14 112.429 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.76 148.66 39.79 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.05 -0.523 . . . . 71.13 110.532 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.442 ' HD3' ' CE1' ' A' ' 34' ' ' HIS . 93.7 Cg_endo -87.12 120.9 1.64 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.425 2.083 . . . . 71.35 112.66 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.614 HG22 ' HB3' ' A' ' 31' ' ' LYS . 39.9 p -117.51 119.0 33.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.215 0.531 . . . . 52.45 111.446 177.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.806 HD11 ' HB1' ' A' ' 154' ' ' ALA . 60.2 tp -76.78 130.43 37.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.084 -0.507 . . . . 64.12 110.59 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.42 ' SD ' ' NE1' ' A' ' 123' ' ' TRP . 50.8 ttm -116.15 124.34 50.08 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 116.178 -0.464 . . . . 63.02 111.385 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.9 mt -135.85 124.73 24.08 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.985 -0.552 . . . . 73.51 111.902 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.499 ' HA ' HG12 ' A' ' 27' ' ' VAL . 41.4 t -71.22 118.7 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 122.205 -0.309 . . . . 74.14 111.439 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -66.99 -19.91 65.8 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.023 0.44 . . . . 60.42 111.558 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.695 ' HG3' ' HE1' ' A' ' 116' ' ' PHE . 4.8 mm-40 -81.76 -8.96 59.75 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.989 0.423 . . . . 70.21 111.134 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.37 -44.29 6.94 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.057 0.456 . . . . 61.11 110.92 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 27.2 pt -100.28 128.85 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.196 0.522 . . . . 74.02 111.163 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 177' ' ' ILE . 1.7 mp -93.34 117.99 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 73.34 110.225 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.45 137.81 32.02 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.793 0.806 . . . . 71.51 112.48 -177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -144.78 99.82 3.41 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.229 -0.896 . . . . 65.41 109.69 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 112.719 0.637 . . . . 72.13 112.719 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptt? . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.61 0.243 . . . . 73.14 110.929 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.6 tp -80.23 132.38 35.85 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.954 0.407 . . . . 70.12 111.437 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.628 ' HB ' HD11 ' A' ' 13' ' ' LEU . 8.6 pt -117.13 121.39 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.239 0.542 . . . . 61.24 111.658 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -101.59 122.31 43.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.083 -0.508 . . . . 71.22 111.112 -174.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.451 ' HG3' HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -111.66 118.73 36.47 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 111.988 0.366 . . . . 64.45 111.988 179.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.74 132.62 40.6 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.838 0.351 . . . . 51.31 111.142 172.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 tt -48.23 -47.11 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 112.821 0.674 . . . . 73.14 112.821 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -110.24 -2.59 16.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.411 0.893 . . . . 75.35 113.411 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 9' ' ' THR . 28.5 m -127.21 16.81 7.19 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.195 0.522 . . . . 53.11 111.994 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -50.43 -13.84 0.15 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.282 0.845 . . . . 75.12 113.282 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -53.93 -40.96 67.19 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.887 0.375 . . . . 63.44 111.415 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -85.95 24.94 1.19 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 120.857 0.361 . . . . 73.55 111.38 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.628 HD11 ' HB ' ' A' ' 3' ' ' ILE . 25.0 tp -31.28 120.32 0.23 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.396 0.887 . . . . 62.33 113.396 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -97.85 140.31 32.41 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.181 -0.463 . . . . 63.43 110.785 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.9 p -128.88 96.52 4.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.835 0.35 . . . . 62.4 111.272 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -147.18 -168.85 3.16 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.202 0.525 . . . . 75.41 111.742 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.7 m -127.3 82.97 2.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.172 -0.467 . . . . 42.32 110.663 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -114.16 121.91 35.55 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.136 0.421 . . . . 75.23 112.136 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.31 103.01 1.62 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.664 2.243 . . . . 71.05 112.618 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.57 166.25 11.94 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.308 0.575 . . . . 72.33 112.315 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 25.6 mtpp -123.99 107.81 11.72 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.136 -0.484 . . . . 73.04 111.102 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.406 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 44.0 tp -79.43 94.38 5.54 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.939 -0.476 . . . . 73.03 111.248 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.76 138.88 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.985 0.422 . . . . 72.54 111.683 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.8 t70 57.7 13.38 1.96 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.84 -0.618 . . . . 53.43 112.007 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.406 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 7.9 m-20 63.18 14.6 7.86 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.571 0.348 . . . . 72.13 111.751 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.512 ' HA ' ' HZ2' ' A' ' 173' ' ' LYS . 52.1 tp -114.45 -50.87 2.78 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.966 0.358 . . . . 72.14 111.966 -176.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 172' ' ' VAL . 4.9 m -130.01 152.03 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.207 0.527 . . . . 71.12 112.353 -175.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.441 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 90.4 m-85 -90.95 120.18 31.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.928 -0.578 . . . . 72.34 110.996 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 8.6 pt-20 -99.58 105.64 17.53 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.273 0.559 . . . . 73.51 110.398 172.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.474 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 41.0 t80 -91.64 137.74 32.13 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.027 -0.42 . . . . 73.2 111.169 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.507 ' HE3' HG21 ' A' ' 161' ' ' VAL . 12.1 mmmm -81.82 121.94 27.08 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.15 -0.477 . . . . 73.41 112.047 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.502 ' HA3' HG12 ' A' ' 70' ' ' ILE . . . -121.71 173.18 15.66 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.316 -0.469 . . . . 43.14 113.196 176.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.01 140.55 50.86 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.384 -0.48 . . . . 75.12 111.09 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -73.43 119.77 18.11 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.509 -0.314 . . . . 70.45 110.393 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.7 m -143.77 178.12 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.462 1.125 . . . . 63.31 113.788 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.4 m -123.25 129.99 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.327 -1.306 . . . . 75.41 109.931 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.441 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 112.572 0.582 . . . . 72.42 112.572 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 . . . . . 0 CA--C 1.548 0.902 0 N-CA-C 113.377 0.88 . . . . 61.04 113.377 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -115.97 129.76 56.53 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.4 -0.813 . . . . 61.41 111.879 -169.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' A' ' 72' ' ' LEU . . . 160.19 164.61 15.55 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 119.131 -1.509 . . . . 64.42 114.9 167.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 pt -90.13 138.47 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 122.42 -0.459 . . . . 71.51 110.294 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -48.41 -32.47 7.7 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.775 0.321 . . . . 61.24 111.822 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.502 HG12 ' HA3' ' A' ' 32' ' ' GLY . 35.6 mm -48.48 -58.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.38 0.609 . . . . 72.32 112.056 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 16.4 m -81.14 -28.4 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.993 -0.548 . . . . 73.32 112.136 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' A' ' 67' ' ' GLY . 55.2 mt -71.04 -33.61 70.48 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.953 0.406 . . . . 74.4 111.188 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -58.4 -48.62 80.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.124 -0.489 . . . . 62.45 112.252 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -109.68 13.74 23.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.851 0.315 . . . . 71.4 111.851 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 54.76 71.2 0.55 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.135 0.493 . . . . 73.43 111.916 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 75.3 mt -103.07 125.54 49.85 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 122.2 -0.313 . . . . 73.24 111.248 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.2 145.33 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.75 0.31 . . . . 72.15 110.789 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.24 137.3 35.85 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.026 0.75 . . . . 75.42 113.026 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 78.1 mtp -125.91 145.5 50.24 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.058 -0.974 . . . . 65.05 108.887 169.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.501 ' HB2' ' CD1' ' A' ' 82' ' ' TYR . 16.8 m120 -115.93 -162.28 0.83 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.326 0.584 . . . . 61.23 112.398 -171.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.1 p -100.27 -2.5 33.57 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.148 0.795 . . . . 51.53 113.148 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CD1' ' HB2' ' A' ' 80' ' ' ASN . 24.1 p90 -79.15 -61.4 2.02 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.113 0.782 . . . . 72.42 113.113 -170.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -105.3 -17.51 14.43 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.719 0.771 . . . . 74.43 111.208 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.86 9.53 1.12 Allowed 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.26 -0.882 . . . . 75.54 112.165 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -46.76 -56.91 5.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.193 0.597 . . . . 72.45 112.592 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.0 m -53.35 -36.35 61.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.874 0.369 . . . . 74.33 111.643 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 51.4 tpp -73.88 -63.89 1.12 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.282 0.475 . . . . 73.44 112.282 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -68.47 -29.07 67.62 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.863 -0.523 . . . . 75.52 112.305 -174.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -72.69 -41.81 64.93 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.917 -0.313 . . . . 72.43 110.909 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.71 -39.37 91.26 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.01 0.433 . . . . 74.3 110.325 173.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -57.11 -59.23 5.4 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.996 -0.547 . . . . 72.42 111.775 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.7 tp -62.4 -39.03 82.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 112.263 0.468 . . . . 71.41 112.263 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -71.49 -44.63 64.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 111.99 0.366 . . . . 71.11 111.99 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -63.67 -44.84 92.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.261 0.553 . . . . 74.54 110.287 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.475 ' O ' HG22 ' A' ' 99' ' ' VAL . 48.9 t80 -56.22 -58.07 9.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.505 -0.77 . . . . 74.42 111.283 174.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 53.0 tpp -51.56 -54.07 31.41 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.112 -0.495 . . . . 74.33 111.76 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -57.92 -44.74 87.05 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.962 0.356 . . . . 64.44 111.962 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -72.09 -45.98 58.56 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.368 0.507 . . . . 40.54 112.368 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 95' ' ' PHE . 35.8 m -67.83 -38.05 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 122.186 -0.321 . . . . 42.43 111.615 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.9 mm -63.77 -48.64 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.63 0.253 . . . . 73.44 110.603 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 17.1 t70 -52.51 -47.39 66.65 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.08 0.466 . . . . 71.15 111.873 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -71.15 -42.94 68.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.545 -0.298 . . . . 73.41 111.625 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.549 ' HG3' HG12 ' A' ' 113' ' ' VAL . 12.7 tpt -59.88 -43.18 94.91 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.824 0.305 . . . . 74.34 111.824 -178.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -65.96 -28.55 68.99 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.837 0.31 . . . . 72.24 111.837 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.1 mtmm -69.52 -8.0 43.23 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.251 0.463 . . . . 73.3 112.251 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -99.97 -31.71 11.33 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.301 0.572 . . . . 70.4 110.332 172.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.732 HD21 ' HB3' ' A' ' 111' ' ' ALA . 28.3 t-20 -123.64 -80.34 0.62 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.583 -0.735 . . . . 62.55 111.929 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 73.7 ttt180 72.25 -15.74 0.46 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.915 0.709 . . . . 64.44 112.915 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -80.22 8.89 6.43 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.935 -0.478 . . . . 74.23 111.771 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 57.5 mtmt 60.52 20.23 10.02 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.219 0.533 . . . . 75.0 112.137 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.732 ' HB3' HD21 ' A' ' 107' ' ' ASN . . . -85.42 -62.54 1.51 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.105 -0.498 . . . . 72.34 110.288 172.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -79.52 -46.71 16.87 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.401 -0.363 . . . . 73.3 111.601 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.549 HG12 ' HG3' ' A' ' 103' ' ' MET . 28.0 m -63.81 -29.61 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 113.176 0.806 . . . . 74.12 113.176 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.39 -39.07 68.27 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 122.012 -0.43 . . . . 73.55 110.238 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.64 -47.54 69.28 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.172 -0.467 . . . . 43.13 111.195 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -53.89 -48.86 69.69 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.152 -0.476 . . . . 75.35 110.503 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -54.26 -47.69 72.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.696 -0.684 . . . . 75.22 111.317 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -56.27 -43.33 78.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.235 -0.439 . . . . 73.24 111.123 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -66.81 -60.49 2.62 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.942 0.349 . . . . 65.34 111.942 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -60.94 -35.07 62.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 111.905 0.335 . . . . 72.54 111.905 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.47 ' O ' HG23 ' A' ' 125' ' ' VAL . 58.5 tp60 -67.09 -43.21 83.15 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.687 0.279 . . . . 74.31 110.627 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.23 -35.47 88.1 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.828 -0.701 . . . . 71.45 112.271 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.5 t90 -63.89 -51.7 63.32 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.296 0.238 . . . . 72.25 111.222 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.433 HG22 ' HA ' ' A' ' 121' ' ' GLN . 30.8 m -67.61 -38.03 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 112.306 0.484 . . . . 64.34 112.306 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 121' ' ' GLN . 52.9 t -57.78 -46.55 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.357 0.599 . . . . 74.15 110.854 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.6 m -67.83 -48.95 64.78 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.087 -0.506 . . . . 73.11 111.31 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.22 -41.5 96.97 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.05 0.54 . . . . 61.14 112.447 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.0 mt -84.82 3.31 38.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.243 0.46 . . . . 65.13 112.243 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.46 86.41 0.11 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.337 0.589 . . . . 74.5 110.929 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -54.5 -20.4 7.65 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.62 0.971 . . . . 65.35 113.62 -172.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.81 -47.53 77.71 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.649 0.611 . . . . 64.44 112.649 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -109.91 -30.69 7.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.446 0.535 . . . . 72.23 112.446 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -85.66 -7.11 59.01 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.147 0.795 . . . . 63.41 113.147 -171.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.86 -19.8 66.07 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.726 -0.608 . . . . 73.24 110.538 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -78.95 10.02 3.78 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.002 -0.545 . . . . 70.5 111.873 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.448 HD22 ' HA ' ' A' ' 157' ' ' GLU . 88.0 mt -89.06 161.21 16.67 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.971 0.415 . . . . 74.02 110.948 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.43 137.48 54.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.64 -0.254 . . . . 74.23 111.644 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.665 ' HB3' HG13 ' A' ' 153' ' ' VAL . 56.8 m-85 -107.88 106.96 17.48 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 122.273 -0.267 . . . . 65.54 110.667 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.617 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 39.8 m-85 -102.51 143.67 31.93 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.196 0.522 . . . . 75.4 112.273 -176.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.7 tt -130.5 150.81 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.835 -0.62 . . . . 65.12 110.626 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.44 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -56.21 135.69 49.49 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.352 -0.452 . . . . 61.45 113.669 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.25 -39.62 66.98 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.091 0.472 . . . . 64.11 111.393 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -69.07 -55.92 9.3 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.081 -0.509 . . . . 74.43 111.296 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.07 -25.59 67.05 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.203 0.446 . . . . 43.31 112.203 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.44 -19.03 61.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.75 0.648 . . . . 74.02 112.75 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -70.47 -12.02 61.3 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.225 0.536 . . . . 60.25 111.144 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.41 41.2 2.81 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.369 -0.443 . . . . 62.44 112.967 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.12 -71.72 0.16 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.012 0.434 . . . . 75.23 111.769 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -123.8 -77.39 0.59 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.126 0.488 . . . . 71.51 110.223 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -134.79 -59.98 0.79 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.929 -0.578 . . . . 60.21 110.401 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.445 ' HA2' HG21 ' A' ' 9' ' ' THR . . . 103.28 139.56 10.4 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.294 -0.479 . . . . 73.14 112.837 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -73.73 112.2 9.61 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 122.548 -0.383 . . . . 35.02 111.47 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 138' ' ' PHE . 58.8 t -77.49 88.0 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.648 0.737 . . . . 74.31 110.079 169.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.963 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -79.4 117.53 20.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.534 -0.757 . . . . 70.31 110.471 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.777 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 58.1 mt -88.53 134.73 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.028 0.442 . . . . 52.22 111.991 -172.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.4 mm -103.22 115.48 45.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 116.443 -0.344 . . . . 74.15 111.063 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.448 ' HA ' HD22 ' A' ' 136' ' ' LEU . 38.2 tt0 -108.33 145.4 34.5 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 123.73 0.644 . . . . 74.42 111.831 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -90.2 117.47 28.98 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.06 0.457 . . . . 73.05 110.834 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -132.65 128.8 37.83 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.408 0.521 . . . . 72.31 112.408 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -83.77 116.14 22.56 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.046 -0.525 . . . . 65.01 110.144 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.507 HG21 ' HE3' ' A' ' 31' ' ' LYS . 98.8 t -114.72 105.98 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.472 -0.331 . . . . 62.02 110.483 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 59.81 23.79 12.75 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.292 -0.413 . . . . 73.11 111.615 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.01 -18.91 51.12 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.148 -0.478 . . . . 74.42 113.294 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 28.3 m -82.19 132.72 35.24 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.644 -0.327 . . . . 74.41 111.517 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.23 98.82 11.14 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.548 0.69 . . . . 75.32 111.646 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.92 147.22 48.15 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.103 -0.498 . . . . 75.14 112.09 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.39 120.81 2.18 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.697 2.265 . . . . 64.25 113.008 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.8 p -94.17 129.72 40.66 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.207 0.527 . . . . 74.34 111.187 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.963 HD11 ' HB1' ' A' ' 154' ' ' ALA . 43.7 tp -87.94 123.06 32.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.068 -0.514 . . . . 74.03 111.31 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.777 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 62.8 mtt -92.75 124.07 36.49 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.797 0.332 . . . . 75.21 111.355 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 86.5 mt -132.4 143.39 49.79 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.458 -0.792 . . . . 73.53 109.818 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 175' ' ' ALA . 48.5 t -101.85 122.77 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 122.078 -0.389 . . . . 64.42 111.755 -173.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.512 ' HZ2' ' HA ' ' A' ' 26' ' ' LEU . 22.9 pttm -68.62 -29.37 67.86 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.182 0.438 . . . . 75.12 112.182 -173.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -89.09 5.86 42.54 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.265 0.555 . . . . 63.44 111.36 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.6 ' HB3' ' HB ' ' A' ' 172' ' ' VAL . . . -113.91 -22.96 9.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.899 -0.591 . . . . 72.23 111.278 172.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 172' ' ' VAL . 34.5 pt -129.77 137.15 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.975 0.417 . . . . 42.02 111.198 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.6 mm -103.46 110.87 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.844 0.354 . . . . 73.35 111.489 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -74.15 95.71 2.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.193 -0.458 . . . . 73.23 109.909 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.608 ' HB3' HG13 ' A' ' 3' ' ' ILE . 29.5 tt0 -95.23 119.04 33.06 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.237 0.541 . . . . 75.33 111.37 -174.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 121.434 0.635 . . . . 75.42 112.706 -174.075 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 tpp . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.688 0.28 . . . . 71.01 111.565 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.19 130.09 40.56 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.763 0.315 . . . . 75.44 111.139 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.2 mt -102.66 134.11 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.758 -0.201 . . . . 75.32 111.048 -177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -123.49 141.57 51.87 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.58 0.705 . . . . 74.24 112.282 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.441 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 21.6 ttmm -111.38 110.55 21.06 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.759 -1.109 . . . . 64.34 111.013 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.623 ' HB2' ' H ' ' A' ' 9' ' ' THR . 1.4 m-20 -83.14 149.54 26.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.558 -0.292 . . . . 71.21 110.955 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 175' ' ' ALA . 68.9 mt -61.02 -33.89 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.398 0.618 . . . . 75.24 110.77 173.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -105.14 -29.26 10.49 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.669 0.618 . . . . 72.13 112.669 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.623 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 2.0 m -106.48 11.81 30.29 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.058 0.392 . . . . 71.13 112.058 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.441 ' OD1' ' HG3' ' A' ' 5' ' ' LYS . 17.7 t70 -50.92 -35.93 35.8 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.218 0.451 . . . . 71.03 112.218 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.32 -19.55 35.93 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 111.954 0.353 . . . . 55.33 111.954 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -91.32 -30.11 16.76 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 111.72 0.267 . . . . 75.44 111.72 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.6 tp 40.3 90.8 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.17 0.588 . . . . 61.0 111.787 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 t -103.15 169.5 8.52 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.12 0.785 . . . . 43.22 113.12 -164.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 87.9 p -137.97 150.14 46.76 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.656 -0.702 . . . . 61.22 111.315 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -145.47 175.33 10.41 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.328 -0.396 . . . . 73.11 110.709 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.6 p -133.92 15.66 3.91 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.651 0.612 . . . . 55.41 112.651 -178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 97.6 m-85 -109.92 121.93 40.5 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 120.912 0.386 . . . . 73.01 111.768 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 8.0 Cg_exo -73.43 102.3 1.46 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.87 2.38 . . . . 54.2 113.106 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.1 ptt? -85.89 153.91 21.88 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.354 -0.385 . . . . 63.1 111.588 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 89.6 mttt -99.04 123.9 43.67 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 111.813 0.301 . . . . 75.23 111.813 -174.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 tp -78.44 99.15 6.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.966 0.412 . . . . 42.44 110.949 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -95.71 146.78 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.9 0.381 . . . . 65.45 111.101 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.44 7.76 3.15 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 116.267 -0.424 . . . . 74.32 111.851 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 58.19 21.7 8.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.881 0.372 . . . . 74.25 111.764 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.412 ' O ' ' HG3' ' A' ' 173' ' ' LYS . 40.2 tp -129.46 -43.89 1.26 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.018 0.437 . . . . 70.32 111.718 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 172' ' ' VAL . 13.0 m -134.25 153.34 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.15 0.5 . . . . 72.31 112.288 -175.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.495 ' CE2' ' HB3' ' A' ' 173' ' ' LYS . 95.0 m-85 -91.61 134.47 34.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.238 -0.437 . . . . 72.02 111.105 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 8.7 pt-20 -104.84 131.78 51.9 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.318 0.58 . . . . 71.51 110.81 172.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.571 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 74.7 t80 -130.91 119.07 21.61 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.197 -0.456 . . . . 74.14 111.153 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -101.57 130.67 47.93 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.937 0.399 . . . . 54.04 111.411 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.77 -160.08 10.88 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.354 -0.45 . . . . 71.21 112.785 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -109.26 165.76 11.37 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.439 -0.448 . . . . 63.22 111.761 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -98.34 106.43 18.72 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.406 -0.361 . . . . 64.33 110.614 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.97 159.6 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.141 0.496 . . . . 65.33 111.574 -176.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 5.6 m -127.8 137.59 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.28 -0.418 . . . . 74.53 110.176 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 30.0 ttp180 . . . . . 0 C--O 1.241 0.652 0 CA-C-O 121.573 0.702 . . . . 61.1 112.179 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 43.7 mt-10 . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 121.386 0.613 . . . . 71.24 109.881 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -106.85 148.42 28.56 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.006 -0.543 . . . . 71.14 111.99 -175.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.29 -113.62 1.4 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.935 -0.65 . . . . 64.3 113.294 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.572 HG21 ' HB3' ' A' ' 167' ' ' PRO . 31.4 pt -111.68 132.3 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.194 0.521 . . . . 63.41 112.213 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -51.1 -33.59 26.85 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.015 -0.539 . . . . 72.45 112.109 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.492 HG21 ' HB2' ' A' ' 169' ' ' LEU . 64.5 mt -47.87 -49.56 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 112.329 0.492 . . . . 75.43 112.329 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 23.4 m -85.68 -30.32 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.41 -0.359 . . . . 74.11 111.899 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 66.8 mt -67.82 -49.96 59.37 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.093 0.473 . . . . 75.4 111.211 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -60.85 -36.21 78.54 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.897 -0.592 . . . . 75.42 111.755 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -100.51 8.03 43.75 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.236 0.458 . . . . 61.32 112.236 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 54.89 69.67 0.71 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.673 0.619 . . . . 75.53 112.673 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 73.5 mt -116.61 125.93 52.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.056 -0.52 . . . . 63.52 110.505 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 p -82.58 143.08 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.969 0.414 . . . . 72.55 111.886 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -77.84 129.15 35.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.824 -0.625 . . . . 62.43 112.506 -175.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.5 mmt -136.13 165.22 26.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.984 -0.553 . . . . 72.24 111.169 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -144.91 143.24 30.46 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.276 0.56 . . . . 74.24 111.923 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 21.3 p -40.86 -32.43 0.23 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.753 1.76 . . . . 60.21 115.753 -167.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -51.15 -46.36 61.98 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.86 0.689 . . . . 75.44 112.86 -172.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -103.71 -20.48 13.95 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.007 -0.433 . . . . 62.24 111.551 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.84 -22.32 66.97 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.02 0.378 . . . . 44.33 112.02 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.47 -42.33 54.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.046 0.45 . . . . 72.3 111.312 175.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.9 t -62.83 -42.96 99.95 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.251 0.548 . . . . 65.33 111.233 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.2 ttm -64.31 -43.54 94.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.081 -0.509 . . . . 73.51 110.878 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 91' ' ' TYR . 62.9 m-85 -66.91 -30.49 70.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.998 0.37 . . . . 63.22 111.998 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.8 -53.48 57.37 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.002 0.429 . . . . 71.41 110.488 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.08 -41.24 90.98 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.046 0.45 . . . . 71.15 111.615 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.575 ' HE1' ' HG3' ' A' ' 152' ' ' GLN . 78.7 t80 -56.89 -63.37 1.23 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.04 -0.527 . . . . 74.54 111.602 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.9 mm -57.87 -31.26 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.463 -0.335 . . . . 63.25 111.767 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -56.91 -67.29 0.33 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.055 0.455 . . . . 75.32 111.575 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -63.39 -40.76 98.12 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.175 -0.466 . . . . 63.32 111.102 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.477 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 86.8 t80 -54.94 -55.62 28.7 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.866 -0.606 . . . . 43.12 111.304 178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -55.83 -50.23 71.11 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.883 0.327 . . . . 71.13 111.883 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -62.63 -37.77 87.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.076 0.398 . . . . 75.25 112.076 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -76.07 -46.73 27.63 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.257 -0.277 . . . . 71.44 111.746 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.484 HG12 ' HB3' ' A' ' 174' ' ' GLU . 22.0 m -65.77 -42.55 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 112.085 0.402 . . . . 73.21 112.085 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.1 mm -65.42 -43.53 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 122.228 -0.295 . . . . 54.33 111.071 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.15 -38.9 74.2 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.139 0.495 . . . . 75.31 110.847 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -60.76 -56.59 19.4 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.018 -0.537 . . . . 70.02 111.639 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.637 ' HE2' ' HA ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -67.88 -28.46 67.54 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.127 0.489 . . . . 73.43 111.591 -178.251 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 37.5 tt0 -68.53 -27.2 65.89 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.18 -0.464 . . . . 61.4 111.568 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -72.64 -36.72 68.06 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.902 0.382 . . . . 63.31 111.824 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -86.58 -29.89 22.27 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 111.942 0.349 . . . . 61.01 111.942 -176.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -125.61 -74.92 0.59 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.357 0.502 . . . . 75.5 112.357 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 24.1 ttt180 67.92 -30.73 0.17 Allowed 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 113.02 0.748 . . . . 63.2 113.02 -174.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 111' ' ' ALA . 23.0 t0 -90.94 80.26 5.79 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.652 -0.655 . . . . 70.11 111.925 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.475 ' HG3' ' N ' ' A' ' 111' ' ' ALA . 10.0 ptpp? 50.14 -67.1 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.671 1.588 . . . . 74.2 115.056 169.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 109' ' ' ASP . . . -33.47 -54.51 0.43 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.01 1.115 . . . . 45.23 114.01 -172.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -95.97 -44.88 7.16 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.45 0.537 . . . . 61.32 112.45 -176.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 m -61.53 -37.24 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 112.564 0.579 . . . . 41.53 112.564 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.89 -41.55 87.0 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.081 0.467 . . . . 51.43 110.881 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -64.02 -48.89 74.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.188 -0.46 . . . . 71.42 111.054 176.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -57.85 -48.85 78.58 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.238 -0.437 . . . . 72.04 111.322 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -51.99 -51.71 55.44 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.771 -0.455 . . . . 75.32 109.771 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -57.61 -38.02 74.24 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.143 -0.48 . . . . 74.21 111.298 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 29.7 mmmt -63.52 -62.5 1.63 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.003 0.43 . . . . 72.22 111.81 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.1 tp -69.22 -32.65 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.394 -0.366 . . . . 75.3 111.88 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.411 ' O ' HG23 ' A' ' 125' ' ' VAL . 58.1 tp60 -62.84 -49.39 75.1 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.918 0.39 . . . . 73.52 110.196 175.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.29 -38.23 85.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.88 -0.676 . . . . 51.11 112.556 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 44.3 t90 -60.68 -55.38 33.9 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.306 0.242 . . . . 72.45 111.457 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.7 m -65.85 -40.83 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.079 0.4 . . . . 75.23 112.079 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 121' ' ' GLN . 68.8 t -59.09 -36.11 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.098 0.475 . . . . 62.13 111.223 177.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.5 m -76.51 -47.25 23.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.017 0.437 . . . . 72.43 110.975 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.1 tp -62.2 -36.07 80.79 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.967 -0.561 . . . . 72.4 112.139 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.6 mt -88.56 3.2 51.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.469 0.544 . . . . 74.35 112.469 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.426 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -68.26 81.97 0.24 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.404 0.621 . . . . 43.21 110.911 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -48.07 -45.34 32.35 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.885 1.069 . . . . 63.54 113.885 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -43.31 -46.62 6.42 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.502 0.556 . . . . 64.51 112.502 -171.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.512 ' HG3' ' CD1' ' A' ' 133' ' ' PHE . 2.3 ptp180 -109.74 -42.15 4.35 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.185 0.439 . . . . 70.3 112.185 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.512 ' CD1' ' HG3' ' A' ' 132' ' ' ARG . 52.9 m-85 -71.04 -8.16 51.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.962 0.727 . . . . 73.42 112.962 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -56.01 -22.59 27.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.234 0.54 . . . . 64.23 111.08 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.551 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 58.3 m-20 -76.65 6.05 6.55 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.595 -0.73 . . . . 75.04 112.215 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.8 mt -89.19 148.98 23.34 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.026 0.441 . . . . 73.13 111.579 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.05 146.38 30.2 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.173 -0.467 . . . . 65.11 111.217 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -114.09 125.43 53.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.969 0.414 . . . . 74.02 110.879 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.547 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 58.1 m-85 -126.2 127.95 46.47 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.018 0.437 . . . . 74.33 111.555 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 145' ' ' ALA . 10.3 tt -121.63 152.32 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.341 -0.39 . . . . 71.12 111.176 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.49 136.87 35.48 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 114.142 0.417 . . . . 62.24 114.142 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.05 -41.42 68.1 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.34 0.496 . . . . 54.44 112.34 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.612 ' H ' ' HD2' ' A' ' 143' ' ' ARG . 1.2 mpt_? -80.29 -43.12 21.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.914 0.387 . . . . 71.23 110.975 -177.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.63 -53.49 57.0 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.244 -0.434 . . . . 72.35 111.499 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -59.06 -24.43 62.87 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.492 0.553 . . . . 60.31 112.492 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.72 -29.19 16.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.91 0.386 . . . . 70.22 111.663 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -88.38 -49.32 3.73 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.109 -0.567 . . . . 54.02 113.15 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.75 124.13 10.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.747 0.308 . . . . 61.51 111.22 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -18.41 59.81 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.852 0.358 . . . . 34.35 111.513 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -78.07 44.45 0.48 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.1 0.476 . . . . 53.31 111.29 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.87 179.24 35.37 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.171 -0.468 . . . . 34.5 113.207 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.704 HE22 HG23 ' A' ' 176' ' ' ILE . 46.4 tt0 -98.43 115.85 29.4 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.09 0.471 . . . . 74.33 111.671 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.2 t -81.05 139.57 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.171 0.51 . . . . 74.1 111.916 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.801 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -97.82 133.45 42.32 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.922 -0.581 . . . . 65.54 110.651 175.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 45.6 mm -86.77 124.74 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.73 0.3 . . . . 53.43 111.504 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.443 HG13 ' CD1' ' A' ' 139' ' ' PHE . 46.5 mm -110.57 106.79 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.273 0.559 . . . . 53.2 112.444 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.519 ' HG2' ' N ' ' A' ' 158' ' ' TYR . 28.4 tt0 -103.1 158.65 16.15 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.277 -0.874 . . . . 75.02 110.148 172.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.605 ' HB2' ' HB3' ' A' ' 165' ' ' GLU . 0.6 OUTLIER -115.83 115.01 25.52 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.476 0.655 . . . . 55.25 111.243 168.167 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.482 HH21 HG21 ' A' ' 168' ' ' THR . 3.5 tpp180 -69.04 141.18 54.89 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.408 -0.814 . . . . 73.2 112.153 -176.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.51 102.97 7.17 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.255 -0.43 . . . . 71.41 111.388 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 83.5 t -111.01 90.79 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.963 0.411 . . . . 70.03 110.625 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 58.28 19.69 6.52 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.058 -0.519 . . . . 65.33 111.833 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 112.3 -23.41 16.03 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 116.265 -0.425 . . . . 71.12 112.653 -175.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 92.8 m -84.26 118.63 24.3 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.067 0.461 . . . . 64.33 110.886 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 26.0 mt-10 -85.34 100.32 11.74 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.007 -0.542 . . . . 75.52 111.236 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 25.2 m -98.4 149.79 36.08 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 111.981 0.363 . . . . 74.21 111.981 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.572 ' HB3' HG21 ' A' ' 68' ' ' ILE . 18.0 Cg_endo -58.88 136.25 72.34 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.69 2.26 . . . . 53.54 114.278 -176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.482 HG21 HH21 ' A' ' 159' ' ' ARG . 83.2 m -143.27 108.83 5.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.762 -0.654 . . . . 71.51 110.9 176.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.801 HD11 ' HB1' ' A' ' 154' ' ' ALA . 63.5 tp -82.55 145.41 29.76 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.209 -0.45 . . . . 75.02 111.665 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.683 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 64.7 mtt -126.45 126.47 43.83 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.843 0.354 . . . . 71.3 111.462 176.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -134.51 129.94 35.9 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.091 -0.504 . . . . 75.21 111.2 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 174' ' ' GLU . 22.3 t -80.32 126.86 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 O-C-N 122.019 -0.426 . . . . 65.43 111.711 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.495 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -72.29 -14.59 61.79 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.332 0.493 . . . . 75.21 112.332 -179.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.541 ' H ' HG12 ' A' ' 172' ' ' VAL . 0.4 OUTLIER -81.07 -11.69 59.45 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.9 0.381 . . . . 72.22 111.229 169.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.442 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -96.95 -39.25 9.46 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.981 0.42 . . . . 62.24 110.804 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.704 HG23 HE22 ' A' ' 152' ' ' GLN . 29.6 pt -119.88 114.07 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.087 0.47 . . . . 63.24 111.563 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.438 HD13 ' N ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -94.42 130.42 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 109.282 -0.636 . . . . 63.31 109.282 175.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.438 ' N ' HD13 ' A' ' 177' ' ' ILE . 1.5 pp20? -94.59 153.0 18.07 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.812 0.815 . . . . 71.13 112.961 -172.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -127.09 99.16 5.58 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.418 -0.81 . . . . 73.41 109.694 173.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 64.0 tttm . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.263 0.554 . . . . 64.31 110.637 179.307 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtm . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.796 0.332 . . . . 71.03 111.233 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 15' ' ' SER . 29.8 tp -109.46 130.72 55.49 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.649 -0.5 . . . . 44.11 109.649 170.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.766 HG13 ' HB3' ' A' ' 179' ' ' GLU . 17.4 pt -117.19 127.79 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.191 0.519 . . . . 63.21 111.607 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -121.8 147.61 45.74 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.96 -0.564 . . . . 71.32 112.104 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.426 ' HE3' ' CG2' ' A' ' 177' ' ' ILE . 20.7 ttpp -124.05 117.24 24.26 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.348 -0.387 . . . . 71.04 111.525 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.79 173.31 6.39 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.031 -0.531 . . . . 64.42 111.362 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.805 HD11 ' HB1' ' A' ' 175' ' ' ALA . 57.7 mt -78.28 -49.59 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.055 0.455 . . . . 70.43 111.619 175.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -93.16 -38.62 11.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.006 -0.543 . . . . 73.33 112.13 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -97.9 17.95 17.0 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.701 -0.682 . . . . 73.54 110.945 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -47.68 -39.9 18.57 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.095 1.146 . . . . 71.24 114.095 -169.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.26 -28.0 62.58 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.124 0.416 . . . . 75.02 112.124 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 35.0 tt0 -89.05 25.11 1.91 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 120.669 0.271 . . . . 74.45 111.509 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.458 HD21 ' HB ' ' A' ' 3' ' ' ILE . 7.8 tt -34.67 122.09 0.52 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.324 0.65 . . . . 75.33 111.698 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t -126.64 179.42 5.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.399 -0.364 . . . . 63.12 111.493 -171.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.478 ' HB3' HG22 ' A' ' 3' ' ' ILE . 83.8 p -124.66 148.04 48.2 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.444 -0.344 . . . . 60.51 111.419 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -138.78 -172.74 3.38 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.514 0.673 . . . . 73.33 111.691 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -149.28 29.31 0.79 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.406 -0.815 . . . . 71.31 111.016 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -90.16 113.05 55.89 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 112.026 0.38 . . . . 64.54 112.026 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.54 77.46 1.74 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.189 1.926 . . . . 71.24 112.32 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.3 mtt -84.76 143.27 29.24 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.075 0.465 . . . . 72.45 111.247 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 27.1 ttpp -99.63 118.58 36.46 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.012 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.4 tp -76.24 135.56 39.67 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.882 0.373 . . . . 64.5 111.021 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.23 134.65 65.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.2 0.524 . . . . 53.32 111.656 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.1 t70 61.9 15.93 7.59 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.464 -0.789 . . . . 72.32 111.951 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 59.0 19.72 7.5 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.002 0.521 . . . . 63.11 112.112 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.1 tp -119.74 -49.72 2.32 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.099 0.407 . . . . 62.52 112.099 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.624 HG12 ' HA ' ' A' ' 172' ' ' VAL . 13.6 m -132.53 149.55 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.581 0.586 . . . . 74.23 112.581 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -86.52 144.43 27.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.262 -0.426 . . . . 70.01 111.065 174.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 16.2 pt-20 -122.1 133.42 54.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.038 0.447 . . . . 73.04 110.489 174.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -137.53 135.48 36.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.833 0.349 . . . . 75.23 110.838 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -92.2 121.54 33.83 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.591 0.589 . . . . 71.14 112.591 -173.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.92 165.51 12.93 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.08 -0.509 . . . . 54.54 112.358 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -121.95 145.01 48.53 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 122.367 -0.49 . . . . 73.23 111.109 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -73.62 109.64 7.28 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.328 0.585 . . . . 75.22 112.04 -175.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.47 HG23 HD12 ' A' ' 72' ' ' LEU . 26.8 m -134.63 166.2 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.246 -0.433 . . . . 72.31 110.474 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.5 m -131.4 150.74 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 122.067 -0.395 . . . . 65.22 111.249 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.672 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 34.9 mmt180 . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 121.498 0.666 . . . . 54.44 112.208 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.672 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 48.2 mt-10 . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.568 0.699 . . . . 73.43 110.08 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -85.79 129.29 34.87 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.149 -0.932 . . . . 74.24 112.194 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.92 -149.74 11.68 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.01 -0.615 . . . . 63.01 112.803 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 pt -111.45 154.11 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 122.601 -0.352 . . . . 53.23 111.573 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -41.27 -48.94 3.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.257 0.465 . . . . 65.25 112.257 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.428 HG21 HD22 ' A' ' 169' ' ' LEU . 56.1 mt -49.6 -55.49 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 112.584 0.587 . . . . 72.3 112.584 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.407 ' HA ' HD12 ' A' ' 76' ' ' LEU . 23.0 m -80.53 -34.76 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.333 0.494 . . . . 75.21 112.333 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.47 HD12 HG23 ' A' ' 35' ' ' VAL . 87.3 mt -71.03 -40.81 71.52 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.979 0.419 . . . . 73.23 111.527 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -64.42 -35.98 82.68 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.909 0.385 . . . . 75.24 111.969 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -101.43 4.81 41.69 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.531 0.567 . . . . 70.25 112.531 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.0 70.33 0.62 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.158 0.504 . . . . 72.42 112.149 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 71' ' ' VAL . 76.5 mt -115.04 135.08 54.61 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.287 -0.415 . . . . 74.31 111.25 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.18 143.25 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.577 0.227 . . . . 72.44 111.211 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 7.9 pt-20 -88.88 134.05 34.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.408 0.623 . . . . 73.23 112.631 -176.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.43 138.09 50.6 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.845 -0.616 . . . . 75.5 110.618 171.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.573 HD22 ' N ' ' A' ' 80' ' ' ASN . 0.7 OUTLIER -105.07 144.49 31.81 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.98 -0.554 . . . . 74.12 110.407 175.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 40.9 t -49.32 -16.68 0.2 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.297 1.591 . . . . 65.31 115.297 -169.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -93.59 -19.37 21.24 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.558 -0.714 . . . . 62.5 112.701 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -83.06 -46.51 12.73 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.283 0.563 . . . . 70.52 111.852 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 87' ' ' MET . 9.9 p-10 -108.17 21.77 16.89 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.601 -0.727 . . . . 71.31 112.163 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.603 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -36.26 -50.13 0.72 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.92 1.081 . . . . 75.11 113.92 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.9 t -73.06 -30.48 63.74 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.951 0.405 . . . . 63.53 111.542 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.581 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 80.2 mtp -67.8 -60.38 2.57 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.197 0.443 . . . . 75.2 112.197 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.603 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 6.1 p90 -63.4 -28.26 69.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.178 -0.609 . . . . 75.22 110.654 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -58.2 -40.35 81.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.12 0.486 . . . . 70.41 110.543 172.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.47 80.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.214 -0.448 . . . . 71.44 111.048 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -54.68 -54.39 42.35 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.156 -0.475 . . . . 74.54 111.225 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.5 -35.1 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.52 -0.309 . . . . 74.52 111.74 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.439 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -60.86 -60.43 3.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.776 0.322 . . . . 75.24 111.488 177.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -64.96 -38.66 91.69 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.064 0.459 . . . . 51.05 111.298 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.688 ' HZ ' HD11 ' A' ' 120' ' ' ILE . 41.6 t80 -57.18 -53.25 60.2 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.052 -0.522 . . . . 64.45 111.838 176.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -61.83 -46.92 87.38 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.845 0.355 . . . . 73.33 111.496 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.44 -36.05 82.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.647 -0.251 . . . . 65.12 111.554 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.54 -52.82 34.32 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.513 -0.312 . . . . 73.32 111.782 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.1 m -58.72 -39.31 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 111.893 0.331 . . . . 63.33 111.893 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.511 HD11 ' HB3' ' A' ' 117' ' ' LYS . 17.6 mm -77.95 -36.44 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.147 0.425 . . . . 74.02 112.147 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -60.97 -39.16 88.52 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.32 0.581 . . . . 75.54 109.952 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -71.79 -70.3 0.34 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.468 -0.787 . . . . 60.03 111.438 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 11.9 tpt -63.01 -43.32 99.11 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.835 0.68 . . . . 74.23 112.835 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.455 ' HA ' HG11 ' A' ' 113' ' ' VAL . 32.1 tt0 -71.95 -10.96 60.52 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.032 -0.417 . . . . 75.23 111.591 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -87.16 -45.16 10.93 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.221 -0.299 . . . . 61.42 111.367 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -80.5 -31.35 37.23 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.933 0.345 . . . . 63.11 111.933 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.418 HD21 ' HB3' ' A' ' 112' ' ' ASP . 56.2 t30 -96.04 -51.34 4.48 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 122.268 -0.27 . . . . 74.55 111.625 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 74.06 -35.34 0.3 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.954 1.465 . . . . 71.02 114.954 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.612 ' O ' HG22 ' A' ' 113' ' ' VAL . 28.3 t70 -63.19 121.33 13.39 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.648 -0.658 . . . . 73.42 112.28 -172.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.681 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -46.29 -51.16 15.1 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.438 -0.801 . . . . 64.35 113.129 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.473 ' N ' ' HG2' ' A' ' 110' ' ' LYS . . . -70.26 -33.52 71.71 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.085 0.402 . . . . 72.32 112.085 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.418 ' HB3' HD21 ' A' ' 107' ' ' ASN . 6.6 t70 -77.54 -49.68 14.17 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.032 0.444 . . . . 43.12 110.846 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 109' ' ' ASP . 31.1 m -66.52 -22.59 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 122.058 -0.401 . . . . 64.41 111.073 175.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.58 -50.09 74.25 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.809 0.338 . . . . 53.33 110.322 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.46 -43.81 96.52 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.237 -0.438 . . . . 41.25 111.084 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.413 ' HE1' ' HB3' ' A' ' 174' ' ' GLU . 87.4 t80 -57.73 -58.29 9.02 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.256 -0.429 . . . . 73.41 111.8 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.616 ' HA ' HG22 ' A' ' 120' ' ' ILE . 17.6 ptpt -65.46 -30.96 71.81 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.293 -0.254 . . . . 75.4 111.436 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -58.81 -45.74 89.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.369 0.604 . . . . 74.55 110.501 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -67.44 -57.38 6.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.508 -0.769 . . . . 75.52 111.92 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.688 HD11 ' HZ ' ' A' ' 95' ' ' PHE . 10.5 tp -66.38 -39.56 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 112.257 0.465 . . . . 73.34 112.257 -173.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -73.64 -43.52 59.29 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 122.07 -0.394 . . . . 62.31 110.449 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.0 -34.4 61.86 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.955 -0.64 . . . . 72.21 112.228 174.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -62.85 -57.69 9.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.42 0.288 . . . . 71.21 111.076 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 26.1 m -62.18 -48.88 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 112.414 0.524 . . . . 75.13 112.414 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.03 -29.02 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.788 -0.57 . . . . 74.34 111.952 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.9 t -84.87 -33.85 22.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.846 0.355 . . . . 44.31 111.331 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.473 HD21 HD13 ' A' ' 155' ' ' ILE . 40.2 tp -70.37 -32.76 70.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.218 0.532 . . . . 74.45 111.251 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.6 mt -80.29 2.34 25.01 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.147 -0.478 . . . . 71.34 111.888 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.06 82.39 0.32 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.564 0.697 . . . . 61.04 110.434 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.465 ' NZ ' ' HB3' ' A' ' 130' ' ' LYS . 5.5 ttpm? -65.0 -6.41 8.51 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.716 -0.675 . . . . 74.33 112.72 -170.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.49 -47.23 86.31 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.93 -0.481 . . . . 73.24 111.212 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -108.94 -35.4 6.36 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.039 0.447 . . . . 70.03 111.429 172.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -69.69 -6.65 33.07 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.436 0.532 . . . . 72.12 112.436 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -52.78 -25.76 12.29 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.118 0.414 . . . . 75.41 112.118 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.41 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . 66.9 m-20 -83.33 12.09 5.87 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.211 0.449 . . . . 75.33 112.211 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 81.5 mt -90.28 156.8 18.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.259 0.552 . . . . 72.31 112.093 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.31 126.29 25.98 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.967 -0.56 . . . . 74.23 110.261 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.5 ' HB2' ' CG1' ' A' ' 153' ' ' VAL . 14.0 p90 -116.91 126.78 53.48 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.382 0.61 . . . . 70.4 111.33 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 78' ' ' GLU . 24.5 m-85 -97.95 148.12 23.78 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.706 -0.679 . . . . 71.52 112.18 -172.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 14.1 tt -136.04 150.33 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.716 -0.674 . . . . 74.25 110.592 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.01 140.26 46.73 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.132 -0.556 . . . . 64.13 113.392 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -50.81 -52.9 36.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.854 0.359 . . . . 64.54 111.588 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -54.25 -30.71 51.3 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.169 -0.469 . . . . 74.43 112.149 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.8 -56.49 4.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.489 -0.323 . . . . 73.05 111.266 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.36 -24.21 66.32 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.144 0.497 . . . . 61.22 111.589 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -54.72 -29.23 52.84 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.572 -0.74 . . . . 74.44 112.558 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.5 -34.27 0.1 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.558 -0.83 . . . . 42.11 113.764 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 149' ' ' GLU . . . -56.74 -50.95 70.71 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.47 0.544 . . . . 71.11 112.47 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 148' ' ' ALA . 10.8 pt-20 58.48 -22.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 125.273 1.429 . . . . 71.25 114.362 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 148' ' ' ALA . 20.0 t-20 -88.84 60.76 5.66 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.025 0.916 . . . . 75.01 109.703 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -129.8 172.75 19.96 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.89 -1.05 . . . . 61.13 112.697 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -79.04 144.25 34.84 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.016 0.436 . . . . 64.14 111.396 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.5 ' CG1' ' HB2' ' A' ' 138' ' ' PHE . 37.6 t -114.03 137.14 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.194 -0.457 . . . . 75.2 111.506 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.76 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -104.87 119.76 39.78 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.18 -0.464 . . . . 61.02 110.777 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.473 HD13 HD21 ' A' ' 127' ' ' LEU . 60.7 mt -91.07 138.6 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.159 0.429 . . . . 44.02 112.159 -174.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.1 mm -115.46 120.14 63.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.022 0.439 . . . . 75.11 111.144 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -110.99 157.68 19.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.617 -0.72 . . . . 73.21 111.104 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 135' ' ' ASN . 9.8 p90 -106.89 115.19 29.75 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.187 0.518 . . . . 65.12 111.771 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -115.76 140.04 49.59 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.177 -0.465 . . . . 74.42 111.769 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -102.52 109.41 21.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.505 -0.316 . . . . 72.1 110.385 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 52.7 t -90.39 89.85 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.043 0.449 . . . . 74.15 111.111 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.6 t70 55.38 27.33 9.87 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.866 -0.606 . . . . 74.32 112.308 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 119.23 -1.61 14.44 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.941 -0.647 . . . . 74.43 113.985 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 41.6 m -118.61 121.13 39.44 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 117.397 0.598 . . . . 62.52 111.245 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.25 121.45 26.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.293 0.568 . . . . 73.15 111.796 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.447 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 29.0 m -128.83 137.66 31.46 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 116.202 -0.454 . . . . 74.0 111.873 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 166' ' ' VAL . 5.9 Cg_exo -80.97 118.42 3.39 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.232 2.621 . . . . 72.11 112.845 176.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.3 p -103.95 146.19 29.05 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.29 0.567 . . . . 71.31 112.188 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.76 HD11 ' HB1' ' A' ' 154' ' ' ALA . 69.9 tp -95.47 137.88 33.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.922 -0.581 . . . . 73.05 110.916 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.47 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 25.3 mmt -123.16 124.31 42.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.5 0.32 . . . . 73.24 111.608 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 98.1 mt -139.3 130.21 26.29 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.82 0.448 . . . . 71.5 111.038 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.624 ' HA ' HG12 ' A' ' 27' ' ' VAL . 60.5 t -78.49 121.94 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 112.132 0.419 . . . . 72.2 112.132 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -76.96 -36.8 56.23 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.834 0.349 . . . . 41.13 111.828 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.413 ' HB3' ' HE1' ' A' ' 116' ' ' PHE . 7.0 mm-40 -73.94 6.33 3.44 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.232 0.456 . . . . 61.21 112.232 -172.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.805 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -107.38 -42.75 4.73 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.047 0.451 . . . . 53.32 111.331 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 22.4 pt -96.05 170.21 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.917 -0.583 . . . . 64.32 111.233 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.426 ' CG2' ' HE3' ' A' ' 5' ' ' LYS . 5.2 tp -128.1 111.62 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.669 0.747 . . . . 73.41 111.927 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.2 153.21 22.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.137 -0.938 . . . . 75.11 111.411 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.766 ' HB3' HG13 ' A' ' 3' ' ' ILE . 21.4 tp10 -140.32 136.47 33.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.184 0.516 . . . . 72.42 111.685 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt . . . . . 0 CA--C 1.536 0.423 0 CA-C-N 116.389 -0.369 . . . . 63.11 111.897 -179.366 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.929 0.395 . . . . 60.14 111.791 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.9 tp -134.16 128.41 33.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.522 -0.308 . . . . 72.32 110.225 174.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.574 HG22 ' HB3' ' A' ' 15' ' ' SER . 35.2 pt -111.32 128.09 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 120.9 0.381 . . . . 72.15 111.798 -175.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -124.04 141.69 51.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.16 0.505 . . . . 71.23 112.073 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.65 115.37 30.38 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.389 -0.823 . . . . 75.22 110.356 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.679 ' HA ' HG22 ' A' ' 176' ' ' ILE . 3.9 m-20 -77.14 169.63 17.99 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.274 0.559 . . . . 71.45 112.389 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.434 HG23 ' CD2' ' A' ' 8' ' ' PHE . 10.4 tt -88.54 -31.02 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.029 0.442 . . . . 62.14 111.541 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.566 ' HB2' ' HB2' ' A' ' 152' ' ' GLN . 91.1 m-85 -98.82 -38.25 9.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.219 0.533 . . . . 70.12 111.933 178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.7 p -106.82 21.5 17.42 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.552 0.575 . . . . 73.4 112.552 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 18.1 t70 -45.54 -45.81 13.67 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.053 0.76 . . . . 63.05 113.053 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.43 -26.98 67.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.51 0.672 . . . . 74.22 111.236 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -109.39 24.63 12.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.451 -0.795 . . . . 75.44 111.054 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.411 ' N ' HD23 ' A' ' 13' ' ' LEU . 2.3 pt? -44.35 150.13 0.33 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.808 0.67 . . . . 55.21 112.808 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.5 t -120.8 168.56 11.31 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.621 0.971 . . . . 73.03 113.621 -168.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.574 ' HB3' HG22 ' A' ' 3' ' ' ILE . 61.0 p -133.95 107.06 7.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.924 -1.035 . . . . 54.3 110.69 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -120.16 -177.53 3.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.843 0.354 . . . . 70.3 111.578 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.0 m -147.22 83.55 1.56 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.14 0.495 . . . . 54.35 111.243 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.507 ' HB2' ' HE2' ' A' ' 30' ' ' PHE . 85.7 m-85 -135.55 161.73 61.37 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.161 -0.472 . . . . 72.5 111.042 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.4 158.86 40.44 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.532 2.155 . . . . 71.11 112.613 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -144.08 131.17 20.58 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.248 0.547 . . . . 61.34 112.318 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -123.49 97.52 5.43 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.125 -0.488 . . . . 63.42 110.706 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.3 tp -76.93 116.77 17.89 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.48 0.548 . . . . 65.51 112.48 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.1 p -104.64 139.2 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.058 0.456 . . . . 74.43 111.824 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 59.02 9.56 1.29 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.534 0.734 . . . . 72.22 111.783 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.413 ' O ' ' HE3' ' A' ' 173' ' ' LYS . 32.7 t70 55.42 31.75 17.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.763 0.792 . . . . 71.42 110.36 -174.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.1 tp -124.23 -49.8 1.8 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.876 -0.602 . . . . 74.32 111.214 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.493 HG12 HG22 ' A' ' 172' ' ' VAL . 3.2 m -128.68 143.94 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.581 0.585 . . . . 73.44 112.581 -177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE2' ' HB3' ' A' ' 173' ' ' LYS . 60.8 m-85 -86.61 130.74 34.37 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.117 -0.492 . . . . 75.21 111.522 177.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.95 118.44 30.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.02 -0.991 . . . . 71.21 110.002 173.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.507 ' HE2' ' HB2' ' A' ' 18' ' ' PHE . 6.2 m-85 -108.94 119.43 39.53 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.217 0.451 . . . . 74.04 112.217 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -94.61 89.44 5.78 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.048 0.451 . . . . 74.25 111.358 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.87 -157.76 17.43 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 116.007 -0.542 . . . . 40.34 112.881 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -143.06 132.8 23.88 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 122.029 -0.689 . . . . 74.13 111.635 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -72.08 106.89 4.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.582 0.23 . . . . 74.01 110.447 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -134.41 164.44 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.209 0.528 . . . . 74.21 112.222 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 66' ' ' ARG . 29.4 m -138.67 131.88 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.103 -0.499 . . . . 74.44 110.745 175.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 43.5 ttp180 . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 120.877 0.37 . . . . 73.25 111.556 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 1.2 mp0 . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 121.486 0.66 . . . . 75.45 110.983 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.565 ' HA ' HG12 ' A' ' 36' ' ' VAL . 6.2 ttp180 -83.32 110.69 18.33 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.398 -0.819 . . . . 72.41 111.709 177.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.25 -153.98 12.45 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.852 -0.689 . . . . 71.21 112.943 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' A' ' 167' ' ' PRO . 33.6 pt -112.03 150.52 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.224 -0.574 . . . . 74.04 111.799 176.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -38.39 -56.87 1.2 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.65 0.78 . . . . 72.52 112.724 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.4 mt -53.88 -55.16 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.824 0.676 . . . . 71.11 112.824 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.455 ' HA ' HD12 ' A' ' 76' ' ' LEU . 19.4 m -68.38 -35.2 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.147 0.425 . . . . 71.21 112.147 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.42 -47.01 68.36 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.066 0.46 . . . . 72.2 110.852 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -66.64 -44.15 82.75 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.881 -0.6 . . . . 70.43 111.659 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.443 ' HD2' HD21 ' A' ' 76' ' ' LEU . 78.1 t60 -82.14 -6.04 58.89 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.851 0.358 . . . . 74.55 111.188 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.438 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 62.34 70.08 0.59 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.611 0.72 . . . . 55.12 111.865 176.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.665 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 71.7 mt -111.8 137.72 49.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.401 -0.818 . . . . 71.42 111.418 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.3 p -91.25 143.54 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.081 0.467 . . . . 73.45 111.563 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -79.44 127.46 32.14 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.078 -0.51 . . . . 75.43 112.308 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 35.3 mtm -131.11 164.92 24.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.167 0.508 . . . . 73.43 110.999 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -142.58 158.88 43.21 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.179 -0.464 . . . . 70.24 111.013 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.8 m -49.71 -27.7 5.12 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.565 0.95 . . . . 62.42 113.565 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -48.27 -41.15 27.0 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.101 0.477 . . . . 74.23 111.244 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -105.3 -38.36 6.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.377 0.608 . . . . 71.33 110.972 174.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -71.9 -13.52 61.68 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.917 0.71 . . . . 50.54 112.917 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.55 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -43.69 -66.1 0.42 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.858 0.688 . . . . 73.44 112.858 -177.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.2 t -71.62 -18.28 62.22 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.245 -0.284 . . . . 74.41 111.487 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.27 -63.54 1.06 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.8 -0.182 . . . . 61.12 111.168 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.55 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 17.7 p90 -59.53 -33.08 70.94 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.854 -0.338 . . . . 74.54 110.717 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -57.23 -47.41 81.41 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.131 0.491 . . . . 72.21 110.964 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.14 -38.45 82.17 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.245 -0.434 . . . . 65.54 111.605 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -65.05 -41.33 95.28 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.669 -0.242 . . . . 73.32 111.358 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 88' ' ' PHE . 35.9 mm -62.84 -37.09 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.965 0.412 . . . . 73.33 110.853 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -58.57 -56.26 24.46 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.161 0.505 . . . . 62.23 110.855 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -59.78 -45.09 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.895 -0.593 . . . . 74.01 111.061 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 175' ' ' ALA . 83.0 t80 -56.96 -61.91 2.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.817 -0.629 . . . . 71.12 111.976 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.47 ' O ' HG22 ' A' ' 100' ' ' ILE . 48.5 mtt -53.62 -50.12 66.38 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 111.899 0.333 . . . . 73.31 111.899 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.13 -41.98 97.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.773 0.321 . . . . 74.43 111.638 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -68.57 -48.19 64.86 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.743 0.306 . . . . 74.11 111.63 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.22 -41.35 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.258 0.466 . . . . 54.04 112.258 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 96' ' ' MET . 10.5 tp -68.27 -37.73 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 122.113 -0.367 . . . . 73.31 110.573 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.618 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 15.4 t70 -54.82 -60.92 2.7 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.131 0.491 . . . . 74.1 110.547 175.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -62.36 -34.55 76.91 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.335 -0.393 . . . . 73.13 111.843 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 10.8 tpt -61.38 -42.34 98.56 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.099 0.476 . . . . 54.13 110.883 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.7 -8.59 58.85 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 111.883 0.327 . . . . 75.53 111.883 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 61.7 mmtt -81.58 -27.69 34.18 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.698 -0.626 . . . . 63.22 111.761 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -102.44 -36.92 8.24 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.694 0.627 . . . . 74.33 112.694 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -98.57 -51.06 4.05 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.872 -0.517 . . . . 75.43 111.096 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.63 -36.86 0.27 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.646 0.98 . . . . 75.12 113.646 167.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -82.79 144.32 30.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.239 0.542 . . . . 75.2 112.432 -173.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.07 -38.27 79.02 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.627 -0.715 . . . . 70.53 112.617 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.25 27.26 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.065 0.394 . . . . 51.41 112.065 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -94.97 -61.05 1.55 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.984 0.421 . . . . 71.33 111.285 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.7 m -60.91 -27.53 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 113.185 0.809 . . . . 61.02 113.185 -173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.24 -38.7 88.52 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.04 0.448 . . . . 73.41 110.567 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.1 -46.22 62.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.199 -0.455 . . . . 70.33 111.235 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -57.16 -52.22 66.17 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.133 0.492 . . . . 74.25 111.332 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -61.1 -29.74 69.94 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.849 -0.614 . . . . 75.11 110.515 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -69.38 -46.91 65.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.222 -0.444 . . . . 71.31 111.635 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -59.61 -51.71 68.64 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.812 0.339 . . . . 64.13 111.895 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -67.0 -33.64 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 120.769 0.318 . . . . 75.02 111.507 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.95 -48.61 68.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.911 0.386 . . . . 71.41 110.399 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.63 -35.75 87.07 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.001 -0.619 . . . . 74.5 112.205 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 55.2 t90 -58.3 -57.04 14.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.622 0.369 . . . . 74.3 111.399 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.518 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 m -61.94 -48.2 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.352 0.501 . . . . 74.52 112.352 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.3 -28.92 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 121.912 -0.492 . . . . 64.5 111.896 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.9 m -82.27 -24.87 34.52 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.05 0.452 . . . . 53.25 111.031 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.47 -28.13 22.25 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.973 -0.558 . . . . 71.11 111.828 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.3 mt -79.96 2.43 23.57 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.765 0.654 . . . . 72.21 112.765 -176.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.47 92.11 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.32 0.581 . . . . 74.01 111.173 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -54.64 -43.36 72.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.12 0.785 . . . . 75.22 113.12 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -53.24 -34.87 58.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.351 0.5 . . . . 64.0 112.351 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 132' ' ' ARG . 8.2 mpt_? -102.91 -48.12 4.17 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.26 0.553 . . . . 74.21 111.206 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.468 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 97.6 m-85 -78.3 -6.6 55.55 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.287 0.847 . . . . 73.43 113.287 -171.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -12.02 3.53 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.527 -0.733 . . . . 74.22 111.727 173.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -92.64 18.39 8.8 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.106 0.41 . . . . 55.11 112.106 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 81.0 mt -88.36 144.71 26.23 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.939 -0.476 . . . . 54.12 111.65 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.28 122.21 45.76 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.056 -0.52 . . . . 74.31 110.802 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -97.91 108.6 21.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.855 0.359 . . . . 73.01 111.189 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.665 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 67.3 m-85 -102.88 130.41 49.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.08 0.467 . . . . 74.21 111.666 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.451 HD11 ' HA3' ' A' ' 151' ' ' GLY . 14.3 tt -128.31 155.1 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.084 -0.507 . . . . 75.31 110.9 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.41 143.54 41.44 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.351 -0.452 . . . . 62.33 113.614 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -50.85 -63.76 1.02 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.196 0.443 . . . . 74.4 112.196 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 2.6 mmp_? -49.4 -34.12 15.48 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.23 0.456 . . . . 73.34 112.23 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.654 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -63.88 -56.38 15.78 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.02 0.438 . . . . 43.23 111.732 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.88 -28.89 69.85 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.801 0.334 . . . . 71.4 111.634 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.73 -31.52 63.41 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.104 -0.498 . . . . 64.2 112.148 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.15 -43.93 0.03 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.279 -0.962 . . . . 65.13 114.301 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.654 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -66.29 86.26 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.196 0.522 . . . . 72.24 112.129 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.25 4.22 0.75 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.35 0.5 . . . . 75.41 112.35 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.534 ' O ' ' HB3' ' A' ' 8' ' ' PHE . 3.2 p-10 -91.93 24.08 3.39 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.158 0.504 . . . . 61.04 110.381 170.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.592 ' HA3' ' HB1' ' A' ' 144' ' ' ALA . . . -77.56 134.23 14.32 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 114.232 0.453 . . . . 52.24 114.232 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 8' ' ' PHE . 48.1 tt0 -93.98 134.6 36.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 122.558 0.343 . . . . 65.14 111.005 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 98.7 t -95.01 136.31 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.407 0.521 . . . . 61.43 112.407 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.801 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -103.98 136.21 44.05 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.865 -0.607 . . . . 73.04 110.069 173.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.529 ' HB ' ' HG3' ' A' ' 170' ' ' MET . 62.3 mt -102.53 128.31 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 120.003 -0.679 . . . . 53.34 112.734 -170.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 46.1 mm -102.5 117.63 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.782 0.325 . . . . 54.22 111.49 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -106.74 145.49 31.99 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.252 0.549 . . . . 54.2 112.285 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -77.13 98.14 4.97 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.699 0.761 . . . . 73.34 110.136 171.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.454 ' HB2' ' OG1' ' A' ' 168' ' ' THR . 0.0 OUTLIER -93.43 97.03 10.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.099 -0.501 . . . . 75.32 111.11 -174.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 7.4 p-10 -66.99 119.2 11.56 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.162 0.506 . . . . 75.33 111.217 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.6 t -121.53 105.61 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.084 -0.507 . . . . 72.44 110.899 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 53.41 34.62 18.53 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.416 0.524 . . . . 71.33 112.416 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.15 -23.49 27.09 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.284 -0.417 . . . . 53.3 113.759 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 85.8 m -105.88 113.92 27.76 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.502 -0.411 . . . . 54.51 111.757 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 49.4 mt-10 -73.48 110.24 7.61 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.754 0.312 . . . . 55.13 111.156 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.69 140.14 20.82 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 120.747 0.308 . . . . 61.53 111.145 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.435 ' HB2' HG21 ' A' ' 68' ' ' ILE . 73.4 Cg_endo -74.62 114.35 4.01 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.12 1.88 . . . . 63.13 112.704 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 159' ' ' ARG . 23.7 p -118.78 150.86 39.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.228 0.537 . . . . 61.1 111.588 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.801 HD11 ' HB1' ' A' ' 154' ' ' ALA . 38.7 tp -100.4 140.12 35.1 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.044 -0.526 . . . . 62.33 111.025 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.529 ' HG3' ' HB ' ' A' ' 155' ' ' ILE . 22.2 ptm -123.41 134.63 53.94 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 121.132 0.491 . . . . 61.15 111.236 177.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 86.3 mt -141.6 148.31 39.03 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.146 -0.934 . . . . 74.53 111.433 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.493 HG22 HG12 ' A' ' 27' ' ' VAL . 10.7 t -100.96 122.66 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.254 0.222 . . . . 64.44 110.745 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.51 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -74.13 -5.98 44.92 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.793 -0.567 . . . . 62.43 112.04 -177.246 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.484 ' H ' HG12 ' A' ' 172' ' ' VAL . 9.0 mm-40 -74.67 -15.24 60.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.364 0.602 . . . . 75.53 110.08 170.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . . . -99.03 -22.88 15.5 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.701 -0.682 . . . . 75.44 111.67 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 6' ' ' ASP . 40.3 pt -137.13 130.73 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.281 0.562 . . . . 65.41 111.972 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.3 mm -104.42 118.99 52.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.316 -0.402 . . . . 74.25 110.305 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.55 146.09 25.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.426 0.631 . . . . 72.02 112.167 -176.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -131.23 143.89 50.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.985 -0.552 . . . . 75.3 110.994 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 21.0 pttp . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 121.344 0.592 . . . . 74.14 112.014 -175.542 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.895 0.379 . . . . 71.5 111.594 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' A' ' 178' ' ' GLU . 44.1 tp -95.58 131.44 41.78 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.147 -0.346 . . . . 72.54 110.851 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.6 mt -121.15 118.97 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 122.245 -0.284 . . . . 63.45 110.485 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.418 ' O ' HD12 ' A' ' 13' ' ' LEU . 47.1 p90 -116.41 149.27 39.7 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.107 0.78 . . . . 75.04 113.107 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.685 ' HG3' ' HB2' ' A' ' 10' ' ' ASP . 48.0 tttp -137.07 119.0 15.25 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.544 -1.207 . . . . 62.2 111.416 -173.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 2.8 m-20 -68.85 173.5 5.25 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.451 0.644 . . . . 73.14 111.795 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 175' ' ' ALA . 71.6 mt -81.38 -38.78 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.261 0.553 . . . . 72.1 110.474 168.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -108.69 -44.3 4.07 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.909 -0.587 . . . . 73.55 112.526 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -91.72 14.41 15.36 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.861 0.363 . . . . 61.23 111.868 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.685 ' HB2' ' HG3' ' A' ' 5' ' ' LYS . 7.0 p-10 -61.78 -10.47 9.02 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.783 0.66 . . . . 41.44 112.783 -173.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.77 -27.5 51.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.568 0.699 . . . . 63.42 110.192 173.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -93.32 24.74 3.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.07 -0.968 . . . . 75.32 111.868 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 4' ' ' TYR . 62.8 tp -34.15 109.13 0.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.408 0.683 . . . . 74.23 112.291 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.5 m -113.2 140.77 47.67 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.982 0.734 . . . . 63.34 112.982 -169.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.6 p -110.83 105.54 14.41 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.755 -0.657 . . . . 73.41 110.254 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -123.16 179.89 4.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 120.716 0.294 . . . . 72.22 111.47 -173.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.2 t -109.22 -28.59 8.94 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.892 0.701 . . . . 72.03 112.892 -176.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -66.27 118.32 51.99 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 112.203 0.446 . . . . 74.54 112.203 -175.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -91.24 152.83 3.74 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.112 2.542 . . . . 65.42 113.826 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 20' ' ' MET . 0.6 OUTLIER -114.63 165.77 12.43 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.339 -0.392 . . . . 74.24 111.113 178.331 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -100.01 120.72 40.26 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.094 -0.379 . . . . 42.03 110.532 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.1 tp -83.39 120.89 26.45 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.076 0.465 . . . . 64.45 111.22 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.77 149.07 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.286 -0.415 . . . . 72.21 111.103 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.6 t70 62.8 9.11 3.42 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 116.436 -0.347 . . . . 73.15 111.652 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 55.06 23.43 5.21 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.106 0.479 . . . . 64.04 111.739 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.1 tp -134.16 -43.26 0.79 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.264 -0.425 . . . . 74.3 111.917 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.3 155.58 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.032 0.444 . . . . 71.31 112.164 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 170' ' ' MET . 90.5 m-85 -92.88 149.28 21.37 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.41 -0.359 . . . . 63.12 110.752 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -136.42 116.47 13.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.745 0.418 . . . . 74.11 110.652 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.562 ' CZ ' HD23 ' A' ' 169' ' ' LEU . 16.9 p90 -151.13 134.55 16.2 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.082 1.141 . . . . 72.21 114.082 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.796 ' HG3' ' HB ' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -98.88 120.8 39.94 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.574 -0.739 . . . . 74.31 110.798 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.93 -120.25 0.46 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.972 -0.633 . . . . 52.33 113.158 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -150.64 141.43 22.78 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 122.654 -0.321 . . . . 75.33 110.442 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -77.66 106.48 9.49 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.653 0.263 . . . . 73.33 110.957 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.4 m -143.36 171.96 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.455 0.645 . . . . 72.0 112.434 -175.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.96 128.43 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.807 -0.633 . . . . 71.33 110.686 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 65' ' ' GLU . 47.4 ttp180 . . . . . 0 CA--C 1.539 0.519 0 CA-C-O 121.283 0.563 . . . . 60.1 111.411 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 37' ' ' ARG . 48.5 mt-10 . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.788 0.804 . . . . 63.25 110.146 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -84.11 142.54 30.31 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.916 -1.038 . . . . 70.41 111.917 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.41 -138.78 6.48 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.063 -0.589 . . . . 73.02 113.047 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.8 pt -111.16 142.23 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 O-C-N 122.377 -0.484 . . . . 73.32 111.449 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -44.17 -42.52 6.47 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.593 0.59 . . . . 72.04 112.593 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.0 mt -47.75 -52.2 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.107 0.48 . . . . 63.43 112.216 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 26.7 m -83.3 -34.94 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.19 -0.459 . . . . 64.43 112.059 -174.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.84 -44.24 96.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.834 0.349 . . . . 73.51 111.782 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -67.56 -18.41 65.0 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.238 0.458 . . . . 64.43 112.238 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -111.24 7.15 21.04 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.219 -0.301 . . . . 75.31 111.393 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp 50.73 52.53 14.72 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.29 0.636 . . . . 70.21 112.685 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 55.7 mt -91.4 128.16 37.12 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.997 -0.547 . . . . 54.54 110.644 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.8 p -93.18 147.32 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.584 0.231 . . . . 50.15 111.26 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.09 140.19 30.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.718 0.77 . . . . 73.11 112.989 -175.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 65.3 mtm -135.38 166.08 23.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.243 -0.89 . . . . 61.42 109.609 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.405 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 44.5 t30 -133.16 145.45 50.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.346 0.593 . . . . 72.02 111.938 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.421 ' HA ' ' HB2' ' A' ' 84' ' ' ASP . 41.6 t -42.16 -30.44 0.3 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.928 1.455 . . . . 74.43 114.928 -170.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 20.8 p90 -59.96 -32.24 70.63 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.985 -0.447 . . . . 74.42 111.644 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -101.28 -31.25 11.07 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.763 0.316 . . . . 63.14 111.132 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.421 ' HB2' ' HA ' ' A' ' 81' ' ' CYS . 2.0 m-20 -71.78 -12.38 61.27 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.791 0.663 . . . . 71.35 112.791 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.501 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -31.03 -73.64 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.195 1.184 . . . . 64.43 114.195 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.2 m -71.03 -23.18 62.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.022 0.378 . . . . 54.21 112.022 -176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.8 ttm -70.17 -57.3 5.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.62 -0.264 . . . . 62.13 111.58 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.501 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 11.0 p90 -65.22 -26.14 67.99 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.469 -0.492 . . . . 71.22 110.816 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.31 -42.24 99.2 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.02 0.438 . . . . 55.33 110.915 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.22 -36.19 76.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.098 0.475 . . . . 71.21 111.154 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.17 -55.24 26.81 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.029 -0.532 . . . . 73.41 111.728 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.1 tp -60.58 -29.5 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.185 0.517 . . . . 74.22 111.011 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.52 -58.52 8.23 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.819 -0.628 . . . . 75.11 111.063 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.635 ' HA ' ' HD2' ' A' ' 97' ' ' LYS . 68.1 mttm -64.64 -34.21 77.76 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.178 -0.465 . . . . 75.12 111.28 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.554 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 66.1 t80 -56.02 -53.44 56.87 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.79 -0.641 . . . . 73.13 110.889 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -52.45 -46.63 66.54 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.016 0.436 . . . . 70.44 111.038 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.635 ' HD2' ' HA ' ' A' ' 94' ' ' LYS . 61.9 mttm -52.7 -59.31 4.64 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.813 -0.63 . . . . 65.43 111.783 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -68.24 -43.12 78.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.036 0.754 . . . . 74.21 113.036 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.426 HG12 ' HB3' ' A' ' 174' ' ' GLU . 30.7 m -64.11 -45.03 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.048 0.388 . . . . 74.24 112.048 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 mm -69.01 -37.19 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 122.064 -0.397 . . . . 73.12 110.73 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 105' ' ' LYS . 29.5 t70 -59.94 -45.76 91.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.137 0.494 . . . . 74.33 110.455 174.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -64.41 -50.06 69.09 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.929 -0.578 . . . . 74.41 111.936 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 49.7 tpp -70.56 -47.35 60.72 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.011 0.434 . . . . 74.35 112.032 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -73.96 -19.39 60.69 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 122.066 -0.396 . . . . 73.13 111.43 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 101' ' ' ASP . 86.8 tttt -59.6 -55.03 39.58 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.289 0.566 . . . . 75.22 111.647 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -102.44 -37.69 7.91 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.594 0.59 . . . . 62.01 112.594 -174.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -76.63 -53.65 7.74 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.806 0.336 . . . . 74.13 110.749 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 46.11 11.76 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.865 1.432 . . . . 74.33 114.865 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.464 ' O ' HG22 ' A' ' 113' ' ' VAL . 12.6 t70 -77.62 109.21 11.4 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.676 -0.64 . . . . 64.42 110.21 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -54.21 -27.12 32.26 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.146 0.795 . . . . 73.31 113.146 -174.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.02 -37.0 34.99 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.978 0.418 . . . . 44.41 111.344 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -74.82 -53.13 9.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.299 -0.41 . . . . 73.35 111.354 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 109' ' ' ASP . 22.4 m -58.78 -31.31 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 111.991 0.367 . . . . 53.15 111.991 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.61 -36.92 79.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.814 0.34 . . . . 74.54 110.469 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.26 -48.89 71.65 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.439 -0.346 . . . . 64.43 110.855 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -55.94 -52.01 65.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.179 0.514 . . . . 73.24 111.062 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -56.72 -38.61 72.59 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.843 -0.617 . . . . 71.03 111.489 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -66.03 -41.34 91.05 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.012 0.434 . . . . 73.34 111.347 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -66.32 -49.43 67.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.192 -0.458 . . . . 73.51 111.628 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.9 tp -65.93 -34.35 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.804 0.335 . . . . 73.51 111.033 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -64.08 -49.0 73.98 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.874 0.368 . . . . 62.12 110.966 175.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.53 -39.3 92.97 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.047 -0.596 . . . . 71.22 112.527 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 53.5 t90 -61.38 -56.67 17.69 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.331 0.252 . . . . 74.21 111.327 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.43 -41.89 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.645 0.609 . . . . 71.4 112.645 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.5 p -64.03 -33.58 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.89 -0.506 . . . . 70.1 111.861 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.5 t -80.17 -40.43 27.28 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.089 0.471 . . . . 75.52 111.139 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 155' ' ' ILE . 39.1 tp -67.43 -42.28 83.42 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.279 0.474 . . . . 71.12 112.279 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.2 mt -72.5 1.4 8.16 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.435 0.531 . . . . 72.45 112.435 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.1 72.49 0.18 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.523 0.678 . . . . 62.12 110.623 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -59.49 -22.13 61.13 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.622 -0.717 . . . . 65.14 112.319 -174.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.18 -31.03 63.05 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.203 0.525 . . . . 60.4 110.948 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -109.31 -37.31 5.79 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.812 -0.631 . . . . 73.54 111.545 174.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -93.23 -5.73 49.26 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.656 1.354 . . . . 64.21 114.656 -169.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -58.7 -13.56 6.26 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.096 0.862 . . . . 54.2 111.806 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -90.1 24.46 2.47 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.233 -0.44 . . . . 60.11 112.058 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.0 mt -88.36 153.88 20.83 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.0 0.429 . . . . 74.43 111.001 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.668 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -105.18 112.41 25.53 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.884 0.374 . . . . 61.34 111.286 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -98.43 107.18 19.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.906 0.384 . . . . 75.12 110.946 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 59.7 m-85 -97.82 143.53 28.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.161 0.505 . . . . 63.51 112.297 -177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 145' ' ' ALA . 14.3 tt -134.97 151.47 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.929 -0.578 . . . . 73.35 111.06 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.402 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -63.44 150.68 49.28 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 114.478 0.551 . . . . 54.43 114.478 -176.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -47.3 -58.08 4.51 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.295 0.638 . . . . 74.2 112.104 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -65.5 -45.55 83.14 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.868 0.366 . . . . 65.43 111.691 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.54 -38.01 79.91 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.413 0.523 . . . . 64.24 112.413 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.441 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -63.31 -54.5 36.14 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.177 0.513 . . . . 70.43 111.783 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -68.06 -40.53 82.76 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.272 -0.422 . . . . 74.45 111.146 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.2 -20.77 79.6 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.404 -0.426 . . . . 53.14 113.681 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 63.08 21.91 13.14 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.845 0.683 . . . . 73.11 112.845 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -73.45 82.43 1.45 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.655 0.613 . . . . 72.43 112.655 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.6 m120 74.24 -41.91 0.49 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.834 0.854 . . . . 73.24 113.033 172.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.09 78.7 1.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.363 -0.446 . . . . 64.44 114.095 177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -70.6 102.0 2.16 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.224 -0.574 . . . . 63.33 109.699 172.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 96.6 t -86.65 125.01 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 113.239 0.829 . . . . 64.53 113.239 -172.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.579 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -92.86 113.29 25.53 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.703 -0.681 . . . . 73.43 109.669 169.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.494 HD13 HD21 ' A' ' 127' ' ' LEU . 55.5 mt -92.13 112.98 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.384 0.513 . . . . 74.04 112.384 -170.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.668 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 49.2 mm -90.74 106.17 17.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 120.837 0.351 . . . . 61.52 110.637 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -106.92 132.02 53.34 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.688 -0.687 . . . . 75.43 111.279 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -89.43 138.47 31.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.212 -0.449 . . . . 72.25 111.409 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -137.63 119.65 15.45 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.746 0.307 . . . . 70.23 111.533 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -85.78 92.33 8.58 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.574 0.702 . . . . 74.23 111.223 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.45 102.55 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.109 -0.496 . . . . 63.44 110.42 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 58.64 19.27 6.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.241 0.543 . . . . 65.12 111.038 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.47 -12.93 33.19 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.043 -0.526 . . . . 60.35 113.229 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.5 m -84.25 115.58 22.53 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.451 -0.441 . . . . 74.04 111.074 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.42 117.56 15.32 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.359 0.504 . . . . 71.53 112.359 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.796 ' HB ' ' HG3' ' A' ' 31' ' ' LYS . 25.7 m -128.82 112.32 18.84 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 121.012 0.434 . . . . 75.54 111.595 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.559 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 6.9 Cg_exo -75.1 113.63 3.83 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.521 2.147 . . . . 71.55 112.377 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.493 HG22 ' HB2' ' A' ' 31' ' ' LYS . 44.2 p -109.3 159.05 17.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.59 -0.277 . . . . 40.02 111.504 -176.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.579 HD11 ' HB1' ' A' ' 154' ' ' ALA . 23.0 tp -104.73 126.8 52.17 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.9 0.381 . . . . 71.24 111.038 177.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.611 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 48.6 ttm -105.01 126.12 51.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.281 -0.872 . . . . 63.23 110.993 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.479 ' HB3' HD11 ' A' ' 176' ' ' ILE . 94.4 mt -137.03 123.07 20.29 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.034 -0.53 . . . . 62.24 111.36 -178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.554 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 22.6 t -74.85 122.01 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 122.095 -0.378 . . . . 74.22 111.425 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.411 ' HD3' ' HG2' ' A' ' 174' ' ' GLU . 0.0 OUTLIER -69.33 -11.33 60.72 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.893 0.701 . . . . 73.22 112.893 -176.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.514 ' H ' HG12 ' A' ' 172' ' ' VAL . 24.1 mm-40 -91.83 -11.18 37.25 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.815 0.341 . . . . 74.13 111.598 174.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.488 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -96.14 -38.44 10.16 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.381 0.61 . . . . 64.3 110.232 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' A' ' 171' ' ' LEU . 32.4 pt -127.45 118.94 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.371 -0.831 . . . . 73.02 109.28 168.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.8 tp -94.6 110.86 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.511 0.672 . . . . 61.13 111.563 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.454 ' HB3' HD11 ' A' ' 2' ' ' LEU . 16.7 mm-40 -79.57 115.81 19.41 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.609 -0.723 . . . . 74.34 110.585 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.43 ' O ' HD12 ' A' ' 2' ' ' LEU . 10.1 tp10 -92.92 116.29 28.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.455 0.645 . . . . 65.32 109.856 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.399 -0.819 . . . . 62.12 112.999 -167.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 111.917 0.34 . . . . 73.42 111.917 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 178' ' ' GLU . 38.1 tp -75.22 122.93 24.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.759 0.314 . . . . 61.04 111.261 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.716 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 50.7 mt -97.59 120.79 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.586 0.232 . . . . 73.51 111.016 -174.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 14' ' ' SER . 34.9 p90 -107.85 139.27 42.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.704 0.631 . . . . 75.54 112.704 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.621 ' HG3' ' HB2' ' A' ' 10' ' ' ASP . 52.0 tttp -130.02 122.16 27.87 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.805 -1.089 . . . . 43.32 111.071 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.622 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 33.1 t70 -80.54 173.31 12.72 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.484 0.183 . . . . 75.21 110.552 175.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.5 mt -75.72 -46.23 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.836 -0.54 . . . . 54.01 111.698 176.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -108.49 -41.27 4.88 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.273 0.558 . . . . 74.43 112.122 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.4 16.55 7.37 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.27 0.628 . . . . 64.21 111.804 -175.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.622 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 10.7 p-10 -59.86 -4.26 0.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.952 1.093 . . . . 54.01 113.952 -170.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.53 -19.66 64.97 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.877 -0.514 . . . . 53.53 111.331 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.63 23.35 1.68 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.611 0.244 . . . . 63.32 111.358 170.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.616 HD13 ' HB2' ' A' ' 5' ' ' LYS . 57.2 tp -49.28 104.04 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.516 0.326 . . . . 74.04 110.53 173.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.442 ' HB2' ' CE1' ' A' ' 4' ' ' TYR . 70.0 m -133.51 147.61 51.63 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.223 0.823 . . . . 75.23 113.223 -170.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.2 p -82.51 88.84 6.62 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.632 -0.713 . . . . 53.54 110.568 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -90.11 179.35 5.95 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.766 -0.652 . . . . 70.42 111.855 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.8 p -161.85 25.99 0.12 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.267 0.469 . . . . 72.14 112.267 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -89.69 149.87 43.02 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-O 120.6 0.238 . . . . 72.45 111.625 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.97 72.67 1.53 Allowed 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.804 2.336 . . . . 71.42 113.461 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 55.0 ttp -87.69 115.36 25.08 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.27 -0.423 . . . . 73.53 110.793 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -102.44 159.05 15.76 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.699 0.285 . . . . 63.24 111.67 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 27' ' ' VAL . 47.9 tp -104.86 142.53 34.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.033 0.444 . . . . 60.15 111.408 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.508 HG13 HG23 ' A' ' 27' ' ' VAL . 7.2 p -134.13 141.12 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-N 116.144 -0.48 . . . . 72.43 111.115 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 56.83 23.61 8.27 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.763 0.653 . . . . 74.35 112.763 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 60.91 3.98 0.73 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.041 0.756 . . . . 51.42 113.041 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.521 HD21 HD13 ' A' ' 120' ' ' ILE . 41.0 tp -125.3 -43.56 1.92 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.945 0.72 . . . . 65.21 112.945 -169.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.508 HG23 HG13 ' A' ' 23' ' ' VAL . 1.2 m -123.82 149.4 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.284 0.476 . . . . 43.11 112.284 -175.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.557 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 58.6 m-85 -85.84 147.6 26.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.888 0.375 . . . . 63.23 111.337 176.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.449 ' HB2' HH22 ' A' ' 159' ' ' ARG . 14.9 pt-20 -121.1 137.98 54.41 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.009 -0.541 . . . . 74.44 110.941 176.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -150.75 113.16 4.64 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.404 -0.362 . . . . 75.43 110.119 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -75.07 135.38 41.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.172 0.51 . . . . 62.31 112.331 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.54 133.37 11.43 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.335 -0.46 . . . . 63.21 112.184 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -91.92 152.41 20.07 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.332 0.566 . . . . 74.15 112.173 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -71.11 105.28 3.31 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.568 -0.742 . . . . 65.31 111.636 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.522 HG23 HD12 ' A' ' 72' ' ' LEU . 19.7 m -143.99 -177.97 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.977 0.418 . . . . 75.3 111.595 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.6 m -119.12 145.74 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 112.382 0.512 . . . . 64.02 112.382 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.709 ' HB3' HD22 ' A' ' 72' ' ' LEU . 7.6 tpm_? . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 121.577 0.703 . . . . 74.31 110.807 175.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 33.6 tt0 . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 113.354 0.872 . . . . 73.23 113.354 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -111.2 135.54 51.59 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.4 -0.812 . . . . 75.52 111.862 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' A' ' 72' ' ' LEU . . . 169.56 -170.53 42.74 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.044 -1.074 . . . . 41.14 113.77 169.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.7 pt -103.57 146.65 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.797 -0.237 . . . . 62.32 110.556 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -38.99 -53.15 1.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.997 0.74 . . . . 73.32 112.997 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.609 HG21 HD22 ' A' ' 169' ' ' LEU . 60.7 mt -49.04 -62.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 112.673 0.62 . . . . 62.44 112.673 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 m -66.12 -31.99 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.261 -0.427 . . . . 74.15 112.031 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.709 HD22 ' HB3' ' A' ' 37' ' ' ARG . 76.0 mt -76.59 -33.02 58.45 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.063 0.459 . . . . 64.41 111.39 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -73.29 -42.71 62.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.083 -0.508 . . . . 65.42 111.516 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -94.77 -3.43 49.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 111.782 0.29 . . . . 73.53 111.782 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 65.24 71.63 0.44 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.296 0.57 . . . . 74.3 112.195 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 49.9 mt -108.7 128.51 54.92 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.754 -0.657 . . . . 74.33 110.595 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.4 p -89.57 149.33 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.804 0.335 . . . . 70.21 111.459 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.41 148.83 35.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.401 0.619 . . . . 71.32 112.619 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.72 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 85.4 mtp -140.16 153.09 46.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.425 -0.807 . . . . 74.31 109.956 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.537 ' HB2' ' HE1' ' A' ' 82' ' ' TYR . 13.7 m120 -133.29 139.74 47.06 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.236 0.541 . . . . 73.24 112.081 -174.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 52.0 t -46.22 -36.72 6.35 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.502 1.297 . . . . 70.11 114.502 -172.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.537 ' HE1' ' HB2' ' A' ' 80' ' ' ASN . 1.3 p90 -63.57 -27.44 69.25 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.487 0.551 . . . . 74.32 112.487 -175.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -102.18 -31.77 10.42 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.452 0.538 . . . . 74.44 112.452 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.464 ' O ' ' HD1' ' A' ' 88' ' ' PHE . 9.8 m-20 -76.57 -5.95 49.85 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.473 0.545 . . . . 74.51 112.473 -174.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.517 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . . . -34.19 -72.76 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.005 1.113 . . . . 52.3 114.005 -172.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.7 t -64.59 -31.84 73.24 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.88 0.372 . . . . 65.52 111.553 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.4 mmt -64.64 -63.89 1.01 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.206 -0.452 . . . . 72.42 112.175 -175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.517 ' HE1' ' HA ' ' A' ' 85' ' ' ALA . 1.8 p90 -70.77 -26.69 63.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.133 -0.354 . . . . 65.31 111.461 -176.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -68.01 -41.35 82.34 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.015 0.436 . . . . 72.43 110.11 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -40.44 81.61 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.85 0.357 . . . . 74.41 111.174 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -61.27 -51.0 70.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.368 -0.378 . . . . 74.15 111.695 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.0 tp -62.69 -32.3 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.821 0.343 . . . . 63.42 111.285 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -68.55 -55.85 10.28 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.727 0.269 . . . . 63.21 111.727 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.71 -37.24 73.17 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.071 0.463 . . . . 74.21 110.677 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.648 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 26.0 t80 -61.32 -54.48 43.36 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.034 -0.53 . . . . 74.0 111.284 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -53.78 -49.6 67.91 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.321 -0.4 . . . . 63.23 111.267 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.1 -38.45 90.77 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.679 -0.237 . . . . 73.42 111.438 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -64.23 -52.09 60.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.691 0.282 . . . . 63.12 111.702 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.3 m -64.01 -42.62 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 111.826 0.306 . . . . 55.05 111.826 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.6 mm -62.98 -45.45 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.851 0.358 . . . . 75.2 110.748 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.622 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 18.0 t70 -56.3 -48.09 77.37 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.293 -0.412 . . . . 74.42 111.634 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -66.67 -29.03 68.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.769 0.319 . . . . 72.21 111.536 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.0 tpt -75.58 -54.45 6.98 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.055 0.455 . . . . 71.05 111.367 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -54.05 -34.04 59.01 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.343 0.497 . . . . 71.15 112.343 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -51.4 -36.85 45.36 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.293 -0.255 . . . . 71.52 111.353 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -116.66 -5.87 11.62 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.257 0.836 . . . . 71.15 113.257 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -141.41 35.26 1.67 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.607 0.595 . . . . 75.14 112.607 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -5.82 1.07 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.749 1.388 . . . . 74.41 114.749 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 111' ' ' ALA . 4.4 m-20 -74.99 76.04 2.2 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.61 -0.681 . . . . 72.43 112.413 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt 37.52 -79.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.168 1.387 . . . . 73.21 114.655 171.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 109' ' ' ASP . . . -51.19 -42.82 61.14 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.059 0.762 . . . . 63.24 113.059 -170.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.22 -56.32 17.63 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.946 0.403 . . . . 75.21 111.882 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.8 m -67.9 -32.42 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.591 0.589 . . . . 70.44 112.591 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.69 -34.58 62.67 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.326 -0.233 . . . . 74.41 111.189 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.34 -45.41 72.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.198 0.523 . . . . 61.21 111.009 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -61.18 -46.72 89.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.193 0.52 . . . . 73.01 110.363 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -59.67 -32.58 70.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.921 -0.581 . . . . 54.32 111.307 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HE2' ' HB2' ' A' ' 118' ' ' LYS . 8.9 tppt? -60.17 -45.44 93.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.171 0.51 . . . . 62.45 110.86 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -68.26 -46.88 69.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.07 -0.514 . . . . 75.55 111.189 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.521 HD13 HD21 ' A' ' 26' ' ' LEU . 29.8 mm -58.97 -43.58 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.768 0.318 . . . . 62.21 111.365 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -63.04 -45.23 93.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.569 0.223 . . . . 73.24 110.719 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.08 -42.6 99.85 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.95 -0.643 . . . . 71.15 112.246 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 40.1 t90 -61.39 -49.94 74.88 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.493 0.317 . . . . 74.31 111.294 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.95 -42.05 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.388 0.514 . . . . 73.2 112.388 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.75 -25.28 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.243 0.544 . . . . 73.22 110.938 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.3 m -86.46 -51.55 6.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.191 -0.459 . . . . 73.34 111.117 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.431 HD11 HG21 ' A' ' 155' ' ' ILE . 27.8 tp -59.55 -35.77 74.89 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.184 0.516 . . . . 74.44 111.864 -177.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.7 mt -85.25 3.71 38.19 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.075 -0.511 . . . . 71.13 112.073 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.498 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -62.45 97.74 0.1 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.207 0.527 . . . . 44.3 110.849 176.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 28.7 ttpp -45.33 -64.51 0.7 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.067 1.136 . . . . 62.04 114.067 -170.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.41 -46.55 85.86 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.238 0.829 . . . . 72.53 113.238 -168.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -73.47 -50.99 18.75 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.359 0.6 . . . . 74.23 111.43 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 30.1 m-85 -82.43 -5.78 58.88 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.848 -0.614 . . . . 70.32 112.653 -173.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 26.1 ttpp -50.01 -22.84 1.73 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.102 0.477 . . . . 72.34 111.683 170.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.594 HD22 ' N ' ' A' ' 135' ' ' ASN . 0.8 OUTLIER -82.66 15.07 2.76 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.313 0.486 . . . . 73.05 112.313 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.534 HD21 ' HG2' ' A' ' 157' ' ' GLU . 49.5 mt -89.52 161.72 16.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.32 0.581 . . . . 73.33 112.212 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -123.7 126.33 46.35 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.776 -0.647 . . . . 53.51 111.138 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' A' ' 79' ' ' MET . 43.6 m-85 -96.91 133.55 41.4 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.125 -0.324 . . . . 74.43 110.125 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.443 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 58.2 m-85 -128.74 131.02 47.85 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.084 -0.385 . . . . 72.34 111.561 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.576 HG23 ' HB2' ' A' ' 145' ' ' ALA . 15.4 tt -125.24 148.07 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 120.976 0.417 . . . . 70.33 111.375 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.423 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -57.85 140.88 45.56 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 114.373 0.509 . . . . 64.35 114.373 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -42.03 -54.2 3.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.308 0.643 . . . . 72.25 112.115 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -62.5 -35.71 80.23 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.998 0.428 . . . . 72.54 112.137 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.9 -37.16 48.56 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.146 0.425 . . . . 72.1 112.146 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.576 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -62.81 -56.2 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.932 0.396 . . . . 75.33 111.944 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.09 -21.44 58.94 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.488 -0.324 . . . . 51.12 111.429 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -72.6 -21.87 79.32 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.954 -0.641 . . . . 63.54 112.423 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 61.15 42.05 12.78 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.263 0.468 . . . . 73.54 112.263 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.45 4.35 53.37 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.591 0.589 . . . . 73.51 112.591 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.4 p30 41.91 35.68 0.56 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.344 0.658 . . . . 74.5 112.447 -175.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.68 -135.43 1.01 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.117 -0.492 . . . . 74.14 114.269 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -67.24 104.25 1.43 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.764 0.653 . . . . 73.21 112.764 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.36 118.68 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.215 0.531 . . . . 63.21 110.834 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.687 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -79.86 124.2 28.44 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.949 -0.569 . . . . 65.22 111.209 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 43.3 mm -89.59 120.0 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.673 0.273 . . . . 72.43 111.5 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.3 mm -99.38 107.51 20.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-O 120.971 0.415 . . . . 64.33 111.012 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.534 ' HG2' HD21 ' A' ' 136' ' ' LEU . 0.4 OUTLIER -111.49 137.43 49.31 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.467 -0.788 . . . . 64.45 109.967 -178.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -92.19 123.92 35.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.152 0.501 . . . . 75.43 112.061 -174.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.449 HH22 ' HB2' ' A' ' 29' ' ' GLU . 77.8 mtm180 -130.16 154.3 47.66 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.278 0.561 . . . . 74.2 112.193 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -83.2 143.92 30.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.777 0.658 . . . . 74.13 112.777 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.1 t -128.71 87.9 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.749 -0.659 . . . . 74.35 109.65 167.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 48.37 41.92 17.31 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.835 0.68 . . . . 70.05 112.835 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.72 -23.26 22.33 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.294 -0.479 . . . . 73.34 113.21 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 91.7 m -95.52 106.15 18.2 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.486 -0.42 . . . . 74.23 111.352 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.54 112.64 14.53 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.245 -0.434 . . . . 45.34 111.091 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 35.7 m -119.37 141.72 31.2 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 112.083 0.401 . . . . 75.4 112.083 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 166' ' ' VAL . 8.0 Cg_exo -73.64 114.77 4.12 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.752 2.302 . . . . 44.4 112.117 174.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.8 p -109.37 140.79 42.62 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.927 0.394 . . . . 64.4 111.789 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.687 HD11 ' HB1' ' A' ' 154' ' ' ALA . 64.1 tp -77.54 145.16 37.1 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.97 -0.559 . . . . 74.01 111.962 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.492 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 48.1 ttm -130.18 124.49 32.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.766 -0.652 . . . . 73.21 110.909 176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.87 161.23 33.49 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.05 -0.722 . . . . 73.44 109.05 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.648 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 44.1 t -96.39 131.23 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.501 -0.749 . . . . 73.54 112.114 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.557 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 14.2 tmtt? -56.34 -55.69 30.34 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.185 -0.461 . . . . 74.05 111.611 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -75.25 4.6 6.76 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.017 0.377 . . . . 72.03 112.017 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.26 -21.02 17.5 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.261 0.553 . . . . 75.5 110.473 173.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 68.0 mt -118.73 108.97 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.853 -0.612 . . . . 75.41 110.587 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -92.16 113.96 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.118 0.485 . . . . 72.23 110.503 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.488 ' HB2' HD11 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -91.8 152.68 20.02 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.621 0.724 . . . . 75.32 112.771 -174.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.716 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 9.3 tp10 -114.83 110.87 20.34 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.581 -0.736 . . . . 73.03 109.336 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 61.9 tttm . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 121.261 0.553 . . . . 73.1 112.302 -171.062 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.696 0.284 . . . . 75.05 111.308 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.7 tp -104.19 147.38 27.52 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.153 0.501 . . . . 70.54 111.203 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.26 141.0 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.545 -0.298 . . . . 72.4 110.565 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -122.92 158.75 29.71 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 121.904 -0.498 . . . . 73.14 111.461 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HB3' HD13 ' A' ' 13' ' ' LEU . 5.4 ptpp? -139.04 111.04 7.27 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.136 -0.483 . . . . 72.43 111.754 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 175' ' ' ALA . 7.0 m-20 -75.81 164.32 26.35 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.241 -0.287 . . . . 75.12 110.791 172.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.1 pt -61.19 -9.76 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 121.03 0.443 . . . . 74.24 111.493 173.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -107.92 -30.5 8.45 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.301 -0.409 . . . . 64.24 111.118 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.547 ' HB ' ' H ' ' A' ' 6' ' ' ASP . 11.1 m -92.63 -13.67 29.25 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.087 0.773 . . . . 71.1 113.087 -171.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.438 ' HA ' ' HB2' ' A' ' 5' ' ' LYS . 4.0 p30 -55.54 -16.93 4.45 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.106 0.78 . . . . 74.15 113.106 -173.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -69.26 -46.28 67.66 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.055 0.391 . . . . 64.4 112.055 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -121.07 -1.24 9.84 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.202 0.815 . . . . 53.14 113.202 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 5' ' ' LYS . 3.7 mm? 64.19 169.44 0.17 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.535 0.939 . . . . 64.43 113.535 173.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.8 m -148.01 136.85 21.87 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.949 -0.569 . . . . 72.34 110.678 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.5 p -115.35 119.27 35.72 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.675 0.62 . . . . 74.11 112.675 -172.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -149.7 -169.6 3.42 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.099 -0.501 . . . . 74.22 111.222 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 t -155.3 91.94 1.38 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.026 0.441 . . . . 74.0 111.435 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -130.6 118.75 18.02 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 116.433 -0.349 . . . . 73.3 111.207 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.81 87.68 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.372 2.048 . . . . 73.03 112.207 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.418 ' HG2' ' HB2' ' A' ' 30' ' ' PHE . 64.7 mtt -93.33 148.04 22.4 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.356 0.598 . . . . 63.11 112.123 -177.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -102.17 113.06 26.0 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.623 -0.717 . . . . 65.13 110.303 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.519 HD21 ' HD2' ' A' ' 173' ' ' LYS . 61.4 tp -74.61 87.84 2.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.159 0.504 . . . . 60.13 110.135 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.79 137.43 21.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.087 -0.506 . . . . 72.32 111.544 -175.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.8 12.49 5.74 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.736 -0.665 . . . . 74.23 111.292 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.437 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 66.4 m-20 54.3 22.02 3.47 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.009 -0.542 . . . . 74.54 111.922 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.2 tp -121.71 -41.04 2.49 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.926 0.393 . . . . 71.52 111.259 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 172' ' ' VAL . 4.2 m -137.58 147.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.1 0.476 . . . . 54.24 111.952 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.565 ' O ' ' HA ' ' A' ' 170' ' ' MET . 70.0 m-85 -85.96 145.05 27.3 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.207 -0.451 . . . . 74.34 110.624 176.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 34.5 tt0 -127.63 135.63 50.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.677 0.275 . . . . 74.43 110.88 176.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.418 ' HB2' ' HG2' ' A' ' 20' ' ' MET . 84.4 t80 -128.96 128.43 43.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.861 0.363 . . . . 73.32 111.548 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HA ' HG22 ' A' ' 168' ' ' THR . 1.8 tmmm? -92.31 121.55 33.92 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.231 -0.44 . . . . 73.01 110.837 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.23 -163.35 13.96 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.308 -0.473 . . . . 32.03 113.089 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -121.12 139.37 53.42 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.316 -0.52 . . . . 75.44 111.512 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -75.27 106.15 6.65 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.879 -0.6 . . . . 74.11 110.663 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.67 160.15 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.1 -0.5 . . . . 63.3 111.054 -177.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.549 HG12 ' HB2' ' A' ' 66' ' ' ARG . 34.1 m -128.77 105.14 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.433 0.635 . . . . 72.21 110.94 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.603 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 97.6 mtt180 . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.187 0.518 . . . . 44.51 111.015 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 45.2 mt-10 . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.755 0.788 . . . . 60.45 110.652 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.549 ' HB2' HG12 ' A' ' 36' ' ' VAL . 33.4 ptt85 -95.3 134.72 37.76 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.727 -0.67 . . . . 74.31 112.672 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.72 -133.82 3.03 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.606 -0.724 . . . . 74.41 112.447 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.481 HD12 HD12 ' A' ' 70' ' ' ILE . 21.4 pt -111.12 131.81 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 122.35 -0.5 . . . . 74.15 110.957 176.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.6 -23.14 15.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 111.858 0.318 . . . . 43.14 111.858 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.481 HD12 HD12 ' A' ' 68' ' ' ILE . 55.7 mt -50.71 -56.23 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.236 0.541 . . . . 65.11 111.591 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.7 m -81.16 -30.61 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.146 -0.479 . . . . 74.0 111.693 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.8 mt -65.02 -35.72 82.09 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.131 0.491 . . . . 75.21 110.863 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.36 -40.99 71.95 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.961 -0.563 . . . . 63.25 111.78 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -100.78 -1.04 35.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.43 -0.35 . . . . 63.43 111.779 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt 53.88 70.55 0.59 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.285 0.564 . . . . 72.1 111.583 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 67.3 mt -100.04 135.74 41.01 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.877 -0.601 . . . . 65.13 111.247 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.27 145.97 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.876 0.37 . . . . 75.41 111.281 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -83.47 136.35 34.33 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.575 0.583 . . . . 74.24 112.575 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.2 mmm -115.82 145.59 42.71 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 116.004 -0.543 . . . . 41.43 110.268 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.429 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 15.6 m-80 -88.86 123.86 33.64 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.634 0.605 . . . . 52.22 112.634 -169.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 44.2 t -54.12 -32.94 56.48 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.136 0.791 . . . . 54.23 113.136 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 4.5 p90 -81.71 -30.73 32.41 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.937 0.399 . . . . 60.24 111.865 -176.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -94.69 -47.32 6.55 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.469 0.544 . . . . 71.31 112.469 -170.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.66 ' HA ' ' SD ' ' A' ' 87' ' ' MET . 23.5 m-20 -81.2 18.96 0.99 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.546 0.573 . . . . 71.1 112.546 -174.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . . . -55.94 -42.59 76.4 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.844 0.354 . . . . 53.31 111.849 177.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.507 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 53.3 m -60.24 -36.57 78.05 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.326 0.584 . . . . 71.41 111.091 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.663 ' N ' ' SD ' ' A' ' 87' ' ' MET . 0.6 OUTLIER -66.04 -38.66 88.93 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.014 -0.539 . . . . 65.0 110.278 176.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.44 ' HD2' ' HA ' ' A' ' 85' ' ' ALA . 32.0 m-85 -69.05 -43.86 73.8 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.928 -0.578 . . . . 74.12 112.274 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 86' ' ' SER . 0.1 OUTLIER -62.56 -36.09 81.55 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.959 0.409 . . . . 73.52 110.893 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.1 -40.11 62.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.066 0.46 . . . . 45.34 111.198 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -61.83 -44.09 97.55 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.164 -0.471 . . . . 72.51 110.735 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.33 -34.35 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.121 -0.491 . . . . 73.13 111.259 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -56.03 -51.5 67.56 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.146 0.498 . . . . 74.22 110.976 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -69.66 -43.03 73.39 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.139 -0.482 . . . . 72.42 110.949 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.466 ' CZ ' HG11 ' A' ' 172' ' ' VAL . 68.9 t80 -52.8 -54.08 39.3 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.146 -0.479 . . . . 64.14 111.559 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 57.0 ttp -54.51 -43.82 72.19 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.076 -0.511 . . . . 62.53 110.99 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -54.78 -57.53 11.16 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.101 -0.5 . . . . 64.31 111.497 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -59.55 -55.81 29.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.616 0.599 . . . . 63.04 112.616 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 95' ' ' PHE . 32.6 m -62.82 -43.38 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.718 0.636 . . . . 73.25 112.718 -174.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.9 mm -74.33 -47.49 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 122.138 -0.351 . . . . 65.23 111.785 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 8.9 t70 -61.07 -38.98 88.14 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.992 0.425 . . . . 64.22 110.845 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -69.94 -41.47 74.53 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.98 0.419 . . . . 74.34 110.923 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 49.4 tpp -61.59 -35.15 77.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.322 0.582 . . . . 75.32 111.002 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 32.2 tt0 -68.05 -15.95 63.82 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.912 -0.585 . . . . 71.02 111.793 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 1.7 mmmp? -81.09 -31.53 34.29 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.764 -0.585 . . . . 73.15 111.87 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -115.5 -36.45 4.28 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.473 0.916 . . . . 74.44 113.473 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -91.37 -76.43 0.45 Allowed 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.471 0.545 . . . . 71.44 112.471 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 104' ' ' GLU . 62.5 mtm-85 67.68 -6.49 0.68 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.863 1.06 . . . . 71.34 113.863 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 113' ' ' VAL . 38.3 t70 -68.59 106.0 2.44 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.033 -0.417 . . . . 73.3 110.61 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -48.91 -37.88 21.13 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.8 0.667 . . . . 75.34 112.8 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.91 -44.06 86.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.822 0.344 . . . . 71.41 111.543 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.6 -54.43 9.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.484 -0.326 . . . . 64.11 111.7 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 109' ' ' ASP . 23.0 m -59.26 -33.24 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 112.092 0.404 . . . . 52.01 112.092 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.96 -36.41 77.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.802 0.334 . . . . 71.2 110.587 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.73 -48.84 73.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.392 -0.367 . . . . 74.44 111.171 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -60.15 -50.32 74.13 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.841 0.353 . . . . 72.5 110.947 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -49.49 -49.26 46.39 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.212 0.529 . . . . 74.25 110.488 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.72 -36.3 82.15 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.789 -0.641 . . . . 51.41 111.566 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -67.01 -47.91 70.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.753 0.311 . . . . 54.44 110.791 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 31.3 mm -65.51 -38.72 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.485 -0.325 . . . . 64.34 111.112 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -58.13 -47.43 83.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.861 0.362 . . . . 72.52 110.679 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.3 -33.74 78.56 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.128 -0.558 . . . . 53.12 112.612 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -60.65 -54.28 47.2 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.574 0.35 . . . . 73.4 111.438 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.76 -46.79 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.699 0.629 . . . . 73.05 112.699 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.6 m -60.26 -33.26 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 122.061 -0.4 . . . . 74.34 111.59 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.7 m -77.08 -44.77 29.39 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.054 0.454 . . . . 64.11 111.002 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.482 HD21 HD13 ' A' ' 155' ' ' ILE . 48.4 tp -66.59 -32.17 73.34 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.058 -0.519 . . . . 74.04 112.207 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.7 mt -91.52 1.77 56.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.452 0.538 . . . . 71.3 112.452 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.6 95.81 0.08 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.346 0.593 . . . . 70.12 111.014 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.708 ' H ' ' HD2' ' A' ' 130' ' ' LYS . 2.5 mptp? -58.18 -33.11 68.88 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.17 0.804 . . . . 62.13 113.17 -168.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.51 -47.61 38.76 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.003 0.742 . . . . 64.15 113.003 -172.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 132' ' ' ARG . 0.4 OUTLIER -111.11 -26.32 9.28 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.633 0.605 . . . . 70.22 112.633 174.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.421 ' HD2' HD11 ' A' ' 136' ' ' LEU . 88.8 m-85 -83.19 -5.82 59.26 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.406 0.521 . . . . 75.02 112.406 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.92 -24.77 54.85 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.457 0.646 . . . . 72.31 110.501 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -78.21 13.41 1.5 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.694 -0.685 . . . . 72.42 112.232 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.421 HD11 ' HD2' ' A' ' 133' ' ' PHE . 77.8 mt -88.11 161.99 17.0 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.431 0.634 . . . . 74.43 111.799 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -134.33 122.35 22.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.706 -0.679 . . . . 73.32 110.362 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.42 ' HB3' HG13 ' A' ' 153' ' ' VAL . 82.9 m-85 -105.36 110.8 23.28 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.955 0.407 . . . . 74.23 110.82 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 80.3 m-85 -98.98 147.18 25.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.471 0.545 . . . . 73.25 112.471 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 12.4 tt -147.22 155.77 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.028 -0.533 . . . . 73.21 110.827 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.64 146.11 34.99 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.184 -0.532 . . . . 72.23 113.689 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -54.73 -62.85 1.39 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.105 0.409 . . . . 74.31 112.105 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -61.3 -28.6 69.31 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.898 0.38 . . . . 74.44 111.259 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.597 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -63.62 -53.73 46.92 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.037 0.446 . . . . 74.01 111.304 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.46 -19.13 62.26 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.128 0.49 . . . . 71.44 111.643 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.5 -40.65 34.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.166 -0.47 . . . . 70.32 111.596 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.21 42.02 0.09 OUTLIER Glycine 0 CA--C 1.529 0.953 0 C-N-CA 120.606 -0.807 . . . . 63.22 113.866 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.597 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -154.43 88.2 1.21 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.078 0.466 . . . . 55.25 111.235 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.16 -1.75 11.05 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.38 0.882 . . . . 62.51 113.38 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.36 57.79 3.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.485 0.66 . . . . 74.31 110.392 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -130.87 149.53 19.14 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.705 -0.679 . . . . 71.15 113.492 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -83.72 144.33 29.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.904 0.383 . . . . 73.51 111.477 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 138' ' ' PHE . 22.1 t -88.86 115.15 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.329 0.585 . . . . 72.4 111.479 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.32 109.38 15.77 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.695 -0.684 . . . . 72.33 110.901 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 52.5 mt -86.48 124.84 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.573 0.225 . . . . 64.24 111.272 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 169' ' ' LEU . 48.6 mm -118.05 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 111.967 0.358 . . . . 74.21 111.967 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.498 ' HG2' ' HE1' ' A' ' 170' ' ' MET . 7.3 pt-20 -130.58 158.26 40.48 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.106 0.479 . . . . 72.22 111.273 175.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -78.05 108.8 11.59 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.066 0.46 . . . . 71.23 111.552 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 159' ' ' ARG . 5.6 tpp180 -104.51 128.81 52.53 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.432 -0.349 . . . . 74.25 111.682 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.71 111.24 14.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.735 0.302 . . . . 75.42 110.434 173.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.05 88.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.158 0.504 . . . . 32.54 110.24 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 54.79 33.86 20.59 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.721 -0.672 . . . . 62.0 112.104 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 113.37 -24.74 12.0 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.059 -0.591 . . . . 61.43 113.403 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.479 HG22 HG13 ' A' ' 166' ' ' VAL . 89.8 m -97.31 106.54 18.88 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.438 -0.448 . . . . 74.11 111.044 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -80.54 108.26 14.03 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.272 -0.422 . . . . 71.23 111.636 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 164' ' ' THR . 25.0 m -128.23 142.56 44.97 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 120.908 0.385 . . . . 50.25 111.65 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 17.4 Cg_exo -68.56 119.15 6.16 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.801 2.334 . . . . 72.31 112.921 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 31' ' ' LYS . 38.2 p -107.52 163.68 12.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.983 0.42 . . . . 71.41 112.039 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 51.9 tp -102.06 138.52 38.91 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.604 0.594 . . . . 73.25 112.604 -175.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.565 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 1.2 mpt? -122.87 136.79 54.99 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.418 0.525 . . . . 74.03 112.418 176.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.9 mt -136.81 148.42 47.16 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.57 -0.741 . . . . 73.35 110.08 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.524 ' O ' HG22 ' A' ' 176' ' ' ILE . 58.6 t -87.15 127.46 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.744 0.646 . . . . 55.43 112.744 -173.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.519 ' HD2' HD21 ' A' ' 22' ' ' LEU . 57.4 tttm -52.78 -54.79 28.96 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.81 0.671 . . . . 71.41 112.81 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.08 12.21 0.58 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.818 0.673 . . . . 72.32 112.818 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -114.35 -51.51 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 61.54 109.838 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 172' ' ' VAL . 4.1 tt -102.96 108.97 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.611 -0.722 . . . . 63.23 111.699 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.5 mm -101.35 142.37 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.315 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.13 141.91 50.76 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.249 0.547 . . . . 74.53 112.254 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -135.46 104.11 5.72 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.764 -0.653 . . . . 72.4 110.124 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 121.366 0.603 . . . . 71.11 112.4 -176.234 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.714 0.292 . . . . 73.24 111.091 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 180' ' ' LYS . 21.5 tp -95.38 124.09 39.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.083 -0.34 . . . . 71.14 110.083 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 179' ' ' GLU . 53.5 mt -105.72 129.22 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.497 0.189 . . . . 72.04 111.385 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -122.78 144.67 49.03 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.322 0.582 . . . . 62.24 112.343 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.695 ' HB3' ' HB ' ' A' ' 177' ' ' ILE . 23.7 ttmm -138.55 111.26 7.65 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.804 -0.634 . . . . 64.25 110.903 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.571 ' HA ' HG22 ' A' ' 176' ' ' ILE . 5.6 t70 -83.03 166.16 19.02 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.564 0.346 . . . . 71.23 111.293 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 pt -81.23 -18.18 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 113.069 0.766 . . . . 74.51 113.069 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.62 -42.86 7.46 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.069 0.461 . . . . 74.24 111.555 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.558 HG22 ' HB3' ' A' ' 6' ' ' ASP . 15.2 t -103.85 19.65 19.56 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.998 -0.546 . . . . 64.01 112.092 -176.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 12.4 p-10 -46.06 -40.47 10.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.748 1.018 . . . . 71.14 113.748 -172.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -53.07 -34.76 57.99 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.094 0.473 . . . . 64.45 111.962 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.35 26.5 0.65 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.803 0.668 . . . . 75.32 112.803 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.668 HD13 ' HB2' ' A' ' 5' ' ' LYS . 69.4 tp -32.11 109.28 0.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.286 0.634 . . . . 72.22 112.014 174.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -131.15 -175.88 3.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 111.873 0.323 . . . . 73.24 111.873 -172.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.0 p -150.33 144.28 25.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.17 0.804 . . . . 74.55 113.17 -174.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -144.88 -157.7 0.82 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.736 -0.666 . . . . 75.43 109.963 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.3 t -148.45 86.49 1.54 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.932 -0.48 . . . . 64.11 112.177 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -138.25 101.95 8.26 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.177 -0.465 . . . . 74.21 111.192 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.82 142.76 98.59 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.191 2.594 . . . . 64.02 114.324 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.0 ptp -146.37 161.31 40.64 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.859 -0.61 . . . . 63.12 111.003 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 18.2 ptpt -99.5 158.75 15.52 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.585 0.231 . . . . 74.22 111.061 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.7 tp -107.09 110.45 22.56 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.91 0.385 . . . . 62.25 111.224 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -104.02 145.5 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.032 0.444 . . . . 44.14 111.568 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 63.93 10.55 5.36 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 116.112 -0.495 . . . . 55.12 112.136 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 60.87 12.11 3.64 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.864 0.466 . . . . 74.21 111.875 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.5 tp -127.52 -43.16 1.6 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.938 0.399 . . . . 73.11 111.733 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 172' ' ' VAL . 17.0 m -127.71 148.8 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.254 0.55 . . . . 75.11 112.352 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -86.97 134.37 33.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.293 -0.412 . . . . 62.33 111.132 174.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 36.3 tt0 -103.92 108.07 19.23 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.062 0.458 . . . . 72.0 110.257 174.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.615 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 31.6 t80 -90.37 127.61 36.23 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.247 -0.283 . . . . 71.05 110.335 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.503 ' HD3' ' H ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -74.32 131.12 40.86 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.47 0.652 . . . . 74.23 112.059 -176.618 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.483 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -140.08 174.34 22.5 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.726 -0.67 . . . . 71.2 112.494 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HG3' HG13 ' A' ' 35' ' ' VAL . 16.4 ptpt -151.92 166.28 31.96 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.793 0.664 . . . . 72.41 112.793 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -71.51 106.6 4.04 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.082 -0.963 . . . . 75.3 110.799 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.452 HG23 HD12 ' A' ' 72' ' ' LEU . 31.5 m -138.06 154.58 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.21 0.529 . . . . 63.21 111.788 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.459 HG12 ' HG3' ' A' ' 66' ' ' ARG . 35.1 m -143.05 142.55 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.317 -0.401 . . . . 74.44 111.12 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 5.5 ttm180 . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 120.843 0.354 . . . . 61.15 110.954 174.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 26.3 tt0 . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 121.869 0.842 . . . . 70.33 110.694 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HG3' HG12 ' A' ' 36' ' ' VAL . 11.3 ttm180 -92.5 133.69 35.68 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.15 -0.932 . . . . 74.32 110.606 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.35 -135.78 4.11 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 119.63 -1.271 . . . . 22.11 114.422 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' A' ' 167' ' ' PRO . 12.5 mt -110.27 141.88 24.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.553 -0.324 . . . . 63.52 111.581 -173.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -47.9 -38.04 15.55 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.871 0.367 . . . . 60.31 111.321 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.596 HD13 ' HB2' ' A' ' 169' ' ' LEU . 63.6 mt -60.75 -54.72 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.097 0.475 . . . . 74.24 112.185 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -72.48 -38.3 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.797 -0.638 . . . . 74.45 112.124 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.576 HD22 ' HG2' ' A' ' 65' ' ' GLU . 47.8 mt -68.54 -43.21 77.19 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.148 0.499 . . . . 73.34 110.529 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -54.92 -42.58 72.39 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.939 -0.573 . . . . 63.14 112.09 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -98.84 1.54 45.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.741 0.645 . . . . 75.31 112.741 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.406 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 3.6 mppt? 54.07 69.05 0.76 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.318 0.58 . . . . 62.14 111.46 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 69.5 mt -106.66 137.41 44.74 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.964 -0.562 . . . . 70.41 110.725 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -88.27 151.55 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.109 0.48 . . . . 75.52 111.717 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.0 131.36 44.94 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.206 -0.906 . . . . 72.2 113.374 -175.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.41 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 83.5 mtp -138.6 153.68 48.66 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.931 -0.577 . . . . 73.03 109.946 170.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.46 168.16 28.21 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.168 0.803 . . . . 75.52 113.168 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -36.97 -55.85 0.9 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.71 1.745 . . . . 62.31 115.71 -169.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.462 ' CE2' ' HG2' ' A' ' 83' ' ' GLU . 43.8 p90 -56.96 -31.57 65.15 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.983 0.734 . . . . 75.44 112.983 -170.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.462 ' HG2' ' CE2' ' A' ' 82' ' ' TYR . 58.3 mm-40 -92.38 -44.54 8.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.158 0.504 . . . . 73.55 111.107 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 3.2 m-20 -67.58 -17.95 64.82 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.739 1.014 . . . . 63.42 113.739 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -43.87 -60.98 1.59 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.022 0.439 . . . . 74.12 111.287 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.9 m -72.54 -27.57 62.31 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.349 -0.387 . . . . 73.33 111.677 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.71 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 58.6 tpp -63.28 -65.92 0.62 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 111.495 0.183 . . . . 74.12 111.495 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.477 ' HA ' ' HB3' ' A' ' 91' ' ' TYR . 13.6 p90 -64.31 -22.75 67.06 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 122.12 -0.362 . . . . 74.33 111.38 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -60.65 -55.52 32.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.867 0.365 . . . . 73.32 110.858 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.7 96.26 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.044 0.45 . . . . 74.42 111.292 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.477 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 6.8 t80 -57.36 -55.86 29.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.829 -0.623 . . . . 72.41 111.348 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.7 -32.7 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.779 0.323 . . . . 74.23 111.542 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -65.82 -54.55 25.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.997 0.427 . . . . 75.13 111.073 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -63.77 -41.19 98.02 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.153 0.502 . . . . 70.41 110.532 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CE1' ' HB2' ' A' ' 175' ' ' ALA . 17.8 t80 -55.04 -58.35 7.99 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.852 -0.613 . . . . 74.43 111.647 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.452 ' O ' HG22 ' A' ' 100' ' ' ILE . 46.8 ttp -50.3 -52.01 40.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.019 -0.537 . . . . 61.44 111.559 -177.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -63.52 -50.49 69.39 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.716 0.293 . . . . 72.31 111.436 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.31 -50.64 72.28 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.264 0.468 . . . . 73.01 112.264 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 95' ' ' PHE . 35.1 m -69.44 -40.35 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.58 0.585 . . . . 75.23 112.58 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 96' ' ' MET . 10.9 tp -74.05 -42.11 52.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 120.791 -0.364 . . . . 71.35 111.18 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.12 -29.51 69.81 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.097 0.475 . . . . 62.43 110.282 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -76.09 -65.26 0.94 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.822 -0.626 . . . . 64.3 111.48 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.0 ttt -64.43 -45.26 88.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.764 0.653 . . . . 75.54 112.764 -171.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.743 ' HA ' HG11 ' A' ' 113' ' ' VAL . 36.8 tt0 -68.52 -11.79 60.36 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.235 0.54 . . . . 72.32 111.289 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -82.32 -42.49 18.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.038 -0.528 . . . . 73.41 111.756 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -89.66 -37.19 14.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.514 0.561 . . . . 72.33 112.514 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.455 ' O ' ' HD3' ' A' ' 108' ' ' ARG . 26.8 t-20 -76.15 -60.34 2.37 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.228 -0.295 . . . . 54.12 111.507 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 71.3 -21.69 0.2 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.155 1.169 . . . . 64.14 114.155 175.138 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.511 ' O ' HG22 ' A' ' 113' ' ' VAL . 40.8 m-20 -78.87 129.69 34.83 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.624 0.726 . . . . 64.23 112.595 -176.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -64.1 -8.04 10.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.245 -0.888 . . . . 71.55 112.459 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.03 -41.52 50.64 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 111.878 0.325 . . . . 75.4 111.878 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -95.34 -62.13 1.35 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.65 0.611 . . . . 70.22 112.65 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.743 HG11 ' HA ' ' A' ' 104' ' ' GLU . 27.3 m -57.82 -36.73 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.089 0.774 . . . . 71.41 113.089 -172.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.91 -45.75 87.92 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.83 0.348 . . . . 74.14 110.498 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.06 97.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.347 -0.388 . . . . 74.33 111.463 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.405 ' CE1' ' HG3' ' A' ' 174' ' ' GLU . 48.9 t80 -63.24 -57.62 9.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.309 -0.405 . . . . 73.2 111.373 176.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -52.6 -46.03 66.8 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.418 0.628 . . . . 70.14 111.053 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.53 -40.24 96.14 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.43 -0.805 . . . . 73.42 111.963 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -68.78 -50.6 48.98 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.892 0.377 . . . . 74.14 110.915 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.97 -33.49 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.856 0.36 . . . . 73.31 111.205 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -65.03 -42.27 94.5 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.096 0.474 . . . . 72.55 110.534 174.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.27 -39.26 97.48 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.895 -0.669 . . . . 62.41 112.024 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 49.2 t90 -58.63 -53.92 52.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.531 0.332 . . . . 50.52 111.224 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.4 m -64.19 -46.26 93.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 112.657 0.614 . . . . 72.33 112.657 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.81 -31.53 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.882 -0.511 . . . . 72.13 111.669 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.8 t -78.19 -42.99 29.78 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.208 0.528 . . . . 64.14 111.039 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.27 -31.0 71.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.037 -0.529 . . . . 73.33 112.309 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 71.0 mt -87.2 3.22 47.36 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.031 0.382 . . . . 75.51 112.031 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.72 103.79 0.15 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.062 0.458 . . . . 61.54 112.223 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -62.06 -24.58 67.17 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.897 0.703 . . . . 73.2 112.897 -174.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -80.31 -40.07 27.48 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.339 0.496 . . . . 73.31 112.339 -175.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -100.31 -60.43 1.53 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.218 0.532 . . . . 74.53 112.242 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.412 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 16.5 m-85 -74.11 -5.99 44.97 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.667 0.988 . . . . 74.41 113.667 -168.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 6.2 ttpm? -58.11 -18.65 26.57 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.879 -0.513 . . . . 73.22 111.45 176.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -85.49 15.64 4.38 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.527 0.566 . . . . 65.23 112.527 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 82.1 mt -89.82 142.34 27.79 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.235 0.54 . . . . 53.34 111.472 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.26 153.46 22.13 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.289 -0.414 . . . . 60.03 110.825 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -119.85 138.71 53.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 55.31 110.425 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 50.6 m-85 -134.27 136.5 43.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.12 0.486 . . . . 71.32 111.455 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.51 HD11 ' HA3' ' A' ' 151' ' ' GLY . 8.0 tt -124.47 149.06 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 115.917 -0.583 . . . . 75.4 110.889 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.69 129.74 49.32 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.262 -0.494 . . . . 63.14 113.579 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -46.93 -43.78 19.34 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.648 0.379 . . . . 71.55 111.886 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -49.52 -34.29 16.87 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.247 0.832 . . . . 73.41 113.247 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -94.91 -25.19 16.66 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.029 -0.42 . . . . 71.14 111.857 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.48 -30.24 7.9 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.267 1.21 . . . . 62.33 114.267 -173.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.72 -26.82 67.45 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.719 0.637 . . . . 74.34 112.719 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 169.86 -22.73 0.09 OUTLIER Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.588 -0.815 . . . . 64.15 113.869 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.37 97.79 0.44 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.981 0.42 . . . . 54.31 111.806 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -4.9 21.65 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.361 -0.381 . . . . 62.23 111.94 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -84.81 20.79 1.71 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.745 0.307 . . . . 65.24 111.68 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.51 ' HA3' HD11 ' A' ' 140' ' ' ILE . . . -92.86 135.64 12.77 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.208 -0.52 . . . . 33.02 112.636 176.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.451 ' NE2' HD22 ' A' ' 171' ' ' LEU . 42.8 tt0 -68.84 119.01 12.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.25 0.463 . . . . 52.11 112.25 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 37.6 t -80.08 124.91 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.089 0.471 . . . . 75.02 111.027 172.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -102.21 135.46 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.076 -0.511 . . . . 51.54 110.594 177.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.741 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 61.5 mt -90.28 137.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 112.338 0.496 . . . . 53.03 112.338 -172.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.1 mm -108.47 117.49 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.391 -0.368 . . . . 75.54 111.67 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 35.9 tt0 -110.47 137.11 48.6 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.38 -0.373 . . . . 62.42 111.389 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -73.26 88.14 1.5 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.51 -0.552 . . . . 75.33 109.51 169.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.03 121.65 22.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.166 0.508 . . . . 75.54 110.611 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -69.19 139.78 54.58 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.385 0.612 . . . . 64.32 112.033 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 163' ' ' GLY . 98.3 t -129.78 150.27 34.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.923 -1.51 . . . . 65.33 106.923 167.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.27 70.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.403 0.62 . . . . 73.1 111.058 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 161' ' ' VAL . . . 133.89 -12.47 4.78 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.774 -0.648 . . . . 63.43 113.862 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 m -143.55 148.57 36.16 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.087 -0.655 . . . . 73.22 111.526 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 165' ' ' GLU . 0.2 OUTLIER -110.94 108.74 18.61 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.421 0.629 . . . . 64.4 111.004 177.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.443 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 27.1 m -115.91 130.05 24.7 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.228 -0.442 . . . . 75.42 111.657 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.49 ' HB2' HD13 ' A' ' 68' ' ' ILE . 6.1 Cg_exo -79.66 115.01 3.3 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.633 2.222 . . . . 73.5 113.121 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.9 p -104.53 165.58 10.96 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.169 0.509 . . . . 74.42 111.824 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.67 HD11 ' HB1' ' A' ' 154' ' ' ALA . 21.1 tp -107.13 139.48 41.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.104 -0.498 . . . . 74.31 111.936 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.741 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 62.4 mtt -108.97 126.21 52.86 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 122.61 0.364 . . . . 74.41 111.633 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.451 HD22 ' NE2' ' A' ' 152' ' ' GLN . 82.1 mt -136.81 120.34 17.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.037 -0.529 . . . . 71.41 110.784 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 27' ' ' VAL . 46.0 t -74.22 121.18 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.628 -0.67 . . . . 64.45 111.927 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -70.14 -31.26 68.69 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.606 0.595 . . . . 73.53 112.606 -174.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.405 ' HG3' ' CE1' ' A' ' 116' ' ' PHE . 28.8 mm-40 -82.18 -1.3 48.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.941 0.4 . . . . 65.24 111.629 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.533 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . . . -96.53 -54.83 3.11 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.278 0.561 . . . . 75.54 110.462 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.571 HG22 ' HA ' ' A' ' 6' ' ' ASP . 29.3 pt -95.66 144.61 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.783 -0.644 . . . . 74.11 110.939 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.695 ' HB ' ' HB3' ' A' ' 5' ' ' LYS . 1.7 mp -91.84 110.7 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.348 0.594 . . . . 75.22 109.804 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -106.03 129.53 54.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.151 -0.932 . . . . 60.14 110.648 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 46.2 mt-10 -130.82 98.98 4.77 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.16 0.505 . . . . 73.13 110.818 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.415 ' HA ' HD12 ' A' ' 2' ' ' LEU . 32.8 ttpt . . . . . 0 CA--C 1.535 0.402 0 CA-C-N 116.003 -0.544 . . . . 75.1 111.924 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.558 0.218 . . . . 71.14 110.916 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 15' ' ' SER . 32.0 tp -84.55 138.17 32.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.319 -0.623 . . . . 75.45 109.319 170.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.491 HG22 HD11 ' A' ' 13' ' ' LEU . 53.1 mt -121.03 118.48 56.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.251 -0.277 . . . . 71.02 110.251 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -118.88 146.89 44.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.272 0.471 . . . . 71.1 112.272 -172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.637 ' HB3' HD13 ' A' ' 13' ' ' LEU . 20.8 ptmt -151.37 127.33 10.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.758 0.651 . . . . 75.3 112.758 176.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.791 ' HB3' ' HB ' ' A' ' 9' ' ' THR . 18.3 t70 -79.37 166.13 22.39 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.866 -0.606 . . . . 30.34 110.761 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.404 HG13 ' CD2' ' A' ' 8' ' ' PHE . 19.9 pt -73.21 -41.29 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 113.133 0.79 . . . . 62.13 113.133 -177.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.404 ' CD2' HG13 ' A' ' 7' ' ' ILE . 24.0 p90 -105.66 -14.13 15.36 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.942 -0.473 . . . . 73.44 111.882 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 6' ' ' ASP . 4.1 m -94.82 18.08 12.45 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.935 0.874 . . . . 45.54 109.48 172.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -45.8 -45.05 14.53 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.595 1.158 . . . . 73.11 113.439 -172.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.17 -21.65 66.35 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.153 0.797 . . . . 64.44 113.153 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' ' 9' ' ' THR . 37.7 mt-10 -88.8 24.38 2.05 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.144 0.424 . . . . 71.52 112.144 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.637 HD13 ' HB3' ' A' ' 5' ' ' LYS . 61.0 tp -44.28 118.6 1.56 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.866 0.467 . . . . 75.35 111.495 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -141.44 165.9 26.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.37 0.508 . . . . 73.14 112.37 -175.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 2' ' ' LEU . 99.2 p -112.06 147.17 36.59 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.227 -0.442 . . . . 63.42 111.378 176.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -142.36 -170.37 3.17 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.385 0.612 . . . . 71.44 112.017 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -153.84 63.11 0.72 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.604 -0.725 . . . . 73.33 110.44 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -124.23 157.18 65.23 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 116.232 -0.44 . . . . 71.44 111.73 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.36 148.53 11.56 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.775 2.317 . . . . 62.11 112.777 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -146.31 145.67 30.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.08 0.467 . . . . 72.51 112.107 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -116.12 109.76 17.92 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.354 -0.385 . . . . 74.13 111.593 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.597 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 52.0 tp -79.99 96.7 6.5 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.908 -0.495 . . . . 74.14 110.963 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 p -87.96 140.17 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-O 120.967 0.413 . . . . 73.31 111.187 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.17 8.43 1.52 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.009 0.374 . . . . 71.24 112.009 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.597 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 40.9 m-20 55.17 20.2 3.26 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.214 0.53 . . . . 72.33 111.599 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.0 tp -117.85 -43.21 2.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.217 -0.447 . . . . 71.05 110.749 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 172' ' ' VAL . 16.5 m -133.52 149.69 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.97 0.414 . . . . 74.32 111.731 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -89.59 124.92 34.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.548 -0.297 . . . . 74.24 110.791 174.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 11.8 pt-20 -107.63 143.44 36.09 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.86 0.362 . . . . 71.31 110.885 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.403 ' HD2' HD11 ' A' ' 70' ' ' ILE . 34.3 t80 -151.59 119.58 6.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.643 0.259 . . . . 62.55 111.242 173.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.4 ' HG3' ' OG1' ' A' ' 168' ' ' THR . 2.9 mptp? -74.94 124.75 27.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.856 0.36 . . . . 62.32 111.331 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.88 172.3 42.05 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 114.186 0.435 . . . . 71.3 114.186 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -105.73 116.34 31.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.563 0.345 . . . . 71.24 110.61 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.21 107.05 2.64 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.179 0.514 . . . . 74.4 111.891 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -140.66 156.99 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.016 0.436 . . . . 65.13 111.618 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.11 125.67 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.073 0.463 . . . . 70.01 110.965 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.855 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 32.0 ttt-85 . . . . . 0 CA--C 1.539 0.547 0 CA-C-N 116.537 -0.301 . . . . 63.21 111.515 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.855 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 19.7 mm-40 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 121.278 0.561 . . . . 60.52 110.323 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -82.59 135.3 35.1 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.673 -0.694 . . . . 70.14 111.464 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.09 -142.59 8.94 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.778 -0.725 . . . . 62.11 113.269 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.419 HG21 ' HB2' ' A' ' 167' ' ' PRO . 24.0 pt -111.04 143.84 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 122.499 -0.412 . . . . 62.02 112.015 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -41.66 -42.21 2.45 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.633 -0.712 . . . . 71.02 112.597 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.403 HD11 ' HD2' ' A' ' 30' ' ' PHE . 55.2 mt -51.75 -61.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.246 0.546 . . . . 72.42 112.271 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.8 m -72.29 -34.38 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.116 -0.493 . . . . 73.22 112.227 -174.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.0 -44.18 77.19 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.763 0.316 . . . . 64.32 111.145 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -63.03 -36.67 84.33 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.882 0.372 . . . . 73.24 111.637 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -94.32 2.14 55.86 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.057 0.391 . . . . 74.55 112.057 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 53.11 66.21 1.3 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.937 0.495 . . . . 72.12 112.08 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.4 mt -104.64 129.64 52.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.446 -0.343 . . . . 73.31 111.19 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 140' ' ' ILE . 11.2 p -78.66 137.02 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.787 0.327 . . . . 73.13 111.066 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -85.44 135.86 33.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.257 0.551 . . . . 72.3 112.071 -177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.3 mmm -130.19 159.41 36.94 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.374 -0.83 . . . . 64.23 109.735 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -132.04 140.87 49.04 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.248 0.833 . . . . 74.32 113.248 -169.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.415 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 27.5 p -48.73 -42.82 36.48 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.791 1.034 . . . . 74.25 113.791 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -53.33 -33.09 52.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.354 0.502 . . . . 74.45 112.354 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -103.44 -47.21 4.35 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.083 0.468 . . . . 70.42 111.643 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -77.6 4.8 10.45 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.545 0.572 . . . . 71.34 112.545 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.48 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -48.61 -46.31 39.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.072 0.463 . . . . 61.53 111.712 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 78.4 p -66.08 -41.95 90.02 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.973 -0.558 . . . . 23.31 111.533 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.3 ttp -63.03 -51.76 65.49 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.314 -0.403 . . . . 72.51 111.829 -175.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 91' ' ' TYR . 8.1 p90 -75.87 -17.58 59.75 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 120.199 -0.601 . . . . 72.11 111.582 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -64.8 -45.66 85.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.255 0.55 . . . . 72.43 110.122 170.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.19 -42.58 93.44 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.094 -0.503 . . . . 73.01 110.736 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.506 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 13.9 m-30 -59.06 -49.44 77.89 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.165 0.431 . . . . 73.22 112.165 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.5 tp -65.55 -31.64 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.612 0.244 . . . . 74.35 111.439 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -63.8 -51.15 66.09 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.996 0.426 . . . . 75.33 110.778 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -65.08 -41.76 94.75 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.172 0.51 . . . . 41.22 110.982 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.589 ' HE1' ' HB2' ' A' ' 175' ' ' ALA . 78.7 t80 -58.64 -56.99 15.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.419 -0.809 . . . . 63.51 111.102 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 50.9 ttp -50.74 -48.11 59.13 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.01 0.433 . . . . 43.01 111.463 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.678 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -63.28 -46.57 86.15 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.127 -0.488 . . . . 74.24 111.48 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -70.66 -42.56 70.63 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.255 0.465 . . . . 65.42 112.255 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.36 -33.61 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.18 0.437 . . . . 73.44 112.18 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 97' ' ' LYS . 10.0 tp -67.82 -38.23 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.533 -0.467 . . . . 75.31 110.309 175.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -65.25 -48.03 74.67 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.315 0.579 . . . . 71.43 110.552 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -60.0 -29.89 68.78 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.662 -0.699 . . . . 72.23 111.789 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 54.5 tpp -90.64 -60.52 1.9 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.813 0.339 . . . . 74.02 111.684 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.12 -32.69 68.37 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.144 0.424 . . . . 72.14 112.144 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -55.86 -44.07 77.72 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.287 0.477 . . . . 72.32 112.287 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -95.83 -36.69 11.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.99 0.366 . . . . 72.23 111.99 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -67.09 -62.94 1.18 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.644 -0.253 . . . . 71.24 111.591 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 108' ' ' ARG . 49.1 mtm180 62.59 23.74 14.12 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.992 1.108 . . . . 74.24 113.992 173.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.539 ' O ' HG22 ' A' ' 113' ' ' VAL . 20.3 t70 -120.88 121.24 37.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.691 -0.63 . . . . 74.35 111.391 175.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 3.3 ptpp? -66.44 -1.25 3.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.887 1.069 . . . . 73.44 113.887 -175.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.95 -44.35 8.48 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.83 -0.544 . . . . 72.42 110.862 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -71.08 -51.39 25.46 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.386 -0.37 . . . . 64.2 111.408 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 109' ' ' ASP . 34.4 m -61.84 -28.45 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.727 0.299 . . . . 74.51 111.205 177.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.56 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 18.9 t70 -61.2 -56.33 21.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.082 0.468 . . . . 51.53 110.318 174.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 119' ' ' LYS . . . -59.92 -40.9 90.46 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.828 -0.624 . . . . 71.01 111.245 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -57.02 -61.96 2.09 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.288 0.477 . . . . 75.3 112.288 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 114' ' ' ASP . 62.7 pttt -55.19 -45.23 75.81 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.885 0.374 . . . . 75.33 111.274 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -65.91 -28.63 69.07 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.828 0.307 . . . . 61.24 111.828 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 37.1 tptt -72.75 -56.84 4.67 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.049 0.452 . . . . 74.44 110.739 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.4 tp -68.18 -39.27 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.896 -0.593 . . . . 75.02 111.763 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.532 ' HA ' HE21 ' A' ' 121' ' ' GLN . 0.0 OUTLIER -62.83 -51.41 67.16 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.283 -0.261 . . . . 65.22 111.422 177.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.63 -44.92 68.82 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.913 -0.661 . . . . 74.42 112.656 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -58.71 -58.39 8.79 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 111.561 0.208 . . . . 71.41 111.561 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.469 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.7 m -61.76 -44.68 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 112.546 0.573 . . . . 54.33 112.546 -175.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.1 m -63.34 -26.98 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.88 -0.513 . . . . 73.31 111.418 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 m -81.25 -36.49 29.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.215 0.531 . . . . 63.21 110.767 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 51.4 tp -71.61 -31.39 66.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.736 -0.665 . . . . 73.52 112.102 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 80.7 mt -80.56 2.36 25.83 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.167 0.432 . . . . 65.2 112.167 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.509 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -58.69 103.47 0.16 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.223 0.535 . . . . 71.11 112.012 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 37.8 ttpt -65.74 -23.24 66.69 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.29 0.848 . . . . 73.22 113.29 -171.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -77.87 -31.83 51.59 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.052 0.76 . . . . 62.13 113.052 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -108.35 -51.78 2.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.259 0.552 . . . . 75.33 111.517 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.509 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 45.8 m-85 -71.22 -5.6 33.21 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.943 0.72 . . . . 70.12 112.943 -172.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 21.8 ptmt -51.36 -26.19 7.31 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.067 -0.395 . . . . 62.12 111.556 172.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -82.18 18.53 1.37 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.67 0.618 . . . . 74.33 112.67 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.4 HD11 ' HD2' ' A' ' 133' ' ' PHE . 75.3 mt -89.68 137.32 32.43 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.982 -0.449 . . . . 74.25 111.297 176.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.9 123.82 45.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.258 -0.428 . . . . 35.11 110.603 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.415 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 88.8 m-85 -101.73 106.17 17.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.982 0.42 . . . . 72.42 111.195 -176.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -97.39 136.14 38.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.066 0.46 . . . . 72.3 111.33 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.455 ' O ' HG12 ' A' ' 77' ' ' VAL . 13.2 tt -140.03 154.72 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.784 0.326 . . . . 74.04 110.88 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.18 125.89 35.13 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.706 -0.759 . . . . 71.22 112.145 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -48.5 -47.56 38.76 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.669 0.387 . . . . 71.22 111.751 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.456 HH11 ' HD3' ' A' ' 143' ' ' ARG . 31.3 ttp180 -48.68 -52.4 23.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.087 -0.506 . . . . 73.43 111.408 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.665 ' HB1' ' H ' ' A' ' 151' ' ' GLY . . . -68.62 -28.05 66.56 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.182 0.438 . . . . 71.12 112.182 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.22 -17.8 64.95 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.748 0.419 . . . . 74.43 111.681 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -66.62 -7.97 24.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.172 -0.467 . . . . 64.31 112.004 175.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.0 17.53 76.79 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.106 -0.568 . . . . 62.4 112.806 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.46 -60.87 1.52 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.948 0.404 . . . . 70.15 111.073 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -74.74 -35.81 62.63 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.381 -0.372 . . . . 73.35 111.459 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 21.8 m120 57.69 34.53 24.6 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.943 0.401 . . . . 72.14 111.241 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.665 ' H ' ' HB1' ' A' ' 144' ' ' ALA . . . -54.09 162.47 3.58 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.61 -0.723 . . . . 53.42 114.216 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -59.59 144.44 47.57 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.948 0.722 . . . . 73.11 112.948 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 50.0 t -91.44 127.5 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.99 -0.55 . . . . 75.33 111.526 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -85.21 116.11 23.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.783 -0.644 . . . . 54.51 110.807 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.704 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 62.6 mt -88.8 124.44 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.821 0.343 . . . . 73.4 111.72 -176.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.8 mm -110.52 120.24 60.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.942 0.401 . . . . 62.2 111.775 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 26.0 tt0 -107.78 128.81 54.92 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.245 -0.434 . . . . 64.24 111.947 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -72.62 89.06 1.29 Allowed 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.969 -0.457 . . . . 73.24 110.486 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -92.2 133.95 35.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.926 0.393 . . . . 70.3 111.919 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.86 123.9 33.68 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.094 0.473 . . . . 55.3 111.506 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.6 t -130.1 105.06 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.875 0.369 . . . . 75.2 111.441 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.2 t70 56.19 30.94 17.41 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.335 0.588 . . . . 62.11 111.916 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.41 -24.55 24.04 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.171 -0.537 . . . . 63.02 113.664 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.5 p -90.16 148.58 22.88 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.924 0.392 . . . . 52.35 111.58 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 165' ' ' GLU . 0.1 OUTLIER -102.97 96.47 6.83 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.462 0.649 . . . . 75.53 110.74 178.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 166' ' ' VAL . 25.0 m -104.16 106.59 54.16 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 121.348 0.594 . . . . 63.15 112.066 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 34.2 Cg_exo -62.08 114.35 2.28 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.531 2.154 . . . . 75.41 112.481 176.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.4 ' OG1' ' HG3' ' A' ' 31' ' ' LYS . 90.9 m -99.15 133.07 43.95 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.921 0.391 . . . . 75.33 111.967 -176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 57.8 tp -77.83 140.1 39.35 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.898 -0.592 . . . . 70.32 111.702 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.704 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 24.0 mmt -127.96 124.36 37.1 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.693 0.397 . . . . 71.23 111.597 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.3 mt -141.09 130.63 23.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.651 0.38 . . . . 73.2 111.431 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.54 ' HA ' HG12 ' A' ' 27' ' ' VAL . 19.6 t -79.97 129.17 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.121 0.415 . . . . 63.11 112.121 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -77.48 -15.21 59.43 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.599 0.592 . . . . 71.15 112.599 -175.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.438 ' H ' HG12 ' A' ' 172' ' ' VAL . 3.8 mp0 -57.33 -27.63 62.39 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.846 0.355 . . . . 70.44 111.821 171.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.589 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -97.3 -42.72 7.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.144 -0.48 . . . . 70.52 111.93 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.4 pt -95.9 118.56 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.607 0.718 . . . . 75.41 112.373 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 177' ' ' ILE . 1.6 mp -94.88 115.63 34.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.798 -0.637 . . . . 73.33 110.255 175.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -97.96 112.88 24.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.567 -0.742 . . . . 63.31 111.407 -176.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 2' ' ' LEU . 54.7 mm-40 -97.71 123.03 41.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.557 0.343 . . . . 71.13 110.797 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.6 pttt . . . . . 0 CA--C 1.544 0.748 0 N-CA-C 112.993 0.738 . . . . 74.32 112.993 -171.943 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 111.747 0.277 . . . . 64.21 111.747 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.0 tp -126.18 131.01 52.1 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.857 0.361 . . . . 64.12 110.535 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.584 HG12 ' HB3' ' A' ' 15' ' ' SER . 57.5 mt -98.05 134.11 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 112.004 0.372 . . . . 74.52 112.004 -175.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -123.52 137.27 54.8 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.083 0.468 . . . . 73.45 111.115 171.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -143.54 141.39 30.69 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.989 -0.55 . . . . 71.3 111.361 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.585 ' HB2' ' H ' ' A' ' 9' ' ' THR . 5.2 m-20 -86.98 167.74 13.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.4 0.619 . . . . 75.23 111.258 172.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.446 HD12 ' OD1' ' A' ' 98' ' ' ASN . 15.2 pt -63.05 -26.86 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.97 -0.559 . . . . 64.14 111.458 173.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.475 ' HE1' ' HA ' ' A' ' 152' ' ' GLN . 13.2 p90 -109.95 -35.65 6.09 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.321 0.86 . . . . 75.34 113.321 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.585 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 2.7 m -83.12 15.61 2.76 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.95 0.722 . . . . 75.1 112.95 -173.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -58.28 -15.11 8.93 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.849 0.685 . . . . 74.23 112.849 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -67.81 -56.02 10.77 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 122.156 -0.34 . . . . 74.45 111.267 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -84.14 25.02 0.87 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.832 0.349 . . . . 55.45 111.747 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tt -40.12 131.07 2.08 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.535 0.734 . . . . 62.45 111.589 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 m -126.11 139.9 53.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.143 0.497 . . . . 62.51 112.279 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.584 ' HB3' HG12 ' A' ' 3' ' ' ILE . 47.8 p -111.55 111.04 21.76 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.869 -0.605 . . . . 72.31 110.944 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.414 ' HB3' ' HD1' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -151.05 -156.83 0.75 Allowed 'General case' 0 CA--C 1.544 0.741 0 O-C-N 122.355 -0.216 . . . . 54.31 111.204 -175.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -127.63 24.77 6.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.136 0.421 . . . . 51.44 112.136 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.414 ' HD1' ' HB3' ' A' ' 16' ' ' ASP . 59.1 m-85 -60.18 134.15 90.56 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.03 0.382 . . . . 54.22 112.03 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.99 -169.84 0.88 Allowed 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.779 2.319 . . . . 75.03 113.08 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.6 ptp -145.89 135.43 23.17 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.442 0.534 . . . . 62.55 112.442 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -124.45 100.41 6.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.614 -0.513 . . . . 75.41 109.614 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 27' ' ' VAL . 33.0 tp -93.03 124.46 37.01 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.174 0.805 . . . . 71.21 113.174 -170.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.68 142.35 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.896 -0.593 . . . . 61.02 111.01 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 57.44 13.44 1.82 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.481 0.549 . . . . 75.2 112.481 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 50.76 26.86 2.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.216 0.532 . . . . 74.21 111.03 -172.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.519 HD22 ' HB3' ' A' ' 119' ' ' LYS . 20.0 tp -121.62 -42.71 2.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.159 -0.473 . . . . 70.44 111.967 -174.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.66 HG12 ' HA ' ' A' ' 172' ' ' VAL . 2.6 m -138.19 151.73 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.803 0.668 . . . . 70.22 112.803 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -104.57 138.52 40.79 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.879 -0.6 . . . . 74.54 111.117 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -104.39 137.73 41.84 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.397 . . . . 72.14 110.526 167.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.845 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.4 t80 -115.59 134.25 55.24 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.943 0.401 . . . . 75.34 111.141 177.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -93.1 113.79 26.14 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.199 -0.455 . . . . 72.52 111.859 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.09 -174.82 18.31 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.275 -0.488 . . . . 61.42 113.598 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -128.14 144.25 51.1 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 122.482 -0.422 . . . . 73.54 111.298 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -80.08 114.16 18.79 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.866 -0.42 . . . . 73.2 109.866 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.1 m -144.23 174.42 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.302 0.573 . . . . 73.24 111.949 -174.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.5 m -110.85 121.75 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.168 0.509 . . . . 72.52 110.558 173.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.619 ' HB2' HD13 ' A' ' 72' ' ' LEU . 9.8 mmm180 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 121.095 0.474 . . . . 72.32 111.111 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.462 ' HA ' ' C ' ' A' ' 37' ' ' ARG . 39.7 tt0 . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 121.397 0.617 . . . . 72.23 109.354 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -137.02 122.02 18.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.746 -0.661 . . . . 72.05 111.202 -176.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.53 -148.78 15.5 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.532 -0.842 . . . . 74.22 113.736 175.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.442 HD12 HD12 ' A' ' 70' ' ' ILE . 36.7 pt -111.07 138.82 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 122.417 -0.46 . . . . 64.32 111.356 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -48.14 -35.75 12.16 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.379 0.511 . . . . 75.42 112.379 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.442 HD12 HD12 ' A' ' 68' ' ' ILE . 55.8 mt -49.81 -64.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.401 0.62 . . . . 70.1 112.021 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 18.5 m -74.38 -31.98 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.964 -0.562 . . . . 71.43 112.08 -174.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.619 HD13 ' HB2' ' A' ' 37' ' ' ARG . 72.6 mt -68.7 -30.78 69.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.286 -0.415 . . . . 55.11 111.64 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -90.63 -27.13 19.27 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 111.852 0.316 . . . . 72.12 111.852 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -97.84 3.65 49.82 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.02 -0.425 . . . . 75.2 111.782 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 58.29 70.87 0.62 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.406 0.622 . . . . 73.32 112.581 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 88.0 mt -122.26 138.92 54.33 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.003 -0.544 . . . . 65.33 111.256 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 p -93.76 146.67 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 120.856 0.36 . . . . 72.34 111.842 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.42 127.51 32.29 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.368 0.877 . . . . 54.51 113.368 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.0 mtp -140.26 110.61 6.65 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.172 -0.467 . . . . 75.24 110.139 174.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.499 ' HB2' ' HE1' ' A' ' 82' ' ' TYR . 18.4 m120 -95.74 167.11 11.47 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.852 -0.53 . . . . 54.42 112.134 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 43.1 t -43.5 -56.13 3.82 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.87 1.063 . . . . 72.34 113.87 -172.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.499 ' HE1' ' HB2' ' A' ' 80' ' ' ASN . 13.4 p90 -50.24 -33.0 18.11 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.457 0.54 . . . . 72.23 112.457 -177.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.76 -38.24 9.55 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.773 -0.649 . . . . 64.2 112.087 -174.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 88' ' ' PHE . 25.4 t0 -91.21 -7.63 50.77 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.477 0.547 . . . . 72.13 112.477 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.614 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -39.71 -61.49 0.82 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.369 0.878 . . . . 74.43 113.369 -175.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.4 m -61.86 -35.25 77.74 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.262 0.467 . . . . 62.34 112.262 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.5 ttm -75.74 -54.4 7.01 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.139 0.422 . . . . 72.23 112.139 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.614 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 7.6 p90 -63.47 -27.09 69.04 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.114 -0.634 . . . . 74.51 111.617 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -64.32 -44.8 90.46 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.867 0.365 . . . . 72.42 110.645 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.64 -38.0 89.51 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.2 0.524 . . . . 33.32 110.714 173.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 27.8 t80 -55.82 -50.99 69.0 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.72 -0.673 . . . . 73.42 110.978 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 88' ' ' PHE . 32.6 mm -57.68 -42.72 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 116.283 -0.417 . . . . 61.54 111.593 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.93 -56.38 17.7 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.865 0.32 . . . . 62.33 111.865 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -59.94 -39.21 84.77 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.897 0.379 . . . . 65.5 111.147 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CZ ' HG11 ' A' ' 172' ' ' VAL . 20.3 t80 -59.49 -59.15 5.91 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.121 -0.49 . . . . 72.33 111.221 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 55.6 ttp -52.82 -44.43 66.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.161 -0.472 . . . . 71.34 111.4 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -61.67 -49.56 76.02 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.36 -0.382 . . . . 72.15 111.321 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.446 ' OD1' HD12 ' A' ' 7' ' ' ILE . 26.0 t-20 -61.33 -56.06 24.73 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.76 0.281 . . . . 63.1 111.76 -176.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.577 ' HB ' ' HZ ' ' A' ' 116' ' ' PHE . 27.5 m -57.46 -41.72 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.407 0.521 . . . . 73.53 112.407 -176.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.6 tp -74.74 -35.9 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 122.077 -0.39 . . . . 71.1 111.006 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.73 -13.81 61.03 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.336 0.588 . . . . 70.11 110.8 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -90.36 -37.79 13.77 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.16 -0.337 . . . . 74.53 111.343 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 64.0 mtt -93.13 -62.88 1.29 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.523 0.564 . . . . 71.41 112.523 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.658 ' HA ' HG11 ' A' ' 113' ' ' VAL . 38.9 tt0 -58.29 -26.34 62.9 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.38 0.511 . . . . 72.44 112.38 -174.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -57.27 -46.21 83.31 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 111.991 0.367 . . . . 71.42 111.991 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.02 -14.52 14.72 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.566 0.58 . . . . 74.55 112.566 -175.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.46 ' OD1' HG13 ' A' ' 113' ' ' VAL . 27.6 t-20 -92.72 -68.9 0.77 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.666 0.269 . . . . 70.55 111.398 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 36.6 ttm180 63.14 11.96 5.67 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.248 0.833 . . . . 73.22 113.248 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.621 ' O ' HG22 ' A' ' 113' ' ' VAL . 22.2 t70 -75.53 120.36 20.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.385 -0.822 . . . . 75.41 110.954 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -57.78 -12.31 2.94 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.468 0.914 . . . . 72.12 113.468 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.1 -53.25 4.2 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.997 -0.439 . . . . 75.31 112.043 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -74.12 -60.07 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.238 0.459 . . . . 74.15 112.238 -170.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.658 HG11 ' HA ' ' A' ' 104' ' ' GLU . 27.6 m -60.47 -26.6 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.692 0.282 . . . . 72.32 111.722 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.79 -53.22 50.38 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.573 -0.285 . . . . 75.12 110.483 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -56.57 -43.66 80.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.042 0.449 . . . . 61.24 111.258 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.577 ' HZ ' ' HB ' ' A' ' 99' ' ' VAL . 44.1 t80 -61.07 -59.21 5.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.882 0.372 . . . . 61.11 111.624 177.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -57.0 -35.14 68.88 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.175 0.512 . . . . 55.31 111.169 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -68.97 -40.15 79.02 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.786 -0.643 . . . . 53.34 111.385 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.519 ' HB3' HD22 ' A' ' 26' ' ' LEU . 51.9 mtmt -65.69 -44.18 86.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.512 0.196 . . . . 74.11 111.103 175.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.432 ' CD1' HD11 ' A' ' 26' ' ' LEU . 37.6 mm -62.01 -45.58 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.917 0.389 . . . . 75.45 111.055 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.42 ' O ' HG23 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -58.54 -50.99 71.78 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.184 -0.462 . . . . 62.15 110.776 177.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.73 -36.85 93.88 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.922 -0.656 . . . . 75.32 112.724 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.2 t90 -60.6 -56.4 21.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.642 0.377 . . . . 74.22 111.587 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.536 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.8 m -63.36 -42.72 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 112.241 0.46 . . . . 72.14 112.241 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 121' ' ' GLN . 71.6 t -59.81 -37.23 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 122.066 -0.396 . . . . 75.52 111.43 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.2 t -77.16 -39.62 48.41 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.042 0.449 . . . . 74.43 110.984 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.0 tp -62.41 -28.38 69.75 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.994 0.517 . . . . 73.3 112.148 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 29.3 mt -92.58 1.81 57.05 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.916 0.339 . . . . 64.12 111.916 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.89 108.08 2.43 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.091 0.472 . . . . 65.31 111.451 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -16.58 49.19 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.076 0.769 . . . . 55.41 113.076 -172.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -54.91 -49.05 72.24 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.904 0.383 . . . . 54.25 111.404 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -111.24 -43.34 3.74 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.403 0.62 . . . . 74.1 111.27 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -74.23 -7.26 52.08 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.327 0.862 . . . . 70.52 113.327 -167.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -63.7 -32.35 73.81 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.197 0.523 . . . . 70.31 110.426 170.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -89.7 33.9 0.84 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.003 -0.544 . . . . 75.1 112.199 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.73 156.95 18.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.504 0.669 . . . . 53.02 111.93 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.36 112.63 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.461 -0.79 . . . . 74.01 110.288 172.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.585 ' HB3' HG13 ' A' ' 153' ' ' VAL . 54.5 m-85 -90.9 132.93 35.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.916 0.388 . . . . 70.02 110.226 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.788 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 61.4 m-85 -121.94 125.39 46.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.863 0.364 . . . . 73.14 111.331 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 13.8 tt -113.4 154.63 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 116.552 -0.294 . . . . 73.44 111.348 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.99 142.8 41.42 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.447 -0.342 . . . . 73.11 113.645 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.437 ' HG3' ' HG3' ' A' ' 143' ' ' ARG . 14.2 pt-20 -53.29 -40.06 64.42 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.643 0.609 . . . . 73.24 112.643 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.437 ' HG3' ' HG3' ' A' ' 142' ' ' GLU . 85.1 mtm180 -78.17 -38.44 43.51 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.019 0.377 . . . . 72.32 112.019 -176.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.606 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -74.89 -28.48 60.65 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.085 0.402 . . . . 75.3 112.085 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -50.16 -38.79 41.24 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.04 1.126 . . . . 74.35 114.04 -174.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -73.52 6.16 3.26 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.756 1.021 . . . . 74.23 113.756 -172.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.26 -11.69 1.19 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.981 -1.104 . . . . 64.52 114.881 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -77.93 95.11 4.7 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 117.778 0.789 . . . . 70.14 111.59 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -74.27 19.85 0.12 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.473 0.546 . . . . 72.44 112.473 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -111.49 5.88 19.83 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.943 0.401 . . . . 53.24 110.827 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.81 171.59 52.59 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.423 -0.418 . . . . 63.34 113.472 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.475 ' HA ' ' HE1' ' A' ' 8' ' ' PHE . 37.3 tt0 -86.72 116.96 25.17 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.421 -0.458 . . . . 62.5 112.085 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.585 HG13 ' HB3' ' A' ' 138' ' ' PHE . 27.5 t -83.29 107.17 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.152 0.501 . . . . 71.23 110.589 170.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.484 ' HB1' ' CD1' ' A' ' 169' ' ' LEU . . . -82.09 117.39 22.23 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.065 -0.516 . . . . 64.42 110.89 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 59.4 mt -89.27 105.12 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.854 0.359 . . . . 73.43 111.252 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.5 mm -93.77 117.8 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.027 0.381 . . . . 62.33 112.027 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.86 129.49 56.44 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.393 -0.595 . . . . 73.43 109.393 174.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -90.51 88.99 7.37 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.047 0.451 . . . . 73.23 110.456 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -97.17 159.05 15.13 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.329 0.585 . . . . 71.11 112.171 -170.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.01 134.09 48.7 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.926 -0.579 . . . . 73.02 111.295 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.1 t -119.2 104.84 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.642 0.258 . . . . 73.23 110.962 175.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 60.4 9.75 2.14 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.863 0.69 . . . . 74.04 112.863 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 116.27 2.05 20.06 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.427 -0.416 . . . . 60.22 113.096 -175.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 94.5 m -107.8 130.24 54.99 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.977 0.418 . . . . 52.3 111.966 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -74.03 112.48 10.21 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.986 -0.552 . . . . 74.21 112.191 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 166' ' ' VAL . 27.9 m -129.22 117.4 18.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 121.168 0.508 . . . . 61.31 111.932 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.96 114.5 3.99 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.838 1.692 . . . . 75.13 111.693 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 67.3 p -101.07 129.22 46.91 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.164 0.506 . . . . 74.12 112.047 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.845 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.1 tp -89.81 122.9 33.32 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.84 -0.618 . . . . 74.33 111.087 176.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.658 ' SD ' ' HB ' ' A' ' 27' ' ' VAL . 39.4 tpp -103.22 125.52 49.93 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.755 0.312 . . . . 64.05 111.596 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -140.9 152.09 44.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.189 0.596 . . . . 63.55 109.983 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.66 ' HA ' HG12 ' A' ' 27' ' ' VAL . 41.9 t -89.89 117.34 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.829 0.677 . . . . 72.32 112.829 -173.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -59.88 -31.81 70.15 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.045 -0.525 . . . . 75.0 111.832 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.413 ' HG3' ' HE1' ' A' ' 116' ' ' PHE . 5.5 mm-40 -85.27 11.55 9.85 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.464 -0.335 . . . . 64.4 111.803 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -127.09 -41.87 1.76 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.829 0.347 . . . . 40.42 111.083 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 172' ' ' VAL . 12.8 tt -100.18 132.18 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.093 0.473 . . . . 64.41 111.062 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.5 tp -130.25 153.53 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.95 0.405 . . . . 71.32 111.548 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.05 152.06 41.43 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.115 0.483 . . . . 70.51 111.35 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.506 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 11.2 tp10 -138.98 133.19 31.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.095 0.474 . . . . 61.53 110.697 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 121.729 0.776 . . . . 63.34 112.939 -172.929 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.764 0.316 . . . . 74.34 110.856 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 33.9 tp -100.8 130.92 46.89 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 110.117 -0.327 . . . . 74.14 110.117 173.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.747 ' HB ' HD21 ' A' ' 13' ' ' LEU . 21.1 pt -114.2 123.02 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.22 0.533 . . . . 75.14 111.557 -176.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.525 ' HE1' ' HB2' ' A' ' 16' ' ' ASP . 35.7 p90 -122.8 143.28 49.94 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.231 0.539 . . . . 75.31 112.154 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.731 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 12.0 ptmt -130.1 150.0 51.56 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.688 -0.687 . . . . 75.03 111.242 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 7.0 p-10 -97.81 -178.33 4.06 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.212 0.53 . . . . 62.3 111.261 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.45 -43.83 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 113.239 0.829 . . . . 72.2 113.239 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.519 ' HD2' HG23 ' A' ' 9' ' ' THR . 9.2 p90 -108.48 -52.65 2.74 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.647 1.351 . . . . 71.32 114.647 -168.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.519 HG23 ' HD2' ' A' ' 8' ' ' PHE . 17.7 p -89.48 18.51 5.26 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.67 -0.644 . . . . 73.14 112.616 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.731 ' HB2' ' HB2' ' A' ' 5' ' ' LYS . 3.8 p-10 -50.87 -20.55 1.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.797 1.406 . . . . 71.54 114.797 -172.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -66.86 -19.79 65.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.363 0.602 . . . . 54.44 110.814 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.31 24.94 4.1 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.499 -0.773 . . . . 70.44 110.861 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.747 HD21 ' HB ' ' A' ' 3' ' ' ILE . 7.8 tt -38.52 138.61 0.48 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.815 0.846 . . . . 71.42 112.498 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.0 m -118.72 149.61 41.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.997 0.427 . . . . 62.24 111.934 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.5 p -109.77 129.91 55.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.236 -0.438 . . . . 74.32 110.557 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.525 ' HB2' ' HE1' ' A' ' 4' ' ' TYR . 2.5 t70 -137.41 179.04 6.64 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.657 0.265 . . . . 74.11 111.192 -177.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.7 t -132.74 4.97 3.92 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.275 0.472 . . . . 52.54 112.275 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -78.26 146.08 69.97 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 122.07 -0.394 . . . . 73.05 111.842 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -85.99 126.38 2.85 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.973 2.449 . . . . 64.4 113.386 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 87.7 mmm -89.74 124.63 34.8 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.502 -0.317 . . . . 74.31 111.163 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 56.5 mttm -103.48 112.24 25.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.34 0.256 . . . . 73.52 111.573 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 33.9 tp -84.54 106.65 16.27 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.809 -0.557 . . . . 63.33 112.159 -175.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -98.04 139.29 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.084 0.468 . . . . 74.15 111.131 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 58.32 15.56 3.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.565 0.58 . . . . 75.34 112.565 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 59.98 11.46 2.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.328 0.492 . . . . 61.4 112.328 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.1 tp -115.83 -45.54 2.87 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.07 0.396 . . . . 75.32 112.07 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 172' ' ' VAL . 3.8 m -129.29 143.7 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.431 0.53 . . . . 72.3 112.431 -176.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' A' ' 170' ' ' MET . 98.0 m-85 -92.0 142.03 27.98 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.074 -0.512 . . . . 74.45 110.876 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 16.4 pt-20 -128.87 146.97 50.79 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 110.242 -0.281 . . . . 71.41 110.242 174.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.52 ' CE2' HD13 ' A' ' 70' ' ' ILE . 43.6 p90 -152.48 145.67 24.65 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.626 0.973 . . . . 65.23 113.626 172.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -94.91 130.51 41.49 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.366 -0.834 . . . . 73.11 111.525 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.88 -133.96 7.69 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 114.472 0.549 . . . . 75.25 114.472 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -138.45 123.78 19.36 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.636 -0.332 . . . . 62.32 111.229 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -66.24 107.0 1.82 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.923 0.392 . . . . 74.1 111.839 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.418 HG23 HD12 ' A' ' 72' ' ' LEU . 35.6 m -138.96 168.17 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.267 -0.424 . . . . 61.55 111.481 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.91 144.74 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.482 -0.326 . . . . 72.22 110.933 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 29.6 tpt85 . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 121.832 0.825 . . . . 73.01 111.979 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 35.1 mt-10 . . . . . 0 CA--C 1.539 0.549 0 CA-C-O 121.653 0.74 . . . . 72.45 110.069 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.543 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -114.48 149.56 36.16 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.915 -0.584 . . . . 64.15 111.748 -177.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 141.67 -113.65 0.84 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.205 -0.522 . . . . 63.22 112.802 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.454 HD12 HD12 ' A' ' 70' ' ' ILE . 17.1 pt -111.51 134.52 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.959 0.409 . . . . 43.2 111.85 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -46.25 -36.31 6.02 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.829 -0.623 . . . . 72.21 112.222 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.52 HD13 ' CE2' ' A' ' 30' ' ' PHE . 50.9 mt -48.66 -64.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.304 0.573 . . . . 75.32 112.29 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 33.8 m -66.04 -36.75 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.911 -0.586 . . . . 72.34 112.188 -175.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.418 HD12 HG23 ' A' ' 35' ' ' VAL . 42.7 mt -67.46 -38.32 84.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.095 0.474 . . . . 64.34 111.299 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -66.41 -45.2 80.75 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.077 -0.51 . . . . 74.34 111.247 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -90.43 7.94 36.21 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.38 0.511 . . . . 73.54 112.38 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.8 mttm 57.4 69.08 0.77 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.496 0.665 . . . . 75.34 112.759 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 75.0 mt -114.74 120.86 41.52 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.935 -0.575 . . . . 71.24 110.541 177.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 14.4 p -86.62 144.17 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.911 0.386 . . . . 75.44 111.615 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.55 126.31 30.76 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.105 -0.498 . . . . 71.23 112.214 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.2 mmt -132.35 159.46 39.15 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.201 -0.454 . . . . 71.21 111.133 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.465 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 93.5 m-20 -127.39 147.3 50.27 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.139 0.495 . . . . 65.31 111.175 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 26.1 p -52.19 -16.43 0.8 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.852 1.427 . . . . 52.31 114.852 -169.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 80' ' ' ASN . 50.2 p90 -58.94 -41.63 87.82 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.418 0.525 . . . . 73.43 112.418 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -101.34 -37.92 8.27 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.126 -0.359 . . . . 64.13 111.824 -178.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.64 6.88 0.98 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.833 0.679 . . . . 64.22 112.833 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.32 -50.59 38.85 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.359 0.503 . . . . 73.43 112.359 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.7 m -68.96 -35.27 76.56 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.625 0.25 . . . . 54.11 111.612 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 95.9 mmm -56.46 -50.85 70.51 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.681 0.277 . . . . 62.44 110.698 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -68.32 -33.73 74.85 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.84 0.311 . . . . 72.53 111.84 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -55.6 -54.72 40.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.104 0.478 . . . . 64.51 110.967 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.48 -38.22 68.25 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.2 -0.455 . . . . 71.12 111.792 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -59.01 -54.82 42.77 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.633 -0.258 . . . . 75.03 111.288 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.4 mm -62.4 -35.43 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.696 -0.229 . . . . 73.1 111.272 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.453 ' HE3' ' HD2' ' A' ' 97' ' ' LYS . 57.4 tptt -57.33 -60.56 3.44 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.709 0.29 . . . . 73.43 111.11 175.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -61.77 -39.5 91.86 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.167 0.508 . . . . 72.35 111.097 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.599 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 78.3 t80 -57.36 -56.68 18.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.86 -0.609 . . . . 74.42 111.527 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 51.8 ttm -53.79 -43.7 69.49 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.09 0.472 . . . . 62.32 111.33 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD2' ' HE3' ' A' ' 93' ' ' LYS . 28.0 mtpp -61.71 -43.85 98.06 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.989 -0.55 . . . . 71.32 111.79 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -73.42 -44.45 58.28 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.95 0.352 . . . . 64.14 111.95 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.0 m -66.33 -38.73 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.395 0.517 . . . . 73.35 112.395 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 34.5 mm -65.51 -47.0 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.856 0.36 . . . . 54.25 110.756 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.95 -42.89 85.89 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 72.54 110.512 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -64.83 -35.55 81.48 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.709 -0.678 . . . . 63.44 111.285 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.574 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 15.0 mmt -68.05 -39.62 82.97 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.651 0.241 . . . . 75.43 111.651 177.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.65 -35.68 72.93 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.491 0.663 . . . . 74.43 110.53 171.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -70.09 -46.35 65.04 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.283 -0.871 . . . . 64.01 112.702 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 103' ' ' MET . 0.1 OUTLIER -97.51 -26.15 14.92 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.122 1.156 . . . . 73.32 114.122 -174.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.575 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 87.7 m-20 -124.06 -63.21 1.22 Allowed 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.874 -0.516 . . . . 63.24 112.114 -175.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' A' ' 107' ' ' ASN . 5.9 ptt180 67.91 -14.71 0.22 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.308 1.043 . . . . 74.2 113.399 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 113' ' ' VAL . 24.7 t70 -61.64 127.63 32.37 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.2 -0.313 . . . . 71.23 111.676 -176.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -50.63 -39.64 50.91 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.727 0.64 . . . . 75.21 112.727 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.94 -35.63 50.17 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.648 0.261 . . . . 63.42 111.576 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -67.71 -51.36 50.32 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.783 0.325 . . . . 64.02 111.083 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 109' ' ' ASP . 16.1 m -66.73 -23.07 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 111.813 0.301 . . . . 63.53 111.813 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 29.1 t70 -69.96 -61.43 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.039 -0.356 . . . . 74.33 110.039 171.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.85 -40.16 63.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.865 0.364 . . . . 70.15 111.608 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -58.83 -59.34 5.59 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.384 -0.371 . . . . 73.31 111.242 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 8.4 ptpp? -59.39 -31.8 69.58 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.958 -0.297 . . . . 74.02 111.065 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 33.7 mmtp -62.4 -46.66 87.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.851 0.357 . . . . 74.51 110.802 175.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -67.37 -56.25 10.46 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.071 -0.513 . . . . 60.44 111.991 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.0 tp -67.36 -40.6 85.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.587 0.588 . . . . 61.12 112.587 -175.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 125' ' ' VAL . 14.3 tm0? -68.12 -45.74 72.8 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.023 -0.423 . . . . 71.2 110.737 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.41 -41.61 95.32 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.647 -0.787 . . . . 71.11 112.05 173.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -59.44 -54.1 50.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.4 0.28 . . . . 62.21 111.717 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.0 m -64.82 -36.7 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.485 0.55 . . . . 75.54 112.485 -177.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 121' ' ' GLN . 78.0 t -59.37 -43.51 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.98 -0.45 . . . . 64.4 111.148 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.7 t -76.05 -37.64 58.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.116 0.484 . . . . 74.1 111.119 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.516 ' HA ' ' CD2' ' A' ' 133' ' ' PHE . 51.1 tp -61.25 -33.55 73.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.987 0.515 . . . . 75.52 111.704 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 65.7 mt -88.47 3.01 51.65 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.35 -0.386 . . . . 50.44 111.918 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.27 102.86 0.1 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.151 0.5 . . . . 71.55 111.642 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -62.33 -11.44 15.35 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.794 1.035 . . . . 72.3 113.794 -172.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.97 -48.35 6.03 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.642 0.608 . . . . 74.32 112.642 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.7 tpp85 -92.8 -56.01 3.16 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.185 0.516 . . . . 74.31 111.667 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' A' ' 127' ' ' LEU . 8.0 m-85 -71.2 -5.86 35.13 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.117 0.484 . . . . 74.34 111.975 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 27.6 ttpp -49.81 -21.84 1.25 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.144 -0.48 . . . . 51.51 112.08 172.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -82.18 9.35 8.84 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.916 0.71 . . . . 74.41 112.916 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.25 136.12 33.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.06 0.457 . . . . 75.25 111.771 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.14 118.45 37.01 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.154 -0.475 . . . . 62.42 110.296 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.403 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 66.4 m-85 -97.08 108.32 21.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.001 0.429 . . . . 73.14 111.278 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 45.7 m-85 -98.64 124.49 43.47 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.1 0.476 . . . . 73.33 111.481 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.544 HG23 ' HB2' ' A' ' 145' ' ' ALA . 10.6 tt -135.56 148.75 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.315 -0.402 . . . . 73.44 110.929 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.37 121.94 8.07 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.276 -0.487 . . . . 45.54 112.815 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -32.31 60.81 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.931 0.715 . . . . 73.3 112.931 -175.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -61.32 -39.34 90.15 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.066 0.395 . . . . 74.25 112.066 173.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -80.52 -40.53 25.86 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.939 0.399 . . . . 62.45 111.562 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.544 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -58.56 -20.68 48.69 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.128 -0.487 . . . . 34.21 112.058 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -62.84 -16.89 60.33 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.072 -0.513 . . . . 75.12 111.761 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.13 31.37 14.57 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.252 -0.499 . . . . 41.32 112.485 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.46 -19.89 19.5 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.193 0.442 . . . . 65.34 112.193 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -161.78 -170.87 2.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.641 -0.254 . . . . 75.32 111.08 -176.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -65.66 -66.47 0.54 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.781 0.324 . . . . 65.4 111.784 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.29 146.2 0.21 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.345 -0.455 . . . . 51.34 113.67 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -102.17 135.99 42.78 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.313 -0.522 . . . . 62.33 111.265 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 56.1 t -94.69 127.86 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.19 0.519 . . . . 71.4 112.015 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.901 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -96.05 123.28 39.6 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.688 -0.687 . . . . 64.12 110.422 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 55.4 mt -93.3 118.98 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.18 0.437 . . . . 71.1 112.18 -173.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.0 mm -102.94 117.59 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.677 -0.238 . . . . 63.32 111.222 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -109.76 125.13 52.37 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.16 0.505 . . . . 74.32 111.59 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -87.52 88.87 7.8 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.039 -0.528 . . . . 65.54 109.824 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 159' ' ' ARG . 18.9 ptt85 -124.82 172.49 9.3 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.203 0.525 . . . . 71.32 112.324 -175.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -89.3 135.92 33.31 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.31 0.576 . . . . 63.44 112.213 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 78.1 t -108.8 95.48 3.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.889 -0.782 . . . . 73.03 108.889 169.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.4 t70 69.74 -56.96 0.56 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.533 -0.758 . . . . 73.51 111.564 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.02 6.65 0.14 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 121.1 -0.572 . . . . 60.12 114.224 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.4 m -120.5 134.76 55.23 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.749 0.774 . . . . 64.11 111.697 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -83.28 107.93 16.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.582 -0.281 . . . . 62.45 111.409 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.1 m -128.79 147.32 64.0 Favored Pre-proline 0 N--CA 1.474 0.747 0 CA-C-O 121.078 0.466 . . . . 71.45 112.016 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -90.94 114.72 0.43 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.928 2.419 . . . . 60.03 113.366 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 79.2 p -103.52 154.87 18.99 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.631 -0.259 . . . . 55.1 110.658 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.901 HD11 ' HB1' ' A' ' 154' ' ' ALA . 13.7 tp -100.28 120.89 40.62 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.221 -0.299 . . . . 73.4 111.312 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.643 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 60.8 mtt -107.54 134.89 49.9 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.678 0.621 . . . . 64.45 112.678 -175.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.8 mt -143.41 146.4 33.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.278 -0.874 . . . . 70.31 110.092 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.599 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 44.5 t -77.19 134.67 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 112.277 0.473 . . . . 73.53 112.277 -176.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.698 ' HB3' ' HZ3' ' A' ' 173' ' ' LYS . 5.9 ttpm? -59.6 -47.67 84.66 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.983 -0.553 . . . . 73.31 112.089 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -85.16 11.48 9.76 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.918 0.389 . . . . 71.33 111.964 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.537 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -103.3 -13.07 16.85 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.75 0.31 . . . . 71.25 111.133 173.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.2 pt -136.9 133.58 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.216 0.532 . . . . 45.31 111.485 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.53 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 50.6 mm -94.58 110.79 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.958 0.409 . . . . 70.52 110.218 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.7 123.15 31.55 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.319 -0.4 . . . . 72.21 110.822 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.56 ' HB3' HG13 ' A' ' 3' ' ' ILE . 11.8 tp10 -121.41 139.4 53.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.182 0.515 . . . . 72.24 110.702 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 112.776 0.658 . . . . 43.14 112.776 -172.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.582 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 24.0 mmt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.664 0.269 . . . . 62.11 111.264 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 15' ' ' SER . 57.7 tp -71.98 133.58 45.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.725 0.298 . . . . 72.43 110.781 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.1 mt -97.19 120.47 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 111.872 0.323 . . . . 70.03 111.872 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.464 ' O ' HD12 ' A' ' 13' ' ' LEU . 7.8 m-85 -106.59 115.05 29.53 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.439 -0.346 . . . . 73.42 110.638 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HG2' HD13 ' A' ' 13' ' ' LEU . 97.7 mttt -112.6 112.22 23.6 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.321 0.388 . . . . 62.14 111.231 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.61 154.98 38.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.088 0.47 . . . . 44.41 111.199 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.4 -42.67 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.081 0.467 . . . . 73.05 110.579 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -109.97 -33.54 6.68 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.461 0.911 . . . . 62.32 113.461 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.466 HG23 ' HA2' ' A' ' 151' ' ' GLY . 1.3 m -89.61 15.17 9.95 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 112.729 0.64 . . . . 52.22 112.729 -175.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -54.64 -17.87 3.86 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.93 0.715 . . . . 72.3 112.93 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.45 -33.11 72.08 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.357 0.599 . . . . 70.11 111.13 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -94.08 24.29 4.42 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.997 -0.547 . . . . 53.23 111.845 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 4' ' ' TYR . 65.5 tp -31.04 117.26 0.17 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.787 0.835 . . . . 72.04 112.436 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.6 t -110.01 163.6 13.41 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.284 0.564 . . . . 74.04 112.364 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.582 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 79.3 p -150.17 107.59 3.63 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.598 -0.728 . . . . 73.43 110.688 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -135.71 173.69 11.44 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.25 0.547 . . . . 72.42 112.328 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 m -133.9 84.7 2.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.875 -0.602 . . . . 70.45 110.489 173.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.59 152.01 73.84 Favored Pre-proline 0 N--CA 1.474 0.754 0 CA-C-N 116.367 -0.379 . . . . 75.43 111.381 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -93.0 94.21 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.862 2.374 . . . . 74.54 112.901 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.537 ' HB3' ' HB3' ' A' ' 28' ' ' TYR . 4.0 mpp? -85.41 144.82 27.78 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.857 0.36 . . . . 64.23 111.36 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -99.12 108.1 20.64 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.876 0.37 . . . . 72.03 111.863 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.2 tp -75.75 95.49 3.45 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.046 0.45 . . . . 61.43 111.084 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -86.75 140.34 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.038 0.446 . . . . 74.44 111.71 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.5 t70 58.03 16.46 3.79 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.854 -0.612 . . . . 74.02 111.679 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 57.18 20.4 5.62 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.054 -0.521 . . . . 64.03 111.762 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' A' ' 119' ' ' LYS . 32.2 tp -118.43 -50.17 2.45 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.055 0.455 . . . . 52.2 111.963 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.506 HG12 HG22 ' A' ' 172' ' ' VAL . 14.3 m -130.8 155.38 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 112.581 0.586 . . . . 75.35 112.581 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.537 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 77.5 m-85 -92.24 124.86 36.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.086 -0.506 . . . . 75.05 110.816 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 15.1 pt-20 -101.93 139.32 37.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.997 0.427 . . . . 74.13 110.217 171.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 168' ' ' THR . 42.5 t80 -141.56 112.35 7.2 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.629 -0.259 . . . . 73.04 111.11 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.432 ' HG3' ' H ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -75.48 130.89 39.64 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.33 0.492 . . . . 75.2 112.33 -179.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -126.09 162.04 20.36 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.385 -0.436 . . . . 23.41 113.606 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -97.24 126.83 42.7 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.463 -0.434 . . . . 64.31 111.539 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.408 ' ND1' ' O ' ' A' ' 34' ' ' HIS . 15.9 p80 -74.5 106.57 6.16 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.142 0.496 . . . . 74.35 110.619 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.7 m -140.81 177.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.381 0.61 . . . . 64.43 111.862 -176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 66' ' ' ARG . 34.9 m -132.43 146.87 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.971 -0.559 . . . . 74.54 111.219 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.941 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 56.7 ttt-85 . . . . . 0 C--O 1.245 0.851 0 CA-C-O 121.256 0.551 . . . . 74.21 110.892 174.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.941 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.7 mp0 . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.238 0.542 . . . . 61.54 110.633 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.404 ' HA ' HG12 ' A' ' 36' ' ' VAL . 60.6 mtp180 -87.57 131.76 34.29 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.741 -0.663 . . . . 73.2 111.528 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.32 -150.42 22.02 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.67 -0.776 . . . . 63.53 113.117 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.4 pt -110.45 146.15 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 122.349 -0.501 . . . . 65.21 111.397 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -40.36 -47.38 2.53 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.211 0.604 . . . . 71.13 112.18 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.441 HG13 ' HA3' ' A' ' 32' ' ' GLY . 61.9 mt -48.9 -53.84 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.757 -0.656 . . . . 70.13 112.333 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 m -83.22 -32.0 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 112.087 0.403 . . . . 74.14 112.087 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.75 -36.03 82.42 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.727 0.298 . . . . 73.12 111.367 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -81.42 -6.41 58.91 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.925 0.393 . . . . 75.04 111.324 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -124.48 8.21 8.35 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.952 0.352 . . . . 63.44 111.952 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.1 pttm 39.47 59.31 1.81 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.791 0.805 . . . . 60.02 112.699 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 84.9 mt -93.97 141.9 28.0 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.769 -0.65 . . . . 73.41 111.516 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 p -96.06 140.19 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 120.684 0.278 . . . . 75.04 111.267 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -89.57 148.25 23.48 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.533 0.682 . . . . 74.41 112.744 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.51 ' HG3' ' HB2' ' A' ' 138' ' ' PHE . 15.2 ptp -147.65 165.27 30.93 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.214 -0.903 . . . . 75.22 109.75 174.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.435 ' HA ' ' HD2' ' A' ' 138' ' ' PHE . 3.4 p30 -163.01 157.86 21.43 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.454 0.645 . . . . 73.01 112.259 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.402 ' HA ' ' HE2' ' A' ' 88' ' ' PHE . 64.3 m -37.53 -34.02 0.09 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 116.495 2.035 . . . . 72.5 116.495 -162.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -67.92 -31.98 72.12 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.433 -0.792 . . . . 71.13 112.348 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.87 -46.97 5.74 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.236 0.541 . . . . 73.55 111.913 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' A' ' 79' ' ' MET . 0.4 OUTLIER -95.2 12.89 27.25 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.494 0.924 . . . . 72.13 113.494 -173.001 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -41.06 -61.39 1.0 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.645 0.609 . . . . 64.13 112.645 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.5 m -65.45 -32.8 74.61 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.334 -0.394 . . . . 72.31 111.772 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 67.5 mtm -71.7 -52.62 16.91 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.06 0.392 . . . . 73.31 112.06 -175.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.503 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 16.5 p90 -71.96 -19.39 61.9 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.69 -0.631 . . . . 65.1 111.224 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -64.01 -44.21 93.29 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.08 0.467 . . . . 74.04 110.534 171.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.16 99.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.195 0.521 . . . . 73.05 110.455 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.468 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 44.0 t80 -54.6 -53.1 59.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.588 -0.733 . . . . 62.14 111.972 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.9 tp -67.66 -32.27 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 111.83 0.307 . . . . 72.15 111.83 -177.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' C ' ' HD3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -63.35 -53.25 55.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.665 0.269 . . . . 70.2 110.656 176.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -60.2 -49.48 77.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.934 0.397 . . . . 71.45 110.745 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.492 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 85.1 t80 -51.25 -58.09 7.09 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.082 -0.508 . . . . 61.31 111.916 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -54.57 -49.52 70.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.428 -0.351 . . . . 61.45 111.465 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -65.83 -48.51 71.42 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.605 -0.27 . . . . 73.42 111.7 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.49 -40.3 96.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.715 0.635 . . . . 62.23 112.715 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.7 m -67.95 -45.84 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 122.21 -0.306 . . . . 42.05 111.611 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.4 mm -67.55 -45.42 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.889 0.376 . . . . 73.31 111.131 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.51 -40.98 96.57 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.236 -0.438 . . . . 74.05 111.546 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -58.71 -47.02 86.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.942 0.401 . . . . 63.34 110.885 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.9 ttt -68.67 -45.68 71.08 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.164 0.507 . . . . 52.34 110.737 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -58.93 -37.38 76.55 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.281 -0.418 . . . . 74.43 111.729 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -54.37 -50.91 66.39 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.12 -0.491 . . . . 72.43 112.296 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -102.31 -36.92 8.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.791 0.663 . . . . 64.02 112.791 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -74.89 -56.02 5.19 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.965 -0.46 . . . . 45.44 111.659 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 66.65 -0.47 1.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.876 0.47 . . . . 63.42 112.19 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.547 ' O ' HG22 ' A' ' 113' ' ' VAL . 13.6 t70 -86.24 119.85 26.97 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.132 -0.355 . . . . 73.2 110.717 -177.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -65.64 -35.01 79.56 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.522 0.564 . . . . 74.04 112.522 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.93 -38.64 89.19 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.796 0.331 . . . . 71.14 111.435 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -72.73 -53.17 12.36 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.729 0.27 . . . . 74.34 111.729 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 109' ' ' ASP . 30.0 m -65.55 -21.73 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 112.098 0.407 . . . . 75.14 112.098 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -74.96 -42.35 57.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.965 0.412 . . . . 74.11 110.683 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.12 73.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.98 0.419 . . . . 41.22 110.986 176.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.18 -47.52 85.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.169 -0.468 . . . . 72.44 111.093 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -56.63 -40.87 76.16 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.53 -0.304 . . . . 75.42 110.915 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.5 tppt? -59.26 -40.33 85.67 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.604 0.24 . . . . 62.33 111.171 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.466 ' HB3' HD22 ' A' ' 26' ' ' LEU . 29.3 mmtp -61.73 -57.8 10.52 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.683 -0.235 . . . . 74.4 111.584 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.8 mm -59.95 -45.58 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.021 0.378 . . . . 73.24 112.021 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.447 ' O ' HG23 ' A' ' 125' ' ' VAL . 24.7 tm0? -61.62 -51.61 67.8 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.707 0.289 . . . . 60.42 110.942 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.79 -36.98 93.55 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.724 -0.751 . . . . 65.02 112.378 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -57.16 -53.75 54.58 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.862 0.465 . . . . 72.25 111.596 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.17 -42.44 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 112.189 0.44 . . . . 63.21 112.189 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 121' ' ' GLN . 69.9 t -55.92 -43.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.881 0.372 . . . . 74.31 111.396 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.5 t -72.03 -47.22 53.39 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.195 0.521 . . . . 73.43 111.569 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.497 HD21 HD13 ' A' ' 155' ' ' ILE . 31.5 tp -65.3 -28.06 69.05 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.126 -0.488 . . . . 70.41 111.914 -176.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.9 mt -84.54 2.56 40.63 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.133 0.419 . . . . 75.11 112.133 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.466 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -62.03 78.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.652 0.739 . . . . 53.12 110.977 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -60.08 -15.26 21.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.546 0.943 . . . . 61.31 113.546 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.19 -46.79 87.49 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 122.274 -0.266 . . . . 73.35 111.493 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -109.15 -39.24 5.32 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.836 0.351 . . . . 64.2 111.789 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.492 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 69.5 m-85 -63.62 -4.5 3.0 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.526 0.565 . . . . 65.05 112.526 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -44.35 -26.76 0.36 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 120.952 0.406 . . . . 73.15 111.841 168.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -83.54 20.34 1.4 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 112.79 0.663 . . . . 54.34 112.79 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 71.2 mt -88.51 132.06 34.66 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.925 -0.484 . . . . 75.32 111.318 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.28 123.21 48.44 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.134 -0.485 . . . . 73.3 110.734 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.653 ' HB3' HG13 ' A' ' 153' ' ' VAL . 53.6 m-85 -102.61 125.92 49.51 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.257 -0.277 . . . . 72.12 110.839 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.568 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 75.6 m-85 -121.61 142.14 50.41 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.05 0.389 . . . . 73.31 112.05 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 152' ' ' GLN . 34.4 pt -129.62 173.07 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.89 0.376 . . . . 75.14 111.09 174.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.48 153.88 50.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.274 -0.489 . . . . 72.31 114.01 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.52 -58.42 7.23 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.062 0.458 . . . . 75.44 112.045 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.609 ' HA ' ' HB3' ' A' ' 146' ' ' GLU . 30.3 mtm180 -73.09 -19.37 61.17 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.857 0.36 . . . . 64.33 111.284 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.67 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -61.03 -40.77 94.87 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.271 0.558 . . . . 71.33 110.467 170.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.1 -19.14 40.73 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.083 0.468 . . . . 60.32 111.374 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.609 ' HB3' ' HA ' ' A' ' 143' ' ' ARG . 42.6 tt0 -87.27 -24.26 24.41 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.252 0.464 . . . . 72.41 112.252 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.33 -46.52 0.02 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 120.472 -0.871 . . . . 72.2 114.336 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.67 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -71.0 86.58 0.72 Allowed 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.307 -0.526 . . . . 74.44 111.827 -177.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -61.34 -9.8 5.97 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.247 0.832 . . . . 73.23 113.247 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -93.38 27.21 2.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.809 0.338 . . . . 54.21 111.421 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.466 ' HA2' HG23 ' A' ' 9' ' ' THR . . . -60.44 115.83 8.29 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.469 -0.396 . . . . 62.42 113.698 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.414 ' O ' HG22 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -60.25 134.55 57.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.244 0.545 . . . . 74.01 111.272 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.653 HG13 ' HB3' ' A' ' 138' ' ' PHE . 63.0 t -83.0 109.92 17.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.154 -0.476 . . . . 75.53 111.707 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.719 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -81.06 119.03 23.02 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.04 -0.527 . . . . 53.05 110.197 171.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.497 HD13 HD21 ' A' ' 127' ' ' LEU . 61.5 mt -96.12 117.1 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 112.468 0.544 . . . . 62.31 112.468 -170.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 169' ' ' LEU . 48.2 mm -94.5 113.14 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.723 0.297 . . . . 60.21 111.219 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 158' ' ' TYR . 42.7 tt0 -105.75 157.33 17.51 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.973 0.416 . . . . 63.32 111.305 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.445 ' N ' ' HG2' ' A' ' 157' ' ' GLU . 23.1 p90 -92.51 105.24 17.45 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.967 0.413 . . . . 74.24 111.191 176.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.454 ' HD3' ' OG1' ' A' ' 168' ' ' THR . 54.9 mtp85 -127.44 132.33 50.07 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.966 0.412 . . . . 62.41 111.114 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.83 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 6.4 p-10 -88.25 143.08 27.24 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.768 0.655 . . . . 51.23 112.768 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.0 t -109.29 98.2 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.641 -0.708 . . . . 75.31 110.585 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.1 t70 61.59 7.08 1.72 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.543 0.737 . . . . 62.12 112.918 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.26 -27.72 1.54 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.533 -0.842 . . . . 55.11 114.065 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 84.3 m -104.27 114.49 28.76 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 117.252 0.526 . . . . 70.33 111.125 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.83 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 9.3 pt-20 -76.37 122.54 24.62 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.611 0.72 . . . . 51.54 112.098 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -127.14 149.85 70.63 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.471 -0.786 . . . . 53.34 111.639 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.95 120.72 7.92 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.785 2.323 . . . . 74.1 112.766 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.454 ' OG1' ' HD3' ' A' ' 159' ' ' ARG . 69.6 p -111.22 133.37 53.61 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.79 0.328 . . . . 65.21 111.756 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.719 HD11 ' HB1' ' A' ' 154' ' ' ALA . 68.9 tp -77.36 130.99 37.84 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.179 -0.464 . . . . 63.13 111.258 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.403 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 24.3 mmt -113.27 124.46 52.55 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.594 0.358 . . . . 71.24 111.445 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.99 134.82 38.97 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.076 -0.511 . . . . 73.33 110.864 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.506 HG22 HG12 ' A' ' 27' ' ' VAL . 25.7 t -93.13 126.35 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 122.099 -0.375 . . . . 75.31 111.425 -178.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -72.42 -14.88 61.8 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.831 0.678 . . . . 75.33 112.831 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.468 ' H ' HG12 ' A' ' 172' ' ' VAL . 1.3 mp0 -88.31 -2.4 58.58 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.137 -0.352 . . . . 74.42 111.716 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.5 -46.39 6.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.309 0.576 . . . . 73.43 110.428 174.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.7 pt -105.4 132.18 52.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.498 -0.774 . . . . 65.14 110.504 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.415 ' CG1' ' HB2' ' A' ' 5' ' ' LYS . 46.8 pt -94.85 143.47 11.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.2 0.524 . . . . 61.34 111.314 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -94.25 118.24 31.3 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.612 -0.722 . . . . 71.21 111.331 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -122.97 113.99 19.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.359 0.6 . . . . 73.32 110.897 172.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt . . . . . 0 CA--C 1.536 0.435 0 CA-C-N 115.734 -0.666 . . . . 54.41 112.106 -175.113 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 120.935 0.398 . . . . 73.25 111.643 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 178' ' ' GLU . 42.2 tp -92.34 139.0 31.05 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.521 -0.309 . . . . 75.3 110.943 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.0 mt -125.91 119.21 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 122.384 -0.197 . . . . 74.34 110.473 175.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.716 ' HE1' ' HB2' ' A' ' 16' ' ' ASP . 39.6 p90 -121.81 149.8 42.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.47 0.545 . . . . 72.33 112.47 -173.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.567 ' HB3' HD13 ' A' ' 13' ' ' LEU . 12.4 ptmm? -142.92 127.22 17.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.939 -0.573 . . . . 72.23 111.303 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.85 ' HB3' HG22 ' A' ' 176' ' ' ILE . 2.7 p30 -97.29 179.29 4.94 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.206 0.527 . . . . 74.41 111.63 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -47.12 -34.8 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 115.51 -0.768 . . . . 52.04 112.716 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.582 ' HB2' ' HA2' ' A' ' 151' ' ' GLY . 83.2 m-85 -100.27 -49.61 4.21 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.603 0.594 . . . . 71.21 112.603 -175.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 p -70.33 14.97 0.1 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.028 0.751 . . . . 52.51 113.028 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -47.89 -32.24 6.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.207 0.603 . . . . 53.24 111.933 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.67 -61.96 1.57 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.641 0.608 . . . . 73.51 112.641 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.417 ' C ' HD23 ' A' ' 13' ' ' LEU . 43.1 mt-10 -102.43 -33.16 9.64 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.801 0.667 . . . . 65.21 112.801 -174.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.567 HD13 ' HB3' ' A' ' 5' ' ' LYS . 0.8 OUTLIER 40.42 -170.75 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.21 1.189 . . . . 75.25 114.21 -176.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -149.44 165.65 31.46 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.474 0.654 . . . . 62.5 112.655 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -114.2 170.16 8.49 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.699 -0.682 . . . . 74.42 111.082 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.716 ' HB2' ' HE1' ' A' ' 4' ' ' TYR . 6.5 t70 -154.28 169.15 24.35 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 120.878 0.371 . . . . 71.31 111.486 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.2 p -151.7 19.44 0.71 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.027 0.38 . . . . 54.33 112.027 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -108.65 151.07 41.51 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 121.037 0.446 . . . . 52.21 112.194 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.4 111.99 3.27 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.601 2.2 . . . . 62.42 113.595 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.648 ' SD ' ' HB2' ' A' ' 30' ' ' PHE . 18.5 mmt -106.31 166.27 10.65 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.009 -0.541 . . . . 53.34 110.876 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.523 ' NZ ' ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -134.22 129.05 35.14 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.187 -0.321 . . . . 74.5 111.221 172.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 61.4 tp -87.87 101.96 14.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.766 0.317 . . . . 74.11 111.284 -177.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 p -89.19 139.06 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-O 120.909 0.385 . . . . 73.32 111.58 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.2 15.99 2.11 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.139 -0.482 . . . . 72.22 112.264 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.462 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 52.8 m-20 52.77 26.75 4.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.847 0.459 . . . . 45.13 111.646 -177.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.17 -45.68 2.34 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.103 0.478 . . . . 75.41 111.156 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.404 HG12 HG22 ' A' ' 172' ' ' VAL . 30.3 m -133.68 146.06 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.295 0.569 . . . . 75.13 112.51 -177.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 170' ' ' MET . 96.9 m-85 -87.34 144.91 26.55 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.937 -0.574 . . . . 73.33 110.368 172.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 40.7 mt-10 -118.28 143.57 46.48 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.748 0.308 . . . . 73.33 110.85 170.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.705 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 85.6 t80 -133.03 118.44 18.81 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.806 0.336 . . . . 75.22 111.175 175.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.416 ' NZ ' ' HB2' ' A' ' 31' ' ' LYS . 9.8 mtmp? -84.02 109.33 17.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.793 0.33 . . . . 75.54 111.715 -177.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.531 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -90.76 176.6 41.28 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.14 -0.553 . . . . 72.31 113.851 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.514 ' HG3' HG13 ' A' ' 35' ' ' VAL . 10.8 ptpp? -118.46 163.2 17.11 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.725 -0.279 . . . . 63.4 111.123 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -86.53 111.93 21.06 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.522 0.201 . . . . 53.35 110.904 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.514 HG13 ' HG3' ' A' ' 33' ' ' LYS . 17.3 m -139.65 159.31 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.142 0.496 . . . . 54.15 111.728 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 33.2 m -138.04 122.11 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.354 -0.385 . . . . 70.32 111.407 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.838 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 78.8 mtt180 . . . . . 0 C--O 1.24 0.588 0 CA-C-O 121.49 0.662 . . . . 65.23 111.259 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.838 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 7.1 mp0 . . . . . 0 CA--C 1.535 0.381 0 CA-C-O 121.52 0.676 . . . . 72.13 110.743 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.505 ' O ' ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -96.62 135.27 38.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.552 -0.749 . . . . 73.5 111.631 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.58 -125.68 1.5 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.536 -0.84 . . . . 54.44 113.866 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.7 pt -110.61 131.33 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.404 0.621 . . . . 64.14 112.487 -174.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -50.11 -35.22 24.74 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.413 -0.812 . . . . 52.34 112.598 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.531 HG13 ' HA3' ' A' ' 32' ' ' GLY . 66.3 mt -47.28 -50.2 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.18 0.437 . . . . 74.01 112.18 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 17.3 m -90.61 -32.63 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.11 0.411 . . . . 74.42 112.11 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.47 HD12 HG23 ' A' ' 35' ' ' VAL . 80.3 mt -65.76 -37.44 86.35 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.031 0.443 . . . . 73.01 111.415 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -87.49 -1.73 58.13 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 120.715 0.293 . . . . 74.22 111.611 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -123.65 4.1 8.91 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.838 -0.539 . . . . 73.33 112.158 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp 56.06 67.32 1.02 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.41 0.624 . . . . 65.4 112.335 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 68.1 mt -116.79 136.5 52.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.124 -0.489 . . . . 62.23 111.071 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.28 145.05 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.932 0.396 . . . . 55.45 111.372 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -80.37 122.19 26.63 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.977 0.732 . . . . 64.52 112.977 -173.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 94.4 mmm -125.62 155.69 40.36 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.961 -0.563 . . . . 60.44 109.95 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.414 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 47.6 t-20 -139.41 145.75 39.29 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.841 -0.537 . . . . 74.13 111.4 -176.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.6 p -46.83 -43.13 18.26 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.95 1.093 . . . . 71.31 113.95 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.414 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 38.7 p90 -56.3 -31.44 63.67 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.354 0.502 . . . . 53.42 112.354 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -104.83 -47.25 4.09 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.043 0.449 . . . . 74.11 110.927 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.36 3.26 16.11 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.453 0.538 . . . . 64.54 112.453 -172.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.521 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -40.66 -57.68 1.82 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.297 0.851 . . . . 54.02 113.297 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.5 t -65.01 -33.1 75.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.178 0.436 . . . . 44.42 112.178 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.66 -61.79 1.79 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.416 -0.356 . . . . 75.32 111.791 -174.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.694 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 29.7 p90 -65.48 -30.06 70.8 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.08 -0.387 . . . . 75.02 111.308 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -58.48 -43.34 88.92 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.289 0.566 . . . . 75.21 110.719 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.23 -34.15 77.37 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.987 -0.551 . . . . 73.21 111.274 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.694 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 25.4 m-85 -60.92 -44.07 97.7 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.598 0.237 . . . . 71.2 110.745 173.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.3 mm -55.44 -40.2 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.569 -0.287 . . . . 75.12 111.133 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -55.6 -63.97 1.0 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.774 0.321 . . . . 72.43 111.509 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.91 -31.06 72.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.479 -0.328 . . . . 63.41 111.875 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.508 ' CE1' ' HB2' ' A' ' 175' ' ' ALA . 36.9 t80 -62.53 -58.8 6.27 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.664 0.268 . . . . 72.03 111.322 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 56.5 ttp -59.47 -41.91 90.82 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.95 0.405 . . . . 62.11 110.836 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -55.58 -48.12 75.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.059 -0.519 . . . . 74.4 111.262 177.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -66.61 -54.6 21.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.088 -0.505 . . . . 70.31 112.003 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.4 m -59.8 -38.39 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.162 0.43 . . . . 61.34 112.162 -176.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.53 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 46.4 mm -70.51 -46.77 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 122.207 -0.308 . . . . 72.41 110.971 176.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.8 -24.27 61.63 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.976 0.417 . . . . 63.11 111.859 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -89.34 -29.82 18.86 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.455 -0.339 . . . . 72.1 111.763 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 11.9 tpt -81.11 -53.98 5.93 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.732 0.642 . . . . 71.23 112.732 -172.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -71.05 -10.59 60.02 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.05 0.759 . . . . 71.13 113.05 -174.24 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.66 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -60.72 -48.14 83.13 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.152 0.501 . . . . 64.43 111.042 172.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -107.55 -36.72 6.38 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.841 0.682 . . . . 73.21 112.841 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.524 ' O ' HG13 ' A' ' 113' ' ' VAL . 3.0 m-20 -112.24 41.15 2.04 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.966 0.412 . . . . 55.12 111.893 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -45.05 -30.46 1.07 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.813 0.845 . . . . 64.03 112.966 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -51.76 140.45 19.16 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.618 0.723 . . . . 73.23 112.66 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 54.2 mttp -65.87 -19.92 66.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.742 1.016 . . . . 64.34 113.742 -169.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.04 -20.96 47.63 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.689 -0.632 . . . . 74.11 111.465 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -94.37 -65.43 0.99 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.884 0.328 . . . . 73.51 111.884 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 107' ' ' ASN . 5.1 m -59.55 -45.6 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 112.921 0.712 . . . . 52.14 112.921 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.516 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 26.2 t70 -60.81 -43.81 97.71 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.634 0.255 . . . . 74.55 111.248 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.41 -49.35 74.1 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.858 0.361 . . . . 74.31 111.277 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -56.43 -54.33 46.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.978 0.418 . . . . 71.1 111.332 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.407 ' HA ' HG22 ' A' ' 120' ' ' ILE . 62.2 tttm -61.73 -31.13 71.28 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.435 -0.348 . . . . 42.52 111.237 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -65.76 -43.34 89.2 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.782 0.325 . . . . 54.42 111.237 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -57.5 -58.13 9.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.048 0.452 . . . . 74.05 111.166 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.407 HG22 ' HA ' ' A' ' 117' ' ' LYS . 11.1 tp -64.37 -40.42 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.018 -0.537 . . . . 75.13 112.066 -175.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.62 ' HA ' HE21 ' A' ' 121' ' ' GLN . 0.0 OUTLIER -66.25 -50.73 62.75 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.315 -0.241 . . . . 65.43 111.412 178.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.1 -42.26 61.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.586 -0.816 . . . . 64.23 112.199 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -62.81 -61.9 2.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.332 0.253 . . . . 75.13 111.253 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.5 m -61.26 -44.93 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 112.604 0.594 . . . . 61.14 112.604 -176.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.74 -34.58 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.972 0.415 . . . . 74.1 111.525 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.1 m -80.02 -29.11 39.32 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.031 0.443 . . . . 65.14 111.273 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.9 tp -80.03 -28.82 39.27 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.148 -0.478 . . . . 72.34 111.684 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 93.6 mt -85.14 2.27 44.3 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.598 0.592 . . . . 74.14 112.598 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.21 82.06 0.08 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.231 0.539 . . . . 55.0 110.917 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 65.5 pttt -64.08 -14.99 58.53 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.568 0.951 . . . . 73.4 113.568 -169.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.33 -42.38 98.58 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.138 0.494 . . . . 73.14 110.887 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -108.57 -50.78 2.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.992 -0.549 . . . . 72.33 111.393 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.531 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 55.3 m-85 -66.74 -4.5 9.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.592 0.96 . . . . 72.43 113.592 -173.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 14.1 ptmm? -50.99 -6.6 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.242 0.83 . . . . 72.21 113.242 175.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -77.46 13.28 1.27 Allowed 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.759 -0.588 . . . . 65.21 112.024 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 95.6 mt -89.54 127.92 35.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.014 0.435 . . . . 64.54 111.607 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -100.52 127.59 46.84 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.401 -0.363 . . . . 55.15 110.934 177.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -98.99 110.62 23.2 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.838 0.352 . . . . 73.24 110.976 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.429 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 65.4 m-85 -112.75 139.98 47.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.205 0.526 . . . . 71.11 111.797 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.42 HD11 ' O ' ' A' ' 150' ' ' ASN . 11.2 tt -133.26 155.16 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.821 -0.627 . . . . 74.4 110.96 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.34 125.35 13.03 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.567 -0.349 . . . . 62.02 113.553 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -49.91 -48.8 51.43 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.201 0.445 . . . . 64.44 112.201 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -79.7 -22.11 43.81 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.97 0.414 . . . . 71.14 111.865 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.32 93.36 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.957 0.408 . . . . 73.15 111.296 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.7 -30.93 65.9 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.992 -0.549 . . . . 64.22 111.919 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.81 -28.49 65.76 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.633 0.254 . . . . 74.01 111.668 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.83 -20.53 1.62 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.976 -0.631 . . . . 33.33 113.702 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.84 76.85 0.46 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 117.132 0.466 . . . . 62.05 111.951 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 54.38 103.68 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.72 0.772 . . . . 74.03 112.229 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.577 ' HB3' ' OH ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -54.48 -27.56 38.62 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.282 -0.872 . . . . 74.43 112.604 -173.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 8' ' ' PHE . . . 59.5 -166.21 9.39 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 114.821 0.689 . . . . 55.24 114.821 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -96.44 144.01 26.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.786 0.327 . . . . 60.13 111.387 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 44.8 t -77.99 138.01 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.912 0.387 . . . . 70.13 110.748 171.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.611 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -94.54 133.62 37.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.424 -0.353 . . . . 63.34 111.505 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.761 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 35.4 mm -91.98 113.54 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.751 0.31 . . . . 73.1 111.653 -178.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 49.8 mm -96.45 110.04 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.682 0.277 . . . . 63.43 111.084 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.61 132.93 50.28 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.402 -0.363 . . . . 73.2 110.271 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -90.09 89.13 7.55 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.459 0.647 . . . . 74.34 110.624 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -93.53 111.82 23.57 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.612 -0.722 . . . . 75.24 111.816 -172.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.621 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 32.4 t70 -69.91 118.76 13.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.041 0.448 . . . . 54.24 112.048 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 51.9 t -104.37 93.25 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.092 -0.503 . . . . 75.41 110.681 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 60.13 13.78 4.06 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.015 0.746 . . . . 74.41 113.015 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 133.42 -17.94 4.45 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.824 -0.703 . . . . 72.44 113.351 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.3 m -110.12 106.1 15.44 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.548 -0.384 . . . . 62.11 111.453 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 42.7 mt-10 -73.38 106.32 5.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.75 0.31 . . . . 74.41 111.181 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.7 m -105.18 143.23 26.33 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 120.888 0.375 . . . . 71.04 111.356 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.66 123.58 5.39 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.339 2.026 . . . . 72.54 112.682 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 60.0 p -108.29 125.67 51.95 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.174 0.511 . . . . 74.25 111.129 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.705 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 61.5 tp -78.26 114.69 17.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.023 -0.535 . . . . 72.54 111.121 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.761 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 42.5 ttm -101.82 124.25 47.14 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.464 0.306 . . . . 63.31 111.584 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 81.0 mt -138.33 130.71 28.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.794 0.438 . . . . 62.22 111.353 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.441 ' O ' HG12 ' A' ' 176' ' ' ILE . 39.3 t -82.41 126.83 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 122.012 -0.43 . . . . 72.12 111.853 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -71.21 -33.95 70.38 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.985 0.421 . . . . 72.2 111.845 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.438 ' HG2' HG12 ' A' ' 172' ' ' VAL . 0.8 OUTLIER -72.81 -4.46 31.78 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.896 0.379 . . . . 72.32 111.343 177.254 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.508 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . . . -101.17 -49.5 4.07 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.15 0.5 . . . . 51.01 110.609 173.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.85 HG22 ' HB3' ' A' ' 6' ' ' ASP . 36.0 pt -101.21 117.45 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.022 -0.536 . . . . 75.13 111.049 176.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 tp -93.57 128.08 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 121.903 -0.498 . . . . 64.11 109.916 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.666 ' HB2' HD11 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -110.43 131.8 54.74 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.863 0.84 . . . . 74.13 113.115 -171.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -94.68 103.48 15.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.819 -1.082 . . . . 63.32 109.309 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 41.9 pttt . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 113.368 0.877 . . . . 71.1 113.368 -169.58 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 120.623 0.249 . . . . 73.4 111.129 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 15' ' ' SER . 29.1 tp -107.14 129.05 54.89 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.903 -0.498 . . . . 64.31 110.721 177.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.512 HG12 ' HB3' ' A' ' 15' ' ' SER . 60.0 mt -110.38 126.26 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.77 0.319 . . . . 71.4 111.124 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -123.38 145.74 48.52 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.933 0.397 . . . . 75.1 111.557 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 3.9 ptpp? -129.36 130.38 45.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.088 0.47 . . . . 71.31 111.652 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 4.0 m-20 -73.02 178.09 4.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.905 -0.588 . . . . 75.22 112.258 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.8 mt -66.56 -41.72 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.122 0.487 . . . . 45.05 111.24 173.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 150' ' ' ASN . 37.9 m-85 -106.28 -32.64 8.09 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.153 -0.476 . . . . 74.4 112.001 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.419 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 2.9 m -93.48 15.0 16.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.278 0.561 . . . . 75.5 111.566 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 13.4 p-10 -60.26 -26.03 66.15 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.08 0.77 . . . . 72.34 113.08 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -68.3 -18.59 64.56 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.858 0.688 . . . . 52.13 112.858 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -85.66 -33.08 21.66 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.646 0.609 . . . . 75.42 112.646 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 56.29 98.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.218 0.532 . . . . 73.21 112.398 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.4 m -95.66 124.63 39.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.157 -0.339 . . . . 55.13 110.73 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.512 ' HB3' HG12 ' A' ' 3' ' ' ILE . 15.3 p -118.69 103.86 10.07 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.074 0.464 . . . . 53.45 112.1 -174.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -132.41 -172.57 2.93 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.035 0.445 . . . . 51.51 111.909 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.1 p -138.42 18.07 2.74 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.413 -0.358 . . . . 71.5 111.809 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -69.11 140.29 90.77 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 111.748 0.277 . . . . 74.42 111.748 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.12 143.25 35.58 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.841 2.361 . . . . 53.4 113.43 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptp -147.35 137.73 23.3 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.992 0.425 . . . . 64.14 111.996 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 67.1 mttm -112.28 156.38 22.49 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.553 -0.294 . . . . 72.0 110.564 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 55.4 tp -121.25 104.5 9.78 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.219 0.451 . . . . 73.54 112.219 -171.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.69 144.92 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-O 121.038 0.447 . . . . 72.41 111.737 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 56.67 12.67 1.17 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.168 -0.469 . . . . 64.23 111.888 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.488 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 62.8 m-20 50.7 29.7 4.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.365 0.602 . . . . 72.14 111.307 -174.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.577 HD22 ' HB3' ' A' ' 119' ' ' LYS . 53.9 tp -126.27 -48.68 1.57 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.899 -0.591 . . . . 75.22 111.41 -177.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 172' ' ' VAL . 10.1 m -128.56 144.86 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.232 -0.44 . . . . 73.13 111.735 -177.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 170' ' ' MET . 98.3 m-85 -85.55 141.09 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 65.42 110.375 176.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 2.8 pm0 -130.97 111.54 12.14 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.389 0.614 . . . . 73.13 111.058 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CZ ' HD23 ' A' ' 169' ' ' LEU . 32.4 p90 -150.46 141.19 22.7 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.977 1.103 . . . . 75.11 113.977 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -94.5 133.64 37.9 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.341 -0.845 . . . . 73.12 111.547 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.63 -167.77 42.44 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.852 -0.69 . . . . 72.21 113.25 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.504 ' HG3' HG13 ' A' ' 35' ' ' VAL . 57.3 tptt -91.74 128.13 37.45 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 122.478 -0.425 . . . . 74.11 110.424 177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -73.62 106.22 5.29 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.06 0.457 . . . . 73.1 110.996 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.504 HG13 ' HG3' ' A' ' 33' ' ' LYS . 27.2 m -137.28 155.22 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.116 -0.493 . . . . 73.43 111.007 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 m -122.54 119.15 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.43 0.633 . . . . 72.13 111.392 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.492 ' HD3' ' OE2' ' A' ' 65' ' ' GLU . 43.0 ttt180 . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 121.059 0.457 . . . . 73.04 111.785 -173.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.633 ' HG2' HD22 ' A' ' 72' ' ' LEU . 28.5 tt0 . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 121.801 0.81 . . . . 72.15 110.16 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -87.44 138.3 31.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.225 -0.898 . . . . 74.23 111.38 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.84 -146.24 9.25 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.447 -0.882 . . . . 62.21 113.612 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.6 pt -110.61 145.04 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.795 0.331 . . . . 72.32 111.763 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 14.9 t70 -41.03 -43.88 2.27 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.625 0.77 . . . . 72.15 112.308 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.9 mt -49.94 -56.29 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.724 0.639 . . . . 73.44 112.724 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.487 ' HA ' HD12 ' A' ' 76' ' ' LEU . 30.1 m -80.23 -35.05 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.394 0.516 . . . . 74.33 112.394 -172.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.633 HD22 ' HG2' ' A' ' 65' ' ' GLU . 85.5 mt -67.53 -46.39 72.96 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.715 0.293 . . . . 72.03 111.657 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -69.25 -21.75 63.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.412 0.523 . . . . 64.53 112.412 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -103.77 8.28 37.2 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 122.129 -0.357 . . . . 74.15 111.243 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.9 tptm 46.49 69.74 0.45 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.698 0.761 . . . . 64.24 112.501 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 71' ' ' VAL . 82.0 mt -106.38 122.03 45.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.644 -0.707 . . . . 64.14 110.343 177.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 p -82.65 141.41 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.09 0.472 . . . . 74.32 111.419 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -79.54 141.41 36.67 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.762 -0.654 . . . . 62.21 112.41 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.424 ' HG3' ' HB2' ' A' ' 84' ' ' ASP . 41.8 tpp -143.55 149.29 37.21 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.923 -0.58 . . . . 63.24 109.903 174.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -130.9 163.69 26.92 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.77 0.655 . . . . 71.21 112.77 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 67.9 m -38.07 -56.46 1.16 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.581 1.326 . . . . 71.14 114.581 -171.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -60.3 -29.76 69.04 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.424 0.898 . . . . 73.34 113.424 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -103.59 -21.34 13.76 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.949 -0.469 . . . . 73.23 111.655 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.424 ' HB2' ' HG3' ' A' ' 79' ' ' MET . 12.5 t70 -77.64 1.15 20.64 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.148 0.425 . . . . 71.23 112.148 -175.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.472 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . . . -39.8 -59.21 1.21 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.444 0.535 . . . . 42.25 112.444 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.7 t -53.23 -39.45 63.78 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.098 -0.501 . . . . 62.14 111.986 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.435 ' O ' ' HD1' ' A' ' 91' ' ' TYR . 25.9 mmt -73.22 -73.88 0.19 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.297 0.48 . . . . 71.41 112.297 -174.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 85' ' ' ALA . 33.4 p90 -55.72 -29.6 59.75 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.406 0.521 . . . . 75.12 112.406 -173.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.427 ' O ' HG22 ' A' ' 92' ' ' ILE . 32.8 mmtp -68.64 -60.49 2.37 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.928 0.394 . . . . 74.22 111.795 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.54 -43.21 99.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.159 0.504 . . . . 54.02 111.972 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.435 ' HD1' ' O ' ' A' ' 87' ' ' MET . 49.5 m-85 -69.74 -37.61 76.52 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.935 0.717 . . . . 73.42 112.935 -176.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 89' ' ' LYS . 11.0 tp -67.03 -33.37 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.304 0.573 . . . . 74.52 110.506 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -66.8 -45.81 77.2 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.914 -0.585 . . . . 71.23 110.975 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -61.7 -39.74 92.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.202 0.525 . . . . 65.54 110.684 172.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.469 ' HE1' ' HB2' ' A' ' 175' ' ' ALA . 89.2 t80 -60.26 -57.89 10.84 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.651 -0.704 . . . . 75.24 111.866 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.1 ptm -54.09 -39.43 66.32 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.842 0.354 . . . . 63.52 111.195 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -64.32 -49.98 69.61 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.66 -0.245 . . . . 71.34 111.574 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -61.43 -46.25 90.92 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.172 0.434 . . . . 64.21 112.172 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.3 m -66.81 -43.06 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.221 0.452 . . . . 75.44 112.221 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.9 mm -69.38 -38.17 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.735 0.302 . . . . 74.1 110.727 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.24 -54.17 40.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.019 0.437 . . . . 65.23 110.915 175.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -68.88 -53.04 23.43 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.22 0.452 . . . . 70.45 112.22 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.7 tpt -65.14 -56.89 10.3 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.254 0.465 . . . . 72.11 112.254 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.8 -43.03 99.88 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.057 0.392 . . . . 72.13 112.057 -174.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -48.97 -45.17 41.65 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.209 0.818 . . . . 74.12 113.209 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.56 18.05 20.12 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.061 0.458 . . . . 72.3 112.095 -176.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.465 ' OD1' HG13 ' A' ' 113' ' ' VAL . 3.1 t-20 -127.61 -65.51 0.92 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.372 -0.377 . . . . 64.2 110.774 176.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 70.01 -25.4 0.15 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.694 0.998 . . . . 74.13 113.694 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' HG22 ' A' ' 113' ' ' VAL . 42.0 m-20 -66.14 112.99 4.19 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.932 0.396 . . . . 75.12 111.584 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -56.05 -32.18 63.82 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.178 0.436 . . . . 71.23 112.178 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.01 -33.96 65.38 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.072 0.397 . . . . 63.24 112.072 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.445 ' HB2' ' OD1' ' A' ' 107' ' ' ASN . 3.3 m-20 -94.05 -55.15 3.31 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.129 0.418 . . . . 75.31 112.129 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.465 HG13 ' OD1' ' A' ' 107' ' ' ASN . 17.0 m -62.79 -35.26 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.999 0.74 . . . . 72.22 112.999 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -75.39 -25.7 57.86 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.283 0.563 . . . . 74.04 110.452 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.05 -44.81 52.93 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.143 -0.48 . . . . 53.04 110.673 173.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.42 -46.28 90.59 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.21 0.529 . . . . 74.24 110.164 173.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -50.3 -42.1 51.99 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.667 -0.697 . . . . 73.22 111.065 171.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -64.33 -42.24 96.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.178 -0.464 . . . . 64.05 111.691 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.577 ' HB3' HD22 ' A' ' 26' ' ' LEU . 14.6 mptt -58.1 -55.18 38.31 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.8 0.333 . . . . 75.45 110.985 174.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.524 HD13 HD21 ' A' ' 26' ' ' LEU . 41.8 mm -59.51 -41.86 86.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.447 -0.342 . . . . 71.25 111.391 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -57.08 -57.08 14.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.512 -0.313 . . . . 74.14 111.13 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.12 -40.11 82.44 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.077 -0.582 . . . . 60.33 112.579 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -61.55 -51.6 67.92 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 111.631 0.234 . . . . 71.0 111.631 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.28 -41.25 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 112.573 0.583 . . . . 73.11 112.573 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.9 m -64.54 -26.0 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 121.936 -0.478 . . . . 71.43 111.37 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.6 t -84.89 -46.84 10.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.901 0.381 . . . . 72.53 110.883 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.5 tp -58.62 -39.21 79.82 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.983 0.513 . . . . 61.05 112.282 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.5 mt -81.6 2.6 28.57 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.226 0.454 . . . . 63.01 112.226 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.45 90.46 0.73 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.108 0.48 . . . . 75.21 111.169 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 23.7 pttm -52.19 -32.34 35.85 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.718 -0.674 . . . . 65.01 112.597 -177.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -65.59 -28.81 69.41 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.354 0.501 . . . . 73.21 112.354 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -108.03 -58.88 1.92 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.543 0.687 . . . . 74.3 111.302 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.552 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 29.7 m-85 -67.9 -3.27 9.26 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.365 0.876 . . . . 73.32 113.365 -172.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 36.9 ttmt -36.11 -32.48 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.886 0.699 . . . . 73.43 112.886 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -91.25 33.08 0.99 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.786 0.662 . . . . 74.52 112.786 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 56.6 mt -88.47 125.99 35.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.215 0.531 . . . . 65.45 111.529 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -101.25 112.84 25.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.042 -0.526 . . . . 62.42 110.532 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.632 ' HB3' HG11 ' A' ' 153' ' ' VAL . 93.1 m-85 -89.81 109.4 20.4 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.543 -0.298 . . . . 63.11 111.257 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.438 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 67.1 m-85 -99.77 124.48 45.08 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.161 0.505 . . . . 71.15 111.662 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.513 ' HB ' HG22 ' A' ' 153' ' ' VAL . 8.6 tt -121.36 146.82 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.08 -0.509 . . . . 73.3 111.134 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.42 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -59.7 124.24 35.67 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.335 -0.46 . . . . 31.21 113.794 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -44.61 -51.1 9.36 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.53 0.567 . . . . 72.23 112.53 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -50.76 -36.42 36.55 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.902 0.705 . . . . 75.3 112.902 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -93.38 -34.57 13.41 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.848 0.356 . . . . 43.21 111.946 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.82 -19.56 51.57 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.524 0.565 . . . . 74.44 112.524 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -65.21 -18.56 65.41 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.865 0.364 . . . . 70.43 111.875 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.72 47.97 0.02 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.714 -0.755 . . . . 44.32 113.346 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.77 116.66 16.84 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.954 0.407 . . . . 72.24 111.614 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -74.5 23.15 0.09 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.258 0.466 . . . . 65.13 112.258 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 8' ' ' PHE . 37.6 m-80 -125.6 18.95 8.04 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.109 0.48 . . . . 65.22 111.001 177.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.2 91.95 1.63 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.079 -0.581 . . . . 75.45 112.46 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -58.96 119.46 7.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.285 0.564 . . . . 73.43 111.617 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 138' ' ' PHE . 91.9 t -87.68 142.16 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.823 0.675 . . . . 70.23 112.823 -175.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.897 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -101.78 133.21 46.89 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.641 -0.709 . . . . 74.32 110.442 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.4 mt -99.94 117.3 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 112.655 0.613 . . . . 71.12 112.655 -171.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 40.9 mm -100.94 123.33 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 111.76 0.282 . . . . 63.34 111.76 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -111.9 133.68 53.94 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.696 0.284 . . . . 74.13 111.046 173.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -84.68 95.57 8.95 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.332 0.586 . . . . 71.34 110.183 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.81 113.38 24.3 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.637 -0.711 . . . . 71.53 111.277 -173.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -74.18 118.24 16.91 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.468 -0.333 . . . . 73.33 110.49 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.52 91.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.781 0.324 . . . . 71.11 111.814 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 t70 52.72 38.54 26.57 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.641 0.608 . . . . 74.54 112.641 173.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 103.03 -5.72 50.42 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.145 -0.55 . . . . 41.33 113.772 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.519 HG22 HG13 ' A' ' 166' ' ' VAL . 61.0 m -110.21 122.19 47.06 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.349 -0.501 . . . . 71.11 110.925 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 165' ' ' GLU . 0.4 OUTLIER -92.69 100.38 12.89 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.285 0.564 . . . . 71.01 111.24 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.519 HG13 HG22 ' A' ' 164' ' ' THR . 19.0 m -108.07 113.27 60.97 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 112.361 0.504 . . . . 62.13 112.361 -177.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.12 113.8 3.87 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.089 1.859 . . . . 62.42 111.611 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.6 p -104.64 151.98 23.02 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.482 -0.326 . . . . 70.23 111.378 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.897 HD11 ' HB1' ' A' ' 154' ' ' ALA . 26.2 tp -102.3 122.95 45.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.54 -0.3 . . . . 74.44 110.857 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.581 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 63.0 mtt -101.81 124.25 47.13 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.599 0.562 . . . . 73.24 111.378 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.9 mt -138.2 130.58 29.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.492 -0.777 . . . . 54.3 110.609 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 174' ' ' GLU . 25.9 t -79.72 123.37 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 122.077 -0.389 . . . . 52.02 111.177 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.498 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -68.75 -11.07 59.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.642 0.608 . . . . 74.55 112.642 -175.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.492 ' H ' HG12 ' A' ' 172' ' ' VAL . 13.9 mm-40 -97.3 -8.3 30.05 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.073 0.463 . . . . 64.52 111.125 172.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.469 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -97.45 -14.37 21.2 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.291 0.567 . . . . 71.4 110.669 175.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 63.4 mt -134.77 128.59 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.469 -0.787 . . . . 61.2 109.806 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 43.5 mm -93.47 128.41 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.773 0.321 . . . . 74.11 111.392 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -84.94 114.44 22.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.245 -0.434 . . . . 73.2 110.949 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.44 112.72 23.46 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.706 0.765 . . . . 72.31 110.89 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.456 ' HB2' ' NZ ' ' A' ' 180' ' ' LYS . 4.9 ttmp? . . . . . 0 CA--C 1.544 0.717 0 CA-C-N 115.657 -0.702 . . . . 64.41 112.095 -172.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.737 0.303 . . . . 73.41 111.761 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.41 160.01 14.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.457 0.303 . . . . 71.42 111.092 -176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 33.9 pt -130.58 138.8 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.976 -0.452 . . . . 73.24 112.037 177.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 14' ' ' SER . 49.7 p90 -122.55 138.24 54.63 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.231 0.539 . . . . 74.43 111.532 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.629 ' HG2' HD12 ' A' ' 13' ' ' LEU . 5.2 mtpm? -132.18 112.91 12.68 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.46 -0.791 . . . . 43.2 111.307 -176.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 176' ' ' ILE . 6.6 m-20 -73.46 155.31 39.39 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.041 -0.412 . . . . 74.22 111.495 173.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 pt -72.46 -24.93 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.967 0.413 . . . . 71.21 111.513 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.73 -41.76 4.92 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.537 0.569 . . . . 73.22 112.537 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m -88.69 15.13 8.66 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.304 0.573 . . . . 71.34 111.548 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.446 ' O ' HD22 ' A' ' 13' ' ' LEU . 34.2 t70 -49.05 -37.81 22.02 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.838 1.051 . . . . 75.35 113.838 -173.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.1 -37.13 81.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.703 0.631 . . . . 75.43 112.703 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -104.2 25.79 9.62 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.887 -0.508 . . . . 65.4 112.014 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.629 HD12 ' HG2' ' A' ' 5' ' ' LYS . 2.2 pt? -44.16 158.76 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.02 -0.536 . . . . 74.33 111.812 173.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 62.6 m -143.55 152.56 41.59 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.425 0.898 . . . . 74.34 113.425 -174.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 78.0 p -91.58 125.41 36.31 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.646 -0.707 . . . . 71.15 109.851 172.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -112.89 175.65 5.35 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.98 0.419 . . . . 73.24 111.708 -171.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.1 t -144.82 8.5 1.28 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.052 0.39 . . . . 51.34 112.052 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.433 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 78.9 m-85 -96.87 150.14 36.55 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 122.221 -0.299 . . . . 74.05 111.674 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -91.66 104.67 0.24 Allowed 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.842 2.361 . . . . 71.42 113.468 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.497 ' N ' ' SD ' ' A' ' 20' ' ' MET . 1.6 mpt? -85.9 162.11 18.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.963 0.411 . . . . 51.52 111.534 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -129.19 119.89 24.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.411 -0.359 . . . . 74.23 111.139 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 tp -74.79 114.37 13.15 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.207 0.527 . . . . 73.32 111.081 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.31 145.63 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.302 -0.408 . . . . 61.32 111.132 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.9 t70 62.79 8.51 3.1 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 120.987 0.422 . . . . 53.52 111.413 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 58.02 11.8 1.59 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.266 0.627 . . . . 74.14 111.598 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 120' ' ' ILE . 30.8 tp -117.51 -46.74 2.66 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.042 -0.526 . . . . 72.13 111.279 -172.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.96 149.22 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.69 0.626 . . . . 53.43 112.69 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.573 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 75.3 m-85 -86.45 123.89 32.17 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.143 -0.48 . . . . 71.2 111.006 175.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -99.86 138.25 37.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.062 -0.517 . . . . 73.41 110.642 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.523 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 46.4 t80 -137.79 122.7 18.93 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.19 0.519 . . . . 75.4 111.562 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -75.37 123.46 25.41 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.57 0.581 . . . . 74.52 112.57 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.15 142.74 15.72 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.197 -0.456 . . . . 71.52 112.873 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -91.7 145.32 24.68 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.707 -0.29 . . . . 72.31 111.185 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -66.72 105.42 1.55 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.302 . . . . 72.32 110.578 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.589 HG23 HD12 ' A' ' 72' ' ' LEU . 10.8 m -146.82 158.84 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.33 0.585 . . . . 71.51 111.419 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.26 146.92 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.084 -0.507 . . . . 63.32 111.171 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.51 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 19.9 mmt85 . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 120.873 0.368 . . . . 73.41 111.136 172.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 39.8 mt-10 . . . . . 0 CA--C 1.537 0.47 0 CA-C-O 121.357 0.599 . . . . 62.01 110.567 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -88.31 132.64 34.33 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.858 -0.61 . . . . 64.41 111.231 177.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.5 -133.65 3.53 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.197 -1.001 . . . . 45.2 113.979 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 70' ' ' ILE . 7.4 pt -111.2 141.48 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.028 0.442 . . . . 73.53 112.189 -175.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -45.99 -34.44 4.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.868 -0.605 . . . . 75.35 112.013 177.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 68' ' ' ILE . 50.7 mt -48.26 -62.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.309 0.576 . . . . 71.54 111.913 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.3 m -77.22 -31.11 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.022 -0.535 . . . . 74.14 112.211 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.589 HD12 HG23 ' A' ' 35' ' ' VAL . 68.8 mt -74.08 -38.61 63.85 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.835 0.35 . . . . 61.01 111.802 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -83.91 -26.18 29.57 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.801 0.334 . . . . 64.2 111.386 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -95.43 -1.12 51.57 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 120.837 0.351 . . . . 73.21 110.745 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.7 tptm 49.65 70.92 0.44 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.141 0.976 . . . . 75.25 112.955 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.1 mt -107.14 148.91 28.25 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.791 -0.641 . . . . 63.41 111.041 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 140' ' ' ILE . 14.1 p -91.08 142.34 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 120.971 0.415 . . . . 64.02 111.873 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -79.16 143.32 35.54 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.964 0.727 . . . . 63.43 112.964 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.45 ' C ' HD22 ' A' ' 80' ' ' ASN . 96.8 mmm -139.46 155.42 47.6 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.28 0.632 . . . . 75.4 110.939 177.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.45 HD22 ' C ' ' A' ' 79' ' ' MET . 0.9 OUTLIER -131.75 133.1 44.42 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.035 0.445 . . . . 72.25 112.145 -173.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.4 p -38.32 -46.76 1.14 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.924 1.453 . . . . 73.34 114.924 -173.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -55.68 -34.76 65.34 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.02 0.438 . . . . 62.04 111.824 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -91.68 -37.69 12.88 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.16 0.505 . . . . 64.11 111.19 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.404 ' OD1' ' HB3' ' A' ' 79' ' ' MET . 3.8 m-20 -72.26 -6.34 42.3 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.602 0.593 . . . . 74.54 112.602 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.473 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -39.6 -63.24 0.59 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 112.992 0.738 . . . . 42.33 112.992 -177.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.5 m -60.35 -35.3 75.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.15 0.5 . . . . 74.54 111.602 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.8 mtp -69.66 -56.48 7.13 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.064 -0.517 . . . . 71.4 112.288 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.473 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 4.2 p90 -68.63 -25.98 65.11 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.915 -0.49 . . . . 70.53 112.304 -175.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.42 ' HA ' HG22 ' A' ' 92' ' ' ILE . 18.4 ptmt -73.91 -32.93 63.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 119.883 -0.727 . . . . 70.32 110.993 176.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.58 74.61 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.465 0.65 . . . . 52.14 110.157 170.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -53.43 -55.92 21.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.131 -0.94 . . . . 74.33 111.174 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.42 HG22 ' HA ' ' A' ' 89' ' ' LYS . 10.4 tp -63.27 -34.45 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 111.744 0.276 . . . . 74.53 111.744 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -63.5 -55.65 22.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.831 0.348 . . . . 73.12 111.213 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -61.09 -42.17 98.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.731 0.3 . . . . 75.2 111.361 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.511 ' O ' HG22 ' A' ' 99' ' ' VAL . 41.0 t80 -52.31 -57.48 9.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.157 -0.474 . . . . 72.55 111.278 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.426 ' HA ' ' CE ' ' A' ' 96' ' ' MET . 3.2 mmt -55.3 -52.95 61.78 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.393 -0.367 . . . . 73.15 111.851 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -54.14 -50.51 66.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.834 0.349 . . . . 65.22 111.481 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -64.17 -56.79 12.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.243 -0.435 . . . . 75.44 111.94 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 95' ' ' PHE . 24.2 m -63.58 -40.09 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.37 0.507 . . . . 75.14 112.37 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.6 mm -69.92 -44.98 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 122.217 -0.302 . . . . 63.31 111.375 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.61 -42.34 98.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.98 0.419 . . . . 62.33 111.035 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -68.38 -49.57 59.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.11 -0.496 . . . . 70.42 111.641 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.4 ttm -66.48 -49.49 66.44 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.923 0.342 . . . . 75.54 111.923 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.35 -11.76 11.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.895 0.379 . . . . 72.1 111.819 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -68.59 -48.0 65.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.861 0.362 . . . . 62.1 111.059 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.51 -36.01 6.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.134 0.42 . . . . 72.01 112.134 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -84.74 19.35 2.07 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 120.961 0.41 . . . . 53.14 111.039 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -28.41 -30.97 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.448 1.647 . . . . 74.21 115.448 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -50.27 118.22 2.85 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.022 0.439 . . . . 62.45 111.586 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 96.1 mttt -56.95 -22.49 38.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.163 -0.471 . . . . 63.44 111.547 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.02 -31.05 44.54 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.039 0.447 . . . . 70.31 111.82 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -77.21 -62.22 1.73 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.195 0.521 . . . . 70.21 110.927 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.3 m -63.24 -24.29 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.739 0.644 . . . . 64.14 112.739 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 20.4 t70 -62.33 -47.94 82.02 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.004 0.43 . . . . 73.33 110.159 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 119' ' ' LYS . . . -59.8 -42.32 93.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.947 -0.569 . . . . 73.0 111.453 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -64.24 -55.17 23.42 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.7 0.285 . . . . 71.32 111.708 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -55.57 -42.33 74.56 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.366 0.603 . . . . 75.31 110.997 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 118' ' ' LYS . 28.0 ttmt -71.35 -30.08 65.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.627 -0.715 . . . . 73.51 110.954 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 37.9 tptt -64.25 -41.66 96.86 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.259 0.552 . . . . 71.34 109.929 173.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.516 HD13 HD21 ' A' ' 26' ' ' LEU . 31.8 mm -65.71 -42.0 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.618 -0.719 . . . . 70.51 110.835 173.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 125' ' ' VAL . 10.9 mm100 -55.84 -51.87 66.01 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.72 0.267 . . . . 70.03 111.72 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.21 -42.85 83.46 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.474 -0.869 . . . . 72.52 112.198 175.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -59.92 -55.54 32.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.94 0.496 . . . . 74.41 111.547 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.0 m -66.98 -42.13 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 112.529 0.566 . . . . 74.02 112.529 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 121' ' ' GLN . 69.1 t -57.73 -34.55 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.254 0.549 . . . . 73.05 111.212 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.5 t -75.94 -42.73 47.78 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.224 -0.444 . . . . 70.25 111.52 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.449 HD21 HD13 ' A' ' 155' ' ' ILE . 30.5 tp -75.0 -29.07 60.78 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.958 -0.565 . . . . 75.33 112.248 -173.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.17 2.75 51.44 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.64 0.607 . . . . 73.22 112.64 -176.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.514 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -60.3 94.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.196 0.522 . . . . 53.23 111.17 177.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.58 -16.85 58.41 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.16 0.8 . . . . 75.42 113.16 -170.365 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.56 ' N ' ' HD2' ' A' ' 130' ' ' LYS . 3.9 m-20 -67.35 -46.01 74.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.002 0.43 . . . . 72.34 111.557 -175.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.556 HH21 ' HE2' ' A' ' 158' ' ' TYR . 39.8 mtp180 -107.36 -48.53 3.43 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.371 0.605 . . . . 70.55 111.796 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.514 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 44.5 m-85 -67.92 -6.33 21.46 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.849 -0.614 . . . . 74.12 112.608 -172.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 38.4 ttpt -53.09 -26.0 14.84 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.099 0.476 . . . . 74.21 110.93 171.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -97.19 34.04 1.84 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.579 0.585 . . . . 44.32 112.579 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.412 HD11 ' HD2' ' A' ' 133' ' ' PHE . 70.6 mt -87.96 151.18 22.98 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.895 0.379 . . . . 73.01 110.87 175.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -108.79 134.62 51.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.673 -0.239 . . . . 64.41 111.453 -178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.576 ' HB3' HG13 ' A' ' 153' ' ' VAL . 66.7 m-85 -109.66 133.46 53.09 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.268 -0.27 . . . . 74.33 110.629 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -129.41 138.89 51.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.089 0.471 . . . . 73.05 111.017 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.48 ' O ' HG12 ' A' ' 77' ' ' VAL . 12.7 tt -141.33 158.85 22.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.367 -0.379 . . . . 73.31 111.139 -175.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.97 137.78 50.16 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.931 -0.652 . . . . 34.22 112.169 173.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -36.92 85.07 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.624 0.602 . . . . 63.21 112.624 -175.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 143' ' ' ARG . 24.6 mmt180 -63.45 -49.3 74.23 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.128 -0.357 . . . . 72.01 111.319 176.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.504 ' HB1' ' HA3' ' A' ' 151' ' ' GLY . . . -55.86 -50.34 70.86 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.022 0.439 . . . . 60.35 111.501 173.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.61 -30.93 65.74 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.12 0.415 . . . . 62.21 112.12 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -102.05 14.74 31.12 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.474 0.546 . . . . 74.13 112.474 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.7 -44.53 0.02 OUTLIER Glycine 0 CA--C 1.531 1.067 0 C-N-CA 119.996 -1.097 . . . . 35.33 114.976 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -111.76 108.93 18.53 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.873 0.694 . . . . 64.25 112.873 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -63.55 -24.59 67.87 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.762 0.315 . . . . 74.44 111.766 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -92.03 19.86 6.37 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.835 0.309 . . . . 71.43 111.835 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.504 ' HA3' ' HB1' ' A' ' 144' ' ' ALA . . . -68.33 163.11 49.06 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.048 -0.596 . . . . 51.33 113.133 178.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.418 ' NE2' HD22 ' A' ' 171' ' ' LEU . 40.6 tt0 -68.11 102.32 1.31 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.417 -0.461 . . . . 70.41 112.038 -177.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 138' ' ' PHE . 24.6 t -80.92 99.93 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.383 0.611 . . . . 72.52 110.332 168.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.678 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -73.8 129.79 38.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.676 -0.693 . . . . 71.33 110.635 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.449 HD13 HD21 ' A' ' 127' ' ' LEU . 57.6 mt -95.57 125.62 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.991 0.424 . . . . 64.54 111.429 -175.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 50.3 mm -100.04 106.7 19.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-O 121.039 0.447 . . . . 73.03 110.695 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.43 152.62 20.15 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.727 -1.124 . . . . 74.33 111.239 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.556 ' HE2' HH21 ' A' ' 132' ' ' ARG . 39.7 p90 -100.3 122.22 42.74 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.983 -0.448 . . . . 74.14 110.62 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.566 ' HE ' ' HB ' ' A' ' 168' ' ' THR . 0.1 OUTLIER -136.93 156.4 48.51 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.873 0.694 . . . . 74.32 112.873 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.46 127.61 32.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.18 -0.918 . . . . 73.25 112.575 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.5 t -129.36 99.93 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.968 -0.56 . . . . 72.11 110.969 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 57.23 25.11 10.65 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.321 0.489 . . . . 72.12 112.321 176.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.46 -23.36 26.77 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.314 -0.469 . . . . 52.14 113.465 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.2 p -101.58 149.3 24.25 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.409 -0.465 . . . . 74.21 111.666 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.27 121.34 34.54 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.324 0.583 . . . . 71.24 112.076 -176.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.77 126.93 26.83 Favored Pre-proline 0 C--O 1.24 0.584 0 O-C-N 121.654 -0.654 . . . . 65.2 111.256 174.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.99 114.53 3.02 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.264 1.976 . . . . 64.11 111.426 171.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.566 ' HB ' ' HE ' ' A' ' 159' ' ' ARG . 10.2 t -101.48 149.81 23.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.303 -0.408 . . . . 50.11 111.888 -176.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.678 HD11 ' HB1' ' A' ' 154' ' ' ALA . 53.0 tp -78.67 128.46 33.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.225 -0.443 . . . . 70.11 110.337 174.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 46.8 tpp -117.7 122.53 43.76 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.868 0.366 . . . . 73.52 111.021 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.418 HD22 ' NE2' ' A' ' 152' ' ' GLN . 98.1 mt -137.78 155.13 49.36 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.808 0.443 . . . . 73.23 109.875 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.505 HG11 ' CE1' ' A' ' 95' ' ' PHE . 40.6 t -99.87 134.82 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.744 -0.598 . . . . 73.02 112.112 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.573 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -60.74 -39.67 89.51 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.155 0.798 . . . . 61.45 113.155 -172.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -95.15 12.43 28.79 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.854 0.687 . . . . 51.52 112.854 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.4 -33.67 8.08 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.558 0.694 . . . . 42.24 109.985 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 6' ' ' ASP . 3.9 tt -128.01 117.59 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.043 -0.98 . . . . 73.44 110.424 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 5' ' ' LYS . 8.3 tp -94.25 129.41 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.585 0.707 . . . . 74.55 111.869 -175.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -92.9 123.58 36.26 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.524 -0.762 . . . . 72.41 110.336 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -124.9 143.37 50.89 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.283 0.563 . . . . 64.51 111.153 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.577 0.703 . . . . 64.35 111.816 179.218 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.949 0.404 . . . . 71.51 111.95 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 178' ' ' GLU . 59.8 tp -134.28 131.9 38.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.659 -0.496 . . . . 63.5 109.659 172.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 54.3 mt -104.1 117.69 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 121.903 -0.498 . . . . 72.04 110.473 -177.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -111.05 142.73 42.81 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.859 0.838 . . . . 74.52 112.233 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -137.46 111.15 8.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.686 -1.143 . . . . 62.05 110.777 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.469 ' HB2' ' H ' ' A' ' 9' ' ' THR . 2.4 m-20 -87.13 174.39 8.66 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.279 0.561 . . . . 54.11 111.489 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.6 mt -68.42 -28.16 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.356 0.598 . . . . 73.24 110.474 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -97.26 -44.0 7.1 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.783 -0.644 . . . . 61.43 112.161 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.469 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 37.8 p -81.07 15.62 1.81 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.319 0.859 . . . . 74.01 113.319 -172.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -54.68 -31.02 57.18 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.913 0.387 . . . . 72.21 111.692 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -71.68 -37.85 70.69 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.205 0.526 . . . . 75.2 111.129 174.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 10.0 tp10 -96.25 25.06 5.17 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.837 -0.619 . . . . 64.25 111.105 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.49 107.22 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.867 0.867 . . . . 62.4 112.089 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.9 t -122.16 175.29 6.45 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.704 0.631 . . . . 71.42 112.704 -166.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.7 p -150.33 130.94 13.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.937 -0.574 . . . . 64.33 111.535 -176.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -123.97 -162.76 1.09 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 120.825 0.345 . . . . 63.04 111.23 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.5 m -152.32 29.95 0.55 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.087 0.47 . . . . 51.12 110.826 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -108.27 146.11 32.91 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.167 -0.47 . . . . 74.43 111.036 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.52 159.14 54.76 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.246 1.964 . . . . 60.23 113.904 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.429 ' N ' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -142.05 128.9 20.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.327 0.584 . . . . 63.21 110.639 174.458 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.695 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 11.2 mmmm -98.91 97.96 9.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.259 -0.428 . . . . 74.0 111.925 -173.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 43.2 tp -75.13 91.21 2.57 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.643 -0.661 . . . . 54.12 111.37 -178.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.3 p -90.5 146.89 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 115.9 -0.591 . . . . 72.3 111.148 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 56.49 11.61 0.89 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 120.788 0.328 . . . . 72.45 111.76 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.477 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 7.9 m-20 52.92 30.68 9.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.164 0.507 . . . . 75.55 111.106 -175.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.462 HD11 HD11 ' A' ' 120' ' ' ILE . 30.0 tp -130.23 -43.5 1.17 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.723 -176.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.13 159.78 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.353 0.501 . . . . 44.35 112.353 -175.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 170' ' ' MET . 66.1 m-85 -103.27 129.97 50.39 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.945 -0.57 . . . . 74.5 111.464 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.695 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 15.3 tt0 -96.43 142.15 28.88 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.877 0.871 . . . . 72.52 110.627 175.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.639 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 63.3 t80 -147.33 130.66 16.59 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.74 0.305 . . . . 74.14 111.222 173.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -94.56 135.95 35.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.006 0.432 . . . . 75.12 111.176 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.749 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -123.02 147.68 16.72 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.203 -0.522 . . . . 72.02 113.192 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -91.22 136.59 32.99 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.607 -0.349 . . . . 62.25 110.724 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -65.25 106.87 1.43 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.119 0.485 . . . . 74.51 110.923 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.423 HG23 HD12 ' A' ' 72' ' ' LEU . 34.4 m -131.84 158.2 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.045 0.45 . . . . 73.1 111.136 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.686 HG12 ' HG3' ' A' ' 66' ' ' ARG . 12.2 m -137.27 137.44 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.772 0.32 . . . . 63.11 111.182 -178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.918 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 6.5 ttm180 . . . . . 0 C--O 1.238 0.471 0 CA-C-O 120.868 0.366 . . . . 53.01 111.863 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.918 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 32.5 tt0 . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 121.838 0.828 . . . . 64.41 109.851 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.686 ' HG3' HG12 ' A' ' 36' ' ' VAL . 40.4 ttp180 -105.51 124.53 49.71 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.297 -0.865 . . . . 73.5 111.652 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.52 -132.28 2.74 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.032 -0.604 . . . . 61.53 113.064 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.624 HD12 HD12 ' A' ' 70' ' ' ILE . 22.1 pt -111.1 137.66 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 112.271 0.471 . . . . 64.25 112.271 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -39.54 -44.49 1.44 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.327 0.651 . . . . 74.2 112.55 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.749 HG13 ' HA3' ' A' ' 32' ' ' GLY . 67.0 mt -40.39 -53.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.773 0.657 . . . . 51.51 112.773 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.479 ' HA ' HD12 ' A' ' 76' ' ' LEU . 23.1 m -94.68 -33.91 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.406 0.521 . . . . 64.03 112.406 -173.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.423 HD12 HG23 ' A' ' 35' ' ' VAL . 62.1 mt -68.38 -49.75 57.9 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.024 0.44 . . . . 62.43 111.534 -176.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -62.67 -21.16 65.52 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 120.854 0.359 . . . . 74.33 111.553 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -104.92 -0.28 27.17 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.822 0.305 . . . . 72.43 111.822 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.42 69.98 0.68 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.247 0.546 . . . . 73.34 112.273 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 91.4 mt -110.85 136.48 49.82 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.095 -0.502 . . . . 62.21 111.086 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.405 HG13 HG23 ' A' ' 140' ' ' ILE . 5.6 p -88.04 142.15 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.17 0.51 . . . . 64.41 111.437 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER -85.71 137.91 32.49 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.342 0.867 . . . . 74.22 113.342 -171.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 75.0 mtp -134.49 140.31 46.1 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.667 -0.697 . . . . 65.14 110.896 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -89.34 157.54 18.14 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.023 0.439 . . . . 75.11 111.937 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 136' ' ' LEU . 79.8 m -53.85 -45.03 70.8 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.919 0.711 . . . . 74.34 112.919 -175.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -60.39 -20.29 59.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.606 0.595 . . . . 53.53 112.606 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -99.42 -28.98 13.01 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.164 0.431 . . . . 51.13 112.164 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.41 -7.53 55.24 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.626 0.602 . . . . 72.43 112.626 -173.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.31 -43.21 10.55 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.078 0.77 . . . . 61.14 113.078 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.3 m -66.97 -39.58 87.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.732 0.301 . . . . 73.22 111.498 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.5 mmt -62.75 -44.44 96.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.401 -0.363 . . . . 70.51 110.657 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -51.91 -52.08 52.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.801 0.334 . . . . 62.32 111.578 173.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -58.84 -43.01 90.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.922 0.391 . . . . 72.13 111.656 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.34 -50.87 23.57 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.025 0.44 . . . . 65.51 111.881 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -58.83 -53.75 54.9 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.781 -0.645 . . . . 75.3 111.86 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.4 mm -64.11 -37.33 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 111.907 0.336 . . . . 72.32 111.907 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -57.36 -62.66 1.62 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.204 0.526 . . . . 75.14 111.028 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.67 -44.67 85.91 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.806 -0.634 . . . . 74.31 111.221 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.536 ' CZ ' HG11 ' A' ' 172' ' ' VAL . 66.1 t80 -61.07 -66.11 0.59 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.936 -0.574 . . . . 72.32 112.314 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 48.0 ttm -54.95 -45.2 74.86 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.174 0.435 . . . . 54.14 112.174 -172.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.31 -43.96 93.08 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.696 0.284 . . . . 74.03 111.643 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -71.19 -43.01 68.27 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.182 0.438 . . . . 65.53 112.182 -176.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.1 m -72.2 -39.05 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.23 0.456 . . . . 54.41 112.23 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.99 -45.97 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 122.152 -0.342 . . . . 75.3 110.26 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.9 -38.76 73.27 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.369 0.604 . . . . 73.51 110.647 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -60.59 -38.85 85.98 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.729 -0.669 . . . . 70.22 111.976 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.48 ' HG2' HG12 ' A' ' 113' ' ' VAL . 35.3 ttm -88.39 -48.85 7.33 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.228 0.455 . . . . 74.55 112.228 -173.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.548 ' HA ' HG11 ' A' ' 113' ' ' VAL . 11.5 pt-20 -62.2 -24.45 67.22 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.174 -0.329 . . . . 70.23 111.814 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -58.54 -54.61 45.14 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.003 0.371 . . . . 74.21 112.003 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -100.6 -37.04 8.94 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.837 0.68 . . . . 62.41 112.837 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -68.39 -50.49 52.64 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.862 -0.524 . . . . 60.44 110.51 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 45.67 19.87 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.676 1.361 . . . . 62.43 114.676 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -102.68 124.51 48.36 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.858 -0.526 . . . . 72.55 110.595 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -52.9 -58.11 8.03 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.626 0.602 . . . . 74.12 112.626 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.61 -11.9 13.49 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.686 0.625 . . . . 71.24 112.686 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -91.16 -63.09 1.31 Allowed 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.927 0.394 . . . . 74.04 111.0 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 104' ' ' GLU . 17.4 m -66.72 -33.74 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 112.631 0.604 . . . . 71.15 112.631 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.18 -31.3 71.62 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.998 0.428 . . . . 75.21 110.343 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.51 -46.01 60.86 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.26 -0.427 . . . . 60.1 111.171 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.455 ' CZ ' ' HG3' ' A' ' 174' ' ' GLU . 85.4 t80 -59.43 -48.0 83.32 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.189 0.519 . . . . 71.25 110.728 175.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -55.18 -39.07 69.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.913 -0.585 . . . . 73.14 110.774 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -65.42 -36.61 84.46 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.054 -0.521 . . . . 75.21 110.972 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -64.0 -52.45 59.52 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.216 -0.447 . . . . 65.13 111.61 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.462 HD11 HD11 ' A' ' 26' ' ' LEU . 42.1 mm -63.41 -42.44 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.853 0.359 . . . . 75.12 111.38 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -60.95 -48.26 82.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.824 0.345 . . . . 74.01 110.922 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.51 -38.22 95.44 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.157 -0.544 . . . . 54.22 112.564 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 50.7 t90 -60.73 -55.1 37.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.647 0.261 . . . . 74.42 111.215 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.2 m -66.17 -47.47 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 112.482 0.549 . . . . 71.31 112.482 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -59.52 -35.93 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 121.995 -0.441 . . . . 62.2 111.684 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.5 t -78.52 -41.46 32.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.913 0.387 . . . . 74.22 111.017 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 155' ' ' ILE . 52.1 tp -63.82 -38.24 90.36 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.104 -0.498 . . . . 74.04 112.02 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 84.3 mt -77.17 3.26 13.1 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.477 0.547 . . . . 65.15 112.477 -177.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.432 ' HB3' ' HD2' ' A' ' 133' ' ' PHE . . . -62.71 78.72 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.442 0.639 . . . . 55.5 111.716 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.665 ' H ' ' HD3' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -39.47 -39.15 0.65 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.35 1.241 . . . . 65.31 114.35 -178.143 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.96 -44.76 67.38 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.271 0.471 . . . . 75.41 112.271 -169.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.691 ' HD2' ' H ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -108.22 -36.33 6.31 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.267 -0.424 . . . . 71.31 111.652 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.432 ' HD2' ' HB3' ' A' ' 129' ' ' ALA . 86.7 m-85 -73.94 -5.79 43.39 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.241 0.46 . . . . 74.34 112.241 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -44.69 -26.52 0.39 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.1 0.476 . . . . 65.23 112.128 168.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -91.89 23.81 3.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.535 0.569 . . . . 71.32 112.535 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.463 ' HB2' ' SG ' ' A' ' 81' ' ' CYS . 66.9 mt -89.38 157.64 18.08 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.206 0.527 . . . . 73.21 111.204 176.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.4 120.83 36.15 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.001 -0.545 . . . . 73.44 110.653 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.402 ' HE2' ' HG ' ' A' ' 81' ' ' CYS . 59.3 m-85 -109.36 121.73 45.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.066 0.46 . . . . 75.43 110.752 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.52 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 56.9 m-85 -110.47 132.01 54.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.402 0.62 . . . . 74.04 111.895 -177.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 145' ' ' ALA . 6.1 tp -115.14 146.87 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.541 -0.754 . . . . 75.33 110.985 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.04 153.9 37.65 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.155 0.422 . . . . 52.22 114.155 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -46.94 -70.55 0.09 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.06 0.763 . . . . 62.45 113.06 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -68.8 -21.74 64.3 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.261 0.553 . . . . 60.2 111.196 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.693 ' HB1' ' HA2' ' A' ' 151' ' ' GLY . . . -66.52 -49.93 64.89 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.879 -0.6 . . . . 73.14 111.577 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.45 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -61.82 -17.95 58.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.183 -0.462 . . . . 40.34 111.865 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -82.22 11.05 5.76 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.16 -0.473 . . . . 72.22 111.711 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.1 54.61 7.87 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.219 -0.515 . . . . 64.23 113.181 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 150' ' ' ASN . . . -115.09 18.71 16.16 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.71 0.633 . . . . 61.45 112.71 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 69.17 -26.42 0.15 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.934 0.716 . . . . 75.01 112.934 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 148' ' ' ALA . 51.1 t30 -77.42 44.52 0.43 Allowed 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.568 0.699 . . . . 63.34 110.529 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.693 ' HA2' ' HB1' ' A' ' 144' ' ' ALA . . . -96.63 100.77 2.52 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.058 -0.519 . . . . 50.23 114.021 -175.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -119.88 126.8 51.83 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.725 0.298 . . . . 74.0 110.575 174.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 81.4 t -86.24 134.39 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.734 0.642 . . . . 72.02 112.734 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.04 122.27 42.07 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.816 -0.629 . . . . 74.21 109.719 170.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.494 HD13 HD21 ' A' ' 127' ' ' LEU . 47.5 mt -91.42 140.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.774 -0.37 . . . . 72.52 111.865 -171.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 168' ' ' THR . 43.3 mm -123.17 109.59 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.227 -0.442 . . . . 72.24 111.183 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 4.0 mp0 -90.86 149.33 21.98 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.261 0.553 . . . . 63.51 111.926 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -87.78 109.34 19.66 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.181 -0.463 . . . . 72.41 109.826 171.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 2.3 mmp_? -110.45 135.4 51.19 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.003 0.371 . . . . 74.51 112.003 -174.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -86.56 116.31 24.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.125 0.488 . . . . 54.33 111.39 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -108.14 90.61 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.294 -0.412 . . . . 62.35 110.778 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.1 t70 57.38 33.54 23.42 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.815 -0.63 . . . . 63.03 111.563 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 100.97 8.2 48.55 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.088 -0.577 . . . . 70.1 113.323 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 m -122.72 106.06 10.61 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 122.473 -0.428 . . . . 65.22 111.021 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -78.31 104.22 8.75 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.926 0.393 . . . . 73.55 111.567 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 35.2 m -118.57 144.15 34.78 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.817 0.342 . . . . 73.04 111.588 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 16.6 Cg_exo -70.42 146.3 55.74 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.974 2.449 . . . . 45.11 113.47 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 90.8 m -136.02 150.74 49.32 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.294 -0.412 . . . . 64.52 110.82 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 58.9 tp -95.8 135.54 37.39 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.595 0.591 . . . . 72.41 112.595 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 36.0 ttp -127.41 130.15 48.81 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.303 0.573 . . . . 75.31 111.762 174.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 88.1 mt -139.61 141.7 37.11 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.61 -0.723 . . . . 64.32 110.895 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.536 HG11 ' CZ ' ' A' ' 95' ' ' PHE . 21.2 t -87.11 132.22 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.538 -0.726 . . . . 71.33 112.309 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -57.88 -39.72 78.53 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.586 0.587 . . . . 61.44 112.586 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 116' ' ' PHE . 23.5 mm-40 -75.54 -0.17 19.43 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 111.971 0.36 . . . . 43.4 111.971 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.72 -30.61 8.86 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.12 0.486 . . . . 74.4 110.481 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 172' ' ' VAL . 5.3 tt -127.45 109.19 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.295 -0.866 . . . . 65.23 111.178 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.4 mm -100.81 118.52 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.407 -0.36 . . . . 75.13 111.142 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.429 ' HB2' HD21 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -92.84 121.36 34.13 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.832 0.825 . . . . 74.3 111.259 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -94.61 111.03 22.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.74 0.781 . . . . 74.24 110.44 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.197 -0.911 . . . . 74.45 111.384 -177.737 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 120.543 0.211 . . . . 74.42 111.012 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 178' ' ' GLU . 59.1 tp -114.53 128.42 56.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.796 0.331 . . . . 75.44 110.866 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.523 HG12 ' HB3' ' A' ' 15' ' ' SER . 52.6 mt -105.24 127.38 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.641 -0.254 . . . . 70.11 110.703 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -118.16 149.0 41.8 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.2 0.524 . . . . 75.11 111.789 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 13' ' ' LEU . 17.0 ttpp -150.64 120.93 7.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.666 -0.697 . . . . 65.12 111.29 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.638 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.3 m-20 -71.83 174.05 7.43 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.778 0.323 . . . . 75.32 110.293 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.8 pt -86.51 -3.97 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.981 0.42 . . . . 63.14 111.433 172.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.444 ' HE1' ' HD2' ' A' ' 94' ' ' LYS . 73.7 m-85 -108.98 -27.61 9.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.11 0.411 . . . . 74.34 112.11 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.638 HG22 ' HB2' ' A' ' 6' ' ' ASP . 2.0 t -106.0 20.33 19.12 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.591 0.589 . . . . 72.44 112.591 -170.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -44.83 -19.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.218 1.192 . . . . 51.34 114.218 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -86.96 -33.26 19.72 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 122.026 -0.421 . . . . 63.12 111.733 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.75 25.49 2.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.81 0.444 . . . . 75.0 111.893 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 5' ' ' LYS . 56.6 tp -38.08 124.34 1.18 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.233 0.613 . . . . 74.42 112.249 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -137.87 174.35 10.67 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.243 0.461 . . . . 55.21 112.243 -175.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.523 ' HB3' HG12 ' A' ' 3' ' ' ILE . 78.5 p -141.39 135.52 30.49 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.635 0.606 . . . . 72.42 112.635 -175.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -129.75 -173.95 3.17 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.04 0.448 . . . . 72.12 111.652 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.5 p -103.89 -3.84 24.27 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.9 0.704 . . . . 73.43 112.9 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 79.9 m-85 -76.36 131.55 74.68 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 112.004 0.372 . . . . 72.12 112.004 -175.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 6.7 Cg_exo -74.0 172.69 15.41 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.113 2.542 . . . . 74.42 113.555 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.0 ptm -111.64 130.75 55.66 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.044 0.387 . . . . 74.31 112.044 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -120.73 98.21 5.91 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.876 -0.416 . . . . 72.15 109.876 172.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.424 HD21 ' HA ' ' A' ' 25' ' ' ASP . 52.8 tp -100.04 133.88 43.77 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.201 -0.454 . . . . 64.52 112.193 -172.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.55 134.7 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.234 0.54 . . . . 73.23 111.722 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 t70 55.73 15.21 1.51 Allowed 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.195 -0.911 . . . . 53.2 111.885 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.424 ' HA ' HD21 ' A' ' 22' ' ' LEU . 4.7 m-20 53.36 25.7 4.76 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.937 0.398 . . . . 72.53 111.867 -175.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 tp -114.26 -49.64 2.84 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.162 -0.472 . . . . 75.53 111.25 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 172' ' ' VAL . 16.9 m -137.42 157.77 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.923 0.392 . . . . 74.15 111.913 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -92.47 149.28 21.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.433 -0.348 . . . . 74.23 110.369 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 31.8 tt0 -125.78 124.48 41.09 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.202 0.314 . . . . 75.3 110.597 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 59.1 t80 -127.45 131.25 50.24 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.006 0.432 . . . . 74.32 110.818 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HG2' HG22 ' A' ' 168' ' ' THR . 36.5 mtmm -119.93 119.09 32.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.73 0.3 . . . . 72.42 110.971 -178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.13 -157.42 19.4 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.217 0.447 . . . . 71.31 114.217 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -112.47 159.04 19.15 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.922 0.391 . . . . 75.32 111.84 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -89.05 107.1 18.85 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.375 -0.375 . . . . 73.13 110.436 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 m -142.34 159.5 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.495 0.664 . . . . 70.14 112.361 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 66' ' ' ARG . 17.3 m -139.15 139.94 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.475 -0.784 . . . . 73.31 110.279 175.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.496 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 20.6 ttt180 . . . . . 0 N--CA 1.468 0.425 0 CA-C-O 121.441 0.639 . . . . 73.21 111.223 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.6 mp0 . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 121.393 0.616 . . . . 63.31 109.558 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 36' ' ' VAL . 11.6 ptm180 -98.27 137.47 36.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.499 -0.773 . . . . 73.53 112.684 -176.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.58 -127.02 4.69 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.914 -0.66 . . . . 52.22 113.296 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 70' ' ' ILE . 23.2 pt -110.55 138.21 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.838 0.352 . . . . 64.54 111.817 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -46.33 -34.75 4.78 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.021 -0.536 . . . . 71.34 111.864 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 68' ' ' ILE . 57.1 mt -48.36 -58.73 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.315 0.579 . . . . 73.42 112.311 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.62 -31.26 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.021 -0.536 . . . . 64.04 112.191 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.2 mt -67.5 -41.36 84.63 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.004 0.43 . . . . 74.31 111.241 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -54.62 -38.25 66.59 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.846 -0.616 . . . . 63.3 111.701 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -107.72 19.51 20.03 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.535 -0.302 . . . . 75.44 111.156 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt 43.89 43.07 5.0 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.897 0.879 . . . . 75.12 113.273 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.1 mt -70.52 162.16 29.31 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.206 0.527 . . . . 64.14 112.135 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.13 141.17 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 116.38 -0.373 . . . . 72.13 110.98 176.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -81.06 119.06 23.06 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.003 0.43 . . . . 72.45 112.065 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 53.2 ttm -112.19 139.48 47.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.062 -0.517 . . . . 74.24 109.82 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.4 ' HB2' ' HD1' ' A' ' 82' ' ' TYR . 15.9 m120 -122.57 156.77 33.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.391 0.615 . . . . 73.21 112.117 -175.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 25.1 p -72.17 -3.18 21.89 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.612 0.967 . . . . 72.4 113.612 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.408 ' CG ' ' N ' ' A' ' 83' ' ' GLU . 11.0 p90 -54.96 -54.83 37.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.914 0.387 . . . . 54.02 111.707 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.408 ' N ' ' CG ' ' A' ' 82' ' ' TYR . 8.8 tp10 -104.17 -45.08 4.81 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.612 0.72 . . . . 71.15 110.583 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.16 18.08 0.09 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.456 -0.793 . . . . 72.52 113.029 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -54.28 -41.74 69.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.231 0.539 . . . . 53.21 110.956 173.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -70.13 -24.4 63.18 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.853 -0.612 . . . . 33.52 111.905 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -62.81 -62.48 1.69 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.65 -0.25 . . . . 63.24 110.784 -179.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.557 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 30.2 p90 -68.38 -23.08 64.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.722 -0.391 . . . . 75.12 111.312 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -54.39 -60.35 3.47 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.188 0.518 . . . . 74.43 111.034 171.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.23 -38.43 75.22 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.176 -0.466 . . . . 73.24 111.414 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.486 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 55.7 t80 -57.13 -52.6 64.66 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.127 -0.488 . . . . 73.5 110.909 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.532 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 41.4 mm -65.81 -31.0 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.03 0.382 . . . . 62.13 112.03 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -59.43 -60.46 3.82 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.039 0.447 . . . . 73.33 111.202 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HD2' ' HE1' ' A' ' 8' ' ' PHE . 8.0 tmtm? -62.05 -41.52 98.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.14 0.495 . . . . 74.12 110.128 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.623 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 21.7 t80 -52.87 -45.87 67.64 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.878 -0.601 . . . . 70.32 111.676 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 55.2 ttp -58.13 -50.14 74.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.304 0.573 . . . . 60.2 110.944 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -64.22 -35.53 81.11 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.114 -0.494 . . . . 70.31 111.786 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.92 -41.91 64.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.563 -0.289 . . . . 74.32 111.631 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.0 m -65.31 -39.6 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.957 -0.464 . . . . 74.35 111.144 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.04 -44.79 95.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.821 0.343 . . . . 63.04 110.398 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.97 -40.11 69.67 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.235 0.54 . . . . 75.21 111.011 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -66.31 -43.99 84.71 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.996 -0.547 . . . . 63.12 112.329 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 96.4 mmm -86.71 -53.69 4.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.772 0.656 . . . . 63.13 112.772 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -49.62 -40.2 38.35 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.739 0.415 . . . . 73.34 111.748 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -53.8 -43.1 69.06 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.225 0.454 . . . . 74.05 112.225 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -102.28 -3.01 27.91 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.466 0.543 . . . . 75.41 112.466 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 4.4 m-20 -101.03 -61.79 1.33 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.297 0.48 . . . . 73.21 112.297 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 107' ' ' ASN . 2.5 ptp180 72.49 -15.29 0.5 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.096 0.958 . . . . 71.45 112.543 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.481 ' O ' HG22 ' A' ' 113' ' ' VAL . 0.4 OUTLIER -71.71 84.5 0.9 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.317 0.58 . . . . 75.13 111.557 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -52.71 -18.82 2.01 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.85 -0.614 . . . . 72.31 112.54 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.42 -42.75 19.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.1 0.407 . . . . 45.55 112.1 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.458 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 37.2 t70 -81.21 -46.08 15.36 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 122.212 -0.305 . . . . 63.23 111.768 -174.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 109' ' ' ASP . 24.3 m -58.42 -27.36 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 122.052 -0.405 . . . . 65.3 111.177 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -70.78 -35.71 72.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.327 -0.397 . . . . 75.43 110.665 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.82 -46.7 74.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.341 -0.39 . . . . 55.0 110.868 176.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 82.5 t80 -62.84 -42.02 99.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.971 0.415 . . . . 73.02 110.384 174.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 117' ' ' LYS . 4.1 tmmm? -50.96 -46.95 61.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.27 -0.423 . . . . 61.44 110.064 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -63.46 -34.66 78.25 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.37 -0.377 . . . . 70.23 111.648 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 116' ' ' PHE . 71.8 mmtt -56.61 -60.73 3.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.991 0.425 . . . . 63.34 111.196 174.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.17 -32.21 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 116.102 -0.499 . . . . 62.51 111.607 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 125' ' ' VAL . 19.5 tm0? -64.57 -55.76 18.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.87 0.367 . . . . 71.2 110.859 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.27 -32.86 78.14 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.871 -0.681 . . . . 53.41 112.471 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 -62.49 -57.7 10.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.207 0.203 . . . . 73.31 111.188 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 30.6 m -63.66 -38.82 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.249 0.463 . . . . 61.33 112.249 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 121' ' ' GLN . 53.4 t -55.39 -44.01 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.173 0.511 . . . . 45.03 111.159 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.9 m -75.62 -35.97 60.37 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.098 0.475 . . . . 74.31 111.016 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 155' ' ' ILE . 41.3 tp -66.41 -28.91 68.99 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.831 -0.622 . . . . 54.53 111.83 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 74.5 mt -90.04 3.97 51.64 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.289 -0.414 . . . . 64.42 112.086 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.476 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -59.63 92.72 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.413 0.625 . . . . 62.34 111.057 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -66.87 -7.86 24.87 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.695 0.998 . . . . 72.43 113.695 -170.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -71.48 -46.38 60.01 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.812 -0.555 . . . . 73.31 111.024 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 44.0 mtm-85 -109.36 -50.38 3.0 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.123 0.487 . . . . 74.32 111.806 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.476 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 22.4 m-85 -68.07 -7.56 30.47 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.404 0.52 . . . . 64.23 112.404 -173.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.51 -14.12 38.16 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.072 0.463 . . . . 72.14 111.324 175.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -93.32 19.36 8.31 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.151 0.426 . . . . 73.41 112.151 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.412 HD11 ' HD2' ' A' ' 133' ' ' PHE . 76.7 mt -88.51 147.29 24.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.318 0.58 . . . . 73.13 111.796 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.4 119.04 38.36 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.055 -0.521 . . . . 71.1 111.28 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -95.04 106.32 18.31 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.883 0.373 . . . . 75.1 110.544 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -94.48 132.81 38.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.519 0.676 . . . . 73.42 112.185 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 tp -124.7 149.08 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.32 -0.855 . . . . 74.33 110.394 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.64 141.56 27.48 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.289 -0.481 . . . . 75.34 113.377 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -48.28 -57.13 6.41 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.055 0.542 . . . . 73.21 111.739 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.424 ' O ' ' HD3' ' A' ' 143' ' ' ARG . 4.0 tmt_? -77.81 -28.97 50.49 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.189 0.518 . . . . 71.42 110.999 177.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.42 78.14 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.139 0.422 . . . . 62.13 112.139 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.33 -40.03 77.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.015 0.436 . . . . 73.41 111.737 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -71.09 -27.36 63.55 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.005 -0.543 . . . . 74.43 111.048 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -78.54 -44.14 11.27 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.218 -0.515 . . . . 74.01 112.963 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 64.83 2.29 1.67 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.286 0.847 . . . . 53.14 113.286 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -133.05 13.02 4.29 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.92 -0.488 . . . . 75.3 111.83 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -151.07 85.01 1.33 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.96 0.41 . . . . 45.53 110.22 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 158.33 133.52 1.56 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.948 -0.644 . . . . 75.23 113.52 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.38 142.12 29.52 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.695 -0.483 . . . . 73.14 109.695 174.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 48.4 t -75.9 117.28 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.581 0.705 . . . . 71.53 111.911 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.82 98.95 8.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.746 -0.661 . . . . 54.53 110.659 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 57.1 mt -85.99 117.08 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 120.794 0.331 . . . . 63.42 111.519 -175.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 51.0 mm -99.58 115.9 41.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.434 -0.348 . . . . 74.12 111.5 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 32.1 tt0 -104.02 144.36 31.65 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.868 -0.606 . . . . 75.54 111.659 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -85.81 88.8 7.61 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.251 0.548 . . . . 74.31 110.233 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.526 ' NH2' HG22 ' A' ' 161' ' ' VAL . 16.0 ttp180 -100.29 154.89 18.11 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.466 0.651 . . . . 71.35 111.959 -174.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.98 142.23 28.0 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.743 -0.662 . . . . 72.33 111.389 176.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.526 HG22 ' NH2' ' A' ' 159' ' ' ARG . 72.1 t -129.22 89.31 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.92 0.39 . . . . 74.31 110.824 171.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 51.76 25.64 3.05 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.926 -0.579 . . . . 71.25 112.305 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 129.18 -37.84 2.13 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.368 -0.444 . . . . 41.23 113.493 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 78.4 p -88.88 119.41 29.36 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.564 -0.374 . . . . 75.03 111.737 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.66 114.31 15.26 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.095 -0.502 . . . . 53.12 111.117 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 161' ' ' VAL . 17.4 m -125.76 138.22 31.54 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 121.042 0.449 . . . . 64.45 112.085 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.495 ' HG2' HG21 ' A' ' 68' ' ' ILE . 15.8 Cg_exo -71.36 115.99 4.51 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.884 2.39 . . . . 54.11 112.62 173.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.472 HG22 ' HG2' ' A' ' 31' ' ' LYS . 69.8 p -96.1 138.89 33.07 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.152 0.501 . . . . 65.45 112.01 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 61.1 tp -89.11 117.3 28.0 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.086 -0.506 . . . . 62.45 111.525 176.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.555 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 61.7 mtt -101.32 124.38 46.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.791 0.329 . . . . 61.43 111.413 176.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.476 ' HB3' HD11 ' A' ' 176' ' ' ILE . 96.0 mt -133.87 122.14 22.75 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.528 -0.306 . . . . 74.03 110.903 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.623 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 59.0 t -68.35 118.97 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.057 0.456 . . . . 51.32 111.899 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.47 -24.23 67.11 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.789 0.663 . . . . 73.32 112.789 -177.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.451 ' HB2' ' HZ ' ' A' ' 116' ' ' PHE . 5.5 tp10 -90.86 -3.08 57.64 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.966 -0.459 . . . . 73.1 111.06 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.583 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -97.03 -44.09 7.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.056 0.455 . . . . 70.11 110.219 175.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 171' ' ' LEU . 29.1 pt -116.79 109.4 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.877 -0.601 . . . . 70.03 110.611 172.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.5 tp -94.42 138.88 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.969 0.414 . . . . 75.11 110.808 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.633 ' HB2' HD11 ' A' ' 2' ' ' LEU . 1.8 pp20? -104.99 153.94 20.76 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.396 0.617 . . . . 71.44 112.394 -174.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 35.3 tt0 -140.09 99.77 3.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 74.11 109.406 172.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.564 ' HB3' HD13 ' A' ' 2' ' ' LEU . 19.3 pttm . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 113.313 0.857 . . . . 74.13 113.313 -170.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 121.041 0.448 . . . . 73.03 111.615 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 34.5 tp -109.53 135.0 51.23 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.571 -0.529 . . . . 72.35 109.571 174.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.0 tt -100.5 120.64 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.284 0.564 . . . . 72.12 111.668 -175.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 47.2 p90 -118.84 143.01 47.21 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.182 0.515 . . . . 72.23 111.416 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 5' ' ' LYS . 19.7 ptpt -140.29 121.88 15.22 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.646 -0.706 . . . . 75.13 110.771 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 9' ' ' THR . 3.6 m-20 -71.45 164.53 25.63 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.813 -0.555 . . . . 71.24 111.119 175.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.3 mt -55.81 -33.07 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.183 -0.462 . . . . 73.12 111.371 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 150' ' ' ASN . 9.1 p90 -109.45 -24.38 11.05 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.28 0.844 . . . . 72.15 113.28 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 152' ' ' GLN . 2.9 m -90.65 14.95 11.94 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.429 0.529 . . . . 63.41 112.429 -173.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.461 ' O ' HD22 ' A' ' 13' ' ' LEU . 8.5 p-10 -62.37 -10.76 12.3 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.619 0.97 . . . . 72.33 113.619 -173.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -86.48 -43.46 12.75 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.105 0.478 . . . . 43.41 111.324 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.75 ' HG3' ' HB2' ' A' ' 144' ' ' ALA . 18.1 mm-40 -96.16 22.9 7.07 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.297 -0.41 . . . . 62.12 111.537 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 2.0 pt? -57.89 165.04 1.92 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.186 0.517 . . . . 61.11 111.868 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 75.3 m -141.37 156.86 45.78 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.512 0.56 . . . . 64.2 112.512 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.6 p -127.24 110.22 12.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.856 -0.611 . . . . 71.31 111.333 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -161.67 176.36 11.05 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.74 -0.467 . . . . 73.14 109.74 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.3 m -123.88 79.86 1.76 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.932 -0.48 . . . . 74.23 111.772 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -98.37 125.73 42.15 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.155 -0.475 . . . . 54.1 111.093 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.03 117.64 4.84 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.613 2.209 . . . . 43.4 112.713 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.434 ' HA ' ' HB3' ' A' ' 30' ' ' PHE . 61.3 mtt -109.84 162.23 14.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.377 0.608 . . . . 54.33 112.412 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 62.4 mttm -127.44 103.06 7.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.901 -0.59 . . . . 64.22 110.219 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 54.0 tp -75.49 101.85 5.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.07 0.462 . . . . 75.13 111.635 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.34 133.86 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.092 0.472 . . . . 74.23 111.783 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t0 56.5 19.21 3.99 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.59 -0.732 . . . . 74.1 112.058 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.419 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 45.3 m-20 59.35 9.86 1.58 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.233 0.613 . . . . 55.41 112.561 -177.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.2 tp -106.21 -47.1 3.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.908 0.385 . . . . 71.33 111.881 -173.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 172' ' ' VAL . 3.2 m -134.71 150.19 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.678 0.622 . . . . 65.1 112.678 -176.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.557 ' HE2' HG21 ' A' ' 176' ' ' ILE . 64.2 m-85 -86.02 122.14 29.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.886 -0.597 . . . . 75.05 110.696 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 33.4 tt0 -114.09 108.48 17.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.604 0.362 . . . . 52.14 110.148 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.434 ' HB3' ' HA ' ' A' ' 20' ' ' MET . 15.1 p90 -143.62 121.0 11.63 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.784 1.031 . . . . 70.31 113.784 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 168' ' ' THR . 10.3 tmtt? -90.72 121.28 32.48 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.891 -1.049 . . . . 74.32 110.794 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.72 -120.95 1.12 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.107 -0.568 . . . . 71.23 113.093 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 69' ' ' ASP . 67.0 mttm -114.09 134.97 54.52 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.319 -0.519 . . . . 73.1 110.449 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -86.85 107.0 18.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.181 0.515 . . . . 73.14 109.62 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.411 HG23 HD12 ' A' ' 72' ' ' LEU . 28.8 m -137.81 145.37 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.981 0.419 . . . . 73.11 111.933 -173.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.56 134.44 65.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.061 0.458 . . . . 71.23 110.919 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.797 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 26.3 mmm180 . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 120.93 0.395 . . . . 74.14 111.372 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.797 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 2.5 mp0 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.218 0.532 . . . . 72.2 111.141 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.45 HH11 ' HD2' ' A' ' 66' ' ' ARG . 9.5 ptm180 -93.24 116.9 29.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.898 -0.592 . . . . 71.23 111.909 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.6 -140.46 5.2 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.547 -0.835 . . . . 72.43 113.812 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.1 pt -110.94 143.61 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 112.354 0.502 . . . . 72.21 112.354 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . 27.3 t70 -45.16 -43.46 9.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.913 -0.585 . . . . 74.24 112.433 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 58.5 mt -49.51 -60.88 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.242 0.46 . . . . 74.14 112.242 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.494 ' HA ' HD12 ' A' ' 76' ' ' LEU . 21.1 m -73.89 -33.11 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.097 0.406 . . . . 52.32 112.097 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.411 HD12 HG23 ' A' ' 35' ' ' VAL . 87.5 mt -74.3 -28.22 61.08 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.014 0.376 . . . . 71.22 112.014 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -83.37 -40.74 19.03 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.661 0.267 . . . . 51.04 111.424 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -86.68 -9.76 55.27 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.076 0.399 . . . . 74.54 112.076 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 67.4 71.13 0.36 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.355 0.598 . . . . 62.11 111.993 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 71' ' ' VAL . 67.6 mt -106.71 135.97 47.33 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.897 -0.592 . . . . 52.13 110.513 176.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.17 140.06 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.218 0.532 . . . . 73.22 112.379 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.23 143.51 57.73 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.396 0.888 . . . . 74.33 113.396 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.616 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 84.7 mtp -134.92 153.67 51.98 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.008 -0.542 . . . . 71.41 110.669 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.457 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 25.1 t-20 -148.06 156.47 42.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.63 0.253 . . . . 65.0 111.06 -177.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 40.9 t -37.32 -48.95 0.94 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.55 1.315 . . . . 72.44 114.55 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 12.2 p90 -59.75 -36.73 77.22 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.143 0.423 . . . . 75.34 112.143 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -81.85 -37.41 27.02 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.867 0.365 . . . . 63.32 111.395 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 2.7 m-20 -66.76 -22.58 66.04 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.689 0.626 . . . . 52.32 112.689 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.434 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -42.4 -64.88 0.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.021 0.439 . . . . 65.22 111.98 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.3 t -64.6 -33.17 75.29 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.887 0.375 . . . . 75.52 111.625 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.467 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 25.4 mmt -64.15 -65.24 0.7 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.278 -0.419 . . . . 75.11 112.034 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.434 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 10.5 p90 -61.66 -28.7 69.58 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.715 -0.394 . . . . 74.32 111.311 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -55.01 -61.64 2.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.724 -0.39 . . . . 75.15 110.799 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.14 82.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.285 -0.416 . . . . 61.13 111.841 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -60.47 -59.71 4.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.22 0.452 . . . . 65.22 112.22 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.3 mm -54.9 -39.77 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.166 0.432 . . . . 74.44 112.166 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -59.54 -57.29 13.62 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.04 0.385 . . . . 73.45 112.04 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.88 -51.8 60.0 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.803 0.335 . . . . 75.41 111.149 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CZ ' HG11 ' A' ' 172' ' ' VAL . 29.3 t80 -46.43 -48.94 18.73 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.095 0.558 . . . . 65.04 112.118 176.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 37.5 ttp -62.09 -34.7 76.8 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.996 0.427 . . . . 74.22 111.377 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.4 -49.71 68.22 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.466 -0.333 . . . . 71.42 110.901 174.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -59.85 -46.32 89.67 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.31 0.485 . . . . 72.05 112.31 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.5 -39.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 112.071 0.397 . . . . 71.12 112.071 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.464 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 15.0 mm -70.27 -49.2 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 122.271 -0.268 . . . . 60.31 111.355 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.6 -41.17 69.62 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.423 0.63 . . . . 73.01 110.5 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -55.29 -57.11 13.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.615 -0.721 . . . . 75.13 110.995 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.567 ' HG3' HG12 ' A' ' 113' ' ' VAL . 12.6 tpt -62.59 -44.76 95.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.476 0.546 . . . . 64.21 112.476 -173.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 11.2 pt-20 -72.46 -38.69 68.17 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.942 -0.474 . . . . 72.3 112.161 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -68.86 -17.97 64.08 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.439 0.533 . . . . 71.42 112.439 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -113.19 -17.0 12.46 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.001 -0.437 . . . . 61.25 112.008 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -128.63 -73.28 0.59 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.627 0.232 . . . . 74.42 111.627 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 28.5 ttt85 75.24 -18.73 0.43 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.999 1.111 . . . . 73.52 113.999 176.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.496 ' O ' HG22 ' A' ' 113' ' ' VAL . 70.9 m-20 -57.91 121.39 10.42 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.743 -0.598 . . . . 64.12 111.782 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -44.58 -49.49 10.12 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.982 -0.554 . . . . 75.4 112.356 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.47 68.43 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.698 0.629 . . . . 61.33 112.698 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -92.7 -39.61 11.18 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 111.951 0.352 . . . . 74.34 111.951 -175.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.567 HG12 ' HG3' ' A' ' 103' ' ' MET . 16.3 m -68.89 -37.11 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.857 -0.527 . . . . 75.53 112.062 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.25 -35.98 74.16 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.963 0.411 . . . . 71.5 110.483 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.97 78.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.125 0.488 . . . . 51.43 111.007 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.17 -48.83 80.07 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.953 -0.567 . . . . 75.13 111.118 174.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -55.6 -38.25 69.18 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.922 -0.581 . . . . 75.5 111.062 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.28 -40.61 96.31 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.473 -0.33 . . . . 72.42 111.509 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -58.8 -57.26 13.81 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.331 -0.395 . . . . 72.42 111.394 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.0 tp -66.55 -35.33 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.34 -0.391 . . . . 61.32 111.384 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -62.31 -45.27 93.99 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.995 0.426 . . . . 73.23 110.609 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.67 -37.52 94.38 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.061 -0.59 . . . . 53.41 112.414 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 49.5 t90 -62.97 -50.25 71.52 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.866 -0.196 . . . . 74.45 111.51 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.5 m -68.59 -41.12 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.665 0.617 . . . . 72.4 112.665 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.95 -29.77 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.778 -0.576 . . . . 70.34 111.621 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.4 t -77.84 -51.29 10.7 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.054 0.454 . . . . 75.11 110.77 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.6 tp -57.94 -46.34 85.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.002 -0.545 . . . . 63.34 112.302 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.62 2.81 21.07 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.434 0.531 . . . . 62.33 112.434 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.09 80.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.377 0.608 . . . . 74.12 111.1 176.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -58.42 -14.62 8.12 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.875 0.694 . . . . 73.53 112.875 -173.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.27 -49.92 75.98 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.784 0.326 . . . . 61.51 111.369 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -112.41 -36.23 5.33 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.254 0.464 . . . . 63.1 112.254 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -67.64 -6.86 22.42 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.832 0.678 . . . . 73.3 112.832 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 14.9 ptmm? -55.31 -17.13 4.17 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.257 0.465 . . . . 73.44 112.257 176.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -90.41 20.96 4.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.448 0.536 . . . . 51.52 112.448 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.44 158.4 17.74 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.1 0.476 . . . . 74.31 111.634 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.81 51.81 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.152 -0.476 . . . . 74.35 110.62 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.616 ' HB2' ' HB2' ' A' ' 79' ' ' MET . 36.1 m-85 -112.18 157.24 21.11 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.218 -0.301 . . . . 71.34 110.888 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -137.53 147.21 44.98 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.806 0.336 . . . . 62.33 111.827 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.513 HD11 ' HA3' ' A' ' 151' ' ' GLY . 14.6 tt -138.67 160.01 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 116.421 -0.354 . . . . 65.21 110.813 177.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.05 156.81 28.37 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.278 -0.487 . . . . 64.32 113.848 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -59.13 -60.33 4.04 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.959 0.409 . . . . 72.12 111.006 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.521 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 4.0 mmp_? -73.69 -32.63 64.04 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.957 0.408 . . . . 62.01 111.104 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.75 ' HB2' ' HG3' ' A' ' 12' ' ' GLU . . . -53.06 -38.67 62.68 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.12 -0.491 . . . . 70.35 112.08 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.29 -39.42 63.95 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.286 0.476 . . . . 74.21 112.286 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -96.43 -17.05 20.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.846 0.355 . . . . 54.24 111.691 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.6 -48.44 13.21 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.216 -0.516 . . . . 71.43 113.172 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 72.26 -46.04 0.63 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.915 0.709 . . . . 62.52 112.915 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -78.54 0.37 26.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.079 0.4 . . . . 70.52 112.079 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 23.0 p-10 -142.45 28.25 1.66 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 111.842 0.312 . . . . 52.43 111.842 -176.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.513 ' HA3' HD11 ' A' ' 140' ' ' ILE . . . -115.36 142.5 17.64 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 120.898 -0.668 . . . . 71.15 113.975 -175.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.43 ' HB3' ' OG1' ' A' ' 9' ' ' THR . 3.7 pt20 -120.24 140.64 50.88 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.728 0.299 . . . . 73.12 110.795 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.612 HG13 ' HB3' ' A' ' 138' ' ' PHE . 39.2 t -86.86 102.78 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 121.363 0.601 . . . . 52.25 111.211 174.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.579 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -78.67 112.25 15.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.993 -0.549 . . . . 73.42 110.337 174.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.705 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 59.8 mt -89.16 119.01 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.15 0.426 . . . . 74.22 112.15 -172.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.9 mm -104.61 117.3 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.801 0.334 . . . . 72.41 111.282 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -107.31 126.73 52.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.006 0.432 . . . . 71.34 111.358 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -84.71 89.07 7.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.205 0.526 . . . . 74.23 109.646 172.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -90.91 149.01 22.08 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.991 -0.55 . . . . 72.11 111.514 -173.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -98.63 121.75 40.97 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.309 -0.405 . . . . 74.44 111.755 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.411 HG23 HG21 ' A' ' 166' ' ' VAL . 99.0 t -110.67 98.55 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 110.046 -0.353 . . . . 72.13 110.046 170.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 57.12 21.3 6.32 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.987 0.423 . . . . 75.22 111.588 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.98 24.5 27.16 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.257 -0.496 . . . . 71.44 112.697 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 m -112.19 141.06 46.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.704 0.288 . . . . 65.12 110.973 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -73.34 109.38 6.82 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.478 0.548 . . . . 74.04 112.478 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 166' ' ' VAL . 24.3 m -128.58 96.51 29.98 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 121.254 0.55 . . . . 73.34 111.799 171.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.79 114.11 3.14 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.472 2.115 . . . . 74.11 112.055 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 5.2 t -107.69 161.06 15.22 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.506 0.558 . . . . 74.33 112.506 -176.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.579 HD11 ' HB1' ' A' ' 154' ' ' ALA . 22.5 tp -111.13 131.75 54.85 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.827 0.346 . . . . 64.43 111.035 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.705 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 46.9 ttm -110.96 125.67 53.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.108 -0.496 . . . . 72.54 111.252 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.86 150.39 50.45 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.623 -0.717 . . . . 74.23 109.996 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 27' ' ' VAL . 47.7 t -89.74 120.73 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.946 -0.471 . . . . 73.22 112.27 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.412 ' HA ' HG22 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -59.49 -46.9 87.47 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.049 -0.523 . . . . 74.3 110.632 179.297 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -63.37 -20.43 65.52 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.003 -0.544 . . . . 61.02 112.307 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.432 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -101.78 -19.71 15.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.315 0.487 . . . . 71.3 112.315 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.557 HG21 ' HE2' ' A' ' 28' ' ' TYR . 9.0 tp -96.01 121.4 46.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.417 0.627 . . . . 63.44 111.866 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.4 mm -99.05 112.14 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.957 0.408 . . . . 74.23 110.927 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.15 134.61 34.98 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.847 0.356 . . . . 62.23 111.466 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -129.99 144.01 51.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.497 0.665 . . . . 71.2 111.258 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.7 pttp . . . . . 0 CA--C 1.541 0.611 0 CA-C-N 115.499 -0.773 . . . . 72.51 112.093 -173.279 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.563 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.51 0.195 . . . . 61.52 110.852 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 179' ' ' GLU . 26.5 tp -84.59 125.53 32.53 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 122.134 -0.354 . . . . 73.44 110.559 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.775 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 56.2 mt -100.32 119.47 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.717 0.294 . . . . 63.42 110.884 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.865 ' HB2' HD11 ' A' ' 176' ' ' ILE . 35.7 p90 -106.59 135.49 48.02 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.3 0.571 . . . . 74.24 112.048 -178.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.531 ' HB2' HD13 ' A' ' 13' ' ' LEU . 74.6 tttt -134.53 114.34 12.72 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.017 -0.992 . . . . 64.32 110.842 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.623 ' HB2' ' H ' ' A' ' 9' ' ' THR . 6.3 m-20 -79.69 161.42 25.82 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.157 0.504 . . . . 64.33 111.263 173.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.4 pt -64.82 -21.07 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.013 -0.54 . . . . 71.41 111.258 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.454 ' HE2' ' HA ' ' A' ' 152' ' ' GLN . 36.9 p90 -109.13 -27.7 9.45 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.388 0.514 . . . . 64.31 112.388 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.623 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 4.8 m -88.88 15.37 8.55 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.236 0.541 . . . . 65.53 111.268 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -57.79 -12.66 3.23 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.516 0.562 . . . . 75.31 112.516 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.43 -61.74 1.7 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.977 0.418 . . . . 73.14 112.064 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -112.97 25.59 11.26 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.124 0.786 . . . . 70.21 113.124 -170.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -42.41 139.39 1.5 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.809 0.338 . . . . 63.1 111.532 176.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.3 m -135.62 178.19 7.23 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.66 0.615 . . . . 62.01 112.66 -168.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.559 ' HB3' HG12 ' A' ' 3' ' ' ILE . 86.6 p -124.28 125.14 43.86 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.299 0.481 . . . . 63.03 112.299 -174.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -137.62 -172.75 3.31 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.2 0.524 . . . . 73.1 111.425 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.2 m -138.45 89.73 2.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.201 -0.454 . . . . 75.23 111.082 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -142.67 132.71 12.24 Favored Pre-proline 0 N--CA 1.473 0.717 0 CA-C-N 116.556 -0.293 . . . . 73.43 111.515 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.11 145.94 14.07 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.704 2.27 . . . . 65.14 112.837 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.5 164.02 27.51 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.108 0.48 . . . . 74.33 112.243 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -121.82 104.26 9.44 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.115 -0.493 . . . . 74.32 110.881 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.5 tp -74.54 104.1 5.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.216 0.531 . . . . 73.33 111.643 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.23 134.42 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 121.341 0.591 . . . . 73.53 111.905 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.2 t70 59.22 14.24 3.48 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.085 -0.961 . . . . 71.41 112.383 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.0 t70 63.55 18.62 11.2 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.595 0.712 . . . . 73.14 110.79 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.433 ' HG ' HG13 ' A' ' 27' ' ' VAL . 59.0 tp -113.57 -50.14 2.86 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.983 -0.553 . . . . 65.15 112.441 -175.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 172' ' ' VAL . 15.5 m -133.54 150.14 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 113.04 0.756 . . . . 62.33 113.04 -175.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 170' ' ' MET . 19.3 m-85 -85.7 125.29 33.08 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.644 -0.707 . . . . 74.41 110.808 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -99.25 127.21 45.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.023 -0.535 . . . . 75.24 110.628 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.754 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 67.3 t80 -119.65 139.65 51.87 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.03 0.443 . . . . 72.22 111.34 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -90.0 126.84 35.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.081 -0.508 . . . . 72.22 111.33 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.72 173.54 14.95 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.989 -0.624 . . . . 74.14 114.44 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -133.33 153.9 51.18 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.894 0.478 . . . . 75.41 109.944 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -91.34 107.03 18.92 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.065 -0.397 . . . . 65.13 110.189 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.512 HG12 HD22 ' A' ' 44' ' ' LEU . 27.4 m -135.22 165.8 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.257 0.551 . . . . 73.55 112.272 -173.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.557 HG21 ' H ' ' A' ' 43' ' ' VAL . 32.1 m -115.9 146.56 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.396 0.517 . . . . 71.02 112.396 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.579 ' HG2' HD13 ' A' ' 72' ' ' LEU . 5.0 mmp_? -127.27 102.82 7.09 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.25 0.548 . . . . 74.15 111.172 172.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 38.2 ttmt -137.39 136.57 37.98 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.188 -0.32 . . . . 55.52 110.718 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -55.63 -24.86 35.9 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.136 0.421 . . . . 61.32 112.136 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.478 ' H ' ' HG2' ' A' ' 38' ' ' LYS . . . -129.32 35.22 2.63 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.306 -0.473 . . . . 71.02 113.279 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 25.4 tt0 -163.85 139.59 6.4 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.587 0.588 . . . . 71.44 112.587 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.487 HD13 HH21 ' A' ' 37' ' ' ARG . 5.4 tp -145.63 82.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.796 0.808 . . . . 71.22 110.925 171.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.557 ' H ' HG21 ' A' ' 36' ' ' VAL . 38.8 t -127.77 100.79 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.86 -0.609 . . . . 75.21 111.097 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.512 HD22 HG12 ' A' ' 35' ' ' VAL . 2.6 pp -113.01 2.73 15.85 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.543 0.571 . . . . 74.12 112.543 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.54 -19.18 63.7 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.131 0.789 . . . . 55.53 113.131 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.83 88.09 0.01 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.855 0.702 . . . . 64.05 114.855 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.9 p -94.88 78.4 3.63 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.061 0.458 . . . . 74.24 110.405 173.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.576 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 33.7 t30 -172.38 -53.64 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.827 0 CA-C-N 115.935 -0.575 . . . . 35.33 111.396 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 48' ' ' ASN . 91.7 Cg_endo -83.29 114.61 2.18 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.03 1.82 . . . . 70.11 112.734 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 92.7 p -73.36 -178.59 3.04 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.038 0.446 . . . . 64.15 111.607 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -133.65 -62.32 0.78 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.998 0.37 . . . . 61.02 111.998 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.571 ' HB3' ' HB2' ' A' ' 135' ' ' ASN . 1.2 mp0 69.0 -58.3 0.5 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.239 0.616 . . . . 75.03 111.66 -175.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -123.03 166.21 15.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.075 0.55 . . . . 44.15 110.262 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.5 -110.52 0.03 OUTLIER Glycine 0 CA--C 1.531 1.066 0 N-CA-C 115.309 0.884 . . . . 63.24 115.309 -169.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -138.45 -164.23 1.6 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.428 0.632 . . . . 50.23 111.674 -172.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -128.71 -40.72 1.54 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.624 -0.716 . . . . 74.52 111.547 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -69.31 153.16 44.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.949 0.722 . . . . 75.14 112.949 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.23 45.32 0.45 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.55 -0.75 . . . . 63.21 111.559 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 63' ' ' HIS . . . -59.62 -17.08 39.86 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 114.97 0.748 . . . . 65.52 114.97 -172.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.466 ' O ' HG23 ' A' ' 64' ' ' VAL . 4.6 p 73.24 152.39 0.13 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.784 0.834 . . . . 73.02 111.273 -174.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -38.5 -61.11 0.73 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.929 1.085 . . . . 74.02 113.929 -171.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.575 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 10.2 pt-20 -82.84 -13.1 56.8 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.136 0.791 . . . . 54.54 113.136 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.495 ' HB3' ' O ' ' A' ' 59' ' ' GLY . 38.7 t-80 -115.71 26.7 9.82 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.213 0.53 . . . . 74.0 111.985 -170.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 60' ' ' SER . 43.3 t -82.44 99.26 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 O-C-N 121.393 -0.817 . . . . 74.3 112.318 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 10.4 pt-20 -27.95 -40.9 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.667 1.358 . . . . 71.14 114.667 170.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -126.23 109.95 12.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.052 0.387 . . . . 72.22 111.293 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.47 -165.73 28.29 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.585 -0.817 . . . . 55.14 113.506 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.3 pt -111.61 145.56 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 122.425 -0.456 . . . . 74.14 111.895 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -46.2 -39.8 10.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.211 0.604 . . . . 73.22 112.044 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.9 mt -53.83 -49.97 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.887 -0.597 . . . . 75.41 112.503 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 23.2 m -87.72 -39.3 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.519 0.563 . . . . 51.1 112.519 -171.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.579 HD13 ' HG2' ' A' ' 37' ' ' ARG . 61.8 mt -64.42 -38.08 89.76 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.189 0.518 . . . . 63.01 111.679 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -84.48 -15.1 47.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.196 -0.457 . . . . 73.02 112.088 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -109.08 4.21 22.83 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 122.185 -0.322 . . . . 74.3 111.349 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.575 ' HG2' ' HB3' ' A' ' 62' ' ' GLU . 49.3 mtmt 58.06 71.12 0.6 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.367 0.603 . . . . 61.51 112.161 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 60.4 mt -127.23 124.16 38.26 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.516 -0.765 . . . . 62.13 110.533 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.94 148.53 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.833 0.349 . . . . 63.35 111.34 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -76.59 130.82 38.4 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.583 0.706 . . . . 74.42 112.604 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.536 ' HG3' ' HB2' ' A' ' 84' ' ' ASP . 12.5 tpt -117.22 122.77 44.92 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.061 -0.972 . . . . 54.53 108.994 171.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -82.84 139.55 33.42 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.212 0.53 . . . . 65.53 112.193 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 62.3 m -52.45 -40.05 61.81 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.204 0.816 . . . . 75.4 113.204 -174.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -57.27 -32.78 66.96 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.882 0.327 . . . . 63.35 111.882 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.48 -36.41 10.34 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.973 0.416 . . . . 71.32 110.949 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.536 ' HB2' ' HG3' ' A' ' 79' ' ' MET . 14.2 t70 -66.92 -11.42 56.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.251 -0.431 . . . . 42.42 111.594 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.597 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -36.68 -54.86 0.89 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.697 0.629 . . . . 62.2 112.697 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.7 t -67.81 -36.19 79.96 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.061 0.393 . . . . 53.42 112.061 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.2 ttm -67.84 -60.63 2.37 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 111.918 0.34 . . . . 75.4 111.918 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 16.0 p90 -62.21 -35.17 78.07 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 120.368 -0.533 . . . . 73.33 111.245 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 42.0 tptt -61.48 -39.36 90.65 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.185 0.517 . . . . 71.21 110.615 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.71 74.73 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.053 -0.521 . . . . 74.2 111.481 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -61.66 -44.76 96.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.529 -0.305 . . . . 73.52 111.519 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 88' ' ' PHE . 42.2 mm -62.04 -35.9 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 120.787 0.327 . . . . 73.22 111.301 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.07 -57.3 13.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.149 0.5 . . . . 72.3 110.831 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -59.58 -45.57 91.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.849 -0.614 . . . . 74.43 111.095 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.627 ' HE2' HG12 ' A' ' 120' ' ' ILE . 47.8 t80 -55.73 -61.54 2.29 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.399 -0.819 . . . . 73.21 111.997 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 58.6 ttp -54.59 -43.8 72.46 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.013 0.435 . . . . 72.34 111.278 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -61.59 -47.83 83.69 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.041 -0.527 . . . . 73.51 111.301 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -70.68 -44.1 67.69 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.448 0.536 . . . . 73.33 112.448 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.687 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . 35.9 m -65.04 -47.2 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.093 0.405 . . . . 70.14 112.093 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.443 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 47.3 mm -63.42 -45.61 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.898 0.38 . . . . 73.12 110.358 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -53.6 -55.4 26.08 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.964 -0.562 . . . . 62.52 112.069 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.687 ' HD2' ' HA ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -66.54 -27.51 67.81 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 122.219 -0.301 . . . . 72.42 111.244 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.496 ' HG3' HG12 ' A' ' 113' ' ' VAL . 12.1 tpt -73.84 -50.78 18.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.821 0.343 . . . . 52.25 111.337 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 9.7 pt-20 -66.35 -25.74 66.95 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.19 -0.319 . . . . 73.21 111.143 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -56.18 -39.21 72.02 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.159 0.429 . . . . 74.43 112.159 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -103.74 -37.91 7.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.037 0.754 . . . . 65.33 113.037 -175.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 108' ' ' ARG . 60.1 t30 -97.34 -35.15 10.8 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.511 0.559 . . . . 74.22 112.511 -173.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.442 ' HB3' ' O ' ' A' ' 107' ' ' ASN . 26.3 ttp180 71.59 -35.7 0.34 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.07 1.137 . . . . 74.12 114.07 174.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.55 ' O ' HG22 ' A' ' 113' ' ' VAL . 72.2 m-20 -65.71 114.38 4.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.807 0.669 . . . . 72.21 112.807 -168.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.74 -24.45 65.72 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.548 -0.751 . . . . 72.41 112.675 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.16 -32.21 58.94 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.894 0.378 . . . . 42.45 111.853 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.65 -51.31 7.85 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.548 -0.296 . . . . 73.24 111.706 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 109' ' ' ASP . 6.4 m -60.63 -31.12 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 111.947 0.351 . . . . 70.33 111.947 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.97 -38.93 83.34 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.91 0.386 . . . . 71.52 110.634 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.6 78.43 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.233 -0.44 . . . . 75.33 111.062 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.473 ' CZ ' ' HG3' ' A' ' 174' ' ' GLU . 22.2 t80 -56.85 -49.25 76.03 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.352 -0.385 . . . . 74.12 111.096 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -57.59 -32.81 67.55 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.626 -0.261 . . . . 72.21 111.067 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -66.63 -39.99 88.55 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.541 0.21 . . . . 73.31 111.286 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -53.65 -58.48 7.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.31 0.576 . . . . 73.43 111.038 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.627 HG12 ' HE2' ' A' ' 95' ' ' PHE . 10.9 tp -67.84 -32.49 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.743 -0.662 . . . . 60.34 111.568 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.41 ' NE2' HG21 ' A' ' 125' ' ' VAL . 23.3 tm0? -58.64 -52.41 65.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.729 0.299 . . . . 71.14 110.709 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.92 -42.9 96.98 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.932 -0.651 . . . . 70.44 112.528 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -58.83 -55.15 38.84 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 111.62 0.23 . . . . 73.1 111.62 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.466 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.7 m -65.25 -48.35 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.373 0.509 . . . . 62.31 112.373 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.41 HG21 ' NE2' ' A' ' 121' ' ' GLN . 92.1 t -57.98 -41.14 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.98 -0.45 . . . . 74.15 111.487 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.5 t -70.44 -47.96 58.24 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.012 0.434 . . . . 64.31 111.139 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.33 -33.81 74.23 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.311 -0.404 . . . . 72.13 111.805 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 80.8 mt -85.13 2.24 44.37 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.212 0.449 . . . . 75.22 112.212 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.62 89.06 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.304 0.574 . . . . 61.24 110.392 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 134' ' ' LYS . 36.3 ttpt -51.66 -59.66 4.03 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 114.373 1.249 . . . . 75.04 114.373 -165.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.81 -34.17 72.7 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.217 0.821 . . . . 75.2 113.217 -168.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -84.0 -53.61 5.44 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.089 0.471 . . . . 71.01 111.375 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.409 ' HD2' HD11 ' A' ' 136' ' ' LEU . 50.7 m-85 -74.46 -3.96 33.79 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.208 0.528 . . . . 62.23 111.763 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 130' ' ' LYS . 33.0 ttpt -35.79 -32.32 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.694 1.198 . . . . 74.12 113.724 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 2.7 p-10 -96.85 35.11 1.59 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.503 0.557 . . . . 73.22 112.503 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.409 HD11 ' HD2' ' A' ' 133' ' ' PHE . 38.2 mt -89.31 162.33 15.89 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.775 0.321 . . . . 61.34 110.622 170.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -132.13 133.5 44.35 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.236 0.458 . . . . 74.12 112.236 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.419 ' HB3' HG13 ' A' ' 153' ' ' VAL . 80.3 m-85 -100.82 107.57 19.16 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.641 0.257 . . . . 74.14 110.413 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 38.6 m-85 -101.54 124.74 47.69 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.863 -0.523 . . . . 74.41 111.616 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 16.9 tt -110.09 151.98 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.965 -0.562 . . . . 71.31 111.293 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.527 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -61.62 140.7 47.38 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 114.405 0.522 . . . . 50.0 114.405 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -44.18 -52.48 7.31 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.146 0.579 . . . . 72.44 112.096 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -51.58 -49.63 61.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.058 -0.519 . . . . 74.52 111.446 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.653 ' HB2' ' HA3' ' A' ' 151' ' ' GLY . . . -64.59 -50.09 68.57 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.237 0.458 . . . . 65.22 112.237 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.73 -41.24 77.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.061 0.458 . . . . 53.51 111.758 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -82.2 -24.86 34.69 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.932 -0.576 . . . . 65.2 111.465 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -101.09 -3.64 54.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.166 -0.54 . . . . 54.05 114.061 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 59.68 24.34 13.2 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.428 0.529 . . . . 74.44 112.428 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -103.51 -173.36 2.29 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.835 0.68 . . . . 64.1 112.835 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -88.98 58.1 4.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.242 0.544 . . . . 53.52 112.112 -172.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.653 ' HA3' ' HB2' ' A' ' 144' ' ' ALA . . . -70.94 167.96 50.66 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.897 -0.668 . . . . 72.12 113.085 173.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.454 ' HA ' ' HE2' ' A' ' 8' ' ' PHE . 45.9 tt0 -70.67 128.12 34.99 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.278 0.473 . . . . 63.31 112.278 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 138' ' ' PHE . 40.6 t -94.48 104.26 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.233 0.54 . . . . 73.5 110.266 170.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.737 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -80.45 136.41 36.33 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.864 -0.607 . . . . 64.15 111.56 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.569 ' HB ' ' HG3' ' A' ' 170' ' ' MET . 39.2 mm -89.23 109.4 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.846 0.355 . . . . 73.35 111.254 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.461 HG13 ' CD1' ' A' ' 139' ' ' PHE . 48.1 mm -93.91 108.12 20.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 120.968 0.413 . . . . 55.43 111.307 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -99.47 149.17 23.48 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.069 -0.968 . . . . 64.31 112.424 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -95.25 122.77 38.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.411 -0.813 . . . . 74.21 110.052 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.632 ' NH2' HG21 ' A' ' 168' ' ' THR . 4.8 ttp180 -156.39 131.08 8.93 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.613 -0.68 . . . . 74.01 112.084 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -103.54 143.91 32.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.198 -0.456 . . . . 64.13 111.521 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.13 100.89 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.454 -0.339 . . . . 72.23 110.444 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.4 t70 66.74 6.57 4.62 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 121.233 0.539 . . . . 64.22 111.514 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 128.78 -21.63 5.29 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.265 -0.493 . . . . 33.21 113.03 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 66.7 p -82.08 106.73 14.22 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.403 -0.469 . . . . 73.3 110.874 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -75.21 111.12 10.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.437 0.636 . . . . 73.32 112.391 -172.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.07 145.4 41.72 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.001 -0.545 . . . . 73.21 111.616 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -78.67 117.88 4.07 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.479 2.119 . . . . 73.51 112.213 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.632 HG21 ' NH2' ' A' ' 159' ' ' ARG . 83.5 m -107.4 122.02 45.77 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.904 0.383 . . . . 74.14 111.67 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.754 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 50.0 tp -88.87 139.94 29.95 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.566 -0.288 . . . . 75.02 110.981 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.569 ' HG3' ' HB ' ' A' ' 155' ' ' ILE . 21.1 ptp -133.87 141.26 47.32 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.714 0.768 . . . . 74.42 112.089 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -139.54 141.21 37.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.557 -1.201 . . . . 70.35 109.345 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.627 ' HA ' HG12 ' A' ' 27' ' ' VAL . 21.9 t -85.18 123.68 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.838 -0.538 . . . . 72.12 111.901 -173.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.437 ' HD3' ' OH ' ' A' ' 28' ' ' TYR . 45.2 tptt -53.17 -47.48 68.77 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.62 0.6 . . . . 55.34 112.62 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.473 ' HG3' ' CZ ' ' A' ' 116' ' ' PHE . 39.9 mm-40 -67.78 -1.92 6.24 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.433 0.531 . . . . 75.33 112.433 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -107.68 -44.55 4.23 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.521 -0.309 . . . . 64.5 110.718 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.865 HD11 ' HB2' ' A' ' 4' ' ' TYR . 9.5 tp -96.27 111.45 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 121.811 0.815 . . . . 41.5 112.193 -175.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.4 mm -105.06 144.07 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.169 -0.469 . . . . 53.34 110.749 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.93 146.83 38.3 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.63 0.729 . . . . 52.3 112.659 -175.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.775 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 8.8 tp10 -114.39 120.42 40.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.182 -0.917 . . . . 73.41 109.596 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.434 ' HB2' ' NZ ' ' A' ' 180' ' ' LYS . 4.9 ttmp? -84.15 109.25 17.58 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.419 0.526 . . . . 62.54 112.419 -171.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 1' ' ' MET . 41.0 t -132.08 89.14 2.63 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.296 0.569 . . . . 62.12 111.044 173.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.69 -63.8 1.24 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.986 -0.552 . . . . 75.45 109.94 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.634 -0.698 . . . . 72.41 111.191 175.22 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.675 0.274 . . . . 75.11 111.125 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.6 tp -89.52 131.47 35.53 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.985 0.422 . . . . 71.22 110.806 174.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 56.7 mt -118.94 120.58 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.385 . . . . 73.15 110.776 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -115.0 133.93 55.62 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.73 0.776 . . . . 72.2 111.244 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.409 ' HG2' ' CD1' ' A' ' 13' ' ' LEU . 34.9 mtpt -120.12 120.0 34.94 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.021 -0.991 . . . . 75.41 111.178 -172.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.93 177.5 3.64 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.764 0.654 . . . . 63.32 112.764 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -70.68 -57.03 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.012 -0.54 . . . . 52.31 111.502 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -102.15 -41.36 6.43 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.529 0.566 . . . . 74.01 112.529 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.54 HG21 ' HA2' ' A' ' 151' ' ' GLY . 12.1 p -80.48 16.28 1.39 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.542 0.571 . . . . 74.34 112.542 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -47.02 -34.7 5.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.16 0.584 . . . . 71.43 111.638 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.44 -39.61 80.32 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.529 0.566 . . . . 64.23 112.529 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -65.96 -33.49 75.94 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.546 0.213 . . . . 72.21 111.279 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.409 ' CD1' ' HG2' ' A' ' 5' ' ' LYS . 11.9 tp 57.2 112.2 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.441 0.904 . . . . 72.24 113.441 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.7 m -104.24 124.79 49.78 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.844 -0.535 . . . . 63.23 111.374 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 83.1 p -140.22 142.17 35.86 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.403 0.52 . . . . 70.21 112.403 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -171.61 -147.87 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.848 -0.614 . . . . 52.3 110.657 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 p -150.06 30.01 0.72 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.331 0.493 . . . . 70.33 112.331 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 97.9 m-85 -89.74 123.41 66.49 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.792 0.33 . . . . 73.12 111.503 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 12.0 Cg_exo -70.8 144.65 49.06 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.237 2.625 . . . . 53.33 113.959 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.434 ' SD ' ' C ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -131.89 166.35 21.82 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.751 -0.658 . . . . 52.13 111.496 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -130.98 136.77 48.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.86 0.362 . . . . 73.44 111.166 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 55.0 tp -87.26 109.34 19.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.061 0.458 . . . . 75.24 112.065 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -98.57 142.99 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.989 0.424 . . . . 71.42 111.041 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 t70 63.11 6.87 2.47 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.986 -0.552 . . . . 73.11 111.432 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.403 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 28.7 m-20 56.52 28.67 14.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.151 0.5 . . . . 65.24 111.979 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.2 tp -134.17 -44.01 0.78 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.102 -0.499 . . . . 64.25 111.861 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' A' ' 172' ' ' VAL . 12.7 m -125.24 148.95 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 112.524 0.565 . . . . 74.02 112.524 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -88.17 151.12 22.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.169 -0.469 . . . . 75.4 112.009 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -107.57 140.88 39.9 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.471 -0.786 . . . . 64.12 111.591 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.715 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 47.9 t80 -139.99 105.75 5.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.21 -0.663 . . . . 71.53 109.21 165.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.614 ' HB3' HG22 ' A' ' 168' ' ' THR . 13.1 ptpt -109.93 121.78 46.04 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.797 0.665 . . . . 74.32 112.797 -171.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.9 -152.85 8.64 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.91 -0.586 . . . . 61.22 113.601 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -117.3 174.07 6.34 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.108 0.48 . . . . 64.51 112.097 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.442 ' CE1' ' HD3' ' A' ' 167' ' ' PRO . 68.7 m80 -97.2 110.58 23.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.071 -0.513 . . . . 75.0 110.073 172.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.68 ' HA ' HD11 ' A' ' 44' ' ' LEU . 18.4 m -135.63 140.77 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.318 0.58 . . . . 64.43 112.18 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 30.2 m -120.0 117.2 52.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.342 0.591 . . . . 62.52 111.338 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.682 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 66.4 ttt180 -99.8 108.09 20.3 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.099 -0.501 . . . . 71.03 110.547 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.472 ' HA ' HG13 ' A' ' 64' ' ' VAL . 62.6 tttm -85.13 112.38 20.63 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.054 -0.521 . . . . 65.54 110.594 -174.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 63.13 -68.29 0.08 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.011 0.525 . . . . 64.33 111.056 -173.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -152.96 -0.56 0.21 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.452 -0.404 . . . . 54.31 113.651 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -105.16 137.89 42.23 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.341 0.497 . . . . 74.22 112.341 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.0 mm -78.31 92.42 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.218 0.532 . . . . 71.54 110.241 173.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -98.89 -42.84 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.643 0.608 . . . . 64.32 112.643 -174.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.68 HD11 ' HA ' ' A' ' 35' ' ' VAL . 4.3 mm? 58.42 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.921 0.711 . . . . 72.24 112.921 -176.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.92 109.03 7.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.791 -0.641 . . . . 72.51 110.116 173.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.04 74.14 0.36 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.229 -0.51 . . . . 53.44 113.086 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.4 p -99.41 126.33 45.29 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.347 0.594 . . . . 71.25 111.918 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.698 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 19.0 p-10 -80.39 177.56 2.9 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.977 -0.556 . . . . 75.02 109.518 170.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.698 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 30.4 Cg_endo -64.0 68.37 0.21 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 121.759 1.64 . . . . 74.34 112.463 173.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.3 t -149.69 129.47 13.29 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.825 -0.625 . . . . 71.21 110.398 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.03 7.64 5.55 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.113 0.483 . . . . 72.4 111.848 -174.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -98.01 22.02 9.92 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.267 0.556 . . . . 70.32 110.43 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -100.96 38.74 1.49 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.029 -0.532 . . . . 70.21 112.281 -173.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.9 81.78 0.03 OUTLIER Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.672 -0.299 . . . . 60.12 113.41 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.15 -20.91 66.68 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.467 0.543 . . . . 35.33 112.467 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.75 14.23 23.91 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.218 0.451 . . . . 73.53 112.218 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -115.09 161.85 17.81 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.768 0.318 . . . . 73.15 110.958 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -70.37 -12.78 61.81 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.942 0.349 . . . . 74.24 111.942 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.28 55.65 2.57 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.382 -0.437 . . . . 75.2 112.407 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.2 t -74.69 13.35 0.64 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 112.359 0.503 . . . . 70.24 112.359 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.66 -15.6 57.29 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.84 0.681 . . . . 72.54 112.84 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.05 -32.13 23.04 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.992 -0.443 . . . . 62.1 111.474 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -88.28 10.93 17.99 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.212 0.449 . . . . 73.45 112.212 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.652 ' HB ' ' HD2' ' A' ' 66' ' ' ARG . 93.9 t -73.22 131.35 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.043 -0.354 . . . . 61.54 110.043 171.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.682 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 27.7 tt0 -77.55 68.65 3.68 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.28 1.038 . . . . 61.15 109.299 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.652 ' HD2' ' HB ' ' A' ' 64' ' ' VAL . 11.0 ptm180 -104.67 140.38 38.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.597 -1.183 . . . . 72.31 111.927 -173.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.94 -131.11 3.72 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.548 -0.834 . . . . 32.4 113.785 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.429 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 32.3 pt -111.09 139.77 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 122.461 -0.435 . . . . 71.41 111.608 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -48.29 -35.76 12.83 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.078 -0.51 . . . . 61.1 112.355 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' A' ' 169' ' ' LEU . 68.4 mt -52.56 -58.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.201 0.524 . . . . 64.13 112.221 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.5 m -75.25 -33.59 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.142 -0.481 . . . . 75.11 111.688 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 64.8 mt -64.98 -34.49 78.57 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.966 0.413 . . . . 73.24 111.037 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -57.55 -48.66 78.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.247 -0.433 . . . . 65.11 111.94 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -99.04 -3.45 34.75 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.325 0.491 . . . . 64.42 112.325 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 59.56 70.86 0.61 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.623 0.725 . . . . 62.51 111.525 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 60.4 mt -98.3 127.78 44.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.667 -0.697 . . . . 74.43 110.951 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.94 143.85 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.66 0.266 . . . . 70.55 110.849 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -84.8 150.91 24.72 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.569 0.7 . . . . 55.5 112.838 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.2 ttm -145.19 138.33 26.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.459 -0.791 . . . . 75.35 110.413 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.526 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 18.0 m-80 -109.77 167.55 10.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.08 -0.509 . . . . 74.34 111.102 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 79.6 m -55.43 -38.92 69.63 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.553 0.945 . . . . 73.4 113.553 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.526 ' CE1' ' HB2' ' A' ' 80' ' ' ASN . 10.8 p90 -65.5 -23.23 66.84 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.654 -0.654 . . . . 73.31 111.406 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -94.13 -32.5 13.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.197 0.523 . . . . 74.32 110.732 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.1 -16.14 38.98 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.606 -0.725 . . . . 60.41 112.31 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.481 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . . . -43.21 -57.55 2.91 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.693 0.627 . . . . 65.44 112.693 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 t -69.92 -27.53 64.85 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 55.23 111.524 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.4 mmt -70.92 -63.36 1.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.535 -0.302 . . . . 65.53 111.637 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.481 ' CE1' ' HA ' ' A' ' 85' ' ' ALA . 5.0 p90 -60.44 -34.3 73.78 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.351 -0.218 . . . . 75.45 111.312 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -58.12 -54.39 47.54 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.935 0.398 . . . . 62.15 111.222 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.96 -35.56 81.58 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.141 0.496 . . . . 61.14 111.059 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.631 ' HE2' ' HG3' ' A' ' 152' ' ' GLN . 56.5 t80 -56.71 -57.02 14.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.765 -0.652 . . . . 73.11 111.043 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 88' ' ' PHE . 48.2 mm -57.83 -37.33 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.768 0.318 . . . . 72.11 111.631 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -60.13 -56.66 18.91 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.005 0.372 . . . . 73.34 112.005 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -72.32 -36.59 68.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.946 0.403 . . . . 75.33 111.835 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.42 ' O ' HG22 ' A' ' 99' ' ' VAL . 55.2 t80 -60.34 -55.34 34.76 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.075 -0.511 . . . . 65.45 111.229 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.1 ttt -54.87 -44.38 73.97 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.172 -0.467 . . . . 65.54 111.317 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -62.89 -46.62 86.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.372 -0.376 . . . . 53.53 111.612 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -63.44 -51.87 63.88 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.686 0.279 . . . . 75.31 111.625 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.487 ' O ' ' SD ' ' A' ' 103' ' ' MET . 32.1 m -64.07 -41.8 93.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.542 0.571 . . . . 71.44 112.542 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.7 mm -66.81 -46.45 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 121.755 -0.591 . . . . 75.33 110.983 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.99 -34.22 75.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.181 0.515 . . . . 73.12 110.993 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -68.93 -57.41 5.54 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.786 -0.643 . . . . 73.44 111.385 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 99' ' ' VAL . 0.2 OUTLIER -66.64 -44.72 81.2 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.007 0.743 . . . . 42.52 113.007 -175.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -50.46 -48.19 56.65 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.367 0.506 . . . . 74.53 112.367 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -60.41 -14.64 20.06 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.821 0.674 . . . . 72.35 112.821 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -115.4 -33.65 5.2 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.358 0.599 . . . . 53.03 111.564 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.465 ' O ' HG13 ' A' ' 113' ' ' VAL . 32.6 m-80 -122.13 28.52 7.46 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.665 -0.698 . . . . 72.32 111.886 -173.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.502 HH11 ' HB2' ' A' ' 109' ' ' ASP . 3.3 ppt_? -38.41 -23.81 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.874 1.805 . . . . 71.22 115.874 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.502 ' HB2' HH11 ' A' ' 108' ' ' ARG . 21.3 t70 -63.38 136.85 57.91 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.792 0.724 . . . . 71.02 111.269 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 110' ' ' LYS . 13.0 mptt -68.95 4.64 1.43 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.306 0.854 . . . . 75.45 113.306 -171.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.5 -47.88 6.91 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.996 0.427 . . . . 55.32 110.848 170.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -70.62 -58.09 4.04 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.989 -0.55 . . . . 72.55 112.234 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 107' ' ' ASN . 5.3 m -61.77 -32.54 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.793 0.294 . . . . 51.01 111.793 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -66.96 -43.25 83.6 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.77 0.319 . . . . 74.25 110.98 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -58.71 -51.42 70.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.028 0.442 . . . . 54.32 110.919 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.695 ' HE1' ' HG3' ' A' ' 174' ' ' GLU . 65.1 t80 -56.11 -50.1 72.0 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.003 -0.544 . . . . 65.25 111.148 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -51.57 -47.18 63.57 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.096 -0.502 . . . . 71.3 111.426 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -66.22 -34.64 78.48 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.013 0.375 . . . . 72.21 112.013 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 31.2 mmmt -60.62 -54.48 44.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.1 0.476 . . . . 70.45 111.301 177.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -71.37 -31.71 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.973 0.416 . . . . 72.02 111.128 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -61.48 -48.87 79.1 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.914 0.388 . . . . 72.14 110.927 176.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.02 -37.19 93.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.867 -0.682 . . . . 62.42 112.431 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.42 ' NE1' ' SD ' ' A' ' 170' ' ' MET . 51.7 t90 -61.77 -56.45 19.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.38 0.272 . . . . 73.44 111.343 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.468 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 m -63.21 -45.78 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.437 0.532 . . . . 73.53 112.437 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 121' ' ' GLN . 82.8 t -56.6 -46.61 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.852 0.358 . . . . 73.01 111.759 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.2 p -70.7 -38.19 73.64 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.968 0.413 . . . . 72.11 111.262 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.448 HD21 HD13 ' A' ' 155' ' ' ILE . 36.5 tp -67.64 -36.3 80.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.255 -0.43 . . . . 72.41 112.124 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 78.8 mt -80.71 2.29 26.61 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.503 0.557 . . . . 61.04 112.503 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 133' ' ' PHE . . . -66.89 87.07 0.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.408 0.623 . . . . 65.34 110.797 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -62.74 -22.75 66.79 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.841 1.052 . . . . 73.32 113.841 -169.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' O ' ' NZ ' ' A' ' 134' ' ' LYS . 24.8 t70 -58.79 -47.33 85.1 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.084 -0.385 . . . . 63.22 111.958 -173.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -102.49 -38.4 7.57 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.136 0.493 . . . . 71.31 111.122 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.408 ' HD2' HD11 ' A' ' 136' ' ' LEU . 45.3 m-85 -68.5 -5.43 19.45 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.714 0.635 . . . . 63.33 112.714 -176.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.427 ' NZ ' ' O ' ' A' ' 131' ' ' ASP . 23.6 pttm -62.37 -7.1 3.87 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.762 -0.586 . . . . 64.34 110.914 168.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.66 9.31 16.61 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 116.32 -0.4 . . . . 72.32 110.689 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.48 ' CD2' ' HA ' ' A' ' 157' ' ' GLU . 90.8 mt -88.65 162.91 16.06 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.905 0.383 . . . . 74.31 111.49 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.66 137.67 40.3 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.445 -0.343 . . . . 52.53 111.415 175.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.698 ' HB3' HG11 ' A' ' 153' ' ' VAL . 89.0 m-85 -100.08 120.92 40.59 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.727 0.299 . . . . 70.53 110.647 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 52.9 m-85 -122.45 139.97 53.26 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.188 0.518 . . . . 64.31 112.081 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.521 HD13 ' N ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -137.67 147.68 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.092 -0.504 . . . . 75.41 110.013 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.521 ' N ' HD13 ' A' ' 140' ' ' ILE . . . -51.14 126.17 26.34 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.433 -0.413 . . . . 65.41 114.046 -176.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -51.59 -59.67 4.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.844 0.354 . . . . 75.05 111.777 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -60.88 -32.29 71.73 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.865 0.364 . . . . 64.43 111.388 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.08 -53.1 50.79 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.541 -0.3 . . . . 74.04 111.139 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.477 ' HB2' HD12 ' A' ' 140' ' ' ILE . . . -64.53 -20.26 66.11 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.07 0.462 . . . . 74.33 111.615 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -69.61 -26.03 64.24 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.013 -0.54 . . . . 71.2 110.811 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -113.63 -58.2 0.4 Allowed Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.13 -0.486 . . . . 61.4 112.307 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.86 92.08 8.54 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.175 0.512 . . . . 61.31 110.97 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.68 -2.46 11.82 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.008 -0.542 . . . . 73.23 112.375 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -124.79 27.56 6.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.763 0.425 . . . . 74.15 110.987 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.54 ' HA2' HG21 ' A' ' 9' ' ' THR . . . -57.67 155.27 20.02 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.961 -0.563 . . . . 71.11 114.432 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.631 ' HG3' ' HE2' ' A' ' 91' ' ' TYR . 43.4 tt0 -68.34 128.93 38.37 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.137 0.494 . . . . 55.41 111.653 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.698 HG11 ' HB3' ' A' ' 138' ' ' PHE . 68.7 t -91.66 144.06 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.239 0.542 . . . . 71.14 112.393 -177.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.806 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -102.93 137.12 41.56 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.803 -0.635 . . . . 54.33 110.409 174.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.448 HD13 HD21 ' A' ' 127' ' ' LEU . 59.9 mt -95.27 126.54 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.381 0.512 . . . . 70.34 112.381 -172.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.1 mm -95.83 110.89 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.494 -0.321 . . . . 74.24 110.858 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.48 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 55.2 tt0 -96.22 148.78 22.37 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.842 -0.617 . . . . 73.04 111.934 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -98.23 123.23 42.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.814 -0.63 . . . . 73.3 110.558 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -121.15 114.49 21.51 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.975 0.417 . . . . 72.0 111.609 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.85 106.04 4.03 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.905 0.384 . . . . 72.33 111.116 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.28 107.66 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 120.742 0.306 . . . . 72.22 110.863 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 58.41 17.92 5.19 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.435 0.531 . . . . 73.11 112.435 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 114.86 -21.86 13.3 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.151 -0.547 . . . . 70.04 113.644 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 83.8 m -105.62 129.39 53.88 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.167 0.483 . . . . 62.5 111.355 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 0.1 OUTLIER -73.28 128.27 35.0 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.397 0.617 . . . . 53.14 112.429 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.76 148.66 39.79 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.05 -0.523 . . . . 71.13 110.532 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.442 ' HD3' ' CE1' ' A' ' 34' ' ' HIS . 93.7 Cg_endo -87.12 120.9 1.64 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.425 2.083 . . . . 71.35 112.66 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.614 HG22 ' HB3' ' A' ' 31' ' ' LYS . 39.9 p -117.51 119.0 33.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.215 0.531 . . . . 52.45 111.446 177.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.806 HD11 ' HB1' ' A' ' 154' ' ' ALA . 60.2 tp -76.78 130.43 37.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.084 -0.507 . . . . 64.12 110.59 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.42 ' SD ' ' NE1' ' A' ' 123' ' ' TRP . 50.8 ttm -116.15 124.34 50.08 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 116.178 -0.464 . . . . 63.02 111.385 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.9 mt -135.85 124.73 24.08 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.985 -0.552 . . . . 73.51 111.902 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.499 ' HA ' HG12 ' A' ' 27' ' ' VAL . 41.4 t -71.22 118.7 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 122.205 -0.309 . . . . 74.14 111.439 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -66.99 -19.91 65.8 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.023 0.44 . . . . 60.42 111.558 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.695 ' HG3' ' HE1' ' A' ' 116' ' ' PHE . 4.8 mm-40 -81.76 -8.96 59.75 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.989 0.423 . . . . 70.21 111.134 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.37 -44.29 6.94 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.057 0.456 . . . . 61.11 110.92 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 27.2 pt -100.28 128.85 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.196 0.522 . . . . 74.02 111.163 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 177' ' ' ILE . 1.7 mp -93.34 117.99 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 73.34 110.225 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.45 137.81 32.02 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.793 0.806 . . . . 71.51 112.48 -177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -144.78 99.82 3.41 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.229 -0.896 . . . . 65.41 109.69 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.76 128.26 38.56 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.719 0.637 . . . . 72.13 112.719 -172.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 82.5 m -112.94 87.08 2.5 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.238 0.542 . . . . 61.54 109.831 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 175.19 -176.22 0.1 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.238 -0.892 . . . . 74.53 109.9 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.252 1.186 0 N-CA-C 112.237 0.458 . . . . 73.45 112.237 178.527 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.506 ' O ' ' HB3' ' A' ' 181' ' ' CYS . 18.9 ptt? . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.61 0.243 . . . . 73.14 110.929 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.6 tp -80.23 132.38 35.85 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.954 0.407 . . . . 70.12 111.437 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.628 ' HB ' HD11 ' A' ' 13' ' ' LEU . 8.6 pt -117.13 121.39 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.239 0.542 . . . . 61.24 111.658 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -101.59 122.31 43.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.083 -0.508 . . . . 71.22 111.112 -174.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.451 ' HG3' HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -111.66 118.73 36.47 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 111.988 0.366 . . . . 64.45 111.988 179.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.74 132.62 40.6 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.838 0.351 . . . . 51.31 111.142 172.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 tt -48.23 -47.11 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 112.821 0.674 . . . . 73.14 112.821 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -110.24 -2.59 16.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.411 0.893 . . . . 75.35 113.411 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 9' ' ' THR . 28.5 m -127.21 16.81 7.19 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.195 0.522 . . . . 53.11 111.994 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -50.43 -13.84 0.15 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.282 0.845 . . . . 75.12 113.282 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -53.93 -40.96 67.19 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.887 0.375 . . . . 63.44 111.415 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -85.95 24.94 1.19 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 120.857 0.361 . . . . 73.55 111.38 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.628 HD11 ' HB ' ' A' ' 3' ' ' ILE . 25.0 tp -31.28 120.32 0.23 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.396 0.887 . . . . 62.33 113.396 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -97.85 140.31 32.41 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.181 -0.463 . . . . 63.43 110.785 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.9 p -128.88 96.52 4.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.835 0.35 . . . . 62.4 111.272 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -147.18 -168.85 3.16 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.202 0.525 . . . . 75.41 111.742 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.7 m -127.3 82.97 2.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.172 -0.467 . . . . 42.32 110.663 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -114.16 121.91 35.55 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.136 0.421 . . . . 75.23 112.136 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.31 103.01 1.62 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.664 2.243 . . . . 71.05 112.618 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.57 166.25 11.94 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.308 0.575 . . . . 72.33 112.315 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 25.6 mtpp -123.99 107.81 11.72 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.136 -0.484 . . . . 73.04 111.102 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.406 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 44.0 tp -79.43 94.38 5.54 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.939 -0.476 . . . . 73.03 111.248 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.76 138.88 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.985 0.422 . . . . 72.54 111.683 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.8 t70 57.7 13.38 1.96 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.84 -0.618 . . . . 53.43 112.007 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.406 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 7.9 m-20 63.18 14.6 7.86 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.571 0.348 . . . . 72.13 111.751 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.512 ' HA ' ' HZ2' ' A' ' 173' ' ' LYS . 52.1 tp -114.45 -50.87 2.78 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.966 0.358 . . . . 72.14 111.966 -176.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 172' ' ' VAL . 4.9 m -130.01 152.03 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.207 0.527 . . . . 71.12 112.353 -175.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.441 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 90.4 m-85 -90.95 120.18 31.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.928 -0.578 . . . . 72.34 110.996 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 8.6 pt-20 -99.58 105.64 17.53 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.273 0.559 . . . . 73.51 110.398 172.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.474 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 41.0 t80 -91.64 137.74 32.13 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.027 -0.42 . . . . 73.2 111.169 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.507 ' HE3' HG21 ' A' ' 161' ' ' VAL . 12.1 mmmm -81.82 121.94 27.08 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.15 -0.477 . . . . 73.41 112.047 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.502 ' HA3' HG12 ' A' ' 70' ' ' ILE . . . -121.71 173.18 15.66 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.316 -0.469 . . . . 43.14 113.196 176.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.01 140.55 50.86 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.384 -0.48 . . . . 75.12 111.09 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -73.43 119.77 18.11 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.509 -0.314 . . . . 70.45 110.393 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.7 m -143.77 178.12 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.462 1.125 . . . . 63.31 113.788 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.4 m -123.25 129.99 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.327 -1.306 . . . . 75.41 109.931 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.441 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.7 OUTLIER -128.63 108.3 10.39 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.572 0.582 . . . . 72.42 112.572 -174.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 pttt -134.71 142.01 46.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.337 -0.616 . . . . 70.32 109.337 169.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 59.45 12.41 2.71 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.215 0.45 . . . . 33.33 112.215 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.56 -2.58 87.92 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.478 -0.392 . . . . 32.05 112.939 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -100.6 -171.71 2.06 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.133 0.492 . . . . 71.1 112.122 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.642 HG12 ' H ' ' A' ' 44' ' ' LEU . 9.9 tt -146.78 130.18 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 116.081 -0.509 . . . . 75.45 111.009 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.0 m -103.83 14.67 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 112.324 0.49 . . . . 73.12 112.324 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.642 ' H ' HG12 ' A' ' 42' ' ' ILE . 2.7 mp -109.71 152.6 25.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.009 0.433 . . . . 64.22 111.581 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.55 -45.53 7.7 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.033 -0.531 . . . . 65.24 111.745 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.21 -81.05 0.05 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.902 -0.666 . . . . 73.15 113.768 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.8 p -103.85 151.45 23.08 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.261 -0.552 . . . . 74.33 111.888 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 61.72 89.93 0.1 OUTLIER Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 123.226 0.611 . . . . 74.43 112.573 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.31 141.92 88.45 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.995 2.463 . . . . 75.33 113.392 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.1 p -90.3 177.15 6.48 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.053 0.454 . . . . 61.42 112.057 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.75 16.16 2.14 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.246 -0.434 . . . . 72.45 111.616 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.07 -24.44 67.46 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.134 0.493 . . . . 74.11 111.892 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -82.83 24.82 0.71 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.11 -0.495 . . . . 73.12 111.537 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.51 73.26 0.23 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.673 -0.299 . . . . 32.21 113.823 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.24 -57.82 0.07 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.812 0.339 . . . . 74.21 111.025 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 59.29 90.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.596 0.712 . . . . 72.0 112.333 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -132.6 112.97 12.5 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.814 -0.63 . . . . 70.4 110.948 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t70 70.27 -63.96 0.38 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.487 0.715 . . . . 71.51 112.457 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.24 67.61 1.18 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 114.366 0.506 . . . . 54.15 114.366 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.9 m -156.14 67.81 0.6 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.312 0.645 . . . . 74.54 109.846 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -47.29 -63.77 0.96 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.762 1.023 . . . . 71.44 113.762 -170.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -103.99 1.89 31.66 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.414 0.626 . . . . 74.2 111.055 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 73.4 m80 56.59 19.8 4.5 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.829 0.677 . . . . 75.5 112.829 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.0 t -63.32 -76.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 122.36 -0.212 . . . . 73.11 111.107 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 70.41 -32.05 0.23 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.377 0.88 . . . . 61.04 113.377 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -115.97 129.76 56.53 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.4 -0.813 . . . . 61.41 111.879 -169.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' A' ' 72' ' ' LEU . . . 160.19 164.61 15.55 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 119.131 -1.509 . . . . 64.42 114.9 167.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 pt -90.13 138.47 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 122.42 -0.459 . . . . 71.51 110.294 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -48.41 -32.47 7.7 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.775 0.321 . . . . 61.24 111.822 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.502 HG12 ' HA3' ' A' ' 32' ' ' GLY . 35.6 mm -48.48 -58.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.38 0.609 . . . . 72.32 112.056 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 16.4 m -81.14 -28.4 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.993 -0.548 . . . . 73.32 112.136 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' A' ' 67' ' ' GLY . 55.2 mt -71.04 -33.61 70.48 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.953 0.406 . . . . 74.4 111.188 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -58.4 -48.62 80.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.124 -0.489 . . . . 62.45 112.252 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -109.68 13.74 23.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.851 0.315 . . . . 71.4 111.851 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 54.76 71.2 0.55 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.135 0.493 . . . . 73.43 111.916 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 75.3 mt -103.07 125.54 49.85 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 122.2 -0.313 . . . . 73.24 111.248 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.2 145.33 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.75 0.31 . . . . 72.15 110.789 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.24 137.3 35.85 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.026 0.75 . . . . 75.42 113.026 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 78.1 mtp -125.91 145.5 50.24 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.058 -0.974 . . . . 65.05 108.887 169.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.501 ' HB2' ' CD1' ' A' ' 82' ' ' TYR . 16.8 m120 -115.93 -162.28 0.83 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.326 0.584 . . . . 61.23 112.398 -171.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.1 p -100.27 -2.5 33.57 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.148 0.795 . . . . 51.53 113.148 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CD1' ' HB2' ' A' ' 80' ' ' ASN . 24.1 p90 -79.15 -61.4 2.02 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.113 0.782 . . . . 72.42 113.113 -170.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -105.3 -17.51 14.43 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.719 0.771 . . . . 74.43 111.208 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.86 9.53 1.12 Allowed 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.26 -0.882 . . . . 75.54 112.165 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -46.76 -56.91 5.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.193 0.597 . . . . 72.45 112.592 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.0 m -53.35 -36.35 61.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.874 0.369 . . . . 74.33 111.643 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 51.4 tpp -73.88 -63.89 1.12 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.282 0.475 . . . . 73.44 112.282 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -68.47 -29.07 67.62 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.863 -0.523 . . . . 75.52 112.305 -174.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -72.69 -41.81 64.93 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.917 -0.313 . . . . 72.43 110.909 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.71 -39.37 91.26 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.01 0.433 . . . . 74.3 110.325 173.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -57.11 -59.23 5.4 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.996 -0.547 . . . . 72.42 111.775 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.7 tp -62.4 -39.03 82.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 112.263 0.468 . . . . 71.41 112.263 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -71.49 -44.63 64.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 111.99 0.366 . . . . 71.11 111.99 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -63.67 -44.84 92.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.261 0.553 . . . . 74.54 110.287 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.475 ' O ' HG22 ' A' ' 99' ' ' VAL . 48.9 t80 -56.22 -58.07 9.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.505 -0.77 . . . . 74.42 111.283 174.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 53.0 tpp -51.56 -54.07 31.41 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.112 -0.495 . . . . 74.33 111.76 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -57.92 -44.74 87.05 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.962 0.356 . . . . 64.44 111.962 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -72.09 -45.98 58.56 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.368 0.507 . . . . 40.54 112.368 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 95' ' ' PHE . 35.8 m -67.83 -38.05 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 122.186 -0.321 . . . . 42.43 111.615 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.9 mm -63.77 -48.64 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.63 0.253 . . . . 73.44 110.603 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 17.1 t70 -52.51 -47.39 66.65 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.08 0.466 . . . . 71.15 111.873 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -71.15 -42.94 68.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.545 -0.298 . . . . 73.41 111.625 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.549 ' HG3' HG12 ' A' ' 113' ' ' VAL . 12.7 tpt -59.88 -43.18 94.91 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.824 0.305 . . . . 74.34 111.824 -178.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -65.96 -28.55 68.99 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.837 0.31 . . . . 72.24 111.837 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.1 mtmm -69.52 -8.0 43.23 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.251 0.463 . . . . 73.3 112.251 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -99.97 -31.71 11.33 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.301 0.572 . . . . 70.4 110.332 172.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.732 HD21 ' HB3' ' A' ' 111' ' ' ALA . 28.3 t-20 -123.64 -80.34 0.62 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.583 -0.735 . . . . 62.55 111.929 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 73.7 ttt180 72.25 -15.74 0.46 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.915 0.709 . . . . 64.44 112.915 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -80.22 8.89 6.43 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.935 -0.478 . . . . 74.23 111.771 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 57.5 mtmt 60.52 20.23 10.02 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.219 0.533 . . . . 75.0 112.137 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.732 ' HB3' HD21 ' A' ' 107' ' ' ASN . . . -85.42 -62.54 1.51 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.105 -0.498 . . . . 72.34 110.288 172.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -79.52 -46.71 16.87 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.401 -0.363 . . . . 73.3 111.601 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.549 HG12 ' HG3' ' A' ' 103' ' ' MET . 28.0 m -63.81 -29.61 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 113.176 0.806 . . . . 74.12 113.176 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.39 -39.07 68.27 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 122.012 -0.43 . . . . 73.55 110.238 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.64 -47.54 69.28 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.172 -0.467 . . . . 43.13 111.195 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -53.89 -48.86 69.69 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.152 -0.476 . . . . 75.35 110.503 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -54.26 -47.69 72.01 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.696 -0.684 . . . . 75.22 111.317 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -56.27 -43.33 78.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.235 -0.439 . . . . 73.24 111.123 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -66.81 -60.49 2.62 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.942 0.349 . . . . 65.34 111.942 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -60.94 -35.07 62.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 111.905 0.335 . . . . 72.54 111.905 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.47 ' O ' HG23 ' A' ' 125' ' ' VAL . 58.5 tp60 -67.09 -43.21 83.15 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.687 0.279 . . . . 74.31 110.627 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.23 -35.47 88.1 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.828 -0.701 . . . . 71.45 112.271 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.5 t90 -63.89 -51.7 63.32 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.296 0.238 . . . . 72.25 111.222 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.433 HG22 ' HA ' ' A' ' 121' ' ' GLN . 30.8 m -67.61 -38.03 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 112.306 0.484 . . . . 64.34 112.306 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 121' ' ' GLN . 52.9 t -57.78 -46.55 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.357 0.599 . . . . 74.15 110.854 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.6 m -67.83 -48.95 64.78 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.087 -0.506 . . . . 73.11 111.31 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.22 -41.5 96.97 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.05 0.54 . . . . 61.14 112.447 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.0 mt -84.82 3.31 38.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.243 0.46 . . . . 65.13 112.243 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.46 86.41 0.11 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.337 0.589 . . . . 74.5 110.929 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -54.5 -20.4 7.65 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.62 0.971 . . . . 65.35 113.62 -172.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.81 -47.53 77.71 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.649 0.611 . . . . 64.44 112.649 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -109.91 -30.69 7.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.446 0.535 . . . . 72.23 112.446 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -85.66 -7.11 59.01 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.147 0.795 . . . . 63.41 113.147 -171.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.86 -19.8 66.07 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.726 -0.608 . . . . 73.24 110.538 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -78.95 10.02 3.78 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.002 -0.545 . . . . 70.5 111.873 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.448 HD22 ' HA ' ' A' ' 157' ' ' GLU . 88.0 mt -89.06 161.21 16.67 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.971 0.415 . . . . 74.02 110.948 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.43 137.48 54.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.64 -0.254 . . . . 74.23 111.644 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.665 ' HB3' HG13 ' A' ' 153' ' ' VAL . 56.8 m-85 -107.88 106.96 17.48 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 122.273 -0.267 . . . . 65.54 110.667 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.617 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 39.8 m-85 -102.51 143.67 31.93 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.196 0.522 . . . . 75.4 112.273 -176.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.7 tt -130.5 150.81 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.835 -0.62 . . . . 65.12 110.626 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.44 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -56.21 135.69 49.49 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.352 -0.452 . . . . 61.45 113.669 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.25 -39.62 66.98 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.091 0.472 . . . . 64.11 111.393 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -69.07 -55.92 9.3 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.081 -0.509 . . . . 74.43 111.296 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.07 -25.59 67.05 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.203 0.446 . . . . 43.31 112.203 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.44 -19.03 61.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.75 0.648 . . . . 74.02 112.75 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -70.47 -12.02 61.3 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.225 0.536 . . . . 60.25 111.144 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.41 41.2 2.81 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.369 -0.443 . . . . 62.44 112.967 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.12 -71.72 0.16 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.012 0.434 . . . . 75.23 111.769 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -123.8 -77.39 0.59 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.126 0.488 . . . . 71.51 110.223 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -134.79 -59.98 0.79 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.929 -0.578 . . . . 60.21 110.401 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.445 ' HA2' HG21 ' A' ' 9' ' ' THR . . . 103.28 139.56 10.4 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.294 -0.479 . . . . 73.14 112.837 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -73.73 112.2 9.61 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 122.548 -0.383 . . . . 35.02 111.47 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 138' ' ' PHE . 58.8 t -77.49 88.0 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.648 0.737 . . . . 74.31 110.079 169.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.963 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -79.4 117.53 20.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.534 -0.757 . . . . 70.31 110.471 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.777 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 58.1 mt -88.53 134.73 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.028 0.442 . . . . 52.22 111.991 -172.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.4 mm -103.22 115.48 45.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 116.443 -0.344 . . . . 74.15 111.063 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.448 ' HA ' HD22 ' A' ' 136' ' ' LEU . 38.2 tt0 -108.33 145.4 34.5 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 123.73 0.644 . . . . 74.42 111.831 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -90.2 117.47 28.98 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.06 0.457 . . . . 73.05 110.834 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -132.65 128.8 37.83 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.408 0.521 . . . . 72.31 112.408 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -83.77 116.14 22.56 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.046 -0.525 . . . . 65.01 110.144 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.507 HG21 ' HE3' ' A' ' 31' ' ' LYS . 98.8 t -114.72 105.98 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.472 -0.331 . . . . 62.02 110.483 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 59.81 23.79 12.75 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.292 -0.413 . . . . 73.11 111.615 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.01 -18.91 51.12 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.148 -0.478 . . . . 74.42 113.294 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 28.3 m -82.19 132.72 35.24 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.644 -0.327 . . . . 74.41 111.517 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.23 98.82 11.14 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.548 0.69 . . . . 75.32 111.646 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.92 147.22 48.15 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.103 -0.498 . . . . 75.14 112.09 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.39 120.81 2.18 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.697 2.265 . . . . 64.25 113.008 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.8 p -94.17 129.72 40.66 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.207 0.527 . . . . 74.34 111.187 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.963 HD11 ' HB1' ' A' ' 154' ' ' ALA . 43.7 tp -87.94 123.06 32.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.068 -0.514 . . . . 74.03 111.31 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.777 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 62.8 mtt -92.75 124.07 36.49 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.797 0.332 . . . . 75.21 111.355 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 86.5 mt -132.4 143.39 49.79 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.458 -0.792 . . . . 73.53 109.818 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 175' ' ' ALA . 48.5 t -101.85 122.77 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 122.078 -0.389 . . . . 64.42 111.755 -173.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.512 ' HZ2' ' HA ' ' A' ' 26' ' ' LEU . 22.9 pttm -68.62 -29.37 67.86 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.182 0.438 . . . . 75.12 112.182 -173.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -89.09 5.86 42.54 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.265 0.555 . . . . 63.44 111.36 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.6 ' HB3' ' HB ' ' A' ' 172' ' ' VAL . . . -113.91 -22.96 9.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.899 -0.591 . . . . 72.23 111.278 172.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 172' ' ' VAL . 34.5 pt -129.77 137.15 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.975 0.417 . . . . 42.02 111.198 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.6 mm -103.46 110.87 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.844 0.354 . . . . 73.35 111.489 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -74.15 95.71 2.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.193 -0.458 . . . . 73.23 109.909 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.608 ' HB3' HG13 ' A' ' 3' ' ' ILE . 29.5 tt0 -95.23 119.04 33.06 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.237 0.541 . . . . 75.33 111.37 -174.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -78.17 107.9 11.09 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.434 0.635 . . . . 75.42 112.706 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.506 ' HB3' ' O ' ' A' ' 1' ' ' MET . 51.3 t -114.94 91.66 3.69 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.811 -0.631 . . . . 55.3 109.356 171.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 53.0 mt -105.84 32.8 4.11 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.629 0.604 . . . . 54.13 112.629 -167.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.255 1.393 0 CA-C-O 118.819 -0.61 . . . . 71.01 110.043 175.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 tpp . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.688 0.28 . . . . 71.01 111.565 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.19 130.09 40.56 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.763 0.315 . . . . 75.44 111.139 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.2 mt -102.66 134.11 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.758 -0.201 . . . . 75.32 111.048 -177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -123.49 141.57 51.87 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.58 0.705 . . . . 74.24 112.282 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.441 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 21.6 ttmm -111.38 110.55 21.06 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.759 -1.109 . . . . 64.34 111.013 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.623 ' HB2' ' H ' ' A' ' 9' ' ' THR . 1.4 m-20 -83.14 149.54 26.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.558 -0.292 . . . . 71.21 110.955 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 175' ' ' ALA . 68.9 mt -61.02 -33.89 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.398 0.618 . . . . 75.24 110.77 173.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -105.14 -29.26 10.49 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.669 0.618 . . . . 72.13 112.669 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.623 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 2.0 m -106.48 11.81 30.29 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.058 0.392 . . . . 71.13 112.058 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.441 ' OD1' ' HG3' ' A' ' 5' ' ' LYS . 17.7 t70 -50.92 -35.93 35.8 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.218 0.451 . . . . 71.03 112.218 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.32 -19.55 35.93 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 111.954 0.353 . . . . 55.33 111.954 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -91.32 -30.11 16.76 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 111.72 0.267 . . . . 75.44 111.72 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.6 tp 40.3 90.8 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.17 0.588 . . . . 61.0 111.787 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 t -103.15 169.5 8.52 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.12 0.785 . . . . 43.22 113.12 -164.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 87.9 p -137.97 150.14 46.76 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.656 -0.702 . . . . 61.22 111.315 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -145.47 175.33 10.41 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.328 -0.396 . . . . 73.11 110.709 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.6 p -133.92 15.66 3.91 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.651 0.612 . . . . 55.41 112.651 -178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 97.6 m-85 -109.92 121.93 40.5 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 120.912 0.386 . . . . 73.01 111.768 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 8.0 Cg_exo -73.43 102.3 1.46 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.87 2.38 . . . . 54.2 113.106 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.1 ptt? -85.89 153.91 21.88 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.354 -0.385 . . . . 63.1 111.588 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 89.6 mttt -99.04 123.9 43.67 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 111.813 0.301 . . . . 75.23 111.813 -174.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 tp -78.44 99.15 6.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.966 0.412 . . . . 42.44 110.949 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -95.71 146.78 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.9 0.381 . . . . 65.45 111.101 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.44 7.76 3.15 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 116.267 -0.424 . . . . 74.32 111.851 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 58.19 21.7 8.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.881 0.372 . . . . 74.25 111.764 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.412 ' O ' ' HG3' ' A' ' 173' ' ' LYS . 40.2 tp -129.46 -43.89 1.26 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.018 0.437 . . . . 70.32 111.718 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 172' ' ' VAL . 13.0 m -134.25 153.34 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.15 0.5 . . . . 72.31 112.288 -175.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.495 ' CE2' ' HB3' ' A' ' 173' ' ' LYS . 95.0 m-85 -91.61 134.47 34.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.238 -0.437 . . . . 72.02 111.105 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 8.7 pt-20 -104.84 131.78 51.9 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.318 0.58 . . . . 71.51 110.81 172.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.571 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 74.7 t80 -130.91 119.07 21.61 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.197 -0.456 . . . . 74.14 111.153 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -101.57 130.67 47.93 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.937 0.399 . . . . 54.04 111.411 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.77 -160.08 10.88 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.354 -0.45 . . . . 71.21 112.785 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -109.26 165.76 11.37 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.439 -0.448 . . . . 63.22 111.761 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -98.34 106.43 18.72 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.406 -0.361 . . . . 64.33 110.614 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.97 159.6 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.141 0.496 . . . . 65.33 111.574 -176.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 5.6 m -127.8 137.59 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.28 -0.418 . . . . 74.53 110.176 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 30.0 ttp180 -125.73 110.79 14.16 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.573 0.702 . . . . 61.1 112.179 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 98.0 mttt -106.27 160.43 15.36 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.843 -1.071 . . . . 74.44 109.507 169.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 39' ' ' GLU . 2.2 mp0 -51.64 -34.35 37.41 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.219 0.452 . . . . 65.5 112.219 -174.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.5 30.07 1.86 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.226 -0.512 . . . . 34.0 113.243 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 1.2 tm-20 -141.43 146.22 36.27 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 122.581 -0.364 . . . . 73.13 110.443 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 tp -153.67 92.91 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-O 121.258 0.551 . . . . 74.44 112.454 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 43' ' ' VAL . 17.8 m -126.75 100.85 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 121.484 0.659 . . . . 61.21 111.084 172.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 44' ' ' LEU . 6.4 mp -55.99 -45.2 79.09 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.007 0.432 . . . . 71.14 112.122 -173.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.88 34.08 0.34 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.47 0.544 . . . . 63.3 112.47 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.3 88.97 0.03 OUTLIER Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.343 -0.456 . . . . 74.11 112.452 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.7 p -82.27 8.81 10.18 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.124 0.787 . . . . 74.01 113.124 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.705 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 13.1 m120 -62.06 -55.69 38.54 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 122.188 -0.32 . . . . 62.55 111.666 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.705 ' HD3' ' HB2' ' A' ' 48' ' ' ASN . 8.3 Cg_endo -88.0 88.15 0.56 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.122 1.881 . . . . 73.1 112.029 176.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.1 p -165.35 101.25 0.72 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.144 0.497 . . . . 53.12 112.133 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 63.24 4.08 1.53 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.214 1.19 . . . . 73.11 114.214 172.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -81.54 -54.31 5.53 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.894 -0.504 . . . . 71.2 110.446 178.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 59.64 19.6 8.22 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.716 -0.675 . . . . 74.51 112.268 173.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.21 -14.51 64.07 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.485 -0.388 . . . . 72.34 113.966 -176.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 56' ' ' GLU . . . -83.34 -21.03 33.26 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.389 -0.477 . . . . 74.03 112.151 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 55' ' ' ALA . 39.7 tt0 72.44 -44.81 0.6 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.303 0.641 . . . . 71.5 112.436 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.42 157.39 8.85 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.444 0.64 . . . . 73.02 111.921 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.04 77.04 10.0 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.331 0.863 . . . . 74.41 113.331 -167.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.59 -33.84 2.98 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 115.63 1.012 . . . . 74.01 115.63 163.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.3 p -61.67 86.83 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.863 0.832 . . . . 75.14 111.717 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -80.89 -66.27 0.91 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.346 0.499 . . . . 63.55 112.346 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.473 ' HB3' HG23 ' A' ' 64' ' ' VAL . 35.9 tt0 -129.36 1.94 5.11 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 120.884 0.373 . . . . 60.44 111.385 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 82.7 t60 64.36 46.31 3.49 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.783 0.801 . . . . 75.51 110.703 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.473 HG23 ' HB3' ' A' ' 62' ' ' GLU . 77.2 t -102.68 159.28 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.381 -0.827 . . . . 74.52 111.269 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 43.7 mt-10 -81.21 60.34 4.29 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.386 0.613 . . . . 71.24 109.881 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -106.85 148.42 28.56 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.006 -0.543 . . . . 71.14 111.99 -175.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.29 -113.62 1.4 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.935 -0.65 . . . . 64.3 113.294 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.572 HG21 ' HB3' ' A' ' 167' ' ' PRO . 31.4 pt -111.68 132.3 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.194 0.521 . . . . 63.41 112.213 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -51.1 -33.59 26.85 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.015 -0.539 . . . . 72.45 112.109 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.492 HG21 ' HB2' ' A' ' 169' ' ' LEU . 64.5 mt -47.87 -49.56 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 112.329 0.492 . . . . 75.43 112.329 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 23.4 m -85.68 -30.32 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.41 -0.359 . . . . 74.11 111.899 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 66.8 mt -67.82 -49.96 59.37 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.093 0.473 . . . . 75.4 111.211 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -60.85 -36.21 78.54 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.897 -0.592 . . . . 75.42 111.755 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -100.51 8.03 43.75 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.236 0.458 . . . . 61.32 112.236 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 54.89 69.67 0.71 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.673 0.619 . . . . 75.53 112.673 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 73.5 mt -116.61 125.93 52.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.056 -0.52 . . . . 63.52 110.505 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 p -82.58 143.08 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.969 0.414 . . . . 72.55 111.886 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -77.84 129.15 35.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.824 -0.625 . . . . 62.43 112.506 -175.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.5 mmt -136.13 165.22 26.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.984 -0.553 . . . . 72.24 111.169 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -144.91 143.24 30.46 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.276 0.56 . . . . 74.24 111.923 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 21.3 p -40.86 -32.43 0.23 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.753 1.76 . . . . 60.21 115.753 -167.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -51.15 -46.36 61.98 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.86 0.689 . . . . 75.44 112.86 -172.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -103.71 -20.48 13.95 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.007 -0.433 . . . . 62.24 111.551 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.84 -22.32 66.97 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.02 0.378 . . . . 44.33 112.02 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.47 -42.33 54.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.046 0.45 . . . . 72.3 111.312 175.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.9 t -62.83 -42.96 99.95 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.251 0.548 . . . . 65.33 111.233 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.2 ttm -64.31 -43.54 94.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.081 -0.509 . . . . 73.51 110.878 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 91' ' ' TYR . 62.9 m-85 -66.91 -30.49 70.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.998 0.37 . . . . 63.22 111.998 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.8 -53.48 57.37 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.002 0.429 . . . . 71.41 110.488 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.08 -41.24 90.98 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.046 0.45 . . . . 71.15 111.615 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.575 ' HE1' ' HG3' ' A' ' 152' ' ' GLN . 78.7 t80 -56.89 -63.37 1.23 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.04 -0.527 . . . . 74.54 111.602 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.9 mm -57.87 -31.26 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.463 -0.335 . . . . 63.25 111.767 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -56.91 -67.29 0.33 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.055 0.455 . . . . 75.32 111.575 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -63.39 -40.76 98.12 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.175 -0.466 . . . . 63.32 111.102 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.477 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 86.8 t80 -54.94 -55.62 28.7 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.866 -0.606 . . . . 43.12 111.304 178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -55.83 -50.23 71.11 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.883 0.327 . . . . 71.13 111.883 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -62.63 -37.77 87.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.076 0.398 . . . . 75.25 112.076 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -76.07 -46.73 27.63 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.257 -0.277 . . . . 71.44 111.746 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.484 HG12 ' HB3' ' A' ' 174' ' ' GLU . 22.0 m -65.77 -42.55 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 112.085 0.402 . . . . 73.21 112.085 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.1 mm -65.42 -43.53 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 122.228 -0.295 . . . . 54.33 111.071 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.15 -38.9 74.2 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.139 0.495 . . . . 75.31 110.847 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -60.76 -56.59 19.4 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.018 -0.537 . . . . 70.02 111.639 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.637 ' HE2' ' HA ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -67.88 -28.46 67.54 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.127 0.489 . . . . 73.43 111.591 -178.251 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 37.5 tt0 -68.53 -27.2 65.89 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.18 -0.464 . . . . 61.4 111.568 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -72.64 -36.72 68.06 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.902 0.382 . . . . 63.31 111.824 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -86.58 -29.89 22.27 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 111.942 0.349 . . . . 61.01 111.942 -176.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -125.61 -74.92 0.59 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.357 0.502 . . . . 75.5 112.357 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 24.1 ttt180 67.92 -30.73 0.17 Allowed 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 113.02 0.748 . . . . 63.2 113.02 -174.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 111' ' ' ALA . 23.0 t0 -90.94 80.26 5.79 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.652 -0.655 . . . . 70.11 111.925 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.475 ' HG3' ' N ' ' A' ' 111' ' ' ALA . 10.0 ptpp? 50.14 -67.1 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.671 1.588 . . . . 74.2 115.056 169.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 109' ' ' ASP . . . -33.47 -54.51 0.43 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.01 1.115 . . . . 45.23 114.01 -172.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -95.97 -44.88 7.16 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.45 0.537 . . . . 61.32 112.45 -176.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 m -61.53 -37.24 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 112.564 0.579 . . . . 41.53 112.564 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.89 -41.55 87.0 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.081 0.467 . . . . 51.43 110.881 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -64.02 -48.89 74.56 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.188 -0.46 . . . . 71.42 111.054 176.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -57.85 -48.85 78.58 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.238 -0.437 . . . . 72.04 111.322 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -51.99 -51.71 55.44 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.771 -0.455 . . . . 75.32 109.771 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -57.61 -38.02 74.24 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.143 -0.48 . . . . 74.21 111.298 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 29.7 mmmt -63.52 -62.5 1.63 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.003 0.43 . . . . 72.22 111.81 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.1 tp -69.22 -32.65 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.394 -0.366 . . . . 75.3 111.88 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.411 ' O ' HG23 ' A' ' 125' ' ' VAL . 58.1 tp60 -62.84 -49.39 75.1 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.918 0.39 . . . . 73.52 110.196 175.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.29 -38.23 85.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.88 -0.676 . . . . 51.11 112.556 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 44.3 t90 -60.68 -55.38 33.9 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.306 0.242 . . . . 72.45 111.457 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.7 m -65.85 -40.83 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.079 0.4 . . . . 75.23 112.079 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 121' ' ' GLN . 68.8 t -59.09 -36.11 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.098 0.475 . . . . 62.13 111.223 177.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.5 m -76.51 -47.25 23.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.017 0.437 . . . . 72.43 110.975 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.1 tp -62.2 -36.07 80.79 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.967 -0.561 . . . . 72.4 112.139 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.6 mt -88.56 3.2 51.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.469 0.544 . . . . 74.35 112.469 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.426 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -68.26 81.97 0.24 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.404 0.621 . . . . 43.21 110.911 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -48.07 -45.34 32.35 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.885 1.069 . . . . 63.54 113.885 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -43.31 -46.62 6.42 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.502 0.556 . . . . 64.51 112.502 -171.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.512 ' HG3' ' CD1' ' A' ' 133' ' ' PHE . 2.3 ptp180 -109.74 -42.15 4.35 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.185 0.439 . . . . 70.3 112.185 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.512 ' CD1' ' HG3' ' A' ' 132' ' ' ARG . 52.9 m-85 -71.04 -8.16 51.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.962 0.727 . . . . 73.42 112.962 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -56.01 -22.59 27.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.234 0.54 . . . . 64.23 111.08 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.551 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 58.3 m-20 -76.65 6.05 6.55 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.595 -0.73 . . . . 75.04 112.215 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.8 mt -89.19 148.98 23.34 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.026 0.441 . . . . 73.13 111.579 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.05 146.38 30.2 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.173 -0.467 . . . . 65.11 111.217 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -114.09 125.43 53.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.969 0.414 . . . . 74.02 110.879 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.547 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 58.1 m-85 -126.2 127.95 46.47 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.018 0.437 . . . . 74.33 111.555 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 145' ' ' ALA . 10.3 tt -121.63 152.32 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.341 -0.39 . . . . 71.12 111.176 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.49 136.87 35.48 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 114.142 0.417 . . . . 62.24 114.142 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.05 -41.42 68.1 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.34 0.496 . . . . 54.44 112.34 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.612 ' H ' ' HD2' ' A' ' 143' ' ' ARG . 1.2 mpt_? -80.29 -43.12 21.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.914 0.387 . . . . 71.23 110.975 -177.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.63 -53.49 57.0 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.244 -0.434 . . . . 72.35 111.499 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -59.06 -24.43 62.87 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.492 0.553 . . . . 60.31 112.492 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.72 -29.19 16.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.91 0.386 . . . . 70.22 111.663 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -88.38 -49.32 3.73 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.109 -0.567 . . . . 54.02 113.15 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.75 124.13 10.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.747 0.308 . . . . 61.51 111.22 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -18.41 59.81 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.852 0.358 . . . . 34.35 111.513 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -78.07 44.45 0.48 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.1 0.476 . . . . 53.31 111.29 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.87 179.24 35.37 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.171 -0.468 . . . . 34.5 113.207 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.704 HE22 HG23 ' A' ' 176' ' ' ILE . 46.4 tt0 -98.43 115.85 29.4 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.09 0.471 . . . . 74.33 111.671 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.2 t -81.05 139.57 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.171 0.51 . . . . 74.1 111.916 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.801 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -97.82 133.45 42.32 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.922 -0.581 . . . . 65.54 110.651 175.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 45.6 mm -86.77 124.74 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.73 0.3 . . . . 53.43 111.504 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.443 HG13 ' CD1' ' A' ' 139' ' ' PHE . 46.5 mm -110.57 106.79 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.273 0.559 . . . . 53.2 112.444 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.519 ' HG2' ' N ' ' A' ' 158' ' ' TYR . 28.4 tt0 -103.1 158.65 16.15 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.277 -0.874 . . . . 75.02 110.148 172.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.605 ' HB2' ' HB3' ' A' ' 165' ' ' GLU . 0.6 OUTLIER -115.83 115.01 25.52 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.476 0.655 . . . . 55.25 111.243 168.167 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.482 HH21 HG21 ' A' ' 168' ' ' THR . 3.5 tpp180 -69.04 141.18 54.89 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.408 -0.814 . . . . 73.2 112.153 -176.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.51 102.97 7.17 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.255 -0.43 . . . . 71.41 111.388 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 83.5 t -111.01 90.79 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.963 0.411 . . . . 70.03 110.625 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 58.28 19.69 6.52 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.058 -0.519 . . . . 65.33 111.833 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 112.3 -23.41 16.03 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 116.265 -0.425 . . . . 71.12 112.653 -175.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 92.8 m -84.26 118.63 24.3 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.067 0.461 . . . . 64.33 110.886 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 26.0 mt-10 -85.34 100.32 11.74 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.007 -0.542 . . . . 75.52 111.236 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 25.2 m -98.4 149.79 36.08 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 111.981 0.363 . . . . 74.21 111.981 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.572 ' HB3' HG21 ' A' ' 68' ' ' ILE . 18.0 Cg_endo -58.88 136.25 72.34 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.69 2.26 . . . . 53.54 114.278 -176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.482 HG21 HH21 ' A' ' 159' ' ' ARG . 83.2 m -143.27 108.83 5.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.762 -0.654 . . . . 71.51 110.9 176.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.801 HD11 ' HB1' ' A' ' 154' ' ' ALA . 63.5 tp -82.55 145.41 29.76 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.209 -0.45 . . . . 75.02 111.665 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.683 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 64.7 mtt -126.45 126.47 43.83 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.843 0.354 . . . . 71.3 111.462 176.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -134.51 129.94 35.9 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.091 -0.504 . . . . 75.21 111.2 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 174' ' ' GLU . 22.3 t -80.32 126.86 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 O-C-N 122.019 -0.426 . . . . 65.43 111.711 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.495 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -72.29 -14.59 61.79 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.332 0.493 . . . . 75.21 112.332 -179.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.541 ' H ' HG12 ' A' ' 172' ' ' VAL . 0.4 OUTLIER -81.07 -11.69 59.45 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.9 0.381 . . . . 72.22 111.229 169.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.442 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -96.95 -39.25 9.46 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.981 0.42 . . . . 62.24 110.804 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.704 HG23 HE22 ' A' ' 152' ' ' GLN . 29.6 pt -119.88 114.07 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.087 0.47 . . . . 63.24 111.563 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.438 HD13 ' N ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -94.42 130.42 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 109.282 -0.636 . . . . 63.31 109.282 175.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.438 ' N ' HD13 ' A' ' 177' ' ' ILE . 1.5 pp20? -94.59 153.0 18.07 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.812 0.815 . . . . 71.13 112.961 -172.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -127.09 99.16 5.58 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.418 -0.81 . . . . 73.41 109.694 173.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -79.95 97.06 6.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.263 0.554 . . . . 64.31 110.637 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 48.6 t -130.22 87.96 2.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.579 0.704 . . . . 73.13 109.798 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 8.0 mp -108.57 93.2 4.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.608 -0.723 . . . . 62.11 110.552 -176.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--O 1.25 1.094 0 CA-C-N 115.673 -0.694 . . . . 55.41 111.568 -177.179 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtm . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.796 0.332 . . . . 71.03 111.233 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 15' ' ' SER . 29.8 tp -109.46 130.72 55.49 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.649 -0.5 . . . . 44.11 109.649 170.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.766 HG13 ' HB3' ' A' ' 179' ' ' GLU . 17.4 pt -117.19 127.79 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.191 0.519 . . . . 63.21 111.607 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -121.8 147.61 45.74 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.96 -0.564 . . . . 71.32 112.104 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.426 ' HE3' ' CG2' ' A' ' 177' ' ' ILE . 20.7 ttpp -124.05 117.24 24.26 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.348 -0.387 . . . . 71.04 111.525 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.79 173.31 6.39 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.031 -0.531 . . . . 64.42 111.362 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.805 HD11 ' HB1' ' A' ' 175' ' ' ALA . 57.7 mt -78.28 -49.59 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.055 0.455 . . . . 70.43 111.619 175.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -93.16 -38.62 11.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.006 -0.543 . . . . 73.33 112.13 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -97.9 17.95 17.0 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.701 -0.682 . . . . 73.54 110.945 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -47.68 -39.9 18.57 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.095 1.146 . . . . 71.24 114.095 -169.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.26 -28.0 62.58 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.124 0.416 . . . . 75.02 112.124 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 35.0 tt0 -89.05 25.11 1.91 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 120.669 0.271 . . . . 74.45 111.509 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.458 HD21 ' HB ' ' A' ' 3' ' ' ILE . 7.8 tt -34.67 122.09 0.52 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.324 0.65 . . . . 75.33 111.698 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t -126.64 179.42 5.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.399 -0.364 . . . . 63.12 111.493 -171.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.478 ' HB3' HG22 ' A' ' 3' ' ' ILE . 83.8 p -124.66 148.04 48.2 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.444 -0.344 . . . . 60.51 111.419 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -138.78 -172.74 3.38 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.514 0.673 . . . . 73.33 111.691 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -149.28 29.31 0.79 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.406 -0.815 . . . . 71.31 111.016 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -90.16 113.05 55.89 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 112.026 0.38 . . . . 64.54 112.026 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.54 77.46 1.74 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.189 1.926 . . . . 71.24 112.32 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.3 mtt -84.76 143.27 29.24 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.075 0.465 . . . . 72.45 111.247 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 27.1 ttpp -99.63 118.58 36.46 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.012 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.4 tp -76.24 135.56 39.67 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.882 0.373 . . . . 64.5 111.021 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.23 134.65 65.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.2 0.524 . . . . 53.32 111.656 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.1 t70 61.9 15.93 7.59 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.464 -0.789 . . . . 72.32 111.951 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 59.0 19.72 7.5 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.002 0.521 . . . . 63.11 112.112 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.1 tp -119.74 -49.72 2.32 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.099 0.407 . . . . 62.52 112.099 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.624 HG12 ' HA ' ' A' ' 172' ' ' VAL . 13.6 m -132.53 149.55 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.581 0.586 . . . . 74.23 112.581 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -86.52 144.43 27.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.262 -0.426 . . . . 70.01 111.065 174.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 16.2 pt-20 -122.1 133.42 54.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.038 0.447 . . . . 73.04 110.489 174.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -137.53 135.48 36.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.833 0.349 . . . . 75.23 110.838 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -92.2 121.54 33.83 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.591 0.589 . . . . 71.14 112.591 -173.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.92 165.51 12.93 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.08 -0.509 . . . . 54.54 112.358 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -121.95 145.01 48.53 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 122.367 -0.49 . . . . 73.23 111.109 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -73.62 109.64 7.28 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.328 0.585 . . . . 75.22 112.04 -175.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.47 HG23 HD12 ' A' ' 72' ' ' LEU . 26.8 m -134.63 166.2 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.246 -0.433 . . . . 72.31 110.474 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.471 HG21 HG13 ' A' ' 43' ' ' VAL . 10.5 m -131.4 150.74 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 122.067 -0.395 . . . . 65.22 111.249 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.672 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 34.9 mmt180 -117.95 115.49 25.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.498 0.666 . . . . 54.44 112.208 176.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.569 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 99.5 mttt -117.38 141.46 48.3 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.251 -1.018 . . . . 72.21 108.251 165.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.08 -24.21 16.59 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.125 0.787 . . . . 74.42 113.125 -173.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -130.2 13.69 5.71 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 120.911 -0.662 . . . . 63.03 113.715 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 37.4 mt-10 -144.3 134.9 24.8 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 117.329 0.564 . . . . 65.12 111.745 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tp -116.73 51.72 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 122.028 0.918 . . . . 75.32 110.426 176.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.471 HG13 HG21 ' A' ' 36' ' ' VAL . 4.7 p -72.48 77.97 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.89 0.852 . . . . 64.02 112.546 -176.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pp -99.03 -0.5 41.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.073 -0.512 . . . . 70.41 111.938 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.55 112.98 16.18 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.407 -0.36 . . . . 73.34 111.883 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.3 -173.86 36.95 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.198 -0.525 . . . . 73.13 113.314 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 p -106.79 178.44 4.56 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.63 -0.335 . . . . 75.34 111.242 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -87.5 116.56 66.54 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 122.189 -0.319 . . . . 70.11 111.175 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.01 123.38 3.56 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.585 2.19 . . . . 55.11 113.138 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.0 t -87.12 117.53 25.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.973 0.416 . . . . 75.51 111.091 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.04 48.85 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.134 0.492 . . . . 63.3 110.254 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -49.15 -56.11 10.23 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.619 -0.719 . . . . 61.53 112.315 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -103.24 88.01 3.02 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.252 0.548 . . . . 74.41 111.38 176.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.2 92.88 0.91 Allowed Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.121 -0.49 . . . . 60.44 112.074 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.76 -50.46 4.67 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.862 0.69 . . . . 62.34 112.862 -174.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.23 -50.81 9.11 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.316 0.858 . . . . 75.32 113.316 -172.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -62.12 156.52 21.41 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.595 0.591 . . . . 74.13 112.595 -175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 60' ' ' SER . 13.1 p-10 -128.08 27.02 5.72 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.071 -0.513 . . . . 72.21 112.205 -175.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.51 82.52 0.01 OUTLIER Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.584 -0.341 . . . . 72.14 112.561 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 58' ' ' ASP . 19.1 t -68.12 92.02 0.38 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.637 0.977 . . . . 43.25 113.637 -171.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -123.78 29.17 6.62 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 122.638 1.208 . . . . 74.12 107.908 166.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -82.03 -38.68 24.64 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.158 -1.383 . . . . 71.02 113.504 -167.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -80.76 26.11 0.42 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.314 0.486 . . . . 72.12 112.314 -170.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.19 146.77 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 122.655 0.382 . . . . 71.14 110.268 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.672 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 48.2 mt-10 -74.7 72.06 1.97 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.568 0.699 . . . . 73.43 110.08 175.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -85.79 129.29 34.87 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.149 -0.932 . . . . 74.24 112.194 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.92 -149.74 11.68 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.01 -0.615 . . . . 63.01 112.803 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 pt -111.45 154.11 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 122.601 -0.352 . . . . 53.23 111.573 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -41.27 -48.94 3.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.257 0.465 . . . . 65.25 112.257 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.428 HG21 HD22 ' A' ' 169' ' ' LEU . 56.1 mt -49.6 -55.49 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 112.584 0.587 . . . . 72.3 112.584 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.407 ' HA ' HD12 ' A' ' 76' ' ' LEU . 23.0 m -80.53 -34.76 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.333 0.494 . . . . 75.21 112.333 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.47 HD12 HG23 ' A' ' 35' ' ' VAL . 87.3 mt -71.03 -40.81 71.52 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.979 0.419 . . . . 73.23 111.527 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -64.42 -35.98 82.68 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.909 0.385 . . . . 75.24 111.969 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -101.43 4.81 41.69 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.531 0.567 . . . . 70.25 112.531 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.0 70.33 0.62 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.158 0.504 . . . . 72.42 112.149 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 71' ' ' VAL . 76.5 mt -115.04 135.08 54.61 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.287 -0.415 . . . . 74.31 111.25 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.18 143.25 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.577 0.227 . . . . 72.44 111.211 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 7.9 pt-20 -88.88 134.05 34.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.408 0.623 . . . . 73.23 112.631 -176.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.43 138.09 50.6 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.845 -0.616 . . . . 75.5 110.618 171.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.573 HD22 ' N ' ' A' ' 80' ' ' ASN . 0.7 OUTLIER -105.07 144.49 31.81 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.98 -0.554 . . . . 74.12 110.407 175.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 40.9 t -49.32 -16.68 0.2 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.297 1.591 . . . . 65.31 115.297 -169.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -93.59 -19.37 21.24 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.558 -0.714 . . . . 62.5 112.701 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -83.06 -46.51 12.73 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.283 0.563 . . . . 70.52 111.852 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 87' ' ' MET . 9.9 p-10 -108.17 21.77 16.89 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.601 -0.727 . . . . 71.31 112.163 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.603 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -36.26 -50.13 0.72 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.92 1.081 . . . . 75.11 113.92 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.9 t -73.06 -30.48 63.74 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.951 0.405 . . . . 63.53 111.542 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.581 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 80.2 mtp -67.8 -60.38 2.57 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.197 0.443 . . . . 75.2 112.197 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.603 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 6.1 p90 -63.4 -28.26 69.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.178 -0.609 . . . . 75.22 110.654 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -58.2 -40.35 81.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.12 0.486 . . . . 70.41 110.543 172.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.47 80.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.214 -0.448 . . . . 71.44 111.048 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -54.68 -54.39 42.35 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.156 -0.475 . . . . 74.54 111.225 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.5 -35.1 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.52 -0.309 . . . . 74.52 111.74 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.439 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -60.86 -60.43 3.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.776 0.322 . . . . 75.24 111.488 177.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -64.96 -38.66 91.69 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.064 0.459 . . . . 51.05 111.298 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.688 ' HZ ' HD11 ' A' ' 120' ' ' ILE . 41.6 t80 -57.18 -53.25 60.2 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.052 -0.522 . . . . 64.45 111.838 176.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -61.83 -46.92 87.38 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.845 0.355 . . . . 73.33 111.496 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.44 -36.05 82.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.647 -0.251 . . . . 65.12 111.554 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.54 -52.82 34.32 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.513 -0.312 . . . . 73.32 111.782 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.1 m -58.72 -39.31 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 111.893 0.331 . . . . 63.33 111.893 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.511 HD11 ' HB3' ' A' ' 117' ' ' LYS . 17.6 mm -77.95 -36.44 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.147 0.425 . . . . 74.02 112.147 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -60.97 -39.16 88.52 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.32 0.581 . . . . 75.54 109.952 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -71.79 -70.3 0.34 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.468 -0.787 . . . . 60.03 111.438 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 11.9 tpt -63.01 -43.32 99.11 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.835 0.68 . . . . 74.23 112.835 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.455 ' HA ' HG11 ' A' ' 113' ' ' VAL . 32.1 tt0 -71.95 -10.96 60.52 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.032 -0.417 . . . . 75.23 111.591 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -87.16 -45.16 10.93 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.221 -0.299 . . . . 61.42 111.367 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -80.5 -31.35 37.23 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.933 0.345 . . . . 63.11 111.933 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.418 HD21 ' HB3' ' A' ' 112' ' ' ASP . 56.2 t30 -96.04 -51.34 4.48 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 122.268 -0.27 . . . . 74.55 111.625 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 74.06 -35.34 0.3 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.954 1.465 . . . . 71.02 114.954 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.612 ' O ' HG22 ' A' ' 113' ' ' VAL . 28.3 t70 -63.19 121.33 13.39 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.648 -0.658 . . . . 73.42 112.28 -172.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.681 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -46.29 -51.16 15.1 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.438 -0.801 . . . . 64.35 113.129 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.473 ' N ' ' HG2' ' A' ' 110' ' ' LYS . . . -70.26 -33.52 71.71 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.085 0.402 . . . . 72.32 112.085 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.418 ' HB3' HD21 ' A' ' 107' ' ' ASN . 6.6 t70 -77.54 -49.68 14.17 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.032 0.444 . . . . 43.12 110.846 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 109' ' ' ASP . 31.1 m -66.52 -22.59 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 122.058 -0.401 . . . . 64.41 111.073 175.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.58 -50.09 74.25 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.809 0.338 . . . . 53.33 110.322 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.46 -43.81 96.52 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.237 -0.438 . . . . 41.25 111.084 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.413 ' HE1' ' HB3' ' A' ' 174' ' ' GLU . 87.4 t80 -57.73 -58.29 9.02 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.256 -0.429 . . . . 73.41 111.8 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.616 ' HA ' HG22 ' A' ' 120' ' ' ILE . 17.6 ptpt -65.46 -30.96 71.81 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.293 -0.254 . . . . 75.4 111.436 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -58.81 -45.74 89.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.369 0.604 . . . . 74.55 110.501 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -67.44 -57.38 6.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.508 -0.769 . . . . 75.52 111.92 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.688 HD11 ' HZ ' ' A' ' 95' ' ' PHE . 10.5 tp -66.38 -39.56 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 112.257 0.465 . . . . 73.34 112.257 -173.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -73.64 -43.52 59.29 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 122.07 -0.394 . . . . 62.31 110.449 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.0 -34.4 61.86 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.955 -0.64 . . . . 72.21 112.228 174.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -62.85 -57.69 9.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.42 0.288 . . . . 71.21 111.076 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 26.1 m -62.18 -48.88 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 112.414 0.524 . . . . 75.13 112.414 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.03 -29.02 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.788 -0.57 . . . . 74.34 111.952 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.9 t -84.87 -33.85 22.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.846 0.355 . . . . 44.31 111.331 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.473 HD21 HD13 ' A' ' 155' ' ' ILE . 40.2 tp -70.37 -32.76 70.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.218 0.532 . . . . 74.45 111.251 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.6 mt -80.29 2.34 25.01 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.147 -0.478 . . . . 71.34 111.888 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.06 82.39 0.32 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.564 0.697 . . . . 61.04 110.434 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.465 ' NZ ' ' HB3' ' A' ' 130' ' ' LYS . 5.5 ttpm? -65.0 -6.41 8.51 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.716 -0.675 . . . . 74.33 112.72 -170.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.49 -47.23 86.31 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.93 -0.481 . . . . 73.24 111.212 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -108.94 -35.4 6.36 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.039 0.447 . . . . 70.03 111.429 172.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -69.69 -6.65 33.07 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.436 0.532 . . . . 72.12 112.436 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -52.78 -25.76 12.29 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.118 0.414 . . . . 75.41 112.118 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.41 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . 66.9 m-20 -83.33 12.09 5.87 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.211 0.449 . . . . 75.33 112.211 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 81.5 mt -90.28 156.8 18.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.259 0.552 . . . . 72.31 112.093 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.31 126.29 25.98 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.967 -0.56 . . . . 74.23 110.261 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.5 ' HB2' ' CG1' ' A' ' 153' ' ' VAL . 14.0 p90 -116.91 126.78 53.48 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.382 0.61 . . . . 70.4 111.33 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 78' ' ' GLU . 24.5 m-85 -97.95 148.12 23.78 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.706 -0.679 . . . . 71.52 112.18 -172.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 14.1 tt -136.04 150.33 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.716 -0.674 . . . . 74.25 110.592 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.01 140.26 46.73 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.132 -0.556 . . . . 64.13 113.392 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -50.81 -52.9 36.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.854 0.359 . . . . 64.54 111.588 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -54.25 -30.71 51.3 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.169 -0.469 . . . . 74.43 112.149 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.8 -56.49 4.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.489 -0.323 . . . . 73.05 111.266 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.36 -24.21 66.32 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.144 0.497 . . . . 61.22 111.589 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -54.72 -29.23 52.84 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.572 -0.74 . . . . 74.44 112.558 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.5 -34.27 0.1 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.558 -0.83 . . . . 42.11 113.764 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 149' ' ' GLU . . . -56.74 -50.95 70.71 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.47 0.544 . . . . 71.11 112.47 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 148' ' ' ALA . 10.8 pt-20 58.48 -22.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 125.273 1.429 . . . . 71.25 114.362 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 148' ' ' ALA . 20.0 t-20 -88.84 60.76 5.66 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.025 0.916 . . . . 75.01 109.703 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -129.8 172.75 19.96 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.89 -1.05 . . . . 61.13 112.697 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -79.04 144.25 34.84 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.016 0.436 . . . . 64.14 111.396 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.5 ' CG1' ' HB2' ' A' ' 138' ' ' PHE . 37.6 t -114.03 137.14 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.194 -0.457 . . . . 75.2 111.506 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.76 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -104.87 119.76 39.78 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.18 -0.464 . . . . 61.02 110.777 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.473 HD13 HD21 ' A' ' 127' ' ' LEU . 60.7 mt -91.07 138.6 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.159 0.429 . . . . 44.02 112.159 -174.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.1 mm -115.46 120.14 63.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.022 0.439 . . . . 75.11 111.144 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -110.99 157.68 19.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.617 -0.72 . . . . 73.21 111.104 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 135' ' ' ASN . 9.8 p90 -106.89 115.19 29.75 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.187 0.518 . . . . 65.12 111.771 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -115.76 140.04 49.59 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.177 -0.465 . . . . 74.42 111.769 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -102.52 109.41 21.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.505 -0.316 . . . . 72.1 110.385 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 52.7 t -90.39 89.85 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.043 0.449 . . . . 74.15 111.111 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.6 t70 55.38 27.33 9.87 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.866 -0.606 . . . . 74.32 112.308 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 119.23 -1.61 14.44 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.941 -0.647 . . . . 74.43 113.985 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 41.6 m -118.61 121.13 39.44 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 117.397 0.598 . . . . 62.52 111.245 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.25 121.45 26.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.293 0.568 . . . . 73.15 111.796 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.447 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 29.0 m -128.83 137.66 31.46 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 116.202 -0.454 . . . . 74.0 111.873 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 166' ' ' VAL . 5.9 Cg_exo -80.97 118.42 3.39 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.232 2.621 . . . . 72.11 112.845 176.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.3 p -103.95 146.19 29.05 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.29 0.567 . . . . 71.31 112.188 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.76 HD11 ' HB1' ' A' ' 154' ' ' ALA . 69.9 tp -95.47 137.88 33.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.922 -0.581 . . . . 73.05 110.916 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.47 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 25.3 mmt -123.16 124.31 42.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.5 0.32 . . . . 73.24 111.608 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 98.1 mt -139.3 130.21 26.29 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.82 0.448 . . . . 71.5 111.038 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.624 ' HA ' HG12 ' A' ' 27' ' ' VAL . 60.5 t -78.49 121.94 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 112.132 0.419 . . . . 72.2 112.132 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -76.96 -36.8 56.23 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.834 0.349 . . . . 41.13 111.828 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.413 ' HB3' ' HE1' ' A' ' 116' ' ' PHE . 7.0 mm-40 -73.94 6.33 3.44 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.232 0.456 . . . . 61.21 112.232 -172.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.805 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -107.38 -42.75 4.73 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.047 0.451 . . . . 53.32 111.331 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 22.4 pt -96.05 170.21 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.917 -0.583 . . . . 64.32 111.233 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.426 ' CG2' ' HE3' ' A' ' 5' ' ' LYS . 5.2 tp -128.1 111.62 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.669 0.747 . . . . 73.41 111.927 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.2 153.21 22.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.137 -0.938 . . . . 75.11 111.411 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.766 ' HB3' HG13 ' A' ' 3' ' ' ILE . 21.4 tp10 -140.32 136.47 33.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.184 0.516 . . . . 72.42 111.685 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -89.25 121.23 31.33 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.389 -0.369 . . . . 63.11 111.897 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 43.4 t -132.53 86.43 2.32 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.24 0.543 . . . . 73.42 109.936 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -175.6 178.04 1.65 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.938 -0.574 . . . . 64.33 111.62 -174.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 . . . . . 0 C--O 1.255 1.394 0 CA-C-N 115.988 -0.551 . . . . 75.43 111.358 178.02 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.929 0.395 . . . . 60.14 111.791 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.9 tp -134.16 128.41 33.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.522 -0.308 . . . . 72.32 110.225 174.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.574 HG22 ' HB3' ' A' ' 15' ' ' SER . 35.2 pt -111.32 128.09 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 120.9 0.381 . . . . 72.15 111.798 -175.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -124.04 141.69 51.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.16 0.505 . . . . 71.23 112.073 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.65 115.37 30.38 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.389 -0.823 . . . . 75.22 110.356 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.679 ' HA ' HG22 ' A' ' 176' ' ' ILE . 3.9 m-20 -77.14 169.63 17.99 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.274 0.559 . . . . 71.45 112.389 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.434 HG23 ' CD2' ' A' ' 8' ' ' PHE . 10.4 tt -88.54 -31.02 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.029 0.442 . . . . 62.14 111.541 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.566 ' HB2' ' HB2' ' A' ' 152' ' ' GLN . 91.1 m-85 -98.82 -38.25 9.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.219 0.533 . . . . 70.12 111.933 178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.7 p -106.82 21.5 17.42 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.552 0.575 . . . . 73.4 112.552 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 18.1 t70 -45.54 -45.81 13.67 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.053 0.76 . . . . 63.05 113.053 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.43 -26.98 67.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.51 0.672 . . . . 74.22 111.236 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -109.39 24.63 12.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.451 -0.795 . . . . 75.44 111.054 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.411 ' N ' HD23 ' A' ' 13' ' ' LEU . 2.3 pt? -44.35 150.13 0.33 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.808 0.67 . . . . 55.21 112.808 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.5 t -120.8 168.56 11.31 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.621 0.971 . . . . 73.03 113.621 -168.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.574 ' HB3' HG22 ' A' ' 3' ' ' ILE . 61.0 p -133.95 107.06 7.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.924 -1.035 . . . . 54.3 110.69 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -120.16 -177.53 3.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.843 0.354 . . . . 70.3 111.578 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.0 m -147.22 83.55 1.56 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.14 0.495 . . . . 54.35 111.243 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.507 ' HB2' ' HE2' ' A' ' 30' ' ' PHE . 85.7 m-85 -135.55 161.73 61.37 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.161 -0.472 . . . . 72.5 111.042 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.4 158.86 40.44 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.532 2.155 . . . . 71.11 112.613 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -144.08 131.17 20.58 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.248 0.547 . . . . 61.34 112.318 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -123.49 97.52 5.43 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.125 -0.488 . . . . 63.42 110.706 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.3 tp -76.93 116.77 17.89 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.48 0.548 . . . . 65.51 112.48 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.1 p -104.64 139.2 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.058 0.456 . . . . 74.43 111.824 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 59.02 9.56 1.29 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.534 0.734 . . . . 72.22 111.783 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.413 ' O ' ' HE3' ' A' ' 173' ' ' LYS . 32.7 t70 55.42 31.75 17.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.763 0.792 . . . . 71.42 110.36 -174.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.1 tp -124.23 -49.8 1.8 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.876 -0.602 . . . . 74.32 111.214 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.493 HG12 HG22 ' A' ' 172' ' ' VAL . 3.2 m -128.68 143.94 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.581 0.585 . . . . 73.44 112.581 -177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE2' ' HB3' ' A' ' 173' ' ' LYS . 60.8 m-85 -86.61 130.74 34.37 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.117 -0.492 . . . . 75.21 111.522 177.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -91.95 118.44 30.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.02 -0.991 . . . . 71.21 110.002 173.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.507 ' HE2' ' HB2' ' A' ' 18' ' ' PHE . 6.2 m-85 -108.94 119.43 39.53 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.217 0.451 . . . . 74.04 112.217 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -94.61 89.44 5.78 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.048 0.451 . . . . 74.25 111.358 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.87 -157.76 17.43 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 116.007 -0.542 . . . . 40.34 112.881 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -143.06 132.8 23.88 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 122.029 -0.689 . . . . 74.13 111.635 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -72.08 106.89 4.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.582 0.23 . . . . 74.01 110.447 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -134.41 164.44 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.209 0.528 . . . . 74.21 112.222 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 66' ' ' ARG . 29.4 m -138.67 131.88 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.103 -0.499 . . . . 74.44 110.745 175.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 43.5 ttp180 -118.16 132.02 56.36 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.877 0.37 . . . . 73.25 111.556 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 40' ' ' GLY . 4.6 tmmm? -94.56 99.51 11.65 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.402 -0.363 . . . . 64.41 110.107 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 62.7 -72.22 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.13 0.572 . . . . 70.1 111.961 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 38' ' ' LYS . . . -146.17 27.3 1.71 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.937 -0.465 . . . . 74.2 111.937 176.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -135.23 136.06 41.45 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 122.556 0.342 . . . . 75.15 111.782 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 mm -78.8 113.19 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.063 0.459 . . . . 71.12 111.629 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.2 t -126.13 48.71 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.554 0.693 . . . . 74.14 110.895 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 45' ' ' ALA . 2.4 pp -83.69 -21.21 32.45 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.397 0.517 . . . . 74.54 112.397 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.524 ' N ' HD12 ' A' ' 44' ' ' LEU . . . -86.46 102.46 14.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.829 0.347 . . . . 73.52 111.319 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.19 -49.99 0.35 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.161 -0.542 . . . . 60.14 112.675 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.1 t -71.14 171.83 10.28 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.953 0.406 . . . . 74.45 111.372 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -106.15 113.97 62.93 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 120.717 0.294 . . . . 75.3 111.722 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -81.34 110.68 2.27 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.105 2.536 . . . . 73.44 112.4 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.8 m -132.01 158.81 40.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.089 0.471 . . . . 73.14 111.907 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.485 ' HB2' ' H ' ' A' ' 165' ' ' GLU . . . -106.04 -75.46 0.63 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.743 -0.662 . . . . 52.25 111.187 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -71.66 -33.06 68.55 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.098 0.475 . . . . 71.13 111.59 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -77.01 97.88 4.79 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.03 -0.532 . . . . 74.34 111.737 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -145.28 100.4 0.23 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-N 116.014 -0.539 . . . . 52.04 112.595 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.11 26.99 5.37 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.506 -0.408 . . . . 72.43 111.834 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 60.23 69.1 0.72 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.414 0.626 . . . . 71.13 111.014 -176.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -151.3 175.44 12.21 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.974 -0.557 . . . . 60.02 111.665 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 59.47 11.52 2.32 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.513 0.561 . . . . 71.32 112.513 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.75 41.92 2.07 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.328 -0.463 . . . . 70.41 113.132 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.1 m -70.98 -26.73 63.28 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.37 0.268 . . . . 74.34 111.707 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.7 t70 71.93 -66.28 0.31 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.428 0.691 . . . . 75.5 111.405 -178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.655 ' HG3' HG23 ' A' ' 64' ' ' VAL . 9.1 pt-20 38.71 37.56 0.2 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.4 0.889 . . . . 70.02 113.4 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 70.7 1.23 3.62 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.084 0.772 . . . . 74.32 113.084 174.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.655 HG23 ' HG3' ' A' ' 62' ' ' GLU . 55.2 t -66.76 148.35 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 122.027 -0.421 . . . . 63.12 111.321 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 1.2 mp0 -73.23 68.94 1.06 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.486 0.66 . . . . 75.45 110.983 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.565 ' HA ' HG12 ' A' ' 36' ' ' VAL . 6.2 ttp180 -83.32 110.69 18.33 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.398 -0.819 . . . . 72.41 111.709 177.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.25 -153.98 12.45 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.852 -0.689 . . . . 71.21 112.943 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' A' ' 167' ' ' PRO . 33.6 pt -112.03 150.52 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.224 -0.574 . . . . 74.04 111.799 176.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -38.39 -56.87 1.2 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.65 0.78 . . . . 72.52 112.724 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.4 mt -53.88 -55.16 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.824 0.676 . . . . 71.11 112.824 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.455 ' HA ' HD12 ' A' ' 76' ' ' LEU . 19.4 m -68.38 -35.2 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.147 0.425 . . . . 71.21 112.147 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.42 -47.01 68.36 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.066 0.46 . . . . 72.2 110.852 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -66.64 -44.15 82.75 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.881 -0.6 . . . . 70.43 111.659 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.443 ' HD2' HD21 ' A' ' 76' ' ' LEU . 78.1 t60 -82.14 -6.04 58.89 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.851 0.358 . . . . 74.55 111.188 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.438 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 62.34 70.08 0.59 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.611 0.72 . . . . 55.12 111.865 176.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.665 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 71.7 mt -111.8 137.72 49.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.401 -0.818 . . . . 71.42 111.418 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.3 p -91.25 143.54 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.081 0.467 . . . . 73.45 111.563 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -79.44 127.46 32.14 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.078 -0.51 . . . . 75.43 112.308 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 35.3 mtm -131.11 164.92 24.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.167 0.508 . . . . 73.43 110.999 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -142.58 158.88 43.21 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.179 -0.464 . . . . 70.24 111.013 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.8 m -49.71 -27.7 5.12 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.565 0.95 . . . . 62.42 113.565 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -48.27 -41.15 27.0 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.101 0.477 . . . . 74.23 111.244 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -105.3 -38.36 6.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.377 0.608 . . . . 71.33 110.972 174.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -71.9 -13.52 61.68 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.917 0.71 . . . . 50.54 112.917 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.55 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -43.69 -66.1 0.42 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.858 0.688 . . . . 73.44 112.858 -177.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.2 t -71.62 -18.28 62.22 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.245 -0.284 . . . . 74.41 111.487 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.27 -63.54 1.06 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.8 -0.182 . . . . 61.12 111.168 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.55 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 17.7 p90 -59.53 -33.08 70.94 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.854 -0.338 . . . . 74.54 110.717 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -57.23 -47.41 81.41 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.131 0.491 . . . . 72.21 110.964 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.14 -38.45 82.17 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.245 -0.434 . . . . 65.54 111.605 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -65.05 -41.33 95.28 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.669 -0.242 . . . . 73.32 111.358 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 88' ' ' PHE . 35.9 mm -62.84 -37.09 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.965 0.412 . . . . 73.33 110.853 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -58.57 -56.26 24.46 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.161 0.505 . . . . 62.23 110.855 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -59.78 -45.09 93.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.895 -0.593 . . . . 74.01 111.061 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 175' ' ' ALA . 83.0 t80 -56.96 -61.91 2.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.817 -0.629 . . . . 71.12 111.976 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.47 ' O ' HG22 ' A' ' 100' ' ' ILE . 48.5 mtt -53.62 -50.12 66.38 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 111.899 0.333 . . . . 73.31 111.899 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.13 -41.98 97.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.773 0.321 . . . . 74.43 111.638 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -68.57 -48.19 64.86 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.743 0.306 . . . . 74.11 111.63 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.22 -41.35 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.258 0.466 . . . . 54.04 112.258 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 96' ' ' MET . 10.5 tp -68.27 -37.73 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 122.113 -0.367 . . . . 73.31 110.573 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.618 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 15.4 t70 -54.82 -60.92 2.7 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.131 0.491 . . . . 74.1 110.547 175.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -62.36 -34.55 76.91 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.335 -0.393 . . . . 73.13 111.843 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 10.8 tpt -61.38 -42.34 98.56 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.099 0.476 . . . . 54.13 110.883 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.7 -8.59 58.85 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 111.883 0.327 . . . . 75.53 111.883 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 61.7 mmtt -81.58 -27.69 34.18 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.698 -0.626 . . . . 63.22 111.761 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -102.44 -36.92 8.24 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.694 0.627 . . . . 74.33 112.694 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -98.57 -51.06 4.05 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.872 -0.517 . . . . 75.43 111.096 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.63 -36.86 0.27 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.646 0.98 . . . . 75.12 113.646 167.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -82.79 144.32 30.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.239 0.542 . . . . 75.2 112.432 -173.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.07 -38.27 79.02 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.627 -0.715 . . . . 70.53 112.617 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.25 27.26 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.065 0.394 . . . . 51.41 112.065 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -94.97 -61.05 1.55 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.984 0.421 . . . . 71.33 111.285 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.7 m -60.91 -27.53 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 113.185 0.809 . . . . 61.02 113.185 -173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.24 -38.7 88.52 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.04 0.448 . . . . 73.41 110.567 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.1 -46.22 62.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.199 -0.455 . . . . 70.33 111.235 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -57.16 -52.22 66.17 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.133 0.492 . . . . 74.25 111.332 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -61.1 -29.74 69.94 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.849 -0.614 . . . . 75.11 110.515 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -69.38 -46.91 65.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.222 -0.444 . . . . 71.31 111.635 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -59.61 -51.71 68.64 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.812 0.339 . . . . 64.13 111.895 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tp -67.0 -33.64 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 120.769 0.318 . . . . 75.02 111.507 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.95 -48.61 68.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.911 0.386 . . . . 71.41 110.399 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.63 -35.75 87.07 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.001 -0.619 . . . . 74.5 112.205 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 55.2 t90 -58.3 -57.04 14.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.622 0.369 . . . . 74.3 111.399 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.518 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 m -61.94 -48.2 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.352 0.501 . . . . 74.52 112.352 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.3 -28.92 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 121.912 -0.492 . . . . 64.5 111.896 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.9 m -82.27 -24.87 34.52 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.05 0.452 . . . . 53.25 111.031 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.47 -28.13 22.25 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.973 -0.558 . . . . 71.11 111.828 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.3 mt -79.96 2.43 23.57 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.765 0.654 . . . . 72.21 112.765 -176.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.47 92.11 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.32 0.581 . . . . 74.01 111.173 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -54.64 -43.36 72.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.12 0.785 . . . . 75.22 113.12 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -53.24 -34.87 58.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.351 0.5 . . . . 64.0 112.351 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 132' ' ' ARG . 8.2 mpt_? -102.91 -48.12 4.17 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.26 0.553 . . . . 74.21 111.206 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.468 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 97.6 m-85 -78.3 -6.6 55.55 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.287 0.847 . . . . 73.43 113.287 -171.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -12.02 3.53 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.527 -0.733 . . . . 74.22 111.727 173.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -92.64 18.39 8.8 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.106 0.41 . . . . 55.11 112.106 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 81.0 mt -88.36 144.71 26.23 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.939 -0.476 . . . . 54.12 111.65 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.28 122.21 45.76 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.056 -0.52 . . . . 74.31 110.802 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -97.91 108.6 21.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.855 0.359 . . . . 73.01 111.189 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.665 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 67.3 m-85 -102.88 130.41 49.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.08 0.467 . . . . 74.21 111.666 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.451 HD11 ' HA3' ' A' ' 151' ' ' GLY . 14.3 tt -128.31 155.1 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.084 -0.507 . . . . 75.31 110.9 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.41 143.54 41.44 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.351 -0.452 . . . . 62.33 113.614 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -50.85 -63.76 1.02 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.196 0.443 . . . . 74.4 112.196 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 2.6 mmp_? -49.4 -34.12 15.48 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.23 0.456 . . . . 73.34 112.23 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.654 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -63.88 -56.38 15.78 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.02 0.438 . . . . 43.23 111.732 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.88 -28.89 69.85 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.801 0.334 . . . . 71.4 111.634 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.73 -31.52 63.41 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.104 -0.498 . . . . 64.2 112.148 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.15 -43.93 0.03 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.279 -0.962 . . . . 65.13 114.301 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.654 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -66.29 86.26 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.196 0.522 . . . . 72.24 112.129 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.25 4.22 0.75 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.35 0.5 . . . . 75.41 112.35 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.534 ' O ' ' HB3' ' A' ' 8' ' ' PHE . 3.2 p-10 -91.93 24.08 3.39 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.158 0.504 . . . . 61.04 110.381 170.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.592 ' HA3' ' HB1' ' A' ' 144' ' ' ALA . . . -77.56 134.23 14.32 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 114.232 0.453 . . . . 52.24 114.232 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 8' ' ' PHE . 48.1 tt0 -93.98 134.6 36.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 122.558 0.343 . . . . 65.14 111.005 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 98.7 t -95.01 136.31 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.407 0.521 . . . . 61.43 112.407 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.801 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -103.98 136.21 44.05 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.865 -0.607 . . . . 73.04 110.069 173.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.529 ' HB ' ' HG3' ' A' ' 170' ' ' MET . 62.3 mt -102.53 128.31 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 120.003 -0.679 . . . . 53.34 112.734 -170.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 46.1 mm -102.5 117.63 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.782 0.325 . . . . 54.22 111.49 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -106.74 145.49 31.99 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.252 0.549 . . . . 54.2 112.285 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -77.13 98.14 4.97 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.699 0.761 . . . . 73.34 110.136 171.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.454 ' HB2' ' OG1' ' A' ' 168' ' ' THR . 0.0 OUTLIER -93.43 97.03 10.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.099 -0.501 . . . . 75.32 111.11 -174.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 7.4 p-10 -66.99 119.2 11.56 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.162 0.506 . . . . 75.33 111.217 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.6 t -121.53 105.61 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.084 -0.507 . . . . 72.44 110.899 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 53.41 34.62 18.53 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.416 0.524 . . . . 71.33 112.416 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.15 -23.49 27.09 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.284 -0.417 . . . . 53.3 113.759 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 85.8 m -105.88 113.92 27.76 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.502 -0.411 . . . . 54.51 111.757 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 49.4 mt-10 -73.48 110.24 7.61 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.754 0.312 . . . . 55.13 111.156 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.69 140.14 20.82 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 120.747 0.308 . . . . 61.53 111.145 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.435 ' HB2' HG21 ' A' ' 68' ' ' ILE . 73.4 Cg_endo -74.62 114.35 4.01 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.12 1.88 . . . . 63.13 112.704 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 159' ' ' ARG . 23.7 p -118.78 150.86 39.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.228 0.537 . . . . 61.1 111.588 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.801 HD11 ' HB1' ' A' ' 154' ' ' ALA . 38.7 tp -100.4 140.12 35.1 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.044 -0.526 . . . . 62.33 111.025 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.529 ' HG3' ' HB ' ' A' ' 155' ' ' ILE . 22.2 ptm -123.41 134.63 53.94 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 121.132 0.491 . . . . 61.15 111.236 177.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 86.3 mt -141.6 148.31 39.03 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.146 -0.934 . . . . 74.53 111.433 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.493 HG22 HG12 ' A' ' 27' ' ' VAL . 10.7 t -100.96 122.66 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.254 0.222 . . . . 64.44 110.745 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.51 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -74.13 -5.98 44.92 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.793 -0.567 . . . . 62.43 112.04 -177.246 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.484 ' H ' HG12 ' A' ' 172' ' ' VAL . 9.0 mm-40 -74.67 -15.24 60.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.364 0.602 . . . . 75.53 110.08 170.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . . . -99.03 -22.88 15.5 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.701 -0.682 . . . . 75.44 111.67 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 6' ' ' ASP . 40.3 pt -137.13 130.73 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.281 0.562 . . . . 65.41 111.972 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.3 mm -104.42 118.99 52.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.316 -0.402 . . . . 74.25 110.305 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.55 146.09 25.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.426 0.631 . . . . 72.02 112.167 -176.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -131.23 143.89 50.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.985 -0.552 . . . . 75.3 110.994 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -89.46 105.85 18.07 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.344 0.592 . . . . 74.14 112.014 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 74.9 m -116.15 88.38 2.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.062 0.458 . . . . 72.33 110.971 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.562 HD22 ' HG3' ' A' ' 183' ' ' GLU . 0.0 OUTLIER -161.66 19.54 0.11 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.228 0.537 . . . . 71.34 111.379 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.562 ' HG3' HD22 ' A' ' 182' ' ' LEU . 38.5 mt-10 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 118.435 -0.793 . . . . 72.01 111.739 -176.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.895 0.379 . . . . 71.5 111.594 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' A' ' 178' ' ' GLU . 44.1 tp -95.58 131.44 41.78 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.147 -0.346 . . . . 72.54 110.851 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.6 mt -121.15 118.97 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 122.245 -0.284 . . . . 63.45 110.485 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.418 ' O ' HD12 ' A' ' 13' ' ' LEU . 47.1 p90 -116.41 149.27 39.7 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.107 0.78 . . . . 75.04 113.107 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.685 ' HG3' ' HB2' ' A' ' 10' ' ' ASP . 48.0 tttp -137.07 119.0 15.25 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.544 -1.207 . . . . 62.2 111.416 -173.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 2.8 m-20 -68.85 173.5 5.25 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.451 0.644 . . . . 73.14 111.795 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 175' ' ' ALA . 71.6 mt -81.38 -38.78 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.261 0.553 . . . . 72.1 110.474 168.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -108.69 -44.3 4.07 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.909 -0.587 . . . . 73.55 112.526 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -91.72 14.41 15.36 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.861 0.363 . . . . 61.23 111.868 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.685 ' HB2' ' HG3' ' A' ' 5' ' ' LYS . 7.0 p-10 -61.78 -10.47 9.02 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.783 0.66 . . . . 41.44 112.783 -173.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.77 -27.5 51.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.568 0.699 . . . . 63.42 110.192 173.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -93.32 24.74 3.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.07 -0.968 . . . . 75.32 111.868 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 4' ' ' TYR . 62.8 tp -34.15 109.13 0.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.408 0.683 . . . . 74.23 112.291 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.5 m -113.2 140.77 47.67 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.982 0.734 . . . . 63.34 112.982 -169.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.6 p -110.83 105.54 14.41 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.755 -0.657 . . . . 73.41 110.254 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -123.16 179.89 4.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 120.716 0.294 . . . . 72.22 111.47 -173.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.2 t -109.22 -28.59 8.94 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.892 0.701 . . . . 72.03 112.892 -176.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -66.27 118.32 51.99 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 112.203 0.446 . . . . 74.54 112.203 -175.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -91.24 152.83 3.74 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.112 2.542 . . . . 65.42 113.826 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 20' ' ' MET . 0.6 OUTLIER -114.63 165.77 12.43 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.339 -0.392 . . . . 74.24 111.113 178.331 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -100.01 120.72 40.26 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.094 -0.379 . . . . 42.03 110.532 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.1 tp -83.39 120.89 26.45 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.076 0.465 . . . . 64.45 111.22 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.77 149.07 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.286 -0.415 . . . . 72.21 111.103 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.6 t70 62.8 9.11 3.42 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 116.436 -0.347 . . . . 73.15 111.652 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 55.06 23.43 5.21 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.106 0.479 . . . . 64.04 111.739 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.1 tp -134.16 -43.26 0.79 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.264 -0.425 . . . . 74.3 111.917 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.3 155.58 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.032 0.444 . . . . 71.31 112.164 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 170' ' ' MET . 90.5 m-85 -92.88 149.28 21.37 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.41 -0.359 . . . . 63.12 110.752 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -136.42 116.47 13.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.745 0.418 . . . . 74.11 110.652 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.562 ' CZ ' HD23 ' A' ' 169' ' ' LEU . 16.9 p90 -151.13 134.55 16.2 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.082 1.141 . . . . 72.21 114.082 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.796 ' HG3' ' HB ' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -98.88 120.8 39.94 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.574 -0.739 . . . . 74.31 110.798 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.93 -120.25 0.46 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.972 -0.633 . . . . 52.33 113.158 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -150.64 141.43 22.78 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 122.654 -0.321 . . . . 75.33 110.442 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -77.66 106.48 9.49 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.653 0.263 . . . . 73.33 110.957 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.545 HG12 HD21 ' A' ' 44' ' ' LEU . 31.4 m -143.36 171.96 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.455 0.645 . . . . 72.0 112.434 -175.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.96 128.43 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.807 -0.633 . . . . 71.33 110.686 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 65' ' ' GLU . 47.4 ttp180 -104.18 113.52 27.13 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.283 0.563 . . . . 60.1 111.411 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 59.3 tttp -99.09 157.01 16.65 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.61 -0.723 . . . . 71.34 110.768 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -11.62 7.74 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.991 0.738 . . . . 74.13 112.991 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.08 -55.07 0.48 Allowed Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.302 -0.475 . . . . 62.11 113.083 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -150.38 -173.69 4.53 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.169 0.509 . . . . 72.21 112.337 -178.172 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.405 HG12 HD13 ' A' ' 44' ' ' LEU . 11.2 tt -107.96 109.12 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.3 0.572 . . . . 60.42 110.97 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.579 HG13 ' H ' ' A' ' 44' ' ' LEU . 3.9 p -79.34 -66.29 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 113.49 0.922 . . . . 64.42 113.49 -172.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.579 ' H ' HG13 ' A' ' 43' ' ' VAL . 6.1 mp 57.62 98.71 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.307 0.575 . . . . 71.42 111.724 -173.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.85 -20.59 13.53 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.04 -0.527 . . . . 72.53 112.111 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.39 118.8 1.99 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.217 -0.516 . . . . 54.33 112.731 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.9 m -150.38 111.63 4.4 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.477 -0.425 . . . . 61.25 111.859 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -98.11 148.6 34.72 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.46 -0.336 . . . . 63.33 110.801 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.11 100.74 0.46 Allowed 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.297 1.998 . . . . 71.33 112.809 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.3 m -91.71 23.7 3.46 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.066 0.395 . . . . 42.12 112.066 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.23 132.83 3.05 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.059 0.392 . . . . 73.31 112.059 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.8 -65.27 1.03 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.176 0.512 . . . . 75.21 110.705 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -80.5 -11.42 59.67 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.043 0.449 . . . . 55.05 111.333 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.6 4.41 60.36 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.271 -0.422 . . . . 61.54 112.87 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.96 84.27 1.25 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.485 0.659 . . . . 73.13 110.874 175.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -89.08 -48.34 7.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.351 -0.841 . . . . 61.23 111.293 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 55.81 34.18 22.95 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.454 0.538 . . . . 71.21 112.454 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -91.18 -33.27 15.48 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.018 0.437 . . . . 65.24 110.92 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.93 66.81 2.44 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 116.225 -0.443 . . . . 64.3 113.625 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.2 p -109.47 108.1 18.48 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.702 0.287 . . . . 73.23 110.843 177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -157.61 24.31 0.28 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 111.954 0.353 . . . . 73.0 111.954 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.24 117.49 34.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.754 0.311 . . . . 74.44 110.897 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -74.43 66.04 1.31 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.232 0.539 . . . . 72.44 111.258 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.1 t -128.79 136.64 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.929 -0.578 . . . . 74.34 110.159 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 37' ' ' ARG . 48.5 mt-10 -76.35 72.42 3.09 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.788 0.804 . . . . 63.25 110.146 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -84.11 142.54 30.31 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.916 -1.038 . . . . 70.41 111.917 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.41 -138.78 6.48 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.063 -0.589 . . . . 73.02 113.047 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.8 pt -111.16 142.23 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 O-C-N 122.377 -0.484 . . . . 73.32 111.449 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -44.17 -42.52 6.47 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.593 0.59 . . . . 72.04 112.593 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.0 mt -47.75 -52.2 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.107 0.48 . . . . 63.43 112.216 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 26.7 m -83.3 -34.94 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.19 -0.459 . . . . 64.43 112.059 -174.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.84 -44.24 96.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.834 0.349 . . . . 73.51 111.782 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -67.56 -18.41 65.0 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.238 0.458 . . . . 64.43 112.238 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -111.24 7.15 21.04 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.219 -0.301 . . . . 75.31 111.393 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp 50.73 52.53 14.72 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.29 0.636 . . . . 70.21 112.685 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 55.7 mt -91.4 128.16 37.12 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.997 -0.547 . . . . 54.54 110.644 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.8 p -93.18 147.32 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.584 0.231 . . . . 50.15 111.26 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.09 140.19 30.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.718 0.77 . . . . 73.11 112.989 -175.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 65.3 mtm -135.38 166.08 23.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.243 -0.89 . . . . 61.42 109.609 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.405 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 44.5 t30 -133.16 145.45 50.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.346 0.593 . . . . 72.02 111.938 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.421 ' HA ' ' HB2' ' A' ' 84' ' ' ASP . 41.6 t -42.16 -30.44 0.3 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.928 1.455 . . . . 74.43 114.928 -170.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 20.8 p90 -59.96 -32.24 70.63 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.985 -0.447 . . . . 74.42 111.644 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -101.28 -31.25 11.07 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.763 0.316 . . . . 63.14 111.132 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.421 ' HB2' ' HA ' ' A' ' 81' ' ' CYS . 2.0 m-20 -71.78 -12.38 61.27 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.791 0.663 . . . . 71.35 112.791 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.501 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -31.03 -73.64 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.195 1.184 . . . . 64.43 114.195 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.2 m -71.03 -23.18 62.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.022 0.378 . . . . 54.21 112.022 -176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.8 ttm -70.17 -57.3 5.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.62 -0.264 . . . . 62.13 111.58 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.501 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 11.0 p90 -65.22 -26.14 67.99 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.469 -0.492 . . . . 71.22 110.816 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.31 -42.24 99.2 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.02 0.438 . . . . 55.33 110.915 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.22 -36.19 76.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.098 0.475 . . . . 71.21 111.154 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.17 -55.24 26.81 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.029 -0.532 . . . . 73.41 111.728 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.1 tp -60.58 -29.5 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.185 0.517 . . . . 74.22 111.011 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.52 -58.52 8.23 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.819 -0.628 . . . . 75.11 111.063 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.635 ' HA ' ' HD2' ' A' ' 97' ' ' LYS . 68.1 mttm -64.64 -34.21 77.76 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.178 -0.465 . . . . 75.12 111.28 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.554 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 66.1 t80 -56.02 -53.44 56.87 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.79 -0.641 . . . . 73.13 110.889 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -52.45 -46.63 66.54 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.016 0.436 . . . . 70.44 111.038 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.635 ' HD2' ' HA ' ' A' ' 94' ' ' LYS . 61.9 mttm -52.7 -59.31 4.64 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.813 -0.63 . . . . 65.43 111.783 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -68.24 -43.12 78.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.036 0.754 . . . . 74.21 113.036 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.426 HG12 ' HB3' ' A' ' 174' ' ' GLU . 30.7 m -64.11 -45.03 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.048 0.388 . . . . 74.24 112.048 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 mm -69.01 -37.19 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 122.064 -0.397 . . . . 73.12 110.73 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 105' ' ' LYS . 29.5 t70 -59.94 -45.76 91.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.137 0.494 . . . . 74.33 110.455 174.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -64.41 -50.06 69.09 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.929 -0.578 . . . . 74.41 111.936 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 49.7 tpp -70.56 -47.35 60.72 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.011 0.434 . . . . 74.35 112.032 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -73.96 -19.39 60.69 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 122.066 -0.396 . . . . 73.13 111.43 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 101' ' ' ASP . 86.8 tttt -59.6 -55.03 39.58 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.289 0.566 . . . . 75.22 111.647 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -102.44 -37.69 7.91 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.594 0.59 . . . . 62.01 112.594 -174.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -76.63 -53.65 7.74 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.806 0.336 . . . . 74.13 110.749 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 46.11 11.76 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.865 1.432 . . . . 74.33 114.865 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.464 ' O ' HG22 ' A' ' 113' ' ' VAL . 12.6 t70 -77.62 109.21 11.4 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.676 -0.64 . . . . 64.42 110.21 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -54.21 -27.12 32.26 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.146 0.795 . . . . 73.31 113.146 -174.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.02 -37.0 34.99 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.978 0.418 . . . . 44.41 111.344 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -74.82 -53.13 9.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.299 -0.41 . . . . 73.35 111.354 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 109' ' ' ASP . 22.4 m -58.78 -31.31 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 111.991 0.367 . . . . 53.15 111.991 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.61 -36.92 79.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.814 0.34 . . . . 74.54 110.469 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.26 -48.89 71.65 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.439 -0.346 . . . . 64.43 110.855 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -55.94 -52.01 65.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.179 0.514 . . . . 73.24 111.062 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -56.72 -38.61 72.59 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.843 -0.617 . . . . 71.03 111.489 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -66.03 -41.34 91.05 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.012 0.434 . . . . 73.34 111.347 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -66.32 -49.43 67.04 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.192 -0.458 . . . . 73.51 111.628 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.9 tp -65.93 -34.35 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.804 0.335 . . . . 73.51 111.033 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -64.08 -49.0 73.98 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.874 0.368 . . . . 62.12 110.966 175.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.53 -39.3 92.97 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.047 -0.596 . . . . 71.22 112.527 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 53.5 t90 -61.38 -56.67 17.69 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.331 0.252 . . . . 74.21 111.327 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.43 -41.89 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.645 0.609 . . . . 71.4 112.645 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.5 p -64.03 -33.58 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.89 -0.506 . . . . 70.1 111.861 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.5 t -80.17 -40.43 27.28 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.089 0.471 . . . . 75.52 111.139 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 155' ' ' ILE . 39.1 tp -67.43 -42.28 83.42 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.279 0.474 . . . . 71.12 112.279 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.2 mt -72.5 1.4 8.16 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.435 0.531 . . . . 72.45 112.435 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.1 72.49 0.18 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.523 0.678 . . . . 62.12 110.623 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -59.49 -22.13 61.13 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.622 -0.717 . . . . 65.14 112.319 -174.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.18 -31.03 63.05 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.203 0.525 . . . . 60.4 110.948 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -109.31 -37.31 5.79 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.812 -0.631 . . . . 73.54 111.545 174.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -93.23 -5.73 49.26 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.656 1.354 . . . . 64.21 114.656 -169.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -58.7 -13.56 6.26 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.096 0.862 . . . . 54.2 111.806 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -90.1 24.46 2.47 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.233 -0.44 . . . . 60.11 112.058 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.0 mt -88.36 153.88 20.83 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.0 0.429 . . . . 74.43 111.001 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.668 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -105.18 112.41 25.53 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.884 0.374 . . . . 61.34 111.286 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -98.43 107.18 19.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.906 0.384 . . . . 75.12 110.946 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 59.7 m-85 -97.82 143.53 28.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.161 0.505 . . . . 63.51 112.297 -177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 145' ' ' ALA . 14.3 tt -134.97 151.47 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.929 -0.578 . . . . 73.35 111.06 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.402 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -63.44 150.68 49.28 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 114.478 0.551 . . . . 54.43 114.478 -176.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -47.3 -58.08 4.51 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.295 0.638 . . . . 74.2 112.104 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -65.5 -45.55 83.14 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.868 0.366 . . . . 65.43 111.691 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.54 -38.01 79.91 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.413 0.523 . . . . 64.24 112.413 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.441 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -63.31 -54.5 36.14 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.177 0.513 . . . . 70.43 111.783 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -68.06 -40.53 82.76 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.272 -0.422 . . . . 74.45 111.146 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.2 -20.77 79.6 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.404 -0.426 . . . . 53.14 113.681 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 63.08 21.91 13.14 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.845 0.683 . . . . 73.11 112.845 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -73.45 82.43 1.45 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.655 0.613 . . . . 72.43 112.655 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.6 m120 74.24 -41.91 0.49 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.834 0.854 . . . . 73.24 113.033 172.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.09 78.7 1.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.363 -0.446 . . . . 64.44 114.095 177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -70.6 102.0 2.16 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.224 -0.574 . . . . 63.33 109.699 172.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 96.6 t -86.65 125.01 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 113.239 0.829 . . . . 64.53 113.239 -172.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.579 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -92.86 113.29 25.53 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.703 -0.681 . . . . 73.43 109.669 169.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.494 HD13 HD21 ' A' ' 127' ' ' LEU . 55.5 mt -92.13 112.98 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.384 0.513 . . . . 74.04 112.384 -170.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.668 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 49.2 mm -90.74 106.17 17.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 120.837 0.351 . . . . 61.52 110.637 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -106.92 132.02 53.34 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.688 -0.687 . . . . 75.43 111.279 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -89.43 138.47 31.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.212 -0.449 . . . . 72.25 111.409 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -137.63 119.65 15.45 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.746 0.307 . . . . 70.23 111.533 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -85.78 92.33 8.58 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.574 0.702 . . . . 74.23 111.223 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.45 102.55 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.109 -0.496 . . . . 63.44 110.42 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 58.64 19.27 6.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.241 0.543 . . . . 65.12 111.038 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.47 -12.93 33.19 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.043 -0.526 . . . . 60.35 113.229 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.5 m -84.25 115.58 22.53 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.451 -0.441 . . . . 74.04 111.074 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.42 117.56 15.32 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.359 0.504 . . . . 71.53 112.359 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.796 ' HB ' ' HG3' ' A' ' 31' ' ' LYS . 25.7 m -128.82 112.32 18.84 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 121.012 0.434 . . . . 75.54 111.595 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.559 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 6.9 Cg_exo -75.1 113.63 3.83 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.521 2.147 . . . . 71.55 112.377 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.493 HG22 ' HB2' ' A' ' 31' ' ' LYS . 44.2 p -109.3 159.05 17.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.59 -0.277 . . . . 40.02 111.504 -176.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.579 HD11 ' HB1' ' A' ' 154' ' ' ALA . 23.0 tp -104.73 126.8 52.17 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.9 0.381 . . . . 71.24 111.038 177.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.611 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 48.6 ttm -105.01 126.12 51.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.281 -0.872 . . . . 63.23 110.993 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.479 ' HB3' HD11 ' A' ' 176' ' ' ILE . 94.4 mt -137.03 123.07 20.29 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.034 -0.53 . . . . 62.24 111.36 -178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.554 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 22.6 t -74.85 122.01 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 122.095 -0.378 . . . . 74.22 111.425 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.411 ' HD3' ' HG2' ' A' ' 174' ' ' GLU . 0.0 OUTLIER -69.33 -11.33 60.72 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.893 0.701 . . . . 73.22 112.893 -176.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.514 ' H ' HG12 ' A' ' 172' ' ' VAL . 24.1 mm-40 -91.83 -11.18 37.25 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.815 0.341 . . . . 74.13 111.598 174.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.488 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -96.14 -38.44 10.16 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.381 0.61 . . . . 64.3 110.232 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' A' ' 171' ' ' LEU . 32.4 pt -127.45 118.94 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.371 -0.831 . . . . 73.02 109.28 168.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.8 tp -94.6 110.86 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.511 0.672 . . . . 61.13 111.563 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.454 ' HB3' HD11 ' A' ' 2' ' ' LEU . 16.7 mm-40 -79.57 115.81 19.41 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.609 -0.723 . . . . 74.34 110.585 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.43 ' O ' HD12 ' A' ' 2' ' ' LEU . 10.1 tp10 -92.92 116.29 28.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.455 0.645 . . . . 65.32 109.856 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -92.13 96.5 10.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.399 -0.819 . . . . 62.12 112.999 -167.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 73.0 m -124.17 88.33 2.89 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.781 -0.645 . . . . 61.22 109.454 169.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 182' ' ' LEU . 1.8 mm? -98.91 -40.35 8.13 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.074 0.464 . . . . 75.4 111.276 -174.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.537 -0.744 . . . . 43.0 111.255 -178.143 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 111.917 0.34 . . . . 73.42 111.917 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 178' ' ' GLU . 38.1 tp -75.22 122.93 24.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.759 0.314 . . . . 61.04 111.261 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.716 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 50.7 mt -97.59 120.79 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.586 0.232 . . . . 73.51 111.016 -174.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 14' ' ' SER . 34.9 p90 -107.85 139.27 42.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.704 0.631 . . . . 75.54 112.704 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.621 ' HG3' ' HB2' ' A' ' 10' ' ' ASP . 52.0 tttp -130.02 122.16 27.87 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.805 -1.089 . . . . 43.32 111.071 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.622 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 33.1 t70 -80.54 173.31 12.72 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.484 0.183 . . . . 75.21 110.552 175.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.5 mt -75.72 -46.23 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.836 -0.54 . . . . 54.01 111.698 176.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -108.49 -41.27 4.88 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.273 0.558 . . . . 74.43 112.122 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.4 16.55 7.37 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.27 0.628 . . . . 64.21 111.804 -175.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.622 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 10.7 p-10 -59.86 -4.26 0.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.952 1.093 . . . . 54.01 113.952 -170.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.53 -19.66 64.97 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.877 -0.514 . . . . 53.53 111.331 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.63 23.35 1.68 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.611 0.244 . . . . 63.32 111.358 170.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.616 HD13 ' HB2' ' A' ' 5' ' ' LYS . 57.2 tp -49.28 104.04 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.516 0.326 . . . . 74.04 110.53 173.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.442 ' HB2' ' CE1' ' A' ' 4' ' ' TYR . 70.0 m -133.51 147.61 51.63 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.223 0.823 . . . . 75.23 113.223 -170.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.2 p -82.51 88.84 6.62 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.632 -0.713 . . . . 53.54 110.568 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -90.11 179.35 5.95 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.766 -0.652 . . . . 70.42 111.855 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.8 p -161.85 25.99 0.12 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.267 0.469 . . . . 72.14 112.267 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -89.69 149.87 43.02 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-O 120.6 0.238 . . . . 72.45 111.625 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.97 72.67 1.53 Allowed 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.804 2.336 . . . . 71.42 113.461 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 55.0 ttp -87.69 115.36 25.08 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.27 -0.423 . . . . 73.53 110.793 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -102.44 159.05 15.76 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.699 0.285 . . . . 63.24 111.67 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 27' ' ' VAL . 47.9 tp -104.86 142.53 34.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.033 0.444 . . . . 60.15 111.408 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.508 HG13 HG23 ' A' ' 27' ' ' VAL . 7.2 p -134.13 141.12 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-N 116.144 -0.48 . . . . 72.43 111.115 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 56.83 23.61 8.27 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.763 0.653 . . . . 74.35 112.763 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 60.91 3.98 0.73 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.041 0.756 . . . . 51.42 113.041 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.521 HD21 HD13 ' A' ' 120' ' ' ILE . 41.0 tp -125.3 -43.56 1.92 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.945 0.72 . . . . 65.21 112.945 -169.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.508 HG23 HG13 ' A' ' 23' ' ' VAL . 1.2 m -123.82 149.4 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.284 0.476 . . . . 43.11 112.284 -175.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.557 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 58.6 m-85 -85.84 147.6 26.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.888 0.375 . . . . 63.23 111.337 176.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.449 ' HB2' HH22 ' A' ' 159' ' ' ARG . 14.9 pt-20 -121.1 137.98 54.41 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.009 -0.541 . . . . 74.44 110.941 176.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -150.75 113.16 4.64 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.404 -0.362 . . . . 75.43 110.119 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -75.07 135.38 41.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.172 0.51 . . . . 62.31 112.331 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.54 133.37 11.43 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.335 -0.46 . . . . 63.21 112.184 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -91.92 152.41 20.07 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.332 0.566 . . . . 74.15 112.173 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -71.11 105.28 3.31 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.568 -0.742 . . . . 65.31 111.636 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.522 HG23 HD12 ' A' ' 72' ' ' LEU . 19.7 m -143.99 -177.97 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.977 0.418 . . . . 75.3 111.595 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 44' ' ' LEU . 23.6 m -119.12 145.74 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 112.382 0.512 . . . . 64.02 112.382 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.709 ' HB3' HD22 ' A' ' 72' ' ' LEU . 7.6 tpm_? -141.15 108.15 5.44 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.577 0.703 . . . . 74.31 110.807 175.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 88.5 tttt -104.49 128.76 52.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.631 -0.713 . . . . 54.3 109.686 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.87 85.29 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.54 0.686 . . . . 74.32 110.266 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.17 -56.27 0.49 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-N 115.179 -0.919 . . . . 71.43 112.402 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 36.2 tt0 -137.72 169.25 18.11 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.409 0.283 . . . . 64.35 110.53 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.557 HD11 HD23 ' A' ' 44' ' ' LEU . 12.0 tt -144.39 130.35 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 121.948 -0.47 . . . . 73.01 111.894 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.04 82.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 120.843 0.354 . . . . 71.25 111.048 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.557 HD23 HD11 ' A' ' 42' ' ' ILE . 4.3 pp -104.59 156.56 17.86 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.166 0.507 . . . . 70.12 112.161 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.34 12.79 3.02 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.943 -0.571 . . . . 72.5 111.097 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.02 -98.41 0.79 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.284 -0.484 . . . . 72.41 112.897 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.2 t -97.3 123.84 41.23 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.524 -0.397 . . . . 35.41 110.952 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 65.8 t30 -105.33 119.28 53.45 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 120.615 0.245 . . . . 72.31 111.246 -177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 10.3 Cg_exo -73.69 38.16 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.288 2.658 . . . . 73.15 113.675 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -99.38 -173.86 2.59 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.801 0.334 . . . . 72.21 111.418 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.89 -2.8 10.52 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.713 1.005 . . . . 52.12 113.713 -174.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -147.96 122.55 9.81 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.548 0.69 . . . . 73.44 111.379 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -88.44 -43.62 11.33 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.4 -0.818 . . . . 72.21 111.947 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.21 -114.67 0.07 OUTLIER Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.435 -0.412 . . . . 54.33 113.217 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 176.2 132.72 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.976 0.417 . . . . 51.35 111.752 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -130.09 99.44 5.07 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.163 0.506 . . . . 63.35 110.262 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.436 ' CG ' ' HE ' ' A' ' 66' ' ' ARG . 14.7 p-10 -110.8 127.6 55.44 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.399 0.618 . . . . 75.44 112.035 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -102.09 71.33 1.25 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.941 -0.572 . . . . 73.44 110.075 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 136.12 84.98 0.18 Allowed Glycine 0 CA--C 1.529 0.968 0 CA-C-N 115.769 -0.65 . . . . 70.31 112.345 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.42 ' O ' HG22 ' A' ' 64' ' ' VAL . 84.9 p -100.4 32.66 2.96 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.916 0.709 . . . . 73.23 112.916 -171.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.73 -56.04 1.6 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.758 0.651 . . . . 70.52 112.758 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -55.89 -57.61 11.34 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.16 0.43 . . . . 73.31 112.16 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -137.15 79.62 1.76 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.965 0.412 . . . . 62.12 110.359 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 66' ' ' ARG . 41.0 t -49.18 -73.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 112.753 0.649 . . . . 75.34 112.753 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 33.6 tt0 66.16 -10.13 0.26 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.354 0.872 . . . . 73.23 113.354 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.439 ' H ' HG12 ' A' ' 64' ' ' VAL . 32.8 ttp85 -111.2 135.54 51.59 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.4 -0.812 . . . . 75.52 111.862 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' A' ' 72' ' ' LEU . . . 169.56 -170.53 42.74 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.044 -1.074 . . . . 41.14 113.77 169.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.7 pt -103.57 146.65 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.797 -0.237 . . . . 62.32 110.556 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -38.99 -53.15 1.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.997 0.74 . . . . 73.32 112.997 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.609 HG21 HD22 ' A' ' 169' ' ' LEU . 60.7 mt -49.04 -62.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 112.673 0.62 . . . . 62.44 112.673 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 m -66.12 -31.99 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.261 -0.427 . . . . 74.15 112.031 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.709 HD22 ' HB3' ' A' ' 37' ' ' ARG . 76.0 mt -76.59 -33.02 58.45 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.063 0.459 . . . . 64.41 111.39 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -73.29 -42.71 62.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.083 -0.508 . . . . 65.42 111.516 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -94.77 -3.43 49.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 111.782 0.29 . . . . 73.53 111.782 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 65.24 71.63 0.44 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.296 0.57 . . . . 74.3 112.195 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 49.9 mt -108.7 128.51 54.92 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.754 -0.657 . . . . 74.33 110.595 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.4 p -89.57 149.33 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.804 0.335 . . . . 70.21 111.459 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.41 148.83 35.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.401 0.619 . . . . 71.32 112.619 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.72 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 85.4 mtp -140.16 153.09 46.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.425 -0.807 . . . . 74.31 109.956 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.537 ' HB2' ' HE1' ' A' ' 82' ' ' TYR . 13.7 m120 -133.29 139.74 47.06 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.236 0.541 . . . . 73.24 112.081 -174.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 52.0 t -46.22 -36.72 6.35 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.502 1.297 . . . . 70.11 114.502 -172.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.537 ' HE1' ' HB2' ' A' ' 80' ' ' ASN . 1.3 p90 -63.57 -27.44 69.25 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.487 0.551 . . . . 74.32 112.487 -175.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -102.18 -31.77 10.42 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.452 0.538 . . . . 74.44 112.452 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.464 ' O ' ' HD1' ' A' ' 88' ' ' PHE . 9.8 m-20 -76.57 -5.95 49.85 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.473 0.545 . . . . 74.51 112.473 -174.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.517 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . . . -34.19 -72.76 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.005 1.113 . . . . 52.3 114.005 -172.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.7 t -64.59 -31.84 73.24 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.88 0.372 . . . . 65.52 111.553 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.4 mmt -64.64 -63.89 1.01 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.206 -0.452 . . . . 72.42 112.175 -175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.517 ' HE1' ' HA ' ' A' ' 85' ' ' ALA . 1.8 p90 -70.77 -26.69 63.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.133 -0.354 . . . . 65.31 111.461 -176.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -68.01 -41.35 82.34 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.015 0.436 . . . . 72.43 110.11 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -40.44 81.61 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.85 0.357 . . . . 74.41 111.174 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -61.27 -51.0 70.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.368 -0.378 . . . . 74.15 111.695 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.0 tp -62.69 -32.3 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.821 0.343 . . . . 63.42 111.285 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -68.55 -55.85 10.28 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.727 0.269 . . . . 63.21 111.727 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.71 -37.24 73.17 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.071 0.463 . . . . 74.21 110.677 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.648 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 26.0 t80 -61.32 -54.48 43.36 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.034 -0.53 . . . . 74.0 111.284 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -53.78 -49.6 67.91 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.321 -0.4 . . . . 63.23 111.267 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.1 -38.45 90.77 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.679 -0.237 . . . . 73.42 111.438 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -64.23 -52.09 60.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.691 0.282 . . . . 63.12 111.702 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.3 m -64.01 -42.62 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 111.826 0.306 . . . . 55.05 111.826 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.6 mm -62.98 -45.45 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.851 0.358 . . . . 75.2 110.748 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.622 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 18.0 t70 -56.3 -48.09 77.37 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.293 -0.412 . . . . 74.42 111.634 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -66.67 -29.03 68.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.769 0.319 . . . . 72.21 111.536 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.0 tpt -75.58 -54.45 6.98 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.055 0.455 . . . . 71.05 111.367 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -54.05 -34.04 59.01 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.343 0.497 . . . . 71.15 112.343 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -51.4 -36.85 45.36 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.293 -0.255 . . . . 71.52 111.353 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -116.66 -5.87 11.62 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.257 0.836 . . . . 71.15 113.257 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -141.41 35.26 1.67 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.607 0.595 . . . . 75.14 112.607 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -5.82 1.07 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.749 1.388 . . . . 74.41 114.749 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 111' ' ' ALA . 4.4 m-20 -74.99 76.04 2.2 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.61 -0.681 . . . . 72.43 112.413 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt 37.52 -79.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.168 1.387 . . . . 73.21 114.655 171.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 109' ' ' ASP . . . -51.19 -42.82 61.14 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.059 0.762 . . . . 63.24 113.059 -170.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.22 -56.32 17.63 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.946 0.403 . . . . 75.21 111.882 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.8 m -67.9 -32.42 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.591 0.589 . . . . 70.44 112.591 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.69 -34.58 62.67 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.326 -0.233 . . . . 74.41 111.189 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.34 -45.41 72.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.198 0.523 . . . . 61.21 111.009 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -61.18 -46.72 89.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.193 0.52 . . . . 73.01 110.363 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -59.67 -32.58 70.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.921 -0.581 . . . . 54.32 111.307 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HE2' ' HB2' ' A' ' 118' ' ' LYS . 8.9 tppt? -60.17 -45.44 93.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.171 0.51 . . . . 62.45 110.86 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -68.26 -46.88 69.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.07 -0.514 . . . . 75.55 111.189 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.521 HD13 HD21 ' A' ' 26' ' ' LEU . 29.8 mm -58.97 -43.58 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.768 0.318 . . . . 62.21 111.365 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -63.04 -45.23 93.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.569 0.223 . . . . 73.24 110.719 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.08 -42.6 99.85 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.95 -0.643 . . . . 71.15 112.246 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 40.1 t90 -61.39 -49.94 74.88 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.493 0.317 . . . . 74.31 111.294 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.95 -42.05 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.388 0.514 . . . . 73.2 112.388 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.75 -25.28 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.243 0.544 . . . . 73.22 110.938 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.3 m -86.46 -51.55 6.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.191 -0.459 . . . . 73.34 111.117 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.431 HD11 HG21 ' A' ' 155' ' ' ILE . 27.8 tp -59.55 -35.77 74.89 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.184 0.516 . . . . 74.44 111.864 -177.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.7 mt -85.25 3.71 38.19 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.075 -0.511 . . . . 71.13 112.073 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.498 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -62.45 97.74 0.1 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.207 0.527 . . . . 44.3 110.849 176.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 28.7 ttpp -45.33 -64.51 0.7 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.067 1.136 . . . . 62.04 114.067 -170.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.41 -46.55 85.86 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.238 0.829 . . . . 72.53 113.238 -168.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -73.47 -50.99 18.75 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.359 0.6 . . . . 74.23 111.43 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 30.1 m-85 -82.43 -5.78 58.88 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.848 -0.614 . . . . 70.32 112.653 -173.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 26.1 ttpp -50.01 -22.84 1.73 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.102 0.477 . . . . 72.34 111.683 170.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.594 HD22 ' N ' ' A' ' 135' ' ' ASN . 0.8 OUTLIER -82.66 15.07 2.76 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.313 0.486 . . . . 73.05 112.313 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.534 HD21 ' HG2' ' A' ' 157' ' ' GLU . 49.5 mt -89.52 161.72 16.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.32 0.581 . . . . 73.33 112.212 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -123.7 126.33 46.35 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.776 -0.647 . . . . 53.51 111.138 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' A' ' 79' ' ' MET . 43.6 m-85 -96.91 133.55 41.4 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.125 -0.324 . . . . 74.43 110.125 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.443 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 58.2 m-85 -128.74 131.02 47.85 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.084 -0.385 . . . . 72.34 111.561 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.576 HG23 ' HB2' ' A' ' 145' ' ' ALA . 15.4 tt -125.24 148.07 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 120.976 0.417 . . . . 70.33 111.375 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.423 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -57.85 140.88 45.56 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 114.373 0.509 . . . . 64.35 114.373 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -42.03 -54.2 3.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.308 0.643 . . . . 72.25 112.115 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -62.5 -35.71 80.23 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.998 0.428 . . . . 72.54 112.137 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.9 -37.16 48.56 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.146 0.425 . . . . 72.1 112.146 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.576 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -62.81 -56.2 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.932 0.396 . . . . 75.33 111.944 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.09 -21.44 58.94 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.488 -0.324 . . . . 51.12 111.429 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -72.6 -21.87 79.32 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.954 -0.641 . . . . 63.54 112.423 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 61.15 42.05 12.78 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.263 0.468 . . . . 73.54 112.263 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.45 4.35 53.37 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.591 0.589 . . . . 73.51 112.591 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.4 p30 41.91 35.68 0.56 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.344 0.658 . . . . 74.5 112.447 -175.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.68 -135.43 1.01 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.117 -0.492 . . . . 74.14 114.269 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -67.24 104.25 1.43 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.764 0.653 . . . . 73.21 112.764 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.36 118.68 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.215 0.531 . . . . 63.21 110.834 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.687 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -79.86 124.2 28.44 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.949 -0.569 . . . . 65.22 111.209 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 43.3 mm -89.59 120.0 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.673 0.273 . . . . 72.43 111.5 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.3 mm -99.38 107.51 20.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-O 120.971 0.415 . . . . 64.33 111.012 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.534 ' HG2' HD21 ' A' ' 136' ' ' LEU . 0.4 OUTLIER -111.49 137.43 49.31 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.467 -0.788 . . . . 64.45 109.967 -178.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -92.19 123.92 35.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.152 0.501 . . . . 75.43 112.061 -174.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.449 HH22 ' HB2' ' A' ' 29' ' ' GLU . 77.8 mtm180 -130.16 154.3 47.66 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.278 0.561 . . . . 74.2 112.193 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -83.2 143.92 30.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.777 0.658 . . . . 74.13 112.777 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.1 t -128.71 87.9 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.749 -0.659 . . . . 74.35 109.65 167.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 48.37 41.92 17.31 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.835 0.68 . . . . 70.05 112.835 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.72 -23.26 22.33 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.294 -0.479 . . . . 73.34 113.21 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 91.7 m -95.52 106.15 18.2 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.486 -0.42 . . . . 74.23 111.352 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.54 112.64 14.53 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.245 -0.434 . . . . 45.34 111.091 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 35.7 m -119.37 141.72 31.2 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 112.083 0.401 . . . . 75.4 112.083 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 166' ' ' VAL . 8.0 Cg_exo -73.64 114.77 4.12 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.752 2.302 . . . . 44.4 112.117 174.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.8 p -109.37 140.79 42.62 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.927 0.394 . . . . 64.4 111.789 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.687 HD11 ' HB1' ' A' ' 154' ' ' ALA . 64.1 tp -77.54 145.16 37.1 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.97 -0.559 . . . . 74.01 111.962 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.492 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 48.1 ttm -130.18 124.49 32.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.766 -0.652 . . . . 73.21 110.909 176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.87 161.23 33.49 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.05 -0.722 . . . . 73.44 109.05 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.648 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 44.1 t -96.39 131.23 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.501 -0.749 . . . . 73.54 112.114 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.557 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 14.2 tmtt? -56.34 -55.69 30.34 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.185 -0.461 . . . . 74.05 111.611 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -75.25 4.6 6.76 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.017 0.377 . . . . 72.03 112.017 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.26 -21.02 17.5 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.261 0.553 . . . . 75.5 110.473 173.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 68.0 mt -118.73 108.97 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.853 -0.612 . . . . 75.41 110.587 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -92.16 113.96 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.118 0.485 . . . . 72.23 110.503 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.488 ' HB2' HD11 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -91.8 152.68 20.02 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.621 0.724 . . . . 75.32 112.771 -174.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.716 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 9.3 tp10 -114.83 110.87 20.34 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.581 -0.736 . . . . 73.03 109.336 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -81.04 95.1 6.72 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.261 0.553 . . . . 73.1 112.302 -171.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 52.9 t -134.32 96.93 3.7 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.585 -0.734 . . . . 73.11 109.834 171.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 64.0 mt -119.36 111.46 18.2 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.229 0.455 . . . . 54.11 112.229 -172.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.951 -0.547 . . . . 54.41 111.18 175.139 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.696 0.284 . . . . 75.05 111.308 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.7 tp -104.19 147.38 27.52 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.153 0.501 . . . . 70.54 111.203 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.26 141.0 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.545 -0.298 . . . . 72.4 110.565 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -122.92 158.75 29.71 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 121.904 -0.498 . . . . 73.14 111.461 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HB3' HD13 ' A' ' 13' ' ' LEU . 5.4 ptpp? -139.04 111.04 7.27 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.136 -0.483 . . . . 72.43 111.754 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 175' ' ' ALA . 7.0 m-20 -75.81 164.32 26.35 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.241 -0.287 . . . . 75.12 110.791 172.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.1 pt -61.19 -9.76 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 121.03 0.443 . . . . 74.24 111.493 173.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -107.92 -30.5 8.45 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.301 -0.409 . . . . 64.24 111.118 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.547 ' HB ' ' H ' ' A' ' 6' ' ' ASP . 11.1 m -92.63 -13.67 29.25 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.087 0.773 . . . . 71.1 113.087 -171.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.438 ' HA ' ' HB2' ' A' ' 5' ' ' LYS . 4.0 p30 -55.54 -16.93 4.45 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.106 0.78 . . . . 74.15 113.106 -173.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -69.26 -46.28 67.66 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.055 0.391 . . . . 64.4 112.055 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -121.07 -1.24 9.84 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.202 0.815 . . . . 53.14 113.202 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 5' ' ' LYS . 3.7 mm? 64.19 169.44 0.17 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.535 0.939 . . . . 64.43 113.535 173.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.8 m -148.01 136.85 21.87 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.949 -0.569 . . . . 72.34 110.678 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.5 p -115.35 119.27 35.72 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.675 0.62 . . . . 74.11 112.675 -172.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -149.7 -169.6 3.42 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.099 -0.501 . . . . 74.22 111.222 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 t -155.3 91.94 1.38 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.026 0.441 . . . . 74.0 111.435 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -130.6 118.75 18.02 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 116.433 -0.349 . . . . 73.3 111.207 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.81 87.68 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.372 2.048 . . . . 73.03 112.207 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.418 ' HG2' ' HB2' ' A' ' 30' ' ' PHE . 64.7 mtt -93.33 148.04 22.4 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.356 0.598 . . . . 63.11 112.123 -177.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -102.17 113.06 26.0 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.623 -0.717 . . . . 65.13 110.303 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.519 HD21 ' HD2' ' A' ' 173' ' ' LYS . 61.4 tp -74.61 87.84 2.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.159 0.504 . . . . 60.13 110.135 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.79 137.43 21.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.087 -0.506 . . . . 72.32 111.544 -175.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.8 12.49 5.74 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.736 -0.665 . . . . 74.23 111.292 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.437 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 66.4 m-20 54.3 22.02 3.47 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.009 -0.542 . . . . 74.54 111.922 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.2 tp -121.71 -41.04 2.49 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.926 0.393 . . . . 71.52 111.259 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 172' ' ' VAL . 4.2 m -137.58 147.84 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.1 0.476 . . . . 54.24 111.952 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.565 ' O ' ' HA ' ' A' ' 170' ' ' MET . 70.0 m-85 -85.96 145.05 27.3 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.207 -0.451 . . . . 74.34 110.624 176.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 34.5 tt0 -127.63 135.63 50.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.677 0.275 . . . . 74.43 110.88 176.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.418 ' HB2' ' HG2' ' A' ' 20' ' ' MET . 84.4 t80 -128.96 128.43 43.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.861 0.363 . . . . 73.32 111.548 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HA ' HG22 ' A' ' 168' ' ' THR . 1.8 tmmm? -92.31 121.55 33.92 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.231 -0.44 . . . . 73.01 110.837 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.23 -163.35 13.96 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.308 -0.473 . . . . 32.03 113.089 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -121.12 139.37 53.42 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.316 -0.52 . . . . 75.44 111.512 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -75.27 106.15 6.65 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.879 -0.6 . . . . 74.11 110.663 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.67 160.15 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.1 -0.5 . . . . 63.3 111.054 -177.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.549 HG12 ' HB2' ' A' ' 66' ' ' ARG . 34.1 m -128.77 105.14 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.433 0.635 . . . . 72.21 110.94 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.603 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 97.6 mtt180 -83.27 108.21 16.34 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.187 0.518 . . . . 44.51 111.015 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -100.61 97.55 8.22 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.94 -0.573 . . . . 72.12 110.448 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 57.02 18.99 4.31 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 121.383 0.611 . . . . 72.54 111.315 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.11 0.58 28.39 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 121.297 -0.478 . . . . 63.22 113.784 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -95.64 147.37 23.66 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.134 0.42 . . . . 74.11 112.134 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 42' ' ' ILE . 10.6 tp -105.51 30.86 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-O 121.67 0.748 . . . . 73.45 111.45 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.0 t -75.8 85.41 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 O-C-N 121.796 -0.565 . . . . 70.24 111.377 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pp -97.99 165.42 11.92 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.743 0.646 . . . . 71.34 112.743 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.06 -4.77 25.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.168 -0.469 . . . . 41.24 111.397 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.94 -170.19 23.64 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.381 -0.438 . . . . 73.11 113.199 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.5 p -97.28 101.41 12.95 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.562 -0.375 . . . . 52.31 111.086 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -113.41 142.6 27.82 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.38 -0.373 . . . . 71.34 110.574 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -44.53 121.33 3.2 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.966 2.444 . . . . 54.51 113.815 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.6 t -113.35 108.33 17.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.147 -0.479 . . . . 21.43 111.724 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.0 79.14 1.41 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.327 0.584 . . . . 71.23 110.624 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -78.52 -42.86 28.28 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.016 -0.538 . . . . 71.34 112.269 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 68.16 -73.72 0.08 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.978 0.418 . . . . 75.04 111.425 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -127.42 87.94 0.33 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 116.393 -0.367 . . . . 54.35 112.412 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.3 105.62 7.08 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 122.666 -0.314 . . . . 71.15 111.133 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -124.31 81.86 1.97 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.187 -0.46 . . . . 73.22 111.267 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -112.09 -169.13 1.41 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.881 0.372 . . . . 74.23 111.61 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 60' ' ' SER . 31.9 t70 -79.75 -3.07 45.91 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.226 0.454 . . . . 74.4 112.226 -175.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.11 79.46 0.01 OUTLIER Glycine 0 CA--C 1.53 1.026 0 N-CA-C 113.901 0.321 . . . . 62.21 113.901 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 58' ' ' ASP . 77.4 p -158.61 158.65 34.28 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.824 0.45 . . . . 73.33 110.939 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 61.22 19.53 10.17 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.435 0.531 . . . . 74.35 112.435 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.86 -6.31 48.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.594 -0.275 . . . . 74.23 111.356 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 44.64 38.67 2.86 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.862 0.865 . . . . 74.13 113.118 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 92.9 t -101.98 124.19 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.087 -0.506 . . . . 71.32 110.565 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 45.2 mt-10 -78.29 66.75 3.94 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.755 0.788 . . . . 60.45 110.652 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.549 ' HB2' HG12 ' A' ' 36' ' ' VAL . 33.4 ptt85 -95.3 134.72 37.76 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.727 -0.67 . . . . 74.31 112.672 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.72 -133.82 3.03 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.606 -0.724 . . . . 74.41 112.447 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.481 HD12 HD12 ' A' ' 70' ' ' ILE . 21.4 pt -111.12 131.81 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 122.35 -0.5 . . . . 74.15 110.957 176.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.6 -23.14 15.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 111.858 0.318 . . . . 43.14 111.858 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.481 HD12 HD12 ' A' ' 68' ' ' ILE . 55.7 mt -50.71 -56.23 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.236 0.541 . . . . 65.11 111.591 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.7 m -81.16 -30.61 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.146 -0.479 . . . . 74.0 111.693 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.8 mt -65.02 -35.72 82.09 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.131 0.491 . . . . 75.21 110.863 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.36 -40.99 71.95 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.961 -0.563 . . . . 63.25 111.78 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -100.78 -1.04 35.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.43 -0.35 . . . . 63.43 111.779 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt 53.88 70.55 0.59 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.285 0.564 . . . . 72.1 111.583 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 67.3 mt -100.04 135.74 41.01 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.877 -0.601 . . . . 65.13 111.247 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.27 145.97 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.876 0.37 . . . . 75.41 111.281 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -83.47 136.35 34.33 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.575 0.583 . . . . 74.24 112.575 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.2 mmm -115.82 145.59 42.71 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 116.004 -0.543 . . . . 41.43 110.268 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.429 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 15.6 m-80 -88.86 123.86 33.64 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.634 0.605 . . . . 52.22 112.634 -169.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 44.2 t -54.12 -32.94 56.48 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.136 0.791 . . . . 54.23 113.136 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 4.5 p90 -81.71 -30.73 32.41 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.937 0.399 . . . . 60.24 111.865 -176.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -94.69 -47.32 6.55 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.469 0.544 . . . . 71.31 112.469 -170.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.66 ' HA ' ' SD ' ' A' ' 87' ' ' MET . 23.5 m-20 -81.2 18.96 0.99 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.546 0.573 . . . . 71.1 112.546 -174.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . . . -55.94 -42.59 76.4 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.844 0.354 . . . . 53.31 111.849 177.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.507 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 53.3 m -60.24 -36.57 78.05 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.326 0.584 . . . . 71.41 111.091 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.663 ' N ' ' SD ' ' A' ' 87' ' ' MET . 0.6 OUTLIER -66.04 -38.66 88.93 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.014 -0.539 . . . . 65.0 110.278 176.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.44 ' HD2' ' HA ' ' A' ' 85' ' ' ALA . 32.0 m-85 -69.05 -43.86 73.8 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.928 -0.578 . . . . 74.12 112.274 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 86' ' ' SER . 0.1 OUTLIER -62.56 -36.09 81.55 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.959 0.409 . . . . 73.52 110.893 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.1 -40.11 62.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.066 0.46 . . . . 45.34 111.198 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -61.83 -44.09 97.55 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.164 -0.471 . . . . 72.51 110.735 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.33 -34.35 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.121 -0.491 . . . . 73.13 111.259 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -56.03 -51.5 67.56 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.146 0.498 . . . . 74.22 110.976 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -69.66 -43.03 73.39 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.139 -0.482 . . . . 72.42 110.949 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.466 ' CZ ' HG11 ' A' ' 172' ' ' VAL . 68.9 t80 -52.8 -54.08 39.3 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.146 -0.479 . . . . 64.14 111.559 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 57.0 ttp -54.51 -43.82 72.19 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.076 -0.511 . . . . 62.53 110.99 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -54.78 -57.53 11.16 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.101 -0.5 . . . . 64.31 111.497 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -59.55 -55.81 29.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.616 0.599 . . . . 63.04 112.616 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 95' ' ' PHE . 32.6 m -62.82 -43.38 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.718 0.636 . . . . 73.25 112.718 -174.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.9 mm -74.33 -47.49 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 122.138 -0.351 . . . . 65.23 111.785 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 8.9 t70 -61.07 -38.98 88.14 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.992 0.425 . . . . 64.22 110.845 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -69.94 -41.47 74.53 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.98 0.419 . . . . 74.34 110.923 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 49.4 tpp -61.59 -35.15 77.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.322 0.582 . . . . 75.32 111.002 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 32.2 tt0 -68.05 -15.95 63.82 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.912 -0.585 . . . . 71.02 111.793 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 1.7 mmmp? -81.09 -31.53 34.29 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.764 -0.585 . . . . 73.15 111.87 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -115.5 -36.45 4.28 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.473 0.916 . . . . 74.44 113.473 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -91.37 -76.43 0.45 Allowed 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.471 0.545 . . . . 71.44 112.471 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 104' ' ' GLU . 62.5 mtm-85 67.68 -6.49 0.68 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.863 1.06 . . . . 71.34 113.863 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 113' ' ' VAL . 38.3 t70 -68.59 106.0 2.44 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.033 -0.417 . . . . 73.3 110.61 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -48.91 -37.88 21.13 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.8 0.667 . . . . 75.34 112.8 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.91 -44.06 86.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.822 0.344 . . . . 71.41 111.543 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.6 -54.43 9.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.484 -0.326 . . . . 64.11 111.7 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 109' ' ' ASP . 23.0 m -59.26 -33.24 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 112.092 0.404 . . . . 52.01 112.092 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.96 -36.41 77.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.802 0.334 . . . . 71.2 110.587 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.73 -48.84 73.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.392 -0.367 . . . . 74.44 111.171 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -60.15 -50.32 74.13 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.841 0.353 . . . . 72.5 110.947 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -49.49 -49.26 46.39 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.212 0.529 . . . . 74.25 110.488 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.72 -36.3 82.15 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.789 -0.641 . . . . 51.41 111.566 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -67.01 -47.91 70.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.753 0.311 . . . . 54.44 110.791 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 31.3 mm -65.51 -38.72 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.485 -0.325 . . . . 64.34 111.112 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -58.13 -47.43 83.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.861 0.362 . . . . 72.52 110.679 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.3 -33.74 78.56 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.128 -0.558 . . . . 53.12 112.612 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -60.65 -54.28 47.2 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.574 0.35 . . . . 73.4 111.438 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.76 -46.79 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.699 0.629 . . . . 73.05 112.699 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.6 m -60.26 -33.26 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 122.061 -0.4 . . . . 74.34 111.59 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.7 m -77.08 -44.77 29.39 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.054 0.454 . . . . 64.11 111.002 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.482 HD21 HD13 ' A' ' 155' ' ' ILE . 48.4 tp -66.59 -32.17 73.34 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.058 -0.519 . . . . 74.04 112.207 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.7 mt -91.52 1.77 56.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.452 0.538 . . . . 71.3 112.452 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.6 95.81 0.08 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.346 0.593 . . . . 70.12 111.014 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.708 ' H ' ' HD2' ' A' ' 130' ' ' LYS . 2.5 mptp? -58.18 -33.11 68.88 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.17 0.804 . . . . 62.13 113.17 -168.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.51 -47.61 38.76 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.003 0.742 . . . . 64.15 113.003 -172.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 132' ' ' ARG . 0.4 OUTLIER -111.11 -26.32 9.28 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.633 0.605 . . . . 70.22 112.633 174.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.421 ' HD2' HD11 ' A' ' 136' ' ' LEU . 88.8 m-85 -83.19 -5.82 59.26 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.406 0.521 . . . . 75.02 112.406 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.92 -24.77 54.85 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.457 0.646 . . . . 72.31 110.501 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -78.21 13.41 1.5 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.694 -0.685 . . . . 72.42 112.232 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.421 HD11 ' HD2' ' A' ' 133' ' ' PHE . 77.8 mt -88.11 161.99 17.0 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.431 0.634 . . . . 74.43 111.799 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -134.33 122.35 22.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.706 -0.679 . . . . 73.32 110.362 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.42 ' HB3' HG13 ' A' ' 153' ' ' VAL . 82.9 m-85 -105.36 110.8 23.28 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.955 0.407 . . . . 74.23 110.82 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 80.3 m-85 -98.98 147.18 25.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.471 0.545 . . . . 73.25 112.471 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 12.4 tt -147.22 155.77 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.028 -0.533 . . . . 73.21 110.827 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.64 146.11 34.99 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.184 -0.532 . . . . 72.23 113.689 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -54.73 -62.85 1.39 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.105 0.409 . . . . 74.31 112.105 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -61.3 -28.6 69.31 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.898 0.38 . . . . 74.44 111.259 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.597 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -63.62 -53.73 46.92 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.037 0.446 . . . . 74.01 111.304 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.46 -19.13 62.26 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.128 0.49 . . . . 71.44 111.643 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.5 -40.65 34.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.166 -0.47 . . . . 70.32 111.596 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -178.21 42.02 0.09 OUTLIER Glycine 0 CA--C 1.529 0.953 0 C-N-CA 120.606 -0.807 . . . . 63.22 113.866 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.597 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -154.43 88.2 1.21 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.078 0.466 . . . . 55.25 111.235 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.16 -1.75 11.05 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.38 0.882 . . . . 62.51 113.38 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.36 57.79 3.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.485 0.66 . . . . 74.31 110.392 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -130.87 149.53 19.14 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.705 -0.679 . . . . 71.15 113.492 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -83.72 144.33 29.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.904 0.383 . . . . 73.51 111.477 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 138' ' ' PHE . 22.1 t -88.86 115.15 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.329 0.585 . . . . 72.4 111.479 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.32 109.38 15.77 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.695 -0.684 . . . . 72.33 110.901 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 52.5 mt -86.48 124.84 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.573 0.225 . . . . 64.24 111.272 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 169' ' ' LEU . 48.6 mm -118.05 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 111.967 0.358 . . . . 74.21 111.967 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.498 ' HG2' ' HE1' ' A' ' 170' ' ' MET . 7.3 pt-20 -130.58 158.26 40.48 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.106 0.479 . . . . 72.22 111.273 175.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -78.05 108.8 11.59 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.066 0.46 . . . . 71.23 111.552 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 159' ' ' ARG . 5.6 tpp180 -104.51 128.81 52.53 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.432 -0.349 . . . . 74.25 111.682 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.71 111.24 14.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.735 0.302 . . . . 75.42 110.434 173.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.05 88.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.158 0.504 . . . . 32.54 110.24 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 54.79 33.86 20.59 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.721 -0.672 . . . . 62.0 112.104 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 113.37 -24.74 12.0 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.059 -0.591 . . . . 61.43 113.403 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.479 HG22 HG13 ' A' ' 166' ' ' VAL . 89.8 m -97.31 106.54 18.88 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.438 -0.448 . . . . 74.11 111.044 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -80.54 108.26 14.03 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.272 -0.422 . . . . 71.23 111.636 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 164' ' ' THR . 25.0 m -128.23 142.56 44.97 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 120.908 0.385 . . . . 50.25 111.65 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 17.4 Cg_exo -68.56 119.15 6.16 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.801 2.334 . . . . 72.31 112.921 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 31' ' ' LYS . 38.2 p -107.52 163.68 12.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.983 0.42 . . . . 71.41 112.039 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 51.9 tp -102.06 138.52 38.91 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.604 0.594 . . . . 73.25 112.604 -175.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.565 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 1.2 mpt? -122.87 136.79 54.99 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.418 0.525 . . . . 74.03 112.418 176.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.9 mt -136.81 148.42 47.16 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.57 -0.741 . . . . 73.35 110.08 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.524 ' O ' HG22 ' A' ' 176' ' ' ILE . 58.6 t -87.15 127.46 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.744 0.646 . . . . 55.43 112.744 -173.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.519 ' HD2' HD21 ' A' ' 22' ' ' LEU . 57.4 tttm -52.78 -54.79 28.96 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.81 0.671 . . . . 71.41 112.81 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.08 12.21 0.58 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.818 0.673 . . . . 72.32 112.818 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 6' ' ' ASP . . . -114.35 -51.51 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 61.54 109.838 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 172' ' ' VAL . 4.1 tt -102.96 108.97 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.611 -0.722 . . . . 63.23 111.699 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.5 mm -101.35 142.37 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.315 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.13 141.91 50.76 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.249 0.547 . . . . 74.53 112.254 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -135.46 104.11 5.72 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.764 -0.653 . . . . 72.4 110.124 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -96.02 111.28 23.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.366 0.603 . . . . 71.11 112.4 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 50.6 t -116.83 87.65 2.74 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.203 0.525 . . . . 70.23 109.65 170.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 5.9 mp -137.14 -169.7 2.55 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.777 -0.647 . . . . 63.21 111.008 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 . . . . . 0 C--O 1.254 1.313 0 CA-C-O 118.69 -0.671 . . . . 73.41 110.876 172.326 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.714 0.292 . . . . 73.24 111.091 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 180' ' ' LYS . 21.5 tp -95.38 124.09 39.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.083 -0.34 . . . . 71.14 110.083 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 179' ' ' GLU . 53.5 mt -105.72 129.22 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.497 0.189 . . . . 72.04 111.385 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -122.78 144.67 49.03 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.322 0.582 . . . . 62.24 112.343 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.695 ' HB3' ' HB ' ' A' ' 177' ' ' ILE . 23.7 ttmm -138.55 111.26 7.65 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.804 -0.634 . . . . 64.25 110.903 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' HA ' HG22 ' A' ' 176' ' ' ILE . 5.6 t70 -83.03 166.16 19.02 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.564 0.346 . . . . 71.23 111.293 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 pt -81.23 -18.18 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 113.069 0.766 . . . . 74.51 113.069 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.62 -42.86 7.46 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.069 0.461 . . . . 74.24 111.555 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.558 HG22 ' HB3' ' A' ' 6' ' ' ASP . 15.2 t -103.85 19.65 19.56 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.998 -0.546 . . . . 64.01 112.092 -176.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 12.4 p-10 -46.06 -40.47 10.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.748 1.018 . . . . 71.14 113.748 -172.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -53.07 -34.76 57.99 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.094 0.473 . . . . 64.45 111.962 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.35 26.5 0.65 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.803 0.668 . . . . 75.32 112.803 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.668 HD13 ' HB2' ' A' ' 5' ' ' LYS . 69.4 tp -32.11 109.28 0.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.286 0.634 . . . . 72.22 112.014 174.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -131.15 -175.88 3.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 111.873 0.323 . . . . 73.24 111.873 -172.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.0 p -150.33 144.28 25.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.17 0.804 . . . . 74.55 113.17 -174.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -144.88 -157.7 0.82 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.736 -0.666 . . . . 75.43 109.963 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.3 t -148.45 86.49 1.54 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.932 -0.48 . . . . 64.11 112.177 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -138.25 101.95 8.26 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.177 -0.465 . . . . 74.21 111.192 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.82 142.76 98.59 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.191 2.594 . . . . 64.02 114.324 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.0 ptp -146.37 161.31 40.64 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.859 -0.61 . . . . 63.12 111.003 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 18.2 ptpt -99.5 158.75 15.52 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.585 0.231 . . . . 74.22 111.061 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.7 tp -107.09 110.45 22.56 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.91 0.385 . . . . 62.25 111.224 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -104.02 145.5 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.032 0.444 . . . . 44.14 111.568 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 63.93 10.55 5.36 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 116.112 -0.495 . . . . 55.12 112.136 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 60.87 12.11 3.64 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.864 0.466 . . . . 74.21 111.875 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.5 tp -127.52 -43.16 1.6 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.938 0.399 . . . . 73.11 111.733 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 172' ' ' VAL . 17.0 m -127.71 148.8 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.254 0.55 . . . . 75.11 112.352 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -86.97 134.37 33.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.293 -0.412 . . . . 62.33 111.132 174.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 36.3 tt0 -103.92 108.07 19.23 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.062 0.458 . . . . 72.0 110.257 174.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.615 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 31.6 t80 -90.37 127.61 36.23 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.247 -0.283 . . . . 71.05 110.335 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.503 ' HD3' ' H ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -74.32 131.12 40.86 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.47 0.652 . . . . 74.23 112.059 -176.618 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.483 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -140.08 174.34 22.5 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.726 -0.67 . . . . 71.2 112.494 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HG3' HG13 ' A' ' 35' ' ' VAL . 16.4 ptpt -151.92 166.28 31.96 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.793 0.664 . . . . 72.41 112.793 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -71.51 106.6 4.04 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.082 -0.963 . . . . 75.3 110.799 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.452 HG23 HD12 ' A' ' 72' ' ' LEU . 31.5 m -138.06 154.58 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.21 0.529 . . . . 63.21 111.788 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.459 HG12 ' HG3' ' A' ' 66' ' ' ARG . 35.1 m -143.05 142.55 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.317 -0.401 . . . . 74.44 111.12 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 5.5 ttm180 -122.76 110.38 15.4 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.843 0.354 . . . . 61.15 110.954 174.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.576 ' HG3' ' HB3' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -130.04 98.73 4.84 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.128 0.49 . . . . 73.11 110.824 173.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 52.64 31.22 9.82 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.811 -0.631 . . . . 70.42 111.945 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.31 -28.61 13.31 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.367 -0.444 . . . . 74.12 113.299 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.576 ' HB3' ' HG3' ' A' ' 38' ' ' LYS . 6.7 tp10 -62.9 123.5 18.66 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.173 0.511 . . . . 53.43 112.137 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.4 mm -101.38 103.19 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 115.973 -0.558 . . . . 74.42 110.876 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 43' ' ' VAL . 11.4 p -120.33 33.98 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-O 121.96 0.886 . . . . 72.42 110.79 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 45' ' ' ALA . 3.2 pp -68.99 -19.87 64.15 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.783 -0.644 . . . . 65.05 112.513 -176.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.496 ' N ' HD12 ' A' ' 44' ' ' LEU . . . -87.56 -13.99 41.41 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.983 0.364 . . . . 34.12 111.983 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.12 71.09 1.76 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.447 -0.406 . . . . 73.03 113.032 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.7 p -118.41 173.32 6.89 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.127 0.489 . . . . 43.11 111.611 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -118.66 98.42 51.18 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 116.407 -0.361 . . . . 71.4 110.657 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.23 99.69 0.82 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.743 2.295 . . . . 74.41 113.147 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 82.5 p -110.91 -171.47 1.83 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.412 -0.358 . . . . 50.42 110.236 174.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.35 -13.75 59.87 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.849 0.356 . . . . 71.2 111.548 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -88.51 87.09 7.16 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.216 0.531 . . . . 72.13 111.796 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -43.86 42.4 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.981 -0.554 . . . . 73.13 110.47 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.53 57.03 0.68 Allowed Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.139 -0.482 . . . . 50.21 112.028 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.23 -11.13 60.54 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.939 0.718 . . . . 61.45 112.939 -175.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 67.85 34.9 4.09 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.124 0.57 . . . . 73.21 112.132 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -87.6 122.87 31.85 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.972 -0.455 . . . . 72.21 111.88 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -111.62 7.12 20.39 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.176 -0.465 . . . . 61.34 112.198 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.16 86.53 0.05 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.557 -0.292 . . . . 73.35 113.72 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.4 m -139.65 31.16 2.07 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.989 0.423 . . . . 71.34 111.35 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -99.39 27.81 4.98 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.105 0.478 . . . . 72.23 111.829 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 63' ' ' HIS . 13.6 pt-20 -91.92 14.25 16.21 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.954 0.724 . . . . 72.33 112.954 -173.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 41.3 m-70 73.66 -38.01 0.39 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.422 0.689 . . . . 71.21 112.207 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 38' ' ' LYS . 45.1 t -51.67 143.35 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.818 0.447 . . . . 72.01 110.972 174.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 26.3 tt0 -79.34 66.42 4.79 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.869 0.842 . . . . 70.33 110.694 -178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HG3' HG12 ' A' ' 36' ' ' VAL . 11.3 ttm180 -92.5 133.69 35.68 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.15 -0.932 . . . . 74.32 110.606 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.35 -135.78 4.11 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 119.63 -1.271 . . . . 22.11 114.422 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' A' ' 167' ' ' PRO . 12.5 mt -110.27 141.88 24.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.553 -0.324 . . . . 63.52 111.581 -173.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -47.9 -38.04 15.55 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.871 0.367 . . . . 60.31 111.321 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.596 HD13 ' HB2' ' A' ' 169' ' ' LEU . 63.6 mt -60.75 -54.72 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.097 0.475 . . . . 74.24 112.185 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -72.48 -38.3 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.797 -0.638 . . . . 74.45 112.124 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.576 HD22 ' HG2' ' A' ' 65' ' ' GLU . 47.8 mt -68.54 -43.21 77.19 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.148 0.499 . . . . 73.34 110.529 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -54.92 -42.58 72.39 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.939 -0.573 . . . . 63.14 112.09 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -98.84 1.54 45.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.741 0.645 . . . . 75.31 112.741 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.406 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 3.6 mppt? 54.07 69.05 0.76 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.318 0.58 . . . . 62.14 111.46 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 69.5 mt -106.66 137.41 44.74 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.964 -0.562 . . . . 70.41 110.725 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -88.27 151.55 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.109 0.48 . . . . 75.52 111.717 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.0 131.36 44.94 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.206 -0.906 . . . . 72.2 113.374 -175.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.41 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 83.5 mtp -138.6 153.68 48.66 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.931 -0.577 . . . . 73.03 109.946 170.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.46 168.16 28.21 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.168 0.803 . . . . 75.52 113.168 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -36.97 -55.85 0.9 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.71 1.745 . . . . 62.31 115.71 -169.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.462 ' CE2' ' HG2' ' A' ' 83' ' ' GLU . 43.8 p90 -56.96 -31.57 65.15 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.983 0.734 . . . . 75.44 112.983 -170.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.462 ' HG2' ' CE2' ' A' ' 82' ' ' TYR . 58.3 mm-40 -92.38 -44.54 8.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.158 0.504 . . . . 73.55 111.107 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 3.2 m-20 -67.58 -17.95 64.82 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.739 1.014 . . . . 63.42 113.739 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -43.87 -60.98 1.59 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.022 0.439 . . . . 74.12 111.287 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.9 m -72.54 -27.57 62.31 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.349 -0.387 . . . . 73.33 111.677 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.71 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 58.6 tpp -63.28 -65.92 0.62 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 111.495 0.183 . . . . 74.12 111.495 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.477 ' HA ' ' HB3' ' A' ' 91' ' ' TYR . 13.6 p90 -64.31 -22.75 67.06 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 122.12 -0.362 . . . . 74.33 111.38 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -60.65 -55.52 32.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.867 0.365 . . . . 73.32 110.858 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.7 96.26 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.044 0.45 . . . . 74.42 111.292 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.477 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 6.8 t80 -57.36 -55.86 29.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.829 -0.623 . . . . 72.41 111.348 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.7 -32.7 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.779 0.323 . . . . 74.23 111.542 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -65.82 -54.55 25.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.997 0.427 . . . . 75.13 111.073 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -63.77 -41.19 98.02 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.153 0.502 . . . . 70.41 110.532 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CE1' ' HB2' ' A' ' 175' ' ' ALA . 17.8 t80 -55.04 -58.35 7.99 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.852 -0.613 . . . . 74.43 111.647 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.452 ' O ' HG22 ' A' ' 100' ' ' ILE . 46.8 ttp -50.3 -52.01 40.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.019 -0.537 . . . . 61.44 111.559 -177.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -63.52 -50.49 69.39 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.716 0.293 . . . . 72.31 111.436 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.31 -50.64 72.28 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.264 0.468 . . . . 73.01 112.264 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 95' ' ' PHE . 35.1 m -69.44 -40.35 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.58 0.585 . . . . 75.23 112.58 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 96' ' ' MET . 10.9 tp -74.05 -42.11 52.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 120.791 -0.364 . . . . 71.35 111.18 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.12 -29.51 69.81 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.097 0.475 . . . . 62.43 110.282 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -76.09 -65.26 0.94 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.822 -0.626 . . . . 64.3 111.48 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.0 ttt -64.43 -45.26 88.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.764 0.653 . . . . 75.54 112.764 -171.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.743 ' HA ' HG11 ' A' ' 113' ' ' VAL . 36.8 tt0 -68.52 -11.79 60.36 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.235 0.54 . . . . 72.32 111.289 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -82.32 -42.49 18.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.038 -0.528 . . . . 73.41 111.756 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -89.66 -37.19 14.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.514 0.561 . . . . 72.33 112.514 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.455 ' O ' ' HD3' ' A' ' 108' ' ' ARG . 26.8 t-20 -76.15 -60.34 2.37 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.228 -0.295 . . . . 54.12 111.507 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 71.3 -21.69 0.2 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.155 1.169 . . . . 64.14 114.155 175.138 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.511 ' O ' HG22 ' A' ' 113' ' ' VAL . 40.8 m-20 -78.87 129.69 34.83 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.624 0.726 . . . . 64.23 112.595 -176.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -64.1 -8.04 10.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.245 -0.888 . . . . 71.55 112.459 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.03 -41.52 50.64 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 111.878 0.325 . . . . 75.4 111.878 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -95.34 -62.13 1.35 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.65 0.611 . . . . 70.22 112.65 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.743 HG11 ' HA ' ' A' ' 104' ' ' GLU . 27.3 m -57.82 -36.73 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 113.089 0.774 . . . . 71.41 113.089 -172.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.91 -45.75 87.92 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.83 0.348 . . . . 74.14 110.498 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.06 97.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.347 -0.388 . . . . 74.33 111.463 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.405 ' CE1' ' HG3' ' A' ' 174' ' ' GLU . 48.9 t80 -63.24 -57.62 9.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.309 -0.405 . . . . 73.2 111.373 176.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -52.6 -46.03 66.8 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.418 0.628 . . . . 70.14 111.053 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.53 -40.24 96.14 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.43 -0.805 . . . . 73.42 111.963 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -68.78 -50.6 48.98 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.892 0.377 . . . . 74.14 110.915 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.97 -33.49 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.856 0.36 . . . . 73.31 111.205 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -65.03 -42.27 94.5 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.096 0.474 . . . . 72.55 110.534 174.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.27 -39.26 97.48 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.895 -0.669 . . . . 62.41 112.024 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 49.2 t90 -58.63 -53.92 52.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.531 0.332 . . . . 50.52 111.224 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.4 m -64.19 -46.26 93.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 112.657 0.614 . . . . 72.33 112.657 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.81 -31.53 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.882 -0.511 . . . . 72.13 111.669 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.8 t -78.19 -42.99 29.78 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.208 0.528 . . . . 64.14 111.039 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.27 -31.0 71.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.037 -0.529 . . . . 73.33 112.309 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 71.0 mt -87.2 3.22 47.36 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.031 0.382 . . . . 75.51 112.031 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.72 103.79 0.15 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.062 0.458 . . . . 61.54 112.223 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -62.06 -24.58 67.17 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.897 0.703 . . . . 73.2 112.897 -174.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -80.31 -40.07 27.48 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.339 0.496 . . . . 73.31 112.339 -175.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -100.31 -60.43 1.53 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.218 0.532 . . . . 74.53 112.242 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.412 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 16.5 m-85 -74.11 -5.99 44.97 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.667 0.988 . . . . 74.41 113.667 -168.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 6.2 ttpm? -58.11 -18.65 26.57 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.879 -0.513 . . . . 73.22 111.45 176.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -85.49 15.64 4.38 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.527 0.566 . . . . 65.23 112.527 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 82.1 mt -89.82 142.34 27.79 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.235 0.54 . . . . 53.34 111.472 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.26 153.46 22.13 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.289 -0.414 . . . . 60.03 110.825 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -119.85 138.71 53.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 55.31 110.425 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 50.6 m-85 -134.27 136.5 43.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.12 0.486 . . . . 71.32 111.455 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.51 HD11 ' HA3' ' A' ' 151' ' ' GLY . 8.0 tt -124.47 149.06 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 115.917 -0.583 . . . . 75.4 110.889 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.69 129.74 49.32 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.262 -0.494 . . . . 63.14 113.579 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -46.93 -43.78 19.34 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.648 0.379 . . . . 71.55 111.886 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -49.52 -34.29 16.87 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.247 0.832 . . . . 73.41 113.247 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -94.91 -25.19 16.66 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.029 -0.42 . . . . 71.14 111.857 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.48 -30.24 7.9 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.267 1.21 . . . . 62.33 114.267 -173.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.72 -26.82 67.45 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.719 0.637 . . . . 74.34 112.719 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 169.86 -22.73 0.09 OUTLIER Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.588 -0.815 . . . . 64.15 113.869 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.37 97.79 0.44 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.981 0.42 . . . . 54.31 111.806 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -4.9 21.65 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.361 -0.381 . . . . 62.23 111.94 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -84.81 20.79 1.71 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.745 0.307 . . . . 65.24 111.68 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.51 ' HA3' HD11 ' A' ' 140' ' ' ILE . . . -92.86 135.64 12.77 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.208 -0.52 . . . . 33.02 112.636 176.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.451 ' NE2' HD22 ' A' ' 171' ' ' LEU . 42.8 tt0 -68.84 119.01 12.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.25 0.463 . . . . 52.11 112.25 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 37.6 t -80.08 124.91 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.089 0.471 . . . . 75.02 111.027 172.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -102.21 135.46 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.076 -0.511 . . . . 51.54 110.594 177.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.741 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 61.5 mt -90.28 137.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 112.338 0.496 . . . . 53.03 112.338 -172.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.1 mm -108.47 117.49 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.391 -0.368 . . . . 75.54 111.67 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 35.9 tt0 -110.47 137.11 48.6 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.38 -0.373 . . . . 62.42 111.389 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -73.26 88.14 1.5 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.51 -0.552 . . . . 75.33 109.51 169.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.03 121.65 22.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.166 0.508 . . . . 75.54 110.611 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -69.19 139.78 54.58 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.385 0.612 . . . . 64.32 112.033 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 163' ' ' GLY . 98.3 t -129.78 150.27 34.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.923 -1.51 . . . . 65.33 106.923 167.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.27 70.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.403 0.62 . . . . 73.1 111.058 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 161' ' ' VAL . . . 133.89 -12.47 4.78 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.774 -0.648 . . . . 63.43 113.862 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 m -143.55 148.57 36.16 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.087 -0.655 . . . . 73.22 111.526 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 165' ' ' GLU . 0.2 OUTLIER -110.94 108.74 18.61 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.421 0.629 . . . . 64.4 111.004 177.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.443 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 27.1 m -115.91 130.05 24.7 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.228 -0.442 . . . . 75.42 111.657 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.49 ' HB2' HD13 ' A' ' 68' ' ' ILE . 6.1 Cg_exo -79.66 115.01 3.3 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.633 2.222 . . . . 73.5 113.121 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.9 p -104.53 165.58 10.96 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.169 0.509 . . . . 74.42 111.824 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.67 HD11 ' HB1' ' A' ' 154' ' ' ALA . 21.1 tp -107.13 139.48 41.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.104 -0.498 . . . . 74.31 111.936 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.741 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 62.4 mtt -108.97 126.21 52.86 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 122.61 0.364 . . . . 74.41 111.633 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.451 HD22 ' NE2' ' A' ' 152' ' ' GLN . 82.1 mt -136.81 120.34 17.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.037 -0.529 . . . . 71.41 110.784 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 27' ' ' VAL . 46.0 t -74.22 121.18 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.628 -0.67 . . . . 64.45 111.927 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -70.14 -31.26 68.69 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.606 0.595 . . . . 73.53 112.606 -174.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.405 ' HG3' ' CE1' ' A' ' 116' ' ' PHE . 28.8 mm-40 -82.18 -1.3 48.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.941 0.4 . . . . 65.24 111.629 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.533 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . . . -96.53 -54.83 3.11 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.278 0.561 . . . . 75.54 110.462 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.571 HG22 ' HA ' ' A' ' 6' ' ' ASP . 29.3 pt -95.66 144.61 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.783 -0.644 . . . . 74.11 110.939 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.695 ' HB ' ' HB3' ' A' ' 5' ' ' LYS . 1.7 mp -91.84 110.7 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.348 0.594 . . . . 75.22 109.804 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -106.03 129.53 54.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.151 -0.932 . . . . 60.14 110.648 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 46.2 mt-10 -130.82 98.98 4.77 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.16 0.505 . . . . 73.13 110.818 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.415 ' HA ' HD12 ' A' ' 2' ' ' LEU . 32.8 ttpt -79.93 112.48 17.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.003 -0.544 . . . . 75.1 111.924 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 53.3 t -129.42 89.4 2.84 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.616 -0.513 . . . . 70.11 109.616 169.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.413 ' O ' HD12 ' A' ' 182' ' ' LEU . 3.3 pp -165.83 153.55 10.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.072 -0.513 . . . . 75.34 111.502 -176.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.811 -0.614 . . . . 63.4 112.08 -176.912 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.558 0.218 . . . . 71.14 110.916 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 15' ' ' SER . 32.0 tp -84.55 138.17 32.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.319 -0.623 . . . . 75.45 109.319 170.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.491 HG22 HD11 ' A' ' 13' ' ' LEU . 53.1 mt -121.03 118.48 56.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.251 -0.277 . . . . 71.02 110.251 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -118.88 146.89 44.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.272 0.471 . . . . 71.1 112.272 -172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.637 ' HB3' HD13 ' A' ' 13' ' ' LEU . 20.8 ptmt -151.37 127.33 10.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.758 0.651 . . . . 75.3 112.758 176.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.791 ' HB3' ' HB ' ' A' ' 9' ' ' THR . 18.3 t70 -79.37 166.13 22.39 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.866 -0.606 . . . . 30.34 110.761 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.404 HG13 ' CD2' ' A' ' 8' ' ' PHE . 19.9 pt -73.21 -41.29 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 113.133 0.79 . . . . 62.13 113.133 -177.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.404 ' CD2' HG13 ' A' ' 7' ' ' ILE . 24.0 p90 -105.66 -14.13 15.36 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.942 -0.473 . . . . 73.44 111.882 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 6' ' ' ASP . 4.1 m -94.82 18.08 12.45 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.935 0.874 . . . . 45.54 109.48 172.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -45.8 -45.05 14.53 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.595 1.158 . . . . 73.11 113.439 -172.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.17 -21.65 66.35 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.153 0.797 . . . . 64.44 113.153 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' ' 9' ' ' THR . 37.7 mt-10 -88.8 24.38 2.05 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.144 0.424 . . . . 71.52 112.144 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.637 HD13 ' HB3' ' A' ' 5' ' ' LYS . 61.0 tp -44.28 118.6 1.56 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.866 0.467 . . . . 75.35 111.495 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -141.44 165.9 26.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.37 0.508 . . . . 73.14 112.37 -175.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 2' ' ' LEU . 99.2 p -112.06 147.17 36.59 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.227 -0.442 . . . . 63.42 111.378 176.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -142.36 -170.37 3.17 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.385 0.612 . . . . 71.44 112.017 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -153.84 63.11 0.72 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.604 -0.725 . . . . 73.33 110.44 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -124.23 157.18 65.23 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 116.232 -0.44 . . . . 71.44 111.73 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.36 148.53 11.56 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.775 2.317 . . . . 62.11 112.777 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -146.31 145.67 30.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.08 0.467 . . . . 72.51 112.107 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -116.12 109.76 17.92 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.354 -0.385 . . . . 74.13 111.593 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.597 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 52.0 tp -79.99 96.7 6.5 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.908 -0.495 . . . . 74.14 110.963 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 p -87.96 140.17 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-O 120.967 0.413 . . . . 73.31 111.187 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.17 8.43 1.52 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.009 0.374 . . . . 71.24 112.009 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.597 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 40.9 m-20 55.17 20.2 3.26 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.214 0.53 . . . . 72.33 111.599 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.0 tp -117.85 -43.21 2.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.217 -0.447 . . . . 71.05 110.749 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 172' ' ' VAL . 16.5 m -133.52 149.69 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.97 0.414 . . . . 74.32 111.731 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -89.59 124.92 34.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.548 -0.297 . . . . 74.24 110.791 174.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 11.8 pt-20 -107.63 143.44 36.09 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.86 0.362 . . . . 71.31 110.885 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.403 ' HD2' HD11 ' A' ' 70' ' ' ILE . 34.3 t80 -151.59 119.58 6.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.643 0.259 . . . . 62.55 111.242 173.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.4 ' HG3' ' OG1' ' A' ' 168' ' ' THR . 2.9 mptp? -74.94 124.75 27.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.856 0.36 . . . . 62.32 111.331 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.88 172.3 42.05 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 114.186 0.435 . . . . 71.3 114.186 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -105.73 116.34 31.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.563 0.345 . . . . 71.24 110.61 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.21 107.05 2.64 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.179 0.514 . . . . 74.4 111.891 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -140.66 156.99 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.016 0.436 . . . . 65.13 111.618 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.426 HG22 ' CD2' ' A' ' 44' ' ' LEU . 31.4 m -133.11 125.67 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.073 0.463 . . . . 70.01 110.965 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.855 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 32.0 ttt-85 -99.67 108.75 21.18 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.537 -0.301 . . . . 63.21 111.515 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -109.69 103.73 12.62 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.817 0.342 . . . . 73.33 110.704 174.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 58.76 15.44 3.78 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.001 0.741 . . . . 72.53 113.001 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.1 -12.71 19.66 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.048 -0.596 . . . . 64.02 113.956 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -101.59 142.16 33.36 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.49 0.645 . . . . 61.2 112.246 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.8 tp -115.72 130.86 69.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.592 -0.731 . . . . 71.21 110.446 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.2 m -105.05 -18.14 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 113.495 0.924 . . . . 64.12 113.495 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.426 ' CD2' HG22 ' A' ' 36' ' ' VAL . 3.0 mm? -74.36 106.05 5.8 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.846 0.355 . . . . 72.31 111.673 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.13 -16.26 59.23 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.808 0.337 . . . . 64.22 111.549 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.23 -81.68 0.11 Allowed Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.3 -0.476 . . . . 73.51 112.843 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.3 t -137.05 105.5 5.78 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.738 0.304 . . . . 71.12 111.633 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -170.97 100.01 0.41 Allowed Pre-proline 0 CA--C 1.543 0.705 0 CA-C-O 120.905 0.383 . . . . 74.2 110.687 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -88.85 -156.41 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.251 2.634 . . . . 51.45 113.76 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.1 p -63.66 -56.15 17.97 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.396 0.517 . . . . 71.21 112.396 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -114.47 -82.35 0.61 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.972 0.415 . . . . 63.35 111.912 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.76 -34.93 2.77 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.43 0.53 . . . . 71.52 112.43 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -151.82 125.11 8.76 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.821 0.343 . . . . 74.2 110.622 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 178.31 159.83 23.55 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.301 -0.476 . . . . 72.34 112.558 -175.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.4 -48.39 2.2 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.221 0.534 . . . . 60.12 111.978 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.54 18.91 6.83 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.238 0.542 . . . . 65.01 110.41 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.77 82.63 1.62 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.646 -0.706 . . . . 75.21 112.06 -175.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 177.47 -74.32 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.484 -0.78 . . . . 62.43 110.165 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.05 95.39 0.1 OUTLIER Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.976 -0.556 . . . . 72.32 112.29 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.5 m -116.76 88.32 2.87 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.269 -0.548 . . . . 71.45 111.921 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -144.66 28.07 1.32 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.824 0.821 . . . . 44.44 109.898 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -91.27 178.55 5.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.41 -0.814 . . . . 64.41 111.702 -172.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -94.46 15.86 16.74 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.393 -0.822 . . . . 74.54 110.684 171.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.3 142.78 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.817 -0.629 . . . . 51.03 110.789 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.855 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 19.7 mm-40 -71.73 70.34 0.7 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.278 0.561 . . . . 60.52 110.323 175.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -82.59 135.3 35.1 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.673 -0.694 . . . . 70.14 111.464 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.09 -142.59 8.94 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.778 -0.725 . . . . 62.11 113.269 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.419 HG21 ' HB2' ' A' ' 167' ' ' PRO . 24.0 pt -111.04 143.84 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 122.499 -0.412 . . . . 62.02 112.015 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -41.66 -42.21 2.45 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.633 -0.712 . . . . 71.02 112.597 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.403 HD11 ' HD2' ' A' ' 30' ' ' PHE . 55.2 mt -51.75 -61.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.246 0.546 . . . . 72.42 112.271 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.8 m -72.29 -34.38 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.116 -0.493 . . . . 73.22 112.227 -174.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.0 -44.18 77.19 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.763 0.316 . . . . 64.32 111.145 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -63.03 -36.67 84.33 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.882 0.372 . . . . 73.24 111.637 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -94.32 2.14 55.86 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.057 0.391 . . . . 74.55 112.057 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 53.11 66.21 1.3 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.937 0.495 . . . . 72.12 112.08 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.4 mt -104.64 129.64 52.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.446 -0.343 . . . . 73.31 111.19 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 140' ' ' ILE . 11.2 p -78.66 137.02 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.787 0.327 . . . . 73.13 111.066 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -85.44 135.86 33.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.257 0.551 . . . . 72.3 112.071 -177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.3 mmm -130.19 159.41 36.94 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.374 -0.83 . . . . 64.23 109.735 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -132.04 140.87 49.04 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.248 0.833 . . . . 74.32 113.248 -169.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.415 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 27.5 p -48.73 -42.82 36.48 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.791 1.034 . . . . 74.25 113.791 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -53.33 -33.09 52.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.354 0.502 . . . . 74.45 112.354 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -103.44 -47.21 4.35 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.083 0.468 . . . . 70.42 111.643 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -77.6 4.8 10.45 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.545 0.572 . . . . 71.34 112.545 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.48 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -48.61 -46.31 39.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.072 0.463 . . . . 61.53 111.712 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 78.4 p -66.08 -41.95 90.02 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.973 -0.558 . . . . 23.31 111.533 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.3 ttp -63.03 -51.76 65.49 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.314 -0.403 . . . . 72.51 111.829 -175.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 91' ' ' TYR . 8.1 p90 -75.87 -17.58 59.75 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 120.199 -0.601 . . . . 72.11 111.582 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -64.8 -45.66 85.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.255 0.55 . . . . 72.43 110.122 170.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.19 -42.58 93.44 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.094 -0.503 . . . . 73.01 110.736 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.506 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 13.9 m-30 -59.06 -49.44 77.89 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.165 0.431 . . . . 73.22 112.165 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.5 tp -65.55 -31.64 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.612 0.244 . . . . 74.35 111.439 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -63.8 -51.15 66.09 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.996 0.426 . . . . 75.33 110.778 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -65.08 -41.76 94.75 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.172 0.51 . . . . 41.22 110.982 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.589 ' HE1' ' HB2' ' A' ' 175' ' ' ALA . 78.7 t80 -58.64 -56.99 15.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.419 -0.809 . . . . 63.51 111.102 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 50.9 ttp -50.74 -48.11 59.13 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.01 0.433 . . . . 43.01 111.463 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.678 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -63.28 -46.57 86.15 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.127 -0.488 . . . . 74.24 111.48 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -70.66 -42.56 70.63 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.255 0.465 . . . . 65.42 112.255 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.36 -33.61 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.18 0.437 . . . . 73.44 112.18 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 97' ' ' LYS . 10.0 tp -67.82 -38.23 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.533 -0.467 . . . . 75.31 110.309 175.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -65.25 -48.03 74.67 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.315 0.579 . . . . 71.43 110.552 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -60.0 -29.89 68.78 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.662 -0.699 . . . . 72.23 111.789 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 54.5 tpp -90.64 -60.52 1.9 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.813 0.339 . . . . 74.02 111.684 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.12 -32.69 68.37 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.144 0.424 . . . . 72.14 112.144 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -55.86 -44.07 77.72 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.287 0.477 . . . . 72.32 112.287 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -95.83 -36.69 11.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.99 0.366 . . . . 72.23 111.99 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -67.09 -62.94 1.18 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.644 -0.253 . . . . 71.24 111.591 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 108' ' ' ARG . 49.1 mtm180 62.59 23.74 14.12 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.992 1.108 . . . . 74.24 113.992 173.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.539 ' O ' HG22 ' A' ' 113' ' ' VAL . 20.3 t70 -120.88 121.24 37.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.691 -0.63 . . . . 74.35 111.391 175.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 3.3 ptpp? -66.44 -1.25 3.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.887 1.069 . . . . 73.44 113.887 -175.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.95 -44.35 8.48 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.83 -0.544 . . . . 72.42 110.862 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -71.08 -51.39 25.46 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.386 -0.37 . . . . 64.2 111.408 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 109' ' ' ASP . 34.4 m -61.84 -28.45 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.727 0.299 . . . . 74.51 111.205 177.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.56 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 18.9 t70 -61.2 -56.33 21.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.082 0.468 . . . . 51.53 110.318 174.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 119' ' ' LYS . . . -59.92 -40.9 90.46 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.828 -0.624 . . . . 71.01 111.245 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -57.02 -61.96 2.09 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.288 0.477 . . . . 75.3 112.288 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 114' ' ' ASP . 62.7 pttt -55.19 -45.23 75.81 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.885 0.374 . . . . 75.33 111.274 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -65.91 -28.63 69.07 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.828 0.307 . . . . 61.24 111.828 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 37.1 tptt -72.75 -56.84 4.67 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.049 0.452 . . . . 74.44 110.739 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.4 tp -68.18 -39.27 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.896 -0.593 . . . . 75.02 111.763 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.532 ' HA ' HE21 ' A' ' 121' ' ' GLN . 0.0 OUTLIER -62.83 -51.41 67.16 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.283 -0.261 . . . . 65.22 111.422 177.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.63 -44.92 68.82 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.913 -0.661 . . . . 74.42 112.656 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -58.71 -58.39 8.79 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 111.561 0.208 . . . . 71.41 111.561 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.469 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.7 m -61.76 -44.68 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 112.546 0.573 . . . . 54.33 112.546 -175.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.1 m -63.34 -26.98 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.88 -0.513 . . . . 73.31 111.418 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 m -81.25 -36.49 29.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.215 0.531 . . . . 63.21 110.767 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 51.4 tp -71.61 -31.39 66.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.736 -0.665 . . . . 73.52 112.102 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 80.7 mt -80.56 2.36 25.83 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.167 0.432 . . . . 65.2 112.167 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.509 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -58.69 103.47 0.16 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.223 0.535 . . . . 71.11 112.012 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 37.8 ttpt -65.74 -23.24 66.69 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.29 0.848 . . . . 73.22 113.29 -171.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -77.87 -31.83 51.59 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.052 0.76 . . . . 62.13 113.052 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -108.35 -51.78 2.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.259 0.552 . . . . 75.33 111.517 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.509 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 45.8 m-85 -71.22 -5.6 33.21 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.943 0.72 . . . . 70.12 112.943 -172.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 21.8 ptmt -51.36 -26.19 7.31 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.067 -0.395 . . . . 62.12 111.556 172.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -82.18 18.53 1.37 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.67 0.618 . . . . 74.33 112.67 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.4 HD11 ' HD2' ' A' ' 133' ' ' PHE . 75.3 mt -89.68 137.32 32.43 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.982 -0.449 . . . . 74.25 111.297 176.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.9 123.82 45.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.258 -0.428 . . . . 35.11 110.603 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.415 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 88.8 m-85 -101.73 106.17 17.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.982 0.42 . . . . 72.42 111.195 -176.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -97.39 136.14 38.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.066 0.46 . . . . 72.3 111.33 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.455 ' O ' HG12 ' A' ' 77' ' ' VAL . 13.2 tt -140.03 154.72 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.784 0.326 . . . . 74.04 110.88 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.18 125.89 35.13 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.706 -0.759 . . . . 71.22 112.145 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -48.5 -47.56 38.76 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.669 0.387 . . . . 71.22 111.751 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.456 HH11 ' HD3' ' A' ' 143' ' ' ARG . 31.3 ttp180 -48.68 -52.4 23.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.087 -0.506 . . . . 73.43 111.408 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.665 ' HB1' ' H ' ' A' ' 151' ' ' GLY . . . -68.62 -28.05 66.56 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.182 0.438 . . . . 71.12 112.182 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.22 -17.8 64.95 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.748 0.419 . . . . 74.43 111.681 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -66.62 -7.97 24.07 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.172 -0.467 . . . . 64.31 112.004 175.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.0 17.53 76.79 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.106 -0.568 . . . . 62.4 112.806 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.46 -60.87 1.52 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.948 0.404 . . . . 70.15 111.073 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -74.74 -35.81 62.63 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.381 -0.372 . . . . 73.35 111.459 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 21.8 m120 57.69 34.53 24.6 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.943 0.401 . . . . 72.14 111.241 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.665 ' H ' ' HB1' ' A' ' 144' ' ' ALA . . . -54.09 162.47 3.58 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.61 -0.723 . . . . 53.42 114.216 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -59.59 144.44 47.57 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.948 0.722 . . . . 73.11 112.948 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 50.0 t -91.44 127.5 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.99 -0.55 . . . . 75.33 111.526 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -85.21 116.11 23.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.783 -0.644 . . . . 54.51 110.807 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.704 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 62.6 mt -88.8 124.44 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.821 0.343 . . . . 73.4 111.72 -176.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.8 mm -110.52 120.24 60.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.942 0.401 . . . . 62.2 111.775 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 26.0 tt0 -107.78 128.81 54.92 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.245 -0.434 . . . . 64.24 111.947 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -72.62 89.06 1.29 Allowed 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.969 -0.457 . . . . 73.24 110.486 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -92.2 133.95 35.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.926 0.393 . . . . 70.3 111.919 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.86 123.9 33.68 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.094 0.473 . . . . 55.3 111.506 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.6 t -130.1 105.06 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.875 0.369 . . . . 75.2 111.441 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.2 t70 56.19 30.94 17.41 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.335 0.588 . . . . 62.11 111.916 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.41 -24.55 24.04 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.171 -0.537 . . . . 63.02 113.664 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.5 p -90.16 148.58 22.88 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.924 0.392 . . . . 52.35 111.58 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 165' ' ' GLU . 0.1 OUTLIER -102.97 96.47 6.83 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.462 0.649 . . . . 75.53 110.74 178.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 166' ' ' VAL . 25.0 m -104.16 106.59 54.16 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 121.348 0.594 . . . . 63.15 112.066 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 34.2 Cg_exo -62.08 114.35 2.28 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.531 2.154 . . . . 75.41 112.481 176.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.4 ' OG1' ' HG3' ' A' ' 31' ' ' LYS . 90.9 m -99.15 133.07 43.95 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.921 0.391 . . . . 75.33 111.967 -176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 57.8 tp -77.83 140.1 39.35 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.898 -0.592 . . . . 70.32 111.702 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.704 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 24.0 mmt -127.96 124.36 37.1 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.693 0.397 . . . . 71.23 111.597 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.3 mt -141.09 130.63 23.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.651 0.38 . . . . 73.2 111.431 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.54 ' HA ' HG12 ' A' ' 27' ' ' VAL . 19.6 t -79.97 129.17 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.121 0.415 . . . . 63.11 112.121 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -77.48 -15.21 59.43 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.599 0.592 . . . . 71.15 112.599 -175.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.438 ' H ' HG12 ' A' ' 172' ' ' VAL . 3.8 mp0 -57.33 -27.63 62.39 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.846 0.355 . . . . 70.44 111.821 171.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.589 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -97.3 -42.72 7.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.144 -0.48 . . . . 70.52 111.93 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.4 pt -95.9 118.56 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.607 0.718 . . . . 75.41 112.373 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 177' ' ' ILE . 1.6 mp -94.88 115.63 34.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.798 -0.637 . . . . 73.33 110.255 175.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -97.96 112.88 24.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.567 -0.742 . . . . 63.31 111.407 -176.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 2' ' ' LEU . 54.7 mm-40 -97.71 123.03 41.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.557 0.343 . . . . 71.13 110.797 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -103.56 96.94 7.07 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.993 0.738 . . . . 74.32 112.993 -171.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 40.6 t -133.78 88.68 2.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.898 -0.592 . . . . 72.12 109.983 173.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 182' ' ' LEU . 4.7 mp -104.88 120.62 41.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.85 0.357 . . . . 73.53 111.596 -172.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 118.656 -0.688 . . . . 74.3 111.173 179.139 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 111.747 0.277 . . . . 64.21 111.747 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.0 tp -126.18 131.01 52.1 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.857 0.361 . . . . 64.12 110.535 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.584 HG12 ' HB3' ' A' ' 15' ' ' SER . 57.5 mt -98.05 134.11 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 112.004 0.372 . . . . 74.52 112.004 -175.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -123.52 137.27 54.8 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.083 0.468 . . . . 73.45 111.115 171.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -143.54 141.39 30.69 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.989 -0.55 . . . . 71.3 111.361 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.585 ' HB2' ' H ' ' A' ' 9' ' ' THR . 5.2 m-20 -86.98 167.74 13.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.4 0.619 . . . . 75.23 111.258 172.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.446 HD12 ' OD1' ' A' ' 98' ' ' ASN . 15.2 pt -63.05 -26.86 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.97 -0.559 . . . . 64.14 111.458 173.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.475 ' HE1' ' HA ' ' A' ' 152' ' ' GLN . 13.2 p90 -109.95 -35.65 6.09 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.321 0.86 . . . . 75.34 113.321 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.585 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 2.7 m -83.12 15.61 2.76 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.95 0.722 . . . . 75.1 112.95 -173.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -58.28 -15.11 8.93 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.849 0.685 . . . . 74.23 112.849 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -67.81 -56.02 10.77 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 122.156 -0.34 . . . . 74.45 111.267 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -84.14 25.02 0.87 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.832 0.349 . . . . 55.45 111.747 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tt -40.12 131.07 2.08 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.535 0.734 . . . . 62.45 111.589 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 m -126.11 139.9 53.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.143 0.497 . . . . 62.51 112.279 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.584 ' HB3' HG12 ' A' ' 3' ' ' ILE . 47.8 p -111.55 111.04 21.76 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.869 -0.605 . . . . 72.31 110.944 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.414 ' HB3' ' HD1' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -151.05 -156.83 0.75 Allowed 'General case' 0 CA--C 1.544 0.741 0 O-C-N 122.355 -0.216 . . . . 54.31 111.204 -175.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -127.63 24.77 6.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.136 0.421 . . . . 51.44 112.136 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.414 ' HD1' ' HB3' ' A' ' 16' ' ' ASP . 59.1 m-85 -60.18 134.15 90.56 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.03 0.382 . . . . 54.22 112.03 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.99 -169.84 0.88 Allowed 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.779 2.319 . . . . 75.03 113.08 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.6 ptp -145.89 135.43 23.17 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.442 0.534 . . . . 62.55 112.442 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -124.45 100.41 6.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.614 -0.513 . . . . 75.41 109.614 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 27' ' ' VAL . 33.0 tp -93.03 124.46 37.01 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.174 0.805 . . . . 71.21 113.174 -170.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.68 142.35 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.896 -0.593 . . . . 61.02 111.01 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 57.44 13.44 1.82 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.481 0.549 . . . . 75.2 112.481 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 50.76 26.86 2.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.216 0.532 . . . . 74.21 111.03 -172.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.519 HD22 ' HB3' ' A' ' 119' ' ' LYS . 20.0 tp -121.62 -42.71 2.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.159 -0.473 . . . . 70.44 111.967 -174.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.66 HG12 ' HA ' ' A' ' 172' ' ' VAL . 2.6 m -138.19 151.73 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.803 0.668 . . . . 70.22 112.803 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -104.57 138.52 40.79 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.879 -0.6 . . . . 74.54 111.117 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -104.39 137.73 41.84 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.397 . . . . 72.14 110.526 167.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.845 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.4 t80 -115.59 134.25 55.24 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.943 0.401 . . . . 75.34 111.141 177.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -93.1 113.79 26.14 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.199 -0.455 . . . . 72.52 111.859 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.09 -174.82 18.31 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.275 -0.488 . . . . 61.42 113.598 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -128.14 144.25 51.1 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 122.482 -0.422 . . . . 73.54 111.298 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -80.08 114.16 18.79 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.866 -0.42 . . . . 73.2 109.866 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.1 m -144.23 174.42 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.302 0.573 . . . . 73.24 111.949 -174.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 44' ' ' LEU . 21.5 m -110.85 121.75 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.168 0.509 . . . . 72.52 110.558 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.62 HH11 HD13 ' A' ' 42' ' ' ILE . 9.8 mmm180 -140.61 117.29 10.93 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.095 0.474 . . . . 72.32 111.111 -174.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -110.72 113.22 25.66 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.965 0.412 . . . . 63.23 110.945 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 60.63 14.5 5.01 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.534 0.568 . . . . 72.44 112.534 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.82 -15.98 21.23 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.257 -0.497 . . . . 60.35 113.688 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -79.72 142.27 35.62 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 117.286 0.543 . . . . 64.02 111.885 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.62 HD13 HH11 ' A' ' 37' ' ' ARG . 5.1 tp -109.88 122.44 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 116.207 -0.451 . . . . 62.02 111.906 -177.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 p -162.95 85.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.396 0.617 . . . . 71.43 112.255 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' HA ' HG22 ' A' ' 36' ' ' VAL . 8.9 mp -57.14 160.33 3.81 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.156 0.798 . . . . 74.23 113.156 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 72.07 4.2 4.94 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.026 -0.988 . . . . 70.54 112.637 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.43 99.13 1.93 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.155 -0.545 . . . . 65.4 112.975 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.8 m -156.53 -77.62 0.09 Allowed 'General case' 0 N--CA 1.476 0.849 0 O-C-N 122.485 -0.42 . . . . 65.21 111.631 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 59.52 93.5 0.06 OUTLIER Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 122.848 0.459 . . . . 72.43 111.813 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.64 155.28 54.56 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.507 2.138 . . . . 54.33 113.325 -177.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 78.3 p -98.74 114.33 26.81 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.325 -0.398 . . . . 65.54 110.77 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.48 -75.48 0.11 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.08 0.4 . . . . 74.14 112.08 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -104.51 21.97 15.79 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.138 0.494 . . . . 73.34 111.391 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 8.6 tp10 -111.73 113.18 25.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.95 0.405 . . . . 64.25 110.641 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.19 36.52 91.91 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.14 -0.552 . . . . 44.01 112.659 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.96 -18.72 58.76 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.213 0.449 . . . . 65.43 112.213 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.67 29.56 7.9 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.399 -0.364 . . . . 75.43 111.388 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.59 144.35 51.87 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.256 0.55 . . . . 73.41 111.95 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -130.74 -0.26 4.32 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.944 -0.571 . . . . 74.51 111.954 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.75 98.74 0.19 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.896 -0.669 . . . . 72.24 113.768 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.3 p -156.6 168.62 26.83 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.484 0.314 . . . . 72.53 110.647 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -99.66 -93.81 0.26 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.923 0.342 . . . . 71.33 111.923 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 53.07 7.83 0.09 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.833 1.049 . . . . 73.23 113.833 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -86.3 -16.7 36.7 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.857 -0.527 . . . . 75.24 110.614 172.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 24.4 t -98.34 163.84 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.997 -1.112 . . . . 72.14 107.997 164.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 64' ' ' VAL . 39.7 tt0 75.67 -5.1 2.24 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.397 0.617 . . . . 72.23 109.354 -171.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -137.02 122.02 18.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.746 -0.661 . . . . 72.05 111.202 -176.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.53 -148.78 15.5 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.532 -0.842 . . . . 74.22 113.736 175.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.442 HD12 HD12 ' A' ' 70' ' ' ILE . 36.7 pt -111.07 138.82 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 122.417 -0.46 . . . . 64.32 111.356 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -48.14 -35.75 12.16 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.379 0.511 . . . . 75.42 112.379 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.442 HD12 HD12 ' A' ' 68' ' ' ILE . 55.8 mt -49.81 -64.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.401 0.62 . . . . 70.1 112.021 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 18.5 m -74.38 -31.98 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.964 -0.562 . . . . 71.43 112.08 -174.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.619 HD13 ' HB2' ' A' ' 37' ' ' ARG . 72.6 mt -68.7 -30.78 69.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.286 -0.415 . . . . 55.11 111.64 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -90.63 -27.13 19.27 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 111.852 0.316 . . . . 72.12 111.852 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -97.84 3.65 49.82 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.02 -0.425 . . . . 75.2 111.782 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 58.29 70.87 0.62 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.406 0.622 . . . . 73.32 112.581 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 88.0 mt -122.26 138.92 54.33 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.003 -0.544 . . . . 65.33 111.256 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 p -93.76 146.67 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 120.856 0.36 . . . . 72.34 111.842 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.42 127.51 32.29 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.368 0.877 . . . . 54.51 113.368 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.0 mtp -140.26 110.61 6.65 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.172 -0.467 . . . . 75.24 110.139 174.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.499 ' HB2' ' HE1' ' A' ' 82' ' ' TYR . 18.4 m120 -95.74 167.11 11.47 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.852 -0.53 . . . . 54.42 112.134 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 43.1 t -43.5 -56.13 3.82 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.87 1.063 . . . . 72.34 113.87 -172.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.499 ' HE1' ' HB2' ' A' ' 80' ' ' ASN . 13.4 p90 -50.24 -33.0 18.11 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.457 0.54 . . . . 72.23 112.457 -177.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.76 -38.24 9.55 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.773 -0.649 . . . . 64.2 112.087 -174.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 88' ' ' PHE . 25.4 t0 -91.21 -7.63 50.77 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.477 0.547 . . . . 72.13 112.477 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.614 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -39.71 -61.49 0.82 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.369 0.878 . . . . 74.43 113.369 -175.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.4 m -61.86 -35.25 77.74 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.262 0.467 . . . . 62.34 112.262 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 44.5 ttm -75.74 -54.4 7.01 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.139 0.422 . . . . 72.23 112.139 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.614 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 7.6 p90 -63.47 -27.09 69.04 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.114 -0.634 . . . . 74.51 111.617 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -64.32 -44.8 90.46 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.867 0.365 . . . . 72.42 110.645 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.64 -38.0 89.51 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.2 0.524 . . . . 33.32 110.714 173.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 27.8 t80 -55.82 -50.99 69.0 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.72 -0.673 . . . . 73.42 110.978 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 88' ' ' PHE . 32.6 mm -57.68 -42.72 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 116.283 -0.417 . . . . 61.54 111.593 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.93 -56.38 17.7 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.865 0.32 . . . . 62.33 111.865 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -59.94 -39.21 84.77 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.897 0.379 . . . . 65.5 111.147 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CZ ' HG11 ' A' ' 172' ' ' VAL . 20.3 t80 -59.49 -59.15 5.91 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.121 -0.49 . . . . 72.33 111.221 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 55.6 ttp -52.82 -44.43 66.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.161 -0.472 . . . . 71.34 111.4 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -61.67 -49.56 76.02 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.36 -0.382 . . . . 72.15 111.321 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.446 ' OD1' HD12 ' A' ' 7' ' ' ILE . 26.0 t-20 -61.33 -56.06 24.73 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.76 0.281 . . . . 63.1 111.76 -176.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.577 ' HB ' ' HZ ' ' A' ' 116' ' ' PHE . 27.5 m -57.46 -41.72 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.407 0.521 . . . . 73.53 112.407 -176.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.6 tp -74.74 -35.9 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 122.077 -0.39 . . . . 71.1 111.006 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.73 -13.81 61.03 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.336 0.588 . . . . 70.11 110.8 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -90.36 -37.79 13.77 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.16 -0.337 . . . . 74.53 111.343 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 64.0 mtt -93.13 -62.88 1.29 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.523 0.564 . . . . 71.41 112.523 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.658 ' HA ' HG11 ' A' ' 113' ' ' VAL . 38.9 tt0 -58.29 -26.34 62.9 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.38 0.511 . . . . 72.44 112.38 -174.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -57.27 -46.21 83.31 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 111.991 0.367 . . . . 71.42 111.991 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.02 -14.52 14.72 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.566 0.58 . . . . 74.55 112.566 -175.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.46 ' OD1' HG13 ' A' ' 113' ' ' VAL . 27.6 t-20 -92.72 -68.9 0.77 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.666 0.269 . . . . 70.55 111.398 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 36.6 ttm180 63.14 11.96 5.67 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.248 0.833 . . . . 73.22 113.248 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.621 ' O ' HG22 ' A' ' 113' ' ' VAL . 22.2 t70 -75.53 120.36 20.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.385 -0.822 . . . . 75.41 110.954 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -57.78 -12.31 2.94 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.468 0.914 . . . . 72.12 113.468 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.1 -53.25 4.2 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.997 -0.439 . . . . 75.31 112.043 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -74.12 -60.07 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.238 0.459 . . . . 74.15 112.238 -170.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.658 HG11 ' HA ' ' A' ' 104' ' ' GLU . 27.6 m -60.47 -26.6 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.692 0.282 . . . . 72.32 111.722 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.79 -53.22 50.38 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.573 -0.285 . . . . 75.12 110.483 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -56.57 -43.66 80.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.042 0.449 . . . . 61.24 111.258 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.577 ' HZ ' ' HB ' ' A' ' 99' ' ' VAL . 44.1 t80 -61.07 -59.21 5.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.882 0.372 . . . . 61.11 111.624 177.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -57.0 -35.14 68.88 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.175 0.512 . . . . 55.31 111.169 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -68.97 -40.15 79.02 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.786 -0.643 . . . . 53.34 111.385 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.519 ' HB3' HD22 ' A' ' 26' ' ' LEU . 51.9 mtmt -65.69 -44.18 86.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.512 0.196 . . . . 74.11 111.103 175.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.432 ' CD1' HD11 ' A' ' 26' ' ' LEU . 37.6 mm -62.01 -45.58 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.917 0.389 . . . . 75.45 111.055 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.42 ' O ' HG23 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -58.54 -50.99 71.78 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.184 -0.462 . . . . 62.15 110.776 177.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.73 -36.85 93.88 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.922 -0.656 . . . . 75.32 112.724 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 43.2 t90 -60.6 -56.4 21.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.642 0.377 . . . . 74.22 111.587 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.536 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.8 m -63.36 -42.72 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 112.241 0.46 . . . . 72.14 112.241 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 121' ' ' GLN . 71.6 t -59.81 -37.23 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 122.066 -0.396 . . . . 75.52 111.43 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.2 t -77.16 -39.62 48.41 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.042 0.449 . . . . 74.43 110.984 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.0 tp -62.41 -28.38 69.75 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.994 0.517 . . . . 73.3 112.148 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 29.3 mt -92.58 1.81 57.05 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.916 0.339 . . . . 64.12 111.916 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.89 108.08 2.43 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.091 0.472 . . . . 65.31 111.451 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -16.58 49.19 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.076 0.769 . . . . 55.41 113.076 -172.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -54.91 -49.05 72.24 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.904 0.383 . . . . 54.25 111.404 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -111.24 -43.34 3.74 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.403 0.62 . . . . 74.1 111.27 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -74.23 -7.26 52.08 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.327 0.862 . . . . 70.52 113.327 -167.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -63.7 -32.35 73.81 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.197 0.523 . . . . 70.31 110.426 170.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -89.7 33.9 0.84 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.003 -0.544 . . . . 75.1 112.199 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.73 156.95 18.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.504 0.669 . . . . 53.02 111.93 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.36 112.63 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.461 -0.79 . . . . 74.01 110.288 172.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.585 ' HB3' HG13 ' A' ' 153' ' ' VAL . 54.5 m-85 -90.9 132.93 35.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.916 0.388 . . . . 70.02 110.226 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.788 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 61.4 m-85 -121.94 125.39 46.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.863 0.364 . . . . 73.14 111.331 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 13.8 tt -113.4 154.63 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 116.552 -0.294 . . . . 73.44 111.348 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.99 142.8 41.42 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.447 -0.342 . . . . 73.11 113.645 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.437 ' HG3' ' HG3' ' A' ' 143' ' ' ARG . 14.2 pt-20 -53.29 -40.06 64.42 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.643 0.609 . . . . 73.24 112.643 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.437 ' HG3' ' HG3' ' A' ' 142' ' ' GLU . 85.1 mtm180 -78.17 -38.44 43.51 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.019 0.377 . . . . 72.32 112.019 -176.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.606 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -74.89 -28.48 60.65 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.085 0.402 . . . . 75.3 112.085 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -50.16 -38.79 41.24 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.04 1.126 . . . . 74.35 114.04 -174.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -73.52 6.16 3.26 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.756 1.021 . . . . 74.23 113.756 -172.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.26 -11.69 1.19 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.981 -1.104 . . . . 64.52 114.881 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -77.93 95.11 4.7 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 117.778 0.789 . . . . 70.14 111.59 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -74.27 19.85 0.12 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.473 0.546 . . . . 72.44 112.473 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -111.49 5.88 19.83 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.943 0.401 . . . . 53.24 110.827 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.81 171.59 52.59 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.423 -0.418 . . . . 63.34 113.472 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.475 ' HA ' ' HE1' ' A' ' 8' ' ' PHE . 37.3 tt0 -86.72 116.96 25.17 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.421 -0.458 . . . . 62.5 112.085 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.585 HG13 ' HB3' ' A' ' 138' ' ' PHE . 27.5 t -83.29 107.17 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.152 0.501 . . . . 71.23 110.589 170.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.484 ' HB1' ' CD1' ' A' ' 169' ' ' LEU . . . -82.09 117.39 22.23 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.065 -0.516 . . . . 64.42 110.89 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 59.4 mt -89.27 105.12 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.854 0.359 . . . . 73.43 111.252 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.5 mm -93.77 117.8 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.027 0.381 . . . . 62.33 112.027 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.86 129.49 56.44 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.393 -0.595 . . . . 73.43 109.393 174.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -90.51 88.99 7.37 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.047 0.451 . . . . 73.23 110.456 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -97.17 159.05 15.13 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.329 0.585 . . . . 71.11 112.171 -170.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.01 134.09 48.7 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.926 -0.579 . . . . 73.02 111.295 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.1 t -119.2 104.84 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.642 0.258 . . . . 73.23 110.962 175.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 60.4 9.75 2.14 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.863 0.69 . . . . 74.04 112.863 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 116.27 2.05 20.06 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.427 -0.416 . . . . 60.22 113.096 -175.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 94.5 m -107.8 130.24 54.99 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.977 0.418 . . . . 52.3 111.966 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -74.03 112.48 10.21 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.986 -0.552 . . . . 74.21 112.191 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 166' ' ' VAL . 27.9 m -129.22 117.4 18.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 121.168 0.508 . . . . 61.31 111.932 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.96 114.5 3.99 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.838 1.692 . . . . 75.13 111.693 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 67.3 p -101.07 129.22 46.91 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.164 0.506 . . . . 74.12 112.047 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.845 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.1 tp -89.81 122.9 33.32 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.84 -0.618 . . . . 74.33 111.087 176.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.658 ' SD ' ' HB ' ' A' ' 27' ' ' VAL . 39.4 tpp -103.22 125.52 49.93 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.755 0.312 . . . . 64.05 111.596 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -140.9 152.09 44.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.189 0.596 . . . . 63.55 109.983 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.66 ' HA ' HG12 ' A' ' 27' ' ' VAL . 41.9 t -89.89 117.34 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.829 0.677 . . . . 72.32 112.829 -173.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -59.88 -31.81 70.15 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.045 -0.525 . . . . 75.0 111.832 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.413 ' HG3' ' HE1' ' A' ' 116' ' ' PHE . 5.5 mm-40 -85.27 11.55 9.85 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.464 -0.335 . . . . 64.4 111.803 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -127.09 -41.87 1.76 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.829 0.347 . . . . 40.42 111.083 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 172' ' ' VAL . 12.8 tt -100.18 132.18 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.093 0.473 . . . . 64.41 111.062 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.5 tp -130.25 153.53 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.95 0.405 . . . . 71.32 111.548 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.05 152.06 41.43 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.115 0.483 . . . . 70.51 111.35 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.506 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 11.2 tp10 -138.98 133.19 31.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.095 0.474 . . . . 61.53 110.697 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -103.57 114.98 29.67 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.729 0.776 . . . . 63.34 112.939 -172.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 42.7 t -133.5 89.78 2.64 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.945 -0.761 . . . . 72.51 108.945 169.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 49.5 mt -121.25 94.74 4.43 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.238 0.459 . . . . 75.01 112.238 -168.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.256 1.421 0 CA-C-O 118.946 -0.55 . . . . 71.04 111.784 176.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.764 0.316 . . . . 74.34 110.856 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 33.9 tp -100.8 130.92 46.89 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 110.117 -0.327 . . . . 74.14 110.117 173.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.747 ' HB ' HD21 ' A' ' 13' ' ' LEU . 21.1 pt -114.2 123.02 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.22 0.533 . . . . 75.14 111.557 -176.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.525 ' HE1' ' HB2' ' A' ' 16' ' ' ASP . 35.7 p90 -122.8 143.28 49.94 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.231 0.539 . . . . 75.31 112.154 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.731 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 12.0 ptmt -130.1 150.0 51.56 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.688 -0.687 . . . . 75.03 111.242 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 7.0 p-10 -97.81 -178.33 4.06 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.212 0.53 . . . . 62.3 111.261 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.45 -43.83 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 113.239 0.829 . . . . 72.2 113.239 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.519 ' HD2' HG23 ' A' ' 9' ' ' THR . 9.2 p90 -108.48 -52.65 2.74 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.647 1.351 . . . . 71.32 114.647 -168.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.519 HG23 ' HD2' ' A' ' 8' ' ' PHE . 17.7 p -89.48 18.51 5.26 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.67 -0.644 . . . . 73.14 112.616 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.731 ' HB2' ' HB2' ' A' ' 5' ' ' LYS . 3.8 p-10 -50.87 -20.55 1.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.797 1.406 . . . . 71.54 114.797 -172.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -66.86 -19.79 65.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.363 0.602 . . . . 54.44 110.814 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.31 24.94 4.1 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.499 -0.773 . . . . 70.44 110.861 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.747 HD21 ' HB ' ' A' ' 3' ' ' ILE . 7.8 tt -38.52 138.61 0.48 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.815 0.846 . . . . 71.42 112.498 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.0 m -118.72 149.61 41.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.997 0.427 . . . . 62.24 111.934 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.5 p -109.77 129.91 55.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.236 -0.438 . . . . 74.32 110.557 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.525 ' HB2' ' HE1' ' A' ' 4' ' ' TYR . 2.5 t70 -137.41 179.04 6.64 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.657 0.265 . . . . 74.11 111.192 -177.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.7 t -132.74 4.97 3.92 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.275 0.472 . . . . 52.54 112.275 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -78.26 146.08 69.97 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 122.07 -0.394 . . . . 73.05 111.842 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -85.99 126.38 2.85 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.973 2.449 . . . . 64.4 113.386 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 87.7 mmm -89.74 124.63 34.8 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.502 -0.317 . . . . 74.31 111.163 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 56.5 mttm -103.48 112.24 25.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.34 0.256 . . . . 73.52 111.573 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 33.9 tp -84.54 106.65 16.27 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.809 -0.557 . . . . 63.33 112.159 -175.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -98.04 139.29 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.084 0.468 . . . . 74.15 111.131 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 58.32 15.56 3.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.565 0.58 . . . . 75.34 112.565 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 59.98 11.46 2.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.328 0.492 . . . . 61.4 112.328 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.1 tp -115.83 -45.54 2.87 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.07 0.396 . . . . 75.32 112.07 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 172' ' ' VAL . 3.8 m -129.29 143.7 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.431 0.53 . . . . 72.3 112.431 -176.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' A' ' 170' ' ' MET . 98.0 m-85 -92.0 142.03 27.98 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.074 -0.512 . . . . 74.45 110.876 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 16.4 pt-20 -128.87 146.97 50.79 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 110.242 -0.281 . . . . 71.41 110.242 174.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.52 ' CE2' HD13 ' A' ' 70' ' ' ILE . 43.6 p90 -152.48 145.67 24.65 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.626 0.973 . . . . 65.23 113.626 172.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -94.91 130.51 41.49 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.366 -0.834 . . . . 73.11 111.525 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.88 -133.96 7.69 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 114.472 0.549 . . . . 75.25 114.472 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -138.45 123.78 19.36 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.636 -0.332 . . . . 62.32 111.229 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -66.24 107.0 1.82 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.923 0.392 . . . . 74.1 111.839 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.418 HG23 HD12 ' A' ' 72' ' ' LEU . 35.6 m -138.96 168.17 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.267 -0.424 . . . . 61.55 111.481 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.414 HG13 HD23 ' A' ' 44' ' ' LEU . 35.6 m -132.91 144.74 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.482 -0.326 . . . . 72.22 110.933 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 29.6 tpt85 -137.12 108.08 6.7 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.832 0.825 . . . . 73.01 111.979 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.887 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 5.6 tppp? -135.96 147.15 47.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.999 -1.0 . . . . 62.24 108.983 169.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -50.28 -51.47 44.63 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.053 0.454 . . . . 72.22 111.929 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.8 34.55 5.59 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.34 -0.457 . . . . 73.31 112.982 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.887 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 9.3 tp10 -162.23 101.88 1.1 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.045 0.45 . . . . 51.22 111.519 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -149.34 158.32 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 116.306 -0.407 . . . . 71.42 110.827 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.0 t 69.11 86.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.714 0.769 . . . . 53.14 110.878 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.414 HD23 HG13 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -82.4 179.61 7.74 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.056 -0.974 . . . . 70.24 112.147 -178.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.07 147.82 50.96 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.022 0.439 . . . . 73.23 111.768 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.23 3.51 85.52 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.354 -0.451 . . . . 73.31 112.965 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.0 t -110.84 132.95 53.76 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.879 0.371 . . . . 62.23 111.435 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -149.92 87.65 5.01 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.785 0.326 . . . . 72.21 110.862 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.45 -67.44 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.983 2.456 . . . . 63.02 113.737 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.8 t -70.07 108.74 4.22 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.495 0.554 . . . . 65.32 112.495 -172.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.34 105.82 17.38 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.06 -0.518 . . . . 53.32 110.69 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -168.81 -50.18 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.915 0.388 . . . . 74.23 111.554 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -84.67 -52.4 6.11 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.64 0.607 . . . . 73.33 112.64 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.57 98.43 1.85 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.367 -0.444 . . . . 50.4 113.108 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -168.56 -38.36 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.862 0.319 . . . . 62.34 111.862 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -28.57 13.32 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.476 0.917 . . . . 62.45 113.476 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.14 142.11 52.42 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.481 0.658 . . . . 74.33 112.317 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -114.34 -3.66 13.07 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.843 -0.617 . . . . 62.14 112.275 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.19 38.16 0.02 OUTLIER Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.406 -0.902 . . . . 65.43 114.245 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.8 m 69.21 128.11 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.693 0.627 . . . . 34.14 112.693 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -98.05 -17.29 19.2 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.293 0.479 . . . . 70.11 112.293 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -94.95 -160.27 0.77 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.505 0.669 . . . . 73.21 110.452 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -112.1 76.11 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.411 0.625 . . . . 74.03 109.45 166.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.6 t -92.3 129.99 42.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.806 -0.634 . . . . 61.43 110.818 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 35.1 mt-10 -80.48 63.97 5.11 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.653 0.74 . . . . 72.45 110.069 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.543 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -114.48 149.56 36.16 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.915 -0.584 . . . . 64.15 111.748 -177.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 141.67 -113.65 0.84 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.205 -0.522 . . . . 63.22 112.802 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.454 HD12 HD12 ' A' ' 70' ' ' ILE . 17.1 pt -111.51 134.52 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.959 0.409 . . . . 43.2 111.85 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -46.25 -36.31 6.02 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.829 -0.623 . . . . 72.21 112.222 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.52 HD13 ' CE2' ' A' ' 30' ' ' PHE . 50.9 mt -48.66 -64.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.304 0.573 . . . . 75.32 112.29 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 33.8 m -66.04 -36.75 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.911 -0.586 . . . . 72.34 112.188 -175.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.418 HD12 HG23 ' A' ' 35' ' ' VAL . 42.7 mt -67.46 -38.32 84.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.095 0.474 . . . . 64.34 111.299 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -66.41 -45.2 80.75 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.077 -0.51 . . . . 74.34 111.247 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -90.43 7.94 36.21 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.38 0.511 . . . . 73.54 112.38 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.8 mttm 57.4 69.08 0.77 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.496 0.665 . . . . 75.34 112.759 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 75.0 mt -114.74 120.86 41.52 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.935 -0.575 . . . . 71.24 110.541 177.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 14.4 p -86.62 144.17 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.911 0.386 . . . . 75.44 111.615 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.55 126.31 30.76 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.105 -0.498 . . . . 71.23 112.214 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.2 mmt -132.35 159.46 39.15 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.201 -0.454 . . . . 71.21 111.133 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.465 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 93.5 m-20 -127.39 147.3 50.27 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.139 0.495 . . . . 65.31 111.175 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 26.1 p -52.19 -16.43 0.8 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.852 1.427 . . . . 52.31 114.852 -169.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 80' ' ' ASN . 50.2 p90 -58.94 -41.63 87.82 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.418 0.525 . . . . 73.43 112.418 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -101.34 -37.92 8.27 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.126 -0.359 . . . . 64.13 111.824 -178.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.64 6.88 0.98 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.833 0.679 . . . . 64.22 112.833 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.32 -50.59 38.85 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.359 0.503 . . . . 73.43 112.359 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.7 m -68.96 -35.27 76.56 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.625 0.25 . . . . 54.11 111.612 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 95.9 mmm -56.46 -50.85 70.51 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.681 0.277 . . . . 62.44 110.698 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -68.32 -33.73 74.85 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.84 0.311 . . . . 72.53 111.84 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -55.6 -54.72 40.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.104 0.478 . . . . 64.51 110.967 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.48 -38.22 68.25 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.2 -0.455 . . . . 71.12 111.792 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -59.01 -54.82 42.77 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.633 -0.258 . . . . 75.03 111.288 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.4 mm -62.4 -35.43 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.696 -0.229 . . . . 73.1 111.272 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.453 ' HE3' ' HD2' ' A' ' 97' ' ' LYS . 57.4 tptt -57.33 -60.56 3.44 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.709 0.29 . . . . 73.43 111.11 175.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -61.77 -39.5 91.86 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.167 0.508 . . . . 72.35 111.097 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.599 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 78.3 t80 -57.36 -56.68 18.66 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.86 -0.609 . . . . 74.42 111.527 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 51.8 ttm -53.79 -43.7 69.49 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.09 0.472 . . . . 62.32 111.33 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD2' ' HE3' ' A' ' 93' ' ' LYS . 28.0 mtpp -61.71 -43.85 98.06 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.989 -0.55 . . . . 71.32 111.79 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -73.42 -44.45 58.28 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.95 0.352 . . . . 64.14 111.95 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.0 m -66.33 -38.73 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.395 0.517 . . . . 73.35 112.395 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 34.5 mm -65.51 -47.0 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.856 0.36 . . . . 54.25 110.756 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.95 -42.89 85.89 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 72.54 110.512 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -64.83 -35.55 81.48 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.709 -0.678 . . . . 63.44 111.285 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.574 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 15.0 mmt -68.05 -39.62 82.97 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.651 0.241 . . . . 75.43 111.651 177.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.65 -35.68 72.93 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.491 0.663 . . . . 74.43 110.53 171.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -70.09 -46.35 65.04 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.283 -0.871 . . . . 64.01 112.702 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 103' ' ' MET . 0.1 OUTLIER -97.51 -26.15 14.92 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.122 1.156 . . . . 73.32 114.122 -174.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.575 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 87.7 m-20 -124.06 -63.21 1.22 Allowed 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.874 -0.516 . . . . 63.24 112.114 -175.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' A' ' 107' ' ' ASN . 5.9 ptt180 67.91 -14.71 0.22 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.308 1.043 . . . . 74.2 113.399 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 113' ' ' VAL . 24.7 t70 -61.64 127.63 32.37 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.2 -0.313 . . . . 71.23 111.676 -176.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -50.63 -39.64 50.91 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.727 0.64 . . . . 75.21 112.727 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.94 -35.63 50.17 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.648 0.261 . . . . 63.42 111.576 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -67.71 -51.36 50.32 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.783 0.325 . . . . 64.02 111.083 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 109' ' ' ASP . 16.1 m -66.73 -23.07 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 111.813 0.301 . . . . 63.53 111.813 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 29.1 t70 -69.96 -61.43 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.039 -0.356 . . . . 74.33 110.039 171.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.85 -40.16 63.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.865 0.364 . . . . 70.15 111.608 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -58.83 -59.34 5.59 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.384 -0.371 . . . . 73.31 111.242 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 8.4 ptpp? -59.39 -31.8 69.58 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.958 -0.297 . . . . 74.02 111.065 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 33.7 mmtp -62.4 -46.66 87.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.851 0.357 . . . . 74.51 110.802 175.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -67.37 -56.25 10.46 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.071 -0.513 . . . . 60.44 111.991 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.0 tp -67.36 -40.6 85.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.587 0.588 . . . . 61.12 112.587 -175.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 125' ' ' VAL . 14.3 tm0? -68.12 -45.74 72.8 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.023 -0.423 . . . . 71.2 110.737 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.41 -41.61 95.32 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.647 -0.787 . . . . 71.11 112.05 173.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -59.44 -54.1 50.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.4 0.28 . . . . 62.21 111.717 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.0 m -64.82 -36.7 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.485 0.55 . . . . 75.54 112.485 -177.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 121' ' ' GLN . 78.0 t -59.37 -43.51 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.98 -0.45 . . . . 64.4 111.148 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.7 t -76.05 -37.64 58.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.116 0.484 . . . . 74.1 111.119 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.516 ' HA ' ' CD2' ' A' ' 133' ' ' PHE . 51.1 tp -61.25 -33.55 73.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.987 0.515 . . . . 75.52 111.704 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 65.7 mt -88.47 3.01 51.65 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.35 -0.386 . . . . 50.44 111.918 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.27 102.86 0.1 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.151 0.5 . . . . 71.55 111.642 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -62.33 -11.44 15.35 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.794 1.035 . . . . 72.3 113.794 -172.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.97 -48.35 6.03 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.642 0.608 . . . . 74.32 112.642 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.7 tpp85 -92.8 -56.01 3.16 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.185 0.516 . . . . 74.31 111.667 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' A' ' 127' ' ' LEU . 8.0 m-85 -71.2 -5.86 35.13 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.117 0.484 . . . . 74.34 111.975 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 27.6 ttpp -49.81 -21.84 1.25 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.144 -0.48 . . . . 51.51 112.08 172.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -82.18 9.35 8.84 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.916 0.71 . . . . 74.41 112.916 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.25 136.12 33.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.06 0.457 . . . . 75.25 111.771 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.14 118.45 37.01 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.154 -0.475 . . . . 62.42 110.296 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.403 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 66.4 m-85 -97.08 108.32 21.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.001 0.429 . . . . 73.14 111.278 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 45.7 m-85 -98.64 124.49 43.47 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.1 0.476 . . . . 73.33 111.481 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.544 HG23 ' HB2' ' A' ' 145' ' ' ALA . 10.6 tt -135.56 148.75 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.315 -0.402 . . . . 73.44 110.929 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.37 121.94 8.07 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.276 -0.487 . . . . 45.54 112.815 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -32.31 60.81 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.931 0.715 . . . . 73.3 112.931 -175.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -61.32 -39.34 90.15 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.066 0.395 . . . . 74.25 112.066 173.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -80.52 -40.53 25.86 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.939 0.399 . . . . 62.45 111.562 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.544 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -58.56 -20.68 48.69 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.128 -0.487 . . . . 34.21 112.058 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -62.84 -16.89 60.33 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.072 -0.513 . . . . 75.12 111.761 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.13 31.37 14.57 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.252 -0.499 . . . . 41.32 112.485 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.46 -19.89 19.5 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.193 0.442 . . . . 65.34 112.193 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -161.78 -170.87 2.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.641 -0.254 . . . . 75.32 111.08 -176.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -65.66 -66.47 0.54 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.781 0.324 . . . . 65.4 111.784 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.29 146.2 0.21 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.345 -0.455 . . . . 51.34 113.67 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -102.17 135.99 42.78 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.313 -0.522 . . . . 62.33 111.265 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 56.1 t -94.69 127.86 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.19 0.519 . . . . 71.4 112.015 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.901 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -96.05 123.28 39.6 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.688 -0.687 . . . . 64.12 110.422 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 55.4 mt -93.3 118.98 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.18 0.437 . . . . 71.1 112.18 -173.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.0 mm -102.94 117.59 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.677 -0.238 . . . . 63.32 111.222 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -109.76 125.13 52.37 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.16 0.505 . . . . 74.32 111.59 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -87.52 88.87 7.8 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.039 -0.528 . . . . 65.54 109.824 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 159' ' ' ARG . 18.9 ptt85 -124.82 172.49 9.3 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.203 0.525 . . . . 71.32 112.324 -175.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -89.3 135.92 33.31 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.31 0.576 . . . . 63.44 112.213 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 78.1 t -108.8 95.48 3.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.889 -0.782 . . . . 73.03 108.889 169.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.4 t70 69.74 -56.96 0.56 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.533 -0.758 . . . . 73.51 111.564 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.02 6.65 0.14 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 121.1 -0.572 . . . . 60.12 114.224 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.4 m -120.5 134.76 55.23 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.749 0.774 . . . . 64.11 111.697 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -83.28 107.93 16.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.582 -0.281 . . . . 62.45 111.409 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.1 m -128.79 147.32 64.0 Favored Pre-proline 0 N--CA 1.474 0.747 0 CA-C-O 121.078 0.466 . . . . 71.45 112.016 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -90.94 114.72 0.43 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.928 2.419 . . . . 60.03 113.366 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 79.2 p -103.52 154.87 18.99 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.631 -0.259 . . . . 55.1 110.658 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.901 HD11 ' HB1' ' A' ' 154' ' ' ALA . 13.7 tp -100.28 120.89 40.62 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.221 -0.299 . . . . 73.4 111.312 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.643 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 60.8 mtt -107.54 134.89 49.9 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.678 0.621 . . . . 64.45 112.678 -175.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.8 mt -143.41 146.4 33.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.278 -0.874 . . . . 70.31 110.092 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.599 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 44.5 t -77.19 134.67 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 112.277 0.473 . . . . 73.53 112.277 -176.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.698 ' HB3' ' HZ3' ' A' ' 173' ' ' LYS . 5.9 ttpm? -59.6 -47.67 84.66 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.983 -0.553 . . . . 73.31 112.089 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -85.16 11.48 9.76 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.918 0.389 . . . . 71.33 111.964 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.537 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -103.3 -13.07 16.85 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.75 0.31 . . . . 71.25 111.133 173.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.2 pt -136.9 133.58 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.216 0.532 . . . . 45.31 111.485 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.53 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 50.6 mm -94.58 110.79 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.958 0.409 . . . . 70.52 110.218 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.7 123.15 31.55 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.319 -0.4 . . . . 72.21 110.822 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.56 ' HB3' HG13 ' A' ' 3' ' ' ILE . 11.8 tp10 -121.41 139.4 53.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.182 0.515 . . . . 72.24 110.702 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.02 132.43 50.75 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.776 0.658 . . . . 43.14 112.776 -172.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 53.6 t -127.32 88.08 2.74 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.967 -0.561 . . . . 73.43 109.993 172.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.25 99.4 6.68 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.985 -0.552 . . . . 73.51 110.655 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 119.185 -0.436 . . . . 71.5 111.923 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.582 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 24.0 mmt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.664 0.269 . . . . 62.11 111.264 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 15' ' ' SER . 57.7 tp -71.98 133.58 45.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.725 0.298 . . . . 72.43 110.781 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.1 mt -97.19 120.47 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 111.872 0.323 . . . . 70.03 111.872 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.464 ' O ' HD12 ' A' ' 13' ' ' LEU . 7.8 m-85 -106.59 115.05 29.53 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.439 -0.346 . . . . 73.42 110.638 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HG2' HD13 ' A' ' 13' ' ' LEU . 97.7 mttt -112.6 112.22 23.6 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.321 0.388 . . . . 62.14 111.231 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.61 154.98 38.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.088 0.47 . . . . 44.41 111.199 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.4 -42.67 94.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.081 0.467 . . . . 73.05 110.579 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -109.97 -33.54 6.68 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.461 0.911 . . . . 62.32 113.461 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.466 HG23 ' HA2' ' A' ' 151' ' ' GLY . 1.3 m -89.61 15.17 9.95 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 112.729 0.64 . . . . 52.22 112.729 -175.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -54.64 -17.87 3.86 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.93 0.715 . . . . 72.3 112.93 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.45 -33.11 72.08 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.357 0.599 . . . . 70.11 111.13 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -94.08 24.29 4.42 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.997 -0.547 . . . . 53.23 111.845 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 4' ' ' TYR . 65.5 tp -31.04 117.26 0.17 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.787 0.835 . . . . 72.04 112.436 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.6 t -110.01 163.6 13.41 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.284 0.564 . . . . 74.04 112.364 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.582 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 79.3 p -150.17 107.59 3.63 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.598 -0.728 . . . . 73.43 110.688 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -135.71 173.69 11.44 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.25 0.547 . . . . 72.42 112.328 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 m -133.9 84.7 2.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.875 -0.602 . . . . 70.45 110.489 173.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.59 152.01 73.84 Favored Pre-proline 0 N--CA 1.474 0.754 0 CA-C-N 116.367 -0.379 . . . . 75.43 111.381 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -93.0 94.21 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.862 2.374 . . . . 74.54 112.901 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.537 ' HB3' ' HB3' ' A' ' 28' ' ' TYR . 4.0 mpp? -85.41 144.82 27.78 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.857 0.36 . . . . 64.23 111.36 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -99.12 108.1 20.64 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.876 0.37 . . . . 72.03 111.863 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.2 tp -75.75 95.49 3.45 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.046 0.45 . . . . 61.43 111.084 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -86.75 140.34 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.038 0.446 . . . . 74.44 111.71 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.5 t70 58.03 16.46 3.79 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.854 -0.612 . . . . 74.02 111.679 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 57.18 20.4 5.62 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.054 -0.521 . . . . 64.03 111.762 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' A' ' 119' ' ' LYS . 32.2 tp -118.43 -50.17 2.45 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.055 0.455 . . . . 52.2 111.963 -176.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.506 HG12 HG22 ' A' ' 172' ' ' VAL . 14.3 m -130.8 155.38 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 112.581 0.586 . . . . 75.35 112.581 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.537 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 77.5 m-85 -92.24 124.86 36.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.086 -0.506 . . . . 75.05 110.816 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 15.1 pt-20 -101.93 139.32 37.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.997 0.427 . . . . 74.13 110.217 171.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 168' ' ' THR . 42.5 t80 -141.56 112.35 7.2 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.629 -0.259 . . . . 73.04 111.11 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.432 ' HG3' ' H ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -75.48 130.89 39.64 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.33 0.492 . . . . 75.2 112.33 -179.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -126.09 162.04 20.36 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.385 -0.436 . . . . 23.41 113.606 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -97.24 126.83 42.7 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.463 -0.434 . . . . 64.31 111.539 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.408 ' ND1' ' O ' ' A' ' 34' ' ' HIS . 15.9 p80 -74.5 106.57 6.16 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.142 0.496 . . . . 74.35 110.619 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.428 HG11 HG23 ' A' ' 43' ' ' VAL . 29.7 m -140.81 177.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.381 0.61 . . . . 64.43 111.862 -176.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 66' ' ' ARG . 34.9 m -132.43 146.87 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.971 -0.559 . . . . 74.54 111.219 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.941 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 56.7 ttt-85 -109.41 121.21 44.68 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.256 0.551 . . . . 74.21 110.892 174.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -131.14 160.64 34.14 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.691 -1.14 . . . . 72.15 110.784 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -55.06 -38.23 67.77 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.066 0.395 . . . . 73.24 112.066 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.41 37.28 2.38 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.091 -0.576 . . . . 63.3 113.358 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -170.71 132.8 0.94 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.756 -0.261 . . . . 61.14 110.731 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 tp -149.6 148.74 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 112.293 0.479 . . . . 60.42 112.293 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.428 HG23 HG11 ' A' ' 35' ' ' VAL . 8.0 p 35.9 80.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.291 1.036 . . . . 55.15 113.517 176.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 44' ' ' LEU . 1.4 mm? -89.45 100.48 13.26 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.88 -0.512 . . . . 71.43 110.587 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.53 69.45 2.28 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.184 0.516 . . . . 64.11 111.633 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.4 163.25 25.03 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.279 -0.486 . . . . 63.23 113.351 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.5 t -96.07 142.8 27.84 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.923 0.392 . . . . 63.1 110.645 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -146.55 130.95 8.69 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.556 -0.293 . . . . 72.5 110.364 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.88 -174.64 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.371 2.048 . . . . 44.23 112.798 176.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.7 p -58.45 117.26 4.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.958 0.409 . . . . 65.34 111.405 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.55 -10.51 37.38 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.146 0.424 . . . . 51.11 112.146 -174.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.437 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 1.7 tm-20 -69.62 78.19 0.42 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.223 0.535 . . . . 64.13 110.766 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 177.7 99.68 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.557 -0.747 . . . . 63.34 110.898 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.03 123.06 0.05 OUTLIER Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.299 -0.477 . . . . 63.43 113.534 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.47 94.51 3.33 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.414 -0.462 . . . . 71.31 110.906 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.14 108.15 5.19 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.543 0.687 . . . . 74.14 111.848 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -125.95 137.64 53.71 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.074 -0.512 . . . . 51.54 111.708 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.19 -41.63 70.04 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.098 -0.501 . . . . 62.32 110.51 172.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.6 -95.61 0.06 OUTLIER Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.923 -0.581 . . . . 61.34 113.188 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.3 p 51.16 15.85 0.32 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.873 0.869 . . . . 72.41 112.741 -176.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -124.19 30.62 6.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.315 0.579 . . . . 62.41 110.714 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -61.42 -0.83 0.43 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.873 0.694 . . . . 64.23 112.873 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -68.21 -20.7 64.86 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.984 0.421 . . . . 74.24 111.056 171.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.0 t -90.2 148.97 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.126 -0.488 . . . . 75.21 110.104 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.941 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.7 mp0 -79.73 72.85 6.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 119.553 -0.859 . . . . 61.54 110.633 178.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.404 ' HA ' HG12 ' A' ' 36' ' ' VAL . 60.6 mtp180 -87.57 131.76 34.29 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.741 -0.663 . . . . 73.2 111.528 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.32 -150.42 22.02 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.67 -0.776 . . . . 63.53 113.117 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.4 pt -110.45 146.15 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 122.349 -0.501 . . . . 65.21 111.397 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -40.36 -47.38 2.53 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.211 0.604 . . . . 71.13 112.18 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.441 HG13 ' HA3' ' A' ' 32' ' ' GLY . 61.9 mt -48.9 -53.84 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.757 -0.656 . . . . 70.13 112.333 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 m -83.22 -32.0 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 112.087 0.403 . . . . 74.14 112.087 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.75 -36.03 82.42 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.727 0.298 . . . . 73.12 111.367 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -81.42 -6.41 58.91 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.925 0.393 . . . . 75.04 111.324 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -124.48 8.21 8.35 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.952 0.352 . . . . 63.44 111.952 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.1 pttm 39.47 59.31 1.81 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.791 0.805 . . . . 60.02 112.699 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 84.9 mt -93.97 141.9 28.0 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.769 -0.65 . . . . 73.41 111.516 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 p -96.06 140.19 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 120.684 0.278 . . . . 75.04 111.267 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -89.57 148.25 23.48 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.533 0.682 . . . . 74.41 112.744 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.51 ' HG3' ' HB2' ' A' ' 138' ' ' PHE . 15.2 ptp -147.65 165.27 30.93 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.214 -0.903 . . . . 75.22 109.75 174.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.435 ' HA ' ' HD2' ' A' ' 138' ' ' PHE . 3.4 p30 -163.01 157.86 21.43 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.454 0.645 . . . . 73.01 112.259 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.402 ' HA ' ' HE2' ' A' ' 88' ' ' PHE . 64.3 m -37.53 -34.02 0.09 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 116.495 2.035 . . . . 72.5 116.495 -162.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -67.92 -31.98 72.12 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.433 -0.792 . . . . 71.13 112.348 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.87 -46.97 5.74 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.236 0.541 . . . . 73.55 111.913 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' A' ' 79' ' ' MET . 0.4 OUTLIER -95.2 12.89 27.25 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.494 0.924 . . . . 72.13 113.494 -173.001 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -41.06 -61.39 1.0 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.645 0.609 . . . . 64.13 112.645 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.5 m -65.45 -32.8 74.61 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.334 -0.394 . . . . 72.31 111.772 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 67.5 mtm -71.7 -52.62 16.91 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.06 0.392 . . . . 73.31 112.06 -175.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.503 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 16.5 p90 -71.96 -19.39 61.9 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.69 -0.631 . . . . 65.1 111.224 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -64.01 -44.21 93.29 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.08 0.467 . . . . 74.04 110.534 171.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.16 99.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.195 0.521 . . . . 73.05 110.455 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.468 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 44.0 t80 -54.6 -53.1 59.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.588 -0.733 . . . . 62.14 111.972 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.9 tp -67.66 -32.27 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 111.83 0.307 . . . . 72.15 111.83 -177.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' C ' ' HD3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -63.35 -53.25 55.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.665 0.269 . . . . 70.2 110.656 176.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -60.2 -49.48 77.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.934 0.397 . . . . 71.45 110.745 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.492 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 85.1 t80 -51.25 -58.09 7.09 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.082 -0.508 . . . . 61.31 111.916 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -54.57 -49.52 70.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.428 -0.351 . . . . 61.45 111.465 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -65.83 -48.51 71.42 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.605 -0.27 . . . . 73.42 111.7 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.49 -40.3 96.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.715 0.635 . . . . 62.23 112.715 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.7 m -67.95 -45.84 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 122.21 -0.306 . . . . 42.05 111.611 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.4 mm -67.55 -45.42 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.889 0.376 . . . . 73.31 111.131 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.51 -40.98 96.57 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.236 -0.438 . . . . 74.05 111.546 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -58.71 -47.02 86.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.942 0.401 . . . . 63.34 110.885 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.9 ttt -68.67 -45.68 71.08 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.164 0.507 . . . . 52.34 110.737 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -58.93 -37.38 76.55 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.281 -0.418 . . . . 74.43 111.729 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -54.37 -50.91 66.39 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.12 -0.491 . . . . 72.43 112.296 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -102.31 -36.92 8.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.791 0.663 . . . . 64.02 112.791 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -74.89 -56.02 5.19 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.965 -0.46 . . . . 45.44 111.659 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 66.65 -0.47 1.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.876 0.47 . . . . 63.42 112.19 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.547 ' O ' HG22 ' A' ' 113' ' ' VAL . 13.6 t70 -86.24 119.85 26.97 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.132 -0.355 . . . . 73.2 110.717 -177.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -65.64 -35.01 79.56 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.522 0.564 . . . . 74.04 112.522 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.93 -38.64 89.19 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.796 0.331 . . . . 71.14 111.435 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -72.73 -53.17 12.36 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.729 0.27 . . . . 74.34 111.729 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 109' ' ' ASP . 30.0 m -65.55 -21.73 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 112.098 0.407 . . . . 75.14 112.098 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -74.96 -42.35 57.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.965 0.412 . . . . 74.11 110.683 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.12 73.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.98 0.419 . . . . 41.22 110.986 176.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.18 -47.52 85.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.169 -0.468 . . . . 72.44 111.093 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -56.63 -40.87 76.16 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.53 -0.304 . . . . 75.42 110.915 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.5 tppt? -59.26 -40.33 85.67 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.604 0.24 . . . . 62.33 111.171 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.466 ' HB3' HD22 ' A' ' 26' ' ' LEU . 29.3 mmtp -61.73 -57.8 10.52 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.683 -0.235 . . . . 74.4 111.584 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.8 mm -59.95 -45.58 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.021 0.378 . . . . 73.24 112.021 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.447 ' O ' HG23 ' A' ' 125' ' ' VAL . 24.7 tm0? -61.62 -51.61 67.8 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.707 0.289 . . . . 60.42 110.942 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.79 -36.98 93.55 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.724 -0.751 . . . . 65.02 112.378 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -57.16 -53.75 54.58 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.862 0.465 . . . . 72.25 111.596 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.17 -42.44 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 112.189 0.44 . . . . 63.21 112.189 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 121' ' ' GLN . 69.9 t -55.92 -43.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.881 0.372 . . . . 74.31 111.396 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.5 t -72.03 -47.22 53.39 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.195 0.521 . . . . 73.43 111.569 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.497 HD21 HD13 ' A' ' 155' ' ' ILE . 31.5 tp -65.3 -28.06 69.05 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.126 -0.488 . . . . 70.41 111.914 -176.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.9 mt -84.54 2.56 40.63 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.133 0.419 . . . . 75.11 112.133 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.466 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -62.03 78.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.652 0.739 . . . . 53.12 110.977 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -60.08 -15.26 21.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.546 0.943 . . . . 61.31 113.546 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.19 -46.79 87.49 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 122.274 -0.266 . . . . 73.35 111.493 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -109.15 -39.24 5.32 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.836 0.351 . . . . 64.2 111.789 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.492 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 69.5 m-85 -63.62 -4.5 3.0 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.526 0.565 . . . . 65.05 112.526 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -44.35 -26.76 0.36 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 120.952 0.406 . . . . 73.15 111.841 168.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -83.54 20.34 1.4 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 112.79 0.663 . . . . 54.34 112.79 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 71.2 mt -88.51 132.06 34.66 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.925 -0.484 . . . . 75.32 111.318 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.28 123.21 48.44 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.134 -0.485 . . . . 73.3 110.734 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.653 ' HB3' HG13 ' A' ' 153' ' ' VAL . 53.6 m-85 -102.61 125.92 49.51 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.257 -0.277 . . . . 72.12 110.839 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.568 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 75.6 m-85 -121.61 142.14 50.41 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.05 0.389 . . . . 73.31 112.05 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 152' ' ' GLN . 34.4 pt -129.62 173.07 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.89 0.376 . . . . 75.14 111.09 174.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.48 153.88 50.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.274 -0.489 . . . . 72.31 114.01 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.52 -58.42 7.23 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.062 0.458 . . . . 75.44 112.045 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.609 ' HA ' ' HB3' ' A' ' 146' ' ' GLU . 30.3 mtm180 -73.09 -19.37 61.17 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.857 0.36 . . . . 64.33 111.284 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.67 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -61.03 -40.77 94.87 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.271 0.558 . . . . 71.33 110.467 170.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.1 -19.14 40.73 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.083 0.468 . . . . 60.32 111.374 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.609 ' HB3' ' HA ' ' A' ' 143' ' ' ARG . 42.6 tt0 -87.27 -24.26 24.41 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.252 0.464 . . . . 72.41 112.252 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.33 -46.52 0.02 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 120.472 -0.871 . . . . 72.2 114.336 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.67 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -71.0 86.58 0.72 Allowed 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.307 -0.526 . . . . 74.44 111.827 -177.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -61.34 -9.8 5.97 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.247 0.832 . . . . 73.23 113.247 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -93.38 27.21 2.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.809 0.338 . . . . 54.21 111.421 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.466 ' HA2' HG23 ' A' ' 9' ' ' THR . . . -60.44 115.83 8.29 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.469 -0.396 . . . . 62.42 113.698 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.414 ' O ' HG22 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -60.25 134.55 57.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.244 0.545 . . . . 74.01 111.272 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.653 HG13 ' HB3' ' A' ' 138' ' ' PHE . 63.0 t -83.0 109.92 17.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.154 -0.476 . . . . 75.53 111.707 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.719 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -81.06 119.03 23.02 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.04 -0.527 . . . . 53.05 110.197 171.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.497 HD13 HD21 ' A' ' 127' ' ' LEU . 61.5 mt -96.12 117.1 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 112.468 0.544 . . . . 62.31 112.468 -170.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 169' ' ' LEU . 48.2 mm -94.5 113.14 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.723 0.297 . . . . 60.21 111.219 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 158' ' ' TYR . 42.7 tt0 -105.75 157.33 17.51 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.973 0.416 . . . . 63.32 111.305 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.445 ' N ' ' HG2' ' A' ' 157' ' ' GLU . 23.1 p90 -92.51 105.24 17.45 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.967 0.413 . . . . 74.24 111.191 176.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.454 ' HD3' ' OG1' ' A' ' 168' ' ' THR . 54.9 mtp85 -127.44 132.33 50.07 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.966 0.412 . . . . 62.41 111.114 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.83 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 6.4 p-10 -88.25 143.08 27.24 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.768 0.655 . . . . 51.23 112.768 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.0 t -109.29 98.2 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.641 -0.708 . . . . 75.31 110.585 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.1 t70 61.59 7.08 1.72 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.543 0.737 . . . . 62.12 112.918 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.26 -27.72 1.54 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.533 -0.842 . . . . 55.11 114.065 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 84.3 m -104.27 114.49 28.76 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 117.252 0.526 . . . . 70.33 111.125 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.83 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 9.3 pt-20 -76.37 122.54 24.62 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.611 0.72 . . . . 51.54 112.098 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -127.14 149.85 70.63 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.471 -0.786 . . . . 53.34 111.639 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.95 120.72 7.92 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.785 2.323 . . . . 74.1 112.766 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.454 ' OG1' ' HD3' ' A' ' 159' ' ' ARG . 69.6 p -111.22 133.37 53.61 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.79 0.328 . . . . 65.21 111.756 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.719 HD11 ' HB1' ' A' ' 154' ' ' ALA . 68.9 tp -77.36 130.99 37.84 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.179 -0.464 . . . . 63.13 111.258 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.403 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 24.3 mmt -113.27 124.46 52.55 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.594 0.358 . . . . 71.24 111.445 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.99 134.82 38.97 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.076 -0.511 . . . . 73.33 110.864 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.506 HG22 HG12 ' A' ' 27' ' ' VAL . 25.7 t -93.13 126.35 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 122.099 -0.375 . . . . 75.31 111.425 -178.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -72.42 -14.88 61.8 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.831 0.678 . . . . 75.33 112.831 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.468 ' H ' HG12 ' A' ' 172' ' ' VAL . 1.3 mp0 -88.31 -2.4 58.58 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.137 -0.352 . . . . 74.42 111.716 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -97.5 -46.39 6.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.309 0.576 . . . . 73.43 110.428 174.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.7 pt -105.4 132.18 52.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.498 -0.774 . . . . 65.14 110.504 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.415 ' CG1' ' HB2' ' A' ' 5' ' ' LYS . 46.8 pt -94.85 143.47 11.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.2 0.524 . . . . 61.34 111.314 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -94.25 118.24 31.3 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.612 -0.722 . . . . 71.21 111.331 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -122.97 113.99 19.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.359 0.6 . . . . 73.32 110.897 172.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -112.55 123.01 49.34 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.734 -0.666 . . . . 54.41 112.106 -175.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.427 ' C ' HD12 ' A' ' 182' ' ' LEU . 51.8 t -121.93 87.82 2.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.265 0.555 . . . . 64.15 109.997 169.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.427 HD12 ' C ' ' A' ' 181' ' ' CYS . 5.8 mp -136.04 135.98 39.87 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.706 -0.679 . . . . 72.2 110.411 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 C--O 1.254 1.326 0 CA-C-O 118.916 -0.564 . . . . 63.14 111.134 177.013 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 120.935 0.398 . . . . 73.25 111.643 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 178' ' ' GLU . 42.2 tp -92.34 139.0 31.05 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.521 -0.309 . . . . 75.3 110.943 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.0 mt -125.91 119.21 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 122.384 -0.197 . . . . 74.34 110.473 175.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.716 ' HE1' ' HB2' ' A' ' 16' ' ' ASP . 39.6 p90 -121.81 149.8 42.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.47 0.545 . . . . 72.33 112.47 -173.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.567 ' HB3' HD13 ' A' ' 13' ' ' LEU . 12.4 ptmm? -142.92 127.22 17.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.939 -0.573 . . . . 72.23 111.303 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.85 ' HB3' HG22 ' A' ' 176' ' ' ILE . 2.7 p30 -97.29 179.29 4.94 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.206 0.527 . . . . 74.41 111.63 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -47.12 -34.8 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 115.51 -0.768 . . . . 52.04 112.716 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.582 ' HB2' ' HA2' ' A' ' 151' ' ' GLY . 83.2 m-85 -100.27 -49.61 4.21 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.603 0.594 . . . . 71.21 112.603 -175.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 p -70.33 14.97 0.1 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.028 0.751 . . . . 52.51 113.028 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -47.89 -32.24 6.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.207 0.603 . . . . 53.24 111.933 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.67 -61.96 1.57 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.641 0.608 . . . . 73.51 112.641 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.417 ' C ' HD23 ' A' ' 13' ' ' LEU . 43.1 mt-10 -102.43 -33.16 9.64 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.801 0.667 . . . . 65.21 112.801 -174.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.567 HD13 ' HB3' ' A' ' 5' ' ' LYS . 0.8 OUTLIER 40.42 -170.75 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.21 1.189 . . . . 75.25 114.21 -176.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -149.44 165.65 31.46 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.474 0.654 . . . . 62.5 112.655 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -114.2 170.16 8.49 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.699 -0.682 . . . . 74.42 111.082 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.716 ' HB2' ' HE1' ' A' ' 4' ' ' TYR . 6.5 t70 -154.28 169.15 24.35 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 120.878 0.371 . . . . 71.31 111.486 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.2 p -151.7 19.44 0.71 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.027 0.38 . . . . 54.33 112.027 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -108.65 151.07 41.51 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 121.037 0.446 . . . . 52.21 112.194 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.4 111.99 3.27 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.601 2.2 . . . . 62.42 113.595 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.648 ' SD ' ' HB2' ' A' ' 30' ' ' PHE . 18.5 mmt -106.31 166.27 10.65 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.009 -0.541 . . . . 53.34 110.876 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.523 ' NZ ' ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -134.22 129.05 35.14 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.187 -0.321 . . . . 74.5 111.221 172.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 61.4 tp -87.87 101.96 14.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.766 0.317 . . . . 74.11 111.284 -177.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 p -89.19 139.06 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-O 120.909 0.385 . . . . 73.32 111.58 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.2 15.99 2.11 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.139 -0.482 . . . . 72.22 112.264 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.462 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 52.8 m-20 52.77 26.75 4.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.847 0.459 . . . . 45.13 111.646 -177.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.17 -45.68 2.34 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.103 0.478 . . . . 75.41 111.156 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.404 HG12 HG22 ' A' ' 172' ' ' VAL . 30.3 m -133.68 146.06 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.295 0.569 . . . . 75.13 112.51 -177.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 170' ' ' MET . 96.9 m-85 -87.34 144.91 26.55 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.937 -0.574 . . . . 73.33 110.368 172.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 40.7 mt-10 -118.28 143.57 46.48 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.748 0.308 . . . . 73.33 110.85 170.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.705 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 85.6 t80 -133.03 118.44 18.81 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.806 0.336 . . . . 75.22 111.175 175.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.416 ' NZ ' ' HB2' ' A' ' 31' ' ' LYS . 9.8 mtmp? -84.02 109.33 17.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.793 0.33 . . . . 75.54 111.715 -177.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.531 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -90.76 176.6 41.28 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.14 -0.553 . . . . 72.31 113.851 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.514 ' HG3' HG13 ' A' ' 35' ' ' VAL . 10.8 ptpp? -118.46 163.2 17.11 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.725 -0.279 . . . . 63.4 111.123 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -86.53 111.93 21.06 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.522 0.201 . . . . 53.35 110.904 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.514 HG13 ' HG3' ' A' ' 33' ' ' LYS . 17.3 m -139.65 159.31 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.142 0.496 . . . . 54.15 111.728 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.757 HG22 HD21 ' A' ' 44' ' ' LEU . 33.2 m -138.04 122.11 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.354 -0.385 . . . . 70.32 111.407 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.838 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 78.8 mtt180 -88.28 107.98 19.09 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.49 0.662 . . . . 65.23 111.259 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 41.7 mtmt -131.68 165.22 24.19 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.566 -1.197 . . . . 75.35 110.164 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -46.79 84.8 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.304 0.574 . . . . 65.55 112.051 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 38' ' ' LYS . . . 93.47 11.08 58.66 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.941 -0.572 . . . . 61.31 114.156 176.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 40.3 mt-10 -132.85 142.93 49.2 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.374 -0.486 . . . . 70.43 111.351 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.7 HG23 ' H ' ' A' ' 43' ' ' VAL . 2.1 tp -148.5 -76.09 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 112.033 0.383 . . . . 61.21 112.033 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.7 ' H ' HG23 ' A' ' 42' ' ' ILE . 12.5 m -88.37 94.88 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.627 0.727 . . . . 70.43 111.154 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.757 HD21 HG22 ' A' ' 36' ' ' VAL . 1.2 mm? -54.59 113.5 1.32 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.561 -0.745 . . . . 73.33 112.53 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.78 -54.38 2.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.113 -0.494 . . . . 53.02 110.242 173.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.88 -13.83 42.0 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.003 -0.544 . . . . 65.13 112.812 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.541 ' HB2' HD12 ' A' ' 44' ' ' LEU . 38.9 m -101.83 175.81 5.42 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.828 0.347 . . . . 72.32 111.058 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -122.83 149.24 55.85 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.475 -0.33 . . . . 62.31 110.719 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.86 130.75 41.55 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.399 2.066 . . . . 62.21 112.644 176.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 63.8 p -64.61 129.13 38.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.865 0.364 . . . . 72.12 111.816 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.38 -93.59 0.5 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.521 -0.308 . . . . 74.42 110.827 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 46.39 30.57 1.08 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.417 0.627 . . . . 71.21 112.111 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.74 90.28 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.501 -0.772 . . . . 71.14 111.736 -174.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.13 33.79 53.49 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.175 -0.536 . . . . 53.22 113.028 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.14 58.87 5.28 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 122.5 -0.412 . . . . 72.12 111.313 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 70.53 -60.87 0.48 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.513 0.725 . . . . 74.2 111.686 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.82 105.25 0.11 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.022 0.439 . . . . 73.51 111.64 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -104.2 6.66 35.74 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.209 -0.451 . . . . 72.4 111.457 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.1 65.23 0.55 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.322 -0.466 . . . . 51.0 113.281 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.1 p -151.23 125.82 9.56 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.545 -0.385 . . . . 54.55 111.484 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 50.03 33.26 6.63 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.789 0.663 . . . . 71.04 112.789 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -62.53 -39.03 92.28 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.068 0.461 . . . . 75.52 112.011 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -95.83 36.38 1.3 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.034 0.445 . . . . 74.04 111.914 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 37' ' ' ARG . 40.5 t -97.34 139.99 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.021 -0.536 . . . . 75.42 110.95 175.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.838 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 7.1 mp0 -85.95 64.82 8.8 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.52 0.676 . . . . 72.13 110.743 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.505 ' O ' ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -96.62 135.27 38.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.552 -0.749 . . . . 73.5 111.631 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.58 -125.68 1.5 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.536 -0.84 . . . . 54.44 113.866 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.7 pt -110.61 131.33 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.404 0.621 . . . . 64.14 112.487 -174.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -50.11 -35.22 24.74 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.413 -0.812 . . . . 52.34 112.598 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.531 HG13 ' HA3' ' A' ' 32' ' ' GLY . 66.3 mt -47.28 -50.2 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.18 0.437 . . . . 74.01 112.18 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 17.3 m -90.61 -32.63 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.11 0.411 . . . . 74.42 112.11 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.47 HD12 HG23 ' A' ' 35' ' ' VAL . 80.3 mt -65.76 -37.44 86.35 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.031 0.443 . . . . 73.01 111.415 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -87.49 -1.73 58.13 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 120.715 0.293 . . . . 74.22 111.611 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -123.65 4.1 8.91 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.838 -0.539 . . . . 73.33 112.158 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp 56.06 67.32 1.02 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.41 0.624 . . . . 65.4 112.335 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 68.1 mt -116.79 136.5 52.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.124 -0.489 . . . . 62.23 111.071 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.28 145.05 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.932 0.396 . . . . 55.45 111.372 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -80.37 122.19 26.63 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.977 0.732 . . . . 64.52 112.977 -173.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 94.4 mmm -125.62 155.69 40.36 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.961 -0.563 . . . . 60.44 109.95 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.414 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 47.6 t-20 -139.41 145.75 39.29 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.841 -0.537 . . . . 74.13 111.4 -176.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.6 p -46.83 -43.13 18.26 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.95 1.093 . . . . 71.31 113.95 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.414 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 38.7 p90 -56.3 -31.44 63.67 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.354 0.502 . . . . 53.42 112.354 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -104.83 -47.25 4.09 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.043 0.449 . . . . 74.11 110.927 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.36 3.26 16.11 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.453 0.538 . . . . 64.54 112.453 -172.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.521 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -40.66 -57.68 1.82 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.297 0.851 . . . . 54.02 113.297 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.5 t -65.01 -33.1 75.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.178 0.436 . . . . 44.42 112.178 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.9 tpt -66.66 -61.79 1.79 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.416 -0.356 . . . . 75.32 111.791 -174.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.694 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 29.7 p90 -65.48 -30.06 70.8 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.08 -0.387 . . . . 75.02 111.308 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -58.48 -43.34 88.92 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.289 0.566 . . . . 75.21 110.719 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.23 -34.15 77.37 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.987 -0.551 . . . . 73.21 111.274 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.694 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 25.4 m-85 -60.92 -44.07 97.7 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.598 0.237 . . . . 71.2 110.745 173.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.3 mm -55.44 -40.2 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.569 -0.287 . . . . 75.12 111.133 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -55.6 -63.97 1.0 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.774 0.321 . . . . 72.43 111.509 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.91 -31.06 72.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.479 -0.328 . . . . 63.41 111.875 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.508 ' CE1' ' HB2' ' A' ' 175' ' ' ALA . 36.9 t80 -62.53 -58.8 6.27 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.664 0.268 . . . . 72.03 111.322 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 56.5 ttp -59.47 -41.91 90.82 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.95 0.405 . . . . 62.11 110.836 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -55.58 -48.12 75.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.059 -0.519 . . . . 74.4 111.262 177.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -66.61 -54.6 21.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.088 -0.505 . . . . 70.31 112.003 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.4 m -59.8 -38.39 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.162 0.43 . . . . 61.34 112.162 -176.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.53 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 46.4 mm -70.51 -46.77 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 122.207 -0.308 . . . . 72.41 110.971 176.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.8 -24.27 61.63 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.976 0.417 . . . . 63.11 111.859 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -89.34 -29.82 18.86 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.455 -0.339 . . . . 72.1 111.763 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 11.9 tpt -81.11 -53.98 5.93 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.732 0.642 . . . . 71.23 112.732 -172.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -71.05 -10.59 60.02 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.05 0.759 . . . . 71.13 113.05 -174.24 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.66 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -60.72 -48.14 83.13 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.152 0.501 . . . . 64.43 111.042 172.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -107.55 -36.72 6.38 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.841 0.682 . . . . 73.21 112.841 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.524 ' O ' HG13 ' A' ' 113' ' ' VAL . 3.0 m-20 -112.24 41.15 2.04 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.966 0.412 . . . . 55.12 111.893 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -45.05 -30.46 1.07 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.813 0.845 . . . . 64.03 112.966 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -51.76 140.45 19.16 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.618 0.723 . . . . 73.23 112.66 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 54.2 mttp -65.87 -19.92 66.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.742 1.016 . . . . 64.34 113.742 -169.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.04 -20.96 47.63 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.689 -0.632 . . . . 74.11 111.465 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -94.37 -65.43 0.99 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.884 0.328 . . . . 73.51 111.884 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 107' ' ' ASN . 5.1 m -59.55 -45.6 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 112.921 0.712 . . . . 52.14 112.921 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.516 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 26.2 t70 -60.81 -43.81 97.71 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.634 0.255 . . . . 74.55 111.248 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.41 -49.35 74.1 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.858 0.361 . . . . 74.31 111.277 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -56.43 -54.33 46.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.978 0.418 . . . . 71.1 111.332 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.407 ' HA ' HG22 ' A' ' 120' ' ' ILE . 62.2 tttm -61.73 -31.13 71.28 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.435 -0.348 . . . . 42.52 111.237 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -65.76 -43.34 89.2 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.782 0.325 . . . . 54.42 111.237 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -57.5 -58.13 9.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.048 0.452 . . . . 74.05 111.166 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.407 HG22 ' HA ' ' A' ' 117' ' ' LYS . 11.1 tp -64.37 -40.42 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.018 -0.537 . . . . 75.13 112.066 -175.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.62 ' HA ' HE21 ' A' ' 121' ' ' GLN . 0.0 OUTLIER -66.25 -50.73 62.75 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.315 -0.241 . . . . 65.43 111.412 178.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.1 -42.26 61.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.586 -0.816 . . . . 64.23 112.199 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -62.81 -61.9 2.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.332 0.253 . . . . 75.13 111.253 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.5 m -61.26 -44.93 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 112.604 0.594 . . . . 61.14 112.604 -176.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.74 -34.58 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.972 0.415 . . . . 74.1 111.525 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.1 m -80.02 -29.11 39.32 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.031 0.443 . . . . 65.14 111.273 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.9 tp -80.03 -28.82 39.27 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.148 -0.478 . . . . 72.34 111.684 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 93.6 mt -85.14 2.27 44.3 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.598 0.592 . . . . 74.14 112.598 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.21 82.06 0.08 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.231 0.539 . . . . 55.0 110.917 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 65.5 pttt -64.08 -14.99 58.53 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.568 0.951 . . . . 73.4 113.568 -169.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.33 -42.38 98.58 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.138 0.494 . . . . 73.14 110.887 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -108.57 -50.78 2.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.992 -0.549 . . . . 72.33 111.393 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.531 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 55.3 m-85 -66.74 -4.5 9.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.592 0.96 . . . . 72.43 113.592 -173.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 14.1 ptmm? -50.99 -6.6 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.242 0.83 . . . . 72.21 113.242 175.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -77.46 13.28 1.27 Allowed 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.759 -0.588 . . . . 65.21 112.024 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 95.6 mt -89.54 127.92 35.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.014 0.435 . . . . 64.54 111.607 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -100.52 127.59 46.84 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.401 -0.363 . . . . 55.15 110.934 177.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -98.99 110.62 23.2 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.838 0.352 . . . . 73.24 110.976 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.429 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 65.4 m-85 -112.75 139.98 47.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.205 0.526 . . . . 71.11 111.797 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.42 HD11 ' O ' ' A' ' 150' ' ' ASN . 11.2 tt -133.26 155.16 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.821 -0.627 . . . . 74.4 110.96 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.34 125.35 13.03 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.567 -0.349 . . . . 62.02 113.553 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -49.91 -48.8 51.43 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.201 0.445 . . . . 64.44 112.201 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -79.7 -22.11 43.81 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.97 0.414 . . . . 71.14 111.865 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.32 93.36 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.957 0.408 . . . . 73.15 111.296 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.7 -30.93 65.9 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.992 -0.549 . . . . 64.22 111.919 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.81 -28.49 65.76 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.633 0.254 . . . . 74.01 111.668 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.83 -20.53 1.62 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.976 -0.631 . . . . 33.33 113.702 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.84 76.85 0.46 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 117.132 0.466 . . . . 62.05 111.951 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 54.38 103.68 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.72 0.772 . . . . 74.03 112.229 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.577 ' HB3' ' OH ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -54.48 -27.56 38.62 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.282 -0.872 . . . . 74.43 112.604 -173.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 8' ' ' PHE . . . 59.5 -166.21 9.39 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 114.821 0.689 . . . . 55.24 114.821 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -96.44 144.01 26.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.786 0.327 . . . . 60.13 111.387 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 44.8 t -77.99 138.01 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.912 0.387 . . . . 70.13 110.748 171.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.611 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -94.54 133.62 37.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.424 -0.353 . . . . 63.34 111.505 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.761 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 35.4 mm -91.98 113.54 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.751 0.31 . . . . 73.1 111.653 -178.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 49.8 mm -96.45 110.04 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.682 0.277 . . . . 63.43 111.084 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.61 132.93 50.28 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.402 -0.363 . . . . 73.2 110.271 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -90.09 89.13 7.55 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.459 0.647 . . . . 74.34 110.624 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -93.53 111.82 23.57 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.612 -0.722 . . . . 75.24 111.816 -172.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.621 ' HA ' ' HA ' ' A' ' 165' ' ' GLU . 32.4 t70 -69.91 118.76 13.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.041 0.448 . . . . 54.24 112.048 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 51.9 t -104.37 93.25 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.092 -0.503 . . . . 75.41 110.681 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 60.13 13.78 4.06 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.015 0.746 . . . . 74.41 113.015 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 133.42 -17.94 4.45 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.824 -0.703 . . . . 72.44 113.351 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.3 m -110.12 106.1 15.44 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.548 -0.384 . . . . 62.11 111.453 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 160' ' ' ASP . 42.7 mt-10 -73.38 106.32 5.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.75 0.31 . . . . 74.41 111.181 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.7 m -105.18 143.23 26.33 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 120.888 0.375 . . . . 71.04 111.356 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.66 123.58 5.39 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.339 2.026 . . . . 72.54 112.682 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 60.0 p -108.29 125.67 51.95 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.174 0.511 . . . . 74.25 111.129 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.705 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 61.5 tp -78.26 114.69 17.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.023 -0.535 . . . . 72.54 111.121 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.761 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 42.5 ttm -101.82 124.25 47.14 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.464 0.306 . . . . 63.31 111.584 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 81.0 mt -138.33 130.71 28.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.794 0.438 . . . . 62.22 111.353 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.441 ' O ' HG12 ' A' ' 176' ' ' ILE . 39.3 t -82.41 126.83 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 122.012 -0.43 . . . . 72.12 111.853 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -71.21 -33.95 70.38 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.985 0.421 . . . . 72.2 111.845 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.438 ' HG2' HG12 ' A' ' 172' ' ' VAL . 0.8 OUTLIER -72.81 -4.46 31.78 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.896 0.379 . . . . 72.32 111.343 177.254 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.508 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . . . -101.17 -49.5 4.07 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.15 0.5 . . . . 51.01 110.609 173.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.85 HG22 ' HB3' ' A' ' 6' ' ' ASP . 36.0 pt -101.21 117.45 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.022 -0.536 . . . . 75.13 111.049 176.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 tp -93.57 128.08 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 121.903 -0.498 . . . . 64.11 109.916 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.666 ' HB2' HD11 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -110.43 131.8 54.74 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.863 0.84 . . . . 74.13 113.115 -171.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -94.68 103.48 15.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.819 -1.082 . . . . 63.32 109.309 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -94.0 96.76 9.89 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.368 0.877 . . . . 71.1 113.368 -169.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 86.4 m -115.83 89.83 3.2 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.446 -0.797 . . . . 74.43 109.162 169.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.4 mt -120.91 -84.45 0.66 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.768 0.655 . . . . 52.01 112.768 -170.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 118.488 -0.768 . . . . 73.41 111.999 -171.888 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 181' ' ' CYS . 25.7 ptt? . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 120.623 0.249 . . . . 73.4 111.129 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 15' ' ' SER . 29.1 tp -107.14 129.05 54.89 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.903 -0.498 . . . . 64.31 110.721 177.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.512 HG12 ' HB3' ' A' ' 15' ' ' SER . 60.0 mt -110.38 126.26 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.77 0.319 . . . . 71.4 111.124 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -123.38 145.74 48.52 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.933 0.397 . . . . 75.1 111.557 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 3.9 ptpp? -129.36 130.38 45.98 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.088 0.47 . . . . 71.31 111.652 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 4.0 m-20 -73.02 178.09 4.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.905 -0.588 . . . . 75.22 112.258 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.8 mt -66.56 -41.72 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.122 0.487 . . . . 45.05 111.24 173.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 150' ' ' ASN . 37.9 m-85 -106.28 -32.64 8.09 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.153 -0.476 . . . . 74.4 112.001 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.419 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 2.9 m -93.48 15.0 16.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.278 0.561 . . . . 75.5 111.566 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 13.4 p-10 -60.26 -26.03 66.15 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.08 0.77 . . . . 72.34 113.08 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -68.3 -18.59 64.56 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.858 0.688 . . . . 52.13 112.858 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -85.66 -33.08 21.66 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.646 0.609 . . . . 75.42 112.646 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 56.29 98.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.218 0.532 . . . . 73.21 112.398 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.4 m -95.66 124.63 39.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.157 -0.339 . . . . 55.13 110.73 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.512 ' HB3' HG12 ' A' ' 3' ' ' ILE . 15.3 p -118.69 103.86 10.07 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.074 0.464 . . . . 53.45 112.1 -174.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -132.41 -172.57 2.93 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.035 0.445 . . . . 51.51 111.909 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.1 p -138.42 18.07 2.74 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.413 -0.358 . . . . 71.5 111.809 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -69.11 140.29 90.77 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 111.748 0.277 . . . . 74.42 111.748 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.12 143.25 35.58 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.841 2.361 . . . . 53.4 113.43 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptp -147.35 137.73 23.3 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.992 0.425 . . . . 64.14 111.996 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 67.1 mttm -112.28 156.38 22.49 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.553 -0.294 . . . . 72.0 110.564 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 55.4 tp -121.25 104.5 9.78 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.219 0.451 . . . . 73.54 112.219 -171.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.69 144.92 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-O 121.038 0.447 . . . . 72.41 111.737 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 56.67 12.67 1.17 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.168 -0.469 . . . . 64.23 111.888 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.488 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 62.8 m-20 50.7 29.7 4.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.365 0.602 . . . . 72.14 111.307 -174.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.577 HD22 ' HB3' ' A' ' 119' ' ' LYS . 53.9 tp -126.27 -48.68 1.57 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.899 -0.591 . . . . 75.22 111.41 -177.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 172' ' ' VAL . 10.1 m -128.56 144.86 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.232 -0.44 . . . . 73.13 111.735 -177.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 170' ' ' MET . 98.3 m-85 -85.55 141.09 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 65.42 110.375 176.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 2.8 pm0 -130.97 111.54 12.14 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.389 0.614 . . . . 73.13 111.058 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CZ ' HD23 ' A' ' 169' ' ' LEU . 32.4 p90 -150.46 141.19 22.7 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.977 1.103 . . . . 75.11 113.977 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -94.5 133.64 37.9 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.341 -0.845 . . . . 73.12 111.547 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.63 -167.77 42.44 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.852 -0.69 . . . . 72.21 113.25 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.504 ' HG3' HG13 ' A' ' 35' ' ' VAL . 57.3 tptt -91.74 128.13 37.45 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 122.478 -0.425 . . . . 74.11 110.424 177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -73.62 106.22 5.29 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.06 0.457 . . . . 73.1 110.996 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.582 ' HB ' HD11 ' A' ' 42' ' ' ILE . 27.2 m -137.28 155.22 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.116 -0.493 . . . . 73.43 111.007 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.64 HG22 ' HA ' ' A' ' 44' ' ' LEU . 31.4 m -122.54 119.15 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.43 0.633 . . . . 72.13 111.392 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.492 ' HD3' ' OE2' ' A' ' 65' ' ' GLU . 43.0 ttt180 -102.09 132.96 47.65 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.059 0.457 . . . . 73.04 111.785 -173.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.474 ' HG2' ' N ' ' A' ' 39' ' ' GLU . 13.5 ttmt -120.48 160.38 23.26 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.313 -0.403 . . . . 73.35 110.995 -178.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.474 ' N ' ' HG2' ' A' ' 38' ' ' LYS . 12.4 tp10 -64.25 83.02 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.629 0.728 . . . . 73.23 110.386 174.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.46 -63.48 0.38 Allowed Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.218 -0.901 . . . . 62.51 112.372 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.55 178.97 8.17 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.296 0.569 . . . . 75.2 112.128 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.582 HD11 ' HB ' ' A' ' 35' ' ' VAL . 8.0 tp -84.91 93.46 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-O 121.883 0.849 . . . . 50.33 110.654 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 43' ' ' VAL . 11.6 p -82.98 36.49 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 N-CA-C 112.622 0.601 . . . . 70.15 112.622 -171.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.64 ' HA ' HG22 ' A' ' 36' ' ' VAL . 2.1 pp -58.63 141.97 50.84 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.627 -0.671 . . . . 72.32 112.086 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.28 175.77 11.13 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.352 -0.385 . . . . 72.52 111.851 -175.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.97 139.31 14.49 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.367 -0.444 . . . . 24.41 113.4 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 64.6 m -156.05 141.13 17.36 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.591 -0.358 . . . . 71.33 111.191 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -70.22 137.43 86.76 Favored Pre-proline 0 N--CA 1.469 0.52 0 O-C-N 122.341 -0.225 . . . . 71.35 111.169 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.45 92.64 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.167 1.911 . . . . 63.42 111.727 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.0 m -62.17 90.08 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.169 0.509 . . . . 65.15 111.948 -176.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.23 -58.59 2.48 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.897 -0.592 . . . . 72.41 110.821 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -71.66 -33.59 68.99 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.196 0.522 . . . . 75.03 110.856 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.802 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 18.3 mp0 -81.51 54.7 2.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.071 -0.513 . . . . 75.35 111.757 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.53 -32.18 80.31 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.031 -0.604 . . . . 74.41 113.843 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -106.13 29.53 6.67 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.466 -0.432 . . . . 72.13 112.077 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.802 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 21.1 tp10 -79.45 60.78 3.3 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.13 0.49 . . . . 73.44 112.057 -175.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 56.98 13.18 1.42 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.747 1.018 . . . . 74.21 113.747 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -82.97 74.05 9.95 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.455 0.645 . . . . 74.24 109.591 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.14 19.96 36.53 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.43 -0.804 . . . . 33.45 113.55 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.6 m 58.92 15.66 4.06 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 112.816 0.673 . . . . 71.23 112.816 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.46 -30.72 71.12 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.144 0.497 . . . . 65.32 110.928 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.75 ' HG3' HG23 ' A' ' 64' ' ' VAL . 10.7 tp10 -82.89 88.28 6.81 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.882 -0.784 . . . . 73.33 108.882 175.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -75.64 64.9 1.75 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.515 0.674 . . . . 74.13 112.54 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.75 HG23 ' HG3' ' A' ' 62' ' ' GLU . 26.7 t -91.66 149.89 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 CA-C-N 115.556 -0.747 . . . . 72.35 110.352 174.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.633 ' HG2' HD22 ' A' ' 72' ' ' LEU . 28.5 tt0 -75.25 69.65 2.11 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.801 0.81 . . . . 72.15 110.16 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -87.44 138.3 31.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.225 -0.898 . . . . 74.23 111.38 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.84 -146.24 9.25 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.447 -0.882 . . . . 62.21 113.612 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.6 pt -110.61 145.04 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.795 0.331 . . . . 72.32 111.763 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 14.9 t70 -41.03 -43.88 2.27 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.625 0.77 . . . . 72.15 112.308 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.9 mt -49.94 -56.29 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.724 0.639 . . . . 73.44 112.724 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.487 ' HA ' HD12 ' A' ' 76' ' ' LEU . 30.1 m -80.23 -35.05 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.394 0.516 . . . . 74.33 112.394 -172.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.633 HD22 ' HG2' ' A' ' 65' ' ' GLU . 85.5 mt -67.53 -46.39 72.96 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.715 0.293 . . . . 72.03 111.657 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -69.25 -21.75 63.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.412 0.523 . . . . 64.53 112.412 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -103.77 8.28 37.2 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 122.129 -0.357 . . . . 74.15 111.243 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.9 tptm 46.49 69.74 0.45 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.698 0.761 . . . . 64.24 112.501 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 71' ' ' VAL . 82.0 mt -106.38 122.03 45.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.644 -0.707 . . . . 64.14 110.343 177.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 p -82.65 141.41 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.09 0.472 . . . . 74.32 111.419 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -79.54 141.41 36.67 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.762 -0.654 . . . . 62.21 112.41 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.424 ' HG3' ' HB2' ' A' ' 84' ' ' ASP . 41.8 tpp -143.55 149.29 37.21 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.923 -0.58 . . . . 63.24 109.903 174.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -130.9 163.69 26.92 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.77 0.655 . . . . 71.21 112.77 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 67.9 m -38.07 -56.46 1.16 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.581 1.326 . . . . 71.14 114.581 -171.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -60.3 -29.76 69.04 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.424 0.898 . . . . 73.34 113.424 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -103.59 -21.34 13.76 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.949 -0.469 . . . . 73.23 111.655 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.424 ' HB2' ' HG3' ' A' ' 79' ' ' MET . 12.5 t70 -77.64 1.15 20.64 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.148 0.425 . . . . 71.23 112.148 -175.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.472 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . . . -39.8 -59.21 1.21 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.444 0.535 . . . . 42.25 112.444 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.7 t -53.23 -39.45 63.78 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.098 -0.501 . . . . 62.14 111.986 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.435 ' O ' ' HD1' ' A' ' 91' ' ' TYR . 25.9 mmt -73.22 -73.88 0.19 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.297 0.48 . . . . 71.41 112.297 -174.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 85' ' ' ALA . 33.4 p90 -55.72 -29.6 59.75 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.406 0.521 . . . . 75.12 112.406 -173.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.427 ' O ' HG22 ' A' ' 92' ' ' ILE . 32.8 mmtp -68.64 -60.49 2.37 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.928 0.394 . . . . 74.22 111.795 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.54 -43.21 99.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.159 0.504 . . . . 54.02 111.972 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.435 ' HD1' ' O ' ' A' ' 87' ' ' MET . 49.5 m-85 -69.74 -37.61 76.52 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.935 0.717 . . . . 73.42 112.935 -176.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 89' ' ' LYS . 11.0 tp -67.03 -33.37 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.304 0.573 . . . . 74.52 110.506 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -66.8 -45.81 77.2 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.914 -0.585 . . . . 71.23 110.975 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -61.7 -39.74 92.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.202 0.525 . . . . 65.54 110.684 172.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.469 ' HE1' ' HB2' ' A' ' 175' ' ' ALA . 89.2 t80 -60.26 -57.89 10.84 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.651 -0.704 . . . . 75.24 111.866 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.1 ptm -54.09 -39.43 66.32 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.842 0.354 . . . . 63.52 111.195 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -64.32 -49.98 69.61 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.66 -0.245 . . . . 71.34 111.574 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -61.43 -46.25 90.92 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.172 0.434 . . . . 64.21 112.172 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.3 m -66.81 -43.06 89.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.221 0.452 . . . . 75.44 112.221 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.9 mm -69.38 -38.17 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 120.735 0.302 . . . . 74.1 110.727 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.24 -54.17 40.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.019 0.437 . . . . 65.23 110.915 175.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -68.88 -53.04 23.43 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.22 0.452 . . . . 70.45 112.22 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.7 tpt -65.14 -56.89 10.3 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.254 0.465 . . . . 72.11 112.254 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.8 -43.03 99.88 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.057 0.392 . . . . 72.13 112.057 -174.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -48.97 -45.17 41.65 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.209 0.818 . . . . 74.12 113.209 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.56 18.05 20.12 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.061 0.458 . . . . 72.3 112.095 -176.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.465 ' OD1' HG13 ' A' ' 113' ' ' VAL . 3.1 t-20 -127.61 -65.51 0.92 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.372 -0.377 . . . . 64.2 110.774 176.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 70.01 -25.4 0.15 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.694 0.998 . . . . 74.13 113.694 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' HG22 ' A' ' 113' ' ' VAL . 42.0 m-20 -66.14 112.99 4.19 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.932 0.396 . . . . 75.12 111.584 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -56.05 -32.18 63.82 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.178 0.436 . . . . 71.23 112.178 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.01 -33.96 65.38 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.072 0.397 . . . . 63.24 112.072 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.445 ' HB2' ' OD1' ' A' ' 107' ' ' ASN . 3.3 m-20 -94.05 -55.15 3.31 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.129 0.418 . . . . 75.31 112.129 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.465 HG13 ' OD1' ' A' ' 107' ' ' ASN . 17.0 m -62.79 -35.26 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.999 0.74 . . . . 72.22 112.999 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -75.39 -25.7 57.86 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.283 0.563 . . . . 74.04 110.452 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.05 -44.81 52.93 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.143 -0.48 . . . . 53.04 110.673 173.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.42 -46.28 90.59 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.21 0.529 . . . . 74.24 110.164 173.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -50.3 -42.1 51.99 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.667 -0.697 . . . . 73.22 111.065 171.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -64.33 -42.24 96.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.178 -0.464 . . . . 64.05 111.691 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.577 ' HB3' HD22 ' A' ' 26' ' ' LEU . 14.6 mptt -58.1 -55.18 38.31 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.8 0.333 . . . . 75.45 110.985 174.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.524 HD13 HD21 ' A' ' 26' ' ' LEU . 41.8 mm -59.51 -41.86 86.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.447 -0.342 . . . . 71.25 111.391 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -57.08 -57.08 14.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.512 -0.313 . . . . 74.14 111.13 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.12 -40.11 82.44 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.077 -0.582 . . . . 60.33 112.579 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -61.55 -51.6 67.92 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 111.631 0.234 . . . . 71.0 111.631 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.28 -41.25 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 112.573 0.583 . . . . 73.11 112.573 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.9 m -64.54 -26.0 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 121.936 -0.478 . . . . 71.43 111.37 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.6 t -84.89 -46.84 10.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.901 0.381 . . . . 72.53 110.883 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.5 tp -58.62 -39.21 79.82 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.983 0.513 . . . . 61.05 112.282 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.5 mt -81.6 2.6 28.57 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.226 0.454 . . . . 63.01 112.226 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.45 90.46 0.73 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.108 0.48 . . . . 75.21 111.169 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 23.7 pttm -52.19 -32.34 35.85 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.718 -0.674 . . . . 65.01 112.597 -177.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -65.59 -28.81 69.41 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.354 0.501 . . . . 73.21 112.354 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -108.03 -58.88 1.92 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.543 0.687 . . . . 74.3 111.302 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.552 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 29.7 m-85 -67.9 -3.27 9.26 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.365 0.876 . . . . 73.32 113.365 -172.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 36.9 ttmt -36.11 -32.48 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.886 0.699 . . . . 73.43 112.886 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -91.25 33.08 0.99 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.786 0.662 . . . . 74.52 112.786 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 56.6 mt -88.47 125.99 35.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.215 0.531 . . . . 65.45 111.529 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -101.25 112.84 25.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.042 -0.526 . . . . 62.42 110.532 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.632 ' HB3' HG11 ' A' ' 153' ' ' VAL . 93.1 m-85 -89.81 109.4 20.4 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.543 -0.298 . . . . 63.11 111.257 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.438 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 67.1 m-85 -99.77 124.48 45.08 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.161 0.505 . . . . 71.15 111.662 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.513 ' HB ' HG22 ' A' ' 153' ' ' VAL . 8.6 tt -121.36 146.82 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.08 -0.509 . . . . 73.3 111.134 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.42 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . -59.7 124.24 35.67 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.335 -0.46 . . . . 31.21 113.794 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -44.61 -51.1 9.36 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.53 0.567 . . . . 72.23 112.53 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -50.76 -36.42 36.55 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.902 0.705 . . . . 75.3 112.902 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -93.38 -34.57 13.41 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.848 0.356 . . . . 43.21 111.946 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.82 -19.56 51.57 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.524 0.565 . . . . 74.44 112.524 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -65.21 -18.56 65.41 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.865 0.364 . . . . 70.43 111.875 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.72 47.97 0.02 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.714 -0.755 . . . . 44.32 113.346 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.77 116.66 16.84 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.954 0.407 . . . . 72.24 111.614 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -74.5 23.15 0.09 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.258 0.466 . . . . 65.13 112.258 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 8' ' ' PHE . 37.6 m-80 -125.6 18.95 8.04 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.109 0.48 . . . . 65.22 111.001 177.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.2 91.95 1.63 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.079 -0.581 . . . . 75.45 112.46 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -58.96 119.46 7.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.285 0.564 . . . . 73.43 111.617 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 138' ' ' PHE . 91.9 t -87.68 142.16 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.823 0.675 . . . . 70.23 112.823 -175.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.897 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -101.78 133.21 46.89 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.641 -0.709 . . . . 74.32 110.442 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.4 mt -99.94 117.3 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 112.655 0.613 . . . . 71.12 112.655 -171.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 40.9 mm -100.94 123.33 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 111.76 0.282 . . . . 63.34 111.76 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -111.9 133.68 53.94 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.696 0.284 . . . . 74.13 111.046 173.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -84.68 95.57 8.95 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.332 0.586 . . . . 71.34 110.183 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.81 113.38 24.3 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.637 -0.711 . . . . 71.53 111.277 -173.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -74.18 118.24 16.91 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.468 -0.333 . . . . 73.33 110.49 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.52 91.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.781 0.324 . . . . 71.11 111.814 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 t70 52.72 38.54 26.57 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.641 0.608 . . . . 74.54 112.641 173.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 103.03 -5.72 50.42 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.145 -0.55 . . . . 41.33 113.772 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.519 HG22 HG13 ' A' ' 166' ' ' VAL . 61.0 m -110.21 122.19 47.06 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.349 -0.501 . . . . 71.11 110.925 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 165' ' ' GLU . 0.4 OUTLIER -92.69 100.38 12.89 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.285 0.564 . . . . 71.01 111.24 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.519 HG13 HG22 ' A' ' 164' ' ' THR . 19.0 m -108.07 113.27 60.97 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 112.361 0.504 . . . . 62.13 112.361 -177.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.12 113.8 3.87 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.089 1.859 . . . . 62.42 111.611 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.6 p -104.64 151.98 23.02 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.482 -0.326 . . . . 70.23 111.378 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.897 HD11 ' HB1' ' A' ' 154' ' ' ALA . 26.2 tp -102.3 122.95 45.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.54 -0.3 . . . . 74.44 110.857 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.581 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 63.0 mtt -101.81 124.25 47.13 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.599 0.562 . . . . 73.24 111.378 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.9 mt -138.2 130.58 29.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.492 -0.777 . . . . 54.3 110.609 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 174' ' ' GLU . 25.9 t -79.72 123.37 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 122.077 -0.389 . . . . 52.02 111.177 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.498 ' HB3' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -68.75 -11.07 59.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.642 0.608 . . . . 74.55 112.642 -175.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.492 ' H ' HG12 ' A' ' 172' ' ' VAL . 13.9 mm-40 -97.3 -8.3 30.05 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.073 0.463 . . . . 64.52 111.125 172.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.469 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -97.45 -14.37 21.2 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.291 0.567 . . . . 71.4 110.669 175.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 63.4 mt -134.77 128.59 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.469 -0.787 . . . . 61.2 109.806 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 43.5 mm -93.47 128.41 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.773 0.321 . . . . 74.11 111.392 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -84.94 114.44 22.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.245 -0.434 . . . . 73.2 110.949 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.44 112.72 23.46 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.706 0.765 . . . . 72.31 110.89 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.456 ' HB2' ' NZ ' ' A' ' 180' ' ' LYS . 4.9 ttmp? -85.49 112.13 20.63 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.657 -0.702 . . . . 64.41 112.095 -172.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 1' ' ' MET . 41.3 t -116.91 87.69 2.75 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.464 0.65 . . . . 60.21 112.222 178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.88 -165.03 0.95 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.51 -0.768 . . . . 63.54 110.256 175.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 183' ' ' GLU . 12.8 mp0 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.854 -0.594 . . . . 72.13 111.833 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.737 0.303 . . . . 73.41 111.761 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.41 160.01 14.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.457 0.303 . . . . 71.42 111.092 -176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 33.9 pt -130.58 138.8 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.976 -0.452 . . . . 73.24 112.037 177.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 14' ' ' SER . 49.7 p90 -122.55 138.24 54.63 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.231 0.539 . . . . 74.43 111.532 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.629 ' HG2' HD12 ' A' ' 13' ' ' LEU . 5.2 mtpm? -132.18 112.91 12.68 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.46 -0.791 . . . . 43.2 111.307 -176.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 176' ' ' ILE . 6.6 m-20 -73.46 155.31 39.39 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.041 -0.412 . . . . 74.22 111.495 173.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 pt -72.46 -24.93 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.967 0.413 . . . . 71.21 111.513 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.73 -41.76 4.92 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.537 0.569 . . . . 73.22 112.537 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m -88.69 15.13 8.66 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.304 0.573 . . . . 71.34 111.548 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.446 ' O ' HD22 ' A' ' 13' ' ' LEU . 34.2 t70 -49.05 -37.81 22.02 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.838 1.051 . . . . 75.35 113.838 -173.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.1 -37.13 81.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.703 0.631 . . . . 75.43 112.703 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -104.2 25.79 9.62 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.887 -0.508 . . . . 65.4 112.014 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.629 HD12 ' HG2' ' A' ' 5' ' ' LYS . 2.2 pt? -44.16 158.76 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.02 -0.536 . . . . 74.33 111.812 173.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 62.6 m -143.55 152.56 41.59 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.425 0.898 . . . . 74.34 113.425 -174.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 78.0 p -91.58 125.41 36.31 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.646 -0.707 . . . . 71.15 109.851 172.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -112.89 175.65 5.35 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.98 0.419 . . . . 73.24 111.708 -171.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.1 t -144.82 8.5 1.28 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.052 0.39 . . . . 51.34 112.052 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.433 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 78.9 m-85 -96.87 150.14 36.55 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 122.221 -0.299 . . . . 74.05 111.674 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -91.66 104.67 0.24 Allowed 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.842 2.361 . . . . 71.42 113.468 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.497 ' N ' ' SD ' ' A' ' 20' ' ' MET . 1.6 mpt? -85.9 162.11 18.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.963 0.411 . . . . 51.52 111.534 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -129.19 119.89 24.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.411 -0.359 . . . . 74.23 111.139 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 tp -74.79 114.37 13.15 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.207 0.527 . . . . 73.32 111.081 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.31 145.63 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.302 -0.408 . . . . 61.32 111.132 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.9 t70 62.79 8.51 3.1 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 120.987 0.422 . . . . 53.52 111.413 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 58.02 11.8 1.59 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.266 0.627 . . . . 74.14 111.598 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 120' ' ' ILE . 30.8 tp -117.51 -46.74 2.66 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.042 -0.526 . . . . 72.13 111.279 -172.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.96 149.22 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.69 0.626 . . . . 53.43 112.69 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.573 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 75.3 m-85 -86.45 123.89 32.17 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.143 -0.48 . . . . 71.2 111.006 175.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -99.86 138.25 37.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.062 -0.517 . . . . 73.41 110.642 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.523 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 46.4 t80 -137.79 122.7 18.93 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.19 0.519 . . . . 75.4 111.562 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -75.37 123.46 25.41 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.57 0.581 . . . . 74.52 112.57 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.15 142.74 15.72 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.197 -0.456 . . . . 71.52 112.873 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -91.7 145.32 24.68 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.707 -0.29 . . . . 72.31 111.185 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -66.72 105.42 1.55 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.302 . . . . 72.32 110.578 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.589 HG23 HD12 ' A' ' 72' ' ' LEU . 10.8 m -146.82 158.84 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.33 0.585 . . . . 71.51 111.419 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.485 HG22 HD21 ' A' ' 44' ' ' LEU . 29.4 m -138.26 146.92 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.084 -0.507 . . . . 63.32 111.171 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.51 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 19.9 mmt85 -123.96 106.32 10.32 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.873 0.368 . . . . 73.41 111.136 172.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.665 ' HB2' HG13 ' A' ' 64' ' ' VAL . 56.3 tptt -137.36 95.92 3.17 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.701 -0.227 . . . . 74.42 111.054 170.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 50.56 -75.84 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.46 0.704 . . . . 72.41 112.541 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 38' ' ' LYS . . . -114.6 -18.68 6.44 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 116.632 -0.258 . . . . 71.41 113.492 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 8.0 tp10 -72.3 117.55 14.09 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.457 -0.437 . . . . 75.54 110.837 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.758 HG13 HG23 ' A' ' 43' ' ' VAL . 5.9 tp -160.1 136.56 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 120.932 0.396 . . . . 72.31 112.034 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.758 HG23 HG13 ' A' ' 42' ' ' ILE . 88.4 t 65.7 105.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.401 0.68 . . . . 51.31 112.448 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.485 HD21 HG22 ' A' ' 36' ' ' VAL . 1.1 mm? -89.76 141.24 28.8 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.244 -0.435 . . . . 70.4 110.428 175.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.46 -36.04 15.65 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.387 0.514 . . . . 60.13 112.387 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -111.56 87.69 0.47 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.318 -0.467 . . . . 72.23 113.207 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.1 m -86.86 98.4 11.19 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.357 -0.496 . . . . 72.23 111.483 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -98.15 150.35 36.65 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.19 -0.459 . . . . 62.44 111.142 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -67.19 137.66 44.59 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.55 2.167 . . . . 71.35 113.844 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.7 m -62.95 124.14 20.32 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.264 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.46 -49.66 2.99 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.38 0.511 . . . . 64.44 112.38 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 59.9 36.85 21.81 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.257 0.551 . . . . 64.12 111.181 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -82.87 -63.65 1.32 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.901 -0.59 . . . . 75.54 110.878 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.46 -104.69 0.24 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.021 -0.609 . . . . 44.44 112.43 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.89 -86.09 0.17 Allowed 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.323 -0.516 . . . . 72.33 110.387 174.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 52.98 13.09 0.33 Allowed 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.529 0.937 . . . . 44.12 113.529 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -126.98 177.34 6.69 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 122.045 -0.41 . . . . 62.05 111.316 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.4 t0 65.94 65.88 0.51 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.897 0.856 . . . . 63.01 110.763 -172.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.0 75.01 0.29 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-N 114.908 -1.042 . . . . 52.14 111.252 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.0 p -75.53 35.76 0.12 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 112.986 0.736 . . . . 54.22 112.986 -173.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 68.95 -36.55 0.34 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.836 1.421 . . . . 72.43 114.836 174.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 60.9 35.43 19.22 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.651 0.66 . . . . 60.13 110.994 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.3 m80 68.03 20.27 9.12 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.851 -0.613 . . . . 61.44 112.452 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.665 HG13 ' HB2' ' A' ' 38' ' ' LYS . 90.9 t -81.86 132.79 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 122.292 -0.255 . . . . 73.41 110.603 172.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 39.8 mt-10 -75.25 68.94 2.04 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.357 0.599 . . . . 62.01 110.567 175.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -88.31 132.64 34.33 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.858 -0.61 . . . . 64.41 111.231 177.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.5 -133.65 3.53 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.197 -1.001 . . . . 45.2 113.979 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 70' ' ' ILE . 7.4 pt -111.2 141.48 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.028 0.442 . . . . 73.53 112.189 -175.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -45.99 -34.44 4.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.868 -0.605 . . . . 75.35 112.013 177.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 68' ' ' ILE . 50.7 mt -48.26 -62.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.309 0.576 . . . . 71.54 111.913 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.3 m -77.22 -31.11 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.022 -0.535 . . . . 74.14 112.211 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.589 HD12 HG23 ' A' ' 35' ' ' VAL . 68.8 mt -74.08 -38.61 63.85 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.835 0.35 . . . . 61.01 111.802 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -83.91 -26.18 29.57 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.801 0.334 . . . . 64.2 111.386 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -95.43 -1.12 51.57 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 120.837 0.351 . . . . 73.21 110.745 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.7 tptm 49.65 70.92 0.44 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.141 0.976 . . . . 75.25 112.955 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.1 mt -107.14 148.91 28.25 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.791 -0.641 . . . . 63.41 111.041 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 140' ' ' ILE . 14.1 p -91.08 142.34 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 120.971 0.415 . . . . 64.02 111.873 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -79.16 143.32 35.54 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.964 0.727 . . . . 63.43 112.964 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.45 ' C ' HD22 ' A' ' 80' ' ' ASN . 96.8 mmm -139.46 155.42 47.6 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.28 0.632 . . . . 75.4 110.939 177.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.45 HD22 ' C ' ' A' ' 79' ' ' MET . 0.9 OUTLIER -131.75 133.1 44.42 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.035 0.445 . . . . 72.25 112.145 -173.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.4 p -38.32 -46.76 1.14 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.924 1.453 . . . . 73.34 114.924 -173.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -55.68 -34.76 65.34 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.02 0.438 . . . . 62.04 111.824 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -91.68 -37.69 12.88 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.16 0.505 . . . . 64.11 111.19 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.404 ' OD1' ' HB3' ' A' ' 79' ' ' MET . 3.8 m-20 -72.26 -6.34 42.3 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.602 0.593 . . . . 74.54 112.602 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.473 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -39.6 -63.24 0.59 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 112.992 0.738 . . . . 42.33 112.992 -177.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.5 m -60.35 -35.3 75.34 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.15 0.5 . . . . 74.54 111.602 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.8 mtp -69.66 -56.48 7.13 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.064 -0.517 . . . . 71.4 112.288 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.473 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 4.2 p90 -68.63 -25.98 65.11 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.915 -0.49 . . . . 70.53 112.304 -175.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.42 ' HA ' HG22 ' A' ' 92' ' ' ILE . 18.4 ptmt -73.91 -32.93 63.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 119.883 -0.727 . . . . 70.32 110.993 176.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.58 74.61 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.465 0.65 . . . . 52.14 110.157 170.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -53.43 -55.92 21.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.131 -0.94 . . . . 74.33 111.174 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.42 HG22 ' HA ' ' A' ' 89' ' ' LYS . 10.4 tp -63.27 -34.45 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 111.744 0.276 . . . . 74.53 111.744 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -63.5 -55.65 22.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.831 0.348 . . . . 73.12 111.213 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -61.09 -42.17 98.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.731 0.3 . . . . 75.2 111.361 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.511 ' O ' HG22 ' A' ' 99' ' ' VAL . 41.0 t80 -52.31 -57.48 9.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.157 -0.474 . . . . 72.55 111.278 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.426 ' HA ' ' CE ' ' A' ' 96' ' ' MET . 3.2 mmt -55.3 -52.95 61.78 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.393 -0.367 . . . . 73.15 111.851 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -54.14 -50.51 66.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.834 0.349 . . . . 65.22 111.481 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -64.17 -56.79 12.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.243 -0.435 . . . . 75.44 111.94 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 95' ' ' PHE . 24.2 m -63.58 -40.09 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.37 0.507 . . . . 75.14 112.37 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.6 mm -69.92 -44.98 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 122.217 -0.302 . . . . 63.31 111.375 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.61 -42.34 98.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.98 0.419 . . . . 62.33 111.035 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -68.38 -49.57 59.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.11 -0.496 . . . . 70.42 111.641 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.4 ttm -66.48 -49.49 66.44 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.923 0.342 . . . . 75.54 111.923 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.35 -11.76 11.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.895 0.379 . . . . 72.1 111.819 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -68.59 -48.0 65.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.861 0.362 . . . . 62.1 111.059 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.51 -36.01 6.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.134 0.42 . . . . 72.01 112.134 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -84.74 19.35 2.07 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 120.961 0.41 . . . . 53.14 111.039 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -28.41 -30.97 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.448 1.647 . . . . 74.21 115.448 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -50.27 118.22 2.85 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.022 0.439 . . . . 62.45 111.586 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 96.1 mttt -56.95 -22.49 38.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.163 -0.471 . . . . 63.44 111.547 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.02 -31.05 44.54 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.039 0.447 . . . . 70.31 111.82 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -77.21 -62.22 1.73 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.195 0.521 . . . . 70.21 110.927 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.3 m -63.24 -24.29 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.739 0.644 . . . . 64.14 112.739 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 20.4 t70 -62.33 -47.94 82.02 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.004 0.43 . . . . 73.33 110.159 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 119' ' ' LYS . . . -59.8 -42.32 93.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.947 -0.569 . . . . 73.0 111.453 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -64.24 -55.17 23.42 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.7 0.285 . . . . 71.32 111.708 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -55.57 -42.33 74.56 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.366 0.603 . . . . 75.31 110.997 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 118' ' ' LYS . 28.0 ttmt -71.35 -30.08 65.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.627 -0.715 . . . . 73.51 110.954 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 37.9 tptt -64.25 -41.66 96.86 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.259 0.552 . . . . 71.34 109.929 173.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.516 HD13 HD21 ' A' ' 26' ' ' LEU . 31.8 mm -65.71 -42.0 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.618 -0.719 . . . . 70.51 110.835 173.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 125' ' ' VAL . 10.9 mm100 -55.84 -51.87 66.01 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.72 0.267 . . . . 70.03 111.72 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.21 -42.85 83.46 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.474 -0.869 . . . . 72.52 112.198 175.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -59.92 -55.54 32.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.94 0.496 . . . . 74.41 111.547 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.0 m -66.98 -42.13 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 112.529 0.566 . . . . 74.02 112.529 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 121' ' ' GLN . 69.1 t -57.73 -34.55 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.254 0.549 . . . . 73.05 111.212 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.5 t -75.94 -42.73 47.78 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.224 -0.444 . . . . 70.25 111.52 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.449 HD21 HD13 ' A' ' 155' ' ' ILE . 30.5 tp -75.0 -29.07 60.78 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.958 -0.565 . . . . 75.33 112.248 -173.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.17 2.75 51.44 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.64 0.607 . . . . 73.22 112.64 -176.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.514 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -60.3 94.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.196 0.522 . . . . 53.23 111.17 177.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -62.58 -16.85 58.41 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.16 0.8 . . . . 75.42 113.16 -170.365 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.56 ' N ' ' HD2' ' A' ' 130' ' ' LYS . 3.9 m-20 -67.35 -46.01 74.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.002 0.43 . . . . 72.34 111.557 -175.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.556 HH21 ' HE2' ' A' ' 158' ' ' TYR . 39.8 mtp180 -107.36 -48.53 3.43 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.371 0.605 . . . . 70.55 111.796 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.514 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 44.5 m-85 -67.92 -6.33 21.46 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.849 -0.614 . . . . 74.12 112.608 -172.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 38.4 ttpt -53.09 -26.0 14.84 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.099 0.476 . . . . 74.21 110.93 171.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -97.19 34.04 1.84 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.579 0.585 . . . . 44.32 112.579 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.412 HD11 ' HD2' ' A' ' 133' ' ' PHE . 70.6 mt -87.96 151.18 22.98 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.895 0.379 . . . . 73.01 110.87 175.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -108.79 134.62 51.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.673 -0.239 . . . . 64.41 111.453 -178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.576 ' HB3' HG13 ' A' ' 153' ' ' VAL . 66.7 m-85 -109.66 133.46 53.09 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.268 -0.27 . . . . 74.33 110.629 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -129.41 138.89 51.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.089 0.471 . . . . 73.05 111.017 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.48 ' O ' HG12 ' A' ' 77' ' ' VAL . 12.7 tt -141.33 158.85 22.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.367 -0.379 . . . . 73.31 111.139 -175.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.97 137.78 50.16 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.931 -0.652 . . . . 34.22 112.169 173.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -36.92 85.07 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.624 0.602 . . . . 63.21 112.624 -175.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 143' ' ' ARG . 24.6 mmt180 -63.45 -49.3 74.23 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.128 -0.357 . . . . 72.01 111.319 176.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.504 ' HB1' ' HA3' ' A' ' 151' ' ' GLY . . . -55.86 -50.34 70.86 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.022 0.439 . . . . 60.35 111.501 173.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.61 -30.93 65.74 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.12 0.415 . . . . 62.21 112.12 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -102.05 14.74 31.12 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.474 0.546 . . . . 74.13 112.474 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.7 -44.53 0.02 OUTLIER Glycine 0 CA--C 1.531 1.067 0 C-N-CA 119.996 -1.097 . . . . 35.33 114.976 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -111.76 108.93 18.53 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.873 0.694 . . . . 64.25 112.873 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -63.55 -24.59 67.87 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.762 0.315 . . . . 74.44 111.766 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -92.03 19.86 6.37 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.835 0.309 . . . . 71.43 111.835 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.504 ' HA3' ' HB1' ' A' ' 144' ' ' ALA . . . -68.33 163.11 49.06 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.048 -0.596 . . . . 51.33 113.133 178.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.418 ' NE2' HD22 ' A' ' 171' ' ' LEU . 40.6 tt0 -68.11 102.32 1.31 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.417 -0.461 . . . . 70.41 112.038 -177.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 138' ' ' PHE . 24.6 t -80.92 99.93 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.383 0.611 . . . . 72.52 110.332 168.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.678 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -73.8 129.79 38.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.676 -0.693 . . . . 71.33 110.635 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.449 HD13 HD21 ' A' ' 127' ' ' LEU . 57.6 mt -95.57 125.62 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.991 0.424 . . . . 64.54 111.429 -175.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 50.3 mm -100.04 106.7 19.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-O 121.039 0.447 . . . . 73.03 110.695 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.43 152.62 20.15 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.727 -1.124 . . . . 74.33 111.239 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.556 ' HE2' HH21 ' A' ' 132' ' ' ARG . 39.7 p90 -100.3 122.22 42.74 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.983 -0.448 . . . . 74.14 110.62 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.566 ' HE ' ' HB ' ' A' ' 168' ' ' THR . 0.1 OUTLIER -136.93 156.4 48.51 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.873 0.694 . . . . 74.32 112.873 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.46 127.61 32.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.18 -0.918 . . . . 73.25 112.575 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.5 t -129.36 99.93 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.968 -0.56 . . . . 72.11 110.969 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 57.23 25.11 10.65 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.321 0.489 . . . . 72.12 112.321 176.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.46 -23.36 26.77 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.314 -0.469 . . . . 52.14 113.465 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.2 p -101.58 149.3 24.25 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.409 -0.465 . . . . 74.21 111.666 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.27 121.34 34.54 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.324 0.583 . . . . 71.24 112.076 -176.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.77 126.93 26.83 Favored Pre-proline 0 C--O 1.24 0.584 0 O-C-N 121.654 -0.654 . . . . 65.2 111.256 174.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.99 114.53 3.02 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.264 1.976 . . . . 64.11 111.426 171.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.566 ' HB ' ' HE ' ' A' ' 159' ' ' ARG . 10.2 t -101.48 149.81 23.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.303 -0.408 . . . . 50.11 111.888 -176.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.678 HD11 ' HB1' ' A' ' 154' ' ' ALA . 53.0 tp -78.67 128.46 33.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.225 -0.443 . . . . 70.11 110.337 174.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 46.8 tpp -117.7 122.53 43.76 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.868 0.366 . . . . 73.52 111.021 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.418 HD22 ' NE2' ' A' ' 152' ' ' GLN . 98.1 mt -137.78 155.13 49.36 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.808 0.443 . . . . 73.23 109.875 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.505 HG11 ' CE1' ' A' ' 95' ' ' PHE . 40.6 t -99.87 134.82 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.744 -0.598 . . . . 73.02 112.112 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.573 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -60.74 -39.67 89.51 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.155 0.798 . . . . 61.45 113.155 -172.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -95.15 12.43 28.79 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.854 0.687 . . . . 51.52 112.854 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.4 -33.67 8.08 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.558 0.694 . . . . 42.24 109.985 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 6' ' ' ASP . 3.9 tt -128.01 117.59 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.043 -0.98 . . . . 73.44 110.424 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 5' ' ' LYS . 8.3 tp -94.25 129.41 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.585 0.707 . . . . 74.55 111.869 -175.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -92.9 123.58 36.26 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.524 -0.762 . . . . 72.41 110.336 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -124.9 143.37 50.89 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.283 0.563 . . . . 64.51 111.153 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -119.54 95.88 4.97 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.577 0.703 . . . . 64.35 111.816 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 40.0 t -117.72 91.04 3.47 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.9 -0.778 . . . . 75.33 108.9 170.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.447 ' N ' HD23 ' A' ' 182' ' ' LEU . 1.6 pt? -153.7 171.83 18.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.23 0.538 . . . . 72.42 112.106 -171.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.909 -0.567 . . . . 62.13 110.8 176.427 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.949 0.404 . . . . 71.51 111.95 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 178' ' ' GLU . 59.8 tp -134.28 131.9 38.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.659 -0.496 . . . . 63.5 109.659 172.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 54.3 mt -104.1 117.69 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 121.903 -0.498 . . . . 72.04 110.473 -177.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -111.05 142.73 42.81 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.859 0.838 . . . . 74.52 112.233 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -137.46 111.15 8.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.686 -1.143 . . . . 62.05 110.777 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.469 ' HB2' ' H ' ' A' ' 9' ' ' THR . 2.4 m-20 -87.13 174.39 8.66 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.279 0.561 . . . . 54.11 111.489 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.6 mt -68.42 -28.16 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.356 0.598 . . . . 73.24 110.474 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -97.26 -44.0 7.1 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.783 -0.644 . . . . 61.43 112.161 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.469 ' H ' ' HB2' ' A' ' 6' ' ' ASP . 37.8 p -81.07 15.62 1.81 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.319 0.859 . . . . 74.01 113.319 -172.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -54.68 -31.02 57.18 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.913 0.387 . . . . 72.21 111.692 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -71.68 -37.85 70.69 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.205 0.526 . . . . 75.2 111.129 174.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 10.0 tp10 -96.25 25.06 5.17 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.837 -0.619 . . . . 64.25 111.105 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.49 107.22 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.867 0.867 . . . . 62.4 112.089 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.9 t -122.16 175.29 6.45 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.704 0.631 . . . . 71.42 112.704 -166.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.7 p -150.33 130.94 13.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.937 -0.574 . . . . 64.33 111.535 -176.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -123.97 -162.76 1.09 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 120.825 0.345 . . . . 63.04 111.23 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.5 m -152.32 29.95 0.55 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.087 0.47 . . . . 51.12 110.826 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -108.27 146.11 32.91 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.167 -0.47 . . . . 74.43 111.036 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.52 159.14 54.76 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.246 1.964 . . . . 60.23 113.904 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.429 ' N ' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -142.05 128.9 20.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.327 0.584 . . . . 63.21 110.639 174.458 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.695 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 11.2 mmmm -98.91 97.96 9.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.259 -0.428 . . . . 74.0 111.925 -173.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 43.2 tp -75.13 91.21 2.57 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.643 -0.661 . . . . 54.12 111.37 -178.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.3 p -90.5 146.89 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 115.9 -0.591 . . . . 72.3 111.148 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 56.49 11.61 0.89 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 120.788 0.328 . . . . 72.45 111.76 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.477 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 7.9 m-20 52.92 30.68 9.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.164 0.507 . . . . 75.55 111.106 -175.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.462 HD11 HD11 ' A' ' 120' ' ' ILE . 30.0 tp -130.23 -43.5 1.17 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.723 -176.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.13 159.78 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.353 0.501 . . . . 44.35 112.353 -175.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 170' ' ' MET . 66.1 m-85 -103.27 129.97 50.39 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.945 -0.57 . . . . 74.5 111.464 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.695 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 15.3 tt0 -96.43 142.15 28.88 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.877 0.871 . . . . 72.52 110.627 175.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.639 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 63.3 t80 -147.33 130.66 16.59 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.74 0.305 . . . . 74.14 111.222 173.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -94.56 135.95 35.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.006 0.432 . . . . 75.12 111.176 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.749 ' HA3' HG13 ' A' ' 70' ' ' ILE . . . -123.02 147.68 16.72 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.203 -0.522 . . . . 72.02 113.192 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -91.22 136.59 32.99 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.607 -0.349 . . . . 62.25 110.724 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -65.25 106.87 1.43 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.119 0.485 . . . . 74.51 110.923 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.423 HG23 HD12 ' A' ' 72' ' ' LEU . 34.4 m -131.84 158.2 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.045 0.45 . . . . 73.1 111.136 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.686 HG12 ' HG3' ' A' ' 66' ' ' ARG . 12.2 m -137.27 137.44 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.772 0.32 . . . . 63.11 111.182 -178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.918 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 6.5 ttm180 -115.1 111.2 20.69 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.868 0.366 . . . . 53.01 111.863 176.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 40' ' ' GLY . 57.9 tptt -107.25 126.44 52.42 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.408 -0.96 . . . . 70.14 108.408 167.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -59.73 82.03 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.716 0.769 . . . . 71.05 111.453 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 38' ' ' LYS . . . 147.73 -28.25 1.46 Allowed Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.229 -0.896 . . . . 64.13 113.322 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -152.34 173.52 14.95 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.018 0.747 . . . . 41.24 113.018 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.9 mm -132.48 125.47 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 115.563 -0.744 . . . . 61.21 111.297 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 43' ' ' VAL . 13.1 p -135.54 47.88 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-O 122.242 1.02 . . . . 45.12 111.385 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.26 -11.09 56.59 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.694 -0.684 . . . . 71.24 112.796 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.94 4.01 43.37 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.159 0.504 . . . . 74.41 111.53 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.11 145.47 32.2 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.217 -0.516 . . . . 53.52 112.905 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 76.9 p -89.08 121.9 31.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 74.44 111.207 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -73.8 146.26 85.24 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.657 -0.247 . . . . 74.12 111.24 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.17 132.23 33.34 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.387 2.058 . . . . 72.25 112.833 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 m -67.2 132.28 47.46 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.475 -0.329 . . . . 62.0 111.444 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.41 154.87 43.02 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.415 0.626 . . . . 74.02 111.302 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.94 -22.22 39.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.558 -0.746 . . . . 74.44 111.655 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.418 ' HA ' ' OD1' ' A' ' 135' ' ' ASN . 10.8 pt-20 -143.21 -148.88 0.25 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.189 -0.46 . . . . 73.31 111.008 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.88 -140.93 0.1 OUTLIER Glycine 0 CA--C 1.532 1.114 0 N-CA-C 114.708 0.643 . . . . 40.12 114.708 -174.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.11 123.03 6.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.098 0.475 . . . . 75.43 111.193 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.0 -26.26 0.49 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.743 -0.662 . . . . 73.51 111.705 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -94.53 -174.75 3.41 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.751 0.31 . . . . 75.42 111.336 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 t70 72.18 -66.54 0.3 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.458 0.703 . . . . 64.21 112.338 172.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.64 21.61 31.94 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.311 -0.471 . . . . 33.32 113.969 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.6 p -117.33 -0.76 11.92 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.351 0.5 . . . . 72.33 112.351 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -74.55 -72.53 0.28 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.793 0.33 . . . . 73.33 111.0 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -95.45 156.9 16.13 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.065 0.459 . . . . 72.34 109.783 172.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -74.36 74.24 1.87 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.354 0.597 . . . . 74.04 111.398 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.4 t -93.8 117.02 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.941 -0.572 . . . . 55.31 110.011 175.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.918 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 32.5 tt0 -78.94 67.48 4.66 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.838 0.828 . . . . 64.41 109.851 -177.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.686 ' HG3' HG12 ' A' ' 36' ' ' VAL . 40.4 ttp180 -105.51 124.53 49.71 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.297 -0.865 . . . . 73.5 111.652 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.52 -132.28 2.74 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.032 -0.604 . . . . 61.53 113.064 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.624 HD12 HD12 ' A' ' 70' ' ' ILE . 22.1 pt -111.1 137.66 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 112.271 0.471 . . . . 64.25 112.271 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -39.54 -44.49 1.44 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.327 0.651 . . . . 74.2 112.55 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.749 HG13 ' HA3' ' A' ' 32' ' ' GLY . 67.0 mt -40.39 -53.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.773 0.657 . . . . 51.51 112.773 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.479 ' HA ' HD12 ' A' ' 76' ' ' LEU . 23.1 m -94.68 -33.91 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.406 0.521 . . . . 64.03 112.406 -173.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.423 HD12 HG23 ' A' ' 35' ' ' VAL . 62.1 mt -68.38 -49.75 57.9 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.024 0.44 . . . . 62.43 111.534 -176.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -62.67 -21.16 65.52 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 120.854 0.359 . . . . 74.33 111.553 -177.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -104.92 -0.28 27.17 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.822 0.305 . . . . 72.43 111.822 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.42 69.98 0.68 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.247 0.546 . . . . 73.34 112.273 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 91.4 mt -110.85 136.48 49.82 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.095 -0.502 . . . . 62.21 111.086 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.405 HG13 HG23 ' A' ' 140' ' ' ILE . 5.6 p -88.04 142.15 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.17 0.51 . . . . 64.41 111.437 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER -85.71 137.91 32.49 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.342 0.867 . . . . 74.22 113.342 -171.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 75.0 mtp -134.49 140.31 46.1 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.667 -0.697 . . . . 65.14 110.896 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -89.34 157.54 18.14 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.023 0.439 . . . . 75.11 111.937 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 136' ' ' LEU . 79.8 m -53.85 -45.03 70.8 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.919 0.711 . . . . 74.34 112.919 -175.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -60.39 -20.29 59.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.606 0.595 . . . . 53.53 112.606 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -99.42 -28.98 13.01 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.164 0.431 . . . . 51.13 112.164 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -76.41 -7.53 55.24 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.626 0.602 . . . . 72.43 112.626 -173.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.31 -43.21 10.55 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.078 0.77 . . . . 61.14 113.078 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.3 m -66.97 -39.58 87.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.732 0.301 . . . . 73.22 111.498 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.5 mmt -62.75 -44.44 96.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.401 -0.363 . . . . 70.51 110.657 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -51.91 -52.08 52.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.801 0.334 . . . . 62.32 111.578 173.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -58.84 -43.01 90.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.922 0.391 . . . . 72.13 111.656 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.34 -50.87 23.57 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.025 0.44 . . . . 65.51 111.881 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -58.83 -53.75 54.9 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.781 -0.645 . . . . 75.3 111.86 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.4 mm -64.11 -37.33 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 111.907 0.336 . . . . 72.32 111.907 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -57.36 -62.66 1.62 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.204 0.526 . . . . 75.14 111.028 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.67 -44.67 85.91 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.806 -0.634 . . . . 74.31 111.221 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.536 ' CZ ' HG11 ' A' ' 172' ' ' VAL . 66.1 t80 -61.07 -66.11 0.59 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.936 -0.574 . . . . 72.32 112.314 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 48.0 ttm -54.95 -45.2 74.86 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.174 0.435 . . . . 54.14 112.174 -172.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.31 -43.96 93.08 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.696 0.284 . . . . 74.03 111.643 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -71.19 -43.01 68.27 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.182 0.438 . . . . 65.53 112.182 -176.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.1 m -72.2 -39.05 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.23 0.456 . . . . 54.41 112.23 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.99 -45.97 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 122.152 -0.342 . . . . 75.3 110.26 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.9 -38.76 73.27 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.369 0.604 . . . . 73.51 110.647 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -60.59 -38.85 85.98 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.729 -0.669 . . . . 70.22 111.976 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.48 ' HG2' HG12 ' A' ' 113' ' ' VAL . 35.3 ttm -88.39 -48.85 7.33 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.228 0.455 . . . . 74.55 112.228 -173.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.548 ' HA ' HG11 ' A' ' 113' ' ' VAL . 11.5 pt-20 -62.2 -24.45 67.22 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.174 -0.329 . . . . 70.23 111.814 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -58.54 -54.61 45.14 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.003 0.371 . . . . 74.21 112.003 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -100.6 -37.04 8.94 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.837 0.68 . . . . 62.41 112.837 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -68.39 -50.49 52.64 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.862 -0.524 . . . . 60.44 110.51 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 45.67 19.87 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.676 1.361 . . . . 62.43 114.676 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -102.68 124.51 48.36 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.858 -0.526 . . . . 72.55 110.595 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -52.9 -58.11 8.03 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.626 0.602 . . . . 74.12 112.626 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.61 -11.9 13.49 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.686 0.625 . . . . 71.24 112.686 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -91.16 -63.09 1.31 Allowed 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.927 0.394 . . . . 74.04 111.0 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 104' ' ' GLU . 17.4 m -66.72 -33.74 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 112.631 0.604 . . . . 71.15 112.631 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.18 -31.3 71.62 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.998 0.428 . . . . 75.21 110.343 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.51 -46.01 60.86 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.26 -0.427 . . . . 60.1 111.171 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.455 ' CZ ' ' HG3' ' A' ' 174' ' ' GLU . 85.4 t80 -59.43 -48.0 83.32 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.189 0.519 . . . . 71.25 110.728 175.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -55.18 -39.07 69.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.913 -0.585 . . . . 73.14 110.774 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -65.42 -36.61 84.46 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.054 -0.521 . . . . 75.21 110.972 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -64.0 -52.45 59.52 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.216 -0.447 . . . . 65.13 111.61 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.462 HD11 HD11 ' A' ' 26' ' ' LEU . 42.1 mm -63.41 -42.44 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.853 0.359 . . . . 75.12 111.38 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -60.95 -48.26 82.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.824 0.345 . . . . 74.01 110.922 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.51 -38.22 95.44 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.157 -0.544 . . . . 54.22 112.564 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 50.7 t90 -60.73 -55.1 37.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.647 0.261 . . . . 74.42 111.215 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.2 m -66.17 -47.47 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 112.482 0.549 . . . . 71.31 112.482 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -59.52 -35.93 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 121.995 -0.441 . . . . 62.2 111.684 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.5 t -78.52 -41.46 32.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.913 0.387 . . . . 74.22 111.017 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 155' ' ' ILE . 52.1 tp -63.82 -38.24 90.36 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.104 -0.498 . . . . 74.04 112.02 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 84.3 mt -77.17 3.26 13.1 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.477 0.547 . . . . 65.15 112.477 -177.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.432 ' HB3' ' HD2' ' A' ' 133' ' ' PHE . . . -62.71 78.72 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.442 0.639 . . . . 55.5 111.716 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.665 ' H ' ' HD3' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -39.47 -39.15 0.65 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.35 1.241 . . . . 65.31 114.35 -178.143 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.96 -44.76 67.38 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.271 0.471 . . . . 75.41 112.271 -169.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.691 ' HD2' ' H ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -108.22 -36.33 6.31 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.267 -0.424 . . . . 71.31 111.652 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.432 ' HD2' ' HB3' ' A' ' 129' ' ' ALA . 86.7 m-85 -73.94 -5.79 43.39 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.241 0.46 . . . . 74.34 112.241 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -44.69 -26.52 0.39 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.1 0.476 . . . . 65.23 112.128 168.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 53' ' ' GLU . 27.3 m-80 -91.89 23.81 3.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.535 0.569 . . . . 71.32 112.535 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.463 ' HB2' ' SG ' ' A' ' 81' ' ' CYS . 66.9 mt -89.38 157.64 18.08 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.206 0.527 . . . . 73.21 111.204 176.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.4 120.83 36.15 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.001 -0.545 . . . . 73.44 110.653 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.402 ' HE2' ' HG ' ' A' ' 81' ' ' CYS . 59.3 m-85 -109.36 121.73 45.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.066 0.46 . . . . 75.43 110.752 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.52 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 56.9 m-85 -110.47 132.01 54.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.402 0.62 . . . . 74.04 111.895 -177.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 145' ' ' ALA . 6.1 tp -115.14 146.87 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.541 -0.754 . . . . 75.33 110.985 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.04 153.9 37.65 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.155 0.422 . . . . 52.22 114.155 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -46.94 -70.55 0.09 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.06 0.763 . . . . 62.45 113.06 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -68.8 -21.74 64.3 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.261 0.553 . . . . 60.2 111.196 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.693 ' HB1' ' HA2' ' A' ' 151' ' ' GLY . . . -66.52 -49.93 64.89 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.879 -0.6 . . . . 73.14 111.577 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.45 ' HB2' HG23 ' A' ' 140' ' ' ILE . . . -61.82 -17.95 58.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.183 -0.462 . . . . 40.34 111.865 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -82.22 11.05 5.76 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.16 -0.473 . . . . 72.22 111.711 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.1 54.61 7.87 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.219 -0.515 . . . . 64.23 113.181 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 150' ' ' ASN . . . -115.09 18.71 16.16 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.71 0.633 . . . . 61.45 112.71 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 69.17 -26.42 0.15 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.934 0.716 . . . . 75.01 112.934 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 148' ' ' ALA . 51.1 t30 -77.42 44.52 0.43 Allowed 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.568 0.699 . . . . 63.34 110.529 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.693 ' HA2' ' HB1' ' A' ' 144' ' ' ALA . . . -96.63 100.77 2.52 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.058 -0.519 . . . . 50.23 114.021 -175.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -119.88 126.8 51.83 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.725 0.298 . . . . 74.0 110.575 174.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 81.4 t -86.24 134.39 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.734 0.642 . . . . 72.02 112.734 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.04 122.27 42.07 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.816 -0.629 . . . . 74.21 109.719 170.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.494 HD13 HD21 ' A' ' 127' ' ' LEU . 47.5 mt -91.42 140.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.774 -0.37 . . . . 72.52 111.865 -171.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 168' ' ' THR . 43.3 mm -123.17 109.59 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.227 -0.442 . . . . 72.24 111.183 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 4.0 mp0 -90.86 149.33 21.98 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.261 0.553 . . . . 63.51 111.926 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -87.78 109.34 19.66 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.181 -0.463 . . . . 72.41 109.826 171.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 2.3 mmp_? -110.45 135.4 51.19 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.003 0.371 . . . . 74.51 112.003 -174.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -86.56 116.31 24.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.125 0.488 . . . . 54.33 111.39 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -108.14 90.61 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.294 -0.412 . . . . 62.35 110.778 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.1 t70 57.38 33.54 23.42 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.815 -0.63 . . . . 63.03 111.563 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 100.97 8.2 48.55 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.088 -0.577 . . . . 70.1 113.323 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 m -122.72 106.06 10.61 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 122.473 -0.428 . . . . 65.22 111.021 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -78.31 104.22 8.75 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.926 0.393 . . . . 73.55 111.567 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 35.2 m -118.57 144.15 34.78 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.817 0.342 . . . . 73.04 111.588 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 16.6 Cg_exo -70.42 146.3 55.74 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.974 2.449 . . . . 45.11 113.47 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 90.8 m -136.02 150.74 49.32 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.294 -0.412 . . . . 64.52 110.82 178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 58.9 tp -95.8 135.54 37.39 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.595 0.591 . . . . 72.41 112.595 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 36.0 ttp -127.41 130.15 48.81 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.303 0.573 . . . . 75.31 111.762 174.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 88.1 mt -139.61 141.7 37.11 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.61 -0.723 . . . . 64.32 110.895 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.536 HG11 ' CZ ' ' A' ' 95' ' ' PHE . 21.2 t -87.11 132.22 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.538 -0.726 . . . . 71.33 112.309 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -57.88 -39.72 78.53 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.586 0.587 . . . . 61.44 112.586 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 116' ' ' PHE . 23.5 mm-40 -75.54 -0.17 19.43 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 111.971 0.36 . . . . 43.4 111.971 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.72 -30.61 8.86 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.12 0.486 . . . . 74.4 110.481 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 172' ' ' VAL . 5.3 tt -127.45 109.19 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.295 -0.866 . . . . 65.23 111.178 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.4 mm -100.81 118.52 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.407 -0.36 . . . . 75.13 111.142 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.429 ' HB2' HD21 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -92.84 121.36 34.13 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.832 0.825 . . . . 74.3 111.259 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -94.61 111.03 22.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.74 0.781 . . . . 74.24 110.44 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -82.16 95.88 7.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.197 -0.911 . . . . 74.45 111.384 -177.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 42.5 t -102.51 88.05 3.16 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.159 0.504 . . . . 73.54 110.048 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.15 140.41 52.28 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.044 -0.526 . . . . 73.53 110.964 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 C--O 1.254 1.322 0 CA-C-O 118.684 -0.674 . . . . 75.13 111.664 178.897 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 120.543 0.211 . . . . 74.42 111.012 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 178' ' ' GLU . 59.1 tp -114.53 128.42 56.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.796 0.331 . . . . 75.44 110.866 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.523 HG12 ' HB3' ' A' ' 15' ' ' SER . 52.6 mt -105.24 127.38 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.641 -0.254 . . . . 70.11 110.703 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -118.16 149.0 41.8 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.2 0.524 . . . . 75.11 111.789 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 13' ' ' LEU . 17.0 ttpp -150.64 120.93 7.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.666 -0.697 . . . . 65.12 111.29 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.638 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.3 m-20 -71.83 174.05 7.43 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.778 0.323 . . . . 75.32 110.293 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.8 pt -86.51 -3.97 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.981 0.42 . . . . 63.14 111.433 172.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.444 ' HE1' ' HD2' ' A' ' 94' ' ' LYS . 73.7 m-85 -108.98 -27.61 9.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.11 0.411 . . . . 74.34 112.11 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.638 HG22 ' HB2' ' A' ' 6' ' ' ASP . 2.0 t -106.0 20.33 19.12 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.591 0.589 . . . . 72.44 112.591 -170.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -44.83 -19.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.218 1.192 . . . . 51.34 114.218 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -86.96 -33.26 19.72 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 122.026 -0.421 . . . . 63.12 111.733 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.75 25.49 2.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.81 0.444 . . . . 75.0 111.893 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 5' ' ' LYS . 56.6 tp -38.08 124.34 1.18 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.233 0.613 . . . . 74.42 112.249 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -137.87 174.35 10.67 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.243 0.461 . . . . 55.21 112.243 -175.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.523 ' HB3' HG12 ' A' ' 3' ' ' ILE . 78.5 p -141.39 135.52 30.49 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.635 0.606 . . . . 72.42 112.635 -175.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -129.75 -173.95 3.17 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.04 0.448 . . . . 72.12 111.652 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.5 p -103.89 -3.84 24.27 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.9 0.704 . . . . 73.43 112.9 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 79.9 m-85 -76.36 131.55 74.68 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 112.004 0.372 . . . . 72.12 112.004 -175.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 6.7 Cg_exo -74.0 172.69 15.41 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.113 2.542 . . . . 74.42 113.555 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.0 ptm -111.64 130.75 55.66 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.044 0.387 . . . . 74.31 112.044 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -120.73 98.21 5.91 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.876 -0.416 . . . . 72.15 109.876 172.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.424 HD21 ' HA ' ' A' ' 25' ' ' ASP . 52.8 tp -100.04 133.88 43.77 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.201 -0.454 . . . . 64.52 112.193 -172.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.55 134.7 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.234 0.54 . . . . 73.23 111.722 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 t70 55.73 15.21 1.51 Allowed 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.195 -0.911 . . . . 53.2 111.885 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.424 ' HA ' HD21 ' A' ' 22' ' ' LEU . 4.7 m-20 53.36 25.7 4.76 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.937 0.398 . . . . 72.53 111.867 -175.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 tp -114.26 -49.64 2.84 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.162 -0.472 . . . . 75.53 111.25 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 172' ' ' VAL . 16.9 m -137.42 157.77 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.923 0.392 . . . . 74.15 111.913 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -92.47 149.28 21.48 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.433 -0.348 . . . . 74.23 110.369 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 31.8 tt0 -125.78 124.48 41.09 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.202 0.314 . . . . 75.3 110.597 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 59.1 t80 -127.45 131.25 50.24 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.006 0.432 . . . . 74.32 110.818 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HG2' HG22 ' A' ' 168' ' ' THR . 36.5 mtmm -119.93 119.09 32.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.73 0.3 . . . . 72.42 110.971 -178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.13 -157.42 19.4 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.217 0.447 . . . . 71.31 114.217 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -112.47 159.04 19.15 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.922 0.391 . . . . 75.32 111.84 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -89.05 107.1 18.85 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.375 -0.375 . . . . 73.13 110.436 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 m -142.34 159.5 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.495 0.664 . . . . 70.14 112.361 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 66' ' ' ARG . 17.3 m -139.15 139.94 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.475 -0.784 . . . . 73.31 110.279 175.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.496 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 20.6 ttt180 -121.45 117.57 27.21 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.441 0.639 . . . . 73.21 111.223 173.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 85.9 tttt -131.86 152.53 50.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.803 -0.635 . . . . 71.43 110.617 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -42.92 -46.89 5.54 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.188 0.518 . . . . 65.44 111.774 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' H ' ' HG2' ' A' ' 38' ' ' LYS . . . -120.57 49.4 0.88 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-N 116.183 -0.462 . . . . 73.02 113.28 178.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.635 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 10.5 tp10 -177.24 138.81 0.25 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.445 0.298 . . . . 75.42 110.777 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.647 HG13 HG23 ' A' ' 43' ' ' VAL . 6.8 tp -163.85 131.17 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 121.066 0.46 . . . . 64.22 112.175 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.647 HG23 HG13 ' A' ' 42' ' ' ILE . 75.7 t 59.97 110.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.672 -0.694 . . . . 42.4 112.08 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.501 HD21 HG22 ' A' ' 36' ' ' VAL . 1.1 mm? -82.93 173.92 11.37 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.136 0.493 . . . . 71.51 111.533 -178.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.42 -63.73 0.3 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.107 -0.497 . . . . 42.54 110.857 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.33 -167.21 13.63 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.444 -0.408 . . . . 44.54 113.121 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.4 p -125.38 -169.9 2.08 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 122.579 -0.365 . . . . 55.3 111.307 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -93.43 154.59 41.29 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 120.699 0.285 . . . . 74.42 111.583 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.82 165.33 32.53 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.38 2.053 . . . . 54.42 112.743 176.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.8 t 61.57 30.2 18.59 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.38 0.61 . . . . 62.3 111.706 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.06 19.37 0.23 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.678 0.621 . . . . 70.24 112.678 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.02 -51.02 27.8 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 122.114 -0.366 . . . . 45.12 110.966 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -69.71 -36.88 76.29 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.987 0.423 . . . . 72.24 110.961 174.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.4 -36.68 2.21 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 116.167 -0.47 . . . . 23.13 114.028 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.79 86.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.974 0.731 . . . . 53.01 112.974 -175.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 42.6 tt0 -131.74 15.56 4.83 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.978 0.894 . . . . 51.33 109.218 171.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -83.0 103.85 12.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.273 -0.876 . . . . 72.51 113.127 -172.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -95.75 -5.28 42.36 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.067 0.46 . . . . 72.31 110.719 170.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.43 81.14 1.53 Allowed Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.143 -0.48 . . . . 50.44 112.879 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.5 m -78.58 73.64 5.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.981 0.42 . . . . 53.33 111.092 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -99.12 -74.87 0.58 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 110.061 -0.348 . . . . 65.41 110.061 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.604 ' HB2' HG23 ' A' ' 64' ' ' VAL . 43.8 mt-10 50.07 21.89 0.82 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.363 0.875 . . . . 73.34 113.363 176.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.5 m80 59.28 19.46 7.6 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.098 0.407 . . . . 71.12 112.098 -175.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.604 HG23 ' HB2' ' A' ' 62' ' ' GLU . 99.6 t -66.16 141.28 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 122.714 0.405 . . . . 64.23 111.841 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 1.6 mp0 -69.74 69.94 0.31 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.393 0.616 . . . . 63.31 109.558 169.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 36' ' ' VAL . 11.6 ptm180 -98.27 137.47 36.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.499 -0.773 . . . . 73.53 112.684 -176.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.58 -127.02 4.69 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.914 -0.66 . . . . 52.22 113.296 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 70' ' ' ILE . 23.2 pt -110.55 138.21 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.838 0.352 . . . . 64.54 111.817 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -46.33 -34.75 4.78 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.021 -0.536 . . . . 71.34 111.864 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 68' ' ' ILE . 57.1 mt -48.36 -58.73 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.315 0.579 . . . . 73.42 112.311 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.62 -31.26 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.021 -0.536 . . . . 64.04 112.191 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.2 mt -67.5 -41.36 84.63 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.004 0.43 . . . . 74.31 111.241 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -54.62 -38.25 66.59 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.846 -0.616 . . . . 63.3 111.701 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -107.72 19.51 20.03 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.535 -0.302 . . . . 75.44 111.156 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt 43.89 43.07 5.0 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.897 0.879 . . . . 75.12 113.273 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.1 mt -70.52 162.16 29.31 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.206 0.527 . . . . 64.14 112.135 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.13 141.17 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 116.38 -0.373 . . . . 72.13 110.98 176.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -81.06 119.06 23.06 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.003 0.43 . . . . 72.45 112.065 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 53.2 ttm -112.19 139.48 47.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.062 -0.517 . . . . 74.24 109.82 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.4 ' HB2' ' HD1' ' A' ' 82' ' ' TYR . 15.9 m120 -122.57 156.77 33.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.391 0.615 . . . . 73.21 112.117 -175.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 25.1 p -72.17 -3.18 21.89 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.612 0.967 . . . . 72.4 113.612 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.408 ' CG ' ' N ' ' A' ' 83' ' ' GLU . 11.0 p90 -54.96 -54.83 37.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.914 0.387 . . . . 54.02 111.707 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.408 ' N ' ' CG ' ' A' ' 82' ' ' TYR . 8.8 tp10 -104.17 -45.08 4.81 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.612 0.72 . . . . 71.15 110.583 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.16 18.08 0.09 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.456 -0.793 . . . . 72.52 113.029 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -54.28 -41.74 69.22 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.231 0.539 . . . . 53.21 110.956 173.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -70.13 -24.4 63.18 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.853 -0.612 . . . . 33.52 111.905 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -62.81 -62.48 1.69 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.65 -0.25 . . . . 63.24 110.784 -179.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.557 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 30.2 p90 -68.38 -23.08 64.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.722 -0.391 . . . . 75.12 111.312 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -54.39 -60.35 3.47 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.188 0.518 . . . . 74.43 111.034 171.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.23 -38.43 75.22 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.176 -0.466 . . . . 73.24 111.414 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.486 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . 55.7 t80 -57.13 -52.6 64.66 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.127 -0.488 . . . . 73.5 110.909 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.532 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 41.4 mm -65.81 -31.0 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.03 0.382 . . . . 62.13 112.03 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -59.43 -60.46 3.82 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.039 0.447 . . . . 73.33 111.202 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HD2' ' HE1' ' A' ' 8' ' ' PHE . 8.0 tmtm? -62.05 -41.52 98.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.14 0.495 . . . . 74.12 110.128 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.623 ' HZ ' HG11 ' A' ' 172' ' ' VAL . 21.7 t80 -52.87 -45.87 67.64 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.878 -0.601 . . . . 70.32 111.676 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 55.2 ttp -58.13 -50.14 74.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.304 0.573 . . . . 60.2 110.944 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -64.22 -35.53 81.11 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.114 -0.494 . . . . 70.31 111.786 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.92 -41.91 64.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.563 -0.289 . . . . 74.32 111.631 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.0 m -65.31 -39.6 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.957 -0.464 . . . . 74.35 111.144 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.04 -44.79 95.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.821 0.343 . . . . 63.04 110.398 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.97 -40.11 69.67 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.235 0.54 . . . . 75.21 111.011 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -66.31 -43.99 84.71 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.996 -0.547 . . . . 63.12 112.329 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 96.4 mmm -86.71 -53.69 4.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.772 0.656 . . . . 63.13 112.772 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -49.62 -40.2 38.35 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.739 0.415 . . . . 73.34 111.748 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -53.8 -43.1 69.06 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.225 0.454 . . . . 74.05 112.225 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -102.28 -3.01 27.91 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.466 0.543 . . . . 75.41 112.466 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 4.4 m-20 -101.03 -61.79 1.33 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.297 0.48 . . . . 73.21 112.297 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 107' ' ' ASN . 2.5 ptp180 72.49 -15.29 0.5 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.096 0.958 . . . . 71.45 112.543 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.481 ' O ' HG22 ' A' ' 113' ' ' VAL . 0.4 OUTLIER -71.71 84.5 0.9 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.317 0.58 . . . . 75.13 111.557 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -52.71 -18.82 2.01 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.85 -0.614 . . . . 72.31 112.54 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.42 -42.75 19.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.1 0.407 . . . . 45.55 112.1 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.458 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 37.2 t70 -81.21 -46.08 15.36 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 122.212 -0.305 . . . . 63.23 111.768 -174.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 109' ' ' ASP . 24.3 m -58.42 -27.36 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 122.052 -0.405 . . . . 65.3 111.177 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -70.78 -35.71 72.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.327 -0.397 . . . . 75.43 110.665 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.82 -46.7 74.35 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.341 -0.39 . . . . 55.0 110.868 176.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 82.5 t80 -62.84 -42.02 99.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.971 0.415 . . . . 73.02 110.384 174.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 117' ' ' LYS . 4.1 tmmm? -50.96 -46.95 61.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.27 -0.423 . . . . 61.44 110.064 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -63.46 -34.66 78.25 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.37 -0.377 . . . . 70.23 111.648 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 116' ' ' PHE . 71.8 mmtt -56.61 -60.73 3.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.991 0.425 . . . . 63.34 111.196 174.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.17 -32.21 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 116.102 -0.499 . . . . 62.51 111.607 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 125' ' ' VAL . 19.5 tm0? -64.57 -55.76 18.33 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.87 0.367 . . . . 71.2 110.859 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.27 -32.86 78.14 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.871 -0.681 . . . . 53.41 112.471 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 -62.49 -57.7 10.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.207 0.203 . . . . 73.31 111.188 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 30.6 m -63.66 -38.82 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.249 0.463 . . . . 61.33 112.249 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 121' ' ' GLN . 53.4 t -55.39 -44.01 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.173 0.511 . . . . 45.03 111.159 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.9 m -75.62 -35.97 60.37 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.098 0.475 . . . . 74.31 111.016 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 155' ' ' ILE . 41.3 tp -66.41 -28.91 68.99 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.831 -0.622 . . . . 54.53 111.83 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 74.5 mt -90.04 3.97 51.64 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.289 -0.414 . . . . 64.42 112.086 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.476 ' HB3' ' CD1' ' A' ' 133' ' ' PHE . . . -59.63 92.72 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.413 0.625 . . . . 62.34 111.057 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -66.87 -7.86 24.87 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.695 0.998 . . . . 72.43 113.695 -170.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -71.48 -46.38 60.01 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.812 -0.555 . . . . 73.31 111.024 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 44.0 mtm-85 -109.36 -50.38 3.0 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.123 0.487 . . . . 74.32 111.806 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.476 ' CD1' ' HB3' ' A' ' 129' ' ' ALA . 22.4 m-85 -68.07 -7.56 30.47 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.404 0.52 . . . . 64.23 112.404 -173.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.51 -14.12 38.16 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.072 0.463 . . . . 72.14 111.324 175.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -93.32 19.36 8.31 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.151 0.426 . . . . 73.41 112.151 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.412 HD11 ' HD2' ' A' ' 133' ' ' PHE . 76.7 mt -88.51 147.29 24.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.318 0.58 . . . . 73.13 111.796 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.4 119.04 38.36 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.055 -0.521 . . . . 71.1 111.28 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -95.04 106.32 18.31 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.883 0.373 . . . . 75.1 110.544 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -94.48 132.81 38.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.519 0.676 . . . . 73.42 112.185 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 tp -124.7 149.08 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.32 -0.855 . . . . 74.33 110.394 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.64 141.56 27.48 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.289 -0.481 . . . . 75.34 113.377 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -48.28 -57.13 6.41 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.055 0.542 . . . . 73.21 111.739 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.424 ' O ' ' HD3' ' A' ' 143' ' ' ARG . 4.0 tmt_? -77.81 -28.97 50.49 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.189 0.518 . . . . 71.42 110.999 177.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.42 78.14 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.139 0.422 . . . . 62.13 112.139 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.33 -40.03 77.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.015 0.436 . . . . 73.41 111.737 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -71.09 -27.36 63.55 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.005 -0.543 . . . . 74.43 111.048 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -78.54 -44.14 11.27 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.218 -0.515 . . . . 74.01 112.963 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 64.83 2.29 1.67 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.286 0.847 . . . . 53.14 113.286 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -133.05 13.02 4.29 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.92 -0.488 . . . . 75.3 111.83 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -151.07 85.01 1.33 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.96 0.41 . . . . 45.53 110.22 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 158.33 133.52 1.56 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.948 -0.644 . . . . 75.23 113.52 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.38 142.12 29.52 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.695 -0.483 . . . . 73.14 109.695 174.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 48.4 t -75.9 117.28 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.581 0.705 . . . . 71.53 111.911 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.82 98.95 8.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.746 -0.661 . . . . 54.53 110.659 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 57.1 mt -85.99 117.08 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 120.794 0.331 . . . . 63.42 111.519 -175.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 51.0 mm -99.58 115.9 41.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.434 -0.348 . . . . 74.12 111.5 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 32.1 tt0 -104.02 144.36 31.65 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.868 -0.606 . . . . 75.54 111.659 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -85.81 88.8 7.61 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.251 0.548 . . . . 74.31 110.233 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.526 ' NH2' HG22 ' A' ' 161' ' ' VAL . 16.0 ttp180 -100.29 154.89 18.11 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.466 0.651 . . . . 71.35 111.959 -174.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.98 142.23 28.0 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.743 -0.662 . . . . 72.33 111.389 176.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.526 HG22 ' NH2' ' A' ' 159' ' ' ARG . 72.1 t -129.22 89.31 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.92 0.39 . . . . 74.31 110.824 171.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 51.76 25.64 3.05 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.926 -0.579 . . . . 71.25 112.305 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 129.18 -37.84 2.13 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.368 -0.444 . . . . 41.23 113.493 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 78.4 p -88.88 119.41 29.36 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.564 -0.374 . . . . 75.03 111.737 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.66 114.31 15.26 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.095 -0.502 . . . . 53.12 111.117 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 161' ' ' VAL . 17.4 m -125.76 138.22 31.54 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 121.042 0.449 . . . . 64.45 112.085 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.495 ' HG2' HG21 ' A' ' 68' ' ' ILE . 15.8 Cg_exo -71.36 115.99 4.51 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.884 2.39 . . . . 54.11 112.62 173.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.472 HG22 ' HG2' ' A' ' 31' ' ' LYS . 69.8 p -96.1 138.89 33.07 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.152 0.501 . . . . 65.45 112.01 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 61.1 tp -89.11 117.3 28.0 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.086 -0.506 . . . . 62.45 111.525 176.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.555 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 61.7 mtt -101.32 124.38 46.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.791 0.329 . . . . 61.43 111.413 176.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.476 ' HB3' HD11 ' A' ' 176' ' ' ILE . 96.0 mt -133.87 122.14 22.75 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.528 -0.306 . . . . 74.03 110.903 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.623 HG11 ' HZ ' ' A' ' 95' ' ' PHE . 59.0 t -68.35 118.97 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.057 0.456 . . . . 51.32 111.899 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.47 -24.23 67.11 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.789 0.663 . . . . 73.32 112.789 -177.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.451 ' HB2' ' HZ ' ' A' ' 116' ' ' PHE . 5.5 tp10 -90.86 -3.08 57.64 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.966 -0.459 . . . . 73.1 111.06 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.583 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -97.03 -44.09 7.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.056 0.455 . . . . 70.11 110.219 175.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 171' ' ' LEU . 29.1 pt -116.79 109.4 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.877 -0.601 . . . . 70.03 110.611 172.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.5 tp -94.42 138.88 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.969 0.414 . . . . 75.11 110.808 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.633 ' HB2' HD11 ' A' ' 2' ' ' LEU . 1.8 pp20? -104.99 153.94 20.76 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.396 0.617 . . . . 71.44 112.394 -174.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 35.3 tt0 -140.09 99.77 3.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 74.11 109.406 172.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.564 ' HB3' HD13 ' A' ' 2' ' ' LEU . 19.3 pttm -102.27 132.52 48.17 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.313 0.857 . . . . 74.13 113.313 -170.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 48.6 t -125.21 88.9 2.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.358 -0.837 . . . . 74.43 109.63 168.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 180' ' ' LYS . 3.1 mm? -121.08 104.27 9.65 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.934 -0.576 . . . . 74.22 110.418 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 119.166 -0.445 . . . . 71.15 111.281 -177.593 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 121.041 0.448 . . . . 73.03 111.615 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 34.5 tp -109.53 135.0 51.23 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.571 -0.529 . . . . 72.35 109.571 174.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.0 tt -100.5 120.64 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.284 0.564 . . . . 72.12 111.668 -175.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 47.2 p90 -118.84 143.01 47.21 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.182 0.515 . . . . 72.23 111.416 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 5' ' ' LYS . 19.7 ptpt -140.29 121.88 15.22 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.646 -0.706 . . . . 75.13 110.771 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 9' ' ' THR . 3.6 m-20 -71.45 164.53 25.63 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.813 -0.555 . . . . 71.24 111.119 175.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.3 mt -55.81 -33.07 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.183 -0.462 . . . . 73.12 111.371 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 150' ' ' ASN . 9.1 p90 -109.45 -24.38 11.05 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.28 0.844 . . . . 72.15 113.28 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 152' ' ' GLN . 2.9 m -90.65 14.95 11.94 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.429 0.529 . . . . 63.41 112.429 -173.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.461 ' O ' HD22 ' A' ' 13' ' ' LEU . 8.5 p-10 -62.37 -10.76 12.3 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.619 0.97 . . . . 72.33 113.619 -173.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -86.48 -43.46 12.75 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.105 0.478 . . . . 43.41 111.324 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.75 ' HG3' ' HB2' ' A' ' 144' ' ' ALA . 18.1 mm-40 -96.16 22.9 7.07 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.297 -0.41 . . . . 62.12 111.537 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 2.0 pt? -57.89 165.04 1.92 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.186 0.517 . . . . 61.11 111.868 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 75.3 m -141.37 156.86 45.78 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.512 0.56 . . . . 64.2 112.512 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.6 p -127.24 110.22 12.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.856 -0.611 . . . . 71.31 111.333 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -161.67 176.36 11.05 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.74 -0.467 . . . . 73.14 109.74 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.3 m -123.88 79.86 1.76 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.932 -0.48 . . . . 74.23 111.772 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -98.37 125.73 42.15 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.155 -0.475 . . . . 54.1 111.093 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.03 117.64 4.84 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.613 2.209 . . . . 43.4 112.713 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.434 ' HA ' ' HB3' ' A' ' 30' ' ' PHE . 61.3 mtt -109.84 162.23 14.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.377 0.608 . . . . 54.33 112.412 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 62.4 mttm -127.44 103.06 7.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.901 -0.59 . . . . 64.22 110.219 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' A' ' 25' ' ' ASP . 54.0 tp -75.49 101.85 5.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.07 0.462 . . . . 75.13 111.635 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.34 133.86 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.092 0.472 . . . . 74.23 111.783 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t0 56.5 19.21 3.99 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.59 -0.732 . . . . 74.1 112.058 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.419 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 45.3 m-20 59.35 9.86 1.58 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.233 0.613 . . . . 55.41 112.561 -177.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.2 tp -106.21 -47.1 3.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.908 0.385 . . . . 71.33 111.881 -173.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 172' ' ' VAL . 3.2 m -134.71 150.19 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.678 0.622 . . . . 65.1 112.678 -176.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.557 ' HE2' HG21 ' A' ' 176' ' ' ILE . 64.2 m-85 -86.02 122.14 29.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.886 -0.597 . . . . 75.05 110.696 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 33.4 tt0 -114.09 108.48 17.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.604 0.362 . . . . 52.14 110.148 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.434 ' HB3' ' HA ' ' A' ' 20' ' ' MET . 15.1 p90 -143.62 121.0 11.63 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.784 1.031 . . . . 70.31 113.784 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 168' ' ' THR . 10.3 tmtt? -90.72 121.28 32.48 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.891 -1.049 . . . . 74.32 110.794 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.72 -120.95 1.12 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.107 -0.568 . . . . 71.23 113.093 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 69' ' ' ASP . 67.0 mttm -114.09 134.97 54.52 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.319 -0.519 . . . . 73.1 110.449 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -86.85 107.0 18.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.181 0.515 . . . . 73.14 109.62 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.484 ' HB ' HD11 ' A' ' 42' ' ' ILE . 28.8 m -137.81 145.37 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.981 0.419 . . . . 73.11 111.933 -173.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 43' ' ' VAL . 2.5 m -127.56 134.44 65.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.061 0.458 . . . . 71.23 110.919 176.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.797 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 26.3 mmm180 -105.7 110.54 22.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.93 0.395 . . . . 74.14 111.372 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -105.51 154.08 20.86 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.036 -0.529 . . . . 74.31 110.472 173.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -60.87 84.73 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.48 0.657 . . . . 51.34 110.957 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.24 -39.28 1.06 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.26 -0.882 . . . . 73.54 113.463 178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -171.23 158.92 5.62 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 117.281 0.541 . . . . 71.3 111.964 -174.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.484 HD11 ' HB ' ' A' ' 35' ' ' VAL . 12.5 tt -90.51 116.66 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-O 121.174 0.512 . . . . 71.41 111.683 177.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 36' ' ' VAL . 34.2 t -108.39 74.72 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.781 0.801 . . . . 53.31 111.359 -178.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 35' ' ' VAL . 1.8 pp -85.86 18.01 3.16 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.34 0.867 . . . . 75.05 113.34 -174.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.85 136.56 47.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.042 0.449 . . . . 71.44 111.514 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.57 -132.09 3.27 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.508 -0.377 . . . . 45.13 112.913 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.4 t -169.51 168.24 9.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.347 0.259 . . . . 73.22 111.096 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -118.92 91.79 43.71 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-O 120.679 0.276 . . . . 74.33 111.033 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -97.01 147.41 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.196 2.597 . . . . 55.42 113.982 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.1 p -77.11 95.76 4.31 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.992 0.425 . . . . 73.32 110.563 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.21 34.68 3.29 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.967 0.413 . . . . 70.45 112.094 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -76.34 78.25 3.1 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.149 0.5 . . . . 64.51 111.444 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -177.86 -64.71 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.923 -0.581 . . . . 55.23 111.181 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.62 92.68 0.14 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.152 -0.547 . . . . 60.41 113.077 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.67 27.16 0.23 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.29 0.567 . . . . 64.03 111.248 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -94.86 -24.9 16.82 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.764 -0.653 . . . . 75.31 112.35 -174.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.59 -145.22 0.07 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 120.443 0.163 . . . . 65.42 111.373 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 66.82 16.66 10.42 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.157 0.429 . . . . 74.22 112.157 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.59 74.01 1.13 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.187 -0.53 . . . . 75.22 113.293 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.1 m -105.7 4.51 30.14 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.65 -0.323 . . . . 74.12 111.638 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.49 -66.55 0.52 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 111.808 0.299 . . . . 72.11 111.808 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 59.99 -77.13 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.045 0.538 . . . . 73.52 112.419 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -81.4 54.64 2.37 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.666 0.746 . . . . 62.1 111.609 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.4 t -140.25 122.31 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.586 -0.734 . . . . 43.11 109.783 175.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.797 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 2.5 mp0 -76.31 66.89 2.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.218 0.532 . . . . 72.2 111.141 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.45 HH11 ' HD2' ' A' ' 66' ' ' ARG . 9.5 ptm180 -93.24 116.9 29.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.898 -0.592 . . . . 71.23 111.909 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.6 -140.46 5.2 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.547 -0.835 . . . . 72.43 113.812 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.1 pt -110.94 143.61 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 112.354 0.502 . . . . 72.21 112.354 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . 27.3 t70 -45.16 -43.46 9.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.913 -0.585 . . . . 74.24 112.433 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 58.5 mt -49.51 -60.88 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.242 0.46 . . . . 74.14 112.242 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.494 ' HA ' HD12 ' A' ' 76' ' ' LEU . 21.1 m -73.89 -33.11 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.097 0.406 . . . . 52.32 112.097 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.411 HD12 HG23 ' A' ' 35' ' ' VAL . 87.5 mt -74.3 -28.22 61.08 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.014 0.376 . . . . 71.22 112.014 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -83.37 -40.74 19.03 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.661 0.267 . . . . 51.04 111.424 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -86.68 -9.76 55.27 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.076 0.399 . . . . 74.54 112.076 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 67.4 71.13 0.36 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.355 0.598 . . . . 62.11 111.993 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 71' ' ' VAL . 67.6 mt -106.71 135.97 47.33 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.897 -0.592 . . . . 52.13 110.513 176.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.17 140.06 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.218 0.532 . . . . 73.22 112.379 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.23 143.51 57.73 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.396 0.888 . . . . 74.33 113.396 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.616 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 84.7 mtp -134.92 153.67 51.98 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.008 -0.542 . . . . 71.41 110.669 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.457 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 25.1 t-20 -148.06 156.47 42.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.63 0.253 . . . . 65.0 111.06 -177.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 40.9 t -37.32 -48.95 0.94 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.55 1.315 . . . . 72.44 114.55 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CE1' ' HB3' ' A' ' 80' ' ' ASN . 12.2 p90 -59.75 -36.73 77.22 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.143 0.423 . . . . 75.34 112.143 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -81.85 -37.41 27.02 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.867 0.365 . . . . 63.32 111.395 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 2.7 m-20 -66.76 -22.58 66.04 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.689 0.626 . . . . 52.32 112.689 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.434 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . . . -42.4 -64.88 0.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.021 0.439 . . . . 65.22 111.98 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.3 t -64.6 -33.17 75.29 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.887 0.375 . . . . 75.52 111.625 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.467 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 25.4 mmt -64.15 -65.24 0.7 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.278 -0.419 . . . . 75.11 112.034 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.434 ' CE2' ' HA ' ' A' ' 85' ' ' ALA . 10.5 p90 -61.66 -28.7 69.58 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.715 -0.394 . . . . 74.32 111.311 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -55.01 -61.64 2.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.724 -0.39 . . . . 75.15 110.799 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.14 82.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.285 -0.416 . . . . 61.13 111.841 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -60.47 -59.71 4.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.22 0.452 . . . . 65.22 112.22 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.3 mm -54.9 -39.77 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.166 0.432 . . . . 74.44 112.166 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -59.54 -57.29 13.62 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.04 0.385 . . . . 73.45 112.04 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.88 -51.8 60.0 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.803 0.335 . . . . 75.41 111.149 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CZ ' HG11 ' A' ' 172' ' ' VAL . 29.3 t80 -46.43 -48.94 18.73 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.095 0.558 . . . . 65.04 112.118 176.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 37.5 ttp -62.09 -34.7 76.8 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.996 0.427 . . . . 74.22 111.377 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.4 -49.71 68.22 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.466 -0.333 . . . . 71.42 110.901 174.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -59.85 -46.32 89.67 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.31 0.485 . . . . 72.05 112.31 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.5 -39.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 112.071 0.397 . . . . 71.12 112.071 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.464 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 15.0 mm -70.27 -49.2 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 122.271 -0.268 . . . . 60.31 111.355 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.6 -41.17 69.62 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.423 0.63 . . . . 73.01 110.5 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -55.29 -57.11 13.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.615 -0.721 . . . . 75.13 110.995 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.567 ' HG3' HG12 ' A' ' 113' ' ' VAL . 12.6 tpt -62.59 -44.76 95.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.476 0.546 . . . . 64.21 112.476 -173.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 11.2 pt-20 -72.46 -38.69 68.17 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.942 -0.474 . . . . 72.3 112.161 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -68.86 -17.97 64.08 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.439 0.533 . . . . 71.42 112.439 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -113.19 -17.0 12.46 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.001 -0.437 . . . . 61.25 112.008 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -128.63 -73.28 0.59 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.627 0.232 . . . . 74.42 111.627 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 28.5 ttt85 75.24 -18.73 0.43 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.999 1.111 . . . . 73.52 113.999 176.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.496 ' O ' HG22 ' A' ' 113' ' ' VAL . 70.9 m-20 -57.91 121.39 10.42 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.743 -0.598 . . . . 64.12 111.782 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -44.58 -49.49 10.12 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.982 -0.554 . . . . 75.4 112.356 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.47 68.43 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.698 0.629 . . . . 61.33 112.698 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -92.7 -39.61 11.18 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 111.951 0.352 . . . . 74.34 111.951 -175.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.567 HG12 ' HG3' ' A' ' 103' ' ' MET . 16.3 m -68.89 -37.11 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.857 -0.527 . . . . 75.53 112.062 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.25 -35.98 74.16 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.963 0.411 . . . . 71.5 110.483 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.97 78.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.125 0.488 . . . . 51.43 111.007 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.17 -48.83 80.07 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.953 -0.567 . . . . 75.13 111.118 174.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -55.6 -38.25 69.18 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.922 -0.581 . . . . 75.5 111.062 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.28 -40.61 96.31 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.473 -0.33 . . . . 72.42 111.509 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -58.8 -57.26 13.81 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.331 -0.395 . . . . 72.42 111.394 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.0 tp -66.55 -35.33 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.34 -0.391 . . . . 61.32 111.384 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -62.31 -45.27 93.99 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.995 0.426 . . . . 73.23 110.609 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.67 -37.52 94.38 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.061 -0.59 . . . . 53.41 112.414 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 49.5 t90 -62.97 -50.25 71.52 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.866 -0.196 . . . . 74.45 111.51 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.5 m -68.59 -41.12 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.665 0.617 . . . . 72.4 112.665 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.95 -29.77 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.778 -0.576 . . . . 70.34 111.621 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.4 t -77.84 -51.29 10.7 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.054 0.454 . . . . 75.11 110.77 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.6 tp -57.94 -46.34 85.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.002 -0.545 . . . . 63.34 112.302 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.62 2.81 21.07 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.434 0.531 . . . . 62.33 112.434 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.09 80.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.377 0.608 . . . . 74.12 111.1 176.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -58.42 -14.62 8.12 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.875 0.694 . . . . 73.53 112.875 -173.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.27 -49.92 75.98 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.784 0.326 . . . . 61.51 111.369 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -112.41 -36.23 5.33 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.254 0.464 . . . . 63.1 112.254 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -67.64 -6.86 22.42 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.832 0.678 . . . . 73.3 112.832 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 14.9 ptmm? -55.31 -17.13 4.17 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.257 0.465 . . . . 73.44 112.257 176.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -90.41 20.96 4.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.448 0.536 . . . . 51.52 112.448 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.44 158.4 17.74 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.1 0.476 . . . . 74.31 111.634 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.81 51.81 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.152 -0.476 . . . . 74.35 110.62 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.616 ' HB2' ' HB2' ' A' ' 79' ' ' MET . 36.1 m-85 -112.18 157.24 21.11 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.218 -0.301 . . . . 71.34 110.888 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -137.53 147.21 44.98 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.806 0.336 . . . . 62.33 111.827 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.513 HD11 ' HA3' ' A' ' 151' ' ' GLY . 14.6 tt -138.67 160.01 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 116.421 -0.354 . . . . 65.21 110.813 177.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.05 156.81 28.37 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.278 -0.487 . . . . 64.32 113.848 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -59.13 -60.33 4.04 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.959 0.409 . . . . 72.12 111.006 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.521 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 4.0 mmp_? -73.69 -32.63 64.04 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.957 0.408 . . . . 62.01 111.104 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.75 ' HB2' ' HG3' ' A' ' 12' ' ' GLU . . . -53.06 -38.67 62.68 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.12 -0.491 . . . . 70.35 112.08 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.29 -39.42 63.95 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.286 0.476 . . . . 74.21 112.286 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -96.43 -17.05 20.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.846 0.355 . . . . 54.24 111.691 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.6 -48.44 13.21 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.216 -0.516 . . . . 71.43 113.172 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 72.26 -46.04 0.63 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.915 0.709 . . . . 62.52 112.915 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -78.54 0.37 26.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.079 0.4 . . . . 70.52 112.079 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 23.0 p-10 -142.45 28.25 1.66 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 111.842 0.312 . . . . 52.43 111.842 -176.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.513 ' HA3' HD11 ' A' ' 140' ' ' ILE . . . -115.36 142.5 17.64 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 120.898 -0.668 . . . . 71.15 113.975 -175.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.43 ' HB3' ' OG1' ' A' ' 9' ' ' THR . 3.7 pt20 -120.24 140.64 50.88 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.728 0.299 . . . . 73.12 110.795 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.612 HG13 ' HB3' ' A' ' 138' ' ' PHE . 39.2 t -86.86 102.78 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 121.363 0.601 . . . . 52.25 111.211 174.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.579 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -78.67 112.25 15.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.993 -0.549 . . . . 73.42 110.337 174.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.705 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 59.8 mt -89.16 119.01 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.15 0.426 . . . . 74.22 112.15 -172.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.9 mm -104.61 117.3 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.801 0.334 . . . . 72.41 111.282 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -107.31 126.73 52.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.006 0.432 . . . . 71.34 111.358 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -84.71 89.07 7.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.205 0.526 . . . . 74.23 109.646 172.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -90.91 149.01 22.08 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.991 -0.55 . . . . 72.11 111.514 -173.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -98.63 121.75 40.97 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.309 -0.405 . . . . 74.44 111.755 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.411 HG23 HG21 ' A' ' 166' ' ' VAL . 99.0 t -110.67 98.55 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 110.046 -0.353 . . . . 72.13 110.046 170.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 57.12 21.3 6.32 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.987 0.423 . . . . 75.22 111.588 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.98 24.5 27.16 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.257 -0.496 . . . . 71.44 112.697 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 m -112.19 141.06 46.35 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.704 0.288 . . . . 65.12 110.973 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -73.34 109.38 6.82 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.478 0.548 . . . . 74.04 112.478 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 166' ' ' VAL . 24.3 m -128.58 96.51 29.98 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 121.254 0.55 . . . . 73.34 111.799 171.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.79 114.11 3.14 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.472 2.115 . . . . 74.11 112.055 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 5.2 t -107.69 161.06 15.22 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.506 0.558 . . . . 74.33 112.506 -176.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.579 HD11 ' HB1' ' A' ' 154' ' ' ALA . 22.5 tp -111.13 131.75 54.85 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.827 0.346 . . . . 64.43 111.035 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.705 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 46.9 ttm -110.96 125.67 53.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.108 -0.496 . . . . 72.54 111.252 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.86 150.39 50.45 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.623 -0.717 . . . . 74.23 109.996 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 27' ' ' VAL . 47.7 t -89.74 120.73 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.946 -0.471 . . . . 73.22 112.27 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.412 ' HA ' HG22 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -59.49 -46.9 87.47 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.049 -0.523 . . . . 74.3 110.632 179.297 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -63.37 -20.43 65.52 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.003 -0.544 . . . . 61.02 112.307 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.432 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . . . -101.78 -19.71 15.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.315 0.487 . . . . 71.3 112.315 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.557 HG21 ' HE2' ' A' ' 28' ' ' TYR . 9.0 tp -96.01 121.4 46.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.417 0.627 . . . . 63.44 111.866 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.4 mm -99.05 112.14 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.957 0.408 . . . . 74.23 110.927 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.15 134.61 34.98 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.847 0.356 . . . . 62.23 111.466 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -129.99 144.01 51.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.497 0.665 . . . . 71.2 111.258 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -131.31 103.74 6.63 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.499 -0.773 . . . . 72.51 112.093 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 43.0 t -133.26 89.84 2.66 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.06 0.457 . . . . 74.14 110.736 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 182' ' ' LEU . 5.2 mp -112.92 96.18 5.81 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.111 0.481 . . . . 52.53 111.388 -174.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 . . . . . 0 C--O 1.253 1.283 0 CA-C-O 118.952 -0.547 . . . . 62.43 111.403 -176.492 . . . . . . . . 0 0 . 1 stop_ save_